PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gao, Y; Nanan, R; Macia, L; Tan, J; Sominsky, L; Quinn, TP; O'Hely, M; Ponsonby, AL; Tang, MLK; Collier, F; Strickland, DH; Dhar, P; Brix, S; Phipps, S; Sly, PD; Ranganathan, S; Stokholm, J; Kristiansen, K; Gray, LEK; Vuillermin, P				Gao, Yuan; Nanan, Ralph; Macia, Laurence; Tan, Jian; Sominsky, Luba; Quinn, Thomas P.; O'Hely, Martin; Ponsonby, Anne-Louise; Tang, Mimi L. K.; Collier, Fiona; Strickland, Deborah H.; Dhar, Poshmaal; Brix, Susanne; Phipps, Simon; Sly, Peter D.; Ranganathan, Sarath; Stokholm, Jakob; Kristiansen, Karsten; Gray, Lawrence E. K.; Vuillermin, Peter			The maternal gut microbiome during pregnancy and offspring allergy and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Gut microbiome; fetal immunity; allergy; asthma	CHAIN FATTY-ACIDS; ATOPIC-DERMATITIS; CHILDHOOD ASTHMA; FARM EXPOSURE; ANTIBIOTIC-TREATMENT; COMMENSAL BACTERIA; PRIMARY PREVENTION; MILK CONSUMPTION; INNATE IMMUNITY; CORD BLOOD	Environmental exposures during pregnancy that alter both the maternal gut microbiome and the infant's risk of allergic disease and asthma include a traditional farm environment and consumption of unpasteurized cow's milk, antibiotic use, dietary fiber, and psychosocial stress. Multiple mechanisms acting in concert may underpin these associations and prime the infant to acquire immune competence and homeostasis following exposure to the extrauterine environment. Cellular and metabolic products of the maternal gut microbiome can promote the expression of microbial pattern recognition receptors, as well as thymic and bone marrow hematopoiesis relevant to regulatory immunity. At birth, transmission of maternally derived bacteria likely leverages this in utero programming to accelerate postnatal transition from a T(H)2- to T(H)1- and T(H)17-dominant immune phenotype and maturation of regulatory immune mechanisms, which in turn reduce the child's risk of allergic disease and asthma. Although our understanding of these phenomena is rapidly evolving, the field is relatively nascent, and we are yet to translate existing knowledge into interventions that substantially reduce disease risk in humans. Here, we review evidence that the maternal gut microbiome impacts the offspring's risk of allergic disease and asthma, discuss challenges and future directions for the field, and propose the hypothesis that maternal carriage of Prevotella copri during pregnancy decreases the offspring's risk of allergic disease via production of succinate, which in turn promotes bone marrow myelopoiesis of dendritic cell precursors in the fetus.	[Gao, Yuan; Sominsky, Luba; O'Hely, Martin; Collier, Fiona; Dhar, Poshmaal; Gray, Lawrence E. K.; Vuillermin, Peter] Deakin Univ, Inst Phys & Mental Hlth & Clin Transformat, Geelong, Vic, Australia; [Gao, Yuan; Sominsky, Luba; Gray, Lawrence E. K.; Vuillermin, Peter] Barwon Hlth, Child Hlth Res Unit, Geelong, Vic, Australia; [Gao, Yuan] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nanan, Ralph; Macia, Laurence; Tan, Jian] Charles Perkins Ctr, Camperdown, NSW, Australia; [Macia, Laurence; Tan, Jian] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Sydney, NSW, Australia; [Quinn, Thomas P.] Deakin Univ, Appl Art Intelligence Inst, Geelong, Vic, Australia; [O'Hely, Martin; Ponsonby, Anne-Louise; Tang, Mimi L. K.; Ranganathan, Sarath] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Ponsonby, Anne-Louise] Florey Inst, Parkville, Vic, Australia; [Ponsonby, Anne-Louise; Tang, Mimi L. K.; Ranganathan, Sarath] Univ Melbourne, Melbourne, Vic, Australia; [Tang, Mimi L. K.; Ranganathan, Sarath] Royal Childrens Hosp, Melbourne, Vic, Australia; [Strickland, Deborah H.] Telethon Inst, Perth, WA, Australia; [Strickland, Deborah H.] Univ Western Australia, Nedlands, WA, Australia; [Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & BioMed, Lyngby, Denmark; [Phipps, Simon] QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Phipps, Simon] Univ Queensland, Sch BioMed Sci, Fac Med, St Lucia, Qld, Australia; [Phipps, Simon; Sly, Peter D.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Sly, Peter D.] Univ Queensland, Child Hlth Res Ctr, Childrens Hlth & Environm Program, St Lucia, Qld, Australia; [Stokholm, Jakob] Univ Copenhagen, Herlev & Gentofte Hosp, COPSAC, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark; [Stokholm, Jakob] Slagelse Hosp, Dept Pediat, Slagelse, Denmark; [Kristiansen, Karsten] BGI Shenzhen, Shenzhen, Peoples R China; [Kristiansen, Karsten] China Natl Genebank, Shenzhen, Peoples R China; [Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Lab Genom & Mol Biomed, Copenhagen, Denmark; [Vuillermin, Peter] Murdoch Childrens Res Inst, Ctr Food Allergy Res, Parkville, Vic, Australia	Deakin University; University of Copenhagen; University of Sydney; University of Sydney; Deakin University; Murdoch Children's Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Children's Hospital Melbourne; Telethon Kids Institute; University of Western Australia; Technical University of Denmark; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland; University of Copenhagen; Beijing Genomics Institute (BGI); University of Copenhagen; Murdoch Children's Research Institute	Gray, LEK (corresponding author), Barwon Hlth, Inst Mental & Phys Hlth & Clin Translat IMPACT, Geelong, Vic 3220, Australia.	Lawrence.gray@barwonhealth.org.au; peter.vuillermin@deakin.edu.au	Strickland, Deborah/AGV-6937-2022; Kristiansen, Karsten/J-5148-2014; Phipps, Simon/F-9170-2010; Pedersen, Susanne Brix/B-3484-2009; Macia, laurence/D-5983-2016	Strickland, Deborah/0000-0003-0114-4201; Kristiansen, Karsten/0000-0002-6024-0917; Phipps, Simon/0000-0002-7388-3612; Pedersen, Susanne Brix/0000-0001-8951-6705; Macia, laurence/0000-0003-0835-851X; Tang, Mimi/0000-0002-3839-5293; Sominsky, Luba/0000-0002-0674-8824; Stokholm, Jakob/0000-0003-4989-9769	National Health and Medical Research Council of Australia [1082307, 1147980, 1134812, 1166319]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by National Health and Medical Research Council of Australia grants 1082307; 1147980; 1134812; 1166319.	Abbring S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073417; Alhasan MM, 2020, ALLERGY, V75, P1979, DOI 10.1111/all.14234; Andersson NW, 2016, ALLERGY, V71, P15, DOI 10.1111/all.12762; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Barrett HL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070890; Bertelsen RJ, 2014, J ALLERGY CLIN IMMUN, V133, P165, DOI 10.1016/j.jaci.2013.07.032; Boddy AM, 2015, BIOESSAYS, V37, P1106, DOI 10.1002/bies.201500059; Bodein A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00963; Bordon Y, 2019, NAT REV IMMUNOL, V19, P537, DOI 10.1038/s41577-019-0207-7; Boyle RJ, 2011, ALLERGY, V66, P509, DOI 10.1111/j.1398-9995.2010.02507.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brick T, 2016, J ALLERGY CLIN IMMUN, V137, P1699, DOI 10.1016/j.jaci.2015.10.042; Burlingham WJ, 1998, NEW ENGL J MED, V339, P1657, DOI 10.1056/NEJM199812033392302; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Carr LE, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.604080; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Collier F, 2019, ALLERGY, V74, P1760, DOI 10.1111/all.13822; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; D'Argenio Valeria, 2018, High Throughput, V7, DOI 10.3390/ht7040038; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979; Depner M, 2020, NAT MED, V26, P1766, DOI 10.1038/s41591-020-1095-x; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dogra S, 2015, MBIO, V6, DOI 10.1128/mBio.02419-14; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dong GH, 2008, J INVEST ALLERG CLIN, V18, P207; Douwes J, 2008, EUR RESPIR J, V32, P603, DOI 10.1183/09031936.00033707; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Flanigan C, 2018, CLIN EXP ALLERGY, V48, P403, DOI 10.1111/cea.13091; Foster JA, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv114; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gao X, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1623-3; Genuneit J, 2011, PAEDIATR PERINAT EP, V25, P436, DOI 10.1111/j.1365-3016.2011.01223.x; Girard C., 2017, mSphere, V2, P00297; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gomez-Arango LF, 2018, GUT MICROBES, V9, P189, DOI 10.1080/19490976.2017.1406584; Gonzalez-Perez G, 2016, J IMMUNOL, V196, P3768, DOI 10.4049/jimmunol.1502322; Gray LEK, 2020, ALLERGY, V75, P1404, DOI 10.1111/all.14159; Hansen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133320; Hechler C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40434-8; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Holder B, 2016, TRAFFIC, V17, P168, DOI 10.1111/tra.12352; Hu MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10703-1; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jasarevic E, 2019, FRONT NEUROENDOCRIN, V55, DOI 10.1016/j.yfrne.2019.100797; Jasarevic E, 2015, NEUROBIOL STRESS, V1, P81, DOI 10.1016/j.ynstr.2014.10.005; Jha AR, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005396; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kanellopoulos-Langevin Colette, 2003, Reprod Biol Endocrinol, V1, P121; Kim JH, 2016, J ALLERGY CLIN IMMUN, V137, P507, DOI 10.1016/j.jaci.2015.08.016; Kim MH, 2018, ALLERGY ASTHMA IMMUN, V10, P516, DOI 10.4168/aair.2018.10.5.516; Kopp MV, 2008, PEDIATRICS, V121, pE850, DOI 10.1542/peds.2007-1492; Korpela K, 2020, CELL, V183, P324, DOI 10.1016/j.cell.2020.08.047; Korpela K, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0567-4; Korpela K, 2018, GENOME RES, V28, P561, DOI 10.1101/gr.233940.117; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Lange NE, 2012, CLIN EXP ALLERGY, V42, P901, DOI 10.1111/j.1365-2222.2011.03950.x; Lannon SMR, 2019, J MATERN-FETAL NEO M, V32, P2702, DOI 10.1080/14767058.2018.1446208; Lapin B, 2015, ANN ALLERG ASTHMA IM, V114, P203, DOI 10.1016/j.anai.2014.11.014; Lauzon-Joset JF, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1303; Levin ME, 2020, J ALLERGY CLIN IMMUN, V145, P415, DOI 10.1016/j.jaci.2019.07.048; Loewen K, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.02070-2017; Macia L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010107; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Metsala J, 2015, CLIN EXP ALLERGY, V45, P137, DOI 10.1111/cea.12356; Metzler S, 2019, PEDIAT ALLERG IMM-UK, V30, P423, DOI 10.1111/pai.13039; Mincham KT, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.601494; Mincham KT, 2018, J CLIN INVEST, V128, P4856, DOI 10.1172/JCI122631; Mishra A, 2021, CELL, V184, P3394, DOI 10.1016/j.cell.2021.04.039; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mortensen MS, 2021, ELIFE, V10, DOI 10.7554/eLife.57051; Mulder B, 2016, CLIN EXP ALLERGY, V46, P1214, DOI 10.1111/cea.12756; Mysorekar IU, 2014, SEMIN REPROD MED, V32, P50, DOI 10.1055/s-0033-1361830; Nakajima A, 2017, J IMMUNOL, V199, P3516, DOI 10.4049/jimmunol.1700248; Neu J, 2016, SEMIN FETAL NEONAT M, V21, P373, DOI 10.1016/j.siny.2016.05.001; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Ober C, 2017, CURR OPIN IMMUNOL, V48, P51, DOI 10.1016/j.coi.2017.08.003; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Patel DD, 2020, J ALLERGY CLIN IMMUN, V146, P467, DOI 10.1016/j.jaci.2020.07.015; Patnode ML, 2021, CELL HOST MICROBE, V29, P664, DOI 10.1016/j.chom.2021.01.007; Pelzer E, 2017, PLACENTA, V54, P30, DOI 10.1016/j.placenta.2016.12.003; Petersen C, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100260; Ponsonby AL, 2021, INT J EPIDEMIOL, V50, P1016, DOI 10.1093/ije/dyaa174; Prescott SL, 2003, ALLERGY, V58, P1187, DOI 10.1034/j.1398-9995.2003.00263.x; Prince AL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023051; Quinn TP, 2018, BIOINFORMATICS, V34, P2870, DOI 10.1093/bioinformatics/bty175; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Rampelli S, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01689-y; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Robert-Gangneux F, 2011, CLIN IMMUNOL, V138, P129, DOI 10.1016/j.clim.2010.12.004; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Roswall J, 2021, CELL HOST MICROBE, V29, P765, DOI 10.1016/j.chom.2021.02.021; Roytio H, 2017, BRIT J NUTR, V118, P343, DOI 10.1017/S0007114517002100; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Ruohtula T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02494; Santner-Nanan B, 2013, J IMMUNOL, V191, P145, DOI 10.4049/jimmunol.1203165; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schram D, 2005, ALLERGY, V60, P611, DOI 10.1111/j.1398-9995.2005.00748.x; Shanahan F, 2019, NAT REV GASTRO HEPAT, V16, P387, DOI 10.1038/s41575-019-0163-5; Shao Y, 2019, NATURE, V574, P117, DOI 10.1038/s41586-019-1560-1; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Steiman CA, 2020, J ALLERGY CLIN IMMUN, V146, DOI 10.1016/j.jaci.2020.06.025; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stokholm J, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax9929; Stokholm J, 2014, LANCET RESP MED, V2, P631, DOI 10.1016/S2213-2600(14)70152-3; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Szajewska H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091319; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; TANG MLK, 1994, LANCET, V344, P983, DOI 10.1016/S0140-6736(94)91641-1; Tapiainen T, 2018, PEDIATR RES, V84, DOI 10.1038/pr.2018.29; Tersigni C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134756; Theis KR, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.018; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Timm S, 2017, CLIN EXP ALLERGY, V47, P929, DOI 10.1111/cea.12916; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; van de Loo KFE, 2016, EUR RESPIR J, V47, P133, DOI 10.1183/13993003.00299-2015; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Venter C, 2022, ALLERGY, V77, P162, DOI 10.1111/all.14949; Veru F, 2014, STRESS, V17, P133, DOI 10.3109/10253890.2013.876404; von Hertzen L, 2011, EMBO REP, V12, P1089, DOI 10.1038/embor.2011.195; Vuillermin PJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14552-1; Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025; Wampach L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07631-x; Waser M, 2007, CLIN EXP ALLERGY, V37, P661, DOI 10.1111/j.1365-2222.2006.02640.x; Wassenaar TM, 2014, LETT APPL MICROBIOL, V59, P572, DOI 10.1111/lam.12334; Wei XC, 2020, J ASTHMA, V57, P167, DOI 10.1080/02770903.2018.1561893; Wibowo MC, 2021, NATURE, V594, P234, DOI 10.1038/s41586-021-03532-0; Wickens K, 2018, PEDIAT ALLERG IMM-UK, V29, P296, DOI 10.1111/pai.12874; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Younge N, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127806; Yu JY, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0220-0; Zhang YX, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4322; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315; Zhong YD, 2015, BRIT J NUTR, V113, P1558, DOI 10.1017/S0007114515000793	157	15	15	4	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2021	148	3					669	678		10.1016/j.jaci.2021.07.011	http://dx.doi.org/10.1016/j.jaci.2021.07.011		SEP 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UP2VR	34310928	Green Published			2022-12-18	WOS:000695242900006
J	Kataoka, S; Kawashima, N; Okuno, Y; Muramatsu, H; Miwata, S; Narita, K; Hamada, M; Murakami, N; Taniguchi, R; Ichikawa, D; Kitazawa, H; Suzuki, K; Nishikawa, E; Narita, A; Nishio, N; Yamamoto, H; Fukasawa, Y; Kato, T; Yamamoto, H; Natsume, J; Kojima, S; Nishino, I; Taketani, T; Ohnishi, H; Takahashi, Y				Kataoka, Shinsuke; Kawashima, Nozomu; Okuno, Yusuke; Muramatsu, Hideki; Miwata, Shunsuke; Narita, Kotaro; Hamada, Motoharu; Murakami, Norihiro; Taniguchi, Rieko; Ichikawa, Daisuke; Kitazawa, Hironobu; Suzuki, Kyogo; Nishikawa, Eri; Narita, Atsushi; Nishio, Nobuhiro; Yamamoto, Hidenori; Fukasawa, Yoshie; Kato, Taichi; Yamamoto, Hiroyuki; Natsume, Jun; Kojima, Seiji; Nishino, Ichizo; Taketani, Takeshi; Ohnishi, Hidenori; Takahashi, Yoshiyuki			Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						JAK inhibitor; interferonopathy; pulmonary hyperten-sion; proteasome 20S subunit beta 9 (PSMB9)	VASCULOPATHY	Background: Type I interferonopathies are a recently established subgroup of autoinflammatory diseases caused by mutations in genes associated with proteasome degradation or cytoplasmic RNA- and DNA-sensing pathways. Objective: This study aimed to unveil the molecular pathogenesis of a patient with novel type I interferonopathy, for which no known genetic mutations have been identified. Methods: We performed the whole-exome sequencing of a 1month-old boy with novel type I interferonopathy. We also investigated proteasome activities using patient-derived B lymphoblastoid cell lines (LCLs) and normal LCLs transduced with the mutant gene. Results: Whole-exome sequencing identified a de novo proteasome 20S subunit beta 9 (PSMB9) p.G156D mutation in the patient who developed fever, a chilblain-like skin rash, myositis, and severe pulmonary hypertension due to the hyperactivation of IFN-a. Patient-derived LCLs revealed reduced proteasome activities, and exogenous transduction of mutant PSMB9 p.G156D into normal LCLs significantly suppressed proteasome activities, and the endogenous PSMB9 protein was lost along with the reduction of other immunoproteasome subunits, PSMB8 and PSMB10 proteins. He responded to the administration of a Janus kinase inhibitor, tofacitinib, and he was successfully withdrawn from venoarterial extracorporeal membranous oxygenation. At age 7 months, he received an unrelated cord blood transplantation. At 2 years posttransplantation, he no longer required tofacitinib and experienced no disease recurrence. Conclusions: We present the case of a patient with a novel type I interferonopathy caused by a de novo PSMB9 p.G156D mutation that suppressed the wild-type PSMB9 protein expression. Janus kinase inhibitor and stem cell transplantation could be curative therapies in patients with severe interferonopathies. (J Allergy Clin Immunol 2021;148:639-44.)	[Kataoka, Shinsuke; Kawashima, Nozomu; Muramatsu, Hideki; Miwata, Shunsuke; Narita, Kotaro; Hamada, Motoharu; Murakami, Norihiro; Taniguchi, Rieko; Ichikawa, Daisuke; Kitazawa, Hironobu; Suzuki, Kyogo; Nishikawa, Eri; Narita, Atsushi; Nishio, Nobuhiro; Yamamoto, Hidenori; Fukasawa, Yoshie; Kato, Taichi; Yamamoto, Hiroyuki; Natsume, Jun; Kojima, Seiji; Takahashi, Yoshiyuki] Nagoya Univ, Dept Pediat, Grad Sch Med, Nagoya, Aichi, Japan; [Okuno, Yusuke] Nagoya Univ Hosp, Med Genom Ctr, Nagoya, Aichi, Japan; [Nishio, Nobuhiro] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Nishino, Ichizo] Natl Inst Neurosci, Natl Ctr Neurol & Psychiat, Dept Neuromuscular Res, Tokyo, Japan; [Taketani, Takeshi] Shimane Univ, Dept Pediat, Fac Med, Matsue, Shimane, Japan; [Ohnishi, Hidenori] Gifu Univ, Dept Pediat, Grad Sch Med, Gifu, Japan	Nagoya University; Nagoya University; Nagoya University; National Center for Neurology & Psychiatry - Japan; Shimane University; Gifu University	Takahashi, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ytakaha@med.nagoya-u.ac.jp	Kawashima, Nozomu/J-8340-2012; Muramatsu, Hideki/ABA-3376-2021	Kawashima, Nozomu/0000-0001-5700-4481; Muramatsu, Hideki/0000-0002-8801-0021; kataoka, shinsuke/0000-0002-8131-4452	Ministry of Health, Labour and Welfare of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry	This work was supported by ''Research on Measures for Intractable diseases'' Project from the Ministry of Health, Labour and Welfare of Japan, and partly by Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry.	Fremond ML, 2016, J ALLERGY CLIN IMMUN, V138, P1752, DOI 10.1016/j.jaci.2016.07.015; Kim H, 2016, J MOL MED, V94, P1111, DOI 10.1007/s00109-016-1465-5; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Liu Y, 2012, ARTHRITIS RHEUM-US, V64, P895, DOI 10.1002/art.33368; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Seo J, 2017, J ALLERGY CLIN IMMUN, V139, P1396, DOI 10.1016/j.jaci.2016.10.030	7	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					639	644		10.1016/j.jaci.2021.03.010	http://dx.doi.org/10.1016/j.jaci.2021.03.010		AUG 2021	6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	33727065				2022-12-18	WOS:000687104900016
J	Posch, W; Vosper, J; Noureen, A; Zaderer, V; Witting, C; Bertacchi, G; Gstir, R; Filipek, PA; Bonn, GK; Huber, LA; Bellmann-Weiler, R; Lass-Florl, C; Wilflingseder, D				Posch, Wilfried; Vosper, Jonathan; Noureen, Asma; Zaderer, Viktoria; Witting, Christina; Bertacchi, Giulia; Gstir, Ronald; Filipek, Przemyslaw A.; Bonn, Guenther K.; Huber, Lukas A.; Bellmann-Weiler, Rosa; Lass-Floerl, Cornelia; Wilflingseder, Doris			C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2-infected primary human airway epithelia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						SARS-CoV-2; complement; anaphylatoxin receptors; primary human airway epithelial cells	COMPLEMENT; RECEPTOR; C5L2	Background: Excessive inflammation triggered by a hitherto undescribed mechanism is a hallmark of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and is associated with enhanced pathogenicity and mortality. Objective: Complement hyperactivation promotes lung injury and was observed in patients suffering from Middle East respiratory syndrome-related coronavirus, SARS-CoV-1, and SARS-CoV-2 infections. Therefore, we investigated the very first interactions of primary human airway epithelial cells on exposure to SARS-CoV-2 in terms of complement component 3 (C3)-mediated effects. Methods: For this, we used highly differentiated primary human 3-dimensional tissue models infected with SARS-CoV-2 patient isolates. On infection, viral load, viral infectivity, intracellular complement activation, inflammatory mechanisms, and tissue destruction were analyzed by real-time RT-PCR, high content screening, plaque assays, luminex analyses, and transepithelial electrical resistance measurements. Results: Here, we show that primary normal human bronchial and small airway epithelial cells respond to SARS-CoV-2 infection by an inflated local C3 mobilization. SARS-CoV-2 infection resulted in exaggerated intracellular complement activation and destruction of the epithelial integrity in monolayer cultures of primary human airway cells and highly differentiated, pseudostratified, mucus-producing, ciliated respiratory tissue models. SARS-CoV-2-infected 3-dimensional cultures secreted significantly higher levels of C3a and the proinflammatory cytokines IL-6, monocyte chemoattractant protein 1, IL-1a, and RANTES. Conclusions: Crucially, we illustrate here for the first time that targeting the anaphylotoxin receptors C3a receptor and C5a receptor in nonimmune respiratory cells can prevent intrinsic lung inflammation and tissue damage. This opens up the exciting possibility in the treatment of COVID-19.	[Posch, Wilfried; Noureen, Asma; Zaderer, Viktoria; Witting, Christina; Bertacchi, Giulia; Lass-Floerl, Cornelia; Wilflingseder, Doris] Med Univ Innsbruck, Inst Hyg & Med Microbiol, Innsbruck, Austria; [Vosper, Jonathan] Med Univ Innsbruck, Inst Med Biochem, Innsbruck, Austria; [Gstir, Ronald; Filipek, Przemyslaw A.; Bonn, Guenther K.; Huber, Lukas A.] ADSI Austrian Drug Screening Inst GmbH, Innsbruck, Austria; [Huber, Lukas A.] Med Univ Innsbruck, Inst Cell Biol, Biocenter Innsbruck, Innsbruck, Austria; [Bellmann-Weiler, Rosa] Med Univ Innsbruck, Univ Hosp Internal Med 2, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Posch, W; Wilflingseder, D (corresponding author), Inst Hyg & Med Microbiol, Schopfstr 41-R311, A-6020 Innsbruck, Austria.	wilfried.posch@i-med.ac.at; doris.wilflingseder@i-med.ac.at	Posch, Wilfried/AAH-6845-2019	Posch, Wilfried/0000-0001-8955-7654; Lass-Florl, Cornelia/0000-0002-2946-7785; Wilflingseder, Doris/0000-0002-5888-5118	Austrian Science Fund (FWF) [34070-B, P33510-B]; Marie Sklodowska-Curie action (CORVOS EU-H2020-MSCA-ITN-2019) [860064]; Anniversary Fund of the Austrian National Bank (OeNB) [P 17614, 17633]; National Institute of Allergy and Infectious Diseases [UM1AI068618]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Marie Sklodowska-Curie action (CORVOS EU-H2020-MSCA-ITN-2019); Anniversary Fund of the Austrian National Bank (OeNB); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors were supported by the Austrian Science Fund (FWF; grant no. P 34070-B to W.P. and grant no. P33510-B to D.W.), Marie Sk1odowska-Curie action (CORVOS EU-H2020-MSCA-ITN-2019; grant no. 860064 to D.W.), the Anniversary Fund of the Austrian National Bank (OeNB; grant no. P 17614 to W.P. and grant no. 17633 to D.W.), and the National Institute of Allergy and Infectious Diseases (grant no. UM1AI068618 to D.W.).	Arborea G, 2017, MOL IMMUNOL, V89, P2, DOI 10.1016/j.molimm.2017.05.012; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Carvelli J, 2020, NATURE, V588, P146, DOI 10.1038/s41586-020-2600-6; Chandorkar P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11271-4; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12; Dijkman R, 2013, J VIROL, V87, P6081, DOI 10.1128/JVI.03368-12; Dijkstra KK, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107588; Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Gamage AM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009130; Gao T., 2020, HIGHLY PATHOGENIC CO, DOI 10.1101/2020.03.29.20041962; Gralinski LE, 2018, MBIO, V9, DOI 10.1128/mBio.01753-18; Gu HM, 2016, FASEB J, V30, P2336, DOI 10.1096/fj.201500044; Gu HM, 2014, FASEB J, V28, P4223, DOI 10.1096/fj.13-247650; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Hiemstra PS, 2015, MOL IMMUNOL, V68, P28, DOI 10.1016/j.molimm.2015.07.030; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jodele S, 2021, BRIT J PHARMACOL, V178, P2832, DOI 10.1111/bph.15187; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kulkarni HS, 2018, J ALLERGY CLIN IMMUN, V141, P1582, DOI 10.1016/j.jaci.2017.11.046; Laumonnier Y, 2017, MOL IMMUNOL, V89, P44, DOI 10.1016/j.molimm.2017.05.019; Li XX, 2019, J IMMUNOL, V202, P3339, DOI 10.4049/jimmunol.1900371; Lipworth B, 2020, J ALLER CL IMM-PRACT, V8, P1798, DOI 10.1016/j.jaip.2020.04.014; Magro C, 2020, TRANSL RES, V220, P1, DOI 10.1016/j.trsl.2020.04.007; Magro G, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198070; Mastaglio S, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108450; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Ramlall V, 2020, NAT MED, V26, P1609, DOI 10.1038/s41591-020-1021-2; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Sachs N, 2019, EMBO J, V38, DOI 10.15252/embj.2018100300; SCHINDLER R, 1990, BLOOD, V76, P1631; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Wang DW, 2020, J COASTAL RES, P1, DOI [10.1001/jama.2020.1585, 10.2112/JCR-SI109-001.1]; Yamamoto H, 2012, IMMUNOBIOLOGY, V217, P1200, DOI 10.1016/j.imbio.2012.08.204; Yan Bingyu, 2020, Res Sq, DOI 10.21203/rs.3.rs-33390/v1; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Zaderer V, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101292; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8193932; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115; Zhu N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17796-z; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	53	15	15	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2083	+		10.1016/j.jaci.2021.03.038	http://dx.doi.org/10.1016/j.jaci.2021.03.038		JUN 2021	21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	33852936	Green Published, hybrid			2022-12-18	WOS:000657814800014
J	Larkin, C; Chen, WW; Szabo, IL; Shan, CX; Dajnoki, Z; Szegedi, A; Buhl, T; Fan, YY; O'Neill, S; Walls, D; Cheng, WK; Xiao, S; Wang, JF; Meng, JH				Larkin, Ciara; Chen, Weiwei; Szabo, Imre Lorinc; Shan, Chunxu; Dajnoki, Zsolt; Szegedi, Andrea; Buhl, Timo; Fan, Yuanyuan; O'Neill, Sandra; Walls, Dermot; Cheng, Wenke; Xiao, Song; Wang, Jiafu; Meng, Jianghui			Novel insights into the TRPV3-mediated itch in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							TRPV3; KERATINOCYTES		[Larkin, Ciara; Shan, Chunxu; O'Neill, Sandra; Walls, Dermot; Wang, Jiafu; Meng, Jianghui] Dublin City Univ, Sch Biotechnol, Fac Sci & Hlth, Dublin, Ireland; [Chen, Weiwei; Fan, Yuanyuan; Cheng, Wenke; Xiao, Song; Wang, Jiafu; Meng, Jianghui] Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China; [Szabo, Imre Lorinc; Dajnoki, Zsolt; Szegedi, Andrea] Univ Debrecen, Dept Dermatol, Fac Med, Debrecen, Hungary; [Buhl, Timo] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany	Dublin City University; Henan University; University of Debrecen; University of Gottingen	Wang, JF (corresponding author), Dublin City Univ, Sch Biotechnol, Fac Sci & Hlth, Dublin, Ireland.; Wang, JF (corresponding author), Henan Univ, Sch Life Sci, Kaifeng, Henan, Peoples R China.	jiafu.wang@dcu.ie; jianghui.meng@dcu.ie	Buhl, Timo/AFP-7298-2022; Wang, Jiafu/AAX-9388-2020	Wang, Jiafu/0000-0002-3654-4400; Meng, Jianghui/0000-0002-3107-4200	Science Foundation Ireland [15/SIRG/3508T, 13/CDA/2093, 17/TIDA/4977]; Hungarian research grants [NKFIH K-128250, NKFIH PD-131689]; European Union [GINOP-2.3.2-15-2016-00050, EFOP-3.6.1-16-2016-00022]; European Regional Development Fund [GINOP-2.3.2-15-2016-00050, EFOP-3.6.1-16-2016-00022]; European Social Fund; Janos Bolyai Research Scholarship grant of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology [UNKP-19-4]; Orla Benson Memorial Scholarship; PRTLI Cycle 5; European Union Structural Funds Programme, European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Hungarian research grants; European Union(European Commission); European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship grant of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology; Orla Benson Memorial Scholarship; PRTLI Cycle 5; European Union Structural Funds Programme, European Union	Science Foundation Ireland funded this research through grants 15/SIRG/3508T (to J.M.) and 13/CDA/2093 and 17/TIDA/4977 (to J.W.). The publication was also supported by Hungarian research grants (NKFIH K-128250 and NKFIH PD-131689), as well as GINOP-2.3.2-15-2016-00050 and EFOP-3.6.1-16-2016-00022 (to A.S. and D.Z.), which were cofinanced by the European Union and the European Regional Development Fund and the European Social Fund. Funding was also provided through a Janos Bolyai Research Scholarship grant of the Hungarian Academy of Sciences (to D.Z.) and the UNKP-19-4 New National Excellence Program of the Ministry for Innovation and Technology (to D.Z.) as well as Orla Benson Memorial Scholarship (to C.L.).The confocal imaging was carried out at the Nano Research Facility in Dublin City University, which was funded under PRTLI Cycle 5. PRTLI was cofunded through the European Regional Development Fund, which is part of the European Union Structural Funds Programme 2011-2015.	Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Meng JH, 2019, J INVEST DERMATOL, V139, P2324, DOI 10.1016/j.jid.2019.04.017; Meng JH, 2018, J ALLERGY CLIN IMMUN, V141, P1677, DOI 10.1016/j.jaci.2017.12.1002; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Schreiber K, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2017.103, 10.1038/nrdp.2018.5]; Seo SH, 2020, J INVEST DERMATOL, V140, P2199, DOI 10.1016/j.jid.2020.02.028; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Yamamoto-Kasai E, 2013, EXP DERMATOL, V22, P820, DOI 10.1111/exd.12273	10	15	16	1	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1110	+		10.1016/j.jaci.2020.09.028	http://dx.doi.org/10.1016/j.jaci.2020.09.028		MAR 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	33035568	hybrid, Green Accepted			2022-12-18	WOS:000635524300020
J	Lodge, CJ; Lowe, AJ; Milanzi, E; Bowatte, G; Abramson, MJ; Tsimiklis, H; Axelrad, C; Robertson, B; Darling, AE; Svanes, C; Wjst, M; Dharmage, SC; Bode, L				Lodge, Caroline J.; Lowe, Adrian J.; Milanzi, Elasma; Bowatte, Gayan; Abramson, Michael J.; Tsimiklis, Helen; Axelrad, Christine; Robertson, Bianca; Darling, Aaron E.; Svanes, Cecilie; Wjst, Matthias; Dharmage, Shyamali C.; Bode, Lars			Human milk oligosaccharide profiles and allergic disease up to 18 years	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Human milk oligosaccharides; allergy; childhood; latent class analysis	CHILDREN; FORMULA; INHIBIT	Background: Human milk oligosaccharides (HMO) are a diverse range of sugars secreted in breast milk that have direct and indirect effects on immunity. The profiles of HMOs produced differ between mothers. Objective: We sought to determine the relationship between maternal HMO profiles and offspring allergic diseases up to age 18 years. Methods: Colostrum and early lactation milk samples were collected from 285 mothers enrolled in a high-allergy-risk birth cohort, the Melbourne Atopy Cohort Study. Nineteen HMOs were measured. Profiles/patterns of maternal HMOs were determined using LCA. Details of allergic disease outcomes including sensitization, wheeze, asthma, and eczema were collected at multiple follow-ups up to age 18 years. Adjusted logistic regression analyses and generalized estimating equations were used to determine the relationship between HMO profiles and allergy. Results: The levels of several HMOs were highly correlated with each other. LCA determined 7 distinct maternal milk profiles with memberships of 10% and 20%. Compared with offspring exposed to the neutral Lewis HMO profile, exposure to acidic Lewis HMOs was associated with a higher risk of allergic disease and asthma over childhood (odds ratio asthma at 18 years, 5.82; 95% CI, 1.59-21.23), whereas exposure to the acidic predominant profile was associated with a reduced risk of food sensitization (OR at 12 years, 0.08; 95% CI, 0.01-0.67). Conclusions: In this high-allergy-risk birth cohort, some profiles of HMOs were associated with increased and some with decreased allergic disease risks over childhood. Further studies are needed to confirm these findings and realize the potential for intervention. (J Allergy Clin Immunol 2021;147:1041-8.)	[Lodge, Caroline J.; Lowe, Adrian J.; Milanzi, Elasma; Bowatte, Gayan; Dharmage, Shyamali C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Lodge, Caroline J.; Lowe, Adrian J.; Axelrad, Christine; Dharmage, Shyamali C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bowatte, Gayan] Univ Peradeniya, Fac Allied Hlth Sci, Dept Basic Sci, Peradeniya, Sri Lanka; [Bowatte, Gayan] Natl Inst Fundamental Studies, Kandy, Sri Lanka; [Abramson, Michael J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Tsimiklis, Helen] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [Robertson, Bianca; Bode, Lars] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Robertson, Bianca; Bode, Lars] Univ Calif San Diego, Larsson Rosenquist Fdn Mother Milk, Infant Ctr Res Excellence, La Jolla, CA 92093 USA; [Darling, Aaron E.] Univ Technol Sydney, Ithree Inst, Ultimo, Australia; [Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Wjst, Matthias] Helmholtz Zentrum Muenchen, Inst Lung Biol & Dis, German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Wjst, Matthias] Klinikum Rechts Der Isar, Inst Med Informat Stat & Epidemiol, Lehrstuhl Med Informat, Munich, Germany	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Peradeniya; National Institute of Fundamental Studies (NIFS); Monash University; Monash University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Technology Sydney; University of Bergen; Haukeland University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lodge, CJ (corresponding author), Univ Melbourne, 207 Bouverie St, Victoria, NSW 3010, Australia.	clodge@unimelb.edu.au		Lodge, Caroline/0000-0002-2342-3888; Bowatte, Gayan/0000-0002-9577-9752; MILANZI, ELASMA/0000-0003-1164-2298; Darling, Aaron/0000-0003-2397-7925	Asthma Australia; National Health and Medical Research Council of Australia	Asthma Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Asthma Australia and the National Health and Medical Research Council of Australia. None of the work was directed by or influenced by these institutions.	Aakko J, 2017, BENEF MICROBES, V8, P563, DOI 10.3920/BM2016.0185; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Borewicz K, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801214; Chong CYL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030274; Doherty AM, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00091; Facinelli B, 2019, J MATERN-FETAL NEO M, V32, P2950, DOI 10.1080/14767058.2018.1450864; Goehring KC, 2016, J NUTR, V146, P2559, DOI 10.3945/jn.116.236919; Goehring KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101692; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Kunz C, 2017, J PEDIATR GASTR NUTR, V64, P789, DOI 10.1097/MPG.0000000000001402; Laucirica DR, 2017, J NUTR, V147, P1709, DOI 10.3945/jn.116.246090; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Lin AE, 2014, J INFECT DIS, V209, P389, DOI 10.1093/infdis/jit464; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; Lowe AJ, 2017, INT J EPIDEMIOL, V46, P25, DOI 10.1093/ije/dyw011; Lowe AJ, 2011, J ALLERGY CLIN IMMUN, V128, P360, DOI 10.1016/j.jaci.2010.05.006; McGuire MK, 2017, AM J CLIN NUTR, V105, P1086, DOI 10.3945/ajcn.116.139980; Miliku K, 2018, ALLERGY, V73, P2070, DOI 10.1111/all.13476; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Quin C, 2020, J BIOL CHEM, V295, P4035, DOI 10.1074/jbc.RA119.011351; Rothman KJ, 2014, J GEN INTERN MED, V29, P1060, DOI 10.1007/s11606-013-2755-z; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Seppo AE, 2017, J ALLERGY CLIN IMMUN, V139, P708, DOI 10.1016/j.jaci.2016.08.031; Sjogren YM, 2007, PEDIAT ALLERG IMM-UK, V18, P20, DOI 10.1111/j.1399-3038.2006.00486.x; Sprenger N, 2017, EUR J NUTR, V56, P1293, DOI 10.1007/s00394-016-1180-6; Tonon KM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061358; Triantis V, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00190; Underwood MA, 2015, PEDIATR RES, V78, P670, DOI 10.1038/pr.2015.162; Venter C, 2020, PEDIAT ALLERG IMM-UK, DOI 10.1111/pai.13303; Xiao L, 2019, EUR J IMMUNOL, V49, P1001, DOI 10.1002/eji.201847971	31	15	16	2	17	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					1041	1048		10.1016/j.jaci.2020.06.027	http://dx.doi.org/10.1016/j.jaci.2020.06.027		MAR 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RG4QF	32650022	Green Submitted			2022-12-18	WOS:000635524300009
J	Tang, HHF; Teo, SM; Sly, PD; Holt, PG; Inouye, M				Tang, Howard H. F.; Teo, Shu Mei; Sly, Peter D.; Holt, Patrick G.; Inouye, Michael			The intersect of genetics, environment, and microbiota in asthma-perspectives and challenges	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; allergy and Immunology; genomics; micro-biota; environment; gene-environment interaction; systems biology	HOUSE-DUST ENDOTOXIN; GENOME-WIDE ASSOCIATION; IFN-GAMMA PRODUCTION; FAMILY-MEMBER 3; CHILDHOOD ASTHMA; GUT MICROBIOME; RHINOVIRUS-C; ALLERGIC DISEASES; AIRWAY MICROBIOTA; IMMUNE-RESPONSES	In asthma, a significant portion of the interaction between genetics and environment occurs through microbiota. The proposed mechanisms behind this interaction are complex and at times contradictory. This review covers recent developments in our understanding of this interaction: the "microbial hypothesis"and the "farm effect"; the role of endotoxin and genetic variation in pattern recognition systems; the interaction with allergen exposure; the additional involvement of host gut and airway microbiota; the role of viral respiratory infections in interaction with the 17q21 and CDHR3 genetic loci; and the importance of in utero and early-life timing of exposures. We propose a unified framework for understanding how all these phenomena interact to drive asthma pathogenesis. Finally, we point out some future challenges for continued research in this field, in particular the need for multiomic integration, as well as the potential utility of asthma endotyping. (J Allergy Clin Immunol 2021;147:781-93.)	[Tang, Howard H. F.; Teo, Shu Mei; Inouye, Michael] Baker Heart & Diabet Inst, Cambridge Baker Syst Genom Initiat, 75 Commercial Rd, Melbourne, Vic 3004, Australia; [Tang, Howard H. F.; Teo, Shu Mei; Inouye, Michael] Univ Cambridge, Cambridge Baker Syst Genom Initiat, Cambridge, England; [Sly, Peter D.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Holt, Patrick G.] Telethon Kids Inst, Perth, WA, Australia; [Inouye, Michael] Univ Cambridge, BHF Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge, England; [Inouye, Michael] Hlth Data Res UK Cambridge, Wellcome Genome Campus, Hinxton, England; [Inouye, Michael] Univ Cambridge, Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England; [Inouye, Michael] Cambridge Univ Hosp, Cambridge, England; [Inouye, Michael] Alan Turing Inst, London, England	University of Cambridge; University of Queensland; Telethon Kids Institute; University of Cambridge; University of Cambridge; University of Cambridge	Tang, HHF (corresponding author), Baker Heart & Diabet Inst, Cambridge Baker Syst Genom Initiat, 75 Commercial Rd, Melbourne, Vic 3004, Australia.; Inouye, M (corresponding author), Univ Cambridge, Cambridge Baker Syst Genom Initiat, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	howard.tang@baker.edu.au; mi336@medschl.cam.ac.uk	Holt, Patrick/H-1548-2011	Holt, Patrick/0000-0003-1193-0935; Inouye, Michael/0000-0001-9413-6520	Australian National Health and Medical Research Council (NHMRC) [1114753]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	H.H.F.T. wishes to acknowledge the Australian National Health and Medical Research Council (NHMRC) (ID: 1114753) for providing partial funding for research. M.I. is funded by the Munz Chair of Cardiovascular Prediction and Prevention.	Abdel-Aziz MI, 2021, J ALLERGY CLIN IMMUN, V147, P123, DOI 10.1016/j.jaci.2020.04.018; Acevedo N, 2015, HUM MOL GENET, V24, P875, DOI 10.1093/hmg/ddu479; Ahmed B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201156; Alnahas S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01562; Altman MC, 2020, J ALLERGY CLIN IMMUN, V145, P1332, DOI 10.1016/j.jaci.2019.12.904; Altomare A, 2019, DIGEST LIVER DIS, V51, P648, DOI 10.1016/j.dld.2018.11.021; An SQ, 2018, PEDIATR PULM, V53, P921, DOI 10.1002/ppul.24037; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Barcik W, 2020, IMMUNITY, V52, P241, DOI 10.1016/j.immuni.2020.01.007; Basnet S, 2019, AM J RESP CELL MOL, V61, P450, DOI 10.1165/rcmb.2018-0220OC; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Belsky DW, 2013, LANCET RESP MED, V1, P453, DOI 10.1016/S2213-2600(13)70101-2; Birzele LT, 2017, ALLERGY, V72, P109, DOI 10.1111/all.13002; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Bonnelykke K, 2018, AM J RESP CRIT CARE, V197, P589, DOI 10.1164/rccm.201705-1021OC; Bonnelykke K, 2016, J ALLERGY CLIN IMMUN, V137, P667, DOI 10.1016/j.jaci.2016.01.006; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brix S, 2015, J ALLERGY CLIN IMMUN, V135, P277, DOI 10.1016/j.jaci.2014.09.036; Cait A, 2018, MUCOSAL IMMUNOL, V11, P785, DOI 10.1038/mi.2017.75; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Carnes MU, 2017, ANN AM THORAC SOC, V14, P324, DOI 10.1513/AnnalsATS.201611-861OC; Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Chung KF, 2017, J ALLERGY CLIN IMMUN, V139, P1071, DOI 10.1016/j.jaci.2017.02.004; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Custovic A, 2018, AM J RESP CRIT CARE, V197, P1265, DOI 10.1164/rccm.201708-1762OC; Das S, 2017, ADV IMMUNOL, V135, P1, DOI 10.1016/bs.ai.2017.06.001; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; DeMuri GP, 2018, CLIN INFECT DIS, V66, P1045, DOI 10.1093/cid/cix941; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dubourg G, 2019, EXPERT REV ANTI-INFE, V17, P437, DOI 10.1080/14787210.2019.1621168; Durack J, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0631-8; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Eder W, 2006, ALLERGY, V61, P1117, DOI 10.1111/j.1398-9995.2006.01128.x; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Ege MJ, 2017, ANN AM THORAC SOC, V14, pS348, DOI 10.1513/AnnalsATS.201702-139AW; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Esneau C, 2019, RHINOVIRUS INFECTIONS: RETHINKING THE IMPACT ON HUMAN HEALTH AND DISEASE, P25, DOI 10.1016/B978-0-12-816417-4.00002-0; Everman JL, 2019, J ALLERGY CLIN IMMUN, V144, P962, DOI 10.1016/j.jaci.2019.01.052; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Frati F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010123; Frei R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091097; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Fyhrquist N, 2014, J ALLERGY CLIN IMMUN, V134, P1301, DOI 10.1016/j.jaci.2014.07.059; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Gao S, 2008, FEBS J, V275, P5201, DOI 10.1111/j.1742-4658.2008.06651.x; Genuneit J, 2013, PEDIAT ALLERG IMM-UK, V24, P293, DOI 10.1111/pai.12053; Gern JE, 2017, J ALLERGY CLIN IMMUN, V140, P836, DOI 10.1016/j.jaci.2016.10.052; Giovannangelo M, 2007, INDOOR AIR, V17, P70, DOI 10.1111/j.1600-0668.2006.00461.x; Goodrich JK, 2017, ANNU REV GENET, V51, P413, DOI 10.1146/annurev-genet-110711-155532; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Grayson MH, 2018, J ALLERGY CLIN IMMUN, V142, P1423, DOI 10.1016/j.jaci.2018.08.033; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hasegawa K, 2017, PEDIATR INFECT DIS J, V36, P1044, DOI [10.1097/INF.0000000000001500, 10.1097/inf.0000000000001500]; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Holt PG, 2019, J ALLERGY CLIN IMMUN, V143, P1176, DOI 10.1016/j.jaci.2018.08.035; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Hufnagl K, 2020, SEMIN IMMUNOPATHOL, V42, P75, DOI 10.1007/s00281-019-00775-y; Igartua C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0227-5; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Jartti T, 2017, J ALLERGY CLIN IMMUN, V140, P895, DOI 10.1016/j.jaci.2017.08.003; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; Johnston Sebastian L, 2007, Proc Am Thorac Soc, V4, P267, DOI 10.1513/pats.200701-030AW; Jones AC, 2019, AM J RESP CRIT CARE, V199, P1537, DOI 10.1164/rccm.201804-0715OC; Kauffmann F, 2012, J ALLERGY CLIN IMMUN, V130, P1229, DOI 10.1016/j.jaci.2012.10.038; Kim KW, 2019, ALLERGY ASTHMA IMMUN, V11, P170, DOI 10.4168/aair.2019.11.2.170; Kirjavainen PV, 2019, NAT MED, V25, P1089, DOI 10.1038/s41591-019-0469-4; Kljaic-Bukvic B, 2014, PEDIAT ALLERG IMM-UK, V25, P552, DOI 10.1111/pai.12258; Kothari PH, 2018, J ALLERGY CLIN IMMUN, V141, P2282, DOI 10.1016/j.jaci.2017.11.057; Kozik A, 2020, CURR OPIN PULM MED, V26, P27, DOI 10.1097/MCP.0000000000000632; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Krusche J, 2019, J ALLERGY CLIN IMMUN, V144, P1684, DOI 10.1016/j.jaci.2019.07.029; Kumar M, 2020, METHODS MOL BIOL, V2055, P595, DOI 10.1007/978-1-4939-9773-2_27; Kurilshikov A, 2017, TRENDS IMMUNOL, V38, P633, DOI 10.1016/j.it.2017.06.003; Larkin EK, 2015, FUTURE VIROL, V10, P883, DOI 10.2217/FVL.15.55; Lau MYZ, 2014, ALLERGY, V69, P1440, DOI 10.1111/all.12454; Lau MYZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43681; Lazar V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01830; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Liu AH, 2015, J ALLERGY CLIN IMMUN, V136, P860, DOI 10.1016/j.jaci.2015.08.012; Liu YP, 2017, CLIN EXP ALLERGY, V47, P371, DOI 10.1111/cea.12903; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Loisel DA, 2016, CLIN EXP ALLERGY, V46, P112, DOI 10.1111/cea.12642; Loss G, 2012, J ALLERGY CLIN IMMUN, V130, P523, DOI 10.1016/j.jaci.2012.05.049; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Maier RM, 2010, APPL ENVIRON MICROB, V76, P2663, DOI 10.1128/AEM.01665-09; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Martinez FD, 2019, IMMUNOL ALLERGY CLIN, V39, P141, DOI 10.1016/j.iac.2018.12.001; Mendy A, 2011, J ASTHMA, V48, P685, DOI 10.3109/02770903.2011.594140; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Morales E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00499; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; O'Neill MB, 2020, HUM MOL GENET, V29, P736, DOI 10.1093/hmg/ddz304; Ober C, 2017, CURR OPIN IMMUNOL, V48, P51, DOI 10.1016/j.coi.2017.08.003; Ober C, 2016, ANN AM THORAC SOC, V13, pS85, DOI 10.1513/AnnalsATS.201507-459MG; Parajuli A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00084; Park HW, 2017, ALLERGY ASTHMA IMMUN, V9, P191, DOI 10.4168/aair.2017.9.3.191; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radon K, 2004, CLIN EXP ALLERGY, V34, P1178, DOI 10.1111/j.1365-2222.2004.02005.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rullo VEV, 2002, J ALLERGY CLIN IMMUN, V110, P582, DOI 10.1067/mai.2002.127511; Sandford AJ, 2000, AM J RESP CRIT CARE, V161, pS202, DOI 10.1164/ajrccm.161.supplement_2.a1q4-11; Sbihi H, 2019, ALLERGY, V74, P2103, DOI 10.1111/all.13812; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Schoettler N, 2019, J ALLERGY CLIN IMMUN, V144, P1495, DOI 10.1016/j.jaci.2019.10.023; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shariff S, 2017, AM J RESP CELL MOL, V56, P796, DOI 10.1165/rcmb.2016-0252OC; Simpson A, 2010, CLIN EXP ALLERGY, V40, P209, DOI 10.1111/j.1365-2222.2009.03391.x; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Smit LAM, 2008, EUR RESPIR J, V31, P1241, DOI 10.1183/09031936.00090607; Smit LAM, 2011, OCCUP ENVIRON MED, V68, P826, DOI 10.1136/oem.2010.060038; Smit LAM, 2009, AM J RESP CRIT CARE, V179, P363, DOI 10.1164/rccm.200810-1533OC; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Steinke JW, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0661-2; Stern DA, 2007, J ALLERGY CLIN IMMUN, V120, P835, DOI 10.1016/j.jaci.2007.05.050; Tang HHF, 2018, ELIFE, V7, DOI 10.7554/eLife.35856; Teo SM, 2018, CELL HOST MICROBE, V24, P341, DOI 10.1016/j.chom.2018.08.005; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Thorsen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12989-7; Thorsen J, 2019, J ALLERGY CLIN IMMUN, V143, pAB299, DOI 10.1016/j.jaci.2018.12.911; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner S, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00118; Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693; van der Valk RJP, 2012, ALLERGY, V67, P767, DOI 10.1111/j.1398-9995.2012.02819.x; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; Vercelli D, 2016, AM J RESP CRIT CARE, V193, P821, DOI 10.1164/rccm.201511-2265ED; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; von Mutius E, 2016, J ALLERGY CLIN IMMUN, V137, P680, DOI 10.1016/j.jaci.2015.12.1301; Wang J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0479-3; Waser M, 2004, CLIN EXP ALLERGY, V34, P389, DOI 10.1111/j.1365-2222.2004.01873.x; Wickens K, 2002, ALLERGY, V57, P1171, DOI 10.1034/j.1398-9995.2002.t01-1-23644.x; Wilson NG, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007645; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zakeri A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01027; Zambelli-Weiner A, 2005, J ALLERGY CLIN IMMUN, V115, P1203, DOI 10.1016/j.jaci.2005.03.001; Zhang YM, 2019, AM J RESP CRIT CARE, V199, P478, DOI 10.1164/rccm.201803-0438OC; Zhang ZH, 2017, J ALLERGY CLIN IMMUN, V139, P54, DOI 10.1016/j.jaci.2016.02.031	188	15	16	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					781	793		10.1016/j.jaci.2020.08.026	http://dx.doi.org/10.1016/j.jaci.2020.08.026		MAR 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RA9TV	33678251				2022-12-18	WOS:000631762400001
J	Steinke, JW; Lawrence, MG; Teague, WG; Braciale, TJ; Patrie, JT; Borish, L				Steinke, John W.; Lawrence, Monica G.; Teague, W. Gerald; Braciale, Thomas J.; Patrie, James T.; Borish, Larry			Bronchoalveolar lavage cytokine patterns in children with severe neutrophilic and paucigranulocytic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe asthma; BAL granulocytes; neutrophilic asthma; eosinophilic asthma; asthma phenotypes; asthma heterogeneity; cytokine; chemokine; rhinovirus	INTERLEUKIN-4; INFECTION	Background: Asthma is a complex heterogeneous disease occurring in adults and children that is characterized by distinct inflammatory patterns. While numerous studies have been performed in adults, little is known regarding the heterogeneity of severe asthma in children, particularly inflammatory signatures involving the air spaces. Objective: We sought to determine the relationship of bronchoalveolar lavage (BAL) cytokine/chemokine expression patterns in children with severe therapy-resistant asthma stratified according to neutrophilic versus nonneutrophilic BAL inflammatory cell patterns. Methods: Children with severe asthma with inadequate symptom control despite therapy underwent diagnostic bronchoscopy and BAL. Inflammatory cytokine/chemokine concentrations were determined using a multiplex protein bead assay. Results: Analysis of BAL constituents with an unbiased clustering approach revealed distinct cytokine/chemokine patterns, and these aligned with pathways associated with type 2 innate lymphoid cells, monocytes, neutrophil trafficking, and T effector cells. All cytokines examined (n = 27) with 1 exception (vascular endothelial growth factor) were overexpressed with BAL neutrophilia compared with nonneutrophilic asthma, and this was confirmed in a cross-validation analysis. Cytokines specifically responsible for T(H)17 (IL-17, IL-6, G-CSF) and T(H)1 differentiation and expression (IL-12, TNF-alpha, IFN-gamma) were enhanced in the neutrophilic cohorts. Neutrophilic groups were also characterized by higher prevalence of bacterial and viral pathogens; however, cytokine expression patterns manifested independently of pathogen expression. Conclusions: The results demonstrate that children with refractory asthma and neutrophilic inflammation had a BAL cytokine pattern consistent with a mixed T(H)17/T(H)1/T(H)2 response. In contrast, nonneutrophilic asthma presented independently of cytokine overexpression.	[Steinke, John W.; Lawrence, Monica G.; Borish, Larry] Univ Virginia, Sch Med, Dept Med, Div Allergy & Immunol, Charlottesville, VA USA; [Steinke, John W.; Braciale, Thomas J.; Borish, Larry] Univ Virginia, Sch Med, Carter Immunol Ctr, Charlottesville, VA USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Child Hlth Res Ctr, Div Resp Med Allergy & Immunol,Dept Pediat, Charlottesville, VA USA; [Patrie, James T.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA USA; [Borish, Larry] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Borish, L (corresponding author), Univ Virginia Hlth Syst, Box 01355, Charlottesville, VA 22908 USA.	lb4m@virginia.edu			Ivy Foundation of Charlottesville; National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program [U10HL109250-07]; National Institute of Allergy and Infectious Diseases [U01A123337]; American Lung Association/American Academy of Allergy, Asthma, and Immunology Allergic Respiratory Diseases Award	Ivy Foundation of Charlottesville; National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lung Association/American Academy of Allergy, Asthma, and Immunology Allergic Respiratory Diseases Award	This work was supported by The Ivy Foundation of Charlottesville, National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program U10HL109250-07 (W.G.T.), National Institute of Allergy and Infectious Diseases U01A123337 (L.B.), and American Lung Association/American Academy of Allergy, Asthma, and Immunology Allergic Respiratory Diseases Award (M.L.).	Alam R, 2017, J ALLERGY CLIN IMMUN, V140, P1004, DOI 10.1016/j.jaci.2016.12.963; Andersson CK, 2017, J ALLERGY CLIN IMMUN, V139, P1819, DOI 10.1016/j.jaci.2016.09.022; Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896; BOEY H, 1989, J ALLERGY CLIN IMMUN, V83, P978, DOI 10.1016/0091-6749(89)90115-2; Core Team R, 2014, R LANG ENV STAT COMP; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Everitt BS, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Gross NJ, 2017, AM J RESP CRIT CARE, V195, P159, DOI 10.1164/rccm.201610-2074PP; Guiddir T, 2017, J ALLER CL IMM-PRACT, V5, P1351, DOI 10.1016/j.jaip.2017.02.003; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Impellizzieri D, 2019, J ALLERGY CLIN IMMUN, V144, P267, DOI 10.1016/j.jaci.2019.01.042; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jarjour NN, 2000, J ALLERGY CLIN IMMUN, V105, P1169, DOI 10.1067/mai.2000.106376; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Teague WG, 2019, J ALLER CL IMM-PRACT, V7, P1803, DOI 10.1016/j.jaip.2018.12.027; Wisniewski JA, 2018, J ALLERGY CLIN IMMUN, V141, P2048, DOI 10.1016/j.jaci.2017.08.020; Woytschak J, 2016, IMMUNITY, V45, P172, DOI 10.1016/j.immuni.2016.06.025; YOUDEN WJ, 1950, CANCER-AM CANCER SOC, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	22	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2021	147	2					686	+		10.1016/j.jaci.2020.05.039	http://dx.doi.org/10.1016/j.jaci.2020.05.039		FEB 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QF1NF	32526308	Green Accepted			2022-12-18	WOS:000616665800030
J	Kanchan, K; Clay, S; Irizar, H; Bunyavanich, S; Mathias, RA				Kanchan, Kanika; Clay, Selene; Irizar, Haritz; Bunyavanich, Supinda; Mathias, Rasika A.			Current insights into the genetics of food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; peanut allergy; genetics; genomics; barrier genes; immune genes; atopic march; Dual Allergen hypothesis; FLG; HLA		Food allergy (FA), a growing public health burden in the United States, and familial aggregation studies support strong roles for both genes and environment in FA risk. Deepening our understanding of the molecular and cellular mechanisms driving FAs is paramount to improving its prevention, diagnosis, and clinical management. In this review, we document lessons learned from the genetics of FA that have aided our understanding of these mechanisms. Although current genetic association studies suffer from low power, heterogeneity in definition of FA, and difficulty in our ability to truly disentangle FA from food sensitization (FS) and general atopy genetics, they reveal a set of genetic loci, genes, and variants that continue to implicate the importance of barrier and immune function genes across the atopic march, and FA in particular. The largest reported effects on FA are from MALT1 (odds ratio, 10.99), FLG (average odds ratio, similar to 2.9), and HLA (average odds ratio, similar to 2.03). The biggest challenge in the field of FA genetics is to elucidate the specific mechanism of action on FA risk and pathogenesis for these loci, and integrative approaches including genetics/genomics with transcriptomics, proteomics, and metabolomics will be critical next steps to translating these genetic insights into practice.	[Kanchan, Kanika; Mathias, Rasika A.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Clay, Selene] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Irizar, Haritz] UCL, Div Psychiat, London, England; [Irizar, Haritz; Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy & Immunol, New York, NY 10029 USA	Johns Hopkins University; University of Chicago; University of London; University College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Mathias, RA (corresponding author), Div Allergy & Clin Immunol, 5501 Hopkins Bayview Circle,3A-62A, Baltimore, MD 21224 USA.	rmathias@jhmi.edu		Clay, Selene/0000-0002-7204-9570	Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [UM1AI109565]; NIH [R01 AI 147028, U19 AI 136053, R01 AI118833]	Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute; National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.K. and R.A.M. are supported in part by the Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute, and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) (award no. UM1AI109565). H.I. and S.B. are supported in part by the NIH (grant nos. NIH R01 AI 147028, U19 AI 136053, and R01 AI118833). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Jacob CMA, 2013, CLINICS, V68, P1004, DOI 10.6061/clinics/2013(07)19; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alberto EJC, 2008, PEDIAT ALLERG IMM-UK, V19, P716, DOI 10.1111/j.1399-3038.2007.00709.x; Amoli MM, 2002, GENES IMMUN, V3, P220, DOI 10.1038/sj.gene.6363872; Asai Y, 2018, J ALLERGY CLIN IMMUN, V141, P1513, DOI 10.1016/j.jaci.2017.10.047; Asai Y, 2018, J ALLERGY CLIN IMMUN, V141, P991, DOI 10.1016/j.jaci.2017.09.015; Asai Y, 2013, J ALLERGY CLIN IMMUN, V132, P239, DOI 10.1016/j.jaci.2013.03.043; Ashley SE, 2017, ALLERGY, V72, P1356, DOI 10.1111/all.13143; Ashley SE, 2017, CLIN EXP ALLERGY, V47, P1032, DOI 10.1111/cea.12942; AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Boehncke WH, 1998, CLIN EXP ALLERGY, V28, P434, DOI 10.1046/j.1365-2222.1998.00246.x; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Buyuktiryaki B, 2016, ALLERGY, V71, P258, DOI 10.1111/all.12785; Campos Eduardo, 2007, Allergol Int, V56, P23, DOI 10.2332/allergolint.O-06-432; Chen TK, 2012, J FORMOS MED ASSOC, V111, P686, DOI 10.1016/j.jfma.2011.11.027; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Davidson WF, 2019, J ALLERGY CLIN IMMUN, V143, P894, DOI 10.1016/j.jaci.2019.01.003; Davis BP, 2016, ANNU REV PATHOL-MECH, V11, P365, DOI 10.1146/annurev-pathol-012615-044241; De Benedetto A, 2008, J INVEST DERMATOL, V128, P1594, DOI 10.1038/sj.jid.5701208; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dreskin SC, 2011, ANN ALLERG ASTHMA IM, V106, P170, DOI 10.1016/j.anai.2010.11.008; Dreskin SC, 2010, CLIN IMMUNOL, V137, P366, DOI 10.1016/j.clim.2010.08.009; du Toit G, 2016, J ALLERGY CLIN IMMUN, V137, P998, DOI 10.1016/j.jaci.2016.02.005; Galli E, 2010, INT J IMMUNOPATH PH, V23, P671, DOI 10.1177/039463201002300233; Gaudieri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030607; Gawronska-Szklarz B, 2001, CLIN PHARMACOL THER, V69, P372, DOI 10.1067/mcp.2001.115541; Gawronska-Szklarz B, 1999, CLIN PHARMACOL THER, V65, P562, DOI 10.1016/S0009-9236(99)70076-7; Gupta RS, 2016, J ALLER CL IMM-PRACT, V4, P956, DOI 10.1016/j.jaip.2016.04.009; Gutierrez-Arcelus M, 2020, NAT GENET, V52, P247, DOI 10.1038/s41588-020-0579-4; Hand S, 2004, CLIN EXP ALLERGY, V34, P720, DOI 10.1111/j.1365-2222.2004.1932.x; Henneman P, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0096-9; Hirota T, 2017, J ALLERGY CLIN IMMUN, V140, P1713, DOI 10.1016/j.jaci.2017.05.034; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; Hong XM, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0460-6; Hourihane JO, 1996, BRIT MED J, V313, P518, DOI 10.1136/bmj.313.7056.518; Howell WM, 1998, CLIN EXP ALLERGY, V28, P156, DOI 10.1046/j.1365-2222.1998.00224.x; Irizar H, 2021, J ALLER CL IMM-PRACT, V9, P119, DOI 10.1016/j.jaip.2020.07.044; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Khor SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18241-w; Kontakioti E, 2014, HUM IMMUNOL, V75, P930, DOI 10.1016/j.humimm.2014.06.022; Koplin JJ, 2016, J ALLERGY CLIN IMMUN, V137, P500, DOI 10.1016/j.jaci.2015.05.051; Koplin JJ, 2013, INT J ENV RES PUB HE, V10, P5364, DOI 10.3390/ijerph10115364; Koppelman GH, 2001, AM J RESP CRIT CARE, V163, P965, DOI 10.1164/ajrccm.163.4.2004164; Kottyan LC, 2019, GENES IMMUN, V20, P281, DOI 10.1038/s41435-018-0034-z; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kusunoki T, 2005, J ALLERGY CLIN IMMUN, V115, P636, DOI 10.1016/j.jaci.2004.12.1114; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Liem Joel J, 2008, Allergy Asthma Clin Immunol, V4, P144, DOI 10.1186/1710-1492-4-4-144; Liu X, 2009, CLIN EXP ALLERGY, V39, P991, DOI 10.1111/j.1365-2222.2009.03228.x; Liu X, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010043, 10.1097/md.0000000000010043]; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Madore AM, 2013, EUR J HUM GENET, V21, P1181, DOI 10.1038/ejhg.2013.13; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Marenholz I, 2018, J ALLERGY CLIN IMMUN, V142, P1368, DOI 10.1016/j.jaci.2018.06.019; Marenholz I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01220-0; Martino DJ, 2017, CLIN EXP ALLERGY, V47, P217, DOI 10.1111/cea.12863; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; MURRAY JS, 1992, EUR J IMMUNOL, V22, P559, DOI 10.1002/eji.1830220239; NISHIMURA Y, 1991, RES IMMUNOL, V142, P459, DOI 10.1016/0923-2494(91)90048-N; ORZECHOWSKAJUZWENKO K, 1990, INT J CLIN PHARM TH, V28, P420; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Pawlik A, 2004, INT ARCH ALLERGY IMM, V133, P233, DOI 10.1159/000076829; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; Rahmoun N, 2018, FETAL PEDIATR PATHOL, V37, P74, DOI 10.1080/15513815.2017.1405468; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rigoli L, 2011, INT J IMMUNOPATH PH, V24, P41, DOI 10.1177/03946320110240S409; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Savilahti EM, 2010, INT ARCH ALLERGY IMM, V152, P169, DOI 10.1159/000265538; Shreffler WG, 2006, ANN ALLERG ASTHMA IM, V96, P865, DOI 10.1016/S1081-1206(10)61351-8; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Tamura K, 2003, INT ARCH ALLERGY IMM, V131, P33, DOI 10.1159/000070432; Tan HTT, 2012, J ALLERGY CLIN IMMUN, V130, P1211, DOI 10.1016/j.jaci.2012.07.022; Tham EH, 2019, ALLERGY ASTHMA IMMUN, V11, P4, DOI 10.4168/aair.2019.11.1.4; Tham EH, 2018, ALLERGY ASTHMA IMMUN, V10, P290, DOI 10.4168/aair.2018.10.4.290; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tsai HJ, 2009, CLIN EXP ALLERGY, V39, P101, DOI 10.1111/j.1365-2222.2008.03111.x; Tsunemi Y, 2002, J DERMATOL SCI, V30, P100, DOI 10.1016/S0923-1811(02)00065-8; van Ginkel CD, 2018, ALLERGY, V73, P1337, DOI 10.1111/all.13432; Varade J, 2011, ANN RHEUM DIS, V70, P711, DOI 10.1136/ard.2010.134593; Venkataraman D, 2014, J ALLERGY CLIN IMMUN, V134, P876, DOI 10.1016/j.jaci.2014.07.033; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Waage J, 2018, NAT GENET, V50, P1072, DOI 10.1038/s41588-018-0157-1; Wahn U, 2000, ALLERGY, V55, P591, DOI 10.1034/j.1398-9995.2000.00111.x; Wataya M, 2001, J HUM GENET, V46, P197, DOI 10.1007/s100380170089; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Winters A, 2019, J ALLERGY CLIN IMMUN, V143, P2326, DOI 10.1016/j.jaci.2019.02.016; Woo JG, 2003, J ALLERGY CLIN IMMUN, V112, P438, DOI 10.1067/mai.2003.1634; Ying XJ, 2013, GENE, V521, P222, DOI 10.1016/j.gene.2013.03.088; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18; Zielinska E, 1997, CLIN PHARMACOL THER, V62, P635, DOI 10.1016/S0009-9236(97)90083-7; Ziyab AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032721	114	15	15	5	23	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					15	28		10.1016/j.jaci.2020.10.039	http://dx.doi.org/10.1016/j.jaci.2020.10.039		JAN 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	33436162	Green Accepted			2022-12-18	WOS:000613645900002
J	Kao, SST; Bassiouni, A; Ramezanpour, M; Finnie, J; Chegeni, N; Colella, AD; Chataway, TK; Wormald, PJ; Vreugde, S; Psaltis, AJ				Kao, Stephen Shih-Teng; Bassiouni, Ahmed; Ramezanpour, Mahnaz; Finnie, John; Chegeni, Nusha; Colella, Alex D.; Chataway, Timothy K.; Wormald, Peter-John; Vreugde, Sarah; Psaltis, Alkis James			Rhinitis, sinusitis, allergy Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal mucus; proteomics; chronic rhinosinusitis; nasal polyps endotypes; proteins		Background: Chronic rhinosinusitis (CRS) has a complex and multifactorial pathogenesis with a heterogeneous inflammatory profile. Proteomic analysis of nasal mucus may enable further understanding of protein abundances and biologic processes present in CRS and its endotypes compared with in healthy patients. Objective: Our aim was to determine differences in the nasal mucus proteome of healthy patients and patients with CRS. Methods: Nasal mucus was obtained from healthy patients, patients with CRS without nasal polyps (CRSsNP), and patients with CRS with nasal polyps (CRSwNP) before surgery. Gel electrophoresis was performed to fractionate the complex protein extracts before mass spectrometry analysis. Gene set enrichment analysis was performed on differentially expressed proteins. Results: A total of 33 patients were included in this study (12 healthy, 10 with CRSsNP, and 11 with CRSwNP). In all, 1142 proteins were identified in mucus samples from healthy patients, 761 in mucus samples from patients with CRSsNP, and 998 in mucus samples from patients with CRSwNP. Dysfunction in immunologic pathways, reduced cellular signaling, and increased cellular metabolism with associated tissue remodeling pathways were present in patients with CRS compared with in healthy patients. Conclusion: Significant downregulation of mucosal immunity and antioxidant pathways with increased tissue modeling processes may account for the clinical manifestations of CRS. Ultimately, the differing proteome and biologic processes provide further insight into CRS pathogenesis and its endotypes.	[Kao, Stephen Shih-Teng; Bassiouni, Ahmed; Ramezanpour, Mahnaz; Wormald, Peter-John; Vreugde, Sarah; Psaltis, Alkis James] Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Woodville South, Australia; [Finnie, John; Chegeni, Nusha; Colella, Alex D.; Chataway, Timothy K.] Univ Adelaide, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia; [Finnie, John; Chegeni, Nusha; Colella, Alex D.; Chataway, Timothy K.] South Australia Pathol, Adelaide, SA, Australia; [Chegeni, Nusha; Colella, Alex D.; Chataway, Timothy K.] Flinders Univ S Australia, Flinders Prote Facil, Dept Human Physiol, Bedford Pk, SA, Australia	University of Adelaide; University of Adelaide; Flinders University South Australia	Psaltis, AJ (corresponding author), Queen Elizabeth Hosp, Dept Otolaryngol Head & Neck Surg, 28 Woodville Rd, Woodville South, SA 5011, Australia.	alkis.psaltis@adelaide.edu.au		Chataway, Tim/0000-0003-0254-8099	Adelaide University Research Training Program Scholarship; Bertha Sudholz Research Scholarship; Garnett Passe Rodney Williams Memorial Foundation Scholarship	Adelaide University Research Training Program Scholarship; Bertha Sudholz Research Scholarship; Garnett Passe Rodney Williams Memorial Foundation Scholarship	This project was supported by the Adelaide University Research Training Program Scholarship, Bertha Sudholz Research Scholarship, and Garnett Passe Rodney Williams Memorial Foundation Scholarship.	[Anonymous], 2013, R FDN STAT COMP; Azuma YT, 2011, CURR PHARM DESIGN, V17, P3776, DOI 10.2174/138161211798357845; Brook I, 2016, EUR J CLIN MICROBIOL, V35, P1059, DOI 10.1007/s10096-016-2640-x; Candia J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14755-5; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Cohen NA, 2017, LARYNGOSCOPE, V127, P44, DOI 10.1002/lary.26198; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Ding GQ, 2007, AM J RHINOL, V21, P359, DOI 10.2500/ajr.2007.21.3037; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dowle AA, 2016, J PROTEOME RES, V15, P3550, DOI 10.1021/acs.jproteome.6b00308; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952; Garcia-Ponce A, 2015, THROMB HAEMOSTASIS, V113, P20, DOI 10.1160/TH14-04-0298; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Hennebert E, 2015, J PROTEOMICS, V128, P83, DOI 10.1016/j.jprot.2015.07.002; Hovenberg HW, 1996, GLYCOCONJUGATE J, V13, P839, DOI 10.1007/BF00702348; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kammerl IE, 2016, AM J PHYSIOL-LUNG C, V311, pL328, DOI 10.1152/ajplung.00156.2016; Kao SST, 2020, RHINOLOGY, V58, P418, DOI 10.4193/Rhin20.034; Kao SST, 2019, INT FORUM ALLERGY RH, V9, P1220, DOI 10.1002/alr.22401; Kao SST, 2020, ALLERGY, V75, P200, DOI 10.1111/all.13964; Kim DH, 2004, ARCH OTOLARYNGOL, V130, P747, DOI 10.1001/archotol.130.6.747; Kim DY, 2015, ALLERGY ASTHMA IMMUN, V7, P421, DOI 10.4168/aair.2015.7.5.421; Kim T, 2011, ALLERGY, V66, P466; Kimura H, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/541984; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kohli P, 2017, EMBO REP, V18, P1521, DOI 10.15252/embr.201643846; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lai XP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01682; Lee CW, 2009, ARCH OTOLARYNGOL, V135, P771, DOI 10.1001/archoto.2009.97; Lee RJ, 2014, AM J RHINOL ALLERGY, V28, P366, DOI 10.2500/ajra.2014.28.4077; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liu Z, 2004, J ALLERGY CLIN IMMUN, V114, P783, DOI 10.1016/j.jaci.2004.04.052; Logdberg L, 2000, BBA-PROTEIN STRUCT M, V1482, P284, DOI 10.1016/S0167-4838(00)00164-3; Lu XQ, 2018, ANN HUM GENET, V82, P102, DOI 10.1111/ahg.12230; Maina Ivy W, 2018, World J Otorhinolaryngol Head Neck Surg, V4, P200, DOI 10.1016/j.wjorl.2018.07.003; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mollenhauer J, 2007, INMUNOLOGIA, V26, P193, DOI DOI 10.1016/S0213-9626(07)70089-6; Mueller SK, 2019, INT FORUM ALLERGY RH, V9, P177, DOI 10.1002/alr.22226; Mueller SK, 2018, INT FORUM ALLERGY RH, V8, P1438, DOI 10.1002/alr.22189; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Ould-Abeih MB, 2012, BIOCHEMISTRY-US, V51, P4807, DOI 10.1021/bi300335r; Park SW, 2013, CLIN EXP ALLERGY, V43, P914, DOI 10.1111/cea.12143; Pothoven KL, 2017, J ALLERGY CLIN IMMUN, V139, P1966, DOI 10.1016/j.jaci.2016.10.039; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; Sabatini F, 2013, EUR J PHARMACOL, V710, P100, DOI 10.1016/j.ejphar.2013.03.048; Schmaier AH, 2016, J THROMB HAEMOST, V14, P28, DOI 10.1111/jth.13194; Shaw L, 2011, BIOCHEM SOC T, V39, P1450, DOI 10.1042/BST0391450; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tomazic PV, 2015, LARYNGOSCOPE, V125, pE91, DOI 10.1002/lary.25003; Tsai YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126853; Turner JH, 2018, J ALLERGY CLIN IMMUN, V141, P1895, DOI 10.1016/j.jaci.2018.02.002; Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Vyssoulis GP, 2007, AM J HYPERTENS, V20, P1016, DOI 10.1016/j.amjhyper.2007.01.010; Wang DD, 2016, AM J PATHOL, V186, P844, DOI 10.1016/j.ajpath.2015.11.023; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Witke W, 2001, J CELL BIOL, V154, P775, DOI 10.1083/jcb.200101113; Wu W, 2017, ONCOL LETT, V14, P5549, DOI 10.3892/ol.2017.6888; Yoshikawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35102-2; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809; Zheng Y, 2008, IMMUNOLOGY, V124, P357, DOI 10.1111/j.1365-2567.2007.02782.x	67	15	16	3	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					168	178		10.1016/j.jaci.2020.06.037	http://dx.doi.org/10.1016/j.jaci.2020.06.037		JAN 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QA7UA	32750382	Bronze			2022-12-18	WOS:000613645900021
J	Nakkam, N; Gibson, A; Mouhtouris, E; Konvinse, KC; Holmes, NE; Chua, KY; Deshpande, P; Li, DM; Ostrov, DA; Trubiano, J; Phillips, EJ				Nakkam, Nontaya; Gibson, Andrew; Mouhtouris, Effie; Konvinse, Katherine C.; Holmes, Natasha E.; Chua, Kyra Y.; Deshpande, Pooja; Li, Danmeng; Ostrov, David A.; Trubiano, Jason; Phillips, Elizabeth J.			Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A*32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							HYPERSENSITIVITY SYNDROME		[Nakkam, Nontaya] Khon Kaen Univ, Dept Pharmacol, Fac Med, Khon Kaen, Thailand; [Nakkam, Nontaya; Konvinse, Katherine C.; Phillips, Elizabeth J.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Gibson, Andrew; Deshpande, Pooja; Phillips, Elizabeth J.] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia; [Mouhtouris, Effie; Holmes, Natasha E.; Chua, Kyra Y.] Univ Melbourne, Austin Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Deshpande, Pooja] Univ Western Australia, Sch Human Sci, Nedlands, WA, Australia; [Li, Danmeng; Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Trubiano, Jason] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Khon Kaen University; Vanderbilt University; Murdoch University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Western Australia; State University System of Florida; University of Florida; Peter Maccallum Cancer Center	Phillips, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.; Phillips, EJ (corresponding author), Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia.	elizabeth.j.phillips@vumc.org		Gibson, Andrew/0000-0001-9653-3298; Konvinse, Katherine/0000-0003-2451-9256; Chua, Kyra Yu Lin/0000-0001-8826-7137; Nakkam, Nontaya/0000-0003-1631-3178	National Institutes of Health [1P50GM11530501, R21AI139021, R34AI136815, 1 R01 HG010863-01, F30AI131780, T32GM7347]; National Health and Medical Research Council of Australia; National Health and Medical Research Council postgraduate scholarship [GNT 1139902]; National Centre for Infections in Cancer	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); National Centre for Infections in Cancer	E.J.P. receives funding from the National Institutes of Health (grants 1P50GM11530501, R21AI139021, R34AI136815, and 1 R01 HG010863-01) and the National Health and Medical Research Council of Australia). J.A.T. is supported by a National Health and Medical Research Council postgraduate scholarship (GNT 1139902) and postgraduate scholarship from the National Centre for Infections in Cancer. K.C.K. is supported by the National Institutes of Health (grants F30AI131780 and T32GM7347).	Ben Romdhane H, 2018, MED MALADIES INFECT, V48, P291, DOI 10.1016/j.medmal.2018.01.002; Blumenthal KG, 2019, LANCET, V393, P183, DOI 10.1016/S0140-6736(18)32218-9; Hsiao SH, 2010, J CLIN PHARM THER, V35, P729, DOI 10.1111/j.1365-2710.2009.01124.x; Konvinse KC, 2019, J ALLERGY CLIN IMMUN, V144, P183, DOI 10.1016/j.jaci.2019.01.045; Kwon HS, 2006, J KOREAN MED SCI, V21, P1108, DOI 10.3346/jkms.2006.21.6.1108; Lye D, 2007, INT J ANTIMICROB AG, V29, P476, DOI 10.1016/j.ijantimicag.2006.11.022; Miyazu D, 2016, AM J CASE REP, V17, P625, DOI 10.12659/AJCR.899149; Trubiano JA, 2018, J ALLER CL IMM-PRACT, V6, P1287, DOI 10.1016/j.jaip.2017.09.004; Van Bambeke F, 2015, DRUGS, V75, P2073, DOI 10.1007/s40265-015-0505-8	9	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2021	147	1					403	405		10.1016/j.jaci.2020.04.056	http://dx.doi.org/10.1016/j.jaci.2020.04.056		JAN 2021	3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PS2UA	32439433	Green Accepted, Bronze			2022-12-18	WOS:000607781700018
J	Mummy, DG; Carey, KJ; Evans, MD; Denlinger, LC; Schiebler, ML; Sorkness, RL; Jarjour, NN; Fain, SB				Mummy, David G.; Carey, Katherine J.; Evans, Michael D.; Denlinger, Loren C.; Schiebler, Mark L.; Sorkness, Ronald L.; Jarjour, Nizar N.; Fain, Sean B.			Ventilation defects on hyperpolarized helium-3 MRI in asthma are predictive of 2-year exacerbation frequency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; magnetic resonance imaging; functional; airway obstruction; patient outcomes assessment	NATIONAL HEART; LUNG; PHENOTYPE; FEATURES; CARE	Background: There is an unmet need for an objective biomarker to predict asthma exacerbations. Objective: Our aim was to assess the ventilation defect percent (VDP) on hyperpolarized helium-3 magnetic resonance imaging as a predictor of exacerbation frequency following imaging. Methods: Subjects underwent hyperpolarized helium-3 and conventional clinical measurements, including pulmonary function tests, during a period of disease stability, and exacerbations were recorded prospectively over the following 2 years. We used a Poisson regression tree model to estimate an optimal VDP threshold for classifying subjects into high- versus low-exacerbation groups and then used statistical regression to compare this VDP threshold against conventional clinical measures as predictors of exacerbations. Results: A total of 67 individuals with asthma (27 males and 40 females, 28 with mild-to-moderate asthma and 39 with severe asthma) had a median VDP of 3.75% (1.2% [first quartile]-7.9% [third quartile]). An optimal VDP threshold of 4.28% was selected on the basis of the maximum likelihood estimation of the regression tree model. Subjects with a VDP greater than 4.28% (n 5 32) had a median of 1.5 exacerbations versus 0.0 for subjects with a VDP less than 4.28% (n 5 35). In a stepwise= multivariate regression model, a VDP greater than 4.28% was associated with an exacerbation incidence rate ratio of 2.5 (95% CI 5 1.3-4.7) versus a VDP less than or equal to 4.28%. However, once individual medical history was included in the model, VDP was no longer significant. Nonetheless, VDP may provide an objective and complementary quantitative marker of individual exacerbation risk that is useful for monitoring individual change in disease status, selecting patients for therapy, and assessing treatment response. Conclusion: VDP measured with magnetic resonance imaging shows promise as a biomarker of prospective asthma.	[Mummy, David G.] Duke Univ, Dept Radiol, Durham, NC 27706 USA; [Mummy, David G.] Duke Univ, Ctr In Vivo Microscopy, Durham, NC 27706 USA; [Carey, Katherine J.; Fain, Sean B.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Carey, Katherine J.; Schiebler, Mark L.; Fain, Sean B.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Denlinger, Loren C.; Jarjour, Nizar N.] Univ Wisconsin, Div Allergy Pulm & Crit Care Med, Madison, WI 53706 USA; [Sorkness, Ronald L.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Fain, Sean B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Evans, Michael D.] Univ Minnesota Twin Cities, Clin & Translat Sci Inst, Minneapolis, MN USA	Duke University; Duke University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Fain, SB (corresponding author), Wisconsin Inst Med Res, Dept Med Phys, Rm 2488,1111 Highland Ave, Madison, WI 53705 USA.	sfain@wisc.edu	; Fain, Sean/K-4260-2016	Mummy, David/0000-0001-7885-109X; Fain, Sean/0000-0001-5461-0646; Evans, Michael/0000-0001-7449-3993	National Institutes of Health/National Heart, Lung, and Blood Institute [U10 HL109168]; National Institutes of Health Clinical Translation and Science Award [UL/TR000427]; National Institutes of Health/National Center for Advancing Translational Sciences [S10 OD016394]; Wisconsin Alumni Research Foundation technology transfer training grant	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Clinical Translation and Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Advancing Translational Sciences; Wisconsin Alumni Research Foundation technology transfer training grant	Funding for this study was provided by National Institutes of Health/National Heart, Lung, and Blood Institute grant U10 HL109168, National Institutes of Health Clinical Translation and Science Award grant UL/TR000427, National Institutes of Health/National Center for Advancing Translational Sciences S10 OD016394, and aWisconsin Alumni Research Foundation technology transfer training grant. The funding sources had no involvement in study design; the collection, analysis, or interpretation of data; the writing of this report; or the decision to submit this article for publication.	Denlinger LC, 2017, AM J RESP CRIT CARE, V195; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Dunican EM, 2018, J CLIN INVEST, V128; Fain SB, 2008, ACAD RADIOL, V15, P753, DOI 10.1016/j.acra.2007.10.019; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Ivanova JI, 2012, J ALLERGY CLIN IMMUN, V129, P1229, DOI 10.1016/j.jaci.2012.01.039; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Kirby M, 2015, RADIOLOGY, V277, P872, DOI 10.1148/radiol.2015150037; Koga T, 2006, RESP MED, V100, P273, DOI 10.1016/j.rmed.2005.05.017; Kupczyk M, 2014, CLIN EXP ALLERGY, V44, P212, DOI 10.1111/cea.12179; Leuppi JD, 2001, AM J RESP CRIT CARE, V163, P406, DOI 10.1164/ajrccm.163.2.9912091; Meltzer EO, 2011, J ALLERGY CLIN IMMUN, V127, P167, DOI 10.1016/j.jaci.2010.08.042; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Mummy DG, 2018, J ALLERGY CLIN IMMUN, V141, P1140, DOI 10.1016/j.jaci.2017.10.016; Osborne ML, 2007, CHEST, V132, P1151, DOI 10.1378/chest.05-3084; Price DB, 2015, LANCET RESP MED, V3, P849, DOI 10.1016/S2213-2600(15)00367-7; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; R Core Team, 2018, R LANG ENV STAT COMP; Svenningsen S, 2019, CHEST, V155, P1178, DOI 10.1016/j.chest.2019.02.403; Svenningsen S, 2018, AM J RESP CRIT CARE, V197, P876, DOI 10.1164/rccm.201709-1948OC; Teague WG, 2018, J ALLER CL IMM-PRACT, V6, P545, DOI 10.1016/j.jaip.2017.05.032; Thomen RP, 2015, RADIOLOGY, V274, P250, DOI 10.1148/radiol.14140080; Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629; Zelleis A, 2008, J COMPUT GRAPH STAT, V17, P492, DOI 10.1198/106186008X319331; Zha W, 2018, ACAD RADIOL, V25, P169, DOI 10.1016/j.acra.2017.09.014	28	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					831	+		10.1016/j.jaci.2020.02.029	http://dx.doi.org/10.1016/j.jaci.2020.02.029			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32173351	Green Accepted			2022-12-18	WOS:000582395800014
J	Shock, A; Humphreys, D; Nimmerjahn, F				Shock, Anthony; Humphreys, David; Nimmerjahn, Falk			Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fc gamma receptors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Intravenous immunoglobulin; Fc gamma receptors autoimmunity; inflammation; neonatal Fc receptor	IMMUNE THROMBOCYTOPENIC PURPURA; B-CELL RECEPTOR; MONOCLONAL-ANTIBODY; IN-VITRO; RECOMBINANT; IVIG; AMELIORATION; COMPLEMENT; MULTIMERS; RIIB	Since the first description of the administration of high doses of pooled serum IgG, also referred to as intravenous IgG (IVIg) therapy, as being able to ameliorate various autoimmune diseases, researchers have been investigating which molecular and cellular pathways underlie IVIg activity. Apart from trying to understand the obvious conundrum that IgG can trigger both autoimmune pathology and resolution of inflammation, the rapidly expanding use of IVIg has led to a lack of availability of this primary blood product, providing a strong rationale for developing recombinant alternatives. During the last decade, a tremendous number of novel insights into IVIg activity brought the goal of replacing IVIg within reach, at least in select indications, and has led to the initiation of several clinical trials. At the forefront of this effort is the modulation of autoantibody half-life and blocking access of autoantibodies to fragment cystallizable gamma receptors (Fc gamma receptors). In this rostrum article, we will briefly discuss current models of IVIg activity, followed by a more specific focus on novel therapeutic avenues that are entering the clinic and may replace IVIg in the future.	[Shock, Anthony; Humphreys, David] UCB Pharma, Slough, Berks, England; [Nimmerjahn, Falk] Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Inst Genet, Erwin Rommelstr 3, D-91054 Erlangen, Germany; [Nimmerjahn, Falk] Med Immunol Campus Erlangen, Erlangen, Germany	UCB Pharma SA; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Nimmerjahn, F (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Biol, Inst Genet, Erwin Rommelstr 3, D-91054 Erlangen, Germany.	falk.nimmerjahn@fau.de			UCB Pharma; Good Publications Practice (GPP3) guidelines	UCB Pharma(UCB Pharma SA); Good Publications Practice (GPP3) guidelines	This article was written by the authors with editorial support funded by UCB Pharma in accordance with Good Publications Practice (GPP3) guidelines (http://www.ismpp.org/gpp3).The article was reviewed and approved for publication by all authors and the sponsor. The authors acknowledge Linda Feighery, PhD, CMPP, and Veronica Porkess, PhD, CMPP, of UCB Pharma for publication and editorial support.	Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Arroyo S, 2019, BLOOD, V134, DOI 10.1182/blood-2019-125993; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Bazin R, 2004, BRIT J HAEMATOL, V127, P90, DOI 10.1111/j.1365-2141.2004.05105.x; Ben Mkaddem S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00811; Bleeker WK, 2000, BLOOD, V95, P1856, DOI 10.1182/blood.V95.5.1856.005k03_1856_1861; Blundell PA, 2017, J BIOL CHEM, V292, P12994, DOI 10.1074/jbc.M117.795047; Bolli R, 2010, BIOLOGICALS, V38, P150, DOI 10.1016/j.biologicals.2009.09.002; Chen B, 2019, ANN RHEUM DIS, V78, P228, DOI 10.1136/annrheumdis-2018-213523; Chen W, 2017, ANN RHEUM DIS, V76, P777, DOI 10.1136/annrheumdis-2017-eular.6434; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; Crow AR, 2008, TRANSFUS MED REV, V22, P103, DOI 10.1016/j.tmrv.2007.12.001; Crow AR, 2011, BLOOD, V118, P6403, DOI 10.1182/blood-2011-08-374223; Czajkowsky DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09526; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Fallah-Arani F, 2015, Multimer Fc proteins, Patent No. [WO2015132364, 2015132364]; Fiebiger BM, 2015, P NATL ACAD SCI USA, V112, pE2385, DOI 10.1073/pnas.1505292112; Flaherty MM, 2012, TOXICOL SCI, V125, P299, DOI 10.1093/toxsci/kfr278; Galeotti C, 2017, INT IMMUNOL, V29, P491, DOI 10.1093/intimm/dxx039; Gershman A, 2016, AM J RESP CRIT CARE, V193; Goulet DR, 2020, PROTEINS, V88, P689, DOI 10.1002/prot.25853; Griffin RA, 2015, United States patent, Patent No. [WO2015158867A1, 2015158867]; Hansen RJ, 2002, THROMB HAEMOSTASIS, V88, P898, DOI 10.1055/s-0037-1613331; Hartung HP, 2009, CLIN EXP IMMUNOL, V158, P23, DOI [10.1111/j.1365-2249.2009.04024.X, 10.1111/j.1365-2249.2009.04024.x]; Horton HM, 2011, J IMMUNOL, V186, P4223, DOI 10.4049/jimmunol.1003412; Hsu Y-M, 2017, United States Patent, Patent No. [WO2017172853A1, 2017172853]; Iwata H, 2015, J INVEST DERMATOL, V135, P916, DOI 10.1038/jid.2014.451; Jain A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4024; Konstaninova TS, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.3388.3388; Lo MS, 2018, INT J RHEUM DIS, V21, P64, DOI 10.1111/1756-185X.13220; Ludwig RJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00603; Machino Y, 2012, BIOCHEM BIOPH RES CO, V418, P748, DOI 10.1016/j.bbrc.2012.01.092; Magnusson SE, 2008, CLIN IMMUNOL, V127, P225, DOI 10.1016/j.clim.2008.02.002; Mekhaiel DNA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00124; Miescher SM, 2005, ANN NY ACAD SCI, V1051, P582, DOI 10.1196/annals.1361.102; Niknami M, 2013, J PERIPHER NERV SYST, V18, P141, DOI 10.1111/jns5.12022; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ortiz DF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9418; Patel DD, 2020, J ALLERGY CLIN IMMUN, V146, P467, DOI 10.1016/j.jaci.2020.07.015; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Qureshi OS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17255-8; Rieth N, 2014, IMMUNOL LETT, V160, P145, DOI 10.1016/j.imlet.2014.01.012; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Rowley TF, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0149-9; Scaradavou A, 1997, BLOOD, V89, P2689, DOI 10.1182/blood.V89.8.2689; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Seeling M, 2017, NAT REV RHEUMATOL, V13, P621, DOI 10.1038/nrrheum.2017.146; Shashidharamurthy R, 2008, BLOOD, V111, P894, DOI 10.1182/blood-2007-04-085944; Spirig R, 2018, J IMMUNOL, V200, P2542, DOI 10.4049/jimmunol.1701171; Sun HP, 2017, J AUTOIMMUN, V84, P97, DOI 10.1016/j.jaut.2017.08.004; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Tillmanns S, 2014, ARTHRITIS RHEUMATOL, V66, pS1238; Tradtrantip L, 2018, NEUROPHARMACOLOGY, V133, P345, DOI 10.1016/j.neuropharm.2018.02.002; Washburn N, 2015, P NATL ACAD SCI USA, V112, pE1297, DOI 10.1073/pnas.1422481112; Zhang XY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.121905; Zhou H, 2017, BLOOD ADV, V1, P504, DOI 10.1182/bloodadvances.2016001917	60	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2020	146	3					492	500		10.1016/j.jaci.2020.06.036	http://dx.doi.org/10.1016/j.jaci.2020.06.036			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NO0HS	32721416	hybrid			2022-12-18	WOS:000569168900003
J	Grozdanovic, MM; Doyle, CB; Liu, L; Maybruck, BT; Kwatia, MA; Thiyagarajan, N; Acharya, KR; Ackerman, SJ				Grozdanovic, Milica M.; Doyle, Christine B.; Liu, Li; Maybruck, Brian T.; Kwatia, Mark A.; Thiyagarajan, Nethaji; Acharya, K. Ravi; Ackerman, Steven J.			Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophils; galectins; Charcot-Leyden; ribonucleases; EDN; ECP; RNase 2; RNase 3; granulogenesis	MAJOR BASIC-PROTEIN; MYELOID CELL-LINE; MOLECULAR-CLONING; PIECEMEAL DEGRANULATION; ULTRASTRUCTURAL-LOCALIZATION; LYSOPHOSPHOLIPASE ACTIVITY; MESSENGER-RNA; T-CELLS; GRANULE; GALECTIN-10	Background: The human eosinophil Charcot-Leyden crystal (CLC) protein is a member of the Galectin superfamily and is also known as galectin-10 (Gal-10). CLC/Gal-10 forms the distinctive hexagonal bipyramidal crystals that are considered hallmarks of eosinophil participation in allergic responses and related inflammatory reactions; however, the glycan-containing ligands of CLC/Gal-10, its cellular function(s), and its role(s) in allergic diseases are unknown. Objective: We sought to determine the binding partners of CLC/Gal-10 and elucidate its role in eosinophil biology. Methods: Intracellular binding partners were determined by ligand blotting with CLC/Gal-10, followed by coimmunoprecipitation and coaffinity purifications. The role of CLC/Gal-10 in eosinophil function was determined by using enzyme activity assays, confocal microscopy, and short hairpin RNA knockout of CLC/Gal-10 expression in human CD34(+) cord blood hematopoietic progenitors differentiated to eosinophils. Results: CLC/Gal-10 interacts with both human eosinophil granule cationic ribonucleases (RNases), namely, eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3), and with murine eosinophil-associated RNases. The interaction is independent of glycosylation and is not inhibitory toward endoRNase activity. Activation of eosinophils with INF-gamma induces the rapid colocalization of CLC/Gal-10 with eosinophil-derived neurotoxin/RNS2 and CD63. Short hairpin RNA knockdown of CLC/Gal-10 in human cord blood derived CD34+ progenitor cells impairs eosinophil granulogenesis. Conclusions: CLC/Gal-10 functions as a carrier for the sequestration and vesicular transport of the potent eosinophil granule cationic RNases during both differentiation and degranulation, enabling their intracellular packaging and extracellular functions in allergic inflammation.	[Grozdanovic, Milica M.; Doyle, Christine B.; Liu, Li; Maybruck, Brian T.; Kwatia, Mark A.; Ackerman, Steven J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA; [Thiyagarajan, Nethaji; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Bath	Ackerman, SJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, MC669,Mol Biol Res Bldg,Rm 2074,900 S Ashland Ave, Chicago, IL 60607 USA.	sackerma@uic.edu		Acharya, K. Ravi/0000-0002-3009-4058	National Institutes of Health (NIH) [AI025230]; NIH [T32 DK07739]; NIH National Research Service Award Fellowship [F32 AI51137]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a grant from the National Institutes of Health (NIH) (AI025230) to S. J. Ackerman. C. B. Doyle and L. Liu were supported in part by an institutional NIH training grant T32 DK07739 (to S.J.A.). L. Liu was also supported in part by an individual NIH National Research Service Award Fellowship (F32 AI51137). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. These funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Acharya KR, 2014, J BIOL CHEM, V289, P17406, DOI 10.1074/jbc.R113.546218; ACKERMAN SJ, 1980, J IMMUNOL, V125, P2118; ACKERMAN SJ, 1993, J IMMUNOL, V150, P456; ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; ACKERMAN SJ, 1982, J EXP MED, V155, P1597, DOI 10.1084/jem.155.6.1597; Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; ACKERMAN SJ, 1981, J IMMUNOL, V127, P1093; Ackerman SJ, 2013, BLOOD, V122, P621, DOI 10.1182/blood-2013-06-508507; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baines KJ, 2014, J ALLERGY CLIN IMMUN, V133, P997, DOI 10.1016/j.jaci.2013.12.1091; BARKER RL, 1989, J IMMUNOL, V143, P952; Batten D, 1997, NUCLEIC ACIDS RES, V25, P4235, DOI 10.1093/nar/25.21.4235; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; BUTTERFIELD JH, 1984, EXP HEMATOL, V12, P163; Calafat J, 1997, EUR J HAEMATOL, V58, P56; Carmo LAS, 2016, J LEUKOCYTE BIOL, V100, P391, DOI 10.1189/jlb.3A1015-480R; Chua JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042549; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; De Re V, 2009, ANN NY ACAD SCI, V1173, P357, DOI 10.1111/j.1749-6632.2009.04627.x; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; DOR PJ, 1984, AM REV RESPIR DIS, V130, P1072; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Dvorak AM, 1997, INT ARCH ALLERGY IMM, V113, P465, DOI 10.1159/000237624; DVORAK AM, 1988, BLOOD, V72, P150; Dyer KD, 2010, J IMMUNOL, V184, P6327, DOI 10.4049/jimmunol.0904043; Furuta GT, 2013, GUT, V62, P1395, DOI 10.1136/gutjnl-2012-303171; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; GLEICH GJ, 1976, J CLIN INVEST, V57, P633, DOI 10.1172/JCI108319; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; GOLIGHTLY LM, 1992, J LEUKOCYTE BIOL, V51, P386, DOI 10.1002/jlb.51.4.386; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; Hoffmann HJ, 2001, BIOCHEM BIOPH RES CO, V282, P194, DOI 10.1006/bbrc.2001.4499; Iyer S, 2005, J MOL BIOL, V347, P637, DOI 10.1016/j.jmb.2005.01.035; Krieg J, 1997, J BIOL CHEM, V272, P26687, DOI 10.1074/jbc.272.42.26687; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Kuwasaki T, 1998, INT ARCH ALLERGY IMM, V117, P77, DOI 10.1159/000053578; Lacy P, 2001, J ALLERGY CLIN IMMUN, V107, P671, DOI 10.1067/mai.2001.113562; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leffler H, 2001, Results Probl Cell Differ, V33, P57; Leffler H, 2018, TRENDS GLYCOSCI GLYC, V31, pSE129, DOI 10.4052/tigg.1724.1SE; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Leonidas DD, 1995, STRUCTURE, V3, P1379, DOI 10.1016/S0969-2126(01)00275-1; Lin TA, 2010, BIOMARKERS, V15, P646, DOI 10.3109/1354750X.2010.511266; Lingblom C, 2017, ALLERGY, V72, P1406, DOI 10.1111/all.13140; Lingblom C, 2017, J IMMUNOL, V198, P4672, DOI 10.4049/jimmunol.1601005; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Logan MR, 2006, ALLERGY, V61, P777, DOI 10.1111/j.1398-9995.2006.01089.x; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Mahmudi-Azer S, 2002, BLOOD, V99, P4039, DOI 10.1182/blood.V99.11.4039; Melo RCN, 2005, TRAFFIC, V6, P866, DOI 10.1111/j.1600-0854.2005.00322.x; Melo RCN, 2010, HISTOL HISTOPATHOL, V25, P1341, DOI 10.14670/HH-25.1341; Mohan CG, 2002, BIOCHEMISTRY-US, V41, P12100, DOI 10.1021/bi0264521; Moqbel R, 2000, CHEM IMMUNOL, V78, P189; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; PAUL CC, 1994, J LEUKOCYTE BIOL, V56, P74, DOI 10.1002/jlb.56.1.74; PAUL CC, 1995, BLOOD, V86, P3737, DOI 10.1182/blood.V86.10.3737.bloodjournal86103737; PAUL CC, 1993, BLOOD, V81, P1193; Percopo CM, 2019, J LEUKOCYTE BIOL, V105, P151, DOI 10.1002/JLB.3AB0318-090RR; Person I.K, 2010, SCIENCE, V364; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Robin C, 1853, GASTROENTEROLOGY, P44; ROSENBERG HF, 1995, J BIOL CHEM, V270, P7876, DOI 10.1074/jbc.270.14.7876; Rosenberg HF, 1998, CELL MOL LIFE SCI, V54, P795, DOI 10.1007/s000180050208; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; ROSENBERG HF, 1989, J EXP MED, V170, P163, DOI 10.1084/jem.170.1.163; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Schoepfer AM, 2013, GASTROENTEROLOGY, V145; Simon D, 2011, J ALLERGY CLIN IMMUN, V127, P194, DOI 10.1016/j.jaci.2010.11.002; Su JY, 2018, MOLECULES, V23, DOI 10.3390/molecules23112931; Su JY, 2019, GLYCOBIOLOGY, V29, P85, DOI 10.1093/glycob/cwy087; Su JY, 2018, GLYCOBIOLOGY, V28, P159, DOI 10.1093/glycob/cwx107; Su JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19465-0; Swaminathan GJ, 1999, BIOCHEMISTRY-US, V38, P13837, DOI 10.1021/bi990756e; Swaminathan GJ, 2002, BIOCHEMISTRY-US, V41, P3341, DOI 10.1021/bi015911f; Trulson A, 2007, CLIN EXP ALLERGY, V37, P208, DOI 10.1111/j.1365-2222.2007.02644.x; UDELL IJ, 1981, AM J OPHTHALMOL, V92, P824, DOI 10.1016/S0002-9394(14)75637-5; von Leyden EV, 1872, VIRCHOWS ARCH, V54, P324; WELLER PF, 1982, J IMMUNOL, V128, P1346; WELLER PF, 1984, J BIOL CHEM, V259, P5100; WELLER PF, 1980, P NATL ACAD SCI-BIOL, V77, P7440, DOI 10.1073/pnas.77.12.7440; WELLER PF, 1981, T ASSOC AM PHYSICIAN, V94, P165; Willetts L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0081-z; Yang D, 2003, BLOOD, V102, P3396, DOI 10.1182/blood-2003-01-0151; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	95	15	15	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					377	+		10.1016/j.jaci.2020.01.013	http://dx.doi.org/10.1016/j.jaci.2020.01.013			23	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	31982451	Green Accepted			2022-12-18	WOS:000558835000028
J	Rekima, A; Bonnart, C; Macchiaverni, P; Metcalfe, J; Tulic, MK; Halloin, N; Rekima, S; Genuneit, J; Zanelli, S; Medeiros, S; Palmer, DJ; Prescott, S; Verhasselt, V				Rekima, Akila; Bonnart, Chrystelle; Macchiaverni, Patricia; Metcalfe, Jessica; Tulic, Meri K.; Halloin, Nicolas; Rekima, Samah; Genuneit, Jon; Zanelli, Samantha; Medeiros, Samara; Palmer, Debra J.; Prescott, Susan; Verhasselt, Valerie			A role for early oral exposure to house dust mite allergens through breast milk in IgE-mediated food allergy susceptibility	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						House dust mite; food allergy; breast-feeding; protease	I HYPERSENSITIVITY RESPONSE; CYSTEINE PROTEASE ACTIVITY; INNATE LYMPHOID-CELLS; GASTROINTESTINAL-TRACT; PROTEOLYTIC ACTIVITY; BARRIER FUNCTION; SENSITIZATION; IMMUNIZATION; TOLERANCE; MICE	Background: Successful prevention of food allergy requires the identification of the factors adversely affecting the capacity to develop oral tolerance to food antigen in early life. Objectives: This study sought to determine whether oral exposure to Dermatophagoides pteronyssinus through breast milk affects gut mucosal immunity with long-term effects on IgE-mediated food allergy susceptibility. Methods: Gut immunity was explored in 2-week-old mice breast-fed by mothers exposed to D pteronyssinus, protease-inactivated D pteronyssinus, or to PBS during lactation. We further analyzed oral tolerance to a bystander food allergen, ovalbumin (OVA). In a proof-of-concept study, Der p 1 and OVA levels were determined in 100 human breast milk samples and the association with prevalence of IgE-mediated egg allergy at 1 year was assessed. Results: Increased permeability, IL-33 levels, type 2 innate lymphoid cell activation, and T(H)2 cell differentiation were found in gut mucosa of mice nursed by mothers exposed to D pteronyssinus compared with PBS. This pro-T(H)2 gut mucosal environment inhibited the induction of antigen-specific FoxP3 regulatory T cells and the prevention of food allergy by OVA exposure through breast milk. In contrast, protease-inactivated D pteronyssinus had no effect on offspring gut mucosal immunity. Based on the presence of Der p 1 and/or OVA in human breast milk, we identified groups of lactating mothers, which mirror the ones found in mice to be responsible for different egg allergy risk. Conclusions: This study highlights an unpredicted potential risk factor for the development of food allergy, that is, D pteronyssinus allergens in breast milk, which disrupt gut immune homeostasis and prevents oral tolerance induction to bystander food antigen through their protease activity.	[Rekima, Akila; Macchiaverni, Patricia; Verhasselt, Valerie] Univ Western Australia, Sch Mol Sci, M310, Perth, WA 6009, Australia; [Bonnart, Chrystelle] INSERM, U1220, Toulouse, France; [Metcalfe, Jessica; Palmer, Debra J.; Prescott, Susan] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Tulic, Meri K.; Halloin, Nicolas; Zanelli, Samantha; Medeiros, Samara] Univ Nice Sophia Antipolis, Immune Tolerance EA6302, Nice, France; [Tulic, Meri K.] INSERM, U1065, Mediterranean Ctr Mol Med, Team 12, Nice, France; [Tulic, Meri K.; Genuneit, Jon; Palmer, Debra J.; Prescott, Susan; Verhasselt, Valerie] Res Grp Worldwide Univ Network, inVIVO Global Network, West New York, NJ USA; [Rekima, Samah] Univ Cote Azur, CNRS, INSERM, Inst Biol Valrose, Nice, France; [Genuneit, Jon] Univ Leipzig, Med Ctr, Dept Pediat, Pediat Epidemiol, Leipzig, Germany; [Medeiros, Samara] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Prescott, Susan] Univ Western Australia, Perth Childrens Hosp, Crawley, Australia; [Prescott, Susan] Univ Western Australia, Sch Med, Crawley, Australia	University of Western Australia; Institut National de la Sante et de la Recherche Medicale (Inserm); Telethon Kids Institute; University of Western Australia; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Leipzig University; Universidade Federal de Minas Gerais; University of Western Australia; University of Western Australia	Verhasselt, V (corresponding author), Univ Western Australia, Sch Mol Sci, M310, Perth, WA 6009, Australia.	valerie.verhasselt@uwa.edu.au	Tulic, Meri K/ABB-5138-2020; Rekima, Akila/AAE-7782-2021; BONNART, Chrystelle/A-1309-2011; Genuneit, Jon/I-9323-2012; Macchiaverni, Patricia/K-8507-2018	Tulic, Meri K/0000-0002-2661-2369; Rekima, Akila/0000-0003-2323-6334; Genuneit, Jon/0000-0001-5764-1528; verhasselt, valerie/0000-0002-5732-9048; Macchiaverni, Patricia/0000-0002-1897-9013	Institut Thematique Multi-Organismes Immunologie, hematologie, pneumologie (IHP)-Circulation, metabolisme, nutrition (CMN) of the Institut National de la Sante et Recherche Medicale; Universite de Nice Sophia Antipolis; Fonds de Dotation ``Recherche en Sante Respiratoire''; Societe Francaise d'Allergologie; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Comite francais d'Evaluation de la Cooperation universitaire et scientifique avec le Bresil (COFECUB) program [867/15]; Larsson-Rosenquist Foundation; University of Western Australia	Institut Thematique Multi-Organismes Immunologie, hematologie, pneumologie (IHP)-Circulation, metabolisme, nutrition (CMN) of the Institut National de la Sante et Recherche Medicale; Universite de Nice Sophia Antipolis; Fonds de Dotation ``Recherche en Sante Respiratoire''; Societe Francaise d'Allergologie; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Comite francais d'Evaluation de la Cooperation universitaire et scientifique avec le Bresil (COFECUB) program; Larsson-Rosenquist Foundation; University of Western Australia	This work was supported by Institut Thematique Multi-Organismes Immunologie, hematologie, pneumologie (IHP)-Circulation, metabolisme, nutrition (CMN) of the Institut National de la Sante et Recherche Medicale, by Universite de Nice Sophia Antipolis, Fonds de Dotation ``Recherche en Sante Respiratoire,'' Societe Francaise d'Allergologie, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Comite francais d'Evaluation de la Cooperation universitaire et scientifique avec le Bresil (COFECUB) program (no. 867/15), the Larsson-Rosenquist Foundation, and the University of Western Australia.	Aceves SS, 2014, CURR OPIN GASTROEN, V30, P391, DOI 10.1097/MOG.0000000000000088; Baiz N, 2017, J ALLERGY CLIN IMMUN, V139, P369, DOI 10.1016/j.jaci.2016.07.021; Beamish LA, 2011, J CROHNS COLITIS, V5, P279, DOI 10.1016/j.crohns.2011.02.017; Bellach J, 2017, J ALLERGY CLIN IMMUN, V139, P1591, DOI 10.1016/j.jaci.2016.06.045; Berin MC, 2015, CLIN EXP ALLERGY, V45, P1483, DOI 10.1111/cea.12598; Blanco C, 1997, J ALLERGY CLIN IMMUN, V99, P308, DOI 10.1016/S0091-6749(97)70047-2; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Castell JV, 1997, AM J PHYSIOL-GASTR L, V273, pG139, DOI 10.1152/ajpgi.1997.273.1.G139; Chirdo FG, 1998, SCAND J GASTROENTERO, V33, P1186, DOI 10.1080/00365529850172557; Cunningham PT, 2012, INT ARCH ALLERGY IMM, V158, P347, DOI 10.1159/000334280; Dallas DC, 2015, J MAMMARY GLAND BIOL, V20, P133, DOI 10.1007/s10911-015-9334-3; Dawod B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00016; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; de Oliveira MG, 2018, CENT EUR J IMMUNOL, V43, P378, DOI 10.5114/ceji.2018.81345; de Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8; Du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P30, DOI 10.1016/j.jaci.2017.11.010; Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865; Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gough L, 1999, J EXP MED, V190, P1897, DOI 10.1084/jem.190.12.1897; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hale LP, 2004, INT IMMUNOPHARMACOL, V4, P255, DOI 10.1016/j.intimp.2003.12.010; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; HOLT PG, 1981, IMMUNOLOGY, V42, P409; HOST A, 1988, ACTA PAEDIATR SCAND, V77, P663, DOI 10.1111/j.1651-2227.1988.tb10727.x; HUSBY S, 1985, SCAND J IMMUNOL, V22, P83, DOI 10.1111/j.1365-3083.1985.tb01862.x; JARRETT E, 1979, NATURE, V280, P145, DOI 10.1038/280145a0; Jarvinen KM, 2019, ANN ALLERG ASTHMA IM, V123, P133, DOI 10.1016/j.anai.2019.04.022; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; KILSHAW PJ, 1984, INT ARCH ALLER A IMM, V75, P8, DOI 10.1159/000233582; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Kim YH, 2012, J ASTHMA, V49, P738, DOI 10.3109/02770903.2012.702841; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Macchiaverni P, 2014, ALLERGY, V69, P395, DOI 10.1111/all.12332; Macchiaverni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139064; Meldrum SJ, 2011, CONTEMP CLIN TRIALS, V32, P771, DOI 10.1016/j.cct.2011.05.019; Mosconi E, 2010, MUCOSAL IMMUNOL, V3, P461, DOI 10.1038/mi.2010.23; Munblit D, 2016, CURR OPIN ALLERGY CL, V16, P427, DOI 10.1097/ACI.0000000000000303; MUTA T, 1994, NATURE, V369, P340, DOI 10.1038/369340a0; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Passalacqua G, 2017, J ALLER CL IMM-PRACT, V5, P13, DOI 10.1016/j.jaip.2016.06.020; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019; Rekima A, 2017, CLIN EXP ALLERGY, V47, P565, DOI 10.1111/cea.12864; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P801, DOI 10.1016/j.jaci.2016.02.030; Sanchez-Borges M, 2013, J ALLERGY CLIN IMMUN, V131, P31, DOI 10.1016/j.jaci.2012.09.026; SanchezBorges M, 1997, J ALLERGY CLIN IMMUN, V99, P738, DOI 10.1016/S0091-6749(97)80005-X; SCALA G, 1995, ALLERGY, V50, P517, DOI 10.1111/j.1398-9995.1995.tb01189.x; Schuijs MJ, 2018, ANN NY ACAD SCI, V1417, P87, DOI 10.1111/nyas.13604; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Takahashi K, 2014, ALLERGOL INT, V63, P51, DOI 10.2332/allergolint.13-OA-0575; Tulic MK, 2016, GUT, V65, P757, DOI 10.1136/gutjnl-2015-310523; Turfkruyer M, 2016, MUCOSAL IMMUNOL, V9, P479, DOI 10.1038/mi.2015.114; Turfkruyer M, 2015, CURR OPIN INFECT DIS, V28, P199, DOI 10.1097/QCO.0000000000000165; Uthoff H, 2003, J IMMUNOL, V171, P3485, DOI 10.4049/jimmunol.171.7.3485; Vadas P, 2001, JAMA-J AM MED ASSOC, V285, P1746, DOI 10.1001/jama.285.13.1746; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39; Wesemann DR, 2016, IMMUNITY, V44, P728, DOI 10.1016/j.immuni.2016.02.002; WILLOUGHBY JB, 1977, J IMMUNOL, V119, P2137; Wong L, 2016, ALLERGY ASTHMA IMMUN, V8, P101, DOI 10.4168/aair.2016.8.2.101	66	15	16	5	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1416	+		10.1016/j.jaci.2019.12.912	http://dx.doi.org/10.1016/j.jaci.2019.12.912			25	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	31954775	Bronze			2022-12-18	WOS:000531063400014
J	Konradsen, JR; Grundstr, J; Hellkvist, L; Tran, TAT; Andersson, N; Gafvelin, G; Kiewiet, MBG; Hamsten, C; Tang, JQ; Parkin, RV; Shamji, MH; Hedlin, G; Cardell, LO; van Hage, M				Konradsen, Jon R.; Grundstr, Jeanette; Hellkvist, Laila; Thi Anh Thu Tran; Andersson, Niklas; Gafvelin, Guro; Kiewiet, M. B. Gea; Hamsten, Carl; Tang, Jiaqian; Parkin, Rebecca V.; Shamji, Mohamed H.; Hedlin, Gunilla; Cardell, Lars-Olaf; van Hage, Marianne			Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Konradsen, Jon R.; Grundstr, Jeanette; Thi Anh Thu Tran; Kiewiet, M. B. Gea; Hamsten, Carl; van Hage, Marianne] Karolinska Inst, Dept Med Solna, Div Immunol & Allergy, Stockholm, Sweden; [Konradsen, Jon R.; Grundstr, Jeanette; Thi Anh Thu Tran; Kiewiet, M. B. Gea; Hamsten, Carl; van Hage, Marianne] Univ Hosp, Solna, Sweden; [Konradsen, Jon R.; Hedlin, Gunilla] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Solna, Sweden; [Konradsen, Jon R.; Hedlin, Gunilla] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Hellkvist, Laila; Cardell, Lars-Olaf] Karolinska Inst, Div ENT Dis, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Hellkvist, Laila; Cardell, Lars-Olaf] Karolinska Univ Hosp, Dept ENT Dis, Solna, Sweden; [Andersson, Niklas] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Gafvelin, Guro] Karolinska Inst, Therapeut Immune Design Unit, Dept Clin Neurosci, Stockholm, Sweden; [Tang, Jiaqian; Parkin, Rebecca V.; Shamji, Mohamed H.] Imperial Coll, Immunomodulat & Tolerance Grp, Allergy & Clin Immunol, Sect Inflammat Repair & Dev,Natl Heart & Lung Ins, London, England; [Tang, Jiaqian; Parkin, Rebecca V.; Shamji, Mohamed H.] MRC & Asthma UK Ctr Allerg Mech Asthma, London, England	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Imperial College London; University of London; King's College London	van Hage, M (corresponding author), Karolinska Inst, Dept Med Solna, Div Immunol & Allergy, Stockholm, Sweden.	Marianne.van.Hage@ki.se	Konradsen, Jon/AAD-5620-2021; Shamji, Mohamed/AAD-1788-2019; Andersson, Niklas/AAN-1633-2020; Shamji, Mohamed/AAU-8811-2020	Konradsen, Jon/0000-0001-7745-8624; Andersson, Niklas/0000-0001-9785-7462; Shamji, Mohamed/0000-0003-3425-3463	Stockholm City Council; ACTA Otolaryngologica; Hesselman Foundation; Swedish Research Council; Swedish Asthma and Allergy Association's Research Foundation; King Gustaf V 80th Birthday Foundation; Swedish Heart-Lung Foundation; Konsul Th C Bergh Foundation; Swedish Cancer and Allergy Foundation; Magnus Bergvall Foundation; Swedish Association for Allergology	Stockholm City Council; ACTA Otolaryngologica; Hesselman Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Asthma and Allergy Association's Research Foundation; King Gustaf V 80th Birthday Foundation; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Konsul Th C Bergh Foundation; Swedish Cancer and Allergy Foundation; Magnus Bergvall Foundation; Swedish Association for Allergology	This work was supported by grants from the Stockholm City Council (M.v.H. and J.R.K.), ACTA Otolaryngologica (L.H.), the Hesselman Foundation (M.v.H. and L.H.), the Swedish Research Council (M.v.H. and L.-O.C.), the Swedish Asthma and Allergy Association's Research Foundation (M.v.H.), the King Gustaf V 80th Birthday Foundation (M.v.H.), the Swedish Heart-Lung Foundation (M.v.H.), the Konsul Th C Bergh Foundation (C.H.), the Swedish Cancer and Allergy Foundation (M.v.H.), the Magnus Bergvall Foundation (C.H.), and the Swedish Association for Allergology (M.v.H.).	Calderon MA, 2014, CLIN EXP ALLERGY, V44, P1228, DOI 10.1111/cea.12331; Guyatt GH, 1997, PEDIATRICS, V99, P165, DOI 10.1542/peds.99.2.165; Hellkvist L, 2018, J ALLERGY CLIN IMMUN, V142, P1338, DOI 10.1016/j.jaci.2018.05.030; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; LEBEL B, 1988, J ALLERGY CLIN IMMUN, V82, P869, DOI 10.1016/0091-6749(88)90092-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Patterson AM, 2016, ANN ALLERG ASTHMA IM, V116, P168, DOI 10.1016/j.anai.2015.11.010; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P1290, DOI 10.1016/j.jaci.2012.02.026; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Witten M, 2013, J ALLERGY CLIN IMMUN, V132, P1248, DOI 10.1016/j.jaci.2013.07.033; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760	13	15	15	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					1005	+		10.1016/j.jaci.2019.11.017	http://dx.doi.org/10.1016/j.jaci.2019.11.017			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KT1GD	31775016				2022-12-18	WOS:000518756700042
J	Vanoni, S; Zeng, C; Marella, S; Uddin, J; Wu, D; Arora, K; Ptaschinski, C; Que, JW; Noah, T; Waggoner, L; Barski, A; Kartashov, A; Rochman, M; Wen, T; Martin, L; Spence, J; Collins, M; Mukkada, V; Putnam, P; Naren, A; Chehade, M; Rothenberg, ME; Hogan, SP				Vanoni, Simone; Zeng, Chang; Marella, Sahiti; Uddin, Jazib; Wu, David; Arora, Kavisha; Ptaschinski, Catherine; Que, Jianwen; Noah, Taeko; Waggoner, Lisa; Barski, Artem; Kartashov, Andrey; Rochman, Mark; Wen, Ting; Martin, Lisa; Spence, Jason; Collins, Margaret; Mukkada, Vincent; Putnam, Phillip; Naren, Anjaparavanda; Chehade, Mirna; Rothenberg, Marc E.; Hogan, Simon P.			Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; esophageal epithelium; basal cell hyperplasia; IL-13; chloride transport	CA2+-ACTIVATED K+ CHANNELS; BREAST-CANCER CELLS; TRANSCRIPTOME ANALYSIS; GENE-EXPRESSION; CONSENSUS RECOMMENDATIONS; GASTROESOPHAGEAL-REFLUX; 11Q13 AMPLICON; ORAL-CANCER; IN-VITRO; CYCLE	Background: The pathology of eosinophilic esophagitis (EoE) is characterized by eosinophil-rich inflammation, basal zone hyperplasia (BZH), and dilated intercellular spaces, and the underlying processes that drive the pathologic manifestations of the disease remain largely unexplored. Objective: We sought to investigate the involvement of the calcium-activated chloride channel anoctamin 1 (ANO1) in esophageal proliferation and the histopathologic features of EoE. Methods: We examined mRNA and protein expression of ANO1 in esophageal biopsy samples from patients with EoE and in mice with EoE. We performed molecular and cellular analyses and ion transport assays on an in vitro esophageal epithelial 3-dimensional model system (EPC2-ALI) and murine models of EoE to define the relationship between expression and function of ANO1 and esophageal epithelial proliferation in patients with EoE. Results: We observed increased ANO1 expression in esophageal biopsy samples from patients with EoE and in mice with EoE. ANO1 was expressed within the esophageal basal zone, and expression correlated positively with disease severity (eosinophils/high-power field) and BZH. Using an in vitro esophageal epithelial 3-dimensional model system revealed that ANO1 undergoes chromatin modification and rapid upregulation of expression after IL-13 stimulation, that ANO1 is the primary apical IL-13-induced Cl- transport mechanism within the esophageal epithelium, and that loss of ANO1-dependent Cl- transport abrogated esophageal epithelial proliferation. Mechanistically, ANO1-dependent regulation of basal cell proliferation was associated with modulation of TP63 expression and phosphorylated cyclin-dependent kinase 2 levels. Conclusions: These data identify a functional role for ANO1 in esophageal cell proliferation and BZH in patients with EoE and provide a rationale for pharmacologic intervention of ANO1 function in patients with EoE.	[Vanoni, Simone; Zeng, Chang; Wu, David; Noah, Taeko; Waggoner, Lisa; Barski, Artem; Kartashov, Andrey; Rochman, Mark; Wen, Ting; Rothenberg, Marc E.; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Arora, Kavisha; Naren, Anjaparavanda] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Martin, Lisa] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Collins, Margaret] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Mukkada, Vincent; Putnam, Phillip] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Nutr & Hepatol, Cincinnati, OH 45229 USA; [Marella, Sahiti; Uddin, Jazib; Ptaschinski, Catherine; Noah, Taeko; Hogan, Simon P.] Univ Michigan, Mary H Weiser Food Allergy Ctr, Ann Arbor, MI 48109 USA; [Marella, Sahiti; Uddin, Jazib; Ptaschinski, Catherine; Noah, Taeko; Hogan, Simon P.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Spence, Jason] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Spence, Jason] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Spence, Jason] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Que, Jianwen] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Chehade, Mirna] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, Mt Sinai Ctr Eosinophil Disorders, New York, NY 10029 USA; [Vanoni, Simone] PharmGenetix Gmbh, Niederalm Anif, Austria	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; Icahn School of Medicine at Mount Sinai	Hogan, SP (corresponding author), Univ Michigan, Mary H Weiser Food Allergy Ctr, Dept Pathol, 5063 BSRB 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu	Martin, Lisa/E-2425-2016; Vanoni, Simone/AAJ-8108-2020	Martin, Lisa/0000-0001-8702-9946; Vanoni, Simone/0000-0002-4464-2959	National Institutes of Health [DK090119, AI112626, AI140133, AI138177]; Food Allergy Research & Education (FARE); Crohn's Colitis Foundation of America; Mary H. Weiser Food Allergy Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Research & Education (FARE); Crohn's Colitis Foundation of America; Mary H. Weiser Food Allergy Center	This work was supported by National Institutes of Health grants DK090119, AI112626, AI140133, and AI138177; Food Allergy Research & Education (FARE); the Crohn's Colitis Foundation of America; and the Mary H. Weiser Food Allergy Center (to S.P.H).	Abonia JP, 2010, J ALLERGY CLIN IMMUN, V126, P140, DOI 10.1016/j.jaci.2010.04.009; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Arora AS, 2003, MAYO CLIN PROC, V78, P830, DOI 10.4065/78.7.830; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Collins Margaret H, 2008, Gastrointest Endosc Clin N Am, V18, P59, DOI 10.1016/j.giec.2007.09.014; Collins MH, 2014, DIGEST DIS, V32, P68, DOI 10.1159/000357012; D'Mello RJ, 2016, MUCOSAL IMMUNOL, V9, P744, DOI 10.1038/mi.2015.98; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Faubion WA, 1998, J PEDIATR GASTR NUTR, V27, P90, DOI 10.1097/00005176-199807000-00016; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Guan LZ, 2016, ONCOTARGET, V7, P78619, DOI 10.18632/oncotarget.12524; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; Habela CW, 2009, J NEUROPHYSIOL, V101, P750, DOI 10.1152/jn.90840.2008; Harada H, 2003, MOL CANCER RES, V1, P729; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Kartashov AV, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0720-3; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koutlas Nathaniel T, 2017, Case Rep Gastroenterol, V11, P382, DOI 10.1159/000477391; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liacouras CA, 2004, CURR OPIN PEDIATR, V16, P560, DOI 10.1097/01.mop.0000141071.47572.eb; Liacouras CA, 1998, J PEDIATR GASTR NUTR, V26, P380, DOI 10.1097/00005176-199804000-00004; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Macfarlane SN, 2000, GLIA, V30, P39, DOI 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO;2-S; MacFarlane SN, 2000, J NEUROSCI, V20, P5245, DOI 10.1523/JNEUROSCI.20-14-05245.2000; Martin LJ, 2015, J ALLERGY CLIN IMMUN, V135, P1519, DOI 10.1016/j.jaci.2015.03.004; Mazzone A, 2015, FASEB J, V29, P152, DOI 10.1096/fj.14-258541; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Noffsinger AE, 2009, ARCH PATHOL LAB MED, V133, P1087, DOI 10.1043/1543-2165-133.7.1087; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Parfitt JR, 2006, MODERN PATHOL, V19, P90, DOI 10.1038/modpathol.3800498; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Sauter DRP, 2015, PFLUG ARCH EUR J PHY, V467, P1495, DOI 10.1007/s00424-014-1598-8; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Shang L, 2016, ONCOTARGET, V7, P24374, DOI 10.18632/oncotarget.8223; Shen MR, 2003, J BIOL CHEM, V278, P39941, DOI 10.1074/jbc.M308232200; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Sherrill JD, 2014, DIGEST DIS, V32, P22, DOI 10.1159/000357005; Shoda T, 2018, LANCET GASTROENTEROL, V3, P477, DOI 10.1016/S2468-1253(18)30096-7; Simon D, 2014, DIGEST DIS, V32, P30, DOI 10.1159/000357006; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Syed A, 2017, DIS ESOPHAGUS, V30, DOI 10.1093/dote/dox050; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Warners MJ, 2017, AM J PHYSIOL-GASTR L, V313, pG230, DOI 10.1152/ajpgi.00058.2017; Warners MJ, 2017, AM J GASTROENTEROL, V112, P1061, DOI 10.1038/ajg.2017.107; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Wen T, 2013, GASTROENTEROLOGY, V145, P1289, DOI 10.1053/j.gastro.2013.08.046; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; WOODFORK KA, 1995, J CELL PHYSIOL, V162, P163, DOI 10.1002/jcp.1041620202; Wu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045761; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	84	15	15	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					239	+		10.1016/j.jaci.2019.07.049	http://dx.doi.org/10.1016/j.jaci.2019.07.049			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31647967	Bronze, Green Accepted			2022-12-18	WOS:000505590800030
J	Vargas-Hernandez, A; Witalisz-Siepracka, A; Prchal-Murhpy, M; Klein, K; Mahapatra, S; Al-Herz, W; Mace, EM; Carisey, AF; Orange, JS; Sexl, V; Forbes, LR				Vargas-Hernandez, Alexander; Witalisz-Siepracka, Agnieszka; Prchal-Murhpy, Michaela; Klein, Klara; Mahapatra, Sanjana; Al-Herz, Waleed; Mace, Emily M.; Carisey, Alexandre F.; Orange, Jordan S.; Sexl, Veronika; Forbes, Lisa R.			Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						STAT5b; natural killer cell deficiency; natural killer cell maturation; perforin; vascular endothelial growth factor; IL-2; IL-15; microtubule-organizing center; lytic granule convergence	GROWTH-HORMONE INSENSITIVITY; MATURE NK-CELLS; GRANULE CONVERGENCE; CUTTING EDGE; DEFICIENCY; IMMUNODEFICIENCY; IDENTIFICATION; CD56(BRIGHT); CYTOTOXICITY; REQUIREMENT	Background: Patients with signal transducer and activator of transcription 5b (STAT5b) deficiency have impairment in T-cell homeostasis and natural killer (NK) cells which leads to autoimmunity, recurrent infections, and combined immune deficiency. Objective: In this study we characterized the NK cell defect in STAT5b(-/-) deficient human NK cells, as well as Stat5b(-/-) mice. Methods: We used multiparametric flow cytometry, functional NK cell assays, microscopy, and a Stat5b(-/-) mouse model to elucidate the effect of impaired and/or absent STAT5b on NK cell development and function. Results: This alteration generated a nonfunctional CD56(bright) NK cell subset characterized by low cytokine production. The CD56(dim) NK cell subset had decreased expression of perforin and CD16 and a greater frequency of cells expressing markers of immature NK cells. We observed low NK cell numbers and impaired NK cell maturation, suggesting that STAT5b is involved in terminal NK cell maturation in Stat5b(-/-) mice. Furthermore, human STAT5b-deficient NK cells had low cytolytic capacity, and fixed-cell microscopy showed poor convergence of lytic granules. This was accompanied by decreased expression of costimulatory and activating receptors. Interestingly, granule convergence and cytolytic function were restored after IL-2 stimulation. Conclusions: Our results show that in addition to the impaired terminal maturation of NK cells, human STAT5b mutation leads to impairments in early activation events in NK cell lytic synapse formation. Our data provide further insight into NK cell defects caused by STAT5b deficiency.	[Vargas-Hernandez, Alexander; Carisey, Alexandre F.; Forbes, Lisa R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Vargas-Hernandez, Alexander; Mahapatra, Sanjana; Carisey, Alexandre F.; Forbes, Lisa R.] Texas Childrens Hosp, William T Shearer Ctr Human Immunobiol, Sect Allergy Immunol & Retrovirol, Houston, TX 77030 USA; [Witalisz-Siepracka, Agnieszka; Prchal-Murhpy, Michaela; Klein, Klara; Sexl, Veronika] Univ Vet Med, Inst Pharmacol & Toxicol, Vienna, Austria; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait; [Mace, Emily M.; Orange, Jordan S.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA	Baylor College of Medicine; Baylor College of Medicine; University of Veterinary Medicine Vienna; Kuwait University; Columbia University	Forbes, LR (corresponding author), Ctr Human Immunobiol, Dept Pediat Immunol Allergy & Rheumatol, 1102 Bates,Suite 330, Houston, TX 77030 USA.	lisa.forbes@bcm.edu	Carisey, Alexandre F/A-5026-2015; Sexl, Veronika/B-8657-2016	Carisey, Alexandre F/0000-0003-1326-2205; Sexl, Veronika/0000-0001-9363-0412; orange, jordan/0000-0001-7117-7725	Chao Physician Scientist Junior Faculty Award; National Institute of Allergy and Infectious Diseases [R01 AI120989]; Jeffrey Modell Foundation Diagnostic and Research Center for Primary Immunodeficiencies; Austrian Science Foundation [FWF SFB-61-07, FWF P28571]	Chao Physician Scientist Junior Faculty Award; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jeffrey Modell Foundation Diagnostic and Research Center for Primary Immunodeficiencies; Austrian Science Foundation(Austrian Science Fund (FWF))	Supported by the Chao Physician Scientist Junior Faculty Award (to L.R.F.), National Institute of Allergy and Infectious Diseases grant R01 AI120989 (to J.S.O.), and the Jeffrey Modell Foundation Diagnostic and Research Center for Primary Immunodeficiencies (to J.S.O. and L.R.F.). V.S. is supported by Austrian Science Foundation grants FWF SFB-61-07 and FWF P28571.	ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Angelo LS, 2015, IMMUNOL RES, V62, P341, DOI 10.1007/s12026-015-8664-y; Banerjee PP, 2007, J EXP MED, V204, P2305, DOI 10.1084/jem.20061893; Bernasconi A, 2006, PEDIATRICS, V118, pE1584, DOI 10.1542/peds.2005-2882; Bezrodnik L, 2015, J CLIN IMMUNOL, V35, P264, DOI 10.1007/s10875-015-0145-5; Boos MD, 2008, IMMUNOL RES, V40, P193, DOI 10.1007/s12026-007-8006-9; Bryceson YT, 2009, BLOOD, V114, P2657, DOI 10.1182/blood-2009-01-201632; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cohen AC, 2006, J IMMUNOL, V177, P2770, DOI 10.4049/jimmunol.177.5.2770; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Crispi S, 2004, FEBS LETT, V562, P27, DOI 10.1016/S0014-5793(04)00166-8; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Freud AG, 2016, CELL REP, V16, P379, DOI 10.1016/j.celrep.2016.05.095; Frey M, 1998, J IMMUNOL, V161, P400; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hsu HT, 2016, J CELL BIOL, V215, P875, DOI 10.1083/jcb.201604136; Hsu HT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005816; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Hwa V, 2007, HORM RES, V68, P218, DOI 10.1159/000101334; Hwa V, 2011, BEST PRACT RES CL EN, V25, P61, DOI 10.1016/j.beem.2010.09.003; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Domaica CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051677; James AM, 2013, BLOOD, V121, P2627, DOI 10.1182/blood-2012-06-437012; Kanai T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00234; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; KOHL S, 1984, J IMMUNOL, V133, P2972; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Ma CA, 2017, BLOOD, V129, P650, DOI 10.1182/blood-2016-09-737817; Mace EM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00545; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; Mace EM, 2010, BLOOD, V116, P1272, DOI 10.1182/blood-2009-12-261487; Mahapatra S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181134; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; MERIDA I, 1991, J IMMUNOL, V147, P2202; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Mukherjee M, 2017, MOL THER, V25, P1757, DOI 10.1016/j.ymthe.2017.06.003; Nadeau K, 2011, J PEDIATR-US, V158, P701, DOI 10.1016/j.jpeds.2010.12.042; Rajala HLM, 2013, BLOOD, V121, P4541, DOI 10.1182/blood-2012-12-474577; RAVICHANDRAN KS, 1994, J BIOL CHEM, V269, P1599; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Ruiz-Garcia R, 2018, J ALLERGY CLIN IMMUN, V142, P605, DOI 10.1016/j.jaci.2017.11.042; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Segovis CM, 2009, J IMMUNOL, V182, P6933, DOI 10.4049/jimmunol.0803840; Tamzalit F, 2014, P NATL ACAD SCI USA, V111, P8565, DOI 10.1073/pnas.1405514111; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Vargas-Hernandez A., 2019, MOL IMMUNOL; Vargas-Hernandez A, 2018, J ALLERGY CLIN IMMUN, V141, P2142, DOI 10.1016/j.jaci.2017.08.040; Villarino AV, 2017, J EXP MED, V214, P2999, DOI 10.1084/jem.20150907; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; Wilk E, 2008, IMMUNOBIOLOGY, V213, P271, DOI 10.1016/j.imbio.2007.10.012	63	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					345	+		10.1016/j.jaci.2019.09.016	http://dx.doi.org/10.1016/j.jaci.2019.09.016			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31600547	Green Accepted			2022-12-18	WOS:000505590800038
J	Hrusch, CL; Stein, MM; Gozdz, J; Holbreich, M; von Mutius, E; Vercelli, D; Ober, C; Sperling, AI				Hrusch, Cara L.; Stein, Michelle M.; Gozdz, Justyna; Holbreich, Mark; von Mutius, Erika; Vercelli, Donata; Ober, Carole; Sperling, Anne I.			T-cell phenotypes are associated with serum IgE levels in Amish and Hutterite children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; atopy; adaptive immunity; T-cell activation; CD4 T cells; CD8 T cells	DENDRITIC CELLS; FARM EXPOSURE; CD8+T CELLS; ASTHMA; RECEPTORS; SENSITIZATION; ENDOTOXEMIA; PREVALENCE; ACTIVATION; EXPRESSION	Objectives: Amish children raised on traditional farms have lower atopy and asthma risk than Hutterite children raised on modern farms. In our previous study we established that the Amish environment affects the innate immune response to decrease asthma and atopy risk. Here we investigated T-cell phenotypes in the same Amish and Hutterite children as in our earlier study to elucidate how this altered innate immunity affects adaptive T cells. Methods: Blood was collected from 30 Amish and 30 Hutterite age- and sex-matched children; cells were cryopreserved until analysis. Flow cytometry was used to analyze cell subsets. Atopy was determined based on allergen-specific and total IgE levels. Results: Children exposed to Amish farms had increased activated regulatory CD4(+) T-cell phenotypes, whereas conventional CD4 T cells expressed lower levels of costimulation molecules and other activation markers. The increase in numbers of circulating activated regulatory CD4(+) T cells was associated with an increase in inhibitory receptors on monocytes in Amish, but not Hutterite, children. Strikingly, the Amish children had a higher proportion of CD28(null)CD8 T cells than the Hutterite children (P < .0001, nonparametric t test), a difference that remained even after accounting for the effects of age and sex (conditional log regression exponential beta = 1.08, P = .0053). The proportion of these cells correlated with high T-cell IFN-gamma production (r(s)= 0.573, P = .005) and low serum IgE levels (r(s) = -0.417, P = .025). Furthermore, CD28(null)( )CD8 T-cell numbers were increased in Amish children, with high expression of the innate genes TNF and TNF-alpha-induced protein 3 (TNFAIP3) in peripheral blood leukocytes. Conclusion: Amish children's blood leukocytes are not only altered in their innate immune status but also have distinct T-cell phenotypes that are often associated with increased antigen exposure.	[Hrusch, Cara L.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Stein, Michelle M.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Gozdz, Justyna; Vercelli, Donata] Univ Arizona, NIEHS Training Program Environm Toxicol, Grad Program Cellular & Mol Med, Arizona Resp Ctr, Tucson, AZ USA; [Gozdz, Justyna; Vercelli, Donata] Univ Arizona, Bio5 Inst, Tucson, AZ USA; [Gozdz, Justyna; Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Gozdz, Justyna; Vercelli, Donata] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Gozdz, Justyna; Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Bio5 Inst, Tucson, AZ USA; [Holbreich, Mark] Allergy & Asthma Consultants, Indianapolis, IN USA; [von Mutius, Erika] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Munich; University of Chicago	Sperling, AI (corresponding author), Univ Chicago, Dept Med, 924 E 57th St,JFK R316, Chicago, IL 60637 USA.	asperlin@uchicago.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212	National Institutes of Health [U19 AI095230, R01 HL085197, T32 HL007605, P30 CA014599]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118758, T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants U19 AI095230, R01 HL085197, and T32 HL007605 (to C.L.H. and M.M.S.). The University of Chicago Flow Cytometry Core is supported by grant P30 CA014599.	Almanzar G, 2016, J CLIN VIROL, V77, P77, DOI 10.1016/j.jcv.2016.02.010; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chui CSC, 2009, HUM IMMUNOL, V70, P686, DOI 10.1016/j.humimm.2009.06.003; Clay BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007525; Dakhama A, 2013, ALLERGY, V68, P666, DOI 10.1111/all.12135; Faivre V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047209; Fuseini H, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0686-1; Galbraith NJ, 2018, IMMUNOBIOLOGY, V223, P365, DOI 10.1016/j.imbio.2017.10.045; Gelfand EW, 2006, J ALLERGY CLIN IMMUN, V117, P577, DOI 10.1016/j.jaci.2005.12.1340; Genuneit J, 2013, PEDIAT ALLERG IMM-UK, V24, P293, DOI 10.1111/pai.12053; Godlove J, 2007, EXP GERONTOL, V42, P412, DOI 10.1016/j.exger.2006.11.015; Hodge G, 2011, CLIN EXP IMMUNOL, V166, P94, DOI 10.1111/j.1365-2249.2011.04455.x; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jensen MA, 2010, MULT SCLER, V16, P30, DOI 10.1177/1352458509352794; Kornete M, 2012, J IMMUNOL, V188, P1064, DOI 10.4049/jimmunol.1101303; Lapko N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00401; Li J, 2018, IMMUNITY, V48, P773, DOI 10.1016/j.immuni.2018.03.018; Lin CY, 2007, J HEPATOL, V46, P816, DOI 10.1016/j.jhep.2006.12.018; Liu JW, 2016, J IMMUNOTHER, V39, P171, DOI 10.1097/CJI.0000000000000122; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Lucin P, 2015, CELL MOL IMMUNOL, V12, P154, DOI 10.1038/cmi.2014.85; Pita-Lopez ML, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0097-5; Manavalan JS, 2003, TRANSPL IMMUNOL, V11, P245, DOI 10.1016/S0966-3274(03)00058-3; Motika CA, 2011, J ALLERGY CLIN IMMUN, V128, P774, DOI 10.1016/j.jaci.2011.06.046; Palmer CD, 2016, J IMMUNOL, V196, P668, DOI 10.4049/jimmunol.1501888; Pfortmueller CA, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0163-0; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Schenk AD, 2009, AM J TRANSPLANT, V9, P64, DOI 10.1111/j.1600-6143.2008.02460.x; Schroder PC, 2017, ALLERGY, V72, P604, DOI 10.1111/all.13069; Shilling RA, 2005, J IMMUNOL, V175, P2061, DOI 10.4049/jimmunol.175.4.2061; Sim GC, 2014, J CLIN INVEST, V124, P99, DOI 10.1172/JCI46266; Stein MM, 2019, GENES IMMUN, V20, P462, DOI 10.1038/s41435-018-0038-8; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Velten FW, 2004, EUR J IMMUNOL, V34, P2800, DOI 10.1002/eji.200324732; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022	38	15	15	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1391	+		10.1016/j.jaci.2019.07.034	http://dx.doi.org/10.1016/j.jaci.2019.07.034			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31401285	Green Accepted, hybrid			2022-12-18	WOS:000495004700029
J	Jing, YK; Kang, DQ; Liu, LY; Huang, H; Chen, AW; Yang, L; Jiang, PP; Li, N; Miller, H; Liu, Z; Zhu, XF; Yang, J; Wang, XC; Sun, JQ; Liu, ZP; Liu, WL; Zhou, XY; Liu, CH				Jing, Yukai; Kang, Danqing; Liu, Luyao; Huang, Huang; Chen, Anwei; Yang, Lu; Jiang, Panpan; Li, Na; Miller, Heather; Liu, Zheng; Zhu, Xiaofei; Yang, Jun; Wang, Xiaochuan; Sun, Jinqiao; Liu, Zhiping; Liu, Wanli; Zhou, Xinyuan; Liu, Chaohong			Dedicator of cytokinesis protein 2 couples with lymphoid enhancer-binding factor 1 to regulate expression of CD21 and B-cell differentiation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Dedicator of cytokinesis protein 2; lymphoid enhancer-binding factor 1; CD21; B cell; B-cell receptor	TRANSCRIPTION FACTOR; DOCK2; FAMILY; LEF-1; TCF-1; MICROCLUSTERS; GENERATION; DEPENDS; CD19; WASP	Background: B-cell receptor (BCR) signaling, combined with CD19 and CD21 signals, imparts specific control of B-cell responses. Dedicator of cytokinesis protein 2 (DOCK2) is critical for the migration and motility of lymphocytes. Although absence of DOCK2 leads to lymphopenia, little is known about the signaling mechanisms and physiologic functions of DOCK2 in B cells. Objective: We sought to determine the underlying molecular mechanism of how DOCK2 regulates BCR signaling and peripheral B-cell differentiation. Methods: In this study we used genetic models for DOCK2, Wiskott-Aldrich syndrome protein (WASP), and lymphoid enhancer-binding factor 1 deficiency to study their interplay in BCR signaling and B-cell differentiation. Results: We found that the absence of DOCK2 led to downregulation of proximal and distal BCR signaling molecules, including CD19, but upregulation of SH2-containing inositol 5 phosphatase 1, a negative signaling molecule. Interestingly, DOCK2 deficiency reduced CD19 and CD21 expression at the mRNA and/or protein levels and was associated with reduced numbers of marginal zone B cells. Additionally, loss of DOCK2 reduced activation of WASP and accelerated degradation of WASP, resulting into reduced actin accumulation and early activation of B cells. Mechanistically, the absence of DOCK2 upregulates the expression of lymphoid enhancer-binding factor 1. These differences were associated with altered humoral responses in the absence of DOCK2. Conclusions: Overall, our study has provided a novel underlying molecular mechanism of how DOCK2 deficiency regulates surface expression of CD21, which leads to downregulation of CD19-mediated BCR signaling and marginal zone B-cell differentiation.	[Jing, Yukai; Kang, Danqing; Yang, Lu; Jiang, Panpan; Liu, Chaohong] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan, Hubei, Peoples R China; [Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan, Hubei, Peoples R China; [Liu, Luyao; Wang, Xiaochuan; Sun, Jinqiao] Fudan Univ, Childrens Hosp, Dept Clin Immunol, Shanghai 201102, Peoples R China; [Huang, Huang; Zhou, Xinyuan] Army Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Chen, Anwei] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Child Infect & Immun, Chongqing, Peoples R China; [Li, Na] Yangtze Univ, Sch Med, Dept Immunol, Jingzhou, Peoples R China; [Miller, Heather] NIAID, Intracellular Parasites Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Zhu, Xiaofei] Xinxiang Med Univ, Sch Lab Med, Dept Clin Immunol, Xinxiang, Henan, Peoples R China; [Yang, Jun] Shenzhen Childrens Hosp, Dept Immunol, Shenzhen, Peoples R China; [Liu, Zhiping] Gannan Med Univ, Sch Basic Med, Ganzhou 341000, Jiangxi, Peoples R China; [Liu, Wanli] Tsinghua Univ, MOE Key Lab Prot Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Life Sci,Inst Immunol, Beijing, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Fudan University; Army Medical University; Chongqing Medical University; Yangtze University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Xinxiang Medical University; Gannan Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University	Sun, JQ (corresponding author), Fudan Univ, Childrens Hosp, Dept Clin Immunol, Shanghai 201102, Peoples R China.; Zhou, XY (corresponding author), Army Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.; Liu, ZP (corresponding author), Gannan Med Univ, Sch Basic Med, Ganzhou 341000, Jiangxi, Peoples R China.; Liu, WL (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Liu, CH (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pathogen Biol, Wuhan 430030, Hubei, Peoples R China.	jinqiaosun@fudan.edu.cn; Zhiping.Liu@gmu.edu.cn; liuwanli@biomed.tsinghua.edu.cn; xinyuanzhou@tmmu.edu.cn; chaohongliu80@126.com	Zhou, Xinyuan/AFS-9817-2022; Jing, Yukai/AAH-3975-2020; xiaofei, Zhu/AAH-2181-2019	xiaofei, Zhu/0000-0001-6360-140X; Zhou, Xinyuan/0000-0002-1374-8240	National Natural Science Foundation of China [81722002, 81861138002, 31560260, 31500709]; Huazhong University of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong University of Science and Technology	Supported by the National Natural Science Foundation of China (81722002, 81861138002, 31560260, and 31500709) and set-up funding from Huazhong University of Science and Technology.	Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Dahlberg CIM, 2015, J AUTOIMMUN, V62, P81, DOI 10.1016/j.jaut.2015.06.003; Dobbs K, 2015, NEW ENGL J MED, V372, P2409, DOI 10.1056/NEJMoa1413462; Fearon DT, 2000, ANNU REV IMMUNOL, V18, P393, DOI 10.1146/annurev.immunol.18.1.393; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang L, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001750; Kuznetsov NV, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0481-6; Liu CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001704; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Otero DC, 2003, J IMMUNOL, V170, P73, DOI 10.4049/jimmunol.170.1.73; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Sun XY, 2018, BLOOD ADV, V2, P401, DOI 10.1182/bloodadvances.2017007880; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Ushijima M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00243; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang J, 2017, CELL REP, V21, P2541, DOI 10.1016/j.celrep.2017.10.117; Wang L, 2010, BIOCHEM BIOPH RES CO, V395, P111, DOI 10.1016/j.bbrc.2010.03.148; Xu LF, 2017, IMMUNITY, V47, P538, DOI 10.1016/j.immuni.2017.08.011; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009; Zhou XY, 2012, J IMMUNOL, V189, P2722, DOI 10.4049/jimmunol.1201150	28	15	15	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2019	144	5					1377	+		10.1016/j.jaci.2019.05.041	http://dx.doi.org/10.1016/j.jaci.2019.05.041			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JK7EU	31405607	Bronze			2022-12-18	WOS:000495004700028
J	Saku, A; Hirose, K; Ito, T; Iwata, A; Sato, T; Kaji, H; Tamachi, T; Suto, A; Goto, Y; Domino, SE; Narimatsu, H; Kiyono, H; Nakajima, H				Saku, Aiko; Hirose, Koichi; Ito, Takashi; Iwata, Arifumi; Sato, Takashi; Kaji, Hiroyuki; Tamachi, Tomohiro; Suto, Akira; Goto, Yoshiyuki; Domino, Steven E.; Narimatsu, Hisashi; Kiyono, Hiroshi; Nakajima, Hiroshi			Fucosyltransferase 2 induces lung epithelial fucosylation and exacerbates house dust mite-induced airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; epithelial fucosylation; fucosyltransferase 2; C3a; monocyte-derived dendritic cells	TERMINAL GLYCOSYLATION; ALLERGIC INFLAMMATION; SALIVARY AGGLUTININ; ASTHMA; CELLS; MICE; SUSCEPTIBILITY; IMMUNITY; ANTIGEN; IL-22	Background: One of the pathognomonic features of asthma is epithelial hyperproduction of mucus, which is composed of a series of glycoproteins; however, it remains unclear how glycosylation is induced in lung epithelial cells from asthmatic patients and how glycan residues play a role in the pathogenesis of asthma. Objective: The objective of this study was to explore comprehensive epithelial glycosylation status induced by allergic inflammation and reveal its possible role in the pathogenesis of asthma. Methods: We evaluated the glycosylation status of lung epithelium using a lectin microarray. We next searched for molecular mechanisms underlying epithelial glycosylation. We also examined whether epithelial glycosylation is involved in induction of allergic inflammation. Results: On allergen inhalation, lung epithelial cells were heavily alpha(1,2)fucosylated by fucosyltransferase 2 (Fut2), which was induced by the IL-13-signal transducer and activator of transcription 6 pathway. Importantly, Fut2-deficient (Fut2(-/-)) mice, which lacked lung epithelial fucosylation, showed significantly attenuated eosinophilic inflammation and airway hyperresponsiveness in house dust mite (HDM)-induced asthma models. Proteome analyses and immunostaining of the HDM-challenged lung identified that complement C3 was accumulated in fucosylated areas. Indeed, Fut2(-/-) mice showed significantly reduced levels of C3a and impaired accumulation of C3a receptor-expressing monocyte-derived dendritic cells in the lung on HDM challenge. Conclusion: Fut2 induces epithelial fucosylation and exacerbates airway inflammation in asthmatic patients in part through C3a production and monocyte-derived dendritic cell accumulation in the lung.	[Saku, Aiko; Hirose, Koichi; Ito, Takashi; Iwata, Arifumi; Tamachi, Tomohiro; Suto, Akira; Nakajima, Hiroshi] Chiba Univ, Dept Allergy & Clin Immunol, Grad Sch Med, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan; [Kiyono, Hiroshi] Chiba Univ, Dept Immunol, Grad Sch Med, Chiba, Japan; [Goto, Yoshiyuki] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Hirose, Koichi] Int Univ Hlth & Welf, Sch Med, Dept Rheumatol, Chiba, Japan; [Sato, Takashi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Glycosci & Glycotechnol Res Grp, Tsukuba, Japan; [Goto, Yoshiyuki; Kiyono, Hiroshi] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan; [Domino, Steven E.] Univ Michigan, Med Ctr, Dept Obstet & Gynecol, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	Chiba University; Chiba University; Chiba University; International University of Health & Welfare; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; University of Tokyo; University of Michigan System; University of Michigan	Hirose, K; Nakajima, H (corresponding author), Chiba Univ, Dept Allergy & Clin Immunol, Grad Sch Med, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	hirose-kh@faculty.chiba-u.jp; nakajimh@faculty.chiba-u.jp	Kiyono, Hiroshi/AAC-6735-2022; Kaji, Hiroyuki/L-7122-2018; Nakajima, Hiroshi/AFU-9313-2022; Hirose, Koichi/I-1506-2017	Kaji, Hiroyuki/0000-0002-0910-9999; Nakajima, Hiroshi/0000-0001-8595-9381; Suto, Akira/0000-0002-2593-565X; Hirose, Koichi/0000-0001-7498-9630	Institute for Global Prominent Research, Chiba University, Japan; Glaxo Smith Kline, Japan; Takeda Science Foundation, Japan; Ministry of Education, Culture, Sports and Technology of the Japanese Government [17K09645]	Institute for Global Prominent Research, Chiba University, Japan; Glaxo Smith Kline, Japan(GlaxoSmithKline); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported in part by the Institute for Global Prominent Research, Chiba University, Japan; a Glaxo Smith Kline Japan Research Grant from Glaxo Smith Kline, Japan; the Takeda Science Foundation, Japan; and Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports and Technology (grant no. 17K09645) of the Japanese Government.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Chen YL, 2005, CLIN EXP ALLERGY, V35, P926, DOI 10.1111/j.1365-2222.2005.02278.x; Domino SE, 2001, MOL CELL BIOL, V21, P8336, DOI 10.1128/MCB.21.24.8336-8345.2001; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fanelli G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15212-z; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gunput STG, 2016, INNATE IMMUN-LONDON, V22, P257, DOI 10.1177/1753425916642614; Gunput STG, 2015, BIOL CHEM, V396, P35, DOI 10.1515/hsz-2014-0200; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hasegawa K, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0635-5; Innes AL, 2011, AM J RESP CRIT CARE, V183, P189, DOI 10.1164/rccm.201003-0488OC; Ito T, 2017, J EXP MED, V214, P3037, DOI 10.1084/jem.20162108; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Kaji H, 2006, NAT PROTOC, V1, P3019, DOI 10.1038/nprot.2006.444; Khan MA, 2014, RESP MED, V108, P543, DOI 10.1016/j.rmed.2014.01.005; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lafkas D, 2015, NATURE, V528, P127, DOI 10.1038/nature15715; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Randolph DA, 1999, J IMMUNOL, V162, P2375; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rhim AD, 2000, GLYCOCONJUGATE J, V17, P385, DOI 10.1023/A:1007156014384; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Scanlin TF, 2000, GLYCOCONJUGATE J, V17, P617, DOI 10.1023/A:1011034912226; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Takahashi K, 2011, J ALLERGY CLIN IMMUN, V128, P1067, DOI 10.1016/j.jaci.2011.06.018; Takeda K, 1996, J IMMUNOL, V157, P3220; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Togayachi A, 2018, J AM SOC MASS SPECTR, V29, P1138, DOI 10.1007/s13361-018-1938-6; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tsou PS, 2013, ANGIOGENESIS, V16, P195, DOI 10.1007/s10456-012-9312-y; Tsukamoto A, 2015, EXP ANIM TOKYO, V64, P57, DOI 10.1538/expanim.14-0050; Wakabayashi M, 2014, J PROTEOME RES, V13, P915, DOI 10.1021/pr400960r; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang YW, 2017, GASTROENTEROLOGY, V152, P193, DOI 10.1053/j.gastro.2016.09.004; Weitnauer M, 2016, MUCOSAL IMMUNOL, V9, P287, DOI 10.1038/mi.2015.126; Welsh KG, 2017, CHEST, V152, P771, DOI 10.1016/j.chest.2017.07.001; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Yokota M, 2017, ALLERGY, V72, P1043, DOI 10.1111/all.13079; Zanin M, 2016, CELL HOST MICROBE, V19, P159, DOI 10.1016/j.chom.2016.01.001; Zou X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43560	57	15	16	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					698	+		10.1016/j.jaci.2019.05.010	http://dx.doi.org/10.1016/j.jaci.2019.05.010			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31125592	Bronze			2022-12-18	WOS:000485222300015
J	Desai, A; Sowerwine, K; Liu, YH; Lawrence, MG; Chovanec, J; Hsu, AP; O'Connell, MP; Kim, J; Boris, L; Jones, N; Wisch, L; Eisch, RR; Carter, MC; Komarow, HD; Zerbe, C; Milner, JD; Maric, I; Sun, XP; Lee, CCR; Tunc, I; Pirooznia, M; Stone, KD; Holland, SM; Metcalfe, DD; Lyons, JJ				Desai, Avanti; Sowerwine, Kathryn; Liu, Yihui; Lawrence, Monica G.; Chovanec, Jack; Hsu, Amy P.; O'Connell, Michael P.; Kim, Jiwon; Boris, Lisa; Jones, Nina; Wisch, Laura; Eisch, Robin R.; Carter, Melody C.; Komarow, Hirsh D.; Zerbe, Christa; Milner, Joshua D.; Maric, Irina; Sun, Xiaoping; Lee, Chyi-Chia R.; Tunc, Ilker; Pirooznia, Mehdi; Stone, Kelly D.; Holland, Steven M.; Metcalfe, Dean D.; Lyons, Jonathan J.			GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FC-EPSILON-RI; DENDRITIC CELL; BONE-MARROW; GATA2; DIFFERENTIATION; KIT; DEGRANULATION; DEFICIENCY; ACTIVATION; EXPRESSION		[Desai, Avanti; Liu, Yihui; Chovanec, Jack; O'Connell, Michael P.; Kim, Jiwon; Wisch, Laura; Eisch, Robin R.; Carter, Melody C.; Komarow, Hirsh D.; Milner, Joshua D.; Stone, Kelly D.; Metcalfe, Dean D.; Lyons, Jonathan J.] NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sowerwine, Kathryn; Hsu, Amy P.; Boris, Lisa; Zerbe, Christa; Holland, Steven M.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lawrence, Monica G.] Univ Virginia, Dept Med, Div Asthma Allergy & Immunol, Charlottesville, VA USA; [Jones, Nina] NCI, Clin Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Maric, Irina; Sun, Xiaoping] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Lee, Chyi-Chia R.] NCI, Lab Pathol, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Tunc, Ilker; Pirooznia, Mehdi] NHLBI, Bioinformat & Computat Biol Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lyons, JJ (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jonathan.lyons@nih.gov	Lee, Chyi-Chia Richard/AAO-1149-2020; Pirooznia, Mehdi/AAG-1878-2019; Lee, Chyi-Chia/I-1938-2013	Pirooznia, Mehdi/0000-0002-4210-6458; Chovanec, Jack/0000-0002-0372-3998; O'Connell, Michael/0000-0002-8615-7660; Lee, Chyi-Chia/0000-0002-5306-7781	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, ZIAAI001192, ZIAAI001091, ZIAAI001183, ZIAAI000646, ZIAAI001092] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Babina M, 2005, CELL MOL LIFE SCI, V62, P214, DOI 10.1007/s00018-004-4480-6; Chou J, 2014, J ALLERGY CLIN IMMUN, V134, P223, DOI 10.1016/j.jaci.2014.01.041; Collado-Torres L, 2017, NAT BIOTECHNOL, V35, P319, DOI 10.1038/nbt.3838; Custovic A., 2017, MIDDLETONS ALLERGY E, P51, DOI DOI 10.1016/B978-0-323-37579-5.00003-9; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Ganapathi KA, 2015, BLOOD, V125, P56, DOI 10.1182/blood-2014-06-580340; Gomes ER, 2005, CURR OPIN ALLERGY CL, V5, P309, DOI 10.1097/01.all.0000173785.81024.33; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harigae H, 1998, GENES CELLS, V3, P39, DOI 10.1046/j.1365-2443.1998.00166.x; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Hundley TR, 2004, BLOOD, V104, P2410, DOI 10.1182/blood-2004-02-0631; Imagawa S, 2003, FASEB J, V17, P1742, DOI 10.1096/fj.02-1134fje; Inage E, 2014, J IMMUNOL, V192, P3936, DOI 10.4049/jimmunol.1302366; Ishijima Y, 2012, GENES CELLS, V17, P285, DOI 10.1111/j.1365-2443.2012.01588.x; Kikuchi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060649; Kirshenbaum Arnold S, 2006, Methods Mol Biol, V315, P105; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Li YP, 2018, J ALLERGY CLIN IMMUN, V142, P1173, DOI 10.1016/j.jaci.2017.10.043; Li YP, 2015, J IMMUNOL, V194, P4328, DOI 10.4049/jimmunol.1500018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; Masuda A, 2007, J IMMUNOL, V178, P360, DOI 10.4049/jimmunol.178.1.360; Morachis JM, 2012, PHARMACOL REV, V64, P505, DOI 10.1124/pr.111.005363; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Ohmori S, 2015, BLOOD, V125, P3306, DOI 10.1182/blood-2014-11-612465; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI 10.1128/MCB.01524-13; Onodera K, 2016, BLOOD, V128, P508, DOI 10.1182/blood-2016-02-698118; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1	35	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					613	+		10.1016/j.jaci.2019.05.007	http://dx.doi.org/10.1016/j.jaci.2019.05.007			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31102699	Bronze			2022-12-18	WOS:000478789300033
J	Lua, WH; Su, CTT; Yeo, JY; Poh, JJ; Ling, WL; Phua, SX; Gan, SKE				Lua, Wai-Heng; Su, Chinh Tran-To; Yeo, Joshua Yi; Poh, Jun-Jie; Ling, Wei-Li; Phua, Ser-Xian; Gan, Samuel Ken-En			Role of the IgE variable heavy chain in Fc epsilon RI alpha and superantigen binding in allergy and immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; IgE; antibodies; variable heavy chain families; allostery; Fc receptor binding; superantigen binding	V-H; STAPHYLOCOCCUS-AUREUS; PROTEIN-A; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; CONSTANT-REGION; POLYCLONAL IGE; B-CELLS; ANTIBODY; RECEPTOR	Background: Variable heavy chain (VH) family frameworks (FWRs) have been reported to affect antibody receptor and superantigen binding; however, such effects in IgE remain largely unknown. Given that VH family biases have been previously reported in IgE of certain allergies, there is a need to investigate this phenomenon for biotechnological and therapeutic purposes. Objective: We sought to investigate the effects of VH families on IgE interaction with Fc epsilon RI alpha, anti-IgE omalizumab, antigen, and superantigen protein A (spA) by using the pertuzumab and trastuzumab IgE models. Methods: Pertuzumab VH1-VH7 family variants of IgE with the same complementarity-determining regions were investigated with regard to their binding interactions to Fc epsilon RI alpha, Her2, omalizumab, and spA. Notable Fc epsilon RI alpha-IgE observations were cross-checked against appropriate trastuzumab IgE VH variants. Computational structural modeling and simulations were also performed for insight into the mechanism of interactions with various VH FWRs. Results: The pertuzumab VH5 IgE variant, but not the trastuzumab VH5 IgE, was found to interact with Fc epsilon RI alpha significantly longer than the respective VH family variants within each model antibody. No significant differences in interaction were found between IgE and omalizumab for the pertuzumab VH variants. Although trastuzumab VH3 interacted with spA, none of our pertuzumab VH variants, including VH3, associated with spA. Conclusion: We found unexpected varying allosteric communications caused by the VH family FWRs to the Fc epsilon RI alpha-, Her2-, and spA-binding regions of pertuzumab IgE, with implications for use of IgE/anti-IgE therapeutics to treat allergy and IgE therapeutics in allergo-oncology.	[Lua, Wai-Heng; Su, Chinh Tran-To; Yeo, Joshua Yi; Poh, Jun-Jie; Ling, Wei-Li; Phua, Ser-Xian; Gan, Samuel Ken-En] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore; [Gan, Samuel Ken-En] ASTAR, P53 Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR)	Gan, SKE (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.	samuelg@bii.a-star.edu.sg	Gan, Samuel Ken-En/AAL-4290-2021; Su, Chinh Tran-To/ABB-1161-2020; Yeo, Joshua/AAK-1791-2021	Gan, Samuel Ken-En/0000-0001-9936-5090; Su, Chinh Tran-To/0000-0001-6465-5987; Yeo, Joshua Yi/0000-0002-0253-0238	A*STAR Industry Alignment Fund (IAF) [IAF111149]	A*STAR Industry Alignment Fund (IAF)	Supported by A*STAR Industry Alignment Fund (IAF) grant IAF111149 and institute core funds.	Akin C, 2017, J ALLERGY CLIN IMMUN, V140, P349, DOI 10.1016/j.jaci.2017.06.007; Bachert C, 2003, CURR ALLERGY ASTHM R, V3, P523, DOI 10.1007/s11882-003-0065-y; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bando Y, 2004, IMMUNOL LETT, V94, P99, DOI 10.1016/j.imlet.2004.04.006; Bax HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09538; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; BLANK U, 1991, J BIOL CHEM, V266, P2639; Chan WT, 2013, BIOSCIENCE REP, V33, P931, DOI 10.1042/BSR20130098; Chen JB, 2017, J ALLERGY CLIN IMMUN, V139, P1195, DOI 10.1016/j.jaci.2016.06.066; Su CTT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02756-3; Coker HA, 2005, J ALLERGY CLIN IMMUN, V116, P445, DOI 10.1016/j.jaci.2005.04.032; Coscia GT, 2018, J ALLERGY CLIN IMMUN, V141, pAB280, DOI 10.1016/j.jaci.2017.12.892; Darcy E, 2017, METHODS MOL BIOL, V1485, P305, DOI 10.1007/978-1-4939-6412-3_15; Davies JM, 2004, CLIN EXP ALLERGY, V34, P429, DOI 10.1111/j.1365-2222.2004.01900.x; Eggel A, 2014, J ALLERGY CLIN IMMUN, V133, P1709, DOI 10.1016/j.jaci.2014.02.005; Eibensteiner P, 2000, IMMUNOLOGY, V101, P112, DOI 10.1046/j.1365-2567.2000.00078.x; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Gan S., 2008, The rapid expression of human Immunoglobulins, Patent No. [UK0810633.8, US61/060.239, 61060239]; Gan SKE, 2008, Patent, Patent No. [UK0810633. 8, 08106338]; Gemma E., 2017, J AUTOIMMUNE DISORD, V3, P40; Genovese A, 2000, INFECT IMMUN, V68, P5517, DOI 10.1128/IAI.68.10.5517-5524.2000; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Guarnera E, 2017, BIOINFORMATICS, V33, P3996, DOI 10.1093/bioinformatics/btx430; Guarnera E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004678; Gutierrez-Granados S, 2018, CRIT REV BIOTECHNOL, V38, P918, DOI 10.1080/07388551.2017.1419459; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; INGANAS M, 1980, SCAND J IMMUNOL, V12, P23, DOI 10.1111/j.1365-3083.1980.tb00037.x; Janda A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00022; Janezic A, 1998, J ALLERGY CLIN IMMUN, V101, P391, DOI 10.1016/S0091-6749(98)70253-2; Karagiannis P, 2009, CANCER IMMUNOL IMMUN, V58, P915, DOI 10.1007/s00262-008-0607-1; Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lim A, 2007, J ALLERGY CLIN IMMUN, V120, P696, DOI 10.1016/j.jaci.2007.05.035; Ling WL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00469; Lua WH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18892-9; Lua WH, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.12; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; PENG ZK, 1994, INT ARCH ALLERGY IMM, V104, P204, DOI 10.1159/000236731; Penichet ML, 2014, Patent, Patent No. 8697079; Pennington LF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11610; Phua SX, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181958; Poh J., 2014, J BIOPROCESS BIOTECH, V4, P157; Poh JJ, 2018, SCI PHONE APPS MOBIL, V4, P4; Potter K N, 1997, Int Rev Immunol, V14, P291, DOI 10.3109/08830189709116521; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; RANDEN I, 1993, EUR J IMMUNOL, V23, P2682, DOI 10.1002/eji.1830231044; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; SASSO EH, 1991, J IMMUNOL, V147, P1877; Schrodinger L., 2019, PYMOL MOL GRAPHICS S; Shiomori T, 2000, J ALLERGY CLIN IMMUN, V105, P449, DOI 10.1067/mai.2000.104256; Silverman GJ, 1996, J IMMUNOL, V157, P4496; SNOW RE, 1995, J IMMUNOL, V154, P5576; Snow RE, 1999, IMMUNOLOGY, V98, P646, DOI 10.1046/j.1365-2567.1999.00910.x; Su CTT, 2018, ANTIBODIES, V7, DOI 10.3390/antib7020020; Tilgner J, 1997, CLIN EXP IMMUNOL, V107, P528, DOI 10.1046/j.1365-2249.1997.d01-960.x; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wiersma EJ, 1998, J IMMUNOL, V160, P5979; Wright JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep11581; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yang DL, 2017, MABS-AUSTIN, V9, P1231, DOI 10.1080/19420862.2017.1367074; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x; Zhao J, 2019, MABS-AUSTIN, V11, P58, DOI 10.1080/19420862.2018.1522178; Zhao J, 2017, PROTEIN ENG DES SEL, V30, P67, DOI 10.1093/protein/gzw065	69	15	16	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					514	+		10.1016/j.jaci.2019.03.028	http://dx.doi.org/10.1016/j.jaci.2019.03.028			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	30995457	hybrid			2022-12-18	WOS:000478789300019
J	Roy, S; Gupta, K; Ganguly, A; Ali, H				Roy, Saptarshi; Gupta, Kshitij; Ganguly, Anirban; Ali, Hydar			beta-Arrestin2 expressed in mast cells regulates ciprofloxacin-induced pseudoallergy and IgE-mediated anaphylaxis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Roy, Saptarshi; Gupta, Kshitij; Ganguly, Anirban; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	alih@upenn.edu	Roy, Saptarshi/ABB-3263-2021	Roy, Saptarshi/0000-0002-4649-0741	National Institutes of Health [R21-AI115688, R01-AI124182]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115688, R01AI124182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants R21-AI115688 and R01-AI124182 (to H.A.).	Galand C, 2016, J ALLERGY CLIN IMMUN, V138, P1356, DOI 10.1016/j.jaci.2016.03.056; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Oskeritzian CA, 2015, J ALLERGY CLIN IMMUN, V135, P1008, DOI 10.1016/j.jaci.2014.10.044; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Sente A, 2018, NAT STRUCT MOL BIOL, V25, P541, DOI 10.1038/s41594-018-0071-3; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051; Takamori A, 2019, J ALLERGY CLIN IMMUN, V143, P1231, DOI 10.1016/j.jaci.2018.10.034; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585	9	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					603	606		10.1016/j.jaci.2019.04.024	http://dx.doi.org/10.1016/j.jaci.2019.04.024			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	31077686	Green Accepted, Bronze			2022-12-18	WOS:000478789300029
J	Frith, K; Joly, AL; Ma, CS; Tangye, SG; Lohse, Z; Seitz, C; Verge, CF; Andersson, J; Gray, P				Frith, Katie; Joly, Anne-Laure; Ma, Cindy S.; Tangye, Stuart G.; Lohse, Zuzana; Seitz, Christina; Verge, Charles F.; Andersson, John; Gray, Paul			The FOXP3 Delta 2 isoform supports Treg cell development and protects against severe IPEX syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							FOXP3 ISOFORMS; POLYENDOCRINOPATHY; IDENTIFICATION; ENTEROPATHY		[Frith, Katie; Gray, Paul] Sydney Childrens Hosp, Dept Immunol & Infect Dis, Sydney, NSW, Australia; [Verge, Charles F.] Sydney Childrens Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Frith, Katie; Verge, Charles F.; Gray, Paul] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Ma, Cindy S.; Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Joly, Anne-Laure; Seitz, Christina; Andersson, John] Karolinska Inst, Immunol & Allergy Unit, Dept Med Solna, Stockholm, Sweden; [Ma, Cindy S.; Tangye, Stuart G.] Garvan Inst Med Res, Div Immunol, Darlinghurst, NSW, Australia; [Lohse, Zuzana] Vejle Hosp, Dept Clin Genet, Vejle, Denmark	University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Karolinska Institutet; Garvan Institute of Medical Research; University of Southern Denmark; Lillebaelt Hospital	Frith, K (corresponding author), Sydney Childrens Hosp, Dept Immunol & Infect Dis, Sydney, NSW, Australia.; Frith, K (corresponding author), Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.	Catherine.frith@health.nsw.gov.au	S, Cindy/B-2340-2012	S, Cindy/0000-0001-5387-8413; Andersson, John/0000-0003-2799-6349	Swedish Cancer Society; Swedish Childhood Cancer Fund; Jeffrey Modell Foundation through Sydney Children's Hospital; Early-Mid Career Research Fellowship from the Department of Health of the New South Wales Government; National Health and Medical Research Council of Australia [1113904, 1042925]	Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Fund; Jeffrey Modell Foundation through Sydney Children's Hospital; Early-Mid Career Research Fellowship from the Department of Health of the New South Wales Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by the Swedish Cancer Society and Swedish Childhood Cancer Fund and the Jeffrey Modell Foundation through Sydney Children's Hospital. C.S. Ma is supported by an Early-Mid Career Research Fellowship from the Department of Health of the New South Wales Government. S.G. Tangye is supported by grants (1113904) and a Principal Research Fellowship (1042925) awarded by the National Health and Medical Research Council of Australia.	Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Gambineri E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02411; Harbuz R, 2010, PRENATAL DIAG, V30, P1072, DOI 10.1002/pd.2613; Joly AL, 2018, CIRC RES, V122, P1385, DOI 10.1161/CIRCRESAHA.117.312340; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moudgil A, 2007, PEDIATR NEPHROL, V22, P1799, DOI 10.1007/s00467-007-0532-0; Otsubo K, 2011, CLIN IMMUNOL, V141, P111, DOI 10.1016/j.clim.2011.06.006; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x	9	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2019	144	1					317	+		10.1016/j.jaci.2019.03.003	http://dx.doi.org/10.1016/j.jaci.2019.03.003			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IF9SM	30904640	Bronze			2022-12-18	WOS:000473432800036
J	Wheeler, JC; Vanoni, S; Zeng, C; Waggoner, L; Yang, YF; Wu, D; Uddin, J; Karns, R; Kottyan, L; Mukkada, V; Rothenberg, ME; Hogan, SP				Wheeler, Justin C.; Vanoni, Simone; Zeng, Chang; Waggoner, Lisa; Yang, Yanfen; Wu, David; Uddin, Jazib; Karns, Rebekah; Kottyan, Leah; Mukkada, Vincent; Rothenberg, Marc E.; Hogan, Simon P.			17 beta-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; IL-13; estrogen; hormone; barrier dysfunction	RECEPTOR-BETA-ISOFORMS; EOSINOPHILIC ESOPHAGITIS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; SIGNALING PATHWAYS; GENDER-DIFFERENCES; MUCOSAL INJURY; IL-13; MECHANISMS; DIAGNOSIS	Background: The incidence of eosinophilic esophagitis (EoE) is greater in male than female subjects, and the underlying molecular basis for this sex bias remains unclear. Objective: We sought to delineate the contribution of the sex hormone estrogen to the EoE phenotype and esophageal epithelial barrier function and remodeling. Methods: We performed demographic and incidence analyses of EoE in male and female subjects from a single-center pediatric cohort. Estrogen-responsive gene expression analyses and estrogen receptor (ESR) immunofluorescence staining of esophageal biopsy specimens from patients with EoE and control subjects were performed. The effect of 17 eta-estradiol (E2) on IL-13-induced signaling pathways, gene expression, and esophageal epithelial architecture and barrier function in a primary human esophageal keratinocyte cell (EPC2) culture system (EPC2-air-liquid interface) was examined. Results: We observed a male predominance in patients with EoE. Analyses of RNA sequencing data sets revealed a significant dysregulation of the estrogen-responsive gene network and expression of ESR1 and ESR2 in esophageal biopsy specimens from patients with EoE compared with control subjects. IL-13 stimulation of EPC2-air-liquid interface cells led to altered cellular architecture with induced dilation of intercellular spaces and barrier dysfunction. Pretreatment of EPC2s with E2 prior to IL-13 exposure abrogated IL-13-induced architectural changes and esophageal barrier dysfunction. Mechanistically, E2-protective effects were dependent on ESR2 and associated with diminishing of IL-13-induced tyrosine kinase 2 and signal transducer and activator of transcription 6 phosphorylation and EoE-dysregulated gene expression. Conclusions: Estrogen-responsive genes are modified in patients with EoE compared with control subjects. E2 attenuated IL-13induced architectural changes and esophageal epithelial barrier dysfunction through inhibition of the IL-13/tyrosine kinase 2/signal transducer and activator of transcription 6 pathway via ESR2-dependent process. Estrogen hormone signaling may protect against development of EoE in female subjects.	[Wheeler, Justin C.; Karns, Rebekah; Mukkada, Vincent] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Vanoni, Simone; Zeng, Chang; Waggoner, Lisa; Yang, Yanfen; Wu, David; Rothenberg, Marc E.; Hogan, Simon P.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH USA; [Uddin, Jazib; Kottyan, Leah] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol,Dept Pediat, Cincinnati, OH USA; [Hogan, Simon P.] Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, 5063 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, 5063 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu	Mukkada, Vincent/AAF-6995-2019; Vanoni, Simone/AAJ-8108-2020	Mukkada, Vincent/0000-0003-4225-5506; Vanoni, Simone/0000-0002-4464-2959; Kottyan, Leah/0000-0003-3979-2220	Food Allergy Research Education; National Institutes of Health [AI112626, DK090119, T32 DK007727, P30 DK078392]; Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; Sunshine Charitable Foundation; Mary H Weiser Food Allergy Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112626, T32AI007413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064008, T32DK007727, P30DK078392] Funding Source: NIH RePORTER	Food Allergy Research Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; Sunshine Charitable Foundation; Mary H Weiser Food Allergy Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by Food Allergy Research & Education, the National Institutes of Health (grant nos. AI112626 and DK090119 to S.P.H., T32 DK007727 to J.C.W., and P30 DK078392), the Campaign Urging Research for Eosinophilic Disease (CURED) Foundation; and the Sunshine Charitable Foundation and its supporters, Denise A. Bunning and David G. Bunning and the Mary H Weiser Food Allergy Center.	Abdulnour-Nakhoul SM, 2013, CLIN IMMUNOL, V148, P265, DOI 10.1016/j.clim.2013.05.004; Al-Khyatt W, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4030-5; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Beppu L, 2015, J PEDIATR GASTR NUTR, V61, P194, DOI 10.1097/MPG.0000000000000668; Bereshchenko O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01332; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cerny KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147685; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Cheng E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157376; D'Mello RJ, 2016, MUCOSAL IMMUNOL, V9, P744, DOI 10.1038/mi.2015.98; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Dellon ES, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.2; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; Dong J, 2013, ONCOL REP, V30, P2771, DOI 10.3892/or.2013.2770; Ebata Toshiya, 1996, Journal of Dermatology (Tokyo), V23, P603; Fatima LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16686-7; Franciosi JP, 2009, CLIN GASTROENTEROL H, V7, P415, DOI 10.1016/j.cgh.2008.10.006; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Ghosh S, 2017, J IMMUNOL, V198, P1782, DOI 10.4049/jimmunol.1601166; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Grishina I, 2014, AGING DIS, V5, P160, DOI 10.14336/AD.2014.0500160; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Harada H, 2003, MOL CANCER RES, V1, P729; Hebenstreit D, 2005, MOL IMMUNOL, V42, P295, DOI 10.1016/j.molimm.2004.09.004; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Honda J, 2016, DIGEST DIS SCI, V61, P1028, DOI 10.1007/s10620-015-3980-6; Ikeda K, 2015, ACTA PHARMACOL SIN, V36, P24, DOI 10.1038/aps.2014.123; Ishimura N, 2015, J GASTROEN HEPATOL, V30, P71, DOI 10.1111/jgh.12746; Jaillon S, 2017, CLIN REV ALLERGY IMM; Janfaza M, 2006, J PEDIATR ENDOCR MET, V19, P901; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kartashov AV, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0720-3; Keselman A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00568; Kim SC, 2018, AM J PHYSIOL-HEART C, V314, pH330, DOI 10.1152/ajpheart.00841.2016; Kinoshita Y, 2015, WORLD J GASTROENTERO, V21, P8433, DOI 10.3748/wjg.v21.i27.8433; Kiran KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127755; Kong KL, 2010, CANCER RES, V70, P8832, DOI 10.1158/0008-5472.CAN-10-0779; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leitner NR, 2017, CYTOKINE, V89, P209, DOI 10.1016/j.cyto.2015.10.015; Leung YK, 2006, P NATL ACAD SCI USA, V103, P13162, DOI 10.1073/pnas.0605676103; Liu L, 2004, ANTICANCER RES, V24, P2919; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Luo F, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0575-6; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Masaka T, 2013, GUT, V62, P6, DOI 10.1136/gutjnl-2011-301389; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Moawad FJ, 2016, CLIN GASTROENTEROL H, V14, P23, DOI 10.1016/j.cgh.2015.08.034; Moore JT, 1998, BIOCHEM BIOPH RES CO, V247, P75, DOI 10.1006/bbrc.1998.8738; Murata T, 1997, CELL IMMUNOL, V175, P33, DOI 10.1006/cimm.1996.1051; Neilsen CV, 2010, CLIN EXP ALLERGY, V40, P427, DOI 10.1111/j.1365-2222.2009.03419.x; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sobrino A, 2010, J MOL ENDOCRINOL, V44, P237, DOI 10.1677/JME-09-0112; Sperry SLW, 2012, AM J GASTROENTEROL, V107, P215, DOI 10.1038/ajg.2011.342; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tong D, 2002, BREAST CANCER RES TR, V71, P249, DOI 10.1023/A:1014465916473; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Rhijn BD, 2013, NEUROGASTROENT MOTIL, V25, P47, DOI 10.1111/nmo.12009; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wen T, 2013, GASTROENTEROLOGY, V145, P1289, DOI 10.1053/j.gastro.2013.08.046; Yang HQ, 2012, WORLD J GASTROENTERO, V18, P393, DOI 10.3748/wjg.v18.i5.393; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zeng C, 2018, J ALLERGY CLIN IMMUN, V142, P1843, DOI 10.1016/j.jaci.2018.03.017; Zheng YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093624, 10.1371/journal.pone.0109765]	80	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2131	2146		10.1016/j.jaci.2018.10.070	http://dx.doi.org/10.1016/j.jaci.2018.10.070			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30578870	Green Accepted, Bronze			2022-12-18	WOS:000470113200018
J	Lee, J; Kim, JY; Yi, MH; Hwang, Y; Lee, IY; Nam, SH; Yong, D; Yong, TS				Lee, Jinyoung; Kim, Ju Yeong; Yi, Myung-hee; Hwang, Younjee; Lee, In-Yong; Nam, Sung-Hyun; Yong, Dongeun; Yong, Tai-Soon			Comparative microbiome analysis of Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Tyrophagus putrescentiae	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DUST; ALLERGEN		[Lee, Jinyoung; Kim, Ju Yeong; Yi, Myung-hee; Lee, In-Yong; Nam, Sung-Hyun; Yong, Tai-Soon] Yonsei Univ, Coll Med, Inst Trop Med, Dept Environm Med Biol, Seoul, South Korea; [Kim, Ju Yeong] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul, South Korea; [Hwang, Younjee; Yong, Dongeun] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Hwang, Younjee; Yong, Dongeun] Yonsei Univ, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Yong, TS (corresponding author), Yonsei Univ, Coll Med, Inst Trop Med, Dept Environm Med Biol, Seoul, South Korea.	tsyong212@yuhs.ac		Lee, Jin-Youn/0000-0002-6941-5509; Yong, Tai-Soon/0000-0002-3445-0769; dongeun, yong/0000-0002-1225-8477; Yi, Myunghee/0000-0001-9537-5726; Kim, Ju Yeong/0000-0003-2456-6298	National Research Foundation of Korea (NRF) - Korean Government (Ministry of Education, Science and Technology) [NRF-2016R1A2B4016194]; Ministry of Health and Welfare, Republic of Korea [HI14C1324]	National Research Foundation of Korea (NRF) - Korean Government (Ministry of Education, Science and Technology)(National Research Foundation of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean Government (Ministry of Education, Science and Technology; grant no. NRF-2016R1A2B4016194) and by the Ministry of Health and Welfare, Republic of Korea (grant no. HI14C1324).	Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Erban T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01046; Hubert J, 2012, MICROB ECOL, V63, P919, DOI 10.1007/s00248-011-9969-6; Kim JY, 2018, CLIN EXP ALLERGY, V48, P607, DOI 10.1111/cea.13104; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Trivedi L, 2003, J ALLERGY CLIN IMMUN, V111, P777, DOI 10.1067/mai.2003.1338; Valerio CR, 2005, J ALLERGY CLIN IMMUN, V116, P1296, DOI 10.1016/j.jaci.2005.09.046	9	15	15	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1620	1623		10.1016/j.jaci.2018.10.062	http://dx.doi.org/10.1016/j.jaci.2018.10.062			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30528614	Bronze			2022-12-18	WOS:000463348900037
J	Potaczek, DP; Unger, SD; Zhang, N; Taka, S; Michel, S; Akdag, N; Lan, F; Helfer, M; Hudemann, C; Eickmann, M; Skevaki, C; Megremis, S; Sadewasser, A; Alhamwe, BA; Alhamdan, F; Akdis, M; Edwards, MR; Johnston, SL; Akdis, CA; Becker, S; Bachert, C; Papadopoulos, NG; Garn, H; Renz, H				Potaczek, Daniel P.; Unger, Sebastian D.; Zhang, Nan; Taka, Styliani; Michel, Sven; Akdag, Nesibe; Lan, Feng; Helfer, Markus; Hudemann, Christoph; Eickmann, Markus; Skevaki, Chrysanthi; Megremis, Spyridon; Sadewasser, Anne; Alhamwe, Bilal Alashkar; Alhamdan, Fahd; Akdis, Mubeccel; Edwards, Michael R.; Johnston, Sebastian L.; Akdis, Cezmi A.; Becker, Stephan; Bachert, Claus; Papadopoulos, Nikolaos G.; Garn, Holger; Renz, Harald			Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; antisense; antiviral; asthma; atopy; DNAzyme; exacerbation; human rhinovirus; RNA; therapy	RESPIRATORY VIRAL-INFECTIONS; BRONCHIAL EPITHELIAL-CELLS; ASTHMA; SITE; DNA; EXACERBATIONS; PREVENTION; RESPONSES; VIRUSES; REPLICATION	Background: Infections with human rhinoviruses (RVs) are responsible for millions of common cold episodes and the majority of asthma exacerbations, especially in childhood. No drugs specifically targeting RVs are available. Objective: We sought to identify specific anti-RV molecules based on DNAzyme technology as candidates to a clinical study. Methods: A total of 226 candidate DNAzymes were designed against 2 regions of RV RNA genome identified to be sufficiently highly conserved between virus strains (ie, the 59-untranslated region and cis-acting replication element) by using 3 test strains: RVA1, RVA16, and RVA29. All DNAzymes were screened for their cleavage efficiency against in vitro-expressed viral RNA. Those showing any catalytic activity were subjected to bioinformatic analysis of their reverse complementarity to 322 published RV genomic sequences. Further molecular optimization was conducted for the most promising candidates. Cytotoxic and off-target effects were excluded in HEK293 cell-based systems. Antiviral efficiency was analyzed in infected human bronchial BEAS-2B cells and ex vivo-cultured human sinonasal tissue. Results: Screening phase-generated DNAzymes characterized by either good catalytic activity or by high RV strain coverage but no single molecule represented a satisfactory combination of those 2 features. Modifications in length of the binding domains of 2 lead candidates, Dua-01(-L12R9) and Dua-02(-L10R11), improved their cleavage efficiency to an excellent level, with no loss in eminent strain coverage (about 98%). Both DNAzymes showed highly favorable cytotoxic/off-target profiles. Subsequent testing of Dua-01-L12R9 in BEAS-2B cells and sinonasal tissue demonstrated its significant antiviral efficiency. Conclusions: Effective and specific management of RV infections with Dua-01-L12R9 might be useful in preventing asthma exacerbations, which should be verified by clinical trials.	[Potaczek, Daniel P.; Unger, Sebastian D.; Akdag, Nesibe; Hudemann, Christoph; Skevaki, Chrysanthi; Alhamwe, Bilal Alashkar; Alhamdan, Fahd; Garn, Holger; Renz, Harald] UGMLC, German Ctr Lung Res DZL, Inst Lab Med, Giessen, Germany; [Potaczek, Daniel P.; Unger, Sebastian D.; Akdag, Nesibe; Hudemann, Christoph; Skevaki, Chrysanthi; Alhamwe, Bilal Alashkar; Alhamdan, Fahd; Garn, Holger; Renz, Harald] Grp Worldwide Univ Network WUN, InVIVO Planetary Hlth, Leeds, W Yorkshire, England; [Eickmann, Markus; Becker, Stephan] Philipps Univ Marburg, Inst Virol, Marburg, Germany; [Potaczek, Daniel P.; Unger, Sebastian D.; Zhang, Nan; Taka, Styliani; Akdag, Nesibe; Lan, Feng; Hudemann, Christoph; Skevaki, Chrysanthi; Megremis, Spyridon; Alhamwe, Bilal Alashkar; Alhamdan, Fahd; Akdis, Mubeccel; Edwards, Michael R.; Johnston, Sebastian L.; Akdis, Cezmi A.; Bachert, Claus; Papadopoulos, Nikolaos G.; Garn, Holger; Renz, Harald] PreDicta Consortium, Marburg, Germany; [Potaczek, Daniel P.] John Paul 2 Hosp, Krakow, Poland; [Zhang, Nan; Lan, Feng; Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, Ghent, Belgium; [Taka, Styliani; Papadopoulos, Nikolaos G.] Univ Athens, Allergy & Clin Immunol Unit, Pediat Clin 2, Athens, Greece; [Michel, Sven; Helfer, Markus; Sadewasser, Anne] Secarna Pharmaceut GmbH, Planegg, Germany; [Megremis, Spyridon; Papadopoulos, Nikolaos G.] Univ Manchester, Div Infect Inflammat & Resp Med, Manchester, Lancs, England; [Akdis, Mubeccel; Akdis, Cezmi A.] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Akdis, Mubeccel; Akdis, Cezmi A.] CK CARE, Davos, Switzerland; [Edwards, Michael R.; Johnston, Sebastian L.] Imperial Coll London, NHLI, Airway Dis Infect Sect, London, England; [Edwards, Michael R.; Johnston, Sebastian L.] MRC, London, England; [Edwards, Michael R.; Johnston, Sebastian L.] Asthma UK Ctr Allerg Mech Asthma, London, England	Philipps University Marburg; Ghent University; Ghent University Hospital; National & Kapodistrian University of Athens; University of Manchester; Swiss Institute of Allergy & Asthma Research; University of Zurich; Imperial College London; University of London; King's College London	Renz, H (corresponding author), Philipps Univ Marburg, Inst Lab Med, Baldinger Str, D-35043 Marburg, Germany.	renzh@med.uni-marburg.de	Alhamdan, Fahd/ABB-7346-2021; Bachert, Claus/J-8825-2012; Alhamwe, Bilal Alashkar/AAT-5358-2021; Johnston, Sebastian Lennox/I-2423-2012; N.G., Papadopoulos/L-8670-2013; Zhang, Nan/AAQ-3944-2020; Akdis, Cezmi/AAV-4844-2020; Hudemann, Christoph/ABF-4275-2020	Alhamwe, Bilal Alashkar/0000-0001-5449-7989; Johnston, Sebastian Lennox/0000-0003-3009-9200; N.G., Papadopoulos/0000-0002-4448-3468; Akdis, Cezmi/0000-0001-8020-019X; Hudemann, Christoph/0000-0001-5807-6882; Megremis, Spyridon/0000-0002-4082-5387; Alashkar Alhamwe, Bilal/0000-0002-7120-0013; Garn, Holger/0000-0002-5178-4023; Potaczek, Daniel Piotr/0000-0003-0324-8506	PreDicta EC FP7 Collaborative Project [260895]; Universities Giessen and Marburg Lung Center (UGMLC); Von Behring-Rontgen-Foundation (Von Behring-Rontgen-Stiftung); German Academic Exchange Service (DAAD) [91559386]; Hessen-Fonds, World University Service (WUS); Hessen State Ministry for Higher Education, Research and the Arts (HMWK); German Research Council (DFG) [SFB1021]; Chair from AsthmaUK [CH11SJ]; Medical Research Council (MRC) Centre [G1000758]; German Center for Lung Research (DZL) [82DZL00502/A2]	PreDicta EC FP7 Collaborative Project; Universities Giessen and Marburg Lung Center (UGMLC); Von Behring-Rontgen-Foundation (Von Behring-Rontgen-Stiftung); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Hessen-Fonds, World University Service (WUS); Hessen State Ministry for Higher Education, Research and the Arts (HMWK); German Research Council (DFG)(German Research Foundation (DFG)); Chair from AsthmaUK; Medical Research Council (MRC) Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Center for Lung Research (DZL)	Supported by the PreDicta EC FP7 Collaborative Project (260895; the PreDicta Consortium members); Universities Giessen and Marburg Lung Center (UGMLC; to H.R., H.G., D.P.P., and C.S.); the German Center for Lung Research (DZL; 82DZL00502/A2; to H.R., H.G., D.P.P., and C.S.); the Von Behring-Rontgen-Foundation (Von Behring-Rontgen-Stiftung; to H.R., H.G., and D.P.P.); the German Academic Exchange Service (DAAD; to B.A.A., personal reference no. 91559386); Hessen-Fonds, World University Service (WUS); the Hessen State Ministry for Higher Education, Research and the Arts (HMWK; to F.A.); the German Research Council (DFG; SFB1021, project C04); a Chair from AsthmaUK (CH11SJ; to S.L.J.); and the Medical Research Council (MRC) Centre grant (G1000758; S.L.J. and M.R.E).	Anderson EC, 2007, J GEN VIROL, V88, P3043, DOI 10.1099/vir.0.82463-0; Arden KE, 2010, J MED VIROL, V82, P1458, DOI 10.1002/jmv.21819; Arden KE, 2009, GENOME MED, V1, DOI 10.1186/gm44; Arden KE, 2010, REV MED VIROL, V20, P156, DOI 10.1002/rmv.644; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bochkov YA, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0608-7; Bochkov YA, 2014, J CLIN MICROBIOL, V52, P2461, DOI 10.1128/JCM.00075-14; Bochkov YA, 2012, MICROBES INFECT, V14, P485, DOI 10.1016/j.micinf.2011.12.011; Bossios A, 2008, CLIN EXP ALLERGY, V38, P1615, DOI 10.1111/j.1365-2222.2008.03058.x; Bossios A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-114; Cairns MJ, 2002, CURR DRUG TARGETS, V3, P269, DOI 10.2174/1389450023347722; Cordey S, 2008, RNA, V14, P1568, DOI 10.1261/rna.1031408; De Palma AM, 2008, MED RES REV, V28, P823, DOI 10.1002/med.20125; Dicke T, 2012, NUCLEIC ACID THER, V22, P117, DOI 10.1089/nat.2011.0294; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Edwards MR, 2017, J ALLERGY CLIN IMMUN, V140, P909, DOI 10.1016/j.jaci.2017.07.025; Faux CE, 2011, EMERG INFECT DIS, V17, P296, DOI 10.3201/eid1702.101123; Feil SC, 2012, ACS MED CHEM LETT, V3, P303, DOI 10.1021/ml2002955; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Fuhst R, 2013, PULM PHARMACOL THER, V26, P281, DOI 10.1016/j.pupt.2012.12.005; Gern JE, 2015, CLIN EXP ALLERGY, V45, P32, DOI 10.1111/cea.12428; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gern JE, 2009, CURR OPIN ALLERGY CL, V9, P73, DOI 10.1097/ACI.0b013e32831f8f1b; Gevaert E, 2017, J ALLERGY CLIN IMMUN, V139, P1849, DOI 10.1016/j.jaci.2017.01.019; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Glanville N, 2015, CURR OPIN VIROL, V11, P83, DOI 10.1016/j.coviro.2015.03.004; Glanville N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003669; Global Initiative for Asthma, 2017, GLOB STRAT ASTHM MAN; Gunson RN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-192; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Homburg U, 2015, J ALLERGY CLIN IMMUN, V136, P797, DOI 10.1016/j.jaci.2015.02.018; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jartti T, 2017, J ALLERGY CLIN IMMUN, V140, P895, DOI 10.1016/j.jaci.2017.08.003; Jartti T, 2011, PEDIAT ALLERG IMM-UK, V22, P350, DOI 10.1111/j.1399-3038.2011.01170.x; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lambert SB, 2007, PEDIATRICS, V120, pe929, DOI 10.1542/peds.2006-3703; Lee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12838; Mackay IM, 2013, J CLIN VIROL, V58, P286, DOI 10.1016/j.jcv.2013.04.020; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Miller EK, 2013, J CLIN VIROL, V57, P291, DOI 10.1016/j.jcv.2013.04.015; Murphy E, 2000, CIRC RES, V86, P245, DOI 10.1161/01.RES.86.3.245; Niespodziana K, 2012, FASEB J, V26, P1001, DOI 10.1096/fj.11-193557; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2017, J ALLERGY CLIN IMMUN, V140, P921, DOI 10.1016/j.jaci.2017.07.001; Phipps KM, 2004, ANTIVIR RES, V61, P49, DOI 10.1016/j.antiviral.2003.08.005; Popp V, 2017, GASTROENTEROLOGY, V152, P176, DOI 10.1053/j.gastro.2016.09.005; Potaczek DP, 2016, J ALLERGY CLIN IMMUN, V137, P1334, DOI 10.1016/j.jaci.2015.12.1344; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Schubert S, 2003, NUCLEIC ACIDS RES, V31, P5982, DOI 10.1093/nar/gkg791; Schubert S, 2004, J MOL BIOL, V339, P355, DOI 10.1016/j.jmb.2004.03.064; Sel S, 2008, J ALLERGY CLIN IMMUN, V121, P910, DOI 10.1016/j.jaci.2007.12.1175; Silverman SK, 2005, NUCLEIC ACIDS RES, V33, P6151, DOI 10.1093/nar/gki930; Soler M, 2004, ANTIVIR THER, V9, P953; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Stone JK, 2008, ANTIMICROB AGENTS CH, V52, P1970, DOI 10.1128/AAC.00011-08; Sun LQ, 2000, PHARMACOL REV, V52, P325; Tapparel C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-224; Turowska A, 2013, TOXICOL APPL PHARM, V272, P365, DOI 10.1016/j.taap.2013.06.020; van der Linden L, 2015, VIRUSES-BASEL, V7, P4529, DOI 10.3390/v7082832; Wagner H, 2006, J EXP MED, V203, P265, DOI 10.1084/jem.20052191; Walton RP, 2008, CURR OPIN ALLERGY CL, V8, P150, DOI 10.1097/ACI.0b013e3282f889df; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911; Zhang Y, 2015, ALLERGY ASTHMA IMMUN, V7, P367, DOI 10.4168/aair.2015.7.4.367	71	15	15	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1403	1415		10.1016/j.jaci.2018.07.026	http://dx.doi.org/10.1016/j.jaci.2018.07.026			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30114391	Green Submitted, Bronze			2022-12-18	WOS:000463348900017
J	Takamori, A; Izawa, K; Kaitani, A; Ando, T; Okamoto, Y; Maehara, A; Tanabe, A; Nagamine, M; Yamada, H; Uchida, S; Uchida, K; Isobe, M; Hatayama, T; Watanabe, D; Ando, T; Ide, T; Matsuzawa, M; Maeda, K; Nakano, N; Tamura, N; Ikeda, K; Ebihara, N; Shimizu, T; Ogawa, H; Okumura, K; Kitaura, J				Takamori, Ayako; Izawa, Kumi; Kaitani, Ayako; Ando, Tomoaki; Okamoto, Yoko; Maehara, Akie; Tanabe, Atsushi; Nagamine, Masakazu; Yamada, Hiromichi; Uchida, Shino; Uchida, Koichiro; Isobe, Masamichi; Hatayama, Tomoki; Watanabe, Daiki; Ando, Taiki; Ide, Takuma; Matsuzawa, Moe; Maeda, Keiko; Nakano, Nobuhiro; Tamura, Naoto; Ikeda, Katsuhisa; Ebihara, Nobuyuki; Shimizu, Toshiaki; Ogawa, Hideoki; Okumura, Ko; Kitaura, Jiro			Identification of inhibitory mechanisms in pseudo-allergy involving Mrgprb2/MRGPRX2-mediated mast cell activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							BINDING		[Takamori, Ayako; Izawa, Kumi; Kaitani, Ayako; Ando, Tomoaki; Okamoto, Yoko; Maehara, Akie; Tanabe, Atsushi; Nagamine, Masakazu; Yamada, Hiromichi; Uchida, Shino; Uchida, Koichiro; Isobe, Masamichi; Hatayama, Tomoki; Watanabe, Daiki; Ando, Taiki; Ide, Takuma; Matsuzawa, Moe; Maeda, Keiko; Nakano, Nobuhiro; Shimizu, Toshiaki; Ogawa, Hideoki; Okumura, Ko; Kitaura, Jiro] Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan; [Okamoto, Yoko] Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Yamada, Hiromichi; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, Tokyo, Japan; [Uchida, Shino] Juntendo Univ, Grad Sch Med, Dept Gastroenterol Immunol, Bunkyo Ku, Tokyo, Japan; [Tamura, Naoto] Juntendo Univ, Grad Sch Med, Dept Internal Med & Rheumatol, Bunkyo Ku, Tokyo, Japan; [Ikeda, Katsuhisa] Juntendo Univ, Grad Sch Med, Dept Otorhinolaryngol, Bunkyo Ku, Tokyo, Japan; [Ebihara, Nobuyuki] Juntendo Univ, Urayasu Hosp, Dept Ophthalmol, Urayasu, Chiba, Japan	Juntendo University; University of Tokyo; Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Kitaura, J (corresponding author), Juntendo Univ, Grad Sch Med, Atopy Allergy Res Ctr, Tokyo, Japan.	j-kitaura@juntendo.ac.jp		Nakano, Nobuhiro/0000-0002-5317-5950	Japan Society for the Promotion of Science (JSPS) KAKENHI [23390257, 26293231]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant nos. 23390257 and 26293231).	Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04647-z; Izawa K, 2014, J ALLERGY CLIN IMMUN, V133, P270, DOI 10.1016/j.jaci.2013.08.008; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Matsukawa T, 2016, GUT, V65, P777, DOI 10.1136/gutjnl-2014-308900; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Shiba E, 2017, J BIOL CHEM, V292, P2924, DOI 10.1074/jbc.M116.768366; Subramanian H, 2016, J ALLERGY CLIN IMMUN, V138, P700, DOI 10.1016/j.jaci.2016.04.051	9	15	15	3	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1231	+		10.1016/j.jaci.2018.10.034	http://dx.doi.org/10.1016/j.jaci.2018.10.034			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30414859	Bronze			2022-12-18	WOS:000460272900047
J	Ahmad, L; Mashbat, B; Leung, C; Brookes, C; Hamad, S; Krokowski, S; Shenoy, AR; Lorenzo, L; Levin, M; O'Hare, P; Zhang, SY; Casanova, JL; Mostowy, S; Sancho-Shimizu, V				Ahmad, Liyana; Mashbat, Bayarchimeg; Leung, Corwin; Brookes, Charlotte; Hamad, Samar; Krokowski, Sina; Shenoy, Avinash R.; Lorenzo, Lazaro; Levin, Michael; O'Hare, Peter; Zhang, Shen-Ying; Casanova, Jean-Laurent; Mostowy, Serge; Sancho-Shimizu, Vanessa			Human TANK-binding kinase 1 is required for early autophagy induction upon herpes simplex virus 1 infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ENCEPHALITIS; ACTIVATION; TBK1		[Ahmad, Liyana; Leung, Corwin; Brookes, Charlotte; Hamad, Samar; O'Hare, Peter; Sancho-Shimizu, Vanessa] Imperial Coll London, Dept Virol, Div Med, London, England; [Mashbat, Bayarchimeg; Levin, Michael; Sancho-Shimizu, Vanessa] Imperial Coll London, Dept Paediat, Div Med, London, England; [Krokowski, Sina; Mostowy, Serge] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect CMBI, London, England; [Krokowski, Sina; Mostowy, Serge] Imperial Coll London, Sect Microbiol, MRC CMBI, London, England; [Shenoy, Avinash R.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England; [Lorenzo, Lazaro; Zhang, Shen-Ying; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, U1163, Necker Branch, Paris, France; [Lorenzo, Lazaro; Zhang, Shen-Ying; Casanova, Jean-Laurent] Univ Paris 05, Imagine Inst, Paris, France; [Zhang, Shen-Ying; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol & Immunol Unit, Paris, France	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Sancho-Shimizu, V (corresponding author), Imperial Coll London, Dept Virol, Div Med, London, England.; Sancho-Shimizu, V (corresponding author), Imperial Coll London, Dept Paediat, Div Med, London, England.	v.sancho-shimizu@imperial.ac.uk	; Lorenzo, Lazaro/H-7902-2017	Mostowy, Serge/0000-0002-7286-6503; Krokowski, Sina/0000-0002-1153-4089; Levin, Michael/0000-0003-2767-6919; O'Hare, Peter/0000-0003-4508-5602; Ahmad, Liyana/0000-0002-0326-5157; Lorenzo, Lazaro/0000-0001-6648-8684	MRC [MR/P028225/1] Funding Source: UKRI; Medical Research Council [MR/P028225/1] Funding Source: Medline; MRF [MRF_C0483] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRF		Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Katzenell S, 2016, J VIROL, V90, P4706, DOI 10.1128/JVI.02908-15; Radtke K, 2013, J VIROL, V87, P3990, DOI 10.1128/JVI.02974-12; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sparrer KMJ, 2017, NAT MICROBIOL, V2, P1543, DOI 10.1038/s41564-017-0017-2; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Zheng C., 2018, J VIROL, P92	11	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2019	143	2					765	+		10.1016/j.jaci.2018.09.013	http://dx.doi.org/10.1016/j.jaci.2018.09.013			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HK2DJ	30296527	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000457718700035
J	Clowry, J; Irvine, AD; McLoughlin, RM				Clowry, Julianne; Irvine, Alan D.; McLoughlin, Rachel M.			Next-generation anti-Staphylococcus aureus vaccines: A potential new therapeutic option for atopic dermatitis?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Staphylococcus aureus; atopic dermatitis; vaccine; T cell	RANDOMIZED PHASE-I; SKIN MICROBIOME; IMMUNOGENICITY; SAFETY; COLONIZATION; 4-ANTIGEN; CHILDREN; TOLERABILITY; ADULTS; SA4AG		[Clowry, Julianne; Irvine, Alan D.] Our Ladys Childrens Hosp Crumlin, Pediat Dermatol, Dublin, Ireland; [Clowry, Julianne; Irvine, Alan D.] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Clowry, Julianne; Irvine, Alan D.] Trinity Coll Dublin, Med Clin, Dublin, Ireland; [McLoughlin, Rachel M.] Trinity Biomed Sci Inst, Sch Biochem & Immunol, Host Pathogen Interact Grp, Dublin, Ireland	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	McLoughlin, RM (corresponding author), Trinity Biomed Sci Inst, Sch Biochem & Immunol, Host Pathogen Interact Grp, Dublin, Ireland.; Irvine, AD (corresponding author), Our Ladys Childrens Hosp Crumlin, Dublin, Ireland.	irvinea@tcd.ie; mclougrm@tcd.ie	Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044; Clowry, Julianne/0000-0002-8526-4966; McLoughlin, Rachel/0000-0003-4553-018X	Science Foundation Ireland Investigator Award [15/IA/3041]	Science Foundation Ireland Investigator Award(Science Foundation Ireland)	Research in the lab is supported by a Science Foundation Ireland Investigator Award (15/IA/3041; to R.M.M.).	Begier E, 2017, VACCINE, V35, P1132, DOI 10.1016/j.vaccine.2017.01.024; Brown AF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005226; Bunikowski R, 2003, PEDIATR ALLERGY IMMU, V14, P55, DOI 10.1034/j.1399-3038.2003.02105.x; Chen WH, 2016, CLIN VACCINE IMMUNOL, V23, P918, DOI 10.1128/CVI.00399-16; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Creech CB, 2017, VACCINE, V35, P385, DOI 10.1016/j.vaccine.2016.11.032; Dillen CA, 2018, J CLIN INVEST, V128, P1026, DOI 10.1172/JCI96481; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Frenck RW, 2017, VACCINE, V35, P375, DOI 10.1016/j.vaccine.2016.11.010; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Goldmann O, 2018, INT J MED MICROBIOL, V308, P625, DOI 10.1016/j.ijmm.2017.09.013; Harkins CP, 2018, BRIT J DERMATOL, V179, P951, DOI 10.1111/bjd.16722; Hung SH, 2007, ANN ALLERG ASTHMA IM, V98, P51, DOI 10.1016/S1081-1206(10)60859-9; Karauzum H, 2017, CURR TOP MICROBIOL, V409, P419, DOI 10.1007/82_2016_1; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Landrum ML, 2017, HUM VACC IMMUNOTHER, V13, P791, DOI 10.1080/21645515.2016.1248326; Levy J, 2015, HUM VACC IMMUNOTHER, V11, P620, DOI 10.1080/21645515.2015.1011021; Marshall H, 2016, J INFECTION, V73, P437, DOI 10.1016/j.jinf.2016.08.004; Meylan P, 2017, J INVEST DERMATOL, V137, P2497, DOI 10.1016/j.jid.2017.07.834; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nissen M, 2015, VACCINE, V33, P1846, DOI 10.1016/j.vaccine.2015.02.024; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Ruzin A, 2018, CLIN TRANSL IMMUNOL, V7, DOI 10.1002/cti2.1009; Schmidt CS, 2012, VACCINE, V30, P7594, DOI 10.1016/j.vaccine.2012.10.038; Silva SH, 2006, J EUR ACAD DERMATOL, V20, P1114, DOI 10.1111/j.1468-3083.2006.01748.x; Varshney AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190537	28	15	15	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					78	81		10.1016/j.jaci.2018.08.038	http://dx.doi.org/10.1016/j.jaci.2018.08.038			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30218675	hybrid, Green Published			2022-12-18	WOS:000454918300008
J	Gardulf, A; Abolhassani, H; Gustafson, R; Eriksson, LE; Hammarstrom, L				Gardulf, Ann; Abolhassani, Hassan; Gustafson, Rolf; Eriksson, Lars E.; Hammarstrom, Lennart			Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Common variable immunodeficiency; specific antibody deficiency; vaccination; influenza; pandemic influenza; immune response; A(H1N1); Pandemrix	MEMORY B-CELLS; CHROMOSOMAL RADIOSENSITIVITY; ANTIBODY-RESPONSE; POLYSACCHARIDE VACCINATION; IMMUNE-DEFICIENCY; PERIPHERAL-BLOOD; TACI MUTATIONS; DISEASE; VIRUS; HLA	Background: A subgroup of patients with common variable immunodeficiencies (CVIDs) responds to vaccination. The aim of this study was to try to identify predictive markers for those with a humoral immune response after influenza vaccination. Methods: Forty-eight patients with CVID (29 female and 19 male patients; mean age, 57.7 years) were vaccinated with the A(H1N1) influenza vaccine Pandemrix (GlaxoSmithKline, Wavre, Belgium) and boosted after 1 month. Blood samples were collected before each vaccination and 2 months later. Patients with a 4-fold titer increase in results on the hemagglutinin inhibition test (>= 1:40) were considered responders and compared with nonresponders for clinical, immunologic, and genetic markers. Results: Eight (16.7%) patients responded to the vaccination. A significantly higher proportion of the responders, who showed a EUROclass SmB 2 Tr norm 21 norm profile (P = .03) with a post-germinal center B-cell pattern (P = .04) in blood, experienced enteropathies (P = .04) compared with nonresponders. On the other hand, bronchiectasis was found exclusively among nonresponders (n = 7), as was autoimmune cytopenia (n = 5). Nonresponders with a EUROclass SmB 2 Tr norm 21 low profile (P = .02) had a significantly greater prevalence of progressive antibody deficiency (P = .048) and, at diagnosis, a higher mean serum IgM level (P = .03), lower mean serum IgG1 level (P = .007), expansion of absolute counts of cytotoxic CD8(+) T cells (P = .033), and increased proportion of memory CD8(+) T cells (P = .044) in blood. CVID-associated HLA markers were not detected in responders (P = .03). Conclusion: About one fifth of the patients with CVIDs achieved protective antibody levels after A(H1N1) vaccination and selected clinical, and immunologic markers were identified that might predict a positive outcome of influenza vaccination. Patients with CVID should be offered vaccination also against seasonal influenza because of the potential severity of the infection and risk for bacterial complications.	[Gardulf, Ann; Abolhassani, Hassan; Hammarstrom, Lennart] Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Alfred Nobels Alle 8, SE-14186 Stockholm, Sweden; [Eriksson, Lars E.] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Gardulf, Ann; Abolhassani, Hassan; Hammarstrom, Lennart] Karolinska Univ Hosp, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, Campus Flemingsberg, Stockholm, Sweden; [Eriksson, Lars E.] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Gustafson, Rolf] Karolinska Univ Hosp, Dept Infect Dis, Immunodeficiency Unit, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, Div Nursing, London, England; [Abolhassani, Hassan] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Res Ctr Immunodeficiencies, Tehran, Iran	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; City University London; Tehran University of Medical Sciences	Gardulf, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Immunol & Transfus Med, Alfred Nobels Alle 8, SE-14186 Stockholm, Sweden.	ann.gardulf@ki.se	Abolhassani, Hassan/B-3465-2014	Abolhassani, Hassan/0000-0002-4838-0407	Jeffrey Modell Foundation, New York, NY; Swedish Research Council, Stockholm, Sweden	Jeffrey Modell Foundation, New York, NY; Swedish Research Council, Stockholm, Sweden(Swedish Research Council)	Supported by the Jeffrey Modell Foundation, New York, NY, and the Swedish Research Council, Stockholm, Sweden.	Abolhassani H, 2014, J INVEST ALLERG CLIN, V24, P6; Agarwal S, 2011, INFLAMM BOWEL DIS, V17, P251, DOI 10.1002/ibd.21376; Aghamohammadi A, 2008, INT ARCH ALLERGY IMM, V147, P87, DOI 10.1159/000135694; Aghamohammadi A, 2008, IMMUNOBIOLOGY, V213, P447, DOI 10.1016/j.imbio.2007.10.018; Al-Herz W, 2003, ANN ALLERG ASTHMA IM, V90, P244, DOI 10.1016/S1081-1206(10)62149-7; Baldassin MPM, 2015, WORLD ALLERGY ORGAN, V8, pA226; Ballow M, 2012, J ALLERGY CLIN IMMUN, V130, P283, DOI 10.1016/j.jaci.2012.04.028; Bodewes R, 2011, J VIROL, V85, P11995, DOI 10.1128/JVI.05213-11; Bogaert DJA, 2016, J MED GENET, V53, P575, DOI 10.1136/jmedgenet-2015-103690; Bonilla FA, 2016, J ALLER CL IMM-PRACT, V4, P38, DOI 10.1016/j.jaip.2015.07.025; Borte S, 2009, BLOOD, V114, P4089, DOI 10.1182/blood-2009-02-207423; Cambronero R, 2000, J IMMUNOL, V164, P488, DOI 10.4049/jimmunol.164.1.488; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; Chapel H, 2012, J ALLERGY CLIN IMMUN, V130, P1197, DOI 10.1016/j.jaci.2012.05.046; Cheraghi T, 2014, J INVEST ALLERG CLIN, V24, P198; Choi SW, 2014, KOREAN J INTERN MED, V29, P256, DOI 10.3904/kjim.2014.29.2.256; Chovancova Z, 2011, VACCINE, V29, P4142, DOI 10.1016/j.vaccine.2011.03.087; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Desombere I, 2002, VACCINE, V20, P2597, DOI 10.1016/S0264-410X(02)00150-0; Driessen GJ, 2011, BLOOD, V118, P6814, DOI 10.1182/blood-2011-06-361881; Eibl MM, 2015, IMMUNOTHERAPY-UK, V7, P1273, DOI 10.2217/IMT.15.74; European Agency for the Evaluation of Medicinal Products (EMEA) CfPMPC, 1997, CPMPBWP21496 EUR AG; European Medicines Agency, 2016, EMA3881822016; European Medicines Agency, PAND ANN 1 SUMM PROD; Fischer MB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00211; Goldacker S, 2007, CLIN IMMUNOL, V124, P294, DOI 10.1016/j.clim.2007.04.011; Hanitsch LG, 2016, VACCINE, V34, P2417, DOI 10.1016/j.vaccine.2016.03.091; Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006; Hong DK, 2011, PEDIATR INFECT DIS J, V30, P67, DOI 10.1097/INF.0b013e3181f127be; Hong R, 2010, J CLIN IMMUNOL, V30, P435, DOI 10.1007/s10875-010-9371-z; Ibanez C, 2005, BIODRUGS, V19, P59; Ikonen N, 2010, EURO SURVEILL, V15; Janssen WJM, 2015, VACCINE, V33, P6320, DOI 10.1016/j.vaccine.2015.09.041; Jolles S, 2013, J ALLER CL IMM-PRACT, V1, P545, DOI 10.1016/j.jaip.2013.09.015; Ko J, 2005, CLIN IMMUNOL, V116, P37, DOI 10.1016/j.clim.2005.03.019; Koopmans W, 2013, J CLIN IMMUNOL, V33, P68, DOI 10.1007/s10875-012-9793-x; Li J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7804; Li ZK, 2013, VACCINE, V31, P4355, DOI 10.1016/j.vaccine.2013.06.108; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Martinez-Gallo M, 2013, J ALLERGY CLIN IMMUN, V131, P468, DOI 10.1016/j.jaci.2012.10.029; Martinez-Pomar N, 2006, CLIN EXP IMMUNOL, V144, P233, DOI 10.1111/j.1365-2249.2006.03063.x; Mccaw JM, 2009, SCIENCE, V325, P1071, DOI 10.1126/science.325_1071a; McQuaid A, 2003, CLIN EXP IMMUNOL, V134, P321, DOI 10.1046/j.1365-2249.2003.02271.x; Mieves JF, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0749-3; Offer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012260; Palanduz S, 1998, CLIN IMMUNOL IMMUNOP, V86, P180, DOI 10.1006/clin.1997.4478; Pedersen G, 2011, SCAND J IMMUNOL, V74, P210, DOI 10.1111/j.1365-3083.2011.02561.x; Peron S, 2007, J EXP MED, V204, P1207, DOI 10.1084/jem.20070087; Rezaei N, 2010, CLIN VACCINE IMMUNOL, V17, P524, DOI 10.1128/CVI.00389-09; Rezaei N, 2008, IRAN J ALLERGY ASTHM, V7, P231, DOI 07.04/ijaai.231234; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Romberg N, 2013, J CLIN INVEST, V123, P4283, DOI 10.1172/JCI69854; Salzer U, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-3; Sanchez-Ramon S, 2016, CLIN IMMUNOL, V169, P80, DOI 10.1016/j.clim.2016.05.006; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013; van Assen S, 2011, CLIN IMMUNOL, V141, P161, DOI 10.1016/j.clim.2011.07.004; van Assen S, 2010, CLIN IMMUNOL, V136, P228, DOI 10.1016/j.clim.2010.03.430; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; VORECHOVSKY I, 1993, MUTAT RES, V290, P255, DOI 10.1016/0027-5107(93)90166-D; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wolf HM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00032; YARCHOAN R, 1983, J CLIN INVEST, V71, P1720, DOI 10.1172/JCI110926; Yong PFK, 2011, ADV IMMUNOL, V111, P47, DOI 10.1016/B978-0-12-385991-4.00002-7; Zhan W, 2011, ALLERGY ASTHMA CL IM, V7, pA28	64	15	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1922	+		10.1016/j.jaci.2018.02.052	http://dx.doi.org/10.1016/j.jaci.2018.02.052			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29678747	Bronze, Green Accepted			2022-12-18	WOS:000452315800025
J	Inagaki, S; Maeda, S; Narita, M; Nakamura, T; Shimosawa, T; Murata, T; Ohya, Y				Inagaki, Shinichiro; Maeda, Shingo; Narita, Masami; Nakamura, Tatsuro; Shimosawa, Tatsuo; Murata, Takahisa; Ohya, Yukihiro			(U)rinary PGDM, a prostaglandin D-2 metabolite, is a novel biomarker for objectively detecting allergic reactions of food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							PLATELET-ACTIVATING-FACTOR; ATOPIC-DERMATITIS; PREVALENCE		[Inagaki, Shinichiro; Narita, Masami; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan; [Maeda, Shingo; Nakamura, Tatsuro; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Shimosawa, Tatsuo] Int Univ Hlth & Welf, Dept Clin Lab, Chiba, Japan	National Center for Child Health & Development - Japan; University of Tokyo; International University of Health & Welfare	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp; ohya-y@ncchd.go.jp	Narita, Masami/AAF-1079-2019	Murata, Takahisa/0000-0002-3328-0796; Inagaki, Shinichiro/0000-0001-7652-7763	Japan Society for the Promotion of Science [17921666]; Japan Agency for Medical Research and Development [17935758]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Supported by a Grant-in-Aid for Scientific Research A form the Japan Society for the Promotion of Science (grant no. 17921666) and Medical Research and Development Programs Focused on Technology Transfers: Development of Advanced Measurement and Analysis Systems from Japan Agency for Medical Research and Development (grant no. 17935758).	Brand PLP, 2014, PEDIAT ALLERG IMM-UK, V25, P755, DOI 10.1111/pai.12313; Cho C, 2016, IMMUN INFLAMM DIS, V4, P64, DOI 10.1002/iid3.94; Dhingra N, 2014, J ALLERGY CLIN IMMUN, V134, P362, DOI 10.1016/j.jaci.2014.03.009; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Khattri S, 2014, J ALLERGY CLIN IMMUN, V133, P1626, DOI 10.1016/j.jaci.2014.03.003; Maeda S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17798-w; McGowan EC, 2013, J ALLERGY CLIN IMMUN, V132, P1216, DOI 10.1016/j.jaci.2013.07.018; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Renert-Yuval Y, 2016, EXPERT OPIN BIOL TH, V16, P1005, DOI 10.1080/14712598.2016.1188076; Sampson HA, 2003, PEDIATRICS, V111, P1601; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Ungar B, 2017, J INVEST DERMATOL, V137, P603, DOI 10.1016/j.jid.2016.09.037; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Vadas P, 2013, J ALLERGY CLIN IMMUN, V131, P144, DOI 10.1016/j.jaci.2012.08.016; van der Valk JPM, 2015, EUR J PEDIATR, V174, P1093, DOI 10.1007/s00431-015-2504-x	16	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1634	+		10.1016/j.jaci.2018.06.032	http://dx.doi.org/10.1016/j.jaci.2018.06.032			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29981807	Bronze			2022-12-18	WOS:000449429800026
J	Yu, M; Mukai, K; Tsai, M; Galli, SJ				Yu, Mang; Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.			Thirdhand smoke component can exacerbate a mouse asthma model through mast cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Thirdhand smoke; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; mast cells; alpha 7 nicotinic acetylcholine receptor; cockroach allergen	NICOTINIC ACETYLCHOLINE-RECEPTOR; ENVIRONMENTAL TOBACCO-SMOKE; NONNEURONAL ACETYLCHOLINE; COCKROACH ALLERGEN; MESSENGER-RNA; EXPOSURE; CHILDREN; HEALTH; DEGRANULATION; MODULATION	Background: Thirdhand smoke (THS) represents the accumulation of secondhand smoke on indoor surfaces and in dust, which, over time, can become more toxic than secondhand smoke. Although it is well known that children of smokers are at increased risk for asthma or asthma exacerbation if the disease is already present, how exposure to THS can influence the development or exacerbation of asthma remains unknown. Objective: We investigated whether epicutaneous exposure to an important component of THS, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), can influence asthma pathology in a mouse model elicited by means of repeated intranasal challenge with cockroach antigen (CRA). Methods: Wild-type mice, alpha 7 nicotinic acetylcholine receptor (nAChR)-or mast cell (MC)-deficient mice, and mice with MCs that lacked alpha 7 nAChRs or were the host's sole source of alpha 7 nAChRs were subjected to epicutaneous NNK exposure, intranasal CRA challenge, or both, and the severity of features of asthma pathology, including airway hyperreactivity, airway inflammation, and airway remodeling, was assessed. Results: We found that alpha 7 nAChRs were required to observe adverse effects of epicutaneous NNK exposure on multiple features of CRA-induced asthma pathology. Moreover, MC expression of alpha 7 nAChRs contributed significantly to the ability of epicutaneous NNK exposure to exacerbate airway hyperreactivity to methacholine, airway inflammation, and airway remodeling in this model. Conclusion: Our results show that skin exposure to NNK, a component of THS, can exacerbate multiple features of a CRA-induced model of asthma in mice and define MCs as key contributors to these adverse effects of NNK.	[Yu, Mang; Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, 269 Campus Dr,Rm 3255, Stanford, CA 94305 USA; [Yu, Mang; Mukai, Kaori; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 269 Campus Dr,Rm 3255, Stanford, CA 94305 USA.; Yu, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, 269 Campus Dr,Rm 3260, Stanford, CA 94305 USA.	yumyu@staford.edu; sgalli@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	National Institutes of Health [R01 AI070813, R01 AR067145, TRDRP 21RT-0147, 26IR-0012]; Department of Pathology and Sean N. Parker Center for Allergy and Asthma Research, Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Sean N. Parker Center for Allergy and Asthma Research, Stanford University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health grants R01 AI070813 and R01 AR067145 and California grants TRDRP 21RT-0147 and 26IR-0012 to S.J.G. and the Department of Pathology and Sean N. Parker Center for Allergy and Asthma Research, Stanford University.	Adhami N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149510; Ahluwalia SK, 2011, CURR OPIN ALLERGY CL, V11, P137, DOI 10.1097/ACI.0b013e3283445921; Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D; Akinbami LJ, 2013, ACAD PEDIATR, V13, P508, DOI 10.1016/j.acap.2013.07.003; Aung G, 2011, IMMUNOLOGY, V132, P527, DOI 10.1111/j.1365-2567.2010.03395.x; Bentayeb M, 2013, J ENVIRON SCI HEAL A, V48, P1783, DOI 10.1080/10934529.2013.826052; Bernert JT, 2010, CANCER EPIDEM BIOMAR, V19, P2969, DOI 10.1158/1055-9965.EPI-10-0711; Blanchet MR, 2007, J LEUKOCYTE BIOL, V81, P1245, DOI 10.1189/jlb.0906548; Blanchet MR, 2005, EUR RESPIR J, V26, P21, DOI 10.1183/09031936.05.00116104; Blanchet MR, 2004, AM J RESP CRIT CARE, V169, P903, DOI 10.1164/rccm.200210-1154OC; Boyce JA, 2003, J ALLERGY CLIN IMMUN, V111, P24, DOI 10.1067/mai.2003.60; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brunnemann KD, 1996, CRIT REV TOXICOL, V26, P121, DOI 10.3109/10408449609017926; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; de Haan JJ, 2013, AM J PHYSIOL-GASTR L, V305, pG383, DOI 10.1152/ajpgi.00333.2012; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; de la Riva-Velasco E, 2012, J ASTHMA, V49, P673, DOI 10.3109/02770903.2012.701363; Dhall S, 2016, CLIN SCI, V130, P1269, DOI 10.1042/CS20160236; Dreyfuss JH, 2010, CA-CANCER J CLIN, V60, P203, DOI 10.3322/caac.20079; Fujii T, 1999, NEUROSCI LETT, V259, P71, DOI 10.1016/S0304-3940(98)00921-5; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gergen PJ, 1999, J ALLERGY CLIN IMMUN, V103, P501, DOI 10.1016/S0091-6749(99)70477-X; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Guinet E, 2004, IMMUNOL LETT, V95, P45, DOI 10.1016/j.imlet.2004.06.003; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Kageyama-Yahara N, 2008, BIOCHEM BIOPH RES CO, V377, P321, DOI 10.1016/j.bbrc.2008.10.004; Karim ZA, 2015, J CARDIOVASC PHARM, V66, P177, DOI 10.1097/FJC.0000000000000260; Kassem NOF, 2014, NICOTINE TOB RES, V16, P961, DOI 10.1093/ntr/ntu016; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Kit BK, 2013, PEDIATRICS, V131, P407, DOI 10.1542/peds.2012-2328; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kuschner WG, 2011, INT J GEN MED, V4, P115, DOI 10.2147/IJGM.S16908; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Martins-Green M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086391; Matsui EC, 2014, ALLERGY, V69, P553, DOI 10.1111/all.12361; Menzies D, 2011, CURR OPIN PULM MED, V17, P116, DOI 10.1097/MCP.0b013e328341ce98; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mishra NC, 2008, J IMMUNOL, V180, P7655, DOI 10.4049/jimmunol.180.11.7655; Mishra NC, 2010, J IMMUNOL, V185, P588, DOI 10.4049/jimmunol.0902227; Pavlov VA, 2008, INT J CLIN EXP MED, V1, P203; Petrick LM, 2011, ENVIRON SCI TECHNOL, V45, P328, DOI 10.1021/es102060v; Pierce RA, 2002, AM J RESP CELL MOL, V26, P10, DOI 10.1165/ajrcmb.26.1.f225; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Quintana PJE, 2013, NICOTINE TOB RES, V15, P1555, DOI 10.1093/ntr/ntt014; Radosa J, 2011, EXP DERMATOL, V20, P677, DOI 10.1111/j.1600-0625.2011.01283.x; Rehan VK, 2009, LUNG, V187, P281, DOI 10.1007/s00408-009-9158-2; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Skok M, 2006, J NEUROIMMUNOL, V171, P86, DOI 10.1016/j.jneuroim.2005.09.011; Sleiman M, 2010, P NATL ACAD SCI USA, V107, P6576, DOI 10.1073/pnas.0912820107; Sly PD, 2011, CURR OPIN ALLERGY CL, V11, P24, DOI 10.1097/ACI.0b013e328342309d; Stapleton M, 2011, J AM BOARD FAM MED, V24, P313, DOI 10.3122/jabfm.2011.03.100180; Sudheer PS, 2006, ANAESTHESIA, V61, P1170, DOI 10.1111/j.1365-2044.2006.04870.x; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184; Yamamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085888; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598	69	15	15	0	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1618	+		10.1016/j.jaci.2018.04.001	http://dx.doi.org/10.1016/j.jaci.2018.04.001			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29678746	Green Accepted, Bronze, Green Published			2022-12-18	WOS:000449429800023
J	Skevaki, C; Hudemann, C; Matrosovich, M; Mobs, C; Paul, S; Wachtendorf, A; Alhamwe, A; Potaczek, DP; Hagner, S; Gemsa, D; Garn, H; Sette, A; Renz, H				Skevaki, Chrysanthi; Hudemann, Christoph; Matrosovich, Mikhail; Moebs, Christian; Paul, Sinu; Wachtendorf, Andreas; Alhamwe, Alashkar; Potaczek, Daniel P.; Hagner, Stefanie; Gemsa, Diethard; Garn, Holger; Sette, Alessandro; Renz, Harald			Influenza-derived peptides cross-react with allergens and provide asthma protection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Influenza virus; asthma; hygiene hypothesis; effector memory cells; heterologous immunity	GUILLAIN-BARRE-SYNDROME; A VIRUS-INFECTION; T-CELL RESPONSES; PANDEMIC INFLUENZA; UNITED-STATES; HAY-FEVER; IMMUNITY; DISEASE; MICE; SUSCEPTIBILITY	Background: The hygiene hypothesis is the leading concept to explain the current asthma epidemic, which is built on the observation that a lack of bacterial contact early in life induces allergic T(H)2 immune responses. Objective: Because little is known about the contribution of respiratory tract viruses in this context, we evaluated the effect of prior influenza infection on the development of allergic asthma. Methods: Mice were infected with influenza and, once recovered, subjected to an ovalbumin- or house dust mite-induced experimental asthma protocol. Influenza-polarized effector memory T (Tem) cells were transferred adoptively to allergen-sensitized animals before allergen challenge. A comprehensive in silico analysis assessed homologies between virus- and allergen-derived proteins. Influenza-polarized Tem cells were stimulated ex vivo with candidate peptides. Mice were immunized with a pool of virus-derived T-cell epitopes. Results: In 2 murine models we found a long-lasting preventive effect against experimental asthma features. Protection could be attributed about equally to CD4(+) and CD8(+) Tem cells from influenza-infected mice. An in silico bioinformatic analysis identified 4 influenza- and 3 allergen-derived MHC class I and MHC class II candidate T-cell epitopes with potential antigen specific cross-reactivity between influenza and allergens. Lymphocytes from influenza-infected mice produced IFN-gamma and IL-2 but not IL-5 on stimulation with the aforementioned peptides. Immunization with a mixture of the influenza peptides conferred asthma protection, and peptide-immunized mice transferred protection through CD4(+) and CD8(+) Tem cells. Conclusion: For the first time, our results illustrate heterologous immunity of virus-infected animals toward allergens. This finding extends the original hygiene hypothesis.	[Skevaki, Chrysanthi; Hudemann, Christoph; Wachtendorf, Andreas; Alhamwe, Alashkar; Potaczek, Daniel P.; Hagner, Stefanie; Gemsa, Diethard; Garn, Holger; Renz, Harald] German Ctr Lung Res DZL, Inst Lab Med & Pathobiochem, Munich, Germany; [Matrosovich, Mikhail] Philipps Univ Marburg, Inst Virol, Marburg, Germany; [Moebs, Christian] Philipps Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany; [Paul, Sinu; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Potaczek, Daniel P.] John Paul 2 Hosp, Krakow, Poland	Philipps University Marburg; Philipps University Marburg; La Jolla Institute for Immunology	Renz, H (corresponding author), Philipps Univ Marburg, Inst Lab Med, Baldingerstr, D-35043 Marburg, Germany.	harald.renz@uk-gm.de	Hudemann, Christoph/ABF-4275-2020; Sette, Alessandro/AFO-8916-2022	Hudemann, Christoph/0000-0001-5807-6882; Potaczek, Daniel Piotr/0000-0003-0324-8506; Mobs, Christian/0000-0002-5197-7669; Alashkar Alhamwe, Bilal/0000-0002-7120-0013; Matrosovich, Mikhail/0000-0003-1618-2083; Garn, Holger/0000-0002-5178-4023	Deutsche Forschungsgemeinschaft (DFG) [SFB 1021]; German Center for Lung Research (DZL) [82DZL00502/A2]; German Academic Exchange Service (DAAD) [91559386]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Center for Lung Research (DZL); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Supported by the Deutsche Forschungsgemeinschaft (DFG)-funded SFB 1021, the German Center for Lung Research (DZL; 82DZL00502/A2), and the German Academic Exchange Service (DAAD; B.A.A., personal reference number: 91559386).	Abeles SR, 2014, J MOL BIOL, V426, P3892, DOI 10.1016/j.jmb.2014.07.002; Abeles SR, 2014, ISME J, V8, P1753, DOI 10.1038/ismej.2014.31; Alrifai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085839; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bomert M, 2011, CLIN CHEM LAB MED, V49, P1691, DOI 10.1515/CCLM.2011.631; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Bystrom J, 2013, VIRUSES-BASEL, V5, P777, DOI 10.3390/v5030777; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Christensen KLY, 2009, CLIN INFECT DIS, V49, P1025, DOI 10.1086/605562; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Conrad ML, 2009, CLIN EXP ALLERGY, V39, P1246, DOI 10.1111/j.1365-2222.2009.03260.x; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; D'Orsogna LJA, 2010, TRANSPL IMMUNOL, V23, P149, DOI 10.1016/j.trim.2010.06.008; de Boer JD, 2013, AM J RESP CELL MOL, V48, P382, DOI 10.1165/rcmb.2012-0331OC; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gerlach T, 2012, VACCINE, V30, P7348, DOI 10.1016/j.vaccine.2012.09.078; Hagner S, 2013, ALLERGY, V68, P322, DOI 10.1111/all.12094; Heidema J, 2008, J IMMUNOL, V181, P5551, DOI 10.4049/jimmunol.181.8.5551; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Krishnamoorthy N, 2012, NAT MED, V18, P1525, DOI 10.1038/nm.2896; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Lotvall J, 2012, WORLD ALLERGY ORGAN, V5, P39; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McMaster SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115725; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ritter M, 2014, CLIN EXP IMMUNOL, V178, P212, DOI 10.1111/cei.12400; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Savic M, 2016, IMMUNOLOGY, V147, P165, DOI 10.1111/imm.12548; Schotsaert M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24402; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Soriano A, 2012, LUPUS, V21, P153, DOI 10.1177/0961203311430222; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steinke JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115271; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tan PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008754; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Vogel G, 2015, SCIENCE, V349, P17, DOI 10.1126/science.349.6243.17; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Wucherpfennig KW, 2004, MOL IMMUNOL, V40, P1009, DOI 10.1016/j.molimm.2003.11.003; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, P3; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC	57	15	15	1	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					804	814		10.1016/j.jaci.2017.07.056	http://dx.doi.org/10.1016/j.jaci.2017.07.056			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29132960	Bronze			2022-12-18	WOS:000443726500013
J	Cho, M; Lee, JE; Lim, H; Shin, HW; Khalmuratova, R; Choi, G; Kim, HS; Choi, WS; Park, YJ; Shim, I; Kim, BS; Kang, CY; Kim, JO; Tanaka, S; Kubo, M; Tung, HY; Landers, CT; Corry, DB; Kheradmand, F; Chung, Y				Cho, Minkyoung; Lee, Jeong-Eun; Lim, Hoyong; Shin, Hyun-Woo; Khalmuratova, Roza; Choi, Garam; Kim, Hyuk Soon; Choi, Wahn Soo; Park, Young-Jun; Shim, Inbo; Kim, Byung-Seok; Kang, Chang-Yuil; Kim, Jae-Ouk; Tanaka, Shinya; Kubo, Masato; Tung, Hui-Ying; Landers, Cameron T.; Corry, David B.; Kheradmand, Farrah; Chung, Yeonseok			Fibrinogen cleavage products and Toll-like receptor 4 promote the generation of programmed cell death 1 ligand 2-positive dendritic cells in allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Protease allergen; PD-L2(+) dendritic cells; fibrinogen cleavage product; mast cell; Toll-like receptor 4	ANTIGEN-PRESENTING CELLS; INNATE LYMPHOID-CELLS; MAST-CELLS; LUNG INFLAMMATION; TYPE-2 RESPONSES; IN-VIVO; C-KIT; IMMUNITY; TH2; INITIATION	Background: Inhaled protease allergens preferentially trigger T(H)2-mediated inflammation in allergic asthma. The role of dendritic cells (DCs) on induction of T(H)2 cell responses in allergic asthma has been well documented; however, the mechanism by which protease allergens induce T(H)2-favorable DCs in the airway remains unclear. Objective: We sought to determine a subset of DCs responsible for T(H)2 cell responses in allergic asthma and the mechanism by which protease allergens induce the DC subset in the airway. Methods: Mice were challenged intranasally with protease allergens or fibrinogen cleavage products (FCPs) to induce allergic airway inflammation. DCs isolated from mediastinal lymph nodes were analyzed for surface phenotype and T-cell stimulatory function. Anti-Thy1.2 and Mas-TRECK mice were used to deplete innate lymphoid cells and mast cells, respectively. Adoptive cell transfer, bone marrow DC culture, anti-IL-13, and Toll-like receptor (TLR) 4-deficient mice were used for further mechanistic studies. Results: Protease allergens induced a remarkable accumulation of T(H)2-favorable programmed cell death 1 ligand 2 (PD-L2)(+) DCs in mediastinal lymph nodes, which was significantly abolished in mice depleted of mast cells and, to a lesser extent, innate lymphoid cells. Mechanistically, FCPs generated by protease allergens triggered IL-13 production from wild-type mast cells but not from TLR4-deficient mast cells, which resulted in an increase in the number of PD-L2(+) DCs. Intranasal administration of FCPs induced an increase in numbers of PD-L2(+) DCs in the airway, which was significantly abolished in TLR4-and mast cell-deficient mice. Injection of IL-13 restored the PD-L2(+) DC population in mice lacking mast cells. Conclusion: Our findings unveil the "protease-FCP-TLR4-mast cell-IL-13'' axis as a molecular mechanism for generation of T(H)2-favorable PD-L2(+) DCs in allergic asthma and suggest that targeting the PD-L2(+) DC pathway might be effective in suppressing allergic T-cell responses in the airway.	[Cho, Minkyoung; Lee, Jeong-Eun; Lim, Hoyong; Choi, Garam; Park, Young-Jun; Shim, Inbo; Kim, Byung-Seok; Kang, Chang-Yuil; Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Lab Immune Regulat, Pharmaceut Sci Res Inst, Seoul, South Korea; [Shin, Hyun-Woo; Khalmuratova, Roza] Seoul Natl Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Shin, Hyun-Woo] Seoul Natl Univ Hosp, Dept Biomed Sci & Otorhinolaryngol Head & Neck Su, Seoul, South Korea; [Kim, Hyuk Soon; Choi, Wahn Soo] Konkuk Univ, Sch Med, Seoul, South Korea; [Kim, Jae-Ouk] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Tanaka, Shinya; Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo, Japan; [Tanaka, Shinya; Kubo, Masato] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan; [Tung, Hui-Ying; Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Landers, Cameron T.] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Corry, David B.; Kheradmand, Farrah] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Konkuk University; Konkuk University Medical Center; International Vaccine Institute; Tokyo University of Science; RIKEN; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Chung, Y (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea.	yeonseok@snu.ac.kr	Park, Youngjun/AAK-2026-2020	Kim, Hyuk Soon/0000-0002-0566-0142; Landers, Cameron/0000-0002-1507-282X; Chung, Yeonseok/0000-0001-5780-4841	National Research Foundation of Korea (NRF) - Korean government (MEST) [2017R1A2B3007392]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2282]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	Supported by research grants 2017R1A2B3007392 (to Y.C.) from the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) and HI14C2282 (to Y.C.) from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; King C, 1998, J IMMUNOL, V161, P3645; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lewkowich IP, 2013, MUCOSAL IMMUNOL, V6, P728, DOI 10.1038/mi.2012.111; Lim H, 2013, IMMUNOL LETT, V156, P140, DOI 10.1016/j.imlet.2013.10.003; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Machado DC, 1996, EUR J IMMUNOL, V26, P2972, DOI 10.1002/eji.1830261224; MARTIN TR, 1989, J CLIN INVEST, V83, P1375, DOI 10.1172/JCI114025; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Na H, 2016, IMMUNE NETW, V16, P1, DOI 10.4110/in.2016.16.1.1; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Porter PC, 2011, BBA-GEN SUBJECTS, V1810, P1059, DOI 10.1016/j.bbagen.2011.04.019; Ray P, 2010, ANN NY ACAD SCI, V1183, P104, DOI 10.1111/j.1749-6632.2009.05122.x; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Tjota MY, 2014, CURR OPIN IMMUNOL, V31, P44, DOI 10.1016/j.coi.2014.09.006; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Vannella KM, 2016, NAT IMMUNOL, V17, P538, DOI 10.1038/ni.3417; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	35	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					530	+		10.1016/j.jaci.2017.09.019	http://dx.doi.org/10.1016/j.jaci.2017.09.019			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29038008	Bronze			2022-12-18	WOS:000440664400021
J	Engeroff, P; Fellmann, M; Yerly, D; Bachmann, MF; Vogel, M				Engeroff, Paul; Fellmann, Marc; Yerly, Daniel; Bachmann, Martin F.; Vogel, Monique			A novel recyclingmechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Fc epsilon RII (CD23); IgE; IgE-immune complexes; B cells; moDC; polarization; antigen recycling; T-cell activation	SIGNAL-TRANSDUCTION; IMMUNE-COMPLEXES; HUMAN-MONOCYTES; T-CELLS; CD23; ASTHMA; ENDOCYTOSIS; ACTIVATION; EXPRESSION; FC-EPSILON-RII/CD23	Background: IgE-immune complexes (IgE-ICs) have been shown to enhance antibody and T-cell responses in mice by targeting CD23 (Fc epsilon RII), the low-affinity receptor for IgE on B cells. In humans, the mechanism by which CD23-expressing cells take up IgE-ICs and process them is not well understood. Objective: To investigate this question, we compared the fate of IgE-ICs in human B cells and in CD23-expressing monocyte-derived dendritic cells (moDCs) that represent classical antigenpresenting cells and we aimed at studying IgE-dependent antigen presentation in both cell types. Methods: B cells and monocytes were isolated from peripheral blood, and monocytes were differentiated into moDCs. Both cell types were stimulated with IgE-ICs consisting of 4-hydroxy-3-iodo-5-nitrophenylacetyl (NIP)-specific IgE JW8 and NIP-BSA to assess binding, uptake, and degradation dynamics. To assess CD23-dependent T-cell proliferation, B cells and moDCs were pulsed with IgE-NIP-tetanus toxoid complexes and cocultured with autologous T cells. Results: IgE-IC binding was CD23-dependent in B cells, and moDCs and CD23 aggregation, as well as IgE-IC internalization, occurred in both cell types. Although IgE-ICs were degraded in moDCs, B cells did not degrade the complexes but recycled them in native form to the cell surface, enabling IgE-IC uptake by moDCs in cocultures. The resulting proliferation of specific T cells was dependent on cell-cell contact between B cells and moDCs, which was explained by increased upregulation of costimulatory molecules CD86 and MHC class II on moDCs induced by B cells. Conclusions: Our findings argue for a novel model in which human B cells promote specific T-cell proliferation on IgE-IC encounter. On one hand, B cells act as carriers transferring antigen to more efficient antigen-presenting cells such as DCs. On the other hand, B cells can directly promote DC maturation and thereby enhance T-cell stimulation.	[Engeroff, Paul; Fellmann, Marc; Yerly, Daniel; Bachmann, Martin F.; Vogel, Monique] Univ Hosp Bern, Inselspital, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Bachmann, Martin F.] Univ Oxford, Jenner Inst, Oxford, England	University of Bern; University Hospital of Bern; University of Oxford; Jenner Institute	Vogel, M (corresponding author), Univ Bern, Inselspital, Dept Immunol, RIA, Sahlihaus 2, CH-3010 Bern, Switzerland.	monique.vogel@dbmr.unibe.ch	Engeroff, Paul/AGS-3183-2022	Engeroff, Paul/0000-0002-3409-512X; Yerly, Daniel/0000-0003-2857-0737	Swiss National Science Foundation (SNF) [31003A_149925]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This project was supported by the Swiss National Science Foundation (SNF grant no. 31003A_149925).	Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; ALDERSON MR, 1992, J IMMUNOL, V149, P1252; Aziz M, 2013, CURR PROTOC IMMUNOL, V31; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chan MA, 2011, INT J IMMUNOGENET, V38, P533, DOI 10.1111/j.1744-313X.2011.01043.x; Chan MA, 2010, CLIN IMMUNOL, V137, P330, DOI 10.1016/j.clim.2010.08.005; Chapuis F, 1997, EUR J IMMUNOL, V27, P431, DOI 10.1002/eji.1830270213; Ding ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28290; Ezeamuzie CI, 2009, INT IMMUNOPHARMACOL, V9, P1110, DOI 10.1016/j.intimp.2009.05.009; Fellmann M, 2015, IMMUN INFLAMM DIS, V3, P339, DOI 10.1002/iid3.72; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Harvey BP, 2014, MOL IMMUNOL, V58, P56, DOI 10.1016/j.molimm.2013.10.013; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Holm J, 2011, J ALLERGY CLIN IMMUN, V127, P1029, DOI 10.1016/j.jaci.2011.01.062; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; LUO HY, 1991, J IMMUNOL, V146, P2122; Maddur MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5092; Mathews JA, 2010, J BIOL CHEM, V285, P37531, DOI 10.1074/jbc.M110.141556; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Mossalayi MD, 2009, INFECT IMMUN, V77, P5537, DOI 10.1128/IAI.01457-08; NEUBERGER MS, 1985, NATURE, V314, P268, DOI 10.1038/314268a0; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Paterson RLK, 1996, EUR J IMMUNOL, V26, P1979, DOI 10.1002/eji.1830260902; PAULEUGENE N, 1995, J LEUKOCYTE BIOL, V57, P160, DOI 10.1002/jlb.57.1.160; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Sanjuan MA, 2016, J ALLERGY CLIN IMMUN, V137, P1651, DOI 10.1016/j.jaci.2016.04.007; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P290, DOI 10.1016/j.jaci.2016.03.042; SHERR E, 1989, J IMMUNOL, V142, P481; Shin JS, 2015, CELL MOL LIFE SCI, V72, P2349, DOI 10.1007/s00018-015-1870-x; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; SUGIE K, 1991, P NATL ACAD SCI USA, V88, P9132, DOI 10.1073/pnas.88.20.9132; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Ten RM, 1999, J IMMUNOL, V163, P3851; Vallhov H, 2015, ALLERGY, V70, P1651, DOI 10.1111/all.12701; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; VERCELLI D, 1988, J EXP MED, V167, P1406, DOI 10.1084/jem.167.4.1406; YOKOTA A, 1992, P NATL ACAD SCI USA, V89, P5030, DOI 10.1073/pnas.89.11.5030; YOKOTA A, 1988, CELL, V55, P611, DOI 10.1016/0092-8674(88)90219-X	42	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					557	+		10.1016/j.jaci.2017.09.024	http://dx.doi.org/10.1016/j.jaci.2017.09.024			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29074459				2022-12-18	WOS:000440664400023
J	Kettner, A; DellaCorte, G; de Blay, F; Jacobsen, L; Jutel, M; Worm, M; Charlon, V; Simonsen, K; Reymond, C; Spertini, F				Kettner, Alexander; DellaCorte, Gilles; de Blay, Frederic; Jacobsen, Lars; Jutel, Marek; Worm, Margitta; Charlon, Vincent; Simonsen, Kim; Reymond, Christophe; Spertini, Francois			Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGEN-SPECIFIC IMMUNOTHERAPY; EFFICACY		[Kettner, Alexander; DellaCorte, Gilles; Charlon, Vincent; Simonsen, Kim; Reymond, Christophe] Anergis SA, Epalinges, Switzerland; [de Blay, Frederic] Univ Strasbourg, Strasbourg Univ Hosp, Chest Dis Dept, Nouvel Hop Civil, Strasbourg, France; [Jacobsen, Lars] Allergy Learning & Consulting, Copenhagen, Denmark; [Jutel, Marek] ALL MED Med Res Inst, Wroclaw, Poland; [Jutel, Marek] Silesian Piasts Univ Med, Dept Clin Immunol, Wroclaw, Poland; [Worm, Margitta] Univ Med Berlin, Allergie Ctr Charite, Klin Dermatol Venerol & Allergol, Berlin, Germany; [Spertini, Francois] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Wroclaw Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, F (corresponding author), CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland.	francois.spertini@chuv.ch		Worm, Margitta/0000-0002-3449-1245; JUTEL, MAREK/0000-0003-1555-9379	Anergis SA (Route de la Corniche, Epalinges, Switzerland); developer of Bet v 1 COP	Anergis SA (Route de la Corniche, Epalinges, Switzerland); developer of Bet v 1 COP	The study was supported by Anergis SA (Route de la Corniche 9B, 1066 Epalinges, Switzerland), the developer of Bet v 1 COP.	Barker SJ, 2006, ANESTHESIOLOGY, V105, P892, DOI 10.1097/00000542-200611000-00008; Dam Petersen K, 2005, Allergol Immunopathol (Madr), V33, P264, DOI 10.1157/13080929; Drachenberg K J, 2003, Allergol Immunopathol (Madr), V31, P77; Fellrath JM, 2003, J ALLERGY CLIN IMMUN, V111, P854, DOI 10.1067/mai.2003.1337; Kantor DB, 2016, J ALLERGY CLIN IMMUN, V138, P1467, DOI 10.1016/j.jaci.2016.04.044; Khinchi MS, 2004, ALLERGY, V59, P45, DOI 10.1046/j.1398-9995.2003.00387.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Phipatanakul W, 2017, CONTEMP CLIN TRIALS, V60, P14, DOI 10.1016/j.cct.2017.06.008; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Spertini F, 2016, J ALLERGY CLIN IMMUN, V138, P162, DOI 10.1016/j.jaci.2016.02.044; Spertini F, 2014, J ALLERGY CLIN IMMUN, V134, P239, DOI 10.1016/j.jaci.2014.04.001	11	15	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2018	142	2					678	680		10.1016/j.jaci.2018.01.052	http://dx.doi.org/10.1016/j.jaci.2018.01.052			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GP2LN	29678749	Bronze			2022-12-18	WOS:000440664400036
J	Venkateshaiah, SU; Mishra, A; Manohar, M; Verma, AK; Rajavelu, P; Niranjan, R; Wild, LG; Parada, NA; Blecker, U; Lasky, JA; Mishra, A				Venkateshaiah, Sathisha Upparahalli; Mishra, Akanksha; Manohar, Murli; Verma, Alok K.; Rajavelu, Priya; Niranjan, Rituraj; Wild, Laurianne G.; Parada, Nereida A.; Blecker, Uwe; Lasky, Joseph A.; Mishra, Anil			A critical role for IL-18 in transformation and maturation of naive eosinophils to pathogenic eosinophils	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Venkateshaiah, Sathisha Upparahalli; Mishra, Akanksha; Manohar, Murli; Verma, Alok K.; Parada, Nereida A.; Lasky, Joseph A.; Mishra, Anil] Tulane Univ, Sch Med, Dept Med, Sect Pulm Dis,TEDC, New Orleans, LA 70112 USA; [Wild, Laurianne G.] Tulane Univ, Sch Med, Sect Allergy & Immunol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Blecker, Uwe] Tulane Univ, Sch Med, Sect Pediat Gastroenterol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Rajavelu, Priya; Niranjan, Rituraj] Cincinnati Childrens Hosp Med Ctr, Allergy & Immunol, Cincinnati, OH 45229 USA; [Mishra, Akanksha] Elite Biosci, Cleveland, OH USA	Tulane University; Tulane University; Tulane University; Cincinnati Children's Hospital Medical Center	Mishra, A (corresponding author), Tulane Univ, Sch Med, Dept Med, Sect Pulm Dis,TEDC, New Orleans, LA 70112 USA.	amishra@tulane.edu	Manohar, Murli/R-8619-2018; Verma, Alok K/AAD-6514-2019	VERMA, ALOK/0000-0001-9301-9162	NIH [R01 AI080581]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the grant NIH R01 AI080581 (to A.M.).	Asosingh K, 2010, J ALLERGY CLIN IMMUN, V125, P918, DOI 10.1016/j.jaci.2010.01.017; Inamura H, 2003, ALLERGY, V58, P959, DOI 10.1034/j.1398-9995.2003.00135.x; Lin LH, 2012, IMMUNOL RES, V52, P276, DOI 10.1007/s12026-012-8339-x; Mesnil C, 2016, J CLIN INVEST, V126, P3279, DOI 10.1172/JCI85664; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Venkateshaiah SU, 2018, J ALLERGY CLIN IMMUN, V141, P906, DOI 10.1016/j.jaci.2017.05.025; Venkateshaiah Sathisha Upparahalli, 2016, Case Rep Gastroenterol, V10, P685; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005	10	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					301	305		10.1016/j.jaci.2018.02.011	http://dx.doi.org/10.1016/j.jaci.2018.02.011			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29499224	Green Accepted, Bronze			2022-12-18	WOS:000437837500037
J	Allam, JP; Andreasen, JN; Mette, J; Serup-Hansen, N; Wustenberg, EG				Allam, Jean-Pierre; Andreasen, Jakob N.; Mette, Janina; Serup-Hansen, Niels; Wuestenberg, Eike Gunther			Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ADHERENCE; EFFICACY; SAFETY		[Allam, Jean-Pierre] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Andreasen, Jakob N.] ALK Abello, Horsholm, Denmark; [Mette, Janina; Serup-Hansen, Niels; Wuestenberg, Eike Gunther] ALK Abello, Hamburg, Germany; [Wuestenberg, Eike Gunther] Univ Dresden, Dept Otorhinolaryngol, Dresden, Germany	University of Bonn; ALK-Abello AS; ALK-Abello AS; Technische Universitat Dresden	Allam, JP (corresponding author), Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany.	Jean-Pierre.Allam@ukb.uni-bonn.de			ALK-Abello	ALK-Abello	Supported by ALK-Abello.	Aboshady OA, 2014, CLIN EXP OTORHINOLAR, V7, P241, DOI 10.3342/ceo.2014.7.4.241; Alutard SQ ALK-Abello Denmark, 2013, GERM SUMM PROD CHAR; AVANZ ALK-Abello Denmark, 2014, GERM SUMM PROD CHAR; Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Compalati E, 2009, ALLERGY, V64, P1570, DOI 10.1111/j.1398-9995.2009.02129.x; GRAZAX ALK-Abello Denmark, 2015, EUR SUMM PROD CHAR; Senna G, 2013, CURR OPIN ALLERGY CL, V13, P656, DOI 10.1097/ACI.0000000000000007; Senna G, 2010, J ALLERGY CLIN IMMUN, V126, P668, DOI 10.1016/j.jaci.2010.06.045; Senna G, 2009, CURR OPIN ALLERGY CL, V9, P544, DOI 10.1097/ACI.0b013e328332b8df; Vita D, 2010, ALLERGY, V65, P668, DOI 10.1111/j.1398-9995.2009.02223.x	11	15	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1898	+		10.1016/j.jaci.2017.12.999	http://dx.doi.org/10.1016/j.jaci.2017.12.999			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29410285	Bronze			2022-12-18	WOS:000432148200037
J	Kennedy, JL; Koziol-White, CJ; Jeffus, S; Rettiganti, MR; Fisher, P; Kurten, M; Eze, A; House, S; Sikes, JD; Askew, E; Putt, C; Panettieri, RA; Jones, SM; Kurten, RC				Kennedy, Joshua L.; Koziol-White, Cynthia J.; Jeffus, Susanne; Rettiganti, Mallikarjuna R.; Fisher, Paige; Kurten, Megan; Eze, Anthony; House, Suzanne; Sikes, James D.; Askew, Emily; Putt, Claire; Panettieri, Reynold A.; Jones, Stacie M.; Kurten, Richard C.			Effects of rhinovirus 39 infection on airway hyperresponsiveness to carbachol in human airways precision cut lung slices	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHILDREN; TOLERANCE		[Kennedy, Joshua L.; Kurten, Megan; Eze, Anthony; House, Suzanne; Sikes, James D.; Askew, Emily; Putt, Claire; Jones, Stacie M.; Kurten, Richard C.] Univ Arkansas Med Sci, Dept Pediat, Div Allergy & Immunol, Little Rock, AR 72205 USA; [Kennedy, Joshua L.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Kennedy, Joshua L.; Rettiganti, Mallikarjuna R.; Jones, Stacie M.; Kurten, Richard C.] Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AR 72205 USA; [Kennedy, Joshua L.] Univ Arkansas Med Sci, Translat Res Inst, Little Rock, AR 72205 USA; [Koziol-White, Cynthia J.] Rutgers State Univ, Dept Med, New Brunswick, NJ USA; [Jeffus, Susanne] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Rettiganti, Mallikarjuna R.; Fisher, Paige] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Jones, Stacie M.; Kurten, Richard C.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Rutgers State University New Brunswick; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kennedy, JL (corresponding author), Univ Arkansas Med Sci, Dept Pediat, Div Allergy & Immunol, Little Rock, AR 72205 USA.; Kennedy, JL (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA.; Kennedy, JL (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Res Inst, Little Rock, AR 72205 USA.; Kennedy, JL (corresponding author), Univ Arkansas Med Sci, Translat Res Inst, Little Rock, AR 72205 USA.	kennedyjoshual@uams.edu	panettieri, reynold/AAG-9485-2019; Kennedy, Josh/P-1869-2019		National Institutes of Health (NIH) [1K08AI121345-01A1, KL2TR000063, UL1TR000039, P20GM121293, P20GM103625]; American Academy of Allergy, Asthma & Immunology AR-Trust pilot award; Marion B. Lyon New Scientist Career Development Award; Center for Translational Science Award (CTSA); UAMS Translational Research Institute Western Consortium Grant; UAMS Clinician Scientist Program; Arkansas Biosciences Institute; NIH [P01 HL114471]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000063, UL1TR000039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI121345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121293, P20GM103625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Allergy, Asthma & Immunology AR-Trust pilot award; Marion B. Lyon New Scientist Career Development Award; Center for Translational Science Award (CTSA); UAMS Translational Research Institute Western Consortium Grant; UAMS Clinician Scientist Program; Arkansas Biosciences Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.L.K. discloses funding from the National Institutes of Health (NIH) (grant nos. 1K08AI121345-01A1, KL2TR000063, UL1TR000039, P20GM121293, and P20GM103625), the American Academy of Allergy, Asthma & Immunology AR-Trust pilot award, Marion B. Lyon New Scientist Career Development Award, Center for Translational Science Award (CTSA) and UAMS Translational Research Institute Western Consortium Grant, UAMS Clinician Scientist Program, and the Arkansas Biosciences Institute. R.A.P. and C.J.K.-W. disclose funding by the NIH (grant no. P01 HL114471).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36; An SS, 2012, AM J PHYSIOL-LUNG C, V303, pL304, DOI 10.1152/ajplung.00126.2012; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Cooper PR, 2011, BRIT J PHARMACOL, V163, P521, DOI 10.1111/j.1476-5381.2011.01257.x; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Perez GF, 2014, EUR RESPIR J, V44, P1075, DOI 10.1183/09031936.00049214; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040	11	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1887	+		10.1016/j.jaci.2017.11.041	http://dx.doi.org/10.1016/j.jaci.2017.11.041			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29317243	Green Accepted, Bronze			2022-12-18	WOS:000432148200033
J	Qiao, YK; Yan, Y; Sen Tan, K; Tan, SSL; Seet, JE; Arumugam, TV; Chow, VTK; Wang, DY; Tran, T				Qiao, Yongkang; Yan, Yan; Sen Tan, Kai; Tan, Sheryl S. L.; Seet, Ju Ee; Arumugam, Thiruma Valavan; Chow, Vincent T. K.; Wang, De Yun; Thai Tran			CD151, a novel host factor of nuclear export signaling in influenza virus infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Influenza A virus (IAV); CD151; nuclear export; host innate immunity; inflammasome; IAV severity	SUPERFAMILY MEMBER CD151; EPITHELIAL-CELLS; LUNG INJURY; IN-VITRO; T-CELLS; TETRASPANIN; INFLAMMATION; REPLICATION; IDENTIFICATION; AMPLIFICATION	Background: Despite advances in our understanding of the mechanisms of influenza A virus (IAV) infection, the crucial virus-host interactions during the viral replication cycle still remain incomplete. Tetraspanin CD151 is highly expressed in the human respiratory tract, but its pathological role in IAV infection is unknown. Objectives: We sought to characterize the functional role and mechanisms of action of CD151 in IAV infection of the upper and lower respiratory tracts with H1N1 and H3N2 strains. Methods: We used CD151-null mice in an in vivo model of IAV infection and clinical donor samples of in vitro-differentiated human nasal epithelial cells cultured at air-liquid interface. Results: As compared with wild-type infected mice, CD151-null infected mice exhibited a significant reduction in virus titer and improvement in survival that is associated with pronounced host antiviral response and inflammasome activation together with accelerated lung repair. Interestingly, we show that CD151 complexes newly synthesized viral proteins with host nuclear export proteins and stabilizes microtubule complexes, which are key processes necessary for the polarized trafficking of viral progeny to the host plasma membrane for assembly. Conclusions: Our results provide new mechanistic insights into our understanding of IAV infection. We show that CD151 is a critical novel host factor of nuclear export signaling whereby the IAV nuclear export uses it to complement its own nuclear export proteins (a site not targeted by current therapy), making this regulation unique, and holds promise for the development of novel alternative/complementary strategies to reduce IAV severity.	[Qiao, Yongkang; Tan, Sheryl S. L.; Arumugam, Thiruma Valavan; Thai Tran] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Block MD9,2 Med Dr, Singapore 117593, Singapore; [Yan, Yan; Sen Tan, Kai; Wang, De Yun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Otolaryngol, Singapore, Singapore; [Seet, Ju Ee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore, Singapore; [Chow, Vincent T. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Yan, Yan] Sun Yat Sen Univ, Program Immunol, Dept Otolargyngol, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China; [Yan, Yan] Sun Yat Sen Univ, Guandong Prov Engn Res Ctr Mol Imaging, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Sun Yat Sen University; Sun Yat Sen University	Tran, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Block MD9,2 Med Dr, Singapore 117593, Singapore.; Wang, DY (corresponding author), Natl Univ Singapore, Dept Otolaryngol, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, 1E Kent Ridge Rd, Singapore 119228, Singapore.	entwdy@nus.edu.sg; phstt@nus.edu.sg	Arumugam, Thiruma/AAG-6958-2019	Arumugam, Thiruma/0000-0002-3377-0939; Chow, Vincent/0000-0003-2634-6213; Tan, Kai Sen/0000-0002-8611-1611; TRAN, Thai/0000-0002-8662-3676	Singapore Ministry of Health's National Medical Research Council (NMRC) under its Individual Research Grant (IRG) scheme [NMRC/1215/2009]; Academic Research Fund Tier 2 grant [MOE2015-T2-2]; NMRC [NMRC/CIRG/1362/2013, NMRC/CIRG/1458/2016]	Singapore Ministry of Health's National Medical Research Council (NMRC) under its Individual Research Grant (IRG) scheme(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Academic Research Fund Tier 2 grant; NMRC(National Medical Research Council, Singapore)	This research is supported in part by the Singapore Ministry of Health's National Medical Research Council (NMRC) under its Individual Research Grant (IRG) scheme (grant no. NMRC/1215/2009 to T.T.), the Academic Research Fund Tier 2 grant (grant no. MOE2015-T2-2 to T.T.), and the NMRC (grant nos. NMRC/CIRG/1362/2013 and NMRC/CIRG/1458/2016 to D.Y.W).	Ashman LK, 2002, J BIOL REG HOMEOS AG, V16, P223; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Bordon Y, 2016, NAT REV IMMUNOL, V16, P1, DOI 10.1038/nri.2015.14; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Campbell GM, 2015, J GEN VIROL, V96, P2951, DOI 10.1099/jgv.0.000240; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Haeuw JF, 2011, BIOCHEM SOC T, V39, P553, DOI 10.1042/BST0390553; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hasegawa H, 1998, J IMMUNOL, V161, P3087; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hua LV, 2001, NEUROPSYCHOPHARMACOL, V25, P729, DOI 10.1016/S0893-133X(01)00269-X; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Ivan FX, 2013, GENOMICS, V101, P101, DOI 10.1016/j.ygeno.2012.11.008; Ivan FX, 2012, FUNCT INTEGR GENOMIC, V12, P105, DOI 10.1007/s10142-011-0247-y; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Li YY, 2014, J ALLERGY CLIN IMMUN, V134, P1282, DOI 10.1016/j.jaci.2014.07.038; Li YG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-114; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Martelli F, 2015, J BIOTECHNOL, V210, P85, DOI 10.1016/j.jbiotec.2015.06.391; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nicholas SA, 2009, CELL RES, V19, P973, DOI 10.1038/cr.2009.44; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Qiao YK, 2017, J ALLERGY CLIN IMMUN, V139, P82, DOI 10.1016/j.jaci.2016.03.029; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Shanmukhappa K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-62; Shi SJ, 2017, CLIN RESPIR J, V11, P352, DOI 10.1111/crj.12346; Shin N, 2015, BIOCHEM BIOPH RES CO, V459, P699, DOI 10.1016/j.bbrc.2015.03.010; Sugiyama MG, 2016, J VIROL, V90, P1812, DOI 10.1128/JVI.02599-15; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Le VB, 2015, AM J RESP CRIT CARE, V191, P804, DOI 10.1164/rccm.201406-1031OC; Wang DY, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0490-0; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Wu JJ, 2014, MOL CELL BIOCHEM, V394, P275, DOI 10.1007/s11010-014-2103-6; Yan Y, 2016, J ALLERGY CLIN IMMUN, V138, P276, DOI 10.1016/j.jaci.2015.11.016	48	15	18	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1799	1817		10.1016/j.jaci.2017.11.032	http://dx.doi.org/10.1016/j.jaci.2017.11.032			19	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29274410	Bronze			2022-12-18	WOS:000432148200026
J	Asai, Y; Eslami, A; van Ginkel, CD; Akhabir, L; Wan, M; Yin, D; Ellis, G; Ben-Shoshan, M; Marenholz, I; Martino, D; Ferreira, MA; Allen, K; Mazer, B; de Groot, H; de Jong, NW; van Wijk, RG; Dubois, AEJ; Grosche, S; Ashley, S; Ruschendorf, F; Kalb, B; Beyer, K; Nothen, MM; Lee, YA; Chin, R; Cheuk, S; Hoffman, J; Jorgensen, E; Witte, JS; Melles, RB; Hong, XM; Wang, XB; Hui, J; Musk, AW; Hunter, M; James, AL; Koppelman, GH; Sandford, AJ; Clarke, AE; Daley, D				Asai, Yuka; Eslami, Aida; van Ginkel, C. Dorien; Akhabir, Loubna; Wan, Ming; Yin, David; Ellis, George; Ben-Shoshan, Moshe; Marenholz, Ingo; Martino, David; Ferreira, Manuel A.; Allen, Katrina; Mazer, Bruce; de Groot, Hans; de Jong, Nicolette W.; van Wijk, Roy Gerth; Dubois, Anthony E. J.; Grosche, Sarah; Ashley, Sarah; Rueschendorf, Franz; Kalb, Birgit; Beyer, Kirsten; Noethen, Markus M.; Lee, Young-Ae; Chin, Rick; Cheuk, Stephen; Hoffman, Joshua; Jorgensen, Eric; Witte, John S.; Melles, Ronald B.; Hong, Xiumei; Wang, Xiaobin; Hui, Jennie; Musk, Arthur W. (Bill); Hunter, Michael; James, Alan L.; Koppelman, Gerard H.; Sandford, Andrew J.; Clarke, Ann E.; Daley, Denise			A Canadian genome-wide association study and meta-analysis confirm HLA as a risk factor for peanut allergy independent of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXPRESSION; GENE		[Asai, Yuka] Queens Univ, Dept Med, Div Dermatol, Kingston, ON, Canada; [Asai, Yuka] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Eslami, Aida; Akhabir, Loubna; Wan, Ming; Yin, David; Ellis, George; Sandford, Andrew J.; Daley, Denise] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [van Ginkel, C. Dorien] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Ben-Shoshan, Moshe] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Marenholz, Ingo] McGill Univ, Montreal Childrens Hosp, Ctr Hlth,Res Inst, Div Allergy & Immunol,Dept Pediat, Montreal, PQ, Canada; [Martino, David; Allen, Katrina] Max Delbruck Ctr Mol Med, Clin Pediat Allergy, Expt & Clin Res Ctr, Berlin, Germany; [de Groot, Hans] Univ Med Berlin, Berlin, Germany; [van Wijk, Roy Gerth] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Beyer, Kirsten] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Rueschendorf, Franz] Diaconessenhuis Voorburg Reinier Graaf Gasthuis, Dept Pediat Allergol, Delft, Netherlands; [Kalb, Birgit] Erasmus MC, Dept Allergol, Rotterdam, Netherlands; [Noethen, Markus M.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Lee, Young-Ae] Hudson Inst Med Res, Clayton, Vic, Australia; [Jorgensen, Eric] Max Delbruck Ctr Mol Med, Berlin, Germany; [Hui, Jennie] Charite Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany; [Koppelman, Gerard H.] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Hong, Xiumei] Univ Hosp Bonn, Bonn, Germany; [Hunter, Michael] Univ Calgary, Cumming Sch Med, Dept Med, Div Rheumatol, Calgary, AB, Canada; [Musk, Arthur W. (Bill)] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Hui, Jennie; Koppelman, Gerard H.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [James, Alan L.] Kaiser Permanente Northern Calif, Redwood City Med Ctr, Dept Ophthalmol, Redwood City, CA USA; [Hui, Jennie] Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Ctr Early Life Origins Dis, Family & Reprod Hlth,Dept Populat, Baltimore, MD USA; [Hunter, Michael] Univ Western Australia, Australia & Pathol & Lab Med, Sch Populat Hlth, Crawley, WA, Australia; [Cheuk, Stephen] Univ Western Australia, Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; [Jorgensen, Eric] Univ Western Australia, Sch Populat Hlth, Perth, WA, Australia; [Noethen, Markus M.] Univ Western Australia, Dept Pulm Physiol & Sleep Med, Sir Charles Gairdner Hosp, Perth, WA, Australia; [Clarke, Ann E.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia	Queens University - Canada; McGill University; University of British Columbia; University of Groningen; University of Groningen; McGill University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute; Erasmus University Rotterdam; Erasmus MC; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Hudson Institute of Medical Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; University of Bonn; University of Calgary; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Daley, D (corresponding author), Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada.	denise.daley@hli.ubc.ca	Allen, Katrina/I-4361-2018; Hui, Jennie/A-9543-2013; Martino, DJ/X-1753-2019; Koppelman, Gerard/AAG-9187-2020; Hunter, Michael L/B-3213-2013; Grosche, Sarah/ABA-8480-2021; Ashley, Sarah/P-1264-2017	Allen, Katrina/0000-0002-1921-4493; Hui, Jennie/0000-0002-1653-2496; Martino, DJ/0000-0001-6823-4696; Hunter, Michael L/0000-0001-6704-4815; Asai, Yuka/0000-0003-1674-3215; Kalb, Birgit/0000-0002-3104-6736; Westerlaken - van Ginkel MD PhD, C. Dorien/0000-0002-5247-2697; Ashley, Sarah/0000-0001-9973-9742; Yin, David/0000-0002-3658-9756; Koppelman, Gerard/0000-0001-8567-3252; Melles, Ronald/0000-0003-1027-4083	Allergy, Genes, and Environment Network of Centres of Excellence (AllerGen NCE); Canadian Institutes of Health Research; Canadian Research Chairs Program; Natural Sciences and Engineering Research Council; Michael Smith Foundation for Health Research/AllerGen NCE postdoctoral research fellowship; Division of Experimental Medicine Entrance Fellowship; Montreal Children's Hospital Foundation; McGill University Health Centre Foundation; Canadian Dermatology Foundation; Canadian Allergy, Asthma and Immunology Foundation; Canadian Society of Allergy and Clinical Immunology; National Institutes of Health [CA112355, RC2 AG036607]; HealthWay; National Health and Medical Research Council (Australia); Australian Research Council; US Department of Defense [W81XWH-10-1-0487]; Clinical Exchange Program fellowship of the Experimental and Clinical Research Center of Max Delbruck Center; Charite Medical School; Nutricia Research Foundation; Dutch Technology Foundation STW, part of the Netherlands Organisation for Scientific Research (NOW); Ministry of Economic Affairs [11868]; Food Allergy Foundation; Siemens Healthcare Diagnostics; HAL Allergy; Intersnack the Netherlands B.V.; ALK-Albello B.V.; Netherlands Anaphylaxis Network; Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute of Drug Abuse; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke	Allergy, Genes, and Environment Network of Centres of Excellence (AllerGen NCE); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research/AllerGen NCE postdoctoral research fellowship; Division of Experimental Medicine Entrance Fellowship; Montreal Children's Hospital Foundation; McGill University Health Centre Foundation; Canadian Dermatology Foundation; Canadian Allergy, Asthma and Immunology Foundation; Canadian Society of Allergy and Clinical Immunology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HealthWay; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); US Department of Defense(United States Department of Defense); Clinical Exchange Program fellowship of the Experimental and Clinical Research Center of Max Delbruck Center; Charite Medical School; Nutricia Research Foundation(Danone Nutricia); Dutch Technology Foundation STW, part of the Netherlands Organisation for Scientific Research (NOW); Ministry of Economic Affairs; Food Allergy Foundation; Siemens Healthcare Diagnostics; HAL Allergy(HAL Allergy Group); Intersnack the Netherlands B.V.; ALK-Albello B.V.(Bioceros B.V.); Netherlands Anaphylaxis Network; Common Fund of the Office of the Director of the National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the Allergy, Genes, and Environment Network of Centres of Excellence (AllerGen NCE), Canadian Institutes of Health Research, Canadian Research Chairs Program (salary award to D.D.), Natural Sciences and Engineering Research Council and Michael Smith Foundation for Health Research/AllerGen NCE postdoctoral research fellowship awards (to A.E.), Division of Experimental Medicine Entrance Fellowship (to Y.A.), Montreal Children's Hospital Foundation, McGill University Health Centre Foundation, Canadian Dermatology Foundation, Canadian Allergy, Asthma and Immunology Foundation, Canadian Society of Allergy and Clinical Immunology, the National Institutes of Health (grant no. CA112355 awarded to J.S.W. and RC2 AG036607 awarded to C.A. Schaefer and N.J. Risch), HealthWay, National Health and Medical Research Council (Australia), Australian Research Council, US Department of Defense (grant no. W81XWH-10-1-0487), and a Clinical Exchange Program fellowship of the Experimental and Clinical Research Center of Max Delbruck Center and Charite Medical School. C.D.v.G., A.E.J.D., and G.H.K. received an unrestricted grant from the Nutricia Research Foundation to complete the Dutch GENEVA cohort. The Dutch IDEAL cohort of N.W.d.J., H.d.G., R.G.v.W., and A.E.J.D. was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NOW) and funded in part by the Ministry of Economic Affairs (project number 11868) and Food Allergy Foundation, Siemens Healthcare Diagnostics, HAL Allergy, Intersnack the Netherlands B.V., ALK-Albello B.V., and the Netherlands Anaphylaxis Network. Funding sources had no role in study design, collection, analysis and interpretation of data or in the decision to submit or writing of the report. The Genotype-Tissue Expression Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by the National Cancer Institute; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute of Drug Abuse; National Institute of Mental Health; and National Institute of Neurological Disorders and Stroke. The data used for the analyses described in this manuscript were obtained from the Genotype-Tissue Expression Project Portal on January 1, 2017, to February 28, 2017.	Asai Y, 2017, J ALLERGY CLIN IMMUN; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304; James AL, 2010, EUR RESPIR J, V35, P273, DOI 10.1183/09031936.00194308; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martino DJ, 2017, CLIN EXP ALLERGY, V47, P217, DOI 10.1111/cea.12863; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; van Ginkel CD, 2015, ALLERGY, V70, P461, DOI 10.1111/all.12569	9	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1513	+		10.1016/j.jaci.2017.10.047	http://dx.doi.org/10.1016/j.jaci.2017.10.047			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29325868	Bronze, Green Accepted			2022-12-18	WOS:000429197800045
J	Lang, JE; Fitzpatrick, AM; Mauger, DT; Guilbert, TW; Jackson, DJ; Lemanske, RF; Martinez, FD; Strunk, RC; Zeiger, RS; Phipatanakul, W; Bacharier, LB; Pongracic, JA; Holguin, F; Cabana, MD; Covar, RA; Raissy, HH; Tang, M; Szefler, SJ				Lang, Jason E.; Fitzpatrick, Anne M.; Mauger, David T.; Guilbert, Theresa W.; Jackson, Daniel J.; Lemanske, Robert F., Jr.; Martinez, Fernando D.; Strunk, Robert C.; Zeiger, Robert S.; Phipatanakul, Wanda; Bacharier, Leonard B.; Pongracic, Jacqueline A.; Holguin, Fernando; Cabana, Michael D.; Covar, Ronina A.; Raissy, Hengameh H.; Tang, Monica; Szefler, Stanley J.		Natl Inst Hlth Natl Heart Lung & B	Overweight/obesity status in preschool children associates with worse asthma but robust improvement on inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; overweight; obesity; children; infants; exacerbation	BODY-MASS INDEX; PERSISTENT CHILDHOOD ASTHMA; YOUNG-CHILDREN; PEDIATRIC ASTHMA; FLUTICASONE PROPIONATE; CONTROLLER THERAPY; OBESITY; MONTELUKAST; BUDESONIDE; SEVERITY	Background: Overweight/obesity (OW) is linked to worse asthma and poorer inhaled corticosteroid (ICS) response in older children and adults. Objective: We sought to describe the relationships between OW and asthma severity and response to ICS in preschool children. Methods: This post hoc study of 3 large multicenter trials involving 2- to 5-year-old children compared annualized asthma symptom days and exacerbations among normal weight (NW) (body mass index: 10th-84th percentiles) versus OW (body mass index: >= 85th percentile) participants. Participants had randomized to daily ICS, intermittent ICS, or daily placebo. Simple and multivariable linear regression was used to compare body mass index groups. Results: Within the group not treated with a daily controller, OW children had more asthma symptom days (90.7 vs 53.2, P = .020) and exacerbations (1.4 vs 0.8, P = .009) thanNW children did. Within the ICS-treated groups, OW and NW children had similar asthma symptom days (daily ICS: 47.2 vs 44.0 days, P = .44; short-term ICS: 61.8 vs 52.9 days, P = .46; as-needed ICS: 53.3 vs 47.3 days, P = .53), and similar exacerbations (daily ICS: 0.6 vs 0.8, P = .10; short-term ICS: 1.1 vs 0.8 days, P = .25; as-needed ICS: 1.0 vs 1.1, P = .72). Compared with placebo, daily ICS in OW led to fewer annualized asthma symptom days (90.7 vs 41.2, P = .004) and exacerbations (1.4 vs 0.6, P = .006), while similar protective ICS effects were less apparent among NW. Conclusions: In preschool children off controller therapy, OW is associated with greater asthma impairment and exacerbations. However, unlike older asthmatic patients, OW preschool children do not demonstrate reduced responsiveness to ICS therapy.	[Lang, Jason E.; Tang, Monica] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Mauger, David T.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Holguin, Fernando] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Guilbert, Theresa W.] Univ Wisconsin, Cincinnati Childrens Hosp, Sch Med & Publ Hlth, Madison, WI USA; [Guilbert, Theresa W.] Univ Wisconsin, Med Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Jackson, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Pediat Sect Allergy Immunol & Rheumatol, Madison, WI USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Strunk, Robert C.] Washington Univ, Sch Med, St Louis, MO USA; [Zeiger, Robert S.] Univ Calif San Diego, Kaiser Permanente Med Ctr, San Diego, CA 92103 USA; [Cabana, Michael D.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Phipatanakul, Wanda; Bacharier, Leonard B.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Pongracic, Jacqueline A.] Childrens Mem Hosp, Chicago, IL 60614 USA; [Covar, Ronina A.] Natl Jewish Hlth, Denver, CO USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Aurora, CO USA; [Raissy, Hengameh H.] Univ New Mexico, Albuquerque, NM 87131 USA	Duke University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cincinnati Children's Hospital Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; Washington University (WUSTL); Kaiser Permanente; University of California System; University of California San Diego; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Harvard Medical School; Ann & Robert H. Lurie Children's Hospital of Chicago; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of New Mexico	Lang, JE (corresponding author), Duke Childrens Hosp & Hlth Ctr, Div Allergy Immunol & Pulm Med, MSRB 1 203 Res Dr, Room 127, Durham, NC 27708 USA.	jason.lang@duke.edu		Bacharier, Leonard/0000-0003-0432-2704; Fitzpatrick, Anne/0000-0002-2933-5926; Szefler, Stanley/0000-0002-6911-3199; Zeiger, Robert/0000-0001-5788-5063	National Heart, Lung, and Blood Institute (NHLBI) AsthmaNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007062] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI) AsthmaNet; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Heart, Lung, and Blood Institute (NHLBI) AsthmaNet.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Aragona Elena, 2016, Hosp Pediatr, V6, P211, DOI 10.1542/hpeds.2015-0094; Bacharier LB, 2009, J ALLERGY CLIN IMMUN, V123, P1077, DOI 10.1016/j.jaci.2008.12.1120; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; BISGAARD H, 1990, LANCET, V336, P649, DOI 10.1016/0140-6736(90)92147-A; Bisgaard H, 2004, PEDIATRICS, V113, P87; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Boulet LP, 2007, RESP MED, V101, P2240, DOI 10.1016/j.rmed.2007.06.031; Camargo CA, 2010, CURR MED RES OPIN, V26, P1629, DOI 10.1185/03007995.2010.483113; Camargo CA, 2010, J ASTHMA, V47, P76, DOI 10.3109/02770900903338494; Carroll CL, 2007, PEDIATRICS, V120, P734, DOI 10.1542/peds.2007-0409; Castro-Rodriguez JA, 2009, PEDIATRICS, V123, pe519, DOI 10.1542/peds.2008-2867; Chen ZH, 2017, AM J RESP CRIT CARE, V195, P1181, DOI 10.1164/rccm.201608-1691OC; CONNETT GJ, 1993, ARCH DIS CHILD, V69, P351, DOI 10.1136/adc.69.3.351; COX G, 1995, J IMMUNOL, V154, P4719; Ducharme FM, 2014, LANCET, V383, P1593, DOI 10.1016/S0140-6736(14)60615-2; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Fitzpatrick AM, 2016, J ALLERGY CLIN IMMUN, V138, P1608, DOI 10.1016/j.jaci.2016.09.028; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Gibson Peter G, 2013, Ann Am Thorac Soc, V10 Suppl, pS138, DOI 10.1513/AnnalsATS.201302-038AW; Ginde AA, 2010, PEDIAT ALLERG IMM-UK, V21, P480, DOI 10.1111/j.1399-3038.2009.00911.x; GLEESON JGA, 1988, BRIT MED J, V297, P163, DOI 10.1136/bmj.297.6642.163; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Knuffman JE, 2009, J ALLERGY CLIN IMMUN, V123, P411, DOI 10.1016/j.jaci.2008.11.016; Lang JE, 2015, J ALLERGY CLIN IMMUN, V135, P886, DOI 10.1016/j.jaci.2014.08.029; Lang JE, 2012, J ASTHMA, V49, P456, DOI 10.3109/02770903.2012.677895; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Luder E, 1998, J PEDIATR-US, V132, P699, DOI 10.1016/S0022-3476(98)70363-4; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Michelson PH, 2009, ANN ALLERG ASTHMA IM, V103, P381, DOI 10.1016/S1081-1206(10)60356-0; Moorman Jeanne E, 2012, Vital Health Stat 3, P1; Mougey E, 2013, CLIN EXP ALLERGY, V43, P512, DOI 10.1111/cea.12076; National Asthma Education and Prevention Program, 2007, NIH PUBL, V07- 4051; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ostrom NK, 2005, J PEDIATR-US, V147, P213, DOI 10.1016/j.jpeds.2005.03.052; Peters JI, 2011, ANN ALLERG ASTHMA IM, V106, P30, DOI 10.1016/j.anai.2010.10.015; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; Sheehan WJ, 2016, NEW ENGL J MED, V375, P619, DOI 10.1056/NEJMoa1515990; Silveira DH, 2015, J PAEDIATR CHILD H, V51, P1001, DOI 10.1111/jpc.12882; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Sutherland ER, 2010, ALLERGY ASTHMA PROC, V31, P20, DOI 10.2500/aap.2010.31.3307; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1043, DOI 10.1016/j.jaci.2007.08.063; Tantisira KG, 2003, THORAX, V58, P1036, DOI 10.1136/thorax.58.12.1036; Telenga ED, 2012, ALLERGY, V67, P1060, DOI 10.1111/j.1398-9995.2012.02855.x; van Gent R, 2007, J ALLERGY CLIN IMMUN, V119, P591, DOI 10.1016/j.jaci.2006.11.007; Wang L, 2011, J ALLERGY CLIN IMMUN, V127, P161, DOI 10.1016/j.jaci.2010.10.035; Zeiger RS, 2011, NEW ENGL J MED, V365, P1990, DOI 10.1056/NEJMoa1104647; Zeiger RS, 2006, J ALLERGY CLIN IMMUN, V117, P45, DOI 10.1016/j.jaci.2005.10.012	54	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1459	+		10.1016/j.jaci.2017.09.043	http://dx.doi.org/10.1016/j.jaci.2017.09.043			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29273557	Green Accepted, Bronze			2022-12-18	WOS:000429197800031
J	Salabert-Le Guen, N; Hemont, C; Delbove, A; Poli, C; Braudeau, C; Fantou, A; Amouriaux, K; Beriou, G; Martin, JC; Colas, L; Soumelis, V; Josien, R				Salabert-Le Guen, Nina; Hemont, Caroline; Delbove, Agathe; Poli, Caroline; Braudeau, Cecile; Fantou, Aurelie; Amouriaux, Karine; Beriou, Gaelle; Martin, Jerome C.; Colas, Luc; Soumelis, Vassili; Josien, Regis			Thymic stromal lymphopoietin does not activate human basophils	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							TSLP; IL-3		[Salabert-Le Guen, Nina; Hemont, Caroline; Delbove, Agathe; Braudeau, Cecile; Fantou, Aurelie; Amouriaux, Karine; Martin, Jerome C.; Josien, Regis] CHU Nantes, Lab Immunol, CIMNA, Nantes, France; [Salabert-Le Guen, Nina; Hemont, Caroline; Braudeau, Cecile; Fantou, Aurelie; Amouriaux, Karine; Beriou, Gaelle; Martin, Jerome C.; Colas, Luc; Josien, Regis] Univ Nantes, INSERM, UMR 1064, Ctr Rech Transplantat & Immunol, Nantes, France; [Salabert-Le Guen, Nina; Braudeau, Cecile; Amouriaux, Karine; Josien, Regis] Univ Nantes, LabEx Immunograft Oncol IGO, Nantes, France; [Salabert-Le Guen, Nina; Amouriaux, Karine; Martin, Jerome C.; Josien, Regis] Univ Nantes, Fac Med, Nantes, France; [Poli, Caroline] CHU Angers, Dept Hematol & Immunol, Angers, France; [Colas, Luc] CHU Nantes, PlateForme Transversale Allergol PFTA, Inst Thorax, Nantes, France; [Colas, Luc] CNRS 6291, UMR1087, INSERM, Nantes, France; [Soumelis, Vassili] Inst Curie, Lab Immunol Clin, Paris, France; [Soumelis, Vassili] INSERM, U932, Paris, France; [Delbove, Agathe] CHU Nantes, Inst Thorax, Serv Pneumol, Nantes, France; [Amouriaux, Karine] CHU Nantes, CRB, Nantes, France; [Martin, Jerome C.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; Nantes Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Icahn School of Medicine at Mount Sinai	Josien, R (corresponding author), CHU Nantes, Lab Immunol, CIMNA, Nantes, France.; Josien, R (corresponding author), Univ Nantes, INSERM, UMR 1064, Ctr Rech Transplantat & Immunol, Nantes, France.; Josien, R (corresponding author), Univ Nantes, LabEx Immunograft Oncol IGO, Nantes, France.; Josien, R (corresponding author), Univ Nantes, Fac Med, Nantes, France.	Regis.josien@univ-nantes.fr	Martin, Jerome/GZG-4189-2022; Josien, Regis/U-4405-2019; Josien, Regis/L-7468-2015	Josien, Regis/0000-0001-7900-7413; Martin, Jerome/0000-0003-0068-8776; POLI, Caroline/0000-0002-4145-5373; Salabert, Nina/0000-0003-1528-4272	LabEX IGO project - "Investissements d'Avenir'' program through the "Agence Nationale de la Recherche'' [ANR11-LABX-0016-01]; IMBIO-DC project; Region des Pays de la Loire	LabEX IGO project - "Investissements d'Avenir'' program through the "Agence Nationale de la Recherche''(French National Research Agency (ANR)); IMBIO-DC project; Region des Pays de la Loire(Region Pays de la Loire)	This work was supported by the LabEX IGO project funded by the "Investissements d'Avenir'' program through the "Agence Nationale de la Recherche'' (grant no. ANR11-LABX-0016-01) and in part by the IMBIO-DC project supported by the "Region des Pays de la Loire.''	Hui CCK, 2014, IMMUN INFLAMM DIS, V2, P44, DOI 10.1002/iid3.20; Khanolkar A, 2013, AM J CLIN PATHOL, V140, P293, DOI 10.1309/AJCPLSN0RQKHJX1A; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Park JH, 2017, AUTOIMMUN REV, V16, P55, DOI 10.1016/j.autrev.2016.09.014; Salter BM, 2015, J ALLERGY CLIN IMMUN, V136, P1636, DOI 10.1016/j.jaci.2015.03.039; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329	7	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1476	+		10.1016/j.jaci.2017.11.012	http://dx.doi.org/10.1016/j.jaci.2017.11.012			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29208546	Bronze			2022-12-18	WOS:000429197800033
J	Maspero, J; Harrison, T; Werkstrom, V; Wu, YP; Gopalan, G; Zangrilli, J				Maspero, Jorge; Harrison, Tim; Werkstrom, Viktoria; Wu, Yanping; Gopalan, Gokul; Zangrilli, James			Clinical Efficacy of Benralizumab in Patients With Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology / World-Allergy-Organization Joint Congress	MAR 02-08, 2018	Orlando, FL	Amer Acad Allergy Asthma & Immunol, World Allergy Org					[Maspero, Jorge] Fdn CIDEA, Buenos Aires, DF, Argentina; [Harrison, Tim] Nottingham City Hosp, Nottingham, England; [Werkstrom, Viktoria] AstraZeneca, Molndal, Sweden; [Wu, Yanping; Gopalan, Gokul; Zangrilli, James] AstraZeneca, Gaithersburg, MD USA	Nottingham University Hospital NHS Trust; Nottingham City Hospital; AstraZeneca; AstraZeneca									0	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2018	141	2		S		36	AB12	AB12		10.1016/j.jaci.2017.12.038	http://dx.doi.org/10.1016/j.jaci.2017.12.038			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	GB8DX					2022-12-18	WOS:000429306700037
J	Shamji, MH; Ceuppens, J; Bachert, C; Hellings, P; Placier, G; Thirion, G; Bovy, N; Durham, SR; Duchateau, J; Legon, T; Pirotton, S				Shamji, Mohamed H.; Ceuppens, Jan; Bachert, Claus; Hellings, Peter; Placier, Gael; Thirion, Gaetan; Bovy, Nicolas; Durham, Stephen R.; Duchateau, Jean; Legon, Thierry; Pirotton, Sabine			Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMUNOTHERAPY; SET		[Shamji, Mohamed H.; Durham, Stephen R.] Imperial Coll London, MRC Asthma UK Ctr, Immunomodulat & Tolerance Grp, Allergy & Clin Immunol Inflammat Repair & Dev, London, England; [Bachert, Claus] Univ Ghent, Upper Airways Res Lab, Ghent, Belgium; [Ceuppens, Jan] UZ Leuven, Dept Allergy & Clin Immunol, Leuven, Belgium; [Hellings, Peter] UZ Leuven, Ear Nose & Throat Dept, Leuven, Belgium; [Placier, Gael; Thirion, Gaetan; Bovy, Nicolas; Duchateau, Jean; Legon, Thierry; Pirotton, Sabine] ASIT Biotech, Brussels, Belgium	Imperial College London; Ghent University; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Shamji, MH (corresponding author), Imperial Coll London, MRC Asthma UK Ctr, Immunomodulat & Tolerance Grp, Allergy & Clin Immunol Inflammat Repair & Dev, London, England.	m.shamji@imperial.ac.uk	Shamji, Mohamed/AAU-8811-2020; Hellings, Peter W/I-4068-2018; Shamji, Mohamed/AAD-1788-2019; Bachert, Claus/J-8825-2012	Shamji, Mohamed/0000-0003-3425-3463; Hellings, Peter W/0000-0001-6898-688X; Ceuppens, Jan/0000-0003-4502-2679	ASIT Biotech; ALK-Abello; Regeneron; Merck; Allergopharma; Circassia; Novartis; Biotech; Biomay; UCB; Boehringer Ingelheim; Allergy Therapeutics; Pneumo Update GmbH; Anergis; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish	ASIT Biotech; ALK-Abello; Regeneron(Regeneron); Merck(Merck & Company); Allergopharma; Circassia; Novartis(Novartis); Biotech; Biomay; UCB(UCB Pharma SA); Boehringer Ingelheim(Boehringer Ingelheim); Allergy Therapeutics; Pneumo Update GmbH; Anergis; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	M. H. Shamji has received grants from ASIT Biotech, ALK-Abello, Regeneron, and Merck and has received personal fees from ASIT Biotech, ALK-Abello, and Allergopharma. J. Ceuppens has received a grant and a consulting fee or honorarium from ASIT Biotech, has consultant arrangements with Pfizer, has received a grant from Circassia, has received payment for lectures from Novartis, and has received travel support from Pfizer. C. Bachert received payment for a clinical study from Biotech. G. Placier has the patents issued (EP20080100019 20080102 and EP20110170031 20110615), in 2016 reported an exercise of warrants from ASIT Biotech, and is currently a shareholder of ASIT Biotech. G. Thirion and N. Bovy report and have received warrants from ASIT Biotech that could be exercised according to the success of the company. S. R. Durham has received grants from ALK-Abello, Regeneron, and Merck and has received personal fees from ALK-Abello, Biomay, UCB, Boehringer Ingelheim, Allergy Therapeutics, Pneumo Update GmbH, and Anergis. J. Duchateau has received personal fees from and is shareholder of ASIT Biotech. T. Legon has received personal fees from and is a shareholder of ASIT Biotech and has a patent issued (EP 2 043 684). S. Pirotton has a patent issued (EP 2 043 684) and is an employee and shareholder of ASIT Biotech. The rest of the authors declare that they have no relevant conflicts of interest.	Castanie HP, 1997, ANAL BIOCHEM, V254, P150, DOI 10.1006/abio.1997.2423; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151; LAFFER S, 1994, J ALLERGY CLIN IMMUN, V94, P689, DOI 10.1016/0091-6749(94)90176-7; Noon L, 1911, LANCET, V1, P1572; Patel D, 2013, J ALLERGY CLIN IMMUN, V131, P103, DOI 10.1016/j.jaci.2012.07.028; Prickett SR, 2013, CLIN EXP ALLERGY, V43, P684, DOI 10.1111/cea.12113; Spertini F, 2014, J ALLERGY CLIN IMMUN, V134, P239, DOI 10.1016/j.jaci.2014.04.001; Thurlings RM, 2010, ARTHRITIS RHEUM-US, V62, P3607, DOI 10.1002/art.27702; Untersmayr E, 2008, J ALLERGY CLIN IMMUN, V121, P1301, DOI 10.1016/j.jaci.2008.04.025; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593	11	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					448	+		10.1016/j.jaci.2017.09.013	http://dx.doi.org/10.1016/j.jaci.2017.09.013			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	29030102	Green Published, hybrid			2022-12-18	WOS:000419312200061
J	Klemann, C; Ammann, S; Heizmann, M; Fuchs, S; Bode, SF; Heeg, M; Fuchs, H; Lehmberg, K; zur Stadt, U; Roll, C; Vraetz, T; Speckmann, C; Lorenz, MR; Schwarz, K; Rohr, J; Feske, S; Ehl, S				Klemann, Christian; Ammann, Sandra; Heizmann, Miriam; Fuchs, Sebastian; Bode, Sebastian F.; Heeg, Maximilian; Fuchs, Hans; Lehmberg, Kai; zur Stadt, Udo; Roll, Claudia; Vraetz, Thomas; Speckmann, Carsten; Lorenz, Myriam Ricarda; Schwarz, Klaus; Rohr, Jan; Feske, Stefan; Ehl, Stephan			Hemophagocytic lymphohistiocytosis as presenting manifestation of profound combined immunodeficiency due to an ORAI1 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELL; ACTIVATION; STIM1		[Klemann, Christian; Ammann, Sandra; Heizmann, Miriam; Fuchs, Sebastian; Heeg, Maximilian; Speckmann, Carsten; Rohr, Jan; Ehl, Stephan] Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany; [Klemann, Christian; Bode, Sebastian F.; Heeg, Maximilian; Fuchs, Hans; Speckmann, Carsten; Rohr, Jan; Ehl, Stephan] Univ Freiburg, Fac Med, Ctr Pediat, Med Ctr, Freiburg, Germany; [Lehmberg, Kai] Univ Med Ctr Hamburg Eppendorf, Pediat Hematol & Oncol, Hamburg, Germany; [zur Stadt, Udo] Univ Med Ctr Hamburg Eppendorf, Ctr Diagnost, Hamburg, Germany; [Roll, Claudia] Univ Witten Herdecke, Vest Childrens Hosp Datteln, Datteln, Germany; [Lorenz, Myriam Ricarda; Schwarz, Klaus] Univ Ulm, Inst Transfus Med, Ulm, Germany; [Schwarz, Klaus] German Red Cross Blood Serv, Inst Clin Transfus Med & Immunogenet Ulm, Ulm, Germany; [Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY USA	University of Freiburg; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Witten Herdecke University; Ulm University; New York University	Ehl, S (corresponding author), Univ Freiburg, Fac Med, Ctr Chron Immunodeficiency, Med Ctr, Freiburg, Germany.; Ehl, S (corresponding author), Univ Freiburg, Fac Med, Ctr Pediat, Med Ctr, Freiburg, Germany.	stephan.ehl@uniklinik-freiburg.de	Klemann, Christian/AAQ-9301-2020; Feske, stefan/ABB-3554-2021; Ehl, Stephan/AAM-6006-2020	Klemann, Christian/0000-0002-5639-8690; Feske, stefan/0000-0001-5431-8178; Ehl, Stephan/0000-0002-9265-2721; Bode, Sebastian/0000-0001-7217-3312; Ammann, Sandra/0000-0003-0385-1890; Speckmann, Carsten/0000-0002-6217-1556; Fuchs, Sebastian/0000-0001-9191-7970	Deutsche Forschungsgemeinschaft (DFG) [SFB1160]; Bundesministerium ffur Bildung und Forschung (BMBF) [01 EO 0803]; Union Chimique Belge (UCB); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097302] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium ffur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Union Chimique Belge (UCB); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S. Feske has patents WO/2009/009655 and WO/2007/081804 and has stock/stock options in Calcimedica Inc. S. Ehl has received grants from Deutsche Forschungsgemeinschaft (DFG) (SFB1160, TP1), Bundesministerium ffur Bildung und Forschung (BMBF) (01 EO 0803), and Union Chimique Belge (UCB) and has consultant arrangements with UCB. The rest of the authors declare that they have no relevant conflicts of interest.	Ammann S, 2017, EUR J IMMUNOL, V47, P364, DOI 10.1002/eji.201646686; Bode SFN, 2015, HAEMATOLOGICA, V100, P978, DOI 10.3324/haematol.2014.121608; Concepcion AR, 2016, J CLIN INVEST, V1, P1; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Frischauf I, 2016, ADV EXP MED BIOL, V898, P25, DOI 10.1007/978-3-319-26974-0_2; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Janka GE, 2014, BLOOD REV, V28, P135, DOI 10.1016/j.blre.2014.03.002; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736	10	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2017	140	6					1721	+		10.1016/j.jaci.2017.05.039	http://dx.doi.org/10.1016/j.jaci.2017.05.039			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FO9KI	28633876	Green Accepted, Bronze			2022-12-18	WOS:000417206000033
J	Richgels, PK; Yamani, A; Chougnet, CA; Lewkowich, IP				Richgels, Phoebe K.; Yamani, Amnah; Chougnet, Claire A.; Lewkowich, Ian P.			Maternal house dust mite exposure during pregnancy enhances severity of house dust mite-induced asthma in murine offspring	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; allergen; pregnancy; maternal exposures; environment	GENE-ENVIRONMENT INTERACTIONS; CHILDHOOD ASTHMA; ALLERGIC SENSITIZATION; TOTAL IGE; CELLS; RISK; TRANSMISSION; CHILDREN; LIFE; SUSCEPTIBILITY	Background: Atopic status of the mother and maternal exposure to environmental factors are associated with increased asthma risk. Moreover, animal models demonstrate that exposure to allergens in strongly sensitized mothers influences offspring asthma development, suggesting that in utero exposures can influence offspring asthma. However, it is unclear whether maternal exposure to common human allergens such as house dust mite (HDM), in the absence of additional adjuvants, influences offspring asthma development. Objective: We sought to determine whether maternal HDM exposure influences asthma development in offspring. Methods: Pregnant female mice were exposed to PBS or HDM during pregnancy. Using offspring of PBS- or HDM-exposed mothers, the magnitude of HDM or Aspergillus fumigatus (AF) extract-induced airway hyperresponsiveness (AHR), airway inflammation, immunoglobulinproduction, T(H)2-associated cytokine synthesis, and pulmonary dendritic cell activity was assessed. Results: Compared with offspring of PBS-exposed mothers, offspring of HDM-exposed mothers demonstrate increased AHR, airway inflammation, T(H)2 cytokine production, and immunoglobulin levels and a modest decrease in the phagocytic capacity of pulmonary macrophage populations following HDM exposure. Increased sensitivity to AF-induced airway disease was not observed. Offspring of HDM-exposed B-cell-deficient mothers also demonstrated increased HDM-induced AHR, suggesting that transfer of maternal immunoglobulins is not required. Conclusions: Our data demonstrate that maternal exposure to HDM during pregnancy increases asthma sensitivity in offspring in an HDM-specific manner, suggesting that vertical transmission of maternal immune responses may be involved. These findings have important implications for regulation of asthma risk, and suggest that exposure to HDM in the developed world may have underappreciated influences on the overall prevalence of allergic asthma.	[Richgels, Phoebe K.; Yamani, Amnah; Chougnet, Claire A.; Lewkowich, Ian P.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lewkowich, IP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Ian.Lewkowich@cchmc.org			National Institute of Environmental Health Sciences [P30 ES006096]; National Heart, Lung, and Blood Institute [R01 HL122300]; Cincinnati Children's Hospital Medical Center Perinatal Infection and Inflammation Collaborative; National Institute of Allergy and Infectious Diseases [R21 AI119385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cincinnati Children's Hospital Medical Center Perinatal Infection and Inflammation Collaborative; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the National Institute of Environmental Health Sciences (grant no. P30 ES006096 to I.P.L.), the National Heart, Lung, and Blood Institute (grant no. R01 HL122300 to I.P.L.), the Cincinnati Children's Hospital Medical Center Perinatal Infection and Inflammation Collaborative (C.A.C. and I.P.L.), and the National Institute of Allergy and Infectious Diseases (grant no. R21 AI119385 to I.P.L.).	Al-Ghouleh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033929; Arshad SH, 2012, J ALLERGY CLIN IMMUN, V130, P427, DOI 10.1016/j.jaci.2012.03.042; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Chen JC, 2016, AM J RESP CRIT CARE, V194, P934, DOI 10.1164/rccm.201508-1703OC; Chiu YHM, 2014, J ALLERGY CLIN IMMUN, V133, P713, DOI 10.1016/j.jaci.2013.09.023; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fedulov AV, 2011, AM J RESP CELL MOL, V44, P285, DOI 10.1165/rcmb.2009-0400OC; Ghosh MK, 2016, J IMMUNOL, V197, P2290, DOI 10.4049/jimmunol.1502483; Ghosh S, 2012, J IMMUNOL, V189, P1322, DOI 10.4049/jimmunol.1200138; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; Hubeau C, 2006, AM J PATHOL, V168, P1931, DOI 10.2353/ajpath.2006.051231; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lewkowich IP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003879; Lewkowich IP, 2004, J IMMUNOL METHODS, V286, P123, DOI 10.1016/j.jim.2003.12.010; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; Liu CA, 2003, J ALLERGY CLIN IMMUN, V112, P899, DOI 10.1016/j.jaci.2003.08.030; Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Matson AP, 2007, J IMMUNOL, V179, P1282, DOI 10.4049/jimmunol.179.2.1282; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; Mikhaylova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070387; Moffatt MF, 1998, CLIN EXP ALLERGY, V28, P56; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Neuman A, 2012, AM J RESP CRIT CARE, V186, P1037, DOI 10.1164/rccm.201203-0501OC; Niedzwiecki M, 2012, ALLERGY, V67, P904, DOI 10.1111/j.1398-9995.2012.02841.x; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Peat J K, 1996, Curr Opin Pulm Med, V2, P7; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Platts-Mills T, 2001, LANCET, V357, P752, DOI 10.1016/S0140-6736(00)04168-4; Platts-Mills TAE, 2000, J ALLERGY CLIN IMMUN, V105, pS503, DOI 10.1016/S0091-6749(00)90051-4; PLATTSMILLS TAE, 1989, J ALLERGY CLIN IMMUN, V83, P416, DOI 10.1016/0091-6749(89)90128-0; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Ronmark E, 2003, J ALLERGY CLIN IMMUN, V112, P747, DOI 10.1016/S0091-6749(03)01866-9; RUIZ RGG, 1992, CLIN EXP ALLERGY, V22, P762, DOI 10.1111/j.1365-2222.1992.tb02816.x; Singh SP, 2011, J IMMUNOL, V187, P4542, DOI 10.4049/jimmunol.1101567; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; SPORIK R, 1995, AM J RESP CRIT CARE, V151, P1388, DOI 10.1164/ajrccm.151.5.7735590; Squillace SP, 1997, AM J RESP CRIT CARE, V156, P1760, DOI 10.1164/ajrccm.156.6.9704026; Stein RT, 1999, AM J EPIDEMIOL, V149, P1030; Straubinger K, 2014, J ALLERGY CLIN IMMUN, V134, P1271, DOI 10.1016/j.jaci.2014.05.034; Szepfalusi Z, 2000, PEDIATR RES, V48, P404, DOI 10.1203/00006450-200009000-00024; Szepfalusi Z, 2000, J ALLERGY CLIN IMMUN, V106, P530; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vercelli D, 2009, J ALLERGY CLIN IMMUN, V123, P26, DOI 10.1016/j.jaci.2008.11.031; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wong GWK, 2008, PEDIATR PULM, V43, P107, DOI 10.1002/ppul.20755; World Health Organization, 2007, 2021 CURR STAT ISS C	59	15	17	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1404	+		10.1016/j.jaci.2016.12.972	http://dx.doi.org/10.1016/j.jaci.2016.12.972			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28192144	Green Accepted, Bronze			2022-12-18	WOS:000414304300020
J	Anderson, WC; Apter, AJ; Dutmer, CM; Searing, DA; Szefler, SJ				Anderson, William C., III; Apter, Andrea J.; Dutmer, Cullen M.; Searing, Daniel A.; Szefler, Stanley J.			Advances in asthma in 2016: Designing individualized approaches to management	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Air quality; airway hyperreactivity; allergen immunotherapy; allergen sensitization; allergy; asthma; biomarkers; climate; chronic obstructive pulmonary disease; eosinophils; exacerbation; exhaled nitric oxide; genetics; ligelizumab; medication adherence; microbiome; patient-centered outcomes; pregnancy; prenatal exposures; respiratory syncytial virus; rhinovirus; roflumilast; tiotropium	EXHALED NITRIC-OXIDE; INNER-CITY CHILDREN; RESPIRATORY SYNCYTIAL VIRUS; INNATE LYMPHOID-CELLS; LUNG-FUNCTION; PRECISION MEDICINE; CHILDHOOD ASTHMA; AIR-POLLUTION; EMERGENCY-DEPARTMENT; MEDICATION ADHERENCE	In this year's Advances in Asthma review, we discuss viral infections in asthmatic patients and potential therapeutic agents, the microbiome, novel genetic associations with asthma, air quality and climate effects on asthma, exposures during development and long-term sequelae of childhood asthma, patient-centered outcomes research, and precision medicine. In addition, we discuss application of biomarkers to precision medicine and new information on asthma medications. New evidence indicates that rhinovirus-triggered asthma exacerbations become more severe as the degree of sensitization to dust mite and mouse increase. The 2 biggest drivers of asthma severity are an allergy pathway starting with allergic sensitization and an environmental tobacco smoke pathway. In addition, allergic sensitization and blood eosinophils can be used to select medications for management of early asthma in young children. These current findings, among others covered in this review, represent significant steps toward addressing rapidly advancing areas of knowledge that have implications for asthma management.	[Anderson, William C., III; Dutmer, Cullen M.; Searing, Daniel A.] Childrens Hosp Colorado, Allergy & Immunol Sect, Aurora, CO USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA; [Szefler, Stanley J.] Childrens Hosp Colorado, Pulm Med Sect, Aurora, CO USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Aurora, CO USA; [Apter, Andrea J.] Univ Penn, Perelman Sch Med, Sect Allergy & Immunol, Philadelphia, PA 19104 USA	Children's Hospital Colorado; Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine	Szefler, SJ (corresponding author), Childrens Hosp Colorado, Breathing Inst, Asthma Res Program, Sect Pulm Med, 13123 E 16th Ave,Box 395, Aurora, CO 80045 USA.	Stanley.Szefler@childrenscolorado.org		Szefler, Stanley/0000-0002-6911-3199	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	S. J. Szefler serves as a consultant for Roche, AstraZeneca, Aerocrine, Daiichi Sankyo, Boehringer Ingelheim, Merck, Genentech, Novartis, and Teva and receives grant support from GlaxoSmithKline. The rest of the authors declare that they have no relevant conflicts of interest.	Akdis CA, 2016, J ALLERGY CLIN IMMUN, V137, P1359, DOI 10.1016/j.jaci.2016.03.020; Anise A, 2016, J ALLERGY CLIN IMMUN, V138, P1503, DOI 10.1016/j.jaci.2016.10.003; Annesi-Maesano I, 2016, J ALLERGY CLIN IMMUN, V138, P57, DOI 10.1016/j.jaci.2016.02.043; [Anonymous], 2007, EXPERT PANEL REPORT; Bandoli G, 2016, J ALLERGY CLIN IMMUN, V138, P918, DOI 10.1016/j.jaci.2016.04.012; Bateman ED, 2016, J ALLERGY CLIN IMMUN, V138, P142, DOI 10.1016/j.jaci.2015.11.035; Berry A, 2016, J ALLERGY CLIN IMMUN, V137, P1317, DOI 10.1016/j.jaci.2016.03.009; Bos LD, 2016, J ALLERGY CLIN IMMUN, V138, P970, DOI 10.1016/j.jaci.2016.08.004; Braido F, 2016, J ALLER CL IMM-PRACT, V4, P823, DOI 10.1016/j.jaip.2016.03.002; Brandt EB, 2016, J ALLERGY CLIN IMMUN, V138, P924, DOI 10.1016/j.jaci.2016.03.037; Bryant-Stephens T, 2016, J ALLERGY CLIN IMMUN, V138, P1526, DOI 10.1016/j.jaci.2016.10.006; Butler MG, 2016, J ALLERGY CLIN IMMUN, V137, P710, DOI 10.1016/j.jaci.2015.09.057; Cohen RT, 2016, J ALLERGY CLIN IMMUN, V138, P1338, DOI 10.1016/j.jaci.2016.06.043; Costello RW, 2016, J ALLER CL IMM-PRACT, V4, P813, DOI 10.1016/j.jaip.2016.04.002; Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, V138, P76, DOI 10.1016/j.jaci.2015.11.027; den Dekker HT, 2016, J ALLERGY CLIN IMMUN, V137, P1026, DOI 10.1016/j.jaci.2015.08.050; Denner DR, 2016, J ALLERGY CLIN IMMUN, V137, P1398, DOI 10.1016/j.jaci.2015.10.017; Ducharme FM, 2016, LANCET RESP MED, V4, P990, DOI 10.1016/S2213-2600(16)30160-6; Dunn RM, 2016, J ALLERGY CLIN IMMUN, V137, P1370, DOI 10.1016/j.jaci.2016.03.004; Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055; Engelkes M, 2016, PEDIAT ALLERG IMM-UK, V27, P201, DOI 10.1111/pai.12507; Fitzpatrick AM, 2016, J ALLERGY CLIN IMMUN, V138, P1608, DOI 10.1016/j.jaci.2016.09.028; Galli SJ, 2016, J ALLERGY CLIN IMMUN, V137, P1289, DOI 10.1016/j.jaci.2016.03.006; Gauvreau GM, 2016, J ALLERGY CLIN IMMUN, V138, P1051, DOI 10.1016/j.jaci.2016.02.027; Gonem S, 2016, J ALLERGY CLIN IMMUN, V137, P417, DOI 10.1016/j.jaci.2015.06.027; Granell R, 2016, J ALLERGY CLIN IMMUN, V138, P1060, DOI 10.1016/j.jaci.2016.01.046; Hamelmann E, 2016, J ALLERGY CLIN IMMUN, V138, P441, DOI 10.1016/j.jaci.2016.01.011; Han MY, 2016, J ALLERGY CLIN IMMUN, V138, P1619, DOI 10.1016/j.jaci.2016.01.037; Hartley RA, 2016, J ALLERGY CLIN IMMUN, V137, P1413, DOI 10.1016/j.jaci.2016.02.001; Hinks TSC, 2016, J ALLERGY CLIN IMMUN, V138, P61, DOI 10.1016/j.jaci.2015.11.020; Jackson DJ, 2016, J ALLERGY CLIN IMMUN, V137, P659, DOI 10.1016/j.jaci.2016.01.002; Johansson MW, 2016, J ALLERGY CLIN IMMUN, V137, P1904, DOI 10.1016/j.jaci.2015.12.1346; Kantor DB, 2016, J ALLERGY CLIN IMMUN, V138, P1467, DOI 10.1016/j.jaci.2016.04.044; Keet CA, 2017, J ALLERGY CLIN IMMUN; Kramer CB, 2016, J ALLERGY CLIN IMMUN, V138, P1600, DOI 10.1016/j.jaci.2016.10.011; Krishnan JA, 2011, J ALLERGY CLIN IMMUN, V127, P123, DOI 10.1016/j.jaci.2010.08.032; Laforest L, 2016, J ALLER CL IMM-PRACT, V4, P890, DOI 10.1016/j.jaip.2016.07.008; Lee A, 2016, J ALLERGY CLIN IMMUN, V138, P740, DOI 10.1016/j.jaci.2016.01.014; Lemanske RF, 2016, J ALLERGY CLIN IMMUN, V138, P711, DOI 10.1016/j.jaci.2016.06.015; Liptzin DR, 2016, J ALLER CL IMM-PRACT, V4, P972, DOI 10.1016/j.jaip.2016.04.016; Liu AH, 2016, J ALLERGY CLIN IMMUN, V138, P1042, DOI 10.1016/j.jaci.2016.06.060; Liu AH, 2016, J ALLERGY CLIN IMMUN, V138, P397, DOI 10.1016/j.jaci.2016.06.013; Lynch JP, 2016, J ALLERGY CLIN IMMUN, V138, P1326, DOI 10.1016/j.jaci.2016.02.039; Maes T, 2016, J ALLERGY CLIN IMMUN, V137, P1433, DOI 10.1016/j.jaci.2016.02.018; Magnus MC, 2016, J ALLERGY CLIN IMMUN, V138, P1319, DOI 10.1016/j.jaci.2016.02.032; Malinovschi A, 2016, J ALLERGY CLIN IMMUN, V138, P1301, DOI 10.1016/j.jaci.2016.01.044; Mansbach JM, 2016, J ALLERGY CLIN IMMUN, V137, P1909, DOI 10.1016/j.jaci.2016.01.036; Martin MA, 2016, J ALLERGY CLIN IMMUN, V138, P1518, DOI 10.1016/j.jaci.2016.10.012; Massoud AH, 2016, NAT MED, V22, P1013, DOI 10.1038/nm.4147; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; McGeachie MJ, 2016, AM J RESP CRIT CARE, V194, P1465, DOI 10.1164/rccm.201602-0250OC; Merchant RK, 2016, J ALLER CL IMM-PRACT, V4, P455, DOI 10.1016/j.jaip.2015.11.022; Michils A, 2016, J ALLERGY CLIN IMMUN, V137, P806, DOI 10.1016/j.jaci.2015.09.054; Miller EK, 2016, J ALLERGY CLIN IMMUN, V137, P734, DOI 10.1016/j.jaci.2015.06.017; Morita H, 2016, J ALLERGY CLIN IMMUN, V138, P1253, DOI 10.1016/j.jaci.2016.09.011; Muraro A, 2016, J ALLERGY CLIN IMMUN, V137, P1347, DOI 10.1016/j.jaci.2016.03.010; Naessens T, 2016, J ALLERGY CLIN IMMUN, V137, P700, DOI 10.1016/j.jaci.2015.09.031; Noguchi T, 2016, J ALLERGY CLIN IMMUN, V138, P1449, DOI 10.1016/j.jaci.2016.05.020; Owens L, 2016, J ALLERGY CLIN IMMUN, V137, P1605, DOI 10.1016/j.jaci.2015.10.030; Ownby DR, 2015, J ALLERGY CLIN IMMUN, V136, P595, DOI 10.1016/j.jaci.2015.02.007; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Perez L, 2016, J ALLERGY CLIN IMMUN, V138, P1593, DOI 10.1016/j.jaci.2016.08.043; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; Pongracic JA, 2016, J ALLERGY CLIN IMMUN, V138, P1030, DOI 10.1016/j.jaci.2016.06.059; Pralong JA, 2016, J ALLERGY CLIN IMMUN, V137, P412, DOI 10.1016/j.jaci.2015.06.026; Rider CF, 2016, J ALLERGY CLIN IMMUN, V138, P1690, DOI 10.1016/j.jaci.2016.02.038; Sarnowski C, 2016, J ALLERGY CLIN IMMUN, V138, P1071, DOI 10.1016/j.jaci.2016.03.018; Schieck M, 2016, J ALLERGY CLIN IMMUN, V138, P421, DOI 10.1016/j.jaci.2015.12.1305; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Schultz ES, 2016, J ALLERGY CLIN IMMUN, V138, P930, DOI 10.1016/j.jaci.2016.04.014; Shelef DQ, 2016, J ALLERGY CLIN IMMUN, V138, P1512, DOI 10.1016/j.jaci.2016.10.001; Siroux V, 2016, J ALLERGY CLIN IMMUN, V137, P1709, DOI 10.1016/j.jaci.2015.10.029; Skevaki C, 2016, J ALLERGY CLIN IMMUN, V137, P1302, DOI 10.1016/j.jaci.2016.03.012; Somineni HK, 2016, J ALLERGY CLIN IMMUN, V137, P797, DOI 10.1016/j.jaci.2015.10.021; Spahn JD, 2016, J ALLERGY CLIN IMMUN, V138, P1296, DOI 10.1016/j.jaci.2016.09.002; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Stempel DA, 2016, NEW ENGL J MED, V375, P840, DOI 10.1056/NEJMoa1606356; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049; Stier MT, 2016, J ALLERGY CLIN IMMUN, V138, P814, DOI 10.1016/j.jaci.2016.01.050; Sulaiman I, 2016, J ALLER CL IMM-PRACT, V4, P900, DOI 10.1016/j.jaip.2016.07.009; Sverrild A, 2016, J ALLERGY CLIN IMMUN; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Szentpetery SE, 2016, J ALLERGY CLIN IMMUN, V138, P1556, DOI 10.1016/j.jaci.2016.08.047; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V135, P1465, DOI 10.1016/j.jaci.2014.12.1942; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Turner S, 2016, J ALLERGY CLIN IMMUN, V138, P107, DOI 10.1016/j.jaci.2015.10.045; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; von Mutius E, 2016, J ALLERGY CLIN IMMUN, V137, P680, DOI 10.1016/j.jaci.2015.12.1301; Wells KE, 2016, J ALLERGY CLIN IMMUN, V137, P1364, DOI 10.1016/j.jaci.2015.12.1334; Yang CW, 2016, CELL, V164, P141, DOI 10.1016/j.cell.2015.11.052; Yang Q, 2016, J ALLERGY CLIN IMMUN, V137, P571, DOI 10.1016/j.jaci.2015.06.037; Zeiger RS, 2017, J ALLER CL IMM-PRACT, V5, P144, DOI 10.1016/j.jaip.2016.07.015; Zoratti EM, 2016, J ALLERGY CLIN IMMUN, V138, P1016, DOI 10.1016/j.jaci.2016.06.061	93	15	15	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2017	140	3					671	680		10.1016/j.jaci.2017.06.015	http://dx.doi.org/10.1016/j.jaci.2017.06.015			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FF8CA	28709967	Bronze			2022-12-18	WOS:000409241500005
J	MacGlashan, DW; Saini, SS				MacGlashan, Donald W., Jr.; Saini, Sarbjit S.			Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							SEVERE ALLERGIC-ASTHMA; FC-EPSILON-RI; POPULATION		[MacGlashan, Donald W., Jr.; Saini, Sarbjit S.] Johns Hopkins Univ, Div Clin Allergy & Immunol, Baltimore, MD USA	Johns Hopkins University	MacGlashan, DW (corresponding author), Johns Hopkins Univ, Div Clin Allergy & Immunol, Baltimore, MD USA.	macglas@jhmi.edu			Novartis; Teva; Astra Zeneca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100952] Funding Source: NIH RePORTER	Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Astra Zeneca(AstraZeneca); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D. W. MacGlashan's institution has received a grant from Novartis for the work under consideration. S. S. Saini's institution has received a grant from Novartis for the work under consideration; has personally received consultancy fees from Teva and Astra Zeneca; and personally receives royalties from UpToDate.	Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Bousquet J, 2007, RESP MED, V101, P1483, DOI 10.1016/j.rmed.2007.01.011; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, P889, DOI 10.1016/j.jaci.2009.09.012; Ishmael S, 2009, J LEUKOCYTE BIOL, V86, P313, DOI 10.1189/jlb.1208724; MacGlashan DW, 2008, J IMMUNOL, V180, P4208, DOI 10.4049/jimmunol.180.6.4208; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MacGlashan DW, 2012, J ALLERGY CLIN IMMUN, V130, P1130, DOI 10.1016/j.jaci.2012.05.038; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1	11	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1680	+		10.1016/j.jaci.2016.12.965	http://dx.doi.org/10.1016/j.jaci.2016.12.965			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28259446	Bronze			2022-12-18	WOS:000400465300030
J	Semprini, R; Caswell-Smith, R; Fingleton, J; Holweg, C; Matthews, J; Weatherall, M; Beasley, R; Braithwaite, I				Semprini, Ruth; Caswell-Smith, Rachel; Fingleton, James; Holweg, Cecile; Matthews, John; Weatherall, Mark; Beasley, Richard; Braithwaite, Irene		Periostin Study Team	Longitudinal variation of serum periostin levels in adults with stable asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STANDARDIZATION		[Semprini, Ruth; Caswell-Smith, Rachel; Fingleton, James; Beasley, Richard; Braithwaite, Irene] Med Res Inst New Zealand, Wellington, New Zealand; [Semprini, Ruth; Caswell-Smith, Rachel; Beasley, Richard; Braithwaite, Irene] Victoria Univ Wellington, Fac Biol Sci, Wellington, New Zealand; [Holweg, Cecile; Matthews, John] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA; [Weatherall, Mark] Univ Otago, Dept Med, Dunedin, New Zealand	Medical Research Institute Of New Zealand; Victoria University Wellington; Roche Holding; Genentech; University of Otago	Semprini, R (corresponding author), Med Res Inst New Zealand, Wellington, New Zealand.; Semprini, R (corresponding author), Victoria Univ Wellington, Fac Biol Sci, Wellington, New Zealand.	ruth.semprini@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019	Weatherall, Mark/0000-0002-0051-9107; Fingleton, James/0000-0001-9148-196X; Semprini, Ruth/0000-0001-5449-0744	Genentech	Genentech(Roche HoldingGenentech)	Supported by Genentech. This study was approved by the New Zealand Health and Disability Ethics committee (13/NTB/185). This study was prospectively registered with Australia and New Zealand Clinical Trials Register (ACTRN12614000235606).	[Anonymous], 2006, AM J RESP CRIT CARE, V173, P811, DOI 10.1164/rrcm.2061014; Caswell-Smith R, 2016, CLIN EXP ALLERGY, V46, P1303, DOI 10.1111/cea.12763; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Fingleton J, 2016, EUR RESPIR J, V47, P1383, DOI 10.1183/13993003.01384-2015; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; Jia GQ, 2012, J ALLERGY CLIN IMMUN, V130, P647, DOI 10.1016/j.jaci.2012.06.025; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Wenzel S, 2016, EUR RESP J S60, V48, P1798	12	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2017	139	5					1687	+		10.1016/j.jaci.2016.11.041	http://dx.doi.org/10.1016/j.jaci.2016.11.041			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ET7HI	28093216	Bronze			2022-12-18	WOS:000400465300033
J	Lau, A; Lester, S; Moraitis, S; Ou, J; Psaltis, AJ; McColl, S; Rischmueller, M; Wormald, PJ; Vreugde, S				Lau, Aden; Lester, Susan; Moraitis, Sophia; Ou, Judy; Psaltis, Alkis J.; McColl, Shaun; Rischmueller, Maureen; Wormald, Peter-John; Vreugde, Sarah			Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NASAL POLYPS; TISSUE		[Lau, Aden; Moraitis, Sophia; Ou, Judy; Psaltis, Alkis J.; Wormald, Peter-John; Vreugde, Sarah] Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia; [Lester, Susan; Rischmueller, Maureen] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA, Australia; [Lester, Susan; Rischmueller, Maureen] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [McColl, Shaun] Univ Adelaide, Dept Mol & Cell Biol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide	Vreugde, S (corresponding author), Univ Adelaide, Dept Surg Otolaryngol Head & Neck Surg, Adelaide, SA, Australia.	sarah.vreugde@adelaide.edu.au		Ou, Judy/0000-0002-3085-5814; Vreugde, Sarah/0000-0003-4719-9785; Psaltis, Alkis/0000-0003-2967-1855	National Health and Medical Research Council; ENT Technologies; Aerin Medical Devices; Smith and Nephew; Garnett Passe and Rodney Williams Memorial Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ENT Technologies; Aerin Medical Devices; Smith and Nephew; Garnett Passe and Rodney Williams Memorial Foundation	S. Moraitis, A. J. Psaltis, P.-J. Wormald, S. Vreugde, and S. McColl are employed by the University of Adelaide. S. McColl's institution has received a grant from the National Health and Medical Research Council. A. J. Psaltis has received consultancy fees from ENT Technologies and Aerin Medical Devices and payment for lectures from Smith and Nephew. S. Vreugde and P.-J. Wormald's institution has received a grant from Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant 2014-2016 for this work. The rest of the authors declare that they have no relevant conflicts of interest.	Blackwell Debra L, 2014, Vital Health Stat 10, P1; Desrosiers M, 2004, CURR ALLERGY ASTHM R, V4, P200, DOI 10.1007/s11882-004-0027-z; Gevaert P, 2005, ALLERGY, V60, P71, DOI 10.1111/j.1398-9995.2004.00621.x; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; Huvenne W, 2009, CURR ALLERGY ASTHM R, V9, P213, DOI 10.1007/s11882-009-0031-4; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Patadia M, 2010, AM J RHINOL ALLERGY, V24, P11, DOI 10.2500/ajra.2010.24.3386	9	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2017	139	4					1371	1373		10.1016/j.jaci.2016.08.052	http://dx.doi.org/10.1016/j.jaci.2016.08.052			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ER4LR	27780741	Bronze			2022-12-18	WOS:000398771800032
J	Al-Mousa, H; Hawwari, A; Al-Ghonaium, A; Al-Saud, B; Al-Dhekri, H; Al-Muhsen, S; Elshorbagi, S; Dasouki, M; El-Baik, L; Alseraihy, A; Ayas, M; Arnaout, R				Al-Mousa, Hamoud; Hawwari, Abbas; Al-Ghonaium, Abdulaziz; Al-Saud, Bandar; Al-Dhekri, Hasan; Al-Muhsen, Saleh; Elshorbagi, Sahar; Dasouki, Majed; El-Baik, Lina; Alseraihy, Amal; Ayas, Mouhab; Arnaout, Rand			Hematopoietic stem cell transplantation corrects WIP deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							WISKOTT-ALDRICH-SYNDROME; WASP		[Al-Mousa, Hamoud; Al-Ghonaium, Abdulaziz; Al-Saud, Bandar; Al-Dhekri, Hasan; Al-Muhsen, Saleh; Elshorbagi, Sahar; Arnaout, Rand] King Faisal Specialist Hosp & Res Ctr, Pediat Allergy & Clin Immunol, Riyadh, Saudi Arabia; [Al-Mousa, Hamoud; Al-Saud, Bandar; Arnaout, Rand] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Al-Mousa, Hamoud; Dasouki, Majed; El-Baik, Lina] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Al-Saud, Bandar] King Khalid Univ Hosp, Pediat Hematol & Oncol, Riyadh, Saudi Arabia; [Alseraihy, Amal; Ayas, Mouhab] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol & Oncol, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Faisal Specialist Hospital & Research Center	Al-Mousa, H (corresponding author), King Faisal Specialist Hosp & Res Ctr, Pediat Allergy & Clin Immunol, Riyadh, Saudi Arabia.; Al-Mousa, H (corresponding author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.; Al-Mousa, H (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh, Saudi Arabia.	hamoudalmousa@kfshrc.edu.sa	Al-Mousa, Hamoud/AAS-4477-2020; Al-muhsen, saleh/E-9315-2014; Hawwari, Abbas/L-1934-2019	Al-muhsen, saleh/0000-0003-3698-9968; Hawwari, Abbas/0000-0001-9643-6500	National Science, Technology and Innovation Plan program in the Kingdom of Saudi Arabia [KACST: 11-BIO-1441-20]	National Science, Technology and Innovation Plan program in the Kingdom of Saudi Arabia	We thank the patients and their families for their trust and cooperation and the nurses and the clinicians for the care of patients. Molecular genetic studies were supported by the National Science, Technology and Innovation Plan program in the Kingdom of Saudi Arabia (KACST: 11-BIO-1441-20).	Lanzi G, 2012, J EXP MED, V209, P29, DOI 10.1084/jem.20110896; Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049; Moratto D, 2011, BLOOD, V118, P1675, DOI 10.1182/blood-2010-11-319376; Ozsahin H, 2008, BLOOD, V111, P439, DOI 10.1182/blood-2007-03-076679; Ramesh N, 2009, IMMUNOL RES, V44, P99, DOI 10.1007/s12026-008-8086-1	5	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2017	139	3					1039	1040		10.1016/j.jaci.2016.08.036	http://dx.doi.org/10.1016/j.jaci.2016.08.036			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EP3QC	27742395	Bronze			2022-12-18	WOS:000397295800039
J	Sabato, V; Van Gasse, A; Cop, N; Claesen, K; Decuyper, II; Faber, MA; Bridts, C; Mertens, C; Hagendorens, M; De Clerck, L; Ebo, DG				Sabato, Vito; Van Gasse, Athina; Cop, Nathalie; Claesen, Karen; Decuyper, Ine I.; Faber, Margaretha A.; Bridts, Chris; Mertens, Christel; Hagendorens, Margo; De Clerck, Luc; Ebo, Didier G.			The Mas-Related G Protein-Coupled Receptor MRGPRX2 Is Expressed on Human Basophils and up-Regulated upon Activation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 03-16, 2017	Atlanta, GA	Amer Acad Allergy, Asthma & Immunol					[Sabato, Vito; Van Gasse, Athina; Cop, Nathalie; Claesen, Karen; Decuyper, Ine I.; Faber, Margaretha A.; Bridts, Chris; Mertens, Christel; Hagendorens, Margo; De Clerck, Luc; Ebo, Didier G.] Univ Antwerp, Immunol Allergol & Rheumatol, Antwerp, Belgium	University of Antwerp			Mertens, Christel/T-8085-2017; BRIDTS, Chris HM/M-7933-2016; Sabato, Vito/B-6479-2017	Mertens, Christel/0000-0003-2359-0771; BRIDTS, Chris HM/0000-0002-3324-7320; Sabato, Vito/0000-0002-1321-314X					0	15	15	1	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2		S		536	AB168	AB168		10.1016/j.jaci.2016.12.550	http://dx.doi.org/10.1016/j.jaci.2016.12.550			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	EV4AF		Bronze			2022-12-18	WOS:000401699800438
J	Wahlstrom, J; Patel, K; Eckhert, E; Kong, D; Horn, B; Cowan, MJ; Dvorak, CC				Wahlstrom, Justin; Patel, Kiran; Eckhert, Erik; Kong, Denice; Horn, Biljana; Cowan, Morton J.; Dvorak, Christopher C.			Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe combined immunodeficiency; transplant; hematopoietic stem cell transplantation; maternal; engraftment; graft-versus-host disease; graft-versus-host; haploidentical; conditioning	STEM-CELL TRANSPLANTATION; IMMUNE RECONSTITUTION; BONE-MARROW; T-CELLS; DONOR; MANIFESTATIONS; CRITERIA; MOTHER	Background: Graft-versus-host disease (GVHD) is a complication of allogeneic hematopoietic stem cell transplantation (HSCT). Transplacental maternal engraftment (TME), the presence of maternal T cells in peripheral blood before transplantation, is detectable in a significant proportion of patients with severe combined immunodeficiency (SCID). Although the presence of TME is associated with a decreased risk of rejecting a maternal graft, it is unknown whether TME plays a role in development of GVHD after HSCT. Objective: The purpose of this study was to determine whether the presence of pretransplantation TME is associated with posttransplantation GVHD in patients with SCID. Methods: This was an institutional retrospective review of 74 patients with SCID undergoing transplantation between 1988 and 2014. The incidence of acute graft-versus-host disease (aGVHD) was compared in patients with versus those without TME. Confounding variables, such as donor type and conditioning regimen, were included in a multivariate regression model. Results: TME was identified in 35 of 74 children. Post-HSCT aGVHD developed with an incidence of 57.1% versus 17.9% in those without TME (P < .001). In univariate analysis donor type (mother) and GVHD prophylaxis (T-cell depletion) were also significant predictors of aGVHD. In multivariate analysis TME and chemotherapy conditioning were independent risk factors for the development of aGVHD (relative risk, 2.75, P = .006 and relative risk, 1.42, P = .02, respectively). Conclusion: TME independently predicts the development of posttransplantation aGVHD, even when controlling for donor type and conditioning used. The presence of TME should be considered when assessing the risk of aGVHD in patients with SCID and designing the approach for GVHD prophylaxis.	[Wahlstrom, Justin; Patel, Kiran; Horn, Biljana; Cowan, Morton J.; Dvorak, Christopher C.] Univ Calif San Francisco, Dept Pediat, Div Pediat Allergy Immunol & Bone Marrow Transpla, San Francisco, CA 94143 USA; [Eckhert, Erik] Univ Calif San Francisco Univ Calif Berkeley Join, San Francisco, CA USA; [Kong, Denice] Univ Calif San Francisco, Dept Surg, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wahlstrom, J (corresponding author), Dept Clin Pediat, 550 16th St,4th Floor,Mailstop 0434, San Francisco, CA 94143 USA.	Justin.wahlstrom@ucsf.edu	Dvorak, Christopher C/AAX-1630-2020	Dvorak, Christopher C/0000-0002-6146-3952; Wahlstrom, Justin/0000-0001-7998-8506	National Institute of Allergy and Infectious Disease (NIAID); National Center for Advancing Translational Sciences (NCATS) Office of Rare Disease Research (ORDR); Rare Disease Clinical Research Network (RDCRN) [U54-AI 082973, R13 AI 094943]; NIAID [U54AI082973]; National Institutes of Health ORDR; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI094943, U54AI082973] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences (NCATS) Office of Rare Disease Research (ORDR); Rare Disease Clinical Research Network (RDCRN); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health ORDR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants from the National Institute of Allergy and Infectious Disease (NIAID), the National Center for Advancing Translational Sciences (NCATS) Office of Rare Disease Research (ORDR), and the Rare Disease Clinical Research Network (RDCRN), U54-AI 082973 and R13 AI 094943. The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the US Government. Funding for M.J.C. and C.C.D. has been provided by grant #U54AI082973 from NIAID and the National Institutes of Health ORDR.	Ball LM, 2008, BONE MARROW TRANSPL, V41, pS58, DOI 10.1038/bmt.2008.56; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Ciurea SO, 2013, BIOL BLOOD MARROW TR, V19, P180, DOI 10.1016/j.bbmt.2012.08.007; Cutler C, 2008, BLOOD, V112, P4425, DOI 10.1182/blood-2008-07-169342; Denianke KS, 2001, BONE MARROW TRANSPL, V28, P227, DOI 10.1038/sj.bmt.1703128; DROR Y, 1993, BLOOD, V81, P2021; Dvorak CC, 2008, BIOL BLOOD MARROW TR, V14, P1125, DOI 10.1016/j.bbmt.2008.07.008; Dvorak CC, 2008, J PEDIAT HEMATOL ONC, V30, P396, DOI 10.1097/MPH.0b013e318168e7a0; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; Dvorak C, 2008, PEDIATR HEMAT ONCOL, V25, P705, DOI 10.1080/08880010802243524; Ferrara JLM, 2006, SEMIN HEMATOL, V43, P3, DOI 10.1053/j.seminhematol.2005.09.001; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Friedrich W, 2011, HEMATOL ONCOL CLIN N, V25, P31, DOI 10.1016/j.hoc.2010.11.003; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Lo YMD, 1996, BLOOD, V88, P4390; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; O'Reilly R J, 1989, Immunodefic Rev, V1, P273; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Palmer K, 2007, J ALLERGY CLIN IMMUN, V120, P423, DOI 10.1016/j.jaci.2007.02.047; Scaradavou A, 1996, BLOOD, V88, P1494, DOI 10.1182/blood.V88.4.1494.bloodjournal8841494; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; Stern M, 2008, BLOOD, V112, P2990, DOI 10.1182/blood-2008-01-135285; THOMPSON LF, 1984, J IMMUNOL, V133, P2513; Wahlstrom Justin T, 2015, Curr Pediatr Rep, V3, P1	27	15	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2017	139	2					628	+		10.1016/j.jaci.2016.04.049	http://dx.doi.org/10.1016/j.jaci.2016.04.049			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EO9IM	27444177	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000397002400028
J	Stein, JV; Gonzalez, SF				Stein, Jens V.; Gonzalez, Santiago F.			Dynamic intravital imaging of cell-cell interactions in the lymph node	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Intravital imaging; 2-photon microscopy; lymph node; cell trafficking; cell interaction	SUBCAPSULAR SINUS MACROPHAGES; FOLLICULAR DENDRITIC CELLS; HIGH ENDOTHELIAL VENULES; B-CELLS; IMMUNE-COMPLEXES; GERMINAL-CENTERS; T-CELLS; ANTIGEN; MIGRATION; ACTIVATION	In the last decade, the application of 2-photon intravital microscopy as a tool to study cell interactions in different areas of the immune system has offered an unprecedented opportunity to understand the complexity of cell behavior in relation to immune functions. In this review we describe the latest advances in the field of live imaging in the lymph nodes, grouping the different cell populations in 2 compartments according to their motility: the sessile compartment, which is formed by resident cells of stromal origin, macrophages, and resident dendritic cells, and the motile compartment, which is mainly formed by T and B lymphocytes. Here we review how the use of in vivo imaging has contributed to our understanding of the role of these cells in the initiation of the immune response in the draining lymph nodes.	[Stein, Jens V.] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Gonzalez, Santiago F.] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland	University of Bern; Universita della Svizzera Italiana	Gonzalez, SF (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	santiago.gonzalez@irb.usi.ch		F. Gonzalez, Santiago/0000-0003-4166-7664; Stein, Jens V/0000-0002-8199-9586	Swiss National Foundation grant [31003A_135649, CR23I3_156234, CRSII3_141918]; Swiss National Foundation (SNF) [145038, 148183]; European Commission Marie Curie Reintegration Grant [612742]	Swiss National Foundation grant(Swiss National Science Foundation (SNSF)); Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Commission Marie Curie Reintegration Grant(European CommissionEuropean Commission Joint Research Centre)	The Stein laboratory is supported by Swiss National Foundation grants 31003A_135649, CR23I3_156234, and CRSII3_141918. The Gonzalez laboratory is supported by Swiss National Foundation (SNF) grants R'equipt (145038) and Ambizione (148183), and a European Commission Marie Curie Reintegration Grant (612742).	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benson RA, 2015, ELIFE, V4, DOI 10.7554/eLife.06994; Brown FD, 2015, J IMMUNOL, V194, P1389, DOI 10.4049/jimmunol.1402520; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Farrell HE, 2015, J VIROL, V89, P7147, DOI 10.1128/JVI.00480-15; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2013, IMMUNITY, V39, P496, DOI 10.1016/j.immuni.2013.08.034; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Iezzi G, 2006, J IMMUNOL, V177, P1250, DOI 10.4049/jimmunol.177.2.1250; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kabashima K, 2003, NAT IMMUNOL, V4, P694, DOI 10.1038/ni943; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kastenmuller W, 2010, EUR J IMMUNOL, V40, P2103, DOI 10.1002/eji.201040482; Klauschen F, 2009, NAT PROTOC, V4, P1305, DOI 10.1038/nprot.2009.129; Kuka M, 2014, ANN NY ACAD SCI, V1319, P38, DOI 10.1111/nyas.12387; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Mandl JN, 2014, CURR OPIN IMMUNOL, V29, P8, DOI 10.1016/j.coi.2014.03.002; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Moalli F, 2014, J EXP MED, V211, P2507, DOI 10.1084/jem.20140137; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Niesner RA, 2011, CYTOM PART A, V79A, P789, DOI 10.1002/cyto.a.21140; Nitschke C, 2008, HISTOCHEM CELL BIOL, V130, P1053, DOI 10.1007/s00418-008-0520-x; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Sagoo P, 2016, NAT MED, V22, P64, DOI 10.1038/nm.4016; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; Vladymyrov M, 2016, J IMMUNOL METHODS, V438, P35, DOI 10.1016/j.jim.2016.08.004; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Winkelmann ER, 2014, VIROLOGY, V450, P278, DOI 10.1016/j.virol.2013.12.021; Woodruff MC, 2014, J EXP MED, V211, P1611, DOI 10.1084/jem.20132327; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	67	15	15	1	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					12	20		10.1016/j.jaci.2016.11.008	http://dx.doi.org/10.1016/j.jaci.2016.11.008			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	28065277	Bronze			2022-12-18	WOS:000393996800002
J	Brandt, EB; Hershey, GKK				Brandt, Eric B.; Hershey, Gurjit K. Khurana			A combination of dexamethasone and anti-IL-17A treatment can alleviate diesel exhaust particle-induced steroid insensitive asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CELLS		[Brandt, Eric B.; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Asthma Res, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hershey, GKK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Asthma Res, Cincinnati, OH 45229 USA.	Gurjit.Hershey@cchmc.org		Brandt, Eric/0000-0003-0617-4100	NHLBI NIH HHS [R01 HL097135] Funding Source: Medline; NIEHS NIH HHS [T32 ES010957] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES010957] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bell MC, 2013, J ALLER CL IMM-PRACT, V1, P110, DOI 10.1016/j.jaip.2013.01.005; Brandt EB, 2015, J ALLERGY CLIN IMMUN, V136, P295, DOI 10.1016/j.jaci.2014.11.043; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Helth Effects Institute,, 2010, 17 HEI; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Martin RA, 2014, RESPIROLOGY, V19, P823, DOI 10.1111/resp.12315; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089	9	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					924	+		10.1016/j.jaci.2016.03.037	http://dx.doi.org/10.1016/j.jaci.2016.03.037			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27264458	Green Accepted, Bronze			2022-12-18	WOS:000385496000038
J	Geary, SM; Morris, AS; Salem, AK				Geary, Sean M.; Morris, Angie S.; Salem, Aliasger K.			Assessing the effect of engineered nanomaterials on the environment and human health	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Nanomaterials	IN-VITRO; NANOPARTICLES; TOXICITY		[Geary, Sean M.; Morris, Angie S.; Salem, Aliasger K.] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA	University of Iowa	Salem, AK (corresponding author), Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA.; Salem, AK (corresponding author), Coll Pharm, 115 S Grand Ave,Rm 228, Iowa City, IA 52242 USA.	aliasger-salem@uiowa.edu			National Institutes of Health [P30 ES005605]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE023520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	A. K. Salem receives research support from the National Institutes of Health (P30 ES005605). The rest of the authors declare that they have no relevant conflicts of interest.	Cho WS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-55; Joshi VB, 2014, AAPS J, V16, P975, DOI 10.1208/s12248-014-9624-5; Juganson K, 2015, BEILSTEIN J NANOTECH, V6, P1788, DOI 10.3762/bjnano.6.183; Kuzmov A, 2015, J CONTROL RELEASE, V219, P500, DOI 10.1016/j.jconrel.2015.07.024; McKee MS, 2016, ENVIRON SCI-NANO, V3, P506, DOI 10.1039/c6en00007j; Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802; Morris AS, 2016, TOXICOL LETT, V241, P207, DOI 10.1016/j.toxlet.2015.11.006; Piccinno F, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1109-9; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; Wongrakpanich A, 2016, ENVIRON SCI-NANO, V3, P365, DOI 10.1039/c5en00271k	10	15	16	0	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					405	408		10.1016/j.jaci.2016.06.009	http://dx.doi.org/10.1016/j.jaci.2016.06.009			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27497279	Green Accepted, Bronze			2022-12-18	WOS:000380835800009
J	Kivisto, JE; Dunder, T; Protudjer, JLP; Karjalainen, J; Huhtala, H; Makela, MJ				Kivisto, Juho E.; Dunder, Teija; Protudjer, Jennifer L. P.; Karjalainen, Jussi; Huhtala, Heini; Makela, Mika J.			Adult but no pediatric anaphylaxis-related deaths in the Finnish population from 1996 to 2013	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASTHMA; VASCULOPATHY; ALLERGY		[Kivisto, Juho E.; Karjalainen, Jussi] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland; [Kivisto, Juho E.] Tampere Univ, Ctr Child Hlth Res, Tampere, Finland; [Kivisto, Juho E.] Univ Hosp, Tampere, Finland; [Kivisto, Juho E.; Protudjer, Jennifer L. P.] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Dunder, Teija] Univ Oulu, PEDEGO Res Ctr, Oulu, Finland; [Dunder, Teija] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Dunder, Teija] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Protudjer, Jennifer L. P.] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, Tampere, Finland; [Makela, Mika J.] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Makela, Mika J.] Univ Helsinki, Helsinki, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Karolinska Institutet; University of Oulu; University of Oulu; University of Oulu; Karolinska Institutet; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Kivisto, JE (corresponding author), Tampere Univ Hosp, Allergy Ctr, Tampere, Finland.; Kivisto, JE (corresponding author), Tampere Univ, Ctr Child Hlth Res, Tampere, Finland.; Kivisto, JE (corresponding author), Univ Hosp, Tampere, Finland.; Kivisto, JE (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.	juho.kivisto@uta.fi		D, Teija/0000-0002-5159-1256; Makela, Mika/0000-0002-2933-3111				Ben-Shoshan M, 2011, ALLERGY, V66, P1, DOI 10.1111/j.1398-9995.2010.02422.x; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kauppi P, 2013, THORAX, V68, P292, DOI 10.1136/thoraxjnl-2011-201028; Kivisto JE, 2016, ALLERGY, V71, P677, DOI 10.1111/all.12837; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Latvala J, 2005, BMJ-BRIT MED J, V330, P1186, DOI 10.1136/bmj.38448.603924.AE; Ma L, 2014, J ALLERGY CLIN IMMUN, V133, P1075, DOI 10.1016/j.jaci.2013.10.029; Malmstrom K, 2000, PEDIATR ALLERGY IMMU, V11, P236, DOI 10.1034/j.1399-3038.2000.00090.x; Sampson HA, 2006, ANN EMERG MED, V47, P373, DOI 10.1016/j.annemergmed.2006.01.018; Van Eyck L, 2015, J ALLERGY CLIN IMMUN, V135, P283, DOI 10.1016/j.jaci.2014.10.010; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	11	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					630	632		10.1016/j.jaci.2016.05.015	http://dx.doi.org/10.1016/j.jaci.2016.05.015			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27343204	Green Published, Bronze			2022-12-18	WOS:000380835800048
J	Resop, RS; Douaisi, M; Craft, J; Jachimowski, LCM; Blom, B; Uittenbogaart, CH				Resop, Rachel S.; Douaisi, Marc; Craft, Joshua; Jachimowski, Loes C. M.; Blom, Bianca; Uittenbogaart, Christel H.			Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sphingosine-1-phosphate; thymic egress; S1P-R1; S1P-R2; T-cell reconstitution; migration; thymus; human immunology	L-SELECTIN CD62L; SPHINGOSINE 1-PHOSPHATE; LYMPHOCYTE EGRESS; HUMAN THYMOCYTES; SPHINGOSINE-1-PHOSPHATE; FTY720; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; CONSTITUENT	Background: The mechanisms that govern the egress of mature thymocytes from the human thymus to the periphery remain understudied yet are of utmost importance to the field of basic immunology, as well as T-cell reconstitution in various immunodeficiencies. We examined the expression and function of sphingosine-1-phosphate (S1P) receptors in human thymocyte egress. Objectives: We aimed to determine whether S1P receptors (S1P-Rs) play a role in mature human thymocyte egress and to identify the thymocyte population or populations that express S1P-Rs and respond to S1P by migrating across a concentration gradient. Methods: Human thymocytes were exposed to S1P in Transwell plate migration assays coupled to flow cytometry to evaluate the response to S1P of thymocytes at different stages of maturation. Constitutive S1P-R expression was quantified by means of real-time PCR in sorted thymocyte subsets and flow cytometry. S1P-R1 and Kruppel-like factor 2 expression were monitored after S1P exposure by using flow cytometry and quantitative PCR. Results: S1P-R1 was the prevalent S1P receptor on mature human thymocytes (CD3(hi) CD27(+) CD69(-)), the population that also demonstrated the greatest response to S1P in migration assays. Pretreatment with FTY720, an S1P-R1 nonselective modulator significantly reduced migration and suggested a role for S1P-R2 in retaining thymocytes in the tissue. Lastly, surface S1P-R1 expression, as well S1PR1 and Kruppel-like factor 2 (KLF2) transcripts, were significantly decreased in mature thymocytes on exposure to S1P. Conclusion: Mature human thymocytes rely on S1P-R1 to migrate toward S1P. Taken in the context of murine work demonstrating that S1P is required for thymocyte egress to the periphery, our data highlight a new key chemokine for human thymocyte egress.	[Resop, Rachel S.; Douaisi, Marc; Craft, Joshua; Uittenbogaart, Christel H.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA; [Jachimowski, Loes C. M.; Blom, Bianca; Uittenbogaart, Christel H.] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Resop, Rachel S.; Uittenbogaart, Christel H.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Uittenbogaart, Christel H.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Douaisi, Marc] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	University of California System; University of California Los Angeles; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Rensselaer Polytechnic Institute	Uittenbogaart, CH (corresponding author), 615 Charles E Young Dr South,BSRB 173, Los Angeles, CA 90095 USA.	uittenbo@ucla.edu	Douaisi, Marc/AAI-5624-2020	Resop, Rachel/0000-0003-3833-2433	NIH [AI28697, CA-16042, 5T32HL086345-08]; National Institutes of Health (NIH) [R21 AI102771, R01 AI080564]; California HIV/AIDS Research Program (CHRP), Dissertation Fellowship [D13-LA-394]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102771, R01AI080564, P30AI028697] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program (CHRP), Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institutes of Health (NIH; R21 AI102771 and R01 AI080564 to C.H.U.) and by the California HIV/AIDS Research Program (CHRP), Dissertation Fellowship (D13-LA-394), and NIH T32 (5T32HL086345-08; to R.S.R.). The services of the UCLA CFAR Cores for Flow Cytometry and Virology were supported by NIH-AI28697, and those of the UCLA Tissue Procurement Core were supported by NIH-CA-16042.	Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Colantonio AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024252; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Fang RHT, 2008, AIDS, V22, P171, DOI 10.1097/QAD.0b013e3282f2589b; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Gurney KB, 2004, J IMMUNOL, V173, P7269, DOI 10.4049/jimmunol.173.12.7269; Gurney KB, 2006, CLIN VACCINE IMMUNOL, V13, P1237, DOI 10.1128/CVI.00184-06; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; Hogquist KA, 2008, IMMUNOL CELL BIOL, V86, P297, DOI 10.1038/icb.2008.20; Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kohno T, 2008, GENES CELLS, V13, P747, DOI 10.1111/j.1365-2443.2008.01202.x; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666; Mudd JC, 2013, BLOOD, V121, P2914, DOI 10.1182/blood-2012-07-445783; Munro JM, 1996, J CLIN PATHOL, V49, P721, DOI 10.1136/jcp.49.9.721; Oskeritzian CA, 2015, MOL IMMUNOL, V63, P104, DOI 10.1016/j.molimm.2014.03.018; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Shannon LA, 2012, J BIOL CHEM, V287, P11656, DOI 10.1074/jbc.M111.310045; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sobel K, 2015, MOL PHARMACOL, V87, P916, DOI 10.1124/mol.114.097261; Spiegel S, 1998, BIOCHEMISTRY-MOSCOW+, V63, P69; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Uittenbogaart CH, 2000, AIDS, V14, P1317, DOI 10.1097/00002030-200007070-00003; UITTENBOGAART CH, 1994, THYMUS, V23, P155; VANHECKE D, 1995, J IMMUNOL, V155, P1862; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Yatomi Y, 1997, J BIOCHEM, V121, P969	50	15	19	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					551	+		10.1016/j.jaci.2015.12.1339	http://dx.doi.org/10.1016/j.jaci.2015.12.1339			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27056271	Green Accepted, Bronze			2022-12-18	WOS:000380835800027
J	Annesi-Maesano, I				Annesi-Maesano, Isabella			United Nations Climate Change Conferences: COP21 a lost opportunity for asthma and allergies and preparing for COP22	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Climate change; asthma; allergies; environmental	EXPOSURE		[Annesi-Maesano, Isabella] Univ Paris 06, Sorbonne Univ, Pierre Louis Inst Epidemiol & Publ Hlth IPLESP UM, Epidemiol Allerg & Resp Dis Dept EPAR,St Antonie, F-75252 Paris 05, France	UDICE-French Research Universities; Sorbonne Universite	Annesi-Maesano, I (corresponding author), INSERM, 27 Rue Chaligny, F-75571 Paris 12, France.; Annesi-Maesano, I (corresponding author), UPMC, IPLESP, Med Sch St Antoine, Epidemiol Allerg & Resp Dis, 27 Rue Chaligny, F-75571 Paris 12, France.	isabella.annesi-maesano@inserm.fr	Annesi-Maesano, Isabella/D-9173-2016	Annesi-Maesano, Isabella/0000-0002-6340-9300				Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Ayres JG, 2009, EUR RESPIR J, V34, P295, DOI 10.1183/09031936.00003409; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Cecchi L, 2010, ALLERGY, V65, P1073, DOI 10.1111/j.1398-9995.2010.02423.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; D'Amato G, 2016, CLIN EXP ALLERGY, V46, P390, DOI 10.1111/cea.12709; D'Amato G, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0073-0; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	10	15	15	0	20	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2016	138	1					57	+		10.1016/j.jaci.2016.02.043	http://dx.doi.org/10.1016/j.jaci.2016.02.043			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DR1IL	27373326	Bronze			2022-12-18	WOS:000379659100006
J	Schrautzer, C; Bokanovic, D; Hemmer, W; Lang, R; Hawranek, T; Schwarz, I; Aberer, W; Sturm, E; Sturm, GJ				Schrautzer, Christoph; Bokanovic, Danijela; Hemmer, Wolfgang; Lang, Roland; Hawranek, Thomas; Schwarz, Ines; Aberer, Werner; Sturm, Eva; Sturm, Gunter Johannes			Sensitivity and specificity of Hymenoptera allergen components depend on the diagnostic assay employed	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							API M 1; HONEYBEE VENOM ALLERGY; VES V 5; MAJOR ALLERGENS; WASP VENOM; IGE; SENSITIZATION; BEE		[Schrautzer, Christoph; Bokanovic, Danijela; Schwarz, Ines; Aberer, Werner; Sturm, Eva; Sturm, Gunter Johannes] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria; [Hemmer, Wolfgang] Floridsdorf Allergy Ctr, Vienna, Austria; [Lang, Roland; Hawranek, Thomas] Paracelsus Private Med Univ, Dept Dermatol, Salzburg, Austria; [Sturm, Gunter Johannes] Allergy Outpatient Clin, Reumannpl, Vienna, Austria	Medical University of Graz; Paracelsus Private Medical University	Sturm, GJ (corresponding author), Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria.; Sturm, GJ (corresponding author), Allergy Outpatient Clin, Reumannpl, Vienna, Austria.	gunter.sturm@medunigraz.at		Sturm, Eva/0000-0003-4898-884X				Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Kohler J, 2014, J ALLERGY CLIN IMMUN, V133, P1383, DOI 10.1016/j.jaci.2013.10.060; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Muller U, 2012, ALLERGY, V67, P1069, DOI 10.1111/j.1398-9995.2012.02847.x; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Sturm GJ, 2012, J ALLERGY CLIN IMMUN, V130, P817, DOI 10.1016/j.jaci.2012.05.047; Sturm GJ, 2011, J ALLERGY CLIN IMMUN, V128, P247, DOI 10.1016/j.jaci.2011.02.021	7	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1603	1605		10.1016/j.jaci.2015.10.041	http://dx.doi.org/10.1016/j.jaci.2015.10.041			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	26768412	Bronze			2022-12-18	WOS:000376180200041
J	Cooper, PJ; Chico, ME; Amorim, LD; Sandoval, C; Vaca, M; Strina, A; Campos, AC; Rodrigues, LC; Barreto, ML; Strachan, DP				Cooper, Philip J.; Chico, Martha E.; Amorim, Leila D.; Sandoval, Carlos; Vaca, Maritza; Strina, Agostino; Campos, Ana Clara; Rodrigues, Laura C.; Barreto, Mauricio L.; Strachan, David P.			Effects of maternal geohelminth infections on allergy in early childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Geohelminths; maternal infections; atopy; wheeze; eczema; early childhood	INTESTINAL PARASITE INFECTION; SKIN-TEST REACTIVITY; HELMINTH-PARASITES; CONTROLLED TRIAL; HAY-FEVER; ASTHMA; ECZEMA; HYGIENE; ATOPY; ENVIRONMENT	Background: Maternal geohelminth infections during pregnancy may protect against allergy development in childhood. Objective: We sought to investigate the effect of maternal geohelminths on the development of eczema, wheeze, and atopy during the first 3 years of life. Methods: A cohort of 2404 neonates was followed to 3 years of age in a rural district in coastal Ecuador. Data on wheeze and eczema were collected by means of questionnaire and physical examination at 13, 24, and 36 months of age. Atopy was measured based on skin prick test (SPT) reactivity to 9 allergens at 36 months. Maternal stool samples were examined for geohelminths by microscopy. Data on potential confounders was collected after birth by questionnaire. Results: Geohelminths were observed in 45.9% of mothers. Eczema and wheeze were reported for 17.7% and 25.9%, respectively, of 2069 (86.1%) children with complete follow-up to 3 years, and allergen SPT reactivity to any allergen was present in 17.2% and to house dust mite in 8.7%. Maternal geohelminth infections were not significantly associated with eczema (adjusted odds ratio [OR], 1.26; 95% CI, 0.98-1.61), wheeze (adjusted OR, 1.02; 95% CI, 0.82-1.27), and SPT reactivity to any allergen (adjusted OR, 0.79; 95% CI, 0.61-1.01). In subgroup analyses maternal geohelminths were associated with a significantly reduced risk of SPT reactivity to mite and other perennial allergens, and maternal ascariasis was associated with an increased risk of eczema and reduced risk of SPT reactivity to all allergens. Conclusion: Our data do not support a protective effect of maternal infections with geohelminth parasites during pregnancy against the development of eczema and wheeze in early childhood, although there was evidence in subgroup analyses for a reduction in SPT reactivity to house dust mites and perennial allergens.	[Cooper, Philip J.; Chico, Martha E.; Sandoval, Carlos; Vaca, Maritza] Lab Invest FEPIS, Ave Via Guayllabamba, Quininde, Ecuador; [Cooper, Philip J.] Pontificia Univ Catolica Ecuador, Ctr Invest Enfermedades Infecciosas, Quito, Ecuador; [Cooper, Philip J.] St Georges Univ London, Inst Infect & Immun, London, England; [Strachan, David P.] St Georges Univ London, Inst Publ Hlth Sci, London, England; [Amorim, Leila D.; Strina, Agostino; Campos, Ana Clara; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Rua Basilio Gama, Salvador, BA, Brazil; [Rodrigues, Laura C.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	Pontificia Universidad Catolica del Ecuador; St Georges University London; St Georges University London; Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine	Cooper, PJ (corresponding author), Casilla 17-22-20418, Quito, Ecuador.	pcooper@sgul.ac.uk	Amorim, Leila/ABG-9480-2021; Barreto, Mauricio L/B-1752-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Amorim, Leila/0000-0002-1112-2332; Barreto, Mauricio L/0000-0002-0215-4930; Cooper, Philip/0000-0002-6770-6871	Wellcome Trust [088862/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by Wellcome Trust grant 088862/Z/09/Z.	Amberbir A, 2011, AM J RESP CRIT CARE, V183, P165, DOI 10.1164/rccm.201006-0989OC; Barreto ML, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-167; Calvopina M., 1997, TERAPEUTICA ANTIPARA, V2; Cooper PJ, 2009, ALLERGY, V64, P5, DOI 10.1111/j.1398-9995.2008.01902.x; Cooper PJ, 2014, THORAX, V69, P232, DOI 10.1136/thoraxjnl-2013-203818; Cooper PJ, 2009, CURR OPIN ALLERGY CL, V9, P29, DOI 10.1097/ACI.0b013e32831f44a6; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Cooper PJ, 2014, INT J EPIDEMIOL 0702; Douwes J, 2008, EUR RESPIR J, V32, P603, DOI 10.1183/09031936.00033707; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elliott AM, 2005, JAMA-J AM MED ASSOC, V294, P2032, DOI 10.1001/jama.294.16.2032-c; Feary J, 2011, ALLERGY, V66, P569, DOI 10.1111/j.1398-9995.2010.02512.x; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; Leonardi-Bee J, 2006, AM J RESP CRIT CARE, V174, P514, DOI 10.1164/rccm.200603-331OC; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Menzies SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002718; Ministerio de Salud Publica del Ecuador, 2011, AT INT ENF PREV INF; Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x; Ndibazza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050325; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strina A, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-11; van den Biggelaar AHJ, 2004, J INFECT DIS, V189, P892, DOI 10.1086/381767; von Mutius E, 2010, CLIN EXP IMMUNOL, V160, P130, DOI 10.1111/j.1365-2249.2010.04138.x; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; WHO, 1985, DIAGN TECHN INT PAR; Williams HC, 2010, SO DO I DEFINE ATOPI; Wiria AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057899; Wlasiuk G, 2012, CURR OPIN ALLERGY CL, V12, P461, DOI 10.1097/ACI.0b013e328357a3bc	31	15	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					899	+		10.1016/j.jaci.2015.07.044	http://dx.doi.org/10.1016/j.jaci.2015.07.044			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26395817	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000371897500034
J	Weinberger, M; Hoegger, M				Weinberger, Miles; Hoegger, Mark			The cough without a cause: Habit cough syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN		[Weinberger, Miles] Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA USA; [Hoegger, Mark] Univ Iowa, Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa	Weinberger, M (corresponding author), Univ Iowa, Childrens Hosp, Dept Pediat, Iowa City, IA USA.	miles-weinberger@uiowa.edu	Hoegger, Mark/K-7926-2019; Weinberger, Miles/H-6743-2019					BERMAN BA, 1966, ANN ALLERGY, V24, P43; Cohlan SQ, 1984, PEDIATRICS, V74; LOKSHIN B, 1991, ANN ALLERGY, V67, P579; ROJAS A R, 1991, Annals of Allergy, V66, P106; Weinberger M, 2014, ALLERGY ASTHMA PROC, V35, P95, DOI 10.2500/aap.2014.35.3711	5	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2016	137	3					930	931		10.1016/j.jaci.2015.09.002	http://dx.doi.org/10.1016/j.jaci.2015.09.002			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DG2LB	26483178	Bronze			2022-12-18	WOS:000371897500038
J	Scala, E; Abeni, D; Pomponi, D; Paganelli, R; Locanto, M; Giani, M; Cecchi, L; Asero, R				Scala, Enrico; Abeni, Damiano; Pomponi, Debora; Paganelli, Roberto; Locanto, Maria; Giani, Mauro; Cecchi, Lorenzo; Asero, Riccardo			Ole e 1, Ole e 7, and Ole e 9: Identifying distinct clinical subsets of olive tree-allergic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CROSS-REACTIVITY; POLLEN; PROFILES		[Scala, Enrico; Pomponi, Debora; Locanto, Maria; Giani, Mauro] IDI IRCCS, Expt Allergy Unit, Rome, Italy; [Abeni, Damiano] IDI IRCCS, Hlth Serv Res Unit, Rome, Italy; [Paganelli, Roberto] Univ G dAnnunzio, Dept Med & Ageing Sci, Chieti, Italy; [Cecchi, Lorenzo] Univ Florence, Interdept Ctr Bioclimatol, Florence, Italy; [Cecchi, Lorenzo] Azienda Sanit Prato, Allergy & Clin Immunol Sect, Prato, Italy; [Asero, Riccardo] Clin San Carlo, Ambulatorio Allergol, Milan, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); G d'Annunzio University of Chieti-Pescara; University of Florence	Scala, E (corresponding author), IDI IRCCS, Expt Allergy Unit, Rome, Italy.	e.scala@idi.it	Paganelli, Roberto/AAF-5712-2020; Scala, Enrico/H-6997-2012; Abeni, Damiano/AAA-1401-2019	Scala, Enrico/0000-0002-9391-9168; Cecchi, Lorenzo/0000-0002-0658-2449				Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Huecas S, 2001, J BIOL CHEM, V276, P27959, DOI 10.1074/jbc.M103041200; Klemans RJB, 2013, J ALLER CL IMM-PRACT, V1, P632, DOI 10.1016/j.jaip.2013.07.014; Ledesma A, 1998, ALLERGY, V53, P520, DOI 10.1111/j.1398-9995.1998.tb04090.x; Palomares O, 2005, CLIN EXP ALLERGY, V35, P345, DOI 10.1111/j.1365-2222.2004.02186.x; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Scala E, 2015, ALLERGY, V70, P933, DOI 10.1111/all.12635; Tejera ML, 1999, J ALLERGY CLIN IMMUN, V104, P797, DOI 10.1016/S0091-6749(99)70290-3; Tordesillas L, 2011, INT ARCH ALLERGY IMM, V156, P291, DOI 10.1159/000323503	10	15	16	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2016	137	2					629	+		10.1016/j.jaci.2015.07.009	http://dx.doi.org/10.1016/j.jaci.2015.07.009			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DC5BN	26316094	Bronze			2022-12-18	WOS:000369235500039
J	Moon, KY; Lee, PH; Kim, BG; Park, CS; Leikauf, GD; Jang, AS				Moon, Kuk-Young; Lee, Pureun-Haneul; Kim, Byeong-Gon; Park, Choon-Sik; Leikauf, George D.; Jang, An-Soo			Claudin 5 in a murine model of allergic asthma: Its implication and response to steroid treatment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE; INJURY		[Moon, Kuk-Young; Lee, Pureun-Haneul; Kim, Byeong-Gon; Park, Choon-Sik; Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Bucheon, South Korea; [Leikauf, George D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Soonchunhyang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Moon, KY (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Genome Res Ctr Allergy & Resp Dis, Bucheon, South Korea.	jas877@schmc.ac.kr		Leikauf, George/0000-0002-4514-7060	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES015675] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES015675] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Dalmasso AP, 2014, J BIOL CHEM, V289, P838, DOI 10.1074/jbc.M113.455766; DeKruyff RH, 2014, IMMUNOL REV, V260, P235, DOI 10.1111/imr.12187; Harkness LM, 2015, PHARMACOL THERAPEUT, V148, P17, DOI 10.1016/j.pharmthera.2014.11.010; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Jang AS, 2012, KOREAN J INTERN MED, V27, P143, DOI 10.3904/kjim.2012.27.2.143; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Olivieri D, 2014, CHEM IMMUNOL ALLERGY, V99, P216, DOI 10.1159/000353307; Schlingmann B, 2015, SEMIN CELL DEV BIOL; Sun Y, 2013, ARCH MED SCI, V9, P361, DOI 10.5114/aoms.2013.33194	9	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2015	136	6					1694	1696		10.1016/j.jaci.2015.08.004	http://dx.doi.org/10.1016/j.jaci.2015.08.004			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CX9RZ	26409663				2022-12-18	WOS:000366044300036
J	Archila, LD; Jeong, D; Pascal, M; Bartra, J; Juan, M; Robinson, D; Farrington, ML; Kwok, WW				Diego Archila, Luis; Jeong, David; Pascal, Mariona; Bartra, Joan; Juan, Manel; Robinson, David; Farrington, Mary L.; Kwok, William W.			Jug r 2-reactive CD41 T cells have a dominant immune role in walnut allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; walnut; Jug r 2; T cells; MHC class II tetramers; epitopes	JUGLANS-REGIA; CENTRAL MEMORY; NONALLERGIC INDIVIDUALS; NATURAL-HISTORY; FOOD ALLERGEN; PEANUT; EXPRESSION; EFFECTOR; DIFFERENTIATION; IDENTIFICATION	Background: Allergic reactions to walnut can be life-threatening. Although IgE epitopes of walnut have been studied, CD4(+) T cell-specific epitopes for walnut remain uncharacterized. In particular, the relationship of both phenotype and frequency of walnut-specific T cells to the disease have not been examined. Objectives: We sought to provide a thorough phenotypic analysis for walnut-reactive T cells in allergic and nonallergic subjects, particularly the relationship of phenotypes and frequencies of walnut-specific T cells with the disease. Methods: The CD154 upregulation assay was used to examine CD4(+) T-cell reactivity toward the walnut allergens Jug r 1, Jug r 2, and Jug r 3. A tetramer-guided epitope mapping approach was used to identify HLA-restricted CD4(+) T-cell epitopes in Jug r 2. Direct ex vivo staining with peptide-major histocompatibility complex class II tetramers enabled comparison of the frequency and phenotype of Jug r 2-specific CD4(+) T cells between allergic and nonallergic subjects. Jug r 2-specific T-cell clones were also generated, and mRNA transcription factor levels were assessed by using quantitative RT-PCR. Intracellular cytokine staining assays were performed for further phenotypic analyses. Results: Jug r 2 was identified as the major allergen that elicited CD4(+) T-cell responses. Multiple Jug r 2 T-cell epitopes were identified. The majority of these T cells in allergic subjects have a CCR4(+) phenotype. A subset of these T cells express CCR4(+) CCR6(+) irrespective of the asthmatic status of the allergic subjects. Intracellular cytokine staining confirmed these T(H)2-, T(H)2/T(H)17-, and T(H)17-like heterogenic profiles. Jug r 2-specific T-cell clones from allergic subjects mainly expressed GATA3, nonetheless, a portion of T-cell clones both GATA3 and RAR-related orphan receptor C (RORC) or RORC alone, confirming the presence of T(H)2, T(H)2/T(H)17, and T(H)17 cells. Conclusions: Jug r 2-specific responses dominate walnut T-cell responses in patients with walnut allergy. Jug r 2 central memory CD4(+) cells and terminal effector T cells were detected in peripheral blood, with the central memory phenotype as the most prevalent phenotype. In addition to conventional T(H)2 cells, T(H)2/T(H)17 and T(H)17 cells were also detected in nonasthmatic and asthmatic patients with walnut allergy. Understanding this T-cell heterogeneity might render better understanding of the disease manifestation.	[Diego Archila, Luis; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Jeong, David; Robinson, David; Farrington, Mary L.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Pascal, Mariona; Juan, Manel] Hosp Clin Barcelona, CDB, Serv Immunol, Barcelona, Spain; [Pascal, Mariona; Bartra, Joan; Juan, Manel] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, E-08007 Barcelona, Spain; [Bartra, Joan] Hosp Clin Barcelona, ICT, Serv Pneumol, Unitat Allergia, Barcelona, Spain; [Jeong, David; Kwok, William W.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; Virginia Mason Medical Center; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Washington; University of Washington Seattle	Kwok, WW (corresponding author), Benaroya Res Inst, 1201 9th Ave, Seattle, WA 98101 USA.	bkwok@benaroyaresearch.org	Pascal, Mariona/HCG-9380-2022; Juan, Manel/Q-2931-2019	Juan, Manel/0000-0002-3064-1648	NIAID NIH HHS [HHSN272200700046C] Funding Source: Medline; PHS HHS [HHSN272200700046C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Archila LD, 2014, CLIN EXP ALLERGY, V44, P986, DOI 10.1111/cea.12324; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Barre A, 2008, MOL IMMUNOL, V45, P1231, DOI 10.1016/j.molimm.2007.09.014; Bin Dhuban K, 2013, INT ARCH ALLERGY IMM, V162, P318, DOI 10.1159/000354028; Blazquez AB, 2010, GASTROENTEROLOGY, V138, P275, DOI 10.1053/j.gastro.2009.09.016; CARBALLIDO JM, 1992, EUR J IMMUNOL, V22, P1357, DOI 10.1002/eji.1830220605; Ciprandi G, 2010, INT IMMUNOPHARMACOL, V10, P226, DOI 10.1016/j.intimp.2009.11.004; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Costa J, 2014, CLIN EXP ALLERGY, V44, P319, DOI 10.1111/cea.12267; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; EBNER C, 1995, J IMMUNOL, V154, P1932; Fleischer DM, 2007, CURR ALLERGY ASTHM R, V7, P175, DOI 10.1007/s11882-007-0018-y; Fleischer DM, 2005, J ALLERGY CLIN IMMUN, V116, P1087, DOI 10.1016/j.jaci.2005.09.002; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HINTZEN RQ, 1993, J IMMUNOL, V151, P2426; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Kwok WW, 2010, J ALLERGY CLIN IMMUN, V125, P1407, DOI 10.1016/j.jaci.2010.03.037; Kwok WW, 2000, J IMMUNOL, V164, P4244, DOI 10.4049/jimmunol.164.8.4244; Mackenzie KJ, 2014, P NATL ACAD SCI USA, V111, pE784, DOI 10.1073/pnas.1316178111; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Nagata K, 1999, J IMMUNOL, V162, P1278; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Novak EJ, 2001, J IMMUNOL, V166, P6665, DOI 10.4049/jimmunol.166.11.6665; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Pastorello EA, 2004, J ALLERGY CLIN IMMUN, V114, P908, DOI 10.1016/j.jaci.2004.06.020; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Renand A, 2014, J ALLERGY CLIN IMMUN, V134, P1456, DOI 10.1016/j.jaci.2014.07.048; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Robotham JM, 2002, J ALLERGY CLIN IMMUN, V109, P143, DOI 10.1067/mai.2002.120558; Rosenfeld L, 2012, INT ARCH ALLERGY IMM, V157, P238, DOI 10.1159/000327841; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Teuber SS, 1998, J ALLERGY CLIN IMMUN, V101, P807, DOI 10.1016/S0091-6749(98)70308-2; Teuber SS, 1999, J ALLERGY CLIN IMMUN, V104, P1311, DOI 10.1016/S0091-6749(99)70029-1; Wallowitz M, 2006, J AGR FOOD CHEM, V54, P8369, DOI 10.1021/jf061329s; Wambre E, 2014, J ALLERGY CLIN IMMUN, V133, P872, DOI 10.1016/j.jaci.2013.10.054; Wambre E, 2012, CURR OPIN IMMUNOL, V24, P700, DOI 10.1016/j.coi.2012.07.009; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	51	15	21	1	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2015	136	4					983	+		10.1016/j.jaci.2015.01.029	http://dx.doi.org/10.1016/j.jaci.2015.01.029			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CT7EJ	25772597	Green Accepted			2022-12-18	WOS:000362976300017
J	Clemmer, GL; Wu, AC; Rosner, B; McGeachie, MJ; Litonjua, AA; Tantisira, KG; Weiss, ST				Clemmer, George L.; Wu, Ann Chen; Rosner, Bernard; McGeachie, Michael J.; Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.			Measuring the corticosteroid responsiveness endophenotype in asthmatic patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; corticosteroids; drug therapy; endophenotype; pharmacogenetics; pharmacologic response	PHENOTYPES; RESPONSES	Background: Inhaled corticosteroids are the most commonly used controller therapies for asthma, producing treatment responses in 6 clinical phenotypes: lung function, bronchodilator response, airway responsiveness, symptoms, need for oral steroids and frequency of emergency department visits and hospitalizations. We hypothesize that treatment response in all of these phenotypes is modulated by a single quantitative corticosteroid responsiveness endophenotype. Objective: We sought to develop a composite phenotype that combines multiple clinical phenotypes to measure corticosteroid responsiveness with high accuracy, stability across populations, and robustness to missing data. Methods: We used principal component analysis to determine a composite corticosteroid responsiveness phenotype that we tested in 4 replication populations. We evaluated the relative accuracy with which the composite and clinical phenotypes measure the endophenotype using treatment effect area under the receiver operating characteristic curve (AUC). Results: In the study population the composite phenotype measured the endophenotype with an AUC of 0.74, significantly exceeding the AUCs of the 6 individual clinical phenotypes, which ranged from 0.56 (P < .001) to 0.67 (P = .015). In 4 replication populations with a total of 22 clinical phenotypes available, the composite phenotype AUC ranged from 0.69 to 0.73, significantly exceeded the AUCs of 14 phenotypes, and was not significantly exceeded by any single phenotype. Conclusion: The composite phenotype measured the endophenotype with higher accuracy, higher stability across populations, and higher robustness to missing data than any clinical phenotype. This should provide the capability to model corticosteroid pharmacologic response and resistance with increased accuracy and reproducibility.	[Clemmer, George L.; Rosner, Bernard; McGeachie, Michael J.; Litonjua, Augusto A.; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA; [Wu, Ann Chen] Harvard Univ, Sch Med, Dept Populat Med, Ctr ChildHealth Care Studies, Cambridge, MA 02138 USA; [Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Cambridge, MA USA; [Wu, Ann Chen] Harvard Univ, Med Sch, Div Gen Pediat,Childrens Hosp Boston, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Clemmer, GL (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	george.clemmer@channing.harvard.edu	Wu, Ann/AAY-4293-2020	Wu, Ann/0000-0003-0599-9063	National Heart, Lung, and Blood Institute [K08 HL088046, U01 HL065899, R01 NR013391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL088046, U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013391] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by the National Heart, Lung, and Blood Institute through K08 HL088046 (primary investigator: A. C. Wu), and U01 HL065899 and R01 NR013391 (primary investigator: S. T. Weiss and K. G. Tantisira).	[Anonymous], 2007, TECHNICAL REPORT; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; Chung KF, 2014, DRUGS, V74, P719, DOI 10.1007/s40265-014-0213-9; Chung Kian Fan, 2013, Ann Am Thorac Soc, V10 Suppl, pS109, DOI 10.1513/AnnalsATS.201304-087AW; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Global strategy for asthma management and prevention, 2012, TECHNICAL REPORT; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Martin RJ, 2007, J ALLERGY CLIN IMMUN, V119, P73, DOI 10.1016/j.jaci.2006.10.035; R Core Team, 2014, R A LANGUAGE AND ENV; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579; Weiss Scott T, 2004, Proc Am Thorac Soc, V1, P364, DOI 10.1513/pats.200409-043MS; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	23	15	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					274	+		10.1016/j.jaci.2015.03.029	http://dx.doi.org/10.1016/j.jaci.2015.03.029			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25951964	Green Accepted			2022-12-18	WOS:000359004900007
J	Jartti, T; Hasegawa, K; Mansbach, JM; Piedra, PA; Camargo, CA				Jartti, Tuomas; Hasegawa, Kohei; Mansbach, Jonathan M.; Piedra, Pedro A.; Camargo, Carlos A., Jr.			Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							LENGTH-OF-STAY; REAL-TIME PCR; PROSPECTIVE MULTICENTER; CHILDREN; INFECTIONS; DIAGNOSIS; SEVERITY; ETIOLOGY; DISEASE; ASTHMA		[Jartti, Tuomas] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Hasegawa, Kohei; Camargo, Carlos A., Jr.] Harvard Univ, Dept Emergency Med, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Mansbach, Jonathan M.] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	University of Turku; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Baylor College of Medicine; Baylor College of Medicine	Jartti, T (corresponding author), Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland.	tuomas.jartti@utu.fi	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067693] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI-67693, U01 AI067693] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baraldo S, 2012, J ALLERGY CLIN IMMUN, V130, P1307, DOI 10.1016/j.jaci.2012.08.005; Beckham JD, 2005, J INFECTION, V50, P322, DOI 10.1016/j.jinf.2004.07.011; Bochkov YA, 2014, J CLIN MICROBIOL, V52, P2461, DOI 10.1128/JCM.00075-14; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P41, DOI 10.1007/s10096-013-1926-5; Hasegawa K, 2014, J INFECT; Hasegawa K, 2015, ACAD PEDIATR, V15, P77, DOI 10.1016/j.acap.2014.06.008; Hendley JO, 2004, J CLIN VIROL, V30, P326, DOI 10.1016/j.jcv.2004.02.011; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jartti T, 2015, J ALLERGY CLIN IMMUN, V135, P691, DOI 10.1016/j.jaci.2014.07.001; Jartti T, 2014, PEDIATR INFECT DIS J, V33, P829, DOI 10.1097/INF.0000000000000313; Knorr L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-62; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mansbach JM, 2012, PEDIATRICS, V130, pE492, DOI 10.1542/peds.2012-0444; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Takeyama A, 2012, J MED VIROL, V84, P1135, DOI 10.1002/jmv.23306; Winchell JM, 2008, J CLIN MICROBIOL, V46, P3116, DOI 10.1128/JCM.00440-08	20	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					509	+		10.1016/j.jaci.2015.02.021	http://dx.doi.org/10.1016/j.jaci.2015.02.021			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25840721	Green Published, Bronze			2022-12-18	WOS:000359004900043
J	Michels, AW; Ostrov, DA				Michels, Aaron W.; Ostrov, David A.			New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T cell; adverse drug reaction; autoimmunity	SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; INDUCED LIVER-INJURY; MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC EPIDERMAL NECROLYSIS; CELIAC-DISEASE; HYPERSENSITIVITY REACTIONS; THYROID AUTOIMMUNITY; MULTIPLE-SCLEROSIS; PEPTIDE REPERTOIRE	Adverse drug reactions (ADRs) are commonplace and occur when a drug binds to its intended pharmacologic target (type A ADR) or an unintended target (type B ADR). Immunologically mediated type B ADRs, such as drug hypersensitivity syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, and Stevens-Johnson syndrome/toxic epidermal necrolysis, can be severe and result in a diverse set of clinical manifestations that include fever and rash, as well as multiple organ failure (liver, kidney, lungs, and/or heart) in the case of drug hypersensitivity syndrome. There is increasing evidence that specific HLA alleles influence the risk of drug reactions. Several features of T cell-mediated ADRs are strikingly similar to those displayed by patients with autoimmune diseases like type I diabetes, such as strong HLA association, organ-specific adaptive immune responses, viral involvement, and activation of innate immunity. There is a need to better predict patient populations at risk for immunologically mediated type B ADRs. Because methods to predict type 1 diabetes by using genetic and immunologic biomarkers have been developed to a high level of accuracy (predicting 100% of subjects likely to progress), new research strategies based on these methods might also improve the ability to predict drug hypersensitivity.	[Michels, Aaron W.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32160 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida	Ostrov, DA (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32160 USA.	ostroda@pathology.ufl.edu		Michels, Aaron/0000-0003-3766-5244	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases [K08 DK095995]; NIH/National Institute of Allergy and Infectious Diseases [R01 AI103348]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK095995] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A. W. Michels has received research support from the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK095995). D. A. Ostrov has received research support from the NIH/National Institute of Allergy and Infectious Diseases (R01 AI103348).	Aihara Y, 2003, BRIT J DERMATOL, V149, P165, DOI 10.1046/j.1365-2133.2003.05368.x; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Ascherio A, 2001, JAMA-J AM MED ASSOC, V286, P3083, DOI 10.1001/jama.286.24.3083; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Baker PR, 2010, J CLIN ENDOCR METAB, V95, pE263, DOI 10.1210/jc.2010-0508; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BATCHELOR JR, 1980, LANCET, V1, P1107; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bowes J, 2008, RHEUMATOLOGY, V47, P399, DOI 10.1093/rheumatology/ken005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castro EMC, 2015, PHARMACOGENET GENOM, V25, P186, DOI 10.1097/FPC.0000000000000124; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Daly AK, 2009, SEMIN LIVER DIS, V29, P400, DOI 10.1055/s-0029-1240009; Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350; Denisov IG, 2015, BIOCHEMISTRY-US, V54, P2227, DOI 10.1021/acs.biochem.5b00079; Deshmukh US, 2011, J AUTOIMMUN, V37, P254, DOI 10.1016/j.jaut.2011.07.002; Eliaszewicz M, 2002, J AM ACAD DERMATOL, V47, P40, DOI 10.1067/mjd.2002.120468; Faulkner L, 2014, CURR OPIN ALLERGY CL, V14, P293, DOI 10.1097/ACI.0000000000000078; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Flynn JC, 2004, CLIN EXP IMMUNOL, V137, P503, DOI 10.1111/j.1365-2249.2004.02553.x; Fontana RJ, 2009, DRUG SAFETY, V32, P55, DOI 10.2165/00002018-200932010-00005; GARLEPP MJ, 1983, BRIT MED J, V286, P338, DOI 10.1136/bmj.286.6362.338; Gebe JA, 2008, J AUTOIMMUN, V30, P197, DOI 10.1016/j.jaut.2007.08.001; Genin E, 2014, PHARMACOGENOMICS J, V14, P281, DOI 10.1038/tpj.2013.40; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; HALL MA, 1990, HUM IMMUNOL, V27, P220, DOI 10.1016/0198-8859(90)90052-Q; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heap GA, 2014, NAT GENET, V46, P1131, DOI 10.1038/ng.3093; Howell WM, 2014, INT J IMMUNOGENET, V41, P1, DOI 10.1111/iji.12088; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Ito Y, 2014, SCIENCE, V346, P363, DOI 10.1126/science.1259077; Jacobson EM, 2008, J AUTOIMMUN, V30, P58, DOI 10.1016/j.jaut.2007.11.010; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Kardaun SH, 2013, BRIT J DERMATOL, V169, P1071, DOI 10.1111/bjd.12501; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Kindmark A, 2008, PHARMACOGENOMICS J, V8, P186, DOI 10.1038/sj.tpj.6500458; Kinnunen T, 2013, BLOOD, V121, P1595, DOI 10.1182/blood-2012-09-457465; Kukreja A, 2000, CELL MOL LIFE SCI, V57, P534, DOI 10.1007/PL00000715; Liss G, 2010, EXPERT OPIN DRUG MET, V6, P1047, DOI 10.1517/17425255.2010.503706; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Molina MJ, 2007, JCR-J CLIN RHEUMATOL, V13, P202, DOI 10.1097/RHU.0b013e318124a8af; Mosenson JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005127; Munthe-Kaas MC, 2007, ALLERGY, V62, P991, DOI 10.1111/j.1398-9995.2007.01377.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ogese MO, 2015, CHEM RES TOXICOL; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Ota T, 2015, INT J MED SCI, V12, P78, DOI 10.7150/ijms.10263; Pavlos R, 2015, ANNU REV MED, V66, P439, DOI 10.1146/annurev-med-050913-022745; Pavlos R, 2014, J ALLER CL IMM-PRACT, V2, P21, DOI 10.1016/j.jaip.2013.11.005; Phillips E, 2009, MOL DIAGN THER, V13, P1, DOI 10.2165/01250444-200913010-00001; Phillips EJ, 2011, J ALLERGY CLIN IMMUN, V127, pS60, DOI 10.1016/j.jaci.2010.11.046; Picard D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001116; Pichler WJ, 2008, WORLD ALLERGY ORGAN, V1, P96, DOI 10.1097/WOX.0b013e3181778282; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Ruyssen-Witrand A, 2012, TISSUE ANTIGENS, V80, P105, DOI 10.1111/j.1399-0039.2012.01939.x; Saito N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008227; Shiohara T, 2007, CLIN REV ALLERG IMMU, V33, P124, DOI 10.1007/s12016-007-8010-9; Simmons K, 2014, RHEUM DIS CLIN N AM, V40, P797, DOI 10.1016/j.rdc.2014.07.008; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Smith KJ, 1997, CLIN EXP DERMATOL, V22, P118, DOI 10.1111/j.1365-2230.1997.tb01038.x; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Sosenko JM, 2008, DIABETES CARE, V31, P528, DOI 10.2337/dc07-1459; Sosenko JM, 2013, DIABETES CARE, V36, P2615, DOI 10.2337/dc13-0425; Stene LC, 2006, AM J GASTROENTEROL, V101, P2333, DOI 10.1111/j.1572-0241.2006.00741.x; Tang W, 2014, WORLD J GASTROENTERO, V20, P13079, DOI 10.3748/wjg.v20.i36.13079; Thong BYH, 2011, WORLD ALLERGY ORGAN, V4, P257, DOI 10.1097/WOX.0b013e31823dc02c; Tjon JML, 2010, IMMUNOGENETICS, V62, P641, DOI 10.1007/s00251-010-0465-9; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Torres Maria J, 2014, Exp Suppl, V104, P165, DOI 10.1007/978-3-0348-0726-5_11; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Vitezica ZG, 2008, AIDS, V22, P540, DOI 10.1097/QAD.0b013e3282f37812; Wang P, 2013, INT J CLIN EXP PATHO, V6, P2668; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	86	15	15	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					252	257		10.1016/j.jaci.2015.06.024	http://dx.doi.org/10.1016/j.jaci.2015.06.024			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	26254052	Green Accepted			2022-12-18	WOS:000359004900004
J	Stephenson, ST; Brown, LAS; Helms, MN; Qu, HY; Brown, SD; Brown, MR; Fitzpatrick, AM				Stephenson, Susan T.; Brown, Lou Ann S.; Helms, My N.; Qu, Hongyan; Brown, Sheena D.; Brown, Milton R.; Fitzpatrick, Anne M.			Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Biomarker; childhood asthma; treatment response; cysteine; inflammation; oxidative stress; refractory asthma; severe asthma	RECEPTOR-BETA; STEROID-BINDING; NITRIC-OXIDE; DNA-BINDING; STRESS; EXPRESSION; BUDESONIDE; INHIBITION; FORMOTEROL; RESPONSES	Background: The mechanisms underlying glucocorticoid responsiveness are largely unknown. Although redox regulation of the glucocorticoid receptor (GR) has been reported, it has not been studied in asthmatic patients. Objective: We characterized systemic cysteine oxidation and its association with inflammatory and clinical features in healthy children and children with difficult-to-treat asthma. We hypothesized that cysteine oxidation would be associated with increased markers of oxidative stress and inflammation, increased features of asthma severity, decreased clinically defined glucocorticoid responsiveness, and impaired GR function. Methods: PBMCs were collected from healthy children (n = 16) and children with asthma (n = 118) aged 6 to 17 years. Children with difficult-to-treat asthma underwent glucocorticoid responsiveness testing with intramuscular triamcinolone. Cysteine, cystine, and inflammatory chemokines and reactive oxygen species generation were quantified, and expression and activity of the GR were assessed. Results: Cysteine oxidation was present in children with difficult-to-treat asthma and accompanied by increased reactive oxygen species generation and increased CCL3 and CXCL1 mRNA expression. Children with the greatest extent of cysteine oxidation had more features of asthma severity, including poorer symptom control, greater medication use, and less glucocorticoid responsiveness despite inhaled glucocorticoid therapy. Cysteine oxidation also modified the GR protein by decreasing available sulfhydryl groups and decreasing nuclear GR expression and activity. Conclusions: A highly oxidized cysteine redox state promotes a posttranslational modification of the GR that might inhibit its function. Given that cysteine oxidation is prevalent in children with difficult-to-treat asthma, the cysteine redox state might represent a potential therapeutic target for restoration of glucocorticoid responsiveness in this population.	[Stephenson, Susan T.; Brown, Lou Ann S.; Helms, My N.; Qu, Hongyan; Brown, Sheena D.; Brown, Milton R.; Fitzpatrick, Anne M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Brown, Lou Ann S.; Helms, My N.; Brown, Milton R.; Fitzpatrick, Anne M.] Childrens Healthcare Atlanta, Ctr Cyst Fibrosis & Airways Dis Res, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Fitzpatrick, AM (corresponding author), 2015 Uppergate Dr, Atlanta, GA 30322 USA.	anne.fitzpatrick@emory.edu	Brown, Sheena/AGK-6465-2022	Fitzpatrick, Anne/0000-0002-2933-5926	National Institutes of Health (NIH) [RO1 NR012021]; National Center for Advancing Translational Sciences of the NIH [UL1 TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012021] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by National Institutes of Health (NIH) grant RO1 NR012021 and supported in part by the National Center for Advancing Translational Sciences of the NIH (award no. UL1 TR000454).	ADCOCK IM, 1995, J IMMUNOL, V154, P3500; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Bergeron C, 2006, J ALLERGY CLIN IMMUN, V117, P703, DOI 10.1016/j.jaci.2005.12.1344; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P1392, DOI 10.1021/bi00302a009; Bossley CJ, 2009, EUR RESPIR J, V34, P1052, DOI 10.1183/09031936.00186508; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; Butler CA, 2012, THORAX, V67, P392, DOI 10.1136/thoraxjnl-2011-200760; CHAKRABORTI PK, 1992, J BIOL CHEM, V267, P11366; CHEN DG, 1994, J BIOL CHEM, V269, P7914; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; ESPOSITO F, 1995, BBA-GENE STRUCT EXPR, V1260, P308, DOI 10.1016/0167-4781(94)00209-L; [Expert Panel Report 3 (EPR-3) National Asthma Education and Prevention Program], 2007, J ALLERGY CLIN IMMUN, V120, pS94; Fitzpatrick AM, 2014, J ALLERGY CLIN IMMUN, V133, P258, DOI 10.1016/j.jaci.2013.10.012; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P1604, DOI 10.1016/j.jaci.2011.03.031; Fitzpatrick AM, 2011, PEDIATR RES, V69, P154, DOI 10.1203/PDR.0b013e3182026370; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V124, P990, DOI 10.1016/j.jaci.2009.08.039; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V123, P146, DOI 10.1016/j.jaci.2008.10.047; Go YM, 2009, TOXICOL SCI, V112, P354, DOI 10.1093/toxsci/kfp205; Go Young-Mi, 2008, V464, P303; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P687, DOI 10.1016/j.jaci.2011.12.001; GRANBERG JP, 1977, ENDOCRINOLOGY, V100, P1160; Howrylak JA, 2014, J ALLERGY CLIN IMMUN, V133, P1289, DOI 10.1016/j.jaci.2014.02.006; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Iyer SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005017; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Juniper EF, 2010, EUR RESPIR J, V36, P1410, DOI 10.1183/09031936.00117509; Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012; Juniper EF, 1996, QUAL LIFE RES, V5, P35, DOI 10.1007/BF00435967; Kelly HW, 2011, J ALLERGY CLIN IMMUN, V128, P278, DOI 10.1016/j.jaci.2011.05.002; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mercado N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041582; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Okamoto K, 1999, J BIOL CHEM, V274, P10363, DOI 10.1074/jbc.274.15.10363; Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128; Panickar JR, 2007, PEDIATR PULM, V42, P573, DOI 10.1002/ppul.20583; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; SILVA CM, 1989, J BIOL CHEM, V264, P6638; SIMONS SS, 1995, METHOD ENZYMOL, V251, P406; Tanaka H, 1999, ANTIOXID REDOX SIGN, V1, P403, DOI 10.1089/ars.1999.1.4-403; ten Brinke A, 2004, AM J RESP CRIT CARE, V170, P601, DOI 10.1164/rccm.200404-440OC	49	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					454	+		10.1016/j.jaci.2015.01.023	http://dx.doi.org/10.1016/j.jaci.2015.01.023			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25748343	Green Accepted			2022-12-18	WOS:000359004900027
J	Gern, JE				Gern, James E.			Promising candidates for allergy prevention	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; prevention; IgE; prebiotics; probiotics; diet; intervention	GUT MICROBIOTA; EARLY-LIFE; DISEASE PREVENTION; ASTHMA; CHILDREN; ATOPY; RISK; EXPOSURE; BIRTH; SENSITIZATION	Recent advances in understanding environmental risk factors for allergic diseases in children have led to renewed efforts aimed at prevention. Factors that modify the probability of developing allergies include prenatal exposures, mode of delivery, diet, patterns of medication use, and exposure to pets and farm animals. Recent advances in microbial detection techniques demonstrate that exposure to diverse microbial communities in early life is associated with a reduction in allergic disease. In fact, microbes and their metabolic products might be essential for normal immune development. Identification of these risk factors has provided new targets for prevention of allergic diseases, and possibilities of altering microbial exposure and colonization to reduce the incidence of allergies is a promising approach. This review examines the rationale, feasibility, and potential effect for the prevention of childhood allergic diseases and explores possible strategies for enhancing exposure to beneficial microbes.	[Gern, James E.] Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA; [Gern, James E.] Univ Wisconsin, Dept Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gern, JE (corresponding author), Univ Wisconsin, Dept Pediat, K4-918 CSC,600 Highland Ave, Madison, WI 53792 USA.	gern@medicine.wisc.edu			National Institutes of Health [UM1 AI114271-01, U19 AI104317-02, P01 HL070831]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI104317, UM1AI114271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants UM1 AI114271-01, U19 AI104317-02, and P01 HL070831.	Alati R, 2006, EPIDEMIOLOGY, V17, P138, DOI 10.1097/01.ede.0000198148.02347.33; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; [Anonymous], 2015, ABOUT THE URBAN FARM; [Anonymous], 2015, ABOUT GROWING POWER; [Anonymous], 2015, YOUTH CORPS; Azad MB, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6471; BARNES RM, 1990, ANAL CHEM, V62, pA1023, DOI 10.1021/ac00218a002; Barnes RM, 1990, ANAL CHEM, V62, p1030A; Bieli C, 2007, J ALLERGY CLIN IMMUN, V120, P1308, DOI 10.1016/j.jaci.2007.07.034; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bousquet J, 2014, J ALLERGY CLIN IMMUN, V133, P1535, DOI 10.1016/j.jaci.2014.01.018; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P867, DOI 10.1016/j.jaci.2014.08.011; Bull MJ, 2001, PEDIATRICS, V107, P1188, DOI 10.1542/peds.107.5.1188; Campbell DE, 2015, CLIN EXP ALLERGY, V45, P844, DOI 10.1111/cea.12531; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Dwyer L., 2014, TAKEPART; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Elazab N, 2013, PEDIATRICS, V132, pE666, DOI 10.1542/peds.2013-0246; Environmental Protection Agency, 2015, STEPS CREAT COMM GAR; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Fujimura KE, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.042; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Hesselmar B, 2015, PEDIATRICS, V135, pE590, DOI 10.1542/peds.2014-2968; Hesselmar B, 2013, PEDIATRICS, V131, pE1829, DOI 10.1542/peds.2012-3345; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Holt PG, 2015, J ALLERGY CLIN IMMUN, V136, P15, DOI 10.1016/j.jaci.2015.05.011; Iqbal S, 2014, AM J PUBLIC HEALTH, V104, pS175, DOI 10.2105/AJPH.2013.301509; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jackson Daniel J, 2014, Ann Am Thorac Soc, V11 Suppl 3, pS139, DOI 10.1513/AnnalsATS.201312-448LD; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; National Prevention Strategy, 2015, NATL PREVENTION STRA; Nieto A, 2014, PEDIAT ALLERG IMM-UK, V25, P516, DOI 10.1111/pai.12272; Okupa AY, 2013, J ALLERGY CLIN IMMUN, V131, DOI 10.1016/j.jaci.2012.08.015; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Prescott SL, 2014, ALLERGOL INT, V63, P11, DOI 10.2332/allergolint.13-RAI-0659; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rosenstein RK, 2014, P NATL ACAD SCI USA, V111, pE4963, DOI 10.1073/pnas.1418959111; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; SILVA M, 1987, ANTIMICROB AGENTS CH, V31, P1231, DOI 10.1128/AAC.31.8.1231; Silverberg JI, 2013, JAMA PEDIATR, V167, P554, DOI 10.1001/jamapediatrics.2013.1319; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Stremnitzer C, 2015, J INVEST DERMATOL, V135, P1790, DOI 10.1038/jid.2015.58; Torgerson TR, 2007, GASTROENTEROLOGY, V132, P1705, DOI 10.1053/j.gastro.2007.02.044; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; von Mutius E, 2010, CLIN EXP IMMUNOL, V160, P130, DOI 10.1111/j.1365-2249.2010.04138.x; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	65	15	15	0	29	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2015	136	1					23	28		10.1016/j.jaci.2015.05.017	http://dx.doi.org/10.1016/j.jaci.2015.05.017			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CM2WE	26145984	Green Accepted			2022-12-18	WOS:000357542200003
J	Chinen, J; Notarangelo, LD; Shearer, WT				Chinen, Javier; Notarangelo, Luigi D.; Shearer, William T.			Advances in basic and clinical immunology in 2014	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Immunology; primary immunodeficiency; dedicator of cytokinesis 8; HIV1; recombination-activating gene 1; intravenous immunoglobulin; common variable immunodeficiency; severe combined immunodeficiency; newborn screening	SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELL TRANSPLANTATION; COMMON VARIABLE IMMUNODEFICIENCY; GENE RAG MUTATIONS; IMMUNE-DEFICIENCY; CAUSES AUTOINFLAMMATION; SIGNAL TRANSDUCER; NLRC4 CAUSES; DEDICATOR; RECEPTOR	Genetic identification of immunodeficiency syndromes has become more efficient with the availability of whole-exome sequencing, expediting the identification of relevant genes and complementing traditional linkage analysis and homozygosity mapping. New genes defects causing immunodeficiency include phophoglucomutase 3 (PGM3), cytidine 59 triphosphate synthase 1 (CTPS1), nuclear factor kappa B-inducing kinase (NIK), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), B-cell chronic lymphocytic leukemia/lymphoma 10 (BCL10), phosphoinositide3 kinase regulatory subunit 1 (PIK3R1), IL21, and Jagunal homolog 1 (JAGN1). New case reports expanded the clinical spectrum of gene defects. For example, a specific recombinationactivating gene 1 variant protein with partial recombinant activity might produce Omenn syndrome or a common variable immunodeficiency phenotype. Central and peripheral B-cell tolerance was investigated in patients with several primary immunodeficiencies, including common variable immunodeficiency and Wiskott-Aldrich syndrome, to explain the occurrence of autoimmunity and inflammatory disorders. The role of IL-12 and IL-15 in the enhancement of natural killer cell activity was reported. Newborn screening for T-cell deficiency is being implemented in more states and is achieving its goal of defining the true incidence of severe combined immunodeficiency and providing early treatment that offers the highest survival for these patients. Definitive treatment of severe immunodeficiency with both hematopoietic stem cell transplantation and gene therapy was reported to be successful, with increasing definition of conditions needed for optimal outcomes. Progress in HIV infection is directed toward the development of an effective vaccine and the eradication of hidden latent virus reservoirs.	[Chinen, Javier; Shearer, William T.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Immunol Allergy & Rheumatol Sect, Houston, TX 77030 USA; [Notarangelo, Luigi D.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Baylor College of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shearer, WT (corresponding author), Texas Childrens Hosp, Allergy & Immunol, 1102 Bates St FC 330-01, Houston, TX 77030 USA.	wtsheare@texaschildrenshospital.org	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Shearer, William/0000-0002-2483-2130	National Institutes of Health [U54AI082978]; David Fund of Texas Children's Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Fund of Texas Children's Hospital	Supported by National Institutes of Health grant U54AI082978 and the David Fund of Texas Children's Hospital.	Abolhassani H, 2014, J ALLERGY CLIN IMMUN, V134, P1375, DOI 10.1016/j.jaci.2014.04.042; Aguilar C, 2014, J ALLERGY CLIN IMMUN, V134, P1131, DOI 10.1016/j.jaci.2014.04.031; Borte S, 2014, J ALLERGY CLIN IMMUN, V134, P226, DOI 10.1016/j.jaci.2014.04.026; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Bras J, 2014, NEW ENGL J MED, V371, P479, DOI 10.1056/NEJMc1405506; Brigida I, 2014, J ALLERGY CLIN IMMUN, V133, P799, DOI 10.1016/j.jaci.2013.12.1043; Buckner CM, 2014, J ALLERGY CLIN IMMUN, V133, P1676, DOI 10.1016/j.jaci.2013.10.050; Burns SO, 2014, J ALLERGY CLIN IMMUN, V134, P215, DOI 10.1016/j.jaci.2013.12.1093; Cagigi A, 2014, J ALLERGY CLIN IMMUN, V133, P592, DOI 10.1016/j.jaci.2013.10.003; Campillo-Gimenez L, 2014, J ALLERGY CLIN IMMUN, V134, P1142, DOI 10.1016/j.jaci.2014.05.040; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Chen K, 2014, J ALLERGY CLIN IMMUN, V133, P880, DOI 10.1016/j.jaci.2013.11.038; Chou J, 2014, J ALLERGY CLIN IMMUN, V134, P223, DOI 10.1016/j.jaci.2014.01.041; Deau MC, 2014, J CLIN INVEST, V124, P3923, DOI 10.1172/JCI75746; Dhanju R, 2014, J ALLERGY CLIN IMMUN, V133, P1467, DOI 10.1016/j.jaci.2013.11.029; Dijkstra KK, 2014, J ALLERGY CLIN IMMUN, V133, P891, DOI 10.1016/j.jaci.2013.09.022; Dvorak CC, 2014, J ALLERGY CLIN IMMUN, V134, P935, DOI 10.1016/j.jaci.2014.06.021; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Frans G, 2014, J ALLERGY CLIN IMMUN, V134, P1209, DOI 10.1016/j.jaci.2014.05.044; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gao YF, 2014, J ALLERGY CLIN IMMUN, V133, P1420, DOI 10.1016/j.jaci.2013.10.059; Garcillan B, 2014, J ALLERGY CLIN IMMUN, V133, P1205, DOI 10.1016/j.jaci.2013.10.002; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Griffith LM, 2014, J ALLERGY CLIN IMMUN, V133, P335, DOI 10.1016/j.jaci.2013.07.052; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Haddad E, 2014, J ALLERGY CLIN IMMUN, V133, P597, DOI 10.1016/j.jaci.2013.10.022; Hanna S, 2014, J ALLERGY CLIN IMMUN, V134, P269, DOI 10.1016/j.jaci.2014.06.001; Hassan A, 2014, J ALLERGY CLIN IMMUN, V133, P1660, DOI 10.1016/j.jaci.2014.02.042; Haynes BF, 2014, J ALLERGY CLIN IMMUN, V134, P3, DOI 10.1016/j.jaci.2014.04.025; Hedayat M, 2014, J ALLERGY CLIN IMMUN, V134, P983, DOI 10.1016/j.jaci.2014.04.037; Hennig C, 2014, J ALLERGY CLIN IMMUN, V133, P172, DOI 10.1016/j.jaci.2013.06.047; Horiuchi K, 2014, J ALLERGY CLIN IMMUN, V134, P411, DOI 10.1016/j.jaci.2014.02.043; IJspeert H, 2014, J ALLERGY CLIN IMMUN, V133, P1124, DOI 10.1016/j.jaci.2013.11.028; Janssen E, 2014, J ALLERGY CLIN IMMUN, V134, P1365, DOI 10.1016/j.jaci.2014.07.042; Jing H, 2014, J ALLERGY CLIN IMMUN, V133, P1667, DOI 10.1016/j.jaci.2014.03.025; Kamili QUA, 2014, J ALLERGY CLIN IMMUN, V134, P1451, DOI 10.1016/j.jaci.2014.07.009; Keles S, 2014, J ALLERGY CLIN IMMUN, V133, P1753, DOI 10.1016/j.jaci.2014.03.032; Kharya G, 2014, J ALLERGY CLIN IMMUN, V134, P1199, DOI 10.1016/j.jaci.2014.04.041; Kim N, 2014, J ALLERGY CLIN IMMUN, V134, P195, DOI 10.1016/j.jaci.2014.02.018; Kitamura A, 2014, J EXP MED, V211, P2385, DOI 10.1084/jem.20141091; Kracker S, 2014, J ALLERGY CLIN IMMUN, V134, P233, DOI 10.1016/j.jaci.2014.02.020; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kumar N, 2014, J ALLERGY CLIN IMMUN, V134, P236, DOI 10.1016/j.jaci.2014.02.037; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; la Marca G, 2014, J ALLERGY CLIN IMMUN, V134, P155, DOI 10.1016/j.jaci.2014.01.040; Lagresle-Peyrou C, 2014, J ALLERGY CLIN IMMUN, V134, P145, DOI 10.1016/j.jaci.2013.12.1083; Lee CE, 2014, BLOOD, V124, P2964, DOI 10.1182/blood-2014-06-578542; Lee PPW, 2014, J ALLERGY CLIN IMMUN, V133, P894, DOI 10.1016/j.jaci.2013.08.051; Lee YN, 2014, J ALLERGY CLIN IMMUN, V133, P1099, DOI 10.1016/j.jaci.2013.10.007; Lemoine R, 2014, J ALLERGY CLIN IMMUN, V134, P1354, DOI 10.1016/j.jaci.2014.07.019; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lougaris V, 2014, J ALLERGY CLIN IMMUN, V133, P1644, DOI 10.1016/j.jaci.2013.12.1085; Lucas CL, 2014, J EXP MED, V211, P2537, DOI 10.1084/jem.20141759; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Maglione PJ, 2014, J ALLERGY CLIN IMMUN, V133, P535, DOI 10.1016/j.jaci.2013.08.022; Magnani A, 2014, J ALLERGY CLIN IMMUN, V134, P655, DOI 10.1016/j.jaci.2014.04.014; Mandala WL, 2014, J ALLERGY CLIN IMMUN, V134, P759, DOI 10.1016/j.jaci.2014.06.030; Torres JM, 2014, J CLIN INVEST, V124, P5239, DOI 10.1172/JCI77493; Marciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028; Martin E, 2014, NATURE, V510, P288, DOI 10.1038/nature13386; Massoud AH, 2014, J ALLERGY CLIN IMMUN, V133, P853, DOI 10.1016/j.jaci.2013.09.029; McKinnon ML, 2014, J ALLERGY CLIN IMMUN, V133, P1458, DOI 10.1016/j.jaci.2013.10.045; Meazza R, 2014, J ALLERGY CLIN IMMUN, V134, P1381, DOI 10.1016/j.jaci.2014.04.043; Menard L, 2014, J ALLERGY CLIN IMMUN, V133, P1149, DOI 10.1016/j.jaci.2013.10.051; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; Pai SY, 2014, J ALLERGY CLIN IMMUN, V134, P221, DOI 10.1016/j.jaci.2014.02.023; Papan C, 2014, J ALLERGY CLIN IMMUN, V133, P1456, DOI 10.1016/j.jaci.2014.02.008; Pieper K, 2014, J ALLERGY CLIN IMMUN, V133, P1222, DOI 10.1016/j.jaci.2013.11.021; Platt C, 2014, J ALLERGY CLIN IMMUN, V134, P262, DOI 10.1016/j.jaci.2013.08.021; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Rose DM, 2014, J ALLERGY CLIN IMMUN, V133, P591, DOI 10.1016/j.jaci.2013.07.054; Ruiz-Garcia R, 2014, J ALLERGY CLIN IMMUN, V134, P218, DOI 10.1016/j.jaci.2014.01.023; Sabry A, 2014, J ALLERGY CLIN IMMUN, V133, P1225, DOI 10.1016/j.jaci.2013.11.031; Salzer E, 2014, J ALLERGY CLIN IMMUN, V133, P1651, DOI 10.1016/j.jaci.2014.02.034; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Schadenberg AWL, 2014, J ALLERGY CLIN IMMUN, V133, P277, DOI 10.1016/j.jaci.2013.08.030; Schubert D, 2014, NAT MED, V20, P1410, DOI 10.1038/nm.3746; Schuetz C, 2014, J ALLERGY CLIN IMMUN, V133, P1211, DOI 10.1016/j.jaci.2013.10.021; Schuetz C, 2014, BLOOD, V123, P281, DOI 10.1182/blood-2013-01-476432; Seite JF, 2014, J ALLERGY CLIN IMMUN, V133, P181, DOI 10.1016/j.jaci.2013.08.042; Serwas NK, 2014, BLOOD, V124, P655, DOI 10.1182/blood-2014-03-564930; Sharfe N, 2014, J ALLERGY CLIN IMMUN, V133, P807, DOI 10.1016/j.jaci.2013.09.032; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Sic H, 2014, J ALLERGY CLIN IMMUN, V134, P420, DOI 10.1016/j.jaci.2014.01.037; Siliciano JD, 2014, J ALLERGY CLIN IMMUN, V134, P12, DOI 10.1016/j.jaci.2014.05.026; Simhadri VR, 2014, J ALLERGY CLIN IMMUN, V134, P1190, DOI 10.1016/j.jaci.2014.06.006; Simon KL, 2014, J ALLERGY CLIN IMMUN, V133, P896, DOI 10.1016/j.jaci.2013.08.050; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Touzot F, 2014, J ALLERGY CLIN IMMUN, V134, P1203, DOI 10.1016/j.jaci.2014.05.039; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; van de Vijver E, 2014, J ALLERGY CLIN IMMUN, V133, P1215, DOI 10.1016/j.jaci.2013.10.020; van Til NP, 2014, J ALLERGY CLIN IMMUN, V133, P1116, DOI 10.1016/j.jaci.2013.10.009; van Zelm MC, 2014, J ALLERGY CLIN IMMUN, V134, P135, DOI 10.1016/j.jaci.2013.11.015; Visentini M, 2014, J ALLERGY CLIN IMMUN, V134, P401, DOI 10.1016/j.jaci.2014.03.017; Wang XW, 2014, J ALLERGY CLIN IMMUN, V133, P905, DOI 10.1016/j.jaci.2013.09.033; Willmann KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6360; Yu XM, 2014, J ALLERGY CLIN IMMUN, V133, P1109, DOI 10.1016/j.jaci.2013.11.018; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	102	15	19	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1132	1141		10.1016/j.jaci.2015.02.037	http://dx.doi.org/10.1016/j.jaci.2015.02.037			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH4DA	25956014				2022-12-18	WOS:000353980700005
J	Gelfand, EW; Alam, R				Gelfand, Erwin W.; Alam, Rafeul			The other side of asthma: Steroid-refractory disease in the absence of T(H)2-mediated inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Steroid-refractory asthma; CD8(+) T cells; T(H)17 cells; neutrophils	CD8(+) T-CELLS; AIRWAY HYPERRESPONSIVENESS		[Gelfand, Erwin W.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Alam, Rafeul] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	gelfande@njhealth.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126895] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chung EH, 2014, ANN ALLERG ASTHMA IM, V112, P211, DOI 10.1016/j.anai.2013.12.006; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jia Y, 2013, J IMMUNOL, V190, P4056, DOI 10.4049/jimmunol.1202640; Kankaanranta H, 2000, J ALLERGY CLIN IMMUN, V106, P77; Li LB, 2007, BLOOD, V110, P1570, DOI 10.1182/blood-2007-01-070755; Lo CY, 2015, J ALLERGY CLIN IMMUN, V135, P1186, DOI 10.1016/j.jaci.2014.10.031; Machura E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/606139; Morishima Y, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/609395; Ohnishi H, 2008, J ALLERGY CLIN IMMUN, V121, P864, DOI 10.1016/j.jaci.2008.01.035; Sjaheim T, 2006, EUR RESPIR J, V28, P1138, DOI 10.1183/09031936.06.00032906; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; van Rensen ELJ, 2005, AM J RESP CRIT CARE, V172, P837, DOI 10.1164/rccm.200504-619OC; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	13	15	15	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1196	1198		10.1016/j.jaci.2015.01.032	http://dx.doi.org/10.1016/j.jaci.2015.01.032			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH4DA	25772592				2022-12-18	WOS:000353980700012
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2014: Moving toward a population health perspective	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists; personalized medicine; severe asthma; therapeutics	GENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; AIR-POLLUTION; LUNG-FUNCTION; ADULT ASTHMA; BRONCHODILATOR RESPONSE; RESPIRATORY SYMPTOMS; PRESCHOOL-CHILDREN; WHEEZE PHENOTYPES; IMMUNE-RESPONSES	Last year's "Advances in pediatric asthma in 2013: Coordinating asthma care" concluded that, "Enhanced communication systems will be necessary among parents, clinicians, health care providers and the pharmaceutical industry so that we continue the pathway of understanding the disease and developing new treatments that address the unmet needs of patients who are at risk for severe consequences of unchecked disease persistence or progression." This year's summary will focus on further advances in pediatric asthma related to prenatal and postnatal factors altering the natural history of asthma, assessment of asthma control, and new insights regarding the management of asthma in children as indicated in Journal of Allergy and Clinical Immunology publications in 2014. A major theme of this review is how new research reports can be integrated into medical communication in a population health perspective to assist clinicians in asthma management. The asthma specialist is in a unique position to convey important messages to the medical community related to factors that influence the course of asthma, methods to assess and communicate levels of control, and new targets for intervention, as well as new immunomodulators. By enhancing communication among patients, parents, primary care physicians, and specialists within provider systems, the asthma specialist can provide timely information that can help to reduce asthma morbidity and mortality.	[Szefler, Stanley J.] Childrens Hosp Colorado, Dept Pediat, Breathing Inst, Pediat Asthma Res Program,Sect Pediat Pulm Med, Aurora, CO 80045 USA; [Szefler, Stanley J.] Univ Colorado Denver, Sch Medicine, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Szefler, SJ (corresponding author), Childrens Hosp Colorado, Sect Pulm Med, Breathing Inst, Pediat Asthma Res Program, 13123 E 16th Ave,Box 395, Aurora, CO 80045 USA.	Stanley.Szefler@childrenscolorado.org		Szefler, Stanley/0000-0002-6911-3199	Public Health Services [AI-90052, ES-18181, HL-98075]; Denver Post Charities, a McCormick Foundation; Colorado Cancer, Cardiovascular, and Pulmonary Disease Program [14 FLA 62707]; Colorado CTSA from the National Center for Research Resources/National Institutes of Health (NIH) [UL1 RR025780]; NIH/National Center for Advancing Translational Sciences [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Denver Post Charities, a McCormick Foundation; Colorado Cancer, Cardiovascular, and Pulmonary Disease Program; Colorado CTSA from the National Center for Research Resources/National Institutes of Health (NIH); NIH/National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by Public Health Services research grants AI-90052, ES-18181, and HL-98075; the Denver Post Charities, a McCormick Foundation; and the Colorado Cancer, Cardiovascular, and Pulmonary Disease Program (14 FLA 62707). Supported in part by Colorado CTSA grant UL1 RR025780 from the National Center for Research Resources/National Institutes of Health (NIH) and UL1 TR000154 from the NIH/National Center for Advancing Translational Sciences.	Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; Apter AJ, 2015, J ALLERGY CLIN IMMUN, V135, P46, DOI 10.1016/j.jaci.2014.10.050; Apter AJ, 2014, J ALLERGY CLIN IMMUN, V133, P49, DOI 10.1016/j.jaci.2013.11.005; Arteaga-Solis E, 2014, J ALLERGY CLIN IMMUN, V133, P1315, DOI 10.1016/j.jaci.2014.01.036; Aung YN, 2014, J ALLER CL IMM-PRACT, V2, P306, DOI 10.1016/j.jaip.2013.12.005; Bacharier LB, 2014, J ALLERGY CLIN IMMUN, V133, P1330, DOI 10.1016/j.jaci.2014.03.005; Beasley R, 2014, J ALLERGY CLIN IMMUN, V133, P39, DOI 10.1016/j.jaci.2013.10.053; Beigelman A, 2014, J ALLERGY CLIN IMMUN, V133, P1016, DOI 10.1016/j.jaci.2014.01.005; Belgrave D, 2014, AM J RESP CRIT CARE, V189, P121, DOI 10.1164/rccm.201312-2206ED; Bird JA, 2014, J ALLERGY CLIN IMMUN, V134, P490, DOI 10.1016/j.jaci.2014.05.002; Birrell MA, 2014, J ALLERGY CLIN IMMUN, V133, P679, DOI 10.1016/j.jaci.2013.12.003; Bousquet J, 2014, J ALLERGY CLIN IMMUN, V133, P1535, DOI 10.1016/j.jaci.2014.01.018; Brandt S, 2014, J ALLERGY CLIN IMMUN, V134, P1028, DOI 10.1016/j.jaci.2014.09.029; Busse WW, 2014, J ALLERGY CLIN IMMUN, V134, P260, DOI 10.1016/j.jaci.2014.05.008; Cabana MD, 2014, J ALLERGY CLIN IMMUN, V133, P27, DOI 10.1016/j.jaci.2013.10.026; Calhoun WJ, 2014, J ALLER CL IMM-PRACT, V2, P193, DOI 10.1016/j.jaip.2013.11.013; Chang TS, 2014, J ALLERGY CLIN IMMUN, V133, P363, DOI 10.1016/j.jaci.2013.09.002; Chiu YHM, 2014, J ALLERGY CLIN IMMUN, V133, P713, DOI 10.1016/j.jaci.2013.09.023; Cicutto L, 2014, J ALLERGY CLIN IMMUN, V134, P1223, DOI 10.1016/j.jaci.2014.10.004; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Dijkstra KK, 2014, J ALLERGY CLIN IMMUN, V133, P891, DOI 10.1016/j.jaci.2013.09.022; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Drake KA, 2014, J ALLERGY CLIN IMMUN, V133, P370, DOI 10.1016/j.jaci.2013.06.043; Ege M, 2013, AM J RESP CRIT CARE, V188, P1188, DOI 10.1164/rccm.201309-1680ED; Fabian MP, 2014, J ALLERGY CLIN IMMUN, V133, P77, DOI 10.1016/j.jaci.2013.06.003; Finkelman FD, 2014, J ALLERGY CLIN IMMUN, V134, P73, DOI 10.1016/j.jaci.2014.04.002; Forno E, 2014, J ALLERGY CLIN IMMUN, V133, P1308, DOI 10.1016/j.jaci.2013.09.041; Galanter JM, 2014, J ALLERGY CLIN IMMUN, V134, P295, DOI 10.1016/j.jaci.2013.08.055; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Global Initiative for Asthma, 2014, GLOBAL INITIATIVE AS; Grabenhenrich LB, 2014, J ALLERGY CLIN IMMUN, V133, P979, DOI 10.1016/j.jaci.2013.11.035; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Guilbert TW, 2014, J ALLER CL IMM-PRACT, V2, P489, DOI 10.1016/j.jaip.2014.06.022; Guxens M, 2014, J ALLERGY CLIN IMMUN, V133, P59, DOI 10.1016/j.jaci.2013.04.044; Haldar P, 2014, J ALLERGY CLIN IMMUN, V133, P921, DOI 10.1016/j.jaci.2013.11.026; Hartwig IRV, 2014, J ALLERGY CLIN IMMUN, V134, P160, DOI 10.1016/j.jaci.2014.01.033; Harvima IT, 2014, J ALLERGY CLIN IMMUN, V134, P530, DOI 10.1016/j.jaci.2014.03.007; Hollams EM, 2014, AM J RESP CRIT CARE, V189, P401, DOI 10.1164/rccm.201302-0323OC; Hollenbach JP, 2014, J ALLERGY CLIN IMMUN, V134, P1245, DOI 10.1016/j.jaci.2014.10.014; Howrylak JA, 2014, J ALLERGY CLIN IMMUN, V133, P1289, DOI 10.1016/j.jaci.2014.02.006; Huang XY, 2014, NEW ENGL J MED, V370, P1376, DOI 10.1056/NEJMp1315416; Huffaker M, 2014, J ALLERGY CLIN IMMUN, V134, P1232, DOI 10.1016/j.jaci.2014.09.010; Humbert M, 2014, J ALLER CL IMM-PRACT, V2, P525, DOI 10.1016/j.jaip.2014.03.010; Iwasaki J, 2014, J ALLERGY CLIN IMMUN, V134, P25, DOI 10.1016/j.jaci.2014.03.014; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P123, DOI 10.1164/rccm.201406-1131ED; Juhn YJ, 2014, J ALLERGY CLIN IMMUN, V134, P247, DOI 10.1016/j.jaci.2014.04.024; Kerkhof M, 2014, J ALLERGY CLIN IMMUN, V133, P68, DOI 10.1016/j.jaci.2013.06.004; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Kuo NW, 2014, J ALLERGY CLIN IMMUN, V134, P731, DOI 10.1016/j.jaci.2014.03.018; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lapin B, 2014, J ALLERGY CLIN IMMUN, V134, P728, DOI 10.1016/j.jaci.2014.05.006; Larsen JM, 2014, J ALLERGY CLIN IMMUN, V133, P1008, DOI 10.1016/j.jaci.2014.01.010; Leung TF, 2014, J ALLERGY CLIN IMMUN, V133, P42, DOI 10.1016/j.jaci.2013.09.018; Linehan MF, 2014, J ALLERGY CLIN IMMUN, V133, P688, DOI 10.1016/j.jaci.2013.08.007; Lodge CJ, 2014, AM J RESP CRIT CARE, V189, P1351, DOI 10.1164/rccm.201308-1487OC; Long A, 2014, J ALLERGY CLIN IMMUN, V134, P560, DOI 10.1016/j.jaci.2014.02.007; Lumia M, 2014, J ALLERGY CLIN IMMUN, V134, P488, DOI 10.1016/j.jaci.2014.04.012; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Lynn J, 2014, J ALLERGY CLIN IMMUN, V134, P1238, DOI 10.1016/j.jaci.2014.09.040; Malka J, 2014, J ALLERGY CLIN IMMUN, V134, P483, DOI 10.1016/j.jaci.2014.03.039; Manners S, 2014, J ALLERGY CLIN IMMUN, V134, P63, DOI 10.1016/j.jaci.2013.10.047; Matsui EC, 2013, AM J RESP CRIT CARE, V188, P1210, DOI 10.1164/rccm.201305-0889OC; Miller EK, 2014, J ALLER CL IMM-PRACT, V2, P537, DOI 10.1016/j.jaip.2014.06.024; Miller RL, 2014, J ALLERGY CLIN IMMUN, V134, P1001, DOI 10.1016/j.jaci.2014.07.064; Montella S, 2013, PEDIATR PULM, V48, P1160, DOI 10.1002/ppul.22761; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moreno-Macias H, 2014, J ALLERGY CLIN IMMUN, V133, P1237, DOI 10.1016/j.jaci.2014.03.020; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Myers JMB, 2014, J ALLERGY CLIN IMMUN, V134, P891, DOI 10.1016/j.jaci.2014.03.037; Nguyen JM, 2014, J ALLERGY CLIN IMMUN, V133, P91, DOI 10.1016/j.jaci.2013.06.029; Nwaru BI, 2014, J ALLERGY CLIN IMMUN, V133, P1084, DOI 10.1016/j.jaci.2013.12.1069; Okelo SO, 2014, J ALLER CL IMM-PRACT, V2, P186, DOI 10.1016/j.jaip.2013.10.005; Ortega VE, 2014, J ALLERGY CLIN IMMUN, V133, P16, DOI 10.1016/j.jaci.2013.10.040; Park HW, 2014, J ALLERGY CLIN IMMUN, V133, P664, DOI 10.1016/j.jaci.2013.12.1042; Pedersen S, 2014, J ALLERGY CLIN IMMUN, V133, P1606, DOI 10.1016/j.jaci.2013.11.003; Pescatore AM, 2014, J ALLERGY CLIN IMMUN, V133, P111, DOI 10.1016/j.jaci.2013.06.002; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Rabinovitch N, 2014, J ALLERGY CLIN IMMUN, V133, P350, DOI 10.1016/j.jaci.2013.07.039; Radhakrishnan DK, 2014, J ALLERGY CLIN IMMUN, V134, P1057, DOI 10.1016/j.jaci.2014.05.012; Reddy MB, 2014, ALLERGY ASTHMA PROC, V35, P119, DOI 10.2500/aap.2014.35.3727; Rodriguez-Martinez CE, 2014, J ALLER CL IMM-PRACT, V2, P326, DOI 10.1016/j.jaip.2014.01.014; Romeo MJ, 2014, J ALLERGY CLIN IMMUN, V133, P952, DOI 10.1016/j.jaci.2013.08.006; Rosas-Salazar C, 2014, J ALLERGY CLIN IMMUN, V133, P357, DOI 10.1016/j.jaci.2013.09.003; Rosenberg SL, 2014, J ALLERGY CLIN IMMUN, V134, P1009, DOI 10.1016/j.jaci.2014.07.005; Savenije OE, 2014, J ALLERGY CLIN IMMUN, V134, P170, DOI 10.1016/j.jaci.2013.12.1080; Schatz M, 2014, J ALLERGY CLIN IMMUN, V133, P1549, DOI 10.1016/j.jaci.2013.10.006; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Sharma S, 2014, J ALLERGY CLIN IMMUN, V134, P1153, DOI 10.1016/j.jaci.2014.04.011; Sharma S, 2014, J ALLERGY CLIN IMMUN, V133, P1246, DOI 10.1016/j.jaci.2013.10.039; Simons E, 2014, J ALLER CL IMM-PRACT, V2, P201, DOI 10.1016/j.jaip.2013.11.014; Smits HH, 2014, J ALLERGY CLIN IMMUN, V134, P1280, DOI 10.1016/j.jaci.2014.08.051; Sorkness CA, 2014, J ALLERGY CLIN IMMUN, V133, P397, DOI 10.1016/j.jaci.2013.11.001; Stockmann C, 2014, J ALLERGY CLIN IMMUN, V134, P1443, DOI 10.1016/j.jaci.2014.09.019; Straubinger K, 2014, J ALLERGY CLIN IMMUN, V134, P1271, DOI 10.1016/j.jaci.2014.05.034; Sutherland ER, 2014, J ALLERGY CLIN IMMUN, V133, P34, DOI 10.1016/j.jaci.2013.10.025; Szefler SJ, 2014, J ALLERGY CLIN IMMUN, V133, P654, DOI 10.1016/j.jaci.2014.01.012; Szefler SJ, 2014, J ALLERGY CLIN IMMUN, V133, P3, DOI 10.1016/j.jaci.2013.10.018; Tai A, 2014, J ALLERGY CLIN IMMUN, V133, P1572, DOI 10.1016/j.jaci.2013.12.1033; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Turner S, 2014, J ALLERGY CLIN IMMUN, V133, P119, DOI 10.1016/j.jaci.2013.07.001; van der Valk RJP, 2014, J ALLERGY CLIN IMMUN, V134, P46, DOI 10.1016/j.jaci.2013.08.053; van Vliet D, 2014, ANN ALLERG ASTHMA IM, V113, P257, DOI 10.1016/j.anai.2014.05.015; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Voorend-van Bergen S, 2014, J ALLERGY CLIN IMMUN, V133, P1599, DOI 10.1016/j.jaci.2013.10.005; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weinberger M, 2014, J ALLERGY CLIN IMMUN, V133, P1014, DOI 10.1016/j.jaci.2013.07.013; Wendell SG, 2014, J ALLERGY CLIN IMMUN, V133, P1255, DOI 10.1016/j.jaci.2013.12.1087; Whyatt RM, 2014, J ALLERGY CLIN IMMUN, V134, P1195, DOI 10.1016/j.jaci.2014.07.027; Wu AC, 2014, J ALLERGY CLIN IMMUN, V133, P723, DOI 10.1016/j.jaci.2013.09.037; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042	112	15	18	0	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2015	135	3					644	652		10.1016/j.jaci.2014.12.1921	http://dx.doi.org/10.1016/j.jaci.2014.12.1921			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CD4PF	25649079				2022-12-18	WOS:000351065000007
J	Azoulay-Alfaguter, I; Strazza, M; Pedoeem, A; Mor, A				Azoulay-Alfaguter, Inbar; Strazza, Marianne; Pedoeem, Ariel; Mor, Adam			The coreceptor programmed death 1 inhibits T-cell adhesion by regulating Rap1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PD-1; TOLERANCE		[Azoulay-Alfaguter, Inbar; Strazza, Marianne; Pedoeem, Ariel; Mor, Adam] NYU, Sch Med, Dept Med, New York, NY 10012 USA	New York University	Azoulay-Alfaguter, I (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10012 USA.	Adam.Mor@NYUMC.org		Strazza, Marianne/0000-0003-2422-2583				Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Kloog Y, 2014, MOL CELL BIOL, V34, P978, DOI 10.1128/MCB.01024-13; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Riley J., 2012, IMMUNOL REV, V229, P114; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Singh AK, 2011, ALLERGY, V66, P155, DOI 10.1111/j.1398-9995.2010.02458.x; Strazza M, 2014, J VIS EXP; Youngblood B, 2013, J IMMUNOL, V191, P540, DOI 10.4049/jimmunol.1203161; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	11	15	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2015	135	2					564	+		10.1016/j.jaci.2014.07.055	http://dx.doi.org/10.1016/j.jaci.2014.07.055			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CB1FL	25240786				2022-12-18	WOS:000349372300035
J	Hollenbach, JP; Cloutier, MM				Hollenbach, Jessica P.; Cloutier, Michelle M.			Implementing school asthma programs: Lessons learned and recommendations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; school-based asthma programs; implementation research; environment; policy	PEDIATRIC ASTHMA; CHILDREN; CARE; DISSEMINATION; INTERVENTION; COMMUNITY; OUTCOMES	Despite significant advances in the treatment of asthma and the development of evidence-based and evidence-informed guidelines, childhood asthma morbidity remains high. One measure of asthma-associated morbidity is school absenteeism. In this rostrum we summarize key themes from 3 articles in this special issue on school-centered asthma programs. All 3 articles in this series describe several common themes that are essential for successful school-based interventions. These themes include the importance of trust and building strong partnerships, the importance of interaction and communication between multiple key stakeholders (ecological framework), the central and often overlooked role of the primary care clinician, the need for sustainable resources, and the importance of context and public policy. We then discuss how to apply the framework of implementation research to inform and evaluate school-based interventions. Finally, we make a series of recommendations for future work.	[Hollenbach, Jessica P.; Cloutier, Michelle M.] Univ Connecticut, Hlth Ctr, Connecticut Childrens Med Ctr, Storrs, CT USA; [Cloutier, Michelle M.] Univ Connecticut, Hlth Ctr, Dept Pediat & Med, Storrs, CT USA	Connecticut Children's Medical Center; University of Connecticut; University of Connecticut	Cloutier, MM (corresponding author), Connecticut Childrens Med Ctr, Childrens Ctr Community Res, 282 Washington St, Hartford, CT 06106 USA.	mclouti@connecticutchildrens.org			GlaxoSmithKline [FLV116794]; ProHealth Physicians; Elsevier	GlaxoSmithKline(GlaxoSmithKline); ProHealth Physicians; Elsevier	This rostrum was funded by GlaxoSmithKline (FLV116794). M. M. Cloutier's institution has received funding from the GlaxoSmithKline foundation (FLV116794), and she receives consultancy fees from ProHealth Physicians, as well as book royalties from Elsevier. J. P. Hollenbach's institution has received funding from GlaxoSmithKline (FLV116794).	Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Albright K, 2013, ACAD PEDIATR, V13, P400, DOI 10.1016/j.acap.2013.06.010; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Chambers DA, 2013, PSYCHIAT SERV, V64, P509, DOI 10.1176/appi.ps.201300032; Cicutto L, 2014, J ALLERGY CLIN IMMUN, V134, P1223, DOI 10.1016/j.jaci.2014.10.004; Cloutier MM, 2011, PEDIATRICS, V127, P11, DOI 10.1542/peds.2010-1943; Cloutier MM, 2009, AM J MANAG CARE, V15, P345; Cloutier MM, 2002, CHEST, V122, P1571, DOI 10.1378/chest.122.5.1571; Cowen MK, 2007, J ASTHMA, V44, P711, DOI 10.1080/02770900701595576; Crain EF, 2002, ENVIRON HEALTH PERSP, V110, P939, DOI 10.1289/ehp.02110939; Gerald LB, 2006, J SCHOOL HEALTH, V76, P291, DOI 10.1111/j.1746-1561.2006.00114.x; Hall CB, 2001, J PEDIATR-US, V139, P267, DOI 10.1067/mpd.2001.116697; Halterman JS, 2011, ARCH PEDIAT ADOL MED, V165, P262, DOI 10.1001/archpediatrics.2011.1; Huang XY, 2014, NEW ENGL J MED, V370, P1376, DOI 10.1056/NEJMp1315416; Huffaker M, 2014, J ALLERGY CLIN IMMUN, V134, P1232, DOI 10.1016/j.jaci.2014.09.010; KAPLAN DL, 1986, J SCHOOL HEALTH, V56, P267, DOI 10.1111/j.1746-1561.1986.tb05748.x; Liao O, 2006, J SCHOOL HEALTH, V76, P313, DOI 10.1111/j.1746-1561.2006.00119.x; Liberty KA, 2010, CHEST, V138, P1349, DOI 10.1378/chest.10-0543; Lynn J, 2014, J ALLERGY CLIN IMMUN, V134, P1238, DOI 10.1016/j.jaci.2014.09.040; Marder D, 1999, J RESP DIS, V20, P630; Mizan SS, 2011, J ASTHMA, V48, P228, DOI 10.3109/02770903.2011.555038; Moonie S, 2008, J SCHOOL HEALTH, V78, P140, DOI 10.1111/j.1746-1561.2007.00276.x; National Institutes of Health/National Heart Lung and Blood Institute, 1997, NIH PUBL; National Toxicology Program, 2007, Natl Toxicol Program Tech Rep Ser, P1; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Sheares BJ, 2007, PEDIATR PULM, V42, P348, DOI 10.1002/ppul.20586; Wheeler LS, 2006, J SCHOOL HEALTH, V76, P340, DOI 10.1111/j.1746-1561.2006.00125.x	27	15	16	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1245	1249		10.1016/j.jaci.2014.10.014	http://dx.doi.org/10.1016/j.jaci.2014.10.014			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	AW1UG	25482869	Bronze			2022-12-18	WOS:000346075400004
J	Renand, A; Newbrough, S; Wambre, E; DeLong, JH; Robinson, D; Kwok, WW				Renand, Amedee; Newbrough, Sally; Wambre, Erik; DeLong, Jonathan H.; Robinson, David; Kwok, William W.			Arginine kinase Pen m 2 as an important shrimp allergen recognized by T(H)2 cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PENAEUS-MONODON; IDENTIFICATION; TROPOMYOSIN; EPITOPES		[Renand, Amedee; Wambre, Erik; DeLong, Jonathan H.; Kwok, William W.] Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA; [Newbrough, Sally; Kwok, William W.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Robinson, David] Virginia Mason Med Ctr, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; Virginia Mason Medical Center	Renand, A (corresponding author), Virginia Mason, Benaroya Res Inst, Seattle, WA 98101 USA.	bkwok@benaroyaresearch.org	Renand, Amedee/A-9884-2018	Renand, Amedee/0000-0003-2265-549X	NIAID NIH HHS [HHSN272200700046C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayuso R, 2008, J ALLERGY CLIN IMMUN, V122, P795, DOI 10.1016/j.jaci.2008.07.023; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Lopata AL, 2010, CLIN EXP ALLERGY, V40, P850, DOI 10.1111/j.1365-2222.2010.03513.x; Ravkov EV, 2013, HUM IMMUNOL, V74, P1542, DOI 10.1016/j.humimm.2013.08.276; SHANTI KN, 1993, J IMMUNOL, V151, P5354; Shiomi K, 2008, INT ARCH ALLERGY IMM, V146, P91, DOI 10.1159/000113512; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, pe1; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wang SP, 2012, HUM IMMUNOL, V73, P426, DOI 10.1016/j.humimm.2011.12.019; Yu CJ, 2003, J IMMUNOL, V170, P445, DOI 10.4049/jimmunol.170.1.445	10	15	16	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1456	1459		10.1016/j.jaci.2014.07.048	http://dx.doi.org/10.1016/j.jaci.2014.07.048			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW1UG	25224098	Green Accepted			2022-12-18	WOS:000346075400033
J	Bhakta, NR; Erle, DJ				Bhakta, Nirav R.; Erle, David J.			IL-17 and "T(H)2-high" asthma: Adding fuel to the fire?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma: cellular/molecular mechanisms; cytokines; endotype; IL-13; IL-17	INNATE LYMPHOID-CELLS; AIRWAY HYPERRESPONSIVENESS; T-CELLS; INFLAMMATION; PRODUCE; SUBSET		[Bhakta, Nirav R.; Erle, David J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Erle, DJ (corresponding author), Lung Biol Ctr, UCSF MC 2922, San Francisco, CA 94143 USA.	david.erle@ucsf.edu		Erle, David/0000-0002-2171-0648	NHLBI NIH HHS [K23HL116657] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL116657] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	15	15	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2014	134	5					1187	1188		10.1016/j.jaci.2014.07.034	http://dx.doi.org/10.1016/j.jaci.2014.07.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AT4UN	25174869				2022-12-18	WOS:000344938900024
J	Papan, C; Hagl, B; Heinz, V; Albert, MH; Ehrt, O; Sawalle-Belohradsky, J; Neumann, J; Ries, M; Bufler, P; Wollenberg, A; Renner, ED				Papan, Cihan; Hagl, Beate; Heinz, Valerie; Albert, Michael H.; Ehrt, Oliver; Sawalle-Belohradsky, Julie; Neumann, Jens; Ries, Martin; Bufler, Philip; Wollenberg, Andreas; Renner, Ellen D.			Beneficial IFN-alpha treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYPER-IGE SYNDROME; HYPERIMMUNOGLOBULIN-E SYNDROME; DOCK8 DEFICIENCY; MUTATIONS; RESPONSES; SURVIVAL		[Papan, Cihan; Hagl, Beate; Heinz, Valerie; Albert, Michael H.; Sawalle-Belohradsky, Julie; Bufler, Philip; Renner, Ellen D.] Univ Childrens Hosp, Dr von Haunersches Kinderspital, Munich, Germany; [Ehrt, Oliver] Univ Munich, Dept Ophthalmol, Munich, Germany; [Neumann, Jens] Univ Munich, Dept Pathol, Munich, Germany; [Wollenberg, Andreas] Univ Munich, Dept Dermatol & Allergol, Munich, Germany; [Ries, Martin] Childrens Hosp, Memmingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich; University of Munich; University of Munich	Papan, C (corresponding author), Univ Childrens Hosp, Dr von Haunersches Kinderspital, Munich, Germany.	Ellen.Renner@med.lmu.de	Renner, Ellen/R-7168-2016; Papan, Cihan/ABE-4478-2020; Hagl, Beate/R-9266-2016	Renner, Ellen/0000-0001-9816-8538; Papan, Cihan/0000-0001-7951-2567; Bufler, Philip/0000-0002-5742-8273; Hagl, Beate/0000-0002-0717-3508				Benninghoff U, 2008, PEDIAT ALLERG IMM-UK, V19, P564, DOI 10.1111/j.1399-3038.2007.00683.x; Bittner TC, 2010, KLIN PADIATR, V222, P351, DOI 10.1055/s-0030-1265135; Boos AC, 2014, ALLERGY IN PRESS; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Keles S., 2014, J ALLERGY C IN PRESS; Kilic SS, 2006, PEDIATRICS, V117, pE1253, DOI 10.1542/peds.2005-2706; Mizesko MC, 2013, J ALLERGY CLIN IMMUN, V131, P840, DOI 10.1016/j.jaci.2012.12.1568; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ozarmagan G, 2005, ACTA DERM-VENEREOL, V85, P433, DOI 10.1080/00015550510030041; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Wollenberg A, 2011, CLIN REV ALLERG IMMU, V41, P272, DOI 10.1007/s12016-010-8227-x; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	17	15	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2014	133	5					1456	1458		10.1016/j.jaci.2014.02.008	http://dx.doi.org/10.1016/j.jaci.2014.02.008			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AG5HS	24698314				2022-12-18	WOS:000335450700029
J	Verstegen, RHJ; Borte, S; Bok, LA; van Zwieten, PHT; von Dobeln, U; Hammarstrom, L; de Vries, E				Verstegen, Ruud H. J.; Borte, Stephan; Bok, Levinus A.; van Zwieten, Paul H. Th; von Dobeln, Ulrika; Hammarstrom, Lennart; de Vries, Esther			Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INTRINSIC DEFECT; T-CELLS; CHILDREN; SYSTEM		[Verstegen, Ruud H. J.; de Vries, Esther] Jeroen Bosch Hosp, Dept Pediat, Shertogenbosch, Netherlands; [Borte, Stephan; Hammarstrom, Lennart] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Immunol & Transfus Med,Dept Lab Med, Stockholm, Sweden; [Borte, Stephan] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Borte, Stephan] Hosp St Georg gGmbH Leipzig, Jeffrey Modell Diagnost & Res Ctr Primary Immunod, ImmunoDeficiencyCtr Leipzig, Leipzig, Germany; [Bok, Levinus A.] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands; [van Zwieten, Paul H. Th] Juliana Childrens Hosp, Dept Pediat, The Hague, Netherlands; [von Dobeln, Ulrika] Karolinska Univ, Hosp Solna, Karolinska Inst, Div Metab Dis,Dept Lab Med, Stockholm, Sweden	Jeroen Bosch Ziekenhuis; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Maxima Medical Center; Karolinska Institutet; Karolinska University Hospital	Verstegen, RHJ (corresponding author), Jeroen Bosch Hosp, Dept Pediat, Shertogenbosch, Netherlands.	e.d.vries@jbz.nl	Verstegen, Ruud/R-8613-2018; Verstegen, Ruud/N-5964-2019	Verstegen, Ruud/0000-0001-6638-8405; Verstegen, Ruud/0000-0001-6638-8405; de Vries, Esther/0000-0003-4311-3550				ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; Bakare N, 2010, VACCINE, V28, P6609, DOI 10.1016/j.vaccine.2010.07.039; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Borte S, 2011, ANN NY ACAD SCI, V1246, P118, DOI 10.1111/j.1749-6632.2011.06350.x; Kusters MAA, 2009, CLIN EXP IMMUNOL, V156, P189, DOI 10.1111/j.1365-2249.2009.03890.x; Kusters MAA, 2010, PEDIATR RES, V67, P557, DOI 10.1203/PDR.0b013e3181d4eca3; Marcus N, 2011, J ALLERGY CLIN IMMUN, V128, P1050, DOI 10.1016/j.jaci.2011.05.031; Nakagawa N, 2011, J ALLERGY CLIN IMMUN, V128, P223, DOI 10.1016/j.jaci.2011.01.052; Nicolas L, 2001, CLIN IMMUNOL, V98, P358, DOI 10.1006/clim.2000.4978; Roat E, 2008, REJUV RES, V11, P573, DOI 10.1089/rej.2007.0648; THILAGANATHAN B, 1993, BRIT J OBSTET GYNAEC, V100, P60, DOI 10.1111/j.1471-0528.1993.tb12952.x; Verstegen RHJ, 2010, PEDIATR RES, V67, P563, DOI 10.1203/PDR.0b013e3181d4ecc1	13	15	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					1208	1211		10.1016/j.jaci.2013.10.010	http://dx.doi.org/10.1016/j.jaci.2013.10.010			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24332217				2022-12-18	WOS:000333531700034
J	Hanania, NA; Noonan, MJ; Corren, J; Korenblat, P; Zheng, YA; Putnam, W; Murray, E; Abelardo, C; Scheerens, H; Maciuca, R; Gray, S; Doyle, R; McClintock, D; Matthews, JG; Yen, K				Hanania, Nicola A.; Noonan, Michael J.; Corren, Jonathan; Korenblat, Phillip; Zheng, Yanan; Putnam, Wendy; Murray, Elaine; Abelardo, Connie; Scheerens, Heleen; Maciuca, Romeo; Gray, Sarah; Doyle, Ramona; McClintock, Dana; Matthews, John G.; Yen, Karl			Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Noonan, Michael J.] Allergy Associates Res, Portland, OR USA; [Corren, Jonathan] Allergy Med Clin, Los Angeles, CA USA; [Korenblat, Phillip] Clin Res Ctr LLC, St Louis, MO USA; [Zheng, Yanan; Putnam, Wendy; Murray, Elaine; Abelardo, Connie; Scheerens, Heleen; Maciuca, Romeo; Gray, Sarah; Doyle, Ramona; McClintock, Dana; Matthews, John G.; Yen, Karl] Genentech Inc, San Francisco, CA 94080 USA	Baylor College of Medicine; Roche Holding; Genentech			Zheng, Yanan/GPX-8908-2022; Hanania, Nicola A/C-5875-2016	Zheng, Yanan/0000-0002-9823-0191; Hanania, Nicola A/0000-0003-3087-9530					0	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		L16	AB402	AB402		10.1016/j.jaci.2013.12.1064	http://dx.doi.org/10.1016/j.jaci.2013.12.1064			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241302016
J	Schuepbach-Mallepell, S; Philippe, V; Bruggen, MC; Watanabe, H; Roques, S; Baldeschi, C; Gaide, O				Schuepbach-Mallepell, Sonia; Philippe, Virginie; Brueggen, Marie-Charlotte; Watanabe, Hideki; Roques, Stephanie; Baldeschi, Christine; Gaide, Olivier			Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopy; atopic dermatitis; asthma; thymic stromallymphopoietin; NACHT-, LRR-, and PYD-containing protein; IL-1; inflammasome; T(H)1; T(H)2	NF-KAPPA-B; ATOPIC-DERMATITIS; CONTACT HYPERSENSITIVITY; TH2 CYTOKINES; MASTER SWITCH; CUTTING EDGE; RECEPTOR; MICE; CASPASE-1; CELLS	Background: Innate immune sensors control key cytokines that regulate T-cell priming and T-cell fate. This is particularly evident in allergic reactions, which represent ideal systems to study the interplay of innate and adaptive immunity. In patients with contact dermatitis, inflammasome-mediated IL-1 activation is responsible for a T(H)1 immune response. Surprisingly, the IL-1 signaling pathway was also proposed to control the activation of thymic stromal lymphopoietin (TSLP), a cytokine implicated in development of the T(H)2 response in patients with atopic dermatitis (AD) and asthma. Objectives: We sought to assess the effect of the inflammasome on TSLP expression levels and the development of AD. Methods: We studied the effect of the inflammasome activator 2,4-dinitrofluorobenzene, and IL-1 beta on TSLP mRNA expression levels in mouse and human cell lines (in vitro assays), as well as in live mice and on human skin transplants. We also assessed the effect of 2,4-dinitrofluorobenzene on TSLP and the TH2 response in mice in which the inflammasome and IL-1 signaling pathways were blocked, either genetically or pharmacologically, in 2 models of AD. Results: We provide in vitro and in vivo evidence that inflammasome activation has an inhibitory role on TSLP mRNA expression and TH2 cell fate in the skin. We also show that solvents influence the activation of TSLP and IL-1b and direct the T-cell fate to a given hapten. Conclusion: Our observations strongly suggest that the TH1 versus TH2 cell fate decision is regulated at multiple levels and starts with innate immune events occurring within peripheral epithelial tissues.	[Schuepbach-Mallepell, Sonia; Philippe, Virginie; Watanabe, Hideki; Roques, Stephanie; Gaide, Olivier] Univ Geneva, Dept Dermatol, CH-1211 Geneva 4, Switzerland; [Schuepbach-Mallepell, Sonia; Philippe, Virginie; Watanabe, Hideki; Roques, Stephanie; Gaide, Olivier] Univ Geneva, Dept Pathol Immunol, CH-1211 Geneva 4, Switzerland; [Baldeschi, Christine] UEVE, INSERM, U861, Dept Dermatol, Evry, France; [Baldeschi, Christine] UEVE, INSERM, U861, I STEM,AFM, Evry, France; [Brueggen, Marie-Charlotte] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Gaide, Olivier] CHU Vaudois, Dept Dermatol & Venereol, CH-1011 Lausanne, Switzerland	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Medical University of Vienna; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Gaide, O (corresponding author), CHU Vaudois, Dept Dermatol Venereol, CH-1011 Lausanne, Switzerland.	olivier.gaide@chuv.ch	baldeschi, christine/U-9386-2018	baldeschi, christine/0000-0001-6624-0507; Bruggen, Marie-Charlotte/0000-0002-8607-6254	Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Supported by grants from the Swiss National Science Foundation ( to S.S.-M. and O.G.).	ALLENBY CF, 1993, CONTACT DERMATITIS, V28, P129, DOI 10.1111/j.1600-0536.1993.tb03371.x; Bogiatzi SI, 2007, J IMMUNOL, V178, P3373, DOI 10.4049/jimmunol.178.6.3373; Bogiatzi SI, 2012, J ALLERGY CLIN IMMUN, V130, P233, DOI 10.1016/j.jaci.2012.04.038; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Corrigan CJ, 2009, ALLERGY, V64, P1014, DOI 10.1111/j.1398-9995.2009.01947.x; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Grigoryev DN, 2010, J ALLERGY CLIN IMMUN, V125, P153, DOI 10.1016/j.jaci.2009.10.024; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Jin HL, 2009, J INVEST DERMATOL, V129, P31, DOI 10.1038/jid.2008.106; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; Kitagaki H, 1997, J IMMUNOL, V159, P2484; KLIGMAN AM, 1966, J INVEST DERMATOL, V47, P375, DOI 10.1038/jid.1966.159; Kurup VP, 1997, ALLERGY, V52, P1215, DOI 10.1111/j.1398-9995.1997.tb02526.x; Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478; Lee HC, 2008, J IMMUNOL, V181, P5189, DOI 10.4049/jimmunol.181.8.5189; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Ma P, 2009, INVEST OPHTH VIS SCI, V50, P2702, DOI 10.1167/iovs.08-3074; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Sano Y, 2013, CLIN EXP IMMUNOL, V171, P330, DOI 10.1111/cei.12021; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shigeno T, 2009, IMMUNOLOGY, V128, pe849, DOI 10.1111/j.1365-2567.2009.03094.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2008, J IMMUNOL, V180, P5826, DOI 10.4049/jimmunol.180.9.5826; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weidinger S, 2005, CLIN EXP ALLERGY, V35, P866, DOI 10.1111/j.1365-2222.2005.02269.x; Wu WH, 2010, J ALLERGY CLIN IMMUN, V126, P290, DOI 10.1016/j.jaci.2010.05.024; Yamanaka K, 2000, J IMMUNOL, V165, P997, DOI 10.4049/jimmunol.165.2.997; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503	34	15	15	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1348	1357		10.1016/j.jaci.2013.06.033	http://dx.doi.org/10.1016/j.jaci.2013.06.033			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	23953709				2022-12-18	WOS:000327538200014
J	Kollmann, D; Geroldinger-Simic, M; Kinaciyan, T; Huber, H; Ebner, C; Lidholm, J; Bohle, B				Kollmann, Dagmar; Geroldinger-Simic, Marija; Kinaciyan, Tamar; Huber, Hans; Ebner, Christof; Lidholm, Jonas; Bohle, Barbara			Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IN-VIVO; IMMUNOTHERAPY; TESTS		[Kollmann, Dagmar; Geroldinger-Simic, Marija; Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Kinaciyan, Tamar] Med Univ Vienna, Dept Dermatol, DIAID, Vienna, Austria; [Huber, Hans] Biomay AG, Vienna, Austria; [Ebner, Christof] Allergy Clin, Vienna, Austria; [Lidholm, Jonas] Thermo Fisher Sci, Uppsala, Sweden	Medical University of Vienna; Medical University of Vienna; Thermo Fisher Scientific	Kollmann, D (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Christian Doppler Lab Immunomodulat, Vienna, Austria.	barbara.bohle@meduniwien.ac.at		Bohle, Barbara/0000-0002-5105-7985; Kinaciyan, Tamar/0000-0002-8238-2561; Lidholm, Jonas/0000-0002-7779-3411				Asero R, 1998, CLIN EXP ALLERGY, V28, P1368, DOI 10.1046/j.1365-2222.1998.00399.x; Bolhaar STHP, 2004, CLIN EXP ALLERGY, V34, P761, DOI 10.1111/j.1365-2222.2004.1939.x; Geroldinger-Simic M, 2013, J ALLERGY CLIN IMMUN, V131, P94, DOI 10.1016/j.jaci.2012.06.039; Geroldinger-Simic M, 2011, J ALLERGY CLIN IMMUN, V127, P616, DOI 10.1016/j.jaci.2010.10.027; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; Sancho AI, 2006, J AGR FOOD CHEM, V54, P5917, DOI 10.1021/jf060880m; Schulten V, 2011, MOL NUTR FOOD RES, V55, P1484, DOI 10.1002/mnfr.201100234; Tresch S, 2003, CLIN EXP ALLERGY, V33, P1153, DOI 10.1046/j.1365-2222.2003.01717.x; VIETHS S, 1994, ALLERGY, V49, P262, DOI 10.1111/j.1398-9995.1994.tb02659.x	9	15	16	1	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					1008	1010		10.1016/j.jaci.2013.05.030	http://dx.doi.org/10.1016/j.jaci.2013.05.030			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23810767				2022-12-18	WOS:000325096500041
J	Horn, B; Cowan, MJ				Horn, Biljana; Cowan, Morton J.			Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe combined immunodeficiency; T cell-depleted stem cell transplantation; alternative donors; immune reconstitution; late effects of transplantation	BONE-MARROW TRANSPLANTS; GENE-THERAPY; DISEASE; RECONSTITUTION; BLOOD	In this review we discuss recent outcomes of hematopoietic cell transplantation (HCT) for patients with severe combined immunodeficiency (SCID), including survival, T- and B-cell reconstitution, and late effects, particularly those related to genotype, use of conditioning regimen, and use of alternative donors. We identify the following issues that require additional data, which can be obtained through cooperative studies: outcomes of patients with SCID who did not receive conditioning before alternative donor HCT; outcomes of patients with SCID who did not receive graft-versus-host disease prophylaxis after T cell-replete HCT; late effects of HCT for patients with SCID, including neurocognitive outcomes, growth, and development; and their relationship to genotype and use of alkylating agents for conditioning. Careful follow-up of outcomes of all newborns receiving diagnoses based on newborn screening programs for SCID is essential because data are scarce on the effects of conditioning regimens in very young patients. A consensus on the definition of T- and B-cell recovery, criteria for additional "boosts,'' pharmacokinetic data of chemotherapy agents used in young children, and uniformity of the use of various chemotherapy agents are needed to compare results among institutions. Finally, development of new nontoxic conditioning regimens for HCT that can be safely used in very young children is required.	[Horn, Biljana; Cowan, Morton J.] Univ Calif San Francisco, Div Allergy Immunol & Blood & Marrow Transplantat, Benioff Childrens Hosp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Horn, B (corresponding author), UCSF, Benioff Childrens Hosp, 505 Parnassus Ave,Suite M-659, San Francisco, CA 94143 USA.	hornb@peds.ucsf.edu			National Institutes of Health/National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R13AI094943, U54AI082973] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M. J. Cowan has received a grant from the National Institutes of Health/National Institute of Allergy and Infectious Disease.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Bertrand Y, 2002, BONE MARROW TRANSPL, V29, P759, DOI 10.1038/sj.bmt.1703531; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Dvorak CC, 2008, BIOL BLOOD MARROW TR, V14, P1125, DOI 10.1016/j.bbmt.2008.07.008; Eapen M, 2012, BIOL BLOOD MARROW TR, V18, P1438, DOI 10.1016/j.bbmt.2012.03.003; Fernandes JF, 2012, BLOOD, V119, P2949, DOI 10.1182/blood-2011-06-363572; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Hassan A, 2012, BLOOD, V120, P3615, DOI 10.1182/blood-2011-12-396879; Honig M, 2012, BONE MARROW TRANSPL, V47, P305, DOI 10.1038/bmt.2011.71; Honig M, 2007, BLOOD, V109, P3595, DOI 10.1182/blood-2006-07-034678; Kamani NR, 2011, BIOL BLOOD MARROW TR, V17, P1783, DOI 10.1016/j.bbmt.2011.05.008; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; O'Marcaigh AS, 2001, BONE MARROW TRANSPL, V27, P703, DOI 10.1038/sj.bmt.1702831; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Patel NC, 2008, J ALLERGY CLIN IMMUN, V122, P1185, DOI 10.1016/j.jaci.2008.10.030; Railey MD, 2009, J PEDIATR-US, V155, P834, DOI 10.1016/j.jpeds.2009.07.049; Sarzotti M, 2003, J IMMUNOL, V342, P1325; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Titman P, 2008, BLOOD, V112, P3907, DOI 10.1182/blood-2008-04-151332	22	15	16	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2013	131	5					1306	1311		10.1016/j.jaci.2013.03.014	http://dx.doi.org/10.1016/j.jaci.2013.03.014			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	144AU	23622119	Green Accepted, Bronze			2022-12-18	WOS:000318912200005
J	Al-Mousa, H; Hawwari, A; Alsum, Z				Al-Mousa, Hamoud; Hawwari, Abbas; Alsum, Zobaida			In DOCK8 deficiency donor cell engraftment post-genoidentical hematopoietic stem cell transplantation is possible without conditioning	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYPER-IGE SYNDROME		[Al-Mousa, Hamoud] King Faisal Specialist Hosp & Res Ctr, Dept Pediat Allergy & Clin Immunol, Riyadh 11211, Saudi Arabia; [Al-Mousa, Hamoud] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Al-Mousa, Hamoud; Hawwari, Abbas] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alsum, Zobaida] King Khaled Univ Hosp, Dept Pediat Allergy & Clin Immunol, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Alfaisal University; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital	Al-Mousa, H (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Pediat Allergy & Clin Immunol, Riyadh 11211, Saudi Arabia.	hamoudalmousa@kfshrc.edu.sa	Hawwari, Abbas/L-1934-2019; Al-Mousa, Hamoud/AAS-4477-2020	Hawwari, Abbas/0000-0001-9643-6500; 				Barlogis V, 2011, J ALLERGY CLIN IMMUN, V128, P420, DOI 10.1016/j.jaci.2011.03.025; Bittner TC, 2010, KLIN PADIATR, V222, P351, DOI 10.1055/s-0030-1265135; Boztug H, 2012, PEDIATR HEMAT ONCOL, V29, P585, DOI 10.3109/08880018.2012.714844; Gatz SA, 2011, BONE MARROW TRANSPL, V46, P552, DOI 10.1038/bmt.2010.169; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P1304, DOI 10.1016/j.jaci.2010.07.034; Metin A, 2012, PEDIATR TRANSPLANT, V16, P398, DOI 10.1111/j.1399-3046.2011.01641.x	6	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1244	1245		10.1016/j.jaci.2012.12.663	http://dx.doi.org/10.1016/j.jaci.2012.12.663			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23352633				2022-12-18	WOS:000317187200041
J	De Swert, L; Veereman, G; Bublin, M; Breiteneder, H; Dilissen, E; Bosmans, E; Mattelaer, C; Bullens, D				De Swert, Liliane; Veereman, Genevieve; Bublin, Merima; Breiteneder, Heimo; Dilissen, Ellen; Bosmans, Eugene; Mattelaer, Caroline; Bullens, Dominique			Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POLLEN		[De Swert, Liliane] UZ Gasthuisberg Leuven, Dept Pediat, Louvain, Belgium; [Veereman, Genevieve] Kindergastroenterol UZ Brussels, Brussels, Belgium; [Bublin, Merima; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Dilissen, Ellen] Katholieke Univ Leuven, Clin Immunol Lab, Dept Microbiol & Immunol, Louvain, Belgium; [Bosmans, Eugene] AML, Antwerp, Belgium; [Mattelaer, Caroline] ZNA, Dept Pathol, Antwerp, Belgium; [Bullens, Dominique] Katholieke Univ Leuven, Lab Pediat Immunol, Dept Microbiol & Immunol, Louvain, Belgium	KU Leuven; University Hospital Leuven; Medical University of Vienna; KU Leuven; ZNA Stuivenberg; KU Leuven	De Swert, L (corresponding author), UZ Gasthuisberg Leuven, Dept Pediat, Louvain, Belgium.	liliane.deswert@uz.kuleuven.be	Bullens, Dominique M A/T-6211-2017	Bullens, Dominique M A/0000-0002-4595-9579; Bublin, Merima/0000-0002-7191-9431				Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Khan S, 2005, BEST PRACT RES CL GA, V19, P177, DOI 10.1016/j.bpg.2005.01.009; Kleine-Tebbe J, 2002, J ALLERGY CLIN IMMUN, V110, P797, DOI 10.1067/mai.2002.128946; Peterson CGB, 2002, AM J GASTROENTEROL, V97, P1755; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Shamji MH, 2011, CLIN EXP ALLERGY, V41, P1235, DOI 10.1111/j.1365-2222.2011.03804.x; Webber CM, 2010, ANN ALLERG ASTHMA IM, V104, P101, DOI 10.1016/j.anai.2009.11.007	9	15	15	1	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					600	602		10.1016/j.jaci.2012.10.057	http://dx.doi.org/10.1016/j.jaci.2012.10.057			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23374273				2022-12-18	WOS:000314661500047
J	Poliani, PL; Fontana, E; Roifman, CM; Notarangelo, LD				Poliani, Pietro Luigi; Fontana, Elena; Roifman, Chaim M.; Notarangelo, Luigi D.			zeta Chain-associated protein of 70 kDa (ZAP70) deficiency in human subjects is associated with abnormalities of thymic stromal cells: Implications for T-cell tolerance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPITHELIAL-CELLS		[Poliani, Pietro Luigi; Fontana, Elena] Univ Brescia, Dept Pathol, Brescia, Italy; [Roifman, Chaim M.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Notarangelo, Luigi D.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	University of Brescia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Poliani, PL (corresponding author), Univ Brescia, Dept Pathol, Brescia, Italy.	luigi.notarangelo@childrens.harvard.edu	Fontana, Elena/K-3845-2016; Notarangelo, Luigi D/F-9718-2016; POLIANI, Pietro Luigi/E-8145-2010	Fontana, Elena/0000-0001-8853-3335; Notarangelo, Luigi D/0000-0002-8335-0262; POLIANI, Pietro Luigi/0000-0002-5662-8978				Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Roifman CM, 2010, J ALLERGY CLIN IMMUN, V126, P1226, DOI 10.1016/j.jaci.2010.07.029; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; White AJ, 2010, J IMMUNOL, V185, P4769, DOI 10.4049/jimmunol.1002151	9	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					597	600		10.1016/j.jaci.2012.11.002	http://dx.doi.org/10.1016/j.jaci.2012.11.002			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23245794				2022-12-18	WOS:000314661500046
J	Greenberg, S; Liu, N; Kaur, A; Lakshminarayanan, M; Zhou, YJ; Nelsen, L; Gates, DF; Kuo, WL; Smugar, SS; Reiss, TF; Barnes, N; Fuhlbrigge, A; Milgrom, H; Schatz, M; Knorr, B				Greenberg, Steven; Liu, Nancy; Kaur, Amarjot; Lakshminarayanan, Mani; Zhou, Yijie; Nelsen, Linda; Gates, Davis F., Jr.; Kuo, Wen-Ling; Smugar, Steven S.; Reiss, Theodore F.; Barnes, Neil; Fuhlbrigge, Anne; Milgrom, Henry; Schatz, Michael; Knorr, Barbara			The Asthma Disease Activity Score: A discriminating, responsive measure predicts future asthma attacks	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; activity; exacerbations; asthma-specific quality of life; regression; validity	RHEUMATOID-ARTHRITIS; ANTIBODY OMALIZUMAB; CLINICAL-PRACTICE; END-POINTS; EXACERBATIONS; MONTELUKAST; VALIDATION; CRITERIA; TRIALS	Background: Classifying asthma severity or activity has evolved, but there are no published weighted composite measures of asthma disease activity that account for the relative importance of the many individual clinical variables that are widely used. Objectives: We sought to develop a weighted and responsive measure of asthma disease activity. Methods: Discriminant and multiple regression analyses based on 2 previously conducted clinical trials were used to develop the Asthma Disease Activity Score (ADAS-6). Results: The ADAS-6 demonstrated content validity because its components assess different manifestations of asthma: FEV1 (percent predicted), Asthma Quality of Life Questionnaire-Symptom domain, rescue beta-agonist use, nocturnal awakenings, peak expiratory flow diurnal variability, and rescue beta-agonist use diurnal variability. The ADAS-6 demonstrated cross-sectional and longitudinal validity. It was discriminating: it distinguished levels of disease activity and response to different treatment intensities (P < .0001). Similar results were obtained with an independent clinical trial. The ADAS-6 was highly responsive to treatment effects, with a standardized effect size exceeding that of other widely used outcome measures. Using ADAS-6 as the primary end point in the montelukast pivotal trials would have significantly reduced the sample size needed to detect a comparable change in outcome. Furthermore, increments in the ADAS-6 predicted the risk of future asthma attacks. A simplified Asthma Disease Activity Score 4-variable version (ADAS-4) demonstrated similar measurement properties. Conclusions: The ADAS-6 and ADAS-4 are novel, weighted, and responsive measures of asthma disease activity. Use of these measures in clinical trials might better separate treatment effects, predict future asthma attacks, and substantially reduce sample size. (J Allergy Clin Immunol 2012;130:1071-7.)	[Greenberg, Steven; Reiss, Theodore F.; Knorr, Barbara] Merck Sharp & Dohme Corp, Clin Res, Whitehouse Stn, NJ USA; [Liu, Nancy; Kaur, Amarjot; Lakshminarayanan, Mani; Zhou, Yijie; Gates, Davis F., Jr.; Kuo, Wen-Ling] Merck Sharp & Dohme Corp, Biostat, Whitehouse Stn, NJ USA; [Nelsen, Linda] Merck Sharp & Dohme Corp, Epidemiol, Whitehouse Stn, NJ USA; [Smugar, Steven S.] Merck Sharp & Dohme Corp, Global Sci & Med Publicat, Whitehouse Stn, NJ USA; [Greenberg, Steven] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Barnes, Neil] Barts & London NHS Trust, London, England; [Fuhlbrigge, Anne] Brigham & Womens Hosp, Div Pulmonary & Crit Care Med, Boston, MA 02115 USA; [Fuhlbrigge, Anne] Harvard Vanguard Med Associates, Boston, MA USA; [Milgrom, Henry] Univ Colorado, Hlth Sci Ctr, Natl Jewish Hlth, Div Pediat Allergy Immunol, Denver, CO USA; [Milgrom, Henry] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; [Schatz, Michael] Kaiser Permanente So Calif Reg, Dept Allergy, San Diego, CA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Columbia University; Barts Health NHS Trust; Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Kaiser Permanente	Greenberg, S (corresponding author), Merck Sharp & Dohme Ltd, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	steven_greenberg@merck.com	Nelsen, Linda/GZL-1004-2022	Smugar, Steve/0000-0002-9379-9928	Merck Sharp Dohme Corp; Merck; GlaxoSmithKline; Novartis; Chiesi; Nycomed/Takeda; National Heart, Lung, and Blood Institute (NHLBI); NHLBI; Agency for Healthcare Research and Quality (AHRQ); Aerocrine; Genentech; MedImmune	Merck Sharp Dohme Corp(Merck & Company); Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Chiesi(Chiesi Pharmaceuticals Inc); Nycomed/Takeda; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Aerocrine; Genentech(Roche HoldingGenentech); MedImmune(AstraZenecaMedimmune)	Supported by Merck Sharp & Dohme Corp, a subsidiary of Merck & Co, Inc.; S. Greenberg, L. Nelsen, and S. S. Smugar are employed by and own stock/stock options in Merck. A. Kaur, M. Lakshminarayanan, Y. Zhou, D. F. Gates, W.-L. Kuo, T. F. Reiss, and B. Knorr and are employed by Merck. N. Barnes has received one or more consulting fees or honoraria from Merck; has consultancy arrangements with GlaxoSmithKline, Mundipharma, Napp Laboratories, and Novartis; has received one or more payments for lecturing from or is on the speakers' bureau for GlaxoSmithKline, Novartis, Chiesi, and Nycomed/Takeda; and has received one or more payments for travel/accommodations/meeting expenses from Boehringer Ingelheim and Nycomed/Takeda. A. Fuhlbrigge has been supported by one or more grants from and has received support for travel from the National Heart, Lung, and Blood Institute (NHLBI); is a board member for Merck; has consultancy arrangements with Merck, GlaxoSmithKline, ICON Medical Imaging, Sunovion, the Lovelace Respiratory Research Institute, and Dmagi; and has received one or more grants from or has one or more grants pending with the NHLBI and the Agency for Healthcare Research and Quality (AHRQ). M. Schatz has received one or more consulting fees or honoraria from Merck; has consultancy arrangements with GlaxoSmithKline, Amgen, and Boston Scientific; and has received one or more grants from or has one or more grants pending with GlaxoSmithKline, Merck, Aerocrine, Genentech, and MedImmune. The rest of the authors declare that they have no relevant conflicts of interest.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; EPR, 2007, NIH PUBLICATION; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Global Initiative for Asthma (GINA), 2008, GLOBAL STRATEGY FOR; Greenberg S, 2012, RESP MED, V106, P500, DOI 10.1016/j.rmed.2011.12.013; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Milgrom H, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e36; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Nathan RA, 2010, ALLERGY ASTHMA PROC, V31, P269, DOI 10.2500/aap.2010.31.3364; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reiss TF, 1998, ARCH INTERN MED, V158, P1213, DOI 10.1001/archinte.158.11.1213; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Zhang J, 2002, EUR RESPIR J, V20, P1102, DOI 10.1183/09031936.02.02402001	20	15	15	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2012	130	5					1071	+		10.1016/j.jaci.2012.07.057	http://dx.doi.org/10.1016/j.jaci.2012.07.057			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	030LE	23036744				2022-12-18	WOS:000310571400005
J	Dizier, MH; Margaritte-Jeannin, P; Madore, AM; Esparza-Gordillo, J; Moffatt, M; Corda, E; Monier, F; Guilloud-Bataille, M; Franke, A; Weidinger, S; Annesi-Maesano, I; Just, J; Pin, I; Kauffmann, F; Cookson, W; Lee, YA; Laprise, C; Lathrop, M; Bouzigon, E; Demenais, F				Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Madore, Anne-Marie; Esparza-Gordillo, Jorge; Moffatt, Miriam; Corda, Eve; Monier, Florent; Guilloud-Bataille, Michel; Franke, Andre; Weidinger, Stephan; Annesi-Maesano, Isabella; Just, Jocelyne; Pin, Isabelle; Kauffmann, Francine; Cookson, William; Lee, Young-Ae; Laprise, Catherine; Lathrop, Mark; Bouzigon, Emmanuelle; Demenais, Florence			The ANO3/MUC15 locus is associated with eczema in families ascertained through asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Positional cloning; association study; family-based association study; logistic regression; eczema; asthma; family sample	GENOME-WIDE ASSOCIATION; ATOPIC-DERMATITIS; GENETICS; EXPRESSION; FILAGGRIN; VARIANTS; LINKAGE; GENES; RISK	Background: A previous genome-wide linkage scan in 295 families of the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) reported strong evidence of linkage of 11p14 to eczema. Objective: Our purpose was to conduct fine-scale mapping of the 11p14 region to identify the genetic variants associated with eczema. Methods: Association analyses were first conducted in the family sample from the French EGEA by using 2 methods: the family-based association method and logistic regression. Replication of the EGEA findings was sought in French Canadian and United Kingdom family samples, which, similarly to EGEA samples, were ascertained through asthma. We also tested for association in 2 German samples ascertained through eczema. Results: We found significant association of eczema with 11p14 genetic variants in the vicinity of the linkage peak in EGEA (P = 10(-4) for rs1050153 by using the family-based association method, which reached the multiple testing-corrected threshold of 10(-4); P = .003 with logistic regression). Pooled analysis of the 3 asthma-ascertained samples showed strong improvement in the evidence for association (P = 6 x 10(-6) for rs293974, P = 3 x 10(-5) for rs1050153, and P = 8 x 10(-5) for rs15783). No association was observed in the eczema-ascertained samples. Conclusion: The significant single nucleotide polymorphisms are located within the overlapping anoctamin 3 (ANO3) and mucin 15 (MUC15) genes. Several lines of evidence suggest that MUC15 is a strong candidate for eczema. Further investigation is needed to confirm our findings and to better understand the role of the ANO3/MUC15 locus in eczema and its relationship with respect to asthma. (J Allergy Clin Immunol 2012;129:154753.)	[Dizier, Marie-Helene] INSERM, U946, Fondat Jean Dausset CEPH, Genet Variat & Human Dis Unit, F-75010 Paris, France; [Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Corda, Eve; Monier, Florent; Guilloud-Bataille, Michel; Bouzigon, Emmanuelle; Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Madore, Anne-Marie; Laprise, Catherine] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; [Esparza-Gordillo, Jorge; Lee, Young-Ae] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Esparza-Gordillo, Jorge; Lee, Young-Ae] Charite, ECRC, D-13353 Berlin, Germany; [Moffatt, Miriam; Cookson, William] Univ London Imperial Coll Sci Technol & Med, Natl Heart Lung Inst, London, England; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Weidinger, Stephan] Univ Clin Schleswig Holstein, Dept Dermatol, Kiel, Germany; [Annesi-Maesano, Isabella] INSERM, U707, F-75010 Paris, France; [Just, Jocelyne] Hop Trousseau, Ctr Diagnost & Traitement Asthme, F-75571 Paris, France; [Pin, Isabelle] Ctr Hosp Univ, Grenoble, France; [Pin, Isabelle] Inst Albert Bonniot, INSERM, U823, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Kauffmann, Francine] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, Villejuif, France; [Kauffmann, Francine] Univ Paris 11, UMRS 1018, Villejuif, France; [Lathrop, Mark] CEA CNG, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Chicoutimi; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dizier, MH (corresponding author), INSERM, U946, Fondat Jean Dausset CEPH, Genet Variat & Human Dis Unit, 27 Rue Juliette Dodu, F-75010 Paris, France.	Marie-Helene.Dizier@inserm.fr	Franke, Andre/B-2151-2010; Weidinger, Stephan/C-8461-2011; Annesi-Maesano, Isabella/D-9173-2016; Demenais, Florence/G-3298-2013; PIN, Isabelle/N-3020-2013; Cookson, William/HHC-1790-2022; Dizier, Marie-Hélène/K-8463-2018; Bouzigon, Emmanuelle/L-2766-2017	Franke, Andre/0000-0003-1530-5811; Weidinger, Stephan/0000-0003-3944-252X; Annesi-Maesano, Isabella/0000-0002-6340-9300; Demenais, Florence/0000-0001-8361-0936; Dizier, Marie-Hélène/0000-0001-8460-7667; Bouzigon, Emmanuelle/0000-0001-5756-4286; Laprise, Catherine/0000-0001-5526-9945	INSERM-Ministry of Research "Cohortes et Collections" [4CH06G]; French Agency for Environmental and Occupational Health Safety [AFSSET-APR-SE-2004]; French Agency of Research [ANR 05-SEST-020-02/05-9-97, ANR 06-CEBS]; European Commission [018996]; French Ministry of Higher Education and Research; Wellcome Trust [WT084703MA]; Asthma UK; LABEX GENMED; French National Agency for Research; German Ministry for Education and Research through the German National Genome Research Network; Deutsche Forschungsgemeinschaft [LE 2042/1-1]; PopGen Biobank; INSERM; University Paris Diderot; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	INSERM-Ministry of Research "Cohortes et Collections"; French Agency for Environmental and Occupational Health Safety; French Agency of Research(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Higher Education and Research; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; LABEX GENMED; French National Agency for Research(French National Research Agency (ANR)); German Ministry for Education and Research through the German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PopGen Biobank; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Diderot; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The French Epidemiological Study on the Genetics and Environment of Asthma was partially funded by grants from INSERM-Ministry of Research "Cohortes et Collections" (grant 4CH06G), the French Agency for Environmental and Occupational Health Safety (grant AFSSET-APR-SE-2004), and the French Agency of Research (grants ANR 05-SEST-020-02/05-9-97 and ANR 06-CEBS). Genotyping of the asthma-ascertained samples was supported by grants from the European Commission (018996), the French Ministry of Higher Education and Research, the Wellcome Trust (WT084703MA), and Asthma UK. This work was also supported by the LABEX GENMED (funded by the French National Agency for Research as part of the "Investissements d'Avenir" program). C. Laprise is the holder of the Canada Research Chair on genetic determinants in asthma and the director of the Inflammation and Remodeling Strategic Group of the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and a member of the Allergen Network, which partially support the French Canadian study. The German study was funded by grants from the German Ministry for Education and Research through the German National Genome Research Network and Deutsche Forschungsgemeinschaft (LE 2042/1-1) and was supported by the PopGen Biobank.; We thank INSERM, the French Ministry of Higher Education and Research, University Paris Diderot, for supporting our research and the EGEA cooperative group:	Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Chakraborty S, 2011, CANCER LETT, V301, P127, DOI 10.1016/j.canlet.2010.11.004; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Guilloud-Bataille M, 2008, HUM GENET, V122, P605, DOI 10.1007/s00439-007-0439-7; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Kabesch M, 2004, CLIN EXP ALLERGY, V34, P340, DOI 10.1111/j.1365-2222.2004.01860.x; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Martin PE, 2011, J ALLERGY CLIN IMMUN, V127, P1473, DOI 10.1016/j.jaci.2011.02.041; Merryman-Simpson AE, 2008, VET DERMATOL, V19, P59, DOI 10.1111/j.1365-3164.2008.00653.x; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Pallesen LT, 2008, J DAIRY SCI, V91, P4477, DOI 10.3168/jds.2008-1204; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rock JR, 2008, DEV DYNAM, V237, P2566, DOI 10.1002/dvdy.21676; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	32	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1547	+		10.1016/j.jaci.2012.04.010	http://dx.doi.org/10.1016/j.jaci.2012.04.010			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22657408				2022-12-18	WOS:000304764600015
J	Gupta, A; Dimeloe, S; Richards, DF; Bush, A; Saglani, S; Hawrylowicz, CM				Gupta, Atul; Dimeloe, Sarah; Richards, David F.; Bush, Andrew; Saglani, Sejal; Hawrylowicz, Catherine M.			Vitamin D binding protein and asthma severity in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							RESPIRATORY-TRACT; LUNG		[Gupta, Atul; Dimeloe, Sarah; Richards, David F.; Bush, Andrew; Saglani, Sejal; Hawrylowicz, Catherine M.] MRC, London, England; [Gupta, Atul; Dimeloe, Sarah; Richards, David F.; Bush, Andrew; Saglani, Sejal; Hawrylowicz, Catherine M.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Gupta, Atul; Dimeloe, Sarah; Richards, David F.; Hawrylowicz, Catherine M.] Kings Coll London, Guys Hosp, Dept Asthma Allergy & Resp Sci, London WC2R 2LS, England; [Gupta, Atul; Bush, Andrew; Saglani, Sejal] Royal Brompton Hosp, Dept Pediat Resp Med, London SW3 6LY, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Royal Brompton Hospital	Gupta, A (corresponding author), MRC, London, England.	catherine.hawrylowicz@kcl.ac.uk	Saglani, Sejal/AAE-5072-2019; Hawrylowicz, Catherine/Q-8483-2017	Saglani, Sejal/0000-0001-5192-6418; Dimeloe, Sarah/0000-0002-4598-6518; Hawrylowicz, Catherine/0000-0002-2337-7463	Medical Research Council [G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Asthma UK [10/058] Funding Source: researchfish; Medical Research Council [G1000758] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; GUHA C, 1995, HEPATOLOGY, V21, P1675; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; METCALF JP, 1991, AM REV RESPIR DIS, V143, P844, DOI 10.1164/ajrccm/143.4_Pt_1.844; Wood AM, 2011, THORAX, V66, P205, DOI 10.1136/thx.2010.140921; Zhao J, 2007, INT ARCH ALLERGY IMM, V142, P219, DOI 10.1159/000097024	10	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2012	129	6					1669	1671		10.1016/j.jaci.2012.02.017	http://dx.doi.org/10.1016/j.jaci.2012.02.017			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	952BL	22460073				2022-12-18	WOS:000304764600030
J	Sicherer, SH; Leung, DYM				Sicherer, Scott H.; Leung, Donald Y. M.			Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2011	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Dermatology; skin disease; urticaria; atopic dermatitis; anaphylaxis; allergy; hypersensitivity disorders; food; drug; insect venom	PROTEIN-INDUCED ENTEROCOLITIS; ATOPIC-DERMATITIS; EOSINOPHILIC ESOPHAGITIS; DENDRITIC CELLS; T-CELLS; COWS MILK; ECZEMA HERPETICUM; INNER-CITY; IGE; CHILDREN	This review highlights some of the research advances in anaphylaxis; hypersensitivity reactions to foods, drugs, and insects; and allergic skin diseases that were reported in the Journal in 2011. Food allergy appears to be increasing in prevalence and carries a strong economic burden. Risk factors can include dietary ones, such as deficiency of vitamin D and timing of complementary foods, and genetic factors, such as filaggrin loss-of-function mutations. Novel mechanisms underlying food allergy include the role of invariant natural killer T cells and influences of dietary components, such as isoflavones. Among numerous preclinical and clinical treatment studies, promising observations include the efficacy of sublingual and oral immunotherapy, a Chinese herbal remedy showing promising in vitro results, the potential immunotherapeutic effects of having children ingest foods with baked-in milk if they tolerate it, and the use of anti-IgE with or without concomitant immunotherapy. Studies of allergic skin diseases, anaphylaxis, and hypersensitivity to drugs and insect venom are elucidating cellular mechanisms, improved diagnostics, and potential targets for future treatment. The role of skin barrier abnormalities, as well as the modulatory effects of the innate and adaptive immune responses, are major areas of investigation. (J Allergy Clin Immunol 2012; 129: 76-85.)	[Sicherer, Scott H.] Mt Sinai Sch Med, Dept Pediat, Div Allergy & Immunol, Elliot & Roslyn Jaffe Food Allergy Inst, New York, NY USA; [Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Div Pediat Allergy Immunol, Denver, CO USA	Icahn School of Medicine at Mount Sinai; National Jewish Health	Sicherer, SH (corresponding author), Mt Sinai Hosp, Div Allergy Immunol, Box 1198,1 Gustave L Levy Pl, New York, NY 10029 USA.	scott.sicherer@mssm.edu			NIH-NIAID	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S. H. Sicherer is a consultant for the Food Allergy Initiative; has received research support from the NIH-NIAID; and has various organizational interests with the American Board of Allergy and Immunology, Food Allergy and Anaphylaxis Network, American Academy of Pediatrics, and the American Academy of Asthma, Allergy & Immunology. D. Y. M. Leung declares that he has no relevant conflicts of interest.	Alonzi C, 2011, J ALLERGY CLIN IMMUN, V127, P1627, DOI 10.1016/j.jaci.2011.01.050; Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Balaji H, 2011, J ALLERGY CLIN IMMUN, V128, P92, DOI 10.1016/j.jaci.2011.02.043; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Begin P, 2011, J ALLERGY CLIN IMMUN, V127, P1624, DOI 10.1016/j.jaci.2011.01.028; Benedetto AD, 2011, J ALLERGY CLIN IMMUN, V128, pe5; Biagtan MJ, 2011, J ALLERGY CLIN IMMUN, V127, P1626, DOI 10.1016/j.jaci.2011.01.045; Bin LH, 2011, J ALLERGY CLIN IMMUN, V127, P430, DOI 10.1016/j.jaci.2010.11.013; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blatman KSH, 2011, J ALLERGY CLIN IMMUN, V127, P1307, DOI 10.1016/j.jaci.2010.12.1118; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Buhl T, 2011, J ALLERGY CLIN IMMUN, V127, P284, DOI 10.1016/j.jaci.2010.10.044; Caubet JC, 2011, J ALLERGY CLIN IMMUN, V128, P1386, DOI 10.1016/j.jaci.2011.07.011; Caubet JC, 2011, J ALLERGY CLIN IMMUN, V127, P218, DOI 10.1016/j.jaci.2010.08.025; Chakravarty SD, 2011, J ALLERGY CLIN IMMUN, V128, P1354, DOI 10.1016/j.jaci.2011.08.023; Chawla KK, 2011, J ALLERGY CLIN IMMUN, V127, P680, DOI 10.1016/j.jaci.2010.10.022; Clark S, 2011, J ALLERGY CLIN IMMUN, V127, P682, DOI 10.1016/j.jaci.2010.10.040; De Benedetto Anna, 2011, J Allergy Clin Immunol, V127, P773, DOI 10.1016/j.jaci.2010.10.018; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V128, P242, DOI 10.1016/j.jaci.2011.02.014; DeBrosse CW, 2011, J ALLERGY CLIN IMMUN, V128, P132, DOI 10.1016/j.jaci.2011.05.006; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; Dreschler K, 2011, J ALLERGY CLIN IMMUN, V127, P487, DOI 10.1016/j.jaci.2010.12.003; DunnGalvin A, 2011, J ALLERGY CLIN IMMUN, V127, P633, DOI 10.1016/j.jaci.2010.12.004; El-Ghaiesh S, 2011, J ALLERGY CLIN IMMUN, V128, P680, DOI 10.1016/j.jaci.2011.04.031; Elsheikh A, 2011, J ALLERGY CLIN IMMUN, V127, P1543, DOI 10.1016/j.jaci.2010.12.1119; Filipiak-Pittroff B, 2011, J ALLERGY CLIN IMMUN; Fujita H, 2011, J ALLERGY CLIN IMMUN, V128, P574, DOI 10.1016/j.jaci.2011.05.016; Gentinetta T, 2011, J ALLERGY CLIN IMMUN, V128, P1227, DOI 10.1016/j.jaci.2011.07.021; Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; Gros E, 2011, J ALLERGY CLIN IMMUN, V128, P1015, DOI 10.1016/j.jaci.2011.05.043; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1420, DOI 10.1016/j.jaci.2011.01.054; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Hansel A, 2011, J ALLERGY CLIN IMMUN, V127, P787, DOI 10.1016/j.jaci.2010.12.009; Harduar-Morano L, 2011, J ALLERGY CLIN IMMUN, V128, P594, DOI 10.1016/j.jaci.2011.04.049; Hasdenteufel F, 2011, J ALLERGY CLIN IMMUN, V128, P1356, DOI 10.1016/j.jaci.2011.05.034; Hennino A, 2011, J ALLERGY CLIN IMMUN, V127, P1064, DOI 10.1016/j.jaci.2010.11.022; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Hong XM, 2011, J ALLERGY CLIN IMMUN, V128, P374, DOI 10.1016/j.jaci.2011.05.007; Houliston L, 2011, J ALLERGY CLIN IMMUN, V127, P98, DOI 10.1016/j.jaci.2010.07.031; Howell MD, 2011, J ALLERGY CLIN IMMUN, V128, P1006, DOI 10.1016/j.jaci.2011.06.003; Hruz P, 2011, J ALLERGY CLIN IMMUN, V128, P1349, DOI 10.1016/j.jaci.2011.09.013; Ito K, 2011, J ALLERGY CLIN IMMUN, V128, P673, DOI 10.1016/j.jaci.2011.04.025; James EA, 2011, J ALLERGY CLIN IMMUN, V128, P100, DOI 10.1016/j.jaci.2011.05.005; Torres MJ, 2011, J ALLERGY CLIN IMMUN, V128, P1365, DOI 10.1016/j.jaci.2011.06.050; Joseph CLM, 2011, J ALLERGY CLIN IMMUN, V127, P1203, DOI 10.1016/j.jaci.2011.02.018; Jung K, 2011, J ALLERGY CLIN IMMUN, V127, P420, DOI 10.1016/j.jaci.2010.10.043; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Kasperkiewicz M, 2011, J ALLERGY CLIN IMMUN, V127, P267, DOI 10.1016/j.jaci.2010.07.042; Kattan JD, 2011, J ALLERGY CLIN IMMUN, V128, P215, DOI 10.1016/j.jaci.2011.04.046; Katz Y, 2011, J ALLERGY CLIN IMMUN, V127, P647, DOI 10.1016/j.jaci.2010.12.1105; Kay AB, 2011, J ALLERGY CLIN IMMUN, V127, P232, DOI 10.1016/j.jaci.2010.10.028; Kerstan A, 2011, J ALLERGY CLIN IMMUN, V127, P495, DOI 10.1016/j.jaci.2010.11.025; Kim Edwin H, 2011, J Allergy Clin Immunol, V127, P640, DOI 10.1016/j.jaci.2010.12.1083; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Korosec P, 2011, J ALLERGY CLIN IMMUN, V128, P671, DOI 10.1016/j.jaci.2011.03.012; Kotz D, 2011, J ALLERGY CLIN IMMUN, V127, P623, DOI 10.1016/j.jaci.2010.11.021; Kranke B, 2011, J ALLERGY CLIN IMMUN, V127, P1645, DOI 10.1016/j.jaci.2011.02.009; Kulis M, 2011, J ALLERGY CLIN IMMUN, V128, P212, DOI 10.1016/j.jaci.2011.02.035; Kulis M, 2011, J ALLERGY CLIN IMMUN, V127, P81, DOI 10.1016/j.jaci.2010.09.014; Le TM, 2011, J ALLERGY CLIN IMMUN, V127, P677, DOI 10.1016/j.jaci.2010.10.003; Leung DYM, 2011, J ALLERGY CLIN IMMUN, V127, P965, DOI 10.1016/j.jaci.2011.02.010; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lieberman JA, 2011, J ALLERGY CLIN IMMUN, V128, P1120, DOI 10.1016/j.jaci.2011.07.012; Lowe AJ, 2011, J ALLERGY CLIN IMMUN, V128, P360, DOI 10.1016/j.jaci.2010.05.006; Maloney JM, 2011, J ALLERGY CLIN IMMUN, V128, P214, DOI 10.1016/j.jaci.2011.04.024; Martos Gustavo, 2011, J Allergy Clin Immunol, V127, P990, DOI 10.1016/j.jaci.2011.01.057; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Maurer M, 2011, J ALLERGY CLIN IMMUN, V128, P202, DOI 10.1016/j.jaci.2011.04.038; McKinney KK, 2011, J ALLERGY CLIN IMMUN, V127, P1629, DOI 10.1016/j.jaci.2011.02.003; Mertes PM, 2011, J ALLERGY CLIN IMMUN, V128, P366, DOI 10.1016/j.jaci.2011.03.003; Metz M, 2011, J ALLERGY CLIN IMMUN, V128, P424, DOI 10.1016/j.jaci.2011.04.012; Monti G, 2011, J ALLERGY CLIN IMMUN, V127, P679, DOI 10.1016/j.jaci.2010.10.017; Nadeau KC, 2011, J ALLERGY CLIN IMMUN, V127, P1622, DOI 10.1016/j.jaci.2011.04.009; Naumann A, 2011, J ALLERGY CLIN IMMUN, V127, P1187, DOI 10.1016/j.jaci.2010.12.1123; Navarini AA, 2011, J ALLERGY CLIN IMMUN, V128, P1128, DOI 10.1016/j.jaci.2011.09.009; Nicolaou N, 2011, J ALLERGY CLIN IMMUN, V127, P684, DOI 10.1016/j.jaci.2010.12.012; Nosbaum A, 2011, J ALLERGY CLIN IMMUN, V128, P1113, DOI 10.1016/j.jaci.2011.05.001; Nowak-Wegrzyn A, 2011, J ALLERGY CLIN IMMUN, V127, P558, DOI 10.1016/j.jaci.2010.12.1098; Nunez R, 2011, J ALLERGY CLIN IMMUN, V128, pe1; Nunez R, 2011, J ALLERGY CLIN IMMUN, V128, P1122, DOI 10.1016/j.jaci.2011.07.020; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Owens G, 2011, J ALLERGY CLIN IMMUN, V127, P264, DOI 10.1016/j.jaci.2010.10.005; Oyoshi MK, 2011, J ALLERGY CLIN IMMUN, V128, P890, DOI 10.1016/j.jaci.2011.06.042; Park JH, 2011, J ALLERGY CLIN IMMUN, V128, P1127, DOI 10.1016/j.jaci.2011.08.026; Patel DA, 2011, J ALLERGY CLIN IMMUN, V128, P110, DOI 10.1016/j.jaci.2011.03.013; Patil SP, 2011, J ALLERGY CLIN IMMUN, V128, P1259, DOI 10.1016/j.jaci.2011.06.015; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; Rachid R, 2011, J ALLERGY CLIN IMMUN, V127, P524, DOI 10.1016/j.jaci.2010.09.030; Reginald K, 2011, J ALLERGY CLIN IMMUN, V128, P82, DOI 10.1016/j.jaci.2011.02.034; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Romano A, 2011, J ALLERGY CLIN IMMUN, V127, pS59, DOI 10.1016/j.jaci.2010.12.1090; Rosenlund H, 2011, J ALLERGY CLIN IMMUN, V127, P1219, DOI 10.1016/j.jaci.2010.11.019; Saini S, 2011, J ALLERGY CLIN IMMUN, V128, P567, DOI 10.1016/j.jaci.2011.06.010; Sampson HA, 2011, J ALLERGY CLIN IMMUN, V127, P1309, DOI 10.1016/j.jaci.2011.01.051; Santos KS, 2011, J ALLERGY CLIN IMMUN, V128, P1367, DOI 10.1016/j.jaci.2011.07.019; Schram ME, 2011, J ALLERGY CLIN IMMUN, V128, P353, DOI 10.1016/j.jaci.2011.03.024; Schwarz A, 2011, J ALLERGY CLIN IMMUN, V128, P826, DOI 10.1016/j.jaci.2011.06.005; Sharief S, 2011, J ALLERGY CLIN IMMUN, V127, P1195, DOI 10.1016/j.jaci.2011.01.017; Sherrill JD, 2011, J ALLERGY CLIN IMMUN, V128, P23, DOI 10.1016/j.jaci.2011.03.046; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P326, DOI 10.1016/j.jaci.2010.11.024; Silverberg JI, 2011, J ALLERGY CLIN IMMUN, V127, P1180, DOI 10.1016/j.jaci.2011.01.063; Simon D, 2011, J ALLERGY CLIN IMMUN, V127, P194, DOI 10.1016/j.jaci.2010.11.002; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, P587, DOI 10.1016/j.jaci.2011.01.038; Slattery Marcia J, 2011, J Allergy Clin Immunol, V128, P668, DOI 10.1016/j.jaci.2011.05.003; Soller L, 2011, J ALLERGY CLIN IMMUN, V128, P426, DOI 10.1016/j.jaci.2011.05.015; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Toda M, 2011, J ALLERGY CLIN IMMUN, V128, P1022, DOI 10.1016/j.jaci.2011.04.020; Turner PJ, 2011, J ALLERGY CLIN IMMUN, V128, P1363, DOI 10.1016/j.jaci.2011.07.005; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; van der Zee T, 2011, J ALLERGY CLIN IMMUN, V128, P1031, DOI 10.1016/j.jaci.2011.07.050; van Hoffen E, 2011, J ALLERGY CLIN IMMUN, V127, P100, DOI 10.1016/j.jaci.2010.08.021; Vanbervliet B, 2011, J ALLERGY CLIN IMMUN, V127, P943, DOI 10.1016/j.jaci.2010.12.002; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P1304, DOI 10.1016/j.jaci.2011.01.020; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Wang JL, 2011, J ALLERGY CLIN IMMUN, V128, P834, DOI 10.1016/j.jaci.2011.07.045; Webb L, 2011, J ALLERGY CLIN IMMUN, V128, P218, DOI 10.1016/j.jaci.2011.02.013; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005	125	15	17	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					76	85		10.1016/j.jaci.2011.11.016	http://dx.doi.org/10.1016/j.jaci.2011.11.016			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	22196526				2022-12-18	WOS:000298634000010
J	Szefler, SJ				Szefler, Stanley J.			Advances in pediatric asthma in 2011: Moving forward	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Airway remodeling; asthma; asthma control; asthma exacerbations; asthma impairment; asthma risk; asthma severity; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists; omalizumab; personalized medicine; severe asthma; therapeutics; tiotropium	EXHALED NITRIC-OXIDE; OBSTRUCTIVE PULMONARY-DISEASE; CHILDHOOD ASTHMA; LUNG-FUNCTION; PERSISTENT ASTHMA; RISK-FACTORS; VITAMIN-D; SOCIOECONOMIC-STATUS; UNCONTROLLED ASTHMA; PRIMARY PREVENTION	Last year's "Advances in pediatric asthma" concluded with the following statement: "Perhaps new directions in personalized medicine and improved health care access and communication will help maintain steady progress in alleviating the burden of this disease in children, especially young children." This year's summary will focus on recent advances in pediatric asthma that show significant accomplishments in reducing asthma morbidity and mortality over the last 10 years and discuss some pathways to further reduce asthma burden, as indicated in Journal of Allergy and Clinical Immunology publications in 2011. Some of the recent reports continue to shed light on methods to improve asthma management through steps to reduce asthma exacerbations, identify features of the disease in early childhood, alter asthma progression, intervene with nutrition, and more effectively implement the asthma guidelines. As new information evolves, it is also time to consider a revision of the asthma guidelines based on key studies that affect our management of the disease since the last revision in 2007. Now is also the time to use information recorded in electronic medical records to develop innovative disease management plans that will track asthma over time and enable timely decisions on interventions to maintain control that can lead to disease remission and prevention. (J Allergy Clin Immunol 2012; 129: 60-8.)	[Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, Denver, CO 80206 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO 80206 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pediat, Boulder, CO 80309 USA; [Szefler, Stanley J.] Univ Colorado, Sch Med, Dept Pharmacol, Boulder, CO 80309 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	Szefler, SJ (corresponding author), Natl Jewish Hlth, Dept Pediat, Div Pediat Clin Pharmacol, 1400 Jackson St,Rm J304 Molly Blank Bldg, Denver, CO 80206 USA.	szeflers@njhealth.org		Szefler, Stanley/0000-0002-6911-3199	Public Health Services [HL-64288, HL-51834, AI-90052, HL-75416, HL-87811, ES-18181, HL-98075]; Colorado Cancer, Cardiovascular, and Pulmonary Disease Program; Colorado CTSA, National Institutes of Health (NIH) [1 UL1 RR025780]; National Center for Research Resources (NCRR); National Institutes of Health; National Heart, Lung, and Blood Institute; National Institute for Allergy and Infectious Diseases; National Institute for Environmental Health Sciences; US Environmental Protection Agency; GlaxoSmithKline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL075416, U10HL051834, R21HL087811, U10HL064288, U10HL098075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES018181] Funding Source: NIH RePORTER	Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); Colorado Cancer, Cardiovascular, and Pulmonary Disease Program; Colorado CTSA, National Institutes of Health (NIH); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Environmental Protection Agency(United States Environmental Protection Agency); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by Public Health Services Research Grants HL-64288, HL-51834, AI90052, HL-75416, HL-87811, ES-18181, and HL-98075 and the Colorado Cancer, Cardiovascular, and Pulmonary Disease Program. Supported in part by Colorado CTSA grant 1 UL1 RR025780 from the National Institutes of Health (NIH) and the National Center for Research Resources (NCRR).; S. J. Szefler has consulted for GlaxoSmithKline, Genentech, Merck, Boehringer-Ingelheim, Novartis, and Schering-Plough and has received research support from the National Institutes of Health; the National Heart, Lung, and Blood Institute; the National Institute for Allergy and Infectious Diseases; the National Institute for Environmental Health Sciences; the US Environmental Protection Agency; and GlaxoSmithKline.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; An P, 2011, J ALLERGY CLIN IMMUN, V127, P1440, DOI 10.1016/j.jaci.2010.12.1114; Apter AJ, 2011, J ALLERGY CLIN IMMUN, V127, P116, DOI 10.1016/j.jaci.2010.11.017; Arbes SJ, 2011, J ALLERGY CLIN IMMUN, V127, P1119, DOI 10.1016/j.jaci.2011.03.023; Barnes PJ, 2012, J ALLERGY CLIN IMMUN, V129, P48, DOI 10.1016/j.jaci.2011.11.006; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bateman ED, 2011, J ALLERGY CLIN IMMUN, V128, P315, DOI 10.1016/j.jaci.2011.06.004; BAUMANN LM, 2011, ALLERGY, V127, P875; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Bougault V, 2011, J ALLERGY CLIN IMMUN, V127, P892, DOI 10.1016/j.jaci.2010.11.003; Breton CV, 2011, AM J RESP CRIT CARE, V184, P191, DOI 10.1164/rccm.201012-2029OC; Bruzzese JM, 2011, AM J RESP CRIT CARE, V183, P998, DOI 10.1164/rccm.201003-0429OC; Busse WW, 2011, J ALLERGY CLIN IMMUN, V128, P740, DOI 10.1016/j.jaci.2011.08.014; Busse WW, 2011, J ALLERGY CLIN IMMUN, V127, P130, DOI 10.1016/j.jaci.2010.11.014; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Castro M, 2011, J ALLERGY CLIN IMMUN, V128, P467, DOI 10.1016/j.jaci.2011.04.051; Chen E, 2011, J ALLERGY CLIN IMMUN, V128, P970, DOI 10.1016/j.jaci.2011.06.040; Cloutier MM, 2011, PEDIATRICS, V127, P11, DOI 10.1542/peds.2010-1943; Collins RA, 2011, J ALLERGY CLIN IMMUN, V128, P301, DOI 10.1016/j.jaci.2011.03.016; Cookson W, 2011, J ALLERGY CLIN IMMUN, V128, P266, DOI 10.1016/j.jaci.2011.06.026; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P1480, DOI 10.1016/j.jaci.2011.03.014; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P390, DOI 10.1016/j.jaci.2010.10.050; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Ducharme FM, 2011, AM J RESP CRIT CARE, V183, P195, DOI 10.1164/rccm.201001-0115OC; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Elmallah MK, 2011, J ALLERGY CLIN IMMUN, V128, P1113, DOI 10.1016/j.jaci.2011.06.014; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Galanter JM, 2011, J ALLERGY CLIN IMMUN, V128, P37, DOI 10.1016/j.jaci.2011.03.050; Gern JE, 2011, NEW ENGL J MED, V364, P769, DOI 10.1056/NEJMe1013713; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Grabenhenrich L, 2011, J ALLERGY CLIN IMMUN, V128, P780, DOI 10.1016/j.jaci.2011.07.054; Gruchalla RS, 2011, J ALLERGY CLIN IMMUN, V128, P64, DOI 10.1016/j.jaci.2011.05.014; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P956, DOI 10.1016/j.jaci.2011.06.027; Guilbert TW, 2011, J ALLERGY CLIN IMMUN, V128, P532, DOI 10.1016/j.jaci.2011.06.037; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Innes AL, 2011, AM J RESP CRIT CARE, V183, P189, DOI 10.1164/rccm.201003-0488OC; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Keet CA, 2011, J ALLERGY CLIN IMMUN, V128, P414, DOI 10.1016/j.jaci.2011.06.011; Kelly HW, 2011, J ALLERGY CLIN IMMUN, V128, P278, DOI 10.1016/j.jaci.2011.05.002; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Knight DA, 2011, J ALLERGY CLIN IMMUN, V128, P557, DOI 10.1016/j.jaci.2011.07.031; Koppelman GH, 2011, J ALLERGY CLIN IMMUN, V128, P479, DOI 10.1016/j.jaci.2011.05.036; Lange NE, 2011, J ALLERGY CLIN IMMUN, V127, P734, DOI 10.1016/j.jaci.2010.11.010; Leonardi NA, 2011, J ALLERGY CLIN IMMUN, V127, P1466, DOI 10.1016/j.jaci.2011.03.001; Lob SH, 2011, PEDIATRICS, V128, P20, DOI 10.1542/peds.2010-1962; Lodge CJ, 2011, J ALLERGY CLIN IMMUN, V128, P782, DOI 10.1016/j.jaci.2011.06.038; Loisel DA, 2011, J ALLERGY CLIN IMMUN, V128, P524, DOI 10.1016/j.jaci.2011.06.016; Loss G, 2011, J ALLERGY CLIN IMMUN, V128, P766, DOI 10.1016/j.jaci.2011.07.048; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lowe A, 2011, J ALLERGY CLIN IMMUN, V128, P1107, DOI 10.1016/j.jaci.2011.08.025; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Mannino DM, 2011, LANCET, V378, P964, DOI 10.1016/S0140-6736(11)61188-4; Marks GB, 2011, J ALLERGY CLIN IMMUN, V128, P789, DOI 10.1016/j.jaci.2011.08.020; Martin PE, 2011, J ALLERGY CLIN IMMUN, V127, P1473, DOI 10.1016/j.jaci.2011.02.041; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Miller EK, 2011, J ALLERGY CLIN IMMUN, V127, P883, DOI 10.1016/j.jaci.2010.11.041; Moore WC, 2011, J ALLERGY CLIN IMMUN, V128, P328, DOI 10.1016/j.jaci.2011.02.042; Motika CA, 2011, J ALLERGY CLIN IMMUN, V128, P774, DOI 10.1016/j.jaci.2011.06.046; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; O'Byrne PM, 2011, J ALLERGY CLIN IMMUN, V128, P257, DOI 10.1016/j.jaci.2011.03.035; Olmedo O, 2011, J ALLERGY CLIN IMMUN, V128, P284, DOI 10.1016/j.jaci.2011.02.044; Omland O, 2011, J ALLERGY CLIN IMMUN, V128, P761, DOI 10.1016/j.jaci.2011.06.006; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Rabinovitch N, 2011, J ALLERGY CLIN IMMUN, V128, P323, DOI 10.1016/j.jaci.2011.05.035; Saude EJ, 2011, J ALLERGY CLIN IMMUN, V127, P757, DOI 10.1016/j.jaci.2010.12.1077; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Schatz M, 2011, J ALLERGY CLIN IMMUN, V128, P273, DOI 10.1016/j.jaci.2011.03.027; Schauberger EM, 2011, J ALLERGY CLIN IMMUN, V128, P753, DOI 10.1016/j.jaci.2011.04.058; Schroer KT, 2011, J ALLERGY CLIN IMMUN, V128, P539, DOI 10.1016/j.jaci.2011.04.018; Scott L, 2011, J ALLERGY CLIN IMMUN, V128, P56, DOI 10.1016/j.jaci.2011.03.020; Sordillo JE, 2011, J ALLERGY CLIN IMMUN, V127, P1165, DOI 10.1016/j.jaci.2011.01.066; Stern G, 2011, J ALLERGY CLIN IMMUN, V128, P293, DOI 10.1016/j.jaci.2011.03.010; Sternthal MJ, 2011, J ALLERGY CLIN IMMUN, V128, P337, DOI 10.1016/j.jaci.2011.05.008; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P937, DOI 10.1016/j.jaci.2011.09.004; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V128, P485, DOI 10.1016/j.jaci.2011.07.010; Szefler SJ, 2011, J ALLERGY CLIN IMMUN, V127, P102, DOI 10.1016/j.jaci.2010.11.018; Tantisira KG, 2011, NEW ENGL J MED, V365, P1173, DOI 10.1056/NEJMoa0911353; Taylor DR, 2011, J ALLERGY CLIN IMMUN, V128, P927, DOI 10.1016/j.jaci.2011.03.051; Thomas A, 2011, J ALLERGY CLIN IMMUN, V128, P915, DOI 10.1016/j.jaci.2011.07.014; Turner S, 2011, AM J RESP CRIT CARE, V184, P407, DOI 10.1164/rccm.201012-2075OC; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; von Jagwitz M, 2011, J ALLERGY CLIN IMMUN, V128, P50, DOI 10.1016/j.jaci.2011.03.005; von Mutius E, 2011, J ALLERGY CLIN IMMUN, V127, P1513, DOI 10.1016/j.jaci.2011.04.026; Wang L, 2011, J ALLERGY CLIN IMMUN, V127, P161, DOI 10.1016/j.jaci.2010.10.035; Weiss S, 2012, J ALLERGY C IN PRESS; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Wood RA, 2011, J ALLERGY CLIN IMMUN, V127, P913, DOI 10.1016/j.jaci.2010.12.1122; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yang IV, 2011, AM J RESP CRIT CARE, V183, P1295, DOI 10.1164/rccm.201010-1579PP; Zeiger RS, 2011, J ALLERGY CLIN IMMUN, V128, P983, DOI 10.1016/j.jaci.2011.08.010; Zeiger RS, 2011, J ALLERGY CLIN IMMUN, V128, P412, DOI 10.1016/j.jaci.2011.06.008; Zhang LJ, 2011, PEDIATRICS, V127, P129, DOI 10.1542/peds.2010-1223	105	15	15	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2012	129	1					60	68		10.1016/j.jaci.2011.11.011	http://dx.doi.org/10.1016/j.jaci.2011.11.011			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	869XT	22196525				2022-12-18	WOS:000298634000008
J	Torres, MJ; Chaves, P; Dona, I; Blanca-Lopez, N; Canto, G; Mayorga, C; Blanca, M				Jose Torres, Maria; Chaves, Patricia; Dona, Inmaculada; Blanca-Lopez, Natalia; Canto, Gabriela; Mayorga, Cristobalina; Blanca, Miguel			T-cell involvement in delayed-type hypersensitivity reactions to infliximab	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BETA-LACTAMS; DRUG; ARTHRITIS		[Jose Torres, Maria; Dona, Inmaculada; Blanca, Miguel] Carlos Haya Hosp, IMABIS Fdn, Allergy Serv, Malaga, Spain; [Chaves, Patricia; Mayorga, Cristobalina] Carlos Haya Hosp, IMABIS Fdn, Allerg Dis Res Lab, Malaga, Spain; [Blanca-Lopez, Natalia; Canto, Gabriela] Infanta Leonor Hosp, Allergy Serv, Madrid, Spain	Hospital Carlos Haya; FIMABIS; Hospital Carlos Haya; Hospital Universitario Infanta Leonor	Torres, MJ (corresponding author), Carlos Haya Hosp, IMABIS Fdn, Allergy Serv, Malaga, Spain.	mjtorresj@gmail.com	Torres, Maria/GVU-3391-2022; Mayorga, Cristobalina/D-7167-2018; Mayorga, Lina/FBO-7730-2022; Chaves Guerrero, Patricia/F-6431-2014; Torres, María José/T-3518-2017	Mayorga, Cristobalina/0000-0001-8852-8077; Chaves Guerrero, Patricia/0000-0003-1364-0130; Torres, María José/0000-0001-5228-471X				Chaves P, 2010, ALLERGY, V65, P1600, DOI 10.1111/j.1398-9995.2010.02459.x; Hausmann OV, 2010, MED CLIN N AM, V94, P791, DOI 10.1016/j.mcna.2010.03.001; Padial A, 2008, CLIN EXP ALLERGY, V38, P822, DOI 10.1111/j.1365-2222.2008.02961.x; PASCUALSALCEDO D, 2011, RHEUMATOLOGY    0322; Seneschal J, 2007, ACTA DERM-VENEREOL, V87, P77, DOI 10.2340/00015555-0193; Torres MJ, 2006, INT J IMMUNOPATH PH, V19, P119; Tutar E, 2004, RHEUMATOLOGY, V43, P674, DOI 10.1093/rheumatology/keh142; Vergara G, 2002, ARCH DERMATOL, V138, P1258, DOI 10.1001/archderm.138.9.1258; Vultaggio A, 2010, ALLERGY, V65, P657, DOI 10.1111/j.1398-9995.2009.02280.x; Zawodniak A, 2010, ALLERGY, V65, P376, DOI 10.1111/j.1398-9995.2009.02180.x; Zeltser R, 2001, ARCH DERMATOL, V137, P893	11	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1365	1367		10.1016/j.jaci.2011.06.050	http://dx.doi.org/10.1016/j.jaci.2011.06.050			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	21839501				2022-12-18	WOS:000298342700035
J	Horner, CC; Mauger, D; Strunk, RC; Graber, NJ; Lemanske, RF; Sorkness, CA; Szefler, SJ; Zeiger, RS; Taussig, LM; Bacharier, LB				Horner, Caroline C.; Mauger, David; Strunk, Robert C.; Graber, Nora J.; Lemanske, Robert F., Jr.; Sorkness, Christine A.; Szefler, Stanley J.; Zeiger, Robert S.; Taussig, Lynn M.; Bacharier, Leonard B.		Natl Heart Lung Blood Inst	Most nocturnal asthma symptoms occur outside of exacerbations and associate with morbidity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; nocturnal symptoms; exacerbation	CHILDHOOD ASTHMA; CHILDREN; SLEEP	Background: Although nocturnal awakenings help categorize asthma severity and control, their clinical significance has not been thoroughly studied. Objective: We sought to determine the clinical consequences of nocturnal asthma symptoms requiring albuterol (NASRAs) in children with mild-to-moderate persistent asthma outside of periods when oral corticosteroids were used for worsening asthma symptoms. Methods: Two hundred eighty-five children aged 6 to 14 years with mild-to-moderate persistent asthma were randomized to receive one of 3 controller regimens and completed daily symptom diaries for 48 weeks. Diary responses were analyzed for the frequency and consequences of NASRAs. Results: NASRAs occurred in 72.2% of participants at least once, and in 24.3% of participants, they occurred 13 or more times. The majority (81.3%) of nocturnal symptoms occurred outside of exacerbation periods and were associated the next day with the following events: albuterol use (56.9% of days preceded by nocturnal symptoms vs 18.1% of days not preceded by nocturnal symptoms; relative risk [RR], 2.3; 95% CI, 2.2-2.4), school absence (5.0% vs 0.3%; RR, 10.6; 95% CI, 7.8-14.4), and doctor contact (3.7% vs 0.2%; RR, 8.8; 95% CI, 6.1-12.5). Similar findings were noted during exacerbation periods (RRs of 1.7 for albuterol use, 5.5 for school absence, and 4.9 for doctor contacts). Nocturnal symptoms did not predict the onset of exacerbations. Conclusion: Nocturnal symptoms requiring albuterol in children with mild-to-moderate persistent asthma receiving controller therapy occurred predominantly outside of exacerbation periods. Despite being poor predictors of exacerbations, they were associated with increases in albuterol use, school absences, and doctor contacts the day after nocturnal symptom occurrences. (J Allergy Clin Immunol 2011;128:977-82.)	[Horner, Caroline C.; Strunk, Robert C.; Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Horner, Caroline C.; Strunk, Robert C.; Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO USA; [Mauger, David; Graber, Nora J.] Penn State Univ, Dept Publ Hlth Sci, Hershey, PA USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Sorkness, Christine A.] Univ Wisconsin, Sch Pharm, Dept Pediat, Madison, WI 53706 USA; [Sorkness, Christine A.] Univ Wisconsin, Dept Med, Dept Pediat, Madison, WI 53706 USA; [Szefler, Stanley J.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Zeiger, Robert S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Zeiger, Robert S.] Kaiser Permanente So Calif, Dept Allergy, San Diego, CA USA; [Taussig, Lynn M.] Univ Denver, Off Provost, Denver, CO 80208 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Jewish Health; University of California System; University of California San Diego; Kaiser Permanente; University of Denver	Horner, CC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis Childrens Hosp, 1 Childrens Pl, St Louis, MO 63110 USA.	horner_k@kids.wustl.edu		Paul, Ian/0000-0002-6344-8609; Zeiger, Robert/0000-0001-5788-5063; Bacharier, Leonard/0000-0003-0432-2704; Szefler, Stanley/0000-0002-6911-3199	National Heart, Lung, and Blood Institute [5U10HL064287, 5U10HL064288, 5U10HL064295, 5U10HL064307, 5U10HL064305, 5U10HL064313]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [RR024992]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI); NNHLBI Childhood Asthma Research and Education (CARE); NIH/NHLBI Asthma Clinical Research Network (ACRN); NIH/National Institute of Allergy; Infectious Diseases Inner-City Asthma Consortium (ICAC); GlaxoSmithKline; NIH/NHLBI Asthma Net; National Institute of Environmental Health Sciences/Environmental Protection Agency Childhood Environmental Health Center; Aerocrine; Genentech; AstraZeneca; Fund for Medical Research and Education (Detroit); Children's Hospital of Minnesota; Toronto Allergy Society; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, M01RR000036, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064313, U10HL064295, U10HL064307, U10HL064288, U10HL064287, U10HL064305] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NNHLBI Childhood Asthma Research and Education (CARE); NIH/NHLBI Asthma Clinical Research Network (ACRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Infectious Diseases Inner-City Asthma Consortium (ICAC); GlaxoSmithKline(GlaxoSmithKline); NIH/NHLBI Asthma Net(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences/Environmental Protection Agency Childhood Environmental Health Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Aerocrine; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Fund for Medical Research and Education (Detroit); Children's Hospital of Minnesota; Toronto Allergy Society; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants 5U10HL064287, 5U10HL064288, 5U10HL064295, 5U10HL064307, 5U10HL064305, and 5U10HL064313 from the National Heart, Lung, and Blood Institute. This study was carried out in part in the General Clinical Research Centers at Washington University School of Medicine (M01 RR00036) and National Jewish Medical and Research Center (M01 RR00051). This publication was made possible by grant no. UL1 RR024992 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.; Disclosure of potential conflict of interest: R. F. Lemanske, Jr, is a speaker for Merck, AstraZeneca, Doembecher Children's Hospital, Washington University, the Medicus Group, the Park Nicolet Institute, the American College of Allergy, Asthma & Immunology, the LA Allergy Society, the Michigan Allergy/Asthma Society, the Medical College of Wisconsin, the Fund for Medical Research and Education (Detroit), Children's Hospital of Minnesota, the Toronto Allergy Society, the American Academy of Allergy, Asthma & Immunology, Beaumont Hospital (Detroit), the University of Illinois, the Canadian Society of Allergy and Clinical Immunology, and New York Presbyterian; has consultant arrangements with AstraZeneca, Map Pharmaceuticals, Gray Consulting, Smith Research, the Merck Childhood Asthma Network, Novartis, Quintiles/Innovax, RC Horowitz & Co, and Scienomics; is an author for Up-to-Date; and is a textbook editor for Elsevier. C. A. Sorkness is on the advisory boards for GlaxoSmithKline, Schering-Plough, and AstraZeneca and receives research support from Schering-Plough and Compleware/Sandoz. S. J. Szefler has consultant arrangements with GlaxoSmithKline, Genentech, Merck, Boehringer Ingelheim, Novartis, and Schering-Plough and receives research support from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) Childhood Asthma Management Program (CAMP), the NNHLBI Childhood Asthma Research and Education (CARE), the NIH/NHLBI Asthma Clinical Research Network (ACRN), the NIH/National Institute of Allergy and Infectious Diseases Inner-City Asthma Consortium (ICAC), GlaxoSmithKline, the NIH/NHLBI Asthma Net, and the National Institute of Environmental Health Sciences/Environmental Protection Agency Childhood Environmental Health Center. R. S. Zeiger has consultant arrangements with Aerocrine, AstraZeneca, Genentech, Merck and Co, MedImmune, Sunovion/Sepracor, and Novartis and receives research support from Aerocrine, Genentech, GlaxoSmithKline, and Merck and Co. L. B. Bacharier receives honoraria from AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Aerocrine and serves on advisory boards for GlaxoSmithKline and Schering-Plough. The rest of the authors have declared that they have no conflict of interest.	Calhoun WJ, 2003, CHEST, V123, p399S, DOI 10.1378/chest.123.3_suppl.399S; Chugh IM, 2006, ASIAN PAC J ALLERGY, V24, P135; Covar RA, 2008, J ALLERGY CLIN IMMUN, V122, P741, DOI 10.1016/j.jaci.2008.08.021; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Fiese BH, 2007, J FAM PSYCHOL, V21, P95, DOI 10.1037/0893-3200.21.1.95; Fuhlbrigge AL, 2006, PEDIATRICS, V118, pE347, DOI 10.1542/peds.2005-2962; Kraft M, 1997, CHEST, V111, P1249, DOI 10.1378/chest.111.5.1249; Kwong GNM, 2002, THORAX, V57, P701, DOI 10.1136/thorax.57.8.701; Landstra AM, 2003, EUR RESPIR J, V21, P627, DOI 10.1183/09031936.03.00085802; Landstra AM, 2002, AM J RESP CRIT CARE, V165, P708, DOI 10.1164/ajrccm.165.5.2102115; Mustafa Ghulam, 2008, J Ayub Med Coll Abbottabad, V20, P36; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Sadeh A, 1998, SLEEP, V21, P379, DOI 10.1093/sleep/21.4.379; Shigemitsu H, 2007, CURR OPIN PULM MED, V13, P49, DOI 10.1097/MCP.0b013e328010a890; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Stores G, 1998, ARCH DIS CHILD, V78, P413, DOI 10.1136/adc.78.5.413; Strunk RC, 2002, J ALLERGY CLIN IMMUN, V110, P395, DOI 10.1067/mai.2002.127433; Sutherland ER, 2005, CURR ALLERGY ASTHM R, V5, P161, DOI 10.1007/s11882-005-0091-z; Sutherland ER, 2005, J ALLERGY CLIN IMMUN, V116, P1179, DOI 10.1016/j.jaci.2005.09.028	19	15	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2011	128	5					977	U407		10.1016/j.jaci.2011.07.018	http://dx.doi.org/10.1016/j.jaci.2011.07.018			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	842FJ	21855126	Green Accepted			2022-12-18	WOS:000296578200009
J	Nosbaum, A; Pecquet, C; Bayrou, O; Amsler, E; Nicolas, JF; Berard, F; Frances, C				Nosbaum, Audrey; Pecquet, Catherine; Bayrou, Olivier; Amsler, Emmanuelle; Nicolas, Jean F.; Berard, Frederic; Frances, Camille			Treatment with propranolol of 6 patients with idiopathic aquagenic pruritus	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Nosbaum, Audrey; Pecquet, Catherine; Bayrou, Olivier; Amsler, Emmanuelle; Frances, Camille] Hop Tenon, AP HP, Allergol & Dermatol Dept, F-75970 Paris, France; [Nosbaum, Audrey; Nicolas, Jean F.; Berard, Frederic] Hosp Civils Lyon, Dept Allergy & Clin Immunol, Ctr Hosp Lyon Sud, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon	Nosbaum, A (corresponding author), Hop Tenon, AP HP, Allergol & Dermatol Dept, F-75970 Paris, France.	audrey.nosbaum@chu-lyon.fr	Nosbaum, Audrey/AAC-9329-2020; Nicolas, Jean-François/AAW-9289-2020; Bérard, Frédéric/F-8099-2013	Nosbaum, Audrey/0000-0003-2281-9052; BERARD, frederic/0000-0003-0094-6122; NICOLAS, JEAN FRANCOIS/0000-0003-4204-803X				BAYOUMI AHM, 1986, LANCET, V2, P464; BIRCHER AJ, 1988, ARCH DERMATOL, V124, P84, DOI 10.1001/archderm.124.1.84; GREAVES M, 1992, EUR J DERMATOL, V2, P282; Misery L, 2003, ANN DERMATOL VENER, V130, P195; THOMSEN K, 1990, J AM ACAD DERMATOL, V22, P697, DOI 10.1016/S0190-9622(08)81053-5	6	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2011	128	5					1113	1113		10.1016/j.jaci.2011.05.001	http://dx.doi.org/10.1016/j.jaci.2011.05.001			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	842FJ	21616525				2022-12-18	WOS:000296578200029
J	Biagtan, MJ; Viswanathan, RK; Evans, MD; Mathur, SK				Biagtan, Mark J.; Viswanathan, Ravi K.; Evans, Michael D.; Mathur, Sameer K.			Clinical utility of the Chronic Urticaria Index	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHRONIC IDIOPATHIC URTICARIA; CHRONIC AUTOIMMUNE URTICARIA		[Biagtan, Mark J.; Viswanathan, Ravi K.; Mathur, Sameer K.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Viswanathan, Ravi K.; Mathur, Sameer K.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Evans, Michael D.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	Biagtan, MJ (corresponding author), Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	sm4@medicine.wisc.edu		Evans, Michael/0000-0001-7449-3993	NIAID NIH HHS [AI007635, T32 AI007635-12, T32 AI007635] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007635] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTRICH M, LAB EVALUATION AUTOI; Altrich ML, 2009, ALLERGY ASTHMA PROC, V30, P28, DOI 10.2500/aap.2009.30.3185; Eckman JA, 2009, J INVEST DERMATOL, V129, P1584, DOI 10.1038/jid.2008.416; Kaplan AP, 2004, J ALLERGY CLIN IMMUN, V114, P465, DOI 10.1016/j.jaci.2004.02.049; Mlynek A, 2008, ALLERGY, V63, P777, DOI 10.1111/j.1398-9995.2008.01726.x; Najib U, 2009, ANN ALLERG ASTHMA IM, V103, P496, DOI 10.1016/S1081-1206(10)60266-9; Sabroe RA, 2002, J ALLERGY CLIN IMMUN, V110, P492, DOI 10.1067/mai.2002.126782; Soundararajan S, 2005, J ALLERGY CLIN IMMUN, V115, P815, DOI 10.1016/j.jaci.2004.12.1120; Staevska M, 2010, J ALLERGY CLIN IMMUN, V125, P676, DOI 10.1016/j.jaci.2009.11.047; Zuberbier T, 2009, ALLERGY, V64, P1427, DOI 10.1111/j.1398-9995.2009.02178.x	10	15	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1626	1627		10.1016/j.jaci.2011.01.045	http://dx.doi.org/10.1016/j.jaci.2011.01.045			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21376378	Green Accepted			2022-12-18	WOS:000291048500047
J	Paccani, SR; Benagiano, M; Savino, MT; Finetti, F; Tonello, F; D'Elios, MM; Baldari, CT				Paccani, Silvia Rossi; Benagiano, Marisa; Savino, Maria Teresa; Finetti, Francesca; Tonello, Fiorella; D'Elios, Mario M.; Baldari, Cosima T.			The adenylate cyclase toxin of Bacillus anthracis is a potent promoter of T(H)17 cell development	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Paccani, Silvia Rossi; Savino, Maria Teresa; Finetti, Francesca; Baldari, Cosima T.] Univ Siena, Dept Evolutionary Biol, I-53100 Siena, Italy; [Benagiano, Marisa; D'Elios, Mario M.] Univ Florence, Dept Internal Med, Florence, Italy; [Benagiano, Marisa] AOUC Firenze, SO Immunoallergol, Policlin Careggi, Florence, Italy; [Tonello, Fiorella] CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy	University of Siena; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; Consiglio Nazionale delle Ricerche (CNR)	Paccani, SR (corresponding author), Univ Siena, Dept Evolutionary Biol, Via Laterina 8, I-53100 Siena, Italy.	baldari@unisi.it	Tonello, Fiorella/AAM-6737-2021; Finetti, Francesca/T-3788-2019; Benagiano, Marisa/AAD-6443-2019; Tonello, Fiorella/G-8957-2013; D'Elios, Mario Milco/Y-9573-2019	Tonello, Fiorella/0000-0001-8935-8938; Finetti, Francesca/0000-0002-3421-1637; Benagiano, Marisa/0000-0003-0792-2326; Tonello, Fiorella/0000-0001-8935-8938; D'Elios, Mario Milco/0000-0001-9160-0930; Baldari, Cosima/0000-0002-4414-6744	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Duverger A, 2006, J IMMUNOL, V176, P1776, DOI 10.4049/jimmunol.176.3.1776; Lin YY, 2010, SEMIN IMMUNOPATHOL, V32, P79, DOI 10.1007/s00281-009-0191-2; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002	9	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2011	127	6					1635	1637		10.1016/j.jaci.2010.12.1104	http://dx.doi.org/10.1016/j.jaci.2010.12.1104			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	769WH	21310477	Bronze			2022-12-18	WOS:000291048500051
J	Bossuyt, X; Borgers, H; Moens, L; Verbinnen, B; Meyts, I				Bossuyt, Xavier; Borgers, Heleen; Moens, Leen; Verbinnen, Bert; Meyts, Isabelle			Age-and serotype-dependent antibody response to pneumococcal polysaccharides	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VACCINE		[Bossuyt, Xavier; Borgers, Heleen; Moens, Leen; Verbinnen, Bert; Meyts, Isabelle] Katholieke Univ Leuven, Expt Immunol Lab, Dept Med Diagnost Sci, Biomed Sci Grp, Louvain, Belgium	KU Leuven	Bossuyt, X (corresponding author), Katholieke Univ Leuven, Expt Immunol Lab, Dept Med Diagnost Sci, Biomed Sci Grp, Louvain, Belgium.		Meyts, Isabelle/Z-3295-2019; Bossuyt, Xavier/B-2085-2019	Bossuyt, Xavier/0000-0001-6856-8485				Balloch A, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.05.008; Borgers H, 2010, CLIN IMMUNOL, V135, P501, DOI 10.1016/j.clim.2010.01.017; Jeurissen A, 2007, CLIN CHEM, V53, P505, DOI 10.1373/clinchem.2006.080051; POMAT WS, 1994, INFECT IMMUN, V62, P1848, DOI 10.1128/IAI.62.5.1848-1853.1994; Rubins JB, 1999, INFECT IMMUN, V67, P5979, DOI 10.1128/IAI.67.11.5979-5984.1999; Simonsen V, 2005, BRAZ J MED BIOL RES, V38, P251, DOI 10.1590/S0100-879X2005000200014; Sorensen RU, 1998, J ALLERGY CLIN IMMUN, V102, P215, DOI 10.1016/S0091-6749(98)70089-2	7	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2011	127	4					1079	1080		10.1016/j.jaci.2010.12.1109	http://dx.doi.org/10.1016/j.jaci.2010.12.1109			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743YL	21306761	Green Accepted			2022-12-18	WOS:000289055800042
J	Kanazawa, H; Tochino, Y; Kyoh, S; Ichimaru, Y; Asai, K; Hirata, K				Kanazawa, Hiroshi; Tochino, Yoshihiro; Kyoh, Shigenori; Ichimaru, Yukikazu; Asai, Kazuhisa; Hirata, Kazuto			Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pentosidine; elderly asthma; lung elasticity; small airways; aging	GLYCATION END-PRODUCTS; LUNG ELASTIC RECOIL; SMALL AIRWAYS; AIR-FLOW; MORTALITY; RISK	Background: Pentosidine is well established as an intermolecular cross-linking type of advanced glycation end products, and it accumulates with aging in various connective tissues. Objective: To determine whether pentosidine contributes to age-related and disease-related impairment of pulmonary functions in patients with asthma. Methods: We measured pentosidine levels in induced sputum from young to elderly patients with asthma and assessed the slope of the nitrogen (N-2) alveolar plateau (delta N-2), closing volume (CV), and closing capacity (CC) from a nitrogen washout curve in a single breath. Results: Pentosidine levels in induced sputum were significantly higher in patients with asthma than in normal controls (patients with asthma: median, 20.1, interquartile range, 16.7-26.5 ng/mL; normal controls: median, 3.0, interquartile range, 0.7-7.5 ng/mL; P <. 001). The levels were closely correlated with age in both normal controls and patients with asthma. However, the slope of age-related increase in pentosidine levels was markedly steeper in patients with asthma than in normal controls. CV/vital capacity, CC/total lung capacity, and delta N-2 increased with aging in both normal controls and patients with asthma. Moreover, in each range of age (21-40, 41-60, 61-80 years), CV/vital capacity, CC/total lung capacity, and delta N-2 were significantly higher in patients with asthma than in normal controls. In addition, pentosidine levels in patients with asthma were closely correlated with each of these variables. Conclusion: Our results demonstrated the association between sputum levels of pentosidine and age-related small airways function in both normal controls and patients with asthma. Moreover, the age-related increase in pentosidine levels was more pronounced in patients with asthma. These findings will herald new era in the pathophysiology of elderly asthma. (J Allergy Clin Immunol 2011;127:899-904.)	[Kanazawa, Hiroshi] Osaka City Univ, Dept Resp Med, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	Osaka Metropolitan University	Kanazawa, H (corresponding author), Osaka City Univ, Dept Resp Med, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	kanazawa-h@med.osaka-cu.ac.jp			Ministry of Education, Science, and Culture, Japan [20590901]	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by a grant-in-aid for scientific research (no. 20590901) from the Ministry of Education, Science, and Culture, Japan.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Bellia V, 2007, CHEST, V132, P1175, DOI 10.1378/chest.06-2824; BELLMUNT MJ, 1995, BBA-MOL BASIS DIS, V1272, P53, DOI 10.1016/0925-4439(95)00069-G; BELLMUNT MJ, 1995, LUNG, V173, P177; Bourdin A, 2006, ALLERGY, V61, P85, DOI 10.1111/j.1398-9995.2006.00970.x; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BROWN PJ, 1984, THORAX, V39, P131, DOI 10.1136/thx.39.2.131; Contoli M, 2010, ALLERGY, V65, P141, DOI 10.1111/j.1398-9995.2009.02242.x; Contoli M, 2010, J ALLERGY CLIN IMMUN, V125, P830, DOI 10.1016/j.jaci.2010.01.003; Gelb AF, 2000, AM J RESP CRIT CARE, V162, P1778, DOI 10.1164/ajrccm.162.5.2001037; Gelb AF, 2002, CHEST, V121, P715, DOI 10.1378/chest.121.3.715; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kanazawa H, 2004, AM J RESP CRIT CARE, V169, P1125, DOI 10.1164/rccm.200401-123OC; King GG, 1998, AM J RESP CRIT CARE, V158, P1900, DOI 10.1164/ajrccm.158.6.9608027; Ling X, 1998, LAB INVEST, V78, P1591; MCCARTHY DS, 1980, THORAX, V35, P298, DOI 10.1136/thx.35.4.298; McNulty M, 2007, AM J HYPERTENS, V20, P242, DOI 10.1016/j.amjhyper.2006.08.009; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Scichilone N, 2009, ALLERGY, V64, P1563, DOI 10.1111/j.1398-9995.2009.02139.x; SELL DR, 1989, J BIOL CHEM, V264, P21597; Sin DD, 2001, EUR RESPIR J, V17, P380, DOI 10.1183/09031936.01.17303800; 't Veen JCCMI, 2000, AM J RESP CRIT CARE, V161, P1902; Vignola AM, 2003, EUR RESPIR J, V22, P795, DOI 10.1183/09031936.03.00112302; Weiner P, 1998, EUR RESPIR J, V12, P564, DOI 10.1183/09031936.98.12030564	27	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2011	127	4					899	904		10.1016/j.jaci.2010.11.020	http://dx.doi.org/10.1016/j.jaci.2010.11.020			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	743YL	21215998	Bronze			2022-12-18	WOS:000289055800010
J	Vickery, BP; Scurlock, AM; Steele, P; Kamilaris, J; Hiegel, AM; Carlisle, SK; Perry, TT; Jones, SM; Burks, AW				Vickery, B. P.; Scurlock, A. M.; Steele, P.; Kamilaris, J.; Hiegel, A. M.; Carlisle, S. K.; Perry, T. T.; Jones, S. M.; Burks, A. W.			Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	American-Academy-of-Allergy-Asthma-and-Immunology Annual Meeting	MAR 18-22, 2011	San Francisco, CA	Amer Acad Allergy Asthma & Immunol					[Vickery, B. P.; Steele, P.; Kamilaris, J.; Burks, A. W.] Duke Univ, Durham, NC USA; [Scurlock, A. M.; Hiegel, A. M.; Carlisle, S. K.; Perry, T. T.; Jones, S. M.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Duke University; University of Arkansas System; University of Arkansas Medical Sciences					NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002557] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004435] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI077932, R01AI068074] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	15	15	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2		S			AB26	AB26		10.1016/j.jaci.2010.12.114	http://dx.doi.org/10.1016/j.jaci.2010.12.114			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	832YI					2022-12-18	WOS:000295846400098
J	Hankin, CS; Lockey, RF				Hankin, Cheryl S.; Lockey, Richard F.			Patient characteristics associated with allergen immunotherapy initiation and adherence	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Patient characteristics; allergen immunotherapy; disparities; utilization; adherence persistence	UNITED-STATES; ASTHMA; PATTERNS; RHINITIS		[Hankin, Cheryl S.] BioMedEcon, Moss Beach, CA USA; [Lockey, Richard F.] Univ S Florida, Coll Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Hankin, CS (corresponding author), BioMed Econ LLC, POB 129, Moss Beach, CA 94038 USA.	chankin@biomedecon.com						Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; [Anonymous], 2006, ALLERGIES AM LANDMAR; Asthma and Allergy Foundation of America; National Pharmaceutical Council, 2005, ETHN DISP BURD TREAT; Ciprandi G, 2008, INT J IMMUNOPATH PH, V21, P477, DOI 10.1177/039463200802100231; Cox L, 2008, DRUG BENEFIT TRENDS, V20, P1; Cox L, 2007, ANN ALLERG ASTHMA IM, V98, P416, DOI 10.1016/S1081-1206(10)60755-7; Cox L, 2009, ANN ALLERG ASTHMA IM, V103, P451, DOI 10.1016/S1081-1206(10)60259-1; Donahue JG, 1999, ANN ALLERG ASTHMA IM, V82, P339, DOI 10.1016/S1081-1206(10)63282-6; Frew AJ, 2010, J ALLERGY CLIN IMMUN, V125, pS306, DOI 10.1016/j.jaci.2009.10.064; Hankin CS, 2008, J ALLERGY CLIN IMMUN, V121, P227, DOI 10.1016/j.jaci.2007.10.026; Hankin CS, 2010, ANN ALLERG ASTHMA IM, V104, P79, DOI 10.1016/j.anai.2009.11.010; Hommers L, 2007, EUR J PUBLIC HEALTH, V17, P278, DOI 10.1093/eurpub/ckl241; Koinis-Mitchell D, 2008, J ASTHMA, V45, P205, DOI 10.1080/02770900801890422; LOWER T, 1993, ANN ALLERGY, V70, P480; Mahesh P A, 2010, Indian J Chest Dis Allied Sci, V52, P91; Moonie SA, 2006, J SCHOOL HEALTH, V76, P18, DOI 10.1111/j.1746-1561.2006.00062.x; More DR, 2002, ANN ALLERG ASTHMA IM, V88, P391, DOI 10.1016/S1081-1206(10)62370-8; PETERSEN KD, 2010, EUR J PUBLIC HL 0519; Rhodes BJ, 1999, ANN ALLERG ASTHMA IM, V82, P281, DOI 10.1016/S1081-1206(10)62609-9; Schatz M, 2006, CHEST, V129, P50, DOI 10.1378/chest.129.1.50; TINKELMAN D, 1995, ANN ALLERG ASTHMA IM, V74, P241; 2008, PEDIAT ALLERGIES AM	22	15	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					46	U493		10.1016/j.jaci.2010.10.014	http://dx.doi.org/10.1016/j.jaci.2010.10.014			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21093021	Bronze			2022-12-18	WOS:000285917300007
J	Brooks, CR; Weinkove, R; Hermans, IF; van Dalen, CJ; Douwes, J				Brooks, Collin R.; Weinkove, Robert; Hermans, Ian F.; van Dalen, Christine J.; Douwes, Jeroen			Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BRONCHIAL-ASTHMA; NKT CELLS		[Brooks, Collin R.; van Dalen, Christine J.; Douwes, Jeroen] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Weinkove, Robert; Hermans, Ian F.] Malaghan Inst Med Res, Wellington, New Zealand	Massey University; Malaghan Institute; Victoria University Wellington	Brooks, CR (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington Campus, Wellington, New Zealand.	C.R.Brooks@massey.ac.nz	Weinkove, Robert/S-4457-2019; Hermans, Ian/I-3961-2013; Weinkove, Robert/I-6991-2012	Weinkove, Robert/0000-0003-3645-7988; Weinkove, Robert/0000-0003-3645-7988; Hermans, Ian/0000-0002-7584-887X; Douwes, Jeroen/0000-0003-3599-4036; Brooks, Collin/0000-0002-3947-2246				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Gibson PG, 1998, AM J RESP CRIT CARE, V158, P36, DOI 10.1164/ajrccm.158.1.9705031; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Im JS, 2008, CLIN IMMUNOL, V127, P214, DOI 10.1016/j.clim.2007.12.005; KRUEGER LA, 2004, CURR PROTOC CYTOM, pCH6; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691	9	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2010	126	4					882	885		10.1016/j.jaci.2010.06.041	http://dx.doi.org/10.1016/j.jaci.2010.06.041			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	658SP	20719374				2022-12-18	WOS:000282510000034
J	Guilbert, TW				Guilbert, Theresa W.			Identifying and managing the infant and toddler at risk for asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Infants; children; asthma; wheezing; inhaled corticosteroids; leukotriene receptor antagonists; Asthma Predictive Index	BUDESONIDE INHALATION SUSPENSION; PRESCHOOL-CHILDREN; YOUNG-CHILDREN; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; PERSISTENT ASTHMA; EFFICACY; SAFETY; MONTELUKAST; CHILDHOOD		Univ Wisconsin, Dept Pediat, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Guilbert, TW (corresponding author), Univ Wisconsin, Dept Pediat, 600 Highland Ave,K4-944,CSC Box 4108, Madison, WI 53792 USA.	tguilbert@wisc.edu		Guilbert, Theresa/0000-0002-6932-712X				Bacharier LB, 2009, J ALLERGY CLIN IMMUN, V123, P1077, DOI 10.1016/j.jaci.2008.12.1120; Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Baker JW, 1999, PEDIATRICS, V103, P414, DOI 10.1542/peds.103.2.414; Bisgaard H, 2005, AM J RESP CRIT CARE, V171, P315, DOI 10.1164/rccm.200407-894OC; Bisgaard H, 2004, PEDIATRICS, V113, P87; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2009, PEDIATRICS, V123, pe519, DOI 10.1542/peds.2008-2867; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Kemp JP, 1999, ANN ALLERG ASTHMA IM, V83, P231, DOI 10.1016/S1081-1206(10)62646-4; Knorr B, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e48; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Qaqundah PY, 2006, J PEDIATR-US, V149, P663, DOI 10.1016/j.jpeds.2006.07.045; Shapiro G, 1998, J ALLERGY CLIN IMMUN, V102, P789, DOI 10.1016/S0091-6749(98)70019-3; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1043, DOI 10.1016/j.jaci.2007.08.063	20	15	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2010	126	2					417	422		10.1016/j.jaci.2010.06.024	http://dx.doi.org/10.1016/j.jaci.2010.06.024			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	642IL	20624654				2022-12-18	WOS:000281203800045
J	Munoz-Cano, R; Carnes, J; Sanchez-Lopez, J; Saiz, A; Bartra, J; Lopez-Matas, MA; Picado, C; Valero, A				Munoz-Cano, Rosa; Carnes, Jeronimo; Sanchez-Lopez, Jaime; Saiz, Albert; Bartra, Joan; Lopez-Matas, M. Angeles; Picado, Cesar; Valero, Antonio			Biological agents: New drugs, old problems	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NATALIZUMAB		[Munoz-Cano, Rosa; Sanchez-Lopez, Jaime; Bartra, Joan; Picado, Cesar; Valero, Antonio] Hosp Clin Barcelona, Dept Pneumol, Allergy Unit, Barcelona, Spain; [Carnes, Jeronimo; Lopez-Matas, M. Angeles] R&D Dept, SL, Labs LETI, Madrid, Spain; [Saiz, Albert] Hosp Clinic IDIBAPS, Dept Neurol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Munoz-Cano, R (corresponding author), Hosp Clin Barcelona, Dept Pneumol, Allergy Unit, Barcelona, Spain.	rmunoz@clinic.ub.es	Sánchez-López, Jaime/L-3020-2014; Saiz, Albert/K-8236-2014; Cano, Rosa Munoz/K-9413-2014; /AFX-9519-2022; /AAL-7347-2021; Bartra, Joan/L-4550-2014; Muñoz, Rosa/AAC-7288-2020	Sánchez-López, Jaime/0000-0003-3600-8138; Saiz, Albert/0000-0002-5793-8791; Cano, Rosa Munoz/0000-0001-8566-8285; Bartra, Joan/0000-0001-7767-4730; Muñoz, Rosa/0000-0001-8566-8285; Carnes, Jeronimo/0000-0003-4050-2577; Lopez-Matas, M. Angeles/0000-0001-9688-6755				Brockow K, 2002, ALLERGY, V57, P45; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2009, J ALLERGY CLIN IMMUN, V124, P652, DOI 10.1016/j.jaci.2009.08.026; Killestein J, 2009, MULT SCLER, V15, P525, DOI 10.1177/1352458508101322; Pichler WJ, 2006, ALLERGY, V61, P912, DOI 10.1111/j.1398-9995.2006.01058.x; Price KS, 2007, ALLERGY ASTHMA PROC, V28, P313, DOI 10.2500/aap.2007.28.3003; YEDNOCK T, 2007, Patent No. 2007103112	8	15	16	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2010	126	2								10.1016/j.jaci.2010.05.004	http://dx.doi.org/10.1016/j.jaci.2010.05.004			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	642IL	20579714				2022-12-18	WOS:000281203800030
J	Chand, HS; Schuyler, M; Joste, N; Hensler, C; Tesfaigzi, Y; Masten, B; Schrader, R; Lipscomb, MF				Chand, Hitendra S.; Schuyler, Mark; Joste, Nancy; Hensler, Charlene; Tesfaigzi, Yohannes; Masten, Barbara; Schrader, Ron; Lipscomb, Mary F.			Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Chand, Hitendra S.; Hensler, Charlene; Lipscomb, Mary F.] Univ New Mexico, Ctr Infect Dis & Immun, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Chand, Hitendra S.; Joste, Nancy; Masten, Barbara; Lipscomb, Mary F.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Schuyler, Mark] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Schrader, Ron] Univ New Mexico, Gen Clin Res Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Chand, Hitendra S.; Tesfaigzi, Yohannes] Lovelace Resp Res Inst, Albuquerque, NM USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Lovelace Respiratory Research Institute	Chand, HS (corresponding author), Univ New Mexico, Ctr Infect Dis & Immun, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	hchand@lrri.org	Chand, Hitendra/AAE-7975-2020	Chand, Hitendra/0000-0002-0574-9307; Tesfaigzi, Yohannes/0000-0002-3997-5839	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068111, P50HL056384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056295, U19AI057234] Funding Source: NIH RePORTER; NCRR NIH HHS [5M01-RR0099, M01 RR000997] Funding Source: Medline; NHLBI NIH HHS [1-P50-HL56384-06-10, P50 HL056384-100001, P50 HL056384, R01 HL068111, R01-HL068111] Funding Source: Medline; NIAID NIH HHS [P01-AI056295-01-05, P01 AI056295, U19-AI57234-01-05, U19 AI057234] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boulet LP, 1997, AM J RESP CRIT CARE, V155, P1835, DOI 10.1164/ajrccm.155.6.9196083; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lipscomb MF, 2002, PHYSIOL REV, V82, P97, DOI 10.1152/physrev.00023.2001; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Moller GM, 1996, CLIN EXP ALLERGY, V26, P517, DOI 10.1111/j.1365-2222.1996.tb00571.x; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Oliver JM, 2010, INT ARCH ALLERGY IMM, V151, P275, DOI 10.1159/000250436	9	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2010	125	5					1157	1158		10.1016/j.jaci.2010.01.020	http://dx.doi.org/10.1016/j.jaci.2010.01.020			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	596LO	20304471	Green Accepted			2022-12-18	WOS:000277686700028
J	Niedoszytko, M; Bruinenberg, M; de Monchy, J; Wijmenga, C; Platteel, M; Jassem, E; Elberink, JNGO				Niedoszytko, Marek; Bruinenberg, Marcel; de Monchy, Jan; Wijmenga, Cisca; Platteel, Mathieu; Jassem, Ewa; Elberink, Joanne N. G. Oude			Gene expression analysis in predicting the effectiveness of insect venom immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Insect venom allergy; venom immunotherapy gene expression; microarray assessment; prediction of treatment efficacy	FALSE DISCOVERY RATE; ALLERGY	Background: Venom immunotherapy (VIT) enables longtime prevention of insect venom allergy in the majority of patients. However, in some, the risk of a resystemic reaction increases after completion of treatment. No reliable factors predicting individual lack of efficacy of VIT are currently available. Objective: To determine the use of gene expression profiles to predict the long-term effect of VIT. Methods: Whole genome gene expression analysis was performed on RNA samples from 46 patients treated with VIT divided into 3 groups: (1) patients who achieved and maintained long-term protection after VIT, (2) patients in whom insect venom allergy relapsed, and (3) patients still in the maintenance phase of VIT. Results: Among the 48.071 transcripts analyzed, 1401 showed a >2 fold difference in gene expression (P <.05); 658 genes (47%) were upregulated and 743 (53%) downregulated. Forty-three transcripts still show significant differences in expression after correction for multiple testing; 12 of 43 genes (28%) were upregulated and 31 of 43 genes (72%) downregulated. A naive Bayes prediction model demonstrated a gene expression pattern characteristic of effective VIT that was present in all patients with successful VIT but absent in all subjects with failure of VIT. The same gene expression profile was present in 88% of patients in the maintenance phase of VIT. Conclusion: Gene expression profiling might be a useful tool to assess the long-term effectiveness of VIT. The analysis of differently expressed genes confirms the involvement of immunologic pathways described previously but also indicates novel factors that might be relevant for allergen tolerance. (J Allergy Clin Immunol 2010;125:1092-7.)	[Niedoszytko, Marek; Jassem, Ewa] Med Univ Gdansk, Dept Allergol, PL-80952 Gdansk, Poland; [Niedoszytko, Marek; de Monchy, Jan; Elberink, Joanne N. G. Oude] Univ Groningen, Dept Allergol, NL-9700 AB Groningen, Netherlands; [Bruinenberg, Marcel; Wijmenga, Cisca; Platteel, Mathieu] Univ Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Bruinenberg, Marcel] Univ Groningen, Lifelines, Univ Med Ctr Groningen, NL-9700 AB Groningen, Netherlands	Fahrenheit Universities; Medical University Gdansk; University of Groningen; University of Groningen; University of Groningen	Niedoszytko, M (corresponding author), Med Univ Gdansk, Dept Allergol, Debinki 7, PL-80952 Gdansk, Poland.	mnied@amg.gda.pl	Niedoszytko, Marek/U-1250-2018; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Niedoszytko, Marek/0000-0003-1089-1911; Wijmenga, Cisca/0000-0002-5635-1614; Jassem, Ewa/0000-0003-4239-4776	Foundation for Polish Science; Polish Ministry of Science and Higher Education [N402085934]; ALK-Abello; Novartis	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); ALK-Abello; Novartis(Novartis)	Supported by the Foundation for Polish Science and a grant from the Polish Ministry of Science and Higher Education, no. N402085934.; Disclosure of potential conflict of interest: J. de Monchy has received research support from ALK-Abello and Novartis. The rest of the authors have declared that they have no conflict of interest.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonifazi F, 2005, ALLERGY, V60, P1459, DOI 10.1111/j.1398-9995.2005.00960.x; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; Elberink JNGO, 1997, J ALLERGY CLIN IMMUN, V99, P153, DOI 10.1016/S0091-6749(97)70314-2; Golden DBK, 2003, AM FAM PHYSICIAN, V67, P2541; Golden DBK, 2000, J ALLERGY CLIN IMMUN, V105, P385, DOI 10.1016/S0091-6749(00)90092-7; Ippoliti F, 2003, PEDIATR ALLERGY IMMU, V14, P216, DOI 10.1034/j.1399-3038.2003.00025.x; Jutel M, 2006, ALLERGY, V61, P796, DOI 10.1111/j.1398-9995.2006.01175.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kazmierska J, 2008, RADIOTHER ONCOL, V86, P211, DOI 10.1016/j.radonc.2007.10.019; Konno S, 2005, J ALLERGY CLIN IMMUN, V115, P1063, DOI 10.1016/j.jaci.2005.01.055; Kononenko I, 2001, ARTIF INTELL MED, V23, P89, DOI 10.1016/S0933-3657(01)00077-X; Lerch E, 1998, J ALLERGY CLIN IMMUN, V101, P606, DOI 10.1016/S0091-6749(98)70167-8; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Mueller H L, 1966, J Asthma Res, V3, P331; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Rueff F, 2001, J ALLERGY CLIN IMMUN, V108, P1027, DOI 10.1067/mai.2001.119154; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Simons FER, 2007, J ALLERGY CLIN IMMUN, V120, pS2, DOI [10.1016/j.jaci.2007.05.001, 10.1016/j.jaci.2007.05.016]; Zimmerli SC, 2007, J INVEST DERMATOL, V127, P2381, DOI 10.1038/sj.jid.5700882; SLC16A14 GENE FUNCTI; COMMD8 GENE FUNCTION	27	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2010	125	5					1092	1097		10.1016/j.jaci.2010.01.021	http://dx.doi.org/10.1016/j.jaci.2010.01.021			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	596LO	20334904	Bronze			2022-12-18	WOS:000277686700019
J	Villalta, D; Asero, R				Villalta, Danilo; Asero, Riccardo			Is the detection of IgE to multiple Bet v 1-homologous food allergens by means of allergen microarray clinically useful?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							BIRCH POLLEN ALLERGY; HYPERSENSITIVITY; SYMPTOMS; ROSACEAE; NUTS		[Villalta, Danilo] AO S Maria degli Angeli, Dipartimento Med Lab, Allergol & Immunol Clin, Pordenone, Italy; [Asero, Riccardo] Clin San Carlo, Paderno Dugnano, MI, Italy		Villalta, D (corresponding author), AO S Maria degli Angeli, Dipartimento Med Lab, Allergol & Immunol Clin, Pordenone, Italy.	r.asero@libero.it						Asero R, 1997, ALLERGY, V52, P560, DOI 10.1111/j.1398-9995.1997.tb02600.x; Asero R, 1996, J ALLERGY CLIN IMMUN, V97, P611, DOI 10.1016/S0091-6749(96)70306-8; Asero R, 2005, INT ARCH ALLERGY IMM, V138, P1, DOI 10.1159/000087352; Asero R, 2008, EUR ANN ALLERGY CLIN, V40, P115; Asero R, 2001, ANN ALLERG ASTHMA IM, V87, P68, DOI 10.1016/S1081-1206(10)62326-5; Asero R, 1999, ANN ALLERG ASTHMA IM, V83, P377, DOI 10.1016/S1081-1206(10)62834-7; BIRCHER AJ, 1994, CLIN EXP ALLERGY, V24, P367, DOI 10.1111/j.1365-2222.1994.tb00248.x; EBO DG, 2009, CLIN EXP ALLERGY; FOGLEHANSSON M, 1993, ALLERGY, V48, P282, DOI 10.1111/j.1398-9995.1993.tb00729.x; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; Palacin A, 2008, CLIN EXP ALLERGY, V38, P1220, DOI 10.1111/j.1365-2222.2007.02927.x	11	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2010	125	5					1158	1161		10.1016/j.jaci.2010.01.043	http://dx.doi.org/10.1016/j.jaci.2010.01.043			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	596LO	20304472				2022-12-18	WOS:000277686700029
J	Wu, AC; Lasky-Su, J; Rogers, CA; Klanderman, BJ; Litonjua, A				Wu, Ann Chen; Lasky-Su, Jessica; Rogers, Christine A.; Klanderman, Barbara J.; Litonjua, Augusto			Polymorphisms of chitinases are not associated with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ACIDIC MAMMALIAN CHITINASE; BRONCHIAL-ASTHMA; CHITOTRIOSIDASE; LUNG; CHILDREN		[Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Wu, Ann Chen; Klanderman, Barbara J.; Litonjua, Augusto] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Ann Chen] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Lasky-Su, Jessica; Litonjua, Augusto] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Litonjua, Augusto] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; [Rogers, Christine A.] Univ Massachusetts, Amherst, MA 01003 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Amherst	Wu, AC (corresponding author), Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA.	ann.wu@childrens.harvard.edu	Wu, Ann/AAY-4293-2020; Rogers, Christine A/M-6007-2017; Rogers, Christine A/A-2189-2008	Wu, Ann/0000-0003-0599-9063; Rogers, Christine A/0000-0003-0887-9606; Rogers, Christine A/0000-0003-0887-9606; Litonjua, Augusto/0000-0003-0422-5875	DIVISION OF LUNG DISEASES [N01HR016044] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719, M01RR000036, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, U01HL075419, P01HL083069, U01HL065899, R01HL076419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056230] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000051, M01RR0099718-24, M01RR00051, RR00036, M01RR02719-14, M01 RR000036, M01 RR002719] Funding Source: Medline; NHLBI NIH HHS [T32 HL07427, R01 HL076419, T32 HL007427, U01 HL075419, U01 HL65899, P01 HL083069, N01HR16044, U01 HL075419-07, N01-HR-16044, U01 HL076419, U01 HL065899] Funding Source: Medline; NIAID NIH HHS [R01 AI056230] Funding Source: Medline; PHS HHS [16045, 16052, 16050, 16047, 16051, 16048, 16049, 16046] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bierbaum S, 2006, INT J IMMUNOGENET, V33, P201, DOI 10.1111/j.1744-313X.2006.00597.x; Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Chatterjee R, 2008, J ALLERGY CLIN IMMUN, V122, P202, DOI 10.1016/j.jaci.2008.04.030; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lasky-Su J, 2006, ADDICT BEHAV, V31, P1088, DOI 10.1016/j.addbeh.2006.03.013; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; Sohn MH, 2009, AM J RESP CRIT CARE, V179, P449, DOI 10.1164/rccm.200809-1422OC; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	12	15	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2010	125	3					754	757		10.1016/j.jaci.2009.12.995	http://dx.doi.org/10.1016/j.jaci.2009.12.995			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	573BK	20226308	Green Accepted			2022-12-18	WOS:000275883200040
J	Falcone, FH; Telford, G; Hooi, D; Brown, AP; Seabra, R; Feary, J; Venn, A; Britton, J; Pritchard, DI				Falcone, Franco H.; Telford, Gary; Hooi, Doreen; Brown, Alan P.; Seabra, Rita; Feary, Johanna; Venn, Andrea; Britton, John; Pritchard, David I.			Antigen-driven basophil activation is indicative of early Necator americanus infection in IgE-seronegative patients	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Helminth; hookworm; Necator americanus; basophil; basophil activation test	HUMAN FILARIAL INFECTIONS; FC-EPSILON-RI; HOOKWORM INFECTION; RECOMBINANT ALLERGENS; ANTIBODY-RESPONSES; PERIPHERAL-BLOOD; IMMUNOGLOBULIN-E; CD63 EXPRESSION; UP-REGULATION; IL-4	Background: Parasitic worms induce a strong, polarized T(H)2-type immune response. The kinetics of gastrointestinal nematode-induced T(H)2-type responses, especially in the context of primary infection, have been extensively studied in experimental infection models but not in human subjects. Objective: We sought to determine the kinetics of basophil sensitization in subjects infected with Necator americanus during the first 12 weeks after infection. Methods: Thirty nonasthmatic subjects with allergic rhinoconjunctivitis were randomized in a double-blind manner to cutaneous administration of either 10 hookworm infective larvae or histamine placebo. Blood samples were taken at regular intervals for 12 weeks, and basophil activation was determined in whole blood by measuring CD63 and CD203c levels on stimulation with N americanus excretions/secretions. Parasite-specific immunoglobulin responses were assessed by means of ELISA and Western blotting. Results: Median values reflecting basophil activation (CD203c/CD63 double-positive cells) in the excretion/secretion-stimulated infected group steadily increased after week 4, consistently achieving statistical significance compared with the placebo group between 6 and 12 weeks after infection. Only parasite-specific IgM levels increased significantly during this period, whereas total and parasite-specific IgE levels did not differ between groups. Conclusion: Basophils are sensitized early in the context of a low-dose primary infection with N americanus in the absence of measurable total and specific IgE serum level increase. (I Allergy Clin Immunol 2009;124:1343-50.)	[Falcone, Franco H.; Telford, Gary; Hooi, Doreen; Brown, Alan P.; Seabra, Rita; Pritchard, David I.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Feary, Johanna; Venn, Andrea; Britton, John] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Pritchard, DI (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.	David.Pritchard@nottingham.ac.uk	Falcone, Franco H/F-9210-2013; Falcone, Franco/AAE-8026-2021	Falcone, Franco H/0000-0002-1732-9932; Falcone, Franco/0000-0002-1732-9932; Feary, Johanna/0000-0003-2903-6907	Wellcome Trust [GR076306/2/04/2, GR065978MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Wellcome Trust (GR076306/2/04/2, GR065978MA).	BALL PAJ, 1969, T ROY SOC TROP MED H, V63, P362, DOI 10.1016/0035-9203(69)90011-X; Boumiza R, 2003, CLIN EXP ALLERGY, V33, P259, DOI 10.1046/j.1365-2222.2003.01594.x; Boumiza Radhia, 2005, Clin Mol Allergy, V3, P9, DOI 10.1186/1476-7961-3-9; BROWN A, 1995, PARASITOLOGY, V110, P555, DOI 10.1017/S0031182000065276; Buhring HJ, 2001, BLOOD, V97, P3303, DOI 10.1182/blood.V97.10.3303; Buhring HJ, 1999, BLOOD, V94, P2343; Chirumbolo Salvatore, 2008, Clin Mol Allergy, V6, P12, DOI 10.1186/1476-7961-6-12; de Weck AL, 2008, INT ARCH ALLERGY IMM, V146, P177, DOI 10.1159/000115885; Devouassoux G, 1999, J ALLERGY CLIN IMMUN, V104, P811, DOI 10.1016/S0091-6749(99)70292-7; Eberlein-Konig B, 2004, J INVEST ALLERG CLIN, V14, P10; Falcone FH, 2001, TRENDS PARASITOL, V17, P126, DOI 10.1016/S1471-4922(00)01846-8; Feary J, 2009, CLIN EXP ALLERGY, V39, P1060, DOI 10.1111/j.1365-2222.2009.03187.x; GANGULY NK, 1988, J CLIN MICROBIOL, V26, P739, DOI 10.1128/JCM.26.4.739-742.1988; GEHA RS, 1985, NATURE, V315, P577, DOI 10.1038/315577a0; Gibbs BF, 2008, CLIN EXP ALLERGY, V38, P480, DOI 10.1111/j.1365-2222.2007.02919.x; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Hennersdorf F, 2005, CELL RES, V15, P325, DOI 10.1038/sj.cr.7290301; Kleine-Tebbe J, 2006, INT ARCH ALLERGY IMM, V141, P79, DOI 10.1159/000094495; KNOL EF, 1991, J ALLERGY CLIN IMMUN, V88, P328, DOI 10.1016/0091-6749(91)90094-5; KOJIMA S, 1972, AM J TROP MED HYG, V21, P913, DOI 10.4269/ajtmh.1972.21.913; Luccioli S, 2002, J ALLERGY CLIN IMMUN, V110, P117, DOI 10.1067/mai.2002.125828; MAXWELL C, 1987, AM J TROP MED HYG, V37, P126, DOI 10.4269/ajtmh.1987.37.126; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mitre E, 2006, J ALLERGY CLIN IMMUN, V117, P939, DOI 10.1016/j.jaci.2005.12.1341; Mitre E, 2004, J IMMUNOL, V172, P2439, DOI 10.4049/jimmunol.172.4.2439; Mortimer K, 2006, AM J TROP MED HYG, V75, P914, DOI 10.4269/ajtmh.2006.75.914; Nopp A, 2006, ALLERGY, V61, P298, DOI 10.1111/j.1398-9995.2006.00987.x; Nouri-Aria KT, 2001, J ALLERGY CLIN IMMUN, V108, P205, DOI 10.1067/mai.2001.117175; Ocmant A, 2005, CYTOKINE, V31, P375, DOI 10.1016/j.cyto.2005.06.007; Ocmant A, 2007, J IMMUNOL METHODS, V320, P40, DOI 10.1016/j.jim.2006.12.002; OGILVIE BM, 1966, NATURE, V209, P1221, DOI 10.1038/2091221a0; OGILVIE BM, 1978, T ROY SOC TROP MED H, V72, P66, DOI 10.1016/0035-9203(78)90303-6; Paris-Kohler A, 2000, J ALLERGY CLIN IMMUN, V105, P339, DOI 10.1016/S0091-6749(00)90085-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; PRITCHARD DI, 1995, PARASITE IMMUNOL, V17, P71, DOI 10.1111/j.1365-3024.1995.tb00968.x; Pritchard DI, 1999, PARASITE IMMUNOL, V21, P439, DOI 10.1046/j.1365-3024.1999.00238.x; PRUZANSKY JJ, 1988, IMMUNOLOGY, V64, P307; QUINNELL RJ, 1995, PARASITE IMMUNOL, V17, P313, DOI 10.1111/j.1365-3024.1995.tb00897.x; Reischl IG, 1997, INT ARCH ALLERGY IMM, V113, P266, DOI 10.1159/000237568; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Valent P, 2004, METHODS, V32, P265, DOI 10.1016/j.ymeth.2003.08.006; Wright V, 2005, CLIN EXP IMMUNOL, V142, P398, DOI 10.1111/j.1365-2249.2005.02945.x	45	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2009	124	6					1343	1350		10.1016/j.jaci.2009.07.039	http://dx.doi.org/10.1016/j.jaci.2009.07.039			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	536VH	19800679				2022-12-18	WOS:000273071500029
J	Reardon, AM; Perzanowski, MS; Whyatt, RM; Chew, GL; Perera, FP; Miller, RL				Reardon, Ann Marie; Perzanowski, Matthew S.; Whyatt, Robin M.; Chew, Ginger L.; Perera, Frederica P.; Miller, Rachel L.			Associations between prenatal pesticide exposure and cough, wheeze, and IgE in early childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PYRETHROID INSECTICIDES; AGRICULTURAL HEALTH; ASTHMA; EXPRESSION; COHORT; WOMEN; LIFE		[Reardon, Ann Marie; Perzanowski, Matthew S.; Whyatt, Robin M.; Chew, Ginger L.; Perera, Frederica P.; Miller, Rachel L.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Reardon, Ann Marie; Perzanowski, Matthew S.; Whyatt, Robin M.; Chew, Ginger L.; Perera, Frederica P.; Miller, Rachel L.] Columbia Ctr Childrens Environm Hlth, New York, NY USA; [Miller, Rachel L.] Columbia Univ, Coll Phys & Surg, Div Pulm Allergy & Crit CareMed, New York, NY USA	Columbia University; Columbia University	Reardon, AM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	rlm14@columbia.edu			NIEHS NIH HHS [P30 ES009089, P01 ES009600-100005, ES008977, R01 ES008977, P01 ES009600, P01 ES09600, R01 ES013163] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, R01ES008977, R01ES013163, P01ES009600] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Diel F, 2003, INFLAMM RES, V52, P154, DOI 10.1007/s000110300066; Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034; Duramad P, 2006, ENVIRON HEALTH PERSP, V114, P1916, DOI 10.1289/ehp.9306; Duramad P, 2006, J APPL TOXICOL, V26, P458, DOI 10.1002/jat.1162; Elia J, 2003, HISTOCHEM CELL BIOL, V120, P33, DOI 10.1007/s00418-003-0546-z; Hoppin JA, 2006, AM J EPIDEMIOL, V163, P1129, DOI 10.1093/aje/kwj138; Hoppin JA, 2008, AM J RESP CRIT CARE, V177, P11, DOI 10.1164/rccm.200706-821OC; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; Salome CM, 2000, EUR RESPIR J, V16, P38, DOI 10.1034/j.1399-3003.2000.16a07.x; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; THIER A, 1998, PLAGUED PESTICIDES A; VIJVERBERG HPM, 1990, CRIT REV TOXICOL, V21, P105, DOI 10.3109/10408449009089875; Whyatt RM, 2002, ENVIRON HEALTH PERSP, V110, P507, DOI 10.1289/ehp.02110507	14	15	15	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2009	124	4					852	854		10.1016/j.jaci.2009.07.046	http://dx.doi.org/10.1016/j.jaci.2009.07.046			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	506UV	19767085	Green Accepted			2022-12-18	WOS:000270802800037
J	Ownby, DR				Ownby, Dennis R.			Has mandatory folic acid supplementation of foods increased the risk of asthma and allergic disease?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Folate; folic acid; asthma; allergy; neural-tube defects; vitamin B9	PREGNANCY		Med Coll Georgia, Sect Allergy Immunol, Dept Pediat, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ownby, DR (corresponding author), Med Coll Georgia, Sect Allergy Immunol, Dept Pediat, BG 1019,1120 15th St, Augusta, GA 30912 USA.	downby@mcg.edu						Akinbami LJ., 2006, STATE CHILDHOOD ASTH; ANGIER RB, 1945, SCIENCE, V102, P227, DOI 10.1126/science.102.2644.227; Bruno Eugene J Jr, 2005, Curr Sports Med Rep, V4, P207, DOI 10.1097/01.CSMR.0000306209.56939.48; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; Milman N, 2006, EUR J HAEMATOL, V76, P200, DOI 10.1111/j.1600-0609.2005.00606.x; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; Wald NJ, 2004, NEW ENGL J MED, V350, P101, DOI 10.1056/NEJMp038186	11	15	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2009	123	6					1260	1261		10.1016/j.jaci.2009.04.023	http://dx.doi.org/10.1016/j.jaci.2009.04.023			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	455WO	19447481				2022-12-18	WOS:000266799100015
J	Liu, AH				Liu, Andrew H.			Innate microbial sensors and their relevance to allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Innate; immunity; receptor; microbial recognition; Toll-like receptor; PAMP; PRR; CLR; NOD-like receptor; antimicrobial peptide; allergy; asthma; hygiene hypothesis	C-REACTIVE PROTEIN; HOUSE-DUST ENDOTOXIN; TOLL-LIKE RECEPTOR-2; SCHOOL-AGE-CHILDREN; PATTERN-RECOGNITION RECEPTOR; INTESTINAL EPITHELIAL-CELLS; HUMAN DENDRITIC CELLS; LPS BINDING-PROTEIN; DOUBLE-STRANDED-RNA; DNA IN-HOUSE	The innate immune system oversees the gateway to immunity with its microbial sensors. Innate microbial sensors are germ line-encoded receptors with genetically predetermined specificities for microbes. The readiness and effectiveness of the innate immune system to provide immediate and appropriate responses at the host-environment interface is dependent on its sensitive and comprehensive microbial detection systems. The purpose of this review is to provide an overview of innate microbial sensors, our growing understanding of their diverse repertoire, and their elegant structural and functional approaches to microbial recognition. Their relevance to allergic disease is also discussed: the potential recognition and uptake of allergens by some of these receptors, inhibited expression of other microbial sensors by allergic immune responses and inflammation, and their upregulation by microbial exposures in early life that may help to protect against the development of allergic immune responses and disease. (J Allergy Clin Immunol 2008;122:846-58.)	Natl Jewish Hlth, Pediat Allergy & Immunol, Denver, CO 80206 USA	National Jewish Health	Liu, AH (corresponding author), Natl Jewish Hlth, Pediat Allergy & Immunol, 1400 Jackson St,K1023, Denver, CO 80206 USA.	liua@njc.org						Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Boehlecke B, 2003, J ALLERGY CLIN IMMUN, V112, P1241, DOI 10.1016/j.jaci.2003.08.052; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Chisholm D, 2004, J ALLERGY CLIN IMMUN, V113, P448, DOI 10.1016/j.jaci.2003.12.011; Christiani DC, 1999, AM J IND MED, V35, P321, DOI 10.1002/(SICI)1097-0274(199904)35:4<321::AID-AJIM1>3.3.CO;2-C; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Currie AJ, 2000, J IMMUNOL, V164, P3878, DOI 10.4049/jimmunol.164.7.3878; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Douwes J, 2006, J ALLERGY CLIN IMMUN, V117, P1067, DOI 10.1016/j.jaci.2006.02.002; Doyle CK, 2003, J IMMUNOL, V171, P836, DOI 10.4049/jimmunol.171.2.836; DUCLOS TW, 1988, J IMMUNOL, V141, P4266; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eldridge MW, 2000, J ALLERGY CLIN IMMUN, V105, P475, DOI 10.1067/mai.2000.104552; Epstein J, 1996, CURR OPIN IMMUNOL, V8, P29, DOI 10.1016/S0952-7915(96)80101-4; Erpenbeck VJ, 2005, AM J PHYSIOL-LUNG C, V288, pL692, DOI 10.1152/ajplung.00362.2004; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fanucchi MV, 2004, AM J RESP CRIT CARE, V170, P1153, DOI 10.1164/rccm.200404-533OC; Finkelman MA, 2006, J ENDOTOXIN RES, V12, P241, DOI 10.1179/096805106X102237; FOREHAND JR, 1989, J CLIN INVEST, V83, P74, DOI 10.1172/JCI113887; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gehring U, 2001, J ALLERGY CLIN IMMUN, V108, P847, DOI 10.1067/mai.2001.119026; Gehring U, 2007, EUR RESPIR J, V29, P1144, DOI 10.1183/09031936.00118806; Gehring U, 2002, AM J RESP CRIT CARE, V166, P939, DOI 10.1164/rccm.200203-256OC; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gereda JE, 2000, JAMA-J AM MED ASSOC, V284, P1652, DOI 10.1001/jama.284.13.1652; Gereda JE, 2001, J ALLERGY CLIN IMMUN, V107, P790, DOI 10.1067/mai.2001.115245; Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Gillespie J, 2006, J ALLERGY CLIN IMMUN, V118, P1265, DOI 10.1016/j.jaci.2006.07.051; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gregory CD, 2000, CURR OPIN IMMUNOL, V12, P27, DOI 10.1016/S0952-7915(99)00047-3; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hortobagyi L, 2008, J ALLERGY CLIN IMMUN, V122, P521, DOI 10.1016/j.jaci.2008.05.002; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144; Kline JN, 1998, J IMMUNOL, V160, P2555; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; Koppelman GH, 2001, AM J RESP CRIT CARE, V163, P965, DOI 10.1164/ajrccm.163.4.2004164; Kukkonen K, 2008, PEDIATRICS, V122, P8, DOI 10.1542/peds.2007-1192; Lam D, 2008, J IMMUNOL, V181, P2925, DOI 10.4049/jimmunol.181.4.2925; Lauener RP, 2002, LANCET, V360, P465, DOI 10.1016/S0140-6736(02)09641-1; Le YY, 2002, INT IMMUNOPHARMACOL, V2, P1, DOI 10.1016/S1567-5769(01)00150-3; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Leung AD, 2008, CLIN EXP ALLERGY, V38, P789, DOI 10.1111/j.1365-2222.2008.02964.x; LeVan TD, 2005, AM J RESP CRIT CARE, V171, P773, DOI 10.1164/rccm.200404-530OC; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Leynaert B, 2006, J ALLERGY CLIN IMMUN, V118, P658, DOI 10.1016/j.jaci.2006.06.015; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Liu AH, 2002, J ALLERGY CLIN IMMUN, V109, P379, DOI 10.1067/mai.2002.122157; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; MICHEL O, 1992, AM REV RESPIR DIS, V146, P352, DOI 10.1164/ajrccm/146.2.352; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; MICHEL O, 1989, J APPL PHYSIOL, V66, P1059, DOI 10.1152/jappl.1989.66.3.1059; MICHEL O, 1991, ANN ALLERGY, V66, P39; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ng N, 2006, J ALLERGY CLIN IMMUN, V117, P1074, DOI 10.1016/j.jaci.2006.03.025; Niyonsaba F, 2002, INT IMMUNOL, V14, P421, DOI 10.1093/intimm/14.4.421; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; PABST MJ, 1982, J IMMUNOL, V128, P123; PABST MJ, 1980, J EXP MED, V151, P101, DOI 10.1084/jem.151.1.101; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Perzanowski MS, 2006, J ALLERGY CLIN IMMUN, V117, P1082, DOI 10.1016/j.jaci.2005.12.1348; Phipatanakul W, 2004, PEDIATRICS, V114, P13, DOI 10.1542/peds.114.1.13; Platts-Mills JA, 2005, J ALLERGY CLIN IMMUN, V116, P384, DOI 10.1016/j.jaci.2005.05.012; Rabinovitch N, 2006, ALLERGY, V61, P650, DOI 10.1111/j.1398-9995.2006.01101.x; Rabinovitch N, 2005, J ALLERGY CLIN IMMUN, V116, P1053, DOI 10.1016/j.jaci.2005.08.045; Raby BA, 2002, AM J RESP CRIT CARE, V166, P1449, DOI 10.1164/rccm.200207-634OC; Raz E, 1996, P NATL ACAD SCI USA, V93, P5141, DOI 10.1073/pnas.93.10.5141; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Remitz A, 2001, J ALLERGY CLIN IMMUN, V107, P196, DOI 10.1067/mai.2001.112131; Rhee CS, 2004, IMMUNOLOGY, V113, P106, DOI 10.1111/j.1365-2567.2004.01930.x; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Roy SR, 2003, J ALLERGY CLIN IMMUN, V112, P571, DOI 10.1067/mai.2003.1711; Rylander R, 2006, CURR OPIN ALLERGY CL, V6, P62, DOI 10.1097/01.all.0000202356.83509.f7; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shnyra A, 1998, J IMMUNOL, V160, P3729; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Tighe H, 2000, J ALLERGY CLIN IMMUN, V106, P124, DOI 10.1067/mai.2000.107927; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trivedi L, 2003, J ALLERGY CLIN IMMUN, V111, P777, DOI 10.1067/mai.2003.1338; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; Valerio CR, 2005, J ALLERGY CLIN IMMUN, V116, P1296, DOI 10.1016/j.jaci.2005.09.046; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Vedanthan PK, 2006, ANN ALLERG ASTHMA IM, V96, P571, DOI 10.1016/S1081-1206(10)63552-1; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Waser M, 2004, CLIN EXP ALLERGY, V34, P389, DOI 10.1111/j.1365-2222.2004.01873.x; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	178	15	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2008	122	5					846	858		10.1016/j.jaci.2008.10.002	http://dx.doi.org/10.1016/j.jaci.2008.10.002			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	372ZF	19000576				2022-12-18	WOS:000260940100001
J	Hartert, TV				Hartert, Tina V.			Are persons with asthma at increased risk of pneumococcal infections, and can we prevent them?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						asthma; pneumococcal disease; pneumococcal vaccine; infection	INNATE; PREVALENCE; CHILDHOOD; IMMUNITY		Vanderbilt Univ, Dept Med, Sch Med, Inst Med & Publ Hlth,Div Allergy Pulm & Crit Care, Nashville, TN 37232 USA	Vanderbilt University	Hartert, TV (corresponding author), Vanderbilt Univ, Dept Med, Sch Med, Inst Med & Publ Hlth,Div Allergy Pulm & Crit Care, Nashville, TN 37232 USA.	tina.hartert@Vanderbilt.Edu						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Cardozo DM, 2008, J MED MICROBIOL, V57, P185, DOI 10.1099/jmm.0.47470-0; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Johnston Sebastian L, 2007, Proc Am Thorac Soc, V4, P267, DOI 10.1513/pats.200701-030AW; Juhn YJ, 2008, J ALLERGY CLIN IMMUN, V122, P719, DOI 10.1016/j.jaci.2008.07.029; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; National Heart Lung and Blood Institute, 2007, NIH PUBL; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC	15	15	15	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					724	725		10.1016/j.jaci.2008.09.008	http://dx.doi.org/10.1016/j.jaci.2008.09.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	19014764				2022-12-18	WOS:000259989000015
J	Giavina-Bianchi, P; Giavina-Bianchi, M; Agondi, R; Kalil, J				Giavina-Bianchi, Pedro; Giavina-Bianchi, Mara; Agondi, Rosana; Kalil, Jorge			Omalizumab and Churg-Strauss syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANTI-IGE; PATIENT; ASTHMA		[Giavina-Bianchi, Pedro; Giavina-Bianchi, Mara; Agondi, Rosana; Kalil, Jorge] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil	Universidade de Sao Paulo	Giavina-Bianchi, P (corresponding author), Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil.	saudesos@saudesos.com.br	KALIL, JORGE/C-8029-2012; Agondi, Rosana/AAV-7531-2021; Giavina-Bianchi, Pedro/I-3112-2014	KALIL, JORGE/0000-0001-8415-4274; Giavina-Bianchi, Pedro/0000-0002-1034-7580				Bargagli E, 2008, INT ARCH ALLERGY IMM, V145, P268, DOI 10.1159/000109296; Giavina-Bianchi P, 2008, INT ARCH ALLERGY IMM, V146, P176, DOI 10.1159/000113524; Giavina-Bianchi P, 2007, INT ARCH ALLERGY IMM, V144, P155, DOI 10.1159/000103228; Giavina-Bianchi P, 2007, J ALLERGY CLIN IMMUN, V119, P1279, DOI 10.1016/j.jaci.2007.01.041; Ruppert AA, 2008, J ALLERGY CLIN IMMUN, V121, P253, DOI 10.1016/j.jaci.2007.10.040; Winchester DE, 2006, NEW ENGL J MED, V355, P1281	6	15	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					217	217		10.1016/j.jaci.2008.05.024	http://dx.doi.org/10.1016/j.jaci.2008.05.024			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD	18602576				2022-12-18	WOS:000257605100041
J	Julius, P; Lommatzsch, M; Kuepper, M; Bratke, K; Faehndrich, S; Luttmann, W; Virchow, JC				Julius, Peter; Lommatzsch, Marek; Kuepper, Michael; Bratke, Kai; Faehndrich, Sebastian; Luttmann, Werner; Virchow, Johann Christian			Safety of segmental allergen challenge in human allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergen challenge; safety; bronchoscopy; allergen dose	BRONCHOALVEOLAR LAVAGE FLUID; HUMAN LUNG EOSINOPHILS; AIRWAY INFLAMMATION; T-CELLS; EXPRESSION; PROVOCATION; PROLIFERATION; BRONCHOSCOPY; RECEPTORS; SECRETION	Background: Segmental allergen challenge is widely used to study mechanisms of human allergic asthma. Despite the relatively large dissemination, limited information is available about the safety of this method. Objective: Observational, retrospective study to report the adverse events of segmental allergen challenge in a large group of volunteers with asthma. Methods: In total, 78 cases from several studies performed between 1994 and 2007 were pooled for this analysis. Volunteers underwent allergen challenge using either a fixed dose of allergen (7 cases) or an individually standardized allergen dose defined by an inhaled allergen test before the challenge (71 cases). A subgroup of 13 volunteers underwent repeated challenges, with more than 6 months between the challenges. Results: With a fixed dose instilled during bronchoscopy, 43% of the participants developed wheezing and coughing, requiring 2-6 puffs of a beta(2)-agonist after segmental allergen challenge. In volunteers with individually standardized doses, a beta(2)-agonist was required in only 19% of the cases. No severe adverse events occurred in all cases studied. Volunteers who underwent repeated challenges did not develop more adverse events than those who underwent 1 challenge. Conclusions: Segmental allergen challenge is a safe tool to study the mechanisms of human allergic asthma, even when repeated challenges are performed in the same patient. It is associated with only a few, tolerable adverse events, especially when the dose of allergen is standardized individually.	[Julius, Peter; Lommatzsch, Marek; Kuepper, Michael; Bratke, Kai; Faehndrich, Sebastian; Luttmann, Werner; Virchow, Johann Christian] Univ Rostock, Klin & Poliklin Innere Med, Abt Pneumol, Dept Pneumol, D-18057 Rostock, Germany	University of Rostock	Julius, P (corresponding author), Univ Rostock, Klin & Poliklin Innere Med, Abt Pneumol, Dept Pneumol, Ernst Heydemann Str 6, D-18057 Rostock, Germany.	peter.julius@med.uni-rostock.de						Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Braunstahl GJ, 2000, AM J RESP CRIT CARE, V161, P2051, DOI 10.1164/ajrccm.161.6.9906121; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Calhoun WJ, 2001, AM J RESP CRIT CARE, V163, P881, DOI 10.1164/ajrccm.163.4.2001060; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Erpenbeck VJ, 2004, AM J RESP CRIT CARE, V169, P578, DOI 10.1164/rccm.200301-104OC; Frew AJ, 1998, EUR RESPIR J, V11, p33S; Hagaman DD, 2001, AM J RESP CELL MOL, V25, P685, DOI 10.1165/ajrcmb.25.6.4541; Hastie AT, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-25; Hastie AT, 2002, AM J RESP CRIT CARE, V165, P266, DOI 10.1164/ajrccm.165.2.2101069; Jarjour NN, 1998, AM J RESP CRIT CARE, V157, P692, DOI 10.1164/ajrccm.157.3.9705020; Julius P, 1999, EUR RESPIR J, V13, P1253, DOI 10.1034/j.1399-3003.1999.13f07.x; Julius P, 2004, CLIN EXP ALLERGY, V34, P1064, DOI 10.1111/j.1365-2222.2004.01986.x; Kelly EAB, 1997, AM J RESP CRIT CARE, V156, P1421, DOI 10.1164/ajrccm.156.5.9703054; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Krug N, 1996, AM J RESP CRIT CARE, V153, P1391, DOI 10.1164/ajrccm.153.4.8616571; Krug N, 2001, AM J RESP CELL MOL, V25, P125, DOI 10.1165/ajrcmb.25.1.4194; Kuepper M, 2005, CLIN EXP ALLERGY, V35, P643, DOI 10.1111/j.1365-2222.2005.02238.x; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; LOMMATZSCH M, 2006, AM J RESP CRIT CARE, V174, P1173; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; METZGER WJ, 1985, CHEST, V87, pS16, DOI 10.1378/chest.87.1_Supplement.16S; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; METZGER WJ, 1986, CHEST, V89, P477, DOI 10.1378/chest.89.4.477; Ndukwu IM, 1999, AM J RESP CRIT CARE, V160, P1516, DOI 10.1164/ajrccm.160.5.9812126; Pilette C, 2004, EUR RESPIR J, V23, P876, DOI 10.1183/09031936.04.00102504; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; Till SJ, 1998, AM J RESP CRIT CARE, V158, P404, DOI 10.1164/ajrccm.158.2.9705007; VANVYVE T, 1992, AM REV RESPIR DIS, V146, P116, DOI 10.1164/ajrccm/146.1.116; Virchow JC, 1998, EUR RESPIR J, V11, P317, DOI 10.1183/09031936.98.11020317; Virchow JC, 1998, AM J RESP CRIT CARE, V158, P2002, DOI 10.1164/ajrccm.158.6.9803023; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Wilson DR, 2002, AM J RESP CRIT CARE, V165, P22, DOI 10.1164/ajrccm.165.1.2010112	36	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					712	717		10.1016/j.jaci.2007.08.058	http://dx.doi.org/10.1016/j.jaci.2007.08.058			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18028992				2022-12-18	WOS:000253918900027
J	Wanich, N; Weiss, C; Furlong, TJ; Sicherer, SH				Wanich, N.; Weiss, C.; Furlong, T. J.; Sicherer, S. H.			Food allergic consumer (FAC) experience in restaurants and food establishments	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	64th Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 14-18, 2008	Philadelphia, PA	Amer Acad Allergy, Asthma & Immunol					[Wanich, N.; Sicherer, S. H.] Mt Sinai Sch Med, New York, NY USA; [Weiss, C.; Furlong, T. J.] Food Allerg & Anaphylaxis Network, Fairfax, VA USA	Icahn School of Medicine at Mount Sinai									0	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		1		698	S182	S182		10.1016/j.jaci.2007.12.673	http://dx.doi.org/10.1016/j.jaci.2007.12.673			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266HZ					2022-12-18	WOS:000253426401162
J	Meliton, AY; Munoz, NM; Leff, AR				Meliton, Angelo Y.; Munoz, Nilda M.; Leff, Alan R.			Blockade of avidity and focal clustering of beta(2)-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; adhesion; cysteinyl leukotrienes; montelukast; AA861; CD11b/CD18; cytokines; chemokines; focal clustering; avidity	MURINE MODEL; TNF-ALPHA; EXPRESSION; INFLAMMATION; CHEMOTAXIS; INHIBITION; SALMETEROL; ACTIVATION; MIGRATION; ASTHMA	Background: Cysteinyl leukotriene (cysLT) antagonism attenuates migration of eosinophils into airways during immune challenge in human subjects and animal models. The intracellular signaling mechanism by which this occurs has not been elucidated. Objective: We sought to determine the relative efficacy and mechanism by which 5-lipoxygenase (5-LO) inhibition and cysLT(1) receptor (cysLT(1)R) antagonism block beta(2)-integrin adhesion in isolated human eosinophils in vitro. Methods: Human blood eosinophils were isolated by means of immunomagnetic separation. Upregulation of CD11b expression, active conformation of CD11b, and focal clustering of beta(2)-integrin caused by IL-5, eotaxin-1 or leukotriene (LT) B-4 was assessed by means of flow cytometry and confocal microscopy. The effect and mechanism of cysLT1 R or 5-LO blockade on these components Of beta(2)-integrin adhesion were determined. Results: Montelukast, a cysLT(1)R antagonist, and AA861, a 5-LO enzyme inhibitor, blocked (1) avidity of beta(2)-integrin, (2) beta(2)-integrin-mediated adhesion to intercellular adhesion molecule 1, and (3) focal clustering of CD11b elicited by LTB4. However, adhesion caused by either IL-5 or eotaxin-1 was not attenuated for eosinophils pretreated with either montelukast or AA861. Conclusion: Our data demonstrate that (1) LTB4 causes autocrine upregulation of adhesion through secretion of cysLTs, and (2) blockade of cysLT(1)R blocks the avidity and focal clustering of CD11b/CD18 for eosinophils activated by LTB4 but not by IL-5 or eotaxin-1. Clinical implications: Unlike cysLT-induced adhesion, adhesion caused by IL-5 or eotaxin-1 is not regulated through the cysLT(1)R, suggesting that cysLTs have specific but limited potential to upregulate eosinophil adhesion.	[Meliton, Angelo Y.; Munoz, Nilda M.; Leff, Alan R.] Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; [Leff, Alan R.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Leff, Alan R.] Univ Chicago, Comm Mol Med Clin Pharmacol & Cell Physiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Leff, AR (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	aleff@medicine.bsd.uchicago.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085779] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 085779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bautz F, 2001, BLOOD, V97, P3433, DOI 10.1182/blood.V97.11.3433; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kawano T, 2003, J ALLERGY CLIN IMMUN, V112, P369, DOI 10.1067/mai.2003.1636; Lee KS, 2007, J ALLERGY CLIN IMMUN, V119, P141, DOI 10.1016/j.jaci.2006.09.001; LEFF AR, 2007, ENCY MOL PHARM; Liu J, 2005, J ALLERGY CLIN IMMUN, V115, P493, DOI 10.1016/j.jaci.2004.11.010; Meliton AY, 2006, EUR RESPIR J, V28, P920, DOI 10.1183/09031936.06.00028406; Meliton AY, 2003, J ALLERGY CLIN IMMUN, V112, P404, DOI 10.1067/mai.2003.1637; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Miyahara Nobuaki, 2006, Allergol Int, V55, P91, DOI 10.2332/allergolint.55.91; Munoz NM, 2006, NAT PROTOC, V1, P2613, DOI 10.1038/nprot.2006.340; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 1997, AM J RESP CRIT CARE, V155, P1398, DOI 10.1164/ajrccm.155.4.9105085; Muz MH, 2006, EXP MOL MED, V38, P109, DOI 10.1038/emm.2006.14; Myo S, 2004, EUR RESPIR J, V23, P511, DOI 10.1183/09031936.04.00065904; Myou S, 2002, J IMMUNOL, V169, P2670, DOI 10.4049/jimmunol.169.5.2670; Nicolete R, 2007, PROSTAG OTH LIPID M, V83, P121, DOI 10.1016/j.prostaglandins.2006.10.007; Ogawa Y, 2006, J ALLERGY CLIN IMMUN, V118, P789, DOI 10.1016/j.jaci.2006.08.009; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Suzuki M, 2003, J ALLERGY CLIN IMMUN, V112, P126, DOI 10.1067/mai.2003.1515; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tholander F, 2005, J BIOL CHEM, V280, P33477, DOI 10.1074/jbc.M506821200; Zhang YJ, 2004, ACTA PHARMACOL SIN, V25, P1341; Zhu XD, 2000, J IMMUNOL METHODS, V240, P157, DOI 10.1016/S0022-1759(00)00192-7; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046	25	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1316	1323		10.1016/j.jaci.2007.07.038	http://dx.doi.org/10.1016/j.jaci.2007.07.038			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17904626				2022-12-18	WOS:000251653800011
J	Ternblay, JN; Bertelli, E; Arques, JL; Regoli, M; Nicoletti, C				Ternblay, Jeffrey N.; Bertelli, Eugenio; Arques, Juan L.; Regoli, Mari; Nicoletti, Claudio			Production of IL-12 by Peyer patch-dendritic cells is critical for the resistance to food allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dendritic cell; food allergy; IL-12; IL-4; Peyer patch	INTERLEUKIN (IL)-4; BALB/C MICE; RESPONSES; PROTEINS; SUSCEPTIBILITY; AUTOIMMUNITY; ACTIVATION; TRANSPORT; MOUSE; MODEL	Background: Dendritic cells (DCs) play a pivotal role in antigen presentation and regulation of immune responses; however, their involvement in food allergy remains to be fully understood. Objective: Our aim was to investigate T(H)1-T(H)2 reciprocal regulation of DCs' function in the gut and systemic immune system and its effect on food allergy in mice with different susceptibility to food allergy. Methods: Freshly isolated CD11c(+)B220(-)DCs from peanut-sensitized allergy-susceptible C3H/HeJ and allergy-resistant Balb/c mice were cultured to determine levels of IL-12p70 produced in the presence of cytokines, including IL-4. Systemic levels of IL-12 were assessed in vivo after antigen challenge with or without IL-4. Targeted oral delivery of microencapsulated neutralizing anti-IL-12 antibody to Peyer patches (PPs) was performed in Balb/c before administration of each sensitizing dose. Results: Peyer patch-DCs but not splenic DCs from sensitized C3H/HeJ but not Balb/c mice produced less IL-4-dependent IL-12p70. In vivo data confirmed this was restricted to the gut immune system, and it was not linked to reduced expression of IL-4 receptor or the lack of functional Toll-like receptor 4: instead, IL-4 failed to inhibit IL-10 production by PP-DCs, a pathway critically involved in IL-4-dependent production of IL-12p70. Finally, neutralization of IL-12 within PPs by specific antibody during antigen presentation significantly increased Balb/c susceptibility to food allergy. Conclusion: Reciprocal THI-T(H)2 control of DCs' function within the inductive site of the gut immune system is altered in food allergy. Clinical implications: Production of IL-12p70 by PP-DCs during antigen presentation is critical for the development of food allergy.	Inst Food Res, GI Biol & Hlth Program, Lab Mucosal Immunol, Norwich, Norfolk, England; Univ Siena, Dept Pharmacol G Segre, I-53100 Siena, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Siena	Nicoletti, C (corresponding author), Inst Food Res, GI Biol & Hlth Program, Lab Mucosal Immunol, Norwich, Norfolk, England.	claudio.nicoletti@bbsrc.ac.uk	Eckhardt, Erik/G-1567-2010; Arques, Juan L/S-4322-2017; Bertelli, Eugenio/J-2948-2012	Arques, Juan L/0000-0002-8548-0183; Bertelli, Eugenio/0000-0002-9681-4556; Regoli, Mari/0000-0002-8835-8386				Adel-Patient K, 2005, ALLERGY, V60, P658, DOI 10.1111/j.1398-9995.2005.00767.x; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Bashir MEH, 2004, J IMMUNOL, V172, P6978, DOI 10.4049/jimmunol.172.11.6978; Berin MC, 2006, ALLERGY, V61, P64, DOI 10.1111/j.1398-9995.2006.01012.x; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Chakravarti S, 2005, J EXP MED, V202, P437, DOI 10.1084/jem.20050308; Chambers SJ, 2004, BIOCHEM BIOPH RES CO, V325, P1258, DOI 10.1016/j.bbrc.2004.10.161; Chambers SJ, 2004, IMMUNOLOGY, V112, P72, DOI 10.1111/j.1365-2567.2004.01846.x; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Lee DA, 2001, J GLAUCOMA, V10, P220, DOI 10.1097/00061198-200106000-00014; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Man AL, 2004, IMMUNOLOGY, V113, P15, DOI 10.1111/j.1365-2567.2004.01964.x; Man AL, 2004, J ALLERGY CLIN IMMUN, V113, P965, DOI 10.1016/j.jaci.2004.02.038; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Morafo V, 2003, J ALLERGY CLIN IMMUN, V111, P1122, DOI 10.1067/mai.2003.1463; Mutwiri George, 2005, Expert Opin Drug Deliv, V2, P791, DOI 10.1517/17425247.2.5.791; Nicoletti C, 2006, MOL IMMUNOL, V43, P542, DOI 10.1016/j.molimm.2005.05.001; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324	25	15	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2007	120	3					659	665		10.1016/j.jaci.2007.04.044	http://dx.doi.org/10.1016/j.jaci.2007.04.044			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	211DV	17599398	Bronze			2022-12-18	WOS:000249505400027
J	Moschese, V; Carsetti, R; Graziani, S; Chini, L; Soresina, AR; La Rocca, M; Bossi, G; Di Cesare, S; Plebani, A				Moschese, Viviana; Carsetti, Rita; Graziani, Simona; Chini, Loredana; Soresina, Anna Rosa; La Rocca, Maria; Bossi, Grazia; Di Cesare, Silvia; Plebani, Alessandro		Italian Primary Immunodeficiency N	Memory B-cell subsets as a predictive marker of outcome in hypogammaglobulinemia during infancy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COMMON VARIABLE IMMUNODEFICIENCY; TRANSIENT HYPOGAMMAGLOBULINEMIA; DEFICIENCY; FEATURES; DISEASE		Univ Roma Tor Vergata, Dept Pediat, Policlin Tor Vergata, I-00133 Rome, Italy; Osped Pediat Bambino Gesu, Ist Ricovero & Cura Carattere Sci, Res Ctr, Rome, Italy; Univ Brescia, Dept Pediat, Pavia, Italy; Policlin San Matteo, IRCCS, Dept Pediat, I-27100 Pavia, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; IRCCS Bambino Gesu; University of Brescia; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Moschese, V (corresponding author), Univ Roma Tor Vergata, Dept Pediat, Policlin Tor Vergata, Viale Oxford 81, I-00133 Rome, Italy.	moschese@med.uniroma2.it	Carsetti, Rita/K-7616-2016; Plebani, Alessandro/C-8593-2011; DI CESARE, SILVIA/AAB-5754-2020; MOSCHESE, VIVIANA/AHE-8931-2022	Carsetti, Rita/0000-0002-2632-1078; DI CESARE, SILVIA/0000-0002-9912-7997; MOSCHESE, VIVIANA/0000-0001-7650-0632				Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Carsetti R, 2005, J ALLERGY CLIN IMMUN, V115, P412, DOI 10.1016/j.jaci.2004.10.048; *INT UN IMM SOC, 1999, CLIN EXP IMMUNOL  S1, V118, pS1; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; MCGEADY SJ, 1987, J PEDIATR-US, V110, P47, DOI 10.1016/S0022-3476(87)80286-X; Stiehm ER OH, 2004, IMMUNOLOGICAL DISORD, P289; TILLER TL, 1978, J PEDIATR-US, V92, P347, DOI 10.1016/S0022-3476(78)80417-X; WALKER A, 1994, ARCH DIS CHILD, V70, P183, DOI 10.1136/adc.70.3.183; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544	10	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					474	476		10.1016/j.jaci.2007.04.002	http://dx.doi.org/10.1016/j.jaci.2007.04.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF	17531302				2022-12-18	WOS:000248654900040
J	Weber-Chrysochoou, C; Crisafulli, D; Almqvist, C; Li, Q; Kemp, AS; Britton, WJ; Marks, GB				Weber-Chrysochoou, Christina; Crisafulli, Daniel; Almqvist, Catarina; Li, Qiang; Kemp, Andrew S.; Britton, Warwick J.; Marks, Guy B.		Childhood Asthma Prevention Study	IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T cells; cytokines; allergens; asthma; allergy; children; eczema	FATTY-ACID MODIFICATION; CHILDHOOD ASTHMA; RISK-FACTORS; AIRWAY HYPERRESPONSIVENESS; CYTOKINE RESPONSES; ATOPIC DISEASE; PREVENTION; CHILDREN; OUTCOMES; SENSITIZATION	Background: Allergen-specific T(H)2-like cytokine responses are considered to be important in sensitization and allergic diseases. Objective: To examine the profile of house dust mite (HDM) stimulated T-cell cytokines and their relationship to allergic disease in children over the period of the first 5 years of life. Methods: Subjects with a family history of asthma who were enrolled antenatally in the Childhood Asthma Prevention Study and had skin prick tests, clinical evaluation for asthma and eczema, and in vitro assessment of lymphocyte cytokine responses to HDM extract performed at ages 18 months (n = 281), 3 years (n = 349), and 5 years (n = 370). IL-13 at 3 and 5 years and IL-5, IL-10, and IFN-gamma at 18 months, 3 years, and 5 years were measured by ELISA. Results: House dust mite-specific cytokine responses increased with age for all cytokines except IFN-gamma. HDM-specific IL-5 responses at 3 years and 5 years were significantly positively related to skin prick test positivity at 5 years. IL-5 responses at 5 years were also significantly related to asthma at 5 years. Other HDM-specific cytokine responses were not related to asthma or eczema at 5 years. Responses were not altered by a HDM avoidance intervention. Conclusion: IL-5 responses to HDM, the dominant local inhalant allergen, are related to the expression of clinical illness at age 5 years. Clinical implications: The T-cell response to HDM, as reflected in IL-5 production, is acquired over the first years of life and may play a role in the expression of allergic airways disease.	Woolcock Inst Med Res, Sydney, NSW 2050, Australia; Cooperat Res Ctr Asthma, Sydney, NSW 2050, Australia; Univ Sydney, Sydney, NSW 2050, Australia; Liverpool Hlth Serv, Sydney, NSW 2050, Australia; Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2050, Australia; Childrens Hosp Westmead, Sydney, NSW 2050, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Marks, GB (corresponding author), Woolcock Inst Med Res, POB M77,Missenden Rd Post Off, Sydney, NSW 2050, Australia.	g.marks@unsw.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Britton, Warwick/0000-0001-6721-9646				Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Chung EK, 2007, ARCH DIS CHILD-FETAL, V92, pF68, DOI 10.1136/adc.2006.106492; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Heaton T, 2005, LANCET, V365, P142, DOI 10.1016/S0140-6736(05)17704-6; Illi S, 2001, J ALLERGY CLIN IMMUN, V108, P709, DOI 10.1067/mai.2001.118786; Jeannin P, 1998, J IMMUNOL, V160, P3555; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Marks GB, 2002, CLIN EXP ALLERGY, V32, P355, DOI 10.1046/j.1365-2222.2002.01292.x; Marks GB, 2006, J ALLERGY CLIN IMMUN, V118, P53, DOI 10.1016/j.jaci.2006.04.004; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Mihrshahi S, 2003, J ALLERGY CLIN IMMUN, V111, P162, DOI 10.1067/mai.2003.36; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MORRISONSMITH J, 1969, BRIT MED J, V2, P723; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Ngoc LP, 2005, CURR OPIN ALLERGY CL, V5, P161, DOI 10.1097/01.all.0000162309.97480.45; PEAT JK, 1994, AUST NZ J MED, V24, P270, DOI 10.1111/j.1445-5994.1994.tb02171.x; Peat JK, 2004, J ALLERGY CLIN IMMUN, V114, P807, DOI 10.1016/j.jaci.2004.06.057; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; Smart JM, 2002, CLIN EXP ALLERGY, V32, P796, DOI 10.1046/j.1365-2222.2002.01391.x; TANG MLK, 1994, LANCET, V344, P983, DOI 10.1016/S0140-6736(94)91641-1; THOMAS WR, 1993, CLIN EXP ALLERGY, V23, P350, DOI 10.1111/j.1365-2222.1993.tb00338.x; TOVEY ER, 1987, J ALLERGY CLIN IMMUN, V79, P93, DOI 10.1016/S0091-6749(87)80022-2; van der Velden VHJ, 2001, CLIN EXP ALLERGY, V31, P997, DOI 10.1046/j.1365-2222.2001.01176.x; VANREIJSEN FC, 1992, J ALLERGY CLIN IMMUN, V90, P184, DOI 10.1016/0091-6749(92)90070-I; WITT C, 1986, J ALLERGY CLIN IMMUN, V77, P698, DOI 10.1016/0091-6749(86)90413-6; Xuan W, 2002, THORAX, V57, P104, DOI 10.1136/thorax.57.2.104; Yabuhara A, 1997, CLIN EXP ALLERGY, V27, P1261, DOI 10.1111/j.1365-2222.1997.tb01170.x; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	35	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2007	120	2					286	292		10.1016/j.jaci.2007.06.034	http://dx.doi.org/10.1016/j.jaci.2007.06.034			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	198VF	17666216				2022-12-18	WOS:000248654900010
J	Taback, SP; Simons, FER				Taback, Shayne P.; Simons, F. Estelle R.			Anaphylaxis and vitamin D: A role for the sunshine hormone?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							BIRTH-COHORT; RISK; CHILDHOOD; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; EPINEPHRINE; POPULATION		Univ Manitoba, Dept Pediat & Child Hlth, Sect Endocrinol & Metab, Winnipeg, MB R3T 2N2, Canada; Univ Manitoba, Dept Immunol, Sect Allergy & Clin Immunol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Simons, FER (corresponding author), 820 Sherbrook Sts, Winnipeg, MB R3A 1R9, Canada.	lmcniven@hsc.mb.ca						Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Camargo CA, 2007, J ALLERGY CLIN IMMUN, V120, P131, DOI 10.1016/j.jaci.2007.03.049; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Hannaway PJ, 2005, ANN ALLERG ASTHMA IM, V95, P143, DOI 10.1016/S1081-1206(10)61203-3; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Holick MF, 2006, PRIMER METABOLIC BON, P106; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Sheikh A, 2001, CLIN EXP ALLERGY, V31, P1571, DOI 10.1046/j.1365-2222.2001.01203.x; Simons FER, 2002, J ALLERGY CLIN IMMUN, V110, P647, DOI 10.1067/mai.2002.127860; Wicklow BA, 2006, ANN NY ACAD SCI, V1079, P310, DOI 10.1196/annals.1375.047; Wjst M, 2006, PEDIAT ALLERG IMM-UK, V17, P477, DOI 10.1111/j.1399-3038.2006.00456.x	20	15	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2007	120	1					128	130		10.1016/j.jaci.2007.05.020	http://dx.doi.org/10.1016/j.jaci.2007.05.020			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	190NS	17606032				2022-12-18	WOS:000248066400018
J	Foster, SB; Paul, ME; Kozinetz, CA; Macias, CG; Shearer, WT				Foster, Samuel B.; Paul, Mary E.; Kozinetz, Claudia A.; Macias, Charles G.; Shearer, William T.			Prevalence of asthma in children and young adults with HIV infection	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYPERRESPONSIVENESS		Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, Houston, TX 77030 USA; Baylor Coll Med, Sect Acad Gen Pediat, Houston, TX 77030 USA; Baylor Coll Med, Sect Emergency Med, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Foster, SB (corresponding author), Baylor Coll Med, Dept Pediat, Sect Allergy & Immunol, Houston, TX 77030 USA.	sbfoster@texaschildrenshospital.org	Paul, Mary/AAA-2722-2021	Shearer, William/0000-0002-2483-2130	NCRR NIH HHS [RR-0188] Funding Source: Medline; NHLBI NIH HHS [HL-079533] Funding Source: Medline; NIAID NIH HHS [AI-07456, AI-36211] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; *HLTH US, 2005, NAT CTR HLTH STAT; JONES CA, 2003, PEDIAT ALLERGY PRINC, P392; LIN RY, 1995, ANN ALLERG ASTHMA IM, V74, P510; Poirier CD, 2001, AM J RESP CRIT CARE, V164, P542, DOI 10.1164/ajrccm.164.4.2010019; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; *TEX DEP STAT HLTH, 2005, ASTHM HLTH FACTS 200; Wallace JM, 1997, CHEST, V111, P121, DOI 10.1378/chest.111.1.121	9	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					750	752		10.1016/j.jaci.2007.01.002	http://dx.doi.org/10.1016/j.jaci.2007.01.002			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17336620				2022-12-18	WOS:000244925000034
J	Knisz, J; Rothman, PB				Knisz, Judit; Rothman, Paul B.			Suppressor of cytokine signaling in allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; asthma; suppressor of cytokine signaling; SOCS; JAK/STAT	RECEPTOR-BETA CHAIN; FACTOR-I RECEPTOR; GROWTH-HORMONE; AIRWAY INFLAMMATION; T-CELLS; TYROSINE-PHOSPHATASE; JAK/STAT PATHWAY; UBIQUITIN LIGASE; INSULIN-RECEPTOR; KINASE-ACTIVITY	The immunopathological hallmark of allergic diseases is elevated total and allergen specific serum IgE levels along with inflammation. This inflammation results from the activation of a cadre of hematopoietic and nonhematopoetic cells. This coordinated activation is the result of the increased production of a variety of soluble factors including chemokines and cytokines. The magnitude and the duration of cytokine action will determine the response to an allergen, either mounting a low-grade immunologic response or resulting in exaggerated reaction such as asthma or atopic dermatitis. Thus, the action of cytokines is tightly regulated both developmentally and within the cell. The suppressor of cytokine signaling (SOCS) protein family represents a novel group of cytoplasmic negative feedback regulators of type I and II cytokines. Several of the signaling pathways regulated by SOCS proteins are important in allergic immune responses. Thus, SOCS proteins may be important regulators of atopy.	Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Rothman, PB (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, SE308 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	paul-rothman@uiowa.edu	Knisz, Judit/HDN-2414-2022		NIAID NIH HHS [AI-054821] Funding Source: Medline; NIDDK NIH HHS [R01 DK-67231] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067231] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Banks AS, 2005, J CLIN INVEST, V115, P2462, DOI 10.1172/JCI23853; Bayle J, 2006, FEBS LETT, V580, P2609, DOI 10.1016/j.febslet.2006.03.093; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Brender C, 2004, MOL CELL BIOL, V24, P6094, DOI 10.1128/MCB.24.13.6094-6103.2004; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; DAVID M, 1993, MOL CELL BIOL, V13, P7515, DOI 10.1128/MCB.13.12.7515; De Sepulveda P, 2000, J BIOL CHEM, V275, P14005, DOI 10.1074/jbc.C000106200; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Dey BR, 2000, BIOCHEM BIOPH RES CO, V278, P38, DOI 10.1006/bbrc.2000.3762; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Federici M, 2002, J IMMUNOL, V169, P434, DOI 10.4049/jimmunol.169.1.434; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Fujimoto M, 2002, INT IMMUNOL, V14, P1343, DOI 10.1093/intimm/dxf094; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jiang H, 2000, J ALLERGY CLIN IMMUN, V105, P1063, DOI 10.1067/mai.2000.107604; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kario E, 2005, J BIOL CHEM, V280, P7038, DOI 10.1074/jbc.M408575200; Krebs DL, 2004, P NATL ACAD SCI USA, V101, P15446, DOI 10.1073/pnas.0406870101; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Linden A, 2002, ALLERGY, V57, P769, DOI 10.1034/j.1398-9995.2002.02164.x; Losman JA, 1999, J IMMUNOL, V162, P3770; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Martens N, 2005, J BIOL CHEM, V280, P13817, DOI 10.1074/jbc.M411596200; Martens N, 2004, EXP CELL RES, V298, P239, DOI 10.1016/j.yexcr.2004.04.002; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; Monni R, 2001, ONCOGENE, V20, P849, DOI 10.1038/sj.onc.1204201; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nigo YI, 2006, P NATL ACAD SCI USA, V103, P2286, DOI 10.1073/pnas.0510685103; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482	60	15	19	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2007	119	3					739	745		10.1016/j.jaci.2006.12.620	http://dx.doi.org/10.1016/j.jaci.2006.12.620			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	146HL	17258308				2022-12-18	WOS:000244925000030
J	Sicherer, SH; Leung, DYM				Sicherer, Scott H.; Leung, Donald Y. M.			Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dermatology; skin disease; urticaria; atopic dermatitis; anaphylaxis; allergy; hypersensitivity disorders; food; drug; insect venom	COWS MILK ALLERGY; ATOPIC-DERMATITIS; DOUBLE-BLIND; IGE; INDUCTION; URTICARIA; CHILDREN; ECZEMA; IMMUNOTHERAPY; POLYMORPHISMS	This review highlights some of the research advances in anaphylaxis; hypersensitivity reactions to foods, drugs, and insects; and allergic skin disease that were reported primarily in the Journal in 2005. Although studies documented deficiencies in community management of anaphylaxis, guidelines and National Institutes of Health summary reports provide direction toward improved research and education. At least 9% of young children outgrow" a tree nut allergy. Advances in food allergy diagnosis include reports of probability of reactions to peanut at various peanut-specific IgE concentrations and skin test response size and the utility of evaluating IgE binding to specific epitopes. Future food allergy treatments might include selection of "less allergenic" fruit cultivars, genetic silencing of major allergens, and treatment of allergic patients with Chinese herbal remedies. Osteopontin might be a useful biomarker for success of venom inummotherapy. Progress in our understanding of the immunology of atopic dermatitis and autoimmune urticaria has also been made. These observations will likely contribute toward optimizing management of these common allergic disorders.	Mt Sinai Sch Med, Elliot & Roslyn Jaffe Food Allergy Inst, Div Allergy & Immunol, Dept Pediat, New York, NY USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80202 USA; Natl Jewish Med & Res Ctr, Div Pediat Allergy Immunol, Denver, CO USA	Icahn School of Medicine at Mount Sinai; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Sicherer, SH (corresponding author), Mt Sinai Hosp, Div Allergy Immunol, Box 1198,1 Gustave L Levy Pl, New York, NY 10029 USA.	scott.sicherer@mssm.edu						Aceves SS, 2005, J ALLERGY CLIN IMMUN, V116, P705, DOI 10.1016/j.jaci.2005.05.011; Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Asero R, 2005, J ALLERGY CLIN IMMUN, V115, P1312, DOI 10.1016/j.jaci.2005.02.018; Asero R, 2005, J ALLERGY CLIN IMMUN, V115, P1088, DOI 10.1016/j.jaci.2004.12.009; Augustin MT, 2005, J ALLERGY CLIN IMMUN, V115, P157, DOI 10.1016/j.jaci.2004.10.009; Beyer K, 2005, J ALLERGY CLIN IMMUN, V116, P704, DOI 10.1016/j.jaci.2005.05.007; Bolhaar STHP, 2005, J ALLERGY CLIN IMMUN, V116, P1080, DOI 10.1016/j.jaci.2005.07.004; Bousquet PJ, 2005, J ALLERGY CLIN IMMUN, V115, P1314, DOI 10.1016/j.jaci.2005.02.026; Burns R, 2005, J ALLERGY CLIN IMMUN, V115, P383, DOI 10.1016/j.jaci.2004.11.019; Clark S, 2005, J ALLERGY CLIN IMMUN, V116, P643, DOI 10.1016/j.jaci.2005.06.026; CORK MJ, 2006, IN PRESS J ALLERGY C; De Swerdt A, 2005, J ALLERGY CLIN IMMUN, V116, P662, DOI 10.1016/j.jaci.2005.04.042; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Fleischer DM, 2005, J ALLERGY CLIN IMMUN, V116, P1087, DOI 10.1016/j.jaci.2005.09.002; Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027; Fonacier L, 2005, J ALLERGY CLIN IMMUN, V115, P1249, DOI 10.1016/j.jaci.2005.04.006; Fontaine C, 2005, J ALLERGY CLIN IMMUN, V115, P633, DOI 10.1016/j.jaci.2004.10.045; Fukunaga A, 2005, J ALLERGY CLIN IMMUN, V116, P397, DOI 10.1016/j.jaci.2005.05.024; Gilissen LJWJ, 2005, J ALLERGY CLIN IMMUN, V115, P364, DOI 10.1016/j.jaci.2004.10.014; Graves PE, 2005, J ALLERGY CLIN IMMUN, V116, P650, DOI 10.1016/j.jaci.2005.05.004; Haileamlak A, 2005, J ALLERGY CLIN IMMUN, V115, P370, DOI 10.1016/j.jaci.2004.10.024; Hauswirth DW, 2005, J ALLERGY CLIN IMMUN, V115, P632, DOI 10.1016/j.jaci.2004.10.034; Hilger C, 2005, J ALLERGY CLIN IMMUN, V115, P617, DOI 10.1016/j.jaci.2004.11.052; Hoetzenecker W, 2005, J ALLERGY CLIN IMMUN, V115, P1276, DOI 10.1016/j.jaci.2005.02.011; Hoffman DR, 2005, J ALLERGY CLIN IMMUN, V115, P611, DOI 10.1016/j.jaci.2004.11.020; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Kalach N, 2005, J ALLERGY CLIN IMMUN, V116, P1321, DOI 10.1016/j.jaci.2005.08.033; Kanda N, 2005, J ALLERGY CLIN IMMUN, V116, P1144, DOI 10.1016/j.jaci.2005.08.014; Kanny G, 2005, J ALLERGY CLIN IMMUN, V115, P179, DOI 10.1016/j.jaci.2004.09.012; Karisola P, 2005, J ALLERGY CLIN IMMUN, V115, P598, DOI 10.1016/j.jaci.2004.09.015; Kim JS, 2005, J ALLERGY CLIN IMMUN, V116, P164, DOI 10.1016/j.jaci.2005.03.039; Konno S, 2005, J ALLERGY CLIN IMMUN, V115, P1063, DOI 10.1016/j.jaci.2005.01.055; Kusel MMH, 2005, J ALLERGY CLIN IMMUN, V116, P1067, DOI 10.1016/j.jaci.2005.06.038; Kusunoki T, 2005, J ALLERGY CLIN IMMUN, V115, P636, DOI 10.1016/j.jaci.2004.12.1114; Lim DLC, 2005, J ALLERGY CLIN IMMUN, V115, P874, DOI 10.1016/j.jaci.2004.12.1117; MORAR N, 2006, IN PRESS J ALLERGY C; Mothes N, 2005, J ALLERGY CLIN IMMUN, V116, P706, DOI 10.1016/j.jaci.2005.06.025; Muller UR, 2005, J ALLERGY CLIN IMMUN, V115, P606, DOI [10.1016/j.jaci.2004.11.012, 10.1016/j.jsci.2004.11.012]; Novak N, 2005, J ALLERGY CLIN IMMUN, V115, P828, DOI 10.1016/j.jaci.2005.01.030; Omata N, 2005, J ALLERGY CLIN IMMUN, V115, P822, DOI 10.1016/j.jaci.2004.12.1121; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Raap U, 2005, J ALLERGY CLIN IMMUN, V115, P1268, DOI 10.1016/j.jaci.2005.02.007; Roberts G, 2005, J ALLERGY CLIN IMMUN, V115, P1291, DOI 10.1016/j.jaci.2005.02.038; Robotham JM, 2005, J ALLERGY CLIN IMMUN, V115, P1284, DOI 10.1016/j.jaci.2005.02.028; Saarinen KM, 2005, J ALLERGY CLIN IMMUN, V116, P869, DOI 10.1016/j.jaci.2005.06.018; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007; Schmid-Grendelmeier P, 2005, J ALLERGY CLIN IMMUN, V115, P1068, DOI 10.1016/j.jaci.2005.01.065; Shreffler WG, 2005, J ALLERGY CLIN IMMUN, V116, P893, DOI 10.1016/j.jaci.2005.06.033; Sicherer SH, 2005, J ALLERGY CLIN IMMUN, V115, P575, DOI 10.1016/j.jaci.2004.12.1122; Soundararajan S, 2005, J ALLERGY CLIN IMMUN, V115, P815, DOI 10.1016/j.jaci.2004.12.1120; Srivastava KD, 2005, J ALLERGY CLIN IMMUN, V115, P171, DOI 10.1016/j.jaci.2004.10.003; Straumann A, 2005, J ALLERGY CLIN IMMUN, V115, P418, DOI 10.1016/j.jaci.2004.11.006; Talhari C, 2005, J ALLERGY CLIN IMMUN, V115, P1089, DOI 10.1016/j.jaci.2004.12.1135; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Untersmayr E, 2005, J ALLERGY CLIN IMMUN, V115, P377, DOI 10.1016/j.jaci.2004.10.029; Van Do T, 2005, J ALLERGY CLIN IMMUN, V116, P1314, DOI 10.1016/j.jaci.2005.07.033; Viljanen M, 2005, J ALLERGY CLIN IMMUN, V115, P1254, DOI 10.1016/j.jaci.2005.03.047; Wang J, 2005, J ALLERGY CLIN IMMUN, V115, P1318, DOI 10.1016/j.jaci.2005.02.021; Wang JL, 2005, J ALLERGY CLIN IMMUN, V115, P1076, DOI 10.1016/j.jaci.2005.02.014; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Williams HC, 2005, J ALLERGY CLIN IMMUN, V116, P1064, DOI 10.1016/j.jaci.2005.08.026; Win PH, 2005, J ALLERGY CLIN IMMUN, V116, P225, DOI 10.1016/j.jaci.2005.03.037; 2005, J ALLERGY CLIN IMM S, V115, pS483	65	15	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2006	118	1					170	177		10.1016/j.jaci.2006.04.018	http://dx.doi.org/10.1016/j.jaci.2006.04.018			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	065UH	16815152	Bronze			2022-12-18	WOS:000239184800020
J	Aoi, N; Masuda, T; Murakami, D; Yajima, T; Mizubuchi, H; Yamada, H; Kawauchi, H; Yoshikai, Y				Aoi, Noriaki; Masuda, Tokuko; Murakami, Daisuke; Yajima, Toshiki; Mizubuchi, Hiroyuki; Yamada, Hisakata; Kawauchi, Hideyuki; Yoshikai, Yasunobu			IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8(+) cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IL-15; allergic rhinitis; T(H)2 cells; CD8(+) T cells	NATURAL-KILLER-CELLS; T-CELLS; AIRWAY HYPERRESPONSIVENESS; INTERFERON-GAMMA; DENDRITIC CELLS; MESSENGER-RNA; GROWTH-FACTOR; INTERLEUKIN-15; INFLAMMATION; INDUCTION	Background: Allergic rhinitis is one of the most common allergic inflammatory diseases characterized by a predominant T(H)2 response with antigen-specific IgE synthesis. IL-15 plays important roles in activation and maintenance of memory CD8(+)T cells capable of producing IFN-gamma, which regulates TH2 responses. Objective: To investigate the roles of endogenous IL-15 in allergic inflammation, we examined allergic rhinitis in IL-15 knockout (KO) mice sensitized with ovalbumin followed by intranasal rechallenge with ovalbumin. Methods: IL-15KO mice were sensitized intraperitoneaily with oval bumin/complete Freund's adjuvant on day 0 and ovalbumin/1FA on day 7, and then were intranasally challenged with ovalbumin on days 21, 22, 23, 24, and 25. Nasal symptoms and histologic changes were examined. IgE production and T(H)2 responses were measured by ELISA. Purified CD8+T cells or recombinant IL-15 were administered into ovalbumin-sensitized mice. Results: The levels of IgE production and TH2 responses in IL-15KO mice were comparable to those in control mice a er ovalbumin sensitization. However, sneezing, infiltration of eosinophils into the nasal mucosa, and TH2 cytokine production were aggravated in ovalbumin-sensitized IL-15KO mice after intranasal challenge with ovalbumin. Adoptive transfer of CD8(+) T cells from ovalbumin-sensitized mice suppressed the T(H)2 responses in mice but not in IL-15KO mice. Administration of IL-15 with oval bumin significantly prevented the development of allergic rhinitis in ovalbumin-sensitized mice. Conclusion: We demonstrate with IL-15KO mice that endogenous IL-15 plays an important role in suppression of allergic rhinitis at effector phase. Intranasal administration of IL-15 is useful as a therapeutic approach to control allergic rhinitis. Clinical implications: Intranasal administration of recombinant IL-15 might become new immunotherapy for allergic rhinitis.	Kyushu Univ, Med Inst Bioregulat, Res Ctr Prevent Infect Dis, Div Host Def, Fukuoka 8128582, Japan; Shimane Univ, Dept Otorhinolaryngol, Izumo, Shimane, Japan	Kyushu University; Shimane University	Yoshikai, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Res Ctr Prevent Infect Dis, Div Host Def, Fukuoka 8128582, Japan.	yoshikai@bioreg.kyushu-u.ac.jp						ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Blauvelt A, 1996, J INVEST DERMATOL, V106, P1047, DOI 10.1111/1523-1747.ep12338641; Borish L, 2003, J ALLERGY CLIN IMMUN, V112, P1021, DOI 10.1016/j.jaci.2003.09.015; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Carson WE, 1995, J CLIN INVEST, V96, P2578, DOI 10.1172/JCI118321; Gelfand EW, 2004, J ALLERGY CLIN IMMUN, V114, pS135, DOI 10.1016/j.jaci.2004.08.043; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Holt PG, 1999, NATURE, V402, pB12; Hoontrakoon R, 2002, AM J RESP CELL MOL, V26, P404, DOI 10.1165/ajrcmb.26.4.4517; InagakiOhara K, 1997, EUR J IMMUNOL, V27, P2885, DOI 10.1002/eji.1830271121; Ishimitsu R, 2001, J IMMUNOL, V166, P1991, DOI 10.4049/jimmunol.166.3.1991; Jonuleit H, 1997, J IMMUNOL, V158, P2610; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Masuda A, 2001, J BIOL CHEM, V276, P26107, DOI 10.1074/jbc.M011475200; Miyahara N, 2004, NAT MED, V10, P865, DOI 10.1038/nm1081; Miyahara N, 2004, J IMMUNOL, V172, P2549, DOI 10.4049/jimmunol.172.4.2549; Mori A, 1996, J IMMUNOL, V156, P2400; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Paludan SR, 1998, SCAND J IMMUNOL, V48, P459; Pawankar R, 2000, CLIN EXP ALLERGY, V30, P318; Ruckert R, 2005, J IMMUNOL, V174, P5507, DOI 10.4049/jimmunol.174.9.5507; Salib RJ, 2003, CLIN OTOLARYNGOL, V28, P291, DOI 10.1046/j.1365-2273.2003.00706.x; Shibaki A, 2002, EXP DERMATOL, V11, P126, DOI 10.1034/j.1600-0625.2002.110204.x; Sugimoto Y, 2000, IMMUNOPHARMACOLOGY, V48, P1, DOI 10.1016/S0162-3109(00)00173-9; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Weiler M, 1998, J AM SOC NEPHROL, V9, P1194; Xystrakis E, 2004, BLOOD, V104, P3294, DOI 10.1182/blood-2004-03-1214; Yajima T, 2005, J IMMUNOL, V174, P3590, DOI 10.4049/jimmunol.174.6.3590; Yajima T, 2002, J IMMUNOL, V168, P1198, DOI 10.4049/jimmunol.168.3.1198; Yajima T, 2002, INT J CANCER, V99, P573, DOI 10.1002/ijc.10395; Yajima T, 2001, EUR J IMMUNOL, V31, P757, DOI 10.1002/1521-4141(200103)31:3<757::AID-IMMU757>3.0.CO;2-Q	36	15	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1359	1366		10.1016/j.jaci.2006.02.018	http://dx.doi.org/10.1016/j.jaci.2006.02.018			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16750998				2022-12-18	WOS:000238332300023
J	Bateman, ED				Bateman, ED			Severity and control of severe asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									Univ Cape Town, Lung Inst, ZA-7937 Cape Town, South Africa; Univ Cape Town, Div Pulmonol, ZA-7937 Cape Town, South Africa	University of Cape Town; University of Cape Town	Bateman, ED (corresponding author), Univ Cape Town, Lung Inst, POB 34560,Groote Schuur 7937, ZA-7937 Cape Town, South Africa.	ebateman@uctgsh1.uct.ac.za						Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; *AM THOR SOC WORKS, 2000, AM J RESP CRIT CARE, V163, P2341; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Chung KF, 1999, EUR RESPIR J, V13, P1198; Delgado-Corcoran Claudia, 2004, Pediatr Crit Care Med, V5, P48, DOI 10.1097/01.CCM.0000105310.00799.51; Foley S, 2006, J ALLERGY CLIN IMMUN, V117, P714, DOI 10.1016/j.jaci.2005.12.1302; Gelfand EW, 2006, J ALLERGY CLIN IMMUN, V117, P577, DOI 10.1016/j.jaci.2005.12.1340; Gibson PG, 2004, EUR RESPIR J, V23, P492, DOI 10.1183/09031936.04.00132904; *GINA, 2002, NAT HEART LUNG BLOOD; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Holgate ST, 2006, J ALLERGY CLIN IMMUN, V117, P496, DOI 10.1016/j.jaci.2006.01.039; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kamath AV, 2005, THORAX, V60, P529, DOI 10.1136/thx.2005.043182; Li JT, 2005, J ALLERGY CLIN IMMUN, V116, pS3, DOI 10.1016/j.jaci.2005.08.017; Moore WC, 2006, J ALLERGY CLIN IMMUN, V117, P487, DOI 10.1016/j.jaci.2006.01.033; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2002, NAT HEART LUNG BLOOD, V02-5075; Sippel JM, 2000, J ALLERGY CLIN IMMUN, V106, P645, DOI 10.1067/mai.2000.109618; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Stoloff SW, 2006, J ALLERGY CLIN IMMUN, V117, P544, DOI 10.1016/j.jaci.2006.01.005; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Wenzel S, 2006, J ALLERGY CLIN IMMUN, V117, P508, DOI 10.1016/j.jaci.2005.12.1316	23	15	16	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2006	117	3					519	521		10.1016/j.jaci.2006.01.028	http://dx.doi.org/10.1016/j.jaci.2006.01.028			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	025JY	16522449				2022-12-18	WOS:000236263100005
J	Skorpinski, EW; McGeady, SL; Yousef, E				Skorpinski, EW; McGeady, SL; Yousef, E			Two cases of accidental epinephrine injection into a finger	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADRENALINE		Alfred I Dupont Hosp Children, Div Clin Immunol & Allergy, Wilmington, DE 19803 USA; Nemours Childrens Clin, Wilmington, DE USA; Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; Jefferson University	Skorpinski, EW (corresponding author), Alfred I Dupont Hosp Children, Div Clin Immunol & Allergy, 1600 Rockland Rd, Wilmington, DE 19803 USA.							Deshmukh N, 1989, J Emerg Med, V7, P408, DOI 10.1016/0736-4679(89)90320-X; Grouhi M, 1999, J ALLERGY CLIN IMMUN, V104, P190, DOI 10.1016/S0091-6749(99)70134-X; McGovern SJ, 1997, J ACCID EMERG MED, V14, P379; Mrvos R, 2002, SOUTHERN MED J, V95, P318; Velissariou I, 2004, EMERG MED J, V21, P387, DOI 10.1136/emj.2003.005462	5	15	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2006	117	2					463	464		10.1016/j.jaci.2005.10.005	http://dx.doi.org/10.1016/j.jaci.2005.10.005			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IM	16461149	Bronze			2022-12-18	WOS:000235687300030
J	Akiyama, H; Amano, H; Bienenstock, J				Akiyama, H; Amano, H; Bienenstock, J			Rat tracheal epithelial responses to water avoidance stress	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mast cell; hypothalamic-pituitary-adremal axis; short-circuit current; corticotropin-releasing factor; substance P	CORTICOTROPIN-RELEASING HORMONE; MAST-CELL DEGRANULATION; AIRWAY INFLAMMATION; SUBSTANCE-P; RECEPTOR; SUSCEPTIBILITY; NEUROTENSIN; ANTAGONIST; ASTHMA; NERVES	Background: Psychologic stress has major effects on many organs and cellular systems. The hypothalamic-pituitaryadrenal axis, corticotropin-releasing factor (CRF), mast cells, and nerves have all been shown to be involved in intestinal epithelial responses to stress. There has been little information in the literature on stress and the lung. Objective: To investigate Wistar rat tracheal epithelial responses to acute water avoidance stress (1 hour). Methods: Tracheal tissue was examined in Ussing chambers. Results: Increases in short-circuit current, but not in conductance, occurred after stress and were inhibited by previous injection of the CRF 1 and 2 receptor antagonist, a-helical CRF-(9-41). Electron microscopic morphologic evidence for tracheal mast cell activation and degranulation was found after stress. Stress and CRIT injection both enhanced responses to substance P, but these effects were not inhibited by alpha-helical CRF. Conclusion: The data suggest that acute stress affects tracheal epithelium and sensitizes it to enhanced responses to substance P, partly through mast cell activation. Many but not all of these effects are mediated by CRE These results offer the possibility that stress may be involved in inflammatory diseases of the lung such as asthma.	Natl Inst Hlth Sci, Div Foods, Setagaya Ku, Tokyo 1588501, Japan; Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Pathol, Hamilton, ON, Canada; McMaster Univ, Dept Mol Med, Hamilton, ON, Canada; St Josephs Hlth Ctr, Brain Body Inst, Hamilton, ON, Canada	National Institute of Health Sciences - Japan; Gunma University; McMaster University; McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario)	Akiyama, H (corresponding author), Natl Inst Hlth Sci, Div Foods, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	akiyama@nihs.go.jp						ALBAZZAZ FJ, 1985, AM REV RESPIR DIS, V131, P86; Alexacos N, 1999, UROLOGY, V53, P1035, DOI 10.1016/S0090-4295(98)00627-X; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; BARONE FC, 1990, AM J PHYSIOL, V258, pG329, DOI 10.1152/ajpgi.1990.258.3.G329; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bienenstock J, 2002, AM J RESP CRIT CARE, V165, P1034, DOI 10.1164/ajrccm.165.8.2202071b; BIENENSTOCK J, 1985, INT ARCH ALLER A IMM, V77, P126, DOI 10.1159/000233766; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; BUSSE WW, 1995, AM J RESP CRIT CARE, V151, P249, DOI 10.1164/ajrccm.151.1.7812562; Castagliuolo I, 1996, AM J PHYSIOL-GASTR L, V271, pG884, DOI 10.1152/ajpgi.1996.271.5.G884; Castagliuolo I, 1998, AM J PHYSIOL-GASTR L, V274, pG1094, DOI 10.1152/ajpgi.1998.274.6.G1094; Christiansen SC, 2000, NEW ENGL J MED, V343, P574, DOI 10.1056/NEJM200008243430810; CSERMELY P, 1998, ANN NY ACAD SCI, V851, P1; FISHER L, 1991, ENDOCRINOLOGY, V129, P1312, DOI 10.1210/endo-129-3-1312; GAO GC, 1991, PEPTIDES, V12, P639, DOI 10.1016/0196-9781(91)90113-4; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Gue M, 1997, AM J PHYSIOL-GASTR L, V272, pG84, DOI 10.1152/ajpgi.1997.272.1.G84; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Holgate ST, 2000, BMJ-BRIT MED J, V320, P231, DOI 10.1136/bmj.320.7229.231; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Hopkins K. D., 1987, BASIC STAT BEHAV SCI, V2nd; Joachim RA, 2004, PSYCHOSOM MED, V66, P564, DOI 10.1097/01.psy.0000132878.08780.93; Joachim RA, 2003, PSYCHOSOM MED, V65, P811, DOI 10.1097/01.PSY.0000088582.50468.A3; KARALIS K, 1991, SCIENCE, V254, P421, DOI 10.1126/science.1925600; Kiliaan AJ, 1998, AM J PHYSIOL-GASTR L, V275, pG1037, DOI 10.1152/ajpgi.1998.275.5.G1037; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; MARSHALL JS, 1994, CURR OPIN IMMUNOL, V6, P853, DOI 10.1016/0952-7915(94)90004-3; McAlexander MA, 1997, NEUROPEPTIDES, V31, P293, DOI 10.1016/S0143-4179(97)90062-7; MCKAY DM, 1994, IMMUNOL TODAY, V15, P533, DOI 10.1016/0167-5699(94)90210-0; MENZAGHI F, 1994, J PHARMACOL EXP THER, V269, P564; Million M, 1999, AM J PHYSIOL-GASTR L, V276, pG1027, DOI 10.1152/ajpgi.1999.276.4.G1027; MONNIKES H, 1993, GASTROENTEROLOGY, V104, P716; Pang XZ, 1998, J PHARMACOL EXP THER, V287, P307; PARE WP, 1989, PHYSIOL BEHAV, V46, P993, DOI 10.1016/0031-9384(89)90203-5; Pothoulakis C, 1998, ANN NY ACAD SCI, V840, P635, DOI 10.1111/j.1749-6632.1998.tb09602.x; RANGACHARI PK, 1985, REGUL PEPTIDES, V12, P9, DOI 10.1016/0167-0115(85)90182-X; Rozniecki JJ, 1999, BRAIN RES, V849, P1, DOI 10.1016/S0006-8993(99)01855-7; Sandberg S, 2004, THORAX, V59, P1046, DOI 10.1136/thx.2004.024604; Santos J, 1999, AM J PHYSIOL-GASTR L, V277, pG391, DOI 10.1152/ajpgi.1999.277.2.G391; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Santos J, 1998, GASTROENTEROLOGY, V114, P640, DOI 10.1016/S0016-5085(98)70577-3; SAUNDERS PR, 1994, AM J PHYSIOL-GASTR L, V267, pG794, DOI 10.1152/ajpgi.1994.267.5.G794; SESTINI P, 1989, AM REV RESPIR DIS, V139, P401, DOI 10.1164/ajrccm/139.2.401; SESTINI P, 1990, AM REV RESPIR DIS, V141, P393, DOI 10.1164/ajrccm/141.2.393; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; Spanos C, 1997, J UROLOGY, V157, P669, DOI 10.1016/S0022-5347(01)65247-9; STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975; STERNBERG EM, 1992, BRAIN RES, V570, P54, DOI 10.1016/0006-8993(92)90563-O; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P4771, DOI 10.1073/pnas.86.12.4771; Tache Y, 1999, Can J Gastroenterol, V13 Suppl A, p18A; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Theoharides TC, 1999, DIGEST DIS SCI, V44, p87S; THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745; van der Kleij HPM, 2003, EUR J PHARMACOL, V476, P249, DOI 10.1016/S0014-2999(03)02189-7; Verdu EF, 2004, BEST PRACT RES CL GA, V18, P315, DOI 10.1016/j.bpg.2003.11.003; WEI ET, 1987, EUR J PHARMACOL, V140, P63, DOI 10.1016/0014-2999(87)90634-0; Weninger SC, 1999, P NATL ACAD SCI USA, V96, P8283, DOI 10.1073/pnas.96.14.8283; WILLIAMS CL, 1987, AM J PHYSIOL, V253, pG582, DOI 10.1152/ajpgi.1987.253.4.G582; WONG YN, 1994, J CHROMATOGR B, V661, P211, DOI 10.1016/0378-4347(94)00346-7; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Yang PC, 1999, J IMMUNOL, V163, P2769; Yates DA, 2001, AM J PHYSIOL-GASTR L, V281, pG124, DOI 10.1152/ajpgi.2001.281.1.G124; YOSHIHARA S, 1995, EUR J PHARMACOL, V280, P113, DOI 10.1016/0014-2999(95)00187-P	63	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2005	116	2					318	324		10.1016/j.jaci.2005.03.040	http://dx.doi.org/10.1016/j.jaci.2005.03.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017ID	16083786				2022-12-18	WOS:000235686400013
J	Fiset, PO; Cameron, L; Hamed, Q				Fiset, PO; Cameron, L; Hamed, Q			Local isotype switching to IgE in airway mucosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							NASAL-MUCOSA; GENE TRANSCRIPTS; EXPRESSION; IL-4; RNA		McGill Univ, Meakins Christie Labs, Dept Pathol & Med, Montreal, PQ H2X 2P2, Canada	McGill University	Hamed, Q (corresponding author), McGill Univ, Meakins Christie Labs, Dept Pathol & Med, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	qutayba.hamid@mcgill.ca						Cameron L, 2000, J ALLERGY CLIN IMMUN, V106, P46; Cameron L, 2003, J IMMUNOL, V171, P3816, DOI 10.4049/jimmunol.171.7.3816; Cameron LA, 1998, J ALLERGY CLIN IMMUN, V101, P330, DOI 10.1016/S0091-6749(98)70244-1; Durham SR, 1997, EUR J IMMUNOL, V27, P2899, DOI 10.1002/eji.1830271123; SMALL P, 1985, ANN ALLERGY, V55, P736	5	15	18	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					233	236		10.1016/j.jaci.2005.03.019	http://dx.doi.org/10.1016/j.jaci.2005.03.019			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990807				2022-12-18	WOS:000235686300042
J	Williams, LK; Peterson, EL; Pladevall, M; Tunceli, K; Ownby, DR; Johnson, CC				Williams, LK; Peterson, EL; Pladevall, M; Tunceli, K; Ownby, DR; Johnson, CC			Timing and intensity of early fevers and the development of allergies and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hygiene hypothesis; fever; asthma; atopy; allergic sensitization	EARLY-LIFE; HAY-FEVER; AGE; SENSITIZATION; INFECTION; RISK; EXPOSURE; CHILDREN; ORDER; ATOPY	Background: Early childhood fevers appear to protect against later allergies and asthma. What is not known is the time in which fevers exert this effect and whether the degree of temperature increase is important. Objective: We sought to examine the relationship between the time and degree of early fevers and later allergies and asthma. Methods: Eight hundred thirty-five children from southeast Michigan were enrolled at birth. Clinic records from their first 2 years were abstracted for episodes of fever. At age 6 to 7 years, children underwent allergy testing. We examined fevers occurring within 6-month intervals in the first 2 years of life and outcomes at age 6 to 7 years. The primary outcome measures were allergic sensitization, asthma, asthma with allergic sensitization, and asthma without allergic sensitization. Results: In the unadjusted analysis each episode of fever between 7 and 12 months of age was associated with a lower odds of allergic sensitization (odds ratio [OR], 0.71; 95% CL 0.54-0.93) and asthma with allergic sensitization (OR, 0.43; 95% Cl, 0.21-0.90) at age 6 to 7 years. Likewise, every VC increase in the maximum temperature between 7 and 12 months was associated with a lower odds of allergic sensitization (OR, 0.77; 95% CI, 0.61-0.96) and asthma with allergic sensitization (OR, 0.62; 95% CI, 0.40-0.94). After adjusting for potential confounders, each episode of fever between 7 and 12 months was associated with a lower likelihood of asthma with allergic sensitization (adjusted OR, 0.33; 95% CI, 0.11-0.94) at age 6 to 7 years. Conclusions: Both the timing and intensity of childhood fevers appear to be important factors in the development of allergies and asthma.	Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI 48202 USA; Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; Henry Ford Hlth Syst, Ctr Hlth Serv Res, Detroit, MI 48202 USA; Med Coll Georgia, Dept Pediat, Sect Allergy & Immunol, Augusta, GA 30912 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University System of Georgia; Augusta University	Williams, LK (corresponding author), Henry Ford Hlth Syst, Dept Internal Med, 1 Ford Pl,3A CHSR, Detroit, MI 48202 USA.	kwillia5@hfhs.org		Johnson, Christine Cole/0000-0002-6864-6604	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050681, R01AI061774, R21AI059415] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL068971] Funding Source: Medline; NIAID NIH HHS [R01AI50681, R01AI61774, R21AI059415] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bodner C, 2000, THORAX, V55, P383, DOI 10.1136/thorax.55.5.383; BROWN RD, 1992, CLIN PEDIATR, V31, P523; Calvani M, 2002, EUR RESPIR J, V20, P391, DOI 10.1183/09031936.02.00274502; Craig JV, 2002, LANCET, V360, P603, DOI 10.1016/S0140-6736(02)09783-0; Dinarello CA, 1999, J INFECT DIS, V179, pS294, DOI 10.1086/513856; Early E, 1999, CLIN EXP IMMUNOL, V116, P527; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Karmaus W, 2004, CLIN EXP ALLERGY, V34, P853, DOI 10.1111/j.1365-2222.2004.01959.x; Karmaus W, 2001, AM J EPIDEMIOL, V154, P909, DOI 10.1093/aje/154.10.909; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Langrish CL, 2002, CLIN EXP IMMUNOL, V128, P118, DOI 10.1046/j.1365-2249.2002.01817.x; Marodi L, 2002, CLIN EXP IMMUNOL, V128, P1, DOI 10.1046/j.1365-2249.2002.01873.x; MARTINEZ FD, 1995, THORAX, V50, P1067, DOI 10.1136/thx.50.10.1067; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Romagnani S, 2004, J ALLERGY CLIN IMMUN, V113, P395, DOI 10.1016/j.jaci.2003.11.025; SAS Institute Inc, 2004, SAS STAT US GUID VER; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; von Hertzen L, 1999, J ALLERGY CLIN IMMUN, V104, P1211, DOI 10.1016/S0091-6749(99)70015-1; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; Williams LK, 2004, J ALLERGY CLIN IMMUN, V113, P291, DOI 10.1016/j.jaci.2003.11.010	23	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2005	116	1					102	108		10.1016/j.jaci.2005.04.021	http://dx.doi.org/10.1016/j.jaci.2005.04.021			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IC	15990781				2022-12-18	WOS:000235686300016
J	Edwards, AM				Edwards, AM			The discovery of cromolyn sodium and its effect on research and practice in allergy and immunology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							DISODIUM-CROMOGLYCATE; INHALATION; IMMEDIATE		St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Newport, Wight, England		Edwards, AM (corresponding author), St Marys Hosp, David Hide Asthma & Allergy Res Ctr, Newport, Wight, England.							ALTOUNYAN RE, 1967, ACTA ALLERGOL, V22, P487; ANREP GV, 1947, LANCET, V252, P557; BOOIJNOORD H, 1971, J ALLERGY CLIN IMMUN, V48, P344, DOI 10.1016/0091-6749(71)90080-7; Easty D, 1971, Trans Ophthalmol Soc U K, V91, P491; MOOTS RJ, 1988, GUT, V29, P1282, DOI 10.1136/gut.29.9.1282; ORR TSC, 1969, NATURE, V223, P197, DOI 10.1038/223197b0; PEPYS J, 1968, LANCET, V2, P134; SCHILLER IW, 1952, J ALLERGY, V23, P234, DOI 10.1016/0021-8707(52)90022-1; SHEARD P, 1970, INT ARCH ALLER A IMM, V38, P217, DOI 10.1159/000230274; SOTER NA, 1979, NEW ENGL J MED, V301, P465, DOI 10.1056/NEJM197908303010903; Stainer R, 2005, BRIT J DERMATOL, V152, P334, DOI 10.1111/J.1365-2133.2004.06303.X; STEFANINI GF, 1995, SCAND J GASTROENTERO, V30, P535, DOI 10.3109/00365529509089786	12	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					885	888		10.1016/j.jaci.2005.01.063	http://dx.doi.org/10.1016/j.jaci.2005.01.063			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15806020	Bronze			2022-12-18	WOS:000228373400042
J	Enriquez, R; Addington, W; Davis, F; Freels, S; Park, CL; Hershow, RC; Persky, V				Enriquez, R; Addington, W; Davis, F; Freels, S; Park, CL; Hershow, RC; Persky, V			The relationship between vaccine refusal and self-report of atopic disease in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						immunization; asthma; allergic rhinitis; eczema; prevalence; cross-sectional survey	CHILDHOOD ASTHMA; ALLERGIC DISEASE; PERTUSSIS VACCINATION; UNITED-STATES; BIRTH COHORT; PREVALENCE; SYMPTOMS; RISK; INFECTION; TRENDS	Background: In the last 3 decades, there has been an unexplained increase in the prevalence of asthma and hay fever. Objective: We sought to determine whether there is an association between childhood vaccination and atopic diseases, and we assessed the self-reported prevalence of atopic diseases in a population that included a large number of families not vaccinating their children. Methods: Surveys were mailed to 2964 member households of the National Vaccine Information Center, which represents people concerned about vaccine safety, to ascertain vaccination and atopic disease status. Results: The data included 515 never vaccinated, 423 partially vaccinated, and 239 completely vaccinated children. In multiple regression analyses there were significant (P <.0005) and dose-dependent negative relationships between vaccination refusal and self-reported asthma or hay fever only in children with no family history of the condition and, for asthma, in children with no exposure to antibiotics during infancy. Vaccination refusal was also significantly (P <.005) and negatively associated with self-reported eczema and current wheeze. A sensitivity analysis indicated that substantial biases would be required to overturn the observed associations. Conclusion: Parents who refuse vaccinations reported less asthma and allergies in their unvaccinated children. Although this relationship was independent of measured confounders, it could be due to differences in other unmeasured lifestyle factors or systematic bias. Further research is needed to verify these results and investigate which exposures are driving the associations between vaccination refusal and allergic disease. The known benefits of vaccination currently outweigh the unproved risk of allergic disease.	Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; Univ London, London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA	Vanderbilt University; University of London; London School of Hygiene & Tropical Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Enriquez, R (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, T-1218 Med Ctr N,116 21st Ave S, Nashville, TN 37232 USA.	Rachel.Enriquez@vanderbilt.edu						Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; American Association for Public Opinion Research, 2004, STAND DEF FIN DISP C; Arias Elizabeth, 2003, Natl Vital Stat Rep, V52, P1; Destefano F, 2002, PEDIATR INFECT DIS J, V21, P498, DOI 10.1097/00006454-200206000-00004; Droste JHJ, 2000, CLIN EXP ALLERGY, V30, P1547; Farooqi IS, 1998, THORAX, V53, P927, DOI 10.1136/thx.53.11.927; GREENLAND S, 2004, MODERN EPIDEMIOLOGY; Gruber C, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e282; Habbick BF, 1999, CAN MED ASSOC J, V160, P1824; Hedeker D, 1996, COMPUT METH PROG BIO, V49, P157, DOI 10.1016/0169-2607(96)01720-8; Henderson J, 1999, BRIT MED J, V318, P1173, DOI 10.1136/bmj.318.7192.1173; Hurwitz EL, 2000, J MANIP PHYSIOL THER, V23, P81, DOI 10.1016/S0161-4754(00)90072-1; Kemp T, 1997, EPIDEMIOLOGY, V8, P678, DOI 10.1097/00001648-199710000-00011; Laubereau B, 2002, EUR J MED RES, V7, P387; Maher JE, 2004, PHARMACOEPIDEM DR S, V13, P1, DOI 10.1002/pds.821; Maitra A, 2004, BRIT MED J, V328, P925, DOI 10.1136/bmj.38045.858889.EB; Matricardi PM, 2002, J ALLERGY CLIN IMMUN, V110, P381, DOI 10.1067/mai.2002.126658; McKeever TM, 2004, AM J PUBLIC HEALTH, V94, P985, DOI 10.2105/AJPH.94.6.985; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Neuzil KM, 1997, VACCINE, V15, P525, DOI 10.1016/S0264-410X(97)00218-1; Nilsson L, 1998, ARCH PEDIAT ADOL MED, V152, P734; Offit PA, 2003, VACCINES WHAT YOU SH; Persky VW, 1998, ANN ALLERG ASTHMA IM, V81, P266, DOI 10.1016/S1081-1206(10)62824-4; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Stempel David A, 2002, Curr Allergy Asthma Rep, V2, P223, DOI 10.1007/s11882-002-0023-0; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Von Mutius E, 1998, CLIN EXP ALLERGY, V28, P45	27	15	16	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					737	744		10.1016/j.jaci.2004.12.1128	http://dx.doi.org/10.1016/j.jaci.2004.12.1128			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15805992				2022-12-18	WOS:000228373400011
J	Larsen, GL; Kang, JKB; Guilbert, T; Morgan, W				Larsen, GL; Kang, JKB; Guilbert, T; Morgan, W			Assessing respiratory function in young children: Developmental considerations	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						airway development; childhood asthma; forced oscillation techniques; interrupter techniques; pulmonary function tests; spirometry; whole body plethysmography	FORCED EXPIRATORY MANEUVERS; AIRWAY-RESISTANCE; INTERRUPTER TECHNIQUE; PRESCHOOL-CHILDREN; LUNG-FUNCTION; BRONCHIAL RESPONSIVENESS; BRONCHODILATOR RESPONSE; IMPULSE OSCILLOMETRY; ASTHMATIC-CHILDREN; AGED 3	The purpose of this review is to provide practitioners and clinical investigators with an update on methods of assessing respiratory function in young children. The importance of this topic is presented in light of the natural history of asthma, as well as maturational changes that occur early in life in terms of airway development. Models of disease are cited to support the concept that injury of the mammalian airway early in postnatal life might have far-reaching consequences in terms of control of airway caliber and responsiveness. The methods currently available to measure respiratory function in our younger patients are outlined. The ability of children to perform the maneuvers necessary for this testing is considered as a function of age. Areas in which research and development are needed are highlighted.	Natl Jewish Ctr Immunol & Resp Med, Dept Pediat, Denver, CO 80206 USA; Univ Arizona, Coll Med, Tucson, AZ USA	National Jewish Health; University of Arizona	Larsen, GL (corresponding author), Natl Jewish Ctr Immunol & Resp Med, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	larseng@njc.org		Guilbert, Theresa/0000-0002-6932-712X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067818, P01HL036577] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 36577, HL 67818] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Arets HGM, 2001, EUR RESPIR J, V18, P655, DOI 10.1183/09031936.01.00204301; Aurora P, 2004, AM J RESP CRIT CARE, V169, P1152, DOI 10.1164/rccm.200310-1453OC; Badier M, 1999, PEDIATR PULM, V27, P117, DOI 10.1002/(SICI)1099-0496(199902)27:2<117::AID-PPUL8>3.0.CO;2-H; Barbato A, 2003, AM J RESP CRIT CARE, V168, P798, DOI 10.1164/rccm.200305-650OC; BARNES PJ, 1997, LUNG SCI FDN, P1269; Beelen RMJ, 2003, THORAX, V58, P761, DOI 10.1136/thorax.58.9.761; Beydon N, 2002, AM J RESP CRIT CARE, V165, P1388, DOI 10.1164/rccm.2011082; Beydon N, 2003, AM J RESP CRIT CARE, V168, P640, DOI 10.1164/rccm.200303-449OC; Bisgaard H, 2000, AM J RESP CRIT CARE, V162, P187, DOI 10.1164/ajrccm.162.1.9910039; Bisgaard H, 1995, EUR RESPIR J, V8, P2067, DOI 10.1183/09031936.95.08122067; Bridge PD, 2001, EUR RESPIR J, V17, P495, DOI 10.1183/09031936.01.17304950; Bridge PD, 1999, EUR RESPIR J, V13, P792, DOI 10.1034/j.1399-3003.1999.13d16.x; BRUGMAN SM, 1995, CLIN CHEST MED, V16, P637; BUSSE W, 1995, AM J RESP CRIT CARE, V151, P1635, DOI 10.1164/ajrccm.151.5.7735626; Busse WW, 1997, AM J RESP CRIT CARE, V156, P314, DOI 10.1164/ajrccm.156.1.9612121; BYE MR, 1992, AM J DIS CHILD, V146, P977, DOI 10.1001/archpedi.1992.02160200099037; CARTER ER, 1994, PEDIATR PULM, V17, P211, DOI 10.1002/ppul.1950170402; CASTLEMAN WL, 1990, AM J PATHOL, V137, P821; CASTLEMAN WL, 1987, AM J PATHOL, V129, P277; Chan EY, 2003, THORAX, V58, P344, DOI 10.1136/thorax.58.4.344; COLASURDO GN, 1994, AM J PHYSIOL-LUNG C, V267, pL739, DOI 10.1152/ajplung.1994.267.6.L739; Colasurdo GN, 1998, AM J RESP CRIT CARE, V157, P1506, DOI 10.1164/ajrccm.157.5.9705026; Crenesse D, 2001, PEDIATR PULM, V32, P56, DOI 10.1002/ppul.1089; CRONER S, 1992, ALLERGY, V47, P150, DOI 10.1111/j.1398-9995.1992.tb00956.x; DAB I, 1976, PEDIATR RES, V10, P996, DOI 10.1203/00006450-197612000-00009; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Ducharme FM, 1998, CHEST, V113, P1322, DOI 10.1378/chest.113.5.1322; Ducharme FM, 1998, CHEST, V113, P1566, DOI 10.1378/chest.113.6.1566; DUIVERMAN EJ, 1986, B EUR PHYSIOPATH RES, V22, P433; DUIVERMAN EJ, 1986, B EUR PHYSIOPATH RES, V22, P27; Eigen H, 2001, AM J RESP CRIT CARE, V163, P619, DOI 10.1164/ajrccm.163.3.2002054; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; Gelfand AS, 1997, PEDIATR PULM, V23, P198, DOI 10.1002/(SICI)1099-0496(199703)23:3&lt;198::AID-PPUL5&gt;3.0.CO;2-K; Goldman MD, 2002, PEDIATR PULM, V34, P312, DOI 10.1002/ppul.10168; Goldman MD, 2001, PULM PHARMACOL THER, V14, P341, DOI 10.1006/pupt.2001.0310; Grigg J, 1996, EUR RESPIR J, V9, pS16; Hadjikoumi I, 2003, PEDIATR PULM, V36, P495, DOI 10.1002/ppul.10384; HAXHIUPOSKURICA B, 1993, AM J PHYSIOL, V264, pL606, DOI 10.1152/ajplung.1993.264.6.L606; Hellinckx J, 1998, EUR RESPIR J, V12, P438, DOI 10.1183/09031936.98.12020438; HISLOP AA, 1990, AM J RESP CELL MOL, V3, P191; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; KANENGISER S, 1994, PEDIATR PULM, V18, P144, DOI 10.1002/ppul.1950180305; Klug B, 1998, PEDIATR PULM, V25, P322, DOI 10.1002/(SICI)1099-0496(199805)25:5<322::AID-PPUL6>3.0.CO;2-K; Klug B, 1996, PEDIATR PULM, V21, P290; Klug B, 1997, EUR RESPIR J, V10, P1599, DOI 10.1183/09031936.97.10071599; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Krawiec ME, 2001, AM J RESP CRIT CARE, V163, P1338, DOI 10.1164/ajrccm.163.6.2005116; LANDAU LI, 1993, PEDIATR PULM, V16, P31, DOI 10.1002/ppul.1950160107; Lanz MJ, 1997, PEDIATR PULM, V24, P305; Larsen GL, 1999, J PEDIATR-US, V135, pS21; Larsen GL, 1999, J ALLERGY CLIN IMMUN, V103, P371, DOI 10.1016/S0091-6749(99)70458-6; Larsen GL, 2004, PEDIATR PULM, V38, P97, DOI 10.1002/ppul.20060; LARSEN GL, 2003, PEDIAT ALLERGY PRINC, P357; LEBECQUE P, 1991, PEDIATR PULM, V10, P117, DOI 10.1002/ppul.1950100214; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Lombardi E, 2001, THORAX, V56, P691, DOI 10.1136/thorax.56.9.691; Lowe L, 2002, LANCET, V359, P1904, DOI 10.1016/S0140-6736(02)08781-0; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; Malmberg LP, 2002, CLIN PHYSIOL FUNCT I, V22, P64, DOI 10.1046/j.1365-2281.2002.00396.x; Marotta A, 2003, J ALLERGY CLIN IMMUN, V112, P317, DOI 10.1067/mai.2003.1627; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; Martinez FD, 2003, NEW ENGL J MED, V349, P1473, DOI 10.1056/NEJMe030041; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McKenzie SA, 2002, ARCH DIS CHILD, V87, P248, DOI 10.1136/adc.87.3.248; McKenzie SA, 2001, EUR RESPIR J, V18, P977, DOI 10.1183/09031936.01.00071901; McKenzie SA, 2000, EUR RESPIR J, V15, P833, DOI 10.1034/j.1399-3003.2000.15e04.x; Merkus PJFM, 2001, AM J RESP CRIT CARE, V163, P1350, DOI 10.1164/ajrccm.163.6.2005076; MORGAN W, 2005, IN PRESS CHILDHOOD A; MORGAN WJ, 1988, PEDIATR PULM, V5, P232, DOI 10.1002/ppul.1950050410; Nielsen KG, 2001, AM J RESP CRIT CARE, V164, P256, DOI 10.1164/ajrccm.164.2.2011121; Nielsen KG, 2001, AM J RESP CRIT CARE, V164, P554, DOI 10.1164/ajrccm.164.4.2006119; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; OswaldMammosser M, 1997, PEDIATR PULM, V24, P78, DOI 10.1002/(SICI)1099-0496(199708)24:2<78::AID-PPUL2>3.0.CO;2-E; Phagoo SB, 1996, EUR RESPIR J, V9, P1374, DOI 10.1183/09031936.96.09071374; POLGAR G, 1971, STANDARD VALUES PULM, P87; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; SHORE S, 1987, J APPL PHYSIOL, V62, P1837, DOI 10.1152/jappl.1987.62.5.1837; Sly PD, 2003, THORAX, V58, P742, DOI 10.1136/thorax.58.9.742; SORKNESS R, 1991, J APPL PHYSIOL, V70, P375, DOI 10.1152/jappl.1991.70.1.375; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; TAUSSIG LM, 1977, AM REV RESPIR DIS, V116, P1031; TEPPER RS, 1992, PEDIATR PULM, V13, P6, DOI 10.1002/ppul.1950130104; TEPPER RS, 1987, J APPL PHYSIOL, V62, P1155, DOI 10.1152/jappl.1987.62.3.1155; Uhl EW, 1996, AM J RESP CRIT CARE, V154, P1834, DOI 10.1164/ajrccm.154.6.8970378; Umetsu DT, 2003, J ALLERGY CLIN IMMUN, V112, P480, DOI 10.1067/mai.2003.1717; Vilozni D, 2001, AM J RESP CRIT CARE, V164, P2200, DOI 10.1164/ajrccm.164.12.2101002; Vink GR, 2003, PEDIATR PULM, V35, P214, DOI 10.1002/ppul.10235; WEISS KB, 1992, NEW ENGL J MED, V326, P862, DOI 10.1056/NEJM199203263261304; WENZEL SE, 1989, AM REV RESPIR DIS, V139, P450, DOI 10.1164/ajrccm/139.2.450; WILSON NM, 1992, ARCH DIS CHILD, V67, P491, DOI 10.1136/adc.67.4.491; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; ZAPLETAL A, 1987, PROGR RESPIR RES, V22, P220	98	15	18	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					657	666		10.1016/j.jaci.2004.12.1112	http://dx.doi.org/10.1016/j.jaci.2004.12.1112			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15805980				2022-12-18	WOS:000228373400001
J	Isogai, S; Jedrzkiewicz, S; Taha, R; Hamid, Q; Martin, JG				Isogai, S; Jedrzkiewicz, S; Taha, R; Hamid, Q; Martin, JG			Resident CD8(+) T cells suppress CD4(+) T cell-dependent late allergic airway responses	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CD8(+) T cells; CD4(+) T cells; T(H)2 cytokines; eosinophils; late allergic responses; Brown Norway rat	BROWN-NORWAY RATS; MONOCLONAL-ANTIBODIES; CONTACT SENSITIVITY; ANTIGEN CHALLENGE; DEPLETION; HYPERRESPONSIVENESS; INFLAMMATION; EOSINOPHILIA; CD4+; RESPONSIVENESS	Background: The role of CD8(+) T cells in the immune response to airway challenge with an allergen is poorly understood. Objective: The aim of this study was to test the hypothesis that resident naive CD8(+) T cells modulate the magnitude of CD4(+) T cell-dependent allergic airway responses. Methods: Cervical lymph node CD4(+) T cells (2 X 10(6)) were harvested from ovalbumin (OVA)- or sham-sensitized rats and injected intraperitoneally into naive Brown Norway recipients. The recipients were treated with a CD8 alpha mAb (OX-8) to deplete the resident CD8+ T cells (n = 12) or mouse ascites (n = 12). Two days after adoptive transfer, the recipient animals were OVA challenged, lung resistance was measured for 8 hours, and bronchoalveolar lavage (BAL) was performed. Results: After OVA challenge, primed CD4-transferred CD8-depleted rats had larger early airway responses and late airway responses compared with primed CD4-transferred CD8-nondepleted rats (early airway responses: 158.6% +/- 19.2% vs 115.7% +/- 5.9%, P < .05; late airway responses: 8.5% +/- 1.7% vs 4.4% +/- 0.9%, P < .05). BAL eosinophilia was also greater (4.67% +/- 0.45% vs 2.34 +/- 0.26%, P < .01). The cells in BAL fluid expressing IL-4 mRNA were not significantly changed by CD8 depletion, but IL-5 mRNA(+) cells were higher in number, and IFN-gamma mRNA+ cells were fewer in the CD8-depleted group. Conclusions: Resident CD8(+) T cells downregulate the late allergic response and airway inflammation evoked by CD4(+) T-cell transfers in Brown Norway rats. This downregulation does not require antigen priming.	McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada	McGill University	Martin, JG (corresponding author), McGill Univ, Dept Med, Meakins Christie Labs, 3626 St Urbain, Montreal, PQ H2X 2P2, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363				Allakhverdi Z, 2000, AM J RESP CRIT CARE, V162, P1123, DOI 10.1164/ajrccm.162.3.9910001; ASKENASE PW, 1995, INT ARCH ALLERGY IMM, V107, P363, DOI 10.1159/000237033; AZUMA M, 1992, INT J CANCER, P33; EIDELMAN DH, 1988, AM REV RESPIR DIS, V137, P1033, DOI 10.1164/ajrccm/137.5.1033; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; Haczku A, 1997, IMMUNOLOGY, V91, P176, DOI 10.1046/j.1365-2567.1997.d01-2221.x; Hamelmann E, 1996, J EXP MED, V183, P1719, DOI 10.1084/jem.183.4.1719; Hirji N, 1997, J IMMUNOL, V158, P1833; Hogan SP, 1998, AM J RESP CRIT CARE, V157, P210, DOI 10.1164/ajrccm.157.1.9702074; Hojo M, 2000, J PHARMACOL EXP THER, V293, P410; Huang TJ, 1999, IMMUNOLOGY, V96, P416; Isogai S, 2004, J ALLERGY CLIN IMMUN, V114, P1345, DOI 10.1016/j.jaci.2004.09.021; Isogai S, 2003, J ALLERGY CLIN IMMUN, V112, P547, DOI 10.1067/mai.2003.1682; Laberge S, 1996, J ALLERGY CLIN IMMUN, V98, P617, DOI 10.1016/S0091-6749(96)70096-9; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Mishima H, 1998, AM J RESP CRIT CARE, V158, P1863, DOI 10.1164/ajrccm.158.6.9709123; Mosmann TR, 1997, CIBA F SYMP, V204, P148; Noble A, 1998, J IMMUNOL, V160, P559; OLIVENSTEIN R, 1993, J CLIN INVEST, V92, P1477, DOI 10.1172/JCI116725; RENZ H, 1994, J IMMUNOL, V152, P351; ROLAPLESZCZYNSK.M, 1998, INT ARCH ALLERGY IMM, V64, P361; Suzuki M, 2002, J ALLERGY CLIN IMMUN, V109, P803, DOI 10.1067/mai.2002.123233; Suzuki M, 1999, J IMMUNOL, V163, P5574; Tsuji RF, 2002, J EXP MED, V196, P1277, DOI 10.1084/jem.20020649; WATANABE A, 1995, J CLIN INVEST, V96, P1303, DOI 10.1172/JCI118165	27	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					521	526		10.1016/j.jaci.2004.11.036	http://dx.doi.org/10.1016/j.jaci.2004.11.036			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753899				2022-12-18	WOS:000227687000014
J	Kawano, T; Matsuse, H; Kondo, Y; Machida, I; Saeki, S; Tomari, S; Mitsuta, K; Fukushima, C; Obase, Y; Shimoda, T; Kohno, S				Kawano, T; Matsuse, H; Kondo, Y; Machida, I; Saeki, S; Tomari, S; Mitsuta, K; Fukushima, C; Obase, Y; Shimoda, T; Kohno, S			Tacrolimus reduces urinary excretion of leukotriene E4 and inhibits aspirin-induced asthma to threshold dose of aspirin	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						aspirin-induced asthma; tacrolimus; leukotriene eosinophilic cationic protein; 11-dehydrothroinhoxane B-2	BLOOD MONONUCLEAR-CELLS; MULTIDRUG-RESISTANCE; CYCLOSPORINE-A; FK506; SENSITIVITY; INTOLERANT; EXPRESSION; RELEASE; DRUGS; C-4	Background: The exact mechanism of aspirin-induced asthma is not clear. It has been postulated that precipitation of asthma attacks by aspirin is linked to inhibition of COX activity and massive release of cysteinyl leukotriene into the airway. Tacrolimus, a macrolide-derived immunosuppressant, is used for immunosuppression in organ transplantation and also for allergic diseases such as atopic dermatitis. Objective: We evaluated the effects of tacrolimus in aspirin-induced asthma by using a double-blind, crossover study design. Methods: Twelve patients with aspirin-induced asthma (male:female, 3:9; mean age +/- SD, 36.7 +/- 7.2 years) received either tacrolimus (0.1 mg/kg) or placebo 2 hours before the threshold dose of oral aspirin. Results: In the placebo arm, oral aspirin significantly decreased FEV1 concomitant with significant increases in sputum eosinophilic cationic protein and urinary leukotriene E-4 levels. Tacrolimus significantly inhibited bronchoconstriction and abrogated aspirin-induced increase in both sputum eosinophilic cationic protein and urinary leukotriene E-4 levels. Conclusion: The current study suggested that tacrolimus inhibited bronchoconstriction to a threshold dose of aspirin by inhibition of cysteinyl leukotriene excretion.	Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan	Nagasaki University	Matsuse, H (corresponding author), Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	hmatsuse@net.nagasaki-u.ac.jp						Altenberg Guillermo A., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P53, DOI 10.2174/1568011043482160; Barnes PJ, 2000, CHEM IMMUNOL, V78, P72; BOHME M, 1994, ADV ENZYME REGUL, V34, P371, DOI 10.1016/0065-2571(94)90023-X; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cheer S M, 2001, Am J Clin Dermatol, V2, P389, DOI 10.2165/00128071-200102060-00005; DEPAULIS A, 1991, J IMMUNOL, V147, P4278; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Evoli A, 2002, MUSCLE NERVE, V25, P111, DOI 10.1002/mus.10018; Fung JJ, 2004, TRANSPLANTATION, V77, pS41, DOI 10.1097/01.TP.0000126926.61434.A5; Grude P, 2002, TRANSPLANTATION, V73, P1824, DOI 10.1097/00007890-200206150-00021; Henry ML, 1999, CLIN TRANSPLANT, V13, P209, DOI 10.1034/j.1399-0012.1999.130301.x; Jawien J, 2002, EUR J CLIN INVEST, V32, P134, DOI 10.1046/j.0014-2972.2001.00954.x; Jedlitschky G, 2002, VITAM HORM, V64, P153, DOI 10.1016/S0083-6729(02)64005-1; Kahan B D, 2001, Curr Opin Crit Care, V7, P242, DOI 10.1097/00075198-200108000-00006; Kavallaris M, 1997, ANTI-CANCER DRUG, V8, P17, DOI 10.1097/00001813-199701000-00002; Keppler D, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P83; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Matsuo N, 2001, ANN ALLERG ASTHMA IM, V86, P671, DOI 10.1016/S1081-1206(10)62297-1; MORI A, 1994, INT ARCH ALLERGY IMM, V104, P32, DOI 10.1159/000236745; Nakano R, 1998, BIOCHEM BIOPH RES CO, V251, P307, DOI 10.1006/bbrc.1998.9472; *NIH NAT HEART LUN, 1995, GLOBL STRATEGY ASTHM; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Obase Y, 2002, CHEST, V121, P143, DOI 10.1378/chest.121.1.143; Obase Y, 2001, ANN ALLERG ASTHMA IM, V87, P74, DOI 10.1016/S1081-1206(10)62328-9; Picado C, 2002, ALLERGY, V57, P58, DOI 10.1034/j.1398-9995.57.s72.14.x; Przepiorka D, 1999, Biol Blood Marrow Transplant, V5, P94, DOI 10.1053/bbmt.1999.v5.pm10371361; Sasakawa Y, 2000, EUR J PHARMACOL, V403, P281, DOI 10.1016/S0014-2999(00)00592-6; Scott LJ, 2003, DRUGS, V63, P1247, DOI 10.2165/00003495-200363120-00006; Sperr WR, 1997, INT ARCH ALLERGY IMM, V114, P68, DOI 10.1159/000237645; SZCZEKLIK A, 1990, EUR RESPIR J, V3, P588; Volm M, 1998, ANTICANCER RES, V18, P2905; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Wollenberg A, 2001, J ALLERGY CLIN IMMUN, V107, P519, DOI 10.1067/mai.2001.112942	34	15	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2004	114	6					1278	1281		10.1016/j.jaci.2004.09.003	http://dx.doi.org/10.1016/j.jaci.2004.09.003			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	877NN	15577823				2022-12-18	WOS:000225577400004
J	Annett, RD; Brody, JL; Scherer, DG; Perkett, EA				Annett, RD; Brody, JL; Scherer, DG; Perkett, EA			Perception of risk associated with asthma research procedures among adolescents, parents, and pediatricians	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bioethics; risk-benefit evaluation	VENIPUNCTURE PAIN; MINIMAL RISK; CHILDREN	Background: Little empirical data exist about how adolescents with asthma, their parents, and pediatricians view the risks and benefits associated with asthma clinical research. Objective: Two studies examined similarities and differences in the perception of risks and benefits associated with asthma research. Methods: In study I questionnaires were completed by adolescents with asthma and parents at the end of an audio and written presentation of a hypothetical research vignette. In study II adolescents with asthma, their parents, and pediatricians rated the risks and benefits associated with discreet asthma research procedures. Results: In study I adolescents and parents made distinctions in riskiness among the asthma research procedures (P < .001 and P < .001, respectively). With the exception of venipuncture, rank orders of risk ratings among procedures were similar for both groups. In study II significant differences in risk and benefit ratings for individual procedures were found among respondent groups, including experimental medication, placebo, and venipuncture. Overall, asthma research procedures were viewed as more beneficial than risky (P < .001). Conclusion: Participants generally viewed asthma research procedures as more beneficial than risky. Overall, the relative risk rankings among all respondents were similar. However, there were between-group difference in ratings of risk associated with venipuncture and experimental medication. Parents and adolescents rated the benefit of placebo significantly higher than did pediatricians.	Univ New Mexico, Dept Pediat, Ctr Hlth Sci, Albuquerque, NM 87131 USA; Oregon Res Inst, Eugene, OR 97403 USA; Univ New Mexico, Coll Educ, Albuquerque, NM 87131 USA	University of New Mexico; Oregon Research Institute; University of New Mexico	Annett, RD (corresponding author), Univ New Mexico, Dept Pediat, Ctr Hlth Sci, MSC-10-5590,1, Albuquerque, NM 87131 USA.	rdannett@unm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064677] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 64677, R01 HL064677] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abramovitch R, 1995, ETHICS BEHAV, V5, P25, DOI 10.1207/s15327019eb0501_3; Brody JL, 2003, ETHICS BEHAV, V13, P79, DOI 10.1207/S15327019EB1301_10; Churchill Larry R, 2003, IRB, V25, P1, DOI 10.2307/3564297; COHN LD, 1995, PEDIATRICS, V95, P713; Fogas BS, 2001, J DEV BEHAV PEDIATR, V22, P211, DOI 10.1097/00004703-200108000-00001; FRADET C, 1990, PAIN, V40, P53, DOI 10.1016/0304-3959(90)91050-S; FREEDMAN B, 1993, HASTINGS CENT REP, V23, P13, DOI 10.2307/3562813; Goodenough B, 1999, PAIN, V80, P179, DOI 10.1016/S0304-3959(98)00201-2; KODISH E, 2003, J PEDIATR, V142, P90; Kolk AM, 2000, CHILD CARE HLTH DEV, V26, P251, DOI 10.1046/j.1365-2214.2000.00145.x; LANDER J, 1992, J PAIN SYMPTOM MANAG, V7, P343, DOI 10.1016/0885-3924(92)90087-X; MICHAELS TF, 1979, J SOC PSYCHOL, V109, P223, DOI 10.1080/00224545.1979.9924197; *OFF HUM RES PROT, 2001, IRB GUID, pCH6; SULLIVAN DS, 1973, AM PSYCHOL, V28, P587, DOI 10.1037/h0034831; Weijer C, 2000, J LAW MED ETHICS, V28, P344, DOI 10.1111/j.1748-720X.2000.tb00686.x	15	15	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2004	114	5					1138	1145		10.1016/j.jaci.2004.07.058	http://dx.doi.org/10.1016/j.jaci.2004.07.058			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	870HI	15536422	Bronze			2022-12-18	WOS:000225047800022
J	Weidinger, S; Mempel, M; Ollert, M; Elser, I; Rakoski, J; Kohn, FM; Ring, J				Weidinger, S; Mempel, M; Ollert, M; Elser, I; Rakoski, J; Kohn, FM; Ring, J			Anaphylaxis to mizolastine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CETIRIZINE; URTICARIA; EFFICACY		Tech Univ Munich, GSF Natl Res Ctr Environm & Hlth, Dept Dermatol & Allergy, D-8000 Munich, Germany; Tech Univ Munich, GSF Natl Res Ctr Environm & Hlth, Div Environm Dermatol & Allergy, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich	Weidinger, S (corresponding author), Tech Univ Munich, GSF Natl Res Ctr Environm & Hlth, Dept Dermatol & Allergy, D-8000 Munich, Germany.		Ring, Johannes/GLN-4341-2022; Weidinger, Stephan/C-8461-2011	Ring, Johannes/0000-0001-8236-3152; Weidinger, Stephan/0000-0003-3944-252X; Ollert, Markus W./0000-0002-8055-0103				Bachert C, 2001, ALLERGY, V56, P653, DOI 10.1034/j.1398-9995.2001.00756.x; Brostoff J, 1996, ALLERGY, V51, P320; Calista D, 2001, BRIT J DERMATOL, V144, P196, DOI 10.1046/j.1365-2133.2001.03980.x; ELLIS KE, 2003, CMAJ, V169, P307; Karamfilov T, 1999, BRIT J DERMATOL, V140, P979, DOI 10.1046/j.1365-2133.1999.02849.x; Leynadier F, 1996, ANN ALLERG ASTHMA IM, V76, P163, DOI 10.1016/S1081-1206(10)63417-5; Schroter S, 2002, CLIN EXP DERMATOL, V27, P185, DOI 10.1046/j.1365-2230.2002.00988.x; Simons F. Estelle R., 2003, Journal of Allergy and Clinical Immunology, V112, pS42, DOI 10.1016/S0091-6749(03)01876-1; Simons FER, 1999, CLIN EXP ALLERGY, V29, P125, DOI 10.1046/j.1365-2222.1999.0290s3125.x; Tella R, 2002, J INVEST ALLERG CLIN, V12, P136	10	15	15	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2004	114	4					979	981		10.1016/j.jaci.2004.06.056	http://dx.doi.org/10.1016/j.jaci.2004.06.056			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	861SO	15480348				2022-12-18	WOS:000224439100042
J	Frank, MM				Frank, MM			Hereditary angioedema: A half century of progress	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						hereditary angioedema	ANGIONEUROTIC-EDEMA; REPLACEMENT THERAPY; INHIBITOR; PERMEABILITY; DEFICIENCY; DISEASES		Duke Univ, Ctr Med, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Ctr Med, Dept Immunol & Med, Durham, NC 27710 USA	Duke University; Duke University	Frank, MM (corresponding author), Duke Univ, Ctr Med, Dept Pediat, Box 3556, Durham, NC 27710 USA.	frank007@mc.duke.edu						AGOSTINI A, 2004, IN PRESS J ALLERGY C; ALSENZ J, 1989, J CLIN INVEST, V83, P1794, DOI 10.1172/JCI114084; Binkley KE, 2000, J ALLERGY CLIN IMMUN, V106, P546; Bork K, 2000, LANCET, V356, P213, DOI 10.1016/S0140-6736(00)02483-1; Bowen T, 2004, J ALLERGY CLIN IMMUN, V114, P629, DOI 10.1016/j.jaci.2004.06.043; Caliezi C, 2000, PHARMACOL REV, V52, P91; Cicardi M, 2003, MEDICINE, V82, P274, DOI 10.1097/00005792-200307000-00006; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; FRANK MM, 1972, NEW ENGL J MED, V286, P808, DOI 10.1056/NEJM197204132861503; FRANK MM, 1979, ARTHRITIS RHEUM, V22, P1295, DOI 10.1002/art.1780221118; GADEK JE, 1980, NEW ENGL J MED, V302, P542, DOI 10.1056/NEJM198003063021002; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; Pappalardo E, 2003, IMMUNOL LETT, V86, P271, DOI 10.1016/S0165-2478(03)00029-4; SPAULDING WB, 1960, ANN INTERN MED, V53, P739, DOI 10.7326/0003-4819-53-4-739; Wen L, 2004, J ALLERGY CLIN IMMUN, V113, P585, DOI 10.1016/j.jaci.2004.02.003	18	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2004	114	3					626	628		10.1016/j.jaci.2004.06.035	http://dx.doi.org/10.1016/j.jaci.2004.06.035			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	853AX	15356568				2022-12-18	WOS:000223799600024
J	Ferrari, E; Tsay, A; Eggleston, PA; Spisni, A; Chapman, MD				Ferrari, E; Tsay, A; Eggleston, PA; Spisni, A; Chapman, MD			Environmental detection of mouse allergen by means of immunoassay for recombinant Mus m 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mouse allergen; occupational asthma; in vitro diagnostics; allergen standardization; immunoassay; recombinant allergen; inner-city asthma	MAJOR URINARY PROTEIN; ASSESS AIRBORNE RAT; PHEROMONE BINDING; X-RAY; MICE; EXPRESSION; EXPOSURE; ELISA	Background: Mouse urinary allergens are an important cause of occupational asthma in animal facilities. Domestic exposure to mouse allergens is a risk factor for asthma among inner-city residents. Objective: We sought to develop a sensitive and specific assay for assessing environmental mouse allergen exposure. Methods: An ELISA for recombinant (r)Mus m 1 was developed by using rabbit polyclonal antibodies to rMus m 1 that were affinity purified against the natural allergen. Assay specificity was established by means of immunoblotting and ELISA. Mus m 1 levels in mouse, other mammalian allergenic products, and house dust samples from inner-city homes were compared. Results: Polyclonal antibodies to Mus m 1 showed a single 20-kd band on immunoblots against rMus m 1 and male mouse urine. Parallel dose-response curves were obtained by using mouse urine extract and natural Mus m 1 or rMus m 1. Mus m 1 was detected in mouse allergenic products (0.10-10.0 mug/mL) and in gerbil allergenic products (0.1 mug/mL) but was less than the limit of detection in epithelial extracts from 10 other animal species. Environmental measurements showed an excellent correlation between Mus m 1 levels in house dust extracts from inner-city asthma studies by using 2 different Mus m 1 standards (n = 22; r = 0.99; P < .001). Conclusions: A highly sensitive ELISA has been developed with rMus m 1. This assay is suitable for monitoring domestic and environmental exposure to mouse urinary allergens.	INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA; Univ Parma, Dept Expt Med, Sect Chem & Struct Biochem, I-43100 Parma, Italy; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	INDOOR Biotechnologies; University of Parma; Johns Hopkins University	Chapman, MD (corresponding author), INDOOR Biotechnol Inc, 1216 Harris St, Charlottesville, VA 22903 USA.	aspin@unipr.it	Spisni, Alberto/AAY-7778-2020	Chapman, Martin/0000-0002-0845-3632				BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Bush RK, 1998, J ALLERGY CLIN IMMUN, V102, P99, DOI 10.1016/S0091-6749(98)70060-0; Chapman MC, 2001, ALLERGY, V56, P604, DOI 10.1034/j.1398-9995.2001.00049.x; CLISSOLD PM, 1984, BIOCHEM GENET, V22, P379, DOI 10.1007/BF00484236; COCKCROFT A, 1981, LANCET, V1, P827; Ferrari E, 1997, FEBS LETT, V401, P73, DOI 10.1016/S0014-5793(96)01436-6; Gordon S, 1997, OCCUP ENVIRON MED, V54, P135, DOI 10.1136/oem.54.2.135; Gordon S, 2001, ILAR J, V42, P37; Gordon S, 2001, J ALLERGY CLIN IMMUN, V108, P288, DOI 10.1067/mai.2001.117258; Harrison D J, 2001, ILAR J, V42, P17; HASTIE ND, 1979, CELL, V17, P449, DOI 10.1016/0092-8674(79)90171-5; Hollander A, 1999, ALLERGY, V54, P142, DOI 10.1034/j.1398-9995.1999.00630.x; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; JONES RB, 1995, AM IND HYG ASSOC J, V56, P398, DOI 10.1202/0002-8894(1995)056<0398:TEORHO>2.0.CO;2; Korpi A, 2004, J ALLERGY CLIN IMMUN, V113, P677, DOI 10.1016/j.jaci.2003.11.039; Kuser PR, 2001, ACTA CRYSTALLOGR D, V57, P1863, DOI 10.1107/S090744490101825X; Lucke C, 1999, EUR J BIOCHEM, V266, P1210, DOI 10.1046/j.1432-1327.1999.00984.x; MAGERT HJ, 1995, P NATL ACAD SCI USA, V92, P2091, DOI 10.1073/pnas.92.6.2091; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; OHMAN JL, 1994, J ALLERGY CLIN IMMUN, V94, P810, DOI 10.1016/0091-6749(94)90147-3; Pacheco KA, 2003, AM J RESP CRIT CARE, V167, P983, DOI 10.1164/rccm.2112062; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1070, DOI 10.1067/mai.2000.110796; Phipatanakul W, 2000, J ALLERGY CLIN IMMUN, V106, P1075, DOI 10.1067/mai.2000.110795; Phipatanakul Wanda, 2002, Curr Allergy Asthma Rep, V2, P412, DOI 10.1007/s11882-002-0075-1; Platts-Mills J. A., 2004, Journal of Allergy and Clinical Immunology, V113, pS230, DOI 10.1016/j.jaci.2004.01.285; PRICE JA, 1990, CLIN EXP ALLERGY, V20, P71, DOI 10.1111/j.1365-2222.1990.tb02778.x; Renstrom A, 1997, CLIN EXP ALLERGY, V27, P1314; Renstrom A, 1999, ALLERGY, V54, P150, DOI 10.1034/j.1398-9995.1999.00631.x; STEPPAN SJ, 2004, IN PRESS SYST BIOL; Timm DE, 2001, PROTEIN SCI, V10, P997, DOI 10.1110/ps.52201; Vailes L. D., 2004, Journal of Allergy and Clinical Immunology, V113, pS137, DOI 10.1016/j.jaci.2003.12.491; Wood R A, 2001, ILAR J, V42, P12	32	15	16	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2004	114	2					341	346		10.1016/j.jaci.2004.04.028	http://dx.doi.org/10.1016/j.jaci.2004.04.028			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	847OU	15316513				2022-12-18	WOS:000223405600020
J	Polosa, R; Sapsford, RJ; Dokic, D; Cacciola, RR; Prosperini, G; Devalia, JL; Holgate, ST; Howarth, PH; Davies, DE				Polosa, R; Sapsford, RJ; Dokic, D; Cacciola, RR; Prosperini, G; Devalia, JL; Holgate, ST; Howarth, PH; Davies, DE			Induction of the epidermal growth factor receptor and its ligands in nasal epithelium by ozone	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						growth factors; air pollution; neutrophils; environmental health; tissue survival	NECROSIS-FACTOR-ALPHA; UPPER AIRWAYS INFLAMMATION; C-ERBB RECEPTORS; AMBIENT OZONE; MUCIN PRODUCTION; LUNG-TISSUE; CELLS; EXPRESSION; ASTHMA; CHILDREN	Background: Ozone is a photochemical oxidant pollutant that is an important public health hazard. Although the inflammatory response that occurs in response to ozone inhalation is well characterized, the mechanisms underlying epithelial cell activation are not well understood. Objective: Because the epidermal growth factor receptor (EGFR) is a central regulator of epithelial function, we tested the hypothesis that nasal epithelial cells respond to ozone-induced oxidant stress by modulating expression of the EGFR and its ligands, EGF and transforming growth factor-alpha (TGF-alpha). Methods: Normal volunteers were exposed to air or 400 parts per billion ozone for 2 hours, and then nasal biopsy specimens were harvested 6 hours later for immunohistochemical analysis of EGFR, EGF, and TGF-alpha. Nasal epithelial cell cultures were exposed in vitro to ozone or TNF-alpha; mediator release was measured by ELISA and cellular EGFR expression by immunoblotting and fluorescence-activated cell sorting analysis. Results; Epithelial expression of the EGFR, EGF, and TGF-alpha were all significantly (P < .05) increased in the nsal biopsy specimens after ozone exposure, and there was a significant positive correlation between EGFR expression and the increase in neutrophil numbers in the nasal expthelium (P = .001, rho = 0.87). In vitro exposure of primary nasal epithelial cell cultures to ozone had no effect on EGFR expression, even though IL-8 release was enhanced. In contrast, exposure to TNF-&alpha; caused EGFR levels to increase significantly. Conclusion; These data suggest that the ozone-induced increase in EGFR expression observed in vivo is indirect, perhaps mediated by neutrophil-derived TNF-&alpha;.	Southampton Gen Hosp, Sch Med, Resp Cell & Mol Biol Div, Southampton SO16 6YD, Hants, England; Univ Catania, Dipartimento Med Interna & Specialist, Catania, Italy; St Bartholomews Hosp, London, England	University of Southampton; University of Catania; University of London; Queen Mary University London	Davies, DE (corresponding author), Southampton Gen Hosp, Sch Med 810, Resp Cell & Mol Biol Div, Southampton SO16 6YD, Hants, England.		Davies, Donna E/H-2993-2012	Howarth, Peter/0000-0003-0619-7927; Davies, Donna/0000-0002-5117-2991				ARIS RM, 1993, AM REV RESPIR DIS, V148, P1363, DOI 10.1164/ajrccm/148.5.1363; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Balmes JR, 1996, AM J RESP CRIT CARE, V153, P904, DOI 10.1164/ajrccm.153.3.8630571; BARROW RE, 1993, LUNG, V171, P335, DOI 10.1007/BF00165699; BRADDING P, 1993, J IMMUNOL, V151, P3853; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Briviba K, 1997, BIOL CHEM, V378, P1259; Burgel PR, 2000, J ALLERGY CLIN IMMUN, V106, P705, DOI 10.1067/mai.2000.109823; Calderon MA, 1997, J ALLERGY CLIN IMMUN, V99, P65, DOI 10.1016/S0091-6749(97)70302-6; CALDERONGARCIDUENAS L, 1992, AM J PATHOL, V140, P225; Campbell AM, 1997, ALLERGY, V52, P483, DOI 10.1111/j.1398-9995.1997.tb02591.x; CASTILLEJOS M, 1992, AM REV RESPIR DIS, V145, P276, DOI 10.1164/ajrccm/145.2_Pt_1.276; Chabot F, 1998, EUR RESPIR J, V11, P745; Davies DE, 1999, ALLERGY, V54, P771; DELARCO JE, 1980, J BIOL CHEM, V255, P3685; DEVALIA JL, 1990, RESP MED, V84, P303, DOI 10.1016/S0954-6111(08)80058-3; DEVLIN RB, 1991, AM J RESP CELL MOL, V4, P72, DOI 10.1165/ajrcmb/4.1.72; FINOTTO S, 1994, J IMMUNOL, V153, P2278; FRISCHER TM, 1993, AM REV RESPIR DIS, V148, P961, DOI 10.1164/ajrccm/148.4_Pt_1.961; GERRITY TR, 1988, J APPL PHYSIOL, V65, P393, DOI 10.1152/jappl.1988.65.1.393; GRAHAM DE, 1990, AM REV RESPIR DIS, V142, P152, DOI 10.1164/ajrccm/142.1.152; GREGORY H, 1975, NATURE, V257, P325, DOI 10.1038/257325a0; HARKEMA JR, 1987, AM J PATHOL, V128, P29; HIGGINS ITT, 1990, AM REV RESPIR DIS, V141, P1136, DOI 10.1164/ajrccm/141.5_Pt_1.1136; Jaspers I, 1998, J CELL PHYSIOL, V177, P313, DOI 10.1002/(SICI)1097-4652(199811)177:2<313::AID-JCP13>3.0.CO;2-A; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; KULLE TJ, 1985, AM REV RESPIR DIS, V132, P36; LAWRENCE WT, 1994, CLIN DERMATOL, V12, P157, DOI 10.1016/0738-081X(94)90266-6; LINN W S, 1986, Toxicology and Industrial Health, V2, P99; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCDONNELL WF, 1983, J APPL PHYSIOL, V54, P1345, DOI 10.1152/jappl.1983.54.5.1345; Nadel JA, 1998, EUR RESPIR J, V12, P1250, DOI 10.1183/09031936.98.12061250; Neelam B, 1998, BIOCHEMISTRY-US, V37, P4884, DOI 10.1021/bi972548x; OHKAWARA Y, 1992, AM J RESP CELL MOL, V7, P385, DOI 10.1165/ajrcmb/7.4.385; PALOMBELLA VJ, 1987, J BIOL CHEM, V262, P1950; PIERSON ED, 1992, PACIFIC ISLAND FLYIN, V90, P1; Polito AJ, 1998, J ALLERGY CLIN IMMUN, V102, P714, DOI 10.1016/S0091-6749(98)70008-9; Polosa R, 2000, J ALLERGY CLIN IMMUN, V106, P1124; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; PRYOR WA, 1976, ENVIRON HEALTH PERSP, V16, P180; PRYOR WA, 1991, OXIDATIVE DAMAGE & REPAIR, P496; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rusznak C, 1996, EUR RESPIR J, V9, P2298, DOI 10.1183/09031936.96.09112298; SCHMIEGEL W, 1993, P NATL ACAD SCI USA, V90, P863, DOI 10.1073/pnas.90.3.863; SCHUSTER A, 1992, AM J PHYSIOL, V262, pL86, DOI 10.1152/ajplung.1992.262.1.L86; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Vulcano M, 1998, CLIN EXP IMMUNOL, V113, P39, DOI 10.1046/j.1365-2249.1998.00631.x; WARDLAW AJ, 1993, CLIN EXP ALLERGY, V23, P81, DOI 10.1111/j.1365-2222.1993.tb00303.x; XING Z, 1993, AM J PATHOL, V143, P1009; ZWICK H, 1991, AM REV RESPIR DIS, V144, P1075, DOI 10.1164/ajrccm/144.5.1075	51	15	16	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2004	113	1					120	126		10.1016/j.jaci.2003.09.040	http://dx.doi.org/10.1016/j.jaci.2003.09.040			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	760MP	14713916				2022-12-18	WOS:000187837900016
J	Casale, TB; Weiler, JM; Gelfand, EW; Szefler, SJ				Casale, TB; Weiler, JM; Gelfand, EW; Szefler, SJ			In response to a position paper of the antihistamine impairment roundtable - Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Creighton Univ, Omaha, NE 68131 USA; Univ Iowa, Iowa City, IA USA; Natl Jewish Med & Res Ctr, Denver, CO USA	Creighton University; University of Iowa; National Jewish Health	Casale, TB (corresponding author), Creighton Univ, 601 N 30th St,suite 5850, Omaha, NE 68131 USA.		Casale, Thomas B/K-4334-2013	Casale, Thomas B/0000-0002-3149-7377				Hewlett D, 2003, J ALLERGY CLIN IMMUN, V112, P1246, DOI 10.1016/j.jaci.2003.10.007	1	15	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2003	112	6					1246	1247		10.1016/j.jaci.2003.09.048	http://dx.doi.org/10.1016/j.jaci.2003.09.048			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	752HC	14530794				2022-12-18	WOS:000187154200037
J	Shirai, T; Hayakawa, H; Akiyama, J; Iwata, M; Chida, K; Nakamura, H; Taniguchi, M; Reshad, K				Shirai, T; Hayakawa, H; Akiyama, J; Iwata, M; Chida, K; Nakamura, H; Taniguchi, M; Reshad, K			Food allergy to green tea	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							EPIGALLOCATECHIN GALLATE; INDUCED ASTHMA		Fujinomiya City Gen Hosp, Dept Internal Med, Fujinomiya, Japan; Hamamatsu Univ Sch Med, Dept Internal Med 2, Hamamatsu, Shizuoka, Japan; Natl Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa, Japan; Reshad Clin Resp Dis & Surg, Shimada, Japan	Hamamatsu University School of Medicine	Shirai, T (corresponding author), Fujinomiya City Gen Hosp, Dept Internal Med, Fujinomiya, Japan.							BRUGNAMI G, 1995, J ALLERGY CLIN IMMUN, V96, P457, DOI 10.1016/S0091-6749(95)70287-3; Crespo JF, 2001, J ALLERGY CLIN IMMUN, V108, P295, DOI 10.1067/mai.2001.116860; HARA Y, 2000, GREEN TEA HLTH BENEF; Leser C, 2001, J INVEST ALLERG CLIN, V11, P89; Shirai T, 1997, ANN ALLERG ASTHMA IM, V79, P65, DOI 10.1016/S1081-1206(10)63087-6; SHIRAI T, 1994, CHEST, V106, P1801, DOI 10.1378/chest.106.6.1801; SHIRAI T, 2003, IN PRESS CLIN EXP AL	7	15	17	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2003	112	4					805	806		10.1016/S0091-6749(03)01885-2	http://dx.doi.org/10.1016/S0091-6749(03)01885-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730LA	14564370				2022-12-18	WOS:000185831200027
J	Borger, P; Black, JL; Roth, M				Borger, P; Black, JL; Roth, M			Asthma and the CCAAT-enhancer binding proteins: A holistic view on airway inflammation and remodeling	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; inflammation; remodeling; CCAAT-enhancer binding proteins	NF-KAPPA-B; COLONY-STIMULATING FACTOR; HUMAN T-LYMPHOCYTES; MUSCLE CELL-PROLIFERATION; ACUTE-PHASE CONDITIONS; GENE-EXPRESSION; C/EBP-BETA; SMOOTH-MUSCLE; BRONCHOALVEOLAR LAVAGE; MESSENGER-RNA	Asthma is an airway disease with increasing prevalence characterized by intermittent reversible airway obstruction, airway inflammation, and airway wall remodeling. The disease is generally triggered by inhalation of allergens, but nonallergic asthma triggers are quite common. The pathogenesis of asthma is well documented, and a great deal of research has been carried out to elucidate the underlying mechanisms. A multitude of articles have focused on cells alleged to be involved in the pathogenesis, including circulating cells from the immunologic compartment (ie, eosinophils; and T lymphocytes) and resident cells, such as fibroblasts, airway smooth muscle cells, and, more recently, the airway epithelium. Despite the enormous amount of research, it is still unclear what exactly causes asthma. A general feature of most studies is an enhanced activation status of asthmatic cells, suggesting a general defect with respect to regulation of cellular responses. Here we discuss the ubiquitous transcription factor family of CCAAT-enhancer binding proteins (C/EBPs) and its involvement in inflammation and proliferation. We propose that an imbalance of C/EBP isoform expression might lead to an enhanced activity of asthmatic cells and provide an overall hypothesis that both airway inflammation and remodeling can be conceived as the result of an imbalance of C/EBP isoform expression.	Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Royal Prince Alfred Hosp, Woolcock Ins Med Res, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Borger, P (corresponding author), Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia.		Roth, Michael/H-8657-2019; Black, Judith L/C-6559-2008	Roth, Michael/0000-0002-8139-2821; 				ALAM T, 1993, J BIOL CHEM, V268, P15681; Ammit AJ, 2001, J APPL PHYSIOL, V91, P1431, DOI 10.1152/jappl.2001.91.3.1431; An MR, 1996, MOL CELL BIOL, V16, P2295; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Bentley AM, 1996, AM J RESP CRIT CARE, V153, P551, DOI 10.1164/ajrccm.153.2.8564096; Bettiol J, 2000, ALLERGY, V55, P1134, DOI 10.1034/j.1398-9995.2000.00711.x; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Borger P, 1998, AM J RESP CELL MOL, V19, P400, DOI 10.1165/ajrcmb.19.3.2765; Borger P, 1998, J ALLERGY CLIN IMMUN, V101, P231, DOI 10.1016/S0091-6749(98)70388-4; Borger P, 1999, CLIN EXP ALLERGY, V29, P772; Borger P, 2000, CLIN EXP ALLERGY, V30, P920; Borger P, 1996, BLOOD, V87, P691, DOI 10.1182/blood.V87.2.691.bloodjournal872691; BRASIER AR, 1990, EMBO J, V9, P3933, DOI 10.1002/j.1460-2075.1990.tb07614.x; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; CALKHOVEN CF, 1994, NUCLEIC ACIDS RES, V22, P5540, DOI 10.1093/nar/22.25.5540; Calkhoven CF, 2000, GENE DEV, V14, P1920; CHEN HM, 1993, J BIOL CHEM, V268, P25311; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DIEHL AM, 1994, GASTROENTEROLOGY, V106, P1625, DOI 10.1016/0016-5085(94)90420-0; DUNN SM, 1994, BLOOD, V83, P2469, DOI 10.1182/blood.V83.9.2469.2469; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Escoubet-Lozach L, 2002, J ALLERGY CLIN IMMUN, V110, P553, DOI 10.1067/mai.2002.128076; FLINT KC, 1985, CLIN SCI, V68, P427, DOI 10.1042/cs0680427; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Hamid QA, 2000, J ALLERGY CLIN IMMUN, V105, P20, DOI 10.1016/S0091-6749(00)90172-6; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Lai CKW, 1996, CLIN EXP ALLERGY, V26, P138, DOI 10.1111/j.1365-2222.1996.tb00072.x; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; Lee NA, 2001, J ALLERGY CLIN IMMUN, V107, P945, DOI 10.1067/mai.2001.116002; Lee YM, 1996, MOL CELL BIOL, V16, P4257; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li-Weber M, 2001, EUR J IMMUNOL, V31, P3694, DOI 10.1002/1521-4141(200112)31:12<3694::AID-IMMU3694>3.0.CO;2-S; Li-Weber M, 2001, EUR J IMMUNOL, V31, P2623, DOI 10.1002/1521-4141(200109)31:9<2623::AID-IMMU2623>3.0.CO;2-4; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Linden A, 2001, INT ARCH ALLERGY IMM, V126, P179, DOI 10.1159/000049511; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Niehof M, 2001, J MOL BIOL, V309, P855, DOI 10.1006/jmbi.2001.4708; O'Rourke JP, 1999, BIOCHEM BIOPH RES CO, V262, P696, DOI 10.1006/bbrc.1999.1256; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Pan Z, 1999, J BIOL CHEM, V274, P23242, DOI 10.1074/jbc.274.33.23242; Panettieri RA, 1998, AM J RESP CRIT CARE, V158, pS133, DOI 10.1164/ajrccm.158.supplement_2.13tac900; Plager DA, 2001, GENOMICS, V71, P271, DOI 10.1006/geno.2000.6391; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Raught B, 1996, CANCER RES, V56, P4382; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; RAY BK, 1994, EUR J BIOCHEM, V222, P891, DOI 10.1111/j.1432-1033.1994.tb18937.x; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; ROBINSON D, 1993, AM REV RESPIR DIS, V148, P401, DOI 10.1164/ajrccm/148.2.401; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; ROTH M, 2002, IN PRESS LANCET; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Stewart AG, 1995, BRIT J PHARMACOL, V116, P3219, DOI 10.1111/j.1476-5381.1995.tb15127.x; Stewart AG, 1997, BRIT J PHARMACOL, V121, P361, DOI 10.1038/sj.bjp.0701128; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293; Vietor I, 1996, J BIOL CHEM, V271, P5595, DOI 10.1074/jbc.271.10.5595; Viksman MY, 1997, AM J RESP CRIT CARE, V155, P858, DOI 10.1164/ajrccm.155.3.9117017; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; WILSON JW, 1992, AM REV RESPIR DIS, V145, P958, DOI 10.1164/ajrccm/145.4_Pt_1.958; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	72	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2002	110	6					841	846		10.1067/mai.2002.130047	http://dx.doi.org/10.1067/mai.2002.130047			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	624TL	12464948	Bronze			2022-12-18	WOS:000179777400004
J	Weiler, JM; Quinn, SA; Woodworth, GG; Brown, DD; Layton, MA; Maves, KK				Weiler, JM; Quinn, SA; Woodworth, GG; Brown, DD; Layton, MA; Maves, KK			Does heparin prophylaxis prevent exacerbations of hereditary angioedema?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hereditary angioedema; heparin; C1 esterase inhibitor	4TH C4 COMPONENT; C1 INHIBITOR; DIFFERENT POLYANIONS; FACTOR-H; 2ND C2; COMPLEMENT ACTIVATION; BINDING-SITE; 1ST C1; POTENTIATION; PATHWAY	Background: Hereditary angioedema (HAE) is a rare disorder characterized by episodes of angioedema of the skin, mucous membranes, and gastrointestinal tract resulting from a defect in the gene that produces C1 esterase inhibitor. Although in vitro laboratory data and past reports suggested that heparin might be efficacious in preventing HAE attacks, no controlled study has been reported to examine heparin's efficacy in this regard. Objectives: We sought to determine the safety and efficacy of inhaled and subcutaneous heparin versus that of placebo in the prevention of HAE attacks. Methods: We performed a double-blind, double-dummy, saline placebo-controlled, randomized, 3-way crossover study with 11 visits. Results: The study was designed to enroll 24 patients. Twenty-two patients were randomized and received the study drug. Patients did not have a significant decrease in average flare intensity after they received injected or inhaled heparin compared with that seen after placebo, the primary endpoint. However, when patients received injected heparin, they had a statistically significant decrease in average flare intensity compared with that seen with inhaled heparin after a normalizing transformation was applied. When the means are back transformed, this translates into median flare intensities of 9.2, 8.0, and 5.1 in the patients treated with inhaled heparin, placebo, and injected heparin, respectively. There were no significant differences when individual symptoms were examined, when total numbers of flares over a 6-week observation period were examined, or when global evaluations by the patients and investigators were evaluated. Adverse event severity was fairly uniform across treatments, with the majority of events classified as moderate and the remainder split between mild and severe. Injected heparin treatment was associated with higher rates of relatedness than other treatments, which was partially explained by 17 adverse events specifically related to the injection process itself (tenderness, bruising, redness, pain, and itching at the injection site). The injection treatment was also associated with a larger overall number of reported adverse events (70 vs 48 in the placebo treatment). Tenderness and bruising at the injection site were entirely confined to the injected heparin treatment. Conclusions: Injected and inhaled heparin failed to attenuate average flare intensity, the primary endpoint, compared with placebo. Interestingly, after patients injected heparin, they had a significant decrease in average flare intensity compared with that seen after inhalation of heparin. There were no differences among groups in other efficacy parameters. Taken together, these data indicate that commercial heparin was ineffective in preventing exacerbations of HAE.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA; Towncrest Internal Med, Iowa City, IA USA	University of Iowa; University of Iowa	Weiler, JM (corresponding author), Iowa Clin Res Corp, POB 2959, Iowa City, IA 52244 USA.			Brown, Donald/0000-0002-2740-2654	NCRR NIH HHS [M01-RR-59] Funding Source: Medline; FDA HHS [FD-R-001001-01] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FDA HHS		BAKER PJ, 1975, J IMMUNOL, V114, P554; BERGAMASCHINI L, 1983, ALLERGY, V38, P81; BOACKLE RJ, 1983, MOL IMMUNOL, V20, P1157, DOI 10.1016/0161-5890(83)90139-6; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; CICARDI M, 1991, J ALLERGY CLIN IMMUN, V87, P768, DOI 10.1016/0091-6749(91)90120-D; COLMAN RW, 1976, ANN INTERN MED, V85, P399, DOI 10.7326/0003-4819-85-3-399; COON WW, 1979, J CLIN PHARMACOL, V19, P337, DOI 10.1002/j.1552-4604.1979.tb02490.x; DAVIS AE, 1988, ANNU REV IMMUNOL, V6, P595, DOI 10.1146/annurev.iy.06.040188.003115; Ecker EE, 1929, J INFECT DIS, V44, P250, DOI 10.1093/infdis/44.3.250; Edens E, 1993, COMPLEMENT PROFILES, V1, P96; EDENS RE, 1994, IMMUNOPHARMACOLOGY, V27, P145, DOI 10.1016/0162-3109(94)90049-3; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; Haas S, 1999, BLOOD COAGUL FIBRIN, V10, pS11; HORNER AA, 1982, J BIOL CHEM, V257, P8749; HORTIN GL, 1991, IMMUNOL INVEST, V20, P75, DOI 10.3109/08820139109054926; JAQUES LB, 1979, SCIENCE, V206, P528, DOI 10.1126/science.386509; Jensen NF, 1998, ANESTH ANALG, V87, P480, DOI 10.1097/00000539-199808000-00047; KAZATCHKINE MD, 1981, J CLIN INVEST, V67, P223, DOI 10.1172/JCI110017; LENNICK M, 1986, BIOCHEMISTRY-US, V25, P3890, DOI 10.1021/bi00361a023; Levine HT, 1992, IMMUNOL ALLERGY PRAC, V14, P162; LINHARDT RJ, 1991, CHEM IND-LONDON, P45; LOOS M, 1976, IMMUNOCHEMISTRY, V13, P257, DOI 10.1016/0019-2791(76)90224-X; LOOS M, 1976, IMMUNOCHEMISTRY, V13, P789, DOI 10.1016/0019-2791(76)90202-0; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; METZGER WJ, 1984, ANN ALLERGY, V52, P269; NAGAKI K, 1976, INT ARCH ALLER A IMM, V50, P172, DOI 10.1159/000231494; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; RAEPPLE E, 1976, IMMUNOCHEMISTRY, V13, P251, DOI 10.1016/0019-2791(76)90223-8; RENT R, 1975, J IMMUNOL, V114, P120; RENT R, 1976, CLIN EXP IMMUNOL, V23, P264; SHARATH MD, 1985, IMMUNOPHARMACOLOGY, V9, P73, DOI 10.1016/0162-3109(85)90002-5; SHEFFER AL, 1987, J ALLERGY CLIN IMMUN, V80, P855, DOI 10.1016/S0091-6749(87)80277-4; SIM RB, 1980, BIOCHIM BIOPHYS ACTA, V612, P433, DOI 10.1016/0005-2744(80)90126-6; WEILER J M, 1991, Complement and Inflammation, V8, P240; WEILER JM, 1978, J EXP MED, V147, P409, DOI 10.1084/jem.147.2.409; WEILER JM, 1992, J IMMUNOL, V148, P3210	39	15	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2002	109	6					995	1000		10.1067/mai.2002.124892	http://dx.doi.org/10.1067/mai.2002.124892			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	566RU	12063530	Bronze			2022-12-18	WOS:000176442700016
J	Kircher, MF; Haeusler, M; Nickel, R; Lamb, JR; Renz, H; Beyer, K				Kircher, MF; Haeusler, M; Nickel, R; Lamb, JR; Renz, H; Beyer, K			V beta 18.1(+) and V alpha 2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T-cell receptors; allergy; T lymphocytes; flow cytometry	RECEPTOR-BETA-CHAIN; PERIPHERAL-BLOOD LYMPHOCYTES; RHEUMATOID-ARTHRITIS; RAGWEED ALLERGEN; RESPONSES; DERMATOPHAGOIDES; SUPERANTIGEN; REPERTOIRE; MICE; ENCEPHALOMYELITIS	Background: The recognition of allergenic peptides by T cells through their T-cell receptor (TCR) represents a crucial step in the initiation of an allergen-specific immune response. In parallel to the superantigen-driven restricted expansion of Vbeta subsets in autoimmune and infectious diseases, reports in animals and human subjects have shown a similar capacity of classical antigens. Objective: The study was performed to analyze the Valpha/Vbeta expression in house dust mite (HDM) allergy. Methods: The TCR repertoire of 15 subjects with HDM allergy, 22 atopic subjects without HDM allergy, and 19 nonatopic individuals, members of 2 extended and 4 nuclear families, was determined. By using flow cytometry, the expression of 22 Vbeta and 3 Valpha elements was analyzed in vivo and after in vitro allergen stimulation. Results: In comparison with nonatopic and atopic individuals without HDM allergy, freshly isolated PBMCs of individuals with HDM allergy showed a significantly higher frequency of Vbeta18(+) and Valpha2.3(+) T cells. Although members of all 3 groups had a similar lymphocyte proliferation response after in vitro stimulation with Der p 1 or Der p 1 peptide(101-131), a significant expansion of Vbeta18(+) and Va2.3+ T cells in vitro occurred only in individuals with HDM allergy. Moreover, the degree of expansion correlated with the levels of allergen-specific IgE antibodies. No expansion of Vbeta18(+) and Valpha2.3(+) was observed after mitogen stimulation with PHA, indicating allergen specificity of the response. Conclusion: Our results strongly suggest restricted TCR Valpha/Vbeta gene use in HDM allergy and might be a step toward TCR-based immunotherapy.	Mt Sinai Sch Med, Div Pediat Allergy & Immunol, New York, NY 10029 USA; Humboldt Univ, Charite, Inst Clin Chem & Biochem, Berlin, Germany; Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, Berlin, Germany; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Mol Imaging Res, Boston, MA 02114 USA; Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Marburg, Inst Clin Chem & Mol Diagnost, Marburg, Germany	Icahn School of Medicine at Mount Sinai; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Edinburgh; Philipps University Marburg	Beyer, K (corresponding author), Mt Sinai Sch Med, Div Pediat Allergy & Immunol, Box 1198,1 Gustave L Levy Pl, New York, NY 10029 USA.							ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Bakakos P, 2001, J ALLERGY CLIN IMMUN, V107, P1089, DOI 10.1067/mai.2001.114651; Beyer K, 1999, J IMMUNOL, V162, P1186; CHAPMAN MD, 1980, J IMMUNOL, V125, P587; Cheng KC, 1998, J ALLERGY CLIN IMMUN, V101, P51, DOI 10.1016/S0091-6749(98)70193-9; Clark Stephen P., 1995, Immunogenetics, V42, P531; DAVEY MP, 1991, HUM IMMUNOL, V32, P194, DOI 10.1016/0198-8859(91)90056-F; DORION BJ, 1995, PEDIATR ALLERGY IMMU, V6, P95, DOI 10.1111/j.1399-3038.1995.tb00266.x; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; HALVORSEN R, 1986, INT ARCH ALLER A IMM, V80, P62, DOI 10.1159/000234027; Herz U, 1999, EUR J IMMUNOL, V29, P3028, DOI 10.1002/(SICI)1521-4141(199909)29:09<3028::AID-IMMU3028>3.0.CO;2-J; HIGGINS JA, 1994, J ALLERGY CLIN IMMUN, V93, P891, DOI 10.1016/0091-6749(94)90383-2; HOWELL MD, 1991, P NATL ACAD SCI USA, V88, P10921, DOI 10.1073/pnas.88.23.10921; HUANG SK, 1995, J IMMUNOL, V154, P6157; JARMAN ER, 1994, J ALLERGY CLIN IMMUN, V94, P844, DOI 10.1016/0091-6749(94)90152-X; Kim BS, 1999, J IMMUNOL, V162, P7049; Liebers V, 1997, INT ARCH ALLERGY IMM, V112, P133, DOI 10.1159/000237444; MALHOTRA U, 1992, J IMMUNOL, V149, P1802; MATIS LA, 1990, ANNU REV IMMUNOL, V8, P65; Matsumoto Y, 2000, J IMMUNOL, V164, P2248, DOI 10.4049/jimmunol.164.4.2248; MOFFATT F, 1994, LANCET, V343, P1597, DOI 10.1016/S0140-6736(94)93057-0; Moffatt MF, 1997, IMMUNOGENETICS, V46, P226, DOI 10.1007/s002510050266; MOLLER DR, 1988, J CLIN INVEST, V82, P1183, DOI 10.1172/JCI113715; Noguchi E, 1998, GENOMICS, V47, P121, DOI 10.1006/geno.1997.5054; OBRIEN RM, 1992, J ALLERGY CLIN IMMUN, V89, P1021, DOI 10.1016/0091-6749(92)90225-Q; Offner H, 2000, J CLIN INVEST, V105, P1465, DOI 10.1172/JCI9213; OHEHIR RE, 1989, IMMUNOLOGY, V66, P499; OHEHIR RE, 1993, J ALLERGY CLIN IMMUN, V92, P105, DOI 10.1016/0091-6749(93)90044-G; OHMEN JD, 1994, IMMUNITY, V1, P35, DOI 10.1016/1074-7613(94)90007-8; PALIARD X, 1991, SCIENCE, V253, P325, DOI 10.1126/science.1857971; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; RENZ H, 1993, J IMMUNOL, V151, P7206; RENZ H, 1993, J IMMUNOL, V151, P1907; SOTTINI A, 1993, J AUTOIMMUN, V6, P621, DOI 10.1006/jaut.1993.1051; UPHAM JW, 1995, CLIN EXP ALLERGY, V25, P634, DOI 10.1111/j.1365-2222.1995.tb01111.x; Vollmer J, 1997, EUR J IMMUNOL, V27, P1865, DOI 10.1002/eji.1830270808; Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239; WEDDERBURN LR, 1993, P NATL ACAD SCI USA, V90, P8214, DOI 10.1073/pnas.90.17.8214; Werfel T, 1997, INT ARCH ALLERGY IMM, V113, P384, DOI 10.1159/000237610; YSSEL H, 1992, J IMMUNOL, V148, P738; Yurovsky VV, 1998, AM J RESP CELL MOL, V18, P370, DOI 10.1165/ajrcmb.18.3.2935; Zhi-Jun Y, 1997, J IMMUNOL METHODS, V210, P25, DOI 10.1016/S0022-1759(97)00171-3	43	15	18	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2002	109	3					517	523		10.1067/mai.2002.121945	http://dx.doi.org/10.1067/mai.2002.121945			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	534KW	11898001	Bronze			2022-12-18	WOS:000174586400021
J	Moore, WC; Hasday, JD; Meltzer, SS; Wisnewski, PL; White, B; Bleecker, ER				Moore, WC; Hasday, JD; Meltzer, SS; Wisnewski, PL; White, B; Bleecker, ER			Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; disease severity; inflammation; segmental allergen challenge	MAST-CELLS; BRONCHOALVEOLAR LAVAGE; MUCOSAL INFLAMMATION; AIRWAY INFLAMMATION; ANTIGEN CHALLENGE; T-CELLS; IMMEDIATE; HISTAMINE; INTERMITTENT; PROVOCATION	Background: The relationship between severity of asthma and bronchial inflammation is poorly understood. Objective: We examined acute and subacute inflammatory responses to allergen in subjects with mild and moderate persistent asthma to evaluate whether different cellular and mediator responses to endobronchial allergen challenge are associated with differences in disease severity. Methods: Segmental allergen challenge was performed in 8 subjects with mild and 10 subjects with moderate allergic asthma to compare baseline airways inflammation and allergen-induced inflammatory responses 24 hours later. This evaluation was repeated after 6 weeks in 9 subjects to investigate the reproducibility of these inflammatory responses. Results: Subjects with mild and moderate asthma had similar decreases in FEV1 in response to segmental allergen challenge (9.1% +/- 4.2% vs 15.1% +/- 4.6%, P = .35). There was no difference in inflammatory cell counts or cytokine concentrations in the groups with mild and moderate asthma at baseline or after saline or allergen challenge. Repeat segmental allergen challenge 6 weeks later showed that these cellular and cytokine responses were reproducible. Conclusion: Segmental allergen challenge in subjects with mild and moderate asthma produces similar allergen-specific physiologic and inflammatory responses that are reproducible 6 weeks later. In this model of allergic asthma, acute responses to allergen do not appear to be related to disease severity.	Wake Forest Univ, Baptist Med Ctr, Ctr Human Genom, Sch Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Pulm & Crit Care Med Sect, Winston Salem, NC 27109 USA; Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; Vet Adm Med Ctr, Res Serv, Baltimore, MD 21218 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Moore, WC (corresponding author), Wake Forest Univ, Baptist Med Ctr, Ctr Human Genom, Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.							[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BLEECKER ER, 1991, J ALLERGY CLIN IMMUN, V88, P808; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Bowton DL, 1998, ANN ALLERG ASTHMA IM, V80, P207, DOI 10.1016/S1081-1206(10)62957-2; CASALE TB, 1987, J CLIN INVEST, V80, P1507, DOI 10.1172/JCI113234; CHATHAM M, 1982, AM REV RESPIR DIS, V126, P235; Chetta A, 1997, CHEST, V111, P852, DOI 10.1378/chest.111.4.852; Chu HW, 1998, AM J RESP CRIT CARE, V158, P1936, DOI 10.1164/ajrccm.158.6.9712073; Colice GL, 1999, AM J RESP CRIT CARE, V160, P1962, DOI 10.1164/ajrccm.160.6.9902112; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; DUPUIS R, 1992, J ALLERGY CLIN IMMUN, V89, P850, DOI 10.1016/0091-6749(92)90441-4; Glantz SA., 1997, PRIMER BIOSTATISTICS; Holgate ST, 1997, AM J RESP CRIT CARE, V156, P1377, DOI 10.1164/ajrccm.156.5.9610064; Jarjour NN, 1997, AM J RESP CRIT CARE, V155, P1515, DOI 10.1164/ajrccm.155.5.9154851; Laitinen LA, 1996, J ALLERGY CLIN IMMUN, V98, pS3, DOI 10.1016/S0091-6749(96)80122-9; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; METZGER WJ, 1987, AM REV RESPIR DIS, V135, P433; *NAT ASTHM ED PROG, 1997, NIH PUBL; ROCHE WR, 1989, LANCET, V1, P520; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SHAVER JR, 1995, AM J RESP CRIT CARE, V152, P1189, DOI 10.1164/ajrccm.152.4.7551369; Synek M, 1996, AM J RESP CRIT CARE, V154, P224, DOI 10.1164/ajrccm.154.1.8680684; Teeter JG, 1998, CHEST, V113, P272, DOI 10.1378/chest.113.2.272; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002	35	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2001	108	6					908	914		10.1067/mai.2001.119413	http://dx.doi.org/10.1067/mai.2001.119413			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	505WK	11742266				2022-12-18	WOS:000172938400004
J	De Sanctis, GT; Daheshia, M; Daser, A				De Sanctis, GT; Daheshia, M; Daser, A			Genetics of airway hyperresponsiveness	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						asthma; inbred mice; quantitative trait loci; genetics; methacholine; acetycholine; airway hyperresponsiveness; airway reactivity	TRANSGENIC MICE; HYPERREACTIVITY; RESPONSIVENESS; INFLAMMATION; EXPRESSION; ACETYLCHOLINE; INTERLEUKIN-8; SUSCEPTIBILITY; RESPONSES; BLOOD	Asthma is a disease characterized by intermittent airway obstruction, inflammatory cell infiltrates, increased mucus production, lung epithelial remodeling, and airway hyperreactivity. The genetics of asthma, as investigated in animal models, is poorly understood. Because no animal model of asthma mimics all of the pathologic and physiological features of asthma, genetic studies have focused on several phenotypes, including intrinsic or native airway hyperreactivity. It is generally accepted that both genetic and environmental factors determine the phenotypic expression of this complex disease. The genetics of airway hyperresponsiveness, as investigated in the mouse, are presented in this review. The inbred mouse currently represents the most valuable genetic resource for understanding the factors that control this complex phenotype.	Brigham & Womens Hosp, Dept Med, Div Pulm, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Crit Care Div, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Inst Lab Med & Pathobiochem, Berlin, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	De Sanctis, GT (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.							Chanez P, 1996, INT ARCH ALLERGY IMM, V111, P83, DOI 10.1159/000237350; CHIBA Y, 1995, RES COMMUN MOL PATH, V90, P169; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; de Sanctis GT, 1999, J CLIN INVEST, V103, P507, DOI 10.1172/JCI4017; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; DICOSMO BF, 1994, J CLIN INVEST, V94, P2028, DOI 10.1172/JCI117556; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; EWART S, 1995, J APPL PHYSIOL, V79, P560, DOI 10.1152/jappl.1995.79.2.560; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; FAVRE C, 1990, BLOOD, V75, P67; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; GAVETT SH, 1993, AM J PHYSIOL, V265, pL493, DOI 10.1152/ajplung.1993.265.5.L493; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hansen G, 2000, P NATL ACAD SCI USA, V97, P6751, DOI 10.1073/pnas.97.12.6751; ISHIDA K, 1990, J IMMUNOL, V144, P3907; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Konno S, 1993, Arerugi, V42, P42; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; LONGPHRE M, 1995, AM J RESP CELL MOL, V13, P586, DOI 10.1165/ajrcmb.13.5.7576695; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Pattemore PK, 1999, EUR RESPIR J, V14, P650, DOI 10.1034/j.1399-3003.1999.14c27.x; PLOPPER CG, 1983, AM REV RESPIR DIS, V128, pS37; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Tang WL, 1996, J CLIN INVEST, V98, P2845, DOI 10.1172/JCI119113; Wang JM, 2000, J IMMUNOL, V165, P4051, DOI 10.4049/jimmunol.165.7.4051; Webb DC, 2000, J IMMUNOL, V165, P108, DOI 10.4049/jimmunol.165.1.108; ZHANG LY, 1995, EXP LUNG RES, V21, P503, DOI 10.3109/01902149509031755	35	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2001	108	1					11	20		10.1067/mai.2001.116429	http://dx.doi.org/10.1067/mai.2001.116429			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	458AN	11447377				2022-12-18	WOS:000170171200002
J	Lee, HM; Malm, L; Dabbagh, K; Dao-Pick, T; Ueki, IF; Kim, S; Shim, JJ; Nadel, JA				Lee, HM; Malm, L; Dabbagh, K; Dao-Pick, T; Ueki, IF; Kim, S; Shim, JJ; Nadel, JA			Epidermal growth factor receptor signaling mediates regranulation of rat nasal goblet cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						secretory cell growth; epidermal growth factor receptor cascade; epidermal growth factor receptor tyrosine kinase activation; nasal hypersecretion; mucin expression	MUCIN GENE-EXPRESSION; INTERLEUKIN-8; HYPERPLASIA	Background: Mucus hypersecretion is a common response to inflammation in the lower airways and is a hallmark of chronic rhinitis, Objective: The purpose of this study was to elucidate the mechanisms of regranulation (mucus production) of goblet cells in nasal epithelium, Methods: Because neutrophils induce an epidermal growth Factor (EGFR) cascade, we induced degranulation of goblet cells in rat nasal respiratory epithelium by means of intranasal inhalation of N-formyl-methionyl-leucyl-phenylalanine (fMLP). and we examined regranulation of the goblet cells and the role of EGFR inhibitors and neutrophils in the regranulation process. Results: In the control state Alcian blue/periodic acid-Schiff and mucin MUC5AC staining was present. Degranulation was induced in the nasal septal epithelium 4 hours after intranasal inhalation of fMLP (10(-7) mol/L): 48 hours later, goblet-cell regranulation was complete. In the control state EGFR protein staining was absent in the epithelium, but after fMLP-induced degranulation. EGFR protein was expressed. After pretreatment with BIBX1522, a selective EGFR tyrosine kinase inhibitor, fMLP-induced degranulation was unaffected, but goblet-cell regranulation was prevented completely, Conclusion: These data suggest a role for the EGFR cascade in neutrophil-dependent production of goblet-cell mucins, Proving this theory will require the use of selective EGFR inhibitors in clinical studies of nasal hypersecretory states.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nadel, JA (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Box 0130, San Francisco, CA 94143 USA.							BOAT TF, 1994, TXB RESP MED, P1418; Burgel PR, 2000, J ALLERGY CLIN IMMUN, V106, P705, DOI 10.1067/mai.2000.109823; Chapelin C, 1996, EUR RESPIR J, V9, P2474, DOI 10.1183/09031936.96.09122474; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Ichikawa T, 2000, LIFE SCI, V67, pPL1095; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Lee HM, 2000, AM J PHYSIOL-LUNG C, V278, pL185, DOI 10.1152/ajplung.2000.278.1.L185; Lou YP, 1998, AM J RESP CRIT CARE, V157, P1927, DOI 10.1164/ajrccm.157.6.9709113; Nocker RET, 1996, INT ARCH ALLERGY IMM, V109, P183, DOI 10.1159/000237218; OZAKI T, 1992, AM REV RESPIR DIS, V145, P85, DOI 10.1164/ajrccm/145.1.85; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; RICHMANEISENSTA.JB, 1993, LUNG CELL MOL PHYSL, V264, pL413; Rowe-Jones Jilian M., 1997, Rhinology (Utrecht), V35, P113; Shim JJ, 2001, AM J PHYSIOL-LUNG C, V280, pL134, DOI 10.1152/ajplung.2001.280.1.L134; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Takeyama K, 1998, AM J PHYSIOL-LUNG C, V275, pL294, DOI 10.1152/ajplung.1998.275.2.L294; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Voynow JA, 1998, LUNG, V176, P345, DOI 10.1007/PL00007616	20	15	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2001	107	6					1046	1050		10.1067/mai.2001.115140	http://dx.doi.org/10.1067/mai.2001.115140			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	445JR	11398083	hybrid			2022-12-18	WOS:000169454800017
J	Ambach, A; Bonnekoh, B; Gollnick, H				Ambach, A; Bonnekoh, B; Gollnick, H			Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						perforin; atopic dermatitis; rhinoconjunctivitis allergica; releasability; CD8(+) lymphocytes	MEDIATED CYTOTOXICITY; HISTAMINE-RELEASE; STAPHYLOCOCCUS-AUREUS; BRONCHIAL-ASTHMA; SUPERANTIGEN; EXPRESSION; RESPONSES; IGE; FAS; LYMPHOCYTES	Background: As a plasma membrane pore-forming protein, perforin is essential for T-cell cytotoxicity mediated by lytic granules. Recent studies on the immune system of perforin knockout mice demonstrated striking similarities to the immunopathology of atopic diseases. Objective: We sought to investigate the perforin system of atopic patients, Methods: Monoclonal antibodies were used to characterize perforin-positive PBMCs of patients with exacerbated atopic dermatitis (AD) and asymptomatic rhinoconjunctivitis allergica (RCA) by means of immunoflow cytometry, In addition, a perforin release assay was developed to quantify the velocity of ionomycin and phorbol 12-myristate 13-acetate-induced secretion of lytic granules. Results: In atopic patients significantly fewer lymphocytes contained perforin-positive lytic granules compared with those of healthy control subjects (patients with AD: 14% +/- 5%, n = 13, P < ,0001; patients with RCA: 24% +/- 5%, n = 9, P < ,01; healthy control subjects: 33% +/- 11%, n = 13). Of all CD8(hi+) cytotoxic T lymphocytes (CTLs), only 18% +/- 9% and 17% +/- 12% were perforin-positive in patients: with AD and RCA, respectively, compared with 44% +/- 13% in control subjects (P < .0001), In addition, perforin-positive CD8(hi+) CTLs of atopic patients released their perforin twice as fast and more completely than control CTLs. This means that 50% of initially perforin-positive CD8(hi+) CTLs from patients: with AD and RCA released their perforin completely within 32 +/- 16 and 36 +/- 19 minutes, respectively, and an over 85% release was reached within 113 +/- 41 and 118 +/- 60 minutes, respectively In CTLs of healthy control subjects, however, it took 61 +/- 40 minutes to achieve a 50% release of lytic granules, and an 85% depletion was not reached in 60% of healthy control subjects, even after 180 minutes. Conclusion: The perforin hyperreleasability explains, at least in part, the decreased percentage of perforin-positive CD8(hi+) CTLs in atopic patients. These distortions in the system of lytic granules of atopic patients may contribute to the functional defects observed in T-cell cytotoxicity in vivo and in vitro in patients with AD and RCA.	Otto Von Guericke Univ, Dept Dermatol & Venerol, D-39120 Magdeburg, Germany	Otto von Guericke University	Ambach, A (corresponding author), Otto Von Guericke Univ, Dept Dermatol & Venerol, Leipziger Str 44, D-39120 Magdeburg, Germany.							Akdis M, 1999, J IMMUNOL, V163, P466; Ambach A, 2000, J INVEST DERMATOL, V115, P545; ARCHER CB, 1983, BRIT J DERMATOL, V109, P559, DOI 10.1111/j.1365-2133.1983.tb07679.x; Behrendt C, 2000, EUR J DERMATOL, V10, P365; Bischoff SC, 1996, INT ARCH ALLERGY IMM, V110, P261, DOI 10.1159/000237297; BUTLER JM, 1983, J ALLERGY CLIN IMMUN, V71, P490, DOI 10.1016/0091-6749(83)90467-0; Christodoulopoulos P, 2000, J ALLERGY CLIN IMMUN, V105, P211, DOI 10.1016/S0091-6749(00)90068-X; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Hauk PJ, 2000, J ALLERGY CLIN IMMUN, V105, P782, DOI 10.1067/mai.2000.105807; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; HWANG KC, 1985, CLIN ALLERGY, V15, P67, DOI 10.1111/j.1365-2222.1985.tb02257.x; Jappe U, 1998, J INVEST DERMATOL, V110, P844, DOI 10.1046/j.1523-1747.1998.00177.x; JENSEN JR, 1985, ACTA DERM-VENEREOL, P105; Kagi D, 1999, EUR J IMMUNOL, V29, P3262, DOI 10.1002/(SICI)1521-4141(199910)29:10<3262::AID-IMMU3262>3.0.CO;2-A; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Leung DYM, 1999, J ALLERGY CLIN IMMUN, V104, pS99, DOI 10.1016/S0091-6749(99)70051-5; LEUNG DYM, 1983, J CLIN INVEST, V72, P1482, DOI 10.1172/JCI111104; LEUNG DYM, 1983, J IMMUNOL, V130, P1678; LEUNG DYM, 1981, J ALLERGY CLIN IMMUN, V67, P450, DOI 10.1016/0091-6749(81)90098-1; LOWIN B, 1994, P NATL ACAD SCI USA, V91, P11571, DOI 10.1073/pnas.91.24.11571; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Majlessi L, 1999, J IMMUNOL, V162, P4391; MARONE G, 1985, INT ARCH ALLER A IMM, V77, P103, DOI 10.1159/000233761; Matloubian M, 1999, J VIROL, V73, P2527, DOI 10.1128/JVI.73.3.2527-2536.1999; NAKATA M, 1992, INT IMMUNOL, V4, P1049, DOI 10.1093/intimm/4.9.1049; Nomiyama K, 1988, J Dermatol, V15, P241; PARKER CW, 1977, J INVEST DERMATOL, V68, P302, DOI 10.1111/1523-1747.ep12494569; Peng SL, 1998, J IMMUNOL, V160, P652; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; QUINTI I, 1986, J ALLERGY CLIN IMMUN, V77, P586, DOI 10.1016/0091-6749(86)90350-7; REINHOLD U, 1986, HAUTARZT, V37, P438; RING J, 1985, ACTA DERM-VENEREOL, P9; ROLAPLESZCZYNSKI M, 1981, J INVEST DERMATOL, V76, P279, DOI 10.1111/1523-1747.ep12526118; Rubesa G, 1997, J NEUROIMMUNOL, V74, P198, DOI 10.1016/S0165-5728(96)00236-6; Rukavina D, 1998, BLOOD, V92, P2410, DOI 10.1182/blood.V92.7.2410.2410_2410_2420; Schnyder B, 1998, CLIN EXP ALLERGY, V28, P1412, DOI 10.1046/j.1365-2222.1998.00419.x; Shiomori T, 2000, J ALLERGY CLIN IMMUN, V105, P449, DOI 10.1067/mai.2000.104256; Skov L, 2000, J ALLERGY CLIN IMMUN, V105, P820, DOI 10.1067/mai.2000.105524; STINGL G, 1981, J INVEST DERMATOL, V76, P468, DOI 10.1111/1523-1747.ep12521135; STRANNEGARD O, 1991, HDB ATOPIC ECZEMA, P221; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Valenta R, 2000, J ALLERGY CLIN IMMUN, V105, P432, DOI 10.1067/mai.2000.104783; VONDERHELM D, 1987, ARCH DERMATOL RES, V279, P536, DOI 10.1007/BF00413286	43	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2001	107	5					878	886		10.1067/mai.2001.114240	http://dx.doi.org/10.1067/mai.2001.114240			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	434JX	11344356	Bronze			2022-12-18	WOS:000168812300017
J	Daley-Yates, PT; Richards, DH				Daley-Yates, PT; Richards, DH			Pharmacokinetic (PK) and pharmacodynamic (PD) relationships for intranasal corticosteroids (INCS)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Glaxo Wellcome Res & Dev Ltd, Greenford, Middx, England; Glaxo Wellcome Res & Dev Ltd, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline									0	15	15	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		1023	S313	S313						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172301019
J	Levetin, E				Levetin, E			Effects of climate change on airborne pollen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Tulsa, Tulsa, OK 74104 USA	University of Tulsa									0	15	16	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2		S		565	S172	S172						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	405RE					2022-12-18	WOS:000167172300563
J	Aalberse, RC; van Ree, R				Aalberse, RC; van Ree, R			Monoclonal antibody assays for allergens: Pick your antibodies with care!	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						monoclonal antibodies; assays; allergens	IGE		Univ Amsterdam, Acad Med Ctr, Clin & Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam								AALBERSE RC, 1984, ARB P EHRLICH I BUND, V79, P137; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; VANMILLIGEN FJ, 1992, INT ARCH ALLERGY IMM, V99, P63, DOI 10.1159/000236337; vanRee R, 1997, ALLERGY, V52, P795	4	15	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2000	106	4					625	626		10.1067/mai.2000.110226	http://dx.doi.org/10.1067/mai.2000.110226			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	365ZP	11031330				2022-12-18	WOS:000089980600003
J	Nutku, E; Gounni, AS; Olivenstein, R; Hamid, Q				Nutku, E; Gounni, AS; Olivenstein, R; Hamid, Q			Evidence for expression of eosinophil-associated IL-12 messenger RNA and immunoreactivity in bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; IL-12; cytokines; asthma; magnetic cell sorting technique; immunofluorescence staining	CELL STIMULATORY FACTOR; INDUCED AIRWAY HYPERRESPONSIVENESS; PERIPHERAL-BLOOD EOSINOPHILS; FACTOR INTERLEUKIN-12; ATOPIC ASTHMA; IDENTIFICATION; RESPONSES; LOCALIZATION; LYMPHOCYTES; CYTOKINES	Background: Eosinophils are a source of cytokines within the airways of asthmatic individuals that may exert an important immunoregulatory influence. Objectives: We examined IL-12 messenger (m)RNA and protein expression in eosinophils from peripheral blood and bronchoalveolar lavage (BAL) fluid obtained from subjects with atopic asthma (n = 7), patients with chronic bronchitis (n = 5), and nonatopic healthy control subjects (n = 7). To further define this IL-12(+) population of eosinophils for the expression of other cytokines, we colocalized IL-12 and IL-5 within the peripheral blood eosinophils. Methods: To detect IL-12 mRNA and protein expression, we used in situ hybridization and immunocytochemistry techniques. The double-immunocytochemistry technique was used to localize IL-12 protein to BAL eosinophils and to colocalize IL-5 and IL-12 in peripheral blood eosinophils. Results: IL-12 mRNA and immunoreactive protein were localized to peripheral blood eosinophils. BAL fluid-derived eosinophils from asthmatic subjects were also reactive to IL-12. The percentage of peripheral blood eosinophils expressing mRNA for IL-12 was significantly lower in asthmatic subjects compared with that found in eosinophils obtained from patients with chronic bronchitis (P < .001) and control patients (P < .05). Colocalization studies demonstrated that the percentages of IL-12(+) eosinophils that are also IL-5(+) were 72% in asthmatic subjects and only 11% in control subjects (P < .001). Conclusion: These results suggest that eosinophils are a potential source of IL-12. Eosinophil-derived IL-12 may contribute and modulate the local allergic inflammatory responses.	McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada; McGill Univ, Montreal Chest Hosp, Montreal, PQ H2X 2P2, Canada	McGill University; McGill University	Hamid, Q (corresponding author), McGill Univ, Meakins Christie Labs, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.		Gounni, Abdelilah Soussi/AAH-3456-2020	Gounni, Abdelilah/0000-0003-1265-6560; Soussi Gounni, Abdelilah/0000-0002-7282-0388				[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; AZZAWI M, 1990, AM REV RESPIR DIS, V142, P1407, DOI 10.1164/ajrccm/142.6_Pt_1.1407; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grewe M, 1998, J IMMUNOL, V161, P415; HAMID Q, 1987, P NATL ACAD SCI USA, V84, P6760, DOI 10.1073/pnas.84.19.6760; HAMID Q, 1992, BLOOD, V80, P1496; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Iwamoto I, 1996, AM J RESP CRIT CARE, V154, P1257, DOI 10.1164/ajrccm.154.5.8912732; KINIWA M, 1992, J CLIN INVEST, V90, P262, DOI 10.1172/JCI115846; Kraan TCTMV, 1997, J IMMUNOL, V158, P5560; Lacy P, 1997, MEM I OSWALDO CRUZ, V92, P125, DOI 10.1590/S0074-02761997000800017; Lamkhioued B, 1996, ANN NY ACAD SCI, V796, P203, DOI 10.1111/j.1749-6632.1996.tb32582.x; LeviSchaffer F, 1996, IMMUNOLOGY, V87, P155; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Moller GM, 1996, AM J RESP CELL MOL, V14, P439; MOQBEL R, 1991, J EXP MED, V174, P749, DOI 10.1084/jem.174.3.749; MOQBEL R, 1995, J IMMUNOL, V155, P4939; Nakajima H, 1996, J IMMUNOL, V156, P4859; Naseer T, 1997, AM J RESP CRIT CARE, V155, P845, DOI 10.1164/ajrccm.155.3.9117015; PODLASKI FJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P230, DOI 10.1016/0003-9861(92)90162-P; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Schwarze J, 1998, J ALLERGY CLIN IMMUN, V102, P86, DOI 10.1016/S0091-6749(98)70058-2; Woerly G, 1999, INT ARCH ALLERGY IMM, V118, P95, DOI 10.1159/000024038; WOLF SF, 1991, J IMMUNOL, V146, P3074	26	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2000	106	2					288	292		10.1067/mai.2000.107932	http://dx.doi.org/10.1067/mai.2000.107932			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	343NH	10932072				2022-12-18	WOS:000088708100011
J	Laitinen, A; Karjalainen, EM; Altraja, A; Laitinen, LA				Laitinen, A; Karjalainen, EM; Altraja, A; Laitinen, LA			Histopathologic features of early and progressive asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; airway inflammation; repair; remodeling; basement membrane; tenascin; fibronectin; collagen; integrin receptors	BRONCHIAL EPITHELIAL-CELLS; COLONY-STIMULATING FACTOR; NEWLY DIAGNOSED ASTHMA; BASEMENT-MEMBRANE; AIRWAY INFLAMMATION; INHALED CORTICOSTEROIDS; SUBEPITHELIAL FIBROSIS; EXTRACELLULAR-MATRIX; LUNG DEVELOPMENT; T-LYMPHOCYTES	During the last decade, morphologic studies on bronchial biopsy specimens have led to our present understanding of asthma as an inflammatory airways disease, However, little knowledge exists about the sequence of cellular events during the disease or of possible mucosal changes early in asthma, So far the primary cause, the site of damage, and the mechanisms inducing the inflammatory reaction remain to be elucidated. A multifactorial genetic susceptibility may be important for the development of asthma, Suggested factors that may trigger changes in the cells' morphologic and functional phenotype are viral infections, allergen exposure, maternal factors, diet, and smoking, Current evidence has implied that interactions between epithelial cells and the subepithelial connective tissue in the mucosa are important for normal homeostatic balance. Changes in airway epithelial phenotype possibly resulting from altered gene expression in its lining cells may be very important even as a first line change in asthma.	Univ Helsinki, Cent Hosp, Dept Med, FIN-00290 Helsinki, Finland; Siltavuorenpenger Univ Helsinki, Inst Biomed, Dept Anat, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Laitinen, LA (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, Haartmanninkatu 4, FIN-00290 Helsinki, Finland.							Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; BELLINI A, 1993, J ALLERGY CLIN IMMUN, V92, P412, DOI 10.1016/0091-6749(93)90120-5; BENTLEY AM, 1992, AM REV RESPIR DIS, V146, P500, DOI 10.1164/ajrccm/146.2.500; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; CARDOSO WV, 1995, AM J RESP CELL MOL, V12, P464, DOI 10.1165/ajrcmb.12.5.7742011; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; DUNNILL MS, 1969, THORAX, V24, P176, DOI 10.1136/thx.24.2.176; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Engvall E, 1996, J CELL BIOCHEM, V61, P493; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; FILLEY WV, 1982, LANCET, V2, P11; Hackett BP, 1996, ANNU REV PHYSIOL, V58, P51, DOI 10.1146/annurev.physiol.58.1.51; JainVora S, 1997, AM J RESP CELL MOL, V17, P541, DOI 10.1165/ajrcmb.17.5.2883; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; JEFFERY PK, 1992, AM REV RESPIR DIS, V145, P890, DOI 10.1164/ajrccm/145.4_Pt_1.890; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; LAITINEN LA, 1991, AM REV RESPIR DIS, V143, P423, DOI 10.1164/ajrccm/143.2.423; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LINNALA A, 1995, AM J RESP CELL MOL, V13, P578, DOI 10.1165/ajrcmb.13.5.7576694; LUNDGREN R, 1988, EUR RESPIR J, V1, P883; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S; MCGOWAN SE, 1992, FASEB J, V6, P2895, DOI 10.1096/fasebj.6.11.1644255; MERKER HJ, 1994, MICROSC RES TECHNIQ, V28, P95, DOI 10.1002/jemt.1070280203; METTE SA, 1993, AM J RESP CELL MOL, V8, P562, DOI 10.1165/ajrcmb/8.5.562; OHASHI Y, 1992, AM REV RESPIR DIS, V145, P1469, DOI 10.1164/ajrccm/145.6.1469; OLIVIERI D, 1995, CURR OPIN PULMON MED, V1, P31; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; PESCI A, 1993, AM REV RESPIR DIS, V147, P684, DOI 10.1164/ajrccm/147.3.684; Pilewski JM, 1997, AM J PHYSIOL-LUNG C, V273, pL256, DOI 10.1152/ajplung.1997.273.1.L256; POST M, 1997, LUNG SCI FDN, P1003; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Rennard SI, 1996, J ALLERGY CLIN IMMUN, V98, pS278, DOI 10.1016/S0091-6749(96)70076-3; ROCHE WR, 1989, LANCET, V1, P520; ROMAN J, 1997, LUNG SCI FDN, P737; SEMINARIO MC, 1994, CURR OPIN IMMUNOL, V6, P860, DOI 10.1016/0952-7915(94)90005-1; SOUSA AR, 1993, AM REV RESPIR DIS, V147, P1557, DOI 10.1164/ajrccm/147.6_Pt_1.1557; SOUSA AR, 1994, AM J RESP CELL MOL, V10, P142, DOI 10.1165/ajrcmb.10.2.8110469; Spindel ER, 1996, AM J RESP CELL MOL, V14, P407, DOI 10.1165/ajrcmb.14.5.8624244; TRIGG CJ, 1994, AM J RESP CRIT CARE, V150, P17, DOI 10.1164/ajrccm.150.1.8025745; Virtanen I, 1996, AM J RESP CELL MOL, V15, P184, DOI 10.1165/ajrcmb.15.2.8703474; WEINACKER A, 1995, AM J RESP CELL MOL, V12, P547, DOI 10.1165/ajrcmb.12.5.7537970	49	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	2	S			S509	S513		10.1016/S0091-6749(00)90052-6	http://dx.doi.org/10.1016/S0091-6749(00)90052-6			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	286JG	10669533	Bronze			2022-12-18	WOS:000085439600010
J	Brand, U; Bellinghausen, I; Enk, AH; Jonuleit, H; Becker, D; Knop, J; Saloga, J				Brand, U; Bellinghausen, I; Enk, AH; Jonuleit, H; Becker, D; Knop, J; Saloga, J			Allergen-specific immune deviation from a T(H)2 to a T(H)1 response induced by dendritic cells and collagen type I	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T-cell differentiation; dendritic cells; collagen type I	COLONY-STIMULATING FACTOR; BEE VENOM; EXTRACELLULAR-MATRIX; T-LYMPHOCYTES; B-CELLS; ANTIGEN; IMMUNOTHERAPY; IGE; INTERLEUKIN-12; EXPRESSION	Background: Atopy and IgE production are associated with enhanced allergen-specific T(H)2 responses. Therefore a causative treatment may result from the deviation of this T(H)2-dominated immune response toward a T(H)1 response. Objective: This study was carried out to analyze whether dendritic cells, the most potent antigen-presenting cells that are also known to induce antigen-specific T(H)1 responses. are suitable for therapy of atopic diseases by shifting the allergen-specific T(H)2 response toward a T(H)1 response. Methods: Monocyte-derived dendritic cells were used to present allergens in vitro to autologous CD4(+) T cells of allergic persons. Because collagen type I activates dendritic tells and enhances the secretion of IL-12, we performed allergen presentation assays also in the presence of collagen type I. Results: After stimulation with allergen-pulsed dendritic cells the production of IFN-gamma as well as that of IL-4 and IL-5 by CD4(+) T cells was enhanced. In the presence of collagen type I, however, a significant shirt toward a T(H)1 response with increased production of IFN-gamma and a decreased production of IL-5 could be observed. When T cells were stimulated directly with anti-CD3 and anti-CD28 in the absence of antigen-presenting cells, it was demonstrated that collagen type I also exerted a direct effect on T cells, increasing their IFN-gamma production. Conclusion: These data indicate that collagen type I influences dendritic cells as well as T cells in a way that a shift in cytokine production results in a T(H)1 response even in already-sensitized atopic individuals.	Univ Mainz, Hautklin, Dept Dermatol, Clin Res Unit, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Saloga, J (corresponding author), Univ Mainz, Hautklin, Dept Dermatol, Clin Res Unit, Langenbeckstr 1, D-55131 Mainz, Germany.		Jonuleit, Helmut/D-8059-2011	Jonuleit, Helmut/0000-0002-5672-9365				Bellinghausen I, 1997, EUR J IMMUNOL, V27, P1131, DOI 10.1002/eji.1830270513; Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; FERRANTE A, 1986, INT ARCH ALLER A IMM, V81, P284, DOI 10.1159/000234148; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631; ISHIZAKA T, 1984, FED PROC, V43, P2840; JACOBS DM, 1977, J IMMUNOL, V118, P21; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kalinski P, 1997, ADV EXP MED BIOL, V417, P363; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; LEVIN D, 1993, J IMMUNOL, V151, P6742; LUNDGREN M, 1989, EUR J IMMUNOL, V19, P1311, DOI 10.1002/eji.1830190724; MCHUGH SM, 1995, CLIN EXP ALLERGY, V25, P828, DOI 10.1111/j.1365-2222.1995.tb00025.x; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; Schuler G, 1995, ADV EXP MED BIOL, V378, P43; SOMASSE T, 1996, J EXP MED, V184, P473; SORNASSE T, 1992, J EXP MED, V175, P15, DOI 10.1084/jem.175.1.15; Suri RM, 1998, J IMMUNOL METHODS, V214, P149, DOI 10.1016/S0022-1759(98)00048-9; Tschoetschel U, 1997, INT IMMUNOL, V9, P147, DOI 10.1093/intimm/9.1.147; VERCELLI D, 1993, ALLERGY PROC, V14, P413, DOI 10.2500/108854193778792795; VILLACRESERIKSSON M, 1995, CLIN EXP IMMUNOL, V102, P46; VIS BD, 1998, J IMMUNOL, V160, P1666; WIERENGA EA, 1990, J IMMUNOL, V144, P4651	28	15	19	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1999	104	5					1052	1059		10.1016/S0091-6749(99)70088-6	http://dx.doi.org/10.1016/S0091-6749(99)70088-6			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	257JH	10550752				2022-12-18	WOS:000083778400030
J	Crapo, JD; Day, BJ				Crapo, JD; Day, BJ			Modulation of nitric oxide responses in asthma by extracellular antioxidants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; extracellular superoxide dismutase; antioxidants; inflammation; nitric oxide; peroxynitrite; nitrotyrosine	SUPEROXIDE-DISMUTASE; GUINEA-PIGS; IN-VITRO; SYNTHASE; AIRWAYS; LOCALIZATION; ADHESION; SYSTEM; LUNG		Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	National Jewish Health	Crapo, JD (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.							ALVING K, 1993, EUR RESPIR J, V6, P1368; Brady TC, 1997, AM J PHYSIOL-LUNG C, V273, pL1002, DOI 10.1152/ajplung.1997.273.5.L1002; BRAVE SR, 1993, NEUROSCI LETT, V161, P93, DOI 10.1016/0304-3940(93)90148-E; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Fukai T, 1999, CIRC RES, V85, P23; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0; HEISS LN, 1994, P NATL ACAD SCI USA, V91, P267, DOI 10.1073/pnas.91.1.267; HOGMAN M, 1993, AM REV RESPIR DIS, V148, P1474; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO LJ, 1990, HYPERTENSION, V16, P477, DOI 10.1161/01.HYP.16.5.477; INAGAKI M, 1993, J ASTHMA, V30, P401, DOI 10.3109/02770909309056744; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; KOBZIK L, 1993, AM J RESP CELL MOL, V9, P371, DOI 10.1165/ajrcmb/9.4.371; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUO HP, 1992, EUR J PHARMACOL, V221, P385; MARKLUND SL, 1984, BIOCHEM J, V222, P649, DOI 10.1042/bj2220649; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; OURY TD, 1994, LAB INVEST, V70, P889; Oury TD, 1996, LAB INVEST, V75, P617; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380; SadeghiHashjin G, 1996, AM J RESP CRIT CARE, V153, P1697, DOI 10.1164/ajrccm.153.5.8630623; STRETTON D, 1991, CLIN EXP PHARMACOL P, V18, P675, DOI 10.1111/j.1440-1681.1991.tb01380.x; Su WY, 1996, AM J PHYSIOL-LUNG C, V271, pL581, DOI 10.1152/ajplung.1996.271.4.L581; TAYLORROBINSON AW, 1994, EUR J IMMUNOL, V24, P980, DOI 10.1002/eji.1830240430; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; YATES DH, 1995, AM J RESP CRIT CARE, V152, P892, DOI 10.1164/ajrccm.152.3.7663801	31	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1999	104	4	1				743	746		10.1016/S0091-6749(99)70282-4	http://dx.doi.org/10.1016/S0091-6749(99)70282-4			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	248NG	10518816				2022-12-18	WOS:000083281200003
J	D'Amato, G; Noschese, P; Russo, M; Gilder, J; Liccardi, G				D'Amato, G; Noschese, P; Russo, M; Gilder, J; Liccardi, G			Pollen asthma in the deep	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							SMALLER		Azienda Osped Alta Specialita A Cardarelli, Dept Pulm Dis, Div Pneumol & Allergol, Naples, Italy	Antonio Cardarelli Hospital	D'Amato, G (corresponding author), Hosp A Cardarelli, Div Pneumol & Allergol, Via Rione Sirignano 10, I-80121 Naples, Italy.							BUSSE WW, 1972, J ALLERGY CLIN IMMUN, V50, P289, DOI 10.1016/0091-6749(72)90027-9; DAmato G, 1996, ANN ALLERG ASTHMA IM, V77, P147, DOI 10.1016/S1081-1206(10)63501-6; DAMATO G, 1989, J ALLERGY CLIN IMMUN, V83, P116, DOI 10.1016/0091-6749(89)90485-5; DAMATO G, 1991, ANN ALLERGY, V67, P421; SOLOMON WR, 1983, J ALLERGY CLIN IMMUN, V72, P443, DOI 10.1016/0091-6749(83)90579-1	5	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1999	104	3	1				710	710		10.1016/S0091-6749(99)70350-7	http://dx.doi.org/10.1016/S0091-6749(99)70350-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241EP	10482854				2022-12-18	WOS:000082870000043
J	Kim, YK; Cho, SH; Koh, YY; Son, JW; Lee, BJ; Min, KU; Kim, YY				Kim, YK; Cho, SH; Koh, YY; Son, JW; Lee, BJ; Min, KU; Kim, YY			Linkage between IgE receptor-mediated histamine releasability from basophils and gene marker of chromosome 11q13	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Basophil histamine release; chromosome 11q13; asthma; IgE-receptor; linkage analysis	HIGH-AFFINITY; SERUM IGE; BETA-SUBUNIT; ASTHMA; RELEASE; PATHOGENESIS	Background: The genetics of the regulation of the release of mediators involving the interaction of IgE with cells and their ability to release mediators have not been extensively investigated. With use of the candidate gene approach, it was reported that the gene regulating the beta chain of the high-affinity receptor for IgE is on chromosome 11q13. Objective: To determine whether gene(s) in chromosome 11q13 may control the expression of maximal histamine release from basophil to anti-IgE stimuli, linkage analysis between this phenotype and the gene marker of chromosome 11q13 was performed. Methods: Maximal histamine release to anti-IgE and calcium ionophore A23187 and genotyping chromosome 11q13 with use of microsatellite marker (D11S97) were performed in 56 probands with asthma and 59 of their siblings. The linkage was analyzed by affected sib-pair analysis and the quantitative trait locus approach. Results: Maximal histamine release (mean +/- SE) to anti-IgE and A23187 was 43.3% +/- 3.5% and 30.9 +/- 3.4% in probands and 29.5% +/- 2.6% and 22.2% +/- 2.7 in siblings, respectively. Of 20 sib-pairs with the maximal histamine release to anti-IgE more than 33% (mean plus 1 SD of nonasthmatic controls), 11 (55%) shared 2 D11S97 alleles, 9 (45%) shared 1 allele, and neither sib-pair shared identical alleles, which indicates a significant linkage of maximal histamine to anti-IgE and gene marker of chromosome 11q13 (P = .02), The difference (mean +/- SE) of the maximal histamine release to anti-IgE between each proband and sibling was smaller in sib-pairs with 2 identical alleles than in those with 1 identical allele and with no identical allele (14.1% +/- 2.6% vs 25.8% +/- 3.1% vs 41.0% +/- 4.9%). However, the difference (mean +/- SE) to A23187 between each proband and sibling was not different among the 3 groups (9.7% +/- 1.8% vs 17.9% +/- 3.6% vs 10.4% +/- 4.8%). Conclusion: Maximal histamine release from basophils to anti-IgE stimuli was linked to the gene marker of chromosome 11q13.	Seoul Natl Univ, Coll Med, Dept Internal Med, Chongno Gu, Seoul 110774, South Korea; Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 110774, South Korea; Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul 110774, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, YK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Chongno Gu, 28 Yungun Dong, Seoul 110774, South Korea.		Koh, Young Yull/D-6059-2012; Cho, Sang Heon/J-2793-2012; Koh, Young Yull/J-5368-2012; Min, Kyung-Up/J-5468-2012					ALBER G, 1991, J BIOL CHEM, V266, P22613; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CASOLARO V, 1990, AM REV RESPIR DIS, V142, P1108, DOI 10.1164/ajrccm/142.5.1108; CONROY MC, 1977, J IMMUNOL, V118, P1317; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; ISHIZAKA K, 1968, J ALLERGY, V42, P330, DOI 10.1016/0021-8707(68)90095-6; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LICHTENSTEIN LM, 1986, J ALLERGY CLIN IMMUN, V77, P291, DOI 10.1016/S0091-6749(86)80106-3; LICHTENSTEIN LM, 1975, J IMMUNOL, V114, P1692; LICHTENSTEIN LM, 1991, ANN NY ACAD SCI, V629, P48; MACGLASHAN DW, 1993, J ALLERGY CLIN IMMUN, V91, P605, DOI 10.1016/0091-6749(93)90266-I; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; MARONE G, 1986, J IMMUNOL, V137, P3582; MARONE G, 1989, CLIN IMMUNOL IMMUNOP, V50, P24; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MCCGLASHAN DW, 1983, J IMMUNOL, V130, P2330; MCFADDEN ER, 1984, J ALLERGY CLIN IMMUN, V73, P413, DOI 10.1016/0091-6749(84)90347-6; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; SAMPSON HA, 1983, J ALLERGY CLIN IMMUN, V71, P473, DOI 10.1016/0091-6749(83)90464-5; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SHAH S, 1994, ANN HUM GENET, V58, P381, DOI 10.1111/j.1469-1809.1994.tb00734.x	22	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1999	104	3	1				618	622		10.1016/S0091-6749(99)70333-7	http://dx.doi.org/10.1016/S0091-6749(99)70333-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241EP	10482837				2022-12-18	WOS:000082870000025
J	Manzolli, S; Macedo-Soares, MF; Vianna, EO; Sannomiya, P				Manzolli, S; Macedo-Soares, MF; Vianna, EO; Sannomiya, P			Allergic airway inflammation in hypothyroid rats	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; allergy; IgE; thyroid; hypothyroidism; thyroxine; ovalbumin	MONOCLONAL-ANTIBODY; HUMAN-LYMPHOCYTES; GUINEA-PIGS; ASTHMA; PHASE; RESPONSES; HYPERREACTIVITY; RECEPTORS	Background: Hormones play a modulating role in allergic inflammation. Hyperthyroidism may increase the severity of asthma, and hypothyroidism may ameliorate coexistent asthma. The mechanisms regulating this interaction are not completely understood. Objective: The purpose of this study was to test the hypothesis that thyroid hormones influence the development of allergic airway inflammation after antigen challenge in rats. Methods: The experimental design included either sensitized or nonsensitized surgically thyroidectomized and sham-operated rats. Experiments were performed 50 days after surgery. Thyroidectomized rats and sham-operated controls were sensitized by subcutaneous injection of ovalbumin (OVA) and Al(OH)(3) and challenged 14 days later by OVA inhalation. Bronchoalveolar lavages mere performed 24 hours after challenge. Results: Compared with controls, thyroidectomized animals presented markedly decreased cell yields from bronchoalveolar lavage fluid after OVA challenge. The impaired response was not related to changes in the number of circulating leukocytes, Determination of antibody serum concentrations indicated that thyroidectomized rats presented a marked reduction in the level of anti-OVA IgE compared with controls, without significant differences in IgG(1) and IgG(2a) serum concentrations. Reversal of the impaired responses was attained by 16-day treatment of hypothyroid animals with thyroxine, but not by 1- or 3-day treatment. Conclusion: The data presented suggest that the continuing deficiency of thyroid hormones influences the development of the inflammatory component of asthma. This is due, at least in part, to a decrease in the production of IgE.	Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, SP, Brazil; Univ Sao Paulo, Med Sch Ribeirao Preto, Div Pulm, Ribeirao Preto, Brazil; Butanan Inst, Immunopathol Lab, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Sannomiya, P (corresponding author), Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, Av Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, SP, Brazil.		Vianna, Elcio/I-2508-2016; Sannomiya, Paulina/G-1814-2012	Vianna, Elcio/0000-0003-1902-6326; 				Abrahamson EM, 1941, J CLIN ENDOCRINOL, V1, P402, DOI 10.1210/jcem-1-5-402; AYRES J, 1981, LANCET, V2, P1110; Boulet LP, 1997, AM J RESP CRIT CARE, V155, P1835, DOI 10.1164/ajrccm.155.6.9196083; BUSH RK, 1977, J ALLERGY CLIN IMMUN, V59, P398, DOI 10.1016/0091-6749(77)90025-2; CASACO A, 1989, ALLERGOL IMMUNOPATH, V17, P105; CASACO A, 1991, CAN J PHYSIOL PHARM, V69, P886, DOI 10.1139/y91-134; Casale TB, 1997, J ALLERGY CLIN IMMUN, V100, P110, DOI 10.1016/S0091-6749(97)70202-1; Chandler MHH, 1997, PHARMACOTHERAPY, V17, P224; Charlesworth EN, 1996, J ALLERGY CLIN IMMUN, V98, pS291, DOI 10.1016/S0091-6749(96)80114-X; CHATTERJEE S, 1983, ACTA ENDOCRINOL-COP, V103, P95, DOI 10.1530/acta.0.1030095; Diaz BL, 1996, INT ARCH ALLERGY IMM, V111, P36, DOI 10.1159/000237343; DIAZ P, 1989, AM REV RESPIR DIS, V139, P1383, DOI 10.1164/ajrccm/139.6.1383; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Garcia-Leme J., 1989, HORMONES INFLAMMATIO; GARCIALEME J, 1993, MEDIAT INFLAMM, V2, P181, DOI 10.1155/S0962935193000250; GOLDBERG A, 1990, ANN ALLERGY, V64, P179; HOFFMAN DA, 1982, AM J EPIDEMIOL, V115, P243, DOI 10.1093/oxfordjournals.aje.a113296; Laitinen LA, 1996, J ALLERGY CLIN IMMUN, V98, pS3, DOI 10.1016/S0091-6749(96)80122-9; MORSE HC, 1969, J IMMUNOL, V102, P327; Niimi A, 1996, J ALLERGY CLIN IMMUN, V97, P1308, DOI 10.1016/S0091-6749(96)70200-2; OGILVIE BM, 1967, IMMUNOLOGY, V12, P113; Pizzichini E, 1997, J ALLERGY CLIN IMMUN, V99, P539, DOI 10.1016/S0091-6749(97)70082-4; Punnonen J, 1997, J ALLERGY CLIN IMMUN, V100, P792, DOI 10.1016/S0091-6749(97)70276-8; SANTING RE, 1994, J ALLERGY CLIN IMMUN, V93, P1021, DOI 10.1016/S0091-6749(94)70051-6; TSAI JS, 1974, J CLIN ENDOCR METAB, V38, P919, DOI 10.1210/jcem-38-5-919; UNDERWOOD SL, 1995, IMMUNOLOGY, V85, P256; VIANNA EO, 1995, AM J RESP CRIT CARE, V151, P809; WILLIAMS RS, 1979, J CLIN ENDOCR METAB, V48, P503, DOI 10.1210/jcem-48-3-503	28	15	21	1	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1999	104	3	1				595	600		10.1016/S0091-6749(99)70329-5	http://dx.doi.org/10.1016/S0091-6749(99)70329-5			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241EP	10482833				2022-12-18	WOS:000082870000021
J	Andersson, O; Cassel, TN; Gronneberg, R; Bronnegard, M; Stierna, P; Nord, M				Andersson, O; Cassel, TN; Gronneberg, R; Bronnegard, M; Stierna, P; Nord, M			In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						glucocorticoid receptor; asthma; bronchoalveolar lavage; fluticasone; Clara cell secretory protein	BIPHENYL-BINDING PROTEIN; HORMONAL-REGULATION; MESSENGER-RNA; BRONCHOALVEOLAR LAVAGE; RABBIT UTEROGLOBIN; EXPRESSION; LUNG; GENE; TRANSCRIPTION; TISSUE	Background: In vivo regulation of the glucocorticoid receptor (GR) by glucocorticoids provides a means of modulating sensitivity of targeted cells. Objective: We sought to determine the in vivo modulation of GR mRNA expression by fluticasone propionate (FP) in subjects with mild asthma. Methods: Ten atopic asthmatic subjects were treated with FP 250 mu g twice daily for 4 weeks. Before and after treatment, the patients underwent fiberoptic bronchoscopy with endobronchial biopsy and sampling of venous blood for measurements of GR mRNA levels, A solution hybridization assay was used for quantitative analysis of GR mRNA. In addition, a 24-hour urinary cortisol excretion and an adrenocorticotropic hormone test before and after treatment with FP were performed. Results: A high interindividual variation in GR mRNA expression was seen. However, we detected a significant reduction of the GR mRNA levels in the endobronchial biopsy specimens after FP treatment (36.6 +/- 23.1 and 25.0 +/- 10.9 amol GR mRNA/mu g RNA, respectively; P < .01). In the peripheral blood lymphocytes an even more striking downregulation of the GR by its cognate ligand was documented (30.3 +/- 26.5 and 8.8 +/- 5 amol GR mRNA/mu g RNA, respectively; P < .001), possibly reflecting differences in glucocorticoid sensitivity between tissues. A small but significant reduction of the 24-hour urinary cortisol excretion was observed (233 +/- 109 and 157 +/- 66 nmol/L, respectively; P < .01), whereas the feedback regulation of glucocorticoid synthesis by means of the hypothalamic-pituitary-adrenal axis as assessed by the adrenocorticotropic hormone test remained normal after treatment with FP. Conclusion: The results in this study confirm the potency of the inhaled corticosteroid FP and provide evidence for a considerable tissue-specific interindividual variation in the expression of the GR.	Huddinge Univ Hosp, Karolinska Inst, Dept Lung Med, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Otorhinolaryngol, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pediat, S-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Andersson, O (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Dept Lung Med, S-14186 Huddinge, Sweden.							Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; ANDERSSON O, 1991, AM J RESP CELL MOL, V5, P6, DOI 10.1165/ajrcmb/5.1.6; ANDERSSON O, 1994, J BIOL CHEM, V269, P19081; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BOURGEOIS S, 1978, CANCER RES, V38, P4279; BROERS JLV, 1992, LAB INVEST, V66, P337; BRONNEGARD M, 1996, AM J RESP CRIT CARE, V154, pS32; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CATO ACB, 1985, ANTICANCER RES, V5, P65; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CRABTREE GR, 1981, CANCER RES, V41, P4853; DERENDORF H, 1993, J CLIN PHARMACOL, V33, P115, DOI 10.1002/j.1552-4604.1993.tb03930.x; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; ENCIO IJ, 1991, J BIOL CHEM, V266, P7182; FULLER R, 1995, RESP MED, V89, P3, DOI 10.1016/0954-6111(95)90259-7; GRONEMEYER H, 1992, FASEB J, V6, P2524, DOI 10.1096/fasebj.6.8.1592204; HAGEN G, 1990, NUCLEIC ACIDS RES, V18, P2939, DOI 10.1093/nar/18.10.2939; Hecht K, 1997, J BIOL CHEM, V272, P26659, DOI 10.1074/jbc.272.42.26659; HOGGER P, 1994, STEROIDS, V59, P597, DOI 10.1016/0039-128X(94)90054-X; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HONOUR JW, 1994, RESP MED, V88, P9, DOI 10.1016/S0954-6111(05)80035-6; JENSEN SM, 1994, INT J CANCER, V58, P629, DOI 10.1002/ijc.2910580503; Knutsson PU, 1996, J ALLERGY CLIN IMMUN, V97, P655, DOI 10.1016/S0091-6749(96)70311-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE SJ, 1995, J INVEST MED, V43, P241; LUND J, 1986, TOXICOL APPL PHARM, V83, P486, DOI 10.1016/0041-008X(86)90231-0; MAXWELL DL, 1993, EUR RESPIR J, V6, P1145; MONTEFORT S, 1992, EUR RESPIR J, V5, P815; Nicklas R A, 1997, Curr Opin Pulm Med, V3, P51, DOI 10.1097/00063198-199701000-00008; NOBUKUNI Y, 1995, BIOCHEMISTRY-US, V34, P8207, DOI 10.1021/bi00025a028; NORD M, 1992, ARCH BIOCHEM BIOPHYS, V296, P302, DOI 10.1016/0003-9861(92)90576-I; ODONNELL D, 1995, BRAIN RES, V687, P133, DOI 10.1016/0006-8993(95)00479-A; Otto C, 1997, J BIOL CHEM, V272, P26665, DOI 10.1074/jbc.272.42.26665; RAY A, 1995, CHEST, V107, pS139, DOI 10.1378/chest.107.3_Supplement.139S; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; SANDMOLLER A, 1991, MECH DEVELOP, V34, P57, DOI 10.1016/0925-4773(91)90091-J; SCHMIDT TJ, 1994, RECEPTOR, V4, P229; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; TORKKELI T, 1978, BIOCHIM BIOPHYS ACTA, V544, P578, DOI 10.1016/0304-4165(78)90332-X; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YEHUDA R, 1995, ARCH GEN PSYCHIAT, V52, P583	44	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1999	103	4					595	600		10.1016/S0091-6749(99)70230-7	http://dx.doi.org/10.1016/S0091-6749(99)70230-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	186HY	10200007	Bronze			2022-12-18	WOS:000079723900010
J	Kanda, N; Tamaki, K				Kanda, N; Tamaki, K			Ganglioside GQ1b enhances Ig production by human PBMCs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ganglioside; GQ1b; immunoglobulin; T cell; IL-6; IL-10	BLOOD-BRAIN-BARRIER; HUMAN B-CELLS; IMMUNOGLOBULIN PRODUCTION; CEREBROSPINAL-FLUID; HUMAN KERATINOCYTES; IMMUNE-RESPONSE; LYMPHOCYTES-B; MESSENGER-RNA; T-CELLS; PROLIFERATION	Background: Gangliosides are glycosphingolipids that contain sialic acid and have various immunomodulatory effects. Objective: We studied in vitro effects of gangliosides on human humoral immune responses, Methods: PBMCs from healthy volunteers were cultured with gangliosides GM1, GM2, GM3, GD1a, GD1b, GD2, GD3, GT1b, and GQ1b, The amounts of IgG, IgM, and IgA and cytokine activity in the culture supernatants were measured with use of an ELISA, Proliferation was determined by [H-3] thymidine uptake, Results: Among the various gangliosides tested, GQ1b most strongly enhanced spontaneous IgG, IgM, and IgA production by human PBMCs. The effect of GQ1b was revealed at 0.1 mu mol/L, increased dose dependently, and was maximized at 10 mu mol/L. Weaker but significant stimulatory effects on the Ig production were manifested by GM2 and GD1a, whereas GT1b and GD1b were inhibitory. None of the gangliosides examined affected the proliferation of PBMCs. GQ1b did not enhance Ig production of B cells alone, Anti-IL-6 and anti-IL-10 antibody each partially blocked GQ1b-induced enhancement of the Ig production by PBMCs, and the addition of both antibodies completely blocked the enhancement. GQ1b enhanced both IL-6 and IL-10 production of T cells without affecting those of monocytes or B cells. GQ1b enhanced Ig production of T and B cell culture without monocytes. When T cells were preincubated with GQ1b, washed and added to B cells and monocytes, and then cultured together the Ig production was also enhanced, although to a lesser extent than the whole time incubation. Exogenous IL-6 and IL-10 each enhanced Ig production of B cells alone, and the addition of both gave additive effects, Conclusion: These results suggest that GQ1b mag indirectly enhance Ig production of B cells bg promoting IL-6 and IL-10 production of T cells in whole PBMC culture. That GQ1b may act as an important immunostimulator is also indicated.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kanda, N (corresponding author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kanda, Naoko/AAD-1808-2020					ALARCONRIQUELME ME, 1992, CLIN IMMUNOL IMMUNOP, V62, P264, DOI 10.1016/0090-1229(92)90101-S; BELLAMY A, 1986, J NEUROIMMUNOL, V12, P107, DOI 10.1016/0165-5728(86)90024-X; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; CSERR HF, 1992, J NEUROIMMUNOL, V41, P195, DOI 10.1016/0165-5728(92)90070-2; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; ESSELMAN WJ, 1977, J IMMUNOL, V119, P1994; FARRANT J, 1985, CLIN EXP IMMUNOL, V61, P189; GEE AP, 1987, BONE MARROW TRANSPL, V2, P155; GOUY H, 1995, J IMMUNOL, V155, P5160; GOUY H, 1994, J IMMUNOL, V152, P3271; HOON DSB, 1988, CELL IMMUNOL, V111, P410, DOI 10.1016/0008-8749(88)90104-9; KATO E, 1994, BIOCHEM BIOPH RES CO, V203, P1750, DOI 10.1006/bbrc.1994.2389; KIMATA H, 1995, EUR J IMMUNOL, V25, P302, DOI 10.1002/eji.1830250151; KIMATA H, 1991, CLIN EXP IMMUNOL, V85, P151; Kimata H, 1996, CLIN IMMUNOL IMMUNOP, V79, P197, DOI 10.1006/clin.1996.0068; KIMATA H, 1994, EUR J IMMUNOL, V24, P2910, DOI 10.1002/eji.1830241149; KIMATA H, 1994, BLOOD, V84, P1193, DOI 10.1182/blood.V84.4.1193.bloodjournal8441193; LEON A, 1988, J NEUROSCI, V8, P746; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; MILLER HC, 1975, J IMMUNOL, V115, P839; Minai Y, 1996, CELL IMMUNOL, V172, P200, DOI 10.1006/cimm.1996.0233; MOMOI T, 1986, BIOCHEM BIOPH RES CO, V13, P865; NAORA H, 1994, J IMMUNOL, V152, P5691; RADSAK K, 1982, H-S Z PHYSIOL CHEM, V363, P263, DOI 10.1515/bchm2.1982.363.1.263; RODDEN FA, 1991, J NEUROSURG, V74, P606, DOI 10.3171/jns.1991.74.4.0606; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; RYAN JL, 1979, EUR J IMMUNOL, V9, P171, DOI 10.1002/eji.1830090215; SAQR HE, 1993, J NEUROCHEM, V61, P395; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P835, DOI 10.1111/1523-1747.ep12607015; SELA BA, 1981, EUR J IMMUNOL, V11, P347, DOI 10.1002/eji.1830110417; SENN HJ, 1989, EUR J BIOCHEM, V181, P657, DOI 10.1111/j.1432-1033.1989.tb14773.x; STEVENS A, 1992, ACTA NEUROL SCAND, V86, P485, DOI 10.1111/j.1600-0404.1992.tb05129.x; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; TRBOJEVICCEPE M, 1990, J CLIN CHEM CLIN BIO, V28, P863; WESSELINGH SL, 1994, J IMMUNOL, V152, P1289; YADA Y, 1991, BIOCHEM J, V279, P665, DOI 10.1042/bj2790665; YADA Y, 1993, BIOCHEM BIOPH RES CO, V190, P688, DOI 10.1006/bbrc.1993.1104; ZUBIAGA AM, 1990, INT IMMUNOL, V2, P1047, DOI 10.1093/intimm/2.11.1047; [No title captured]	42	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1998	102	5					813	820		10.1016/S0091-6749(98)70022-3	http://dx.doi.org/10.1016/S0091-6749(98)70022-3			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	139MR	9819299				2022-12-18	WOS:000077033400016
J	Jalaludin, B; Wei, XA; Mahmic, A; Peat, J; Tovey, E; Leeder, S				Jalaludin, B; Wei, XA; Mahmic, A; Peat, J; Tovey, E; Leeder, S			Association between Der p 1 concentration and peak expiratory flow rate in children with wheeze: A longitudinal analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Der p 1; asthma; children; dust mite atopy; peak expiratory rate; random effects model; longitudinal analysis	HOUSE-DUST-MITE; ALLERGEN EXPOSURE; SYDNEY SCHOOLCHILDREN; ASTHMATIC SYMPTOMS; CHILDHOOD ASTHMA; SEVERITY; POPULATION; AUSTRALIA; REGIONS; RISK	Background: House dust mite (HDM) allergen exposure has been well documented as an environmental cause of airway hyperresponsiveness (AHR) and asthma symptoms, The relationship between asthma morbidity and exposure to low concentrations of HDM allergen suggests that there may be no safe exposure threshold to HDM allergen. Objective: We aimed to investigate the associations between Der p 1 in bedding and lung function in 30 children with a history of wheezing in a longitudinal study, Methods: After a cross-sectional study of school children, which included histamine challenge for AHR and skin testing for dust mite atopy, we made repeated measurements of HDM allergens in children with a history of wheeze over a 12-month period, These children also kept a daily asthma diary in which they recorded their peak expiratory flow rates (PEFRs). We used a repeated measures model to determine the association between PEFR and HDM allergen concentration. Results: There was a significant association between PEFRs and HDM allergen concentration (beta-coefficient = -14.17, P =.0024) in children with HDM atopy. An association was not found in children without HDM atopy. Conclusions: These findings support the hypothesis that HDM allergens have an adverse effect on the lung function of children with wheeze and highlight the importance of maintaining low dust mite allergen levels throughout the year in the home environment of children sensitized to HDMs.	Western Sydney Area Hlth Serv, Western Sector Publ Hlth Unit, MPH, N Parramatta, NSW 2151, Australia; Royal Prince Alfred Hosp, Inst Resp Med, Sydney, NSW, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; New Childrens Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Jalaludin, B (corresponding author), Western Sydney Area Hlth Serv, Western Sector Publ Hlth Unit, MPH, 13 New St, N Parramatta, NSW 2151, Australia.		Jalaludin, Bin/ABC-1066-2020; Tovey, Euan R/G-8604-2017	Jalaludin, Bin/0000-0001-7664-9621; Tovey, Euan R/0000-0002-1802-7266				BJORNSSON E, 1995, CLIN EXP ALLERGY, V25, P423, DOI 10.1111/j.1365-2222.1995.tb01073.x; CHANYEUNG M, 1995, AM J RESP CRIT CARE, V152, P1805, DOI 10.1164/ajrccm.152.6.8520740; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; FRISCHER TH, 1993, PEDIATR PULM, V16, P13, DOI 10.1002/ppul.1950160104; GRAY EJ, 1994, AIR POLLUTION HLTH R; KIVITY S, 1993, J ALLERGY CLIN IMMUN, V91, P844, DOI 10.1016/0091-6749(93)90341-C; KUEHR J, 1994, J ALLERGY CLIN IMMUN, V94, P44, DOI 10.1016/0091-6749(94)90070-1; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; MARKS GB, 1994, AUST NZ J MED, V24, P202, DOI 10.1111/j.1445-5994.1994.tb00558.x; MARKS GB, 1995, CLIN EXP ALLERGY, V25, P114, DOI 10.1111/j.1365-2222.1995.tb01015.x; MARKS GB, 1995, J ALLERGY CLIN IMMUN, V96, P441, DOI 10.1016/S0091-6749(95)70285-7; PEAT JK, 1994, EUR RESPIR J, V7, P1805, DOI 10.1183/09031936.94.07101805; PEAT JK, 1994, AUST NZ J MED, V24, P270, DOI 10.1111/j.1445-5994.1994.tb02171.x; PEAT JK, 1993, CLIN EXP ALLERGY, V23, P812, DOI 10.1111/j.1365-2222.1993.tb00258.x; Peat JK, 1996, EUR RESPIR J, V9, P1545, DOI 10.1183/09031936.96.09071545; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; REDDEL HK, 1995, AM J RESP CRIT CARE, V151, P1320, DOI 10.1164/ajrccm.151.5.7735580; SAS Institute, 1997, SAS STAT SOFTW CHANG; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; VANDERHEIDE S, 1994, J ALLERGY CLIN IMMUN, V93, P470, DOI 10.1016/0091-6749(94)90356-5; vanStrien RT, 1996, EUR RESPIR J, V9, P926, DOI 10.1183/09031936.96.09050926; ZOCK JP, 1994, EUR RESPIR J, V7, P1254, DOI 10.1183/09031936.94.07071254	22	15	15	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1998	102	3					382	386		10.1016/S0091-6749(98)70124-1	http://dx.doi.org/10.1016/S0091-6749(98)70124-1			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	124ZN	9768577				2022-12-18	WOS:000076212800008
J	Quirce, S; Hinojosa, M; Blanco, R; Cespon, C; Yoldi, M				Quirce, S; Hinojosa, M; Blanco, R; Cespon, C; Yoldi, M			Aspergillus fumigatus is the causative agent of hypersensitivity pneumonitis caused by esparto dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXTRINSIC ALLERGIC ALVEOLITIS; STIPA-TENACISSIMA		Hosp Ramon y Cajal, Dept Allergy, E-28034 Madrid, Spain; Hosp Ramon y Cajal, Dept Immunol, E-28034 Madrid, Spain; Hosp Severo Ochoa, Dept Pulmonol, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; Severo Ochoa University Hospital	Quirce, S (corresponding author), Av Pio XII,92,8-10, Madrid 28036, Spain.		s, q/AAD-7171-2020					GAMBOA PM, 1990, ALLERGOL IMMUNOPATH, V18, P331; Hinojosa M, 1996, J ALLERGY CLIN IMMUN, V98, P985, DOI 10.1016/S0091-6749(96)80016-9; Hinojosa Macias M, 1984, Med Clin (Barc), V82, P214; Schuyler M, 1997, CHEST, V111, P534, DOI 10.1378/chest.111.3.534; ZAMARRON C, 1992, J INTERN MED, V232, P177, DOI 10.1111/j.1365-2796.1992.tb00568.x	5	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1998	102	1					147	148		10.1016/S0091-6749(98)70067-3	http://dx.doi.org/10.1016/S0091-6749(98)70067-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	102DX	9679860				2022-12-18	WOS:000074909500022
J	Lie, WJH; Mul, FPJ; Roos, D; Verhoeven, AJ; Knol, EF				Lie, WJH; Mul, FPJ; Roos, D; Verhoeven, AJ; Knol, EF			Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						basophils; cytokines; signal transduction; allergy	PROTEIN-KINASE-C; METHIONYL-LEUCYL-PHENYLALANINE; LATE-PHASE RESPONSE; HISTAMINE-RELEASE; ANTIGEN CHALLENGE; MEDIATOR RELEASE; MAST-CELLS; LEUKOTRIENE GENERATION; ACTIVATING-FACTOR; ATOPIC SUBJECTS	In most secretory cells, an increase in the cytosolic free Ca2+ concentration ([Ca2+](i)) is associated with the exocytosis response. In this study we have evaluated the effect of thapsigargin on histamine release from purified (70% to 97% pure) human basophils of nonallergic donors. Thapsigargin (2 mu mol/L), by inhibiting the uptake of Ca2+ in the stores of the endoplasmic reticulum, leads within 1 minute to a gradual increase in [Ca2+](i) in human basophils. Incubation of basophils with thapsigargin by itself induced only a very small release of histamine (5.6% +/- 1.8%). However, under suboptimal conditions of stimulation with other agonists, preincubation of basophils with thapsigargin significantly enhanced histamine release. Most strikingly, addition of thapsigargin made basophils extremely sensitive for histamine release induced by IL-3 (maximum histamine release, 71% +/- 7%), IL-5 (maximum histamine release, 43% +/- 8%), or granulocyte-macrophage colony-stimulating factor (GM-CSF) (maximum histamine release, 57% +/- 10%). These cytokines by themselves did not induce histamine release in purified basophils. The effect of thapsigargin was mimicked to a limited extent by addition of platelet-activating factor. We conclude that depletion of the Ca2+ stores may be a critical event in the activation of receptor-mediated histamine release in human basophils.	Netherlands Red Cross, Blood Transfus Serv, Cent Lab, NL-1066 CX Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Clin & Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Roos, D (corresponding author), Netherlands Red Cross, Blood Transfus Serv, Cent Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.			Knol, Edward/0000-0001-7368-9820; Mul, FPJ/0000-0002-8234-9972				ALAM R, 1992, J CLIN INVEST, V89, P723, DOI 10.1172/JCI115648; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; BIJSTERBOSCH MK, 1986, BIOCHEM BIOPH RES CO, V137, P500, DOI 10.1016/0006-291X(86)91238-6; BISCHOFF SC, 1990, P NATL ACAD SCI USA, V87, P6813, DOI 10.1073/pnas.87.17.6813; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; BISCHOFF SC, 1993, EUR J IMMUNOL, V23, P761, DOI 10.1002/eji.1830230329; BRUNNER T, 1991, J IMMUNOL, V147, P237; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; DAHINDEN CA, 1989, J EXP MED, V170, P1787, DOI 10.1084/jem.170.5.1787; DEBOER M, 1986, J IMMUNOL, V136, P3447; FREW AJ, 1991, CLIN EXP IMMUNOL, V85, P70; GILBERT HS, 1975, BLOOD, V46, P279; GUO CB, 1994, AM J RESP CELL MOL, V10, P384, DOI 10.1165/ajrcmb.10.4.7510984; HASTIE R, 1979, LAB INVEST, V40, P554; HIRAI K, 1988, J IMMUNOL, V141, P3958; HIRAI K, 1990, J EXP MED, V172, P1525, DOI 10.1084/jem.172.5.1525; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; ILIOPOULOS O, 1992, J IMMUNOL, V148, P2223; IRVINE RF, 1990, FEBS LETT, V1, P5; KATO M, 1992, LYMPHOKINE CYTOK RES, V11, P287; KEIJ JF, 1989, CYTOMETRY, V10, P814, DOI 10.1002/cyto.990100623; KNOL EF, 1991, EUR J IMMUNOL, V21, P881, DOI 10.1002/eji.1830210404; KNOL EF, 1992, J ALLERGY CLIN IMMUN, V90, P92, DOI 10.1016/S0091-6749(06)80015-1; KNOL EF, 1993, J IMMUNOL, V151, P4926; KOENDERMAN L, 1989, J IMMUNOL, V142, P623; KOSHINO T, 1993, CLIN EXP ALLERGY, V23, P919, DOI 10.1111/j.1365-2222.1993.tb00276.x; KUNA P, 1992, J IMMUNOL, V149, P636; KURIMOTO Y, 1991, EUR J IMMUNOL, V21, P361, DOI 10.1002/eji.1830210217; LEE RJ, 1995, MOL BIOL CELL, V6, P825, DOI 10.1091/mbc.6.7.825; LICHTENSTEIN LM, 1991, ANN NY ACAD SCI, V629, P48; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; LOPEZ AF, 1990, J CELL PHYSIOL, V145, P69, DOI 10.1002/jcp.1041450111; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; MACDONALD SM, 1989, J IMMUNOL, V142, P3527; MACGLASHAN DW, 1993, J IMMUNOL, V151, P6359; MARUYAMA N, 1994, AM J RESP CRIT CARE, V150, P1086, DOI 10.1164/ajrccm.150.4.7921441; MASSEY W, 1993, J IMMUNOL, V150, P1084; MELDOLESI J, 1993, CURR BIOL, V3, P910, DOI 10.1016/0960-9822(93)90235-G; METZ DC, 1994, BBA-MOL CELL RES, V1220, P199, DOI 10.1016/0167-4889(94)90136-8; MITCHELL EB, 1982, LANCET, V1, P127; MIYAJIMA A, 1993, BLOOD, V82, P1960; MUL FPJ, 1992, J IMMUNOL METHODS, V149, P207, DOI 10.1016/0022-1759(92)90252-O; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Roos D, 1986, Methods Enzymol, V132, P225; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SIRAGANIAN RP, 1975, J IMMUNOL METHODS, V7, P283, DOI 10.1016/0022-1759(75)90025-3; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TSUNODA Y, 1993, BIOCHIM BIOPHYS ACTA, V1154, P105, DOI 10.1016/0304-4157(93)90008-C; WARNER JA, 1987, J IMMUNOL, V139, P161; WARNER JA, 1989, J IMMUNOL, V142, P1669; WARNER JA, 1990, J IMMUNOL, V145, P1897	57	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1998	101	5					683	690		10.1016/S0091-6749(98)70178-2	http://dx.doi.org/10.1016/S0091-6749(98)70178-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZN926	9600507	Bronze			2022-12-18	WOS:000073697400018
J	Naclerio, RM; Baroody, F				Naclerio, RM; Baroody, F			Understanding the inflammatory processes in upper allergic airway disease and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, IL				ENDOTHELIAL ADHESION MOLECULES; NASAL ANTIGEN CHALLENGE; HISTAMINE-RELEASE; MEDIATOR RELEASE; NEUROPEPTIDE-Y; CELL-ADHESION; DRY AIR; RHINITIS; EOSINOPHILS; RESPONSES		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Naclerio, RM (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.				NIAID NIH HHS [AI01236] Funding Source: Medline; NIDCD NIH HHS [DC02714] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AHARONSON EF, 1974, J APPL PHYSIOL, V37, P654, DOI 10.1152/jappl.1974.37.5.654; Andersen, 1982, NOSE UPPER AIRWAY PH, P45; BARANIUK JN, 1990, AM J PHYSIOL, V258, pL81, DOI 10.1152/ajplung.1990.258.2.L81; BARANIUK JN, 1992, J APPL PHYSIOL, V73, P1867, DOI 10.1152/jappl.1992.73.5.1867; BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; BAROODY FM, 1994, AM J RESP CRIT CARE, V149, P1457, DOI 10.1164/ajrccm.149.6.7516250; BAROODY FM, 1996, CLIN IMMUNOLOGY PRIN, P889; BASCOM R, 1988, J ALLERGY CLIN IMMUN, V81, P570, DOI 10.1016/0091-6749(88)90198-4; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BIRCHALL MA, 1993, CLIN OTOLARYNGOL, V18, P139, DOI 10.1111/j.1365-2273.1993.tb00546.x; Bousquet J, 1996, INT ARCH ALLERGY IMM, V110, P207, DOI 10.1159/000237289; BRAUNSTEIN G, 1991, AM REV RESPIR DIS, V144, P630, DOI 10.1164/ajrccm/144.3_Pt_1.630; DEFFEBACH ME, 1987, AM REV RESPIR DIS, V135, P463; Desrosiers M, 1996, ANN OTO RHINOL LARYN, V105, P146, DOI 10.1177/000348949610500210; DESROSIERS M, IN PRESS J ALLERGY C; Fry F.A., 1973, J AEROSOL SCI, V4, P113; Gauvreau GM, 1996, AM J RESP CRIT CARE, V154, P1267, DOI 10.1164/ajrccm.154.5.8912734; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; Godthelp T, 1996, J ALLERGY CLIN IMMUN, V97, P800, DOI 10.1016/S0091-6749(96)80158-8; Howard OMZ, 1996, TRENDS BIOTECHNOL, V14, P46, DOI 10.1016/0167-7799(96)80920-6; ILIOPOULOS O, 1990, J ALLERGY CLIN IMMUN, V86, P851, DOI 10.1016/S0091-6749(05)80146-0; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; KALINER MA, 1993, J ALLERGY CLIN IMMUN, V92, P144, DOI 10.1016/0091-6749(93)90096-X; Kita H, 1996, J EXP MED, V183, P2421, DOI 10.1084/jem.183.6.2421; KONNO A, 1979, ANN OTO RHINOL LARYN, V88, P258, DOI 10.1177/000348947908800219; LEE BJ, 1994, J ALLERGY CLIN IMMUN, V94, P1006, DOI 10.1016/0091-6749(94)90119-8; LIM MC, 1995, AM J RESP CRIT CARE, V151, P136, DOI 10.1164/ajrccm.151.1.7812543; LIPPMANN M, 1970, ANN OTO RHINOL LARYN, V79, P519, DOI 10.1177/000348947007900314; LOBB RR, 1992, ADHESION ITS ROLE IN, P1; MAN SFP, 1979, J APPL PHYSIOL, V46, P205, DOI 10.1152/jappl.1979.46.2.205; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; MONGAR JL, 1957, J PHYSIOL-LONDON, V135, P320, DOI 10.1113/jphysiol.1957.sp005713; MONTEFORT S, 1993, EUR RESPIR J, V6, P1044; MYGIND N, 1990, RHINITIS ASTHMA; Naclerio RM, 1997, J ALLERGY CLIN IMMUN, V100, P505, DOI 10.1016/S0091-6749(97)70143-X; Naclerio RM, 1996, J ALLERGY CLIN IMMUN, V98, P721, DOI 10.1016/S0091-6749(96)70118-5; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; OLLERENSHAW S, 1989, NEW ENGL J MED, V320, P1244, DOI 10.1056/NEJM198905113201904; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; SUNG CP, 1991, CIRC RES, V68, P314, DOI 10.1161/01.RES.68.1.314; TOGIAS A, 1990, AM REV RESPIR DIS, V141, P1428, DOI 10.1164/ajrccm/141.6.1428; TOGIAS AG, 1988, AM REV RESPIR DIS, V137, P625, DOI 10.1164/ajrccm/137.3.625; WACHS M, 1989, J ALLERGY CLIN IMMUN, V84, P492, DOI 10.1016/0091-6749(89)90362-X; Wagenmann M, 1997, AM J RESP CRIT CARE, V155, P426, DOI 10.1164/ajrccm.155.2.9032173; Willatt D. J., 1993, Rhinology (Utrecht), V31, P63	51	15	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S345	S351		10.1016/S0091-6749(98)70217-9	http://dx.doi.org/10.1016/S0091-6749(98)70217-9			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	ZA245	9500725				2022-12-18	WOS:000072343900001
J	Rachelefsky, GS				Rachelefsky, GS			Pharmacologic management of allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	21st Century Management of Upper Respiratory Allergic Diseases - a Focus on Allergy and Asthma	JAN 13-14, 1997	CHICAGO, ILLINOIS						Allergy Res Fdn INc, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Div Allergy & Immunol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rachelefsky, GS (corresponding author), Allergy Res Fdn INc, 11620 Wilshire Blvd, Los Angeles, CA 90025 USA.							CLISSOLD SP, 1989, DRUGS, V37, P42, DOI 10.2165/00003495-198937010-00003; CRETICOS PS, 1995, ASTHMA RHINITIS, P1394; *CSR, 1995, SAF EFF CLAR D LESS; DELAFUENTE JC, 1989, CLIN PHARMACY, V8, P474; Hornby PJ, 1996, CLIN OBSTET GYNECOL, V39, P17, DOI 10.1097/00003081-199603000-00005; *ICR, 1994, EUR J ALLERGY CLIN I, V49, P1; SALVAGGIO JE, 1992, CECIL TXB MED, P1457; SIMONS E, 1995, ASTHMA RHINITIS, P1325; STEMPEL D, 1996, DRUG BENEFIT TRENDS, V8, P11	9	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	2	S			S367	S369		10.1016/S0091-6749(98)70222-2	http://dx.doi.org/10.1016/S0091-6749(98)70222-2			3	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZA245	9500730				2022-12-18	WOS:000072343900006
J	Lin, FL; Woodmansee, D; Patterson, R				Lin, FL; Woodmansee, D; Patterson, R			Near-fatal anaphylaxis to topical bacitracin ointment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USN, San Diego Med Ctr, Dept Clin Invest, San Diego, CA 92134 USA; USN, San Diego Med Ctr, Dept Internal Med, San Diego, CA 92134 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; Northwestern University	Lin, FL (corresponding author), USN, San Diego Med Ctr, Dept Clin Invest, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.							Comaish J S, 1967, Br J Clin Pract, V21, P97; EEDY DJ, 1990, POSTGRAD MED J, V66, P858, DOI 10.1136/pgmj.66.780.858; GOH C L, 1986, Australasian Journal of Dermatology, V27, P125, DOI 10.1111/j.1440-0960.1986.tb00307.x; KNOWLES SR, 1995, INT J DERMATOL, V34, P572, DOI 10.1111/j.1365-4362.1995.tb02958.x; LOWENTHAL M, 1993, ANN ALLERGY, V71, P481; ROUPE G, 1969, ARCH DERMATOL, V100, P450, DOI 10.1001/archderm.100.4.450; SCHECHTER JF, 1984, ARCH DERMATOL, V120, P909, DOI 10.1001/archderm.120.7.909; VALE MA, 1978, ARCH DERMATOL, V114, P800, DOI 10.1001/archderm.1978.01640170094034	8	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1998	101	1	1				136	137		10.1016/S0091-6749(98)70209-X	http://dx.doi.org/10.1016/S0091-6749(98)70209-X			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR872	9449517				2022-12-18	WOS:000071539800025
J	Cloosterman, SGM; Hofland, ID; Lukassen, HGM; Wieringa, MH; Folgering, HTM; vanderHeide, S; Brunekreef, B; vanSchayck, CP				Cloosterman, SGM; Hofland, ID; Lukassen, HGM; Wieringa, MH; Folgering, HTM; vanderHeide, S; Brunekreef, B; vanSchayck, CP			House dust mite avoidance measures improve peak flow and symptoms in patients with allergy but without asthma: A possible delay in the manifestation of clinical asthma?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						house dust mite; allergen avoidance; peak flow; asthma symptoms; prevention	SOLIDIFIED BENZYL BENZOATE; DER-P-I; CHILDHOOD ASTHMA; CONTROLLED TRIAL; LIQUID-NITROGEN; EXPOSURE; SEVERITY; ACAROSAN; PREVENTION; ACARICIDE	Background: Asthma caused by allergy to house dust mite is a growing problem. Patients,vith allergy who do not have asthma (yet) might develop asthma depending on exposure to precipitating factors. Objective: We sought to determine whether house dust mite avoidance measures have an effect on the development of asthma. Methods: Patients with allergy (n = 29) who had no diagnosis of asthma (FEV1 of 99.1% +/- 10.6% of predicted, peak how variability of 5.21% +/- 3.41%, reversibility of FEV1 after 400 mu g salbutamol of 3.92% +/- 3.73% according to the reference values) were randomly allocated (subjects blinded) to a treatment (n = 16) and a placebo group (n = 13). House dust mite avoidance treatment consisted of applying Acarosan (Allergopharma, J. Ganzer KG, Hamburg, Germany) (the placebo group used water) to the boors (living room, bedroom), and the use of covers for mattresses and bedding that were impermeable to house dust mite (the placebo group used cotton covers for mattresses only). We tested whether the intervention had an effect on peak flow parameters and asthma symptom scores during 6 weeks of treatment. Results: Significant improvements were seen in the treatment group in symptom scores (Borg score) for disturbed sleep, breathlessness, wheeze, and overall symptom score. Slight but statistically significant improvements in peak how (morning, evening, and variability) were seen in the treatment group also. No significant changes were seen in the placebo group. Conclusions: Although this study is not long enough to study the development of asthma, the results indicates that house dust mite avoidance measures had an effect on peak how parameters and asthma symptoms in patients with allergy but without asthma. These findings might implicate that a shift in developing clinically manifest asthma could be achieved with house dust mite avoidance measures. To give a better answer to whether preventing the development of asthma is possible, larger studies with a longer follow-up period are necessary.	UNIV NIJMEGEN,DEPT PULM DIS,MED CTR DEKKERSWALD,NL-6500 HB NIJMEGEN,NETHERLANDS; AGR UNIV WAGENINGEN,DEPT EPIDEMIOL & PUBL HLTH,WAGENINGEN,NETHERLANDS; UNIV GRONINGEN,DEPT ALLERGY,NL-9700 AB GRONINGEN,NETHERLANDS	Radboud University Nijmegen; Wageningen University & Research; University of Groningen	Cloosterman, SGM (corresponding author), UNIV NIJMEGEN,DEPT GEN PRACTICE & SOCIAL MED,MED CTR DEKKERSWALD,POB 9101,NL-6500 HB NIJMEGEN,NETHERLANDS.			brunekreef, bert/0000-0001-9908-0060				ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; CARSWELL F, 1995, CLIN EXP ALLERGY, V25, P99, DOI 10.1111/j.1365-2222.1995.tb01012.x; CHANYEUNG M, 1995, AM J RESP CRIT CARE, V152, P1805, DOI 10.1164/ajrccm.152.6.8520740; Cloosterman S. G. M., 1994, European Respiratory Journal, V7, p399S; COLLOFF MJ, 1992, CLIN EXP ALLERGY, V22, P1, DOI 10.1111/j.1365-2222.1992.tb01763.x; DONKERS JM, 1995, EUR RESPIR J, V8, P499; DORWARD AJ, 1988, THORAX, V43, P98, DOI 10.1136/thx.43.2.98; GILLIES DRN, 1987, CLIN ALLERGY, V17, P105, DOI 10.1111/j.1365-2222.1987.tb02327.x; HEGARTY JM, 1993, ALLERGY, V48, P108; Hide DW, 1996, ALLERGY, V51, P89, DOI 10.1111/j.1398-9995.1996.tb04563.x; HUSS RW, 1994, J ALLERGY CLIN IMMUN, V94, P27, DOI 10.1016/0091-6749(94)90067-1; KALRA S, 1993, THORAX, V48, P10, DOI 10.1136/thx.48.1.10; KNIEST FM, 1991, CLIN EXP ALLERGY, V21, P39, DOI 10.1111/j.1365-2222.1991.tb00802.x; LAUSCHADENDORF S, 1991, J ALLERGY CLIN IMMUN, V87, P41, DOI 10.1016/0091-6749(91)90211-6; MARKS GB, 1995, CLIN EXP ALLERGY, V25, P114, DOI 10.1111/j.1365-2222.1995.tb01015.x; MARKS GB, 1994, CLIN EXP ALLERGY, V24, P1078, DOI 10.1111/j.1365-2222.1994.tb02746.x; MITCHELL EB, 1985, CLIN ALLERGY, V15, P235, DOI 10.1111/j.1365-2222.1985.tb02280.x; *NAT HEART LUNG BL, 1992, EUR RESPIR J, V5, P601; NINAN TK, 1993, THORAX, V48, P582, DOI 10.1136/thx.48.5.582-b; Peat JK, 1996, EUR RESPIR J, V9, P1545, DOI 10.1183/09031936.96.09071545; Peat JK, 1996, AM J RESP CRIT CARE, V153, P141, DOI 10.1164/ajrccm.153.1.8542107; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; PLATTSMILLS TAE, 1995, J ALLERGY CLIN IMMUN, V96, P435, DOI 10.1016/S0091-6749(95)70284-9; PLATTSMILLS TAE, 1989, J ALLERGY CLIN IMMUN, V83, P417; RIDOUT S, 1993, BRIT J CLIN PRACT, V47, P141; RIJCKEN B, 1996, EUROPEAN COMMUNITY R, P180; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; SPORIK R, 1992, EXP APPL ACAROL, V16, P141, DOI 10.1007/BF01201497; WALSHAW MJ, 1986, Q J MED, V58, P199; WARNER JA, 1991, RESP MED, V85, P101, DOI 10.1016/S0954-6111(06)80285-4; WARNER JO, 1990, CLIN EXP ALLERGY, V20, P15, DOI 10.1111/j.1365-2222.1990.tb02465.x; *WHO NIH, 1995, GLOB IN ASTHM; Woolcock AJ, 1995, ALLERGY, V50, P935, DOI 10.1111/j.1398-9995.1995.tb02504.x	36	15	15	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1997	100	3					313	319		10.1016/S0091-6749(97)70243-4	http://dx.doi.org/10.1016/S0091-6749(97)70243-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XX479	9314342				2022-12-18	WOS:A1997XX47900007
J	Merget, R; Heger, M; Globisch, A; Rasche, K; Gillissen, A; Gebler, A; SchultzeWerninghaus, G; Krieg, M				Merget, R; Heger, M; Globisch, A; Rasche, K; Gillissen, A; Gebler, A; SchultzeWerninghaus, G; Krieg, M			Quantitative bronchial challenge tests with wheat flour dust administered by Spinhaler: Comparison with aqueous wheat flour extract inhalation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Bakers' asthma; wheat flour; bronchial challenge; occupational asthma; diagnosis	OCCUPATIONAL-ASTHMA; BRONCHOPROVOCATION; AMYLASE; BAKERS	Background: quantitative bronchial challenge tests with flour dust for the diagnosis of bakers' asthma may be performed by inhalation of flour delivered to the patient's respiratory tract by sophisticated equipment. Objective: This study was carried out to assess the diagnostic value of bronchial challenge tests with hour dust inhalation from capsules administered by a Spinhaler (Fisons Inc., Loughborough, U.K.) and to compare this method quantitatively with bronchial challenge tests with a commercially available wheat Flour extract. Methods: A highly selected group of 36 bakers with work-related symptoms of rhinitis or asthma were referred to our department, a tertiary referral center, from 1992 to 1995. Thirty-four of the subjects and 10 atopic control subjects were included in this study, After the assessment of bronchial hyperresponsiveness on day 1, subjects were randomized to inhale an aqueous wheat flour extract at concentrations of 0.01, 0.1, 1, 10, and 100 mg/ml by tidal volume breathing for 10 minutes or to inhale wheat flour dust filled in capsules on days 2 and 3. One, two, and four capsules (maximum of 7 cumulative capsules) of flour dust were administered by a Spinhaler, In addition, skin prick tests were performed with a battery of environmental and occupational allergens, Total serum IgE and specific IgE to wheat hour were measured by standard pocedures. Results: Seventeen bakers and two control subjects demonstrated a positive skin test response to wheat hour (wheal greater than or equal to 3 mm), Fifteen bakers demonstrated a fall of 50% or more in specific airway conductance after inhalation of the commercial wheat hour extract, and II demonstrated such a fall in specific airway conductance after inhalation of wheat dust. Three control subjects had a positive bronchial challenge response to the extract, but dust inhalation from the capsule did not cause positive bronchial reactions in control subjects, When a 50% fall of specific airway conductance was used as criterion for a positive bronchial provocation test result, sensitivity for the extract or dust inhalation was 0.44 and 0.32, respectively, and specificity was 0.7 and 1.0, respectively, If only subjects with a positive skin test response to wheat flour were considered, sensitivity of both tests was 0.65. With more stringent criteria for the gold standard, there was a trend for a higher sensitivity but a lower specificity of the extract inhalation, Both methods were safe. Conclusion: The validity of bronchial challenge tests with wheat hour dust inhaled from Spinhaler capsules was superior to that of tests done with a commercially available aqueous wheat hour extract, The higher specificity of the Spinhaler method might be an advantage if bronchial challenge tests are used as confirmation tests.	UNIV HOSP BERGMANNSHEIL, DEPT INTERNAL MED, DIV PNEUMONOL ALLERGOL & SLEEP MED, BOCHUM, GERMANY; UNIV HOSP BERGMANNSHEIL, DEPT CLIN CHEM TRANSFUS & LAB MED, BOCHUM, GERMANY; RUHR UNIV BOCHUM, DEPT MED COMP SCI BIOMETR & EPIDEMIOL, DIV MED, D-4630 BOCHUM, GERMANY	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum								BAUR X, 1986, LANCET, V1, P43; BAUR X, 1988, J ALLERGY CLIN IMMUN, V81, P321, DOI 10.1016/0091-6749(88)90846-9; BONER AL, 1986, ANN ALLERGY, V57, P363; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P823, DOI 10.1016/0091-6749(89)90346-1; CLOUTIER Y, 1989, EUR RESPIR J, V2, P769; DELUCA S, 1988, EUR RESPIR J, V1, P540; GODNICCVAR J, 1990, AM J IND MED, V18, P541, DOI 10.1002/ajim.4700180504; LEONHARDT L, 1989, ALLERGOLOGIE, V12, P336; LIN FJ, 1995, OCCUP ENVIRON MED, V52, P54, DOI 10.1136/oem.52.1.54; LOSADA E, 1992, J ALLERGY CLIN IMMUN, V89, P118, DOI 10.1016/S0091-6749(05)80048-X; MERGET R, 1994, ALLERGY, V49, P897, DOI 10.1111/j.1398-9995.1994.tb00797.x; Pepys J, 1975, CLIN ASPECTS IMMUNOL, P55; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sander I., 1996, Atemwegs- und Lungenkrankheiten, V22, P350; SCHULTZEWERNINGHAUS G, 1991, INT ARCH ALLER A IMM, V94, P371, DOI 10.1159/000235407; ZWEIG MH, 1993, CLIN CHEM, V39, P561	16	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1997	100	2					199	207		10.1016/S0091-6749(97)70225-2	http://dx.doi.org/10.1016/S0091-6749(97)70225-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XR351	9275141				2022-12-18	WOS:A1997XR35100010
J	Campbell, DE; Kemp, AS				Campbell, DE; Kemp, AS			Cyclosporine restores cytokine imbalance in childhood atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											Campbell, DE (corresponding author), ROYAL CHILDRENS HOSP,DEPT IMMUNOL,MELBOURNE,VIC 3052,AUSTRALIA.			Campbell, Dianne/0000-0002-0907-6963				ANDERSSON J, 1992, IMMUNOLOGY, V75, P136; Bemer V, 1995, EUR J IMMUNOL, V25, P3394, DOI 10.1002/eji.1830251229; Campbell DE, 1997, CLIN EXP IMMUNOL, V107, P392, DOI 10.1111/j.1365-2249.1997.278-ce1172.x; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; TANG M, 1993, CLIN EXP IMMUNOL, V92, P120; TANG MLK, 1994, LANCET, V344, P983, DOI 10.1016/S0140-6736(94)91641-1; VANJOOST T, 1994, BRIT J DERMATOL, V130, P634	7	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				857	859		10.1016/S0091-6749(97)80025-5	http://dx.doi.org/10.1016/S0091-6749(97)80025-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215259				2022-12-18	WOS:A1997XH19300024
J	Dvorak, AM; Morgan, ES				Dvorak, AM; Morgan, ES			Diamine oxidase-gold enzyme-affinity ultrastructural demonstration that human gut mucosal mast cells secrete histamine by piecemeal degranulation in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						mast cells; diamine oxidase gold; histamine; piecemeal degranulation; human inflammatory bowel disease; histaminase; collagen; secretion; extracellular matrix	CROSS-LINKING ENZYMES; CROHNS-DISEASE; ULCERATIVE-COLITIS; BIOPSY SAMPLES; FACTOR-XIII; IN-VIVO; TRANSGLUTAMINASE; RELEASE; BASOPHILS; GRANULES	Biopsy specimens of human ilea were prepared for the ultrastructural detection of histamine in vivo with a new enzyme-affinity method (Dvornak et al., J Histochem Cytochem 1993; 41:787-800). Human gut mucosal mast cells contained histamine in cytoplasmic secretory granules that were electron dense, regardless of underlying substructural patterns. Partially and completely empty cytoplasmic granules, characteristic for piecemeal degranulation (Dvorak et al., Int Arch Allergy Immunol 1992;99:74-83) had diminished and absent histamine stores, whereas electron-dense grannies in the same cells retainer! there histamine. Interstitial collagen (but not basal lamina of other cells) near secretory mad cells avidly bound histamine, thereby providing a potential source for re-release of extracellular histamine stores, These studies provide the first documentation of histamine secretion in vivo during piecemeal degranulation of human mast cells.	HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; BETH ISRAEL DEACONESS MED CTR,HARVARD DIGEST DIS CTR,DEPT PATHOL,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Dvorak, AM (corresponding author), BETH ISRAEL DEACONESS MED CTR,DEPT PATHOL,E CAMPUS,330 BROOKLINE AVE,BOSTON,MA 02215, USA.				NIAID NIH HHS [AI-33372] Funding Source: Medline; NIDDK NIH HHS [DK-34854] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; AHRENSTEDT O, 1994, J GASTROEN HEPATOL, V9, P539, DOI 10.1111/j.1440-1746.1994.tb01557.x; AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435, DOI 10.1002/jlb.59.3.435; BAENKLER HW, 1987, HEPATO-GASTROENTEROL, V34, P289; BARRETT KE, 1985, EUR J PHARMACOL, V107, P279, DOI 10.1016/0014-2999(85)90071-8; Beil WJ, 1996, INT ARCH ALLERGY IMM, V109, P383, DOI 10.1159/000237267; BENDAYAN M, 1984, J ELECTRON MICR TECH, V1, P349, DOI 10.1002/jemt.1060010405; Bissonnette EY, 1996, J IMMUNOL, V156, P218; CLARKE DD, 1959, ARCH BIOCHEM BIOPHYS, V79, P338, DOI 10.1016/0003-9861(59)90413-8; DAGOSTINO L, 1988, GASTROENTEROLOGY, V95, P1503, DOI 10.1016/S0016-5085(88)80069-6; DARGENIO G, 1995, GUT, V37, P690, DOI 10.1136/gut.37.5.690; DVORAK AM, 1992, INT ARCH ALLERGY IMM, V98, P158, DOI 10.1159/000236180; DVORAK AM, 1993, ANN SURG, V217, P260, DOI 10.1097/00000658-199303000-00008; Dvorak AM, 1996, BLOOD, V88, P4090; DVORAK AM, 1995, BLOOD, V86, P3560; DVORAK AM, 1992, INT ARCH ALLERGY IMM, V99, P74, DOI 10.1159/000236338; Dvorak AM, 1996, J LEUKOCYTE BIOL, V59, P824, DOI 10.1002/jlb.59.6.824; DVORAK AM, 1991, J LEUKOCYTE BIOL, V49, P197, DOI 10.1002/jlb.49.2.197; DVORAK AM, 1988, EOS-RIV IMMUNOL, V8, P50; DVORAK AM, 1980, HUM PATHOL, V11, P606, DOI 10.1016/S0046-8177(80)80072-4; DVORAK AM, 1993, J HISTOCHEM CYTOCHEM, V41, P787, DOI 10.1177/41.6.8315271; DVORAK AM, 1994, BLOOD, V83, P3600; DVORAK AM, 1994, INT ARCH ALLERGY IMM, V105, P8, DOI 10.1159/000236796; DVORAK AM, 1993, INT ARCH ALLERGY IMM, V102, P33, DOI 10.1159/000236548; DVORAK AM, 1996, INT ARCH ALLERGY IMM, V11, P238; Dvorak AM, 1992, GRANULOCYTE RESPONSE, P169; DVORAK HF, 1975, CLIN HAEMATOL, V4, P651; FESUS L, 1985, J BIOL CHEM, V260, P3771; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; FOX CC, 1990, GASTROENTEROLOGY, V99, P119, DOI 10.1016/0016-5085(90)91238-2; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; GALLI SJ, 1991, CURR OPIN IMMUNOL, V3, P865, DOI 10.1016/S0952-7915(05)80005-6; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HIDASI V, 1995, J HISTOCHEM CYTOCHEM, V43, P1173, DOI 10.1177/43.11.7560900; Jarisch R, 1996, INT ARCH ALLERGY IMM, V110, P7, DOI 10.1159/000237304; LANTZ M, 1991, J CLIN INVEST, V88, P2026, DOI 10.1172/JCI115530; LUK GD, 1980, J CLIN INVEST, V66, P66, DOI 10.1172/JCI109836; MALONE MH, 1986, NEW ENGL REG ALLERGY, V7, P241; MCLEOD RS, 1994, DIS COLON RECTUM, V37, P26, DOI 10.1007/BF02047210; ONDERDONK AB, 1992, J CLIN MICROBIOL, V30, P312, DOI 10.1128/JCM.30.2.312-317.1992; OSHITANI N, 1995, AM J GASTROENTEROL, V90, P1116; PAFF GH, 1955, ANAT REC, V121, P579, DOI 10.1002/ar.1091210309; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V105, P701, DOI 10.1016/0016-5085(93)90886-H; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; RAITHEL M, 1995, INT ARCH ALLERGY IMM, V108, P127, DOI 10.1159/000237129; RAITHEL M, 1989, AGENTS ACTIONS, V28, P164, DOI 10.1007/BF01967396; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; ROKKAS T, 1990, GASTROENTEROLOGY, V98, P1493, DOI 10.1016/0016-5085(90)91081-G; SCHRODE J, 1978, J BIOL CHEM, V253, P4837; SPILLMANN D, 1994, CURR OPIN STRUC BIOL, V4, P677, DOI 10.1016/S0959-440X(94)90165-1; Taylor S. L., 1978, Journal of Food Safety, V1, P173, DOI 10.1111/j.1745-4565.1978.tb00271.x	53	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				812	820		10.1016/S0091-6749(97)80016-4	http://dx.doi.org/10.1016/S0091-6749(97)80016-4			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215250				2022-12-18	WOS:A1997XH19300015
J	Gentile, DA; Skoner, DP				Gentile, DA; Skoner, DP			The relationship between airway hyperreactivity (AHR) and sodium, potassium adenosine triphosphatase (Na+, K+ ATPase) enzyme inhibition	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						sodium; potassium adenosine triphosphatase; ouabain; methacholine; airway hyperreactivity; allergy; asthma	PLATELET-ACTIVATING FACTOR; SMOOTH-MUSCLE; GROWTH-FACTOR; CIRCULATING INHIBITOR; BRONCHIAL REACTIVITY; TRANSPORT INHIBITORS; HISTAMINE; CALCIUM; INVITRO; ASTHMA	Previous studies have documented the presence of a sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme inhibitor on platelet membranes and in the plasma of patients with allergy, many of whom historically had airway hyperreactivity (AHR). The purpose of this study was to investigate the relationship between methacholine AAR and Na+,K+ ATPase enzyme inhibition. In the first experiment, 47 adult subjects (13 allergic, 5 potentially allergic, 12 asthmatic, and 17 control subjects) were tested for platelet membrane Na+,K+ ATPase inhibition and AHR Area under the methacholine dose-response curve (AUG) was expressed as percent baseline FEV(1) x log concentration of methacholine (log [mg/ml]) and plotted as a function of the difference in postfreezing and prefreezing platelet membrane Na+,K+ ATPase activities (reflective of membrane-bound inhibitor), which was expressed as nanomoles per microgram of protein per minute (nmol/mu g protein/min). A significant (r = -0.44, p < 0.005) negative correlation between the two was detected, such that high levels of AHR (low AUG) were associated with high levels of membrane-bound inhibitor. To test for a causal relationship between the two, the ability of a Na+,K+ ATPase inhibitor to directly influence the level of AHR was determined in a second experiment. Eight allergic and 10 control subjects were administered AHR tests on 2 different days, immediately after inhalation of either nebulized ouabain (1 mg) or placebo in a double-blind fashion. Ouabain versus placebo inhalation decreased the PC20 in four of the patients with allergy. Additionally, ouabain increased methacholine AHR in patients with allergy, as manifested by a lower AUC in seven of the eight patients. In contrast, the mean AUC for the ouabain versus placebo prechallenges did not change significantly in the control group. Finally, a positive correlation was demonstrated between the levels of platelet membrane Na+,K+ ATPase inhibition and bronchial responsiveness to ouabain (r = 0.49, p < 0.05). These results provide both correlative and mechanistic evidence for a causal relationship between Na+,K+ ATPase enzyme inhibition and AHR.	UNIV PITTSBURGH, CHILDRENS HOSP PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								AGARAWAL KP, 1986, J APPL PHYSIOL, V60, P2089; AMELLAL M, 1984, BRIT J PHARMACOL, V82, P423, DOI 10.1111/j.1476-5381.1984.tb10777.x; AUDERA C, 1988, CLIN IMMUNOL IMMUNOP, V46, P352, DOI 10.1016/0090-1229(88)90054-2; BULLOCK CG, 1981, J PHYSIOL-LONDON, V318, pP46; BURNEY P, 1987, CHEST, V91, pS143, DOI 10.1378/chest.91.6.143S; BURNEY PGJ, 1986, BRIT MED J, V292, P1483, DOI 10.1136/bmj.292.6534.1483; BURNEY PGJ, 1989, THORAX, V44, P36, DOI 10.1136/thx.44.1.36; CHANDE VT, 1992, ANN EMERG MED, V21, P1111, DOI 10.1016/S0196-0644(05)80653-5; CHIDECKEL EW, 1987, BRIT J PHARMACOL, V92, P609, DOI 10.1111/j.1476-5381.1987.tb11363.x; CUSS FM, 1986, LANCET, V2, P189; DEUEL TF, 1984, J CLIN INVEST, V74, P669, DOI 10.1172/JCI111482; FONSECA V, 1992, BR J CLIN PHARM, V33, P161; Franzone JS, 1991, INT J TISSUE REACT, V18, P131; FROSSARD N, 1983, BIOCHEM PHARMACOL, V32, P3259, DOI 10.1016/0006-2952(83)90215-0; GENTILE DA, 1993, J LAB CLIN MED, V122, P85; GENTILE DA, 1993, PEDIATR ASTHMA ALLER, V7, P217, DOI 10.1089/pai.1993.7.217; GINSBERG MH, 1981, ADV INFLAMMAT RES, V2, P53; HOPP RJ, 1987, J ALLERGY CLIN IMMUN, V80, P821, DOI 10.1016/S0091-6749(87)80272-5; JAVAID A, 1988, BRIT MED J, V297, P454, DOI 10.1136/bmj.297.6646.454; KNAUER KA, 1981, NEW ENGL J MED, V304, P1404, DOI 10.1056/NEJM198106043042307; KNOX AJ, 1990, CLIN SCI, V79, P325, DOI 10.1042/cs0790325; KNOX AJ, 1988, BRIT J CLIN PHARMACO, V25, P758, DOI 10.1111/j.1365-2125.1988.tb05264.x; KNOX AJ, 1990, CLIN SCI, V79, P315, DOI 10.1042/cs0790315; KOLA A, 1992, CLIN EXP IMMUNOL, V88, P368; KRZESINSKI JM, 1992, AM J HYPERTENS, V5, P661, DOI 10.1093/ajh/5.9.661; LICHTSTEIN D, 1982, P NATL ACAD SCI-BIOL, V79, P1453, DOI 10.1073/pnas.79.5.1453; LINDGREN SHS, 1990, ACTA PHYSIOL SCAND, V140, P209, DOI 10.1111/j.1748-1716.1990.tb08993.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUMLEY P, 1989, BRIT J PHARMACOL, V97, P783, DOI 10.1111/j.1476-5381.1989.tb12017.x; MARCUS AJ, 1987, J CLIN INVEST, V79, P179, DOI 10.1172/JCI112781; MARCUS AJ, 1984, P NATL ACAD SCI-BIOL, V81, P903, DOI 10.1073/pnas.81.3.903; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; METZGER WJ, 1989, CLIN RES, V37, pA926; MIDDLETON E, 1985, J ALLERGY CLIN IMMUN, V76, P341, DOI 10.1016/0091-6749(85)90651-7; PAGE C, 1990, CLIN EXP ALLERGY, V20, P339, DOI 10.1111/j.1365-2222.1990.tb02790.x; PAGE CP, 1993, ALLERGY PRINCIPLES P, P212; PAGE CP, 1991, ANN NY ACAD SCI, V629, P38; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RODRIGUEZPEREZ F, 1993, GASTROENTEROLOGY, V105, P863, DOI 10.1016/0016-5085(93)90906-S; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SCHEID CR, 1979, NATURE, V277, P32, DOI 10.1038/277032a0; SKONER DP, 1990, J LAB CLIN MED, V115, P535; SKONER DP, 1991, J ALLERGY CLIN IMMUN, V87, P476, DOI 10.1016/0091-6749(91)90005-9; SNEDDON JM, 1972, NATURE-NEW BIOL, V236, P103, DOI 10.1038/newbio236103a0; SOUHRADA M, 1981, J APPL PHYSIOL, V51, P346, DOI 10.1152/jappl.1981.51.2.346; SOUHRADA M, 1984, SCIENCE, V225, P723, DOI 10.1126/science.6087455; STANDLEY PR, 1991, AM J HYPERTENS, V4, P546, DOI 10.1093/ajh/4.6.546; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; TOUVAY C, 1991, PULMON PHARM, V41, P43; TURAIHI K, 1989, METABOLISM, V38, P773, DOI 10.1016/0026-0495(89)90065-6; UMEMOTO S, 1990, J BIOL CHEM, V265, P14864; ZAR JH, 1984, BIOSTAT ANAL, P260	52	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1997	99	3					367	373						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WM422	9058693				2022-12-18	WOS:A1997WM42200014
J	Host, A; Halken, S; Jacobsen, HP; Estmann, A; Mortensen, S; Mygil, S				Host, A; Halken, S; Jacobsen, HP; Estmann, A; Mortensen, S; Mygil, S			The natural course of cow's milk protein allergy/intolerance.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									ODENSE UNIV HOSP,DEPT PEDIAT,DK-5000 ODENSE,DENMARK; SONDERBORG HOSP,DEPT PEDIAT,SONDERBORG,DENMARK	University of Southern Denmark; Odense University Hospital									0	15	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1988	1988						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201982
J	Taniguchi, M; Makino, Y; Cui, JQ; Masuda, K; Kawano, T; Sato, H; Kondo, E; Koseki, H				Taniguchi, M; Makino, Y; Cui, JQ; Masuda, K; Kawano, T; Sato, H; Kondo, E; Koseki, H			V alpha 14(+) NK T cells: A novel lymphoid cell lineage with regulatory function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						V alpha 14(+) NK T; novel T lymphoid cells; regulatory function	RECEPTOR-ALPHA-CHAIN; CLASS-I MOLECULES; ANTIGEN RECEPTOR; BONE-MARROW; BETA+ THYMOCYTES; MICE; EXPRESSION; SUBSET; TCR; POPULATIONS	A novel lymphoid lineage, NK T cells, was recently found. The NKT cells are the major population in the periphery comprising 5% of splenic T cells and 40% of bone marrow T cells. They express a unique TCR composed of invariant V alpha 14J alpha 281 and V beta 8.2 together with NK receptor (NKRPI). Surprisingly, the invariant V alpha 14(+) TCR is exclusively expressed on NK T cells but not on conventional T cells. As the selective decrease in V alpha 14(+) NK T cell population in the periphery is tightly correlated with autoimmune disease development, V alpha 14(+) NK T cells control development of autoimmune diseases. We also found that V alpha 14 TCR gene rearrangement and transcripts were detected at an early embryogenesis (d9.5) before the thymus formation. Therefore NK T cells are in the distinct category from conventional T cells. The target of NK T cells is found to be CD1 (class 1b, monomorphic class I MHC-like molecule) present on bone marrow-derived cells and is killed by Fas-FasL interaction or perforin-mediated mechanisms. These results indicate that NK T cells consist of an immunoregulatory system different from defense system in terms of homogeneous repertoire, extrathymic development in early stage of gestation, and their regulatory functional role.			Taniguchi, M (corresponding author), CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOL IMMUNOL,CHUO KU,1-8-1 INOHANA,CHIBA 260,JAPAN.		Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854				ADACHI Y, 1995, P NATL ACAD SCI USA, V92, P1200, DOI 10.1073/pnas.92.4.1200; BALLAS ZK, 1990, J IMMUNOL, V145, P1039; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; IKUTA K, 1992, ANNU REV IMMUNOL, V10, P759; IMAI K, 1986, P NATL ACAD SCI USA, V83, P8708, DOI 10.1073/pnas.83.22.8708; KIKLY K, 1992, J IMMUNOL, V149, P3489; KOSEKI H, 1990, P NATL ACAD SCI USA, V87, P5248, DOI 10.1073/pnas.87.14.5248; KOSEKI H, 1991, P NATL ACAD SCI USA, V88, P7518, DOI 10.1073/pnas.88.17.7518; Koseki H, 1989, Int Immunol, V1, P557, DOI 10.1093/intimm/1.6.557; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LEVITSKY HI, 1991, J IMMUNOL, V146, P1113; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; MASUDA K, IN PRESS J IMMUNOL; Mieza MA, 1996, J IMMUNOL, V156, P4035; MORETTA L, 1994, ADV IMMUNOL, V55, P341; OHKIHAMAZAKI H, 1995, INT IMMUNOL, V7, P493, DOI 10.1093/intimm/7.3.493; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; STROMINGER JL, 1989, SCIENCE, V244, P943, DOI 10.1126/science.2658058; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; SYKES M, 1990, J IMMUNOL, V145, P3209; TAKAHAMA Y, 1991, J IMMUNOL, V146, P1134; TAKEDA K, 1993, J EXP MED, V177, P155, DOI 10.1084/jem.177.1.155; TANIGUCHI M, 1982, LYMPHOKINES, P77; TANIGUCHI M, 1996, IN PRESS P NATL ACAD; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	32	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	2	S			S263	S269		10.1016/S0091-6749(96)70074-X	http://dx.doi.org/10.1016/S0091-6749(96)70074-X			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WC447	8977535				2022-12-18	WOS:A1996WC44700012
J	Torres, MJ; Giron, MD; Corzo, JL; Rodriguez, F; Moreno, F; Perez, E; Blanca, M; MartinezValverde, A				Torres, MJ; Giron, MD; Corzo, JL; Rodriguez, F; Moreno, F; Perez, E; Blanca, M; MartinezValverde, A			Release of inflammatory mediators after cow's milk intake in a newborn with idiopathic pulmonary hemosiderosis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGY; TESTS; SKIN		REG HOSP,DEPT PEDIAT,PEDIATR ALLERGY SECT,MALAGA,SPAIN				Torres, Maria/GVU-3391-2022; Torres, María José/T-3518-2017; Perez-Inestrosa, Ezequiel/H-9801-2015	Torres, María José/0000-0001-5228-471X; Perez-Inestrosa, Ezequiel/0000-0001-7546-5273				GAGA M, 1991, J IMMUNOL, V147, P816; HIENER DC, 1969, AM J DIS CHILD, V100, P500; HOLLAND NH, 1962, J PEDIATR-US, V61, P181, DOI 10.1016/S0022-3476(62)80252-2; KONDO N, 1993, J ALLERGY CLIN IMMUN, V91, P658, DOI 10.1016/0091-6749(93)90272-H; Lee S K, 1978, Adv Pediatr, V25, P39; LIVINGST.CS, 1967, ARCH DIS CHILD, V42, P543, DOI 10.1136/adc.42.225.543; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; RASANEN L, 1992, CLIN EXP ALLERGY, V22, P385, DOI 10.1111/j.1365-2222.1992.tb03100.x; SOERGEL KH, 1962, AM J MED, V32, P499, DOI 10.1016/0002-9343(62)90051-7; TAINIO VM, 1990, ALLERGY, V45, P189, DOI 10.1111/j.1398-9995.1990.tb00482.x	10	15	20	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1996	98	6	1				1120	1123		10.1016/S0091-6749(96)80201-6	http://dx.doi.org/10.1016/S0091-6749(96)80201-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WB378	8977515				2022-12-18	WOS:A1996WB37800019
J	Binkley, KE				Binkley, KE			Allergy to supplemental lactase enzyme	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MONOCLONAL-ANTIBODY; ALPHA-AMYLASE; ASPERGILLUS; ANTIGENS; FUNGI		UNIV TORONTO,TORONTO,ON,CANADA	University of Toronto								BAUR X, 1994, CLIN EXP ALLERGY, V24, P465, DOI 10.1111/j.1365-2222.1994.tb00935.x; HILTON J, 1994, TOXICOL LETT, V73, P43, DOI 10.1016/0378-4274(94)90187-2; KANNY G, 1995, J ALLERGY CLIN IMMUN, V95, P132, DOI 10.1016/S0091-6749(95)70161-3; KAPPE R, 1993, J CLIN MICROBIOL, V31, P2489, DOI 10.1128/JCM.31.9.2489-2490.1993; KUMAR A, 1993, ALLERGY PROC, V14, P189, DOI 10.2500/108854193778878664; LUNDGREN B, 1992, J CLIN MICROBIOL, V30, P391, DOI 10.1128/JCM.30.2.391-395.1992; PUENTE P, 1991, INFECT IMMUN, V59, P4478, DOI 10.1128/IAI.59.12.4478-4485.1991; Sakamoto T, 1991, Arerugi, V40, P1320; SHEN HD, 1992, CLIN EXP ALLERGY, V22, P485, DOI 10.1111/j.1365-2222.1992.tb00151.x	9	15	15	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1414	1416		10.1016/S0091-6749(96)70213-0	http://dx.doi.org/10.1016/S0091-6749(96)70213-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648041	Bronze			2022-12-18	WOS:A1996VD60700033
J	Loh, RKS; Jabara, HH; Geha, RS				Loh, RKS; Jabara, HH; Geha, RS			Mechanisms of inhibition of IgE synthesis by nedocromil sodium: Nedocromil sodium inhibits deletional switch recombination in human B cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergy; isotype switching; CD40; IL-4; asthma	OBSTRUCTIVE AIRWAYS DISEASE; EXERCISE-INDUCED ASTHMA; EPSILON-TRANSCRIPTS; HUMAN-LYMPHOCYTES; CD40; INTERLEUKIN-4; INDUCTION; IL-4; CROMOGLYCATE; EXPRESSION	IgE synthesis requires IL-4 and a T cell-B interaction that involves the B-cell antigen CD40 and its ligand expressed on activated T cells. Nedocromil sodium (NS), an effective prophylactic agent in asthma, inhibits IgE synthesis by human B cells. In this report we examined the mechanisms of this inhibition. NS targeted the B cells because it inhibited IgE synthesis induced by anti-CD40 and IL-4 in highly purified B cells (>98% CD19(+)). NS had no effect on the induction of epsilon germline transcripts by IL-4 but strongly inhibited CD40-mediated S mu-->S epsilon deletional switch recombination. The effect of NS was not specific for CD40 because it inhibited IgE synthesis in B cells stimulated with hydrocortisone plus IL-4. Moreover, the effects of NS was specific for IgE because it inhibited CD40/IL-4-driven IgG(4) synthesis by B cells sorted for lack of surface expression of IgG(4). NS caused only modest inhibition of spontaneous IgE synthesis by B cells from patients with hyper-IgE syndrome, suggesting that it has little effect on B cells that have already undergone isotype switching. These results strongly suggest that NS inhibits IgE isotype switching by inhibiting deletional switch recombination and that NS has a novel potential mechanism for the prevention of asthma and other allergic diseases.	HARVARD UNIV,DIV IMMUNOL,CHILDRENS HOSP,MED SCH,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School					NIAID NIH HHS [AI-31541, AI-31136] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031541, U19AI031541, R01AI031136] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BAUER CP, 1986, EUR J RESPIR DIS, V69, P252; BEAUVAIS F, 1989, DRUGS, V37, P4, DOI 10.2165/00003495-198900371-00003; BRUIJNZEEL PLB, 1989, BRIT J PHARMACOL, V96, P631, DOI 10.1111/j.1476-5381.1989.tb11862.x; CHURCH MK, 1991, ASTHMA ITS PATHOLOGY, P561; COCKS BG, 1993, INT IMMUNOL, V5, P657, DOI 10.1093/intimm/5.6.657; DAMON M, 1989, EUR RESPIR J, V2, P202; DEBELIC M, 1986, EUR J RESPIR DIS, V69, P266; DELPRETE G, 1988, J IMMUNOL, V140, P4193; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FANSLOW WC, 1992, J IMMUNOL, V149, P655; FINK JN, 1994, J ALLERGY CLIN IMMUN, V94, P473, DOI 10.1016/0091-6749(94)90203-8; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; GONZALEZ JP, 1987, DRUGS, V34, P560, DOI 10.2165/00003495-198734050-00004; GRUBER MF, 1989, J IMMUNOL, V142, P4144; JABARA HH, 1991, J IMMUNOL, V147, P1557; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; JABARA HH, 1993, J IMMUNOL, V151, P4528; JABARA HH, 1990, J IMMUNOL, V145, P3468; KIMATA H, 1993, J IMMUNOL, V151, P6723; LEUNG KBP, 1988, THORAX, V43, P756, DOI 10.1136/thx.43.10.756; LOH R, 1994, IMMUNOL LETT, V45, P99; LOH RKS, 1994, J ALLERGY CLIN IMMUN, V94, P784, DOI 10.1016/0091-6749(94)90187-2; LOH RKS, 1994, J EXP MED, V180, P663, DOI 10.1084/jem.180.2.663; MILLS FC, 1992, J IMMUNOL, V149, P1075; NEALE MG, 1987, BRIT J CLIN PHARMACO, V24, P493, DOI 10.1111/j.1365-2125.1987.tb03203.x; PRETOLANI M, 1993, J ALLERGY CLIN IMMUN, V91, P809, DOI 10.1016/0091-6749(93)90201-P; RAMESH N, 1994, IMMUNOL REV, V138, P87, DOI 10.1111/j.1600-065X.1994.tb00848.x; SHAPIRA S, 1992, J EXP MED, V289, P292; SHAPIRA SK, 1991, P NATL ACAD SCI USA, V88, P7528, DOI 10.1073/pnas.88.17.7528; SIEGHART W, 1981, BIOCHEM PHARMACOL, V30, P2737, DOI 10.1016/0006-2952(81)90552-9; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; THYPHRONITIS G, 1989, P NATL ACAD SCI USA, V86, P5580, DOI 10.1073/pnas.86.14.5580; UMETSU DT, 1985, J EXP MED, V162, P202, DOI 10.1084/jem.162.1.202; VERCELLI D, 1989, J EXP MED, V169, P1295, DOI 10.1084/jem.169.4.1295; VERCELLI D, 1990, J CLIN INVEST, V85, P1666, DOI 10.1172/JCI114618; WARRINGA RAJ, 1993, J ALLERGY CLIN IMMUN, V91, P802, DOI 10.1016/0091-6749(93)90200-Y; WELLS E, 1983, BIOCHEM PHARMACOL, V32, P837, DOI 10.1016/0006-2952(83)90585-3; WU CY, 1991, J CLIN INVEST, V87, P870, DOI 10.1172/JCI115092; ZHANG K, 1991, J IMMUNOL, V146, P1836	42	15	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1996	97	5					1141	1150		10.1016/S0091-6749(96)70269-5	http://dx.doi.org/10.1016/S0091-6749(96)70269-5			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UL261	8626993				2022-12-18	WOS:A1996UL26100016
J	Quirce, S; Tabar, AI; Olaguibel, JM; Cuevas, M				Quirce, S; Tabar, AI; Olaguibel, JM; Cuevas, M			Occupational contact urticaria syndrome caused by globe artichoke (Cynara scolymus)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HOSP VIRGEN CAMINO,DEPT ALLERGY,PAMPLONA,SPAIN; HOSP RAMON Y CAJAL,DEPT IMMUNOL,E-28034 MADRID,SPAIN	Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Ramon y Cajal			s, q/AAD-7171-2020; RIVERA, JOSE MARIA OLAGUIBEL/AAK-3845-2020	RIVERA, JOSE MARIA OLAGUIBEL/0000-0002-9126-4559				DELAHOZ B, 1991, ANN ALLERGY, V67, P487; KROGH G, 1981, J AM ACAD DERMATOL, V5, P328; KROOK G, 1977, CONTACT DERMATITIS, V3, P27, DOI 10.1111/j.1600-0536.1977.tb03583.x; MEDING B, 1983, CONTACT DERMATITIS, V9, P314, DOI 10.1111/j.1600-0536.1983.tb04399.x; QUIRCE S, 1989, ALLERGY, V44, P532, DOI 10.1111/j.1398-9995.1989.tb04197.x	5	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1996	97	2					710	711		10.1016/S0091-6749(96)70319-6	http://dx.doi.org/10.1016/S0091-6749(96)70319-6			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW087	8621859				2022-12-18	WOS:A1996TW08700019
J	Sousa, AR; Lane, SJ; Atkinson, BA; Poston, RN; Lee, TH				Sousa, AR; Lane, SJ; Atkinson, BA; Poston, RN; Lee, TH			The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						glucocorticoid; asthma; adhesion molecules; purified protein derivative of Mycobacterium tuberculosis; in vivo; mononuclear cells	LEUKOCYTE ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; GLUCOCORTICOID RECEPTOR CHARACTERISTICS; CELL-ADHESION; MONOCLONAL-ANTIBODY; EOSINOPHIL ADHERENCE; CYTOKINE GENERATION; CARBOHYDRATE LIGAND; ENDOTHELIAL-CELLS; EXPRESSION	We have used the classical tuberculin cutaneous delayed hypersensitivity immune response to investigate the effects of corticosteroids on mononuclear cell function in nine subjects with corticosteroid-resistant asthma (CRA) and six subjects with corticosteroid-sensitive asthma (CSA), who demonstrated sensitivity to intradermal purified protein derivative (PPD) of Mycobacterium tuberculosis. In a double-blind, crossover, placebo-controlled study, patients were given oral prednisolone or placebo, starting on day 0, and a predetermined intradermal dose of PPD on day 7. On day 9 the site of the induration was measured and biopsied for immunohistochemical analysis. There was no difference in skin induration between the CSA and CRA groups during the placebo arm of the study (p = 0.38). Prednisolone significantly suppressed the cutaneous induration (p < 0.003) in the CSA group but not in the CRA group. As compared with placebo, the number of macrophages (p = 0.018), eosinophils (p = 0.009), and T memory cells (p = 0.009) was suppressed by prednisolone in the CSA group but not in the CRA group. No significant suppression of the number of neutrophils or monocytes/immature macrophages was induced by prednisolone in either group. There was no difference in intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leukocyte adhesion molecule-1 expression in blood vessels or epidermis between the CSA and CRA groups, with no suppression by prednisolone in either group. These finding suggest a defect in the responsiveness of cellular immune mechanisms to the suppressive effects of corticosteroids in steroid-resistant asthma. The differential suppressive effects of corticosteroids on cellular recruitment in the PPD response between the individuals with CSA and those with CRA are not due to modulation of expression of endothelial adhesion molecules.	UNITED MED & DENT SCH,GUYS HOSP,DEPT ALLERGY & RESP MED & EXPT PATHOL,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London			Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059				ANDREW SM, 1987, HISTOCHEM J, V19, P426, DOI 10.1007/BF01675753; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BROWN PH, 1991, LANCET, V337, P576, DOI 10.1016/0140-6736(91)91639-C; CARMICHAEL J, 1981, BRIT MED J, V282, P1419, DOI 10.1136/bmj.282.6274.1419; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1016, DOI 10.1164/ajrccm/144.5.1016; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; DOBRINA A, 1991, J CLIN INVEST, V88, P20, DOI 10.1172/JCI115278; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FLAVELL DJ, 1987, J HISTOCHEM CYTOCHEM, V35, P1217, DOI 10.1177/35.11.3309045; GRIFFITHS CEM, 1989, J AM ACAD DERMATOL, V20, P617, DOI 10.1016/S0190-9622(89)70073-6; HOUSE AK, 1986, TRANSPLANT P, V18, P211; HOWARTH PH, 1993, J ALLERGY CLIN IMMUN, V91, P170; KAY AB, 1981, CLIN EXP IMMUNOL, V44, P576; KIRKHAM BW, 1991, J RHEUMATOL, V18, P821; LANE SJ, 1993, AM REV RESPIR DIS, V147, P690, DOI 10.1164/ajrccm/147.3.690; LANE SJ, 1991, AM REV RESPIR DIS, V143, P1020, DOI 10.1164/ajrccm/143.5_Pt_1.1020; LANE SJ, 1994, AM J RESP CELL MOL, V11, P42, DOI 10.1165/ajrcmb.11.1.8018337; LANE SJ, 1990, LANCET, V336, P1265, DOI 10.1016/0140-6736(90)92886-M; LANGHOFF E, 1986, LANCET, V2, P1296; LEUNG DYM, 1994, J ALLERGY CLIN IMMUN, V93, P197; MADDOX PH, 1987, J CLIN PATHOL, V40, P1256, DOI 10.1136/jcp.40.10.1256; Matusiewicz S. P., 1993, Thorax, V48, P1060; NORRIS P, 1991, J INVEST DERMATOL, V96, P763, DOI 10.1111/1523-1747.ep12471720; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; POSTON RN, 1990, MICRO 90, P525; POZNANSKY MC, 1984, CLIN SCI, V67, P639, DOI 10.1042/cs0670639; RALFKIAER E, 1989, HISTOPATHOLOGY, V14, P637, DOI 10.1111/j.1365-2559.1989.tb02205.x; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; SHER ER, 1994, J CLIN INVEST, V93, P33, DOI 10.1172/JCI116963; SMITH CH, 1993, AM REV RESPIR DIS, V148, pS75, DOI 10.1164/ajrccm/148.6_Pt_2.S75; SMITH SH, 1986, IMMUNOLOGY, V58, P63; SOUSA AR, 1994, AM J RESP CELL MOL, V10, P142, DOI 10.1165/ajrcmb.10.2.8110469; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TAI PC, 1984, NATURE, V309, P182, DOI 10.1038/309182a0; THORNHILL MH, 1991, J IMMUNOL, V146, P592; TURK JL, 1966, INT ARCH ALLER A IMM, V30, P248, DOI 10.1159/000229810; WELLER PF, 1991, P NATL ACAD SCI USA, V88, P7430, DOI 10.1073/pnas.88.16.7430; WELLICOME SM, 1990, J IMMUNOL, V144, P2558; WILKINSON JR, 1991, INT ARCH ALLER A IMM, V94, P220, DOI 10.1159/000235365; WILKINSON JRW, 1989, J CLIN INVEST, V84, P1930, DOI 10.1172/JCI114381	41	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1996	97	2					698	706		10.1016/S0091-6749(96)70317-2	http://dx.doi.org/10.1016/S0091-6749(96)70317-2			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TW087	8621857				2022-12-18	WOS:A1996TW08700017
J	Norgaard, A; Bernard, H; Wal, JM; Peltre, G; Skov, IPS; Poulsen, LK; BindslevJensen, C				Norgaard, A; Bernard, H; Wal, JM; Peltre, G; Skov, IPS; Poulsen, LK; BindslevJensen, C			Allergenicity of individual cow milk proteins in DBPCFC-positive milk allergic adults	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Bindslev-Jensen, Carsten/H-1877-2011; Poulsen, Lars K/J-3065-2019	Bindslev-Jensen, Carsten/0000-0002-8940-038X; Poulsen, Lars K/0000-0002-1730-847X					0	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				218	218						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600218
J	Rosenthal, R; Lavins, BJ; Hanby, LA				Rosenthal, R; Lavins, BJ; Hanby, LA			Effect of treatment with zafirlukast (ACCOLATE(TM)) on bronchial hyperresponsiveness in patients with mild-to-moderate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1996	97	1	3				270	270						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TV536					2022-12-18	WOS:A1996TV53600270
J	Novembre, E; Frongia, G; Lombardi, E; Resti, M; Zammarchi, E; Vierucci, A				Novembre, E; Frongia, G; Lombardi, E; Resti, M; Zammarchi, E; Vierucci, A			The preventive effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						exercise-induced asthma; furosemide; children	COLD; AIR	Background: Exercise-induced asthma can be prevented by treatment with inhaled furosemide. Objective: In this study we evaluated the effect and duration of action of two doses (15 and 30 mg) of inhaled furosemide in prevention of exercise-induced asthma in children. Methods: Ten children with exercise-induced asthma (8 boys and 2 girls, aged 6 to 13 years) were included in the study. Each patient was tested with three treatment regimens (placebo, 15 mg of furosemide, and 30 mg of furosemide) in random order on 3 separate days. Patients performed exercise challenges on a treadmill at 20 minutes and 1, 2, 3, and 6 hours after each treatment. Pulmonary function, urinary output, and fluid intake were monitored. Results: Both doses of furosemide had a significantly greater protective effect than placebo, but there was no significant difference between the two doses of furosemide. The higher dose of furosemide was associated with increased urinary output and had a longer duration of action. Conclusion: A 30 mg dose of furosemide is more effective for treatment of exercise-induced asthma in terms of duration but has a significant diuretic effect.			Novembre, E (corresponding author), OSPED A MEYER,DEPT PEDIAT,ALLERGY & CLIN IMMUNOL UNIT,VL GIORDANO 13,FLORENCE,ITALY.		Lombardi, Enrico/K-3356-2016; Resti, Massimo/AAB-8756-2019	Lombardi, Enrico/0000-0003-4749-9091; Resti, Massimo/0000-0001-6350-1361				ANDERSON SA, 1986, J ALLERGY CLIN IMMUN, V76, P763; BLANCO S, 1988, LANCET, V2, P252; NOVEMBRE E, 1994, J ALLERGY CLIN IMMUN, V94, P201, DOI 10.1016/0091-6749(94)90041-8; ODONNELL WJ, 1992, AM REV RESPIR DIS, V146, P1518, DOI 10.1164/ajrccm/146.6.1518; SEIDENBERG J, 1992, ARCH DIS CHILD, V67, P214, DOI 10.1136/adc.67.2.214	5	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1995	96	6	1				906	909		10.1016/S0091-6749(95)70227-X	http://dx.doi.org/10.1016/S0091-6749(95)70227-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TN124	8543748				2022-12-18	WOS:A1995TN12400007
J	BIRNBAUM, J; ORLANDO, JP; CHARPIN, D; VERVLOET, D				BIRNBAUM, J; ORLANDO, JP; CHARPIN, D; VERVLOET, D			COCKROACHES AND MITES SHARE THE SAME BEDS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note											BIRNBAUM, J (corresponding author), HOP ST MARGUERITE,DEPT CHEST DIS,DIV ALLERGY,F-13277 MARSEILLE 9,FRANCE.							BIRNBAUM J, 1991, LANCET, V337, P249, DOI 10.1016/0140-6736(91)92225-Q; CHAPMAN MD, 1993, INSIGHTS ALLERGY, V8, P6; KANG BC, 1990, CLIN REV ALLERG, V8, P87	3	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1995	96	4					561	562		10.1016/S0091-6749(95)70303-9	http://dx.doi.org/10.1016/S0091-6749(95)70303-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TA095	7560671				2022-12-18	WOS:A1995TA09500020
J	LEBOURGEOIS, M; CORMIER, C; KINDERMANS, C; SOUBERBIELLE, JC; GARABEDIAN, M; DEBLIC, J; SCHEINMANN, P				LEBOURGEOIS, M; CORMIER, C; KINDERMANS, C; SOUBERBIELLE, JC; GARABEDIAN, M; DEBLIC, J; SCHEINMANN, P			INHALED BECLOMETHASONE AND BONE METABOLISM IN YOUNG ASTHMATIC-CHILDREN - A 6-MONTH STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							BUDESONIDE		HOP NECKER ENFANTS MALAD,DEPT PHYSIOL,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,CNRS,URA 583,F-75743 PARIS 15,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS)	LEBOURGEOIS, M (corresponding author), HOP NECKER ENFANTS MALAD,SERV PNEUMOL & ALLERGOL PEDIAT,DEPT PEDIAT PULMONOL,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.							DELMAS PD, 1986, J BONE MINER RES, V1, P333; KONIG P, 1993, J PEDIATR-US, V122, P219, DOI 10.1016/S0022-3476(06)80116-2; SORVA R, 1992, J ALLERGY CLIN IMMUN, V90, P808, DOI 10.1016/0091-6749(92)90106-C; TOOGOOD JH, 1991, J ALLERGY CLIN IMMUN, V88, P572, DOI 10.1016/0091-6749(91)90150-M; WOLTHERS OD, 1993, PEDIATR PULM, V19, P341	5	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1995	96	4					565	567		10.1016/S0091-6749(95)70305-5	http://dx.doi.org/10.1016/S0091-6749(95)70305-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TA095	7560673				2022-12-18	WOS:A1995TA09500022
J	FERNANDES, L; MESQUITA, AM				FERNANDES, L; MESQUITA, AM			ANACARDIUM-OCCIDENTALE (CASHEW) POLLEN ALLERGY IN PATIENTS WITH ALLERGIC BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CASHEW; ALLERGIC ASTHMA POLLINATION; PEAK EXPIRATORY FLOW RATE	PEAK EXPIRATORY FLOW; FEV1	Background: The cashew tree grows in abundance in the hills and plains of Goa, India. Because of the financial yield, more and more trees are being planted each year. The cashew tree powers once a year between January and March, but pollination is mostly entomophilous. Objective: For the first time, a study was conducted to establish the possible tale of the cashew pollen in triggering allergic asthma. Methods: A stock solution of pollen extract was prepared with the standard weight/volume method for intradermal skin rests and a bronchial provocation tests (BPTs). The protein content of the antigen, estimated with the use of Folin phenol reagent and a spectrophotometer, was 28.72 mg/ml. Ten healthy volunteers and 65 subjects with allergic asthma, as documented by previous positive skirt test reactions to various pollens, were studied. Results: Of the 65 patients, 26 (40%) had positive skin test reactions in various grades. BPTs were performed in 22 of the 26 patients after their baseline peak expiratory flow volume was assessed. Twenty (90.9%) patients had a positive BPT result, and the majority of patients had grade III and grade IV reactions. None of the control subjects (n = 10) had positive responses to either intradermal tests or the BPT. Serum IgE levels, estimated by ELISA, were high in patients with positive skin rest responses and showed a linear correlation with cutaneous sensitivity. Control subjects showed normal levels of IgE (39.0 +/- 7.87 IU/ml). Conclusions: This study provided us with knowledge of an additional pollen, Anacardium occidentale, which could trigger an asthmatic response in allergic individuals.	GOA MED COLL, DEPT TB & CHEST DIS, PANAJI, GOA, INDIA	Goa Medical College & Hospital								BAPNA A, 1990, LUNG INDIA, V8, P76; BROWN WG, 1979, J ALLERGY CLIN IMMUN, V63, P328, DOI 10.1016/0091-6749(79)90127-1; BRYANT D H, 1975, Clinical Allergy, V5, P145, DOI 10.1111/j.1365-2222.1975.tb01847.x; FISH JE, 1988, ALLERGY PRINCIPLES P, P1122; GARCIAORTEGA P, 1992, J ALLERGY CLIN IMMUN, V89, P987, DOI 10.1016/0091-6749(92)90221-M; KELLY CA, 1988, THORAX, V43, P335, DOI 10.1136/thx.43.4.335; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NIPHADKER PV, 1985, LUNG INDIA, V3, P21; NORMAN PS, 1992, J ALLERGY CLIN IMMUN, V89, P923, DOI 10.1016/0091-6749(92)90213-L; NOWAK RM, 1982, ANN EMERG MED, V11, P64, DOI 10.1016/S0196-0644(82)80298-9; Shivpuri DN, 1962, INDIAN J CHEST DIS, V4, P102; SPEELBERG B, 1991, J ALLERGY CLIN IMMUN, V87, P1128, DOI 10.1016/0091-6749(91)92159-X	12	15	16	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1995	95	2					501	504		10.1016/S0091-6749(95)70311-X	http://dx.doi.org/10.1016/S0091-6749(95)70311-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH697	7852665				2022-12-18	WOS:A1995QH69700001
J	ZUBELDIA, JM; GIL, P; MIRALLES, P; DEBARRIO, M; ARANZABAL, A; HERRERO, T; RUBIO, M; BOUZAS, E; BAEZA, ML				ZUBELDIA, JM; GIL, P; MIRALLES, P; DEBARRIO, M; ARANZABAL, A; HERRERO, T; RUBIO, M; BOUZAS, E; BAEZA, ML			HYPERSENSITIVITY PNEUMONITIS CAUSED BY SOYBEAN ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IDENTIFICATION; DUST		DEPT INTERNAL MED,ALLERGY SECT,MADRID,SPAIN; DEPT INFECT DIS,MADRID,SPAIN				Zubeldia, Jose M./H-3518-2016	Zubeldia, Jose M./0000-0003-3110-274X				CORMIER Y, 1986, THORAX, V41, P28, DOI 10.1136/thx.41.1.28; GONZALEZ R, 1991, INT ARCH ALLER A IMM, V95, P53, DOI 10.1159/000235454; HILL LW, 1929, JAMA-J AM MED ASSOC, V93, P985; RODRIGO MJ, 1990, J ALLERGY CLIN IMMUN, V85, P778, DOI 10.1016/0091-6749(90)90198-D; SWANSON MC, 1991, J ALLERGY CLIN IMMUN, V87, P783, DOI 10.1016/0091-6749(91)90123-6	5	15	16	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1995	95	2					622	626		10.1016/S0091-6749(95)70325-X	http://dx.doi.org/10.1016/S0091-6749(95)70325-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH697	7852674				2022-12-18	WOS:A1995QH69700015
J	PORRI, F; LEMIERE, C; BIRNBAUM, J; GUILLOUX, L; DIDELOT, R; VERVLOET, D; CHARPIN, D				PORRI, F; LEMIERE, C; BIRNBAUM, J; GUILLOUX, L; DIDELOT, R; VERVLOET, D; CHARPIN, D			PREVALENCE OF LATEX ALLERGY IN ATOPIC AND NONATOPIC SUBJECTS FROM THE GENERAL-POPULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1995	95	1	2				154	154						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QE854					2022-12-18	WOS:A1995QE85400056
J	BOUTIN, Y; JOBIN, M; BEDARD, PM; HEBERT, M; HEBERT, J				BOUTIN, Y; JOBIN, M; BEDARD, PM; HEBERT, M; HEBERT, J			POSSIBLE DUAL ROLE OF ANTIIDIOTYPIC ANTIBODIES IN COMBINED PASSIVE AND ACTIVE IMMUNOTHERAPY IN HONEYBEE STING ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HONEYBEE; VENOM; IMMUNOTHERAPY; ANTIIDIOTYPIC; IMMUNOGLOBULINS	ANTIIDIOTYPIC ANTIBODIES; VENOM IMMUNOTHERAPY; IMMUNOGLOBULIN; IMMUNIZATION; INDIVIDUALS; POLLEN; SERA	Background: Passive infusion of beekeepers' plasma was shown to protect patients against systemic reactions occurring during active immunotherapy by mechanisms still to be clarified. If is tempting to speculate that anti-idiotypic antibodies could play a role because they are found in beekeepers' plasma and are involved in the regulation of IgE synthesis. Methods: In this report we studied the effects of passive infusion of a beekeeper's plasma rich in anti-idiotypic antibodies to a patient who experienced systemic reactions to honeybee venom. Results: We reported, during the days after the infusion, a decrease of clinical sensitivity to the honeybee venom. Indeed, the patient tolerated a cumulative dose of 280 mu g of venom without adverse reactions. We also observed decreases in skin mast cell and in basophil sensitivity. After the plasma infusion, a modified rush immunotherapy with honeybee venom was initiated in our parient. In the following 76 weeks, increased levels of anti-idiotypic antibodies in the serum of the patient were associated with a diminution. of specific antibodies (IgG and IgE) to honeybee venom. Conclusion: These results suggest a dual role of anti-id in our combined protocol of passive and active immunotherapy: an immediate action on clinical sensitivity along with a decrease of skin mast cell and basophil sensitivity and an immunoregulatory role on specific antibody production.	CHUL,CTR RECH INFLAMMAT & RHUMATOL IMMUNOL,ST FOY G1V 4G2,PQ,CANADA; SOC CANADIENNE CROIX ROUGE,CTR TRANSFUS,ST FOY,PQ,CANADA	Laval University								BARNARD JH, 1973, J ALLERGY CLIN IMMUN, V52, P259, DOI 10.1016/0091-6749(73)90044-4; BEDARD PM, 1986, J ALLERGY CLIN IMMUN, V78, P1121, DOI 10.1016/0091-6749(86)90260-5; BLASER K, 1980, J IMMUNOL, V125, P24; BOSE R, 1986, CLIN EXP IMMUNOL, V66, P231; BOUSQUET J, 1987, J ALLERGY CLIN IMMUN, V79, P947, DOI 10.1016/0091-6749(87)90245-4; BOUSQUET J, 1987, ALLERGY, V42, P401, DOI 10.1111/j.1398-9995.1987.tb00355.x; BRUNET C, 1992, J ALLERGY CLIN IMMUN, V89, P87, DOI 10.1016/S0091-6749(05)80044-2; CASTRACANE JM, 1988, INT ARCH ALLER A IMM, V86, P288, DOI 10.1159/000234586; DESSEIN A, 1980, J IMMUNOL, V124, P71; DWYER JM, 1992, NEW ENGL J MED, V326, P107; GEHA RS, 1983, J IMMUNOL, V130, P1634; GEHA RS, 1983, J CLIN INVEST, V71, P46, DOI 10.1172/JCI110750; GOLDEN DBK, 1984, ANN ALLERGY, V53, P444; HEBERT J, 1990, CLIN EXP IMMUNOL, V80, P413; KHAN RH, 1991, J ALLERGY CLIN IMMUN, V88, P199, DOI 10.1016/0091-6749(91)90329-M; LESSOF MH, 1978, JOHNS HOPKINS MED J, V142, P1; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LICHTENSTEIN LM, 1964, J EXP MED, V10, P50; MAZER BD, 1991, J ALLERGY CLIN IMMUN, V87, P976, DOI 10.1016/0091-6749(91)90420-S; MOSS RB, 1987, J ALLERGY CLIN IMMUN, V79, P387, DOI 10.1016/0091-6749(87)90160-6; MULLER U, 1992, J ALLERGY CLIN IMMUN, V89, P529, DOI 10.1016/0091-6749(92)90319-W; MULLER UR, 1986, J ALLERGY CLIN IMMUN, V78, P115, DOI 10.1016/0091-6749(86)90123-5; NYDEGGER UE, 1984, VOX SANG, V47, P92, DOI 10.1111/j.1423-0410.1984.tb01567.x; NYDEGGER UE, 1989, CLIN IMMUNOL IMMUNOP, V53, pS72, DOI 10.1016/0090-1229(89)90072-X; RAMIREZ DA, 1981, ANN ALLERGY, V47, P435; REISMAN RE, 1985, J ALLERGY CLIN IMMUN, V75, P735; SAINTREMY JMR, 1988, EUR J IMMUNOL, V18, P83, DOI 10.1002/eji.1830180113; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; URBANEK R, 1986, CLIN ALLERGY, V13, P317; VALACER DJ, 1991, J ALLERGY CLIN IMMUN, V88, P349, DOI 10.1016/0091-6749(91)90096-7; YUNGINGER JW, 1979, J ALLERGY CLIN IMMUN, V63, P340, DOI 10.1016/0091-6749(79)90129-5	31	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1994	93	6					1039	1046		10.1016/S0091-6749(94)70053-2	http://dx.doi.org/10.1016/S0091-6749(94)70053-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NT172	7516355				2022-12-18	WOS:A1994NT17200013
J	DYER, PD				DYER, PD			LATE-ONSET ANGIOEDEMA AFTER INTERRUPTION OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							EDEMA				DYER, PD (corresponding author), FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045, USA.							HEDNER T, 1992, BRIT MED J, V304, P941, DOI 10.1136/bmj.304.6832.941; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; JAIN M, 1992, CHEST, V102, P871, DOI 10.1378/chest.102.3.871; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; 1987, BRIT MED J, V294, P91	5	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1994	93	5					947	948		10.1016/0091-6749(94)90391-3	http://dx.doi.org/10.1016/0091-6749(94)90391-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL919	8182239				2022-12-18	WOS:A1994NL91900022
J	UMETSU, DT; SCHLOSSMAN, CM; OCHS, HD; HERSHFIELD, MS				UMETSU, DT; SCHLOSSMAN, CM; OCHS, HD; HERSHFIELD, MS			HETEROGENEITY OF PHENOTYPE IN 2 SIBLINGS WITH ADENOSINE-DEAMINASE DEFICIENCY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ADENOSINE DEAMINASE DEFICIENCY; SEVERE COMBINED IMMUNODEFICIENCY	COMBINED IMMUNODEFICIENCY; GENE; MUTATION	Adenosine deaminase (ADA) deficiency is the cause of about one third of the autosomal recessively inherited cases of severe combined immunodeficiency. Disease severity in ADA deficiency is variable, presumably related in part to heterogeneity in the genotypes causing the disease. We now report on two children in a single family with ADA deficiency who presented with distinct clinical courses. One child presented with severe immunodeficiency and recurrent infections that led to the diagnosis of severe combined immunodeficiency and ADA deficiency at 7 months of age. The older child, who was diagnosed at 3 years of age (after the diagnosis of the younger child), did not have a history of serious or opportunistic infections. Although she was lymphopenic, immune responsiveness was intact, in terms of antibody production, delayed-type hypersensitivity, and in vitro T-cell function. The difference in clinical course in these two siblings is an important observation and demonstrates that the phenotypic expression of ADA deficiency can vary within a family, even in a situation in which protective isolation from infectious pathogens was not a factor in causing the milder course. These observations indicate that expression of disease severity in ADA deficiency may depend to a significant degree on environmental factors and/or on heterogeneity at other genetic loci, which may regulate or modify the expression of the ADA gene or the activity of its product. Furthermore, these observations hightlight the importance of recognizing patients with ADA deficiency who present with less sever disease and support the impression that functional immunity in patients with the ''late-onset'' form of ADA deficiency can deteriorate over time. In such patients unexplained lymphopenia may be a useful early marker for ADA deficiency even before the onset of severe infections.	KAISER PERMANENTE MED CTR,DEPT PEDIAT,SANTA CLARA,CA; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	Kaiser Permanente; University of Washington; University of Washington Seattle; Duke University	UMETSU, DT (corresponding author), STANFORD UNIV,DEPT PEDIAT,RM S348,STANFORD,CA 94305, USA.				NIAID NIH HHS [R01AI26322, KO7AI01026] Funding Source: Medline; NIDDK NIH HHS [R01DK20902] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K07AI001026, R01AI026322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020902] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; ARRENDONDOVEGA FX, IN PRESS AM J HUM GE; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; GEFFNER ME, 1986, AM J DIS CHILD, V140, P1194, DOI 10.1001/archpedi.1986.02140250120047; GIBLETT ER, 1972, LANCET, V2, P1067; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; Hirschhorn R, 1983, Birth Defects Orig Artic Ser, V19, P73; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; HIRSCHHORN R, 1975, LANCET, V1, P73; HIRSCHHORN R, 1979, J CLIN INVEST, V64, P1130, DOI 10.1172/JCI109552; HONG R, 1970, NEW ENGL J MED, V282, P470, DOI 10.1056/NEJM197002262820903; KREDICH NM, 1989, METABOLIC BASIS INHE, P1045; LEVY Y, 1988, J PEDIATR-US, V113, P312, DOI 10.1016/S0022-3476(88)80271-3; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; MCINNES B, 1992, J CLIN INVEST, V90, P306, DOI 10.1172/JCI115863; PYUN KH, 1989, CLIN IMMUNOL IMMUNOP, V51, P252, DOI 10.1016/0090-1229(89)90024-X; RUBINSTEIN A, 1979, NEW ENGL J MED, V300, P387, DOI 10.1056/NEJM197902223000802; Wedgwood R J, 1975, Birth Defects Orig Artic Ser, V11, P331; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	20	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1994	93	2					543	550		10.1016/0091-6749(94)90365-4	http://dx.doi.org/10.1016/0091-6749(94)90365-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MY581	8120281				2022-12-18	WOS:A1994MY58100017
J	ALAM, R; YORK, J; BOYARS, M; GRANT, JA; STAFFORD, S; FORSYTHE, P; LEE, J; WEIDO, A				ALAM, R; YORK, J; BOYARS, M; GRANT, JA; STAFFORD, S; FORSYTHE, P; LEE, J; WEIDO, A			DETECTION AND QUANTITATION OF RANTES AND MIP-1 ALPHA IN BRONCHOALVEOLAR LAVAGE (BAL) FLUID AND THEIR MESSENGER-RNA IN LAVAGE CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1994	93	1	2				183	183						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MV317					2022-12-18	WOS:A1994MV31700125
J	NIINIMAKI, A; REIJULA, K; PIRILA, T; KOISTINEN, AM				NIINIMAKI, A; REIJULA, K; PIRILA, T; KOISTINEN, AM			PAPAIN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN A COSMETOLOGIST	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note							WORKERS		UNIV OULU,CENT HOSP,DEPT DERMATOL,SF-90220 OULU 22,FINLAND; UNIV OULU,CENT HOSP,DEPT OCCUPAT MED,SF-90220 OULU 22,FINLAND; UNIV OULU,CENT HOSP,DEPT OTORHINOLARYNGOL,SF-90220 OULU 22,FINLAND; MED COLL WISCONSIN,DIV ALLERGY IMMUNOL,MILWAUKEE,WI 53226	University of Oulu; University of Oulu; University of Oulu; Medical College of Wisconsin								BAUR X, 1982, CLIN ALLERGY, V12, P9, DOI 10.1111/j.1365-2222.1982.tb03121.x; FLINDT MLH, 1978, LANCET, V25, P430; MANSFIELD LE, 1983, J ALLERGY CLIN IMMUN, V71, P371, DOI 10.1016/0091-6749(83)90064-7; NOVEY HS, 1980, CLIN ALLERGY, V10, P721, DOI 10.1111/j.1365-2222.1980.tb02157.x; TARLO SM, 1978, CLIN ALLERGY, V8, P207, DOI 10.1111/j.1365-2222.1978.tb03216.x	5	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1993	92	3					492	493		10.1016/0091-6749(93)90129-4	http://dx.doi.org/10.1016/0091-6749(93)90129-4			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LX309	8360400				2022-12-18	WOS:A1993LX30900016
J	SOPARKAR, GR; PATEL, PC; COCKCROFT, DW				SOPARKAR, GR; PATEL, PC; COCKCROFT, DW			INHALANT ATOPIC SENSITIVITY TO GRASSHOPPERS IN RESEARCH LABORATORIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; OCCUPATIONAL ASTHMA; GRASSHOPPERS; ALLERGEN CHALLENGE	ARTHROPODS; HISTAMINE; ALLERGY; ASTHMA	Background: Atopic sensitivity to insects, in both occupational and nonoccupational settings, is common. Methods: A 26-year-old man with atopic asthma experienced worsened asthma and urticaria on exposure to grasshoppers in a research laboratory; he along with 16 other persons who work with grasshoppers from two laboratories and 26 control subjects were studied. The patient underwent a controlled allergen inhalation test with aqueous grasshopper dropping antigen. All subjects were assessed by means of a questionnaire. All but one (who refused because of severe skin reactions after contact with grasshoppers) had skin prick tests with three extracts Of grasshopper and with grass pollen, cat dander, and Dermatophagoides farinae. Results: The allergen challenge was positive with an isolated early asthmatic response (23% fall forced expiratory volume in 1 second [FEV1]) at 1:4096 (approximately 25 mug/ml), and a borderline fall in provocative concentration of methacholine causing a 20% fall in FEV1. Seven of 16 (43.8%) workers had positive grasshopper skin test results compared with one of 26 (3.8%) control subjects (p = 0.0052). Sensitization occurred even in otherwise nonatopic workers (5 of 12). Symptoms of asthma on exposure (n = 4) correlated better with positive skin test results than did cutaneous symptoms (n = 8). Conclusion: Atopic sensitization to grasshoppers in research laboratories is a significant occupational health problem.	UNIV SASKATCHEWAN, ROYAL UNIV HOSP,DEPT MED,DIV RESP MED,ELLIS HALL, 5TH FLOOR, SASKATOON S7N 4J9, SK, CANADA	University of Saskatchewan								BAGENSTOSE AH, 1980, J ALLERGY CLIN IMMUN, V65, P71, DOI 10.1016/0091-6749(80)90180-3; BALDO BA, 1988, INT ARCH ALLER A IMM, V85, P278, DOI 10.1159/000234518; BELLAS TE, 1990, CLIN REV ALLERG, V8, P15; BELLAS TE, 1982, INSECTS CAUSE INHALA; BERNTON H S, 1972, British Journal of Diseases of the Chest, V66, P61, DOI 10.1016/S0007-0971(72)80008-1; BERNTON HS, 1964, J ALLERGY, V35, P506, DOI 10.1016/0021-8707(64)90082-6; BURGE PS, 1980, CLIN ALLERGY, V10, P355, DOI 10.1111/j.1365-2222.1980.tb02119.x; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; Frankland A. W., 1953, Ann Allergy Minneapolis, V11, P445; MATHEWS KP, 1989, IMMUNOL ALLERGY CLIN, V9, P321; SCHNITZK.WF, 1974, PEDIATRICS, V53, P280; Steel R.G.D., 1980, PRINCIPLES STAT; TEE RD, 1988, J ALLERGY CLIN IMMUN, V3, P517; VONDERBIJL VWJ, 1963, ALLERG ASTHMA, V9, P154; WIRTZ RA, 1984, ANNU REV ENTOMOL, V29, P47, DOI 10.1146/annurev.en.29.010184.000403; ZSCHUNKE E, 1978, ARCH DERMATOL, V114, P1715, DOI 10.1001/archderm.114.11.1715b	17	15	16	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				61	65		10.1016/0091-6749(93)90038-H	http://dx.doi.org/10.1016/0091-6749(93)90038-H			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353	8335857				2022-12-18	WOS:A1993LQ35300010
J	[Anonymous]				[Anonymous]			TASK-FORCE ON ALLERGIC REACTIONS TO LATEX	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							CONTACT URTICARIA; RUBBER; HYPERSENSITIVITY; ANAPHYLAXIS; IGE											BEUERS U, 1990, LANCET, V335, P1095, DOI 10.1016/0140-6736(90)92664-4; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P443; JAEGER D, 1992, J ALLERGY CLIN IMMUN, V89, P759, DOI 10.1016/0091-6749(92)90385-F; KWITTKEN PL, 1992, ALLERGY PROC, V13, P123, DOI 10.2500/108854192778878782; MEEROPOL E, 1990, NEW ENGL J MED, V323, P1072; MONERETVAUTRIN DA, 1991, ANESTHESIOLOGY, V74, P391, DOI 10.1097/00000542-199102000-00048; OWNBY DR, 1991, AM J ROENTGENOL, V156, P903, DOI 10.2214/ajr.156.5.2017949; SLATER JE, 1990, ANN ALLERGY, V65, P411; SLATER JE, 1989, NEW ENGL J MED, V320, P1126, DOI 10.1056/NEJM198904273201707; SLATER JE, 1991, J UROLOGY, V146, P578, DOI 10.1016/S0022-5347(17)37860-6; SPANER D, 1989, J ALLERGY CLIN IMMUN, V83, P1135, DOI 10.1016/0091-6749(89)90457-0; SUSSMAN GL, 1991, JAMA-J AM MED ASSOC, V265, P2844, DOI 10.1001/jama.265.21.2844; TAYLOR JS, 1989, J AM ACAD DERMATOL, V21, P874, DOI 10.1016/S0190-9622(89)70271-1; TURJANMAA K, 1988, CONTACT DERMATITIS, V19, P241, DOI 10.1111/j.1600-0536.1988.tb02920.x; TURJANMAA K, 1987, CONTACT DERMATITIS, V17, P270, DOI 10.1111/j.1600-0536.1987.tb01476.x; 1990, FED REGISTER, V55, P51254	16	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1993	92	1	1				16	18						3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LQ353					2022-12-18	WOS:A1993LQ35300003
J	ATKINS, PC; VONALLMEN, C; VALENZANO, M; ZWEIMAN, B				ATKINS, PC; VONALLMEN, C; VALENZANO, M; ZWEIMAN, B			THE EFFECTS OF GENDER ON ALLERGEN-INDUCED HISTAMINE-RELEASE IN ONGOING ALLERGIC CUTANEOUS REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						GENDER; HISTAMINE; ANTIGEN; NEUTROPHILS; SKIN CHAMBER	MEDIATOR RELEASE; SKIN; RESPONSES; HUMANS	Background: Marked variability in the amount of histamine released in the first hour of ongoing cutaneous reactions has been noted. This variability occurs even among subjects with similar degrees of skin test reactivity to antigen. Methods: To determine gender effects on mediator release, we retrospectively compared: (1) skin chamber histamine release after a 0 to 1-hour and 1 to 5-hour exposure to antigen; (2) neutrophil accumulation after 5 hours of antigen exposure and skin test reactivity to antigen, histamine, and codeine in 91 male and 60 female subjects. Results: There was no difference in skin test reactivity to antigen, histamine, or codeine between male and female subjects. However, in the group as a whole, male subjects released higher amounts of histamine in the first hour (74 +/- 4 ng/ml) than female subjects (55 +/- 4 ng/ml), (p < 0.01). When subjects were matched for equivalent skin reactivity to antigen, male subjects who were sensitive to 10 PNU/ml and 1 PNU/ml released more histamine (67 +/- 9 ng/ml and 82 +/- 9 ng/ml) than female subjects (51 +/- 7 ng/ml and 55 +/- 7 ng/ml) (p < 0.05 and < 0.01). In the most sensitive subjects, those with skin sensitivity to 0.01 PNU/ml of antigen, there was not a significant difference between the histamine release in the first hour in male (79 +/- 12 ng/ml) or female (69 +/- 9 ng/ml) subjects. No difference was observed between male and female subjects in either neutrophil or histamine accumulation in the 1- to 5-hour period. Conclusions: Since the first hour release of histamine is secondary to mast cell activation and the 1- to 5-hour histamine release is secondary to basophil activation, we conclude that the gender of the subject influences the degree of in vivo antigen-induced histamine release from mast cells.			ATKINS, PC (corresponding author), HOSP UNIV PENN,DEPT MED,DIV ALLERGY & IMMUNOL,SILVERSTEIN PAVILION,SUITE B,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.				NIAID NIH HHS [AI 14332] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014332] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ATKINS PC, 1982, J ALLERGY CLIN IMMUN, V69, P39, DOI 10.1016/0091-6749(82)90085-9; ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P371, DOI 10.1016/S0091-6749(05)80100-9; FLEEKOP PD, 1987, J ALLERGY CLIN IMMUN, V80, P140, DOI 10.1016/0091-6749(87)90122-9; GAMBO PM, 1989, ALLERGOL IMMUNOPATH, V77, P279; LOPEZ LR, 1988, J ALLERGY CLIN IMMUN, V81, P1143, DOI 10.1016/0091-6749(88)90882-2; ROSEN LB, 1987, AM J DERMATOPATH, V9, P208, DOI 10.1097/00000372-198706000-00005; SHALIT M, 1989, J ALLERGY CLIN IMMUN, V83, P691, DOI 10.1016/0091-6749(89)90084-5; SKASSABROCIEK W, 1987, J ALLERGY CLIN IMMUN, V80, P711, DOI 10.1016/0091-6749(87)90292-2; TALBOT SF, 1984, J ALLERGY CLIN IMMUN, V74, P819, DOI 10.1016/0091-6749(84)90185-4; Turlington B S, 1988, Am J Cardiovasc Pathol, V2, P151	11	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					1031	1034		10.1016/0091-6749(93)90216-3	http://dx.doi.org/10.1016/0091-6749(93)90216-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	7684052				2022-12-18	WOS:A1993LC97800010
J	MALO, JL				MALO, JL			THE CASE FOR CONFIRMING OCCUPATIONAL ASTHMA - WHY, HOW MUCH, HOW FAR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							FLOW-RATE; DIAGNOSIS; TESTS				MALO, JL (corresponding author), HOP SACRE COEUR, DEPT CHEST MED, 5400 W GOUIN, MONTREAL H4J 1C5, QUEBEC, CANADA.							Bernstein IL, 1993, ASTHMA WORKPLACE; BURGE PS, 1979, THORAX, V34, P317, DOI 10.1136/thx.34.3.317; CARTIER A, 1984, CLIN ALLERGY, V14, P193, DOI 10.1111/j.1365-2222.1984.tb02652.x; CLOUTIER Y, 1989, EUR RESPIR J, V2, P769; COTE J, 1990, J ALLERGY CLIN IMMUN, V85, P592, DOI 10.1016/0091-6749(90)90098-O; HENNEBERGER PK, 1991, CHEST, V100, P1515, DOI 10.1378/chest.100.6.1515; MALO JL, UNPUB QUEBEC SYSTEM; MALO JL, IN PRESS J ALLERGY C; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; PERRIN B, 1992, EUR RESPIR J, V5, P40; VANDENPLAS O, 1992, AM REV RESPIR DIS, V145, P582, DOI 10.1164/ajrccm/145.3.582	11	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1993	91	5					967	970		10.1016/0091-6749(93)90207-V	http://dx.doi.org/10.1016/0091-6749(93)90207-V			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LC978	8491945				2022-12-18	WOS:A1993LC97800001
J	VIJAY, HM; YOUNG, NM; CURRAN, IHA; COPELAND, DF; BERNSTEIN, IL				VIJAY, HM; YOUNG, NM; CURRAN, IHA; COPELAND, DF; BERNSTEIN, IL			A MAJOR ANTIGEN OF ALTERNARIA-ALTERNATA WITH POTENTIAL FOR SAFE AND EFFECTIVE IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ALLERGY EXTRACTS		NATL RES COUNCIL CANADA,OTTAWA K1A 0R6,ONTARIO,CANADA; UNIV CINCINNATI,CINCINNATI,OH 45221	National Research Council Canada; University System of Ohio; University of Cincinnati	VIJAY, HM (corresponding author), HLTH & WELF CANADA,HLTH PROTECT BRANCH,BUR DRUG RES,SIR FG BANTING BLDG,OTTAWA K1A 0L2,ONTARIO,CANADA.							CURRAN IHA, 1992, J ALLERGY CLIN IMMUN, V89, P283; DEARDS MJ, 1991, MOL IMMUNOL, V28, P409, DOI 10.1016/0161-5890(91)90154-C; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; GREENERT S, 1971, LANCET, V2, P1121; MATTHIESEN F, 1992, J ALLERGY CLIN IMMUN, V89, P241; PARIS S, 1991, J ALLERGY CLIN IMMUN, V88, P902, DOI 10.1016/0091-6749(91)90247-L; REED CE, 1989, J ALLERGY CLIN IMMUN, V84, P4, DOI 10.1016/0091-6749(89)90171-1; VIJAY HM, 1989, EPITOPES ATOPIC ALLE, P14; VIJAY MH, 1981, INT ARCH ALLER A IMM, V54, P410	9	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1993	91	4					826	828		10.1016/0091-6749(93)90338-G	http://dx.doi.org/10.1016/0091-6749(93)90338-G			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KY251	8473669				2022-12-18	WOS:A1993KY25100001
J	FOLKERTS, G; VERHEYEN, A; JANSSEN, M; NIJKAMP, FP				FOLKERTS, G; VERHEYEN, A; JANSSEN, M; NIJKAMP, FP			VIRUS-INDUCED AIRWAY HYPERRESPONSIVENESS IN THE GUINEA-PIG CAN BE TRANSFERRED BY BRONCHOALVEOLAR CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PARAINFLUENZA-3 VIRUS; INVITRO AIRWAY RESPONSIVENESS; BRONCHOALVEOLAR CELLS; HISTAMINE	RESPIRATORY-TRACT INFECTION; BOVINE ALVEOLAR MACROPHAGES; INFLAMMATORY MEDIATORS; ASTHMA; INFLUENZA; HYPERREACTIVITY; REACTIVITY; BACTERIAL; INVITRO; RESPONSIVENESS	For the investigation of whether inflammatory cells were responsible for virus-induced airway hyperresponsiveness, tracheal spirals from healthy guinea pigs were incubated in organ baths with different numbers of bronchoalveolar cells obtained from guinea pigs 4 days after their inoculation with parainfluenza-3 (P-3) virus or control solution. Airway responsiveness was measured by performance of histamine concentration/response (C/R) curves on the Preparations incubated with 5 x 10(5) cells/ml obtained from guinea pigs treated with P-3 virus demonstrated a significant upward shift of the histamine C/R curve. The maximal contraction was increased by 26% as compared with the tissues incubated with the same number of cells from animals inoculated with control solution. When the number of cells was increased further to 5 x 10(6) cells/ml, no additional upward shift of the C/R curve was seen; the increase in maximal contraction was 24%. Tracheal spirals incubated with 5 x 10(4) cells/ml did not affect the histamine C/R curves. Addition of P-3 virus to the organ bath during the incubation period with the cells did not affect the histamine C/R curve either, irrespective of the inoculation solution or the number of bronchoalveolar cells used. The relative number of alveolar macrophages in bronchoalveolar lavage fluid decreased significantly from 86.3% +/- 2.6% in the control group to 71.8% +/- 3.3% in the P-3 virus group as a consequence of a significant increase in the percentage of monocytes, lymphocytes, and eosinophils. These results suggest that bronchoalveolar cells are causally involved in the virus-induced airway hyperresponsiveness.	JANSSEN RES FDN,DEPT CARDIOVASC PHARMACOL,BEERSE,NETHERLANDS		FOLKERTS, G (corresponding author), UNIV UTRECHT,FAC PHARM,DEPT PHARMACOL,POSTBUS 80082,3508 TB UTRECHT,NETHERLANDS.							AQUILINA AT, 1980, AM REV RESPIR DIS, V122, P3; BARNES PJ, 1988, PHARMACOL REV, V40, P49; BEASLEY R, 1988, THORAX, V43, P679, DOI 10.1136/thx.43.9.679; BRYSON DG, 1983, J COMP PATHOL, V93, P379; BUCKNER CK, 1985, AM REV RESPIR DIS, V132, P305; BUSSE WW, 1990, J ALLERGY CLIN IMMUN, V85, P671, DOI 10.1016/0091-6749(90)90181-3; COUCH RB, 1981, J INFECT DIS, V144, P284, DOI 10.1093/infdis/144.3.284; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FOLKERTS G, 1990, BRIT J CLIN PHARMACO, V30, pS159, DOI 10.1111/j.1365-2125.1990.tb05493.x; FOLKERTS G, 1988, AM REV RESPIR DIS, V137, P1441, DOI 10.1164/ajrccm/137.6.1441; Folkerts G, 1990, Agents Actions Suppl, V31, P139; FOLKERTS G, 1992, IN PRESS EUR J PHARM; HALL WJ, 1978, ANN INTERN MED, V88, P203, DOI 10.7326/0003-4819-88-2-203; INOUE H, 1986, AM REV RESPIR DIS, V133, P367; JAKAB GJ, 1982, ADV VET SCI COMP MED, V26, P155; JONGEJAN RC, 1990, AM REV RESPIR DIS, V142, P1129, DOI 10.1164/ajrccm/142.5.1129; JONGEJAN RC, 1991, IN PRESS AM REV RESP; KATSUMATA U, 1990, AM REV RESPIR DIS, V141, P1158, DOI 10.1164/ajrccm/141.5_Pt_1.1158; LAEGREID WW, 1989, J LEUKOCYTE BIOL, V45, P283, DOI 10.1002/jlb.45.4.283; LAITINEN LA, 1991, AM REV RESPIR DIS, V143, P358, DOI 10.1164/ajrccm/143.2.358; LAITINEN LA, 1980, EUR J RESPIR DIS, V10, P51; LEMEN RJ, 1990, SEMIN RESPIR MED, V11, P321, DOI 10.1055/s-2007-1006216; LITTLE JW, 1978, AM REV RESPIR DIS, V118, P295; MCINTOSH K, 1973, J PEDIATR-US, V82, P578, DOI 10.1016/S0022-3476(73)80582-7; NIJKAMP FP, 1988, ASTHMA BASIC MECHANI, P315; NIWA Y, 1985, INFLAMMATION, V9, P53, DOI 10.1007/BF00915412; OOSTERHOT AJM, 1990, LIFE SCI, V46, P1255; RAPHAEL GD, 1986, EUR J RESPIR DIS, V69, P44; RHODEN KJ, 1989, BRIT J PHARMACOL, V98, P325, DOI 10.1111/j.1476-5381.1989.tb16898.x; TAMAOKI J, 1987, EUR J PHARMACOL, V138, P421, DOI 10.1016/0014-2999(87)90482-1; TOTH T, 1983, ARCH VIROL, V75, P219, DOI 10.1007/BF01315276; VERHEYEN A, 1988, J PARASITOL, V74, P939, DOI 10.2307/3282213	34	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1992	90	3	1				364	372		10.1016/S0091-6749(05)80016-8	http://dx.doi.org/10.1016/S0091-6749(05)80016-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JP520	1326573				2022-12-18	WOS:A1992JP52000014
J	JACOBSON, RS; HOFFMAN, DR; KEMENY, DM				JACOBSON, RS; HOFFMAN, DR; KEMENY, DM			THE CROSS-REACTIVITY BETWEEN BEE AND VESPID HYALURONIDASES HAS A STRUCTURAL BASIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	19	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1992	89	1	2				292	292						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HB760					2022-12-18	WOS:A1992HB76000542
J	SHEN, HD; CHOO, KB; WANG, SR; LIN, WL; CHANG, ZN; HAN, SH				SHEN, HD; CHOO, KB; WANG, SR; LIN, WL; CHANG, ZN; HAN, SH			IMMUNOBLOT ANALYSIS OF COMPONENTS OF PENICILLIUM-NOTATUM RECOGNIZED BY HUMAN IGE ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						PENICILLIUM-NOTATUM; ALLERGENS; IMMUNOBLOTTING	CANDIDA-ALBICANS; ALLERGENS; ALTERNARIA; ANTIGENS	Components of the crude extract of Penicillium notatum recognized by human IgE antibodies (Abs) were investigated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. The allergenic components were identified with sera from 19 allergic patients and 20 blood donors. The allergen-Ab complexes were visualized by I-125-labeled monoclonal antihuman IgE and autoradiography. A total of 11 allergenic components, ranging in molecular weights (MWs) from 94,000 to 20,000 daltons, were identified. Heterogeneity in the IgE-binding patterns of the serum samples tested was also observed. However, the major allergen appears to be the component with an MW of about 68,000 daltons that was recognized by IgE Abs in 56% of the 39 sera analyzed. Furthermore, the component with an MW of about 64,000 daltons that was recognized by IgE Abs in 46% of the sera analyzed was also considered as an important allergen. Results obtained from this study will be useful in additional characterization of allergens of P. notatum and related fungal species.	VET GEN HOSP,DEPT MED RES,SHIH PAI,TAIPEI 11217,TAIWAN; VET GEN HOSP,DEPT INTERNAL MED,TAIPEI,TAIWAN; NATL YANG MING MED COLL,INST MICROBIOL & IMMUNOL,TAIPEI,TAIWAN	National Yang Ming Chiao Tung University								AAS K, 1980, ALLERGY, V35, P443, DOI 10.1111/j.1398-9995.1980.tb01791.x; Al-Doory Y, 1984, MOULD ALLERGY; CHANG Z-N, 1988, Proceedings of the National Science Council Republic of China Part B Life Sciences, V12, P140; COLLINSWILLIAMS C, 1972, ANN ALLERGY, V30, P557; GUTMAN AA, 1980, ALLERGIC DIS DIAGNOS, P100; HYDE H A, 1972, Clinical Allergy, V2, P153, DOI 10.1111/j.1365-2222.1972.tb01280.x; KRAMER CL, 1960, MYCOLOGIA, V52, P545, DOI 10.2307/3756087; KROUTIL LA, 1987, J ALLERGY CLIN IMMUN, V80, P170, DOI 10.1016/0091-6749(87)90126-6; LICORISH K, 1985, J ALLERGY CLIN IMMUN, V76, P819, DOI 10.1016/0091-6749(85)90755-9; NAKANISHI K, 1990, ANN ALLERGY, V64, P219; NARANJO P, 1958, J ALLERGY, V29, P362, DOI 10.1016/0021-8707(58)90042-X; Nilsson S., 1984, MOULD ALLERGY WORKSH, P13; PFEIL T, 1990, INT ARCH ALLER A IMM, V91, P224, DOI 10.1159/000235121; SAVOLAINEN J, 1990, ALLERGY, V45, P54, DOI 10.1111/j.1398-9995.1990.tb01084.x; SHEN HD, 1989, CLIN EXP ALLERGY, V19, P191, DOI 10.1111/j.1365-2222.1989.tb02363.x; SHEN HD, 1988, CLIN ALLERGY, V18, P401, DOI 10.1111/j.1365-2222.1988.tb02888.x	16	15	15	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1991	88	5					802	807		10.1016/0091-6749(91)90188-T	http://dx.doi.org/10.1016/0091-6749(91)90188-T			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GQ452	1955639				2022-12-18	WOS:A1991GQ45200016
J	GLYNNBARNHART, AM; ERZURUM, SC; LEFF, JA; MARTIN, RJ; COCHRAN, JE; COTT, GR; SZEFLER, SJ				GLYNNBARNHART, AM; ERZURUM, SC; LEFF, JA; MARTIN, RJ; COCHRAN, JE; COTT, GR; SZEFLER, SJ			EFFECT OF LOW-DOSE METHOTREXATE ON THE DISPOSITION OF GLUCOCORTICOIDS AND THEOPHYLLINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ASTHMA; METHOTREXATE; THEOPHYLLINE; PREDNISOLONE; METHYLPREDNISOLONE; GLUCOCORTICOIDS; PHARMACOKINETICS	RHEUMATOID-ARTHRITIS; DEPENDENT ASTHMA; THERAPY; PREDNISOLONE; EFFICACY; SAFETY; DRUGS; LIVER	Low-dose methotrexate (MTX) therapy has been recently proposed as alternative therapy for patients with severe steroid-requiring asthma. Several questions have been raised regarding the mechanism of action, including alteration of pharmacokinetics of two medications used in these patients, specifically, glucocorticoids and theophylline. To address this question, pharmacokinetic studies were performed at baseline and after 6 weeks of treatment with either intramuscular MTX or placebo (folic acid). Plasma concentrations of theophylline were measured by fluorescence polarization immunoassay (TDx, Abbott Diagnostics, Abbott Park, Ill.). Prednisolone, methylprednisolone, and cortisol concentrations were measured by high-performance liquid chromatography. Fifteen adults were enrolled in the double-blind, placebo-controlled trial. No change in prednisolone pharmacokinetic parameters was found. Theophylline clearance decreased an average of 19% in patients randomized to receive MTX, from 48.0 +/- 2.0 ml/hr/kg to 38.9 +/- 3.6 ml/hr/kg (p < 0.05). This change resembles change observed with theophylline and phenobarbital clearance in which a high degree of interpatient variability is observed. The most likely explanation for the change in theophylline clearance is inhibition of hepatic microsomal enzyme activity. Three patients complained of adverse effects, and dosage was reduced in one patient. The variable effect of MTX on theophylline clearance indicates that theophylline concentration monitoring should be performed in patients receiving both drugs.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,ROOM K926,1400 JACKSON ST,DENVER,CO 80206; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,SCH PHARM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT PEDIAT,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT MED,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT PHARMACOL,DENVER,CO 80262	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								BARTOSZEK M, 1987, CLIN PHARMACOL THER, V42, P424, DOI 10.1038/clpt.1987.173; CAPEL ID, 1979, CLIN CHEM, V25, P1381; EVANS WE, 1985, J RHEUMATOL, V12, pS15; Gibaldi M, 1982, PHARMACOKINETICS; KREMER JM, 1986, ARTHRITIS RHEUM, V29, P822, DOI 10.1002/art.1780290702; LANDAY RA, 1978, J ALLERGY CLIN IMMUN, V62, P27, DOI 10.1016/0091-6749(78)90068-4; MARQUIS JF, 1982, NEW ENGL J MED, V307, P1189, DOI 10.1056/NEJM198211043071906; MULLARKEY MF, 1988, NEW ENGL J MED, V318, P603, DOI 10.1056/NEJM198803103181004; MULLARKEY MF, 1986, ANN ALLERGY, V56, P347; PARAMSOTHY J, 1988, BRIT J DERMATOL, V119, P761, DOI 10.1111/j.1365-2133.1988.tb03500.x; ROCCI ML, 1983, COMPUT PROG BIOMED, V16, P203, DOI 10.1016/0010-468X(83)90082-X; ROSE JQ, 1980, J ALLERGY CLIN IMMUN, V66, P366, DOI 10.1016/0091-6749(80)90115-3; SHERGY WJ, 1988, AM J MED, V85, P771; SZEFLER SJ, 1982, J ALLERGY CLIN IMMUN, V69, P455, DOI 10.1016/0091-6749(82)90121-X; TANGLIU DDS, 1982, CLIN PHARMACOL THER, V31, P358, DOI 10.1038/clpt.1982.46; TOLMAN KG, 1985, J RHEUMATOL, V12, P29; TUGWELL P, 1987, ANN INTERN MED, V107, P358, DOI 10.7326/0003-4819-107-2-358; WEINBERGER M, 1978, NEW ENGL J MED, V299, P852, DOI 10.1056/NEJM197810192991603; WEINSTEIN GD, 1977, ANN INTERN MED, V86, P199, DOI 10.7326/0003-4819-86-2-199	19	15	17	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1991	88	2					180	186		10.1016/0091-6749(91)90326-J	http://dx.doi.org/10.1016/0091-6749(91)90326-J			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB225	1880318				2022-12-18	WOS:A1991GB22500005
J	RO, JY; BUCKNER, CK; BRENDEL, JK; FISHLEDER, RI; GRAZIANO, FM				RO, JY; BUCKNER, CK; BRENDEL, JK; FISHLEDER, RI; GRAZIANO, FM			INFLUENCE OF INDOMETHACIN AND L-CYSTEINE ON HISTAMINE AND PEPTIDOLEUKOTRIENE RELEASE FROM SUPERFUSED TRACHEAS TAKEN FROM GUINEA-PIGS PASSIVELY SENSITIZED WITH IGG1 AND IGE ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ARACHIDONIC-ACID METABOLISM; SLOW-REACTING SUBSTANCE; IMMUNOLOGICAL RELEASE; INDUCED CONTRACTION; MEDIATOR RELEASE; MAST-CELLS; HUMAN LUNG; ANAPHYLAXIS; INVITRO; ANTIGEN	We have previously reported differences in mediator release during equivalent levels of antigen (Ag)-induced smooth muscle contraction of guinea pig pulmonary tissues after passive sensitization with IgG1 versus IgE antibodies (Abs). In the present study, we have examined the influence of indomethacin (5 x 10(-6) mol/L) and L-cysteine (3 or 10 mmol/L) on mediator release from superfused trachea taken from guinea pigs passively sensitized with IgG1 or IgE Ab 1 day before in vitro studies. Tissues were challenged with Ag (oxazolone-human serum albumin conjugate), and contractions and superfusate histamine and peptidoleukotrienes were monitored at discrete time intervals thereafter. Superfusate mediator contents were determined by spectrophotofluorimetry (histamine) and RAST (peptidoleukotrienes). The profiles of peptidoleukotrienes were examined with high-pressure liquid chromatography. At equivalent levels of contraction, significantly less histamine and peptidoleukotrienes were found in superfusate samples after sensitization with IgE Abs. None of the drug pretreatments significantly altered Ag-induced histamine release after IgG1 or IgE sensitization. Indomethacin resulted in an increase in total measurable peptidoleukotrienes found only after IgG1 receptor activation, but it did prolong tracheal contractions with both Abs. L-cysteine, 10 mmol/L, resulted in an increase in total measurable superfusate peptidoleukotriene content under all experimental conditions. The percentage increase in peptidoleukotriene content from that found without drug pretreatment was larger in the case of IgE compared to IgG1 sensitization. During early time periods, after Ag challenge, measurable peptidoleukotriene levels in superfusate samples were similar for both Abs in the presence of L-cysteine, 10 mmol/L. These data suggest that there is a differential pattern of peptidoleukotriene metabolism after activation of IgG1 versus IgE receptors in guinea pig trachea.	UNIV WISCONSIN,SCH PHARM,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED,MADISON,WI 53706; UNIV WISCONSIN,DEPT ANESTHESIOL,MADISON,WI 53706; WILLIAM S MIDDLETON MEM VET ADM MED CTR,MADISON,WI 53705	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital					NHLBI NIH HHS [HL 28585, HL 33237] Funding Source: Medline; NIAID NIH HHS [AI 00652] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028585, R01HL033237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K07AI000652] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS GK, 1979, J IMMUNOL, V122, P555; AHARONY D, 1983, BIOCHEM BIOPH RES CO, V117, P574, DOI 10.1016/0006-291X(83)91239-1; AXEN RJ, 1976, NATURE, P1302; BENACERRAF B, 1963, J EXP MED, V117, P937, DOI 10.1084/jem.117.6.937; BLOCH KJ, 1963, J EXP MED, V117, P965, DOI 10.1084/jem.117.6.965; CHURCH MK, 1975, BRIT J PHARMACOL, V55, P423, DOI 10.1111/j.1476-5381.1975.tb06947.x; COLLIER HOJ, 1967, BRIT J PHARM CHEMOTH, V30, P283, DOI 10.1111/j.1476-5381.1967.tb02135.x; CONSTANTINE JW, 1965, J PHARM PHARMACOL, V17, P384, DOI 10.1111/j.2042-7158.1965.tb07688.x; ENERBACK L, 1986, MAST CELL DIFFERENTI, P1; FISHLEDER RI, 1987, J PHARMACOL EXP THER, V242, P558; FISHLEDER RI, 1984, J PHARMACOL EXP THER, V230, P534; GRAZIANO F, 1981, J IMMUNOL, V127, P1067; GRAZIANO FM, 1984, J CLIN INVEST, V73, P1215, DOI 10.1172/JCI111307; HAND JM, 1979, INT J IMMUNOPHARMACO, V1, P189, DOI 10.1016/0192-0561(79)90041-9; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; ISHIZAKA K, 1975, ADV IMMUNOL, V23, P1; JORG A, 1982, J EXP MED, V155, P390, DOI 10.1084/jem.155.2.390; KATZ HR, 1985, J ALLERGY CLIN IMMUN, V76, P250, DOI 10.1016/0091-6749(85)90638-4; KAY AB, 1971, J IMMUNOL, V107, P899; MARTIN LN, 1982, J IMMUNOL METHODS, V52, P205, DOI 10.1016/0022-1759(82)90046-1; ORANGE RP, 1971, J EXP MED, V134, pS136; OVARY Z, 1976, INT ARCH ALLER A IMM, V51, P416, DOI 10.1159/000231616; OVARY Z, 1963, J EXP MED, V117, P951, DOI 10.1084/jem.117.6.951; PEARCE FL, 1985, FRONTIERS HISTAMINE, P411; PIPER PJ, 1977, PHARMACOL THER PT B, V3, P75, DOI 10.1016/0306-039X(77)90005-8; RADMARK O, 1980, BIOCHEM BIOPH RES CO, V96, P1679, DOI 10.1016/0006-291X(80)91367-4; RODNEY WM, 1981, ANAL BIOCHEM, V118, P96; ROUZER CA, 1980, J EXP MED, V152, P1236, DOI 10.1084/jem.152.5.1236; SHANAHAN F, 1984, CAN J PHYSIOL PHARM, V62, P734, DOI 10.1139/y84-121; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; SNYDER DW, 1984, J PHARMACOL EXP THER, V231, P224; STERINBORDA L, 1983, N-S ARCH PHARMACOL, V324, P58, DOI 10.1007/BF00647839; UNDEM BJ, 1985, AM REV RESPIR DIS, V131, P260; UNDEM BJ, 1987, AM REV RESPIR DIS, V136, P1183, DOI 10.1164/ajrccm/136.5.1183; UNDEM BJ, 1987, EUR J PHARMACOL, V142, P31, DOI 10.1016/0014-2999(87)90650-9; WARNER JA, 1989, J LEUKOCYTE BIOL, V45, P558, DOI 10.1002/jlb.45.6.558; WONG DTO, 1976, INT ARCH ALLER A IMM, V50, P155, DOI 10.1159/000231492	37	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1991	87	6					1150	1160		10.1016/0091-6749(91)92161-S	http://dx.doi.org/10.1016/0091-6749(91)92161-S			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR066	1710633	Bronze			2022-12-18	WOS:A1991FR06600015
J	BIERMAN, CW; MAXWELL, D; RYTINA, E; EMANUEL, MB; LEE, TH				BIERMAN, CW; MAXWELL, D; RYTINA, E; EMANUEL, MB; LEE, TH			EFFECT OF H1-RECEPTOR BLOCKADE ON LATE CUTANEOUS REACTIONS TO ANTIGEN - A DOUBLE-BLIND, CONTROLLED-STUDY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CELL-MEDIATOR RELEASE; SKIN-BLISTER FLUID; ALLERGIC RESPONSES; HISTAMINE; IGE; STANDARDIZATION; ACTIVATION; EXTRACTS; RAGWEED; HUMANS	This study is of the effect of the blockade of histamine H-1 receptors by a long-acting antihistamine on the immediate and late clinical response to antigen (Ag) and on the recruitment of eosinophils in the late-phase cutaneous reaction. Ten adult volunteers with late-phase reactions to the intradermal injection of either Dermatophagoides pteronyssinus or Phleum pratense (timothy) pollen performed a double-blind, crossover study. Each volunteer took astemizole, 10 mg, or identical placebo, daily for 2 weeks. Ag in the concentration that induced a late reaction in the screening visit was injected intradermally at the end of each drug period. The early reaction was measured serially for 30 minutes and the late reaction at 4 and 6 hours. Biopsies of the Ag and control sites were also performed at 6 hours. After a 6-week washout period, subjects then took the opposite medication for 2 weeks and returned for skin testing and biopsy. Skin testing demonstrated that astemizole inhibited the immediate response to both histamine and allergen but had no effect on the late response at 4 hours and at 6 hours. Biopsy specimens revealed no significant effect on eosinophil recruitment at 6 hours. We conclude that histamine H-1-receptor blockade has no effect on the late cutaneous reaction to Ag.	GUYS HOSP,SCH MED,DEPT ALLERGY,LONDON SE1 9RT,ENGLAND; GUYS HOSP,SCH MED,DEPT PATHOL,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	BIERMAN, CW (corresponding author), UNIV WASHINGTON,DEPT PEDIAT,DIV ALLERGY,4540 SAND POINT WAY NE,SEATTLE,WA 98105, USA.		Lee, Tak/AAA-9526-2020	Lee, Tak/0000-0002-7554-4059				ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977; ATKINS P, 1973, J ALLERGY CLIN IMMUN, V51, P263, DOI 10.1016/0091-6749(73)90128-0; ATKINS PC, 1987, J ALLERGY CLIN IMMUN, V79, P12, DOI 10.1016/S0091-6749(87)80008-8; ATKINS PC, 1988, ANN ALLERGY, V60, P27; BIERMAN CW, 1990, J ALLERGY CLIN IMMUN, V86, P278, DOI 10.1016/S0091-6749(05)80084-3; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; CHARLESWORTH EN, 1989, J CLIN INVEST, V83, P1519, DOI 10.1172/JCI114047; DOLOVICH J, 1983, ANN ALLERGY, V50, P241; DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; DORSCH W, 1981, J ALLERGY CLIN IMMUN, V67, P117, DOI 10.1016/0091-6749(81)90006-3; DORSCH W, 1982, J ALLERGY CLIN IMMUN, V70, P236, DOI 10.1016/0091-6749(82)90059-8; FLEEKOP PD, 1988, J ALLERGY CLIN IMMUN, V80, P140; FREW AJ, 1988, J IMMUNOL, V141, P4158; FREW AJ, 1988, J ALLERGY CLIN IMMUN, V81, P1117, DOI 10.1016/0091-6749(88)90878-0; GENDREAUREID L, 1986, J ALLERGY CLIN IMMUN, V77, P335, DOI 10.1016/S0091-6749(86)80114-2; HARVEY RP, 1980, J ALLERGY CLIN IMMUN, V65, P136, DOI 10.1016/0091-6749(80)90198-0; MICHEL L, 1988, J ALLERGY CLIN IMMUN, V82, P102; NAGY L, 1982, NEW ENGL J MED, V306, P497, DOI 10.1056/NEJM198203043060901; PIPKORN U, 1987, J CLIN INVEST, V80, P957, DOI 10.1172/JCI113188; POOTHULLIL J, 1976, J ALLERGY CLIN IMMUN, V57, P164, DOI 10.1016/0091-6749(76)90035-X; REED CE, 1989, J ALLERGY CLIN IMMUN, V84, P4, DOI 10.1016/0091-6749(89)90171-1; RICHERSON HB, 1979, J ALLERGY CLIN IMMUN, V64, P67, DOI 10.1016/0091-6749(79)90085-X; VENGE P, 1987, INT ARCH ALLER A IMM, V82, P333, DOI 10.1159/000234219; WASSERMAN SJ, IN PRESS ALLERGY AST	25	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1991	87	5					1013	1019		10.1016/0091-6749(91)90425-N	http://dx.doi.org/10.1016/0091-6749(91)90425-N			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FM095	1673976	Bronze			2022-12-18	WOS:A1991FM09500015
J	BRUNET, C; BEDARD, PM; HEBERT, J				BRUNET, C; BEDARD, PM; HEBERT, J			EFFECTS OF H-1-ANTIHISTAMINE DRUG REGIMEN ON HISTAMINE-RELEASE BY NONLESIONAL SKIN MAST-CELLS OF PATIENTS WITH CHRONIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHU LAVAL,UNITE RECH INFLAMMAT & IMMUNOL RHUMATOL,NO 9800,2705 BLV LAURIER,ST FOY G1V 4G2,QUEBEC,CANADA	Laval University								ATKINS PC, 1981, J ALLERGY CLIN IMMUN, V68, P286, DOI 10.1016/0091-6749(81)90153-6; BEDARD PM, 1986, J ALLERGY CLIN IMMUN, V78, P1121, DOI 10.1016/0091-6749(86)90260-5; BRUNET C, 1988, J ALLERGY CLIN IMMUN, V82, P398, DOI 10.1016/0091-6749(88)90011-5; COHEN RW, 1986, J ALLERGY CLIN IMMUN, V77, P802, DOI 10.1016/0091-6749(86)90377-5; JUHLIN L, 1987, J ALLERGY CLIN IMMUN, V80, P599, DOI 10.1016/0091-6749(87)90014-5; JUHLIN L, 1967, ACTA DERM-VENER    S, P383; KAPLAN AP, 1978, J ALLERGY CLIN IMMUN, V61, P350, DOI 10.1016/0091-6749(78)90113-6; Lewis T., 1927, BLOOD VESSELS HUMAN; LICHTENSTEIN LM, 1975, J PHARMACOL EXP THER, V192, P441; MOTA I, 1960, BRIT J PHARM CHEMOTH, V15, P396, DOI 10.1111/j.1476-5381.1960.tb01262.x; NATBONY SF, 1983, J ALLERGY CLIN IMMUN, V71, P177, DOI 10.1016/0091-6749(83)90096-9; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P371, DOI 10.1016/0091-6749(80)90215-8; TING S, 1981, J ALLERGY CLIN IMMUN, V68, P65, DOI 10.1016/0091-6749(81)90125-1	13	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1990	86	5					787	793		10.1016/S0091-6749(05)80184-8	http://dx.doi.org/10.1016/S0091-6749(05)80184-8			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EJ631	1699989				2022-12-18	WOS:A1990EJ63100012
J	RAFFERTY, P				RAFFERTY, P			ANTIHISTAMINES IN THE TREATMENT OF CLINICAL ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	MEETING ON HISTAMINE AND DISEASE : A FORUM ON CURRENT AND FUTURE MANAGEMENT	AUG 25-26, 1989	CARLSBAD, CA	MERRELL DOW PHARM							RAFFERTY, P (corresponding author), WESTERN INFIRM & ASSOCIATED HOSP,LEVEL 10 MED,GLASGOW G11 6NT,SCOTLAND.							BUSSE W, 1988, J ALLERGY CLIN IMMUN, V81, P212; CHAND N, 1986, ALLERGY, V41, P473, DOI 10.1111/j.1398-9995.1986.tb00331.x; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; COOKSON WOM, IN PRESS 13TH P INT; Diamantis W., 1981, PHARMACOLOGIST, V23, P149; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; FADEL R, 1987, CLIN ALLERGY, V17, P373, DOI 10.1111/j.1365-2222.1987.tb02027.x; FIELDS DAS, 1984, J ALLERGY CLIN IMMUN, V73, P400, DOI 10.1016/0091-6749(84)90415-9; FORNEAU E, 1933, ARCH INT PHARMACOD T, V46, P178; HOWARTH PH, 1985, J ALLERGY CLIN IMMUN, V75, pA166; KARLIN JM, 1972, ANN ALLERGY, V30, P342; LITTLE MM, 1987, J ALLERGY CLIN IMMUN, V79, P204; MASUMOTO Y, 1989, EUR J CLIN PHARMACOL, V36, pA285; PATEL KR, 1984, BRIT MED J, V288, P1496, DOI 10.1136/bmj.288.6429.1496; POPA VT, 1980, CHEST, V78, P442, DOI 10.1378/chest.78.3.442; RAFFERTY P, 1987, AM REV RESPIR DIS, V136, P369, DOI 10.1164/ajrccm/136.2.369; RAFFERTY P, 1987, AM REV RESPIR DIS, V135, P181; TAYTARD A, 1987, BRIT J CLIN PHARMACO, V24, P743, DOI 10.1111/j.1365-2125.1987.tb03240.x; THOSH SK, 1989, THORAX, V44, P851; TOWNLEY RG, 1989, ANN ALLERGY, V63, P455; ZECHEL HJ, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1184	21	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1990	86	4	2	S			647	650		10.1016/S0091-6749(05)80231-3	http://dx.doi.org/10.1016/S0091-6749(05)80231-3			4	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EH093	1977784				2022-12-18	WOS:A1990EH09300012
J	WINKELSTEIN, JA; FEARON, E				WINKELSTEIN, JA; FEARON, E			CARRIER DETECTION OF THE X-LINKED PRIMARY IMMUNODEFICIENCY DISEASES USING X-CHROMOSOME INACTIVATION ANALYSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Johns Hopkins University	WINKELSTEIN, JA (corresponding author), JOHNS HOPKINS UNIV HOSP,SCH MED,DEPT PEDIAT CMSC 1103,EUDOWOOD DIV IMMUNOL,BALTIMORE,MD 21205, USA.				NATIONAL CANCER INSTITUTE [R01CA035494, R37CA035494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; NCI NIH HHS [CA-35494] Funding Source: Medline; NIGMS NIH HHS [GM-07309, GM-07184] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLAESE RM, 1968, LANCET, V1, P1056; BRUTON OC, 1952, PEDIATRICS, V9, P722; CONLEY ME, 1988, J PEDIATR-US, V112, P688, DOI 10.1016/S0022-3476(88)80683-8; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FEARON ER, 1988, BLOOD, V72, P1735; FLEISHER TA, 1980, NEW ENGL J MED, V302, P1429, DOI 10.1056/NEJM198006263022601; GALLIN JI, 1983, ANN INTERN MED, V99, P657, DOI 10.7326/0003-4819-99-5-657; GEALY WJ, 1980, LANCET, V1, P63; Gelfand E W, 1983, Birth Defects Orig Artic Ser, V19, P65; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GOODSHIP J, 1988, LANCET, V1, P729; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KIVAN SP, 1986, J CLIN INVEST, V77, P649; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCKUSICK VA, 1989, MENDELIAN INHERITANC; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; OCHS HD, 1973, J PEDIATR-US, V83, P77, DOI 10.1016/S0022-3476(73)80316-6; PEACOCKE M, 1987, P NATL ACAD SCI USA, V84, P3430, DOI 10.1073/pnas.84.10.3430; PRCHAL JT, 1980, BLOOD, V56, P1048; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; PURTILO DT, 1977, NEW ENGL J MED, V297, P1077, DOI 10.1056/NEJM197711172972001; ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001; STIEHM ER, 1966, AM J MED, V40, P805, DOI 10.1016/0002-9343(66)90163-X; VOGELSTEIN B, 1985, SCIENCE, V227, P642, DOI 10.1126/science.2982210; WINDHORS.DB, 1967, LANCET, V1, P737; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759; 1989, IMMUNOL REV, V1, P173	35	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1990	85	6					1090	1097		10.1016/0091-6749(90)90055-9	http://dx.doi.org/10.1016/0091-6749(90)90055-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DK509	2191994				2022-12-18	WOS:A1990DK50900016
J	BERNSTEIN, DI; ZEISS, CR				BERNSTEIN, DI; ZEISS, CR			GUIDELINES FOR PREPARATION AND CHARACTERIZATION OF CHEMICAL-PROTEIN CONJUGATE ANTIGENS - REPORT OF THE SUBCOMMITTEE-ON-PREPARATION-AND-CHARACTERIZATION-OF-LOW-MOLECULAR-WEIGHT-ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BERNSTEIN DI, 1984, J ALLERGY CLIN IMMUN, V74, P258, DOI 10.1016/0091-6749(84)90255-0; BERNSTEIN DI, 1988, ALLERGY PRINCIPLES P, V2, P1197; BIAGINI RE, 1985, J ALLERGY CLIN IMMUN, V76, P794, DOI 10.1016/0091-6749(85)90750-X; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; LISS GM, 1988, J ALLERGY CLIN IMMUN, V82, P55, DOI 10.1016/0091-6749(88)90051-6; MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; TSE CST, 1979, TOXICOL APPL PHARM, V51, P39, DOI 10.1016/0041-008X(79)90006-1; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1980, INT ARCH ALLER A IMM, V61, P380; ZEISS CR, 1980, J ALLERGY CLIN IMMUN, V65, P346, DOI 10.1016/0091-6749(80)90211-0	11	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	2	S			820	822		10.1016/0091-6749(89)90345-X	http://dx.doi.org/10.1016/0091-6749(89)90345-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CC527	2809030	Bronze			2022-12-18	WOS:A1989CC52700005
J	WHITE, MV; BAER, H; KUBOTA, Y; KALINER, M				WHITE, MV; BAER, H; KUBOTA, Y; KALINER, M			NEUTROPHILS AND MAST-CELLS - CHARACTERIZATION OF CELLS RESPONSIVE TO NEUTROPHIL-DERIVED HISTAMINE-RELEASING ACTIVITY (HRA-N)	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIH,CTR DRUGS & BIOL,OFF BIOL RES & REVIEW,ALLERGEN PROD LAB,BETHESDA,MD 20205; NCI,DERMATOL BRANCH,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WHITE, MV (corresponding author), NIAID,ALLERG DIS SECT,CLIN INVEST LAB,BLDG 10,ROOM 11C207,BETHESDA,MD 20892, USA.				PHS HHS [A107507-03] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALAM R, 1988, J CLIN INVEST, V82, P2056, DOI 10.1172/JCI113826; BARRETT K E, 1984, Agents and Actions, V14, P488, DOI 10.1007/BF01973856; BENYON RC, 1987, J IMMUNOL, V138, P861; CONNELL JT, 1968, J ALLERGY, V41, P101; DURHAM SR, 1984, J ALLERGY CLIN IMMUN, V74, P49, DOI 10.1016/0091-6749(84)90086-1; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KEAHEY TM, 1987, J ALLERGY CLIN IMMUN, V80, P831, DOI 10.1016/S0091-6749(87)80273-7; LEMANSKE R, 1982, CRC CRIT REV IMMUNOL, V1, P547; LEMANSKE RF, 1983, J IMMUNOL, V131, P929; LEMANSKE RF, 1983, J IMMUNOL, V130, P2837; LIU MC, 1986, J IMMUNOL, V136, P2588; MURPHY KR, 1986, AM REV RESPIR DIS, V134, P62; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; SOLLEY GO, 1976, J CLIN INVEST, V58, P408, DOI 10.1172/JCI108485; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; TANNENBAUM S, 1980, J IMMUNOL, V125, P325; THUESON DO, 1979, J IMMUNOL, V123, P626; WHITE MV, 1987, J IMMUNOL, V139, P1624; WHITE MV, 1988, J IMMUNOL, V141, P3575; ZHEUTLIN LM, 1984, J IMMUNOL, V133, P2180	21	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1989	84	5	1				773	780		10.1016/0091-6749(89)90308-4	http://dx.doi.org/10.1016/0091-6749(89)90308-4			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA314	2478609				2022-12-18	WOS:A1989CA31400017
J	PATTERSON, R; DYKEWICZ, MS; EVANS, R; GRAMMER, LC; GREENBERGER, PA; HARRIS, KE; LAWRENCE, ID; PRUZANSKY, JJ; ROBERTS, M; SHAUGHNESSY, MA; ZEISS, CR				PATTERSON, R; DYKEWICZ, MS; EVANS, R; GRAMMER, LC; GREENBERGER, PA; HARRIS, KE; LAWRENCE, ID; PRUZANSKY, JJ; ROBERTS, M; SHAUGHNESSY, MA; ZEISS, CR			IGG ANTIBODY AGAINST FORMALDEHYDE HUMAN-SERUM PROTEINS - A COMPARISON WITH OTHER IGG ANTIBODIES AGAINST INHALANT PROTEINS AND REACTIVE CHEMICALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATTERSON, R (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MED,ALLERGY IMMUNOL SECT,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.		Greenberger, Paul/L-2770-2019	Greenberger, Paul/0000-0003-3882-8498; Grammer, Leslie/0000-0001-6860-2014	NIAID NIH HHS [AI 11403] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI011403] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BASCOM R, 1985, AM REV RESPIR DIS, V131, P463; BROUGHTON A, 1988, AM J IND MED, V13, P463, DOI 10.1002/ajim.4700130406; FINK JN, 1972, CHEST, V62, P277, DOI 10.1378/chest.62.3.277; FINK JN, 1988, ALLERGY PRINCIPLES P, V2, P1237; FINK JN, 1985, ALLERGIC DISEASES DI, P679; FITZSIMONS R, 1986, ANN ALLERGY, V57, P291; GRAMMER LC, 1987, ANN ALLERGY, V58, P151; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; GUTMAN AA, 1985, ALLERGIC DISEASES DI, P123; Horssfall FL, 1934, J IMMUNOL, V27, P553; KARR RM, 1980, CLIN IMMUNOLOGY, V2, P1336; LANDSTEINER K, 1914, Z IMMUNITATSFORSCH, V20, P618; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; MALO JL, 1983, J ALLERGY CLIN IMMUN, V72, P413, DOI 10.1016/0091-6749(83)90508-0; MILLER MM, 1976, CLIN ALLERGY, V6, P451, DOI 10.1111/j.1365-2222.1976.tb01929.x; PATTERSON R, 1987, J ALLERGY CLIN IMMUN, V79, P705, DOI 10.1016/0091-6749(87)90199-0; PATTERSON R, 1977, AM J MED, V63, P257, DOI 10.1016/0002-9343(77)90240-6; PATTERSON R, 1976, AM REV RESPIR DIS, V114, P315; PATTERSON R, 1983, ANN INTERN MED, V99, P18, DOI 10.7326/0003-4819-99-1-18; PATTERSON R, 1982, J ALLERGY CLIN IMMUN, V70, P19, DOI 10.1016/0091-6749(82)90196-8; PATTERSON R, 1982, INT ARCH ALLER A IMM, V69, P30, DOI 10.1159/000233142; PATTERSON R, 1981, J ALLERGY CLIN IMMUN, V68, P128, DOI 10.1016/0091-6749(81)90171-8; PATTERSON R, 1979, AM REV RESPIR DIS, V120, P1259; PATTERSON R, 1978, J CLIN INVEST, V62, P971, DOI 10.1172/JCI109226; PATTERSON R, 1986, INT ARCH ALLER A IMM, V79, P53, DOI 10.1159/000233942; PATTERSON R, 1978, J ALLERGY CLIN IMMUN, V62, P103, DOI 10.1016/0091-6749(78)90086-6; PATTERSON R, 1986, AM J MED, V60, P144; PROSS HF, 1987, J ALLERGY CLIN IMMUN, V79, P797, DOI 10.1016/0091-6749(87)90213-2; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x; THRASHER JD, 1987, ARCH ENVIRON HEALTH, V42, P347, DOI 10.1080/00039896.1987.9934357; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WALKER CL, 1989, J OCCUP ENVIRON MED, V31, P315; ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1; ZEISS CR, 1983, ANN INTERN MED, V98, P8, DOI 10.7326/0003-4819-98-1-8; ZEISS CR, 1987, J ALLERGY CLIN IMMUN, V79, P59, DOI 10.1016/S0091-6749(87)80017-9; ZEISS CR, 1980, J ALLERGY CLIN IMMUN, V65, P346, DOI 10.1016/0091-6749(80)90211-0	36	15	17	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1989	84	3					359	366		10.1016/0091-6749(89)90421-1	http://dx.doi.org/10.1016/0091-6749(89)90421-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AR199	2778242				2022-12-18	WOS:A1989AR19900014
J	MCMANUS, MS; KOENIG, JQ; ALTMAN, LC; PIERSON, WE				MCMANUS, MS; KOENIG, JQ; ALTMAN, LC; PIERSON, WE			PULMONARY EFFECTS OF SULFUR-DIOXIDE EXPOSURE AND IPRATROPIUM BROMIDE PRETREATMENT IN ADULTS WITH NONALLERGIC ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WASHINGTON, DEPT ENVIRONM HLTH, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NIEHS NIH HHS [2 RO1 ES 02366] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002366] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AARONSON DW, 1985, ALLERGIC DISEASES DI, P253; AAS K, 1981, ALLERGY, V36, P3, DOI 10.1111/j.1398-9995.1981.tb01818.x; BARNES PJ, 1987, AM REV RESPIR DIS, V136, pS42, DOI 10.1164/ajrccm/136.4_Pt_2.S42; DIXON WJ, 1983, BMDP STATISTICAL SOF; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; FISHER AB, 1968, J CLIN INVEST, V47, P2045, DOI 10.1172/JCI105890; FRANK NR, 1962, J APPL PHYSIOL, V17, P252, DOI 10.1152/jappl.1962.17.2.252; GOLDMAN M, 1970, J APPL PHYSIOL, V28, P113, DOI 10.1152/jappl.1970.28.1.113; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HARRIES MG, 1981, LANCET, V1, P5; HOCKLEY B, 1985, BRIT J DIS CHEST, V79, P379, DOI 10.1016/0007-0971(85)90072-5; HORN BR, 1975, NEW ENGL J MED, V292, P1152, DOI 10.1056/NEJM197505292922204; HORSTMAN D, 1986, Toxicology and Industrial Health, V2, P289; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; KOENIG JQ, 1982, J ALLERGY CLIN IMMUN, V69, P339, DOI 10.1016/0091-6749(82)90143-9; KOENIG JQ, 1983, J TOXICOL ENV HEALTH, V11, P129, DOI 10.1080/15287398309530327; KOENIG JQ, 1980, ENVIRON RES, V22, P145, DOI 10.1016/0013-9351(80)90126-7; LINN WS, 1985, ENVIRON RES, V37, P445, DOI 10.1016/0013-9351(85)90126-4; MACKLEY PT, 1986, AM PHYSL SOC HDB 1 2, V3; MYERS DJ, 1986, AM REV RESPIR DIS, V133, P1154; PARTRIDGE MR, 1981, THORAX, V36, P530, DOI 10.1136/thx.36.7.530; RONDINELLI RCA, 1987, AM IND HYG ASSOC J, V48, P299, DOI 10.1202/0002-8894(1987)048<0299:TEOSDO>2.0.CO;2; RUFFIN RE, 1982, J ALLERGY CLIN IMMUN, V69, P60, DOI 10.1016/0091-6749(82)90089-6; RUFFIN RE, 1977, J ALLERGY CLIN IMMUN, V59, P136, DOI 10.1016/0091-6749(77)90215-9; RYAN G, 1981, J ALLERGY CLIN IMMUN, V67, P156, DOI 10.1016/0091-6749(81)90012-9; SHEPPARD D, 1980, AM REV RESPIR DIS, V122, P873; SHEPPARD D, 1986, CHEST, V90, P584, DOI 10.1378/chest.90.4.584; SNASHALL PD, 1982, THORAX, V37, P118, DOI 10.1136/thx.37.2.118; Steel R.G.D., 1980, PRINCIPLES STAT; STURANI C, 1985, RESPIRATION, V48, P321, DOI 10.1159/000194846; SZCZEKLIK A, 1977, RESPIRATION, V34, P323, DOI 10.1159/000193844; TAM E, 1983, AM REV RESPIR DIS, V127, P257; TAN WC, 1982, THORAX, V37, P671, DOI 10.1136/thx.37.9.671; ULLAH MI, 1981, THORAX, V36, P523, DOI 10.1136/thx.36.7.523; WEGENER T, 1987, RESPIRATION, V52, P1	35	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1989	83	3					619	626		10.1016/0091-6749(89)90074-2	http://dx.doi.org/10.1016/0091-6749(89)90074-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T8596	2522475				2022-12-18	WOS:A1989T859600008
J	JYO, T; KODOMARI, Y; KODOMARI, N; KUWABARA, W; KATSUTANI, T; OTSUKA, T; TSUBOI, S; OKA, S; SHIGETA, S; ONO, K				JYO, T; KODOMARI, Y; KODOMARI, N; KUWABARA, W; KATSUTANI, T; OTSUKA, T; TSUBOI, S; OKA, S; SHIGETA, S; ONO, K			THERAPEUTIC EFFECT AND TITERS OF THE SPECIFIC IGE AND IGG ANTIBODIES IN PATIENTS WITH SEA SQUIRT ALLERGY (HOYA ASTHMA) UNDER A LONG-TERM HYPOSENSITIZATION WITH 3 SEA SQUIRT ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HIROSHIMA UNIV,FAC ENGN,DEPT FERMENTAT TECHNOL,HIROSHIMA 730,JAPAN	Hiroshima University	JYO, T (corresponding author), HIROSHIMA PREFECTURAL HOSP,DEPT INTERNAL MED,UJINA MACHI,HIROSHIMA 734,JAPAN.							DAIBO A, 1984, JPN J ALLERGOL, V33, P692; IRONS JS, 1975, J ALLERGY CLIN IMMUN, V56, P64, DOI 10.1016/0091-6749(75)90035-4; JYO T, 1981, Japanese Journal of Thoracic Diseases, V19, P223; JYO T, 1980, OCCUPATIONAL ASTHMA, P209; JYO T, 1985, ALERGIA, V14, P26; JYO T, 1978, JPN J ALLERGOL, V27, P842; JYO T, 1975, JPN J ALLERGOL, V25, P703; JYO T, 1974, JPN J ALLERGOL, V23, P464; LICHTENSTEIN LM, 1968, J IMMUNOL, V101, P317; OKA S, 1982, J BIOCHEM-TOKYO, V91, P1403, DOI 10.1093/oxfordjournals.jbchem.a133828; OKA S, 1987, J ALLERGY CLIN IMMUN, V80, P57, DOI 10.1016/S0091-6749(87)80191-4; OKA S, 1979, INT ARCH ALLER A IMM, V59, P408, DOI 10.1159/000232288; SUZUKI H, 1984, J BIOCHEM-TOKYO, V96, P849, DOI 10.1093/oxfordjournals.jbchem.a134903; TAKAO Y, 1984, JPN J ALLERGOL, V33, P733; TANIFUJI K, 1984, Japanese Journal of Allergology, V33, P78; TSUBOI S, 1987, JPN J ALLERGOL, V36, P735	16	15	14	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1989	83	2	1				386	393		10.1016/0091-6749(89)90123-1	http://dx.doi.org/10.1016/0091-6749(89)90123-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T4489	2918184	Bronze			2022-12-18	WOS:A1989T448900004
J	PALMQVIST, M; BALDER, B; LOWHAGEN, O; MELANDER, B; SVEDMYR, N; WAHLANDER, L				PALMQVIST, M; BALDER, B; LOWHAGEN, O; MELANDER, B; SVEDMYR, N; WAHLANDER, L			LATE ASTHMATIC REACTION PREVENTED BY INHALED SALBUTAMOL AND FORMOTEROL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1989	83	1					244	244						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T0419					2022-12-18	WOS:A1989T041900313
J	MIHALYKA, M; WONG, J; JAMES, AL; ANDERSON, SD; PARE, PD				MIHALYKA, M; WONG, J; JAMES, AL; ANDERSON, SD; PARE, PD			THE EFFECT ON AIRWAY FUNCTION OF INSPIRED AIR CONDITIONS AFTER ISOCAPNIC HYPERVENTILATION WITH DRY AIR	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV BRITISH COLUMBIA,ST PAULS HOSP,PULM RES LAB,1081 BURARD ST,VANCOUVER V6Z 1Y6,BC,CANADA; ROYAL PRINCE ALFRED HOSP,CAMPERDOWN,NSW 2050,AUSTRALIA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Sydney			Pare, Peter D/C-7425-2011					ANDERSON SD, 1985, EUR J RESPIR DIS, V67, P20; ANDERSON SD, 1982, EUR J RESPIR DIS, V63, P459; BAILE EM, 1987, J APPL PHYSIOL, V62, P526, DOI 10.1152/jappl.1987.62.2.526; BAILE EM, 1985, J APPL PHYSIOL, V58, P217, DOI 10.1152/jappl.1985.58.1.217; CHEN WY, 1977, RESPIRATION, V34, P305, DOI 10.1159/000193842; DEAL EC, 1980, AM REV RESPIR DIS, V121, P621; DEAL EC, 1979, J APPL PHYSIOL, V46, P467, DOI 10.1152/jappl.1979.46.3.467; DEAL EC, 1979, J APPL PHYSIOL, V46, P476, DOI 10.1152/jappl.1979.46.3.476; ESCHENBACHER WL, 1985, AM REV RESPIR DIS, V131, P894; HAHN A, 1984, AM REV RESPIR DIS, V130, P575; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; MCFADDEN ER, 1986, J CLIN INVEST, V78, P18, DOI 10.1172/JCI112549; MONTGOMERY DC, 1976, DESIGN ANAL EXPT, P285; OCAIN CF, 1980, J APPL PHYSIOL, V49, P875, DOI 10.1152/jappl.1980.49.5.875; SAVARD GK, 1985, J APPL PHYSIOL, V58, P4, DOI 10.1152/jappl.1985.58.1.4; SCHARF SM, 1985, CHEST, V88, P586, DOI 10.1378/chest.88.4.586; SCHOEFFEL RE, 1981, BRIT MED J, V283, P1285, DOI 10.1136/bmj.283.6302.1285; SHEPPARD D, 1984, AM REV RESPIR DIS, V130, P52; STRAUSS RH, 1978, J CLIN INVEST, V61, P433, DOI 10.1172/JCI108954; TESSIER P, 1987, AM REV RESPIR DIS, V136, P1418, DOI 10.1164/ajrccm/136.6.1418; WEAST RC, 1978, HDB CHEM PHYSICS, pE38; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; 1962, AM REV RESPIR DIS, V85, P762	23	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1988	82	5	1				842	848		10.1016/0091-6749(88)90088-7	http://dx.doi.org/10.1016/0091-6749(88)90088-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	R1708	3192867				2022-12-18	WOS:A1988R170800019
J	BRUNET, C; BEDARD, PM; HEBERT, J				BRUNET, C; BEDARD, PM; HEBERT, J			ANALYSIS OF COMPOUND 48/80-INDUCED SKIN HISTAMINE-RELEASE AND LEUKOTRIENE PRODUCTION IN CHRONIC URTICARIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											HEBERT, J (corresponding author), CHU LAVAL,UNITE RECH INFLAMMAT & IMMUNOL RHUMATOL,2705 BLVD LAURIER,QUEBEC CITY G1V 4G2,QUEBEC,CANADA.							BEDARD PM, 1986, J ALLERGY CLIN IMMUN, V78, P1121, DOI 10.1016/0091-6749(86)90260-5; ELIAS J, 1986, J ALLERGY CLIN IMMUN, V78, P914, DOI 10.1016/0091-6749(86)90240-X; GREAVES MW, 1974, CLIN ALLERGY, V4, P265, DOI 10.1111/j.1365-2222.1974.tb01384.x; JUHLIN L, 1967, ACTA DERM-VENEREOL, V47, P383; KAPLAN AP, 1978, J ALLERGY CLIN IMMUN, V61, P350, DOI 10.1016/0091-6749(78)90113-6; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; LAWRENCE ID, 1987, J ALLERGY CLIN IMMUN, V79, P179; MEKORI YA, 1983, J ALLERGY CLIN IMMUN, V72, P681, DOI 10.1016/0091-6749(83)90629-2; NATBONY SF, 1983, J ALLERGY CLIN IMMUN, V71, P177, DOI 10.1016/0091-6749(83)90096-9; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P436, DOI 10.1016/0091-6749(80)90237-7; PHANUPHAK P, 1980, J ALLERGY CLIN IMMUN, V65, P371, DOI 10.1016/0091-6749(80)90215-8; RESHEF A, 1987, J ALLERGY CLIN IMMUN, V79, P248; ROSENSTREICH DL, 1986, J ALLERGY CLIN IMMUN, V78, P1099, DOI 10.1016/0091-6749(86)90256-3; SOBOTKA AK, 1979, J IMMUNOL, V122, P511; TALBOT SF, 1985, J CLIN INVEST, V76, P650, DOI 10.1172/JCI112018; ZWEIMAN B, 1976, J ALLERGY CLIN IMMUN, V58, P657, DOI 10.1016/0091-6749(76)90177-9	16	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1988	82	3	1				398	402		10.1016/0091-6749(88)90011-5	http://dx.doi.org/10.1016/0091-6749(88)90011-5			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q3229	2459174	Bronze			2022-12-18	WOS:A1988Q322900011
J	KRZANOWSKI, JJ; POLSON, JB				KRZANOWSKI, JJ; POLSON, JB			MECHANISM OF ACTION OF METHYLXANTHINES IN ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											KRZANOWSKI, JJ (corresponding author), UNIV S FLORIDA,COLL MED,MED CTR,DEPT PHARMACOL & THERAPEUT,BOX 9,12901 BRUCE B DOWNS BLVD,TAMPA,FL 33612, USA.							ABDELLATIF AA, 1986, PHARMACOL REV, V38, P227; BARNES PJ, 1987, TRENDS PHARMACOL SCI, V8, P285, DOI 10.1016/0165-6147(87)90115-5; BARNES PJ, 1987, Q J MED, V63, P359; BARNES PJ, 1986, EUR J RESPIR DIS, V69, P80; BARNES PJ, 1988, AIRWAYS NEURAL CONTR, P71; BERGSTRAND H, 1978, MOL CELL BIOCHEM, V21, P9; BERKOWITZ BA, 1971, EUR J PHARMACOL, V13, P193, DOI 10.1016/0014-2999(71)90150-6; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; DUNCAN RA, 1987, BIOCHEM PHARMACOL, V36, P307, DOI 10.1016/0006-2952(87)90286-3; DUNCAN RA, 1988, THESIS U S FLORIDA T; DUTOIT JI, IN PRESS AM REV RESP; FREDHOLM BB, 1985, ACTA MED SCAND, V217, P149; FREDHOLM BB, 1980, EUR J RESPIR DIS, V61, P29; HIGBEE MD, 1982, J ALLERGY CLIN IMMUN, V70, P377, DOI 10.1016/0091-6749(82)90028-8; KOLBECK RC, 1977, LUNG, V156, P178; KRZANOWSKI JJ, 1987, ARCH INT PHARMACOD T, V287, P224; LUNELL E, 1982, EUR J CLIN PHARMACOL, V22, P395, DOI 10.1007/BF00542541; MANN JS, 1985, BRIT J CLIN PHARMACO, V19, P685, DOI 10.1111/j.1365-2125.1985.tb02696.x; PEACH MJ, 1972, P NATL ACAD SCI USA, V69, P834, DOI 10.1073/pnas.69.4.834; POISNER AM, 1973, BIOCHEM PHARMACOL, V22, P469, DOI 10.1016/0006-2952(73)90288-8; POLSON JB, 1982, BIOCHEM PHARMACOL, V31, P3403, DOI 10.1016/0006-2952(82)90618-9; POLSON JB, 1978, CLIN EXP PHARMACOL P, V5, P535; POLSON JB, 1985, BIOCHEM PHARMACOL, V34, P1875, DOI 10.1016/0006-2952(85)90301-6; RALL TW, 1985, PHARMACOL BASIS THER, P595; TULINSILVER J, 1981, J ALLERGY CLIN IMMUN, V67, P45, DOI 10.1016/0091-6749(81)90044-0; WOOLCOCK AJ, 1988, 44TH P ANN M AM AC A	26	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1988	82	2					143	145		10.1016/0091-6749(88)90992-X	http://dx.doi.org/10.1016/0091-6749(88)90992-X			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P8741	3403859				2022-12-18	WOS:A1988P874100002
J	BROOKS, CD; KARL, KJ				BROOKS, CD; KARL, KJ			HAY-FEVER TREATMENT WITH COMBINED ANTIHISTAMINE AND CYCLOOXYGENASE-INHIBITING DRUGS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BROOKS, CD (corresponding author), BRONSON METHODIST HOSP,BRONSON CLIN INVEST UNIT,252 E LOVELL ST,KALAMAZOO,MI 49007, USA.							ADAMS SS, 1975, ARZNEIMITTEL-FORSCH, V25, P1786; ADCOCK JJ, 1982, BRIT J PHARMACOL, V77, P570, DOI 10.1111/j.1476-5381.1982.tb09333.x; BAUMGARTEN CR, 1986, J IMMUNOL, V137, P1323; BEDWANI JR, 1983, CLIN OTOLARYNGOL, V8, P337; BISGAARD H, 1986, CLIN ALLERGY, V16, P289, DOI 10.1111/j.1365-2222.1986.tb01960.x; BOCTOR AM, 1986, PROSTAG LEUKOTR ESS, V23, P229, DOI 10.1016/0262-1746(86)90190-3; BROOKS CD, 1981, ANN ALLERGY, V47, P316; BROOKS CD, 1985, ANN ALLERGY, V55, P557; BROOKS CD, 1984, J ALLERGY CLIN IMMUN, V73, P584, DOI 10.1016/0091-6749(84)90515-3; DENNIS RG, 1976, ARCH OTOLARYNGOL, V102, P420; DIXON M, 1979, BRIT J PHARMACOL, V66, P203, DOI 10.1111/j.1476-5381.1979.tb13666.x; GREIG ME, 1975, J MED CHEM, V18, P112, DOI 10.1021/jm00235a027; GRIFFIN RL, 1986, PHARMACOLOGIST, V28, P142; HEAVEY DJ, 1984, PROSTAGLANDINS, V28, P755, DOI 10.1016/0090-6980(84)90033-9; HIGGS GA, 1984, PROSTA LEUKOTR MED, V13, P89, DOI 10.1016/0262-1746(84)90107-0; JACKSON RT, 1970, CURR THER RES CLIN E, V12, P711; KARIM SMM, 1978, PROSTAGLANDINS, V15, P457, DOI 10.1016/0090-6980(78)90129-6; LUNG MA, 1984, J PHYSL, P349; MAGRO AM, 1982, INT J IMMUNOPHARMACO, V4, P15, DOI 10.1016/0192-0561(82)90004-2; MCLEAN JA, 1983, J ALLERGY CLIN IMMUN, V72, P187, DOI 10.1016/0091-6749(83)90528-6; MORRELLI HF, 1978, CLIN PHARM BASIC PRI, P987; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NORMAN PS, 1983, CURRENT THERAPY ALLE, P1; SCHIANTARELLI P, 1981, EUR J PHARMACOL, V73, P363, DOI 10.1016/0014-2999(81)90239-9; SNEDECOR GW, 1967, STATISTICAL METHODS, P132; TOKUNAGA M, 1981, ANN RHEUM DIS, V40, P462, DOI 10.1136/ard.40.5.462; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; WOJNAR RJ, 1980, J ALLERGY CLIN IMMUN, V66, P37, DOI 10.1016/0091-6749(80)90136-0	29	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1988	81	6					1110	1117		10.1016/0091-6749(88)90877-9	http://dx.doi.org/10.1016/0091-6749(88)90877-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P0023	2897986				2022-12-18	WOS:A1988P002300007
J	BROIDE, DH; LOVE, S; ALTMAN, R; WASSERMAN, SI				BROIDE, DH; LOVE, S; ALTMAN, R; WASSERMAN, SI			EVALUATION OF CETIRIZINE IN THE TREATMENT OF PATIENTS WITH SEASONAL ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					176	176		10.1016/0091-6749(88)90268-0	http://dx.doi.org/10.1016/0091-6749(88)90268-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274					2022-12-18	WOS:A1988M027400055
J	CORBO, GM; FORESI, A; MORANDINI, S; VALENTE, S; MATTOLI, S; CIAPPI, G				CORBO, GM; FORESI, A; MORANDINI, S; VALENTE, S; MATTOLI, S; CIAPPI, G			PROBIT ANALYSIS APPLIED TO THE ALLERGEN DOSE-RESPONSE CURVE - A METHOD FOR EPIDEMIOLOGIC SURVEYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CATTOLICA SACRO CUORE, POLICLIN A GEMELLI SERV FISIOPATOL RESP, I-00168 ROME, ITALY	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	CORBO, GM (corresponding author), CTR AUXOL ITALIANO, DIV PNEUMOL PEDIAT, I-28044 VERBANIA, ITALY.		CORBO, Giuseppe Maria/AAB-9964-2019; Mattoli, Sabrina/H-8211-2014	CORBO, Giuseppe Maria/0000-0002-8104-4659; Mattoli, Sabrina/0000-0002-6866-604X				BARBEE RA, 1976, ANN INTERN MED, V84, P129, DOI 10.7326/0003-4819-84-2-129; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P15, DOI 10.1016/0091-6749(81)90117-2; BJORKSTEN F, 1984, J ALLERGY CLIN IMMUN, V73, P324, DOI 10.1016/0091-6749(84)90404-4; BRITTON WJ, 1986, INT J EPIDEMIOL, V15, P202, DOI 10.1093/ije/15.2.202; BURROWS B, 1976, ANN INTERN MED, V84, P134, DOI 10.7326/0003-4819-84-2-134; BURROWS B, 1983, CHEST, V84, P657, DOI 10.1378/chest.84.6.657; BURROWS B, 1982, J ALLERGY CLIN IMMUN, V70, P199, DOI 10.1016/0091-6749(82)90042-2; COCKCROFT DW, 1979, AM REV RESPIR DIS, V120, P1053; FERRIS BG, 1978, AM REV RESPIR DIS S, V118, P36; Finney D. J., 1971, PROBIT ANAL, P1; GODFREY RC, 1976, CLIN ALLERGY, V6, P79, DOI 10.1111/j.1365-2222.1976.tb01415.x; HAAHTELA T, 1980, ALLERGY, V35, P433, DOI 10.1111/j.1398-9995.1980.tb01790.x; HAAHTELA T, 1980, ALLERGY, V35, P425, DOI 10.1111/j.1398-9995.1980.tb01789.x; LEE RE, 1977, ANN ALLERGY, V38, P231; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; MALLING HJ, 1984, ALLERGY, V39, P596, DOI 10.1111/j.1398-9995.1984.tb01979.x; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MARSH DG, 1977, IMMUNOGENETICS, V5, P235, DOI 10.1007/BF01570479; NORMAN PS, 1973, J ALLERGY CLIN IMMUN, V52, P210, DOI 10.1016/0091-6749(73)90059-6; RUSSELL G, 1976, BRIT J DIS CHEST, V70, P104, DOI 10.1016/0007-0971(76)90014-0; SERUP J, 1984, ALLERGY, V39, P359, DOI 10.1111/j.1398-9995.1984.tb01953.x; STEEL RGD, 1981, PRINCIPLES PROCEDURE, P535; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; VOLLMER WM, 1986, CHEST, V90, P416, DOI 10.1378/chest.90.3.416; WATSON H K, 1982, Allergy (Copenhagen), V37, P24; WEISS ST, 1985, AM REV RESPIR DIS, V131, P573, DOI 10.1164/arrd.1985.131.4.573; WOOLCOCK AJ, 1978, CLIN ALLERGY, V8, P155, DOI 10.1111/j.1365-2222.1978.tb00460.x	27	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					41	47		10.1016/0091-6749(88)90218-7	http://dx.doi.org/10.1016/0091-6749(88)90218-7			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274	3339189	Bronze			2022-12-18	WOS:A1988M027400007
J	SHEPPARD, D				SHEPPARD, D			MECHANISMS OF ACUTE INCREASES IN AIRWAY RESPONSIVENESS CAUSED BY ENVIRONMENTAL CHEMICALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,CARDIOVASC RES INST,CTR LUNG BIOL,SAN FRANCISCO,CA 94110; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,MED SERV,SAN FRANCISCO,CA 94110	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco								AIZAWA H, 1985, J APPL PHYSIOL, V59, P1918, DOI 10.1152/jappl.1985.59.6.1918; CIBULAS W, 1986, J ALLERGY CLIN IMMUN, V77, P828, DOI 10.1016/0091-6749(86)90380-5; EASTON RE, 1967, ARCH ENVIRON HEALTH, V15, P160, DOI 10.1080/00039896.1967.10664897; ERSPAMER V, 1981, TRENDS NEUROSCI, V4, P267, DOI 10.1016/0166-2236(81)90084-9; FITZGERALD M, 1983, PAIN, V15, P109, DOI 10.1016/0304-3959(83)90012-X; GOLDEN JA, 1978, AM REV RESPIR DIS, V118, P287; GORDON T, 1985, AM REV RESPIR DIS, V132, P1106; GORDON T, 1984, J APPL PHYSIOL, V57, P1034, DOI 10.1152/jappl.1984.57.4.1034; HOLTZMAN MJ, 1979, AM REV RESPIR DIS, V120, P1059; HOLTZMAN MJ, 1983, AM REV RESPIR DIS, V127, P686; LEE HK, 1985, AM REV RESPIR DIS, V132, P1005; LEE LY, 1979, J APPL PHYSIOL, V46, P1108, DOI 10.1152/jappl.1979.46.6.1108; LEE LY, 1977, J APPL PHYSIOL, V43, P626, DOI 10.1152/jappl.1977.43.4.626; LUNDBERG JM, 1984, CELL TISSUE RES, V235, P251; LUNDBERG JM, 1983, ACTA PHYSIOL SCAND, V119, P243, DOI 10.1111/j.1748-1716.1983.tb07334.x; MURLAS C, 1985, PROSTAGLANDINS, V30, P563, DOI 10.1016/0090-6980(85)90020-6; MURLAS C, 1985, J APPL PHYSIOL, V58, P1630, DOI 10.1152/jappl.1985.58.5.1630; MURLAS CG, 1985, AM REV RESPIR DIS, V131, P314; OBYRNE PM, 1984, AM REV RESPIR DIS, V130, P220; OBYRNE PM, 1984, AM REV RESPIR DIS, V130, P214; SELTZER J, 1986, J APPL PHYSIOL, V60, P1321, DOI 10.1152/jappl.1986.60.4.1321; SHEPPARD D, 1986, J APPL PHYSIOL, V60, P1213, DOI 10.1152/jappl.1986.60.4.1213; THOMPSON JE, 1987, AM REV RESPIR DIS, V136, P43, DOI 10.1164/ajrccm/136.1.43; THOMPSON JE, 1986, AM REV RESPIR DIS, V134, P1213	24	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1988	81	1					128	132		10.1016/0091-6749(88)90231-X	http://dx.doi.org/10.1016/0091-6749(88)90231-X			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M0274	2828449				2022-12-18	WOS:A1988M027400020
J	SORENSEN, RU; KALLICK, MD; BERGER, M				SORENSEN, RU; KALLICK, MD; BERGER, M			HOME TREATMENT OF ANTIBODY-DEFICIENCY SYNDROMES WITH INTRAVENOUS IMMUNE GLOBULIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									RAINBOW BABIES & CHILDRENS HOSP,DEPT PATHOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	SORENSEN, RU (corresponding author), RAINBOW BABIES & CHILDRENS HOSP,DEPT PEDIAT,2101 ADELBERT RD,CLEVELAND,OH 44106, USA.				NCRR NIH HHS [RR80-24] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMMANN AJ, 1982, CLIN IMMUNOL IMMUNOP, V22, P60, DOI 10.1016/0090-1229(82)90022-8; ASHIDA ER, 1986, J CLIN IMMUNOL, V6, P306, DOI 10.1007/BF00917331; BERGER M, 1980, ANN INTERN MED, V93, P55, DOI 10.7326/0003-4819-93-1-55; BUCKLEY RH, 1985, CLIN IMMUNOL ALLERGY, V5, P141; BUCKLEY RH, 1982, J CLIN IMMUNOL, V2, pS15, DOI 10.1007/BF00918362; BUCKLEY RH, 1986, ARCH INTERN MED, V146, P377, DOI 10.1001/archinte.146.2.377; BURKS AW, 1986, NEW ENGL J MED, V314, P560, DOI 10.1056/NEJM198602273140907; CUNNINGHAMRUNDLES C, 1984, ANN INTERN MED, V101, P435, DOI 10.7326/0003-4819-101-4-435; CUNNINGHAMRUNDLES C, 1985, VOX SANG, V49, P8, DOI 10.1111/j.1423-0410.1985.tb01138.x; LAZERSON J, 1972, J PEDIATR-US, V81, P330, DOI 10.1016/S0022-3476(72)80304-4; LEIKOLA J, 1973, BLOOD, V42, P111, DOI 10.1182/blood.V42.1.111.111; LEVINE PH, 1976, ARCH INTERN MED, V136, P792, DOI 10.1001/archinte.136.7.792; LEVINE PH, 1974, NEW ENGL J MED, V291, P1381, DOI 10.1056/NEJM197412262912604; MONTANARO A, 1984, AM J MED S3A, V76, P62; MORELL A, 1982, VOX SANG, V43, P212, DOI 10.1111/j.1423-0410.1982.tb00014.x; NADORP JHS, 1973, EUR J CLIN INVEST, V3, P317, DOI 10.1111/j.1365-2362.1973.tb00357.x; NOLTE MT, 1979, CLIN EXP IMMUNOL, V36, P237; OCHS HD, 1982, J CLIN IMMUNOL, V2, pS22, DOI 10.1007/BF00918363; OCHS HD, 1984, AM J MED, V76, P78, DOI 10.1016/0002-9343(84)90324-3; OCHS HD, 1986, LANCET, V1, P610; ROIFMAN CM, 1985, AM J MED, V79, P171, DOI 10.1016/0002-9343(85)90006-3; SCHIFF RI, 1985, VOX SANG, V49, P15, DOI 10.1111/j.1423-0410.1985.tb01139.x; SCHIFF RI, 1984, CLIN IMMUNOL IMMUNOP, V31, P13, DOI 10.1016/0090-1229(84)90185-5; SCHMIDT AP, 1969, NEW ENGL J MED, V280, P188, DOI 10.1056/NEJM196901232800404; SORENSEN RU, 1984, AM J MED, V76, P83, DOI 10.1016/0002-9343(84)90325-5; SORENSEN RU, 1984, AM J MED, V76, P73, DOI 10.1016/0002-9343(84)90323-1; STAWCZYNSKI H, 1973, PEDIATRICS, V51, P986; VYAS GN, 1968, LANCET, V2, P312; WELLS JV, 1977, CLIN IMMUNOL IMMUNOP, V8, P265, DOI 10.1016/0090-1229(77)90116-7	29	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1987	80	6					810	815		10.1016/S0091-6749(87)80270-1	http://dx.doi.org/10.1016/S0091-6749(87)80270-1			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	L5020	3693759				2022-12-18	WOS:A1987L502000007
J	BURNEY, PGJ				BURNEY, PGJ			ASTHMA MORTALITY - ENGLAND AND WALES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											BURNEY, PGJ (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,617 N WOLFE ST,BALTIMORE,MD 21205, USA.			Burney, Peter/0000-0001-8635-5678				ANDERSON HR, 1980, BRIT MED J, V281, P1191, DOI 10.1136/bmj.281.6249.1191; ANDERSON HR, 1986, J EPIDEMIOL COMMUN H, V40, P121, DOI 10.1136/jech.40.2.121; [Anonymous], 1984, Thorax, V39, P505; AYRES JG, 1986, THORAX, V41, P111, DOI 10.1136/thx.41.2.111; BRITTON JR, 1986, THORAX, V41, P239; BURNEY PGJ, 1986, LANCET, V2, P323; BURNEY PGJ, IN PRESS CHEST S; CHARLTON JRH, 1983, LANCET, V1, P691; COCHRANE GM, 1975, THORAX, V30, P300, DOI 10.1136/thx.30.3.300; GANDEVIA B, 1973, MED J AUSTRALIA, V1, P273, DOI 10.5694/j.1326-5377.1973.tb119742.x; INMAN WHW, 1969, LANCET, V2, P279; JENKINS PF, 1980, CLIN ALLERGY, V11, P611; JOHNSON AJ, 1984, BRIT MED J, V288, P1870, DOI 10.1136/bmj.288.6434.1870; KEATING G, 1984, BRIT MED J, V289, P348, DOI 10.1136/bmj.289.6441.348; MACDONALD JB, 1976, BRIT MED J, V2, P721, DOI 10.1136/bmj.2.6038.721; MACDONALD JB, 1976, BRIT MED J, V1, P1493, DOI 10.1136/bmj.1.6024.1493; MODELL M, 1983, BRIT MED J, V286, P2027, DOI 10.1136/bmj.286.6383.2027; ORMEROD LP, 1980, BRIT MED J, V280, P687, DOI 10.1136/bmj.280.6215.687; SPEIZER FE, 1968, BRIT MED J, V1, P339, DOI 10.1136/bmj.1.5588.339; STOLLEY PD, 1972, AM REV RESPIR DIS, V105, P883; 1982, BR MED J, V285, P1251; [No title captured]	22	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			379	382		10.1016/0091-6749(87)90054-6	http://dx.doi.org/10.1016/0091-6749(87)90054-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3305667				2022-12-18	WOS:A1987K103700006
J	HOFFMAN, DR				HOFFMAN, DR			ALLERGENS IN HYMENOPTERA VENOM .18. IMMUNOBLOTTING STUDIES OF VENOM ALLERGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											HOFFMAN, DR (corresponding author), E CAROLINA UNIV,SCH MED,DEPT PATHOL,GREENVILLE,NC 27834, USA.							BENGTSSON A, 1985, INT ARCH ALLER A IMM, V78, P139, DOI 10.1159/000233876; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9; FORD SA, 1985, INT ARCH ALLER A IMM, V78, P15, DOI 10.1159/000233855; GEISSLER W, 1986, J ALLERGY CLIN IMMUN, V77, P24, DOI 10.1016/0091-6749(86)90317-9; HOFFMAN DR, 1984, J ALLERGY CLIN IMMUN, V74, P93, DOI 10.1016/0091-6749(84)90094-0; HOFFMAN DR, 1987, CLIN REV ALLERG, V5, P75; HOFFMAN DR, 1976, J ALLERGY CLIN IMMUN, V58, P551, DOI 10.1016/0091-6749(76)90201-3; HOFFMAN DR, 1977, J ALLERGY CLIN IMMUN, V59, P364, DOI 10.1016/0091-6749(77)90019-7; HOFFMAN DR, 1987, J ALLERGY CLIN IMMUN, V80, P300, DOI 10.1016/0091-6749(87)90035-2; HOFFMAN DR, 1977, J ALLERGY CLIN IMMUN, V59, P147, DOI 10.1016/0091-6749(77)90217-2; HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P599, DOI 10.1016/0091-6749(85)90036-3; HOFFMAN DR, 1979, ANN ALLERGY, V42, P224; HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P606, DOI 10.1016/0091-6749(85)90037-5; HUSSAIN R, 1986, J IMMUNOL, V136, P1859; KEMENY DM, 1983, J ALLERGY CLIN IMMUN, V71, P505, DOI 10.1016/0091-6749(83)90469-4; KING TP, 1978, BIOCHEMISTRY-US, V17, P5165, DOI 10.1021/bi00617a016; KING TP, 1984, ARCH BIOCHEM BIOPHYS, V230, P1, DOI 10.1016/0003-9861(84)90080-8; KING TP, 1976, ARCH BIOCHEM BIOPHYS, V172, P661, DOI 10.1016/0003-9861(76)90121-1; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; SUTTON R, 1982, J IMMUNOL METHODS, V52, P183, DOI 10.1016/0022-1759(82)90044-8; SZEWCZYK B, 1985, ANAL BIOCHEM, V150, P403, DOI 10.1016/0003-2697(85)90528-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	23	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	1				307	313		10.1016/0091-6749(87)90036-4	http://dx.doi.org/10.1016/0091-6749(87)90036-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1036	3305664				2022-12-18	WOS:A1987K103600012
J	STABLEFORTH, DE				STABLEFORTH, DE			ASTHMA MORTALITY AND PHYSICIAN COMPETENCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											STABLEFORTH, DE (corresponding author), E BIRMINGHAM HOSP,DEPT THORAC MED,BORDESLEY GREEN RD,BIRMINGHAM B9 5ST,W MIDLANDS,ENGLAND.							COCHRANE GM, 1975, THORAX, V30, P300, DOI 10.1136/thx.30.3.300; MACDONALD JB, 1976, BRIT MED J, V1, P1493, DOI 10.1136/bmj.1.6024.1493; ORMEROD LP, 1980, BRIT MED J, V280, P687, DOI 10.1136/bmj.280.6215.687; OSMAN J, IN PRESS BR J DIS CH; SPEIGHT ANP, 1983, BRIT MED J, V286, P1253, DOI 10.1136/bmj.286.6373.1253; 1982, BR MED J, V285, P1251	6	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1987	80	3	2	S			463	466		10.1016/0091-6749(87)90076-5	http://dx.doi.org/10.1016/0091-6749(87)90076-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	K1037	3624699				2022-12-18	WOS:A1987K103700024
J	BANTZ, EW; DOLEN, WK; NELSON, HS				BANTZ, EW; DOLEN, WK; NELSON, HS			A DOUBLE-BLIND EVALUATION OF SKIN-TEST SUPPRESSION PRODUCED BY 2 DOSES OF TERFENADINE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR,ALLERGY IMMUNOL SERV,AURORA,CO 80045									BACKHOUSE CI, 1982, PRACTITIONER, V226, P347; BANTZ EW, IN PRESS ANN ALLERGY; BRANDON ML, 1980, ANN ALLERGY, V44, P71; FOWLE ASE, 1971, EUR J CLIN PHARMACOL, V3, P215, DOI 10.1007/BF00565009; GARTEIZ DA, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1185; GENDREAUREID L, 1986, J ALLERGY CLIN IMMUN, V77, P335, DOI 10.1016/S0091-6749(86)80114-2; GILMAN AG, 1985, PHARMACOL BASIS THER, P618; HOWARTH PH, 1984, THORAX, V39, P668, DOI 10.1136/thx.39.9.668; HUTHER KJ, 1977, EUR J CLIN PHARMACOL, V12, P195, DOI 10.1007/BF00609860; KEMP JP, 1985, ANN ALLERGY, V54, P502; KINSOLVI.CR, 1973, PHARMACOLOGIST, V15, P221; KULSHRESTHA VK, 1978, BRIT J CLIN PHARMACO, V6, P25, DOI 10.1111/j.1365-2125.1978.tb01677.x; LONG WF, 1985, J ALLERGY CLIN IMMUN, V76, P113, DOI 10.1016/0091-6749(85)90813-9; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; MOSER L, 1978, EUR J CLIN PHARMACOL, V14, P417, DOI 10.1007/BF00716383; OKERHOLM RA, 1981, BIOPHARM DRUG DISPOS, V2, P185, DOI 10.1002/bdd.2510020211; REINBERG A, 1965, J ALLERGY, V36, P273, DOI 10.1016/0021-8707(65)90086-9; TAYLOR RJ, 1985, J ALLERGY CLIN IMMUN, V76, P103, DOI 10.1016/0091-6749(85)90811-5; VOORHORST R, 1980, ALLERGY, V35, P247, DOI 10.1111/j.1398-9995.1980.tb01762.x; WEBER RW, 1979, J ALLERGY CLIN IMMUN, V63, P116, DOI 10.1016/0091-6749(79)90201-X	20	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1987	80	1					99	103		10.1016/S0091-6749(87)80198-7	http://dx.doi.org/10.1016/S0091-6749(87)80198-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J2194	2885357				2022-12-18	WOS:A1987J219400016
J	BLACK, JL; SMITH, CM; ANDERSON, SD				BLACK, JL; SMITH, CM; ANDERSON, SD			CROMOLYN SODIUM INHIBITS THE INCREASED RESPONSIVENESS TO METHACHOLINE THAT FOLLOWS ULTRASONICALLY NEBULIZED WATER CHALLENGE IN PATIENTS WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ROYAL PRINCE ALFRED HOSP,DEPT THORAC MED,CAMPERDOWN,NSW 2050,AUSTRALIA	University of Sydney	BLACK, JL (corresponding author), UNIV SYDNEY,DEPT PHARMACOL,SYDNEY,NSW 2006,AUSTRALIA.		Black, Judith L/C-6559-2008	Anderson, Sandra/0000-0002-6308-8770				ANDERSON SD, 1983, THORAX, V38, P284, DOI 10.1136/thx.38.4.284; BLACK JL, 1985, THORAX, V40, P427, DOI 10.1136/thx.40.6.427; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; CREESE BR, 1983, PROSTA LEUKOTR MED, V11, P161, DOI 10.1016/0262-1746(83)90016-1; DIXON M, 1980, BRIT J PHARMACOL, V70, P11, DOI 10.1111/j.1476-5381.1980.tb10898.x; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FULLER RW, 1986, AM REV RESPIR DIS, V133, P252; GOLDEN JA, 1978, AM REV RESPIR DIS, V118, P287; HAHN AG, 1984, THORAX, V39, P919, DOI 10.1136/thx.39.12.919; HOLTZMAN MJ, 1983, AM REV RESPIR DIS, V127, P686; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; LEE TH, 1982, J ALLERGY CLIN IMMUN, V70, P73, DOI 10.1016/0091-6749(82)90232-9; PATEL KR, 1984, CLIN ALLERGY, V14, P143, DOI 10.1111/j.1365-2222.1984.tb02645.x; REES PJ, 1985, THORAX, V40, P603, DOI 10.1136/thx.40.8.603; ROSENTHAL R R, 1984, Journal of Allergy and Clinical Immunology, V73, P179; SHAW RJ, 1985, ALLERGY, V40, P48, DOI 10.1111/j.1398-9995.1985.tb04154.x; SMITH CM, 1986, J ALLERGY CLIN IMMUN, V77, P729, DOI 10.1016/0091-6749(86)90419-7; SUZUKI S, 1985, ANN ALLERGY, V54, P136; WALTERS EH, 1981, THORAX, V36, P571, DOI 10.1136/thx.36.8.571	19	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1987	80	1					39	44		10.1016/S0091-6749(87)80188-4	http://dx.doi.org/10.1016/S0091-6749(87)80188-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	J2194	3110247				2022-12-18	WOS:A1987J219400006
J	LEONARD, EJ				LEONARD, EJ			2 POPULATIONS OF HUMAN-BLOOD BASOPHILS - EFFECT OF PREDNISONE ON CIRCULATING NUMBERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LEONARD, EJ (corresponding author), NCI,FREDERICK CANC RES FACIL,IMMUNOBIOL LAB,IMMUNOPATHOL SECT,BLDG 560,RM 12-71,FREDERICK,MD 21701, USA.							ALTERI E, 1983, BLOOD, V62, P918; Askenase P W, 1977, Prog Allergy, V23, P199, DOI 10.1159/000314242; CARON GA, 1969, 3 P ANN LEUC CULT C, P287; CLAMAN HN, 1971, J LAB CLIN MED, V78, P499; COLBERT RA, 1986, P NATL ACAD SCI USA, V83, P72, DOI 10.1073/pnas.83.1.72; DUNSKY EH, 1979, J ALLERGY CLIN IMMUN, V63, P426, DOI 10.1016/0091-6749(79)90217-3; DVORAK HF, 1970, J EXP MED, V132, P558, DOI 10.1084/jem.132.3.558; ESSELLIER AF, 1954, ENDOCRINOLOGY, V54, P477; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; GALILI U, 1980, BLOOD, V56, P1077; LEONARD EJ, 1979, INT ARCH ALLER A IMM, V58, P460, DOI 10.1159/000232227; LEONARD EJ, 1985, J ALLERGY CLIN IMMUN, V76, P556, DOI 10.1016/0091-6749(85)90775-4; LEONARD EJ, 1984, J LEUKOCYTE BIOL, V35, P405; LETTBROWN MA, 1977, J IMMUNOL, V118, P815; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; OTSUKA H, 1985, J ALLERGY CLIN IMMUN, V76, P695, DOI 10.1016/0091-6749(85)90673-6; PAGE LB, 1960, SYLLABUS LABORATORY; SAAVEDRADELGADO AMP, 1980, J ALLERGY CLIN IMMUN, V66, P464, DOI 10.1016/0091-6749(80)90007-X; VANFURTH R, 1980, MONONUCLEAR PHAGOCYT, P279	19	15	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1987	79	5					775	780		10.1016/0091-6749(87)90210-7	http://dx.doi.org/10.1016/0091-6749(87)90210-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	H4349	3571769				2022-12-18	WOS:A1987H434900013
J	VEDAL, S; CHANYEUNG, M; ENARSON, DA; CHAN, H; DORKEN, E; TSE, KS				VEDAL, S; CHANYEUNG, M; ENARSON, DA; CHAN, H; DORKEN, E; TSE, KS			PLICATIC ACID SPECIFIC IGE AND NONSPECIFIC BRONCHIAL HYPERRESPONSIVENESS IN WESTERN RED-CEDAR WORKERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											VEDAL, S (corresponding author), UNIV BRITISH COLUMBIA, VANCOUVER GEN HOSP, DEPT MED, DIV RESP, 2775 HEATHER ST, VANCOUVER V5Z 3J5, BC, CANADA.							ANDERSON S, 1980, STATISTICAL METHODS, P161; BROOKS SM, 1982, J ALLERGY CLIN IMMUN, V70, P56, DOI 10.1016/0091-6749(82)90202-0; BRYANT DH, 1976, CLIN ALLERGY, V6, P523, DOI 10.1111/j.1365-2222.1976.tb01937.x; CHANYEUNG M, 1973, AM REV RESPIR DIS, V108, P1094; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; HOGG JC, 1981, J ALLERGY CLIN IMMUN, V67, P421, DOI 10.1016/0091-6749(81)90094-4; KILLIAN D, 1976, CLIN ALLERGY, V6, P219, DOI 10.1111/j.1365-2222.1976.tb01900.x; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P299; KLEINBAUM DG, 1978, APPLIED REGRESSION A, P131; LAM S, 1983, J ALLERGY CLIN IMMUN, V72, P134, DOI 10.1016/0091-6749(83)90520-1; MOIRA CY, 1984, AM REV RESPIR DIS, V130, P1038; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; ROTHMAN KJ, 1982, EPIDEMIOLOGIC ANAL P, P13; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P248; TSE KS, 1982, CLIN ALLERGY, V12, P249, DOI 10.1111/j.1365-2222.1982.tb02525.x; WEISS ST, 1980, AM REV RESPIR DIS, V122, P697, DOI 10.1164/arrd.1980.122.5.697	17	15	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1986	78	6					1103	1109		10.1016/0091-6749(86)90257-5	http://dx.doi.org/10.1016/0091-6749(86)90257-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	F3026	3782674				2022-12-18	WOS:A1986F302600003
J	FRANK, MM				FRANK, MM			C1 ESTERASE INHIBITOR - CLINICAL CLUES TO THE PATHOPHYSIOLOGY OF ANGIOEDEMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											FRANK, MM (corresponding author), NIH,CTR CLIN,ROOM 11N228,BETHESDA,MD 20205, USA.							BRECY H, 1975, BIOMED EXPRESS, V23, P328; BRICKMAN CM, 1986, J ALLERGY CLIN IMMUN, V77, P749, DOI 10.1016/0091-6749(86)90424-0; BRICKMAN CM, 1986, J ALLERGY CLIN IMMUN, V77, P758, DOI 10.1016/0091-6749(86)90425-2; Caldwell JR, 1972, CLIN IMMUNOL IMMUNOP, V1, P39; DONALDSON VH, 1969, J CLIN INVEST, V48, P642, DOI 10.1172/JCI106022; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GADEK JE, 1977, CLIN RES, V25, P357; GEHA RS, 1985, NEW ENGL J MED, V312, P534, DOI 10.1056/NEJM198502283120902; GELFAND JA, 1979, MEDICINE, V58, P321, DOI 10.1097/00005792-197907000-00004; GELFAND JA, 1976, NEW ENGL J MED, V295, P1444, DOI 10.1056/NEJM197612232952602; QUASTEL M, 1983, J CLIN INVEST, V71, P1041, DOI 10.1172/JCI110831; RATNOFF OD, 1969, J EXP MED, V129, P315, DOI 10.1084/jem.129.2.315; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; ROSEN FS, 1971, J CLIN INVEST, V50, P2143, DOI 10.1172/JCI106708; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; SCHREIBER AD, 1976, BLOOD, V48, P567; SPAULDING WB, 1960, ANN INTERN MED, V53, P739, DOI 10.7326/0003-4819-53-4-739; WONG PY, 1974, ANN INTERN MED, V80, P577, DOI 10.7326/0003-4819-80-5-577; ZURAW B L, 1985, Complement, V2, P92	20	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				848	850		10.1016/0091-6749(86)90228-9	http://dx.doi.org/10.1016/0091-6749(86)90228-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3782652				2022-12-18	WOS:A1986E971300003
J	GERBER, MA; RAPACZ, P; KALTER, SS; BALLOW, M				GERBER, MA; RAPACZ, P; KALTER, SS; BALLOW, M			CELL-MEDIATED-IMMUNITY IN CAT-SCRATCH DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SW FDN RES & EDUC,SAN ANTONIO,TX 78284	Texas Biomedical Research Institute	GERBER, MA (corresponding author), UNIV CONNECTICUT,CTR HLTH,SCH MED,DEPT PEDIAT,FARMINGTON,CT 06032, USA.							Boros D L, 1978, Prog Allergy, V24, P183, DOI 10.1159/000314417; CARITHERS HA, 1969, J AMER MED ASSOC, V207, P312, DOI 10.1001/jama.207.2.312; CARITHERS MA, 1963, PEDIATRICS, V31, P1039; EMMONS RW, 1976, J CLIN MICROBIOL, V4, P112; KALTER SS, 1977, LANCET, V2, P606; KALTER SS, 1972, J INFECT DIS, V126, P464, DOI 10.1093/infdis/126.4.464; KLEIN JO, 1982, REPORT COMMITTEE INF, P58; MARGILETH AM, 1968, PEDIATRICS, V42, P803; MARGILETH AM, 1984, AM J DIS CHILD, V138, P711, DOI 10.1001/archpedi.1984.02140460003003; SCHULKIND ML, 1974, J PEDIATR-US, V85, P199, DOI 10.1016/S0022-3476(74)80392-6; Warwick W J, 1967, Prog Med Virol, V9, P256	11	15	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	1986	78	5	1				887	890		10.1016/0091-6749(86)90235-6	http://dx.doi.org/10.1016/0091-6749(86)90235-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E9713	3782655				2022-12-18	WOS:A1986E971300010
J	BAER, H; ANDERSON, MC; HELM, RM; YUNGINGER, JW; LOWENSTEIN, H; GJESING, B; WHITE, W; DOUGLASS, G; PHILLIPS, PR; SCHUMACHER, M; HEWITT, B; GUERIN, BG; CHARPIN, J; CARREIRA, J; LOMBARDERO, M; EKRAMODDOULLAH, AKM; KISIL, F; EINARSSON, R				BAER, H; ANDERSON, MC; HELM, RM; YUNGINGER, JW; LOWENSTEIN, H; GJESING, B; WHITE, W; DOUGLASS, G; PHILLIPS, PR; SCHUMACHER, M; HEWITT, B; GUERIN, BG; CHARPIN, J; CARREIRA, J; LOMBARDERO, M; EKRAMODDOULLAH, AKM; KISIL, F; EINARSSON, R			THE PREPARATION AND TESTING OF THE PROPOSED INTERNATIONAL REFERENCE (IRP) BERMUDA GRASS (CYNODON-DACTYLON)-POLLEN EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,ROCHESTER,MN 55905; UNIV COPENHAGEN,PROT LAB,DK-1168 COPENHAGEN K,DENMARK; GREER LABS,LENOIR,NC; UNIV ARIZONA,HLTH SCI CTR,TUCSON,AZ 85721; HOLLISTER STIER LABS,SPOKANE,WA; LAB STALLRGENES,JOINVILLE LE PONT,FRANCE; CLIN PNEUMOPHTISIOL ALLERGOL,MARSEILLE,FRANCE; UNIV MANITOBA,WINNIPEG R3T 2N2,MANITOBA,CANADA; PHARMACIA AB,UPPSALA,SWEDEN; ABELLO SA,MADRID,SPAIN	Mayo Clinic; University of Copenhagen; University of Arizona; University of Arizona Health Sciences; University of Manitoba; Pfizer; Pharmacia Corporation	BAER, H (corresponding author), US FDA,OFF BIOL RES & REVIEW,8800 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ANDERSON MC, 1984, RAST INHIBITION PROC; AXELSEN NH, 1983, SCAND J IMMUNOL S, V17; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; MAY JC, 1979, J ALLERGY CLIN IMMUN, V63, P87, DOI 10.1016/0091-6749(79)90197-0; MAY JC, 1982, J BIOL STAND, V10, P249, DOI 10.1016/S0092-1157(82)80026-7; RICHMAN PG, 1984, TOTAL PROTEIN NINHYD; SIRAGANIAN RP, 1980, MANUAL CLIN IMMUNOLO, P808	7	15	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	1				624	631		10.1016/0091-6749(86)90080-1	http://dx.doi.org/10.1016/0091-6749(86)90080-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5682	3771953	Bronze			2022-12-18	WOS:A1986E568200011
J	LESLIE, S				LESLIE, S			THE CONTIN DELIVERY SYSTEM - DOSING CONSIDERATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											LESLIE, S (corresponding author), NAPP RES CTR,CAMBRIDGE,ENGLAND.							ARKINSTALL W, 1985, 15 WORLD C DIS CHEST; BORODA C, 1973, J CLIN PHARMACOL, V13, P383, DOI 10.1002/j.1552-4604.1973.tb00183.x; COHEN BM, 1984, J ASTHMA, V21, P305, DOI 10.3109/02770908409077441; FAIRSHTER RD, 1985, AM J MED, V79, P48, DOI 10.1016/0002-9343(85)90088-9; FANTA CH, AM J MED; FINK JN, 1985, AM J MED, V79, P58, DOI 10.1016/0002-9343(85)90090-7; HENDELES L, 1985, CHEST, V87, P758, DOI 10.1378/chest.87.6.758; HENDELES L, 1986, J ALLERGY CLIN IMMUN, V78, pR30; KARIM A, 1985, CLIN PHARMACOL THER, V38, P77, DOI 10.1038/clpt.1985.138; LASSETER K, 1984, J SOC MED, V78, P141; REED C, 1985, JAN UPD METH THER BO; RIVINGTON R, EXPERIENCE UNIPHYL O; RIVINGTON RN, 1985, AM J MED, V79, P67, DOI 10.1016/0002-9343(85)90092-0	13	15	19	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1986	78	4	2				768	773		10.1016/0091-6749(86)90059-X	http://dx.doi.org/10.1016/0091-6749(86)90059-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E5684	3771963				2022-12-18	WOS:A1986E568400017
J	JUNIPER, EF; LATIMER, KM; MORRIS, MM; ROBERTS, RS; HARGREAVE, FE				JUNIPER, EF; LATIMER, KM; MORRIS, MM; ROBERTS, RS; HARGREAVE, FE			AIRWAY RESPONSES TO HYPERVENTILATION OF COLD DRY AIR - DURATION OF PROTECTION BY CROMOLYN SODIUM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MCMASTER UNIV,DEPT MED,HAMILTON L8S 4L8,ONTARIO,CANADA; MCMASTER UNIV,DEPT CLIN EPIDEMIOL & BIOSTAT,HAMILTON L8S 4L8,ONTARIO,CANADA	McMaster University; McMaster University	JUNIPER, EF (corresponding author), ST JOSEPHS HOSP,DEPT MED,FIRESTONE REG CHEST & ALLERGY UNIT,50 CHARLTON AVE E,HAMILTON L8N 4A6,ONTARIO,CANADA.							BARYISHAY E, 1983, AM REV RESPIR DIS, V127, P572, DOI 10.1164/arrd.1983.127.5.572; BRESLIN FJ, 1980, AM REV RESPIR DIS, V122, P11; BUNDGAARD A, 1982, CLIN ALLERGY, V12, P601, DOI 10.1111/j.1365-2222.1982.tb02559.x; DEAL EC, 1979, J APPL PHYSIOL, V46, P476, DOI 10.1152/jappl.1979.46.3.476; FANTA CH, 1981, AM REV RESPIR DIS, V123, P161; FERRUS L, 1980, RESP PHYSIOL, V39, P367, DOI 10.1016/0034-5687(80)90067-5; KLEINBAUM DG, 1978, APPLIED REGRESSION A, P289; KLEINBAUM DG, 1978, APPLIED REGRESSION A, P264; LATIMER KM, 1983, AM REV RESPIR DIS, V128, P440, DOI 10.1164/arrd.1983.128.3.440; LATIMER KM, 1984, THORAX, V39, P277, DOI 10.1136/thx.39.4.277; OBYRNE PM, 1982, THORAX, V37, P913, DOI 10.1136/thx.37.12.913; OBYRNE PM, 1982, AM REV RESPIR DIS, V125, P281; PATEL KR, 1982, THORAX, V37, P663, DOI 10.1136/thx.37.9.663; PATEL KR, 1984, CLIN ALLERGY, V14, P87, DOI 10.1111/j.1365-2222.1984.tb02195.x; RACHIELE A, 1983, B EUR PHYSIOPATH RES, V19, P465; ROSSING TH, 1982, J APPL PHYSIOL, V52, P1119, DOI 10.1152/jappl.1982.52.5.1119; SCHOEFFEL RE, 1983, AUST NZ J MED, V13, P157, DOI 10.1111/j.1445-5994.1983.tb02672.x; WALDEN SM, 1984, AM REV RESPIR DIS, V130, P357; WILSON NM, 1982, THORAX, V37, P657, DOI 10.1136/thx.37.9.657	19	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1986	78	3	1				387	391		10.1016/0091-6749(86)90022-9	http://dx.doi.org/10.1016/0091-6749(86)90022-9			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	E1148	3093556				2022-12-18	WOS:A1986E114800003
J	CRAYTON, JW				CRAYTON, JW			ADVERSE REACTIONS TO FOODS - RELEVANCE TO PSYCHIATRIC-DISORDERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CRAYTON, JW (corresponding author), UNIV CHICAGO,DEPT PSYCHIAT,5841 S MARYLAND AVE,CHICAGO,IL 60637, USA.							ADER R, 1975, PSYCHOSOM MED, V37, P333, DOI 10.1097/00006842-197507000-00007; ALLEN FN, 1944, NEW ENGL J MED, V231, P414; ANDERSON GH, 1983, CAN J PHYSIOL PHARM, V61, P271, DOI 10.1139/y83-042; ASHKENAZI A, 1979, AM J PSYCHIAT, V136, P1306; BARTROP RW, 1977, LANCET, V1, P834; BEARD CM, 1880, PRACTICAL TREATISE N; BRODSKY CM, 1983, PSYCHOSOMATICS, V24, P731, DOI 10.1016/S0033-3182(83)73168-3; CHATEL JC, 1970, AM J PSYCHIAT, V126, P1404, DOI 10.1176/ajp.126.10.1404; CLARKE T W, 1950, Ann Allergy, V8, P175; COOKE WT, 1966, BRAIN, V89, P663, DOI 10.1093/brain/89.4.663; COOKE WT, 1966, BRAIN, V89, P683, DOI 10.1093/brain/89.4.683; CRAYTON JW, 1979, BIOL PSYCHIAT, V14, P803; CRAYTON JW, 1977, J NEUROL NEUROSUR PS, V40, P455, DOI 10.1136/jnnp.40.5.455; DAVISON HM, 1942, SO MED J, V42, P712; DENMAN AM, 1980, BIOCH SCHIZOPHRENIA; DOHAN FC, 1973, AM J PSYCHIAT, V130, P685, DOI 10.1176/ajp.130.6.685; DOHAN FC, 1966, ACTA PSYCHIAT SCAND, V42, P125, DOI 10.1111/j.1600-0447.1966.tb01920.x; DOHAN FC, 1984, BIOL PSYCHIAT, V19, P385; FREUD S, 1963, EARLY PSYCHOANALYTIC; HEMMINGS WA, 1978, GUT, V19, P715, DOI 10.1136/gut.19.8.715; HUGHES EC, 1978, ANN ALLERGY, V40, P393; Jansson B, 1984, Lakartidningen, V81, P448; KELLER SE, 1981, SCIENCE, V213, P1397, DOI 10.1126/science.6973822; KINNELL HG, 1982, PSYCHOL MED, V12, P85, DOI 10.1017/S0033291700043312; KITTLER FJ, 1970, ANN ALLERGY, V28, P203; KLEIN DF, 1984, J CLIN PSYCHIATRY MO, V2, P14; Mandell M, 1968, Conn Med, V32, P300; MARKS IM, 1974, PSYCHOL MED, V4, P89, DOI 10.1017/S0033291700040344; MARKS IM, 1973, PSYCHOL MED, V3, P436, DOI 10.1017/S0033291700054246; MAY CD, 1984, NUTR REV, V42, P72, DOI 10.1111/j.1753-4887.1984.tb02293.x; MILES HHW, 1951, NEW ENGL J MED, V245, P711, DOI 10.1056/NEJM195111082451901; MILLMAN M, 1976, ANN ALLERGY, V36, P149; MITCHELL SW, 1911, FAT BLOOD ESSAY TREA; NASR S, 1981, J AFFECT DISORDERS, V3, P291, DOI 10.1016/0165-0327(81)90030-6; OSBORNE M, 1982, BIOL PSYCHIAT, V17, P627; OSSOFSKY HJ, 1974, COMPR PSYCHIAT, V15, P19, DOI 10.1016/0010-440X(74)90060-1; OSSOFSKY HJ, 1976, COMPR PSYCHIAT, V17, P335, DOI 10.1016/0010-440X(76)90008-0; PEARSON DJ, 1983, LANCET, V1, P1259; PERLEY MJ, 1962, NEW ENGL J MED, V266, P421, DOI 10.1056/NEJM196203012660901; PITTS FN, 1984, J CLIN PSYCHIATRY MO, V2, P25; POTKIN SG, 1981, AM J PSYCHIAT, V138, P1208; RANDOLPH T G, 1945, Ann Allergy, V3, P418; RANDOLPH TG, 1947, J PEDIATR, V31, P560, DOI 10.1016/S0022-3476(47)80145-3; RANDOLPH TG, 1966, INT J SOC PSYCHIATR, V12, P245, DOI 10.1177/002076406601200401; RICE JR, 1978, AM J PSYCHIAT, V135, P1417; RICHELSON E, 1982, J CLIN PSYCHIAT, V43, P4; RIX KJB, 1984, BRIT J PSYCHIAT, V145, P121, DOI 10.1192/bjp.145.2.121; ROWE AH, 1972, FOOD ALLERGY ITS MAN; SINGH MM, 1976, SCIENCE, V191, P401, DOI 10.1126/science.1246624; STORMS LH, 1982, ARCH GEN PSYCHIAT, V39, P323; TORREY EF, 1984, AM J PSYCHIAT, V141, P966; VEITH I, 1965, HYSTERIA HIST DISEAS; WOODRUFF RA, 1971, J AMER MED ASSOC, V215, P425, DOI 10.1001/jama.215.3.425; WOODRUFF RA, 1971, AM J PSYCHIATRY, V127, P957; Wurtman R J, 1983, Experientia Suppl, V44, P356; ZIOUDROU C, 1979, J BIOL CHEM, V254, P2446; 1980, DSM 3 DIAGNOSTIC STA	57	15	15	1	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	1986	78	1	2	S			243	250		10.1016/0091-6749(86)90018-7	http://dx.doi.org/10.1016/0091-6749(86)90018-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	D2997	3522711	Bronze			2022-12-18	WOS:A1986D299700018
J	NORMAN, PS				NORMAN, PS			WHY STANDARDIZED EXTRACTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											NORMAN, PS (corresponding author), JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,DIV CLIN IMMUNOL,5601 LOCH RAVEN BLVD,BALTIMORE,MD 21239, USA.							FORD A, 1985, J ALLERGY CLIN IMMUN, V75, P676, DOI 10.1016/0091-6749(85)90093-4; FORD AW, 1985, INT ARCH ALLER A IMM, V76, P58, DOI 10.1159/000233662; FRIESEN GL, 1984, IMMUNOL ALLERGY PRAC, V6, P163; GJESING B, 1985, J ALLERGY CLIN IMMUN, V75, P258, DOI 10.1016/0091-6749(85)90055-7; HELM RM, 1984, J ALLERGY CLIN IMMUN, V73, P790, DOI 10.1016/0091-6749(84)90449-4	5	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1986	77	3					405	406		10.1016/0091-6749(86)90173-9	http://dx.doi.org/10.1016/0091-6749(86)90173-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	A5367	3950250				2022-12-18	WOS:A1986A536700002
J	GEISSLER, W; MAASCH, HJ; WINTER, G; WAHL, R				GEISSLER, W; MAASCH, HJ; WINTER, G; WAHL, R			KINETICS OF ALLERGEN RELEASE FROM HOUSE DUST MITE DERMATOPHAGOIDES-PTERONYSSINUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									ALLERGOPHARMA JOACHIM GANZER KG,POB 1109,D-2057 REINBEK,FED REP GER	Allergopharma								ANDERSON MC, 1981, TECHNICAL B ALLERGEN; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHAPMAN MD, 1980, J IMMUNOL, V125, P587; CHAPMAN MD, 1982, 11 P INT C ALL CLIN, P531; GEISSLER W, 1983, FOL ALLERGOL IMMU S4, V30, P127; JERMYN MA, 1975, ANAL BIOCHEM, V68, P332, DOI 10.1016/0003-2697(75)90713-7; KRILIS S, 1984, J ALLERGY CLIN IMMUN, V74, P132, DOI 10.1016/0091-6749(84)90275-6; LEMAO J, 1980, J ALLERGY CLIN IMMUN, V65, P381, DOI 10.1016/0091-6749(80)90217-1; LIND P, 1984, ALLERGY, V39, P259, DOI 10.1111/j.1398-9995.1984.tb00863.x; LIND P, 1982, Allergy (Copenhagen), V37, P39; Lowenstein H, 1978, Prog Allergy, V25, P1, DOI 10.1159/000314432; MAASCH HJ, 1984, ANN M EUROPEAN ACADE; MARSH DG, 1981, J ALLERGY CLIN IMMUN, V67, P206, DOI 10.1016/0091-6749(81)90063-4; PELTRE G, 1982, IMMUNOL LETT, V5, P127, DOI 10.1016/0165-2478(82)90096-7; PELTRE G, 1981, P EUROPEAN ACADEMY A; STEWART GA, 1980, AUST J EXP BIOL MED, V58, P259, DOI 10.1038/icb.1980.26; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Voorhorst R., 1964, Allergie Asthma, V10, P329; WAHL R, 1983, ANAL BIOCHEM, V134, P189, DOI 10.1016/0003-2697(83)90282-8; WEEKE B, 1973, SCAND J IMMUNOL, V2, P149, DOI 10.1111/j.1365-3083.1973.tb03796.x	21	15	18	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				24	31		10.1016/0091-6749(86)90317-9	http://dx.doi.org/10.1016/0091-6749(86)90317-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	3944372				2022-12-18	WOS:A1986AZD3600005
J	YOUNGER, RE; HERROD, HG; LIEBERMAN, PL; TROUY, RL; CRAWFORD, LV				YOUNGER, RE; HERROD, HG; LIEBERMAN, PL; TROUY, RL; CRAWFORD, LV			CHARACTERISTICS OF DIATRIZOATE-INDUCED BASOPHIL HISTAMINE-RELEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV TENNESSEE,CTR HLTH SCI,LEBONHEUR CHILDRENS MED CTR,DEPT PEDIAT,ALLERGY IMMUNOL SECT,MEMPHIS,TN 38163; BAPTIST MEM HOSP,DEPT MED,MEMPHIS,TN 38146	University of Tennessee System; University of Tennessee Health Science Center; Baptist Memorial Hospital Memphis; University of Tennessee System; University of Tennessee Health Science Center								ARROYAVE CM, 1980, INVEST RADIOL, V15, P521; BEAVEN MA, 1972, CLIN CHIM ACTA, V37, P91, DOI 10.1016/0009-8981(72)90419-6; BEDARD R M, 1984, Journal of Allergy and Clinical Immunology, V73, P166; BRASCH RC, 1970, INVEST RADIOL, V5, P510, DOI 10.1097/00004424-197011000-00017; CARR DH, 1981, INVEST RADIOL, V16, P133, DOI 10.1097/00004424-198103000-00010; DYER J, 1983, J ALLERGY CLIN IMMUN, V71, P148, DOI 10.1016/0091-6749(83)90361-5; EGGLESTON PA, 1984, AM REV RESPIR DIS, V130, P86; FINDLAY SR, 1981, J CLIN INVEST, V67, P1604, DOI 10.1172/JCI110195; HOOK WA, 1981, IMMUNOLOGY, V43, P723; ISHIZAKA T, 1984, FED PROC, V43, P2840; KUTT H, 1963, NEUROLOGY, V13, P492, DOI 10.1212/WNL.13.6.492; LANG J, 1975, INVEST RADIOL, V10, P314, DOI 10.1097/00004424-197507000-00005; LANG JH, 1971, J MED CHEM, V14, P233, DOI 10.1021/jm00285a014; LASSER EC, 1974, RADIOLOGY, V110, P49, DOI 10.1148/110.1.49; LASSER EC, 1970, INVEST RADIOL, V5, P446; LASSER EC, 1971, AMER J ROENTGENOL RA, V113, P415; LASSER EC, 1970, INVEST RADIOL, V5, P513; LICHTENSTEIN LM, 1975, J IMMUNOL, V114, P1692; LIEBERMAN P, 1983, 11 P INT C ALL CLIN, P61; RAPOPORT S, 1982, RADIOLOGY, V143, P321, DOI 10.1148/radiology.143.2.7071332; RICE MC, 1983, J ALLERGY CLIN IMMUN, V72, P180, DOI 10.1016/0091-6749(83)90527-4; RING J, 1978, CLIN EXP IMMUNOL, V34, P302; RING J, 1978, CLIN EXP IMMUNOL, V32, P105; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; SHAPIRO GA, 1977, RADIOLOGY, V124, P641, DOI 10.1148/124.3.641; SIEGLE RL, 1978, J UROLOGY, V119, P581, DOI 10.1016/S0022-5347(17)57557-6; SIEGLE RL, 1976, INVEST RADIOL, V11, P98, DOI 10.1097/00004424-197603000-00004; SIEGLE RL, 1980, INVEST RADIOL, V15, pS13, DOI 10.1097/00004424-198011001-00005; SIMON RA, 1979, J ALLERGY CLIN IMMUN, V63, P289; SIRAGANIAN RP, 1977, J IMMUNOL, V119, pB207; WITTEN DM, 1975, JAMA-J AM MED ASSOC, V231, P974	31	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1986	77	1	1				94	100		10.1016/0091-6749(86)90329-5	http://dx.doi.org/10.1016/0091-6749(86)90329-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZD36	2418089				2022-12-18	WOS:A1986AZD3600017
J	COCKCROFT, DW; BERSCHEID, BA; MURDOCK, KY; GORE, BP				COCKCROFT, DW; BERSCHEID, BA; MURDOCK, KY; GORE, BP			SENSITIVITY AND SPECIFICITY OF HISTAMINE PC-20 MEASUREMENTS IN A RANDOM-POPULATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					142	142		10.1016/0091-6749(85)90286-6	http://dx.doi.org/10.1016/0091-6749(85)90286-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ACF22					2022-12-18	WOS:A1985ACF2200151
J	ELLIS, EF				ELLIS, EF			STEROID MYOPATHY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material											ELLIS, EF (corresponding author), CHILDRENS HOSP,DEPT PEDIAT,BUFFALO,NY 14222, USA.							AFIFI AK, 1968, JOHNS HOPKINS MED J, V123, P158; BOWYER SL, 1985, J ALLERGY CLIN IMMUN, V76, P234, DOI 10.1016/0091-6749(85)90708-0; BRAUNSTEIN PW, 1981, ACTA NEUROPATHOL, V55, P167, DOI 10.1007/BF00691314; Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137; DUBOIS DC, 1980, ENDOCRINOLOGY, V107, P1649, DOI 10.1210/endo-107-5-1649; DUBOIS EL, 1958, JAMA-J AM MED ASSOC, V167, P1590, DOI 10.1001/jama.1958.02990300016004; FREYBERG RH, 1958, ARTHRITIS RHEUM, V1, P215, DOI 10.1002/art.1780010304; GOODMAN M, 1978, AM J MED, V65, P868, DOI 10.1016/0002-9343(78)90808-2; HARTER JG, 1963, NEW ENGL J MED, V269, P591, DOI 10.1056/NEJM196309192691201; VANMARLE W, 1980, BRIT MED J, V281, P271, DOI 10.1136/bmj.281.6235.271-a; WILLIAMS AJ, 1983, THORAX, V38, P813, DOI 10.1136/thx.38.11.813; Yates D A, 1971, Rheumatol Phys Med, V11, P28, DOI 10.1093/rheumatology/11.1.28	12	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	3					431	432		10.1016/0091-6749(85)90722-5	http://dx.doi.org/10.1016/0091-6749(85)90722-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ARC09	4031315				2022-12-18	WOS:A1985ARC0900002
J	LARSSON, K; GRONNEBERG, R; HJEMDAHL, P				LARSSON, K; GRONNEBERG, R; HJEMDAHL, P			BRONCHODILATATION AND INHIBITION OF ALLERGEN-INDUCED BRONCHOCONSTRICTION BY CIRCULATING EPINEPHRINE IN ASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									KAROLINSKA HOSP,DEPT THORAC MED,S-10401 STOCKHOLM 60,SWEDEN; SODERSJUKHUSET,DEPT CLIN PHYSIOL,S-10064 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital	LARSSON, K (corresponding author), KAROLINSKA INST,DEPT PHARMACOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN.			Hjemdahl, Paul/0000-0001-5346-275X				BARNES P, 1980, NEW ENGL J MED, V303, P263, DOI 10.1056/NEJM198007313030506; BARNES PJ, 1981, THORAX, V36, P435, DOI 10.1136/thx.36.6.435; BARNES PJ, 1982, CLIN SCI, V62, P349, DOI 10.1042/cs0620349; BORUM P, 1980, J ALLERGY CLIN IMMUN, V66, P25, DOI 10.1016/0091-6749(80)90134-7; BUTCHERS PR, 1980, BRIT J PHARMACOL, V71, P663, DOI 10.1111/j.1476-5381.1980.tb10987.x; BUTCHERS PR, 1979, BRIT J PHARMACOL, V67, P23; CRYER PE, 1980, NEW ENGL J MED, V303, P436; GRONNEBERG R, 1980, ALLERGY, V35, P409, DOI 10.1111/j.1398-9995.1980.tb01786.x; GRONNEBERG R, 1981, ALLERGY, V36, P33, DOI 10.1111/j.1398-9995.1981.tb01822.x; HEGARDT B, 1983, EUR J RESPIR DIS, V64, P112; HJEMDAHL P, 1979, LIFE SCI, V25, P131, DOI 10.1016/0024-3205(79)90384-9; HJEMDAHL P, 1984, AM J PHYSIOL, V247, pE13, DOI 10.1152/ajpendo.1984.247.1.E13; HJEMDAHL P, 1983, ACTA PHYSL SCAND S, V515, P45; HOLROYDE MC, 1977, AGENTS ACTIONS, V7, P421, DOI 10.1007/BF01966847; LARSSON K, 1982, CHEST, V82, P560, DOI 10.1378/chest.82.5.560; LYONS HA, 1976, BRONCHIAL ASTHMA MEC, P727; NYBERG G, 1977, BRIT J CLIN PHARMACO, V4, P275, DOI 10.1111/j.1365-2125.1977.tb00712.x; PEGELOW KO, 1980, ALLERGY, V35, P509, DOI 10.1111/j.1398-9995.1980.tb01798.x; TING S, 1983, J ALLERGY CLIN IMMUN, V71, P437, DOI 10.1016/0091-6749(83)90458-X; TOHMEH JF, 1980, J CLIN INVEST, V65, P836, DOI 10.1172/JCI109735; WARREN JB, 1982, BRIT J DIS CHEST, V76, P147, DOI 10.1016/S0007-0971(82)80050-8; WARREN JB, 1983, CLIN SCI, V64, P475, DOI 10.1042/cs0640475	22	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	5					586	593		10.1016/0091-6749(85)90034-X	http://dx.doi.org/10.1016/0091-6749(85)90034-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AHV07	3989143				2022-12-18	WOS:A1985AHV0700008
J	MAGNUSSON, CGM; MASSON, PL				MAGNUSSON, CGM; MASSON, PL			IMMUNOGLOBULIN-E ASSAYED AFTER PEPSIN DIGESTION BY AN AUTOMATED AND HIGHLY SENSITIVE PARTICLE COUNTING IMMUNOASSAY - APPLICATION TO HUMAN CORD BLOOD	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CATHOLIC UNIV LOUVAIN, INT INST CELLULAR & MOLEC PATHOL, EXPTL MED UNIT, B-1200 BRUSSELS, BELGIUM	Universite Catholique Louvain								AALBERSE RC, 1974, J LAB CLIN MED, V83, P831; BARBEE RA, 1981, J ALLERGY CLIN IMMUN, V68, P106, DOI 10.1016/0091-6749(81)90167-6; BASUYAU JP, 1980, NOUV PRESSE MED, V9, P591; BAZARAL M, 1971, J IMMUNOL, V107, P794; BAZARAL M, 1972, J ALLERGY CLIN IMMUN, V49, P189, DOI 10.1016/0091-6749(72)90113-3; BELUT D, 1980, DIGEST DIS SCI, V25, P323, DOI 10.1007/BF01308055; Bennich H, 1971, Adv Immunol, V13, P1; BENNICH H, 1978, IMMEDIATE HYPERSENSI, P15; BOUSQUET J, 1983, ANN ALLERGY, V51, P291; BURROWS B, 1981, AM REV RESPIR DIS, V124, P523; BUSINCO L, 1983, CLIN ALLERGY, V13, P503, DOI 10.1111/j.1365-2222.1983.tb02631.x; CESKA M, 1972, IMMUNOCHEMISTRY, V9, P1021, DOI 10.1016/0019-2791(72)90112-7; COLLETCASSART D, 1983, Patent No. 823069174; CRONER S, 1982, ARCH DIS CHILD, V57, P364, DOI 10.1136/adc.57.5.364; DANNAEUS A, 1978, ACTA PAEDIATR SCAND, V67, P497, DOI 10.1111/j.1651-2227.1978.tb16360.x; DEUSCHL H, 1977, CLIN ALLERGY, V7, P195, DOI 10.1111/j.1365-2222.1977.tb01442.x; DJURUP R, 1983, ALLERGY, V38, P173, DOI 10.1111/j.1398-9995.1983.tb01603.x; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; FOUCARD T, 1974, ACTA PAEDIATR SCAND, V63, P129, DOI 10.1111/j.1651-2227.1974.tb04361.x; FOUCARD T, 1975, INT ARCH ALLER A IMM, V48, P812, DOI 10.1159/000231369; GAMO T, 1977, CLIN ALLERGY, V7, P597, DOI 10.1111/j.1365-2222.1977.tb01490.x; GANJU A, 1979, ANN ALLERGY, V43, P271; GERRARD JW, 1980, ANN ALLERGY, V44, P261; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; GORDON RR, 1982, LANCET, V1, P72; HAMBURGE.RN, 1974, J ALLERGY CLIN IMMUN, V53, P94; HAMBURGER RN, 1982, ANN ALLERGY, V49, P9; HAMBURGER RN, 1979, CONSULTANT, V19, P23; HELLSING K, 1969, BIOCHEM J, V114, P151, DOI 10.1042/bj1140151; INGANAS M, 1981, INT ARCH ALLER A IMM, V65, P51, DOI 10.1159/000232737; JOHANSSON SG, 1968, INT ARCH ALLER A IMM, V34, P1; JOHANSSON SG, 1967, IMMUNOLOGY, V13, P381; JOHANSSON SGO, 1976, CLIN ALLERGY, V6, P91, DOI 10.1111/j.1365-2222.1976.tb01417.x; JOHNS P, 1976, J IMMUNOL METHODS, V10, P231, DOI 10.1016/0022-1759(76)90174-5; KAISER H, 1965, Z ANAL CHEM FRESENIU, V209, P1; KJELLMAN NIM, 1982, ALLERGY, V37, P463; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; KJELLMAN NIM, 1977, ACTA ALLERGOL, V32, P91, DOI 10.1111/j.1398-9995.1977.tb02615.x; KJELLMAN NIM, 1976, ACTA PAEDIATR SCAND, V65, P601, DOI 10.1111/j.1651-2227.1976.tb04939.x; KJELLMAN NIM, 1976, ACTA PAEDIATR SCAND, V65, P465, DOI 10.1111/j.1651-2227.1976.tb04915.x; LING NR, 1981, INT ARCH ALLER A IMM, V66, P459, DOI 10.1159/000232854; MAGNUSSON CGM, 1981, CLIN ALLERGY, V11, P453, DOI 10.1111/j.1365-2222.1981.tb01619.x; MAGNUSSON CGM, 1982, J ALLERGY CLIN IMMUN, V70, P326, DOI 10.1016/0091-6749(82)90021-5; MAGNUSSON CGM, 1983, INT ARCH ALLER A IMM, V71, P144, DOI 10.1159/000233378; MAGNUSSON CGM, 1981, Patent No. 813052610; MAGNUSSON CGM, INT ARCH ALLERGY APP; MAGNUSSON CGM, 1984, INT S PREVENTION ALL, P35; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; Masson P L, 1981, Methods Enzymol, V74 Pt C, P106; MERRETT TG, 1978, CLIN ALLERGY, V8, P543, DOI 10.1111/j.1365-2222.1978.tb01508.x; MERRETT TG, 1975, RADIOIMMUNOASSAY REL, P21; MICHEL FB, 1980, J ALLERGY CLIN IMMUN, V65, P422, DOI 10.1016/0091-6749(80)90234-1; ORGEL HA, 1975, J ALLERGY CLIN IMMUN, V56, P296, DOI 10.1016/0091-6749(75)90104-9; ORGEL HA, 1974, J ALLERGY CLIN IMMUN, V53, P213, DOI 10.1016/0091-6749(74)90083-9; PECOUD A, 1982, CLIN ALLERGY, V12, P75, DOI 10.1111/j.1365-2222.1982.tb03128.x; POLMAR SH, 1972, PEDIATRICS, V50, P279; POLMAR SH, 1973, J IMMUNOL, V110, P1253; Ringel KP, 1982, LABORATORIUMSBLATTER, V32, P26; STEVENSON DD, 1971, J ALLERGY CLIN IMMUN, V48, P61, DOI 10.1016/0091-6749(71)90088-1; THOMAS J, 1979, ANN ALLERGY, V43, P144; WEIL GJ, 1983, J CLIN INVEST, V71, P1124, DOI 10.1172/JCI110862; Wiener AS, 1936, ANN EUGENIC, V7, P141, DOI 10.1111/j.1469-1809.1936.tb02135.x; WILLIAMS RC, 1972, J CLIN INVEST, V51, P955, DOI 10.1172/JCI106890; ZAROU DM, 1964, AM J OBSTET GYNECOL, V88, P565, DOI 10.1016/0002-9378(64)90881-6	64	15	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	4					513	524		10.1016/S0091-6749(85)80026-9	http://dx.doi.org/10.1016/S0091-6749(85)80026-9			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AFY44	3920302				2022-12-18	WOS:A1985AFY4400013
J	RACHELEFSKY, GS; SIEGEL, SC				RACHELEFSKY, GS; SIEGEL, SC			ASTHMA IN INFANTS AND CHILDREN - TREATMENT OF CHILDHOOD ASTHMA .2.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review									UNIV CALIF LOS ANGELES, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles								AAS K, 1971, ACTA PAEDIATR SCAND, V60, P264, DOI 10.1111/j.1651-2227.1971.tb06655.x; BECKER AB, 1983, J PEDIATR-US, V102, P465, DOI 10.1016/S0022-3476(83)80679-9; BENZVI Z, 1982, PEDIATRICS, V70, P348; BERMAN BA, 1983, PEDIATR CLIN N AM, V30, P915; BLYTHE ME, 1975, BRIT MED J, V1, P62, DOI 10.1136/bmj.1.5949.62; BRUUN EGON, 1949, ACTA ALLERGOL, V2, P122, DOI 10.1111/j.1398-9995.1949.tb03295.x; CHUNG JTN, 1979, BMJ-BRIT MED J, V2, P1033, DOI 10.1136/bmj.2.6197.1033; CITRON K M, 1958, Thorax, V13, P229, DOI 10.1136/thx.13.3.229; COTTON EK, 1975, PEDIATR CLIN N AM, V22, P163; DAVIS WJ, 1976, DRUG THER, V6, P175; DAWOOD AG, 1977, CLIN ALLERGY, V7, P161, DOI 10.1111/j.1365-2222.1977.tb01437.x; DICKSON W, 1979, MAST CELL ITS ROLE H, P343; DUSDIEKER L, 1982, J PEDIATR-US, V101, P281; EDMONDS AT, 1980, BMJ-BRIT MED J, V281, P841; EITCHES RW, 1985, AM J DIS CHILD, V139, P264, DOI 10.1001/archpedi.1985.02140050058022; FANTA CH, 1983, AM J MED, V74, P845, DOI 10.1016/0002-9343(83)91076-8; FELDMAN CH, 1984, J ALLERGY CLIN IMMUN, V73, P356, DOI 10.1016/0091-6749(84)90408-1; FURUKAWA CT, 1984, PEDIATRICS, V74, P453; GALANT SP, 1978, J ALLERGY CLIN IMMUN, V61, P73, DOI 10.1016/0091-6749(78)90228-2; GODFREY S, 1975, J PEDIATR-US, V87, P465, DOI 10.1016/S0022-3476(75)80663-9; GOLDSTEIN DE, 1983, PEDIATRICS, V72, P60; HAMILTON G, 1971, LANCET, V1, P31; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HASKELL RJ, 1983, ARCH INTERN MED, V143, P1324, DOI 10.1001/archinte.143.7.1324; HERRING S, 1981, ANN ALLERGY, V46, P24; HILL DJ, 1982, BRIT MED J, V284, P306, DOI 10.1136/bmj.284.6312.306; HILLER EJ, 1975, BRIT J DIS CHEST, V69, P103; HOWELL JBL, 1967, LANCET, V2, P539; HUGHES A M, 1973, Clinical Allergy, V3, P127, DOI 10.1111/j.1365-2222.1973.tb01316.x; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; JOHNSTONE D, 1961, PEDIATRICS, V27, P39; KATTAN M, 1980, J PEDIATR-US, V96, P596, DOI 10.1016/S0022-3476(80)80872-9; KATZ RM, 1978, J PEDIATR-US, V92, P663, DOI 10.1016/S0022-3476(78)80318-7; KATZ RM, 1979, CURR MED RES OPIN, V6, P45; KATZ RM, 1983, ANN ALLERGY, V50, P23; KELLY WH, 1982, CLIN PHARM, V1, P49; KLEIN R, 1977, PEDIATRICS, V60, P7; KORSGAARD J, 1983, ALLERGY, V38, P93, DOI 10.1111/j.1398-9995.1983.tb01592.x; LAM S, 1979, J ALLERGY CLIN IMMUN, V63, P28, DOI 10.1016/0091-6749(79)90158-1; LAVIN N, 1976, J ALLERGY CLIN IMMUN, V57, P80, DOI 10.1016/0091-6749(76)90081-6; LEE HS, 1981, J PEDIATR-US, V99, P805, DOI 10.1016/S0022-3476(81)80418-0; LEVY G, 1975, J PEDIATR-US, V86, P789, DOI 10.1016/S0022-3476(75)80374-X; LEWIS CE, 1984, PEDIATRICS, V74, P478; LICHTENSTEIN LM, 1984, AM REV RESPIR DIS, V129, P657, DOI 10.1164/arrd.1984.129.5.657; MASELLI R, 1970, J PEDIATR, V76, P777, DOI 10.1016/S0022-3476(70)80305-5; McALLEN MONICA K., 1961, THORAX, V16, P30, DOI 10.1136/thx.16.1.30; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; MORRIS HG, 1985, J ALLERGY CLIN IMMUN, V75, P1, DOI 10.1016/0091-6749(85)90002-8; MUNCH EP, 1982, EUR J RESPIR DIS, V63, P143; MURRAY AB, 1983, PEDIATRICS, V71, P418; NEWTH CJL, 1982, AUST NZ J MED, V12, P232, DOI 10.1111/j.1445-5994.1982.tb02467.x; NOLAN G, 1982, ANN ALLERGY, V49, P93; NORMAN PS, 1985, CHEST, V87, pS62, DOI 10.1378/chest.87.1.62S; OHMAN JL, 1984, J ALLERGY CLIN IMMUN, V74, P230, DOI 10.1016/0091-6749(84)90251-3; ORGEL HA, 1983, ANN ALLERGY, V51, P21; PECK C, 1983, CLIN PHARMACOL THER, V33, P259; PEDERSEN S, 1983, NEW ENGL J MED, V308, P1328, DOI 10.1056/NEJM198306023082205; PEDERSEN S, 1984, PEDIATRICS, V74, P534; PEPYS J, 1968, LANCET, V2, P134; PIERSON WE, 1974, PEDIATRICS, V54, P282; PLATTSMILLS TAE, 1982, LANCET, V2, P675; RACHELEFSKY G, 1985, J ALLERGY CLIN IMMUN, V75, P105, DOI 10.1016/0091-6749(85)90136-8; RACHELEFSKY G, AM J MED; RACHELEFSKY GS, 1980, ANN ALLERGY, V45, P207; RACHELEFSKY GS, 1985, CHEST, V87, pS98, DOI 10.1378/chest.87.1_Supplement.98S-a; RACHELEFSKY GS, 1978, ANN ALLERGY, V40, P252; RACHELEFSKY GS, 1982, PEDIATRICS, V69, P397; RACHELEFSKY GS, 1981, ANN ALLERGY, V47, P143; RIVLIN J, 1984, J PEDIATR-US, V104, P470, DOI 10.1016/S0022-3476(84)81119-1; SCHRAA JC, 1982, CHEST, V82, P181, DOI 10.1378/chest.82.2.181; SCHULLER DE, 1982, CLIN PEDIATR, V21, P135, DOI 10.1177/000992288202100301; SCHWARTZ AL, 1980, AM J DIS CHILD, V134, P474, DOI 10.1001/archpedi.1980.02130170024009; SEGAL MS, 1971, ANN ALLERGY, V29, P135; SETTIPANE GA, 1979, JAMA-J AM MED ASSOC, V241, P811, DOI 10.1001/jama.241.8.811; SHAPIRO GG, 1983, PEDIATRICS, V71, P510; SLY RM, 1977, J ALLERGY CLIN IMMUN, V59, P128, DOI 10.1016/0091-6749(77)90214-7; SLY RM, 1985, ANN ALLERGY, V54, P209; SLY RM, 1978, J ALLERGY CLIN IMMUN, V62, P76, DOI 10.1016/0091-6749(78)90082-9; SZEFLER SJ, 1983, PEDIATR CLIN N AM, V30, P943; TINKELMAN DG, 1984, J ASTHMA, V21, P311, DOI 10.3109/02770908409077442; TOOGOOD JH, 1984, EUR J RESPIR DIS, V65, P35; TOOGOOD JH, 1981, J ALLERGY CLIN IMMUN, V67, P317, DOI 10.1016/0091-6749(81)90028-2; TUCHINDA M, 1973, J ALLERGY CLIN IMMUN, V51, P131, DOI 10.1016/0091-6749(73)90018-3; TURNERWARWICK M, 1957, BRIT MED J, V2, P67, DOI 10.1136/bmj.2.5036.67; VALOVIRTA E, 1984, ANN ALLERGY, V53, P85; VAZ R, 1982, J PEDIATR-US, V100, P660, DOI 10.1016/S0022-3476(82)80781-6; WARNER JO, 1978, LANCET, V2, P912; WEINBERGER M, 1984, J ALLERGY CLIN IMMUN, V73, P525, DOI 10.1016/0091-6749(84)90505-0; WEINBERGER M, 1985, ANN ALLERGY, V54, P1; WHITING B, 1984, BRIT J CLIN PHARMACO, V17, P1; WOOD DW, 1972, J ALLERGY CLIN IMMUN, V50, P75, DOI 10.1016/0091-6749(72)90002-4; WYATT R, 1978, NEW ENGL J MED, V299, P1387, DOI 10.1056/NEJM197812212992504; YUNGINGER JW, 1966, ANN ALLERGY, V24, P469; 1956, LANCET, V2, P803	94	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	76	3					409	425		10.1016/0091-6749(85)90718-3	http://dx.doi.org/10.1016/0091-6749(85)90718-3			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ARC09	2863296				2022-12-18	WOS:A1985ARC0900001
J	SACCAR, CL; DANISH, M; RAGNI, MC; ROCCI, ML; GREENE, J; YAFFE, SJ; MANSMANN, HC				SACCAR, CL; DANISH, M; RAGNI, MC; ROCCI, ML; GREENE, J; YAFFE, SJ; MANSMANN, HC			THE EFFECT OF PHENOBARBITAL ON THEOPHYLLINE DISPOSITION IN CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PEDIAT,DIV ALLERGY & CLIN IMMUNOL,PHILADELPHIA,PA 19107; CHILDRENS HOSP,DIV CLIN PHARMACOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV ALLERGY,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104	Jefferson University; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania								BROOKS SM, 1972, NEW ENGL J MED, V286, P1125, DOI 10.1056/NEJM197205252862103; BURGER PC, 1966, AM J PATHOL, V48, P793; CUCINELL SA, 1965, CLIN PHARMACOL THER, V6, P420; ELLIS EF, 1976, PEDIATRICS, V58, P542; JELLIFFE RW, 1966, CLIN RES, V14, P160; JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349; JUSKO WJ, 1976, AM J HOSP PHARM, V33, P1193, DOI 10.1093/ajhp/33.11.1193; LANDAY RA, 1978, J ALLERGY CLIN IMMUN, V62, P27, DOI 10.1016/0091-6749(78)90068-4; LEUNG P, 1977, J ALLERGY CLIN IMMUN, V59, P440, DOI 10.1016/0091-6749(77)90007-0; LOHMANN SM, 1976, J PHARMACOL EXP THER, V196, P213; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; PAULINI K, 1971, Beitraege zur Pathologie, V143, P283; Paulini K, 1970, Beitr Pathol, V141, P327; PIAFSKY KM, 1977, CLIN PHARMACOL THER, V22, P336; ROCCI ML, 1983, COMPUT PROG BIOMED, V16, P203, DOI 10.1016/0010-468X(83)90082-X; SIMONS FER, 1975, PEDIATRICS, V55, P735; WALSON PD, 1977, J PEDIATR-US, V91, P321, DOI 10.1016/S0022-3476(77)80844-5; WEINBERG.MM, 1974, J PEDIATR-US, V84, P421; WILLIAMS JF, 1979, BIOCHEM PHARMACOL, V28, P2935, DOI 10.1016/0006-2952(79)90589-6; 1981, SUBPROGRAM ANAL VARI	20	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	6					716	719		10.1016/0091-6749(85)90099-5	http://dx.doi.org/10.1016/0091-6749(85)90099-5			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ALA84	4008801				2022-12-18	WOS:A1985ALA8400014
J	TAMURA, G; MUE, S; ISHIHARA, T; TAKISHIMA, T				TAMURA, G; MUE, S; ISHIHARA, T; TAKISHIMA, T			THE SINGLE EXPOSURE METHOD FOR INHALATION CHALLENGE WITH ALLERGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									TOHOKU UNIV, SCH MED, DEPT INTERNAL MED 1, 1-1 SEIRYO MACHI, SENDAI, MIYAGI 980, JAPAN	Tohoku University								AAS K, 1975, BRONCHIAL PROVOCATIO, P42; ADAMS GK, 1979, J IMMUNOL, V122, P555; ATKINS PC, 1980, J ALLERGY CLIN IMMUN, V66, P478, DOI 10.1016/0091-6749(80)90009-3; BROCKLEHURST WE, 1960, J PHYSIOL-LONDON, V151, P416, DOI 10.1113/jphysiol.1960.sp006449; CAVANAUGH MJ, 1977, J ALLERGY CLIN IMMUN, V59, P41, DOI 10.1016/0091-6749(77)90175-0; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; FISH JE, 1981, J APPL PHYSIOL, V50, P1079, DOI 10.1152/jappl.1981.50.5.1079; GIMENO F, 1972, AM REV RESPIR DIS, V105, P68; HYATT RE, 1970, J APPL PHYSIOL, V28, P675, DOI 10.1152/jappl.1970.28.5.675; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; LEWIS RA, 1974, J EXP MED, V140, P1133, DOI 10.1084/jem.140.5.1133; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; NARASBHAT K, 1976, J ALLERGY CLIN IMMUN, V58, P647, DOI 10.1016/0091-6749(76)90176-7; OLIVE JT, 1972, AM REV RESPIR DIS, V106, P366, DOI 10.1164/arrd.1972.106.3.366; OREHEK J, 1980, AM REV RESPIR DIS, V121, P297; RYAN G, 1981, AM REV RESPIR DIS, V123, P195; SPECTOR S, 1979, J ALLERGY CLIN IMMUN, V64, P580, DOI 10.1016/0091-6749(79)90016-2; SPECTOR SL, 1971, J ALLERGY CLIN IMMUN, V48, P120, DOI 10.1016/0091-6749(71)90093-5; SPECTOR SL, 1974, MED CLIN N AM, V58, P71, DOI 10.1016/S0025-7125(16)32178-2; TAKISHIMA T, 1981, CHEST, V80, P600, DOI 10.1378/chest.80.5.600; TOWNLEY RG, 1965, J ALLERGY, V36, P121, DOI 10.1016/0021-8707(65)90161-9	22	15	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1985	75	1					47	54		10.1016/0091-6749(85)90011-9	http://dx.doi.org/10.1016/0091-6749(85)90011-9			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ABF26	3968328	Bronze			2022-12-18	WOS:A1985ABF2600007
J	BROOKS, CD; NELSON, AL; METZLER, C				BROOKS, CD; NELSON, AL; METZLER, C			EFFECT OF FLURBIPROFEN, A CYCLOOXYGENASE INHIBITING DRUG, ON INDUCED ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UPJOHN CO,KALAMAZOO,MI 49001	Pfizer	BROOKS, CD (corresponding author), BRONSON CLIN INVEST UNIT,252 E LOVELL ST,KALAMAZOO,MI 49007, USA.							ADAMS SS, 1973, 13TH P INT C RHEUM, P173; ADCOCK JJ, 1982, BRIT J PHARMACOL, V77, P570, DOI 10.1111/j.1476-5381.1982.tb09333.x; BROOKS CD, 1981, ANN ALLERGY, V47, P316; BROOKS CD, 1982, J ALLERGY CLIN IMMUN, V70, P373, DOI 10.1016/0091-6749(82)90027-6; Burka J F, 1980, Adv Prostaglandin Thromboxane Res, V8, P1755; COCKBILL SR, 1979, BRIT J PHARMACOL, V67, P73; CROOK D, 1976, J PHARM PHARMACOL, V28, P535, DOI 10.1111/j.2042-7158.1976.tb02787.x; ECCLES R, 1978, ACTA OTO-LARYNGOL, V86, P464, DOI 10.3109/00016487809107526; ENGLISH GM, 1976, OTOLARYNGOLOGY TXB, P261; FAIRFAX AJ, 1981, BR J PHARM, V74, P984; FISH JE, 1981, AM REV RESPIR DIS, V123, P609; GOTH A, 1978, ALLERGY PRINCIPLES P, P457; GREIG ME, 1975, J MED CHEM, V18, P112, DOI 10.1021/jm00235a027; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; KASSIS V, 1981, DRUG DEVELOP RES, V1, P55, DOI 10.1002/ddr.430010107; KORDANSKY D, 1978, ANN INTERN MED, V88, P508, DOI 10.7326/0003-4819-88-4-508; KUMAR P, 1980, CLIN RES, V28, P805; LEE P, 1976, J RHEUMATOL, V3, P283; LEWIS RA, 1980, FED PROC, V39, P905; MAROM Z, 1981, J CLIN INVEST, V67, P1695, DOI 10.1172/JCI110207; MARONE G, 1979, J IMMUNOL, V123, P1669; MCLEAN JA, 1983, J ALLERGY CLIN IMMUN, V72, P187, DOI 10.1016/0091-6749(83)90528-6; NACLERIO RM, 1983, J ALLERGY CLIN IMMUN, V71, P89, DOI 10.1016/0091-6749(83)90128-8; OKAZAKI T, 1977, PROSTAGLANDINS, V13, P681, DOI 10.1016/0090-6980(77)90239-8; RICHERSON HB, 1968, J ALLERGY, V41, P269, DOI 10.1016/0021-8707(68)90032-4; SHANKER R, 1970, J APPL PHYSL, V28, P162; TOKUNAGA M, 1981, ANN RHEUM DIS, V40, P462, DOI 10.1136/ard.40.5.462; WOJNAR RJ, 1980, J ALLERGY CLIN IMMUN, V66, P37, DOI 10.1016/0091-6749(80)90136-0	28	15	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	5					584	589		10.1016/0091-6749(84)90515-3	http://dx.doi.org/10.1016/0091-6749(84)90515-3			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SS045	6715724	Bronze			2022-12-18	WOS:A1984SS04500008
J	LONNERHOLM, G; FOUCARD, T; LINDSTROM, B				LONNERHOLM, G; FOUCARD, T; LINDSTROM, B			DOSE, PLASMA-CONCENTRATION, AND EFFECT OF ORAL TERBUTALINE IN LONG-TERM TREATMENT OF CHILDHOOD ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN	National Board of Health & Welfare	LONNERHOLM, G (corresponding author), UNIV HOSP UPPSALA,DEPT PEDIAT,S-75185 UPPSALA,SWEDEN.							BILLING B, 1982, EUR J RESPIR DIS, V63, P399; CLARE RA, 1979, BIOMED MASS SPECTROM, V6, P31, DOI 10.1002/bms.1200060108; CONOLLY ME, 1982, J ALLERGY CLIN IMMUN, V70, P423, DOI 10.1016/0091-6749(82)90004-5; FORMGREN H, 1975, SCAND J RESPIR DIS, V56, P321; FORMGREN H, 1970, SCAND J RESPIR DIS, V51, P195; FREEDMAN BJ, 1971, BRIT MED J, V1, P633, DOI 10.1136/bmj.1.5750.633; JACOBSSON SE, 1980, BIOMED MASS SPECTROM, V7, P265, DOI 10.1002/bms.1200070608; JENNE JW, 1981, LUNG, V159, P295, DOI 10.1007/BF02713930; LAMONT H, 1982, EUR J RESPIR DIS, V63, P13; LARSSON S, 1977, J ALLERGY CLIN IMMUN, V59, P93, DOI 10.1016/0091-6749(77)90209-3; LEFERINK JG, 1977, J CHROMATOGR, V143, P299, DOI 10.1016/S0378-4347(00)81810-1; LEFERINK JG, 1979, THESIS UTRECHT; LEGGE JS, 1971, BRIT MED J, V1, P637, DOI 10.1136/bmj.1.5750.637; LONNERHOLM G, 1981, BRIT MED J, V282, P1029, DOI 10.1136/bmj.282.6269.1029; MCFADDEN ER, 1981, J ALLERGY CLIN IMMUN, V68, P91, DOI 10.1016/0091-6749(81)90164-0; NYBERG L, 1984, EUR J RESPIR DIS, V65, P149; Polgar G, 1971, PULMONARY FUNCTION T; SACKNER MA, 1975, CHEST, V68, P616, DOI 10.1378/chest.68.5.616; SVEDMYR K, 1982, ALLERGY, V37, P119, DOI 10.1111/j.1398-9995.1982.tb01885.x; TAUDORF E, 1981, ALLERGY, V36, P495, DOI 10.1111/j.1398-9995.1981.tb01861.x; VANDENBERG W, 1980, ANN ALLERGY, V44, P235; VANDENBERG W, 1982, J ALLERGY CLIN IMMUN, V69, P410, DOI 10.1016/0091-6749(82)90115-4; VANDENBERG W, 1982, INT J CLIN PHARM THE, V32, P159; VANDENBERG W, 1982, THESIS UTRECHT; WEBER RW, 1982, J ALLERGY CLIN IMMUN, V70, P417, DOI 10.1016/0091-6749(82)90003-3; WOLFE JD, 1978, NEW ENGL J MED, V298, P363, DOI 10.1056/NEJM197802162980703	26	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	4					508	515		10.1016/0091-6749(84)90362-2	http://dx.doi.org/10.1016/0091-6749(84)90362-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM089	6707393				2022-12-18	WOS:A1984SM08900013
J	SLEPIAN, IK; SCHWARTZ, SA; WEISS, JJ; ROTH, SL; MATHEWS, KP				SLEPIAN, IK; SCHWARTZ, SA; WEISS, JJ; ROTH, SL; MATHEWS, KP			IMMUNODEFICIENCY WITH HYPER IGM AFTER SYSTEMIC LUPUS-ERYTHEMATOSUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48104; UNIV MICHIGAN,SCH MED,DEPT PEDIAT & COMMUN DIS,ANN ARBOR,MI 48104	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan								ACKERMAN BD, 1964, PEDIATRICS, V34, P211; ASHMAN RF, 1982, J ALLERGY CLIN IMMUN, V70, P465, DOI 10.1016/0091-6749(82)90010-0; BARTH WF, 1965, AM J MED, V39, P319, DOI 10.1016/0002-9343(65)90058-6; BURTIN P, 1961, REV FR ETUD CLIN BIO, V6, P286; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; BUTLER WT, 1974, J CLIN INVEST, V54, P14; CHANH TC, 1980, J IMMUNOL, V125, P108; CLAMAN HN, 1972, NEW ENGL J MED, V287, P388, DOI 10.1056/NEJM197208242870806; CLAMAN HN, 1970, PEDIATRICS, V46, P89; COCHRAN M, 1973, POSTGRAD MED J, V49, P355, DOI 10.1136/pgmj.49.571.355; COOPER DA, 1979, CLIN EXP IMMUNOL, V37, P145; CRUCHAUD ANDRE, 1962, JOUR EXPTL MED, V115, P1141, DOI 10.1084/jem.115.6.1141; DAGUILLARD F, 1975, UNION MED CAN, V104, P393; DAVIS JS, 1981, TXB RHEUMATOLOGY, V1, P703; EDWARDS NL, 1980, CLIN IMMUNOL IMMUNOP, V17, P76, DOI 10.1016/0090-1229(80)90075-6; FAUCI AS, 1980, CELL IMMUNOL, V49, P43, DOI 10.1016/0008-8749(80)90054-4; FELDMAN G, 1975, J PEDIATR-US, V87, P534, DOI 10.1016/S0022-3476(75)80815-8; FRANKLIN RM, 1977, AM J OPHTHALMOL, V84, P563, DOI 10.1016/0002-9394(77)90453-6; FUDENBERG HH, 1962, ARTHRITIS RHEUM, V5, P565, DOI 10.1002/art.1780050605; GEHA RS, 1979, J CLIN INVEST, V64, P385, DOI 10.1172/JCI109473; GLEICH GJ, 1965, NEW ENGL J MED, V272, P331, DOI 10.1056/NEJM196502182720702; GOLDMAN AS, 1967, J PEDIATR-US, V70, P16, DOI 10.1016/S0022-3476(67)80161-6; GOTOFF SP, 1980, IMMUNOLOGIC DISORDER, P410; HERMANS PE, 1966, AM J MED, V40, P78, DOI 10.1016/0002-9343(66)90189-6; Hobbs J R, 1967, Clin Exp Immunol, V2, P589; HONG R, 1962, J PEDIATR-US, V61, P831, DOI 10.1016/S0022-3476(62)80193-0; HORWITZ DA, 1974, ARTHRITIS RHEUM, V17, P363, DOI 10.1002/art.1780170405; HUNTLEY CC, 1963, PEDIATRICS, V32, P407; ISRAELASSELAIN R, 1960, SOC MED HOPITAUX PAR, V76, P519; IWATA T, 1981, AM J MED, V71, P385, DOI 10.1016/0002-9343(81)90164-9; KRANTMAN HJ, 1980, CLIN EXP IMMUNOL, V40, P147; LITWIN SD, 1973, IMMUNOLOGY, V25, P573; MARSHALL WC, 1964, ARCH DIS CHILD, V39, P18, DOI 10.1136/adc.39.203.18; MARUYAMA H, 1971, J JAP SOC INTERN MED, V60, P42; MCMILLAN R, 1976, J IMMUNOL, V116, P1592; MILLER DG, 1967, ANN INTERN MED, V66, P507, DOI 10.7326/0003-4819-66-3-507; MITSUYA H, 1981, J IMMUNOL, V127, P311; MITSUYA H, 1979, J CLIN LAB IMMUNOL, V2, P337; NICHOLSON JKA, 1981, J IMMUNOL, V126, P2382; NIES KM, 1978, ARTHRITIS RHEUM, V21, P51, DOI 10.1002/art.1780210109; NIES KM, 1981, CLIN IMMUNOL IMMUNOP, V19, P118, DOI 10.1016/0090-1229(81)90053-2; OCHS HD, 1980, IMMUNOLOGIC DISORDER, P249; PETTY RE, 1979, CLIN EXP IMMUNOL, V37, P83; RACHELEFSKY GS, 1975, CLIN EXP IMMUNOL, V19, P1; RIEGER CHL, 1974, PEDIATRICS, V54, P508; ROSEN F, 1965, N ENGL J MED, V275, P769; ROSEN FS, 1961, PEDIATRICS, V28, P182; ROSEN FS, 1961, LANCET, V1, P700; ROSEN FS, 1963, NEW ENGL J MED, V269, P1336, DOI 10.1056/NEJM196312192692502; SANTOS GW, 1970, PHARMACOLOGICAL TREA, P24; SCHIFF RI, 1974, J IMMUNOL, V112, P376; SCHIMKE RN, 1969, AM J DIS CHILD, V118, P626, DOI 10.1001/archpedi.1969.02100040628018; SCHWABER JF, 1981, CLIN IMMUNOL IMMUNOP, V19, P91, DOI 10.1016/0090-1229(81)90050-7; Schwartz R, 1968, HUMAN TRANSPLANTATIO, P440; SCHWARTZ SA, 1977, J CLIN INVEST, V59, P1176, DOI 10.1172/JCI108742; SETTIPANE GA, 1978, J ALLERGY CLIN IMMUN, V62, P162, DOI 10.1016/0091-6749(78)90101-X; SMITH CK, 1970, AM J MED, V48, P113, DOI 10.1016/0002-9343(70)90105-1; SOOTHILL JF, 1962, CLIN SCI, V23, P27; SOOTHILL JF, 1966, LANCET, V1, P7452; STERN LM, 1975, AUST PAEDIATR J, V11, P38; STIEHM ER, 1966, AM J MED, V40, P805, DOI 10.1016/0002-9343(66)90163-X; TALAL N, 1976, CLIN EXP IMMUNOL, V25, P377; THEOFILOPOULOS AN, 1974, ARTHRITIS RHEUM-US, V17, P272, DOI 10.1002/art.1780170312; THOMAS P, 1973, POSTGRAD MED J, V49, P349, DOI 10.1136/pgmj.49.571.349; VANALTEN PJ, 1968, NATURE, V217, P358, DOI 10.1038/217358a0; VANDERGIESSEN M, 1976, CLIN IMMUNOL IMMUNOP, V5, P388, DOI 10.1016/0090-1229(76)90048-9; Yegin O, 1978, Turk J Pediatr, V20, P116; 1979, CLIN IMMUNOL IMMUNOP, V13, P297	68	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	6					846	857		10.1016/0091-6749(84)90458-5	http://dx.doi.org/10.1016/0091-6749(84)90458-5			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SV829	6609946	Bronze			2022-12-18	WOS:A1984SV82900014
J	WARREN, JB; DALTON, N; TURNER, C; CLARK, TJH				WARREN, JB; DALTON, N; TURNER, C; CLARK, TJH			PROTECTIVE EFFECT OF CIRCULATING EPINEPHRINE WITHIN THE PHYSIOLOGIC RANGE ON THE AIRWAY RESPONSE TO INHALED HISTAMINE IN NONASTHMATIC SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									GUYS HOSP,DEPT RESP MED,LONDON SE1 9RT,ENGLAND; GUYS HOSP,DEPT CLIN CHEM,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust								BARNES P, 1980, NEW ENGL J MED, V303, P263, DOI 10.1056/NEJM198007313030506; BARNES PJ, 1981, THORAX, V36, P435, DOI 10.1136/thx.36.6.435; BARNES PJ, 1982, CLIN SCI, V62, P661, DOI 10.1042/cs0620661; CHOWIENCZYK PJ, 1981, THORAX, V36, P944, DOI 10.1136/thx.36.12.944; DIAMOND L, 1977, J PHARM EXP THER, V181, P434; DRAZEN JL, 1978, J APPL PHYSL, V44, P330; Jackson DE, 1912, J PHARMACOL EXP THER, V4, P59; JONES RS, 1972, THORAX, V27, P572, DOI 10.1136/thx.27.5.572; KINDERMANN W, 1982, KLIN WOCHENSCHR, V60, P505, DOI 10.1007/BF01756096; LARSSON K, 1982, CHEST, V5, P560; LEFCOE NM, 1971, AM REV RESPIR DIS, V104, P562; PEULER JD, 1977, LIFE SCI, V21, P625, DOI 10.1016/0024-3205(77)90070-4; WARREN JB, 1984, CLIN SCI, V66, P87, DOI 10.1042/cs0660087; WARREN JB, 1982, BRIT J DIS CHEST, V76, P147, DOI 10.1016/S0007-0971(82)80050-8; WARREN JB, 1983, CLIN SCI, V64, P475, DOI 10.1042/cs0640475; WARREN JB, 1983, CLIN SCI, V66, P79; 1982, LANCET, V1, P1224	17	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	74	5					683	686		10.1016/0091-6749(84)90230-6	http://dx.doi.org/10.1016/0091-6749(84)90230-6			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TT169	6389647				2022-12-18	WOS:A1984TT16900005
J	YUNGINGER, JW				YUNGINGER, JW			ALLERGEN STANDARDIZATION - 1984	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									MAYO MED SCH,DEPT PEDIAT,ROCHESTER,MN 55901; MAYO MED SCH,DEPT INTERNAL MED ALLERGY,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic	YUNGINGER, JW (corresponding author), MAYO CLIN & MAYO FDN,ALLERG DIS RES LAB,406 GUGGENHEIM BLDG,ROCHESTER,MN 55905, USA.							AAS K, 1978, ALLERGY, V33, P130, DOI 10.1111/j.1398-9995.1978.tb01522.x; BJORKSTEN F, 1984, J ALLERGY CLIN IMMUN, V73, P324, DOI 10.1016/0091-6749(84)90404-4; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; GLEICH GJ, 1974, J ALLERGY CLIN IMMUN, V53, P158, DOI 10.1016/0091-6749(74)90004-9; HELM RM, UNPUB J ALLERGY CLIN; Lowenstein H, 1978, Prog Allergy, V25, P1, DOI 10.1159/000314432; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; TURKLETAUB PC, 1983, OFFICE BIOL PROPOSED; VARGA JM, 1972, J ALLERGY CLIN IMMUN, V49, P274, DOI 10.1016/0091-6749(72)90095-4; YUNGINGER JW, 1983, PEDIATR CLIN N AM, V30, P795; YUNGINGER JW, 1976, J ALLERGY CLIN IMMUN, V57, P293, DOI 10.1016/0091-6749(76)90085-3; 1982, NLN PUBLICATION NORD, V7, P1	12	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1984	73	3					316	317		10.1016/0091-6749(84)90402-0	http://dx.doi.org/10.1016/0091-6749(84)90402-0			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SK155	6366030				2022-12-18	WOS:A1984SK15500003
J	BARSELA, S; SHALIT, M; KALBFLEISCH, JH; FINK, JN				BARSELA, S; SHALIT, M; KALBFLEISCH, JH; FINK, JN			THE RELATIVE VALUE OF SKIN-TESTS AND RADIOALLERGOSORBENT TEST IN THE DIAGNOSIS OF BEE STING HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MED COLL WISCONSIN,MARCUS LAB IMMUNOL & ALLERGY RES,DEPT MED,ALLERGY IMMUNOL SECT,MILWAUKEE,WI 53233; HADASSAH MED CTR,DEPT MED A,ALLERGY SECT,JERUSALEM,ISRAEL	Medical College of Wisconsin; Hebrew University of Jerusalem; Hadassah University Medical Center	BARSELA, S (corresponding author), VET ADM MED CTR,RES SERV 151,WOOD,WI 53193, USA.							ABKIEWICZ C, 1979, S AFR MED J, V55, P285; BARSELA S, 1981, ANN ALLERGY, V47, P460; BOOTH BH, 1980, ALLERGIC DISEASES DI, P87; BOUSQUET J, 1982, CLIN ALLERGY, V12, P331, DOI 10.1111/j.1365-2222.1982.tb02537.x; CHIPPS BE, 1980, J PEDIATR-US, V97, P177, DOI 10.1016/S0022-3476(80)80470-7; GALEN RS, 1972, NORMALITY PREDICTIVE; HOFFMAN DR, 1979, ANN ALLERGY, V43, P211; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; KEMENY DM, 1980, CLIN ALLERGY, V10, P413, DOI 10.1111/j.1365-2222.1980.tb02124.x; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LIGHT WC, 1975, CLIN ALLERGY, V5, P383; MARINEY D, 1980, INT ARCH ALLERGY APP, V62, P442; NORMAN PS, 1978, ALLERGY PRINCIPLES P, P257; PARKER JL, 1982, J ALLERGY CLIN IMMUN, V69, P200, DOI 10.1016/0091-6749(82)90100-2; PATRIZZI R, 1979, ALLERGY, V34, P219; REISMAN RE, 1979, J ALLERGY CLIN IMMUN, V64, P3, DOI 10.1016/0091-6749(79)90074-5; SANTRACH PJ, 1980, ANN ALLERGY, V45, P130; SCHWARTZ HJ, 1981, J ALLERGY CLIN IMMUN, V67, P81, DOI 10.1016/0091-6749(81)90051-8; YUNGINGER JW, 1978, J ALLERGY CLIN IMMUN, V61, P93, DOI 10.1016/0091-6749(78)90231-2; 1981, BMDP STATISTICAL SOF	20	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	6					690	694		10.1016/0091-6749(83)90631-0	http://dx.doi.org/10.1016/0091-6749(83)90631-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RW048	6643873				2022-12-18	WOS:A1983RW04800010
J	BUSH, RK; VOSS, MJ; BASHIRIAN, S				BUSH, RK; VOSS, MJ; BASHIRIAN, S			DETECTION OF ALTERNARIA ALLERGENS BY CROSSED RADIOIMMUNOELECTROPHORESIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	BUSH, RK (corresponding author), WILLIAM S MIDDLETON MEM VET ADM HOSP,ALLERGY SECT,MADISON,WI 53705, USA.							AUKRUST L, 1979, INT ARCH ALLER A IMM, V60, P68, DOI 10.1159/000232324; AUKRUST L, 1980, ADV ALLERGOLOGY APPL, P475; AUKRUST L, 1979, INT ARCH ALLER A IMM, V58, P371; BUSH RK, 1982, CLIN ALLERGY, V12, P29, DOI 10.1111/j.1365-2222.1982.tb03123.x; CREMER NE, 1977, METHODS IMMUNOLOGY, P87; HARBOE N, 1973, Scandinavian Journal of Immunology, V2, P161; HOFFMAN DR, 1981, ANN ALLERGY, V46, P310; HUSSAIN R, 1981, J ALLERGY CLIN IMMUN, V67, P217, DOI 10.1016/0091-6749(81)90064-6; Lowenstein H, 1978, Prog Allergy, V25, P1, DOI 10.1159/000314432; LOWENSTEIN H, 1980, ADV ALLERGOLOGY APPL, P573; NYHOLM L, 1982, J ALLERGY CLIN IMMUN, V69, P97; VIJAY HM, 1979, INT ARCH ALLER A IMM, V60, P229, DOI 10.1159/000232347; WEEKE B, 1974, ACTA ALLERGOL, V29, P402, DOI 10.1111/j.1398-9995.1974.tb01661.x; WEEKE B, 1973, SCAND J IMMUNOL, V2, P149, DOI 10.1111/j.1365-3083.1973.tb03796.x; YUNGINGER JW, 1980, J ALLERGY CLIN IMMUN, V66, P138, DOI 10.1016/0091-6749(80)90061-5	15	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	2					239	244		10.1016/0091-6749(83)90105-7	http://dx.doi.org/10.1016/0091-6749(83)90105-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC188	6681618	Bronze			2022-12-18	WOS:A1983QC18800010
J	CLAUSEN, RW; YANARI, SS				CLAUSEN, RW; YANARI, SS			IMMUNE-COMPLEX - MEDIATED DISEASE NOT A FACTOR IN PATIENTS ON MAINTENANCE VENOM IMMUNOTHERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									HENRY FORD HOSP,DIV ALLERGY & CLIN IMMUNOL,DETROIT,MI 48202	Henry Ford Health System; Henry Ford Hospital								CARPENTIER NA, 1982, NEW ENGL J MED, V307, P1174, DOI 10.1056/NEJM198211043071903; COYLE PK, 1982, INFECT IMMUN, V36, P498, DOI 10.1128/IAI.36.2.498-503.1982; DIMARIO U, 1981, J CLIN LAB IMMUNOL, V5, P95; GOLDEN DBK, 1980, ANN INTERN MED, V92, P620, DOI 10.7326/0003-4819-92-5-620; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HADGSON HFJ, 1976, CLIN SCI MOD MED, V51, P1; HAMILTON RG, 1981, J ALLERGY CLIN IMMUN, V67, P14, DOI 10.1016/0091-6749(81)90039-7; IRVINE WJ, 1977, CLIN EXP IMMUNOL, V30, P16; LIGHT WC, 1977, J ALLERGY CLIN IMMUN, V59, P391, DOI 10.1016/0091-6749(77)90024-0; LOCKWOOD CM, 1977, EXP HEMATOL, V5, P117; NYDEGGER UE, 1974, J CLIN INVEST, V54, P297, DOI 10.1172/JCI107765; OAI YM, 1977, KIDNEY INT, V11, P275; PALLONE F, 1981, J CLIN LAB IMMUNOL, V5, P23; SHEEHAN RK, 1965, J AMER MED ASSOC, V193, P155, DOI 10.1001/jama.1965.03090020069022; WOODROFFE AJ, 1976, KIDNEY INT, V10, P552	15	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	72	2					199	203		10.1016/0091-6749(83)90530-4	http://dx.doi.org/10.1016/0091-6749(83)90530-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RD959	6224840				2022-12-18	WOS:A1983RD95900015
J	KAHN, CR; MARSH, DG				KAHN, CR; MARSH, DG			ANALYSIS OF GRASS GROUP-I ALLERGENS USING MONOCLONAL-ANTIBODIES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228					0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					95	95		10.1016/0091-6749(83)90149-5	http://dx.doi.org/10.1016/0091-6749(83)90149-5			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200026
J	MORRIS, HG; SHERMAN, NA; SILVERS, WS; MILLS, D; SHEPPERDSON, FT				MORRIS, HG; SHERMAN, NA; SILVERS, WS; MILLS, D; SHEPPERDSON, FT			TIMED EFFECTS OF AN ORAL ADRENERGIC BRONCHODILATOR ON PULMONARY-FUNCTION AND MEASUREMENTS OF PLASMA AND LEUKOCYTE CYCLIC-AMP - DIVERGENCE IN DURATION OF DRUG-ACTION AND DEVELOPMENT OF TOLERANCE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											MORRIS, HG (corresponding author), NATL JEWISH HOSP & RES CTR,3800 E COLFAX AVE,DENVER,CO 80206, USA.				NHLBI NIH HHS [HL 22026] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROADUS AE, 1971, ANN NY ACAD SCI, V185, P50; BROOKS SM, 1979, J ALLERGY CLIN IMMUN, V63, P401, DOI 10.1016/0091-6749(79)90213-6; CLAYTON D, 1979, J ALLERGY CLIN IMMUN, V63, P152; CONNOLLY ME, 1976, J CLIN INVEST, V58, P1307; Conover WJ, 1980, PRACTICAL NONPARAMET, P299; Diamond J, 1978, Adv Cyclic Nucleotide Res, V9, P327; FRANKLIN TJ, 1975, MOL PHARMACOL, V11, P485; FRENCH EB, 1971, BRIT J HAEMATOL, V21, P423, DOI 10.1111/j.1365-2141.1971.tb02702.x; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HARRIS RJ, 1975, PRIMER MULTIVARIATE, P80; JENNE JW, 1977, J ALLERGY CLIN IMMUN, V59, P383, DOI 10.1016/0091-6749(77)90023-9; Larsson S, 1977, Acta Med Scand Suppl, V608, P1; Lefkowitz R J, 1978, Adv Cyclic Nucleotide Res, V9, P1; MAO CC, 1974, ANAL BIOCHEM, V59, P63, DOI 10.1016/0003-2697(74)90009-8; MITCHELL HW, 1979, EUR J PHARMACOL, V54, P69, DOI 10.1016/0014-2999(79)90409-6; MORRIS HG, 1978, J ALLERGY CLIN IMMUN, V61, P294, DOI 10.1016/0091-6749(78)90050-7; MORRIS HG, 1977, CLIN PHARMACOL THER, V22, P352; MORRIS HG, 1977, J CYCLIC NUCL PROT, V3, P439; MORRIS HG, 1978, CHEST, V73, pS973; MUKHERJEE C, 1975, P NATL ACAD SCI USA, V72, P1945, DOI 10.1073/pnas.72.5.1945; NELSON HS, 1975, J ALLERGY CLIN IMMUN, V55, P299, DOI 10.1016/0091-6749(75)90002-0; NELSON HS, 1977, AM REV RESPIR DIS, V116, P871; NIAUDET P, 1976, EUR J IMMUNOL, V6, P834, DOI 10.1002/eji.1830061117; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; PLUMMER AL, 1978, CHEST, V73, P949, DOI 10.1378/chest.73.6.949; STEEL CM, 1971, BRIT J HAEMATOL, V21, P413, DOI 10.1111/j.1365-2141.1971.tb02701.x; STEINER AL, 1972, J BIOL CHEM, V247, P1114; SVEDMYR NLV, 1976, CHEST, V69, P479, DOI 10.1378/chest.69.4.479; TIPTON WR, 1981, LUNG, V159, P199, DOI 10.1007/BF02713916; TRIPP SL, 1978, ANAL LETT, V11, P727; VANDENBERG W, 1980, ANN ALLERGY, V44, P235; VANDENBERG W, 1982, J ALLERGY CLIN IMMUN, V69, P410, DOI 10.1016/0091-6749(82)90115-4; WEHMANN RE, 1974, J CLIN INVEST, V53, P173, DOI 10.1172/JCI107535; WESSELS MR, 1979, MOL PHARMACOL, V16, P10; YU DTY, 1976, CLIN EXP IMMUNOL, V25, P472	35	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	3					266	276		10.1016/0091-6749(83)90080-5	http://dx.doi.org/10.1016/0091-6749(83)90080-5			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QH188	6298298				2022-12-18	WOS:A1983QH18800002
J	OHTA, K; MANZARA, T; HARBECK, RJ; KIRKPATRICK, CH				OHTA, K; MANZARA, T; HARBECK, RJ; KIRKPATRICK, CH			HUMAN TONSILLAR IGE BIOSYNTHESIS INVITRO .1. ENHANCEMENT OF IGE AND IGG SYNTHESIS IN THE PRESENCE OF POKEWEED MITOGEN BY T-CELL IRRADIATION	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											OHTA, K (corresponding author), NATL JEWISH HOSP & RES CTR,NATL ASTHMA CTR,CONRAD D STEPHENSON LAB RES IMMUNOL,DEPT MED,DENVER,CO 80206, USA.				NCRR NIH HHS [RR-05842] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31; BRANDTZAEG P, 1978, CLIN EXP IMMUNOL, V31, P367; BROCHIER J, 1978, IMMUNOLOGY, V35, P827; BUCKLEY RH, 1978, IMMUNOL REV, V41, P288, DOI 10.1111/j.1600-065X.1978.tb01469.x; CHIORAZZI N, 1977, J IMMUNOL, V118, P48; FAUCI AS, 1976, J IMMUNOL, V117, P2100; FISER PM, 1979, J IMMUNOL, V123, P1788; GALILI U, 1974, J IMMUNOL, V112, P1628; GEHA RS, 1981, J CLIN INVEST, V68, P783, DOI 10.1172/JCI110315; GHORY AC, 1980, CLIN EXP IMMUNOL, V40, P581; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; GUPTA S, 1977, CLIN EXP IMMUNOL, V28, P347; HIRANO T, 1977, J IMMUNOL, V119, P1235; ISHIZAKA K, 1966, J IMMUNOL, V97, P75; ISHIZAKA K, 1976, ADV IMMUNOL, V23, P1, DOI 10.1016/S0065-2776(08)60318-1; ISHIZAKA T, 1975, PROG ALLERGY, V19, P60, DOI 10.1159/000313384; JARRETT EEE, 1978, IMMUNOL REV, V41, P52, DOI 10.1111/j.1600-065X.1978.tb01460.x; KEIGHTLEY RG, 1976, J IMMUNOL, V117, P1538; KLINMAN NR, 1969, CLIN EXP IMMUNOL, V4, P473; KORSRUD FR, 1980, CLIN EXP IMMUNOL, V39, P361; OHTA K, 1980, INT ARCH ALLER A IMM, V63, P129, DOI 10.1159/000232618; OKUMURA K, 1971, J IMMUNOL, V107, P1682; OVARY Z, 1978, IMMUNOL REV, V41, P26, DOI 10.1111/j.1600-065X.1978.tb01459.x; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P579; ROMAGNANI S, 1980, CLIN EXP IMMUNOL, V42, P167; ROMAGNANI S, 1977, CLIN EXP IMMUNOL, V28, P332; SAMPSON HA, 1981, J IMMUNOL, V127, P829; SAXON A, 1980, J CLIN INVEST, V65, P1457, DOI 10.1172/JCI109810; SAXON A, 1979, CLIN IMMUNOL IMMUNOP, V14, P474, DOI 10.1016/0090-1229(79)90100-4; SIEGAL FP, 1977, J IMMUNOL, V118, P642; SIEGAL FP, 1978, NEW ENGL J MED, V299, P172, DOI 10.1056/NEJM197807272990404; SURJAN L, 1978, CLIN EXP IMMUNOL, V31, P382; TADA T, 1975, PROG ALLERGY, V19, P122, DOI 10.1159/000313387; TADA T, 1970, Journal of Immunology, V104, P377; THOMAS Y, 1980, J IMMUNOL, V125, P2402; TJIO AH, 1979, J IMMUNOL, V122, P2131; TURNER KJ, 1981, CLIN EXP IMMUNOL, V43, P458; WALDMANN TA, 1974, LANCET, V2, P609; WATANABE N, 1977, J IMMUNOL, V118, P485; WATANABE N, 1976, J EXP MED, V143, P833, DOI 10.1084/jem.143.4.833	40	15	16	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	2					212	223		10.1016/0091-6749(83)90102-1	http://dx.doi.org/10.1016/0091-6749(83)90102-1			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QC188	6600465	Bronze			2022-12-18	WOS:A1983QC18800007
J	REISMAN, RE; HALE, R; WYPYCH, JI				REISMAN, RE; HALE, R; WYPYCH, JI			ALLERGY TO HONEYBEE BODY COMPONENTS - DISTINCTION FROM BEE VENOM SENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SUNY BUFFALO,BUFFALO GEN HOSP,ALLERGY RES LAB,BUFFALO,NY 14260; KANSAS UNIV,MED CTR,DEPT MED,WICHITA,KS	Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NIAID NIH HHS [R01 AI1450104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014501] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENSON RL, 1930, J ALLERGY, V1, P105; ELLIS RALPH V., 1932, JOUR ALLERGY, V3, P247, DOI 10.1016/S0021-8707(32)90340-2; FORCK G, 1979, 10TH P INT C INT ASS; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P6; LIGHT WC, 1976, CLIN ALLERGY, V6, P293, DOI 10.1111/j.1365-2222.1976.tb01909.x; MULLER U, 1979, ALLERGY, V34, P369, DOI 10.1111/j.1398-9995.1979.tb02006.x; REISMAN RE, 1979, J ALLERGY CLIN IMMUN, V64, P281, DOI 10.1016/0091-6749(79)90145-3; REISMAN RE, 1976, J ALLERGY CLIN IMMUN, V57, P547, DOI 10.1016/0091-6749(76)90005-1; REISMAN RE, 1979, J ALLERGY CLIN IMMUN, V64, P3, DOI 10.1016/0091-6749(79)90074-5; REISMAN RE, 1981, MONOGRAPH INSECT ALL; WYPYCH JI, 1979, J ALLERGY CLIN IMMUN, V63, P267, DOI 10.1016/0091-6749(79)90111-8; YUNGINGER JW, 1978, J ALLERGY CLIN IMMUN, V61, P93, DOI 10.1016/0091-6749(78)90231-2; YUNGINGER JW, 1979, J ALLERGY CLIN IMMUN, V64, P1, DOI 10.1016/0091-6749(79)90073-3	14	15	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					18	20		10.1016/0091-6749(83)90541-9	http://dx.doi.org/10.1016/0091-6749(83)90541-9			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ461	6185554				2022-12-18	WOS:A1983PZ46100003
J	SCHULLER, DE				SCHULLER, DE			THE SPECTRUM OF ANTIHISTAMINES ADVERSELY AFFECTING PULMONARY-FUNCTION IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					147	147		10.1016/0091-6749(83)90359-7	http://dx.doi.org/10.1016/0091-6749(83)90359-7			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200236
J	SWEENEY, MJ; KLOTZ, SD				SWEENEY, MJ; KLOTZ, SD			FREQUENCY OF IGE MEDIATED RADIO CONTRAST DYE REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1983	71	1					147	147		10.1016/0091-6749(83)90360-3	http://dx.doi.org/10.1016/0091-6749(83)90360-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PZ462					2022-12-18	WOS:A1983PZ46200237
J	LINDBERG, RE; PINNAS, JL; JONES, JF				LINDBERG, RE; PINNAS, JL; JONES, JF			POLLEN-INDUCED CHEMI-LUMINESCENCE - INHIBITION BY SERUM FROM ALLERGIC INDIVIDUALS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV ARIZONA,COLL MED,DEPT PEDIAT,TUCSON,AZ 85721; UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,TUCSON,AZ 85721	University of Arizona; University of Arizona					NIAID NIH HHS [AI16514-01, AI-18210] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AAS K, 1971, J ALLERGY CLIN IMMUN, V48, P134, DOI 10.1016/0091-6749(71)90008-X; BERRENS L, 1973, INT ARCH ALLER A IMM, V45, P30, DOI 10.1159/000230996; CAVELTI PA, 1950, J ALLERGY, V21, P532, DOI 10.1016/0021-8707(50)90105-5; CHARPIN J, 1962, POLLINOSE, V1; DOLL NJ, 1980, J CLIN INVEST, V66, P457, DOI 10.1172/JCI109876; FERRANTE A, 1978, J IMMUNOL METHODS, V24, P389, DOI 10.1016/0022-1759(78)90143-6; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; HENSON PM, 1972, J IMMUNOL, V109, P1182; Kearney T.H., 1960, ARIZONA FLORA; MARSH DG, 1968, FED PROC, V27, P368; MORTON DJ, 1969, J RETICULOENDOTH SOC, V6, P525; OLSSON I, 1980, ALLERGY, V35, P1, DOI 10.1111/j.1398-9995.1980.tb01711.x; ROSEN H, 1976, J CLIN INVEST, V58, P50, DOI 10.1172/JCI108458; ROSSI F, 1972, J RETICULOENDOTH SOC, V12, P127; SELLERS ED, 1931, J ALLERGY, V3, P166; SELVARAJ RJ, 1966, NATURE, V211, P1272, DOI 10.1038/2111272a0; TEDESCO F, 1975, FEBS LETT, V51, P232, DOI 10.1016/0014-5793(75)80894-5; TOMASI TB, 1980, J ALLERGY CLIN IMMUN, V65, P12, DOI 10.1016/0091-6749(80)90171-2; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WEBER RW, 1978, J ALLERGY CLIN IMMUN, V61, P172, DOI 10.1016/0091-6749(78)90385-8; WIDE L, 1967, LANCET, V2, P1105	21	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	69	4					388	396		10.1016/0091-6749(82)90151-8	http://dx.doi.org/10.1016/0091-6749(82)90151-8			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	NL280	7069075				2022-12-18	WOS:A1982NL28000010
J	YOSHIZAWA, Y; NAKAZAWA, T; RIPANI, LM; MOORE, VL				YOSHIZAWA, Y; NAKAZAWA, T; RIPANI, LM; MOORE, VL			DEVELOPMENT OF CHRONIC PULMONARY INFLAMMATION IN IMMUNIZED GUINEA-PIGS BY AEROSOL CHALLENGE WITH ANTIGEN - RELATIONSHIP OF IMMUNE-COMPLEX DISEASE AND CELL-MEDIATED HYPERSENSITIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM MED CTR,RES SERV 151,WOOD,WI 53193; MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53233	US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin					NHLBI NIH HHS [HL 15389] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALLOW M, 1969, J IMMUNOL, V103, P944; BARROWCLIFF DF, 1968, THORAX, V23, P490, DOI 10.1136/thx.23.5.490; BERNARDO J, 1979, AM REV RESPIR DIS, V120, P985; BICE DE, 1976, J ALLERGY CLIN IMMUN, V58, P250, DOI 10.1016/0091-6749(76)90130-5; GHOSE T, 1974, CLIN ALLERGY, V4, P119, DOI 10.1111/j.1365-2222.1974.tb01369.x; GOTZE O, 1979, J EXP MED, V149, P372, DOI 10.1084/jem.149.2.372; HANSEN PJ, 1974, INT ARCH ALLER A IMM, V47, P498, DOI 10.1159/000231244; JUNGI TW, 1981, IMMUNOLOGY, V43, P271; LARSEN GL, 1981, AM REV RESPIR DIS, V123, P434; LOPEZ M, 1976, ANNU REV MED, V27, P453, DOI 10.1146/annurev.me.27.020176.002321; MOORE VL, 1980, J ALLERGY CLIN IMMUN, V65, P365, DOI 10.1016/0091-6749(80)90214-6; MOORE VL, 1974, J ALLERGY CLIN IMMUN, V53, P319, DOI 10.1016/0091-6749(74)90115-8; MOORE VL, 1975, J CLIN INVEST, V56, P937, DOI 10.1172/JCI108173; MYRVIK QN, 1961, J IMMUNOL, V86, P128; Pepys J, 1969, Monogr Allergy, V4, P1; PETERSON LB, 1979, AM REV RESPIR DIS, V119, P991; REYNOLDS HY, 1977, J CLIN INVEST, V59, P165, DOI 10.1172/JCI108615; RICHERSON HB, 1972, J LAB CLIN MED, V79, P745; RICHERSON HB, 1978, AM REV RESPIR DIS, V117, P5; ROBERTS RC, 1977, AM REV RESPIR DIS, V116, P1075; ROSKA AKB, 1977, CLIN IMMUNOL IMMUNOP, V8, P213, DOI 10.1016/0090-1229(77)90111-8; ROSKA AKB, 1979, AM REV RESPIR DIS, V120, P129; SANTIVES T, 1976, J ALLERGY CLIN IMMUN, V57, P582, DOI 10.1016/0091-6749(76)90010-5; SCHATZ M, 1977, J ALLERGY CLIN IMMUN, V60, P27, DOI 10.1016/0091-6749(77)90079-3; SCHUYLER MR, 1978, ANN INTERN MED, V88, P355, DOI 10.7326/0003-4819-88-3-355; WILSON MR, 1981, CLIN ALLERGY, V11, P131, DOI 10.1111/j.1365-2222.1981.tb01576.x	26	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1982	70	2					114	119		10.1016/0091-6749(82)90238-X	http://dx.doi.org/10.1016/0091-6749(82)90238-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PB591	6212608				2022-12-18	WOS:A1982PB59100007
J	CAPRON, A; DESSAINT, JP; CAPRON, M				CAPRON, A; DESSAINT, JP; CAPRON, M			IMMUNOREGULATION OF PARASITE INFECTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CAPRON, A (corresponding author), INST PASTEUR, CTR IMMUNOL & BIOL PARASITAIRE,INSERM,U167,CNRS, EQUIPE RECH 422, BP 345, F-59019 LILLE, FRANCE.							ANDERSON HR, 1974, CLIN ALLERGY, V4, P171, DOI 10.1111/j.1365-2222.1974.tb01374.x; AURIAULT C, PARASITE IMMUNOL; BAZIN H, 1980, J IMMUNOL, V124, P2373; BOUT D, 1977, INSERM (Institut National de la Sante et de la Recherche Medicale) Colloque, V72, P71; BUTTERWORTH AE, 1977, J EXP MED, V145, P136, DOI 10.1084/jem.145.1.136; BUTTERWORTH AE, 1979, J IMMUNOL, V122, P1314; BUTTERWORTH AE, 1975, NATURE, V256, P727, DOI 10.1038/256727a0; CAMUS D, 1979, EUR J IMMUNOL, V9, P341, DOI 10.1002/eji.1830090417; Capron A., 1976, P263; CAPRON A, 1975, NATURE, V253, P474, DOI 10.1038/253474a0; CAPRON A, 1977, EUR J IMMUNOL, V7, P315, DOI 10.1002/eji.1830070515; CAPRON A, 1977, AM J TROP MED HYG, V26, P39, DOI 10.4269/ajtmh.1977.26.39; CAPRON A, 1977, PATHOL BIOL, V25, P287; CAPRON A, 1977, INSERM (Institut National de la Sante et de la Recherche Medicale) Colloque, V72, P217; CAPRON A, ANN IMMUNOL; CAPRON A, AM J TROP MED HYG; CAPRON A, 1976, MOL BIOL ASPECTS ACU, P153; CAPRON M, 1978, J IMMUNOL, V121, P2518; CAPRON M, 1979, J IMMUNOL, V123, P2220; CAPRON M, 1978, EUR J IMMUNOL, V8, P127, DOI 10.1002/eji.1830080211; CARLIER Y, 1980, J IMMUNOL, V124, P2442; Clegg J A, 1972, Int J Parasitol, V2, P79, DOI 10.1016/0020-7519(72)90036-7; DESSAINT JP, 1980, CELL IMMUNOL, V51, P280, DOI 10.1016/0008-8749(80)90260-9; DESSAINT JP, 1979, CELL IMMUNOL, V46, P24, DOI 10.1016/0008-8749(79)90242-9; DESSAINT JP, 1975, CLIN EXP IMMUNOL, V20, P427; DESSAINT JP, 1979, CELL IMMUNOL, V46, P12, DOI 10.1016/0008-8749(79)90241-7; DESSAINT JP, 1977, EUR J IMMUNOL, V7, P624, DOI 10.1002/eji.1830070909; GOLDRING OL, 1976, CLIN EXP IMMUNOL, V26, P181; GONZALEZMOLINA A, 1976, J IMMUNOL, V117, P1838; HAQUE A, CLIN EXP IMMUNOL; JOSEPH M, 1977, CELL IMMUNOL, V34, P247, DOI 10.1016/0008-8749(77)90247-7; JOSEPH M, 1980, CLIN EXP IMMUNOL, V40, P416; JOSEPH M, 1978, CLIN EXP IMMUNOL, V33, P48; MAZINGUE C, INT ARCH ALLERGY APP; MELEWICZ FM, 1979, FED PROC, V38, P925; Ramalho-Pinto F.J., 1979, Parasite Immunology (Oxford), V1, P295, DOI 10.1111/j.1365-3024.1979.tb00715.x; ROUSSEAUXPREVOS.R, 1977, THESIS; ROUSSEAUXPREVOST R, 1978, IMMUNOLOGY, V35, P33; ROUSSEAUXPREVOST R, 1977, IMMUNOLOGY, V33, P501; ROUSSEAUXPREVOST R, 1980, INT ARCH ALLER A IMM, V62, P86, DOI 10.1159/000232497; SADUN EH, 1970, EXP PARASITOL, V28, P435, DOI 10.1016/0014-4894(70)90112-8; SANTORO F, 1978, CLIN EXP IMMUNOL, V32, P435; SHER A, 1975, PARASITOLOGY, V70, P347, DOI 10.1017/S0031182000052124; SHER A, 1978, J EXP MED, V148, P46, DOI 10.1084/jem.148.1.46; Smithers S.R., 1976, Advances Parasit, V14, P399, DOI 10.1016/S0065-308X(08)60518-7; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; TORPIER G, 1979, NATURE, V278, P447, DOI 10.1038/278447a0; TORPIER G, 1979, J ULTRA MOL STRUCT R, V67, P276, DOI 10.1016/S0022-5320(79)80028-3; YODOI J, 1979, J IMMUNOL, V123, P455	49	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	2					91	96		10.1016/0091-6749(80)90054-8	http://dx.doi.org/10.1016/0091-6749(80)90054-8			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KD119	6967497				2022-12-18	WOS:A1980KD11900001
J	HEINER, DC; DEWECK, AL; SKVARIL, F; MULLER, U; UNDERDOWN, B				HEINER, DC; DEWECK, AL; SKVARIL, F; MULLER, U; UNDERDOWN, B			IGG4 ANTIBODY-RESPONSES TO 5 BEE VENOM ANTIGENS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	3					201	201						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JJ620					2022-12-18	WOS:A1980JJ62000124
J	KATCHER, ML; REED, CE				KATCHER, ML; REED, CE			PREVENTION OF ANTIGEN-INDUCED BRONCHOCONSTRICTION BY IODOXAMIDE ETHYL, A NEW ORALLY ACTIVE ANTI-ALLERGIC DRUG	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,SCH MED,DEPT MED,MADISON,WI 53792	University of Wisconsin System; University of Wisconsin Madison	KATCHER, ML (corresponding author), UNIV WISCONSIN,SCH MED,CTR CLIN SCI,DEPT PEDIAT,MADISON,WI 53792, USA.							BROOKS CD, 1979, J ALLERGY CLIN IMMUN, V63, P161; BUI T, 1978, J ALLERGY CLIN IMMUN, V61, P189, DOI 10.1016/0091-6749(78)90441-4; BUI T, 1979, J ALLERGY CLIN IMMUN, V63, P160; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; JOHNSON HG, 1978, INT ARCH ALLER A IMM, V56, P481, DOI 10.1159/000232062; JOHNSON HG, 1978, INT ARCH ALLER A IMM, V56, P416, DOI 10.1159/000232051; JOHNSON HG, 1979, AGENTS ACTIONS, V9, P235, DOI 10.1007/BF01966693; REED CE, 1979, J ALLERGY CLIN IMMUN, V63, P164; WRIGHT JB, 1978, J MED CHEM, V21, P930, DOI 10.1021/jm00207a016	9	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	3					223	226		10.1016/0091-6749(80)90043-3	http://dx.doi.org/10.1016/0091-6749(80)90043-3			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KH358	7410746				2022-12-18	WOS:A1980KH35800009
J	RAGHUPRASAD, PK; BROOKS, SM; LITWIN, A; EDWARDS, JJ; BERNSTEIN, IL; GALLAGHER, J				RAGHUPRASAD, PK; BROOKS, SM; LITWIN, A; EDWARDS, JJ; BERNSTEIN, IL; GALLAGHER, J			QUILLAJA BARK (SOAPBARK)-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CINCINNATI,COLL MED,DEPT ENVIRONM HLTH,DIV CLIN STUDIES,CINCINNATI,OH 45267; UNIV CINCINNATI,COLL MED,DEPT MED,CINCINNATI,OH 45267	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati								BOHNER C. B., 1941, JOUR ALLERGY, V12, P290, DOI 10.1016/S0021-8707(41)80012-4; BROOKS SM, 1978, AM REV RESPIR DIS, V118, P75; BUSH RK, 1978, AM REV RESPIR DIS, V117, P601; CHANYEUNG M, 1976, AM REV RESPIR DIS, V114, P1027; EATON KK, 1973, CLIN ALLERGY, V2, P307; GAUNT IF, 1974, FOOD COSMET TOXICOL, V12, P641, DOI 10.1016/0015-6264(74)90235-1; GOLD W M, 1973, P169; HOFFMAN DR, 1979, ANN ALLERGY, V42, P224; HOWIE AD, 1976, THORAX, V31, P585, DOI 10.1136/thx.31.5.585; MARKIN EL, 1930, J ALLERG, V1, P346; MILNE J, 1969, MED J AUSTRALIA, V2, P741, DOI 10.5694/j.1326-5377.1969.tb107378.x; NORMAN PS, 1978, ALLERGY PRINCIPLES P, P256; ORDMAN D, 1949, S Afr Med J, V23, P973; PARKER CD, 1965, ARCH INTERN MED, V115, P452, DOI 10.1001/archinte.1965.03860160078013; PICKERING C A C, 1972, Clinical Allergy, V2, P213, DOI 10.1111/j.1365-2222.1972.tb01285.x; REED CE, 1974, J ALLERGY CLIN IMMUN, V53, P34, DOI 10.1016/0091-6749(74)90097-9; SOSMAN AJ, 1969, NEW ENGL J MED, V281, P977, DOI 10.1056/NEJM196910302811802; WIDE L, 1967, LANCET, V2, P1105	18	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	65	4					285	287		10.1016/0091-6749(80)90157-8	http://dx.doi.org/10.1016/0091-6749(80)90157-8			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JN548	7358945				2022-12-18	WOS:A1980JN54800008
J	SZCZEKLIK, A; PIETON, R; SIERADZKI, J				SZCZEKLIK, A; PIETON, R; SIERADZKI, J			ALTERATION IN BOTH INSULIN RELEASE AND ITS HYPOGLYCEMIC EFFECTS IN ATOPIC BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SZCZEKLIK, A (corresponding author), COPERNICUS ACAD MED,INST INTERNAL MED,SKAWINSKA 8,PL-31066 KRAKOW,POLAND.							Abrahamson EM, 1941, J CLIN ENDOCRINOL, V1, P402, DOI 10.1210/jcem-1-5-402; ADAMKIEWICZ VW, 1959, AM J PHYSIOL, V197, P377, DOI 10.1152/ajplegacy.1959.197.2.377; CHARLES MA, 1976, DIABETES, V25, P256, DOI 10.2337/diabetes.25.4.256; CHRISTENSEN NJ, 1979, DIABETOLOGIA, V16, P211, DOI 10.1007/BF01221946; CLARKE WL, 1979, AM J PHYSIOL, V236, pE147, DOI 10.1152/ajpendo.1979.236.2.E147; DAUGHADAY WH, 1974, TXB ENDOCRINOLOGY; GARBER AJ, 1976, J CLIN INVEST, V58, P7, DOI 10.1172/JCI108460; GAVIN JR, 1973, J BIOL CHEM, V248, P2202; GAZOMESLIERDERO.J, 1965, THESIS MARSEILLE; GRILL V, 1978, J CLIN INVEST, V61, P1343; GRODSKY GM, 1967, DIABETES; IMURA H, 1971, J CLIN INVEST, V50, P1069, DOI 10.1172/JCI106578; IMURA H, 1968, J CLIN ENDOCR METAB, V28, P1079; INOUE S, 1967, J ALLERGY, V40, P337, DOI 10.1016/0021-8707(67)90023-8; KONIG F, 1935, MED KLIN, V17, P545; KUO WN, 1973, J BIOL CHEM, V248, P2705; LIMBIRD LE, 1977, CLIN RES, V25, P736; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; NEWMAN RJ, 1976, BRIT MED J, V2, P447, DOI 10.1136/bmj.2.6033.447; OTTLECZ A, 1978, INT ARCH ALLER A IMM, V56, P284, DOI 10.1159/000232032; PORTE D, 1976, METABOLISM, V25, P1453, DOI 10.1016/S0026-0495(76)80163-1; PTAK W, 1977, CLIN EXP IMMUNOL, V29, P140; RHODES J, 1975, NATURE, V257, P597, DOI 10.1038/257597a0; SANYAL RK, 1959, NATURE, V184, P2020, DOI 10.1038/1842020a0; SIREK A, 1970, Acta Diabetologica Latina, V7, P777, DOI 10.1007/BF01556818; SIREK OV, 1975, DIABETOLOGIA, V11, P269, DOI 10.1007/BF00422390; SWERN N, 1932, J ALLERGY, V2, P375; SZCZEKLIK A, 1977, RESPIRATION, V34, P323, DOI 10.1159/000193844; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAKINO M, 1976, PATHOGENESIS THERAPY, P164; WEGIERKO J, 1935, PRESSE MED, V71, P1379	31	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1980	66	5					424	427		10.1016/0091-6749(80)90123-2	http://dx.doi.org/10.1016/0091-6749(80)90123-2			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KQ965	7002978	Bronze			2022-12-18	WOS:A1980KQ96500012
J	BLEECKER, ER; ROSENTHAL, RR; MENKES, HA; NORMAN, PS; PERMUTT, S				BLEECKER, ER; ROSENTHAL, RR; MENKES, HA; NORMAN, PS; PERMUTT, S			PHYSIOLOGIC EFFECTS OF INHALED HISTAMINE IN ASTHMA - REVERSIBLE CHANGES IN PULMONARY MECHANICS AND TOTAL LUNG CAPACITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,DEPT MED,DIV RESPIRATORY,BALTIMORE,MD 21239; JOHNS HOPKINS UNIV,GOOD SAMARITAN HOSP,SCH MED,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21239	Johns Hopkins University; Johns Hopkins University	BLEECKER, ER (corresponding author), BALTIMORE CITY HOSP,DIV PULM MED,BALTIMORE,MD 21224, USA.							ANDERSON SD, 1972, AM REV RESPIR DIS, V106, P30, DOI 10.1164/arrd.1972.106.1.30; AUSTEN KF, 1975, AM REV RESPIR DIS, V112, P423; BROWN R, 1978, AM REV RESPIR DIS, V118, P685, DOI 10.1164/arrd.1978.118.4.685; CASTERLINE CL, 1976, J ALLERGY CLIN IMMUN, V58, P607, DOI 10.1016/0091-6749(76)90207-4; CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; DEKOCK MA, 1966, J APPL PHYSIOL, V21, P185, DOI 10.1152/jappl.1966.21.1.185; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; FISH JE, 1976, AM REV RESPIR DIS, V113, P579; FREEDMAN S, 1975, J APPL PHYSIOL, V38, P974, DOI 10.1152/jappl.1975.38.6.974; GOLD WM, 1967, J APPL PHYSIOL, V23, P433, DOI 10.1152/jappl.1967.23.4.433; HABIB MP, 1978, AM REV RESPIR DIS, V117, P265; JUNIPER EF, 1979, AM REV RESPIR DIS, V119, P135; LEMEN R, 1974, J APPL PHYSIOL, V37, P600, DOI 10.1152/jappl.1974.37.4.600; MANSELL A, 1974, J APPL PHYSIOL, V37, P297, DOI 10.1152/jappl.1974.37.3.297; MCFADDEN ER, 1973, NEW ENGL J MED, V288, P221, DOI 10.1056/NEJM197302012880501; MCFADDEN ER, 1975, J ALLERGY CLIN IMMUN, V56, P18, DOI 10.1016/0091-6749(75)90030-5; MCFADDEN ER, 1977, J APPL PHYSIOL, V42, P746, DOI 10.1152/jappl.1977.42.5.746; OLIVE JT, 1972, AM REV RESPIR DIS, V106, P366, DOI 10.1164/arrd.1972.106.3.366; PERESS L, 1976, AM J MED, V61, P165, DOI 10.1016/0002-9343(76)90165-0; PERMUTT S, 1973, P15; PERMUTT S, 1971, 38 CIBA F STUD GROUP, P63; ROSENTHAL RR, 1977, J APPL PHYSIOL, V42, P600, DOI 10.1152/jappl.1977.42.4.600; ROSENTHAL RR, 1978, J ALLERGY CLIN IMMUN, V61, P139, DOI 10.1016/0091-6749(78)90275-0; Snedecore G.W., 1967, STATISTICAL METHODS, P6; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; STALCUP SA, 1977, NEW ENGL J MED, V297, P592, DOI 10.1056/NEJM197709152971107; STANESCU DC, 1973, B PHYSIO-PATHOL RESP, V9, P523; WOOLCOCK AJ, 1966, AM J MED, V41, P259, DOI 10.1016/0002-9343(66)90021-0	29	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					597	602		10.1016/0091-6749(79)90020-4	http://dx.doi.org/10.1016/0091-6749(79)90020-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512253				2022-12-18	WOS:A1979HX84300008
J	CHAI, H				CHAI, H			ANTIGEN AND METHACHOLINE CHALLENGE IN CHILDREN WITH ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											CHAI, H (corresponding author), NATL ASTHMA CTR, 1999 JULIAN ST, DENVER, CO 80204 USA.							CHAI H, 1975, J ALLERGY CLIN IMMUN, V56, P323, DOI 10.1016/0091-6749(75)90107-4; GODFREY S, 1973, J ALLERGY CLIN IMMUN, V52, P199, DOI 10.1016/0091-6749(73)90058-4; GOLD W, 1973, ASTHMA PHYSIOLOGY IM, P177; MOLK L, UNPUBLISHED; TOWNLEY RG, 1975, J ALLERGY CLIN IMMUN, V56, P427, DOI 10.1016/0091-6749(75)90061-5	5	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					575	579		10.1016/0091-6749(79)90015-0	http://dx.doi.org/10.1016/0091-6749(79)90015-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX843	512248				2022-12-18	WOS:A1979HX84300003
J	DAVID, MF				DAVID, MF			INDUCTION OF HYPORESPONSIVENESS TO PARTICULATE ANTIGEN BY FEEDING - SEQUENCE OF IMMUNOLOGICAL RESPONSE TO FED ANTIGEN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV MANITOBA,DEPT PAEDIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED MICROBIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,WINNIPEG CLIN,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Manitoba; University of Manitoba; University of Manitoba								AHLSTEDT S, 1977, IMMUNOLOGY GUT; ANDRE C, 1974, EUR J IMMUNOL, V4, P701, DOI 10.1002/eji.1830041013; ANDRE C, 1975, J EXP MED, V142, P1909; ASHERSON GL, 1977, CELL IMMUNOL, V33, P145, DOI 10.1016/0008-8749(77)90142-3; BATTISTO JR, 1963, J EXP MED, V118, P1021, DOI 10.1084/jem.118.6.1021; BAZIN H, 1970, J IMMUNOL, V105, P1049; BOHL EH, 1972, INFECT IMMUN, V6, P289, DOI 10.1128/IAI.6.3.289-301.1972; BURROWS W, 1947, J INFECT DIS, V81, P261, DOI 10.1093/infdis/81.3.261; CANTOR HM, 1967, NATURE, V215, P744, DOI 10.1038/215744a0; CHASE MW, 1946, P SOC EXP BIOL MED, V61, P257; CRABBE PA, 1969, J EXP MED, V130, P723, DOI 10.1084/jem.130.4.723; CROWLE AJ, 1966, ANN ALLERGY, V24, P195; CUNNINGHAM AJ, 1968, IMMUNOLOGY, V14, P599; DAVID MF, 1977, ANN ALLERGY, V38, P386; DAVID MF, 1977, J ALLERGY CLIN IMMUN, V60, P180, DOI 10.1016/0091-6749(77)90122-1; DOLEZEL J, 1971, CELL IMMUNOL, V2, P458, DOI 10.1016/0008-8749(71)90056-6; FREI PC, 1965, P NATL ACAD SCI USA, V53, P20, DOI 10.1073/pnas.53.1.20; FRETER R, 1963, J IMMUNOL, V91, P724; GERSHON RK, 1972, J IMMUNOL, V108, P586; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GRISCELLI C, 1969, J EXP MED, V130, P1427, DOI 10.1084/jem.130.6.1427; GRUSKAY FL, 1955, PEDIATRICS, V16, P763; HENNEY CS, 1970, SCIENCE, V169, P696, DOI 10.1126/science.169.3946.696; KORENBLAT PE, 1968, J ALLERGY, V41, P226, DOI 10.1016/0021-8707(68)90046-4; MATTINGLY JA, 1978, J IMMUNOL, V121, P1878; MOLLER G, 1965, J EXP MED, V121, P969, DOI 10.1084/jem.121.6.969; NGAN J, 1978, J IMMUNOL, V120, P861; OGRA PL, 1968, NEW ENGL J MED, V279, P893, DOI 10.1056/NEJM196810242791701; RICH RR, 1974, J IMMUNOL, V112, P1360; RICHMAN LK, 1978, J IMMUNOL, V121, P2429; ROTHBERG RM, 1973, J IMMUNOL, V111, P1906; ROWLEY DA, 1964, J EXP MED, V120, P987, DOI 10.1084/jem.120.6.987; SABIN AB, 1961, AM J DIS CHILD, V101, P546, DOI 10.1001/archpedi.1961.04020060004002; SCHRADER JW, 1974, J EXP MED, V139, P1582, DOI 10.1084/jem.139.6.1582; TADA T, 1975, TRANSPLANT REV, V26, P106; TALMAGE DW, 1951, J IMMUNOL, V67, P243; THOMAS HC, 1974, IMMUNOLOGY, V27, P631; Tomasi T B Jr, 1968, Adv Immunol, V9, P1, DOI 10.1016/S0065-2776(08)60441-1; VAZ NM, 1977, J ALLERGY CLIN IMMUN, V60, P110, DOI 10.1016/0091-6749(77)90035-5; WALKER WA, 1972, SCIENCE, V177, P608, DOI 10.1126/science.177.4049.608; WELLS HG, 1911, J INFECT DIS, V8, P77; 1972, BRIT MED J, V3, P430	42	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	3					164	172		10.1016/0091-6749(79)90091-5	http://dx.doi.org/10.1016/0091-6749(79)90091-5			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HL221	381360				2022-12-18	WOS:A1979HL22100003
J	GELB, AF; LYONS, HA; FAIRSHTER, RD; GLAUSER, FL; MORRISSEY, R; CHETTY, K; SCHIFFMAN, P				GELB, AF; LYONS, HA; FAIRSHTER, RD; GLAUSER, FL; MORRISSEY, R; CHETTY, K; SCHIFFMAN, P			P-PULMONALE IN STATUS-ASTHMATICUS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF IRVINE,IRVINE MED CTR-F870,ORANGE,CA 92668; SUNY DOWNSTATE MED CTR,BROOKLYN,NY 11203; KINGS CTY HOSP CTR,BROOKLYN,NY 11203; UNIV CALIF IRVINE,COLL MED,IRVINE,CA 92664; VET ADM HOSP,LONG BEACH,CA 90822; UNIV CALIF LOS ANGELES,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024; LOS ALTOS HOSP,LONG BEACH,CA; DOCTORS HOSP,LAKEWOOD,CA	University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles								AMBIAVAGAR M, 1967, ANAESTHESIA, V22, P375, DOI 10.1111/j.1365-2044.1967.tb02760.x; BLACK LF, 1972, MAYO CLIN PROC, V47, P493; BOREN HG, 1966, AM J MED, V41, P96, DOI 10.1016/0002-9343(66)90008-8; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; GUNSTONE RF, 1971, THORAX, V26, P39, DOI 10.1136/thx.26.1.39; Harkavy J, 1942, AM HEART J, V23, P692, DOI 10.1016/S0002-8703(42)90546-5; HELANDER E, 1962, ACTA ALLERGOL, V17, P112, DOI 10.1111/j.1398-9995.1962.tb02934.x; IISALO EUM, 1969, ACTA MED SCAND, V185, P51; Kahn MH, 1927, AM J MED SCI, V173, P555; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; MIYAMOTO T, 1961, JPN HEART J, V2, P524; PERMUTT S, 1971, CIBA S, P63; REBUCK AS, 1973, NEW ENGL J MED, V288, P66, DOI 10.1056/NEJM197301112880203; REBUCK AS, 1971, AM J MED, V51, P788, DOI 10.1016/0002-9343(71)90307-X; ROBOTHAM JL, 1978, J APPL PHYSIOL, V44, P703, DOI 10.1152/jappl.1978.44.5.703; SCHARF SM, 1978, AM REV RESPIR DIS, V117, P174; STALCUP SA, 1977, NEW ENGL J MED, V297, P592, DOI 10.1056/NEJM197709152971107; ZIMMERMAN HA, 1951, DIS CHEST, V20, P46, DOI 10.1378/chest.20.1.46; 1962, AM REV RESPIR DIS, V85, P762	21	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	1					18	22		10.1016/0091-6749(79)90077-0	http://dx.doi.org/10.1016/0091-6749(79)90077-0			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HC424	36421				2022-12-18	WOS:A1979HC42400005
J	JACOBSON, KW; DESHAZO, RD				JACOBSON, KW; DESHAZO, RD			SELECTIVE IMMUNOGLOBULIN A DEFICIENCY ASSOCIATED WITH NODULAR LYMPHOID HYPERPLASIA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									FITZSIMONS ARMY MED CTR, ALLERGY IMMUNOL SERV, DENVER, CO 80240 USA									AMENT ME, 1972, GASTROENTEROLOGY, V62, P216; AMMANN AJ, 1971, MEDICINE, V50, P223, DOI 10.1097/00005792-197105000-00004; AMMANN AJ, 1976, IMMUNOLOGIC DISORDER, P199; ANDERSON KE, 1974, GASTROENTEROLOGY, V67, P709; BAKER J, 1976, J ALLERGY CLIN IMMUN, V58, P713, DOI 10.1016/0091-6749(76)90182-2; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROWN WR, 1976, GASTROENTEROLOGY, V71, P985; Buckley R H, 1975, Birth Defects Orig Artic Ser, V11, P134; BUCKLEY RH, 1969, NEW ENGL J MED, V281, P465, DOI 10.1056/NEJM196908282810903; CASSIDY JT, 1969, NEW ENGL J MED, V280, P275; Cooper M D, 1975, Birth Defects Orig Artic Ser, V11, P143; CRABBE PA, 1968, INT ARCH ALLER A IMM, V34, P362, DOI 10.1159/000230130; CRABBE PA, 1966, GUT, V7, P119, DOI 10.1136/gut.7.2.119; DOUGLAS AP, 1970, GASTROENTEROLOGY, V59, P414; FISHER CH, 1975, AM J ROENTGENOL, V125, P207, DOI 10.2214/ajr.125.1.207; GRYBOSKI JD, 1968, PEDIATRICS, V42, P833; HERMANS PE, 1967, FED PROC, V26, P1606; HONG R, 1972, AM J PATHOL, V69, P491; Horowitz S, 1975, Birth Defects Orig Artic Ser, V11, P129; ISOBE Y, 1977, ACTA HISTOCHEM CYTOC, V10, P161, DOI 10.1267/ahc.10.161; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; JONES EG, 1974, AM J DIG DIS, V19, P791, DOI 10.1007/BF01071937; KIRKPATRICK CH, 1968, ARCH INTERN MED, V121, P273, DOI 10.1001/archinte.121.3.273; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LAWTON AR, 1972, CLIN IMMUNOL IMMUNOP, V1, P84; LEVINSON AI, 1974, CELL IMMUNOL, V14, P321, DOI 10.1016/0008-8749(74)90216-0; MILANO AM, 1971, AM J DIG DIS, V16, P735, DOI 10.1007/BF02239601; NOTMAN DD, 1975, ANN INTERN MED, V83, P464, DOI 10.7326/0003-4819-83-4-464; ROCKEY JH, 1964, J LAB CLIN MED, V63, P205; STROBER W, 1976, NEW ENGL J MED, V294, P351, DOI 10.1056/NEJM197602122940701; TAN E, 1976, MANUAL CLIN IMMUNOLO; VASSALLO CL, 1970, AM REV RESPIR DIS, V101, P245; WEBSTER ADB, 1976, CLIN GASTROENTEROL, V5, P323; WEBSTER ADB, 1977, GUT, V18, P364, DOI 10.1136/gut.18.5.364; WINCHESTER RJ, 1976, MANUAL CLIN IMMUNOLO; ZINNEMAN HH, 1975, DIG DIS, V125, P207	36	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	64	6					516	521		10.1016/0091-6749(79)90061-7	http://dx.doi.org/10.1016/0091-6749(79)90061-7			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HX840	512269				2022-12-18	WOS:A1979HX84000007
J	KARR, RM; BRACH, BB; WILSON, MR; ANICETTI, V; SALVAGGIO, JE				KARR, RM; BRACH, BB; WILSON, MR; ANICETTI, V; SALVAGGIO, JE			CHANGE IN LEVELS OF ARTERIAL BLOOD HISTAMINE DURING EXERCISE-INDUCED ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					153	153						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400063
J	WOLFE, JD; ROSENTHAL, RR; BLEECKER, E; LAUBE, B; NORMAN, PS; PERMUTT, S				WOLFE, JD; ROSENTHAL, RR; BLEECKER, E; LAUBE, B; NORMAN, PS; PERMUTT, S			EFFECT OF CORTICOSTEROIDS ON CHOLINERGIC HYPER-REACTIVITY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1979	63	3					162	162						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GN274					2022-12-18	WOS:A1979GN27400091
J	KOOISTRA, JB; PASCH, R; REED, CE				KOOISTRA, JB; PASCH, R; REED, CE			EFFECTS OF AIR CLEANERS ON HAY-FEVER SYMPTOMS IN AIR-CONDITIONED HOMES	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,HLTH SCI CTR,DEPT MED,ALLERGY SECT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								CRIEP LH, 1936, J ALLERGY, V7, P120; FRIEDLAENDER S, 1954, Ann Allergy, V12, P419; Gay LN, 1933, J AMER MED ASSOC, V100, P1382, DOI 10.1001/jama.1933.02740180004002; Nelson T, 1933, J AMER MED ASSOC, V100, P1385, DOI 10.1001/jama.1933.02740180007003; NORMAN PS, 1966, INT ENCYCLOPEDIA P 6, V2; SMALL WS, 1961, J ALLERGY, V32, P458, DOI 10.1016/0021-8707(61)90025-9; SPIEGELMAN J, 1961, ANN ALLERGY, V19, P613; SPIEGELMAN J, 1968, J ALLERGY, V42, P193, DOI 10.1016/S0021-8707(68)90116-0; SPIEGELMAN J, 1963, J ALLERGY, V34, P426, DOI 10.1016/0021-8707(63)90007-8; Vaughan W.T., 1933, J ALLERGY, V5, P37, DOI [10.1016/S0021-8707(33)90168-9, DOI 10.1016/S0021-8707(33)90168-9]	10	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	5					315	319		10.1016/0091-6749(78)90053-2	http://dx.doi.org/10.1016/0091-6749(78)90053-2			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EY714	346629				2022-12-18	WOS:A1978EY71400007
J	PATTERSON, R; HARRIS, KE				PATTERSON, R; HARRIS, KE			QUALITATIVE EVALUATION OF AIRWAY RESPONSES TO IMMUNOLOGICAL AND PHARMACOLOGIC STIMULI IN RHESUS-MONKEYS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											PATTERSON, R (corresponding author), NORTHWESTERN UNIV, SCH MED, DEPT MED, ALLERGY IMMUNOL SECT, CHICAGO, IL 60611 USA.							AMDUR MO, 1958, AM J PHYSIOL, V192, P364, DOI 10.1152/ajplegacy.1958.192.2.364; BELL C, 1966, BIOCHEM PHARMACOL, V15, P1085, DOI 10.1016/0006-2952(66)90273-5; CARLYLE RF, 1963, BRIT J PHARM CHEMOTH, V21, P137, DOI 10.1111/j.1476-5381.1963.tb01509.x; COTTON DJ, 1977, J APPL PHYSIOL, V42, P101, DOI 10.1152/jappl.1977.42.1.101; COX B, 1970, J PHARM PHARMACOL, V22, P231, DOI 10.1111/j.2042-7158.1970.tb08505.x; HOGARTHS.RS, 1967, IMMUNOLOGY, V13, P535; ISHIZAKA K, 1968, J IMMUNOL, V100, P554; ISHIZAKA T, 1970, J IMMUNOL, V104, P854; ITKIN IH, 1967, J ALLERGY, V40, P245, DOI 10.1016/0021-8707(67)90087-1; KELLY JF, 1974, J LAB CLIN MED, V83, P738; MILLER MM, 1976, J LAB CLIN MED, V88, P995; PATTERSON R, 1976, J LAB CLIN MED, V87, P1016; PATTERSON R, 1976, J CLIN INVEST, V57, P586, DOI 10.1172/JCI108314; PATTERSON R, 1971, INT ARCH ALLER A IMM, V41, P592, DOI 10.1159/000230552; PATTERSON R, 1969, J LAB CLIN MED, V73, P924; PATTERSON R, 1969, PROG ALLERGY, V13, P332, DOI 10.1159/000287510; PATTERSON R, 1972, CLIN EXP IMMUNOL, V10, P267; PATTERSON R, 1976, J LAB CLIN MED, V87, P65; PATTERSON R, 1974, ANNU REV MED, V25, P53, DOI 10.1146/annurev.me.25.020174.000413; PIPER PJ, 1969, NATURE, V223, P29, DOI 10.1038/223029a0; SNEDECOR GW, 1973, STATISTICAL METHODS, P59	21	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	4					261	267		10.1016/0091-6749(78)90201-4	http://dx.doi.org/10.1016/0091-6749(78)90201-4			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EV080	416064				2022-12-18	WOS:A1978EV08000026
J	SCHACHTER, EN; KREISMAN, H; LITTNER, M; BECK, GJ; VONCKEN, F				SCHACHTER, EN; KREISMAN, H; LITTNER, M; BECK, GJ; VONCKEN, F			AIRWAY RESPONSES TO EXERCISE IN MILD ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article											SCHACHTER, EN (corresponding author), YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510, USA.							ANDERSON SD, 1975, BRIT J DIS CHEST, V69, P1; ANDERSON SD, 1972, AM REV RESPIR DIS, V106, P30, DOI 10.1164/arrd.1972.106.1.30; BOUHUYS A, 1973, T NEW YORK ACAD SCI, V35, P537, DOI 10.1111/j.2164-0947.1973.tb01526.x; BOUHUYS A, 1969, J CLIN INVEST, V48, P1159, DOI 10.1172/JCI106073; BOUHUYS A, 1974, BREATHING PHYSIOLOGY, P188; CROPP GJA, 1975, PEDIATRICS, V56, P868; DESPAS PJ, 1972, J CLIN INVEST, V51, P3235, DOI 10.1172/JCI107150; FISHER HK, 1970, AM REV RESPIR DIS, V101, P885; FREEDMAN S, 1975, J APPL PHYSIOL, V38, P974, DOI 10.1152/jappl.1975.38.6.974; GODFREY S, 1973, J ALLERGY CLIN IMMUN, V52, P199, DOI 10.1016/0091-6749(73)90058-4; HAYNES RL, 1976, AM REV RESPIR DIS, V114, P739; KENDALL MG, 1967, ADV THEORY STAT, V2, P311; KIVILOOG J, 1975, SCAND J RESPIR DIS, V56, P73; KONIG P, 1973, ARCH DIS CHILD, V48, P513, DOI 10.1136/adc.48.7.513; MCFADDEN ER, 1977, J APPL PHYSIOL, V42, P746, DOI 10.1152/jappl.1977.42.5.746; MCNEILL RS, 1966, Q J MED, V35, P55; MILDON A, 1974, AM REV RESPIR DIS, V110, P409; NADEL JA, 1961, J APPL PHYSIOL, V16, P717, DOI 10.1152/jappl.1961.16.4.717; NADEL JA, 1973, ASTHMA, P31; PIERSON WE, 1969, J ALLERGY, V43, P136, DOI 10.1016/S0021-8707(69)80004-3; SLY RM, 1970, ANN ALLERGY, V28, P1; Snedecor G W, 1967, STATISTICAL METHODS, P172; VIRGULTO J, 1973, J APPL PHYSIOL, V35, P145, DOI 10.1152/jappl.1973.35.1.145; ZUSKIN E, 1973, J ALLERGY CLIN IMMUN, V51, P218, DOI 10.1016/0091-6749(73)90141-3; ZUSKIN E, 1974, NEW ENGL J MED, V290, P660, DOI 10.1056/NEJM197403212901205	25	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	6					390	398		10.1016/0091-6749(78)90119-7	http://dx.doi.org/10.1016/0091-6749(78)90119-7			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC593	659730				2022-12-18	WOS:A1978FC59300008
J	SIMON, RA; SCHATZ, M; STEVENSON, DD; CURRY, N; YAMAMOTO, F; PLOW, E; RING, H; ARROYAVE, CM				SIMON, RA; SCHATZ, M; STEVENSON, DD; CURRY, N; YAMAMOTO, F; PLOW, E; RING, H; ARROYAVE, CM			RADIOGRAPHIC CONTRAST-MEDIA (RCM) INFUSIONS - MEASUREMENT OF MEDIATORS AND CORRELATION WITH CLINICAL PARAMETERS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					145	145		10.1016/0091-6749(78)90295-6	http://dx.doi.org/10.1016/0091-6749(78)90295-6			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173		Bronze			2022-12-18	WOS:A1978ES17300056
J	TURKELTAUB, PC; MARSH, DG; LICHTENSTEIN, LM; NORMAN, PS				TURKELTAUB, PC; MARSH, DG; LICHTENSTEIN, LM; NORMAN, PS			DEVELOPMENT OF LONG-LASTING IMMEDIATE HYPERSENSITIVITY IN NONATOPIC VOLUNTEERS PARENTERALLY IMMUNIZED WITH A PURIFIED GRASS POLLEN EXTRACT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract													turkeltaub, paul/U-7729-2019; turkeltaub, paul/AAG-6160-2019	turkeltaub, paul/0000-0002-7350-1469					0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1978	61	3					171	171		10.1016/0091-6749(78)90381-0	http://dx.doi.org/10.1016/0091-6749(78)90381-0			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ES173					2022-12-18	WOS:A1978ES17300142
J	FAIRSHTER, RD; CHIU, JT; WILSON, AF; NOVEY, HS				FAIRSHTER, RD; CHIU, JT; WILSON, AF; NOVEY, HS			LARGE AIRWAY CONSTRICTION IN ALLERGIC RHINITIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV CALIF BERKELEY,DEPT MED,BERKELEY,CA 94720	University of California System; University of California Berkeley								BOREN HG, 1966, AM J MED, V41, P96, DOI 10.1016/0002-9343(66)90008-8; BOUHUYS A, 1970, J CLIN INVEST, V49, P106, DOI 10.1172/JCI106209; BUIST AS, 1973, AM REV RESPIR DIS, V108, P1078; BUIST AS, 1973, AM REV RESPIR DIS, V107, P744; DOGGETT W E, 1976, American Review of Respiratory Disease, V113, P158; DUBOIS AB, 1956, J CLIN INVEST, V35, P327, DOI 10.1172/JCI103282; ENGEL LA, 1974, J APPL PHYSIOL, V37, P194, DOI 10.1152/jappl.1974.37.2.194; FISH JE, 1976, AM REV RESPIR DIS, V113, P579; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; GROSSMAN J, 1975, J ALLERGY CLIN IMMUN, V55, P49, DOI 10.1016/S0091-6749(75)80007-8; KORY RC, 1961, AM J MED, V30, P243, DOI 10.1016/0002-9343(61)90096-1; MORGAN EJ, 1976, THORAX, V31, P80, DOI 10.1136/thx.31.1.80; MORRIS JF, 1975, AM REV RESPIR DIS, V111, P755; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; PRIDE NB, 1967, J APPL PHYSIOL, V23, P646, DOI 10.1152/jappl.1967.23.5.646; WEITZMAN RH, 1974, AM J MED, V57, P767, DOI 10.1016/0002-9343(74)90851-1	17	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	3					243	246		10.1016/0091-6749(77)90157-9	http://dx.doi.org/10.1016/0091-6749(77)90157-9			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CZ249	838993	Bronze			2022-12-18	WOS:A1977CZ24900010
J	FLAHERTY, DK; MARTIN, JM; STORMS, WW; KRIZ, RJ; SURFUS, JE; REED, CE				FLAHERTY, DK; MARTIN, JM; STORMS, WW; KRIZ, RJ; SURFUS, JE; REED, CE			ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN ASTHMATICS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN,IMMUNOL SECT,ALLERGY LAB,MADISON,WI 53706; UNIV WISCONSIN,DEPT PREVENT MED,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison								BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CHESS L, 1976, FED PROC, V35, P591; GALE RP, 1975, J IMMUNOL, V114, P1047; GAROVOY MR, 1975, CELL IMMUNOL, V20, P197, DOI 10.1016/0008-8749(75)90097-0; GREENBERG AH, 1973, CLIN EXP IMMUNOL, V15, P251; HOLM G, 1972, INT ARCH ALLER A IMM, V43, P671, DOI 10.1159/000230883; HOLM G, 1973, CLIN EXP IMMUNOL, V13, P29; KEDAR E, 1974, J IMMUNOL, V112, P37; KRIS R, 1976, CHEST, V69, P455; LUTZ W, 1973, HDB EXPT IMMUNOLOGY, pA1; MACLENNAN IC, 1972, TRANSPLANT REV-DENMA, V13, P67; MACLENNAN IC, 1969, IMMUNOLOGY, V17, P897; MCINTOSH K, 1973, CHEST S, V63, pS43; MENDES NF, 1973, J IMMUNOL, V111, P860; MINOR TE, 1974, J PEDIATR-US, V85, P472, DOI 10.1016/S0022-3476(74)80447-6; MINOR TE, 1976, AM REV RESPIR DIS, V113, P149; NEISEN DL, 1976, FED P, V35, P591; PAPAMICHAIL M, 1975, CLIN EXP IMMUNOL, V20, P459; Perlmann P, 1970, Cell Immunol, V1, P300, DOI 10.1016/0008-8749(70)90051-1; RAGERZIS.B, 1974, NATURE, V251, P542, DOI 10.1038/251542a0; SCORNIK JC, 1974, J IMMUNOL, V113, P1527; SHORE SL, 1974, NATURE, V251, P350, DOI 10.1038/251350a0; WISLOFF F, 1974, INT ARCH ALLER A IMM, V47, P139, DOI 10.1159/000231208; 1962, AM REV RESPIR DIS, V85, P762	24	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	59	1					48	53		10.1016/0091-6749(77)90176-2	http://dx.doi.org/10.1016/0091-6749(77)90176-2			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CS828	319137				2022-12-18	WOS:A1977CS82800008
J	MARX, JJ; KETTRICKMARX, MA; MITCHELL, PD; FLAHERTY, DK				MARX, JJ; KETTRICKMARX, MA; MITCHELL, PD; FLAHERTY, DK			CORRELATION OF EXPOSURE TO VARIOUS RESPIRATORY PATHOGENS WITH FARMERS LUNG-DISEASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MARSHFIELD MED FDN,MARSHFIELD,WI 54449; MARSFIELD MED CTR LABS,MARSFIELD,WI; UNIV WISCONSIN,ALLERGY SECT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison								BARBORIAK JJ, 1973, J LAB CLIN MED, V82, P372; EDWARDS JH, 1976, CLIN ALLERGY, V6, P19, DOI 10.1111/j.1365-2222.1976.tb01408.x; FINK JN, 1975, INT ARCH ALLER A IMM, V49, P831, DOI 10.1159/000231466; FINK JN, 1973, CHEST, V64, P416, DOI 10.1378/chest.64.4.416; FLAHERTY DK, 1974, J LAB CLIN MED, V84, P298; MARX J J JR, 1976, American Review of Respiratory Disease, V113, P128; MOORE VL, 1975, J LAB CLIN MED, V85, P540; MOORE VL, 1975, J CLIN INVEST, V56, P937, DOI 10.1172/JCI108173; PEPYS J, 1969, MONOGRAPHS ALLERGY, V4; ROBERTS RC, 1976, J ALLERGY CLIN IMMUN, V57, P518, DOI 10.1016/0091-6749(76)90002-6; ROBERTS RC, 1973, J ALLERGY CLIN IMMUN, V52, P297, DOI 10.1016/0091-6749(73)90048-1; WENZEL FJ, 1974, AM REV RESPIR DIS, V109, P464; WENZEL FJ, 1974, TISSUE REACTIONS SPO; 1968, PHS74 US DEP HEW MON	14	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1977	60	3					169	173		10.1016/0091-6749(77)90120-8	http://dx.doi.org/10.1016/0091-6749(77)90120-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	DU852	197136				2022-12-18	WOS:A1977DU85200004
J	BLUMBERG, MZ; BUCKLEY, JM				BLUMBERG, MZ; BUCKLEY, JM			TOTAL EOSINOPHIL COUNT IN ASTHMATIC-CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NATL JEWISH HOSP & RES CTR, DIV PEDIAT ALLERGY, DENVER, CO 80206 USA	National Jewish Health								ARNOLDSSON HANS, 1958, ACTA ALLERGOL, V12, P96, DOI 10.1111/j.1398-9995.1958.tb03050.x; BEST WR, 1951, BLOOD, V6, P61, DOI 10.1182/blood.V6.1.61.61; CLINE MJ, 1974, NEW ENGL J MED, V291, P1187, DOI 10.1056/NEJM197411282912211; COOKSON DU, 1963, AM REV RESPIR DIS, V88, P636; DOE RP, 1956, J CLIN ENDOCR METAB, V16, P196, DOI 10.1210/jcem-16-2-196; FIREMAN P, 1970, J ALLERGY, V45, P117; HALBERG F, 1953, P SOC EXP BIOL MED, V82, P160; HALBERG FRANZ, 1951, JOUR LANCET, V71, P312; HALBERG FRANZ, 1953, JOUR LANCET, V73, P20; INOUE S, 1967, J ALLERGY, V40, P337, DOI 10.1016/0021-8707(67)90023-8; KAINE HD, 1955, J LAB CLIN MED, V45, P247; KOCHWESE.J, 1968, ARCH INTERN MED, V121, P255, DOI 10.1001/archinte.121.3.255; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; LOWELL FC, 1967, J AMER MED ASSOC, V202, P875, DOI 10.1001/jama.202.9.875; MACFARLANE JCW, 1951, BRIT MED J, V2, P1187, DOI 10.1136/bmj.2.4741.1187; MASELLI R, 1970, J ALLERGY, V45, P117; OHMAN JL, 1972, J ALLERGY CLIN IMMUN, V50, P151, DOI 10.1016/0091-6749(72)90046-2; REED CE, 1970, J ALLERGY, V46, P90, DOI 10.1016/0021-8707(70)90076-6; RUD F, 1947, ACTA PSYCHIATR NEU S, V40; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; UHRBRAND H, 1958, ACTA MED SCAND, V160, P99; VAZQUEZ AM, 1973, J PEDIATR-US, V83, P578, DOI 10.1016/S0022-3476(73)80218-5; VISSCHER MB, 1955, ANN NY ACAD SCI, V59, P834, DOI 10.1111/j.1749-6632.1955.tb45986.x	23	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					493	498		10.1016/0091-6749(76)90066-X	http://dx.doi.org/10.1016/0091-6749(76)90066-X			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BR201	944205				2022-12-18	WOS:A1976BR20100014
J	BUSSE, WW; STORMS, WW; FLAHERTY, DK; CRANDALL, M; REED, CE				BUSSE, WW; STORMS, WW; FLAHERTY, DK; CRANDALL, M; REED, CE			ALTERNARIA IGG PRECIPITINS AND ADVERSE REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WISCONSIN, DEPT MED, MADISON, WI USA	University of Wisconsin System; University of Wisconsin Madison								DOLOVICH J, 1973, J ALLERGY CLIN IMMUN, V52, P38, DOI 10.1016/0091-6749(73)90119-X; FINK JN, 1968, J LAB CLIN MED, V71, P20; FLAHERTY DK, 1974, J LAB CLIN MED, V84, P298; KAWAI T, 1972, J ALLERGY CLIN IMMUN, V49, P134; KNIKER WT, 1968, J EXP MED, V127, P119, DOI 10.1084/jem.127.1.119; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; Pepys J, 1969, Monogr Allergy, V4, P1; SALVAGGIO J, 1972, CHEST, V62, P242, DOI 10.1378/chest.62.3.242	9	15	15	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	4					367	372		10.1016/0091-6749(76)90094-4	http://dx.doi.org/10.1016/0091-6749(76)90094-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BM689	57129				2022-12-18	WOS:A1976BM68900011
J	GROSSMAN, J				GROSSMAN, J			OCCURRENCE OF ARRHYTHMIAS IN HOSPITALIZED ASTHMATIC-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									USA WILLIAM BEAUMONT MED CTR,DEPT MED,SERV ALLERGY IMMUNOL,EL PASO,TX	William Beaumont Army Medical Center								AYERS SM, 1969, AM J MED, V46, P495; BATES DV, 1971, RESPIRATORY FUNCTION, P131; CAMARATA SJ, 1971, CIRCULATION, V44, P688, DOI 10.1161/01.CIR.44.4.688; COLLINS JM, 1969, BRIT J PHARMACOL, V36, P35, DOI 10.1111/j.1476-5381.1969.tb08301.x; CROFTON J, 1969, RESPIRATORY DISEASE, P419; FORMGREN H, 1972, AM HEART J, V84, P710, DOI 10.1016/0002-8703(72)90189-5; HOLFORD FD, 1973, AM REV RESPIR DIS, V108, P879; HUDSON LD, 1973, CHEST, V63, P661, DOI 10.1378/chest.63.5.661; INNES IR, 1970, PHARMACOLOGICAL BASI, P500; JEWETT JF, 1973, NEW ENGL J MED, V288, P265; LEHR D, 1972, NEW ENGL J MED, V287, P987; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; NICHOLSON DP, 1973, AM REV RESPIR DIS, V108, P241; SHEEHY AF, 1972, ARCH INTERN MED, V130, P37, DOI 10.1001/archinte.130.1.37; SHELDON JM, 1967, MANUAL CLINICAL ALLE, P133; SPEIZER FE, 1968, BRIT MED J, V1, P339, DOI 10.1136/bmj.1.5588.339; 1973, LANCET, V2, P950	17	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	4					310	317		10.1016/0091-6749(76)90087-7	http://dx.doi.org/10.1016/0091-6749(76)90087-7			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BM689	1262607				2022-12-18	WOS:A1976BM68900004
J	LIGHT, WC; REISMAN, RE; ILEA, VS; WYPYCH, JI; OKAZAKI, T; ARBESMAN, CE				LIGHT, WC; REISMAN, RE; ILEA, VS; WYPYCH, JI; OKAZAKI, T; ARBESMAN, CE			STUDIES OF ANTIGENICITY AND ALLERGENICITY OF PHOSPHOLIPASE-A2 OF BEE VENOM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									BUFFALO GEN HOSP,ALLERGY RES LAB,BUFFALO,NY 14203; SUNY BUFFALO,DEPT MED,BUFFALO,NY; SUNY BUFFALO,DEPT MICROBIOL,BUFFALO,NY	Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BENTON AW, 1963, SCIENCE, V142, P228, DOI 10.1126/science.142.3589.228; BROCKLEHURST WE, 1967, HDB EXPT IMMUNOLOGY, P1155; CESKA M, 1972, J ALLERGY CLIN IMMUN, V49, P1, DOI 10.1016/0091-6749(72)90117-0; CHARAVEJASARN CC, 1975, INT ARCH ALLERGY APP, V48, P69; FRANKLIN RM, 1974, P SOC EXP BIOL MED, V147, P585, DOI 10.3181/00379727-147-38393; FUJITA Y, 1975, INT ARCH ALLER A IMM, V49, P724, DOI 10.1159/000231456; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JOHANSSON SG, 1971, INT ARCH ALLER A IMM, V41, P443, DOI 10.1159/000230538; LEVINE BB, 1971, INT ARCH ALLER A IMM, V40, P113, DOI 10.1159/000230398; LICHTENSTEIN LM, 1964, J EXP MED, V120, P507, DOI 10.1084/jem.120.4.507; LIGHT W C, 1975, Clinical Allergy, V5, P389, DOI 10.1111/j.1365-2222.1975.tb01878.x; MAY CD, 1970, J ALLERGY, V46, P12, DOI 10.1016/0021-8707(70)90056-0; SHEPHERD GW, 1974, PREP BIOCHEM, V4, P71, DOI 10.1080/00327487408068187; SOBOTKA A, 1974, J ALLERGY CLIN IMMUN, V53, P103	15	15	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	58	2					322	329		10.1016/0091-6749(76)90138-X	http://dx.doi.org/10.1016/0091-6749(76)90138-X			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CA661	59745				2022-12-18	WOS:A1976CA66100010
J	LOWELL, FC; OHMAN, JL; WILLIAMS, M				LOWELL, FC; OHMAN, JL; WILLIAMS, M			DOUBLE-BLIND TRIAL OF INHALED FLUNISOLIDE IN BRONCHIAL-ASTHMA	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					257	257						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000165
J	SHAPIRO, GG; TATTONI, DS; KELLEY, VC; PIERSON, WE; BIERMAN, CW				SHAPIRO, GG; TATTONI, DS; KELLEY, VC; PIERSON, WE; BIERMAN, CW			GROWTH, PULMONARY, AND ENDOCRINE FUNCTION IN CHRONIC ASTHMA PATIENTS ON DAILY AND ALTERNATE-DAY ADRENOCORTICOSTEROID THERAPY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									UNIV WASHINGTON,SCH MED,DEPT PEDIAT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle								ACKERMAN GL, 1968, NEW ENGL J MED, V278, P405, DOI 10.1056/NEJM196802222780801; BRAVER DA, 1967, ARCH OPHTHALMOL-CHIC, V77, P161; DAVID DS, 1969, LANCET, V2, P149; ELY RS, 1954, PEDIATRICS, V13, P403; FALLIERS CJ, 1972, J ALLERGY CLIN IMMUN, V49, P156, DOI 10.1016/0091-6749(72)90109-1; GILES CL, 1962, JAMA-J AM MED ASSOC, V182, P719, DOI 10.1001/jama.1962.03050460011003; GLENN EM, 1953, J CLIN ENDOCR METAB, V13, P911, DOI 10.1210/jcem-13-8-911; GRABER AL, 1965, J CLIN ENDOCR METAB, V25, P11, DOI 10.1210/jcem-25-1-11; GRAHAM CB, 1972, RADIOL CLIN N AM, V10, P185; HARTER JG, 1963, NEW ENGL J MED, V269, P591, DOI 10.1056/NEJM196309192691201; HARTER JG, 1965, ARTHRITIS RHEUM, V8, P445; JUBIZ W, 1970, ARCH INTERN MED, V125, P472, DOI 10.1001/archinte.125.3.472; LIVANOU T, 1967, LANCET, V2, P856; MEIKLE AW, 1975, J CLIN ENDOCR METAB, V40, P290, DOI 10.1210/jcem-40-2-290; MORRIS HG, 1974, J ALLERGY CLIN IMMUN, V54, P350, DOI 10.1016/0091-6749(74)90025-6; NELSON DH, 1952, J CLIN ENDOCR METAB, V12, P519, DOI 10.1210/jcem-12-5-519; Polgar G, 1971, PULMONARY FUNCTION T; PORTER CC, 1950, J BIOL CHEM, V185, P201; SADEGHIN.A, 1969, PEDIATRICS, V43, P277; SOYKA TF, 1962, ADV PEDIATR, V19, P47; 1973, DIS CHEST, V43, P217	21	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					430	439		10.1016/0091-6749(76)90058-0	http://dx.doi.org/10.1016/0091-6749(76)90058-0			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BR201	177474				2022-12-18	WOS:A1976BR20100006
J	SPECTOR, SL; FARR, RS				SPECTOR, SL; FARR, RS			HETEROGENEITY OF ASTHMATIC-PATIENTS - INDIVIDUALIZED APPROACH TO DIAGNOSIS AND TREATMENT	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									NATL JEWISH HOSP & RES CTR,DEPT MED,ALLERGY & CLIN IMMUNOL SECT,DENVER,CO 80206	National Jewish Health								AUSTEN K F, 1973, P109; BIAS W B, 1973, P39; BUCKLEY JM, 1974, CHEST, V66, P244, DOI 10.1378/chest.66.3.244; CABEZAS GA, 1971, J APPL PHYSIOL, V31, P651, DOI 10.1152/jappl.1971.31.5.651; CASTRODELAMATA R, 1962, J PHARMACOL EXP THER, V135, P197; CHAI H, 1973, J ALLERGY CLIN IMMUN, V51, P65, DOI 10.1016/S0091-6749(73)80001-6; Coombs RRA., 1968, CLIN ASPECTS IMMUNOL, V2, P575; DEKKER E, 1956, J PSYCHOSOM RES, V1, P58, DOI 10.1016/0022-3999(56)90035-6; FALLIERS CJ, 1966, J ALLERGY, V38, P183, DOI 10.1016/0021-8707(66)90041-4; Farr RS, 1973, CHEST, V63, p64S; GOLDBERG ND, 1973, 5 P INT C PHARM, V5, P146; GRIECO MH, 1971, J ALLERGY CLIN IMMUN, V48, P143, DOI 10.1016/0091-6749(71)90009-1; GROSS GN, 1974, CHEST, V66, P397, DOI 10.1378/chest.66.4.397; HANSEN-PRUSS O. C., 1955, ANN ALLERGY, V13, P1; HARTER JG, 1967, J ALLERGY, V40, P327, DOI 10.1016/0021-8707(67)90022-6; ITKIN IH, 1970, J ALLERGY, V45, P146, DOI 10.1016/0021-8707(70)90124-3; KARLIN JM, 1972, ANN ALLERGY, V30, P342; KEIGHLEY JF, 1966, ANN INTERN MED, V65, P985, DOI 10.7326/0003-4819-65-5-985; KENNEDY M C S, 1969, British Journal of Diseases of the Chest, V63, P165, DOI 10.1016/S0007-0971(69)80014-8; KINSMAN RA, 1974, PSYCHOSOM MED, V36, P129, DOI 10.1097/00006842-197403000-00005; KINSMAN RA, 1973, J ALLERGY CLIN IMMUN, V52, P284, DOI 10.1016/0091-6749(73)90047-X; KINSMAN RA, 1973, PSYCHOSOM MED, V35, P250, DOI 10.1097/00006842-197305000-00008; LEIST ER, 1974, NEW ENGL J MED, V291, P710, DOI 10.1056/NEJM197410032911406; LEVINE BB, 1970, INT ARCH ALLER A IMM, V39, P156, DOI 10.1159/000230343; LINDBLAD JH, 1961, J ALLERGY, V32, P392, DOI 10.1016/0021-8707(61)90016-8; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; MACDONALD AG, 1968, BRIT J ANAESTH, V40, P508, DOI 10.1093/bja/40.7.508; MACDONALD AG, 1967, BRIT J ANAESTH, V39, P919, DOI 10.1093/bja/39.12.919; MARCELLE R, 1969, ACTA ALLERGOL, V24, P432, DOI 10.1111/j.1398-9995.1969.tb03757.x; MARSH DG, 1973, SCIENCE, V179, P691, DOI 10.1126/science.179.4074.691; MATHE AA, 1971, PSYCHOSOM MED, V33, P323, DOI 10.1097/00006842-197107000-00003; NADEL JA, 1965, J APPL PHYSIOL, V20, P164, DOI 10.1152/jappl.1965.20.1.164; Pepys J, 1973, Clin Allergy, V3, P1, DOI 10.1111/j.1365-2222.1973.tb01304.x; PHILIPP RL, 1972, J PSYCHOSOM RES, V16, P193, DOI 10.1016/0022-3999(72)90044-X; REED CE, 1974, J ALLERGY CLIN IMMUN, V53, P34, DOI 10.1016/0091-6749(74)90097-9; REISMAN RE, 1970, J ALLERGY, V46, P162, DOI 10.1016/0021-8707(70)90095-X; RUBIN LD, 1973, INTAL CROMOLYN SODIU; SHELDON JM, 1967, NONIMMUNOLOGIC FACTO, P26; SHELDON JM, 1967, DRUGS USEFUL ALLERGI, P130; SIEGAL S, 1964, J ALLERGY, V35, P252, DOI 10.1016/0021-8707(64)90007-3; SPECTOR S, 1976, AM REV RESPIR DIS, V113, P43; SPECTOR SL, 1974, J ALLERGY CLIN IMMUN, V54, P367, DOI 10.1016/0091-6749(74)90027-X; SPECTOR SL, 1975, J ALLERGY CLIN IMMUN, V56, P308, DOI 10.1016/0091-6749(75)90105-0; SPECTOR SL, 1974, J ALLERGY CLIN IMMUN, V53, P91; SPECTOR SL, 1971, J ALLERGY CLIN IMMUN, V48, P120, DOI 10.1016/0091-6749(71)90093-5; SPECTOR SL, 1974, MED CLIN N AM, V58, P71, DOI 10.1016/S0025-7125(16)32178-2; SPECTOR SL, 1973, SURGICAL PEDIATRICS, P313; STONE SH, 1964, SCIENCE, V146, P1061, DOI 10.1126/science.146.3647.1061; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAKINO Y, 1971, J ALLERGY, V47, P247, DOI 10.1016/S0091-6749(71)80003-9; VAZ NM, 1970, SCIENCE, V168, P852, DOI 10.1126/science.168.3933.852; VONDRA V, 1972, Bulletin de Physio-Pathologie Respiratoire, V8, P506; WARDLAW AC, 1970, INT ARCH ALLER A IMM, V38, P573, DOI 10.1159/000230313; YU DYC, 1972, J APPL PHYSIOL, V32, P823, DOI 10.1152/jappl.1972.32.6.823; ZAID G, 1966, NEW ENGL J MED, V275, P580, DOI 10.1056/NEJM196609152751103	55	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	5					499	511		10.1016/0091-6749(76)90067-1	http://dx.doi.org/10.1016/0091-6749(76)90067-1			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	BR201	4485				2022-12-18	WOS:A1976BR20100015
J	TOWNLEY, R; GUIRGIS, H; BEWTRA, A; WATT, G; BURKE, K; CARNEY, K				TOWNLEY, R; GUIRGIS, H; BEWTRA, A; WATT, G; BURKE, K; CARNEY, K			IGE LEVELS AND METHACHOLINE INHALATION RESPONSES IN MONOZYGOUS AND DIZYGOUS TWINS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					227	227						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000093
J	WEINBERGER, M; HUDGEL, D; SPECTOR, S; CHIDSEY, C				WEINBERGER, M; HUDGEL, D; SPECTOR, S; CHIDSEY, C			TROLEANDOMYCIN (TAO) - INHIBITOR OF THEOPHYLLINE METABOLISM	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1976	57	3					262	262						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	BJ240					2022-12-18	WOS:A1976BJ24000178
J	DAY, RP; BEHMANN, S; DOLOVICH, J; HARGREAVE, FE				DAY, RP; BEHMANN, S; DOLOVICH, J; HARGREAVE, FE			INFLAMMATORY EFFECTS OF LEUKOCYTES AND PLATELETS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																		BENVENISTE J, 1974, NATURE, V249, P581, DOI 10.1038/249581a0; 1974, J ALLERG CL, V54, P244; 1973, J ALLERG CL, V52, P38	3	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					87	87						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800046
J	LEIFERMAN, KM; YUNGINGER, JW; LARSON, JB; GLEICH, GJ				LEIFERMAN, KM; YUNGINGER, JW; LARSON, JB; GLEICH, GJ			EFFECT OF CROMOLYN SODIUM POWDER AS A TREATMENT FOR RAGWEED POLLINOSIS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									MAYO CLIN & MAYO FDN,DEPT MED,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,ALLERGIC DIS RES LAB,ROCHESTER,MN 55901; MAYO CLIN & MAYO FDN,DEPT PEDIAT,ROCHESTER,MN 55901	Mayo Clinic; Mayo Clinic; Mayo Clinic								BERG T, 1971, INT ARCH ALLER A IMM, V41, P452, DOI 10.1159/000230539; BERNSTEIN IL, 1972, J ALLERGY CLIN IMMUN, V50, P235, DOI 10.1016/0091-6749(72)90017-6; BLAIR H, 1973, Clinical Allergy, V3, P283, DOI 10.1111/j.1365-2222.1973.tb01335.x; BLUMENTHAL MN, 1973, J ALLERGY CLIN IMMUN, V52, P105, DOI 10.1016/0091-6749(73)90082-1; BURGHER LW, 1971, CHEST, V60, P210, DOI 10.1378/chest.60.3.210; CAPEL LH, 1971, LANCET, V1, P575; CHAMPION RH, 1971, LANCET, V1, P187; CHANYEUNG M, 1971, CAN MED ASSOC J, V105, P827; Coffman D A, 1971, Br J Clin Pract, V25, P403; COX J S G, 1971, British Journal of Diseases of the Chest, V65, P189, DOI 10.1016/0007-0971(71)90028-3; CULLEN KJ, 1973, AUSTR FAMILY PHYSICI, V2, P441; DIXON WJ, 1969, INTRO STATISTICAL AN, P335; DURHAM OC, 1946, J ALLERGY, V17, P79, DOI 10.1016/0021-8707(46)90025-1; ENGSTROM I, 1971, ACTA ALLERGOL, V26, P101, DOI 10.1111/j.1398-9995.1971.tb01285.x; ENGSTROM L, 1971, ANN ALLERGY, V29, P505; FOX ZR, 1972, CAN MED ASSOC J, V106, P975; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P346, DOI 10.1016/0091-6749(75)90006-8; GLEICH GJ, 1975, J ALLERGY CLIN IMMUN, V55, P334, DOI 10.1016/0091-6749(75)90005-6; GLEICH GJ, 1974, ALLERGOLOGY, P44; HENDERSON LL, 1975, J ALLERGY CLIN IMMUN, V55, P10, DOI 10.1016/S0091-6749(75)80003-0; HETHERINGTON HD, 1973, MED J AUSTRALIA, V1, P493, DOI 10.5694/j.1326-5377.1973.tb110515.x; HOLOPAIN.E, 1971, LANCET, V1, P55; Hopper I, 1972, J Laryngol Otol, V86, P725; ILLUM P, 1973, ACTA ALLERGOL, V28, P416, DOI 10.1111/j.1398-9995.1973.tb01455.x; IRANI FA, 1972, AM REV RESPIR DIS, V106, P179, DOI 10.1164/arrd.1972.106.2.179; LOPEZ M, 1969, J ALLERGY, V44, P118, DOI 10.1016/0021-8707(69)90008-2; MANNERS B, 1973, Clinical Allergy, V3, P311, DOI 10.1111/j.1365-2222.1973.tb01339.x; MYGIND N, 1972, ACTA ALLERGOL, V27, P372, DOI 10.1111/j.1398-9995.1972.tb01436.x; NORMAN PS, 1966, INT ENCYCLOPEDIA PHA, V2, P639; OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; SMITH JM, 1968, BRIT MED J, V2, P340, DOI 10.1136/bmj.2.5601.340; SMITH JM, 1971, LANCET, V1, P295; TAYLOR B, 1971, NEW ZEAL MED J, V74, P374; TAYLOR G, 1971, Clinical Allergy, V1, P189, DOI 10.1111/j.1365-2222.1971.tb03018.x; THORNE MG, 1972, ACTA ALLERGOL, V27, P307, DOI 10.1111/j.1398-9995.1972.tb01430.x; TOOGOOD JH, 1971, AM REV RESPIR DIS, V104, P323, DOI 10.1164/arrd.1971.104.3.323; WIDE L, 1967, LANCET, V2, P1105; YUNGINGER JW, 1973, J CLIN INVEST, V52, P1268, DOI 10.1172/JCI107294	38	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	6					481	490		10.1016/0091-6749(75)90066-4	http://dx.doi.org/10.1016/0091-6749(75)90066-4			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AZ301	812895				2022-12-18	WOS:A1975AZ30100007
J	LOWELL, FC				LOWELL, FC			SOME UNTESTED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN CLINICAL ALLERGY	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material									MASSACHUSETTS GEN HOSP,ALLERGY UNIT,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital									0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	56	3					168	169		10.1016/0091-6749(75)90088-3	http://dx.doi.org/10.1016/0091-6749(75)90088-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ290	1151011				2022-12-18	WOS:A1975AQ29000002
J	RAYNOR, GS; OGDEN, EC; HAYES, JV				RAYNOR, GS; OGDEN, EC; HAYES, JV			SPATIAL VARIABILITY IN AIRBORN POLLEN CONCENTRATIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NEW YORK STATE MUSEUM & SCI SERV,ALBANY,NY; US ATOM ENERGY COMM,ALBANY,NY	United States Department of Energy (DOE)								OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; RAYNOR GS, 1970, J ALLERGY, V45, P329, DOI 10.1016/0021-8707(70)90041-9; RAYNOR GS, 1974, J APPL METEOROL, V13, P87, DOI 10.1175/1520-0450(1974)013<0087:MTADOA>2.0.CO;2	3	15	16	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	3					195	202		10.1016/0091-6749(75)90016-0	http://dx.doi.org/10.1016/0091-6749(75)90016-0			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V8448	1112951				2022-12-18	WOS:A1975V844800007
J	WASSERMAN, SI; GOETZL, EJ; AUSTEN, KF				WASSERMAN, SI; GOETZL, EJ; AUSTEN, KF			INACTIVATION OF HUMAN SRS-A BY INTACT HUMAN EOSINOPHILS AND BY EOSINOPHIL ARYLSULFATASE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1975	55	2					72	72						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	V5498					2022-12-18	WOS:A1975V549800008
J	COFFEY, RG; MIDDLETON, E				COFFEY, RG; MIDDLETON, E			EFFECTS OF GLUCOCORTICOSTEROIDS ON URINARY-EXCRETION OF CYCLIC-AMP AND ELECTROLYTES BY ASTHMATIC CHILDREN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									CHILDRENS ASTHMA RES INST & HOSP, DENVER, CO 80204 USA; SLOAN KETTERING INST CANC RES, NEW YORK, NY 10021 USA	Memorial Sloan Kettering Cancer Center								AVIADO DM, 1970, J CLIN PHARMACOL N D, V10, P3; BERNSTEIN RA, 1972, J LAB CLIN MED, V80, P772; BRODIE BB, 1966, PHARMACOL REV, V18, P273; CHAI H, 1973, AM J DIS CHILD, V125, P757, DOI 10.1001/archpedi.1973.04160050095021; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; KARKI NT, 1956, ACTA PHYSIOL SCAND, V39, P7; LOCKEY SD, 1967, J ALLERGY, V40, P349, DOI 10.1016/0021-8707(67)90024-X; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; LOGSDON PJ, 1973, J ALLERGY CLIN IMMUN, V52, P148, DOI 10.1016/0091-6749(73)90031-6; MAKINO S, 1970, J ALLERGY, V46, P178, DOI 10.1016/0021-8707(70)90096-1; MANGANIELLO V, 1972, J CLIN INVEST, V51, P2763, DOI 10.1172/JCI107096; MARTEL PJ, 1962, J ENDOCRINOL, V24, P159, DOI 10.1677/joe.0.0240159; MIDDLETON E, 1968, J ALLERGY, V42, P288, DOI 10.1016/0021-8707(68)90022-1; Middleton E Jr, 1972, Adv Intern Med, V18, P177; MILLS JN, 1966, PHYSIOL REV, V46, P128, DOI 10.1152/physrev.1966.46.1.128; MILLS JN, 1961, J PHYSIOL-LONDON, V156, P415, DOI 10.1113/jphysiol.1961.sp006684; MILLS JN, 1958, J ENDOCRINOL, V17, P41, DOI 10.1677/joe.0.0170041; MITCHELL RG, 1954, J CLIN ENDOCR METAB, V14, P707, DOI 10.1210/jcem-14-7-707; MORRIS HG, 1972, J ALLERGY CLIN IMMUN, V50, P138, DOI 10.1016/0091-6749(72)90044-9; MORRIS HG, 1973, J PHARMACOL EXP THER, V184, P180; OATES JA, 1962, CLIN CHIM ACTA, V7, P488; PARKER CW, 1973, J CLIN INVEST, V52, P48, DOI 10.1172/JCI107173; REINBERG A, 1970, ANN ENDOCRINOL-PARIS, V31, P277; ROSENBAUM JD, 1952, J CLIN INVEST, V31, P507, DOI 10.1172/JCI102635; SAGEL J, 1973, J CLIN ENDOCR METAB, V37, P570, DOI 10.1210/jcem-37-4-570; Schales O, 1941, J BIOL CHEM, V140, P879; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; SILBER R H, 1957, Methods Biochem Anal, V4, P139, DOI 10.1002/9780470110201.ch4; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TAUSSKY HERTHA H., 1961, STANDARD METHODS CLIN CHEM, V3, P99; TOWNLEY RG, 1972, J ALLERGY CLIN IMMUN, V49, P88; TOWNLEY RG, 1970, J ALLERGY, V45, P71; VONEULER US, 1955, ACTA PHYSIOL SCAND, V33, P10; WALTON J, 1970, ARCH INTERN MED, V126, P601, DOI 10.1001/archinte.126.4.601; WEBEL ML, 1972, J LAB CLIN MED, V80, P765; WILLIAMS RH, 1972, P SOC EXP BIOL MED, V139, P447	37	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	1					41	53		10.1016/S0091-6749(74)80007-2	http://dx.doi.org/10.1016/S0091-6749(74)80007-2			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	T5232	4365298				2022-12-18	WOS:A1974T523200006
J	MCDONALD, JR; TAN, EM; STEVENSON, DD; VAUGHAN, JH				MCDONALD, JR; TAN, EM; STEVENSON, DD; VAUGHAN, JH			PLATELET-AGGREGATION IN ASTHMATIC AND NORMAL SUBJECTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									SCRIPPS CLIN & RES FDN, DIV ALLERGY IMMUNOL, 476 PROSPECT ST, LA JOLLA, CA 92037 USA	Scripps Research Institute								ARDLIE NG, 1966, NATURE, V212, P415, DOI 10.1038/212415a0; ARDLIE NG, 1967, THROMB DIATH HAEMOST, V18, P670; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; COLE B, 1971, ANN NY ACAD SCI, V185, P477; FISHEL CW, 1970, FED PROC, V62, P640; HARWELL WB, 1973, J ALLERGY CLIN IMMUN, V51, P274, DOI 10.1016/0091-6749(73)90129-2; HERMANN RG, 1966, P SOC EXP BIOL MED, V123, P654; Holmsen H, 1969, Scand J Haematol Suppl, V8, P3; MACMILLAN DC, 1966, NATURE, V211, P140, DOI 10.1038/211140a0; MATHISON DA, 1973, J ALLERGY CLIN IMMUN, V51, P94, DOI 10.1016/S0091-6749(73)80037-5; MATHISON DA, 1973, JAMA-J AM MED ASSOC, V224, P1134, DOI 10.1001/jama.224.8.1134; MCDONALD JR, 1972, J ALLERGY CLIN IMMUN, V50, P198, DOI 10.1016/0091-6749(72)90014-0; MCDONALD JW, 1973, J LAB CLIN MED, V81, P838; MILLS DCB, 1967, NATURE, V213, P35, DOI 10.1038/213035a0; MILLS DCB, 1967, J PHYSIOL-LONDON, V193, P443, DOI 10.1113/jphysiol.1967.sp008369; MITCHELL JR, 1964, BRIT J HAEMATOL, V10, P78, DOI 10.1111/j.1365-2141.1964.tb00681.x; MUSTARD JF, 1970, PHARMACOL REV, V22, P97; MUSTARD JF, CHRONOLOG PLATELET A; OBRIEN JR, 1963, NATURE, V200, P763, DOI 10.1038/200763a0; OBRIEN JR, 1962, J CLIN PATHOL, V15, P446, DOI 10.1136/jcp.15.5.446; OBRIEN JR, 1961, J CLIN PATHOL, V14, P140, DOI 10.1136/jcp.14.2.140; SALZMAN EW, 1972, NEW ENGL J MED, V286, P358; SOLINGER A, 1973, J ALLERGY CLIN IMMUN, V51, P29; WEISS HJ, 1968, J CLIN INVEST, V47, P2169, DOI 10.1172/JCI105903; ZUCKER MB, 1968, P SOC EXP BIOL MED, V127, P547	25	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	54	4					200	208		10.1016/0091-6749(74)90062-1	http://dx.doi.org/10.1016/0091-6749(74)90062-1			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	U3236	4153435				2022-12-18	WOS:A1974U323600002
J	OKAZAKI, T; VERVLOET, D; ATTALLAH, A; LEE, J; ARBESMAN, CE				OKAZAKI, T; VERVLOET, D; ATTALLAH, A; LEE, J; ARBESMAN, CE			PROSTAGLANDIN SYNTHESIS AND ALLERGIC REACTIONS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					75	75						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000026
J	REISMAN, RE; WYPYCH, JI; YEAGLE, N; ARBESMAN, CE				REISMAN, RE; WYPYCH, JI; YEAGLE, N; ARBESMAN, CE			STINGING INSECT HYPERSENSITIVITY .3. DETECTION AND CLINICAL SIGNIFICANCE OF IGE ANTIBODIES TO INSECT VENOM IN MAN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract																			0	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1974	53	2					110	111						2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	S0380					2022-12-18	WOS:A1974S038000114
J	CUSHMAN, P				CUSHMAN, P			PERSISTENT INCREASED IMMUNOGLOBULIN-M IN TREATED NARCOTIC ADDICTION - ASSOCIATION WITH LIVER-DISEASE AND CONTINUING HEROIN USE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10027	Columbia University								BLAESE RM, 1971, J CLIN INVEST, V50, P2331, DOI 10.1172/JCI106731; CHERUBIN CE, 1972, ANN INTERN MED, V76, P391, DOI 10.7326/0003-4819-76-3-391; CHERUBIN CE, 1972, ANN INTERN MED, V76, P385, DOI 10.7326/0003-4819-76-3-385; CUSHMAN P, 1971, NEW YORK STATE J MED, V71, P1768; CUSHMAN P, 1973, AM J MED, V54, P320, DOI 10.1016/0002-9343(73)90026-0; CUSHMAN P, 1972, 4 NAT C METH TREATM; DOLE VP, 1972, NEW YORK STATE J MED, V72, P471; GRIECO MH, 1973, J ALLERGY CLIN IMMUN, V51, P152, DOI 10.1016/0091-6749(73)90020-1; KREEK MJ, 1972, ANN INTERN MED, V77, P598, DOI 10.7326/0003-4819-77-4-598; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; NICKERSON DS, 1970, ANN INTERN MED, V72, P661; STIMMEL B, 1972, J AMER MED ASSOC, V222, P811, DOI 10.1001/jama.222.7.811; WALSH JH, 1970, J INFECT DIS, V121, P550, DOI 10.1093/infdis/121.5.550	13	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	52	2					122	128		10.1016/0091-6749(73)90084-5	http://dx.doi.org/10.1016/0091-6749(73)90084-5			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	Q4190	4723889				2022-12-18	WOS:A1973Q419000007
J	HARWELL, WB; PATTERSON, JT; LIEBERMAN, P; BEACHEY, E				HARWELL, WB; PATTERSON, JT; LIEBERMAN, P; BEACHEY, E			PLATELET-AGGREGATION IN ATOPIC AND NORMAL-PATIENTS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									VET ADM HOSP, MEMPHIS, TN 38104 USA; UNIV TENNESSEE, MED SCH, DEPT ALLERGY & CLIN IMMUNOL, MEMPHIS, TN 38103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center								BEACHEY EH, 1969, J IMMUNOL, V102, P42; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; BUCHER HW, 1969, EXPERIENTIA, V25, P280, DOI 10.1007/BF02034393; COLE B, 1971, ANN NY ACAD SCI, V185, P477; LOGSDON PJ, 1972, J ALLERGY CLIN IMMUN, V50, P45, DOI 10.1016/0091-6749(72)90078-4; MIDDLETON E, 1968, J ALLERGY, V42, P288, DOI 10.1016/0021-8707(68)90022-1; MILLS DCB, 1967, NATURE, V213, P35, DOI 10.1038/213035a0; MILLS DCB, 1967, J PHYSIOL-LONDON, V193, P443, DOI 10.1113/jphysiol.1967.sp008369; MUSTARD JF, 1970, PHARMACOL REV, V22, P97; REED CE, 1967, J ALLERGY, V39, P127; SALZMAN EW, 1972, NEW ENGL J MED, V286, P358; SKOZA L, 1967, THROMB DIATH HAEMOST, V18, P713; SOLINGER A, 1972, J ALLERGY CLIN IMMUN, V49, P107; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2	14	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	5					274	284		10.1016/0091-6749(73)90129-2	http://dx.doi.org/10.1016/0091-6749(73)90129-2			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P5931	4348913	Bronze			2022-12-18	WOS:A1973P593100003
J	KIRKPATRICK, CH; MEEK, JC; RICH, RR				KIRKPATRICK, CH; MEEK, JC; RICH, RR			MECHANISM OF ALLERGY TO COMPONENTS OF COMMERCIAL BOVINE THYROTROPIN	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									NIAID, LAB CLIN INVEST, BETHESDA, MD 20014 USA; UNIV KANSAS, MED CTR, DEPT MED, KANSAS CITY, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kansas; University of Kansas Medical Center								AUSTEN KF, 1971, IMMUNOLOGICAL DISEAS; BAYLESS TM, 1967, JOHNS HOPKINS MED J, V120, P310; BLIZZARD RM, 1968, PEDIATRICS, V42, P231; HAYS MT, 1967, J CLIN ENDOCR METAB, V27, P1540, DOI 10.1210/jcem-27-11-1540; HEINER DC, 1962, AM J DIS CHILD, V103, P634, DOI 10.1001/archpedi.1962.02080020649003; HINKLE NH, 1961, AM J DIS CHILD, V102, P449; HOLLAND NH, 1962, J PEDIATR-US, V61, P181, DOI 10.1016/S0022-3476(62)80252-2; KIRKPATRICK CH, 1971, ANN INTERN MED, V74, P955, DOI 10.7326/0003-4819-74-6-955; KIRKPATRICK CH, 1972, J CLIN INVEST, V51, P2948, DOI 10.1172/JCI107119; KIVEL RM, 1964, NEW ENGL J MED, V271, P769, DOI 10.1056/NEJM196410082711504; Louria D B, 1967, Trans Assoc Am Physicians, V80, P236; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MCKENZIE JM, 1958, ENDOCRINOLOGY, V63, P372, DOI 10.1210/endo-63-3-372; MEEK JC, 1970, J CLIN ENDOCR METAB, V31, P48, DOI 10.1210/jcem-31-1-48; Odell W D, 1967, Recent Prog Horm Res, V23, P47; OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347; ROTHBERG RM, 1965, PEDIATRICS, V35, P571; SHERMAN WB, 1964, JAMA-J AM MED ASSOC, V190, P224; TAUNTON OD, 1965, J CLIN ENDOCR METAB, V25, P266, DOI 10.1210/jcem-25-2-266; TAYLOR KB, 1961, BRIT MED J, V2, P924, DOI 10.1136/bmj.2.5257.924	20	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	5					296	302		10.1016/0091-6749(73)90131-0	http://dx.doi.org/10.1016/0091-6749(73)90131-0			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	P5931	4121389	Bronze			2022-12-18	WOS:A1973P593100005
J	TENNENBA.JI; LOWNEY, E				TENNENBA.JI; LOWNEY, E			LOCALIZED HEAT AND COLD URTICARIA - RARE PHENOMENA OCCURRING IN SAME INDIVIDUAL	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Note									OHIO STATE UNIV HOSP,DEPT MED,DIV ALLERGY,COLUMBUS,OH 43210; OHIO STATE UNIV HOSP,DEPT MED,DEPT DERMATOL,COLUMBUS,OH 43210	Ohio State University; Ohio State University								BAER RL, 1971, IMMUNOLOGICAL DISEAS; DELORME P, 1969, J ALLERGY, V43, P284, DOI 10.1016/0021-8707(69)90149-X; Hopkins JG, 1938, ARCH DERMATOL SYPH, V38, P679, DOI 10.1001/archderm.1938.01480170003001; HOUSER DD, 1970, AM J MED, V49, P23, DOI 10.1016/S0002-9343(70)80110-3; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P366, DOI 10.1016/0091-6749(71)90083-2; WANDERER AA, 1971, J ALLERGY CLIN IMMUN, V48, P13, DOI 10.1016/0091-6749(71)90050-9	7	15	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1973	51	1					57	59		10.1016/0091-6749(73)90009-2	http://dx.doi.org/10.1016/0091-6749(73)90009-2			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	O5651	4682230				2022-12-18	WOS:A1973O565100008
J	PATTERSON, R; SUSZKO, IM; ZEISS, CR				PATTERSON, R; SUSZKO, IM; ZEISS, CR			REACTIONS OF PRIMATE RESPIRATORY MAST-CELLS	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		HASTIE R, 1971, CLIN EXP IMMUNOL, V8, P45; HORSFIELD GI, 1965, J PATHOL BACTERIOL, V90, P599, DOI 10.1002/path.1700900228; HORVATH L, 1952, ACTA MORPH ACAD SCI, V2, P35; MASON TE, 1969, J HISTOCHEM CYTOCHEM, V17, P563, DOI 10.1177/17.9.563; MOTA I, 1960, NATURE, V186, P245, DOI 10.1038/186245a0; PATTERSON R, 1969, J LAB CLIN MED, V73, P924; PATTERSON R, 1971, J IMMUNOL, V106, P1274; PATTERSON R, 1970, AM REV RESPIR DIS, V102, P412; Patterson Richard W., IN PRESS; SELYE H, 1965, MAST CELL, P50; SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182; UVNAS B, 1968, BIOCHEMISTRY ACUTE A, P131	12	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	1					7	+		10.1016/0091-6749(72)90075-9	http://dx.doi.org/10.1016/0091-6749(72)90075-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	M9284	4113508				2022-12-18	WOS:A1972M928400002
J	SMITH, HJ; GOKCEN, M; OZKARAGOZ, K				SMITH, HJ; GOKCEN, M; OZKARAGOZ, K			SIMPLIFIED RADIOIMMUNOASSAY TECHNIQUE FOR MEASURING HUMAN IGE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article																		BATES RW, 1971, LABORATORY DIAGNOSIS, P332; BAZARAL M, 1972, J ALLERGY CLIN IMMUN, V49, P189, DOI 10.1016/0091-6749(72)90113-3; CATT K, 1967, SCIENCE, V158, P1570, DOI 10.1126/science.158.3808.1570; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; Hunter W. M., 1967, HDB EXPT IMMUNOLOGY, P608; JOHANSSON SG, 1968, INT ARCH ALLER A IMM, V34, P1; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MCLAUGHLAN P, 1971, NATURE-NEW BIOL, V232, P245, DOI 10.1038/newbio232245a0; OGAWA M, 1971, AM J MED, V51, P193, DOI 10.1016/0002-9343(71)90238-5; OUCHTERLONY O, 1958, PROGR ALLERGY, V5, P12	10	15	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.		1972	50	4					193	+		10.1016/0091-6749(72)90013-9	http://dx.doi.org/10.1016/0091-6749(72)90013-9			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	N6855	4627419				2022-12-18	WOS:A1972N685500001
J	Sampath, V; Abrams, EM; Adlou, B; Akdis, C; Akdis, M; Brough, HA; Chan, SS; Chatchatee, P; Chinthrajah, RS; Cocco, RR; Deschildre, A; Eigenmann, P; Galvan, C; Gupta, R; Hossny, E; Koplin, JJ; Lack, G; Levin, M; Shek, LP; Makela, M; Mendoza-Hernandez, D; Muraro, A; Papadopoulous, NG; Pawankar, R; Perrett, KP; Roberts, G; Sackesen, C; Sampson, H; Tang, MLK; Togias, A; Venter, C; Warren, CM; Wheatley, LM; Wong, GWK; Beyer, K; Nadeau, KC; Renz, H				Sampath, Vanitha; Abrams, Elissa M.; Adlou, Bahmana; Akdis, Cezmi; Akdis, Mubeccel; Brough, Helen A.; Chan, Susan; Chatchatee, Pantipa; Chinthrajah, R. Sharon; Cocco, Renata Rodrigues; Deschildre, Antoine; Eigenmann, Philippe; Galvan, Cesar; Gupta, Ruchi; Hossny, Elham; Koplin, Jennifer J.; Lack, Gideon; Levin, Michael; Shek, Lynette P.; Makela, Mika; Mendoza-Hernandez, David; Muraro, Antonella; Papadopoulous, Nikolaos G.; Pawankar, Ruby; Perrett, Kirsten P.; Roberts, Graham; Sackesen, Cansin; Sampson, Hugh; Tang, Mimi L. K.; Togias, Alkis; Venter, Carina; Warren, Christopher Michael; Wheatley, Lisa M.; Wong, Gary W. K.; Beyer, Kirsten; Nadeau, Kari C.; Renz, Harald			Food allergy across the globe	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Food allergy; guidelines; prevention; treatment; epidemiology	PEANUT ALLERGY; PRIMARY PREVENTION; JAPANESE GUIDELINES; DIETARY PREVENTION; ESPGHAN COMMITTEE; BARRIER INTEGRITY; NATURAL-HISTORY; EGG ALLERGY; INFANTS; CHILDREN	The prevalence of food allergy (FA) is increasing in some areas of the globe, highlighting the need for better strategies for prevention, diagnosis, and therapy. In the last few decades, we have made great strides in understanding the causes and mechanisms underlying FAs, prompting guideline updates. Earlier guidelines recommended avoidance of common food allergens during pregnancy and lactation and delaying the introduction of allergenic foods in children aged between 1 and 3 years. Recent guidelines for allergy prevention recommend consumption of a healthy and diverse diet without eliminating or increasing the consumption of allergenic foods during pregnancy or breast-feeding. Early introduction of allergenic foods is recommended by most guidelines for allergy prevention after a period of exclusive breast-feedng (6 months [World Health Organization] or 4 months [European Academy of Allergy and Clinical Immunology]). New diagnostics for FA have been developed with varied availability of these tests in different countries. Finally, the first oral immunotherapy drug for FA was approved by the US Food and Drug Administration and European Medicines Agency in 2020. In this review, we will address the global prevalence of FA, our current understanding of the causes of FA, and the latest guidelines for preventing, diagnosing, and treating FA. We will also discuss similarities and differences between FA guidelines. (J Allergy Clin Immunol 2021;148:1347-64.)	[Sampath, Vanitha; Adlou, Bahmana; Chinthrajah, R. Sharon; Nadeau, Kari C.] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Sampath, Vanitha; Adlou, Bahmana; Chinthrajah, R. Sharon; Nadeau, Kari C.] Stanford Univ, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Abrams, Elissa M.] Univ Manitoba, Sect Allergy & Clin Immunol, Dept Paediat, Winnipeg, MB, Canada; [Abrams, Elissa M.] Univ British Columbia, Div Allergy & Immunol, Dept Paediat, Vancouver, BC, Canada; [Akdis, Cezmi; Akdis, Mubeccel] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Brough, Helen A.; Chan, Susan; Lack, Gideon] Kings Coll London, Dept Women & Childrens Hlth Pediatr Allergy, Sch Life Course Sci, Fac Life Sci & Med, London, England; [Brough, Helen A.; Chan, Susan; Lack, Gideon] Kings Coll London, Peter Gorer Dept Immunobiol, Sch Immunol & Microbial Sci, London, England; [Brough, Helen A.; Chan, Susan; Lack, Gideon] Childrens Allergy Serv & Evelina Childrens Hosp G, London, England; [Brough, Helen A.; Chan, Susan; Lack, Gideon] St Thomass NHS Fdn Trust, London, England; [Chatchatee, Pantipa] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med,Div Allergy & Immunol,Dept Pediat, Thai Red Cross Soc,Pediat Allergy & Clin Immun, Bangkok, Thailand; [Cocco, Renata Rodrigues] Albert Einstein Med Sch, Sao Paulo, Brazil; [Deschildre, Antoine] Univ Lille, Pediat Pulmonol & Allergy Unit, Hop Jeanne Flandre, CHU Lille, Lille, France; [Eigenmann, Philippe] Univ Hosp Geneva, Geneva, Switzerland; [Eigenmann, Philippe] Univ Geneva, Geneva, Switzerland; [Galvan, Cesar] Natl Reference Ctr Allergy Asthma & Immunol, Natl Inst Children Hlth, Lima, Peru; [Galvan, Cesar] B&D Hlth Clin, Int Clin, Lima, Peru; [Gupta, Ruchi; Warren, Christopher Michael] Northwestern Univ, Ctr Food Allergy & Asthma Res, Feinberg Sch Med, Chicago, IL 60611 USA; [Gupta, Ruchi; Warren, Christopher Michael] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Hossny, Elham] Ain Shams Univ, Childrens Hosp, Pediat Allergy Immunol & Rheumatol Unit, Cairo, Egypt; [Koplin, Jennifer J.; Perrett, Kirsten P.; Tang, Mimi L. K.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Koplin, Jennifer J.; Perrett, Kirsten P.; Tang, Mimi L. K.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Levin, Michael] Univ Cape Town, Dept Paediat, Div Paediat Allergy, Cape Town, South Africa; [Levin, Michael] Worldwide Univ Network, InVIVO Planetary Hlth Grp, Singapore, Singapore; [Shek, Lynette P.] Natl Univ Singapore, Dept Paediat, Singapore, Singapore; [Makela, Mika] Helsinki Univ Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Makela, Mika] Univ Helsinki, Helsinki, Finland; [Mendoza-Hernandez, David] Inst Nacl Pediat, Allergy Serv, Mexico City, DF, Mexico; [Muraro, Antonella] Padua Univ Hosp, Dept Woman & Child Hlth, Food Allergy Ctr, Padua, Italy; [Papadopoulous, Nikolaos G.] Natl & Kapodistrian Univ Athens, Dept Allergy, Athens, Greece; [Papadopoulous, Nikolaos G.] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Pawankar, Ruby] Nippon Med Sch, Dept Pediat, Bunkyo Ku, Sendai, Tokyo, Japan; [Roberts, Graham] Univ Southampton, Fac Med, Clin & Expt Sci & Human Dev Hlth, Southampton, Hants, England; [Roberts, Graham] Univ Hosp Southampton NHS Fdn Hosp, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Roberts, Graham] St Mary Hosp, David Hide Asthma & Allergy Res Ctr, Isle Of Wight, England; [Sackesen, Cansin] Koc Univ, Sch Med, Dept Pediat, Div Pediat Allergy, Istanbul, Turkey; [Sampson, Hugh] Icahn Sch Med Mt Sinai, Dept Pediat, Kravis Childrens Hosp, Elliot & Roslyn Jaffe Food Allergy Inst,Div Aller, New York, NY 10029 USA; [Togias, Alkis; Wheatley, Lisa M.] NIAID, Div Allergy Immunol & Transplantat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Venter, Carina] Univ Colorado, Childrens Hosp Colorado, Pediat Allergy & Immunol, Boulder, CO 80309 USA; [Wong, Gary W. K.] Chinese Univ Hong Kong, Dept Pediat, Hong Kong, Peoples R China; [Beyer, Kirsten] Charite Univ Med Berlin, Dept Pediat Resp Med Immunol & Crit Care Med, Berlin, Germany; [Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany; [Renz, Harald] German Ctr Lung Res DZL, Marburg, Germany; [Renz, Harald] Univ Giessen, Marburg, Germany; [Renz, Harald] Marburg Lung Ctr, Marburg, Germany; [Renz, Harald] Sechenov Univ, Immunopathol Lab, Dept Clin Immunol & Allergol, Moscow, Russia	Stanford University; Stanford University; University of Manitoba; University of British Columbia; Swiss Institute of Allergy & Asthma Research; University of Zurich; University of London; King's College London; University of London; King's College London; Chulalongkorn University; Thai Red Cross Society; Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Geneva; University of Geneva; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Egyptian Knowledge Bank (EKB); Ain Shams University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Cape Town; National University of Singapore; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Padua; Azienda Ospedaliera - Universita di Padova; National & Kapodistrian University of Athens; University of Manchester; Nippon Medical School; University of Southampton; Koc University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Children's Hospital Colorado; University of Colorado System; University of Colorado Boulder; Chinese University of Hong Kong; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Justus Liebig University Giessen; Sechenov First Moscow State Medical University	Nadeau, KC (corresponding author), Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, 240 Pasteur Dr,BMI Rm 1755, Palo Alto, CA 94304 USA.	knadeau@stanford.edu	Perrett, Kirsten/P-8813-2019	Perrett, Kirsten/0000-0002-5683-996X; Hossny, Elham/0000-0001-6876-6318; Mendoza-Hernandez, David Alejandro/0000-0002-6162-7136; Shek, Lynette/0000-0001-9064-8983; Koplin, Jennifer/0000-0002-7576-5142; Brough, Helen/0000-0001-7203-0813; Tang, Mimi/0000-0002-3839-5293; Makela, Mika/0000-0002-2933-3111	Deutsche Zentrum fur Lungenforschung (DZL, German Lung Center) [82DZL00502]; Deutsche Forschungsgemeinschaft (DFG) [SFB 1021]	Deutsche Zentrum fur Lungenforschung (DZL, German Lung Center); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	E. M. Abrams is an employee of the Public Health Agency of Canada (PHAC). C. Akdis reports grants from the Swiss National Science Foundation, EU CURE, and Novartis Research Institutes (Basel Switzerland); is Chair of the European Academy of Allergy and Clinical Immunology (EAACI) Guidelines on Environmental Science in Allergic diseases and Asthma; and is Editor-in-Chief of Allergy. M. Akdis reports grants from the Swiss National Science Foundation, EU CURE, and Novartis Research Institutes (Basel Switzerland). H. A. Brough reports receiving research grants from the National Institutes of Health (NIH), Aimmune, and DBV Technologies and speaker fees from DBV Technologies and Sanofi; is Pediatric Section Chair, the EAACI; and is President Elect Royal Society of Medicine. S. Chan reports grants from the NIH and Aimmune and has received a medical device from Primus. R. S. Chinthrajah reports grants from the National Institute of Allergy and Infectious Diseases (NIAID), CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, Stanford Maternal and Child Health Research Institute, and Food Allergy Research & Education (FARE) and is an Advisory Board Member at Alladapt Therapeutics, Novartis, Genentech, Sanofi, Allergenis, and Nutricia. A. Deschildre receives consulting fees, honoraria, or support for attending meetings/travel from Aimmune Therapeutics, DBV Technologies, Nestle Health Science, Nutricia, Novartis, and AstraZeneca; participated on a Data Safety Monitoring Board or Advisory Board at Aimmune and Novartis; has a leadership role at SFA (societe Francaise d'Allergologie) (ongoing), and SP2A (Societe Pediatrique de Pneumologie et Allergologie) (stopped in 2019); and is past president of the Cercle d'investigations Cliniques et Biologiques en Allergie Alimentaire. P. Eigenmann receives grants, consulting fees, speaking fees, honorarium, royalties, stock options, or travel support from Ulrich Muller Gierock Foundation, Thermo Fisher Scientific, DBV Technologies, Nestle, Danone, Novartis, Abbott, Alexia, University Hospitals of Geneva, ALK, UpToDate, Elsevier, and EAACI. C. Galvan reports payment from Reckitt Benckiser Mead Johnson. D. Mendoza-Hernandez reports payment or honoraria from Nestle and Thermo Fisher Scientific. J. J. Koplin reports grants from the National Health and Medical Research Council of Australia. G. Lack receives grants from NIAID, NIH, FARE, MRC & Asthma UK Centre, UK Department of Health through the National Institute for Health Research, National Peanut Board, The Davis Foundation, UK Food Standards Agency, and Medical Research Council; consulting fees, payment, honorarium, or travel support from Novartis, Sanofi-Genyzme, Regeneron, ALK-Abello, Lurie Children's Hospital, ALK-Abello, Northwestern University Feinberg School of Medicine, DBV Technologies, the American Academy of Allergy, Asthma & Immunology (AAAAI), and Nestle; is on the Scientific Advisory Board in DBV Technologies, Lurie Children's Hospital, ALK-Abello, and Novartis; and holds stock or stock options for DBV Technologies and Mighty Mission Me. A. Muraro discloses speaker's fee from Mylan, Viatris, Aimmune, DVB Technologies, Nestle Health Institute, Nestle Purina, and Nutricia. N. G. Papadopoulous reports grants from Gerolymatos International SA and Capricare; payment or honoraria from HAL, Menarini/Faes Farma, MSD, Biomay, Novartis, Nutricia, Sanofi, Boehringer Ingelheim, Mylan/Meda, and Asit Biotech; and participating on the Advisory Board at HAL, Menarini/Faes Farma, Novartis, Nutricia, GlaxoSmithKline (GSK), AstraZeneca, and Mylan/Meda. K. P.; Perrett reports grants from Melbourne Children's Clinician-Scientist Fellowship; research grants from the National Health and Medical Research Council, the Immune Tolerance Network, DBV Technologies, and GSK; consulting fees from Aravax; and serving as Chair of the Scientific Advisory Board for AllergyPal. G. Roberts reports grants from United Kingdom Food Standards Agency to assess the epidemiology of food allergy and is a member of the EAACI Food Allergy Guideline Group. C. Sackesen reports payment, honoraria, or travel support from Abbott Company and Nutricia; is the head of a food allergy group at the Turkish Society of Allergy and Clinical Immunology; and has patents planned for a twice-baked cow's milk product as a hypoallergenic milk food. H. Sampson reports grants, consulting fees, stock options, and travel support from NIAID, NIH, Elsevier, DBV Technologies, N-Fold LLC, Siolta Therapeutics, and DBV Technologies. M.L.K. Tang reports grants, drugs received, contracts, travel support, leadership or fiduciary role, stocks or stock options, or consulting fees from the National Health and Medical Research Council (Australia), Prota Therapeutics Pty Ltd, Murdoch Children's Research Institute, Pfizer, Prota Therapeutics, the EAAACI, the Asia Pacific Association of Allergy, Asthma and Clinical Immunology, the AAAAI, the International Union of Immunological Societies, the Australasian Society of Clinical Immunology and Allergy, Anaphylaxis Australia Incorporated, the Melbourne Academic Centre for Health, and the World Allergy Organization; is member of the International Expert Panel on Guidelines for Food Allergy in Schools, Health World Ltd; has patents including ``A method of including tolerance to an antigen and allergy treatment''; and is an employee of Prota Therapeutics. A. Togias is a paid employee of the US Federal Government, which funds food allergy research in the United States and across the globe. C. Venter reports grants, payment, or honoraria from Danone, Nestle Nutrition Institute, Reckitt Benckiser, Abbott, Before Brands, Sifter, and Else Nutrition and leadership or fiduciary role at the American Academy of Asthma, Allergy and Immmunology, the European Academy of Asthma, Allergy and Immunology, and Food Allergy Research and Education. C. M. Warren reports grants from the NIAID and FARE. K. Beyer received support (grants, consulting or speaker fees) from Aimmune Therapeutics, ALK, DBV, Bencard, Nestle , Novartis, and Allergopharma; was on the Advisory Board or the Data Safety Monitoring Board of Aimmune Therapeutics, Bencard, DBV, Nestle, and Novartis; has a leadership or fiduciary role at AGATE (Anaphylaxis Training and Education), GPA (German Society for Pediatric Allergology & Environmental Medicine), DGKJ (German Society for Allergology & Clinical Immunology), and DAAB (German Allergy and Asthma Association). K. C.; Nadeau reports grants from the NIAID, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences, and FARE; is Director of the World Allergy Organization; Advisor at Cour Pharma; consultant for Excellergy, Red tree ventures, and Phylaxis; cofounder of Before Brands, Alladapt, Latitude, and IgGenix; and National Scientific Committee member at the Immune Tolerance Network, and NIH clinical research centers, outside the submitted work; patents include ``Mixed allergen composition and methods for using the same,'' "Granulocyte-based methods for detecting and monitoring immune system disorders,'' "Methods and assays for detecting and quantifying pure subpopulations of white blood cells in immune system disorders,'' and ``Methods of isolating allergen-specific antibodies from humans and uses thereof.'' H. Renz reports grants from Deutsche Zentrum fur Lungenforschung (DZL, German Lung Center, no. 82DZL00502) and Deutsche Forschungsgemeinschaft (DFG)-funded SFB 1021. The rest of the authors declare that they have no relevant conflicts of interest. Z. K. Ballas (editor) disclosed no relevant financial relationships.	Abrams E, 2019, PAED CHILD HEALT-CAN, V24, P56, DOI 10.1093/pch/pxy195; Aghapour M, 2018, AM J RESP CELL MOL, V58, P157, DOI 10.1165/rcmb.2017-0200TR; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Alfano DN, 2020, J IMMUNOL, V204, P2337, DOI 10.4049/jimmunol.1900281; Allen JW, 2020, ALLERGY, V75, P673, DOI 10.1111/all.13979; Altunbulakli C, 2018, J ALLERGY CLIN IMMUN, V142, P1643, DOI 10.1016/j.jaci.2018.07.005; Andorf S, 2018, LANCET GASTROENTEROL, V3, P85, DOI 10.1016/S2468-1253(17)30392-8; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; [Anonymous], 2019, FOLLOWON STUDY MULTI; [Anonymous], 2021, POSITION PAPERORAL I; [Anonymous], 2010, INFANT FEEDING ADVIC; [Anonymous], 2018, OPEN LABEL STUDY PRO; [Anonymous], 2019, PRIMARY PREVENTION A; [Anonymous], 2012, GUIA CLINICA ALERGIA; [Anonymous], 2012, GUIDELINES MANAGEMEN; [Anonymous], 2016, HKIA POSITION PAPER; [Anonymous], 2010, AMS MOH CLIN PRACTIC; [Anonymous], 2018, ASSESSING HLTH BENEF; [Anonymous], 2019, RANDOMISED CONTROLLE; [Anonymous], 2016, STATEMENT ROLE HYDRO; [Anonymous], 2020, INFANT FEEDING ALLER; [Anonymous], 2011, DIAGNOSTICO TRATAMIE; [Anonymous], 2021, POSITION PAPER EVIDE; [Anonymous], 2017, ORAL PEANUT IMMUNOTH; [Anonymous], 2014, GUIDELINES DIAGNOSIS; Avila Castanon Lourdes, 2002, Rev Alerg Mex, V49, P74; Bages MC, 2020, REV COLOMB GASTROENT, V35, P54; Ballmer-Weber BK, 2011, INT J VITAM NUTR RES, V81, P173, DOI 10.1024/0300-9831/a000055; Barnes PJ, 2018, NAT REV IMMUNOL, V18, P454, DOI 10.1038/s41577-018-0006-6; Basera W, 2015, ANN ALLERG ASTHMA IM, V115, P113, DOI 10.1016/j.anai.2015.06.003; Begin P, 2020, ALLERGY ASTHMA CL IM, V16, DOI 10.1186/s13223-020-0413-7; Bischoff SC, 2000, INT ARCH ALLERGY IMM, V121, P270, DOI 10.1159/000024340; Bohle Barbara, 2022, Handb Exp Pharmacol, V268, P173, DOI 10.1007/164_2021_496; Botha M, 2019, J ALLERGY CLIN IMMUN, V143, P662, DOI 10.1016/j.jaci.2018.07.023; Brough HA, 2022, ALLERGY, V77, P416, DOI 10.1111/all.15006; Brown-Whitehorn T, 2020, FOOD PROTEIN INDUCED; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Buyuktiryaki B, 2016, J ALLER CL IMM-PRACT, V4, P265, DOI 10.1016/j.jaip.2015.12.012; Cao S, 2021, J ALLER CL IMM-PRACT, V9, P3705, DOI 10.1016/j.jaip.2021.05.020; Caraballo JC, 2011, RESPIROLOGY, V16, P340, DOI 10.1111/j.1440-1843.2010.01910.x; Castenmiller J, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5780; Chan AWM, 2016, HONG KONG MED J, V22, P279, DOI 10.12809/hkmj154763; Chan ES, 2013, PAED CHILD HEALT-CAN, V18, P545, DOI 10.1093/pch/18.10.545; Chinthrajah RS, 2019, LANCET, V394, P1437, DOI 10.1016/S0140-6736(19)31793-3; Comite Nacional de Alergia, 2018, Arch Argent Pediatr, V116, ps1, DOI 10.5546/aap.2018.S1; Committee American College of Allergy Asthma and Immunology, 2006, JAMA PEDIAT, V97, P1; Conrado AB, 2021, J ALLERGY CLIN IMMUN, V148, P1515, DOI 10.1016/j.jaci.2021.03.048; Cuello-Garcia CA, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0102-7; D'Auria E, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00545; Dai H, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02115-8; Dang TD, 2019, ALLERGY, V74, P318, DOI 10.1111/all.13572; Dang TD, 2012, J ALLERGY CLIN IMMUN, V129, P1056, DOI 10.1016/j.jaci.2012.01.056; de Silva D, 2020, PEDIAT ALLERG IMM-UK, V31, P813, DOI 10.1111/pai.13273; DesRoches A, 2010, J INVEST ALLERG CLIN, V20, P289; di Mauro G, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0111-6; Dougherty JA, 2021, ANN PHARMACOTHER, V55, P344, DOI 10.1177/1060028020944370; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Ebisawa M, 2020, ALLERGOL INT, V69, P370, DOI 10.1016/j.alit.2020.03.004; Ebisawa M, 2017, ALLERGOL INT, V66, P248, DOI 10.1016/j.alit.2017.02.001; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Fewtrell M, 2017, J PEDIATR GASTR NUTR, V64, P119, DOI 10.1097/MPG.0000000000001454; Fiocchi A, 2006, ANN ALLERG ASTHMA IM, V97, P10, DOI 10.1016/S1081-1206(10)61364-6; Fiocchi A, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0055-2; Fisher HR, 2018, ANN ALLERG ASTHMA IM, V121, P313, DOI 10.1016/j.anai.2018.06.008; Fleischer DM, 2021, J ALLER CL IMM-PRACT, V9, P22, DOI 10.1016/j.jaip.2020.11.002; Fleischer DM, 2015, ANN ALLERG ASTHMA IM, V115, P87, DOI 10.1016/j.anai.2015.06.001; Folletti I, 2017, CURR OPIN ALLERGY CL, V17, P90, DOI 10.1097/ACI.0000000000000349; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Garcia MB, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236923; Gonzales-Gonzalez VA, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0245-x; Greer FR, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2019-0281; Guimaraes TC, 2015, ALLERGOL IMMUNOPATH, V43, P424, DOI 10.1016/j.aller.2014.03.004; Gupta RS, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.5630; Gupta RS, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1235; Halken S, 2021, PEDIAT ALLERG IMM-UK, V32, P843, DOI 10.1111/pai.13496; Hilvo M, 2021, JAMA PEDIATR, V175, P425, DOI [10.1001/jamapediatrics.2020.5320, 10.1001/jamapediatrics.2020.5311]; Hossny E, 2019, WORLD ALLERGY ORGAN, V12, DOI 10.1016/j.waojou.2019.100089; Host A, 2008, PEDIAT ALLERG IMM-UK, V19, P1, DOI 10.1111/j.1399-3038.2007.00680.x; Jin YX, 2019, SCI TOTAL ENVIRON, V649, P308, DOI 10.1016/j.scitotenv.2018.08.353; Kansu A, 2016, TURKISH J PEDIATR, V58, P1; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Keil T, 2010, ALLERGY, V65, P482, DOI 10.1111/j.1398-9995.2009.02171.x; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Koplin JJ, 2012, ALLERGY, V67, P1415, DOI 10.1111/all.12015; Koplin JJ, 2019, J ALLER CL IMM-PRACT, V7, P375, DOI 10.1016/j.jaip.2018.11.010; Krawiec M, 2021, ALLERGY, V76, P2684, DOI 10.1111/all.14758; Kummeling I, 2009, ALLERGY, V64, P1493, DOI 10.1111/j.1398-9995.2009.02046.x; Kung SJ, 2014, CLIN REV ALLERG IMMU, V46, P241, DOI 10.1007/s12016-012-8341-z; Kung SJ, 2011, ANN ALLERG ASTHMA IM, V106, P538, DOI 10.1016/j.anai.2011.02.003; Leal F, 1991, ACTUALIZACIONES PEDI, V1, P3; Leal F, 1991, ACTUALIZACIONES PEDI, V1, P14; Lee BW, 2010, SINGAP MED J, V51, P599; Lee TH, 2019, ASIAN PAC J ALLERGY, V37, P1, DOI 10.12932/AP-250817-0150; Leino MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071278; Li J, 2020, J ALLER CL IMM-PRACT, V8, P1349, DOI 10.1016/j.jaip.2019.11.042; Loh W, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092043; Lucas JSA, 2004, CLIN EXP ALLERGY, V34, P1115, DOI 10.1111/j.1365-2222.2004.01982.x; Mabelane T, 2018, PEDIAT ALLERG IMM-UK, V29, P841, DOI 10.1111/pai.12969; Marenholz I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01220-0; Mariscal-Castro Juan, 2020, Rev Alerg Mex, V67, P214, DOI 10.29262/ram.v67i3.740; Marrs T, 2019, ALLERGY, V74, P2212, DOI 10.1111/all.13868; Marrugo J, 2008, ALLERGOL IMMUNOPATH, V36, P320, DOI 10.1016/S0301-0546(08)75863-4; Martinez J, 2005, REV MED CHILE, V133, P195; Matthai J, 2020, INDIAN PEDIATR, V57, P723, DOI 10.1007/s13312-020-1916-5; Mendoza-Quispe Daniel, 2018, Rev. perú. med. exp. salud publica, V35, P708, DOI 10.17843/rpmesp.2018.354.3763; Michaudel C, 2018, J ALLERGY CLIN IMMUN, V142, P942, DOI 10.1016/j.jaci.2017.11.044; Muche-Borowski C, 2009, DTSCH ARZTEBL INT, V106, P625, DOI 10.3238/arztebl.2009.0625; Mulder D, 2021, MUCOSAL IMMUNOL, V4, P139; Mullins RJ, 2015, J ALLERGY CLIN IMMUN, V136, P367, DOI 10.1016/j.jaci.2015.05.009; Munasir Z, 2013, ASIA PAC ALLERGY, V3, P23, DOI 10.5415/apallergy.2013.3.1.23; Muraro A, 2004, PEDIAT ALLERG IMM-UK, V15, P291, DOI 10.1111/j.1399-3038.2004.00127.x; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Naspitz Charles K., 2004, J. Pediatr. (Rio J.), V80, P203, DOI 10.2223/1184; Navarro D, 2004, ARCH VENEZOLANOS PUE, V67, P181; Netting MJ, 2017, J ALLER CL IMM-PRACT, V5, P1617, DOI 10.1016/j.jaip.2017.03.013; Netting MJ, 2014, NUTRITION, V30, P1225, DOI 10.1016/j.nut.2014.02.015; Nurmatov U, 2017, ALLERGY, V72, P1133, DOI 10.1111/all.13124; Okubo Y, 2019, PEDIATR EMERG CARE, V35, P769, DOI 10.1097/PEC.0000000000001543; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127; Otsu K, 2011, DISCOV MED, V12, P319; Pajno GB, 2018, ALLERGY, V73, P799, DOI 10.1111/all.13319; Pelkonen AS, 2012, PEDIAT ALLERG IMM-UK, V23, P103, DOI 10.1111/j.1399-3038.2012.01298.x; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Peters RL, 2017, J ALLERGY CLIN IMMUN, V140, P145, DOI 10.1016/j.jaci.2017.02.019; Prescott SL, 2005, MED J AUSTRALIA, V182, P464, DOI 10.5694/j.1326-5377.2005.tb06787.x; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Recto MST, 2017, ASIA PAC ALLERGY, V7, P102, DOI 10.5415/apallergy.2017.7.2.102; */* S   5, 2010, J ALLERGY CLIN IMM S, V126, pS, DOI DOI 10.1016/J.JACI.2010.10.007; Sahiner UM, 2021, ALLERGY, V76, P2002, DOI 10.1111/all.14776; Sampath V, 2018, ANN ALLERG ASTHMA IM, V120, P254, DOI 10.1016/j.anai.2018.01.004; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Sanchez-Borges M, 2010, J INVEST ALLERG CLIN, V20, P623; Sasaki M, 2018, J ALLERGY CLIN IMMUN, V141, P391, DOI 10.1016/j.jaci.2017.05.041; Schafer Torsten, 2014, Allergo J Int, V23, P186; Schoemaker AA, 2015, ALLERGY, V70, P963, DOI 10.1111/all.12630; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Sigurdardottir ST, 2021, ALLERGY, V76, P2855, DOI 10.1111/all.14857; Sole D, 2018, SOC BRASILEIRA PED 2, V2, P39, DOI DOI 10.5935/2526-5393.20180005; Soriano VX, 2019, J ALLERGY CLIN IMMUN, V144, P1327, DOI 10.1016/j.jaci.2019.07.032; Soto-Quiros M, 1998, ALLERGY, V53, P1141, DOI 10.1111/j.1398-9995.1998.tb03833.x; Stiefel G, 2017, CLIN EXP ALLERGY, V47, P719, DOI 10.1111/cea.12957; SUAREZFARINAS M, 2021, ACCURATE REPROD DIAG, DOI DOI 10.1111/ALL.14905; Sudharson S, 2021, ALLERGY, V76, P3359, DOI 10.1111/all.15021; Sweeney A, 2021, ALLERGY ASTHMA CL IM, V17, DOI 10.1186/s13223-021-00531-8; Tang R, 2019, CLIN REV ALLERG IMMU, V57, P98, DOI 10.1007/s12016-018-8725-9; Tham EH, 2019, PEDIAT ALLERG IMM-UK, V30, P681, DOI 10.1111/pai.13098; Tham EH, 2018, PEDIAT ALLERG IMM-UK, V29, P18, DOI 10.1111/pai.12820; Togias A, 2017, ANN ALLERG ASTHMA IM, V118, P166, DOI 10.1016/j.anai.2016.10.004; Turner PJ, 2018, CLIN EXP ALLERGY, V48, P912, DOI 10.1111/cea.13218; Uotila R, 2020, ALLERGY, V75, P2977, DOI 10.1111/all.14430; van Ginkel CD, 2018, ALLERGY, V73, P1337, DOI 10.1111/all.13432; Venter C, 2020, J ALLER CL IMM-PRACT, V8, P2017, DOI 10.1016/j.jaip.2020.01.029; Venter C, 2020, ALLERGY, V75, P497, DOI 10.1111/all.14051; Vickery BP, 2017, J ALLERGY CLIN IMMUN, V139, P173, DOI 10.1016/j.jaci.2016.05.027; Vita AA, 2019, J LEUKOCYTE BIOL, V106, P95, DOI 10.1002/JLB.3MIR1118-414RR; Wang H, 2020, INT J DERMATOL VENER, V3, P135; Wang M, 2019, J ALLERGY CLIN IMMUN, V143, P1892, DOI 10.1016/j.jaci.2018.11.016; Warren CM, 2021, J ALLER CL IMM-PRACT, V9, P4087, DOI 10.1016/j.jaip.2021.07.020; Warren CM, 2021, IMMUNOL ALLERGY CLIN, V41, P189, DOI 10.1016/j.iac.2021.01.007; Warren CM, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-0898-7; Winters A, 2019, J ALLERGY CLIN IMMUN, V143, P2326, DOI 10.1016/j.jaci.2019.02.016; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xepapadaki P, 2016, ALLERGY, V71, P350, DOI 10.1111/all.12801; Xian M, 2020, ALLERGY ASTHMA IMMUN, V12, P56, DOI 10.4168/aair.2020.12.1.56; Xian M, 2016, J ALLERGY CLIN IMMUN, V138, P890, DOI 10.1016/j.jaci.2016.07.003; Yanagida N, 2016, ALLERGOL INT, V65, P135, DOI 10.1016/j.alit.2015.10.010; Yu SS, 2021, ADV THER, V38, P4321, DOI 10.1007/s12325-021-01843-2	170	14	14	18	58	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2021	148	6					1347	1364		10.1016/j.jaci.2021.10.018	http://dx.doi.org/10.1016/j.jaci.2021.10.018		DEC 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XM1ZO	34872649	Green Accepted			2022-12-18	WOS:000728634000001
J	Shamji, MH; Larson, D; Eifan, A; Scadding, GW; Qin, TL; Lawson, K; Sever, ML; Macfarlane, E; Layhadi, JA; Wurtzen, PA; Parkin, RV; Sanda, S; Harris, KM; Nepom, GT; Togias, A; Durham, SR				Shamji, Mohamed H.; Larson, David; Eifan, Aarif; Scadding, Guy W.; Qin, Tielin; Lawson, Kaitie; Sever, Michelle L.; Macfarlane, Ellen; Layhadi, Janice A.; Wurtzen, Peter A.; Parkin, Rebecca, V; Sanda, Srinath; Harris, Kristina M.; Nepom, Gerald T.; Togias, Alkis; Durham, Stephen R.			Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Sublingual immunotherapy; subcutaneous immuno-therapy; IgE-FAB; blocking antibodies; IgG(4); IgA(1); IgA(2); allergic rhinitis	POLLEN IMMUNOTHERAPY; BINDING; CELLS	Introduction: There is no detailed comparison of allergen-specific immunoglobulin responses following sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT). Objective: We sought to compare nasal and systemic timothy grass pollen (TGP)-specific antibody responses during 2 years of SCIT and SLIT and 1 year after treatment discontinuation in a double-blind, double-dummy, placebo-controlled trial. Methods: Nasal fluid and serum were obtained yearly (perprotocol population, n = 84). TGP-specific IgA(1), IgA(2), IgG(4), IgG, and IgE were measured in nasal fluids by ELISA. TGPspecific IgA(1), IgA(2), and Phleum pratense (Phl p)1, 2, 4, 5b, 6, 7, 11, and 12 IgE and IgG(4) were measured in sera by ELISA and ImmunoCAP, respectively. Results: At years 2 and 3, TGP-IgA(1/2) levels in nasal fluid were elevated in SLIT compared with SCIT (4.2- and 3.0-fold for IgA(1), 2.0- and 1.8-fold for IgA(2), respectively; all P<.01). TGP-IgA(1) level in serum was elevated in SLIT compared with SCIT at years 1, 2, and 3 (4.6-, 5.1-, and 4.7-fold, respectively; all P<.001). Serum TGP-IgG level was higher in SCIT compared with SLIT (2.8-fold) at year 2. Serum TGP-IgG(4) level was higher in SCIT compared with SLIT at years 1, 2, and 3 (10.4-, 27.4-, and 5.1-fold, respectively; all P<.01). Serum IgG(4) levels to Phl p1, 2, 5b, and 6 were increased at years 1, 2, and 3 in SCIT and SLIT compared with placebo (Phl p1: 11.8- and 3.9-fold; Phl p2: 31.6- and 4.4-fold; Phl p5b: 135.5- and 5.3-fold; Phl p6: 145.4- and 14.7-fold, respectively, all at year 2 when levels peaked; P<.05). IgE to TGP in nasal fluid increased in the SLIT group at year 2 but not at year 3 compared with SCIT (2.8-fold; P = .04) and placebo (3.1-fold; P = .02). IgA to TGP and IgE and IgG(4) to TGP components stratified participants according to treatment group and clinical response. Conclusions: The observed induction of IgA(1/2) in SLIT and IgG(4) in SCIT suggest key differences in the mechanisms of action.	[Shamji, Mohamed H.; Eifan, Aarif; Scadding, Guy W.; Macfarlane, Ellen; Layhadi, Janice A.; Parkin, Rebecca, V; Durham, Stephen R.] Imperial Coll, Natl Heart & Lung Inst Allergy & Clin Immunol, Asthma UK Ctr Allerg Mech Asthma, NIHR Biomed Res Ctr, London, England; [Larson, David; Qin, Tielin; Harris, Kristina M.; Nepom, Gerald T.; Durham, Stephen R.] Immune Tolerance Network, Bethesda, MD USA; [Lawson, Kaitie; Sever, Michelle L.] Rho Fed Syst Div, Durham, NC USA; [Wurtzen, Peter A.] ALK, Translat Res, Horsholm, Denmark; [Sanda, Srinath] Immune Tolerance Network, San Francisco, CA USA; [Nepom, Gerald T.] Virginia Mason, Benaroya Res Inst, Seattle, WA USA; [Togias, Alkis] NIAID, NIH, Rockville, MD USA	Imperial College London; University of London; King's College London; Immune Tolerance Network; Immune Tolerance Network; Benaroya Research Institute; Virginia Mason Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shamji, MH (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	m.shamji@imperial.ac.uk		Layhadi, Janice/0000-0002-5242-1806	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [UM1AI109565]; Immune Tolerance Network	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Immune Tolerance Network	The research reported in this publication was sponsored by the Immune Tolerance Network and supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award no. UM1AI109565). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berger William E, 2004, Paediatr Drugs, V6, P233, DOI 10.2165/00148581-200406040-00003; Burks AW, 2013, J ALLERGY CLIN IMMUN, V131, P1288, DOI 10.1016/j.jaci.2013.01.049; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Hoof I, 2020, J ALLERGY CLIN IMMUN, V146, P180, DOI 10.1016/j.jaci.2019.11.046; Huoman J, 2019, PEDIAT ALLERG IMM-UK, V30, P522, DOI 10.1111/pai.13047; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Mobs C, 2012, J ALLERGY CLIN IMMUN, V130, P1108, DOI 10.1016/j.jaci.2012.07.056; Mobs C, 2010, J IMMUNOL, V184, P2194, DOI 10.4049/jimmunol.0901379; Pilette C, 2007, J IMMUNOL, V178, P4658, DOI 10.4049/jimmunol.178.7.4658; PLATTSMILLS TAE, 1976, J CLIN INVEST, V57, P1041, DOI 10.1172/JCI108346; Radulovic S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002893.pub2; Renand A, 2018, J ALLERGY CLIN IMMUN, V141, P1750, DOI 10.1016/j.jaci.2017.09.041; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Shamji MH, 2012, ALLERGY, V67, P217, DOI 10.1111/j.1398-9995.2011.02745.x; Shamji MH, 2006, J IMMUNOL METHODS, V317, P71, DOI 10.1016/j.jim.2006.09.004; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P2086, DOI 10.1016/j.jaci.2019.02.001; Shamji MH, 2019, J ALLERGY CLIN IMMUN, V143, P1067, DOI 10.1016/j.jaci.2018.09.039; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Wambre E, 2014, J ALLERGY CLIN IMMUN, V133, P872, DOI 10.1016/j.jaci.2013.10.054; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wollmann E, 2015, J ALLERGY CLIN IMMUN, V136, P806, DOI 10.1016/j.jaci.2015.02.034	27	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2021	148	4					1061	+		10.1016/j.jaci.2021.03.030	http://dx.doi.org/10.1016/j.jaci.2021.03.030		OCT 2021	22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WD6BK	33819508	hybrid			2022-12-18	WOS:000705023300016
J	Buchheit, KM; Lewis, E; Gakpo, D; Hacker, J; Sohail, A; Taliaferro, F; Giron, EB; Asare, C; Vukovic, M; Bensko, JC; Dwyer, DF; Shalek, AK; Ordovas-Montanes, J; Laidlaw, TM				Buchheit, Kathleen M.; Lewis, Erin; Gakpo, Deborah; Hacker, Jonathan; Sohail, Aaqib; Taliaferro, Faith; Giron, Evans Berreondo; Asare, Chelsea; Vukovic, Marko; Bensko, Jillian C.; Dwyer, Daniel F.; Shalek, Alex K.; Ordovas-Montanes, Jose; Laidlaw, Tanya M.			Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aspirin-exacerbated respiratory disease; IL-5; nasal polyp; mepolizumab; prostaglandin F-2 alpha; prostaglandin D-2; CRTH2; chronic rhinosinusitis; leukotriene	PROSTAGLANDIN D-2; CHEMOATTRACTANT RECEPTOR; MAST-CELLS; CHRONIC RHINOSINUSITIS; HUMAN EOSINOPHILS; LEUKOTRIENE C-4; IN-VITRO; GENERATION; RELEASE; INTERLEUKIN-5	Background: Eosinophilic asthma and nasal polyposis are hallmarks of aspirin-exacerbated respiratory disease (AERD), and IL-5 inhibition has been shown to provide therapeutic benefit. However, IL-5R alpha is expressed on many cells in addition to eosinophils, and the mechanisms by which IL-5 inhibition leads to clinical benefit in eosinophilic asthma and nasal polyposis are unlikely to be due exclusively to antieosinophil effects. Objective: We sought to identify the mechanisms by which anti-IL-5 treatment with mepolizumab improves respiratory inflammation in AERD. Methods: The clinical characteristics, circulating granulocytes, nasal scraping transcripts, eosinophilic cationic protein, tryptase, and antibody levels, and urinary and nasal eicosanoid levels were measured for 18 subjects with AERD who were taking mepolizumab and compared with those of 18 matched subjects with AERD who were not taking mepolizumab. Results: Subjects taking mepolizumab had significantly fewer peripheral blood eosinophils and basophils, and those cells that remained had higher surface CRTH2 expression than did the cells from subjects not taking mepolizumab. Nasal prostaglandin F-2 alpha, prostaglandin D-2 metabolites, leukotriene B-4, and thromboxane levels were lower in subjects taking mepolizumab, as were urinary levels of tetranor-prostaglandin D-2 and leukotriene E-4. The nasal epithelial cell transcripts that were overexpressed among subjects with AERD who were taking mepolizumab were enriched for genes involved in tight junction formation and cilium organization. Nasal and urinary prostaglandin E-2, tryptase, and antibody levels were not different between the 2 groups. Conclusion: IL-5 inhibition in AERD decreases production of inflammatory eicosanoids and upregulates tight junction-associated nasal epithelial cell transcripts, likely due to decreased IL-5 signaling on tissue mast cells, eosinophils, and epithelial cells. These direct effects on multiple relevant immune cells contribute to the mechanism of benefit afforded by mepolizumab.	[Buchheit, Kathleen M.; Sohail, Aaqib; Dwyer, Daniel F.; Laidlaw, Tanya M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Buchheit, Kathleen M.; Lewis, Erin; Gakpo, Deborah; Hacker, Jonathan; Sohail, Aaqib; Bensko, Jillian C.; Dwyer, Daniel F.; Laidlaw, Tanya M.] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA; [Taliaferro, Faith; Giron, Evans Berreondo; Asare, Chelsea; Ordovas-Montanes, Jose] Boston Childrens Hosp, Div Gastroenterol, Cambridge, MA USA; [Taliaferro, Faith; Vukovic, Marko; Shalek, Alex K.; Ordovas-Montanes, Jose] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Vukovic, Marko; Shalek, Alex K.] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Cambridge, MA USA; [Vukovic, Marko; Shalek, Alex K.] MIT, Dept Chem, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Vukovic, Marko; Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.; Ordovas-Montanes, Jose] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA; [Shalek, Alex K.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA; [Ordovas-Montanes, Jose] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard University	Laidlaw, TM (corresponding author), Brigham & Womens Hosp, 60 Fenwood Rd,Bldg Transformat Med,Rm 5002M, Boston, MA 02115 USA.	taidlaw@bwh.harvard.edu		Bensko, Jillian/0000-0002-0363-6093; Sohail, Aaqib/0000-0002-5917-7316	GlaxoSmithKline; National Institutes of Health [U19AI095219, K23AI139352, R01HL128241, 5U24AI118672]; Vinik Family; Kaye Family; Richard and Susan Smith Family Foundation; HHMI Damon Runyon Cancer Research Foundation Fellowship [DRG-2274-16]; AGA Research Foundation's AGA-Takeda Pharmaceuticals Research Scholar Award [AGA2020-13-01]; Food Allergy Science Initiative; New York Stem Cell Foundation; Beckman Young Investigator Program, a Sloan Fellowship in Chemistry	GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vinik Family; Kaye Family; Richard and Susan Smith Family Foundation; HHMI Damon Runyon Cancer Research Foundation Fellowship; AGA Research Foundation's AGA-Takeda Pharmaceuticals Research Scholar Award; Food Allergy Science Initiative; New York Stem Cell Foundation; Beckman Young Investigator Program, a Sloan Fellowship in Chemistry	Supported by GlaxoSmithKline, the National Institutes of Health (grants U19AI095219, K23AI139352, and R01HL128241), and generous contributions from the Vinik and Kaye Families. J.O.M. is a New York Stem Cell Foundation-Robertson Investigator, and he was supported by the Richard and Susan Smith Family Foundation, the HHMI Damon Runyon Cancer Research Foundation Fellowship (grant DRG-2274-16), the AGA Research Foundation's AGA-Takeda Pharmaceuticals Research Scholar Award in IBD (grant AGA2020-13-01), the Food Allergy Science Initiative, and The New York Stem Cell Foundation. A.K.S. was supported by the Beckman Young Investigator Program, a Sloan Fellowship in Chemistry, and the National Institutes of Health (grant 5U24AI118672).	Bachert C, 2017, J ALLERGY CLIN IMMUN, V140, P1024, DOI 10.1016/j.jaci.2017.05.044; Ban GY, 2017, CLIN EXP ALLERGY, V47, P37, DOI 10.1111/cea.12797; Barretto KT, 2020, ALLERGY, V75, P2127, DOI 10.1111/all.14297; Bhattacharyya N, 2009, ANN OTO RHINOL LARYN, V118, P185, DOI 10.1177/000348940911800305; BISCHOFF SC, 1990, J EXP MED, V172, P1577, DOI 10.1084/jem.172.6.1577; Bochenek G, 2003, J ALLERGY CLIN IMMUN, V111, P743, DOI 10.1067/mai.2003.1387; Boehme SA, 2009, INT IMMUNOL, V21, P621, DOI 10.1093/intimm/dxp031; Buchheit KM, 2020, J ALLERGY CLIN IMMUN, V145, P1574, DOI 10.1016/j.jaci.2020.02.035; Busse WW, 1998, AM J RESP CRIT CARE, V157, pS210, DOI 10.1164/ajrccm.157.6.mar-1; Cahill KN, 2015, J ALLERGY CLIN IMMUN, V135, P245, DOI 10.1016/j.jaci.2014.07.031; Campbell AP, 2017, ANN ALLERG ASTHMA IM, V118, P286, DOI 10.1016/j.anai.2016.12.012; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gorski SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221113; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hamada Kazuyuki, 2004, Allergology International, V53, P179, DOI 10.1111/j.1440-1592.2004.00323.x; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; Hulse KE, 2013, J ALLERGY CLIN IMMUN, V131, P1075, DOI 10.1016/j.jaci.2013.01.043; KAJITA T, 1985, INT ARCH ALLER A IMM, V78, P406, DOI 10.1159/000233922; KOWALSKI ML, 1993, J ALLERGY CLIN IMMUN, V91, P580, DOI 10.1016/0091-6749(93)90264-G; KROEGEL C, 1993, IMMUNOLOGY, V78, P279; Laidlaw TM, 2019, LARYNGOSCOPE, V129, pE61, DOI 10.1002/lary.27564; Laidlaw TM, 2015, J ALLERGY CLIN IMMUN, V135, P1407, DOI 10.1016/j.jaci.2015.02.005; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Lazarinis N, 2018, J ALLERGY CLIN IMMUN, V142, P1080, DOI 10.1016/j.jaci.2018.02.024; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu T, 2013, P NATL ACAD SCI USA, V110, P16987, DOI 10.1073/pnas.1313185110; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; MATHE AA, 1973, BRIT MED J, V1, P193, DOI 10.1136/bmj.1.5847.193; MATSUMOTO S, 1995, PROSTAG LEUKOTR ESS, V52, P417, DOI 10.1016/0952-3278(95)90071-3; McMains KC, 2006, AM J RHINOL, V20, P573, DOI 10.2500/ajr.2006.20.2913; Mesquita-Santos FP, 2006, J IMMUNOL, V176, P1326, DOI 10.4049/jimmunol.176.3.1326; Mita H, 1999, PROSTAG LEUKOTR ESS, V60, P175, DOI 10.1054/plef.1999.0022; Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041; Moon TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108595; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Ochi H, 2000, P NATL ACAD SCI USA, V97, P10509, DOI 10.1073/pnas.180318697; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pal K, 2019, AM J RESP CELL MOL, V60, P413, DOI 10.1165/rcmb.2018-0175OC; Peinhaupt M, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00104; Pinto S, 1997, PROSTAG LEUKOTR ESS, V57, P533, DOI 10.1016/S0952-3278(97)90556-1; RASP G, 1994, CLIN EXP ALLERGY, V24, P1151, DOI 10.1111/j.1365-2222.1994.tb03321.x; ROTHENBERG ME, 1989, J IMMUNOL, V143, P2311; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; Sandig H, 2006, FEBS LETT, V580, P373, DOI 10.1016/j.febslet.2005.11.052; SCHLEIMER RP, 1983, J CLIN INVEST, V71, P1830, DOI 10.1172/JCI110938; Sestini P, 1996, AM J RESP CRIT CARE, V153, P572, DOI 10.1164/ajrccm.153.2.8564100; SMITH AP, 1975, CLIN SCI MOL MED, V48, P421, DOI 10.1042/cs0480421; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Stojkovi UB, 2018, EUR RESPIR J, V52, P1132; Sun LM, 2018, DIAGN PATHOL, V13, DOI 10.1186/s13000-018-0749-1; Takatsu K, 1998, CYTOKINE GROWTH F R, V9, P25, DOI 10.1016/S1359-6101(97)00034-8; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463; Thwaites RS, 2018, JOVE-J VIS EXP, DOI 10.3791/56413; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; Tsukamoto N, 2016, CLIN PHARM DRUG DEV, V5, P102, DOI 10.1002/cpdd.205; Tuttle KL, 2018, J ALLER CL IMM-PRACT, V6, P1045, DOI 10.1016/j.jaip.2018.01.038; Ugajin T, 2011, AM J PATHOL, V179, P775, DOI 10.1016/j.ajpath.2011.04.023; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wright AKA, 2019, ALLERGY, V74, P2488, DOI 10.1111/all.13879; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x	69	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					574	584		10.1016/j.jaci.2021.05.043	http://dx.doi.org/10.1016/j.jaci.2021.05.043		AUG 2021	11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UD3IW	34144111	Green Accepted			2022-12-18	WOS:000687104900009
J	Vavassori, S; Chou, JE; Faletti, LE; Haunerdinger, V; Opitz, L; Joset, P; Fraser, CJ; Prader, S; Gao, XF; Schuch, LA; Wagner, M; Hoefele, J; Maccari, ME; Zhu, Y; Elakis, G; Gabbett, MT; Forstner, M; Omran, H; Kaiser, T; Kessler, C; Olbrich, H; Frosk, P; Almutairi, A; Platt, CD; Elkins, M; Weeks, S; Rubin, T; Planas, R; Marchetti, T; Koovely, D; Klambt, V; Soliman, NA; von Hardenberg, S; Klemann, C; Baumann, U; Lenz, D; Klein-Franke, A; Schwemmle, M; Huber, M; Sturm, E; Hartleif, S; Haaffner, K; Gimpel, C; Brotschi, B; Laube, G; Gungor, T; Buckley, MF; Kottke, R; Staufner, C; Hildebrandt, F; Reu-Hofer, S; Moll, S; Weber, A; Kaur, H; Ehl, S; Hiller, S; Geha, R; Roscioli, T; Griese, M; Schmid, JP				Vavassori, Stefano; Chou, Janet; Faletti, Laura Eva; Haunerdinger, Veronika; Opitz, Lennart; Joset, Pascal; Fraser, Christopher J.; Prader, Seraina; Gao, Xianfei; Schuch, Luise A.; Wagner, Matias; Hoefele, Julia; Maccari, Maria Elena; Zhu, Ying; Elakis, George; Gabbett, Michael T.; Forstner, Maria; Omran, Heymut; Kaiser, Thomas; Kessler, Christina; Olbrich, Heike; Frosk, Patrick; Almutairi, Abduarahman; Platt, Craig D.; Elkins, Megan; Weeks, Sabrina; Rubin, Tamar; Planas, Raquel; Marchetti, Tommaso; Koovely, Danil; Klambt, Verena; Soliman, Neveen A.; von Hardenberg, Sandra; Klemann, Christian; Baumann, Ulrich; Lenz, Dominic; Klein-Franke, Andreas; Schwemmle, Martin; Huber, Michael; Sturm, Ekkehard; Hartleif, Steffen; Haffner, Karsten; Gimpel, Charlotte; Brotschi, Barbara; Laube, Guido; Gungor, Tayfun; Buckley, Michael F.; Kottke, Raimund; Staufner, Christian; Hildebrandt, Friedhelm; Reu-Hofer, Simone; Moll, Solange; Weber, Achim; Kaur, Hundeep; Ehl, Stephan; Hiller, Sebastian; Geha, Raif; Roscioli, Tony; Griese, Matthias; Schmid, Jana Pachlopnik			Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ZNFX1; type I interferon; susceptibility to viral infections; HLH-like disease; virally induced hepatitis; thrombotic microangiopathy; &nbsp; leukoencephalopathy; brain calcification; interstitial lung disease	THROMBOTIC MICROANGIOPATHY; STAT2 DEFICIENCY; INTERFERON; MEASLES; ILLNESS; BINDING; LOAD	Background: Recognition of viral nucleic acids is one of the primary triggers for a type I interferon-mediated antiviral immune response. Inborn errors of type I interferon immunity can be associated with increased inflammation and/or increased susceptibility to viral infections as a result of dysbalanced interferon production. NFX1-type zinc finger-containing 1 (ZNFX1) is an interferon-stimulated double-stranded RNA sensor that restricts the replication of RNA viruses in mice. The role of ZNFX1 in the human immune response is not known. Objective: We studied 15 patients from 8 families with an autosomal recessive immunodeficiency characterized by severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes with hemophagocytic lymphohistiocytosislike disease, early-onset seizures, and renal and lung disease. Methods: Whole exome sequencing was performed on 13 patients from 8 families. We investigated the transcriptome, posttranscriptional regulation of interferon-stimulated genes (ISGs) and predisposition to viral infections in primary cells from patients and controls stimulated with synthetic double stranded nucleic acids. Results: Deleterious homozygous and compound heterozygous ZNFX1 variants were identified in all 13 patients. Stimulation of patient-derived primary cells with synthetic double-stranded nucleic acids was associated with a deregulated pattern of expression of ISGs and alterations in the half-life of the mRNA of ISGs and also associated with poorer clearance of viral infections by monocytes. Conclusion: ZNFX1 is an important regulator of the response to double-stranded nucleic acids stimuli following viral infections. ZNFX1 deficiency predisposes to severe viral infections and a multisystem inflammatory disease. (J Allergy Clin Immunol 2021;148:381-93.)	[Vavassori, Stefano; Prader, Seraina; Planas, Raquel; Marchetti, Tommaso; Koovely, Danil; Schmid, Jana Pachlopnik] Univ Childrens Hosp Zurich, Div Immunol, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Vavassori, Stefano; Haunerdinger, Veronika; Prader, Seraina; Planas, Raquel; Marchetti, Tommaso; Koovely, Danil; Gungor, Tayfun; Schmid, Jana Pachlopnik] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Haunerdinger, Veronika; Gungor, Tayfun] Univ Childrens Hosp Zurich, Div Stem Cell Transplantat, Zurich, Switzerland; [Brotschi, Barbara] Univ Childrens Hosp Zurich, Dept Pediat & Neonatal Intens Care, Zurich, Switzerland; [Laube, Guido] Univ Childrens Hosp Zurich, Div Nephrol, Zurich, Switzerland; [Kottke, Raimund] Univ Childrens Hosp Zurich, Div Neuroradiol, Dept Diagnost Imaging & Intervent, Zurich, Switzerland; [Chou, Janet; Almutairi, Abduarahman; Platt, Craig D.; Elkins, Megan; Weeks, Sabrina; Geha, Raif] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA; [Klambt, Verena; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Faletti, Laura Eva; Maccari, Maria Elena; Ehl, Stephan] Univ Freiburg, Inst Immunodeficiency, Ctr Chron Immunodeficiency, Freiburg, Germany; [Schwemmle, Martin] Univ Freiburg, Inst Virol, Freiburg, Germany; [Haffner, Karsten; Gimpel, Charlotte] Univ Freiburg, Dept Internal Med Nephrol 4, Med Ctr, Fac Med, Freiburg, Germany; [Opitz, Lennart; Klemann, Christian; Baumann, Ulrich] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Huber, Michael] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Joset, Pascal] Univ Zurich, Inst Med Genet, Schlieren, Switzerland; [Fraser, Christopher J.] Queensland Childrens Hosp, South Brisbane, Australia; [Gao, Xianfei; Schuch, Luise A.; Forstner, Maria; Griese, Matthias] Univ Hosp Munich, German Ctr Lung Res DZL, Div Pediat Pneumol, Dr von Hauner Childrens Hosp, Munich, Germany; [Wagner, Matias; Hoefele, Julia] Tech Univ Munich, Inst Human Genet, Sch Med, Klinikum Rechts Isar, Munich, Germany; [Zhu, Ying; Elakis, George; Buckley, Michael F.; Roscioli, Tony] Prince Wales Hosp, New South Wales Hlth Pathol Genom, Sydney, NSW, Australia; [Gabbett, Michael T.] Queensland Univ Technol, Sch Biomed Sci, Ctr Genom & Personalised Hlth, Brisbane, Qld, Australia; [Omran, Heymut; Kaiser, Thomas; Kessler, Christina; Olbrich, Heike] Univ Hosp Munster, Clin Gen Pediat, Munster, Germany; [Frosk, Patrick] Univ Manitoba, Div Clin Immunol & Allergy, Winnipeg, MB, Canada; [Rubin, Tamar] Univ Manitoba, Div Pediat Clin Immunol & Allergy, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Almutairi, Abduarahman] Secur Forces Hosp, Dept Pediat, Riyadh, Saudi Arabia; [Soliman, Neveen A.] Cairo Univ, Dept Pediat, Ctr Pediat Nephrol & Transplantat, Cairo, Egypt; [von Hardenberg, Sandra] Hannover Med Sch, Dept Human Genet, Hannover, Germany; Hannover Med Sch, Dept Paediat Pulmonol Allergy & Neonatol, Hannover, Germany; [Lenz, Dominic; Staufner, Christian] Univ Hosp Heidelberg, Div Neuropediat & Pediat Metab Med, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Klein-Franke, Andreas] Cantonal Hosp Aarau, Div Pediat Hematol & Oncol, Aarau, Switzerland; [Sturm, Ekkehard; Hartleif, Steffen] Univ Hosp Tubingen, Div Pediat Gastroenterol & Hepatol, Tubingen, Germany; [Reu-Hofer, Simone] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Moll, Solange] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Weber, Achim] Univ Hosp, Dept Pathol & Mol Pathol, Zurich, Switzerland; [Weber, Achim] Univ Hosp, Inst Mol Canc Res, Zurich, Switzerland; [Weber, Achim] Univ Zurich, Zurich, Switzerland; [Kaur, Hundeep; Hiller, Sebastian] Univ Basel, Biozentrum, Basel, Switzerland; [Roscioli, Tony] Sydney Childrens Hosp, Ctr Clin Genet, Randwick, NSW, Australia; [Roscioli, Tony] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Roscioli, Tony] Univ New South Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Schmid, Jana Pachlopnik] Univ Zurich, Pediat Immunol, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Freiburg; University of Freiburg; University of Freiburg; University of Zurich; University of Zurich; University of Munich; Technical University of Munich; Queensland University of Technology (QUT); University of Munster; University of Manitoba; University of Manitoba; Security Forces Hospital - Saudi Arabia; Egyptian Knowledge Bank (EKB); Cairo University; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; Kantonsspital Aarau AG (KSA); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Wurzburg; University of Geneva; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Basel; University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; University of Zurich	Schmid, JP (corresponding author), Univ Childrens Hosp Zurich, Div Immunol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.; Geha, R (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu; jana.pachlopnik@kispi.uzh.ch	Lenz, Dominic/GPC-7935-2022; Planas, Raquel/B-6092-2019; Huber, Michael/B-8509-2015; Hiller, Sebastian/B-3573-2008	Planas, Raquel/0000-0002-2478-997X; Huber, Michael/0000-0002-0384-0000; Lenz, Dominic/0000-0002-9561-8190; Brotschi, Barbara/0000-0002-4472-5199; Omran, Heymut/0000-0003-0282-6765; Hiller, Sebastian/0000-0002-6709-4684; Klemann, Christian/0000-0002-5639-8690; Maccari, Maria Elena/0000-0001-6488-7622; Hoefele, Julia/0000-0002-7917-7129; Marchetti, Tommaso/0000-0002-2884-1472; Gabbett, Michael/0000-0002-5828-315X; Klambt, Verena/0000-0003-1180-0794; Gungor, Tayfun/0000-0002-3261-1186; Kottke, Raimund/0000-0003-0166-2770	Schwyzer-Winiker Foundation (Zurich, Switzerland); University of Zurich's Clinical Research Priority Program CYTIMM-Z; Novartis Foundation for Biomedical Research (Basel, Switzerland); Promedica, the Beatrice Ederer-Weber Foundation (Zurich, Switzerland); Helmut Horten Foundation (Zurich, Switzerland); University of Zurich's Cancer Research Center Funding program; National Institutes of Health grants [5K08 AI116979-04, 1R01AI13963301]; Perkin Fund; Deutsche Forschungsgemeinschaft, Germany [SFB1160, TPA01, EXC-2189, 390939984]; Bundesministerium f_ur Bildung und Forschung, Germany (grant HCQ4Surfdefect/E-Rare-3); Deutsche Forschungsgemeinschaft [970/9-1]; German Center for Lung Research (DZL) [FKZ 82DZL23A2]; Dietmar Hopp Foundation (St. Leon-Rot, Germany) [23011235]	Schwyzer-Winiker Foundation (Zurich, Switzerland); University of Zurich's Clinical Research Priority Program CYTIMM-Z; Novartis Foundation for Biomedical Research (Basel, Switzerland); Promedica, the Beatrice Ederer-Weber Foundation (Zurich, Switzerland); Helmut Horten Foundation (Zurich, Switzerland); University of Zurich's Cancer Research Center Funding program; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perkin Fund; Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Bundesministerium f_ur Bildung und Forschung, Germany (grant HCQ4Surfdefect/E-Rare-3); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Center for Lung Research (DZL); Dietmar Hopp Foundation (St. Leon-Rot, Germany)	Funded by grants from the Schwyzer-Winiker Foundation (Zurich, Switzerland [to S.P. and J.P.S.]), the University of Zurich's Clinical Research Priority Program CYTIMM-Z (to R.P. and J.P.S.), the Novartis Foundation for Biomedical Research (Basel, Switzerland [to D.K. and J.P.S.]), Promedica, the Beatrice Ederer-Weber Foundation (Zurich, Switzerland), the Helmut Horten Foundation (Zurich, Switzerland), the University of Zurich's Cancer Research Center Funding program (to S.V. and J.P.S.), National Institutes of Health grants 5K08 AI116979-04 (to J.C.) and 1R01AI13963301 (to R.S.G.), the Perkin Fund (to R.S.G.), the Deutsche Forschungsgemeinschaft, Germany (grants SFB1160, TPA01 and EXC-2189, as well as grant 390939984 [to S.E.]), the Bundesministerium f_ur Bildung und Forschung, Germany (grant HCQ4Surfdefect/E-Rare-3 [to M.G.]), the Deutsche Forschungsgemeinschaft (grant 970/9-1 [to M.G.]), the German Center for Lung Research (DZL) (grant FKZ 82DZL23A2 [to M.F.]), and the Dietmar Hopp Foundation (St. Leon-Rot, Germany; grant 23011235 [to C.S.]).	Beuthien W, 2005, CLIN RHEUMATOL, V24, P507, DOI 10.1007/s10067-005-1093-x; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; Duncan CJA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4227; Filipovich AH, 2011, CURR OPIN ALLERGY CL, V11, P512, DOI 10.1097/ACI.0b013e32834c22f5; Gayden T, 2018, NAT GENET, V50, P1650, DOI 10.1038/s41588-018-0251-4; Gloude NJ, 2020, J CLIN IMMUNOL, V40, P699, DOI 10.1007/s10875-020-00789-4; Hamada H, 2019, INT J ONCOL, V55, P896, DOI 10.3892/ijo.2019.4860; Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110; HARVEY M, 1994, AM J HEMATOL, V46, P152, DOI 10.1002/ajh.2830460220; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Hernandez N, 2019, J EXP MED, V216, P2057, DOI 10.1084/jem.20182295; Hernandez N, 2018, J EXP MED, V215, P2567, DOI 10.1084/jem.20180628; Hunt D, 2014, NEW ENGL J MED, V370, P1270, DOI 10.1056/NEJMc1316118; Ishidate T, 2018, MOL CELL, V70, P639, DOI 10.1016/j.molcel.2018.04.009; Kavanagh D, 2016, BLOOD, V128, P2824, DOI 10.1182/blood-2016-05-715987; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lam MT, 2019, J EXP MED, V216, P2778, DOI 10.1084/jem.20190147; Lavreys L, 2002, CLIN INFECT DIS, V35, P77, DOI 10.1086/340862; Lim HK, 2019, J EXP MED, V216, P2038, DOI 10.1084/jem.20181621; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Malavige GN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003789; Moens L, 2017, J ALLERGY CLIN IMMUN, V139, P1995, DOI 10.1016/j.jaci.2016.10.033; MONAFO WJ, 1994, J PEDIATR-US, V124, P273, DOI 10.1016/S0022-3476(94)70318-3; Pujadas E, 2020, LANCET RESP MED, V8, pE70, DOI 10.1016/S2213-2600(20)30354-4; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmid JP, 2010, IMMUNOL REV, V235, P10, DOI 10.1111/j.0105-2896.2010.00890.x; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Schwerk J, 2019, NAT IMMUNOL, V20, P1610, DOI 10.1038/s41590-019-0527-6; Sood SB, 2017, CLIN CASE REP, V5, P1765, DOI 10.1002/ccr3.1174; Szilasiova J, 2009, CLIN NEUROPHARMACOL, V32, P301, DOI 10.1097/WNF.0b013e3181a2b5fd; Tavernier SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12704-6; Volkmer B, 2019, J ALLERGY CLIN IMMUN, V144, P1441, DOI 10.1016/j.jaci.2019.07.038; Wang Y, 2019, NAT CELL BIOL, V21, P1346, DOI 10.1038/s41556-019-0416-0; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570	37	14	14	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2021	148	2					381	393		10.1016/j.jaci.2021.03.045	http://dx.doi.org/10.1016/j.jaci.2021.03.045		AUG 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	TZ7BX	33872655	Green Accepted, Green Published			2022-12-18	WOS:000684625700016
J	Camoretti-Mercado, B; Lockey, RF				Camoretti-Mercado, Blanca; Lockey, Richard F.			Airway smooth muscle pathophysiology in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Airway smooth muscle; airway remodeling; asthma; deep inspiration; inflammation; bronchodilation; bronchoconstric-tion; bronchial thermoplasty; genetics; epigenetics; bitter taste re-ceptors; olfactory receptors	GENOME-WIDE ASSOCIATION; BITTER TASTE RECEPTORS; TO-MODERATE ASTHMA; NF-KAPPA-B; BRONCHIAL THERMOPLASTY; CELL-PROLIFERATION; EXTRACELLULAR-MATRIX; RISK LOCI; KINASE; RELAXATION	The airway smooth muscle (ASM) cell plays a central role in the pathogenesis of asthma and constitutes an important target for treatment. These cells control muscle tone and thus regulate the opening of the airway lumen and air passage. Evidence indicates that ASM cells participate in the airway hyperresponsiveness as well as the inflammatory and remodeling processes observed in asthmatic subjects. Therapeutic approaches require a comprehensive understanding of the structure and function of the ASM in both the normal and disease states. This review updates current knowledge about ASM and its effects on airway narrowing, remodeling, and inflammation in asthma. (J Allergy Clin Immunol 2021;147:1983-95.)	[Camoretti-Mercado, Blanca; Lockey, Richard F.] Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Camoretti-Mercado, B (corresponding author), Univ S Florida, Dept Internal Med, Div Allergy & Immunol, Morsani Coll Med, Tampa, FL 33612 USA.	bcamoret@health.usf.edu						Aisenberg WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep38231; Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Alvarez-Santos MD, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00701; Anaparti V, 2016, AM J PHYSIOL-LUNG C, V311, pL467, DOI 10.1152/ajplung.00382.2015; Anaparti V, 2015, AM J PHYSIOL-LUNG C, V308, pL1253, DOI 10.1152/ajplung.00402.2014; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Begueret H, 2007, THORAX, V62, P8, DOI 10.1136/thx.2006.062141; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bergeron Celine, 2009, Proc Am Thorac Soc, V6, P301, DOI 10.1513/pats.200808-089RM; Burgess JK, 2016, J PATHOL, V240, P397, DOI 10.1002/path.4808; Busk M, 2013, EUR RESPIR J, V41, P317, DOI 10.1183/09031936.00059712; Camoretti-Mercado B, 2003, RESP PHYSIOL NEUROBI, V137, P223, DOI 10.1016/S1569-9048(03)00149-6; Camoretti-Mercado B, 2000, J BIOL CHEM, V275, P30387, DOI 10.1074/jbc.M000840200; Camoretti-Mercado B, 2020, J ALLERGY CLIN IMMUN, V146, P776, DOI 10.1016/j.jaci.2020.04.036; Camoretti-Mercado B, 2019, J ALLERGY CLIN IMMUN, V144, P1166, DOI 10.1016/j.jaci.2019.07.010; Camoretti-Mercado B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131582; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chakir J, 2015, ANN AM THORAC SOC, V12, P1612, DOI 10.1513/AnnalsATS.201504-208OC; Chakraborty S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54718-6; Chen Y, 2019, EXP THER MED, V17, P3327, DOI 10.3892/etm.2019.7363; Chernyavsky IL, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01680-2017; Chupp G, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00017-2017; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Clifford RL, 2015, AM J PHYSIOL-LUNG C, V308, pL962, DOI 10.1152/ajplung.00021.2015; Comer BS, 2015, AM J RESP CELL MOL, V52, P438, DOI 10.1165/rcmb.2014-0129OC; Dalesio NM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01673; Daya M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08469-7; Delmotte P, 2010, FRONT BIOSCI-LANDMRK, V15, P750, DOI 10.2741/3644; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Denner DR, 2015, ANN AM THORAC SOC, V12, P1302, DOI 10.1513/AnnalsATS.201502-082OC; Dicpinigaitis PV, 1999, PULM PHARMACOL THER, V12, P257, DOI 10.1006/pupt.1999.0205; Dissanayake E, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0648-z; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Facciolongo N, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0554-8; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Forastiere F, 1996, AM J RESP CRIT CARE, V153, P1098, DOI 10.1164/ajrccm.153.3.8630551; Fredberg JJ, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-2; Gallos G, 2015, AM J PHYSIOL-LUNG C, V308, pL931, DOI 10.1152/ajplung.00107.2014; Gallos G, 2012, AM J PHYSIOL-LUNG C, V302, pL248, DOI 10.1152/ajplung.00131.2011; Goorsenberg AWM, 2021, AM J RESP CRIT CARE, V203, P175, DOI 10.1164/rccm.201911-2298OC; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Gump A, 2001, J APPL PHYSIOL, V90, P2306, DOI 10.1152/jappl.2001.90.6.2306; GUNST SJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1267, DOI 10.1152/ajpcell.1995.268.5.C1267; Hall CS, 2020, AM J RESP CRIT CARE, V202, P524, DOI 10.1164/rccm.201905-1021OC; Hamann KJ, 2000, AM J PHYSIOL-LUNG C, V278, pL618, DOI 10.1152/ajplung.2000.278.3.L618; Harkness LM, 2014, PULM PHARMACOL THER, V29, P144, DOI 10.1016/j.pupt.2014.09.003; Herrera AM, 2005, J CELL SCI, V118, P2381, DOI 10.1242/jcs.02368; Holbrook JT, 2016, ANN AM THORAC SOC, V13, P1940, DOI 10.1513/AnnalsATS.201601-043OC; Huang J, 2020, P NATL ACAD SCI USA, V117, P28485, DOI 10.1073/pnas.2003111117; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Ijpma G, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02178-2019; Ijpma G, 2015, AM J RESP CRIT CARE, V191, P884, DOI 10.1164/rccm.201407-1296OC; Ito K, 2002, AM J RESP CRIT CARE, V166, P392, DOI 10.1164/rccm.2110060; James AL, 2018, J APPL PHYSIOL, V125, P1090, DOI 10.1152/japplphysiol.00342.2018; Janssen LJ, 2015, ANN AM THORAC SOC, V12, P1589, DOI 10.1513/AnnalsATS.201506-325LE; JIANG H, 1992, AM J RESP CELL MOL, V7, P567, DOI 10.1165/ajrcmb/7.6.567; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kalbe B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00339; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Khan MA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-11; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klion AD, 2004, BLOOD, V103, P4050, DOI 10.1182/blood-2003-11-3850; Komatsu S, 2020, J CELL PHYSIOL, V235, P114, DOI 10.1002/jcp.28949; Krishnan R, 2008, RESP PHYSIOL NEUROBI, V163, P17, DOI 10.1016/j.resp.2008.04.006; Krishnan R, 2011, AM J RESP CRIT CARE, V184, P1321, DOI 10.1164/rccm.201106-1002ED; KUME H, 1994, J CLIN INVEST, V93, P371, DOI 10.1172/JCI116969; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Lan B, 2018, AM J PHYSIOL-LUNG C, V315, pL645, DOI 10.1152/ajplung.00261.2018; Lan B, 2015, AM J PHYSIOL-LUNG C, V308, pL1, DOI 10.1152/ajplung.00222.2014; Langton D, 2020, RESPIROLOGY, V25, P1243, DOI 10.1111/resp.13830; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Laporte JD, 2000, AM J PHYSIOL-LUNG C, V279, pL932, DOI 10.1152/ajplung.2000.279.5.L932; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Liao SY, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00123-2018; Locke WJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01150; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; MCCRAY PB, 1993, AM J RESP CELL MOL, V8, P573, DOI 10.1165/ajrcmb/8.5.573; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Mead J, 2007, J APPL PHYSIOL, V102, P1708, DOI 10.1152/japplphysiol.01419.2006; Mizuta K, 2011, AM J RESP CELL MOL, V45, P1232, DOI 10.1165/rcmb.2011-0088OC; MOLFINO NA, 1993, AM REV RESPIR DIS, V148, P1238, DOI 10.1164/ajrccm/148.5.1238; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; MURPHY RA, 1994, FASEB J, V8, P311, DOI 10.1096/fasebj.8.3.8143937; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Noble PB, 2013, RESP PHYSIOL NEUROBI, V189, P655, DOI 10.1016/j.resp.2013.10.003; Noble PB, 2013, J APPL PHYSIOL, V114, P1460, DOI 10.1152/japplphysiol.01489.2012; O'Sullivan MJ, 2017, AM J RESP CELL MOL, V57, P683, DOI 10.1165/rcmb.2016-0427OC; Ojiaku CA, 2019, AM J RESP CELL MOL, V61, P209, DOI 10.1165/rcmb.2018-0301OC; Ojiaku CA, 2018, AM J RESP CELL MOL, V58, P575, DOI 10.1165/rcmb.2017-0247OC; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; OSullivan MJ, 2019, J ENG SCI MED DIAGN, V2; Parikh P, 2019, AM J RESP CELL MOL, V61, P51, DOI 10.1165/rcmb.2018-0176OC; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Patel BS, 2020, CURR OPIN PHARMACOL, V51, P19, DOI 10.1016/j.coph.2020.04.002; Pavord ID, 2007, AM J RESP CRIT CARE, V176, P1185, DOI 10.1164/rccm.200704-571OC; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perry MM, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01068-2017; Potaczek DP, 2017, EPIGENOMICS-UK, V9, P539, DOI 10.2217/epi-2016-0162; Prakash YS, 2017, AM J RESP CRIT CARE, V195, P247, DOI 10.1164/rccm.201611-2248ST; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Pretolani M, 2017, J ALLERGY CLIN IMMUN, V139, P1176, DOI 10.1016/j.jaci.2016.08.009; Regamey N, 2008, AM J RESP CRIT CARE, V177, P837, DOI 10.1164/rccm.200707-977OC; Ressmeyer AR, 2010, AM J RESP CELL MOL, V43, P179, DOI 10.1165/rcmb.2009-0222OC; Rijavec M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06103; Robinett KS, 2014, AM J RESP CELL MOL, V50, P678, DOI 10.1165/rcmb.2013-0439RC; Roscioni SS, 2011, J CELL MOL MED, V15, P1551, DOI 10.1111/j.1582-4934.2010.01150.x; Rosner SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171728; Ryan D, 2016, J ALLERGY CLIN IMMUN, V138, P308, DOI 10.1016/j.jaci.2015.11.044; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Salem IH, 2019, AM J RESP CRIT CARE, V199, P536, DOI 10.1164/rccm.201811-2064LE; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sharma P, 2016, AM J PHYSIOL-LUNG C, V310, P1365, DOI 10.1152/ajplung.00373.2015; Shore SA, 1997, AM J RESP CELL MOL, V16, P702, DOI 10.1165/ajrcmb.16.6.9191472; Sinha A, 2013, J ALLERGY CLIN IMMUN, V132, P219, DOI 10.1016/j.jaci.2013.03.035; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sparrow MP, 1999, AM J RESP CELL MOL, V20, P550, DOI 10.1165/ajrcmb.20.4.3385; Sparrow MP, 2003, RESP PHYSIOL NEUROBI, V137, P361, DOI 10.1016/S1569-9048(03)00159-9; Steensels S, 2018, ANNU REV PHYSIOL, V80, P117, DOI 10.1146/annurev-physiol-021317-121332; Stephens NL, 1998, AM J RESP CRIT CARE, V158, pS80, DOI 10.1164/ajrccm.158.supplement_2.13tac300; Sweeney D, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0009-z; Sweeney D, 2014, RESPIROLOGY, V19, P763, DOI 10.1111/resp.12318; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Thompson EE, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00759-w; Thomson NC, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-8; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Trian T, 2015, AM J RESP CRIT CARE, V191, P538, DOI 10.1164/rccm.201409-1582OC; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; Trian T, 2010, AM J RESP CELL MOL, V43, P227, DOI 10.1165/rcmb.2009-0126OC; Van Ly D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056058; Vicente CT, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.54; Wagers S, 2004, J APPL PHYSIOL, V96, P2019, DOI 10.1152/japplphysiol.00924.2003; Wang Kimberley C W, 2019, J Eng Sci Med Diagn Ther, V2, DOI 10.1115/1.4042312; Wang L, 2019, J ENG SCI MED DIAGN, V2; Wang L, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01785-2019; Weist A, 2002, J APPL PHYSIOL, V93, P1069, DOI 10.1152/japplphysiol.00986.2001; Wendell SG, 2020, PHARMACOL REV, V72, P1, DOI 10.1124/pr.118.016899; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Wright DB, 2013, PULM PHARMACOL THER, V26, P42, DOI 10.1016/j.pupt.2012.08.005; Wu AD, 2021, AM J RESP CELL MOL, V64, P59, DOI 10.1165/rcmb.2020-0392OC; Xia YXC, 2013, PULM PHARMACOL THER, V26, P64, DOI 10.1016/j.pupt.2012.05.006; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893; Yim PD, 2011, FASEB J, V25, P1706, DOI 10.1096/fj.10-170530; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021; Zhang HY, 2017, RESP PHYSIOL NEUROBI, V246, P9, DOI 10.1016/j.resp.2017.07.004; Zhu ZZ, 2018, NAT GENET, V50, P857, DOI 10.1038/s41588-018-0121-0	155	14	16	5	22	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					1983	1996		10.1016/j.jaci.2021.03.035	http://dx.doi.org/10.1016/j.jaci.2021.03.035		JUN 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7YB	34092351				2022-12-18	WOS:000657814800001
J	Crosson, T; Wang, JC; Doyle, B; Merrison, H; Balood, M; Parrin, A; Pascal, M; Mindt, BC; Seehus, CR; Ozcan, A; Huang, X; Semenara, E; Lai, NYY; Majdoubi, A; Abdulnour, REE; Rajchgot, T; Rafei, M; Foster, SL; Thibodeau, J; Fritz, JH; Levy, BD; Woolf, CJ; Talbot, S				Crosson, Theo; Wang, Jo-Chiao; Doyle, Benjamin; Merrison, Hannah; Balood, Mohammad; Parrin, Alexandre; Pascal, Maud; Mindt, Barbara C.; Seehus, Corey R.; Ozcan, Alp; Huang, Xuan; Semenara, Elise; Lai, Nicole Y. Y.; Majdoubi, Abdelilah; Abdulnour, Raja-Elie E.; Rajchgot, Trevor; Rafei, Moutih; Foster, Simmie L.; Thibodeau, Jacques; Fritz, Joerg H.; Levy, Bruce D.; Woolf, Clifford J.; Talbot, Sebastien			Fc epsilon R1-expressing nociceptors trigger allergic airway inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neuroimmunity; nociceptor neurons; allergy; asthma; T(H)2; Fc epsilon R1; TRPV1; allergen detection; vagal sensing; substance P	PRIMARY SENSORY NEURONS; INNATE LYMPHOID-CELLS; FC-EPSILON-RI; P38 MAPK; RECEPTOR; GAMMA; IGE; ACTIVATION; STIMULATION; MODEL	Background: Lung nociceptor neurons amplify immune cell activity and mucus metaplasia in response to an inhaled allergen challenge in sensitized mice. Objective: We sought to identify the cellular mechanisms by which these sensory neurons are activated subsequent to allergen exposure. Methods: We used calcium microscopy and electrophysiologic recording to assess whether vagal neurons directly respond to the model allergen ovalbumin (OVA). Next, we generated the first nociceptor-specific Fc epsilon R1 gamma knockdown (TRPV1(Cre)::Fc epsilon R1 gamma(fl/fl)) mice to assess whether this targeted invalidation would affect the severity of allergic inflammation in response to allergen challenges. Results: Lung-innervating jugular nodose complex ganglion neurons express the high-affinity IgE receptor Fc epsilon R1, the levels of which increase in OVA-sensitized mice. Fc epsilon R1 gamma-expressing vagal nociceptor neurons respond directly to OVA complexed with IgE with depolarization, action potential firing, calcium influx, and neuropeptide release. Activation of vagal neurons by IgE-allergen immune complexes, through the release of substance P from their peripheral terminals, directly amplifies T(H)2 cell influx and polarization in the airways. Allergic airway inflammation is decreased in TRPV1(Cre)::Fc epsilon R1 gamma(fl/fl) mice and in Fc epsilon R1 alpha(-/-) mice into which bone marrow has been transplanted. Finally, increased in vivo circulating levels of IgE following allergen sensitization enhances the responsiveness of Fc epsilon R1 to immune complexes in both mouse jugular nodose complex ganglion neurons and human induced pluripotent stem cell-derived nociceptors. Conclusions: Allergen sensitization triggers a feedforward inflammatory loop between IgE-producing plasma cells, Fc epsilon R1-expressing vagal sensory neurons, and T(H)2 cells, which helps to both initiate and amplify allergic airway inflammation. These data highlight a novel target for reducing allergy, namely, Fc epsilon R1 gamma expressed by nociceptors.	[Crosson, Theo; Wang, Jo-Chiao; Balood, Mohammad; Semenara, Elise; Rajchgot, Trevor; Rafei, Moutih; Talbot, Sebastien] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada; [Majdoubi, Abdelilah; Thibodeau, Jacques] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Doyle, Benjamin; Merrison, Hannah; Parrin, Alexandre; Pascal, Maud; Seehus, Corey R.; Ozcan, Alp; Huang, Xuan; Lai, Nicole Y. Y.; Foster, Simmie L.; Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Doyle, Benjamin; Merrison, Hannah; Parrin, Alexandre; Pascal, Maud; Seehus, Corey R.; Ozcan, Alp; Huang, Xuan; Lai, Nicole Y. Y.; Foster, Simmie L.; Woolf, Clifford J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurobiol, Boston, MA 02115 USA; [Abdulnour, Raja-Elie E.; Levy, Bruce D.] Harvard Med Sch, Brigham & Womens Hosp, Pulm & Crit Care Med Div, Dept Internal Med, Boston, MA 02115 USA; [Mindt, Barbara C.; Fritz, Joerg H.] McGill Univ, Dept Microbiol & Immunol, Res Ctr Complex Traits, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University	Talbot, S (corresponding author), 2900 Blvd Edouard Montpetit, Montreal, PQ H4L 3W2, Canada.; Woolf, CJ (corresponding author), 3 Blackfan Circle, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu; sebastien.talbot@umoutreal.ca	Lai, Nicole/HDL-8077-2022; Huang, Xuan/AAB-9043-2022	Huang, Xuan/0000-0002-1116-0865; Majdoubi, Abdelilah/0000-0002-2053-4793; balood, mohammad/0000-0001-5647-7826	National Institute of Health (NIH) [R37NS039518, R01-HL122531]; Canadian Institutes of Health Research [407016, 136802]; Canada Foundation for Innovation [37439, 30017]; Canada Research Chair program [950-231859]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-06824]; Brain Canada Foundation; Health Canada; Azrieli Foundation [4758]; Saputo Research Chair; NIH [K08 HL130540]; BastablePotts Graduate research award from the Canadian Allergy, Asthma and Immunology Foundation;  [NIHP30HD18655]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Brain Canada Foundation; Health Canada; Azrieli Foundation; Saputo Research Chair; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BastablePotts Graduate research award from the Canadian Allergy, Asthma and Immunology Foundation; 	This work was supported by the National Institute of Health (NIH) (grant R37NS039518 [to C.J.W.] ) and grant R01-HL122531 [to B.D.L.] ) , the Canadian Institutes of Health Research (grant 407016 to S.T. and grant 136802 to J.T.) , the Canada Foundation for Innovation (grant 37439 to S.T. and grant 30017 to J.T.) , the Canada Research Chair program (grant 950-231859 to S.T.) , the Natural Sciences and Engineering Research Council of Canada (grant RGPIN-2019-06824 to S.T.) , the Brain Canada Foundation, Health Canada, and the Azrieli Foundation (grant 4758 to S.T.) and the Saputo Research Chair (J.T.) . R.E.A. and J.C.W. hold fellowships from the NIH (K08 HL130540) and a BastablePotts Graduate research award from the Canadian Allergy, Asthma and Immunology Foundation, respectively. The cores used were supported by grant NIHP30HD18655.	Alkhani H, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-43; Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Buhner S, 2012, BBA-MOL BASIS DIS, V1822, P85, DOI 10.1016/j.bbadis.2011.06.004; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chen G, 2017, NAT NEUROSCI, V20, P917, DOI 10.1038/nn.4571; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chuaychoo B, 2005, J ALLERGY CLIN IMMUN, V116, P325, DOI 10.1016/j.jaci.2005.04.005; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; CONTI G, 1992, J NEUROIMMUNOL, V41, P43, DOI 10.1016/0165-5728(92)90194-P; Crosson T, 2019, J INTERN MED, V286, P268, DOI 10.1111/joim.12957; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Farinotti AB, 2019, J EXP MED, V216, P1904, DOI 10.1084/jem.20181657; Foster SL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01463; FURUICHI K, 1985, P NATL ACAD SCI USA, V82, P1522, DOI 10.1073/pnas.82.5.1522; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Goswami SC, 2014, J PAIN, V15, P1338, DOI 10.1016/j.jpain.2014.09.010; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hanes William M, 2016, Bioelectron Med, V3, P18, DOI 10.15424/bioelectronmed.2016.00001; Harada N, 2010, J IMMUNOL, V185, P1303, DOI 10.4049/jimmunol.0902051; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015; Hsu C, 1996, IMMUNOL LETT, V52, P129, DOI 10.1016/0165-2478(96)02599-0; Huber M, 2019, J ALLERGY CLIN IMMUN, V144, pS31, DOI 10.1016/j.jaci.2019.02.004; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kondo T, 2013, NEUROREPORT, V24, P68, DOI 10.1097/WNR.0b013e32835c7df2; Kupari J, 2019, CELL REP, V27, P2508, DOI 10.1016/j.celrep.2019.04.096; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Lee S, 2019, ELIFE, V8, DOI 10.7554/eLife.48118; Li CL, 2018, NEUROSCI BULL, V34, P200, DOI 10.1007/s12264-017-0147-9; Liang H, 2011, J GASTROEN HEPATOL, V26, P1065, DOI 10.1111/j.1440-1746.2011.06710.x; Liu F, 2017, BRAIN BEHAV IMMUN, V61, P165, DOI 10.1016/j.bbi.2016.11.017; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Mackl M, 2014, IMMUNOL LETT, V162, P149, DOI 10.1016/j.imlet.2014.08.007; Magadmi R, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00262; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; Michoud F, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0673-2; Mizushima T, 2006, NEUROSCIENCE, V140, P1337, DOI 10.1016/j.neuroscience.2006.03.024; Mizushima T, 2005, PAIN, V113, P51, DOI 10.1016/j.pain.2004.09.038; Mohamed HA, 2002, J NEUROSCI RES, V69, P110, DOI 10.1002/jnr.10271; Nagashima H, 2019, IMMUNITY, V51, P682, DOI 10.1016/j.immuni.2019.06.009; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Qu LT, 2012, J NEUROSCI, V32, P9554, DOI 10.1523/JNEUROSCI.6355-11.2012; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Ray P, 2018, PAIN, V159, P1325, DOI 10.1097/j.pain.0000000000001217; Renthal W, 2020, NEURON, V108, P128, DOI 10.1016/j.neuron.2020.07.026; Rijnierse A, 2009, J NEUROIMMUNOL, V208, P80, DOI 10.1016/j.jneuroim.2009.01.008; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Solinski HJ, 2019, CELL REP, V26, P3561, DOI 10.1016/j.celrep.2019.02.089; Solis-Lopez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171366; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Talbot S, 2020, J ALLERGY CLIN IMMUN, V145, P1693, DOI 10.1016/j.jaci.2020.01.003; Talbot S, 2016, ANNU REV IMMUNOL, V34, P421, DOI 10.1146/annurev-immunol-041015-055340; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; van der Kleij H, 2010, J ALLERGY CLIN IMMUN, V125, P757, DOI 10.1016/j.jaci.2009.10.054; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang L, 2019, J CLIN INVEST, V129, P3754, DOI 10.1172/JCI128010; Wigerblad G, 2016, ANN RHEUM DIS, V75, P730, DOI 10.1136/annrheumdis-2015-208094; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Xu HP, 2019, IMMUNITY, V51, P696, DOI 10.1016/j.immuni.2019.09.004; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663	81	14	14	7	17	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2021	147	6					2330	2342		10.1016/j.jaci.2020.12.644	http://dx.doi.org/10.1016/j.jaci.2020.12.644		JUN 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SM7MD	33453289	Green Accepted			2022-12-18	WOS:000657783800012
J	Israel, E; Denlinger, LC; Bacharier, LB; LaVange, LM; Moore, WC; Peters, MC; Georas, SN; Wright, RJ; Mauger, DT; Noel, P; Akuthota, P; Bach, J; Bleecker, ER; Cardet, JC; Carr, TF; Castro, M; Cinelli, A; Comhair, SAA; Covar, RA; Alexander, LC; DiMango, EA; Erzurum, SC; Fahy, JV; Fajt, ML; Gaston, BM; Hoffman, EA; Holguin, F; Jackson, DJ; Jain, S; Jarjour, NN; Ji, Y; Kenyon, NJ; Kosorok, MR; Kraft, M; Krishnan, JA; Kumar, R; Liu, AH; Liu, MC; Ly, NP; Marquis, MA; Martinez, FD; Moy, JN; O'Neal, WK; Ortega, VE; Peden, DB; Phipatanakul, W; Ross, K; Smith, LJ; Szefler, SJ; Teague, WG; Tulchinsky, AF; Vijayanand, P; Wechsler, ME; Wenzel, SE; White, SR; Zeki, AA; Ivanova, A				Israel, Elliot; Denlinger, Loren C.; Bacharier, Leonard B.; LaVange, Lisa M.; Moore, Wendy C.; Peters, Michael C.; Georas, Steve N.; Wright, Rosalind J.; Mauger, David T.; Noel, Patricia; Akuthota, Praveen; Bach, Julia; Bleecker, Eugene R.; Cardet, Juan Carlos; Carr, Tara F.; Castro, Mario; Cinelli, Angeles; Comhair, Suzy A. A.; Covar, Ronina A.; Alexander, Laura Crotty; DiMango, Emily A.; Erzurum, Serpil C.; Fahy, John, V; Fajt, Merritt L.; Gaston, Benjamin M.; Hoffman, Eric A.; Holguin, Fernando; Jackson, Daniel J.; Jain, Sonia; Jarjour, Nizar N.; Ji, Yuan; Kenyon, Nicholas J.; Kosorok, Michael R.; Kraft, Monica; Krishnan, Jerry A.; Kumar, Rajesh; Liu, Andrew H.; Liu, Mark C.; Ly, Ngoc P.; Marquis, M. Alison; Martinez, Fernando D.; Moy, James N.; O'Neal, Wanda K.; Ortega, Victor E.; Peden, David B.; Phipatanakul, Wanda; Ross, Kristie; Smith, Lewis J.; Szefler, Stanley J.; Teague, W. Gerald; Tulchinsky, Abigail F.; Vijayanand, Pandurangan; Wechsler, Michael E.; Wenzel, Sally E.; White, Steven R.; Zeki, Amir A.; Ivanova, Anastasia			PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Severe asthma; therapy; clinical trial; biomarkers; precision medicine; adaptive design; master protocol; platform trial	RANDOMIZATION	Severe asthma accounts for almost half the cost associated with asthma. Severe asthma is driven by heterogeneous molecular mechanisms. Conventional clinical trial design often lacks the power and efficiency to target subgroups with specific pathobiological mechanisms. Furthermore, the validation and approval of new asthma therapies is a lengthy process. A large proportion of that time is taken by clinical trials to validate asthma interventions. The National Institutes of Health Precision Medicine in Severe and/or Exacerbation Prone Asthma (PrecISE) program was established with the goal of designing and executing a trial that uses adaptive design techniques to rapidly evaluate novel interventions in biomarker-defined subgroups of severe asthma, while seeking to refine these biomarker subgroups, and to identify early markers of response to therapy. The novel trial design is an adaptive platform trial conducted under a single master protocol that incorporates precision medicine components. Furthermore, it includes innovative applications of futility analysis, cross-over design with use of shared placebo groups, and early futility analysis to permit more rapid identification of effective interventions. The development and rationale behind the study design are described. The interventions chosen for the initial investigation and the criteria used to identify these interventions are enumerated. The biomarker-based adaptive design and analytic scheme are detailed as well as special considerations involved in the final trial design.	[Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Israel, Elliot] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Allergy & Immunol, Boston, MA 02115 USA; [Denlinger, Loren C.; Bach, Julia; Jackson, Daniel J.; Jarjour, Nizar N.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Bacharier, Leonard B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [LaVange, Lisa M.; Kosorok, Michael R.; Marquis, M. Alison; Ivanova, Anastasia] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Moore, Wendy C.; Ortega, Victor E.] Wake Forest Univ Sch Med, Winston Salem, NC USA; [Peters, Michael C.; Fahy, John, V; Ly, Ngoc P.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Georas, Steve N.] Univ Rochester, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Wright, Rosalind J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Mauger, David T.] Penn State Univ, Sch Med, Hershey, PA USA; [Noel, Patricia] NIH, NHLBI, Div Lung Dis, Bldg 10, Bethesda, MD 20892 USA; [Akuthota, Praveen; Alexander, Laura Crotty; Jain, Sonia] Univ Calif San Diego, Dept Med, Pulm Div, La Jolla, CA 92093 USA; [Bleecker, Eugene R.; Carr, Tara F.; Kraft, Monica; Martinez, Fernando D.] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Cardet, Juan Carlos] Univ S Florida, Allergy & Immunol, Tampa, FL 33620 USA; [Castro, Mario] Univ Kansas, Sch Med, Kansas City, KS USA; [Cinelli, Angeles; Tulchinsky, Abigail F.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Comhair, Suzy A. A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Covar, Ronina A.; Wechsler, Michael E.] Natl Jewish Hlth, Denver, CO USA; [DiMango, Emily A.] Columbia Univ, Med Ctr, New York, NY USA; [Fajt, Merritt L.; Wenzel, Sally E.] Univ Pittsburgh, Asthma Inst, Pittsburgh, PA USA; [Gaston, Benjamin M.] Indiana Univ, Wells Ctr Pediat Res, Indianapolis, IN 46204 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Holguin, Fernando; Liu, Andrew H.; Szefler, Stanley J.; Wechsler, Michael E.] Univ Colorado, Sch Med, Aurora, CO USA; [Ji, Yuan] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Kenyon, Nicholas J.; Zeki, Amir A.] Univ Calif Davis, Dept Internal Med, Sch Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA; [Krishnan, Jerry A.] Univ Illinois, Dept Med, Div Pulm, Chicago, IL USA; [Kumar, Rajesh] Lurie Childrens Hosp, Chicago, IL USA; [Liu, Andrew H.; Szefler, Stanley J.] Childrens Hosp Colorado, Aurora, CO USA; [Liu, Mark C.] Johns Hopkins Univ, Dept Med, Pulm & Crit Care Med, Baltimore, MD USA; [Moy, James N.] Rush Univ, Med Ctr, Chicago, IL USA; [O'Neal, Wanda K.] Univ N Carolina, Ctr Environm Med, Asthma & Lung Biol, Chapel Hill, NC 27515 USA; [Peden, David B.] Univ N Carolina, UNC CF Res Ctr, Mars Lung Inst, Chapel Hill, NC USA; [Phipatanakul, Wanda] Boston Childrens Hosp, Boston, MA USA; [Phipatanakul, Wanda] Harvard Med Sch, Boston, MA 02115 USA; [Ross, Kristie] UH Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Smith, Lewis J.] Northwestern Univ, Chicago, IL 60611 USA; [Teague, W. Gerald] Univ Virginia, Sch Med, Charlottesville, VA 22903 USA; [Vijayanand, Pandurangan] La Jolla Inst Immunol, La Jolla, CA USA; [White, Steven R.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; University of California System; University of California San Francisco; University of Rochester; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Diego; University of Arizona; State University System of Florida; University of South Florida; University of Kansas; University of Kansas Medical Center; Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; National Jewish Health; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Chicago; University of California System; University of California Davis; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's Hospital Colorado; Johns Hopkins University; Rush University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Northwestern University; University of Virginia; La Jolla Institute for Immunology; University of Chicago	Israel, E (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	eisrael@partners.org	Kosorok, Michael/ABB-7427-2021	Kenyon, Nicholas/0000-0001-8839-4400; Hoffman, Eric/0000-0001-8456-9437	National Heart, Lung, and Blood Institute, National Institutes of Health [U24 HL138998, 1UG1HL139054, 1UG1HL139098, 1UG1HL139106, 1UG1HL139117, 1UG1HL139118, 1UG1HL139119, 1UG1HL139123, 1UG1HL139124, 1UG1HL139125, 1UG1HL139126]; National Institute of Health Clinical & Translational Science Award [UL1TR002451, UL1TR000427, UL1TR002366, UL1TR002389, UL1TR002489, UL1TR001857, UL1TR001442, UL1TR001872]; Duke/Vanderbilt Trial Innovation Center [5U24TR001608]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health Clinical & Translational Science Award; Duke/Vanderbilt Trial Innovation Center	The PrecISE study is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (grant nos. U24 HL138998, 1UG1HL139054, 1UG1HL139098, 1UG1HL139106, 1UG1HL139117, 1UG1HL139118, 1UG1HL139119, 1UG1HL139123, 1UG1HL139124, 1UG1HL139125, and 1UG1HL139126). Support for site institutional infrastructure came from National Institute of Health Clinical & Translational Science Award grants (grant no. UL1TR002451 [Harvard], grant no. UL1TR000427 [University of Wisconsin], grant no. UL1TR002366 [University of Kansas], grant no. UL1TR002389 [University of Chicago], grant no. UL1TR002489 [University of North Carolina], grant no. UL1TR001857 [University of Pittsburgh], grant no. UL1TR001442 [University of California, San Diego], and grant no. UL1TR001872 [University of California, San Francisco]). The single institutional review bolard is supported by the Duke/Vanderbilt Trial Innovation Center (grant no. 5U24TR001608). The following endowed chair positions contributed additional support: Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research (E.I.) and William W. and Judith H. Busse Professor of Allergy & Asthma Research (L.C.D.). The study also gratefully acknowledges receiving contributed product from Vitaeris, owned and operated by the CSL group (clazakizumab), Vitaflo (M.C.T.), Sun Pharma (imatinib), OM Pharma, a Vifor Pharma Group Company (OM-85, Broncho-Vaxom), Incyte (itacitinib), Laurel Venture (cavosonstat), and GlaxoSmithKline (Advair Diskus and Ventolin).	Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Fuhlbrigge AL, 2017, LANCET RESP MED, V5, P577, DOI 10.1016/S2213-2600(17)30218-7; Israel E, 2017, NEW ENGL J MED, V377, P965, DOI 10.1056/NEJMra1608969; Ivanova A, 2020, J BIOPHARM STAT, V30, P1026, DOI 10.1080/10543406.2020.1821705; Park JW, 2016, NEW ENGL J MED, V375, P11, DOI 10.1056/NEJMoa1513750; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; US Food and Drug Administration, 2019, FDA2018D3124 US FDA	7	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1594	1601		10.1016/j.jaci.2021.01.037	http://dx.doi.org/10.1016/j.jaci.2021.01.037		MAY 2021	8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RY1MN	33667479	Green Accepted, Green Submitted			2022-12-18	WOS:000647680800005
J	James, BN; Oyeniran, C; Sturgill, JL; Newton, J; Martin, RK; Bieberich, E; Weigel, C; Maczis, MA; Palladino, END; Lownik, JC; Trudeau, JB; Cook-Mills, JM; Wenzel, S; Milstien, S; Spiegel, S				James, Briana N.; Oyeniran, Clement; Sturgill, Jamie L.; Newton, Jason; Martin, Rebecca K.; Bieberich, Erhard; Weigel, Cynthia; Maczis, Melissa A.; Palladino, Elisa N. D.; Lownik, Joseph C.; Trudeau, John B.; Cook-Mills, Joan M.; Wenzel, Sally; Milstien, Sheldon; Spiegel, Sarah			Ceramide in apoptosis and oxidative stress in allergic inflammation and asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Apoptosis; asthma; biomarker; ceramide; oxidative stress	VITAMIN-E; AIRWAY EPITHELIUM; OXIDANT STRESS; CELLS; ASSOCIATION; NEUTROPHILS; PHENOTYPES; DISEASE; ORMDL3; HOMEOSTASIS	Background: Nothing is known about the mechanisms by which increased ceramide levels in the lung contribute to allergic responses and asthma severity. Objective: We sought to investigate the functional role of ceramide in mouse models of allergic airway disease that recapitulate the cardinal clinical features of human allergic asthma. Methods: Allergic airway disease was induced in mice by repeated intranasal administration of house dust mite or the fungal allergen Alternaria alternata. Processes that can be regulated by ceramide and are important for severity of allergic asthma were correlated with ceramide levels measured by mass spectrometry. Results: Both allergens induced massive pulmonary apoptosis and also significantly increased reactive oxygen species in the lung. Prevention of increases in lung ceramide levels mitigated allergen-induced apoptosis, reactive oxygen species, and neutrophil infiltration. In contrast, dietary supplementation of the antioxidant a-tocopherol decreased reactive oxygen species but had no significant effects on elevation of ceramide level or apoptosis, indicating that the increases in lung ceramide levels in allergen-challenged mice are not mediated by oxidative stress. Moreover, specific ceramide species were altered in bronchoalveolar lavage fluid from patients with severe asthma compared with in bronchoalveolar lavage fluid from individuals without asthma. Conclusion: Our data suggest that elevation of ceramide level after allergen challenge contributes to the apoptosis, reactive oxygen species generation, and neutrophilic infiltrate that characterize the severe asthmatic phenotype. Ceramide might be the trigger of formation of Creola bodies found in the sputum of patients with severe asthma and could be a biomarker to optimize diagnosis and to monitor and improve clinical outcomes in this disease.	[James, Briana N.; Oyeniran, Clement; Newton, Jason; Weigel, Cynthia; Maczis, Melissa A.; Palladino, Elisa N. D.; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, POB 980614, Richmond, VA 23298 USA; [Martin, Rebecca K.; Lownik, Joseph C.] Virginia Commonwealth Univ, Sch Med, Dept Microbiol & Immunol, Richmond, VA USA; [Sturgill, Jamie L.] Univ Kentucky, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Lexington, KY USA; [Bieberich, Erhard] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Trudeau, John B.; Wenzel, Sally] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Cook-Mills, Joan M.] Indiana Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Oyeniran, Clement] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Newton, Jason] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Kentucky; University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, POB 980614, Richmond, VA 23298 USA.; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, POB 980614, Richmond, VA 23298 USA.	sarah.spiegel@vcuhealth.org	Newton, Jason/AAN-8428-2020	Martin, Rebecca/0000-0001-9948-5463; Newton, Jason/0000-0003-2952-2008; Palladino, Elisa/0000-0003-4224-7725; Lownik, Joseph/0000-0002-9025-8210; Sturgill, Jamie/0000-0001-8856-3227; Weigel, Cynthia/0000-0003-3132-4203	National Institutes of Health [R01AI125433]; National Institutes of Health-National Cancer Institute Cancer Center [P30 CA016059];  [P20GM103527];  [R01NS095215]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	This work was supported by the National Institutes of Health (grant R01AI125433 [to S.S.]). The fluorescence microscopy studies were supported by grant R01NS095215 (to E.B.). J.S. was supported by an Institutional Development Award (P20GM103527.) The Virginia Commonwealth University Lipidomics/Metabolomics, Flow Cytometry, and Microscopy Shared Resources are supported in part by funding from the National Institutes of Health-National Cancer Institute Cancer Center (grant P30 CA016059).	Auerbach A, 2012, CURR OPIN ALLERGY CL, V12, P133, DOI 10.1097/ACI.0b013e32835113d6; Berdnikovs S, 2009, J IMMUNOL, V182, P4395, DOI 10.4049/jimmunol.0803659; Boll S, 2020, ALLERGY, V75, P603, DOI 10.1111/all.14039; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brown SD, 2012, J ALLERGY CLIN IMMUN, V129, P388, DOI 10.1016/j.jaci.2011.11.037; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Chan TK, 2016, J ALLERGY CLIN IMMUN, V138, P84, DOI 10.1016/j.jaci.2016.02.017; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cook-Mills J, 2016, THORAX, V71, P954, DOI 10.1136/thoraxjnl-2016-208494; Corriden R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9369; Cyphert-Daly JM, 2019, J ALLERGY CLIN IMMUN, V144, P1428, DOI 10.1016/j.jaci.2019.07.019; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Debeuf N, 2019, J ALLERGY CLIN IMMUN, V144, P1648, DOI 10.1016/j.jaci.2019.06.041; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gandhi VD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00147; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P673, DOI 10.1038/s41580-018-0046-6; Hoskins A, 2012, ALLERGY, V67, P676, DOI 10.1111/j.1398-9995.2012.02810.x; James B, 2019, J ALLERGY CLIN IMMUN, V144, P634, DOI 10.1016/j.jaci.2019.07.023; Jiang X, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00166; Johnson VJ, 2004, TOXICOLOGY, V201, P67, DOI 10.1016/j.tox.2004.04.019; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kamocki K, 2013, AM J RESP CELL MOL, V48, P87, DOI 10.1165/rcmb.2012-0254OC; Kharitonov SA, 2002, BIOMARKERS, V7, P1, DOI 10.1080/13547500110104233; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kothari PH, 2018, J ALLERGY CLIN IMMUN, V141, P2282, DOI 10.1016/j.jaci.2017.11.057; Krishnamoorthy N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4747; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lee J, 2015, APOPTOSIS, V20, P740, DOI 10.1007/s10495-015-1112-6; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Loser S, 2017, J ALLERGY CLIN IMMUN, V139, P1496, DOI 10.1016/j.jaci.2016.07.033; Lownik JC, 2019, BIOCHEM BIOPH RES CO, V512, P723, DOI 10.1016/j.bbrc.2019.03.120; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maltby S, 2017, RESPIROLOGY, V22, P874, DOI 10.1111/resp.13052; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moore WC, 2011, J ALLERGY CLIN IMMUN, V128, P328, DOI 10.1016/j.jaci.2011.02.042; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Panettieri RA, 2018, IMMUNOL ALLERGY CLIN, V38, P629, DOI 10.1016/j.iac.2018.06.005; Pearson PJK, 2004, THORAX, V59, P652, DOI 10.1136/thx.2004.022616; Peters MC, 2016, LANCET RESP MED, V4, P574, DOI 10.1016/S2213-2600(16)30048-0; Peters SP, 2014, J ALLER CL IMM-PRACT, V2, P650, DOI 10.1016/j.jaip.2014.09.006; Petrache Irina, 2013, Handb Exp Pharmacol, P247, DOI 10.1007/978-3-7091-1511-4_12; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; Qu JJ, 2017, J THORAC DIS, V9, pE32, DOI 10.21037/jtd.2017.01.05; Ray A, 2017, TRENDS IMMUNOL, V38, P942, DOI 10.1016/j.it.2017.07.003; Reinke SN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01740-2016; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Sahiner UM, 2011, WORLD ALLERGY ORGAN, V4, P151, DOI 10.1097/WOX.0b013e318232389e; Salo PM, 2006, J ALLERGY CLIN IMMUN, V118, P892, DOI 10.1016/j.jaci.2006.07.037; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Snelgrove RJ, 2018, CLIN EXP ALLERGY, V48, P1275, DOI 10.1111/cea.13191; Stein MM, 2018, J ALLERGY CLIN IMMUN, V142, P749, DOI 10.1016/j.jaci.2017.12.974; Sturgill Jamie L., 2018, Advances in Biological Regulation, V70, P74, DOI 10.1016/j.jbior.2018.09.001; Trautmann A, 2002, J ALLERGY CLIN IMMUN, V109, P329, DOI 10.1067/mai.2002.121460; Truong-Tran AQ, 2002, AM J RESP CELL MOL, V27, P286, DOI 10.1165/rcmb.2001-0014OC; Uchida M, 2017, ALLERGY, V72, P1521, DOI 10.1111/all.13158; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; White Steven R, 2011, J Allergy (Cairo), V2011, P948406, DOI 10.1155/2011/948406; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x; Yoshihara S, 2006, CLIN EXP IMMUNOL, V144, P212, DOI 10.1111/j.1365-2249.2006.03058.x; Yuan XF, 2017, AM J TRANSL RES, V9, P4137; Zhou CJ, 2011, J ASTHMA, V48, P358, DOI 10.3109/02770903.2011.565848	73	14	15	1	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1936	+		10.1016/j.jaci.2020.10.024	http://dx.doi.org/10.1016/j.jaci.2020.10.024		MAY 2021	22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZE	33130063	Green Submitted, Green Accepted			2022-12-18	WOS:000651594000002
J	Wang, A; Rahman, NT; McGeary, MK; Murphy, M; McHenry, A; Peterson, D; Bosenberg, M; Flavell, RA; King, B; Damsky, W				Wang, Alice; Rahman, Nur-Taz; McGeary, Meaghan K.; Murphy, Michael; McHenry, Austin; Peterson, Danielle; Bosenberg, Marcus; Flavell, Richard A.; King, Brett; Damsky, William			Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Granuloma annulare; tofacitinib; JAK inhibitor; IFN-gamma; oncostatin M	SEVERE PSORIASIS; ALPHA; DIFFERENTIATION; ASSOCIATIONS; OSTEOPONTIN; FIBRONECTIN; PERIOSTIN; ANTIGENS; LESIONS; RISK	Background: Granuloma annulare (GA) is a common cutaneous inflammatory disorder characterized by macrophage accumulation and activation in skin. Its pathogenesis is poorly understood, and there are no effective treatments. The potential health implications of severe GA are unknown. Objective: We sought to better understand GA pathogenesis and evaluate a molecularly targeted treatment approach for this disease. Methods: We used single-cell RNA sequencing to study the immunopathogenesis of GA and also evaluated the efficacy of tofacitinib (a Janus kinase 1/3 inhibitor) in 5 patients with severe, long-standing GA in an open-label clinical trial. Results: Using single-cell RNA sequencing, we found that in GA lesions IFN-gamma production by CD41 T cells is upregulated and is associated with inflammatory polarization of macrophages and fibroblasts. In particular, macrophages upregulate oncostatin M, an IL-6 family cytokine, which appears to act on fibroblasts to alter extracellular matrix production, a hallmark of GA. IL- 15 and IL-21 production appears to feed back on CD4(+) T cells to sustain inflammation. Treatment of 5 patients with recalcitrant GA with tofacitinib inhibited IFN-gamma and oncostatin M, as well as IL-15 and IL-21, activity and resulted in clinical and histologic disease remission in 3 patients and marked improvement in the other 2. Inhibition of these effects at the molecular level paralleled the clinical improvement. Evidence of systemic inflammation is also present in some patients with severe GA and is mitigated by tofacitinib. Conclusions: The Janus kinase-signal transducer and activator of transcription pathway is activated in GA, likely in part through the activity of IFN-gamma and oncostatin M, and Janus kinase inhibitors appear to be an effective treatment.	[Wang, Alice; Murphy, Michael; Peterson, Danielle; Bosenberg, Marcus; King, Brett; Damsky, William] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Rahman, Nur-Taz] Yale Univ, Sch Med, Cushing Whitney Med Lib, Bioinformat Support Program, New Haven, CT USA; [McGeary, Meaghan K.; McHenry, Austin; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Bosenberg, Marcus; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	King, B; Damsky, W (corresponding author), Yale Sch Med, Dept Dermatol, 333 Cedar St,LCI 501,POB 208059, New Haven, CT 06520 USA.	brett.king@yale.edu; william.damsky@yale.edu		Murphy, Michael/0000-0001-6494-7250	Connecticut Regenerative Medicine Research Fund; Li Ka Shing Foundation	Connecticut Regenerative Medicine Research Fund; Li Ka Shing Foundation	The clinical trial was registered with clinicaltrials.gov (NCT03910543). We thank the Yale Center for Clinical Investigation, particularly Y. Strong. The bulk RNA sequencing service was conducted at Yale Stem Cell Center Genomics Core facility, which was supported by the Connecticut Regenerative Medicine Research Fund and the Li Ka Shing Foundation. The 10X library preparation and sequencing was performed at the Yale Center for Genome Analysis, thank you especially to G. Wang. We also thank theYale Dermatopathology Laboratory, particularly D. Mekael. Some figure panels were made using BioRender.	Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Cornejo CM, 2019, J AM ACAD DERMATOL, V81, P1165, DOI 10.1016/j.jaad.2018.07.051; Curtsinger JM, 2012, J IMMUNOL, V189, P659, DOI 10.4049/jimmunol.1102727; Damsky William, 2020, JAAD Case Rep, V6, P69, DOI 10.1016/j.jdcr.2019.10.016; Damsky W, 2020, J AM ACAD DERMATOL, V82, P612, DOI 10.1016/j.jaad.2019.05.098; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Exarchou SA, 2009, SCAND J RHEUMATOL, V38, P328, DOI 10.1080/03009740902922612; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; FRIEDMANBIRNBAUM R, 1978, BRIT J DERMATOL, V98, P425; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gjerde AM, 2016, EUR J HOSP PHARM, V23, P166, DOI 10.1136/ejhpharm-2015-000741; Gonzalez-Gonzalez L, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00225; Grewal SK, 2017, J AM ACAD DERMATOL, V76, P765, DOI 10.1016/j.jaad.2016.11.044; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Grunewald J, 2016, EUR RESPIR J, V47, P898, DOI 10.1183/13993003.01209-2015; Kaufmann A, 2001, J LEUKOCYTE BIOL, V69, P248; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; KOH MS, 1984, CLIN EXP DERMATOL, V9, P293, DOI 10.1111/j.1365-2230.1984.tb00800.x; Leonard Warren J, 2016, F1000Res, V5, DOI 10.12688/f1000research.7634.1; Matos TR, 2017, J CLIN INVEST, V127, P4031, DOI 10.1172/JCI93396; Mempel M, 2002, J INVEST DERMATOL, V118, P957, DOI 10.1046/j.1523-1747.2002.01783.x; Min MS, 2020, J AM ACAD DERMATOL, V83, P63, DOI 10.1016/j.jaad.2019.12.028; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; OIKARINEN A, 1989, ACTA DERM-VENEREOL, V69, P277; Piette EW, 2016, J AM ACAD DERMATOL, V75, P457, DOI 10.1016/j.jaad.2015.03.054; Piette EW, 2016, J AM ACAD DERMATOL, V75, P467, DOI 10.1016/j.jaad.2015.03.055; Prodanowich S, 2005, J AM ACAD DERMATOL, V52, P262, DOI 10.1016/j.jaad.2004.06.017; Rautela J, 2017, CURR OPIN IMMUNOL, V44, P1, DOI 10.1016/j.coi.2016.10.004; Richards CD, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7040095; Rubin CB, 2019, CUTIS, V103, P102; Schmieder SJ., 2020, STATPEARLS; Stefanaki K, 2007, J CUTAN PATHOL, V34, P392, DOI 10.1111/j.1600-0560.2006.00626.x; Su CM, 2015, J IMMUNOL, V195, P3355, DOI 10.4049/jimmunol.1403191; Thornsberry LA, 2013, AM J CLIN DERMATOL, V14, P279, DOI 10.1007/s40257-013-0029-5; Wahlstrom J, 2009, CLIN IMMUNOL, V133, P353, DOI 10.1016/j.clim.2009.08.008; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Wu JJ, 2017, J AM ACAD DERMATOL, V76, P81, DOI 10.1016/j.jaad.2016.07.042; Zollinger AJ, 2017, MATRIX BIOL, V60-61, P27, DOI 10.1016/j.matbio.2016.07.011	40	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1795	1809		10.1016/j.jaci.2020.10.012	http://dx.doi.org/10.1016/j.jaci.2020.10.012		MAY 2021	15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	SD7ZH	33317858				2022-12-18	WOS:000651594300001
J	Waserman, S; Cruickshank, H; Hildebrand, KJ; Mack, D; Bantock, L; Bingemann, T; Chu, DK; Cuello-Garcia, C; Ebisawa, M; Fahmy, D; Fleischer, DM; Galloway, L; Gartrell, G; Greenhawt, M; Hamilton, N; Hourihane, J; Langlois, M; Loh, R; Muraro, A; Rosenfield, L; Schoessler, S; Tang, MLK; Weitzner, B; Wang, JL; Brozek, JL				Waserman, Susan; Cruickshank, Heather; Hildebrand, Kyla J.; Mack, Douglas; Bantock, Laura; Bingemann, Theresa; Chu, Derek K.; Cuello-Garcia, Carlos; Ebisawa, Motohiro; Fahmy, David; Fleischer, David M.; Galloway, Lisa; Gartrell, Greg; Greenhawt, Matthew; Hamilton, Nicola; Hourihane, Jonathan; Langlois, Michael; Loh, Richard; Muraro, Antonella; Rosenfield, Lana; Schoessler, Sally; Tang, Mimi L. K.; Weitzner, Brenda; Wang, Julie; Brozek, Jan L.			Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Food allergy; food hypersensitivity; schools; school teachers; child care; child day care centers; health education; epinephrine; secondary prevention; practice guidelines	EPINEPHRINE AUTO-INJECTORS; QUALITY-OF-LIFE; PEDIATRIC ANAPHYLAXIS; CLINICAL-FEATURES; EMERGENCY-DEPARTMENT; NUT-ALLERGY; SOCIOECONOMIC-STATUS; SELF-EFFICACY; ACTION PLANS; KNOWLEDGE	Food allergy management in child care centers and schools is a controversial topic, for which evidence-based guidance is needed. Following the Grading of Recommendations Assessment, Development, and Evaluation approach, we conducted systematic literature reviews of the anticipated health effects of selected interventions for managing food allergy in child care centers and schools; we compiled data about the costs, feasibility, acceptability, and effects on health equity of the selected interventions; and we developed the following conditional recommendations: we suggest that child care centers and schools implement allergy training and action plans; we suggest that they use epinephrine (adrenaline) to treat suspected anaphylaxis; we suggest that they stock unassigned epinephrine autoinjectors, instead of requiring students to supply their own personal autoinjectors to be stored on site for designated at-school use; and we suggest that they do not implement site-wide food prohibitions (eg, "nut-free'' schools) or allergen-restricted zones (eg, "milk-free'' tables), except in the special circumstances identified in this document. The recommendations are labeled "conditional'' due to the low quality of available evidence. More research is needed to determine with greater certainty which interventions are likely to be the most beneficial. Policymakers might need to adapt the recommendations to fit local circumstances.	[Waserman, Susan; Cruickshank, Heather; Mack, Douglas; Chu, Derek K.; Fahmy, David; Hamilton, Nicola; Brozek, Jan L.] McMaster Univ, Div Clin Immunol & Allergy, Dept Med, Hamilton, ON, Canada; [Cuello-Garcia, Carlos; Brozek, Jan L.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Hildebrand, Kyla J.] Univ British Columbia, Div Allergy & Immunol, Dept Pediat Rics, Vancouver, BC, Canada; [Bantock, Laura] Univ Rochester, Dept Primary Med Serv, Sun Peaks Community Hlth Ctr, Rochester, NY USA; [Bingemann, Theresa] Univ Rochester, Dept Allergy & Immunol, Rochester Reg Hlth, Rochester, NY USA; [Bingemann, Theresa] Univ Rochester, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Cuello-Garcia, Carlos] Natl Hosp Org, Qual Hlth Care Residency Program, Tecnol Monterrey Sch Med, Sagamihara, Kanagawa, Japan; [Ebisawa, Motohiro] Natl Hosp Org, Dept Allergy, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Fleischer, David M.] Univ Colorado, Sch Med, Dept Pediat Allergy Immunol, Boulder, CO USA; [Fleischer, David M.; Greenhawt, Matthew] Childrens Hosp Colorado, Dept Allergy & Immunol, Aurora, CO USA; [Galloway, Lisa; Gartrell, Greg] Sch Dist 73, Kamloops, BC, Canada; [Hourihane, Jonathan] Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Hourihane, Jonathan] Royal Coll Surgeons Ireland, Dept Paediat, Dublin, Ireland; [Langlois, Michael] Dist Sch Board Niagara, St Catharines, ON, Canada; [Loh, Richard] Princess Margaret Hosp Children, Dept Immunol, Subiaco, WA, Australia; [Muraro, Antonella] Univ Padua, Food Allergy Ctr, Padua, Italy; [Rosenfield, Lana] Univ Manitoba, Dept Internal Med, Sect Allergy & Clin Immunol, Winnipeg, MB, Canada; [Schoessler, Sally] Allergy & Asthma Network, Vienna, Austria; [Tang, Mimi L. K.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Tang, Mimi L. K.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Weitzner, Brenda] Univ Toronto, Dept Family Med, Toronto, ON, Canada; [Wang, Julie] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY USA	McMaster University; McMaster University; University of British Columbia; University of Rochester; University of Rochester; University of Rochester; Tecnologico de Monterrey; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; Children's Hospital Colorado; University College Cork; Royal College of Surgeons - Ireland; University of Padua; University of Manitoba; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Toronto; Icahn School of Medicine at Mount Sinai	Waserman, S (corresponding author), McMaster Univ, Hlth Sci Ctr, Room 3V49,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	waserman@mcmaster.ca		Tang, Mimi/0000-0002-3839-5293; Hildebrand, Kyla/0000-0003-3825-8202; Chu, Derek/0000-0001-8269-4496	Allergy, Genes and Environment Network (AllerGen)	Allergy, Genes and Environment Network (AllerGen)	This work was supported by the Allergy, Genes and Environment Network (AllerGen), a federally funded research network established by Innovation, Science and Economic Development Canada through the Network of Centres of Excellent (NCE). AllerGen contributed Can$50,000 to this project, which was used to remunerate the research coordinator and support the costs of hosting a guideline panel meeting in Atlanta, Ga, USA.	Agarwal NS, 2015, J ALLERGY CLIN IMMUN, V135, pAB138, DOI 10.1016/j.jaci.2014.12.1385; Aktas ON, 2019, J SCH NURS, V35, P316, DOI 10.1177/1059840518777303; Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016; Alsuhaibani MA, 2019, J FAM MED PRIM CARE, V8, P2975, DOI 10.4103/jfmpc.jfmpc_562_19; American Academy of Allergy Asthma and Immunology, 2020, ANAPHYLAXIS EMERGENC; Andrew E, 2018, PREHOSP EMERG CARE, V22, P445, DOI 10.1080/10903127.2017.1402110; [Anonymous], 2004, DATA HLTH BRIEF EPIN; [Anonymous], 2016, LIFE THREATENING ALL; [Anonymous], UNDERLYING CAUSE DEA; [Anonymous], 2015, JRSM OPEN; [Anonymous], 2014, LIFE THREATENING ALL; Anvari S, 2017, ANN ALLERG ASTHMA IM, V119, pS19; Atal Z, 2016, J ALLERGY CLIN IMMUN, V137, pAB85, DOI 10.1016/j.jaci.2015.12.405; Australasian Society of Clinical Immunology and Allergy, 2020, ACTION PLAN ANAPHYLA; Avedissian T, 2018, BMJ PAEDIATR OPEN, V2, DOI 10.1136/bmjpo-2018-000260; Azevedo J, 2017, ALLERGY, V72, P767, DOI 10.1111/all.13249; Banerjee DK, 2007, ARCH DIS CHILD, V92, P980, DOI 10.1136/adc.2006.113118; Bansal PJ, 2005, ANN ALLERG ASTHMA IM, V94, P55, DOI 10.1016/S1081-1206(10)61286-0; Bartnikas LM, 2017, J ALLERGY CLIN IMMUN, V140, P465, DOI 10.1016/j.jaci.2017.01.040; Ben-Shoshan M, 2008, ANN ALLERG ASTHMA IM, V100, P570, DOI 10.1016/S1081-1206(10)60056-7; Bilaver LA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3678; Boros CA, 2000, J PAEDIATR CHILD H, V36, P36, DOI 10.1046/j.1440-1754.2000.00444.x; C.S. Mott Children's Hospital, 2009, ARE SCH DOING ENOUGH, P6; C.S. Mott Children's Hospital, 2014, NUT FREE LUNCH PAREN, P20; Canadian Society of Allergy and Clinical Immunology, 2016, ANAPHYLAXIS SCH OTHE; Canon N, 2019, ALLERGY RHINOL, V10, DOI 10.1177/2152656719856324; Canon N, 2018, J IMMUNOL, V200; Carlisle SK, 2010, J SCH NURS, V26, P360, DOI 10.1177/1059840510369482; Carrillo E, 2016, PREHOSP EMERG CARE, V20, P239, DOI 10.3109/10903127.2015.1086843; Cherkaoui S, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0055-x; Cicutto L, 2012, ALLERGY, V67, P131, DOI 10.1111/j.1398-9995.2011.02721.x; Civelek E, 2017, ASIAN PAC J ALLERGY, V35, P212, DOI 10.12932/AP0752; Clark AT, 2008, J ALLERGY CLIN IMMUN, V122, P286, DOI 10.1016/j.jaci.2008.05.015; Coombs R, 2011, PAED CHILD HEALT-CAN, V16, P341, DOI 10.1093/pch/16.6.341; CRESPO JF, 1995, ALLERGY, V50, P257, DOI 10.1111/j.1398-9995.1995.tb01143.x; Crow KM., 2018, INCREASING KNOWLEDGE; Cummings AJ, 2010, ALLERGY, V65, P933, DOI 10.1111/j.1398-9995.2010.02342.x; Davis CM, 2011, J ALLERGY CLIN IMMUN, V127, pAB266, DOI 10.1016/j.jaci.2010.12.1061; De Schryver S, 2017, PEDIAT ALLERG IMM-UK, V28, P715, DOI 10.1111/pai.12770; de Silva IL, 2008, ALLERGY, V63, P1071, DOI 10.1111/j.1398-9995.2008.01719.x; De Swert LFA, 2008, EUR J PEDIATR, V167, P1251, DOI 10.1007/s00431-007-0661-2; Dean J, 2016, HEALTH SOC CARE COMM, V24, pE43, DOI 10.1111/hsc.12244; Denny SA, 2019, J ALLERGY CLIN IMMUN, V8, P380; Devetak I, 2018, ZDRAV VARST, V57, P124, DOI 10.2478/sjph-2018-0016; Dickson MA, 2019, J ALLERGY CLIN IMMUN, V143, pAB147, DOI 10.1016/j.jaci.2018.12.447; Dogru M, 2017, GUNCEL PEDIATRI, V15, P12, DOI 10.4274/jcp.58070; Dolansky G, 2014, CAN J EMERG MED, V15, pS83; Dubus JC, 2019, EUR J PEDIATR, V178, P69, DOI 10.1007/s00431-018-3246-3; Dumeier HK, 2018, EUR J PEDIATR, V177, P575, DOI 10.1007/s00431-017-3073-y; Dunn JD, 2014, AM J MED, V127, pS45, DOI 10.1016/j.amjmed.2013.09.013; Eck K, 2019, CURR DEV NUTR, V3, P1082; Eigenmann PA, 2001, ALLERGY, V56, P540, DOI 10.1034/j.1398-9995.2001.056006540.x; Eldredge Christina, 2014, WMJ, V113, P155; Elhassan SM, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000077; Ercan H, 2012, PEDIAT ALLERG IMM-UK, V23, P428, DOI 10.1111/j.1399-3038.2012.01307.x; Eriksson NE, 2003, J INVEST ALLERG CLIN, V13, P149; Esenboga S, 2020, ALLERGOL IMMUNOPATH, V48, P3, DOI 10.1016/j.aller.2019.07.009; Ewan PW, 2005, CLIN EXP ALLERGY, V35, P751, DOI 10.1111/j.1365-2222.2005.02266.x; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Feuille E, 2017, J PEDIATR-US, V190, P93, DOI 10.1016/j.jpeds.2017.07.038; Field MJ, 2019, ALLERGY, V74, P304; Fong AT, 2017, J PAEDIATR CHILD H, V53, P630, DOI 10.1111/jpc.13570; Ford L, 2016, INTERN MED J, V46, P7, DOI 10.1111/imj.10_13197; Foster AA, 2015, J ALLERGY, V2015, pE5; Frost DW, 2005, CAN J PUBLIC HEALTH, V96, P250, DOI 10.1007/BF03405156; Furukawa M, 2015, J ALLERGY CLIN IMMUN, V135, pAB138, DOI 10.1016/j.jaci.2014.12.1387; Gaspar A, 2015, EUR ANN ALLERGY CLIN, V47, P197; Gilchrist C, 2018, CLIN EXP ALLERGY, V48, P1555; Glancy E, 2014, J ALLERGY CLIN IMMUN, V133, pAB24, DOI 10.1016/j.jaci.2013.12.113; Perez RG, 2018, ALLERGY, V73, P351, DOI 10.1111/all.13538; Gonzalez-Mancebo E, 2019, ALLERGOL IMMUNOPATH, V47, P60, DOI 10.1016/j.aller.2018.05.005; Goossens NJ, 2013, PEDIAT ALLERG IMM-UK, V24, P567, DOI 10.1111/pai.12099; Grabenhenrich LB, 2018, J ALLER CL IMM-PRACT, V6, P1898, DOI 10.1016/j.jaip.2018.02.026; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Greenhawt M, 2018, ANN ALLERG ASTHMA IM, V121, P174, DOI 10.1016/j.anai.2018.04.015; Greenhawt M, 2014, ANN ALLERG ASTHMA IM, V113, P506, DOI 10.1016/j.anai.2014.06.027; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2010, PEDIAT ALLERG IMM-UK, V21, P927, DOI 10.1111/j.1399-3038.2010.01005.x; Gupta RS, 2009, ANN ALLERG ASTHMA IM, V103, P43, DOI 10.1016/S1081-1206(10)60142-1; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hamato FA., 2016, COGENT MED, V3, P102; Haney MO, 2019, ALLERGOL IMMUNOPATH, V47, P558, DOI 10.1016/j.aller.2019.03.002; Hawthorne DL, 2018, CAN J DIET PRACT RES, V79, P99, DOI 10.3148/cjdpr-2018-011; Hogue SL, 2018, J SCHOOL HEALTH, V88, P396, DOI 10.1111/josh.12620; Ikeda M, 2016, ALLERGY, V71, P502; James JM, 2007, CURR ALLERGY ASTHM R, V7, P167, DOI 10.1007/s11882-007-0017-z; Jeong K, 2017, ALLERGY ASTHMA IMMUN, V9, P423, DOI 10.4168/aair.2017.9.5.423; Julia-Benito JC, 2017, ALLERGOL IMMUNOPATH, V45, P369, DOI 10.1016/j.aller.2016.10.019; Kao LM, 2018, ANN ALLERG ASTHMA IM, V120, P304, DOI 10.1016/j.anai.2017.12.019; Kastner M, 2010, ALLERGY, V65, P435, DOI 10.1111/j.1398-9995.2009.02294.x; Katsunuma T, 2014, ALLERGY, V69, P273; Kelso JM, 2016, PEDIAT ALLER IMM PUL, V29, P2, DOI 10.1089/ped.2016.0634; Kilger M, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0477-6; Kim JH, 2019, CURR DEV NUTR, V3, P235; Knight K, 2018, CLIN EXP ALLERGY, V48, P1546; Korematsu S, 2017, ASIA PAC ALLERGY, V7, P37, DOI 10.5415/apallergy.2017.7.1.37; Kourosh A, 2015, J ALLERGY CLIN IMMUN, V135, pAB211, DOI 10.1016/j.jaci.2014.12.1624; Lanser BJ, 2016, ANN ALLERG ASTHMA IM, V116, P533, DOI 10.1016/j.anai.2016.03.031; Lee M, 2015, J ALLERGY CLIN IMMUN, V135, pAB205, DOI 10.1016/j.jaci.2014.12.1604; Leo HL, 2019, J ALLERGY CLIN IMMUN, V143, pAB85; Levinson AJ, 2010, ALLERGY ASTHMA CL IM, V6, pE1; Liew WK, 2009, J ALLERGY CLIN IMMUN, V123, P434, DOI 10.1016/j.jaci.2008.10.049; Litarowsky Jean A, 2004, J Sch Nurs, V20, P279; Loh RKS, 2012, ANAPHYLAXIS MANAGEME; Loke P, 2016, J ALLERGY CLIN IMMUN, V138, P529, DOI 10.1016/j.jaci.2016.02.014; Love MA, 2016, J ALLERGY CLIN IMMUN, V137, pAB56, DOI 10.1016/j.jaci.2015.12.185; Lu Stephanie K, 2014, J Allergy (Cairo), V2014, P964504, DOI 10.1155/2014/964504; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; MacGiobuin S, 2017, IR MED J, V110, pE8; Mack J, 2015, CLIN EXP ALLERGY, V45, P1904; Masumoto N, 2011, ALLERGY, V66, P407; Matwiejczyk L, 2021, HEALTH PROMOT J AUST, V32, P107, DOI 10.1002/hpja.308; McIntyre CL, 2005, PEDIATRICS, V116, P1134, DOI 10.1542/peds.2004-1475; McWilliam VL, 2018, J ALLERGY CLIN IMMUN, V141, P982, DOI 10.1016/j.jaci.2017.09.012; Mehl A, 2005, ALLERGY, V60, P1440, DOI 10.1111/j.1398-9995.2005.00909.x; Mercer RD, 2017, J ALLER CL IMM-PRACT, V5, P1288, DOI 10.1016/j.jaip.2017.06.032; Minaker Leia M, 2014, J Allergy (Cairo), V2014, P160363, DOI 10.1155/2014/160363; Moneret-Vautrin DA, 2001, ALLERGY, V56, P1071, DOI 10.1034/j.1398-9995.2001.00047.x; Morris P, 2011, J SCHOOL HEALTH, V81, P471, DOI 10.1111/j.1746-1561.2011.00616.x; Mullins RJ, 2010, CLIN EXP ALLERGY, V40, P1523, DOI 10.1111/j.1365-2222.2010.03573.x; Munoz VL, 2018, SOCIOL HEALTH ILL, V40, P603, DOI 10.1111/1467-9566.12716; Murai H, 2016, ANN ALLERG ASTHMA IM, V117, pS34; Muraro A, 2014, ALLERGY, V69, P1046, DOI 10.1111/all.12441; Mustafa SS, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1135-6; Neupert K, 2019, J ALLER CL IMM-PRACT, V7, P1650, DOI 10.1016/j.jaip.2018.10.050; Nha UNL, 2012, PEDIAT ALLERG IMM-UK, V23, P134, DOI 10.1111/j.1399-3038.2011.01235.x; Nickels AS, 2015, ANN ALLERG ASTHMA IM, V114, P254, DOI 10.1016/j.anai.2014.11.020; Nogic C, 2016, J PAEDIATR CHILD H, V52, P487, DOI 10.1111/jpc.13173; Norton L, 2008, J ALLERGY CLIN IMMUN, V122, P209, DOI 10.1016/j.jaci.2008.04.020; Novembre E, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.4.e8; Nowak-Wegrzyn A, 2001, ARCH PEDIAT ADOL MED, V155, P790, DOI 10.1001/archpedi.155.7.790; Nurmatov U, 2008, J ALLERGY CLIN IMMUN, V122, P353, DOI 10.1016/j.jaci.2008.05.028; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Odhav A, 2015, J ALLERGY CLIN IMMUN, V135, pAB211, DOI 10.1016/j.jaci.2014.12.1625; Orhan F, 2011, CLIN EXP ALLERGY, V41, P1767, DOI 10.1111/j.1365-2222.2011.03859.x; Ortiz-Menendez JC, 2019, ALLERGY, V74, P589, DOI 10.1111/all.13961; Ozen A, 2016, BALK MED J, V33, P539, DOI 10.5152/balkanmedj.2016.15500; Padua I, 2019, ALLERGY, V74, P588, DOI 10.1111/all.13961; Patel BM, 2006, ANN ALLERG ASTHMA IM, V97, P813, DOI 10.1016/S1081-1206(10)60974-X; Patel DA, 2011, J ALLERGY CLIN IMMUN, V128, P110, DOI 10.1016/j.jaci.2011.03.013; Patel D, 2014, J ALLERGY CLIN IMMUN, V133, pAB288, DOI 10.1016/j.jaci.2013.12.1018; Patel DR, 2018, J ALLER CL IMM-PRACT, V6, P671, DOI 10.1016/j.jaip.2017.08.013; Pepper AN, 2017, J ALLER CL IMM-PRACT, V5, P665, DOI 10.1016/j.jaip.2016.12.018; Pham MN, 2019, J ALLER CL IMM-PRACT, V7, P2440, DOI 10.1016/j.jaip.2019.03.013; Polloni L, 2010, ALLERGY, V65, P746; Polloni L, 2009, PEDIAT ALLERG IMM-UK, V20, P65; Polloni L, 2020, PEDIAT ALLERG IMM-UK, V31, P380, DOI 10.1111/pai.13212; Polloni L, 2016, PEDIAT ALLERG IMM-UK, V27, P356, DOI 10.1111/pai.12550; Polloni Laura, 2013, Clin Transl Allergy, V3, P39, DOI 10.1186/2045-7022-3-39; Pouessel G, 2018, ALLERGY, V73, P1902, DOI 10.1111/all.13483; Pouessel G, 2020, CLIN EXP ALLERGY, V50, P74, DOI 10.1111/cea.13519; Pouessel G, 2019, PEDIAT ALLERG IMM-UK, V30, P767, DOI 10.1111/pai.13091; Pouessel G, 2019, PEDIAT ALLERG IMM-UK, V30, P341, DOI 10.1111/pai.13015; Powers Jill, 2007, J Sch Nurs, V23, P252; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Protudjer JLP, 2015, J ALLER CL IMM-PRACT, V3, P68, DOI 10.1016/j.jaip.2014.09.021; Pulcini JM, 2010, ALLERGY ASTHMA PROC, V31, P141, DOI 10.2500/aap.2010.31.3315; Pumphrey RSH, 2007, J ALLERGY CLIN IMMUN, V119, P1018, DOI 10.1016/j.jaci.2007.01.021; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; Rame JM, 2017, REV FR ALLERGOL, V57, P67, DOI 10.1016/j.reval.2016.10.017; Rance F, 2005, CLIN EXP ALLERGY, V35, P167, DOI 10.1111/j.1365-2222.2005.02162.x; Ravarotto L, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0100-8; Redmond M, 2016, ANN ALLERG ASTHMA IM, V116, P518, DOI 10.1016/j.anai.2016.03.013; Robinson H, 2013, J ALLERGY CLIN IMMUN, V131, pAB124, DOI 10.1016/j.jaci.2012.12.1113; Robinson M, 2017, ANN ALLERG ASTHMA IM, V119, P164, DOI 10.1016/j.anai.2017.06.001; Ross NL, 2019, J ALLERGY CLIN IMMUN, V143, pAB215, DOI 10.1016/j.jaci.2018.12.655; Rudders SA, 2017, J ALLER CL IMM-PRACT, V5, P1421, DOI 10.1016/j.jaip.2017.04.036; Sampson MA, 2006, J ALLERGY CLIN IMMUN, V117, P1440, DOI 10.1016/j.jaci.2006.03.009; Sasaki K, 2015, ALLERGOL INT, V64, P156, DOI 10.1016/j.alit.2014.10.005; Sasaki M, 2018, J ALLERGY CLIN IMMUN, V141, P391, DOI 10.1016/j.jaci.2017.05.041; Sasaki M, 2014, J ALLERGY CLIN IMMUN, V133, pAB125, DOI 10.1016/j.jaci.2013.12.467; Schunemann HJ, 2017, J CLIN EPIDEMIOL, V81, P101, DOI 10.1016/j.jclinepi.2016.09.009; Shah SS, 2011, J ALLERGY CLIN IMMUN, V127, pAB139, DOI 10.1016/j.jaci.2010.12.554; Shah SS, 2014, J ALLER CL IMM-PRACT, V2, P288, DOI 10.1016/j.jaip.2013.09.016; Shah SS, 2013, CLIN PEDIATR, V52, P812, DOI 10.1177/0009922813497425; Shaker M, 2019, ANN ALLERG ASTHMA IM, V122, P79, DOI 10.1016/j.anai.2018.06.035; Shaker M, 2018, J ALLER CL IMM-PRACT, V6, P2073, DOI 10.1016/j.jaip.2018.04.036; Shaker M, 2017, ANN ALLERG ASTHMA IM, V119, P160, DOI 10.1016/j.anai.2017.05.020; Shaker MS, 2019, JAMA PEDIATR, V173, P169, DOI 10.1001/jamapediatrics.2018.4275; Sharma HP, 2012, J ALLERGY CLIN IMMUN, V129, pAB133, DOI 10.1016/j.jaci.2011.12.445; Sicherer SH, 2001, J PEDIATR-US, V138, P560, DOI 10.1067/mpd.2001.111821; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V104, P186, DOI 10.1016/S0091-6749(99)70133-8; Simons FER, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0080-1; Simons FER, 2011, WORLD ALLERGY ORGAN, V4, P13, DOI 10.1097/WOX.0b013e318211496c; Simons FER, 2009, ANN ALLERG ASTHMA IM, V102, P403, DOI 10.1016/S1081-1206(10)60512-1; Simons FER, 2005, ANN ALLERG ASTHMA IM, V94, P534, DOI 10.1016/S1081-1206(10)61129-5; Simonte SJ, 2003, J ALLERGY CLIN IMMUN, V112, P180, DOI 10.1067/mai.2003.1486; Smith TD, 2018, J ALLER CL IMM-PRACT, V6, P680, DOI 10.1016/j.jaip.2017.12.012; Song TT, 2014, ALLERGY, V69, P983, DOI 10.1111/all.12387; Steffens C, 2017, PREHOSP EMERG CARE, V21, P563, DOI 10.1080/10903127.2017.1308610; Szychlinski C, 2015, J ALLER CL IMM-PRACT, V3, P805, DOI 10.1016/j.jaip.2015.04.017; Szychlinski C, 2013, J ALLERGY CLIN IMMUN, V131, pAB148, DOI 10.1016/j.jaci.2012.12.1191; Thomson H, 2017, J PAEDIATR CHILD H, V53, P698, DOI 10.1111/jpc.13483; Tiyyagura GK, 2014, PREHOSP EMERG CARE, V18, P46, DOI 10.3109/10903127.2013.825352; Torabi B., 2016, PAED CHILD HEALT-CAN, V21, pe39; Tsuang A, 2019, J ALLER CL IMM-PRACT, V7, P309, DOI 10.1016/j.jaip.2018.05.015; Tsuang A, 2017, J ALLER CL IMM-PRACT, V5, P1418, DOI 10.1016/j.jaip.2017.04.014; Turner P, 2011, ANN ALLERG ASTHMA IM, V106, P494, DOI 10.1016/j.anai.2011.02.001; Twichell S, 2013, J ALLERGY CLIN IMMUN, V131, pAB34, DOI 10.1016/j.jaci.2012.12.805; Tyquin B, 2017, INTERN MED J, V47, P20, DOI 10.1111/imj.51_13578; Uguz A, 2005, CLIN EXP ALLERGY, V35, P746, DOI 10.1111/j.1365-2222.2005.02257.x; Umasunthar T, 2013, CLIN EXP ALLERGY, V43, P1333, DOI 10.1111/cea.12211; Urrutia-Pereira M, 2018, ALLERGOL IMMUNOPATH, V46, P421, DOI 10.1016/j.aller.2017.09.018; Vale S, 2019, J PAEDIATR CHILD H, V55, P143, DOI 10.1111/jpc.14307; Vokits Kathleen, 2014, NASN Sch Nurse, V29, P287; Wada KJ, 2018, J ALLERGY CLIN IMMUN, V141, pAB154, DOI 10.1016/j.jaci.2017.12.492; Wahl A, 2015, J SCH NURS, V31, P91, DOI 10.1177/1059840514526889; Wainstein BK, 2007, CLIN EXP ALLERGY, V37, P839, DOI 10.1111/j.1365-2222.2007.02726.x; Ward CE, 2015, ANN ALLERG ASTHMA IM, V114, P312, DOI 10.1016/j.anai.2014.12.022; Watson WTA., 2010, ALLERGY ASTHMA CL IM, V6, P10, DOI [10.1186/1710-1492-6-S1-P10, DOI 10.1186/1710-1492-6-S1-P10]; White MV, 2016, PEDIAT ALLER IMM PUL, V29, P149, DOI 10.1089/ped.2016.0675; White MV, 2015, ALLERGY ASTHMA PROC, V36, P306, DOI 10.2500/aap.2015.36.3859; Worm M, 2014, ALLERGY, V69, P1397, DOI 10.1111/all.12475; Wright BL, 2015, ANN ALLERG ASTHMA IM, V115, P75, DOI 10.1016/j.anai.2015.04.008; Wright BL, 2014, J ALLERGY CLIN IMMUN, V133, pAB25, DOI 10.1016/j.jaci.2013.12.114; Wright CD, 2017, ANN ALLERG ASTHMA IM, V118, P461, DOI 10.1016/j.anai.2017.02.002; Wu F, 1998, ALLERGY ASTHMA PROC, V19, P307, DOI 10.2500/108854198778557719; Xu YS, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-38; Yanagida N, 2019, PEDIAT ALLERG IMM-UK, V30, P773, DOI 10.1111/pai.13095; Yeh CY, 2018, J ALLERGY CLIN IMMUN, V141, pAB88, DOI 10.1016/j.jaci.2017.12.284; Yu JW, 2006, J ALLERGY CLIN IMMUN, V118, P466, DOI 10.1016/j.jaci.2006.04.024	221	14	14	3	14	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2021	147	5					1561	1578		10.1016/j.jaci.2021.01.034	http://dx.doi.org/10.1016/j.jaci.2021.01.034		MAY 2021	18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	RY1MN	33965093				2022-12-18	WOS:000647680800003
J	Schoos, AMM; Nwaru, BI; Borres, MP				Schoos, Ann-Marie M.; Nwaru, Bright I.; Borres, Magnus P.			Component-resolved diagnostics in pet allergy: Current perspectives and future directions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Pet allergy; dog; cat; horse; asthma risk; component-resolved diagnostics	FEL D 1; ANIMAL-DERIVED LIPOCALIN; DOG ALLERGEN; FURRY ANIMALS; IMMUNOLOGICAL CHARACTERIZATION; INHALANT ALLERGENS; CROSS-REACTIVITY; HAZELNUT ALLERGY; SERUM ALBUMINS; CAT ALLERGENS	Furry mammals kept as pets are important allergen sources. The prevalence of sensitization to dander from various animals appears to be increasing worldwide. Several mammalian allergens from diverse species and distinct protein families have been characterized, and some are available for component resolved diagnostics (CRD). This review presents an overview of mammalian aeroallergens, with a focus on cat, dog, and horse allergens. The potential of CRD in fine-tuning the diagnostic workup following traditional methods based on whole-allergen extracts and allergen immunotherapy is discussed. The review highlights the clinical utility of CRD, particularly as a marker/ predictor of increased asthma risk and disease severity. Finally, several perspectives of the future implications of CRD are offered in the context of furry animal allergens. (J Allergy Clin Immunol 2021;147:1164-73.)	[Schoos, Ann-Marie M.] Univ Copenhagen, Herlev & Gentofte Hosp, COpenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Schoos, Ann-Marie M.] Slagelse Sygehus, Dept Pediat, Slagelse, Denmark; [Nwaru, Bright I.] Univ Gothenburg, Inst Med, Krefting Res Ctr, Gothenburg, Sweden; [Nwaru, Bright I.] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Borres, Magnus P.] Thermo Fisher Sci, Uppsala, Sweden; [Borres, Magnus P.] Uppsala Univ, Dept Maternal & Child Hlth, Uppsala, Sweden	University of Copenhagen; University of Gothenburg; University of Gothenburg; Thermo Fisher Scientific; Uppsala University	Schoos, AMM (corresponding author), Univ Copenhagen, Gentofte & Herlev Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Ledreborg Alle 34, DK-2820 Gentofte, Denmark.	ann-marie.schoos@dbac.dk		Schoos, Ann-Marie Malby/0000-0002-5827-0885	Knut and AliceWallenberg Foundation; VBG Group Herman Krefting Foundation on Asthma and Allergy	Knut and AliceWallenberg Foundation(Knut & Alice Wallenberg Foundation); VBG Group Herman Krefting Foundation on Asthma and Allergy	B.I.N. is supported by the Knut and AliceWallenberg Foundation, theWallenberg Centre for Molecular and Translational Medicine, and the VBG Group Herman Krefting Foundation on Asthma and Allergy. The funding agencies of B.I.N. did not have any role in design and conduct of the study; collection, management, and interpretation of the data; or preparation, review, or approval of the manuscript.	American Veterinary Medical Association, US PET OWNERSHIP STA; Apostolovic D, 2016, ALLERGY, V71, P1490, DOI 10.1111/all.12955; Aranda CS, 2018, PEDIAT ALLERG IMM-UK, V29, P321, DOI 10.1111/pai.12860; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; Asarnoj A, 2016, J ALLERGY CLIN IMMUN, V137, P813, DOI 10.1016/j.jaci.2015.09.052; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Basagana M, 2017, J INVEST ALLERG CLIN, V27, P185, DOI 10.18176/jiaci.0150; Basagana M, 2012, INT ARCH ALLERGY IMM, V159, P143, DOI 10.1159/000336388; Bjerg A, 2015, PEDIAT ALLERG IMM-UK, V26, P557, DOI 10.1111/pai.12422; Bonnet B, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0239-8; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Chan SK, 2018, ALLERGY ASTHMA IMMUN, V10, P97, DOI 10.4168/aair.2018.10.2.97; Chruszcz M, 2013, BBA-GEN SUBJECTS, V1830, P5375, DOI 10.1016/j.bbagen.2013.06.016; Curin M, 2011, INT ARCH ALLERGY IMM, V154, P258, DOI 10.1159/000321113; Davila I, 2018, ALLERGY, V73, P1206, DOI 10.1111/all.13391; Eder K, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0163-8; Eller E, 2016, ALLERGY, V71, P556, DOI 10.1111/all.12820; Fall T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35245-2; FEDIAF, STATISTICS-ABINGDON; Gonzalez-de-Olano D, 2018, CLIN EXP ALLERGY, V48, P1368, DOI 10.1111/cea.13226; Goodman RE, 2020, J ALLER CL IMM-PRACT, V8, P2506, DOI 10.1016/j.jaip.2020.06.043; Gronlund H, 2010, INT ARCH ALLERGY IMM, V151, P265, DOI 10.1159/000250435; Hamilton RG, 2020, J ALLER CL IMM-PRACT, V8, P2495, DOI 10.1016/j.jaip.2020.07.021; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Heinzerling LM, 2009, ALLERGY, V64, P1498, DOI 10.1111/j.1398-9995.2009.02093.x; Hilger C, 1997, ALLERGY, V52, P179, DOI 10.1111/j.1398-9995.1997.tb00972.x; Hilger C, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0732-z; Hilger C, 2012, CURR ALLERGY ASTHM R, V12, P438, DOI 10.1007/s11882-012-0283-2; Hilger C, 2012, J ALLERGY CLIN IMMUN, V129, P1149, DOI 10.1016/j.jaci.2011.10.017; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; Jeal H, 2009, ALLERGY, V64, P855, DOI 10.1111/j.1398-9995.2008.01899.x; Kack U, 2018, J ALLERGY CLIN IMMUN, V142, P1113, DOI 10.1016/j.jaci.2018.05.012; Kelly SM, 2018, J ALLERGY CLIN IMMUN, V142, P1990, DOI 10.1016/j.jaci.2018.07.033; Klemans RJB, 2013, J ALLERGY CLIN IMMUN, V131, P157, DOI 10.1016/j.jaci.2012.08.010; Kofler L, 2012, EUR ANN ALLERGY CLIN, V44, P89; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Konradsen JR, 2015, J ALLERGY CLIN IMMUN, V135, P616, DOI 10.1016/j.jaci.2014.08.026; Konradsen JR, 2014, PEDIAT ALLERG IMM-UK, V25, P187, DOI 10.1111/pai.12198; Lange L, 2017, ALLERGY, V72, P598, DOI 10.1111/all.13050; Liccardi G, 2016, TRANSL MED UNISA, V14, P9; Liccardi G, 2015, EUR ANN ALLERGY CLIN, V47, P163; Liccardi G, 2020, J ALLER CL IMM-PRACT, V8, P2399, DOI 10.1016/j.jaip.2020.02.041; Liccardi G, 2011, CURR ALLERGY ASTHM R, V11, P421, DOI 10.1007/s11882-011-0214-7; Masthoff LJN, 2013, J ALLERGY CLIN IMMUN, V132, P393, DOI 10.1016/j.jaci.2013.02.024; Mattsson L, 2010, CLIN EXP ALLERGY, V40, P1276, DOI 10.1111/j.1365-2222.2010.03533.x; Mattsson L, 2009, J ALLERGY CLIN IMMUN, V123, P362, DOI 10.1016/j.jaci.2008.11.021; McDonald RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005726; McWilliam V, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0555-8; Meiser JB, 2001, J ALLERGY CLIN IMMUN, V107, P744, DOI 10.1067/mai.2001.114340; Melen E, 2020, CLIN TRANSL ALLERGY, V10, DOI 10.1186/s13601-020-00319-w; Morris DO, 2010, VET DERMATOL, V21, P441, DOI 10.1111/j.1365-3164.2010.00882.x; Nagao Mizuho, 2017, Clin Mol Allergy, V15, P4, DOI 10.1186/s12948-017-0061-8; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nordlund B, 2012, ALLERGY, V67, P661, DOI 10.1111/j.1398-9995.2012.02797.x; Nwaru BI, 2019, J ALLER CL IMM-PRACT, V7, P1230, DOI 10.1016/j.jaip.2018.12.018; Park YB, 2013, ALLERGY ASTHMA IMMUN, V5, P295, DOI 10.4168/aair.2013.5.5.295; Patelis A, 2016, CLIN EXP ALLERGY, V46, P730, DOI 10.1111/cea.12607; Perzanowski MS, 2016, J ALLERGY CLIN IMMUN, V138, P1582, DOI 10.1016/j.jaci.2016.05.017; Roberts G, 2020, J ALLERGY CLIN IMMUN, V146, P821, DOI 10.1016/j.jaci.2020.02.031; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Rytkonen-Nissinen M, 2015, ALLERGY ASTHMA IMMUN, V7, P384, DOI 10.4168/aair.2015.7.4.384; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarelainen S, 2004, CLIN EXP ALLERGY, V34, P1576, DOI 10.1111/j.1365-2222.2004.02071.x; Satyaraj E, 2019, ALLERGY, V74, P5, DOI 10.1111/all.14013; Savvatianos S, 2015, J ALLERGY CLIN IMMUN, V136, P192, DOI 10.1016/j.jaci.2015.03.037; Schmitz R, 2013, INT ARCH ALLERGY IMM, V162, P263, DOI 10.1159/000353344; Schoos AMM, 2016, ALLERGY, V71, P684, DOI 10.1111/all.12853; Schoos AMM, 2017, J ALLERGY CLIN IMMUN, V140, P1693, DOI 10.1016/j.jaci.2017.01.041; Schoos AMM, 2016, J ALLERGY CLIN IMMUN, V137, P1277, DOI 10.1016/j.jaci.2015.09.035; Schoos AMM, 2020, J ALLER CL IMM-PRACT, V8, P1592, DOI 10.1016/j.jaip.2019.12.012; Schoos AMM, 2017, J ALLER CL IMM-PRACT, V5, P1754, DOI 10.1016/j.jaip.2017.03.028; Simpson A, 2015, J ALLERGY CLIN IMMUN, V136, P1224, DOI 10.1016/j.jaci.2015.03.027; Smith DM, 2016, ANN ALLERG ASTHMA IM, V116, P188, DOI 10.1016/j.anai.2015.12.006; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; Smith W, 2011, INT ARCH ALLERGY IMM, V156, P159, DOI 10.1159/000322879; Steering Committee Authors Review Panel Members, 2020, WORLD ALLERGY ORGAN, V13; Sterner Therese, 2019, Clin Mol Allergy, V17, P6, DOI 10.1186/s12948-019-0110-6; Suzuki S, 2019, CLIN EXP ALLERGY, V49, P495, DOI 10.1111/cea.13355; Tanaka M, 2019, ALLERGOL INT, V68, P259, DOI 10.1016/j.alit.2018.08.003; Thorsteinsdottir S, 2016, ALLERGY, V71, P1736, DOI 10.1111/all.12980; Tsolakis N, 2018, CLIN EXP ALLERGY, V48, P1186, DOI 10.1111/cea.13135; Ukleja-Sokolowska N, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0167-4; Uriarte SA, 2020, J INVEST ALLERG CLIN, V30, P169, DOI 10.18176/jiaci.0415; Uriarte SA, 2016, ALLERGY, V71, P1066, DOI 10.1111/all.12917; Vachova M, 2020, INT ARCH ALLERGY IMM, V181, P278, DOI 10.1159/000505518; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; van Ree R, 1999, J ALLERGY CLIN IMMUN, V104, P1223, DOI 10.1016/S0091-6749(99)70017-5; van Wijk RG, 2018, J ALLERGY CLIN IMMUN, V142, P1058, DOI 10.1016/j.jaci.2018.08.006; Vicente-Serrano J, 2007, PEDIAT ALLERG IMM-UK, V18, P503, DOI 10.1111/j.1399-3038.2007.00548.x; Victor S, 2019, CLIN EXP ALLERGY, V49, P701, DOI 10.1111/cea.13362; Villalta D, 2019, EUR ANN ALLERGY CLIN, V51, P186, DOI 10.23822/EurAnnACI.1764-1489.89; Wang YJ, 2017, ONCOTARGET, V8, P90796, DOI 10.18632/oncotarget.21822; Warm K, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-20; Wintersand A, 2019, ALLERGY, V74, P1472, DOI 10.1111/all.13785; Wisniewski JA, 2013, CLIN EXP ALLERGY, V43, P1160, DOI 10.1111/cea.12169; Yamamoto-Hanada K, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100105; Zahradnik E, 2017, VET SCI, V4, P1	97	14	14	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1164	1173		10.1016/j.jaci.2020.12.640	http://dx.doi.org/10.1016/j.jaci.2020.12.640		APR 2021	10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	33444632	Bronze			2022-12-18	WOS:000637368900005
J	Shiratori-Hayashi, M; Yamaguchi, C; Eguchi, K; Shiraishi, Y; Kohno, K; Mikoshiba, K; Inoue, K; Nishida, M; Tsuda, M				Shiratori-Hayashi, Miho; Yamaguchi, Chiharu; Eguchi, Kazushi; Shiraishi, Yuto; Kohno, Keita; Mikoshiba, Katsuhiko; Inoue, Kazuhide; Nishida, Motohiro; Tsuda, Makoto			Astrocytic STAT3 activation and chronic itch require IP3R1/TRPC-dependent Ca21 signals in mice	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Contact dermatitis; chronic itch; astrocytes; STAT3; lip-ocalin-2; Ca2+signal; TRPC; IL-6; primary afferent sensory neuron	REACTIVE ASTROGLIOSIS; SYNAPTIC-TRANSMISSION; RECEPTOR; RELEASE; PATHWAY; PLASTICITY; RESPONSES; CHANNELS; SUBUNIT	Background: Chronic itch is a debilitating symptom of inflammatory skin diseases, but the underlying mechanism is poorly understood. We have recently demonstrated that astrocytes in the spinal dorsal horn become reactive in models of atopic and contact dermatitis via activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) and critically contribute to chronic itch. In general, STAT3 is transiently activated; however, STAT3 activation in reactive astrocytes of chronic itch model mice persistently occurs via an unknown mechanism. Objective: We aimed to determine the mechanisms of persistent activation of astrocytic STAT3 in chronic itch conditions. Methods: To determine the factors that are required for persistent activation of astrocytic STAT3, Western blotting and calcium imaging with cultured astrocytes or spinal cord slices were performed. Thereafter, chronic itch model mice were used for genetic and behavioral experiments to confirm the role of the factors determined to mediate persistent STAT3 activation from in vitro and ex vivo experiments in chronic itch. Results: IP3 receptor type 1 (IP3R1) knockdown in astrocytes suppressed IL-6-induced persistent STAT3 activation and expression of lipocalin-2 (LCN2), an astrocytic STAT3dependent inflammatory factor that is required for chronic itch. IP3R1-dependent astrocytic Ca2+ responses involved Ca2+ influx through the cation channel transient receptor potential canonical (TRPC), which was required for persistent STAT3 activation evoked by IL-6. IL-6 expression was upregulated in dorsal root ganglion neurons in a mouse model of chronic itch. Dorsal root ganglion neuron-specific IL-6 knockdown, spinal astrocyte-specific IP3R1 knockdown, and pharmacologic spinal TRPC inhibition attenuated LCN2 expression and chronic itch. Conclusion: Our findings suggest that IP3R1/TRPC channel- mediated Ca2+ signals elicited by IL-6 in astrocytes are necessary for persistent STAT3 activation, LCN2 expression, and chronic itch, and they may also provide new targets for therapeutic intervention. (J Allergy Clin Immunol 2021;147:1341-53.)	[Shiratori-Hayashi, Miho; Yamaguchi, Chiharu; Eguchi, Kazushi; Shiraishi, Yuto; Kohno, Keita; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka, Japan; [Inoue, Kazuhide] Kyushu Univ, Dept Mol & Syst Pharmacol, Fukuoka, Japan; [Nishida, Motohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Translat Pharmaceut Sci, Fukuoka, Japan; [Mikoshiba, Katsuhiko] RIKEN Ctr Biosyst Dynam Res, Kobe, Hyogo, Japan; [Mikoshiba, Katsuhiko] Toho Univ, Fac Sci, Chiba, Japan; [Mikoshiba, Katsuhiko] Shanghai Tech Univ, Shanghai Inst Immunochem Studies, Shanghai, Peoples R China; [Nishida, Motohiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Div Cardiocirculatory Signaling, Okazaki, Aichi, Japan; [Nishida, Motohiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Okazaki, Aichi, Japan	Kyushu University; Kyushu University; Kyushu University; RIKEN; Toho University; ShanghaiTech University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Tsuda, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuda@phar.kyushu-u.ac.jp	Shiratori-Hayashi, Miho/ABD-6887-2021		Japanese Society for the Promotion of Science [JP19K22500, JP19H05658, JP16H06237, JP19K16260]; Japanese Agency for Medical Research and Development (AMED) [JP18ek0410034]; Astellas Foundation for Research on Metabolic Disorders; Yamaguchi Foundation; AMED [JP20gm0910006, JP20am0101091]; Naito Foundation	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Astellas Foundation for Research on Metabolic Disorders; Yamaguchi Foundation; AMED; Naito Foundation(Naito Memorial Foundation)	This work was supported by the Japanese Society for the Promotion of Science Grants-inAid for Scientific Research program (grants JP19K22500 and JP19H05658 [to M.T.] and JP16H06237 and JP19K16260 [to M.S.-H.], the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japanese Agency for Medical Research and Development (AMED) (grant JP18ek0410034 [to M.T. and M.S.-H.], the Astellas Foundation for Research on Metabolic Disorders (to M.S.-H.), the Yamaguchi Foundation (to M.S.-H.), the Core Research for Evolutional Science and Technology program from AMED (grant JP20gm0910006 [to M.T.]), the Naito Foundation (to M.T.), and the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research) from AMED (grant JP20am0101091 [to M.T.]).	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Adebiyi A, 2010, CIRC RES, V106, P1603, DOI 10.1161/CIRCRESAHA.110.216804; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chen XY, 2017, MOL NEUROBIOL, V54, P7555, DOI 10.1007/s12035-016-0227-2; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dong P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12770-0; Du LX, 2019, GLIA, V67, P1680, DOI 10.1002/glia.23639; Elg S, 2007, J COMP NEUROL, V503, P35, DOI 10.1002/cne.21351; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Foley J, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00003; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kesherwani V, 2012, NEUROL RES, V34, P504, DOI 10.1179/1743132812Y.0000000038; Koga K, 2020, J ALLERGY CLIN IMMUN, V145, P183, DOI 10.1016/j.jaci.2019.09.034; Kohro Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14306; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kwon J, 2017, EXP NEUROBIOL, V26, P42, DOI 10.5607/en.2017.26.1.42; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li HL, 2015, CELL CALCIUM, V58, P565, DOI 10.1016/j.ceca.2015.09.004; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu T, 2016, PAIN, V157, P806, DOI 10.1097/j.pain.0000000000000439; Machida A, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-36; Meads MB, 2016, ONCOGENE, V35, P2723, DOI 10.1038/onc.2015.334; Miller G, 2007, SCIENCE, V318, P188, DOI 10.1126/science.318.5848.188; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; O'Callaghan JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102003; Okubo Y, 2019, GLIA, V67, P113, DOI 10.1002/glia.23531; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; Sherwood MW, 2017, GLIA, V65, P502, DOI 10.1002/glia.23107; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shiratori-Hayashi M, 2015, NAT MED, V21, P927, DOI 10.1038/nm.3912; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Takata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066525; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Tsuda M, 2018, NEUROSCI RES, V126, P9, DOI 10.1016/j.neures.2017.08.010; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Verma N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7064; Wang FS, 2012, P NATL ACAD SCI USA, V109, P7911, DOI 10.1073/pnas.1120380109; Yoshihara K, 2018, J PHARMACOL SCI, V137, P101, DOI 10.1016/j.jphs.2018.04.007	66	14	14	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2021	147	4					1341	1353		10.1016/j.jaci.2020.06.039	http://dx.doi.org/10.1016/j.jaci.2020.06.039		APR 2021	13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RJ1NP	32781002				2022-12-18	WOS:000637368900023
J	Li, H; Wang, HQ; Sokulsky, L; Liu, SX; Yang, R; Liu, XJ; Zhou, LJ; Li, J; Huang, C; Li, FF; Lei, X; Jia, HX; Cheng, JL; Li, FG; Yang, M; Zhang, GJ				Li, Hui; Wang, Huaqi; Sokulsky, Leon; Liu, Shaoxia; Yang, Rui; Liu, Xiaojie; Zhou, Lujia; Li, Juan; Huang, Chun; Li, Fangfang; Lei, Xu; Jia, Hongxia; Cheng, Jiuling; Li, Fuguang; Yang, Ming; Zhang, Guojun			Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; single-cell RNA-sequencing; T lymphocytes; B lymphocytes; monocytes; neutrophils; macrophages; cytokines; chemokines		Background: Asthma exacerbations are associated with heightened asthma symptoms, which can result in hospitalization in severe cases. However, the molecular immunologic processes that determine the course of an exacerbation remain poorly understood, impeding the progression of development of effective therapies. Objective: Our aim was to identify candidate genes that are strongly associated with asthma exacerbation at a cellular level. Methods: Subjects with asthma exacerbation and healthy control subjects were recruited, and bronchoalveolar lavage fluid was isolated from these subjects via bronchoscopy. Cells were isolated through fluorescence-activated cell sorting, and single-cell RNA sequencing was performed on enriched cell populations. Results: We showed that the levels of monocytes, CD8(+) T cells, and macrophages are significantly elevated in the bronchoalveolar lavage fluid of patients. A set of cytokines and intracellular transduction regulators are associated with asthma exacerbations and are shared across multiple cell clusters, forming a complicated molecular framework. An additional group of core exacerbation-associated modules is activated, including eukaryotic initiation factor 2 signaling, ephrin receptor signaling, and C-X-C chemokine receptor type 4 signaling in the subpopulations of CD8(+) T cells (C1-a) and monocyte clusters (C7 clusters), which are associated with infection. Conclusion: Our study identified a significant number of severe asthma-associated genes that are differentially expressed by multiple cell clusters.	[Li, Hui; Wang, Huaqi; Liu, Shaoxia; Yang, Rui; Li, Juan; Huang, Chun; Li, Fangfang; Lei, Xu; Jia, Hongxia; Cheng, Jiuling; Zhang, Guojun] Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China; [Sokulsky, Leon; Yang, Ming] Univ Newcastle, Prior Res Ctr Hlth Lungs, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW, Australia; [Sokulsky, Leon; Yang, Ming] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW, Australia; [Liu, Xiaojie; Zhou, Lujia; Li, Fuguang; Yang, Ming] Zhengzhou Univ, Acad Med Sci, Coll Basic Med Sci, Zhengzhou, Peoples R China; [Liu, Xiaojie; Zhou, Lujia; Li, Fuguang; Yang, Ming] Zhengzhou Univ, Dept Immunol, Coll Basic Med Sci, Zhengzhou, Peoples R China	Zhengzhou University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Zhengzhou University; Zhengzhou University	Zhang, GJ (corresponding author), Zhengzhou Univ, Dept Resp Med, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.; Yang, M (corresponding author), Sch Biomed Sci & Pharm, Prior Res Ctr Hlth Lungs, Fac Hlth, Lot 1 Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia.; Yang, M (corresponding author), Hunter Med Res Inst, Lot 1 Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia.; Yang, M (corresponding author), Zhengzhou Univ, Acad Med Sci, Zhengzhou, Peoples R China.	ming.yang@newcastle.edu.au; gjzhangzzu@126.com		Li, Hui/0000-0003-3814-9137	University-Hospital Joint Fostering Fund of Zhengzhou University [23230016]; China National Natural Science Foundation [81874042, 81970030]	University-Hospital Joint Fostering Fund of Zhengzhou University; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Supported by a University-Hospital Joint Fostering Fund of Zhengzhou University (grant 23230016) and China National Natural Science Foundation Project Grants (81874042 and 81970030).	Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Bedke N, 2009, J IMMUNOL, V182, P3660, DOI 10.4049/jimmunol.0802471; Bigler J, 2017, AM J RESP CRIT CARE, V195, P1311, DOI 10.1164/rccm.201604-0866OC; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Bleecker ER, 2016, LANCET, V388, P2115, DOI 10.1016/S0140-6736(16)31324-1; BORISH L, 1992, J IMMUNOL, V149, P3078; BOUSQUET J, 1991, INT ARCH ALLER A IMM, V94, P227, DOI 10.1159/000235367; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chen J, 2018, NAT MICROBIOL, V3, P172, DOI 10.1038/s41564-017-0081-7; Chiba Y, 2009, INT J IMMUNOPATH PH, V22, P929, DOI 10.1177/039463200902200408; COYLE AJ, 1995, J EXP MED, V181, P1229, DOI 10.1084/jem.181.3.1229; de Marcken M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw1347; DePasquale EAK, 2019, CELL REP, V29, P1718, DOI 10.1016/j.celrep.2019.09.082; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eberwine J, 2014, NAT METHODS, V11, P25, DOI 10.1038/nmeth.2769; Elias JA, 1997, AM J PHYSIOL-LUNG C, V273, pL648, DOI 10.1152/ajplung.1997.273.3.L648; Farne HA, 2017, CURR OPIN IMMUNOL, V48, P31, DOI 10.1016/j.coi.2017.07.017; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Ghildyal R, 2005, J MED VIROL, V75, P608, DOI 10.1002/jmv.20315; Haley KJ, 2011, AM J PHYSIOL-LUNG C, V301, pL693, DOI 10.1152/ajplung.00348.2010; Hansbro PM, 2017, IMMUNOL REV, V278, P41, DOI 10.1111/imr.12543; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hew M, 2010, INTERN MED J, V40, P323, DOI 10.1111/j.1445-5994.2010.02192.x; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuo CHS, 2017, AM J RESP CRIT CARE, V195, P443, DOI 10.1164/rccm.201512-2452OC; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Li JJ, 2010, J IMMUNOL, V185, P4401, DOI 10.4049/jimmunol.1001039; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Loza MJ, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0482-9; Matsunuma R, 2018, P NATL ACAD SCI USA, V115, pE11978, DOI 10.1073/pnas.1810598115; Message SD, 2001, EUR RESPIR J, V18, P1013, DOI 10.1183/09031936.01.00228701; Modena BD, 2017, AM J RESP CRIT CARE, V195, P1449, DOI 10.1164/rccm.201607-1407OC; Moore WC, 2011, J ALLERGY CLIN IMMUN, V128, P328, DOI 10.1016/j.jaci.2011.02.042; Noble A, 2016, EUR J IMMUNOL, V46, P1438, DOI 10.1002/eji.201545939; Ogasawara T, 2017, P NATL ACAD SCI USA, V114, pE741, DOI 10.1073/pnas.1613528114; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Peters MC, 2019, J ALLERGY CLIN IMMUN, V143, P104, DOI 10.1016/j.jaci.2017.12.1009; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reinke SN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01740-2016; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Stoeckle C, 2013, ALLERGY, V68, P1622, DOI 10.1111/all.12311; Tanaka H, 2001, J ALLERGY CLIN IMMUN, V107, P331, DOI 10.1067/mai.2001.112275; Nguyen TH, 2018, J IMMUNOL, V200, P237, DOI 10.4049/jimmunol.1601950; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Ubel C, 2014, J ALLERGY CLIN IMMUN, V133, P198, DOI 10.1016/j.jaci.2013.09.049; Wang Y, 2014, IMMUNITY, V40, P355, DOI 10.1016/j.immuni.2014.01.002; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	69	14	14	6	20	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2021	147	3					941	954		10.1016/j.jaci.2020.09.032	http://dx.doi.org/10.1016/j.jaci.2020.09.032		MAR 2021	14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	RA9TV	33039479				2022-12-18	WOS:000631762400016
J	Goleva, E; Calatroni, A; LeBeau, P; Berdyshev, E; Taylor, P; Kreimer, S; Cole, RN; Leung, DYM				Goleva, Elena; Calatroni, Agustin; LeBeau, Petra; Berdyshev, Evgeny; Taylor, Patricia; Kreimer, Simion; Cole, Robert N.; Leung, Donald Y. M.			Atopic dermatitis and inflammatory skin disease Skin tape proteomics identifies pathways associated with transepidermal water loss and allergen polysensitization in atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; food allergy; skin barrier; proteomics; transepidermal water loss; IgE	BARRIER FUNCTION; ECZEMA SEVERITY; FOOD ALLERGY; EXPRESSION; SWEAT; MECHANISMS; SERPINB12; PROTEINS; SCORE; FORCE	Background: Atopic dermatitis (AD) and food allergy (FA) are associated with skin barrier dysfunction. Objective: Skin biomarkers are needed for skin barrier interventions studies. Methods: In this study, skin tape strip (STS) samples were collected from nonlesional skin of 62 children in AD FA+, AD FA2, and nonatopic groups for mass spectrometry proteomic analysis. transepidermal water loss and allergic sensitization were assessed. STS proteomic analysis results were validated in an independent cohort of 41 adults with AD with and without FA versus nonatopic controls. Results: A group of 45 proteins was identified as a principal component 1 (PC1) with the highest expression in AD FA+ STSs. This novel set of STS proteins was highly correlative to skin transepidermal water loss and allergic sensitization. PC1 proteins included keratin intermediate filaments; proteins associated with inflammatory responses (S100 proteins, alarmins, protease inhibitors); and glycolysis and antioxidant defense enzymes. Analysis of PC1 proteins expression in an independent adult AD cohort validated differential expression of STS PC1 proteins in the skin of adult patients with AD with the history of clinical reactions to peanut. Conclusions: STS analysis of nonlesional skin of AD children identified a cluster of proteins with the highest expression in AD FA+ children. The differential expression of STS PC1 proteins was confirmed in a replicate cohort of adult AD patients with FA to peanut, suggesting a unique STS proteomic endotype for AD FA+ that persists into adulthood. Collectively, PC1 proteins are associated with abnormalities in skin barrier integrity and may increase the risk of epicutaneous sensitization to food allergens.	[Goleva, Elena; Taylor, Patricia; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Calatroni, Agustin; LeBeau, Petra] Rho Fed Syst Div Inc, Chapel Hill, NC USA; [Berdyshev, Evgeny] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Kreimer, Simion; Cole, Robert N.] Johns Hopkins Univ, Baltimore, MD USA	National Jewish Health; National Jewish Health; Johns Hopkins University	Leung, DYM (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	LeungD@njhealth.org		Leung, Donald/0000-0002-0177-3844	National Institutes of Health/National Institute of Allergy and Infectious Diseases Atopic Dermatitis Research Network [U19AI117673, UM2AI117870]; Edelstein Family Chair of Pediatric Allergy; National Center for Research Resources [UL1 TR-002535]	National Institutes of Health/National Institute of Allergy and Infectious Diseases Atopic Dermatitis Research Network; Edelstein Family Chair of Pediatric Allergy; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases Atopic Dermatitis Research Network U19AI117673 and UM2AI117870, the Edelstein Family Chair of Pediatric Allergy, and UL1 TR-002535 from the National Center for Research Resources.	Alexander H, 2018, J INVEST DERMATOL, V138, P2295, DOI 10.1016/j.jid.2018.09.001; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Chamlin SL, 2002, J AM ACAD DERMATOL, V47, P198, DOI 10.1067/mjd.2002.124617; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Davidson WF, 2019, J ALLERGY CLIN IMMUN, V143, P894, DOI 10.1016/j.jaci.2019.01.003; Drislane C, 2020, ANN ALLERG ASTHMA IM, V124, P36, DOI 10.1016/j.anai.2019.10.008; Dyjack N, 2018, J ALLERGY CLIN IMMUN, V141, P1298, DOI 10.1016/j.jaci.2017.10.046; Edqvist PHD, 2015, J HISTOCHEM CYTOCHEM, V63, P129, DOI 10.1369/0022155414562646; Elias PM, 2008, CURR ALLERGY ASTHM R, V8, P299, DOI 10.1007/s11882-008-0048-0; Emerson RM, 2000, BRIT J DERMATOL, V142, P288, DOI 10.1046/j.1365-2133.2000.03300.x; Feldt J, 2019, EXPERT REV MOL MED, V20, DOI 10.1017/erm.2018.7; Flohr C, 2010, BRIT J DERMATOL, V163, P1333, DOI 10.1111/j.1365-2133.2010.10068.x; Flohr C, 2014, J INVEST DERMATOL, V134, P345, DOI 10.1038/jid.2013.298; Fluhr JW, 2006, EXP DERMATOL, V15, P483, DOI 10.1111/j.1600-0625.2006.00437.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Goleva E, 2019, J CLIN INVEST, V129, P1463, DOI 10.1172/JCI124608; Haines RL, 2012, J CELL SCI, V125, P3923, DOI 10.1242/jcs.099655; Hendricks AJ, 2018, J DERMATOL SCI, V89, P105, DOI 10.1016/j.jdermsci.2017.11.005; Horimukai K, 2016, ALLERGOL INT, V65, P103, DOI 10.1016/j.alit.2015.09.004; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Jensen JM, 2000, J INVEST DERMATOL, V115, P708, DOI 10.1046/j.1523-1747.2000.00103.x; Kawashima H, 2000, PEDIATR INT, V42, P448, DOI 10.1046/j.1442-200x.2000.01253.x; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kenny FN, 2015, CELL TISSUE RES, V360, P571, DOI 10.1007/s00441-014-2064-9; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; KUBLER MD, 1991, J CELL SCI, V100, P153; Kumar V, 2015, J CELL BIOL, V211, P1057, DOI 10.1083/jcb.201404147; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; Larsson J., 2019, EULERR AREA PROPORTI; Lenth R., 2022, COMPUTER SOFTWARE; Leshem YA, 2015, BRIT J DERMATOL, V172, P1353, DOI 10.1111/bjd.13662; Leung DYM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav2685; Li S, 2017, BRIT J DERMATOL, V177, pE125, DOI 10.1111/bjd.15409; Lowe AJ, 2018, ANN ALLERG ASTHMA IM, V120, P145, DOI 10.1016/j.anai.2017.11.023; Murota H, 2018, ALLERGOL INT, V67, P455, DOI 10.1016/j.alit.2018.06.003; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; Nakatsuji T, 2019, ANN ALLERG ASTHMA IM, V122, P263, DOI 10.1016/j.anai.2018.12.003; Niehaus JZ, 2015, BIOCHEMISTRY-US, V54, P6756, DOI 10.1021/acs.biochem.5b01042; Niehaus JZ, 2015, J HISTOCHEM CYTOCHEM, V63, P854, DOI 10.1369/0022155415600498; Noethel B, 2018, MOL BIOL CELL, V29, P2317, DOI 10.1091/mbc.E17-06-0387; Omori-Miyake M, 2014, J INVEST DERMATOL, V134, P1342, DOI 10.1038/jid.2013.503; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; R Core Team, 2018, R LANG ENV STAT COMP; Ray R, 2005, J BIOL CHEM, V280, P9761, DOI 10.1074/jbc.C400581200; Reichelt J, 1997, J CELL SCI, V110, P2175; Relchelt J, 2002, J CELL SCI, V115, P2639; Rerknimitr P, 2017, J INVEST DERMATOL, V137, P248, DOI 10.1016/j.jid.2016.07.036; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts G, 2005, J ALLERGY CLIN IMMUN, V115, P1291, DOI 10.1016/j.jaci.2005.02.038; Sarkar D, 2008, USE R, P1; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Simpson EL, 2018, J INVEST DERMATOL, V138, P2224, DOI 10.1016/j.jid.2018.03.1517; Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353; STALDER JF, 1993, DERMATOLOGY, V186, P23, DOI 10.1159/000247298; Williams MR, 2017, J INVEST DERMATOL, V137, P2460, DOI 10.1016/j.jid.2017.09.010; Yu W, 2016, NAT REV IMMUNOL, V16, P751, DOI 10.1038/nri.2016.111	59	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1367	1378		10.1016/j.jaci.2020.04.022	http://dx.doi.org/10.1016/j.jaci.2020.04.022			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32360271	Green Accepted			2022-12-18	WOS:000596937900018
J	Morin, A; McKennan, CG; Pedersen, CET; Stokholm, J; Chawes, BL; Schoos, AMM; Naughton, KA; Thorsen, J; Mortensen, MS; Vercelli, D; Trivedi, U; Sorensen, SJ; Bisgaard, H; Nicolae, DL; Bonnelykke, K; Ober, C				Morin, Andreanne; McKennan, Chris G.; Pedersen, Casper-Emil T.; Stokholm, Jakob; Chawes, Bo L.; Schoos, Ann-Marie Malby; Naughton, Katherine A.; Thorsen, Jonathan; Mortensen, Martin S.; Vercelli, Donata; Trivedi, Urvish; Sorensen, Soren J.; Bisgaard, Hans; Nicolae, Dan L.; Bonnelykke, Klaus; Ober, Carole			Epigenetic landscape links upper airway microbiota in infancy with allergic rhinitis at 6 years of age	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic rhinitis; microbiota; DNA methylation; gene expression; early life; upper airways	ASTHMA; RISK; COLONIZATION; PREGNANCY; EXPOSURE; SAMPLES; WHEEZE; ARRAY	Background: The upper airways present a barrier to inhaled allergens and microbes, which alter immune responses and subsequent risk for diseases, such as allergic rhinitis (AR). Objective: We tested the hypothesis that early-life microbial exposures leave a lasting signature in DNA methylation that ultimately influences the development of AR in children. Methods: We studied upper airway microbiota at 1 week, 1 month, and 3 months of life, and measured DNA methylation and gene expression profiles in upper airway mucosal cells and assessed AR at age 6 years in children in the Copenhagen Prospective Studies on Asthma in Childhood birth cohort. Results: We identified 956 AR-associated differentially methylated CpGs in upper airway mucosal cells at age 6 years, 792 of which formed 3 modules of correlated differentially methylated CpGs. The eigenvector of 1 module was correlated with the expression of genes enriched for lysosome and bacterial invasion of epithelial cell pathways. Early-life microbial diversity was lower at 1 week (richness P = .0079) in children with AR at age 6 years, and reduced diversity at 1 week was also correlated with the same module's eigenvector (r = -0.25; P = 3.3 x 10(-5)). We show that the effect of microbiota richness at 1 week on risk for AR at age 6 years was mediated in part by the epigenetic signature of this module. Conclusions: Our results suggest that upper airway microbial composition in infancy contributes to the development of AR during childhood, and this trajectory is mediated, at least in part, through altered DNA methylation patterns in upper airway mucosal cells.	[Morin, Andreanne; Naughton, Katherine A.; Nicolae, Dan L.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [McKennan, Chris G.; Nicolae, Dan L.] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Pedersen, Casper-Emil T.; Stokholm, Jakob; Chawes, Bo L.; Schoos, Ann-Marie Malby; Thorsen, Jonathan; Bisgaard, Hans; Bonnelykke, Klaus] Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood, COPSAC, Copenhagen, Denmark; [Mortensen, Martin S.; Trivedi, Urvish; Sorensen, Soren J.] Univ Copenhagen, Sect Microbiol, Dept Biol, Copenhagen, Denmark; [Vercelli, Donata] Univ Arizona Hlth Sci, Dept Cellular & Mol Med, Tucson, AZ USA; [Vercelli, Donata] Univ Arizona Hlth Sci, Asthma & Airway Dis Res Ctr, Tucson, AZ USA	University of Chicago; University of Chicago; University of Copenhagen; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Cummings Life Sci Ctr, 920 E 58th St,Rm 507C, Chicago, IL 60615 USA.	c-ober@genetics.uchicago.edu	Thorsen, Jonathan/AAQ-9269-2021; Mortensen, Martin Steen/M-5141-2014; Bisgaard, Hans/N-4761-2016	Thorsen, Jonathan/0000-0003-0200-0461; Mortensen, Martin Steen/0000-0001-5483-7533; Trivedi, Urvish/0000-0003-1541-6212; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769; Schoos, Ann-Marie Malby/0000-0002-5827-0885; Nicolae, Dan/0000-0002-0918-4630	National Institutes of Health (NIH) [HL129735]; Lundbeck Foundation [R16-A1694]; Danish Ministry of Health [903516]; Danish Council for Strategic Research [0603-00280B]; Danish Council for Independent Research [10-082884, 271-08-0815]; Capital Region Research Foundation; Bourse de formation postdoctorale - Fonds de recherche du Quebec - Sante; NIH [AI133765, AI144722]; Novo Nordisk Fonden	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Health; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Capital Region Research Foundation; Bourse de formation postdoctorale - Fonds de recherche du Quebec - Sante; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the National Institutes of Health (NIH) (grant no. HL129735 to H.B. and C.O.). Copenhagen Prospective Studies on Asthma in Childhood is funded by private and public research funds (complete list onwww.copsac.com), including the Lundbeck Foundation (grant no. R16-A1694), the Danish Ministry of Health (grant no. 903516), the Danish Council for Strategic Research (grant no. 0603-00280B), the Danish Council for Independent Research (grant nos. 10-082884 and 271-08-0815), and the Capital Region Research Foundation. A.M. is supported by Bourse de formation postdoctorale -Fonds de recherche du Quebec -Sante. D.V. was supported in part by the NIH (grant nos. AI133765 and AI144722). U.T. and S.J.S. are supported by the Novo Nordisk Fonden.	Andrews S., 2010, FASTQC QUALITY CONTR; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bosch Astrid A T M, 2017, Am J Respir Crit Care Med, V196, P1582, DOI [10.1164/rccm.201703-0554OC, 10.1164/rccm.201703-0554oc]; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Cardenas A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11058-3; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Forno E, 2019, LANCET RESP MED, V7, P336, DOI 10.1016/S2213-2600(18)30466-1; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Ta LDH, 2018, J ALLERGY CLIN IMMUN, V142, P86, DOI 10.1016/j.jaci.2018.01.032; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Man WH, 2019, AM J RESP CRIT CARE, V200, P760, DOI 10.1164/rccm.201810-1993OC; Mandal S., 2015, MICROB ECOL HEALTH D, V26, DOI DOI 10.3402/MEHD.V26.27663; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKennan C, 2019, BIOMETRIKA, V106, P823, DOI 10.1093/biomet/asz037; Meltzer EO, 2009, J ALLERGY CLIN IMMUN, V124, pS43, DOI 10.1016/j.jaci.2009.05.013; Mortensen MS, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0215-9; Nicodemus-Johnson J, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90151; Oksanen J., 2020, VEGAN COMMUNITY ECOL, V2, P1; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pidsley R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1066-1; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schoos AMM, 2016, ALLERGY, V71, P684, DOI 10.1111/all.12853; Schoos AMM, 2019, PEDIAT ALLERG IMM-UK, V30, P716, DOI 10.1111/pai.13109; Stokholm J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02573-2; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Thornton J, 2019, NONPROFIT POLICY FOR, V10, DOI 10.1515/npf-2019-0037; Thorsteinsdottir S, 2016, ALLERGY, V71, P1736, DOI 10.1111/all.12980; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Waage J, 2018, NAT GENET, V50, P1072, DOI 10.1038/s41588-018-0157-1; Wang N, 2019, EBIOMEDICINE, V43, P587, DOI 10.1016/j.ebiom.2019.04.047; Yang IV, 2017, J ALLERGY CLIN IMMUN, V139, P1478, DOI 10.1016/j.jaci.2016.07.036	49	14	15	2	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1358	1366		10.1016/j.jaci.2020.07.005	http://dx.doi.org/10.1016/j.jaci.2020.07.005			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32693091	Green Accepted, hybrid			2022-12-18	WOS:000596937900017
J	Slight-Webb, S; Smith, M; Bylinska, A; Macwana, S; Guthridge, C; Lu, RF; Merrill, JT; Chakravarty, E; Arriens, C; Munroe, ME; Maecker, HT; Utz, PJ; Guthridge, JM; James, JA				Slight-Webb, Samantha; Smith, Miles; Bylinska, Aleksandra; Macwana, Susan; Guthridge, Carla; Lu, Rufei; Merrill, Joan T.; Chakravarty, Eliza; Arriens, Cristina; Munroe, Melissa E.; Maecker, Holden T.; Utz, Paul J.; Guthridge, Joel M.; James, Judith A.			Autoantibody-positive healthy individuals with lower lupus risk display a unique immuneendotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ANA plus healthy; SLE; Autoantibodies; immune suppression; T cells; race; cytokines	STEM-CELL FACTOR; IMMUNE-RESPONSES; DENDRITIC CELLS; SLE PATIENTS; C-KIT; ERYTHEMATOSUS; CLASSIFICATION; SERUM	Background: Autoimmune diseases comprise a spectrum of illnesses and are on the rise worldwide. Although antinuclear antibodies (ANAs) are detected in many autoimmune diseases, up to 20% of healthy women are ANA-positive (ANA+) and most will never develop clinical symptoms. Furthermore, disease transition is higher among ANA+ African Americans compared with ANA+ European Americans. Objective: We sought to determine the immune features that might define and prevent transition to clinical autoimmunity in ANA+ healthy individuals. Methods: We comprehensively phenotyped immune profiles of African Americans and European Americans who are ANA-negative (ANA-) healthy, ANA+ healthy, or have SLE using single cell mass cytometry, next-generation RNA-sequencing, multiplex cytokine profiling, and phospho-signaling analyses. Results: We found that, compared with both ANA- and ANA+ healthy individuals, patients with SLE of both races displayed T-cell expansion and elevated expression of type I and II interferon pathways. We discovered a unique immune signature that suggests a suppressive immune phenotype and reduced CD11C+ autoimmunity-associated B cells in healthy ANA+ European Americans that is absent in their SLE or even healthy ANA- counterparts, or among African American cohorts. In contrast, ANA+ healthy African Americans exhibited elevated expression of T-cell activation markers and higher plasma levels of IL-6 than did healthy ANA+ European Americans. Conclusions: We propose that this novel immune signature identified in ANA+ healthy European Americans may protect them from T-cell expansion, heightened activation of interferon pathways, and disease transition.	[Slight-Webb, Samantha; Smith, Miles; Bylinska, Aleksandra; Macwana, Susan; Guthridge, Carla; Lu, Rufei; Merrill, Joan T.; Chakravarty, Eliza; Arriens, Cristina; Munroe, Melissa E.; Guthridge, Joel M.; James, Judith A.] Oklahoma Med Res Fdn, Dept Arthrit & Clin Immunol, Oklahoma City, OK USA; [Arriens, Cristina; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK USA; [Lu, Rufei; Arriens, Cristina; Guthridge, Joel M.; James, Judith A.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Maecker, Holden T.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Utz, Paul J.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University; Stanford University	James, JA (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Judith-James@omrf.org	Merrill, Joan/HDL-9141-2022	Smith, Miles/0000-0003-0651-809X	National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences through the National Institutes of Health [U19AI082714, U19AI082719, U54GM104938, U01AI101934, P30AR073750, R01AR072401, UM1AI44292 T32AI007633, S10RR026735]; Oklahoma Medical Research Foundation J. Donald and Patricia Capra Fellowship Support; Oklahoma Medical Research Foundation Lou C. Kerr Chair in Biomedical Research	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of General Medical Sciences through the National Institutes of Health; Oklahoma Medical Research Foundation J. Donald and Patricia Capra Fellowship Support; Oklahoma Medical Research Foundation Lou C. Kerr Chair in Biomedical Research	This work was supported by the National Institute of Allergy and Infectious Diseases, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and an Institutional Development Award from the National Institute of General Medical Sciences through the National Institutes of Health (U19AI082714, U19AI082719, U54GM104938, U01AI101934, P30AR073750, R01AR072401, UM1AI44292 T32AI007633 [S.S.W.], and S10RR026735) and was conceived through interactions of the National Institute of Allergy and Infectious Diseases Autoimmunity Centers of Excellence and National Institute of Allergy and Infectious Diseases Cooperative Working Group on Autoimmune Disease Prevention programs. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health or one of its institutes. This work was also supported by the Oklahoma Medical Research Foundation J. Donald and Patricia Capra Fellowship Support to R.L. and the Oklahoma Medical Research Foundation Lou C. Kerr Chair in Biomedical Research to J.A.J.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2019, FASTQC QUALITY CONTR; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Au EYL, 2018, HONG KONG MED J, V24, P261, DOI 10.12809/hkmj177007; Baglaenko Y, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1752-3; Bego MG, 2006, EXP HEMATOL, V34, P555, DOI 10.1016/j.exphem.2005.11.012; Bruner BF, 2012, ARTHRITIS RHEUM-US, V64, P3677, DOI 10.1002/art.34651; Bushnell B., 2019, BBTOOLS SUITE FAST M; Cho KA, 2017, BIOCHEM BIOPH RES CO, V487, P856, DOI 10.1016/j.bbrc.2017.04.141; Coit P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0037-1; de Vries RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004482; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fayyaz A, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000078; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Granados HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183887; Guo YX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192704; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jog NR, 2019, ANN RHEUM DIS, V78, P1235, DOI 10.1136/annrheumdis-2019-215361; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Kheir JM, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2017-000247; Ko K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00309; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lewis MJ, 2017, RHEUMATOLOGY, V56, P67, DOI 10.1093/rheumatology/kew399; Li QZ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3271; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu RF, 2016, J AUTOIMMUN, V74, P182, DOI 10.1016/j.jaut.2016.06.001; Lyn-Cook BD, 2014, MOL IMMUNOL, V61, P38, DOI 10.1016/j.molimm.2014.05.001; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Menard LC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87310; National Institutes of Health, 2005, NIH AUTOIMMUNE DISEA; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Perez D, 2018, CLIN CHEM LAB MED, V56, P1771, DOI 10.1515/cclm-2017-0241; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pradier A, 2014, EUR J IMMUNOL, V44, P511, DOI 10.1002/eji.201343868; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Ritterhouse LL, 2011, ARTHRITIS RHEUM-US, V63, P3931, DOI 10.1002/art.30598; Rosenberg-Hasson Y, 2014, IMMUNOL RES, V58, P224, DOI 10.1007/s12026-014-8491-6; Sharma S, 2015, J AUTOIMMUN, V60, P51, DOI 10.1016/j.jaut.2015.04.002; Shovman O, 2005, ANN NY ACAD SCI, V1050, P380, DOI 10.1196/annals.1313.120; Slight-Webb S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124575; Slight-Webb S, 2016, ARTHRITIS RHEUMATOL, V68, P2492, DOI 10.1002/art.39706; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Urban SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004357; Vista ES, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2017-000214; Wandstrat AE, 2006, J AUTOIMMUN, V27, P153, DOI 10.1016/j.jaut.2006.09.001; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019; Weckerle CE, 2012, ARTHRITIS RHEUM-US, V64, P2947, DOI 10.1002/art.34483; Yu SC, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22898	51	14	15	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1419	1433		10.1016/j.jaci.2020.04.047	http://dx.doi.org/10.1016/j.jaci.2020.04.047			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	PC3XH	32446964	Green Accepted			2022-12-18	WOS:000596937900023
J	Zwaveling, S; van Wijk, RG; Karim, F				Zwaveling, Suzanne; van Wijk, Roy Gerth; Karim, Faiz			Pulmonary edema in COVID-19: Explained by bradykinin?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Zwaveling, Suzanne; Karim, Faiz] Groene Hart Hosp, Dept Internal Med, Gouda, India; [van Wijk, Roy Gerth; Karim, Faiz] Erasmus MC, Sect Allergy, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Zwaveling, S (corresponding author), Groene Hart Hosp, Dept Internal Med, Gouda, India.	suzanne.zwaveling@ghz.nl						[Anonymous], 2020, J RENAL INJ PREV, DOI [DOI 10.34172/JRIP.2020.19], 10.34172/jrip.2020.19]; Busse PJ, 2020, NEW ENGL J MED, V382, P1136, DOI 10.1056/NEJMra1808012; Hosoki K, 2020, J ALLERGY CLIN IMMUN, V146, P285, DOI 10.1016/j.jaci.2020.05.033; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Sodhi CP, 2018, AM J PHYSIOL-LUNG C, V314, pL17, DOI 10.1152/ajplung.00498.2016; van de Veerdonk FL, 2020, ELIFE, V9, DOI 10.7554/eLife.57555; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19	7	14	14	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2020	146	6					1454	1455		10.1016/j.jaci.2020.08.038	http://dx.doi.org/10.1016/j.jaci.2020.08.038			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	QR0PE	33077247	Green Published, Bronze			2022-12-18	WOS:000624916500001
J	Kim, AR; Han, D; Choi, JY; Seok, J; Kim, SE; Seo, SH; Takahashi, H; Amagai, M; Park, SH; Kim, SC; Shin, EC; Kim, JH				Kim, A. Reum; Han, Dawoon; Choi, Ji Young; Seok, Joon; Kim, Song-Ee; Seo, Seong-Hoon; Takahashi, Hayato; Amagai, Masayuki; Park, Su-Hyung; Kim, Soo-Chan; Shin, Eui-Cheol; Kim, Jong Hoon			Targeting inducible costimulator expressed on CXCR5(+)PD-1(+) T-H cells suppresses the progression of pemphigus vulgaris	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						pemphigus vulgaris; T follicular helper cell; desmoglein; inducible costimulator; humoral immunity	FOLLICULAR HELPER-CELL; MEMORY TFH CELLS; ICOS; PHENOTYPE; DIFFERENTIATION; AUTOANTIBODIES; POLYMORPHISMS; DESMOGLEIN-3; EXPANSION; SUBCLASS	Background: Pemphigus vulgaris (PV) is an autoimmune bullous disease mediated by autoantibodies against desmoglein 3 (DSG3). Inducible costimulator (ICOS) is a costimulatory receptor expressed on T cells and influences the activity of T follicular helper (T-FH) cells in various autoimmune diseases, but the roles of ICOS and T-FH cells in PV remain unclear. Objective: We examined the immunological characteristics, antigen specificity, and pathogenicity of CD4(+) T-cell subpopulations, as well as the therapeutic effect of anti-ICOS blocking antibodies in PV. Methods: A mouse model of PV was established by adoptive transfer of immune cells from the skin-draining lymph nodes or spleens of DSG3-expressing skin-grafted Dsg3(-/-) mice into Rag1(-/-) mice. The T-FH cells and CD4(+) T cells in PBMCs from PV patients were examined by flow cytometry. Results: Among CD4(+) T cells from the mouse model, ICOS-positive T-FH cells were associated with B-cell differentiation and were required for disease induction. Using an MHC class II tetramer, DSG3-specific ICOS+ T-FH cells were found to be associated with anti-DSG3 antibody production and expanded in the absence of B cells. In human PV, the frequency of ICOS1 CXCR5(+) PD-1(+) memory CD4(+) T cells correlated with the autoantibody level. Treatment with anti-ICOS blocking antibodies targeting ICOS+ T-FH cells decreased the anti-DSG3 antibody level and delayed disease progression in vivo. Conclusions: Mouse Dsg3-specific ICOS+ T-FH cells and human ICOS(+)CXCR5(+)PD-1(+) T-H cells are associated with the anti-DSG3 antibody response in PV. ICOS expressed on CXCR5(+)PD-1(+) T-H cells may be a therapeutic target for PV.	[Kim, A. Reum; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, 291 Daehak Ro, Daejeon 34141, South Korea; [Han, Dawoon; Choi, Ji Young; Kim, Song-Ee; Seo, Seong-Hoon; Kim, Soo-Chan; Kim, Jong Hoon] Yonsei Univ, Gangnam Severance Hosp, Dept Dermatol, Coll Med, 211 Eonjuro, Seoul 06273, South Korea; [Han, Dawoon; Choi, Ji Young; Kim, Song-Ee; Seo, Seong-Hoon; Kim, Soo-Chan; Kim, Jong Hoon] Yonsei Univ, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea; [Seok, Joon; Park, Su-Hyung] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Translat Immunol & Vaccinol, Daejeon, South Korea; [Takahashi, Hayato; Amagai, Masayuki] Keio Univ, Dept Dermatol, Sch Med, Tokyo, Japan	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Keio University	Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, 291 Daehak Ro, Daejeon 34141, South Korea.; Kim, SC (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Dermatol, Coll Med, 211 Eonjuro, Seoul 06273, South Korea.	kimsc@yuhs.ac; ecshin@kaist.ac.kr	Takahashi, Hayato/AAV-7707-2021; Park, Su-Hyung/N-3514-2014; Amagai, Masayuki/K-5325-2013; Kim, Jong Hoon/I-3135-2019	Takahashi, Hayato/0000-0001-6768-8821; Park, Su-Hyung/0000-0001-6363-7736; Amagai, Masayuki/0000-0003-3314-7052; Kim, Jong Hoon/0000-0002-3385-8180; KIM, SOO-CHAN/0000-0002-2327-4755	National Research Foundation grants of South Korea [NRF-2018R1D1A1B07045532, NRF-2018M3A9D3079498]	National Research Foundation grants of South Korea	This work was supported by National Research Foundation grants of South Korea (NRF-2018R1D1A1B07045532 and NRF-2018M3A9D3079498).	Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Dalla-Costa R, 2010, HUM IMMUNOL, V71, P809, DOI 10.1016/j.humimm.2010.04.001; Futei Y, 2003, J AM ACAD DERMATOL, V49, P1023, DOI 10.1016/S0190-9622(03)02160-1; Futei Y, 2001, J DERMATOL SCI, V26, P55, DOI 10.1016/S0923-1811(00)00158-4; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Hata T, 2013, J IMMUNOL, V191, P83, DOI 10.4049/jimmunol.1203536; Hennerici T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148919; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Kasperkiewicz M, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.26; Kim J, 2018, IMMUNITY, V48, P161, DOI 10.1016/j.immuni.2017.11.025; Kim JH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01259; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Luo CM, 2013, J NEUROIMMUNOL, V256, P55, DOI 10.1016/j.jneuroim.2012.12.001; Mittereder N, 2016, J IMMUNOL, V197, P491, DOI 10.4049/jimmunol.1502241; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Narbutt J, 2010, J CUTAN MED SURG, V14, P291, DOI [10.2310./7750.2010.09061, 10.2310/7750.2010.09061]; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; Saleh MA, 2012, J INVEST DERMATOL, V132, P1141, DOI 10.1038/jid.2011.449; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Takahashi H, 2008, J IMMUNOL, V181, P1526, DOI 10.4049/jimmunol.181.2.1526; Takahashi H, 2011, J CLIN INVEST, V121, P3677, DOI 10.1172/JCI57379; Taylor DK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf5307; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Veldman C, 2003, J IMMUNOL, V170, P635, DOI 10.4049/jimmunol.170.1.635; Vella LA, 2019, J CLIN INVEST, V129, P3185, DOI 10.1172/JCI125628; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Walker EJ, 2009, ARTHRITIS RHEUM-US, V60, P931, DOI 10.1002/art.24412; Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Yoshie N, 2016, ENDOCR J, V63, P61, DOI 10.1507/endocrj.EJ15-0435; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	38	14	14	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2020	146	5					1070	+		10.1016/j.jaci.2020.03.036	http://dx.doi.org/10.1016/j.jaci.2020.03.036			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OP5VH	32311391	Bronze			2022-12-18	WOS:000588153700011
J	Permaul, P; Gaffin, JM; Petty, CR; Baxi, SN; Lai, PS; Sheehan, WJ; Camargo, CA; Gold, DR; Phipatanakul, W				Permaul, Perdita; Gaffin, Jonathan M.; Petty, Carter R.; Baxi, Sachin N.; Lai, Peggy S.; Sheehan, William J.; Camargo, Carlos A., Jr.; Gold, Diane R.; Phipatanakul, Wanda			Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; obesity; body mass index; BMI; inner-city; urban; school; nitrogen dioxide; NO2; children; environment; exposure; indoor; pollutant; air	EXHALED NITRIC-OXIDE; INNER-CITY CHILDREN; INDOOR AIR-POLLUTION; NITROGEN-DIOXIDE; RESPIRATORY HEALTH; ENVIRONMENTAL INTERVENTION; MULTIPOLLUTANT EXPOSURE; ALLERGIC SENSITIZATION; MEDICATION USE; ASSOCIATION	Background: Sparse data address the effects of nitrogen dioxide (NO2) exposure in inner-city schools on obese students with asthma. Objective: We sought to evaluate relationships between classroom NO2 exposure and asthma symptoms and morbidity by body mass index (BMI) category. Methods: The School Inner-City Asthma Study enrolled students aged 4 to 13 years with asthma from 37 inner-city schools. Students had baseline determination of BMI percentile. Asthma symptoms, morbidity, pulmonary inflammation, and lung function were monitored throughout the subsequent academic year. Classroom NO2 data, linked to enrolled students, were collected twice per year. We determined the relationship between classroom NO2 levels and asthma outcomes by BMI stratification. Results: A total of 271 predominantly black (35%) or Hispanic students (35%) were included in analyses. Fifty percent were normal weight (5-84th BMI percentile), 15% overweight (>= 85-94th BMI percentile), and 35% obese (>95th BMI percentile). For each 10-parts per billion increase in NO2, obese students had a significant increase in the odds of having an asthma symptom day (odds ratio [OR], 1.86; 95% CI, 1.15-3.02) and in days caregiver changed plans (OR, 4.24; 95% CI, 2.33-7.70), which was significantly different than normal weight students who exhibited no relationship between NO2 exposure and symptom days (OR, 0.90; 95% CI, 0.57-1.42; pairwise interaction P > .03) and change in caregiver plans (OR, 1.37; 95% CI, 0.67-2.82; pairwise interaction P = .02). Relationships between NO2 levels and lung function and fractional exhaled nitric oxide did not differ by BMI category. If we applied a conservative Holm-Bonferroni correction for 16 comparisons (obese vs normal weight and overweight vs normal weight for 8 outcomes), these findings would not meet statistical significance (all P >.003). Conclusions: Obese BMI status appears to increase susceptibility to classroom NO2 exposure effects on asthma symptoms in inner-city children. Environmental interventions targeting indoor school NO2 levels may improve asthma health for obese children. Although our findings would not remain statistically significant after adjustment for multiple comparisons, the large effect sizes warrant future study of the interaction of obesity and pollution in pediatric asthma.	[Permaul, Perdita] New York Presbyterian Weill Cornell Med, Div Pediat Pulmonol Allergy & Immunol, New York, NY USA; [Permaul, Perdita] Weill Cornell Med Coll, New York, NY USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Pulm Med, Boston, MA 02115 USA; [Gaffin, Jonathan M.; Baxi, Sachin N.; Lai, Peggy S.; Camargo, Carlos A., Jr.; Phipatanakul, Wanda] Harvard Med Sch, Boston, MA 02115 USA; [Petty, Carter R.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA 02115 USA; [Baxi, Sachin N.; Phipatanakul, Wanda] Boston Childrens Hosp, Div Allergy & Immunol, 300 Longwood Ave, Boston, MA 02115 USA; [Lai, Peggy S.; Gold, Diane R.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Lai, Peggy S.] Massachusetts Gen Hosp, Div Pulm & Crit Care, Boston, MA 02114 USA; [Sheehan, William J.] Childrens Natl Hlth Syst, Div Allergy & Immunol, Washington, DC USA; [Sheehan, William J.] George Washington Univ, Sch Med, Washington, DC USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Gold, Diane R.] Brigham & Womens Hosp, Charming Div Network Med, 75 Francis St, Boston, MA 02115 USA	Cornell University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Children's National Health System; George Washington University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Phipatanakul, W (corresponding author), Boston Childrens Hosp, Div Allergy & Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; GAFFIN, JONATHAN/0000-0003-2213-4504; Hauptman, Marissa/0000-0002-0028-8927	National Institutes of Health [R01 AI 073964, U01 AI 110397, K24 AI 106822, K23 AI 123517, R01 ES 030100, R01 AI 144119, K23 AI 104780]; Allergy and Asthma Awareness Initiative, Inc.; Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergy and Asthma Awareness Initiative, Inc.; Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University	This research is supported by the National Institutes of Health (grant nos. R01 AI 073964, U01 AI 110397, and K24 AI 106822 [PI, W.P.], grant no. K23 AI 123517 [PI, P.P], grant no. R01 ES 030100 [PI, J.M.G.], grant no. R01 AI 144119 [PI, P.S.L.], and grant no. K23 AI 104780 [PI, W.J.S.]). Funding was provided by The Allergy and Asthma Awareness Initiative, Inc. This work was conducted with support from Harvard Catalyst j The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.	Akinbami LJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2354; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Barreto M, 2005, PEDIAT ALLERG IMM-UK, V16, P52, DOI 10.1111/j.1399-3038.2005.00220.x; Belanger K, 2013, EPIDEMIOLOGY, V24, P320, DOI 10.1097/EDE.0b013e318280e2ac; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Breysse Patrick N, 2010, Proc Am Thorac Soc, V7, P102, DOI 10.1513/pats.200908-083RM; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Choi H, 2018, ENVIRON INT, V121, P308, DOI 10.1016/j.envint.2018.08.061; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Dong GH, 2013, INT J OBESITY, V37, P94, DOI 10.1038/ijo.2012.125; Dutmer CM, 2018, CURR OPIN ALLERGY CL, V18, P139, DOI 10.1097/ACI.0000000000000423; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Flashner BM, 2020, PEDIATR PULM, V55, P503, DOI 10.1002/ppul.24597; Forno E, 2017, AM J RESP CRIT CARE, V195, P314, DOI 10.1164/rccm.201605-1039OC; Gaffin JM, 2018, J ALLERGY CLIN IMMUN, V141, P2249, DOI 10.1016/j.jaci.2017.08.028; Gergen PJ, 2016, J ALLER CL IMM-PRACT, V4, P22, DOI 10.1016/j.jaip.2015.07.024; Gergen PJ, 2015, IMMUNOL ALLERGY CLIN, V35, P101, DOI 10.1016/j.iac.2014.09.006; Godwin C, 2007, INDOOR AIR, V17, P109, DOI 10.1111/j.1600-0668.2006.00459.x; Gold DR, 2017, J ALLERGY CLIN IMMUN, V140, P933, DOI 10.1016/j.jaci.2017.04.024; Hansel NN, 2008, ENVIRON HEALTH PERSP, V116, P1428, DOI 10.1289/ehp.11349; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Hulin M, 2010, INDOOR AIR, V20, P502, DOI 10.1111/j.1600-0668.2010.00673.x; Ierodiakonou D, 2016, J ALLERGY CLIN IMMUN, V137, P390, DOI 10.1016/j.jaci.2015.05.028; Jackson DJ, 2009, J ALLERGY CLIN IMMUN, V124, P949, DOI 10.1016/j.jaci.2009.07.024; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Keet CA, 2017, J ALLERGY CLIN IMMUN, V140, P822, DOI 10.1016/j.jaci.2017.01.036; Koehler C, 2016, INT ARCH ALLERGY IMM, V171, P27, DOI 10.1159/000450751; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; Lang JE, 2008, AM J PHYSIOL-LUNG C, V294, pL1013, DOI 10.1152/ajplung.00122.2007; Lang JE, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2119; Lang JE, 2019, CURR OPIN PULM MED, V25, P34, DOI 10.1097/MCP.0000000000000537; Levy I, 2014, ENVIRON HEALTH PERSP, V122, P65, DOI 10.1289/ehp.1306518; Lu KD, 2013, J ALLERGY CLIN IMMUN, V131, P1017, DOI 10.1016/j.jaci.2012.12.1570; Lugogo N, 2018, J ALLERGY CLIN IMMUN, V141, P1096, DOI 10.1016/j.jaci.2017.04.047; Matsui EC, 2014, ALLERGY, V69, P553, DOI 10.1111/all.12361; Matsui EC, 2008, IMMUNOL ALLERGY CLIN, V28, P665, DOI 10.1016/j.iac.2008.03.004; Matsui EC, 2017, JAMA-J AM MED ASSOC, V317, P1027, DOI 10.1001/jama.2016.21048; McCormack MC, 2009, ENVIRON HEALTH PERSP, V117, P294, DOI 10.1289/ehp.11770; Mohan A, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0877-z; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Mortimer KM, 2002, EUR RESPIR J, V19, P699, DOI 10.1183/09031936.02.00247102; Norback D, 2019, ENVIRON INT, V125, P252, DOI 10.1016/j.envint.2019.01.036; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Oakes M, 2014, ENVIRON INT, V69, P90, DOI 10.1016/j.envint.2014.03.030; Ogawa & Co Inc, 2006, NO NO2 NOX SO2 SAMPL; Ogden CL, 2018, JAMA-J AM MED ASSOC, V319, P2410, DOI 10.1001/jama.2018.5158; Paulin LM, 2014, INDOOR AIR, V24, P416, DOI 10.1111/ina.12085; Paulin LM, 2017, ENVIRON RES, V159, P118, DOI 10.1016/j.envres.2017.07.052; Peters U, 2018, J ALLERGY CLIN IMMUN, V141, P1169, DOI 10.1016/j.jaci.2018.02.004; Phipatanakul W, 2011, J ASTHMA, V48, P1007, DOI 10.3109/02770903.2011.624235; Pilotto LS, 2004, INT J EPIDEMIOL, V33, P208, DOI 10.1093/ije/dyh018; Rao DR, 2015, ANN ALLERG ASTHMA IM, V114, P256, DOI 10.1016/j.anai.2014.12.004; Salonen H, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.05.081; Sasso F, 2019, RESP MED, V148, P31, DOI 10.1016/j.rmed.2019.01.007; Sheehan WJ, 2017, JAMA PEDIATR, V171, P31, DOI 10.1001/jamapediatrics.2016.2543; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Tashiro H, 2019, AM J RESP CELL MOL, V61, P702, DOI 10.1165/rcmb.2019-0144OC; Tobias TAM, 2019, CLIN EXP ALLERGY, V49, P838, DOI 10.1111/cea.13391; van Amsterdam JGC, 2003, CLIN EXP ALLERGY, V33, P187, DOI 10.1046/j.1365-2222.2003.01597.x; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; Wooding DJ, 2019, AM J RESP CRIT CARE, V200, P565, DOI 10.1164/rccm.201809-1657OC; Wu TD, 2019, J ALLERGY CLIN IMMUN, V143, P803, DOI 10.1016/j.jaci.2018.10.008; Wu TD, 2018, J ALLER CL IMM-PRACT, V6, P2157, DOI 10.1016/j.jaip.2018.04.020	67	14	14	3	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2020	146	4					813	+		10.1016/j.jaci.2020.03.003	http://dx.doi.org/10.1016/j.jaci.2020.03.003			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	OH2JO	32197971	Green Accepted			2022-12-18	WOS:000582395800012
J	Deya-Martinez, A; Flinn, AM; Gennery, AR				Deya-Martinez, Angela; Flinn, Aisling M.; Gennery, Andrew R.			Neonatal thymectomy in children-accelerating the immunologic clock?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Thymus; neonatal thymectomy; immunosenescence; T-lymphocyte; immunodeficiency	CONGENITAL HEART-DISEASE; T-CELL COMPARTMENT; MYASTHENIA-GRAVIS; CARDIAC TRANSPLANTATION; THYMIC ACTIVITY; IMMUNE FUNCTION; EARLY-CHILDHOOD; RECEPTOR; AUTOIMMUNITY; DEFECTS	The thymus is critical for central tolerance and diverse T-lymphocyte repertoire development, to provide lifelong defense against pathogens while maintaining self-tolerance. Peak thymic output occurs in utero, during infancy, and in early childhood, diminishing throughout life Infants with congenital heart disease requiring sternotomy often undergo thymectomy to clear the surgical field. The long-term effects of early thymectomy are just being appreciated. Many patients remain asymptomatic despite immunologic findings mirroring those of immunosenescence. Few develop increased infection or lymphoreticular malignancy risk. When considering the effects of infant thymectomy, patients with partial DiGeorge syndrome or hypomorphic recombination activating gene (RAG) mutations may be instructive. These patients are lymphocytopenic, with increased early-onset infection and autoimmunity risk that is not seen in most patients who underwent thymectomy during infancy. The thymic structure of patients with partial DiGeorge syndrome or hypomorphic RAG is abnormal, with disrupted architecture inclining to perturbation of central tolerance. Similar findings may be seen in patients with myasthenia gravis, although disrupted peripheral tolerance may play a greater role in autoimmunity development. In conclusion, thymectomy during infancy may increase future risk of infection or autoimmunity, with premature immunosenescence mediated through disruption of central and peripheral tolerance mechanisms initiated by early cessation or diminution of thymic output. Ideally, some thymic tissue should be preserved at the time of surgery.	[Deya-Martinez, Angela] Univ Barcelona, Funct Unit Clin Immunol & Primary Immunodeficienc, Allergy & Clin Immunol Dept, Hosp St Joan de Deu,Pediat Res Inst St Joan de De, Barcelona, Spain; [Flinn, Aisling M.; Gennery, Andrew R.] Great North Childrens Hosp, Paediat Immunol & Haematopoiet Stem Cell Transpla, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Primary Immunodeficiency Grp, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England	University of Barcelona; Newcastle University - UK	Gennery, AR (corresponding author), Great North Childrens Hosp, Clin Resource Bldg,Floor 4,Block 2, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	a.r.gennery@ncl.ac.uk		Flinn, Aisling/0000-0001-9397-0214; Deya-Martinez, Angela/0000-0002-8026-7674				Adams SP, 2018, CLIN EXP IMMUNOL, V191, P198, DOI 10.1111/cei.13062; [Anonymous], 2018, AM J MED GENET A, V176, P2121, DOI 10.1002/ajmg.a.38474; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Bomken S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02912; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Bosticardo M, 2019, AM J HUM GENET, V105, P549, DOI 10.1016/j.ajhg.2019.07.014; Chang CC, 2019, RHEUMATOLOGY, V58, P135, DOI 10.1093/rheumatology/key236; De Ravin SS, 2010, BLOOD, V116, P1263, DOI 10.1182/blood-2010-02-267583; Douek DC, 2000, VACCINE, V18, P1638, DOI 10.1016/S0264-410X(99)00499-5; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Eberle P, 2009, CLIN EXP IMMUNOL, V155, P189, DOI 10.1111/j.1365-2249.2008.03809.x; Ekman-Joelsson BM, 2017, CARDIOL YOUNG, V27, P1823, DOI 10.1017/S104795111700155X; Elder RW, 2015, PEDIATR CARDIOL, V36, P1411, DOI 10.1007/s00246-015-1174-9; Evoli A, 2002, NEUROLOGY, V59, P1844, DOI 10.1212/01.WNL.0000032502.89361.0C; Eysteinsdottir JH, 2004, CLIN EXP IMMUNOL, V136, P349, DOI 10.1111/j.1365-2249.2004.02437.x; Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960; Gennery AR, 1998, LANCET, V351, P1778, DOI 10.1016/S0140-6736(97)08486-9; Gerli R, 1999, J ALLERGY CLIN IMMUN, V103, P865, DOI 10.1016/S0091-6749(99)70431-8; Giardino G, 2019, BLOOD, V133, P2586, DOI 10.1182/blood.2018885244; Gilhus NE, 2015, EUR J NEUROL, V22, P17, DOI 10.1111/ene.12599; Ginn-Pease ME, 2001, J INTERF CYTOK RES, V21, P515, DOI 10.1089/10799900152434394; Gossel G, 2017, ELIFE, V6, DOI 10.7554/eLife.23013; Gudmundsdottir J, 2016, J ALLERGY CLIN IMMUN, V138, P1439, DOI 10.1016/j.jaci.2016.05.014; Habel A, 2014, EUR J PEDIATR, V173, P757, DOI 10.1007/s00431-013-2240-z; Holhlfeld R, 1999, CONT NEUROL SERIES, P87; Klein L, 2019, NAT REV IMMUNOL, V19, P7, DOI 10.1038/s41577-018-0083-6; Lee YN, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6109; Lepletier A, 2017, FRONT HORM RES, V48, P19, DOI 10.1159/000452903; Levin N, 2005, J NEUROL SCI, V237, P39, DOI 10.1016/j.jns.2005.05.009; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Mancebo E, 2008, CLIN EXP IMMUNOL, V154, P375, DOI 10.1111/j.1365-2249.2008.03771.x; Marcovecchio GE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00447; MARX A, 1989, AM J PATHOL, V134, P865; McLean-Tooke A, 2011, SCAND J IMMUNOL, V73, P577, DOI 10.1111/j.1365-3083.2011.02527.x; McLean-Tooke A, 2008, J ALLERGY CLIN IMMUN, V122, P362, DOI 10.1016/j.jaci.2008.03.033; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Minchenberg SB, 2018, CLIN IMMUNOL, V194, P100, DOI 10.1016/j.clim.2018.07.007; Miskovic Rada, 2015, Open Access Maced J Med Sci, V3, P439, DOI 10.3889/oamjms.2015.096; Montin D, 2019, J ALLER CL IMM-PRACT, V7, P2369, DOI 10.1016/j.jaip.2019.03.014; Morsheimer MM, 2016, J ALLER CL IMM-PRACT, V4, P491, DOI 10.1016/j.jaip.2015.11.034; Offor U, 2018, BRIT J HAEMATOL, V181, P113; Oh J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003352; Ohara M, 2018, INTERNAL MED, V57, P601, DOI 10.2169/internalmedicine.9167-17; Pawelec G, 2017, BIOGERONTOLOGY, V18, P717, DOI 10.1007/s10522-017-9682-z; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Prelog M, 2009, CLIN IMMUNOL, V130, P123, DOI 10.1016/j.clim.2008.08.023; Ricci S, 2018, CLIN IMMUNOL, V188, P81, DOI 10.1016/j.clim.2017.12.011; Romi F, 2002, J NEUROIMMUNOL, V128, P82, DOI 10.1016/S0165-5728(02)00145-5; Sauce D, 2012, J IMMUNOL, V189, P5541, DOI 10.4049/jimmunol.1201235; Sauce D, 2011, CURR OPIN IMMUNOL, V23, P543, DOI 10.1016/j.coi.2011.05.001; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schadenberg AWL, 2014, J ALLERGY CLIN IMMUN, V133, P277, DOI 10.1016/j.jaci.2013.08.030; Sempowski GD, 2001, J IMMUNOL, V166, P2808, DOI 10.4049/jimmunol.166.4.2808; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; STEINMANN GG, 1985, SCAND J IMMUNOL, V22, P563, DOI 10.1111/j.1365-3083.1985.tb01916.x; Sun Y, 2004, CLIN IMMUNOL, V112, P284, DOI 10.1016/j.clim.2004.04.005; Szurek E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141161; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; van den Broek T, 2017, EUR J IMMUNOL, V47, P1970, DOI 10.1002/eji.201746971; van den Broek T, 2016, J CLIN INVEST, V126, P1126, DOI 10.1172/JCI84997; van Gent R, 2011, BLOOD, V118, P627, DOI 10.1182/blood-2011-03-341396; Watad A, 2017, GERONTOLOGY, V63, P515, DOI 10.1159/000478012; Ye P, 2002, CRIT REV IMMUNOL, V22, P483; Yu XM, 2014, J ALLERGY CLIN IMMUN, V133, P1109, DOI 10.1016/j.jaci.2013.11.018	65	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					236	243		10.1016/j.jaci.2020.02.028	http://dx.doi.org/10.1016/j.jaci.2020.02.028			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32169378	Bronze			2022-12-18	WOS:000558835000002
J	Ferrua, F; Marangoni, F; Aiuti, A; Roncarolo, MG				Ferrua, Francesca; Marangoni, Francesco; Aiuti, Alessandro; Roncarolo, Maria Grazia			Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Gene therapy; Wiskott-Aldrich syndrome; lentiviral vector; hematopoietic stem/progenitor cell; reduced-intensity conditioning			[Ferrua, Francesca; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Ferrua, Francesca; Aiuti, Alessandro] IRCCS San Raffaele Sci Inst, Bone Marrow Transplantat Unit, Milan, Italy; [Marangoni, Francesco] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA; [Marangoni, Francesco] Univ Calif Irvine, Inst Immunol, Irvine, CA USA; [Aiuti, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Roncarolo, Maria Grazia] Stanford Univ, Sch Med, Div Stem Cell Transplantat & Regenerat Med, Dept Pediat, Stanford, CA USA; [Roncarolo, Maria Grazia] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of California System; University of California Irvine; University of California System; University of California Irvine; Vita-Salute San Raffaele University; Stanford University; Stanford University	Roncarolo, MG (corresponding author), Lorry I Lokey Stem Cell Res Bldg, Stanford, CA 94305 USA.	mg1@stanford.edu	Ferrua, Francesca/K-4340-2016	Ferrua, Francesca/0000-0002-5695-4490	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21 AR072849]	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	F. Marangoni is supported by a grant from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant no. R21 AR072849). The San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) is a joint venture between the Italian Telethon Foundation and Ospedale San Raffaele. Wiskott-Aldrich syndrome gene therapy was licensed to GlaxoSmithKline in 2014 and then transferred to Orchard Therapeutics in April 2018. F. Ferrua and A. Aiuti are investigators of trials nos. NCT01515462 and NCT03837483.	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Burroughs LM, 2020, BLOOD, V135, P2094, DOI 10.1182/blood.2019002939; Candotti F, 2018, J CLIN IMMUNOL, V38, P13, DOI 10.1007/s10875-017-0453-z; Cavazzana M, 2019, NAT REV DRUG DISCOV, V18, P447, DOI 10.1038/s41573-019-0020-9; Ferrua F, 2019, BLOOD, V134, DOI 10.1182/blood-2019-124665; Ferrua F, 2019, LANCET HAEMATOL, V6, pE239, DOI 10.1016/S2352-3026(19)30021-3; Labrosse R, 2019, BLOOD, V134, P4629; Marangoni F, 2009, MOL THER, V17, P1073, DOI 10.1038/mt.2009.31; Morris EC, 2017, BLOOD, V130, P1327, DOI 10.1182/blood-2017-04-777136; Sereni L, 2019, J ALLERGY CLIN IMMUN, V144, P825, DOI 10.1016/j.jaci.2019.03.012	10	14	14	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2020	146	2					262	265		10.1016/j.jaci.2020.06.018	http://dx.doi.org/10.1016/j.jaci.2020.06.018			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	MZ0TA	32623069	Green Accepted, Green Submitted			2022-12-18	WOS:000558835000005
J	Clark, AD; Nair, N; Anderson, AE; Thalayasingam, N; Naamane, N; Skelton, AJ; Diboll, J; Barton, A; Eyre, S; Isaacs, JD; Pratt, AG; Reynard, LN				Clark, Alexander D.; Nair, Nisha; Anderson, Amy E.; Thalayasingam, Nishanthi; Naamane, Najib; Skelton, Andrew J.; Diboll, Julie; Barton, Anne; Eyre, Stephen; Isaacs, John D.; Pratt, Arthur G.; Reynard, Louise N.			Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Rheumatoid arthritis; adaptive immunity; immune-mediated disease; CD4(+) T cell; B cell; genetics; expression quantitative trait locus; DNA methylation; methylation quantitative trait locus; pathogenesis	EPIGENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; SUPER-ENHANCERS; EXPRESSION; ARCHITECTURE; MARKERS	Background: Defining regulatory mechanisms through which noncoding risk variants influence the cell-mediated pathogenesis of immune-mediated disease (IMD) has emerged as a priority in the post-genome-wide association study era. Objectives: With a focus on rheumatoid arthritis, we sought new insight into genetic mechanisms of adaptive immune dysregulation to help prioritize molecular pathways for targeting in this and related immune pathologies. Methods: Whole-genome methylation and transcriptional data from isolated CD4(+) T cells and B cells of more than 100 genotyped and phenotyped patients with inflammatory arthritis, all of whom were naive to immunomodulatory treatments, were obtained. Analysis integrated these comprehensive data with genome-wide association study findings across IMDs and other publicly available resources. Results: We provide strong evidence that disease-associated DNA variants regulate cis-CpG methylation in CD4(+) T and/or B cells at 37% RA loci. Using paired, cell-specific transcriptomic data and causal inference testing, we identify examples where site-specific DNA methylation in turn mediates gene expression, including FCRL3 in both cell types and ORMDL3/GSDMB, IL6ST/ANKRD55, and JAZF1 in CD4(+) T cells. A number of genes regulated in this way highlight mechanisms common to RA and other IMDs including multiple sclerosis and asthma, in turn distinguishing them from osteoarthritis, a primarily degenerative disease. Finally, we corroborate the observed effects experimentally. Conclusions: Our observations highlight important mechanisms of genetic risk in RA and the wider context of immune dysregulation. They confirm the utility of DNA methylation profiling as a tool for causal gene prioritization and, potentially, therapeutic targeting in complex IMD.	[Clark, Alexander D.; Anderson, Amy E.; Thalayasingam, Nishanthi; Naamane, Najib; Diboll, Julie; Isaacs, John D.; Pratt, Arthur G.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Nair, Nisha; Barton, Anne; Eyre, Stephen] Univ Manchester, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Versus Arthrit Ctr Genet & Genom, Manchester, Lancs, England; [Nair, Nisha; Barton, Anne; Eyre, Stephen] Manchester Univ NHS Fdn Trust, NIHR Manchester Musculoskeletal BRC, Manchester, Lancs, England; [Skelton, Andrew J.] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Isaacs, John D.; Pratt, Arthur G.] Newcastle Upon Tyne Hosp NHS Trust, Musculoskeletal Serv Directorate, Newcastle Upon Tyne, Tyne & Wear, England; [Reynard, Louise N.] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Skelton, Andrew J.] UCB, Slough, Berks, England	Newcastle University - UK; University of Manchester; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; UCB Pharma SA	Pratt, AG (corresponding author), Newcastle Univ, Musculoskeletal Res Grp, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	arthur.pratt@ncl.ac.uk		Isaacs, John/0000-0002-6103-7056; Pratt, Arthur/0000-0002-9909-8209; Reynard, Louise/0000-0002-6613-1797; Anderson, Amy/0000-0003-0532-623X	Academy of Medical Sciences; JGW Patterson Foundation; Pfizer; National Institute of Health Research (NIHR) Newcastle Biomedical Research Centre at Newcastle Hospitals Foundation Trust and Newcastle University; NIHR Manchester Musculoskeletal Biomedical Research Centre; British Medical Association; Wellcome Trust clinical training fellowship; MRC/Versus Arthritis stratified medicine award [MR/K015346/1]; Versus Arthritis [21754]; MRC [MR/P020941/1, G1001518] Funding Source: UKRI	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); JGW Patterson Foundation; Pfizer(Pfizer); National Institute of Health Research (NIHR) Newcastle Biomedical Research Centre at Newcastle Hospitals Foundation Trust and Newcastle University; NIHR Manchester Musculoskeletal Biomedical Research Centre; British Medical Association; Wellcome Trust clinical training fellowship(Wellcome Trust); MRC/Versus Arthritis stratified medicine award; Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this work came from the Academy of Medical Sciences, the JGW Patterson Foundation, and an unrestricted research grant from Pfizer. It was further supported by the National Institute of Health Research (NIHR) Newcastle Biomedical Research Centre at Newcastle Hospitals Foundation Trust and Newcastle University, the NIHR Manchester Musculoskeletal Biomedical Research Centre, and the British Medical Association (Doris Hillier Award to A.G.P.). Newcastle researchers received infrastructural support via the Versus Arthritis Research into Inflammatory Arthritis Centre. N.T. was supported by a Wellcome Trust clinical training fellowship. N. Nair was funded by an MRC/Versus Arthritis stratified medicine award (grant no. MR/K015346/1), and data generation was supported by Versus Arthritis (grant no. 21754).	Ai RZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04310-9; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Frank-Bertoncelj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14852; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Gee F, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-53; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Glossop JR, 2016, EPIGENOMICS-UK, V8, P209, DOI 10.2217/epi.15.103; Guo SC, 2017, MOD RHEUMATOL, V27, P441, DOI 10.1080/14397595.2016.1218595; Gutierrez-Arcelus M, 2015, PLOS GENET, V11, P25; Hannon E, 2018, AM J HUM GENET, V103, P654, DOI 10.1016/j.ajhg.2018.09.007; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004404; Imgenberg-Kreuz J, 2018, ANN RHEUM DIS, V77, P736, DOI 10.1136/annrheumdis-2017-212379; Iqbal K, 2019, RHEUMATOLOGY, V58, P1268, DOI 10.1093/rheumatology/kez008; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Javierre BM, 2016, CELL, V167, P1369, DOI 10.1016/j.cell.2016.09.037; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Julia A, 2017, HUM MOL GENET, V26, P2803, DOI 10.1093/hmg/ddx177; Kasela S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006643; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kothari PH, 2018, J ALLERGY CLIN IMMUN, V141, P2282, DOI 10.1016/j.jaci.2017.11.057; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Ligthart S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1119-5; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Millstein J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-23; Morita S, 2016, NAT BIOTECHNOL, V34, P1060, DOI 10.1038/nbt.3658; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Peters JE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005908; Phipson B, 2016, BIOINFORMATICS, V32, P286, DOI 10.1093/bioinformatics/btv560; Pierce BL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03209-9; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, P13; Rushton MD, 2015, HUM MOL GENET, V24, P7432, DOI 10.1093/hmg/ddv433; Schmiedel BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13426; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Thalayasingam N, 2018, ARTHRITIS RHEUMATOL, V70, P361, DOI 10.1002/art.40393; Urbut SM, 2019, NAT GENET, V51, P187, DOI 10.1038/s41588-018-0268-8; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Ventham NT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13507; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Yang ML, 2014, FEBS J, V281, P3193, DOI 10.1111/febs.12853; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	58	14	15	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1438	1451		10.1016/j.jaci.2019.12.910	http://dx.doi.org/10.1016/j.jaci.2019.12.910			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	31945409	Green Published, hybrid			2022-12-18	WOS:000531063400016
J	Codispoti, CD; Bandi, S; Moy, JN; Mahdavinia, M				Codispoti, Christopher D.; Bandi, Sindhura; Moy, James N.; Mahdavinia, Mahboobeh			Running a virtual allergy division and training program in the time of COVID-19 pandemic	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Virtual; allergy division; training program; COVID-19; pandemic			[Codispoti, Christopher D.; Bandi, Sindhura; Moy, James N.; Mahdavinia, Mahboobeh] Rush Univ, Div Allergy & Immunol, Dept Internal Med, Med Ctr, Chicago, IL USA	Rush University	Mahdavinia, M (corresponding author), Rush Univ, Med Ctr, Allergy & Immunol Div, 1725 W Harrison St,Ste 117, Chicago, IL 60601 USA.	Mahboobeh_mahdavinia@rush.edu		Mahdavinia, mahboobeh/0000-0003-4004-203X				Martin P, 2018, J TELEMED TELECARE, V24, P271, DOI 10.1177/1357633X17698868; Shaker MS, 2020, J ALLER CL IMM-PRACT, V8, P1477, DOI 10.1016/j.jaip.2020.03.012; White S., ACGME COMMON PROGRAM	3	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1357	1359		10.1016/j.jaci.2020.03.018	http://dx.doi.org/10.1016/j.jaci.2020.03.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	32243877	Bronze, Green Published			2022-12-18	WOS:000531063400006
J	Rha, MS; Kim, SW; Chang, DY; Lee, JK; Kim, J; Park, SH; Khalmuratova, R; Lim, HS; Eun, KM; Hong, SN; Kim, DW; Shin, EC				Rha, Min-Seok; Kim, Sang-Wook; Chang, Dong-Yeop; Lee, Jin-Ku; Kim, Jihye; Park, Su-Hyung; Khalmuratova, Roza; Lim, Hee-Suk; Eun, Kyoung Mi; Hong, Seung-No; Kim, Dae Woo; Shin, Eui-Cheol			Superantigen-related T(H)2 CD4(+) T cells in nonasthmatic chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; nasal polyp; T cells; superantigen; Staphylococcus aureus enterotoxin; T(H)2	STAPHYLOCOCCUS-AUREUS ENTEROTOXIN; BCL-2; IGE; APOPTOSIS; PROTEIN; LYMPHOCYTE; EXPRESSION; ANTIBODIES; EXOTOXINS; RESPONSES	Background: Staphylococcus aureus enterotoxin (SAE) superantigens are detected in nasal polyps (NPs), and SAE-specific IgE predicts asthma comorbidity in patients with NPs. However, roles of SAE superantigens and superantigen-related T-cell responses remain to be elucidated in nonasthmatic patients. Objective: We investigated the presence of SAEs and SAE-related T-cell receptor (TCR) V beta (TCRV beta) in nonasthmatic NPs, the phenotypes and functions of SAE-related T cells, and the clinical implication of SAE-related T-cell expansion. Methods: Sinonasal tissue samples were obtained from patients with nonasthmatic chronic rhinosinusitis (CRS) with NPs (CRSwNP), patients with CRS without NPs (CRSsNP), and control subjects. SAE genes were detected by PCR, and the TCRV beta distribution and T-cell phenotypes were examined by flow cytometry. Results: Various SAE genes were detected not only in NPs but also in sinonasal mucosa from patients with CRSsNP and from controls. The S aureus enterotoxin I (SEI) gene was detected in all NPs. The fraction of SEI-responsive TCRV beta(+) (TCRV beta 1(+) and V beta 5.1(+)) CD4(+) T cells was significantly increased only in NPs and the ethmoidal mucosa of patients with CRSwNP, indicating superantigen-induced expansion. The expanded TCRV beta 5.1(+) CD4(+) T cells expressed proliferation marker Ki-67 and the T(H)2 transcription factor GATA3. Furthermore, TCRV beta 5.1(+) CD4(+) T cells in NPs highly expressed T(H)2 markers, including IL-17RB, thymic stromal lymphoprotein receptor, and chemoattractant receptor-homologous molecule expressed on T(H)2 cells, with a potent T(H)2 cytokine-producing ability. Moreover, the expansion of TCRV beta 1(+) or V beta 5.1(+) CD4(+) T cells was associated with the Lund-Mackay computed tomography score, indicating disease extent. Conclusion: In nonasthmatic patients with CRSwNP, superantigen-related expansion of CD4(+) T cells with T(H)2 differentiation was associated with the disease extent.	[Rha, Min-Seok; Chang, Dong-Yeop; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Kim, Jihye; Park, Su-Hyung; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, BioMed Sci & Engn Interdisciplinary Program, Daejeon, South Korea; [Kim, Sang-Wook; Chang, Dong-Yeop] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Kim, Sang-Wook; Chang, Dong-Yeop] Gyeongsang Natl Univ, Dept Otorhinolaryngol, Jinju, South Korea; [Lee, Jin-Ku] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon, South Korea; [Khalmuratova, Roza] Seoul Natl Univ, Coll Med, Obstruct Upper Airway Res Lab, Dept Pharmacol, Seoul, South Korea; [Lim, Hee-Suk; Eun, Kyoung Mi; Hong, Seung-No; Kim, Dae Woo] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 425 Shindaebang 2 Dong, Seoul 07061, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Gyeongsang National University; Gyeongsang National University; Ajou University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DW (corresponding author), Seoul Natl Univ, Coll Med, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, 425 Shindaebang 2 Dong, Seoul 07061, South Korea.; Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, 291 Daehak Ro, Daejeon 34141, South Korea.	kicubi@daum.net; ecshin@kaist.ac.kr	Kim, Sang-Wook/AAT-1042-2020; Park, Su-Hyung/N-3514-2014	Park, Su-Hyung/0000-0001-6363-7736; Kim, Jihye/0000-0001-6297-4562; Lee, Jin-Ku/0000-0003-0263-3234; Rha, Min-Seok/0000-0003-1426-7534	Korean Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea [A100678]; National Research Foundation - Ministry of Science and ICT, Republic of Korea [NRF-2018M3A9D3079498, NRF-2019R1A2C2087170]	Korean Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation - Ministry of Science and ICT, Republic of Korea	Supported by a grant from the Korean Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea (A100678) and also by the National Research Foundation Grant, which is funded by the Ministry of Science and ICT, Republic of Korea (NRF-2018M3A9D3079498 and NRF-2019R1A2C2087170).	AKBAR AN, 1993, J EXP MED, V178, P427, DOI 10.1084/jem.178.2.427; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bachert C, 2019, LANCET, V394, P1638, DOI 10.1016/S0140-6736(19)31881-1; Bachert C, 2016, JAMA-J AM MED ASSOC, V315, P469, DOI 10.1001/jama.2015.19330; Bachert C, 2012, J ALLERGY CLIN IMMUN, V130, P376, DOI 10.1016/j.jaci.2012.05.012; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bernstein JM, 2011, LARYNGOSCOPE, V121, P647, DOI 10.1002/lary.21400; Bose S, 2016, J ALLER CL IMM-PRACT, V4, P584, DOI 10.1016/j.jaip.2016.04.008; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chen JB, 2017, J ALLERGY CLIN IMMUN, V139, P1195, DOI 10.1016/j.jaci.2016.06.066; Chen TR, 2004, INT J FOOD MICROBIOL, V92, P189, DOI 10.1016/j.ijfoodmicro.2003.10.002; Conley DB, 2006, AM J RHINOL, V20, P534, DOI 10.2500/ajr.2006.20.2941; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Cousins DJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao0392; El Fiky LM, 2009, AM J RHINOL ALLERGY, V23, P264, DOI 10.2500/ajra.2009.23.3313; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hopkins C, 2019, NEW ENGL J MED, V381, P55, DOI 10.1056/NEJMcp1800215; Huang L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01826; Huvenne W, 2010, ALLERGY, V65, P1013, DOI 10.1111/j.1398-9995.2009.02313.x; Huvenne W, 2010, CLIN EXP ALLERGY, V40, P1079, DOI 10.1111/j.1365-2222.2010.03464.x; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Kim DW, 2011, AM J RHINOL ALLERGY, V25, pE255, DOI 10.2500/ajra.2011.25.3727; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lam EPS, 2016, J ALLERGY CLIN IMMUN, V137, P1514, DOI 10.1016/j.jaci.2015.10.019; Langier S, 2011, RHINOLOGY, V49, P570, DOI 10.4193/Rhino.11.090; Lin YT, 2007, ALLERGY, V62, P520, DOI 10.1111/j.1398-9995.2006.01297.x; Lin YT, 2003, J IMMUNOL, V171, P1102, DOI 10.4049/jimmunol.171.2.1102; LUND VJ, 1995, ANN OTO RHINOL LARYN, V104, P17, DOI 10.1177/000348949510410s02; Mitson-Salazar A, 2016, J ALLERGY CLIN IMMUN, V137, P907, DOI 10.1016/j.jaci.2015.08.007; Muralimohan G, 2008, INT ARCH ALLERGY IMM, V147, P59, DOI 10.1159/000128660; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Okano M, 2011, CLIN EXP ALLERGY, V41, P171, DOI 10.1111/j.1365-2222.2010.03584.x; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Rochman Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8858; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Seiberling KA, 2005, LARYNGOSCOPE, V115, P1580, DOI 10.1097/01.mlg.0000168111.11802.9c; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Teufelberger AR, 2019, TRENDS MOL MED, V25, P696, DOI 10.1016/j.molmed.2019.05.003; Thomas D, 2009, INFECT IMMUN, V77, P2043, DOI 10.1128/IAI.01388-08; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Tripathi A, 2005, AM J RHINOL, V19, P327, DOI 10.1177/194589240501900401; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Van Zele T, 2008, AM J RHINOL, V22, P223, DOI 10.2500/ajr.2008.22.3161; Wang XD, 2016, J ALLERGY CLIN IMMUN, V138, P1344, DOI 10.1016/j.jaci.2016.05.041; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; We J, 2015, AM J RHINOL ALLERGY, V29, pE24, DOI 10.2500/ajra.2015.29.4131; YOSHINO T, 1994, BLOOD, V83, P1856; Yu RL, 2009, AM J RHINOL ALLERGY, V23, P15, DOI 10.2500/ajra.2009.23.3252	52	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2020	145	5					1378	+		10.1016/j.jaci.2019.12.915	http://dx.doi.org/10.1016/j.jaci.2019.12.915			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LK7TB	31987845				2022-12-18	WOS:000531063400011
J	Martin-Serrano, A; Mayorga, C; Barrionuevo, E; Perez, N; Romano, A; Moreno, E; Ariza, A; Perez-Inestrosa, E; Torres, MJ; Montanez, MI				Martin-Serrano, Angela; Mayorga, Cristobalina; Barrionuevo, Esther; Perez, Natalia; Romano, Antonino; Moreno, Esther; Ariza, Adriana; Perez-Inestrosa, Ezequiel; Torres, Maria J.; Montanez, Maria I.			Design of an antigenic determinant of cefaclor: Chemical structure-IgE recognition relationship	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							IMMEDIATE ALLERGIC REACTIONS; CROSS-REACTIVITY; CEPHALOSPORINS		[Martin-Serrano, Angela; Mayorga, Cristobalina; Ariza, Adriana; Perez-Inestrosa, Ezequiel; Torres, Maria J.; Montanez, Maria I.] Hosp Reg Univ Malaga, Andalusian Ctr Nanomed & Biotechnol BIONAN, Malaga, Spain; [Martin-Serrano, Angela; Mayorga, Cristobalina; Ariza, Adriana; Torres, Maria J.; Montanez, Maria I.] Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga, Spain; [Mayorga, Cristobalina; Barrionuevo, Esther; Perez, Natalia; Torres, Maria J.] Hosp Reg Univ Malaga, Allergy Unit, Malaga, Spain; [Romano, Antonino] Casa Cura Quisisana, Rome, Italy; [Romano, Antonino] Fdn Mediterranea GB Morgagni, Catania, Italy; [Moreno, Esther] Salamanca Univ Hosp, IBSAL, Allergy Unit, Salamanca, Spain; [Perez-Inestrosa, Ezequiel] Univ Malaga, IBIMA, Dept Quim Organ, Malaga, Spain; [Perez-Inestrosa, Ezequiel] Inst Invest Biomed Malaga, IBIMA, Biomimet Dendrimers & Photon Lab, Malaga, Spain; [Torres, Maria J.] Univ Malaga, Dept Med, Malaga, Spain	Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Montanez, MI (corresponding author), Hosp Reg Univ Malaga, Andalusian Ctr Nanomed & Biotechnol BIONAN, Malaga, Spain.; Montanez, MI (corresponding author), Hosp Reg Univ Malaga, Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga, Spain.	maribel.montanez@ibima.eu	Torres, Maria/GVU-3391-2022; Romano, Antonino/D-3102-2017; Montanez, Maria I/B-7194-2014; Ortiz, Ángela Martín-Serrano/AAU-2287-2021; Mayorga, Lina/FBO-7730-2022; Torres Jaen, Maria Jose/T-3518-2017; Ariza Veguillas, Adriana/X-3696-2018	Romano, Antonino/0000-0001-9742-9898; Montanez, Maria I/0000-0001-6641-5979; Ortiz, Ángela Martín-Serrano/0000-0002-2908-8910; MORENO, ESTHER/0000-0003-0953-3025; Torres Jaen, Maria Jose/0000-0001-5228-471X; Ariza Veguillas, Adriana/0000-0003-1524-9602	State Secretariat for Research, Development and Innovation of the Ministry of Economy and Competitiveness (MINECO); European Regional Development Fund [ERDF] [CTQ2016-75870P]; Institute of Health "Carlos III'' (ISCIII) of MINECO; ERDF: "Una manera de hacer Europa'' [PI12/02529, PI15/01206, CP15/00103, PI17/01237, RETIC ARADYAL RD16/0006/0001, RETIC ARADYAL RD16/0006/0012, RETIC ARADYAL RD16/0006/0019]; Andalusian Regional Ministry of Economy and Knowledge; Andalusian Regional Ministry of Health [PI-0699-2011, PI-0179-2014, PI-02502016]; Premio UNICAJA a la innovacion en biomedicina y salud; Andalusian Regional Ministry Health [RC-0004-2016]; ISCIII of MINECO; European Social Fund: "El FSE invierte en futuro''; ERDF: "Andalucia se mueve con Europa'' [CTS-06603]	State Secretariat for Research, Development and Innovation of the Ministry of Economy and Competitiveness (MINECO); European Regional Development Fund [ERDF](European Commission); Institute of Health "Carlos III'' (ISCIII) of MINECO; ERDF: "Una manera de hacer Europa''; Andalusian Regional Ministry of Economy and Knowledge; Andalusian Regional Ministry of Health; Premio UNICAJA a la innovacion en biomedicina y salud; Andalusian Regional Ministry Health; ISCIII of MINECO; European Social Fund: "El FSE invierte en futuro''; ERDF: "Andalucia se mueve con Europa''	The present study has been supported by the State Secretariat for Research, Development and Innovation of the Ministry of Economy and Competitiveness (MINECO) (grants cofunded by the European Regional Development Fund [ERDF]: grant no. CTQ2016-75870P); Institute of Health ``Carlos III'' (ISCIII) of MINECO (grants cofunded by ERDF: ``Una manera de hacer Europa'': grant nos. PI12/02529, PI15/01206, CP15/00103, PI17/01237, RETIC ARADYAL RD16/0006/0001, 0012, and 0019); Andalusian Regional Ministry of Economy and Knowledge (grants cofunded by ERDF: ``Andaluc~ia se mueve con Europa'': grant no. CTS-06603); Andalusian Regional Ministry of Health (grant nos. PI-0699-2011, PI-0179-2014, and PI-02502016); and `"Premio UNICAJA a la innovacion en biomedicina y salud.'' C.M. holds a 'Nicolas Monardes' research contract by Andalusian Regional Ministry Health (grant no. RC-0004-2016). M.I.M. holds a"`Miguel Servet I'' contract (grant no. both by ISCIII of MINECO (grants cofunded by European Social Fund: "El FSE invierte en futuro'').	Antunez C, 2006, J ALLERGY CLIN IMMUN, V117, P404, DOI 10.1016/j.jaci.2005.10.032; Azuaje J, 2013, J ORG CHEM, V78, P4402, DOI 10.1021/jo4003163; Blanca M, 2009, ALLERGY, V64, P183, DOI [10.1111/j.1398-9995.2008.01924.x, 10.1111/j.1398-9995.2008.01916.x]; BLANCA M, 1991, ALLERGY, V46, P632, DOI 10.1111/j.1398-9995.1991.tb00635.x; Brockow K, 2013, ALLERGY, V68, P702, DOI 10.1111/all.12142; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Montanez MI, 2011, CHEM RES TOXICOL, V24, P706, DOI 10.1021/tx100446g; Mayorga C, 2016, ALLERGY, V71, P1103, DOI 10.1111/all.12886; MORENO F, 1995, INT ARCH ALLERGY IMM, V108, P74, DOI 10.1159/000237121; Perez-Inestrosa E, 2005, CURR OPIN ALLERGY CL, V5, P323, DOI 10.1097/01.all.0000173788.73401.69; Romano A, 2000, J ALLERGY CLIN IMMUN, V106, P1177; Sanchez-Sancho F, 2003, J MOL RECOGNIT, V16, P148, DOI 10.1002/jmr.621; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; Venemalm L, 2001, BIOORG MED CHEM LETT, V11, P1869, DOI 10.1016/S0960-894X(01)00348-1; Yang MS, 2018, ALLERGY, V73, P1833, DOI 10.1111/all.13435	15	14	14	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2020	145	4					1301	+		10.1016/j.jaci.2019.11.036	http://dx.doi.org/10.1016/j.jaci.2019.11.036			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	LA0FR	31821817	Bronze			2022-12-18	WOS:000523633400029
J	Johannessen, A; Lonnebotn, M; Calciano, L; Benediktsdottir, B; Bertelsen, RJ; Braback, L; Dharmage, S; Franklin, KA; Gislason, T; Holm, M; Janson, C; Jarvis, D; Jogi, R; Kim, JL; Kirkeleit, J; Lodge, C; Malinovschi, A; Martinez-Moratalla, J; Nilsen, RM; Pereira-Vega, A; Real, FG; Schlunssen, V; Accordini, S; Svanes, C				Johannessen, Ane; Lonnebotn, Marianne; Calciano, Lucia; Benediktsdottir, Bryndis; Bertelsen, Randi Jacobsen; Braback, Lennart; Dharmage, Shyamali; Franklin, Karl A.; Gislason, Thorarinn; Holm, Mathias; Janson, Christer; Jarvis, Deborah; Jogi, Rain; Kim, Jeong-Lim; Kirkeleit, Jorunn; Lodge, Caroline; Malinovschi, Andrei; Martinez-Moratalla, Jesus; Nilsen, Roy Miodini; Pereira-Vega, Antonio; Real, Francisco Gomez; Schlunssen, Vivi; Accordini, Simone; Svanes, Cecilie			Being overweight in childhood, puberty, or early adulthood: Changing asthma risk in the next generation?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Ageing Lungs in European Cohorts study; epidemiology; multilevel mediation model; offspring; parental risk factors	BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; EPIGENETIC INHERITANCE; OBESITY; DISEASE; TRANSMISSION; ADIPOSITY	Background: Overweight status and asthma have increased during the last decades. Being overweight is a known risk factor for asthma, but it is not known whether it might also increase asthma risk in the next generation. Objective: We aimed to examine whether parents being overweight in childhood, adolescence, or adulthood is associated with asthma in their offspring. Methods: We included 6347 adult offspring (age, 18-52 years) investigated in the Respiratory Health in Northern Europe, Spain and Australia (RHINESSA) multigeneration study of 2044 fathers and 2549 mothers (age, 37-66 years) investigated in the European Community Respiratory Health Survey (ECRHS) study. Associations of parental overweight status at age 8 years, puberty, and age 30 years with offspring's childhood overweight status (potential mediator) and offspring's asthma with or without nasal allergies (outcomes) was analyzed by using 2-level logistic regression and 2-level multinomial logistic regression, respectively. Counterfactual-based mediation analysis was performed to establish whether observed associations were direct or indirect effects mediated through the offspring's own overweight status. Results: We found statistically significant associations between both fathers' and mothers' childhood overweight status and offspring's childhood overweight status (odds ratio, 2.23 [95% CI, 1.45-3.42] and 2.45 [95% CI, 1.86-3.22], respectively). We also found a statistically significant effect of fathers' onset of being overweight in puberty on offspring's asthma without nasal allergies (relative risk ratio, 2.31 [95% CI, 1.23-4.33]). This effect was direct and not mediated through the offspring's own overweight status. No effect on offspring's asthma with nasal allergies was found. Conclusion: Our findings suggest that metabolic factors long before conception can increase asthma risk and that male puberty is a time window of particular importance for offspring's health.	[Johannessen, Ane; Lonnebotn, Marianne; Kirkeleit, Jorunn] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5021 Bergen, Norway; [Johannessen, Ane; Lonnebotn, Marianne; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Calciano, Lucia; Accordini, Simone] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Benediktsdottir, Bryndis] Univ Iceland, Fac Med, Reykjavik, Iceland; [Benediktsdottir, Bryndis; Gislason, Thorarinn] Landspitali Univ Hosp, Dept Sleep, Reykjavik, Iceland; [Bertelsen, Randi Jacobsen; Real, Francisco Gomez] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Braback, Lennart] Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden; [Dharmage, Shyamali] Univ Melbourne, Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Vic, Australia; [Franklin, Karl A.] Umea Univ, Surg, Dept Surg & Perioperat Sci, Umea, Sweden; [Holm, Mathias] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Jarvis, Deborah] Imperial Coll, Natl Heart & Lung Inst, Fac Med, London, England; [Jogi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Kim, Jeong-Lim] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Occupat & Environm Med, Gothenburg, Sweden; [Lodge, Caroline] Univ Melbourne, Dept Populat Hlth, Melbourne, Vic, Australia; [Malinovschi, Andrei] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Martinez-Moratalla, Jesus] CHUA, Serv Neurol, Serv Salud Castilla La Mancha SESCAM, Albacete, Spain; [Nilsen, Roy Miodini] Bergen Univ Coll, Dept Nursing, Bergen, Norway; [Pereira-Vega, Antonio] Hosp Juan Ramon Jimenez, Pneumol Sect, Huelva, Spain; [Real, Francisco Gomez] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Schlunssen, Vivi] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Svanes, Cecilie] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Verona; University of Iceland; Landspitali National University Hospital; University of Bergen; University of Melbourne; Umea University; Sahlgrenska University Hospital; Imperial College London; University of Gothenburg; University of Melbourne; Uppsala University; Western Norway University of Applied Sciences; Hospital Juan Ramon Jimenez; University of Bergen; Haukeland University Hospital; Aarhus University; University of Bergen	Lonnebotn, M (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5021 Bergen, Norway.	marianne.lonnebotn@uib.no	Svanes, Cecilie/N-7556-2017; Braback, Lennart/A-3793-2015	Svanes, Cecilie/0000-0001-8512-5192; Lodge, Caroline/0000-0002-2342-3888; Schlunssen, Vivi/0000-0003-4915-1734; Nilsen, Roy Miodini/0000-0002-6340-4593; Johannessen, Ane/0000-0003-3269-8354; Franklin, Karl/0000-0002-5306-1697; Jarvis, Deborah/0000-0002-1753-3896; Braback, Lennart/0000-0001-9930-7755; Gomez Real, Francisco/0000-0001-5407-3270; Calciano, Lucia/0000-0001-9801-5080	European Union's Horizon 2020 research and innovation program as part of the ALEC study (Ageing Lungs in European Cohorts study) [633212]; Research Council of Norway [214123, 228174]; Bergen Medical Research Foundation (Norway); Western Norwegian Regional Health Authorities [912011, 911892, 911631]; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Danish Woods Foundation [444508795]; Danish Working Environment Authority [20150067134]; Swedish Lung Foundation; Swedish Asthma and Allergy Association; Estonian Research Council [PUT562]	European Union's Horizon 2020 research and innovation program as part of the ALEC study (Ageing Lungs in European Cohorts study); Research Council of Norway(Research Council of Norway); Bergen Medical Research Foundation (Norway); Western Norwegian Regional Health Authorities; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; Danish Woods Foundation; Danish Working Environment Authority; Swedish Lung Foundation; Swedish Asthma and Allergy Association; Estonian Research Council(Estonian Research Council)	This study was funded by the European Union's Horizon 2020 research and innovation program as part of the ALEC study (Ageing Lungs in European Cohorts study, grant no. 633212). The RHINESSA generation study also received funding by the Research Council of Norway (grant nos. 214123 and 228174), the Bergen Medical Research Foundation (Norway), the Western Norwegian Regional Health Authorities (grant nos. 912011, 911892, and 911631), the Norwegian Labour Inspection, the Norwegian Asthma and Allergy Association, the Danish Woods Foundation (grant no. 444508795), the Danish Working Environment Authority (grant no. 20150067134), the Swedish Lung Foundation, the Swedish Asthma and Allergy Association, and the Estonian Research Council (grant no. PUT562). The funding agencies had no direct role in the conduct of the study; the collection, management, statistical analysis, and interpretation of the data; and the preparation or approval of the manuscript.	Accordini S, 2018, INT J EPIDEMIOL, V47, P1106, DOI 10.1093/ije/dyy031; Bandalos DL, 2014, STRUCT EQU MODELING, V21, P102, DOI 10.1080/10705511.2014.859510; Braback L, 2005, RESP MED, V99, P1010, DOI 10.1016/j.rmed.2005.02.004; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Dolton P, 2017, ECON HUM BIOL, V24, P140, DOI 10.1016/j.ehb.2016.11.005; Dratva J, 2016, PUBLIC HEALTH NUTR, V19, P1944, DOI 10.1017/S136898001600015X; Dumas O, 2016, ALLERGY, V71, P1295, DOI 10.1111/all.12876; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Hofler M, 2005, BMC Med Res Methodol, V5, P28, DOI 10.1186/1471-2288-5-28; Janson C, 2007, CLIN RESPIR J, V1, P16, DOI 10.1111/j.1752-699X.2007.00001.x; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Kuiper IN, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0687-4; Lafeuille MH, 2013, J ASTHMA, V50, P900, DOI 10.3109/02770903.2013.810244; Lai MHC, 2015, J EXP EDUC, V83, P423, DOI 10.1080/00220973.2014.907229; Lonnebotn M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195697; Lutz SM, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1749-y; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Muthen B., APPL CAUSALLY DEFINE; Pearl J., 2012, P 17 C UNC ART INT; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sales VM, 2017, CELL METAB, V25, P559, DOI 10.1016/j.cmet.2017.02.016; Skulstad SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181794; Soubry A, 2014, BIOESSAYS, V36, P359, DOI 10.1002/bies.201300113; Svanes C, 2017, INT J EPIDEMIOL, V46, P235, DOI 10.1093/ije/dyw151; VanderWeele TJ, 2010, EPIDEMIOLOGY, V21, P540, DOI 10.1097/EDE.0b013e3181df191c; Wang L, 2015, RESP MED, V109, P955, DOI 10.1016/j.rmed.2015.06.001; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	35	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2020	145	3					791	+		10.1016/j.jaci.2019.08.030	http://dx.doi.org/10.1016/j.jaci.2019.08.030			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	KT1GD	31505189	hybrid, Green Published			2022-12-18	WOS:000518756700017
J	Fallon, PG; Schwartz, C				Fallon, Padraic G.; Schwartz, Christian			The high and lows of type 2 asthma and mouse models	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Asthma; allergic airway disease; mouse models; type 2 inflammation			[Fallon, Padraic G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Med, Dublin, Ireland; [Schwartz, Christian] Univ Klinikum Erlangen, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, Erlangen, Germany; [Schwartz, Christian] Friedrich Alexander Univ FAU Erlangen Nurnberg, Erlangen, Germany	Trinity College Dublin; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fallon, PG (corresponding author), Trinity Coll Dublin, Sch Med, Dublin 2, Ireland.	pfallon@tcd.ie	Fallon, Padraic/Y-2711-2019	Fallon, Padraic/0000-0002-8401-7293				Branchett WJ, 2020, J ALLERGY CLIN IMMUN, V145, P666, DOI 10.1016/j.jaci.2019.08.006; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P334, DOI 10.1016/j.jaci.2007.11.028; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Karvonen AM, 2019, J ALLERGY CLIN IMMUN, V144, P1402, DOI 10.1016/j.jaci.2019.07.035; Lambrecht BN, 2019, IMMUNITY, V50, P975, DOI 10.1016/j.immuni.2019.03.018; Matha L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214286; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC	10	14	14	2	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2020	145	2					496	498		10.1016/j.jaci.2019.11.031	http://dx.doi.org/10.1016/j.jaci.2019.11.031			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KK6ZG	31812572	Bronze			2022-12-18	WOS:000512887400012
J	Engeroff, P; Caviezel, F; Mueller, D; Thoms, F; Bachmann, MF; Vogel, M				Engeroff, Paul; Caviezel, Flurin; Mueller, David; Thoms, Franziska; Bachmann, Martin F.; Vogel, Monique			CD23 provides a noninflammatory pathway for IgE-allergen complexes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						IgE sensitization; IgE-allergen complex; CD23; Fc epsilon RI; IgE clearance; inflammation	VIRUS-LIKE PARTICLES; B-CELLS; INTERNATIONAL CONSENSUS; MAST-CELLS; AFFINITY; MECHANISMS; BINDING; INHIBITION; ACTIVATION; TRANSPORT	Background: Type I hypersensitivity is mediated by allergen-specific IgE, which sensitizes the high-affinity IgE receptor Fc epsilon RI on mast cells and basophils and drives allergic inflammation upon secondary allergen contact. CD23/Fc epsilon RII, the low-affinity receptor for IgE, is constitutively expressed on B cells and has been shown to regulate immune responses. Simultaneous binding of IgE to Fc epsilon RI and CD23 is blocked by reciprocal allosteric inhibition, suggesting that the 2 receptors exert distinct roles in IgE handling. Objective: We aimed to study how free IgE versus precomplexed IgE-allergen immune complexes (IgE-ICs) target the 2 IgE receptors Fc epsilon RI and CD23, and we investigated the functional implications of the 2 pathways. Methods: We performed binding and activation assays with human cells in vitro and IgE pharmacokinetics and anaphylaxis experiments in vivo. Results: We demonstrate that Fc epsilon RI preferentially binds free IgE and CD23 preferentially binds IgE-ICs. We further show that those different binding properties directly translate to distinct biological functions: free IgE initiated allergic inflammation through Fc epsilon RI on allergic effector cells, while IgE-ICs were noninflammatory because of reduced Fc epsilon RI binding and enhanced CD23-dependent serum clearance. Conclusion: We propose that IgE-ICs are noninflammatory through reduced engagement by Fc epsilon RI but increased targeting of the CD23 pathway.	[Engeroff, Paul; Caviezel, Flurin; Mueller, David; Bachmann, Martin F.; Vogel, Monique] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Engeroff, Paul; Caviezel, Flurin; Mueller, David; Bachmann, Martin F.; Vogel, Monique] Univ Bern, Dept BioMed Res, Bern, Switzerland; [Thoms, Franziska] Zurich Univ Hosp, Dept Dermatol, Schlieren, Switzerland; [Bachmann, Martin F.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England	University of Bern; University Hospital of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of Oxford; Jenner Institute	Vogel, M (corresponding author), Inselspital Bern, Dept Rheumatol Immunol & Allergol, Sahlihaus 2, CH-3010 Bern, Switzerland.	monique.vogel@dbmr.unibe.ch	Caviezel, Flurin/AAI-7670-2020; Engeroff, Paul/AGS-3183-2022	Engeroff, Paul/0000-0002-3409-512X	Swiss National Science Foundation (SNF) [310030_179165]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Supported by funding from the Swiss National Science Foundation (SNF grant 310030_179165 to M.Vogel).	Acharya M, 2010, CLIN EXP IMMUNOL, V162, P12, DOI 10.1111/j.1365-2249.2010.04210.x; Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Chan MA, 2010, CLIN IMMUNOL, V137, P330, DOI 10.1016/j.clim.2010.08.005; Cheng LE, 2010, J IMMUNOL, V185, P5040, DOI 10.4049/jimmunol.1001900; Conrad DH, 2007, CURR ALLERGY ASTHM R, V7, P331, DOI 10.1007/s11882-007-0050-y; Crawford G, 2018, NAT IMMUNOL, V19, P859, DOI 10.1038/s41590-018-0161-8; Dhaliwal B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45533; Dhaliwal B, 2013, MOL IMMUNOL, V56, P693, DOI 10.1016/j.molimm.2013.07.005; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; Ding ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28290; Engeroff P, 2018, ALLERGY, V73, P341, DOI 10.1111/all.13268; Engeroff P, 2018, J ALLERGY CLIN IMMUN, V142, P557, DOI 10.1016/j.jaci.2017.09.024; Felce JH, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat0756; Fellmann M, 2015, IMMUN INFLAMM DIS, V3, P339, DOI 10.1002/iid3.72; Ford JW, 2009, CELL IMMUNOL, V254, P124, DOI 10.1016/j.cellimm.2008.08.003; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gasser P, 2018, CURR OPIN IMMUNOL, V54, P86, DOI 10.1016/j.coi.2018.05.015; Gieras A, 2016, J ALLERGY CLIN IMMUN, V137, P1557, DOI 10.1016/j.jaci.2015.08.055; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Hjort C, 2017, J ALLERGY CLIN IMMUN, V140, P1167, DOI 10.1016/j.jaci.2017.04.014; Hoffmann Hans Jurgen, 2014, Methods Mol Biol, V1192, P57, DOI 10.1007/978-1-4939-1173-8_4; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Holm J, 2011, J ALLERGY CLIN IMMUN, V127, P1029, DOI 10.1016/j.jaci.2011.01.062; Jabs F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02312-7; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Jutel M, 2016, J ALLERGY CLIN IMMUN, V137, P358, DOI 10.1016/j.jaci.2015.12.1300; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kilmon MA, 2001, J IMMUNOL, V167, P3139, DOI 10.4049/jimmunol.167.6.3139; Lewis G, 2004, IMMUNOGENETICS, V56, P564, DOI 10.1007/s00251-004-0728-4; LUO HY, 1991, J IMMUNOL, V146, P2122; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Metcalfe DD, 2009, J ALLERGY CLIN IMMUN, V124, P639, DOI 10.1016/j.jaci.2009.08.035; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Pali-Scholl I, 2016, CURR OPIN IMMUNOL, V42, P113, DOI 10.1016/j.coi.2016.08.004; PAULEUGENE N, 1995, J LEUKOCYTE BIOL, V57, P160, DOI 10.1002/jlb.57.1.160; Payet M, 1999, ALLERGY, V54, P1125; Pennington LF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11610; Platzer B, 2011, IMMUNOL LETT, V141, P36, DOI 10.1016/j.imlet.2011.08.004; Reginald K, 2013, IMMUNOL CELL BIOL, V91, P167, DOI 10.1038/icb.2012.70; Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199; Schwartz C, 2014, P NATL ACAD SCI USA, V111, pE5169, DOI 10.1073/pnas.1412663111; Selb R, 2017, J ALLERGY CLIN IMMUN, V139, P290, DOI 10.1016/j.jaci.2016.03.042; SHERR E, 1989, J IMMUNOL, V142, P481; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Sutton BJ, 2015, IMMUNOL REV, V268, P222, DOI 10.1111/imr.12340; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Uermosi C, 2010, J ALLERGY CLIN IMMUN, V126, P375, DOI 10.1016/j.jaci.2010.05.040; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Yabuuchi S, 2002, INT IMMUNOPHARMACOL, V2, P453, DOI 10.1016/S1567-5769(01)00187-4; YU P, 1994, NATURE, V369, P753, DOI 10.1038/369753a0; Zha LS, 2018, J ALLERGY CLIN IMMUN, V142, P1529, DOI 10.1016/j.jaci.2017.09.054	58	14	14	2	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					301	+		10.1016/j.jaci.2019.07.045	http://dx.doi.org/10.1016/j.jaci.2019.07.045			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31437490	hybrid, Green Published			2022-12-18	WOS:000505590800034
J	Wen, KK; Han, SS; Vyas, YM				Wen, Kuo-Kuang; Han, Seong-Su; Vyas, Yatin M.			Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Primary immunodeficiency; Wiskott-Aldrich syndrome; Golgi morphology; DNA damage	X-LINKED THROMBOCYTOPENIA; ACTIN POLYMERIZATION; WASP; MUTATIONS; TRANSCRIPTION; SENSITIVITY; INSTABILITY; DISRUPTION; APOPTOSIS; ACTIVATOR	Background: Wiskott-Aldrich syndrome (WAS) is an X-linked primary immune deficiency disorder resulting from Wiskott-Aldrich syndrome protein (WASp) deficiency. Lymphocytes from patients with WAS manifest increased DNA damage and lymphopenia from cell death, yet how WASp influences DNA damage-linked cell survival is unknown. A recently described mechanism promoting cell survival after ionizing radiation (IR)-induced DNA damage involves fragmentation and dispersal of the Golgi apparatus, known as the Golgi-dispersal response (GDR), which uses the Golgi phosphoprotein 3 (GOLPH3)-DNA-dependent protein kinase (DNA-PK)-myosin XVIIIA-F-actin signaling pathway. Objective: We sought to define WASp's role in the DNA damage-induced GDR and its disruption as a contributor to the development of radiosensitivity-linked immunodeficiency in patients with WAS. Methods: In human T-H and B-cell culture systems, DNA damage-induced GDR elicited by IR or radiomimetic chemotherapy was monitored in the presence or absence of WASp or GOLPH3 alone or both together. Results: WASp deficiency completely prevents the development of IR-induced GDR in human T-H and B cells, despite the high DNA damage load. Loss of WASp impedes nuclear translocation of GOLPH3 and its colocalization with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Surprisingly, however, depletion of GOLPH3 alone or depolymerization of F-actin in WASp-sufficient T-H cells still allows development of robust GDR, suggesting that WASp, but not GOLPH3, is essential for GDR and cell survival after IR-induced DNA-damage in human lymphocytes. Conclusion: The study identifies WASp as a novel effector of the nucleus-to-Golgi cell-survival pathway triggered by IR-induced DNA damage in cells of the hematolymphoid lineage and proposes an impaired GDR as a new cause for development of a "radiosensitive" form of immune dysregulation in patients with WAS.	Univ Iowa, Carver Coll Med, Div Pediat Hematol Oncol, Iowa City, IA 52242 USA; Stead Family Univ, Iowa Childrens Hosp, Iowa City, IA USA	University of Iowa	Vyas, YM (corresponding author), Univ Iowa, Carver Coll Med, Div Pediat Hematol Oncol, Stead Family Univ,Iowa Childrens Hosp, Iowa City, IA 52242 USA.	yatin-vyas@uiowa.edu		Vyas, Yatin/0000-0002-4595-0267; Han, Seong-Su/0000-0001-9824-6751	National Institutes of Health/National Institute of Allergy and Infectious Diseases [R21AI138051]; Carver College of Medicine Bridge grant	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Carver College of Medicine Bridge grant	Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant R21AI138051 (to Y.M.V.) and the Carver College of Medicine Bridge grant (to Y.M.V.).	Albert MH, 2010, BLOOD, V115, P3231, DOI 10.1182/blood-2009-09-239087; Alekhina O, 2017, J CELL SCI, V130, P2235, DOI 10.1242/jcs.199570; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Bhattacharya K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25411; Buschman MD, 2015, CANCER RES, V75, P624, DOI 10.1158/0008-5472.CAN-14-3081; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Colon-Franco JM, 2011, J CELL SCI, V124, P3118, DOI 10.1242/jcs.083725; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Egorov M, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00007; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Garcia-Pichardo D, 2017, MOL CELL, V66, P597, DOI 10.1016/j.molcel.2017.05.014; Heylmann D, 2014, BBA-REV CANCER, V1846, P121, DOI 10.1016/j.bbcan.2014.04.009; How PC, 2011, J BIOL CHEM, V286, P8565, DOI 10.1074/jbc.M110.175174; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Keszei M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1468954; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Liu CY, 2017, P NATL ACAD SCI USA, V114, P346, DOI 10.1073/pnas.1608576114; Makhoul C, 2018, BIOCHEM SOC T, V46, P1063, DOI 10.1042/BST20180323; Matas OB, 2004, TRAFFIC, V5, P838, DOI 10.1111/j.1600-0854.2004.00225.x; Menotti M, 2019, NAT MED, V25, P130, DOI 10.1038/s41591-018-0262-9; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Ouasti S, 2007, CELL DEATH DIFFER, V14, P453, DOI 10.1038/sj.cdd.4402043; Rawlings SL, 1999, BLOOD, V94, P3872, DOI 10.1182/blood.V94.11.3872.423k37_3872_3882; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Sadhukhan S, 2014, J IMMUNOL, V193, P150, DOI 10.4049/jimmunol.1302923; Sarkar K, 2018, J ALLERGY CLIN IMMUN, V142, P219, DOI 10.1016/j.jaci.2017.11.023; Sarkar K, 2015, BLOOD, V126, P1670, DOI 10.1182/blood-2015-05-646182; Sarkar K, 2014, BLOOD, V124, P3409, DOI 10.1182/blood-2014-07-587642; Schrank BR, 2018, NATURE, V559, P61, DOI 10.1038/s41586-018-0237-5; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tang DM, 2016, MOL BIOL CELL, V27, P137, DOI 10.1091/mbc.E15-09-0650; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Teitell MA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001336; Vece TJ, 2016, J CLIN IMMUNOL, V36, P377, DOI 10.1007/s10875-016-0271-8; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Wei JH, 2017, CURR OPIN CELL BIOL, V47, P43, DOI 10.1016/j.ceb.2017.03.008; Wei JH, 2010, TRAFFIC, V11, P1391, DOI 10.1111/j.1600-0854.2010.01114.x; Westerberg LS, 2010, J EXP MED, V207, P1145, DOI 10.1084/jem.20091245; Yoshimi A, 2013, PEDIATR BLOOD CANCER, V60, P836, DOI 10.1002/pbc.24359; Yu HJ, 2019, CELL RES, V29, P666, DOI 10.1038/s41422-019-0189-9; Zhou LN, 2017, HUM IMMUNOL, V78, P565, DOI 10.1016/j.humimm.2017.05.004	48	14	17	1	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2020	145	1					324	334		10.1016/j.jaci.2019.09.026	http://dx.doi.org/10.1016/j.jaci.2019.09.026			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	KA1WZ	31604087	Green Accepted, Bronze			2022-12-18	WOS:000505590800036
J	Imoto, Y; Kato, A; Takabayashi, T; Stevens, W; Norton, JE; Suh, LA; Carter, RG; Weibman, AR; Hulse, KE; Harris, KE; Peters, AT; Grammer, LC; Tan, BK; Welch, K; Shintani-Smith, S; Conley, DB; Kern, RC; Fujieda, S; Schleimer, RP				Imoto, Yoshimasa; Kato, Atsushi; Takabayashi, Tetsuji; Stevens, Whitney; Norton, James E.; Suh, Lydia A.; Carter, Roderick G.; Weibman, Ava R.; Hulse, Kathryn E.; Harris, Kathleen E.; Peters, Anju T.; Grammer, Leslie C.; Tan, Bruce K.; Welch, Kevin; Shintani-Smith, Stephanie; Conley, David B.; Kern, Robert C.; Fujieda, Shigeharu; Schleimer, Robert P.			Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis; fibrin; fibrinolysis; coagulation; thrombin; asthma; thrombin-activatable fibrinolysis inhibitor	PROTEIN-C INHIBITOR; ALLERGEN CHALLENGE; PLASMINOGEN-ACTIVATOR; VENOUS THROMBOSIS; BLOOD-PLATELETS; ASTHMA; TAFI; INFLAMMATION; ASSOCIATION; DISEASES	Background: Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory disease subdivided based on the presence or absence of nasal polyps (NPs). Histologic features of chronic rhinosinusitis with nasal polyps (CRSwNP) include inflammatory cell infiltration and excessive fibrin deposition in NPs. Thrombin-activatable fibrinolysis inhibitor (TAFI) is an enzyme that plays an antifibrinolytic role in the body. The significance of TAFI has been documented in patients with chronic inflammatory diseases, including chronic lung disease; however, it has not been evaluated in the pathogenesis of NPs. Objective: The objective of this study was to evaluate the potential role of TAFI in the pathogenesis of NPs. Methods: Nasal lavage fluid was collected from control subjects and patients with CRS. We measured levels of thrombin/antithrombin complex (TATc) and TAFI protein using an ELISA. Results: TATc levels in nasal lavage fluid were significantly increased in patients with CRSwNP and patients with chronic rhinosinusitis without nasal polyps (CRSsNP) compared with control subjects, and TAFI levels in nasal lavage fluid were also significantly increased in patients with CRSwNP compared with those in control subjects and patients with CRSsNP. There was a significant correlation between TATc and TAFI levels in nasal lavage fluid. Interestingly, patients with CRS and asthma showed increased TATc and TAFI levels in nasal lavage fluid compared with those in patients with CRS without asthma, especially patients with CRSwNP. Conclusions: Increased TATc and TAFI levels in nasal passages of patients with CRSwNP might participate in fibrin deposition in NPs and might play a role in the pathogenesis of CRSwNP and asthma.	[Imoto, Yoshimasa; Kato, Atsushi; Stevens, Whitney; Norton, James E.; Suh, Lydia A.; Carter, Roderick G.; Weibman, Ava R.; Hulse, Kathryn E.; Harris, Kathleen E.; Peters, Anju T.; Grammer, Leslie C.; Schleimer, Robert P.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy & Immunol, Chicago, IL 60611 USA; [Imoto, Yoshimasa; Kato, Atsushi; Takabayashi, Tetsuji; Tan, Bruce K.; Welch, Kevin; Shintani-Smith, Stephanie; Conley, David B.; Kern, Robert C.; Fujieda, Shigeharu] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Imoto, Yoshimasa; Takabayashi, Tetsuji; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, 23-3 Shimoaizuki, Fukui 9101193, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Fukui	Imoto, Y (corresponding author), Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, 23-3 Shimoaizuki, Fukui 9101193, Japan.	yimoto@u-fukui.ac.jp	Smith, Stephanie Shintani/AAY-4854-2020	Smith, Stephanie Shintani/0000-0002-0605-3993	National Institutes of Health [R37HL068546, U19AI106683]; Ernest S. Bazley Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001424] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL068546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106683, R01AI137174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ernest S. Bazley Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grants R37HL068546 and U19AI106683 (Chronic Rhinosinusitis Integrative Studies Program [CRISP]) from the National Institutes of Health and by the Ernest S. Bazley Foundation.	Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; Beyazit Y, 2016, INTERNAL MED, V55, P1831, DOI 10.2169/internalmedicine.55.6473; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Brims FJH, 2009, THORAX, V64, P1037, DOI 10.1136/thx.2009.114439; Carrieri C, 2011, J THROMB HAEMOST, V9, P154, DOI 10.1111/j.1538-7836.2010.04120.x; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; de Bruijne ELE, 2007, THROMB HAEMOSTASIS, V97, P181, DOI 10.1160/TH06-07-0407; EATON DL, 1991, J BIOL CHEM, V266, P21833; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fujimoto H, 2006, AM J PATHOL, V168, P1086, DOI 10.2353/ajpath.2006.050610; Fujimoto H, 2003, AM J RESP CRIT CARE, V167, P1687, DOI 10.1164/rccm.200208-905OC; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; GABAZZA EC, 1994, THROMB HAEMOSTASIS, V71, P199; Haruna S, 2009, RHINOLOGY, V47, P66; Hayashi S, 2006, PHARMACOLOGY, V76, P46, DOI 10.1159/000089718; Hemker HC, 2004, CURR OPIN HEMATOL, V11, P170, DOI 10.1097/01.moh.0000130314.33410.d7; Hulse KE, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-015-0579-0; Idell Steven, 2002, Am J Respir Med, V1, P383; Idzko M, 2015, J ALLERGY CLIN IMMUN, V135, P1416, DOI 10.1016/j.jaci.2015.04.028; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Kornerup KN, 2007, PLATELETS, V18, P319, DOI 10.1080/09537100701230436; Kowal K, 2006, CLIN EXP ALLERGY, V36, P426, DOI 10.1111/j.1365-2222.2006.02446.x; Laidlaw TM, 2015, J ALLERGY CLIN IMMUN, V135, P1407, DOI 10.1016/j.jaci.2015.02.005; Lam K, 2014, CURR OPIN OTOLARYNGO, V22, P231, DOI 10.1097/MOO.0000000000000052; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Liu XF, 2000, J IMMUNOL, V165, P5255, DOI 10.4049/jimmunol.165.9.5255; MAESTRELLI P, 1990, CLIN EXP ALLERGY, V20, P367, DOI 10.1111/j.1365-2222.1990.tb02795.x; Mahdavinia M, 2014, J ALLERGY CLIN IMMUN, V133, P1759, DOI 10.1016/j.jaci.2013.12.1092; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Meltzer EO, 2004, OTOLARYNG HEAD NECK, V131, pS1, DOI 10.1016/j.otohns.2004.09.067; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Metzger W J, 1987, Agents Actions Suppl, V21, P151; Mitsui C, 2016, J ALLERGY CLIN IMMUN, V137, P400, DOI 10.1016/j.jaci.2015.05.041; Mosnier LO, 2003, BLOOD, V101, P4844, DOI 10.1182/blood-2002-09-2944; Orikaza CM, 2014, THROMB RES, V133, P120, DOI 10.1016/j.thromres.2013.10.040; Owczarek D, 2012, J CROHNS COLITIS, V6, P13, DOI 10.1016/j.crohns.2011.06.005; Pearlman AN, 2008, CURR OPIN OTOLARYNGO, V16, P226, DOI 10.1097/MOO.0b013e3282fdcc9a; Perrio MJ, 2007, CLIN EXP ALLERGY, V37, P1688, DOI 10.1111/j.1365-2222.2007.02829.x; Peters MJL, 2009, ANN RHEUM DIS, V68, P1232, DOI 10.1136/ard.2008.097485; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; Schadinger SL, 2010, J THROMB HAEMOST, V8, P2523, DOI 10.1111/j.1538-7836.2010.04024.x; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; Schouten M, 2009, J THROMB HAEMOST, V7, P1592, DOI 10.1111/j.1538-7836.2009.03523.x; Shah SA, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00129; Shimizu S, 2011, AM J RHINOL ALLERGY, V25, P7, DOI 10.2500/ajra.2011.25.3535; Sneeboer MMS, 2016, J ALLERGY CLIN IMMUN, V137, P1727, DOI 10.1016/j.jaci.2015.10.038; Stevens WW, 2015, AM J RESP CRIT CARE, V192, P682, DOI 10.1164/rccm.201412-2278OC; Stevens WW, 2015, IMMUN INFLAMM DIS, V3, P14, DOI 10.1002/iid3.46; Sullivan PJ, 2000, RESPIRATION, V67, P514, DOI 10.1159/000067466; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; Takabayashi T, 2012, J ALLERGY CLIN IMMUN, V130, P410, DOI 10.1016/j.jaci.2012.02.046; Takahashi T, 2017, J ALLERGY CLIN IMMUN, V140, P720, DOI 10.1016/j.jaci.2017.01.022; Takeda T, 2018, ALLERGOL INT, V67, P326, DOI 10.1016/j.alit.2017.11.008; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Tan BK, 2017, J ALLERGY CLIN IMMUN, V139, P699, DOI 10.1016/j.jaci.2016.06.063; Tokunaga T, 2015, ALLERGY, V70, P995, DOI 10.1111/all.12644; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; van Zaane B, 2010, J THROMB HAEMOST, V8, P2483, DOI 10.1111/j.1538-7836.2010.04034.x; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Vilahur G, 2017, CARDIOVASC RES, V113, P1046, DOI 10.1093/cvr/cvx086; Wagers SS, 2004, J CLIN INVEST, V114, P104, DOI 10.1172/JCI200419569	71	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2019	144	6					1566	+		10.1016/j.jaci.2019.08.040	http://dx.doi.org/10.1016/j.jaci.2019.08.040			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	JT0NR	31562871	Green Accepted, Bronze			2022-12-18	WOS:000500694900014
J	Lee, EY; Oh, SS; White, MJ; Eng, CS; Elhawary, JR; Borrell, LN; Nuckton, TJ; Zeiger, AM; Keys, KL; Mak, ACY; Hu, DL; Huntsman, S; Contreras, MG; Samedy, LA; Goddard, PC; Salazar, SL; Brigino-Buenaventura, EN; Davis, A; Meade, KE; LeNoir, MA; Lurmann, FW; Burchard, EG; Eisen, EA; Balmes, JR				Lee, Eunice Y.; Oh, Sam S.; White, Marquitta J.; Eng, Celeste S.; Elhawary, Jennifer R.; Borrell, Luisa N.; Nuckton, Thomas J.; Zeiger, Andrew M.; Keys, Kevin L.; Mak, Angel C. Y.; Hu, Donglei; Huntsman, Scott; Contreras, Maria G.; Samedy, Lesly-Anne; Goddard, Page C.; Salazar, Sandra L.; Brigino-Buenaventura, Emerita N.; Davis, Adam; Meade, Kelley E.; LeNoir, Michael A.; Lurmann, Fred W.; Burchard, Esteban G.; Eisen, Ellen A.; Balmes, John R.			Ambient air pollution, asthma drug response, and telomere length in African American youth	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Ozone; fine particulate matter with a diameter of 2.5 mu m or less; telomeres; asthma; minority; children	OXIDATIVE STRESS; PARTICULATE MATTER; LUNG-FUNCTION; GALA II; RESIDENTIAL SEGREGATION; GENETIC ANCESTRY; EXPOSURE; URBAN; MORTALITY; DISEASE	Background: Telomere length (TL) can serve as a potential biomarker for conditions associated with chronic oxidative stress and inflammation, such as asthma. Air pollution can induce oxidative stress. Understanding the relationship between TL, asthma, and air pollution is important for identifying risk factors contributing to unhealthy aging in children. Objectives: We sought to investigate associations between exposures to ambient air pollutants and TL in African American children and adolescents and to examine whether African ancestry, asthma status, and steroid medication use alter the association. Methods: Linear regression was used to examine associations between absolute telomere length (aTL) and estimated annual average residential ozone (O-3) and fine particulate matter with a diameter of 2.5 mu m or less (PM2.5) exposures in a cross-sectional analysis of 1072 children in an existing asthma case-control study. African ancestry, asthma status, and use of steroid medications were examined as effect modifiers. Results: Participants' aTLs were measured by using quantitative PCR. A 1-ppb and 1 mu g/m(3) increase in annual average exposure to O-3 and PM2.5 were associated with a decrease in aTL of 37.1 kilo-base pair (kb; 95% CI, -66.7 to -7.4 kb) and 57.1 kb (95% CI, -118.1 to 3.9 kb), respectively. African ancestry and asthma were not effect modifiers; however, exposure to steroid medications modified the relationships between TL and pollutants. Past-year exposure to O-3 and PM2.5 was associated with shorter TLs in patients without steroid use. Conclusion: Exposure to air pollution was associated with shorter TLs in nonasthmatic children and adolescents. This was not the case for asthmatic children as a group, but those receiving steroid medication had less shortening than those not using steroids. Reduced exposure to air pollution in childhood might help to preserve TL.	[Lee, Eunice Y.; Samedy, Lesly-Anne; Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Lee, Eunice Y.; Oh, Sam S.; White, Marquitta J.; Eng, Celeste S.; Elhawary, Jennifer R.; Nuckton, Thomas J.; Zeiger, Andrew M.; Keys, Kevin L.; Mak, Angel C. Y.; Hu, Donglei; Huntsman, Scott; Contreras, Maria G.; Goddard, Page C.; Salazar, Sandra L.; Burchard, Esteban G.; Balmes, John R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Borrell, Luisa N.] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Contreras, Maria G.] San Francisco State Univ, San Francisco, CA 94132 USA; [Brigino-Buenaventura, Emerita N.] Kaiser Permanente Vallejo Med Ctr, Dept Allergy & Immunol, Vallejo, CA USA; [Davis, Adam; Meade, Kelley E.] Childrens Hosp & Res Ctr, Oakland, CA USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Lurmann, Fred W.] Sonoma Technol, Petaluma, CA USA; [Eisen, Ellen A.; Balmes, John R.] Univ Calif Berkeley, Sch Publ Hlth, Environm Hlth Sci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; City University of New York (CUNY) System; California State University System; San Francisco State University; Kaiser Permanente; University of California System; University of California Berkeley	Lee, EY (corresponding author), UCSF, Sch Pharm, Dept Bioengn & Therapeut Sci, Rock Hall Box 2911,1550 4th St,Rm 582, San Francisco, CA 94158 USA.; Lee, EY (corresponding author), UCSF, Sch Med, Dept Bioengn & Therapeut Sci, Rock Hall Box 2911,1550 4th St,Rm 582, San Francisco, CA 94158 USA.; Burchard, EG (corresponding author), UCSF, Sch Pharm, Dept Bioengn & Therapeut Sci, Rock Hall Box 2911,1550 4th St,Rm 584B, San Francisco, CA 94158 USA.; Burchard, EG (corresponding author), UCSF, Sch Med, Dept Bioengn & Therapeut Sci, Rock Hall Box 2911,1550 4th St,Rm 584B, San Francisco, CA 94158 USA.; Balmes, JR (corresponding author), San Francisco Gen Hosp, Div Occupat & Environm Med, 1001 Potrero Ave,SFGH 30, San Francisco, CA 94143 USA.; Eisen, EA (corresponding author), UCB, Sch Publ Hlth, 751 Univ Hall, Berkeley, CA 94704 USA.	izeunice@gmail.com; esteban.burchard@ucsf.edu; eeisen@berkeley.edu; john.balmes@ucsf.edu	Borrell, Luisa N./G-8753-2018	Borrell, Luisa N./0000-0002-0560-4853; Samedy, Lesly-Anne/0000-0002-3914-0970; Elhawary, Jennifer/0000-0003-3326-1680; LEE, EUNICE/0000-0002-4900-0955; Davis, Adam/0000-0002-8004-9722	Sandler Family Foundation; American Asthma Foundation; RWJFAmos Medical Faculty Development Program; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Institute of Health; General Medical Sciences [T32GM007546]; National Institutes of Health [R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, R01HL141992]; National Institute of Health and Environmental Health Sciences [R01ES015794, R21ES24844]; National Institute on Minority Health and Health Disparities [P60MD006902, RL5GM118984, R01MD010443]; Tobacco-Related Disease Research Program [27IR-0030]; National Institute for Occupational Health and Safety grant [T42 OH008429]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128439, R01HL141992, R01HL117004, R01HL135156, K01HL140218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL5GM118984, T32GM007546] Funding Source: NIH RePORTER	Sandler Family Foundation; American Asthma Foundation; RWJFAmos Medical Faculty Development Program; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health and Environmental Health Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Tobacco-Related Disease Research Program(University of California System); National Institute for Occupational Health and Safety grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Sandler Family Foundation; the American Asthma Foundation; the RWJFAmos Medical Faculty Development Program; the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; the National Institute of Health; General Medical Sciences grant T32GM007546; National Institutes of Health grants R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, and R01HL141992; National Institute of Health and Environmental Health Sciences grants R01ES015794 and R21ES24844; National Institute on Minority Health and Health Disparities grants P60MD006902 RL5GM118984, and R01MD010443; the Tobacco-Related Disease Research Program under award no. 27IR-0030; and National Institute for Occupational Health and Safety grant T42 OH008429.	Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bijnens E, 2015, ENVIRON INT, V79, P1, DOI 10.1016/j.envint.2015.02.008; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Borrell LN, 2013, AM J RESP CRIT CARE, V187, P697, DOI 10.1164/rccm.201211-2116OC; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, pA607, DOI 10.1289/ehp.021100607; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fleischman L., 2017, FUMES FENCELINE HLTH; Foreman MG, 2011, AM J RESP CRIT CARE, V184, P414, DOI 10.1164/rccm.201011-1928OC; Guerra S, 2014, AM J RESP CRIT CARE, V190, P356, DOI 10.1164/rccm.201407-1248ED; Hoffmann TJ, 2011, GENOMICS, V98, P422, DOI 10.1016/j.ygeno.2011.08.007; Hou LF, 2012, ENVIRON INT, V48, P71, DOI 10.1016/j.envint.2012.06.020; Hoxha M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-41; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jerrett M, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-49; Jones MR, 2014, AM J PUBLIC HEALTH, V104, P2130, DOI 10.2105/AJPH.2014.302135; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lee EY, 2017, J OCCUP ENVIRON MED, V59, P446, DOI [10.1097/JOM.0000000000000996, 10.1097/jom.0000000000000996]; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Martens DS, 2017, JAMA PEDIATR, V171, P1160, DOI 10.1001/jamapediatrics.2017.3024; Mikati I, 2018, AM J PUBLIC HEALTH, V108, P480, DOI [10.2105/AJPH.2017.304297, 10.2105/ajph.2017.304297]; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P386, DOI 10.1289/ehp.8500; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; Neophytou AM, 2016, AM J RESP CRIT CARE, V193, P1271, DOI 10.1164/rccm.201508-1706OC; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Perrone MG, 2013, ENVIRON POLLUT, V176, P215, DOI 10.1016/j.envpol.2013.01.012; Perrone S, 2010, J MATERN-FETAL NEO M, V23, P63, DOI 10.3109/14767058.2010.509940; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Pope CA, 2015, CIRC RES, V116, P108, DOI 10.1161/CIRCRESAHA.116.305060; Putaud JP, 2004, ATMOS ENVIRON, V38, P2579, DOI 10.1016/j.atmosenv.2004.01.041; Qian ZM, 2009, ARCH ENVIRON OCCUP H, V64, P168, DOI 10.1080/19338240903240616; Samake A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11178-0; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Sorensen M, 2005, CANCER EPIDEM BIOMAR, V14, P1340, DOI 10.1158/1055-9965.EPI-04-0899; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Townsley DM, 2016, NEW ENGL J MED, V375, P1095, DOI 10.1056/NEJMc1607752; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; Walton RT, 2016, ENVIRON INT, V96, P41, DOI 10.1016/j.envint.2016.08.021; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167; Zhao B, 2018, CARDIOVASC DIAGN THE, V8, P480, DOI 10.21037/cdt.2018.06.05; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	56	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					839	+		10.1016/j.jaci.2019.06.009	http://dx.doi.org/10.1016/j.jaci.2019.06.009			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Allergy; Immunology	IW8CV	31247265	Bronze, Green Accepted			2022-12-18	WOS:000485222300027
J	Mulhern, CM; Hong, Y; Omoyinmi, E; Jacques, TS; D'Arco, F; Hemingway, C; Brogan, PA; Eleftheriou, D				Mulhern, Ciara M.; Hong, Ying; Omoyinmi, Ebun; Jacques, Thomas S.; D'Arco, Felice; Hemingway, Cheryl; Brogan, Paul A.; Eleftheriou, Despina			Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							A20		[Jacques, Thomas S.] Histopathol Dept, London, England; [Eleftheriou, Despina] ARUK Ctr Adolescent Rheumatol, London, England; [Mulhern, Ciara M.; Hong, Ying; Omoyinmi, Ebun; Brogan, Paul A.; Eleftheriou, Despina] UCL Great Ormond St Inst Child Hlth, London, England; [D'Arco, Felice] Great Ormond St Hosp Children NHS Fdn Trust, Neuroradiol Dept, London, England; [Hemingway, Cheryl] Great Ormond St Hosp Children NHS Fdn Trust, Paediat Neurol Dept, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Eleftheriou, D (corresponding author), ARUK Ctr Adolescent Rheumatol, London, England.; Eleftheriou, D (corresponding author), UCL Great Ormond St Inst Child Hlth, London, England.	d.eleftheriou@ucl.ac.uk	D'Arco, Felice/AAE-6902-2019	D'Arco, Felice/0000-0001-7396-591X; Brogan, Paul/0000-0001-6178-6893	Arthritis Research UK [20164, 21593, 21791] Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Aeschlimann FA, 2018, ANN RHEUM DIS, V77, P728, DOI 10.1136/annrheumdis-2017-212403; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Guedes RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-122; Lee Y, 2017, J IMMUNOL, V198; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	6	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2019	144	3					863	+		10.1016/j.jaci.2019.05.026	http://dx.doi.org/10.1016/j.jaci.2019.05.026			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IW8CV	31175876	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000485222300032
J	Tumes, D; Hirahara, K; Papadopoulos, M; Shinoda, K; Onodera, A; Kumagai, J; Yip, KH; Pant, H; Kokubo, K; Kiuchi, M; Aoki, A; Obata-Ninomiya, K; Tokoyoda, K; Endo, Y; Kimura, MY; Nakayama, T				Tumes, Damon; Hirahara, Kiyoshi; Papadopoulos, Magdalene; Shinoda, Kenta; Onodera, Atsushi; Kumagai, Jin; Yip, Kwok Ho; Pant, Harshita; Kokubo, Kota; Kiuchi, Masahiro; Aoki, Ami; Obata-Ninomiya, Kazushige; Tokoyoda, Koji; Endo, Yusuke; Kimura, Motoko Y.; Nakayama, Toshinori			Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; allergy; inflammation; epigenetics; natural killer T cells	TRANSCRIPTION FACTOR PLZF; ROR-GAMMA-T; NKT CELLS; AIRWAY INFLAMMATION; METHYLTRANSFERASE ACTIVITY; CUTTING EDGE; HOMOLOG 2; DIFFERENTIATION; POLYCOMB; RECEPTOR	Background: Natural killer T (NKT) cells express a T-cell receptor that recognizes endogenous and environmental glycolipid antigens. Several subsets of NKT cells have been identified, including IFN-gamma-producing NKT1 cells, IL-4-producing NKT2 cells, and IL-17-producing NKT17 cells. However, little is known about the factors that regulate their differentiation and respective functions within the immune system. Objective: We sought to determine whether the polycomb repressive complex 2 protein enhancer of zeste homolog 2 (Ezh2) restrains pathogenicity of NKT cells in the context of asthma-like lung disease. Methods: Numbers of invariant natural killer T (iNKT) 1, iNKT2, and iNKT17 cells and tissue distribution, cytokine production, lymphoid tissue localization, and transcriptional profiles of iNKT cells from wild-type and Ezh2 knockout (KO) iNKT mice were determined. The contribution of NKT cells to development of spontaneous and house dust mite-induced airways pathology, including airways hyperreactivity (AHR) to methacholine, was also assessed in wild-type, Ezh2 KO, and Ezh2 KO mice lacking NKT cells. Results: Ezh2 restrains development of pathogenic NKT cells, which induce spontaneous asthma-like disease in mice. Deletion of Ezh2 increased production of IL-4 and IL-13 and induced spontaneous AHR, lung inflammation, mucus production, and IgE. Increased IL-4 and IL-13 levels, AHR, lung inflammation, and IgE levels were all dependent on iNKT cells. In house dust mite-exposed animals Ezh2 KO resulted in enhanced AHR that was also dependent on iNKT cells. Conclusion: Ezh2 is a central regulator of iNKT pathogenicity and suppresses the ability of iNKT cells to induce asthma-like pathology.	[Tumes, Damon; Hirahara, Kiyoshi; Papadopoulos, Magdalene; Shinoda, Kenta; Onodera, Atsushi; Kumagai, Jin; Kokubo, Kota; Kiuchi, Masahiro; Aoki, Ami; Obata-Ninomiya, Kazushige; Endo, Yusuke; Kimura, Motoko Y.; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Tumes, Damon; Yip, Kwok Ho; Pant, Harshita] SA Pathol, Ctr Canc Biol, North Terrace, Adelaide, SA 5000, Australia; [Tumes, Damon; Yip, Kwok Ho; Pant, Harshita] Univ South Australia, Adelaide, SA 5000, Australia; [Tumes, Damon] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Tokoyoda, Koji] Deutsch Rheuma Forschungszentrum Berlin, Leibniz Inst, Berlin, Germany	Chiba University; Centre for Cancer Biology; SA Pathology; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Deutsches Rheuma-Forschungszentrum (DRFZ)	Tumes, D (corresponding author), SA Pathol, Ctr Canc Biol, North Terrace, Adelaide, SA 5000, Australia.; Tumes, D (corresponding author), Univ South Australia, Adelaide, SA 5000, Australia.	damon.tumes@unisa.edu.au	Tumes, Damon J/B-9917-2009; Hirahara, Kiyoshi/E-2460-2017	Tumes, Damon J/0000-0001-5709-857X; Obata-Ninomiya, Kazushige/0000-0002-0984-6518; Yip, Kwok Ho/0000-0002-8453-0118; Kiuchi, Masahiro/0000-0002-0227-4502; Hirahara, Kiyoshi/0000-0002-9128-9449	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment); Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [26221305, 21390147, 26293165, 24592083, 00707193, 10586598, 24790461, 25860352]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development, AMED [JP18ek0410030, JP18ek0410045]; AMED-PRIME, AMED [JP18gm6110005]; AMED-CREST, AMED [JP18gm1210003]; Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation; Japanese Society for the Promotion of Science postdoctoral fellowship [2109747]; Hospital Research Foundation [045-83100-01]	Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); AMED-PRIME, AMED; AMED-CREST, AMED; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hospital Research Foundation	Supported by the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment) and grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan; Grants-in-Aid for Scientific Research [S] #26221305, [B] #21390147 and #26293165 [C] #24592083, #00707193, and #10586598, Young Scientists [B] #24790461, and #25860352), the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and Development, AMED (nos. JP18ek0410030 and JP18ek0410045); AMED-PRIME, AMED (no. JP18gm6110005); AMED-CREST, AMED (no. JP18gm1210003); the Uehara Memorial Foundation; the Naito Foundation; and the Takeda Science Foundation. D.T. was supported by a Japanese Society for the Promotion of Science postdoctoral fellowship (#2109747) and a midcareer fellowship from the Hospital Research Foundation (#045-83100-01).	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Albacker LA, 2013, NAT MED, V19, P1297, DOI 10.1038/nm.3321; Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Brooks CR, 2010, J ALLERGY CLIN IMMUN, V126, P882, DOI 10.1016/j.jaci.2010.06.041; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dobenecker MW, 2015, J EXP MED, V212, P297, DOI 10.1084/jem.20141499; Engel I, 2016, NAT IMMUNOL, V17, P728, DOI 10.1038/ni.3437; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Gaya M, 2018, CELL, V172, P517, DOI 10.1016/j.cell.2017.11.036; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Hou TY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00790; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim PJ, 2006, J IMMUNOL, V177, P6650, DOI 10.4049/jimmunol.177.10.6650; King IL, 2012, NAT IMMUNOL, V13, P44, DOI 10.1038/ni.2172; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Koh YI, 2010, INT ARCH ALLERGY IMM, V153, P239, DOI 10.1159/000314364; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Matangkasombut P, 2009, J ALLERGY CLIN IMMUN, V123, P1181, DOI 10.1016/j.jaci.2009.02.013; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; McKnight CG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188221; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakayama T, 2017, ANNU REV IMMUNOL, V35, P53, DOI 10.1146/annurev-immunol-051116-052350; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Onodera A, 2015, MOL CELL BIOL, V35, P3841, DOI 10.1128/MCB.00677-15; Pobezinsky LA, 2015, NAT IMMUNOL, V16, P517, DOI 10.1038/ni.3146; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Reynolds C, 2009, J ALLERGY CLIN IMMUN, V124, P860, DOI 10.1016/j.jaci.2009.07.022; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Tumes DJ, 2017, IMMUNOL REV, V278, P8, DOI 10.1111/imr.12560; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Vasanthakumar A, 2017, EMBO REP, V18, P619, DOI 10.15252/embr.201643237; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	52	14	14	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2019	144	2					549	+		10.1016/j.jaci.2019.02.024	http://dx.doi.org/10.1016/j.jaci.2019.02.024			22	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IN6LC	30851295	Green Accepted, Bronze			2022-12-18	WOS:000478789300022
J	Calzoni, E; Platt, CD; Keles, S; Kuehn, HS; Beaussant-Cohen, S; Zhang, Y; Pazmandi, J; Lanzi, G; Pala, F; Tahiat, A; Artac, H; Heredia, RJ; Dmytrus, J; Reisli, I; Uygun, V; Uygun, D; Bingol, A; Basaran, E; Djenouhat, K; Benhalla, N; Bendahmane, C; Emiroglu, M; Kirchhausen, T; Pasham, M; Jones, J; Wallace, JG; Zheng, LX; Boisson, B; Porta, F; Rosenzweig, SD; Su, H; Giliani, S; Lenardo, M; Geha, RS; Boztug, K; Chou, J; Notarangelo, LD				Calzoni, Enrica; Platt, Craig D.; Keles, Sevgi; Kuehn, Hye Sun; Beaussant-Cohen, Sarah; Zhang, Yu; Pazmandi, Julia; Lanzi, Gaetana; Pala, Francesca; Tahiat, Azzeddine; Artac, Hasibe; Heredia, Raul Jimenez; Dmytrus, Jasmin; Reisli, Ismail; Uygun, Vedat; Uygun, Dilara; Bingol, Aysen; Basaran, Erdem; Djenouhat, Kamel; Benhalla, Nafissa; Bendahmane, Chafa; Emiroglu, Melike; Kirchhausen, Tomas; Pasham, Mithun; Jones, Jennifer; Wallace, Jacqueline G.; Zheng, Lixin; Boisson, Bertrand; Porta, Fulvio; Rosenzweig, Sergio D.; Su, Helen; Giliani, Silvia; Lenardo, Michael; Geha, Raif S.; Boztug, Kaan; Chou, Janet; Notarangelo, Luigi D.			F-BAR domain only protein 1 (FCHO1) deficiency is a novel cause of combined immune deficiency in human subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Calzoni, Enrica; Zhang, Yu; Pala, Francesca; Su, Helen; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zheng, Lixin; Lenardo, Michael] NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Calzoni, Enrica; Lanzi, Gaetana; Giliani, Silvia] Univ Brescia, Dept Mol & Translat Med, A Nocivelli Inst Mol Med, Brescia, Italy; [Platt, Craig D.; Beaussant-Cohen, Sarah; Jones, Jennifer; Wallace, Jacqueline G.; Geha, Raif S.; Chou, Janet] Harvard Med Sch, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Keles, Sevgi; Reisli, Ismail] Necmettin Erbakan Univ, Div Pediat Immunol & Allergy, Meram Med Fac, Konya, Turkey; [Kuehn, Hye Sun; Rosenzweig, Sergio D.] NIH, Serv Immunol, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Pazmandi, Julia; Heredia, Raul Jimenez; Dmytrus, Jasmin; Boztug, Kaan] Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Tahiat, Azzeddine; Djenouhat, Kamel] Rouiba Hosp, Med Biol Lab, Algiers, Algeria; [Tahiat, Azzeddine; Djenouhat, Kamel] Univ Algiers 1, Algiers Fac Med, Algiers, Algeria; [Artac, Hasibe] Selcuk Univ, Fac Med, Pediat Immunol & Allergy, Konya, Turkey; [Emiroglu, Melike] Selcuk Univ, Fac Med, Pediat Infect Dis, Konya, Turkey; [Uygun, Vedat] Antalya Hosp, Pediat Bone Marrow Transplantat Unit, Med Pk, Antalya, Turkey; [Uygun, Dilara; Bingol, Aysen] Akdeniz Univ, Sch Med, Dept Immunol Allergy, Antalya, Turkey; [Basaran, Erdem] Akdeniz Univ, Sch Med, Dept Pediat Pulmonol, Antalya, Turkey; [Benhalla, Nafissa] Beni Messous Univ Hosp, Dept Pediat, Algiers, Algeria; [Bendahmane, Chafa] Meftah Hosp, Dept Pediat, Blida, Algeria; [Kirchhausen, Tomas; Pasham, Mithun] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Kirchhausen, Tomas; Pasham, Mithun] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Boisson, Bertrand] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Boisson, Bertrand] Necker Hosp Sick Children, INSERM, U1163, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Boisson, Bertrand] Paris Descartes Univ, Imagine Inst, Paris, France; [Porta, Fulvio] ASST Spedali Civili Brescia, Childrens Hosp, Pediat Oncohaematol & BMT Unit, Brescia, Italy; [Boztug, Kaan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, St Anna Childrens Hosp, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat, Childrens Canc Res Inst, Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Brescia; Harvard University; Boston Children's Hospital; Harvard Medical School; Necmettin Erbakan University; Selcuk University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Selcuk University; Selcuk University; Akdeniz University; Akdeniz University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hospital Spedali Civili Brescia; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital; Medical University of Vienna; Saint Anna Children's Hospital	Chou, J (corresponding author), Harvard Med Sch, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA.	janet.chou@childrens.harvard.edu; luigi.notarangelo2@nih.gov	Boisson, Bertrand/I-2485-2017; Boztug, Kaan/AAM-4161-2021; Pala, Francesca/AAE-8664-2019; Emiroğlu, Melike/AAH-3566-2019; Boisson, Bertrand/AAC-6058-2019; uygun, vedat/AGH-4534-2022; Giliani, Silvia/AAX-8843-2020	Boisson, Bertrand/0000-0001-5240-3555; Boztug, Kaan/0000-0001-8387-9185; Boisson, Bertrand/0000-0001-5240-3555; uygun, vedat/0000-0003-3257-7798; Giliani, Silvia/0000-0001-8137-4642; Pala, Francesca/0000-0003-4537-9061; Jimenez Heredia, Raul/0000-0002-1406-0608; Wallace, Jacqueline/0000-0001-6565-2534; BEAUSSANT COHEN, Sarah/0000-0002-5591-9730; Tahiat, Azzeddine/0000-0003-3272-8904; Emiroglu, Melike/0000-0003-1307-0246	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; "Angelo Nocivelli'' Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001122, ZIAAI001059, ZIAAI001222] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; "Angelo Nocivelli'' Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, and by the "Angelo Nocivelli'' Foundation.	Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Compeer EB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04088-w; Erman B, 2017, SCAND J IMMUNOL, V85, P227, DOI 10.1111/sji.12523; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hollopeter G, 2014, ELIFE, V3, DOI 10.7554/eLife.03648; Jabara HH, 2016, NAT GENET, V48, P74, DOI 10.1038/ng.3465; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Maffucci P, 2019, P NATL ACAD SCI USA, V116, P950, DOI 10.1073/pnas.1808403116; Marchingo JM, 2014, SCIENCE, V346, P1123, DOI 10.1126/science.1260044; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Umasankar PK, 2014, ELIFE, V3, DOI 10.7554/eLife.04137	12	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2317	+		10.1016/j.jaci.2019.02.014	http://dx.doi.org/10.1016/j.jaci.2019.02.014			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30822429	Bronze, Green Accepted			2022-12-18	WOS:000470113200044
J	Chen, X; Lin, H; Yang, DP; Xu, W; Liu, GW; Liu, XM; Sheng, JZ; Huang, HF				Chen, Xi; Lin, Hui; Yang, Daping; Xu, Wei; Liu, Guangwei; Liu, Xinmei; Sheng, Jianzhong; Huang, Hefeng			Early-life undernutrition reprograms CD4(+) T-cell glycolysis and epigenetics to facilitate asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Early-life undernutrition; asthma; CD4(+) T cells; glycolysis; DNA methylation	INTRAUTERINE GROWTH-RETARDATION; PROTEIN RESTRICTION; METABOLIC-CONTROL; PRETERM BIRTH; FETAL-GROWTH; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; EXPRESSION; EFFECTOR	Background: Exposure to early-life undernutrition is closely related to higher risks of adverse immunologic outcomes in adulthood. Although it has been suggested that asthma has its origins in early life, its underlying mechanisms remain largely unknown. Objective: We characterized the effects of early-life undernutrition on T lymphocytes, which play a pivotal role in immune diseases, and we investigated whether this contributes to susceptibility to asthma in adulthood. Methods: Pregnant mice were fed a protein restriction diet (PRD) to establish an early-life undernutrition model. Naive CD4(+) T cells (CD4(+) CD62L(hi)CD44(-)) from offspring were used throughout the study. T(H)2 differentiation was examined by using fluorescence-activated cell sorting and ELISA under T(H)2-polarized conditions in vitro and through ovalbumin-induced experimental asthma in vivo. T-cell metabolism was measured with a Seahorse XF96 Analyzer. DNA methylation levels were measured by using bisulfite sequencing. Results: PRD CD4(+) T cells displayed increased activation and proliferation and were prone to differentiate into T(H)2 cells both in vitro and in vivo, leading to susceptibility to experimental asthma. Mechanistically, early-life undernutrition upregulated mechanistic target of rapamycin 1-dependent glycolysis and induced conserved noncoding DNA sequence 1 DNA hypomethylation in the T(H)2 cytokine locus of CD4(+) T cells. Glycolysis blockades undermined increased T(H)2 skewing and alleviated experimental asthma in PRD mice. Conclusion: Early-life undernutrition induced mechanistic target of rapamycin 1-dependent glycolysis upregulation and T(H)2 cytokine locus hypomethylation in CD4(+) T cells, resulting in increased T-cell activation, proliferation, and T(H)2 skewing and further susceptibility to experimental asthma.	[Chen, Xi; Lin, Hui; Liu, Xinmei; Huang, Hefeng] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, 1961 Huashan Rd, Shanghai 200030, Peoples R China; [Chen, Xi; Lin, Hui; Liu, Xinmei; Huang, Hefeng] Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, 1961 Huashan Rd, Shanghai 200030, Peoples R China; [Yang, Daping] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Wei] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai, Peoples R China; [Liu, Guangwei] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Key Lab Cell Proliferat & Regulat Biol,Minist Edu, Beijing, Peoples R China; [Sheng, Jianzhong] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Zhejiang, Peoples R China; [Huang, Hefeng] Zhejiang Univ, Minist Educ, Key Lab Reprod Genet, Hangzhou, Zhejiang, Peoples R China; [Chen, Xi; Liu, Xinmei; Huang, Hefeng] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Beijing Normal University; Zhejiang University; Zhejiang University	Huang, HF (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, 1961 Huashan Rd, Shanghai 200030, Peoples R China.; Liu, XM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, 1961 Huashan Rd, Shanghai 200030, Peoples R China.; Sheng, JZ (corresponding author), Zhejiang Univ, Sch Med, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	nanlilac@hotmail.com; shengjz@zju.edu.cn; huanghefg@sjtu.edu.cn	Xu, Wei/AAG-2857-2019; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020; Huang, He-Feng/AAN-7985-2020	Huang, He-Feng/0000-0003-4344-8019; Liu, Guangwei/0000-0002-6008-2891	National Key Research and Development Program of China [2017YFC1001303]; National Natural Science Foundation of China [81490742, 31471405, 81671456]; Shanghai Sailing Program [17YF1420700]; China Postdoctoral Science Foundation [2016M601616]; Canada NSFC [81661128010]; International Cooperation Project of China [81661128010]; Interdisciplinary Key Program of Shanghai Jiao Tong University [YG2014ZD08]; Shen Kang Three Year Action plan [16CR3003A]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Canada NSFC; International Cooperation Project of China; Interdisciplinary Key Program of Shanghai Jiao Tong University; Shen Kang Three Year Action plan	This study was supported by the National Key Research and Development Program of China (2017YFC1001303 to H.H.), the National Natural Science Foundation of China (31471405 to H.H. and 81671456 to X.L.), the major program of the National Natural Science Foundation of China (81490742 to H.H.), the Shanghai Sailing Program (17YF1420700 to X.C.), the China Postdoctoral Science Foundation (2016M601616 to X.C.), the International Cooperation Project of China and Canada NSFC (81661128010 to H.H.), the Interdisciplinary Key Program of Shanghai Jiao Tong University (YG2014ZD08 to H.H.), and the Shen Kang Three Year Action plan (16CR3003A to H.H.).	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cai T, 2019, J ALLERGY CLIN IMMUN, V143, P229, DOI 10.1016/j.jaci.2018.03.007; Canoy D, 2007, THORAX, V62, P396, DOI 10.1136/thx.2006.066241; Chen X, 2016, J LEUKOCYTE BIOL, V100, P1349, DOI 10.1189/jlb.2A1115-492R; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Cummings AM, 2007, ENVIRON RES, V104, P96, DOI 10.1016/j.envres.2006.10.003; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dumitru C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00540; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fung JN, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126458; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goyal R, 2010, REPROD SCI, V17, P227, DOI 10.1177/1933719109351935; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hornsby E, 2018, J ALLERGY CLIN IMMUN, V141, P269, DOI 10.1016/j.jaci.2017.02.039; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Jiang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03852-2; Kallen B, 2013, EUR RESPIR J, V41, P671, DOI 10.1183/09031936.00041912; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kobayashi H, 2014, MOL MED REP, V9, P1483, DOI 10.3892/mmr.2014.2057; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Layman AAK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15677; Lewis ED, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070713; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Matheson MC, 2017, J ASTHMA, V54, P616, DOI 10.1080/02770903.2016.1249284; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Nakajima A, 2017, J IMMUNOL, V199, P3516, DOI 10.4049/jimmunol.1700248; Pelgrom LR, 2017, EUR J IMMUNOL, V47, P1266, DOI 10.1002/eji.201646728; Pike K, 2012, SEMIN FETAL NEONAT M, V17, P92, DOI 10.1016/j.siny.2012.01.003; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Salam RA, 2014, CURR OPIN CLIN NUTR, V17, P249, DOI 10.1097/MCO.0000000000000051; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Song MH, 2017, BMB REP, V50, P49, DOI [10.5483/BMBRep.2017.50.1.193, 10.5483/bmbrep.2017.50.1.193]; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Takeda N, 2013, DEVELOPMENT, V140, P1655, DOI 10.1242/dev.093005; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; van Straten EME, 2010, AM J PHYSIOL-REG I, V298, pR275, DOI 10.1152/ajpregu.00413.2009; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; Wang KCW, 2018, CLIN SCI, V132, P273, DOI 10.1042/CS20171554; Wang KCW, 2017, RESPIROLOGY, V22, P1329, DOI 10.1111/resp.13071; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu XF, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0137-7; Yang JQ, 2016, J ALLERGY CLIN IMMUN, V137, P231, DOI 10.1016/j.jaci.2015.05.004; Zhang XM, 2018, CELL MOL IMMUNOL, V15, P203, DOI 10.1038/cmi.2017.115; Zhao QJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00637; Zhu LQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4158	61	14	15	5	24	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2038	+		10.1016/j.jaci.2018.12.999	http://dx.doi.org/10.1016/j.jaci.2018.12.999			26	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30654047	hybrid			2022-12-18	WOS:000470113200010
J	Moran, I; Avery, DT; Payne, K; Lenthall, H; Davies, EG; Burns, S; Ip, W; Oleastro, MM; Reisli, I; Guner, S; Keles, S; Notarangelo, L; Deenick, EK; Goodnow, CC; Zahra, D; Brink, R; Wong, M; Tangye, SG; Ma, CS; Phan, TG				Moran, Imogen; Avery, Danielle T.; Payne, Kathryn; Lenthall, Helen; Davies, E. Graham; Burns, Siobhan; Ip, Winnie; Oleastro, Matyfffedas M.; Reisli, Ismail; Guner, Sukru; Keles, Sevgi; Notarangelo, Luigi; Deenick, Elissa K.; Goodnow, Christopher C.; Zahra, David; Brink, Robert; Wong, Melanie; Tangye, Stuart G.; Ma, Cindy S.; Tri Giang Phan			B cell-intrinsic requirement for STK4 in humoral immunity in mice and human subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							MST1; IMMUNODEFICIENCY; TRAFFICKING		[Moran, Imogen; Avery, Danielle T.; Payne, Kathryn; Lenthall, Helen; Deenick, Elissa K.; Goodnow, Christopher C.; Zahra, David; Brink, Robert; Tangye, Stuart G.; Ma, Cindy S.; Tri Giang Phan] Garvan Inst Med Res, Div Immunol, Sydney, NSW, Australia; [Moran, Imogen; Deenick, Elissa K.; Goodnow, Christopher C.; Brink, Robert; Tangye, Stuart G.; Ma, Cindy S.; Tri Giang Phan] UNSW Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Davies, E. Graham; Ip, Winnie] UCL Great Ormond St Inst Child Hlth, Infect Immun & Inflammat Theme, London, England; [Davies, E. Graham; Ip, Winnie] Great Ormond St Hosp Sick Children, Dept Immunol, London, England; [Burns, Siobhan] Royal Free London NHS Fdn Trust, Dept Immunol, London, England; [Burns, Siobhan] UCL, Inst Immun & Transplantat, London, England; [Oleastro, Matyfffedas M.] Hosp Pediat Dr Juan P Garrahan, Dept Immunol & Rheumatol, Buenos Aires, DF, Argentina; [Reisli, Ismail; Guner, Sukru; Keles, Sevgi] Necmettin Erbakan Univ, Meram Fac Med, Div Pediat Immunol & Allergy, Konya, Turkey; [Notarangelo, Luigi] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Brink, Robert] Clin Immunogen Res Consortium Australia, Darlinghurst, NSW, Australia; [Wong, Melanie] Childrens Hosp Westmead, Westmead, NSW, Australia; [Wong, Melanie] Univ Sydney, Fac Med, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Hospital de Pediatria Doctor Juan Garrahan; Necmettin Erbakan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Sydney; University of Sydney	Phan, TG (corresponding author), Garvan Inst Med Res, Div Immunol, Sydney, NSW, Australia.; Phan, TG (corresponding author), UNSW Sydney, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia.	t.phan@garvan.org.au	Guner, Sukru Nail/A-9841-2018; Goodnow, Christopher C/V-8108-2018; S, Cindy/B-2340-2012; Deenick, Elissa/AAY-8998-2020	Guner, Sukru Nail/0000-0002-8860-6132; Goodnow, Christopher C/0000-0001-5296-6155; S, Cindy/0000-0001-5387-8413; Deenick, Elissa/0000-0002-9271-0004; Brink, Robert/0000-0002-9586-3655	National Health and Medical Research Council (NHMRC) [1139865]; Office of Health and Medical Research of the NSW State Government; John Cook Brown Foundation; Jeffrey Modell Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Office of Health and Medical Research of the NSW State Government; John Cook Brown Foundation; Jeffrey Modell Foundation	Supported by National Health and Medical Research Council (NHMRC) grant ID1139865, the Office of Health and Medical Research of the NSW State Government, the John Cook Brown Foundation, and the Jeffrey Modell Foundation. The contents of this article are solely the responsibility of the authors and do not reflect the views of the NHMRC.	Abdollahpour H, 2012, BLOOD, V119, P3450, DOI 10.1182/blood-2011-09-378158; Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010; Dang TS, 2016, J CLIN IMMUNOL, V36, P117, DOI 10.1007/s10875-016-0232-2; Halacli SO, 2015, CLIN IMMUNOL, V161, P316, DOI 10.1016/j.clim.2015.06.010; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kurz ARM, 2016, J CLIN INVEST, V126, P4125, DOI 10.1172/JCI87043; Li CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14275; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Schipp C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02400	9	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2019	143	6					2302	+		10.1016/j.jaci.2019.02.010	http://dx.doi.org/10.1016/j.jaci.2019.02.010			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	IB2QG	30796983	Green Submitted, Bronze			2022-12-18	WOS:000470113200039
J	Tham, EH; Dyjack, N; Kim, BE; Rios, C; Seibold, MA; Leung, DYM; Goleva, E				Tham, Elizabeth Huiwen; Dyjack, Nathan; Kim, Byung Eui; Rios, Cydney; Seibold, Max A.; Leung, Donald Y. M.; Goleva, Elena			Expression and function of the ectopic olfactory receptor OR10G7 in patients with atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; olfactory receptor; sensory; ATP; keratinocytes	HUMAN KERATINOCYTES; CONTACT-DERMATITIS; EXTRACELLULAR ATP; ISOEUGENOL; RELEASE; SENSITIZATION; PATTERNS; CHILDREN; ALLERGEN; BURDEN	Background: Ectopic olfactory receptors (ORs) are found in the skin, but their expression and biological function in normal skin and skin form patients with atopic dermatitis (AD) are unknown. Objectives: We sought to characterize the expression of ORs in the skin and assess OR-mediated biological responses of primary human keratinocytes in the presence of odorant ligands. Methods: OR expression was examined by using wholetranscriptome sequencing of skin tape strips collected from patients with AD and healthy control (HC) subjects. OR10G7 and filaggrin 1 (FLG-1) expression was analyzed by using RTPCR and immunostaining in skin biopsy specimens and primary human keratinocytes from patients with AD and HC subjects. ATP and cyclic AMP production by control and OR10G7 small interfering RNA-transfected keratinocytes in response to odorant stimulation with acetophenone and eugenol was assessed. Results: A total of 381 OR gene transcripts were detected in the skin samples, with the greatest OR expression detected in the skin tape strips corresponding to the upper granular layer of the skin. OR10G7 expression was significantly increased in skin biopsy specimens from patients with AD compared with those from HC subjects (P 5.01) and inversely correlated with FLG-1 expression (P 5.009). OR10G7 expression was greatest in undifferentiated keratinocytes from patients with AD and was downregulated with progressive differentiation. Primary human keratinocytes produced ATP, an essential neurotransmitter in sensory pathways, in response to acetophenone and eugenol, odorants previously identified as potential ligands for this receptor. This response was abolished in OR10G7 small interfering RNA-transfected keratinocytes. Conclusions: OR10G7 is expressed at significantly greater levels in undifferentiated keratinocytes from patients with AD compared with HC subjects. OR10G7 is likely involved in transmission of skin-induced chemosensory responses to odorant stimulation, which might modulate differential nociceptive responses in AD skin.	[Tham, Elizabeth Huiwen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Tham, Elizabeth Huiwen] Natl Univ Hlth Syst, Natl Univ Hosp, Khoo Teck Puat Natl Univ Childrens Med Inst, Singapore, Singapore; [Tham, Elizabeth Huiwen; Dyjack, Nathan; Kim, Byung Eui; Rios, Cydney; Seibold, Max A.; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO USA	National University of Singapore; National University of Singapore; National Jewish Health	Goleva, E (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	GolevaE@njhealth.org		Dyjack, Nathan/0000-0001-6944-6252; Kim, Byung Eui/0000-0003-4923-1814	National Medical Research Council (NMRC) Research Training Fellowship grant from the NMRC, Singapore [MH 095:003\008-225]; National Institutes of Health [1U19AI117673, R01AR41256, UL1RR025780]; Edelstein Family Chair of Pediatric Allergy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER	National Medical Research Council (NMRC) Research Training Fellowship grant from the NMRC, Singapore(National Medical Research Council, Singapore); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edelstein Family Chair of Pediatric Allergy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	E.H.T. is supported by a National Medical Research Council (NMRC) Research Training Fellowship grant (MH 095:003\008-225) from the NMRC, Singapore. This work was supported by National Institutes of Health grants 1U19AI117673, R01AR41256, and UL1RR025780 and the Edelstein Family Chair of Pediatric Allergy.	Andersen HH, 2018, PAIN, V159, P1185, DOI 10.1097/j.pain.0000000000001220; Antunes G, 2016, METHOD CELL BIOL, V132, P127, DOI 10.1016/bs.mcb.2015.11.003; Api A M, 2016, Food Chem Toxicol, V97S, pS25, DOI 10.1016/j.fct.2015.12.013; Api A M, 2016, Food Chem Toxicol, V97S, pS49, DOI 10.1016/j.fct.2015.12.021; Azorin N, 2011, EXP DERMATOL, V20, P401, DOI 10.1111/j.1600-0625.2010.01219.x; Barr TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056744; BARRATT MD, 1992, CONTACT DERMATITIS, V27, P98, DOI 10.1111/j.1600-0536.1992.tb05217.x; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Berdyshev E, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98006; Blome C, 2016, AM J CLIN DERMATOL, V17, P163, DOI 10.1007/s40257-015-0171-3; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Z, 2018, J CELL PHYSIOL, V233, P2104, DOI 10.1002/jcp.25929; Dussor G, 2008, J NEUROPHYSIOL, V99, P1581, DOI 10.1152/jn.01396.2007; Dyjack N, 2018, J ALLERGY CLIN IMMUN, V141, P1298, DOI 10.1016/j.jaci.2017.10.046; Engel-Yeger B, 2011, J EUR ACAD DERMATOL, V25, P152, DOI 10.1111/j.1468-3083.2010.03729.x; Engel-Yeger B, 2007, J AM ACAD DERMATOL, V57, P610, DOI 10.1016/j.jaad.2007.05.001; Filanovsky MG, 2016, J PEDIATR-US, V169, P284, DOI 10.1016/j.jpeds.2015.10.077; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Hegg CC, 2003, J NEUROSCI, V23, P8291; Heydorn S, 2003, CONTACT DERMATITIS, V48, P317, DOI 10.1034/j.1600-0536.2003.00133.x; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Kim S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1047; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Moehring F, 2018, ELIFE, V7, DOI [10.7554/elife.31684, 10.7554/eLife.31684]; Mollanazar NK, 2016, CLIN REV ALLERG IMMU, V51, P263, DOI 10.1007/s12016-015-8488-5; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Onami K, 2014, J INVEST DERMATOL, V134, P1951, DOI 10.1038/jid.2014.93; Raison-Peyron N, 2016, CONTACT DERMATITIS, V75, P106, DOI 10.1111/cod.12579; Schnuch A, 2007, CONTACT DERMATITIS, V57, P1, DOI 10.1111/j.1600-0536.2007.01088.x; Sondersorg AC, 2014, J BIOL CHEM, V289, P17529, DOI 10.1074/jbc.M113.499699; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Tammannavar P, 2013, BMJ CASE REP, V2013; Trimmer C, 2014, JOVE-J VIS EXP, DOI 10.3791/51640; Tsai T, 2017, EXP DERMATOL, V26, P58, DOI 10.1111/exd.13132; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Vakharia PP, 2017, ANN ALLERG ASTHMA IM, V119, P548, DOI 10.1016/j.anai.2017.09.076; von der Weid B, 2015, NAT NEUROSCI, V18, P1455, DOI 10.1038/nn.4100; Weber FC, 2010, J EXP MED, V207, P2609, DOI 10.1084/jem.20092489; Weyrich LS, 2015, AUSTRALAS J DERMATOL, V56, P268, DOI 10.1111/ajd.12253; White IR, 1999, CONTACT DERMATITIS, V41, P272, DOI 10.1111/j.1600-0536.1999.tb06160.x; White JML, 2007, BRIT J DERMATOL, V157, P580, DOI 10.1111/j.1365-2133.2007.08017.x	50	14	18	1	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1838	+		10.1016/j.jaci.2018.11.004	http://dx.doi.org/10.1016/j.jaci.2018.11.004			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30445058	Green Accepted, Bronze			2022-12-18	WOS:000466784600020
J	Wheatley, LM; Wood, R; Nadeau, K; Liu, A; Zoratti, E; Bacharier, L; Brittain, E; Calderon, M; Casale, T; Chipps, B; Cox, L; Creticos, PS; Desai, M; Dreborg, S; Durham, S; Gergen, PJ; Gruchalla, R; Nelson, H; O'Hehir, RE; Plaut, M; Schwaninger, JM; Tilles, S; Vickery, B; Wittenberg, KM; Togias, A				Wheatley, Lisa M.; Wood, Robert; Nadeau, Kari; Liu, Andrew; Zoratti, Edward; Bacharier, Leonard; Brittain, Erica; Calderon, Moises; Casale, Thomas; Chipps, Bradley; Cox, Linda; Creticos, Peter S.; Desai, Manisha; Dreborg, Sten; Durham, Stephen; Gergen, Peter J.; Gruchalla, Rebecca; Nelson, Harold; O'Hehir, Robyn E.; Plaut, Marshall; Schwaninger, Julie M.; Tilles, Stephen; Vickery, Brian; Wittenberg, Kim M.; Togias, Alkis			Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Aeroallergen; immunotherapy; asthma; allergic rhinitis; rhinoconjunctivitis; multi-allergen; prevention	HOUSE-DUST-MITE; GRASS ALLERGEN TABLETS; RANDOMIZED CONTROLLED-TRIAL; 1ST 6 YEARS; SUBLINGUAL IMMUNOTHERAPY; DOUBLE-BLIND; FOLLOW-UP; SUBCUTANEOUS IMMUNOTHERAPY; IMMUNOLOGICAL RESPONSE; DOSE-RESPONSE	The Agency for Healthcare Research and Quality and the National Institute of Allergy and Infectious Diseases organized a workshop to develop trial concepts that could improve the use and effectiveness of aeroallergen immunotherapy (AAIT). Expert groups were formed to accomplish the following tasks: (1) propose a study design to compare the effectiveness and safety of subcutaneous versus sublingual AAIT; (2) propose a study design to compare the effectiveness and safety of AAIT by using 1 or a few allergens versus all or most allergens to which a patient is sensitized; (3) propose a study design to determine whether AAIT can alter the progression of childhood allergic airways disease; and (4) propose a study design to determine the optimal dose and duration of AAIT to achieve maximal effectiveness with acceptable safety. Study designs were presented by the workgroups, extensively discussed at the workshop, and revised for this report. The proposed trials would be of long duration and require large highly characterized patient populations. Scientific caveats and feasibility matters are discussed. These concepts are intended to help the development of clinical trials that can address some of the major questions related to the practice of AAIT for the management and prevention of allergic airways disease.	[Wheatley, Lisa M.; Gergen, Peter J.; Plaut, Marshall; Schwaninger, Julie M.; Togias, Alkis] NIAID, Div Allergy Immunol & Transplantat, NIH, Rockville, MD USA; [Wood, Robert] Johns Hopkins Univ, Baltimore, MD USA; [Nadeau, Kari] Stanford Univ, Stanford, CA 94305 USA; [Liu, Andrew] Childrens Hosp Colorado, Aurora, CO USA; [Liu, Andrew] Univ Colorado, Sch Med, Aurora, CO USA; [Zoratti, Edward] Henry Ford Hosp, Detroit, MI 48202 USA; [Bacharier, Leonard] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Brittain, Erica] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Calderon, Moises; Durham, Stephen] Imperial Coll London, London, England; [Casale, Thomas] Univ S Florida, Tampa, FL USA; [Chipps, Bradley] Capital Allergy & Resp Dis Ctr, Sacramento, CA USA; [Cox, Linda] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA; [Creticos, Peter S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Desai, Manisha] Stanford Univ, Quantitat Sci Unit, Stanford, CA 94305 USA; [Dreborg, Sten] Uppsala Univ, Uppsala, Sweden; [Gruchalla, Rebecca] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Nelson, Harold] Natl Jewish Hlth, Denver, CO USA; [O'Hehir, Robyn E.] Alfred Hosp, Melbourne, Vic, Australia; [O'Hehir, Robyn E.] Monash Univ, Sch Med, Melbourne, Vic, Australia; [Tilles, Stephen] Univ Washington, Seattle, WA 98195 USA; [Vickery, Brian] Univ N Carolina, North Carolina Childrens Hosp, Chapel Hill, NC 27515 USA; [Wittenberg, Kim M.] Agcy Healthcare Res & Qual, Ctr Evidence & Practice Improvement, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Henry Ford Health System; Henry Ford Hospital; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London; State University System of Florida; University of South Florida; Nova Southeastern University; Johns Hopkins University; Stanford University; Uppsala University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Jewish Health; Florey Institute of Neuroscience & Mental Health; Monash University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Agency for Healthcare Research & Quality	Wheatley, LM (corresponding author), NIAID, Div Allergy Immunol & Transplantat, NIH, 5601 Fishers Lane MSC9827, Bethesda, MD 20892 USA.	lisa.wheatley@nih.gov	Cox, Linda/AAP-1697-2021; O'Hehir, Robyn/H-3627-2011	Cox, Linda/0000-0002-5258-6870; O'Hehir, Robyn/0000-0002-3489-7595; Bacharier, Leonard/0000-0003-0432-2704	Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases (NIAID); Agency for Healthcare Research and Quality (AHRQ) [HHSA 290-2007-10061-I]; US Department of Health and Human Services (HHS)	Division of Allergy, Immunology, and Transplantation; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); US Department of Health and Human Services (HHS)	The workshop was supported by funds from the Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID). The associated AHRQ product was funded under contract no. HHSA 290-2007-10061-I (Task Order 2) from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services (HHS). The authors of this manuscript are responsible for its content. Statements in the manuscript do not necessarily represent the official views of or imply endorsement by AHRQ, NIAID, or HHS.	ABRAMSON MJ, 1995, AM J RESP CRIT CARE, V151, P969; Acquistapace F, 2009, PEDIAT ALLERG IMM-UK, V20, P660, DOI 10.1111/j.1399-3038.2009.00860.x; Adkinson NF, 1997, NEW ENGL J MED, V336, P324, DOI 10.1056/NEJM199701303360502; Amar SM, 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI 10.1016/j.jaci.2009.04.037; [Anonymous], 2015, GLOB STRAT ASTHM MAN; Anto JM, 2017, J ALLERGY CLIN IMMUN, V139, P388, DOI 10.1016/j.jaci.2016.12.940; Antunez C, 2008, PEDIAT ALLERG IMM-UK, V19, P210, DOI 10.1111/j.1399-3038.2007.00604.x; Bacharier LB, 2015, ANN ALLERG ASTHMA IM, V115, P463, DOI 10.1016/j.anai.2015.09.019; Bahceciler NN, 2013, IMMUNOTHERAPY-UK, V5, P183, DOI [10.2217/IMT.12.161, 10.2217/imt.12.161]; Barnes ML, 2010, CLIN EXP ALLERGY, V40, P242, DOI 10.1111/j.1365-2222.2009.03381.x; Blaiss M, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; BOUSQUET J, 1995, AM J RESP CRIT CARE, V152, P1737, DOI 10.1164/ajrccm.152.5.7582321; Bufford JD, 2008, CLIN EXP ALLERGY, V38, P1635, DOI 10.1111/j.1365-2222.2008.03018.x; Calamita Z, 2006, ALLERGY, V61, P1162, DOI 10.1111/j.1398-9995.2006.01205.x; Calderon M, 2006, J INVEST ALLERG CLIN, V16, P338; Calderon MA, 2011, ALLERGY, V66, P1345, DOI 10.1111/j.1398-9995.2011.02669.x; Calderon MA, 2011, CLIN EXP ALLERGY, V41, P1263, DOI 10.1111/j.1365-2222.2011.03835.x; Calderon MA, 2012, CURR OPIN ALLERGY CL, V12, P249, DOI 10.1097/ACI.0b013e32835358b3; Calderon MA, 2012, J ALLERGY CLIN IMMUN, V129, P929, DOI 10.1016/j.jaci.2011.11.019; Calderon MA, 2011, J ALLERGY CLIN IMMUN, V127, P30, DOI 10.1016/j.jaci.2010.08.024; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Chanez P, 1996, ALLERGY, V51, P850; Ciprandi G, 2010, INT J IMMUNOPATH PH, V23, P637, DOI 10.1177/039463201002300227; Cox L, 2007, ANN ALLERG ASTHMA IM, V98, P416, DOI 10.1016/S1081-1206(10)60755-7; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Creticos PS, 2014, J ALLERGY CLIN IMMUN, V133, P751, DOI 10.1016/j.jaci.2013.10.041; Creticos PS, 2013, J ALLERGY CLIN IMMUN, V131, P1342, DOI 10.1016/j.jaci.2013.03.019; Creticos PS, 1996, NEW ENGL J MED, V334, P501, DOI 10.1056/NEJM199602223340804; CRETICOS PS, 1989, J ALLERGY CLIN IMMUN, V84, P197, DOI 10.1016/0091-6749(89)90325-4; Creticos PS, 2015, SUBLINGUAL IMMUNOTHE; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Demoly P, 2016, J ALLERGY CLIN IMMUN, V137, P444, DOI 10.1016/j.jaci.2015.06.036; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Devillier P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-71; Di Bona D, 2015, JAMA INTERN MED, V175, P1301, DOI 10.1001/jamainternmed.2015.2840; Didier A, 2007, J ALLERGY CLIN IMMUN, V120, P1338, DOI 10.1016/j.jaci.2007.07.046; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Durham SR, 2006, J ALLERGY CLIN IMMUN, V117, P802, DOI 10.1016/j.jaci.2005.12.1358; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; Durham SR, 2012, J ALLERGY CLIN IMMUN, V129, P717, DOI 10.1016/j.jaci.2011.12.973; Durham SR, 2011, J ALLERGY CLIN IMMUN, V127, P3, DOI 10.1016/j.jaci.2010.11.032; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Eifan AO, 2010, CLIN EXP ALLERGY, V40, P922, DOI 10.1111/j.1365-2222.2009.03448.x; Ellis AK, 2017, J ALLERGY CLIN IMMUN, V140, P486, DOI 10.1016/j.jaci.2016.11.043; Esch RE, 2003, ARB P EHRLICH I BUND, V94, P17; Esch RE, 2008, ANN ALLERG ASTHMA IM, V100, P475, DOI 10.1016/S1081-1206(10)60474-7; Ewbank PA, 2003, J ALLERGY CLIN IMMUN, V111, P155, DOI 10.1067/mai.2003.41; Ferdousi HA, 2005, PEDIAT ALLERG IMM-UK, V16, P478, DOI 10.1111/j.1399-3038.2005.00296.x; Frew AJ, 2006, J ALLERGY CLIN IMMUN, V117, P319, DOI 10.1016/j.jaci.2005.11.014; Garden FL, 2016, EUR RESPIR J, V47, P499, DOI 10.1183/13993003.00284-2015; GODDEN DJ, 1994, AM J RESP CRIT CARE, V149, P106, DOI 10.1164/ajrccm.149.1.8111567; Grant T, 2017, J ALLER CL IMM-PRACT, V5, P1008, DOI 10.1016/j.jaip.2016.10.020; Grier TJ, 2016, ANN ALLERG ASTHMA IM, V116, P455, DOI 10.1016/j.anai.2016.02.015; Grier TJ, 2015, ANN ALLERG ASTHMA IM, V115, P496, DOI 10.1016/j.anai.2015.10.002; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; HAUGAARD L, 1993, J ALLERGY CLIN IMMUN, V91, P709, DOI 10.1016/0091-6749(93)90190-Q; Horak E, 2003, BRIT MED J, V326, P422, DOI 10.1136/bmj.326.7386.422; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Institute of Medicine (US) Committee on the Assessment of Asthma and Indoor Air, 2000, CLEAR AIR ASTHM IND; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kanchongkittiphon W, 2015, ENVIRON HEALTH PERSP, V123, P6, DOI [10.1289/ehp.1307922, 10.1289/ehp.123-A6]; Keles S, 2011, J ALLERGY CLIN IMMUN, V128, P808, DOI 10.1016/j.jaci.2011.04.033; Kercsmar CM, 2019, J ALLERGY CLIN IMMUN, V143, P1760, DOI 10.1016/j.jaci.2018.10.060; Kristiansen M, 2017, PEDIAT ALLERG IMM-UK, V28, P18, DOI 10.1111/pai.12661; Krouse RZ, 2017, J ALLERGY CLIN IMMUN, V139, P1052, DOI 10.1016/j.jaci.2016.08.041; Linnemann DESL, 2014, IMMUNOTHERAPY-UK, V6, P871, DOI [10.2217/IMT.14.55, 10.2217/imt.14.55]; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lent AM, 2006, J ALLERGY CLIN IMMUN, V118, P1249, DOI 10.1016/j.jaci.2006.07.055; Lin SY, 2013, COMP EFFECTIVENESS R; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Marogna M, 2007, ANN ALLERG ASTHMA IM, V98, P274, DOI 10.1016/S1081-1206(10)60718-1; Marogna M, 2010, J ALLERGY CLIN IMMUN, V126, P969, DOI 10.1016/j.jaci.2010.08.030; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Massie T., STAT REV BIOL LICENS; Migueres M, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-16; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; MOLLER C, 1984, ALLERGY, V39, P37, DOI 10.1111/j.1398-9995.1984.tb01931.x; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Mungan D, 1999, ANN ALLERG ASTHMA IM, V82, P485, DOI 10.1016/S1081-1206(10)62726-3; Nanda A, 2004, J ALLERGY CLIN IMMUN, V114, P1339, DOI 10.1016/j.jaci.2004.08.049; National Asthma Education and Prevention Program, 2007, 3 NAT ASTHM ED PREV; Nelson HS, 2014, J ALLER CL IMM-PRACT, V2, P144, DOI 10.1016/j.jaip.2013.11.018; Nelson HS, 2009, CURR OPIN ALLERGY CL, V9, P549, DOI 10.1097/ACI.0b013e328330ee69; Nelson HS, 2009, J ALLERGY CLIN IMMUN, V123, P763, DOI 10.1016/j.jaci.2008.12.013; Nelson HS, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; Nolte H, 2016, J ALLERGY CLIN IMMUN, V138, P1631, DOI 10.1016/j.jaci.2016.06.044; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; NORMAN PS, 1978, J ALLERGY CLIN IMMUN, V61, P370, DOI 10.1016/0091-6749(78)90116-1; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Olaguibel JM, 1997, ALLERGY, V52, P168, DOI 10.1111/j.1398-9995.1997.tb00971.x; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Passalacqua G, 2014, CURR OPIN ALLERGY CL, V14, P20, DOI 10.1097/ACI.0000000000000018; Penagos M, 2006, ANN ALLERG ASTHMA IM, V97, P141, DOI 10.1016/S1081-1206(10)60004-X; Pfaar O, 2017, ALLERGY, V72, P1035, DOI 10.1111/all.13133; Plopper CG, 2007, TOXICOL PATHOL, V35, P97, DOI 10.1080/01926230601132030; Radulovic S, 2011, ALLERGY, V66, P740, DOI 10.1111/j.1398-9995.2011.02583.x; Radulovic S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002893.pub2; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Rochat MK, 2010, J ALLERGY CLIN IMMUN, V126, P1170, DOI 10.1016/j.jaci.2010.09.008; Ross RN, 2000, CLIN THER, V22, P329, DOI 10.1016/S0149-2918(00)80037-5; Scadding GW, 2017, JAMA-J AM MED ASSOC, V317, P615, DOI 10.1001/jama.2016.21040; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Strachan DP, 1996, BRIT MED J, V312, P1195; Tabar AI, 2011, J ALLERGY CLIN IMMUN, V127, P57, DOI 10.1016/j.jaci.2010.10.025; Tabatabaian F, 2015, ALLERGY ASTHMA PROC, V36, P100, DOI 10.2500/aap.2015.36.3830; Tahamiler R, 2008, ORL-J OTO-RHIN-LARYN, V70, P144, DOI 10.1159/000124286; TePas EC, 2004, ANN ALLERG ASTHMA IM, V92, P25, DOI 10.1016/S1081-1206(10)61706-1; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; TURKELTAUB PC, 1994, ARB PEI GSH, V87, P79; Turkeltaub PC, 1994, ARB P EHRLICH I BUND, P114; Valovirta E, 2018, J ALLERGY CLIN IMMUN, V141, P529, DOI 10.1016/j.jaci.2017.06.014; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Yukselen A, 2012, INT ARCH ALLERGY IMM, V157, P288, DOI 10.1159/000327566; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zieglmayer P, 2016, ANN ALLERG ASTHMA IM, V117, P690, DOI 10.1016/j.anai.2016.10.015; Zoratti EM, 2016, J ALLERGY CLIN IMMUN, V138, P1016, DOI 10.1016/j.jaci.2016.06.061; 2008, DRUG TODAY B, V44, P31; 2011, J ALLERGY CLIN IMMUN, V127, P72, DOI DOI 10.1016/J.JACI.2010.11.035; 2009, J ALLERGY CLIN IMMUN, V124, P150, DOI DOI 10.1016/J.JACI.2009.04.037; 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI DOI 10.1016/J.JACI.2009.10.035; 2011, J ALLERGY CLIN IMMUN, V127, P57, DOI DOI 10.1016/J.JACI.2010.10.025; 2011, J ALLERGY CLIN IMMUN, V127, P64, DOI DOI 10.1016/J.JACI.2010.11.034	128	14	17	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2019	143	5					1711	1726		10.1016/j.jaci.2019.01.032	http://dx.doi.org/10.1016/j.jaci.2019.01.032			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HW6FP	30731123	Bronze			2022-12-18	WOS:000466784600005
J	Kulthanan, K; Hunnangkul, S; Tuchinda, P; Chularojanamontri, L; Weerasubpong, P; Subchookul, C; Maurer, M				Kulthanan, Kanokvalai; Hunnangkul, Saowalak; Tuchinda, Papapit; Chularojanamontri, Leena; Weerasubpong, Puncharas; Subchookul, Chanika; Maurer, Marcus			Treatments of cold urticaria: A systematic review	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Cold urticaria; meta-analysis; systematic review; treatment; efficacy; safety; antihistamines; omalizumab	TEMPERATURE THRESHOLD MEASUREMENT; CYPROHEPTADINE; OMALIZUMAB; ANTIHISTAMINES; METAANALYSIS; RUPATADINE; KETOTIFEN; SYMPTOMS	Background: Several treatment options for cold urticaria (ColdU) have been studied and reported, but systematic reviews and meta-analyses are limited. Objectives: We sought to meta-analyze and review the efficacy and safety of ColdU treatments. Methods: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. Suitable reports were identified by searching PubMed, Scopus, and Web of Science. Our systematic review included 16 studies, 9 of which met the eligibility criteria for the meta-analysis. We analyzed the effects of treatments on critical temperature thresholds (CTTs) and critical stimulation time thresholds (CSTTs), as well as on rates of complete response and adverse events. Results: Our pooled meta-analyses showed that nonsedating second-generation H1-antihistamines (nsAHs) are effective in the treatment of ColdU and that updosing of nsAHs significantly reduced CTTs relative to their own standard doses and placebos. In 4 studies involving CSTTs, updosing of nsAHs also resulted in significantly better CSTTs than their own standard doses or placebos. Omalizumab resulted in a marked reduction of CTTs in H1-antihistamine-resistant patients. Of 118 adverse events in 8 studies, standard-dose nsAHs, updosed nsAHs, and omalizumab produced lower numbers of adverse events than first-generation antihistamines. Conclusions: Our study showed that greater dosages of nsAHs were more effective than standard dosages in controlling ColdU symptoms. Increasing the dosages was not significantly associated with higher adverse event rates. Omalizumab at 150 and 300 mg every 4 weeks was shown to be effective for patients with ColdU refractory to antihistamines.	[Kulthanan, Kanokvalai; Tuchinda, Papapit; Chularojanamontri, Leena; Weerasubpong, Puncharas; Subchookul, Chanika] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Dermatol, Bangkok, Thailand; [Hunnangkul, Saowalak] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, 2 Wanglang Rd, Bangkok 10700, Thailand; [Maurer, Marcus] Charite Univ Med Berlin, Dept Dermatol & Allergy, Charitepl 1, D-10117 Berlin, Germany	Mahidol University; Mahidol University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hunnangkul, S (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, 2 Wanglang Rd, Bangkok 10700, Thailand.; Maurer, M (corresponding author), Charite Univ Med Berlin, Dept Dermatol & Allergy, Charitepl 1, D-10117 Berlin, Germany.	s_hunnangkul@hotmail.com; Marcus.Maurer@charite.de	Maurer, Marcus/ABG-2174-2020	Maurer, Marcus/0000-0002-4121-481X; Kulthanan, Kanokvalai/0000-0002-7618-821X				Abajian M, 2016, ACTA DERM-VENEREOL, V96, P56, DOI 10.2340/00015555-2150; BLACK AK, 1981, BRIT J CLIN PHARMACO, V12, P327, DOI 10.1111/j.1365-2125.1981.tb01221.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dubertret L, 2003, J AM ACAD DERMATOL, V48, P578, DOI 10.1067/mjd.2003.144; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gorczyza M, 2017, BRIT J DERMATOL, V176, P259, DOI 10.1111/bjd.14820; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; HOUSER DD, 1970, AM J MED, V49, P23, DOI 10.1016/S0002-9343(70)80110-3; Krause K, 2013, ALLERGY, V68, P921, DOI 10.1111/all.12171; Magerl M, 2007, ALLERGY, V62, P1465, DOI 10.1111/j.1398-9995.2007.01500.x; Magerl M, 2016, ALLERGY, V71, P780, DOI 10.1111/all.12884; Magerl M, 2015, J EUR ACAD DERMATOL, V29, P2043, DOI 10.1111/jdv.12739; Magerl M, 2012, BRIT J DERMATOL, V166, P1095, DOI 10.1111/j.1365-2133.2012.10822.x; MARTINEZ FV, 1992, J INVEST ALLERG CLIN, V2, P258; Maurer M, 2018, J ALLERGY CLIN IMMUN, V141, P638, DOI 10.1016/j.jaci.2017.06.032; Maurer M, 2017, J ALLERGY CLIN IMMUN, V140, P870, DOI 10.1016/j.jaci.2017.01.042; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Metz M, 2017, J ALLERGY CLIN IMMUN, V140, P864, DOI 10.1016/j.jaci.2017.01.043; Metz M, 2010, ANN ALLERG ASTHMA IM, V104, P86, DOI 10.1016/j.anai.2009.11.013; NEITTAANMAKI H, 1984, J AM ACAD DERMATOL, V11, P483, DOI 10.1016/S0190-9622(84)70196-4; NEITTAANMAKI H, 1988, DERMATOLOGICA, V177, P98, DOI 10.1159/000248523; Saini S, 2011, J ALLERGY CLIN IMMUN, V128, P567, DOI 10.1016/j.jaci.2011.06.010; Siebenhaar F, 2007, CLIN EXP DERMATOL, V32, P241, DOI 10.1111/j.1365-2230.2007.02376.x; Siebenhaar F, 2004, J ALLERGY CLIN IMMUN, V114, P1224, DOI 10.1016/j.jaci.2004.07.018; Siebenhaar F, 2009, J ALLERGY CLIN IMMUN, V123, P672, DOI 10.1016/j.jaci.2008.12.008; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; STPIERRE JP, 1985, ANN ALLERGY, V55, P840; VISITSUNTHORN N, 1995, ASIAN PAC J ALLERGY, V13, P29; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001; WANDERER AA, 1977, ARCH DERMATOL, V113, P1375, DOI 10.1001/archderm.113.10.1375; WANDERER AA, 1990, J ALLERGY CLIN IMMUN, V85, P965, DOI 10.1016/0091-6749(90)90037-5; Weinstein ME, 2010, ANN ALLERG ASTHMA IM, V104, P518, DOI 10.1016/j.anai.2010.04.002; Zhao ZT, 2016, J ALLERGY CLIN IMMUN, V137, P1742, DOI 10.1016/j.jaci.2015.12.1342	34	14	15	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1311	1331		10.1016/j.jaci.2019.02.005	http://dx.doi.org/10.1016/j.jaci.2019.02.005			21	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30776418	Bronze			2022-12-18	WOS:000463348900005
J	Mahlaoui, N; Picard, C; Bach, P; Costes, L; Courteille, V; Ranohavimparany, A; Alcais, A; Jais, JP; Fischer, A; Bellanne-Chantelot, C; Bustamante, J; Chollet-Martin, S; Drouet, C; Fremeaux-Bacchi, V; Kannen-Giesser, C; Girardin, V; Lambert, N; Proulle, V; Rosain, J; Stasia, MJ; Lyonnet, DS; Theodorou, I; Abou-Chahla, W; Adoue, D; Aladjidi, N; Amoura, Z; Armari-Alla, C; Bader-Meunier, B; Barlogis, V; Bayart, S; Bertrand, Y; Blanche, S; Bodet, D; Bonnotte, B; Borie, R; Boutard, P; Briandet, C; Brion, JP; Brouard, J; Carausu, L; Catherinot, E; Cheikh, N; Cohen-Beaussant, S; Couderc, LJ; Cougoul, P; Couillault, G; de Saint Basile, G; Devoldere, C; Deville, A; Dore, E; Dulieu, F; Durieu, I; Werle, NE; Fieschi, C; Fouyssac, F; Frange, P; Gajdos, V; Galicier, L; Gandemer, V; Gardembas, M; Gaud, C; Grosbois, B; Guffroy, A; Guitton, C; Guillerm, G; Hachulla, E; Hamidou, M; Haro, S; Hatchuel, Y; Hermine, O; Hoarau, C; Hoen, B; Hot, A; Humbert, S; Jaccard, A; Jacquot, S; Jaussaud, R; Jeandel, PY; Jeziorski, E; Kebaili, K; Korganow, AS; Lambotte, O; Lanternier, F; Larroche, C; Le Quellec, A; Le Moigne, E; Le Moing, V; Launay, D; Lebranchu, Y; Lecuit, M; Lefevre, G; Lemal, R; Li-Thiao-Te, V; Lortholary, O; Malphettes, M; Marie-Cardine, A; Silva, NM; Masseau, A; Massot, C; Mazingue, F; Merlin, E; Michel, G; Millot, F; Monlibert, B; Monpoux, F; Moshous, D; Mouthon, L; Munzer, M; Neven, B; Nove-Josserand, R; Nouar, D; Oksenhendler, E; Ouachee-Chardin, M; Pagnier, A; Pasquet, M; Pellier, I; Perel, Y; Perlat, A; Piguet, C; Plantaz, D; Quartier, P; Rieux-Laucat, F; Roblot, P; Rohrlich, PS; Royer, B; Salle, V; Sarrot-Reynauld, F; Servettaz, A; Stephan, JL; Schleinitz, N; Suarez, F; Swiader, L; Taque, S; Thomas, C; Tournilhac, O; Thumerelle, C; Vannier, JP; Viallard, JF				Mahlaoui, Nizar; Picard, Capucine; Bach, Perrine; Costes, Laurence; Courteille, Virginie; Ranohavimparany, Anja; Alcais, Alexandre; Jais, Jean-Philippe; Fischer, Alain; Bellanne-Chantelot, Christine; Bustamante, Jacinta; Chollet-Martin, Sylvie; Drouet, Christian; Fremeaux-Bacchi, Veronique; Kannen-Giesser, Caroline; Girardin, Virginie; Lambert, Nathalie; Proulle, Valerie; Rosain, Jeremie; Stasia, Marie Jose; Lyonnet, Dominique Stoppa; Theodorou, Ioannis; Abou-Chahla, Wadih; Adoue, Daniel; Aladjidi, Nathalie; Amoura, Zahir; Armari-Alla, Corinne; Bader-Meunier, Brigitte; Barlogis, Vincent; Bayart, Sophie; Bertrand, Yves; Blanche, Stephane; Bodet, Damien; Bonnotte, Bernard; Borie, Raphael; Boutard, Patrick; Briandet, Claire; Brion, Jean-Paul; Brouard, Jacques; Carausu, Liana; Catherinot, Emilie; Cheikh, Nathalie; Cohen-Beaussant, Sarah; Couderc, Louis-Jean; Cougoul, Pierre; Couillault, Gerard; de Saint Basile, Genevieve; Devoldere, Catherine; Deville, Anne; Dore, Eric; Dulieu, Fabienne; Durieu, Isabelle; Werle, Natacha Entz; Fieschi, Claire; Fouyssac, Fanny; Frange, Pierre; Gajdos, Vincent; Galicier, Lionel; Gandemer, Virginie; Gardembas, Martine; Gaud, Catherine; Grosbois, Bernard; Guffroy, Aurelien; Guitton, Corinne; Guillerm, Gaelle; Hachulla, Eric; Hamidou, Mohamed; Haro, Sophie; Hatchuel, Yves; Hermine, Olivier; Hoarau, Cyrille; Hoen, Bruno; Hot, Arnaud; Humbert, Sebastien; Jaccard, Arnaud; Jacquot, Serge; Jaussaud, Rolland; Jeandel, Pierre-Yves; Jeziorski, Eric; Kebaili, Kamila; Korganow, Anne-Sophie; Lambotte, Olivier; Lanternier, Fanny; Larroche, Claire; Le Quellec, Alain; Le Moigne, Emmanuelle; Le Moing, Vincent; Launay, David; Lebranchu, Yvon; Lecuit, Marc; Lefevre, Guillaume; Lemal, Richard; Li-Thiao-Te, Valerie; Lortholary, Olivier; Malphettes, Marion; Marie-Cardine, Aude; Silva, Nicolas Martin; Masseau, Agathe; Massot, Christian; Mazingue, Francoise; Merlin, Etienne; Michel, Gerard; Millot, Frederic; Monlibert, Beatrice; Monpoux, Fabrice; Moshous, Despina; Mouthon, Luc; Munzer, Martine; Neven, Benedicte; Nove-Josserand, Raphaelle; Nouar, Dalila; Oksenhendler, Eric; Ouachee-Chardin, Marie; Pagnier, Anne; Pasquet, Marlene; Pellier, Isabelle; Perel, Yves; Perlat, Antoinette; Piguet, Christophe; Plantaz, Dominique; Quartier, Pierre; Rieux-Laucat, Frederic; Roblot, Pascal; Rohrlich, Pierre-Simon; Royer, Bruno; Salle, Valery; Sarrot-Reynauld, Francoise; Servettaz, Amelie; Stephan, Jean-Louis; Schleinitz, Nicolas; Suarez, Felipe; Swiader, Laure; Taque, Sophie; Thomas, Caroline; Tournilhac, Olivier; Thumerelle, Caroline; Vannier, Jean-Pierre; Viallard, Jean-Francois		CEREDIH French PID Study Grp	Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INBORN-ERRORS		[Mahlaoui, Nizar; Picard, Capucine; Bach, Perrine; Costes, Laurence; Courteille, Virginie; Ranohavimparany, Anja; Jais, Jean-Philippe; Fischer, Alain] Necker Enfants Malades Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France; [Mahlaoui, Nizar; Picard, Capucine; Fischer, Alain] Necker Enfants Malades Univ Hosp, AP HP, Pediat Immunohaematol & Rheumatol Unit, Paris, France; [Mahlaoui, Nizar; Jais, Jean-Philippe] Necker Enfants Malades Univ Hosp, AP HP, Biostat Unit, Paris, France; [Picard, Capucine] Necker Enfants Malades Univ Hosp, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Mahlaoui, Nizar; Alcais, Alexandre; Jais, Jean-Philippe] Imagine Inst, INSERM UMR 1163, Lab Human Genet Infect Dis, Necker Branch, Paris, France; [Mahlaoui, Nizar; Picard, Capucine; Alcais, Alexandre; Fischer, Alain] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, INSERM UMR 1163, Paris, France; [Fischer, Alain] Coll France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Fischer, A (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, French Natl Reference Ctr Primary Immune Deficien, Paris, France.; Fischer, A (corresponding author), Necker Enfants Malades Univ Hosp, AP HP, Pediat Immunohaematol & Rheumatol Unit, Paris, France.; Fischer, A (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, INSERM UMR 1163, Paris, France.; Fischer, A (corresponding author), Coll France, Paris, France.	alain.fischer@aphp.fr	Jeandel, Pierre-Yves/ABD-6658-2020; Frange, Pierre/O-6311-2017; Bonnotte, Bernard/ABA-2525-2021; Lecuit, Marc/M-4126-2019; Cougoul, Pierre/AGH-1686-2022; MAHLAOUI, Nizar/AAH-6103-2020; Lanternier, Fanny/AAQ-2815-2021; Brouard, Jacques/AAH-3387-2020; Alcais, Alexandre/J-5882-2017; pasquet, marlene/W-8568-2019; DROUET, Christian/J-8775-2019; JAIS, Jean-Philippe/B-2993-2009; Merlin, Etienne/N-8315-2014; Jeziorski, Eric/AAI-3530-2021; Lambotte, Olivier/GRT-0160-2022; Silva, Nicolas Martins da/HDO-6805-2022; DROUET, Christian/AAE-5682-2020; schleinitz, nicolas/AAL-6751-2020; Rieux-Laucat, Frédéric/A-7916-2017; Lecuit, Marc/J-4073-2013; Hermine, Olivier/Q-7072-2018; Moshous, Despina/B-7507-2017	Bonnotte, Bernard/0000-0002-1098-4598; Lecuit, Marc/0000-0002-4491-1063; Cougoul, Pierre/0000-0002-3184-4439; MAHLAOUI, Nizar/0000-0002-0030-8094; Alcais, Alexandre/0000-0002-1012-2226; DROUET, Christian/0000-0003-1318-4278; JAIS, Jean-Philippe/0000-0002-0708-8776; Merlin, Etienne/0000-0001-6527-7893; Jeziorski, Eric/0000-0003-0318-3044; Silva, Nicolas Martins da/0000-0001-8288-3174; DROUET, Christian/0000-0003-1318-4278; schleinitz, nicolas/0000-0001-9449-3392; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Lecuit, Marc/0000-0002-4491-1063; STASIA, Marie jose/0000-0003-4466-4880; Korganow, Anne-Sophie/0000-0002-1664-6311; Moshous, Despina/0000-0001-6719-3693; LE MOIGNE, Emmanuelle/0000-0001-5103-2406; Humbert, Sebastien/0000-0003-0454-0840; Rosain, Jeremie/0000-0002-2822-161X; Guffroy, Aurelien/0000-0003-0615-5305	French Ministry of Health; LFB; GlaxoSmithKline; CSL Behring; Shire; Octapharma; Binding Site; AT-Europe; Trophee Guillaume	French Ministry of Health; LFB; GlaxoSmithKline(GlaxoSmithKline); CSL Behring; Shire; Octapharma; Binding Site; AT-Europe; Trophee Guillaume	The European Society for Immunodeficiencies Online Database was used to collect the study data. The CEREDIH is funded by the French Ministry of Health. It has received additional, unrestricted educational grants from companies (LFB, GlaxoSmithKline, CSL Behring, Shire, Octapharma, and Binding Site) and patient associations (AT-Europe and Trophee Guillaume).	Beaute J, 2010, CLIN IMMUNOL, V135, P264, DOI 10.1016/j.clim.2010.02.021; Dvorak CC, 2019, J ALLERGY CLIN IMMUN, V143, P405, DOI 10.1016/j.jaci.2018.08.027; Mahlaoui N, 2017, J ALLERGY CLIN IMMUN, V140, P1731, DOI 10.1016/j.jaci.2017.06.020; Meyts I, 2016, J ALLERGY CLIN IMMUN, V138, P957, DOI 10.1016/j.jaci.2016.08.003; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Picard C, 2014, EUR J IMMUNOL, V44, P2854, DOI 10.1002/eji.201444669; Stray-Pedersen A, 2017, J ALLERGY CLIN IMMUN, V139, P232, DOI 10.1016/j.jaci.2016.05.042; Wright CF, 2018, NAT REV GENET, V19, P327	9	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1646	+		10.1016/j.jaci.2018.12.994	http://dx.doi.org/10.1016/j.jaci.2018.12.994			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30639347	Bronze			2022-12-18	WOS:000463348900046
J	Weinstein, CLJ; Ryan, N; Shekar, T; Gates, D; Lane, SJ; Agache, I; Nathan, RA				Weinstein, Cindy L. J.; Ryan, Nicholas; Shekar, Tulin; Gates, Davis; Lane, Stephen J.; Agache, Ioana; Nathan, Robert A.		SPIRO Investigators	Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Formoterol; mometasone furoate; long-acting beta-agonists; serious asthma events; asthma exacerbations; persistent asthma	ACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; SAFETY; SALMETEROL; ADHERENCE; ADULTS	Background: The safety of long-acting beta-agonists added to inhaled corticosteroids for the treatment of persistent asthma has been controversial. Objective: We sought to determine whether administering formoterol in combination with mometasone furoate increases the risk of serious asthmaoutcomes (SAOs) comparedwithmometasone furoate alone. This clinical trial is registered as NCT01471340. Methods: We conducteda 26-week, randomized, double-blind trial in adolescent and adult patients (> 12 years) with persistent asthma in 35 countries with the primary objective of evaluating whether mometasone furoate-formoterol increases the risk of SAOs (adjudicated hospitalization, intubation, or death) compared with mometasone furoate alone. The key efficacy end point was asthma exacerbation(composite of hospitalization of> 24 hours, emergency department visits of < 24 hours requiring systemic corticosteroids, or use of systemic corticosteroids for > 3 consecutive days). Results: Among 11,729 patients (mometasone furoateformoterol, n 5 5,868; mometasone furoate, n 5 5,861), a total of 81 SAOs, all asthma-related hospitalizations, were observed in 71 patients: 45 events from 39 patients receiving mometasone furoate-formoterol and 36 events from 32 patients receiving mometasone furoate. The hazard ratio for the first SAO in the mometasone furoate-formoterol versus mometasone furoate group was 1.22 (95% CI, 0.76-1.94; P 5.411). Asthma exacerbation occurred in 1,487 patients: 708 receiving mometasone furoate-formoterol and 779 receiving mometasone furoate. The hazard ratio for the first asthma exacerbation in the mometasone furoate-formoterol versus mometasone furoate group was 0.89 (95% CI, 0.80-0.98; P 5.021). Conclusions: The addition of formoterol to mometasone furoate maintenance therapy did not increase the risk of serious asthma-related events and reduced the risk of asthma exacerbation.	[Weinstein, Cindy L. J.] Merck & Co Inc, Resp & Immunol Clin Dev, Kenilworth, NJ USA; [Ryan, Nicholas] Merck & Co Inc, Clin Sci, Kenilworth, NJ USA; [Shekar, Tulin; Gates, Davis] Merck & Co Inc, Biostat, Kenilworth, NJ USA; [Lane, Stephen J.] Tallaght Hosp, Dublin, Ireland; [Agache, Ioana] Transylvania Univ, Brasov, Romania; [Nathan, Robert A.] Asthma & Allergy Associates & Res Ctr, Colorado Springs, CO USA	Merck & Company; Merck & Company; Merck & Company; Trinity College Dublin; Transylvania University of Brasov	Weinstein, CLJ (corresponding author), 126 East Lincoln Ave, Rahway, NJ 07065 USA.	cindy.l.weinstein@merck.com	Agache, Ioana/AAP-7403-2020		Merck & Co, Inc, Kenilworth, NJ; Merck Co	Merck & Co, Inc, Kenilworth, NJ(Merck & Company); Merck Co(Merck & Company)	This study was funded by Merck & Co, Inc, Kenilworth, NJ. Merck & Co, Inc was involved in the study design; the collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the article for publication.	[Anonymous], 2008, STAT BRIEF PACK JOIN; [Anonymous], 2011, FDA DRUG SAFETY COMM; CASTLE W, 1993, BRIT MED J, V306, P1034, DOI 10.1136/bmj.306.6884.1034; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; Nelson HS, 2009, ANN ALLERG ASTHMA IM, V102, P11, DOI 10.1016/S1081-1206(10)60101-9; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Peters SP, 2016, NEW ENGL J MED, V375, P850, DOI 10.1056/NEJMoa1511190; Sears MR, 2009, EUR RESPIR J, V33, P21, DOI 10.1183/09031936.00145006; Sears MR, 2014, EUR RESPIR J, V43, P103, DOI 10.1183/09031936.00004713; Stempel DA, 2016, NEW ENGL J MED, V375, P840, DOI 10.1056/NEJMoa1606356; Stempel DA, 2016, NEW ENGL J MED, V374, P1822, DOI 10.1056/NEJMoa1511049; Wells K, 2008, AM J RESP CRIT CARE, V178, P1194, DOI 10.1164/rccm.200808-1233OC; Williams LK, 2004, J ALLERGY CLIN IMMUN, V114, P1288, DOI 10.1016/j.jaci.2004.09.028	14	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2019	143	4					1395	1402		10.1016/j.jaci.2018.10.065	http://dx.doi.org/10.1016/j.jaci.2018.10.065			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HR7QE	30537475	Bronze			2022-12-18	WOS:000463348900016
J	Benevides, L; Costa, RS; Tavares, LA; Russo, M; Martins, GA; da Silva, LLP; Arruda, LK; Cunha, FQ; Carregaro, V; Silva, JS				Benevides, Luciana; Costa, Renata Sesti; Tavares, Lucas Alves; Russo, Momtchilo; Martins, Gislaine A.; da Silva, Luis Lamberti P.; Karla Arruda, L.; Cunha, Fernando Q.; Carregaro, Vanessa; Silva, Joao Santana			B lymphocyte-induced maturation protein 1 controls T(H)9 cell development, IL-9 production, and allergic inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergy; Blimp-1; IL-9; T(H)9 differentiation	TRANSCRIPTIONAL REPRESSOR BLIMP-1; T-CELLS; AIRWAY INFLAMMATION; INTERLEUKIN 9; TGF-BETA; EXPRESSION; DIFFERENTIATION; HOMEOSTASIS; RECEPTOR; LUNG	Background: The transcriptional repressor B lymphocyte-induced maturation protein 1 (Blimp-1) has a key role in terminal differentiation in various T-cell subtypes. However, whether Blimp-1 regulates T(H)9 differentiation and its role in allergic inflammation are unknown. Objective: We aimed to investigate the role of Blimp-1 in T(H)9 differentiation and in the pathogenesis of allergic airway inflammation. Methods: In vitro T(H)9 differentiation, flow cytometry, ELISA, and real-time PCR were used to investigate the effects of Blimp-1 on T(H)9 polarization. T cell-specific Blimp-1-deficient mice, a model of allergic airway inflammation, and T-cell adoptive transfer to recombination-activating gene 1 (Rag-1)(-/-) mice were used to address the role of Blimp-1 in the pathogenesis of allergic inflammation. Results: We found that Blimp-1 regulates T(H)9 differentiation because deleting Blimp-1 increased IL-9 production in CD4(+) T cells in vitro. In addition, we showed that in T cell-specific Blimp-1-deficient mice, deletion of Blimp-1 in T cells worsened airway disease, and this worsening was inhibited by IL-9 neutralization. In asthmatic patients CD4(+)1 T cells in response to TGF-beta plus IL-4 increased IL-9 expression and downregulated Blimp-1 expression compared with expression in healthy control subjects. Blimp-1 overexpression in human T(H)9 cells inhibited IL-9 expression. Conclusion: Blimp-1 is a pivotal negative regulator of T(H)9 differentiation and controls allergic inflammation.	[Benevides, Luciana; Costa, Renata Sesti; Carregaro, Vanessa; Silva, Joao Santana] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, Brazil; [Tavares, Lucas Alves; da Silva, Luis Lamberti P.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cellular & Mol Biol, Ribeirao Preto, Brazil; [Cunha, Fernando Q.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, Brazil; [Silva, Joao Santana] Fiocruz Bi Inst Translat Med Platform, Ribeirao Preto, Brazil; [Russo, Momtchilo] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Martins, Gislaine A.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Martins, Gislaine A.] Cedars Sinai Med Ctr, Dept Med & Biomed Sci, Los Angeles, CA 90048 USA; [Karla Arruda, L.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp, Dept Clin Med, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Universidade de Sao Paulo	Silva, JS (corresponding author), Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.	jsdsilva@fmrp.usp.br	Tavares, Lucas Alves/ABG-2503-2020; Silva, Joao/A-4484-2008; Sesti-Costa, Renata/H-9115-2012; Arruda, L. Karla/D-5845-2013; daSilva, Luis LP/AAD-5657-2019; Tavares, Lucas/GQH-4118-2022; Cunha, Fernando Q/M-3090-2014; LP daSilva, Luis/A-9949-2010; Carregaro, Vanessa/D-2913-2012	Tavares, Lucas Alves/0000-0001-7883-1443; Silva, Joao/0000-0002-3410-3927; Sesti-Costa, Renata/0000-0002-7098-2850; Arruda, L. Karla/0000-0002-7505-210X; daSilva, Luis LP/0000-0003-3558-0087; Tavares, Lucas/0000-0001-7883-1443; LP daSilva, Luis/0000-0003-3558-0087; Carregaro, Vanessa/0000-0002-8435-0766; Cunha, Fernando Queiroz/0000-0003-4755-1670	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2013/08216-2, 2012-08240-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [445983/2014-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant 2013/08216-2 [Center for Research in Inflammatory Disease] and grant 2012-08240-8 [scholarship to L.B.]) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grant 445983/2014-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES (a scholarship to L.B.).	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brough HA, 2014, J ALLERGY CLIN IMMUN, V134, P1329, DOI 10.1016/j.jaci.2014.06.032; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Erpenbeck VJ, 2003, J ALLERGY CLIN IMMUN, V111, P1319, DOI 10.1067/mai.2003.1485; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Gounni AS, 2000, BLOOD, V96, P2163; Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Lin MH, 2013, DIABETOLOGIA, V56, P136, DOI 10.1007/s00125-012-2722-y; Louahed J, 2001, BLOOD, V97, P1035, DOI 10.1182/blood.V97.4.1035; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Salehi S, 2012, J IMMUNOL, V189, P5682, DOI 10.4049/jimmunol.1201966; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang L, 2008, J IMMUNOL, V181, P5249, DOI 10.4049/jimmunol.181.8.5249; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	42	14	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2019	143	3					1119	+		10.1016/j.jaci.2018.06.046	http://dx.doi.org/10.1016/j.jaci.2018.06.046			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HN6CQ	30096391	Green Accepted, Bronze			2022-12-18	WOS:000460272900032
J	Ravi, A; Koster, J; Dijkhuis, A; Bal, SM; Pineros, YSS; Bonta, PI; Majoor, CJ; Sterk, PJ; Lutter, RE				Ravi, Abilash; Koster, Jan; Dijkhuis, Annemiek; Bal, Suzanne M.; Pineros, Yanaika S. Sabogal; Bonta, Peter I.; Majoor, Christof J.; Sterk, Peter J.; Lutter, Ren E.			Interferon-induced epithelial response to rhinovirus 16 in asthma relates to inflammation and FEV1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							TYPE-2 INFLAMMATION; IFN-GAMMA; INFECTION; DEFICIENT; CELLS		[Ravi, Abilash; Dijkhuis, Annemiek; Bal, Suzanne M.; Pineros, Yanaika S. Sabogal; Lutter, Ren E.] Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Dept Oncogen, Amsterdam UMC, Amsterdam, Netherlands; [Ravi, Abilash; Bal, Suzanne M.; Pineros, Yanaika S. Sabogal; Bonta, Peter I.; Majoor, Christof J.; Sterk, Peter J.; Lutter, Ren E.] Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Ravi, A (corresponding author), Univ Amsterdam, Dept Resp Med, Amsterdam UMC, Amsterdam, Netherlands.; Ravi, A (corresponding author), Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam, Netherlands.	a.ravi@amc.nl; r.lutter@amc.nl	Koster, Jan/C-5934-2008; Sabogal, Yanaika/AAZ-5125-2020; Sterk, P.J./AAK-8175-2020	Koster, Jan/0000-0002-0890-7585; Sabogal, Yanaika/0000-0001-7824-9058; Bonta, Peter/0000-0002-0429-4988; Majoor, Christof/0000-0003-2677-9684	Stichting Astma Bestrijding [2013_009]; Lung Foundation [3.2.10.069, 3.2.07.012, 3.2.06.031]; GlaxoSmithKline [CRT 114696]	Stichting Astma Bestrijding; Lung Foundation; GlaxoSmithKline(GlaxoSmithKline)	Supported by the Stichting Astma Bestrijding (project 2013_009) and Netherlands Asthma Foundation (currently Lung Foundation; projects 3.2.10.069, 3.2.07.012, and 3.2.06.031) and GlaxoSmithKline (CRT 114696).	Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Boorsma Martin, 2007, COPD, V4, P321, DOI 10.1080/15412550701597720; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Hansel TT, 2017, EBIOMEDICINE, V19, P128, DOI 10.1016/j.ebiom.2017.03.033; Hoogerwerf JJ, 2009, CRIT CARE MED, V37, P619, DOI 10.1097/CCM.0b013e31819584f9; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Rijssenbeek-Nouwens LH, 2012, EUR RESPIR J, V40, P1374, DOI 10.1183/09031936.00195211; STERK PJ, 1993, EUR RESPIR J, V6, P53, DOI 10.1183/09041950.053s1693; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; van der Sluijs KF, 2013, THORAX, V68, P1122, DOI 10.1136/thoraxjnl-2013-203728; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104	15	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2019	143	1					442	+		10.1016/j.jaci.2018.09.016	http://dx.doi.org/10.1016/j.jaci.2018.09.016			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HG4BD	30296526	Bronze			2022-12-18	WOS:000454918300058
J	Janssen, WJM; Grobarova, V; Leleux, J; Jongeneel, L; van Gijn, M; van Montfrans, JM; Boes, M				Janssen, Willemijn J. M.; Grobarova, Valeria; Leleux, Jardin; Jongeneel, Lieneke; van Gijn, Marielle; van Montfrans, Joris M.; Boes, Marianne			Proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) controls immune synapse stability in human T cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Common variable immunodeficiency; CD2; proline-serine-threonine phosphatase interacting protein 1; T cells; F-actin; immune synapse	COMMON VARIABLE IMMUNODEFICIENCY; PAPA SYNDROME; PTP-PEST; PYODERMA-GANGRENOSUM; TYROSINE-PHOSPHATASE; PYOGENIC ARTHRITIS; RECEPTOR; CD2; REPERTOIRE; ACTIVATION	Background: Proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1) is a cytosolic adaptor protein involved with T-cell activation, differentiation, and migration. On cognate T-cell contact, PSTPIP1 is recruited to surface-expressed CD2, where it regulates F-actin remodeling. An immune synapse (IS) is thereby rapidly formed, consisting of T-cell receptor clusters surrounded by a ring of adhesion molecules, including CD2. Objective: From genetic screening of patients with primary immunodeficiencies, we identified 2 mutations in PSTPIP1, R228C and T274M, which we further characterized in the primary patients' T cells. Methods: F-actin dynamics were assessed in primary T cells from the patients and control subjects by using fluorescence-activated cell sorting. HEK293T and Jurkat cells were transfected with R228C, T274M, and wild-type PSTPIP1 to visualize F-actin in IS formation. CD2-PSTPIP1 association was quantified through immunoprecipitation assays. Results: The patients presented with immunodeficiency without signs of autoinflammation. The patient with the R228C mutation had expansion of mostly naive phenotype T cells and few memory T cells; the patient with the T274M mutation had 75% reduction in CD4 T cells that were predominantly of the memory subset. We observed F-actin polymerization defects in T cells from both patients with PSTPIP1, most notably the patient with the T274M mutation. Capping of CD2-containing membrane microdomains was disrupted. Analysis of IS formation using Jurkat T-cell transfectants revealed a reduction in F-actin accumulation at the IS, again especially in cells from the patient with the T274M PSTPIP1 mutation. T cells from the patient with the T274M mutation migrated spontaneously at increased speed, as assessed in a 3-dimensional collagen matrix, whereas T-cell receptor cross-linking induced a significantly diminished calcium flux. Conclusions: We propose that PSTPIP1 T-cell differentiation defects are caused by defective control of F-actin polymerization. A preactivated polymerized F-actin status, as seen in T cells from patients with the PSTPIP1 T274M mutation, appears particularly damaging. PSTPIP1 controls IS formation and cell adhesion through its function as an orchestrator of the F-actin cytoskeleton.	[Janssen, Willemijn J. M.; Leleux, Jardin; Jongeneel, Lieneke; van Montfrans, Joris M.; Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Lundlaan 7, Utrecht, Netherlands; [Janssen, Willemijn J. M.; Leleux, Jardin; Jongeneel, Lieneke; van Gijn, Marielle; van Montfrans, Joris M.; Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol, Lundlaan 7, Utrecht, Netherlands; [van Gijn, Marielle] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Med Genet, Utrecht, Netherlands; [Grobarova, Valeria] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Charles University Prague	Boes, M (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Lundlaan 7, Utrecht, Netherlands.; Boes, M (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol, Lundlaan 7, Utrecht, Netherlands.	mboes@umcutrecht.nl		, Marianne/0000-0003-3748-8137; Boes, Marianne/0000-0003-2590-1692	Baxalta B.V.	Baxalta B.V.	Supported by an unrestricted grant from Baxalta B.V.	Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Boncristiano M, 2000, EUR J IMMUNOL, V30, P2632, DOI 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO;2-C; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Janssen WJM, 2016, CLIN IMMUNOL, V164, P34, DOI 10.1016/j.clim.2016.01.009; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Lindwall E, 2015, SEMIN ARTHRITIS RHEU, V45, P91, DOI 10.1016/j.semarthrit.2015.02.012; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Paccani SR, 2005, BLOOD, V106, P626, DOI 10.1182/blood-2004-05-2051; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Ramesh M, 2017, CLIN IMMUNOL, V178, P1, DOI 10.1016/j.clim.2015.01.002; ROEDERER M, 1995, CYTOMETRY, V21, P187, DOI 10.1002/cyto.990210211; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032; Schuetz C, 2010, AUTOIMMUN REV, V9, P477, DOI 10.1016/j.autrev.2010.02.005; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Smith EJ, 2010, CURR GENOMICS, V11, P519, DOI 10.2174/138920210793175921; Starnes TW, 2014, BLOOD, V123, P2703, DOI 10.1182/blood-2013-07-516948; Wang DH, 2013, J BIOL CHEM, V288, P4594, DOI 10.1074/jbc.M112.443077; Warnatz K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00210; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wong GK, 2016, J IMMUNOL, V197, P1642, DOI 10.4049/jimmunol.1600526; Yang HL, 2006, J IMMUNOL, V176, P5898, DOI 10.4049/jimmunol.176.10.5898	32	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1947	1955		10.1016/j.jaci.2018.01.030	http://dx.doi.org/10.1016/j.jaci.2018.01.030			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29432774	Bronze			2022-12-18	WOS:000452315800027
J	Kennedy, K; Heimall, J; Spergel, JM				Kennedy, Katie; Heimall, Jennifer; Spergel, Jonathan M.			Advances in atopic dermatitis in 2017	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Atopic dermatitis; eczema; microbiome; transcriptome; biologics	STROMAL LYMPHOPOIETIN VARIATION; SKIN BARRIER; FILAGGRIN LOSS; MICROBIOME; PREVENT; SAFETY; ECZEMA; RISK; COLONIZATION; PREVALENCE	This review encompasses relevant scientific and clinical advances in atopic dermatitis (AD) published in 2017. These include articles from the Journal of Allergy and Clinical Immunology, as well as other prominent publications that have contributed to the emerging field, on the microenvironment of the skin and molecular patterns guiding biologic treatment strategies. The most commonly questioned and explored themes of the year included the effect of the microbiome on AD development, as well as cell signaling and symptom severity. Topics also included the description of patient-specific molecular endotypes within the larger population with AD. All of these factors will create potential opportunities to guide personalized therapy with the broadening array of topical and systemic interventions currently available, as well as providing new insights to guide the development of novel molecularly targeted therapeutics. With recent US Food and Drug Administration approval of the first wave of new targeted therapies for AD, additional information exploring the safety profiles and long-term effects of these medications was also at the forefront in 2017.	[Kennedy, Katie; Heimall, Jennifer; Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy Immunol, Philadelphia, PA 19104 USA; [Heimall, Jennifer; Spergel, Jonathan M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Kennedy, K (corresponding author), 3500 Civ Ctr Blvd,6th Floor, Philadelphia, PA 19104 USA.	kennedyk3@email.chop.edu						Avershina E, 2017, J ALLERGY CLIN IMMUN, V139, P1399, DOI 10.1016/j.jaci.2016.09.056; Bandier J, 2014, DERMATITIS, V25, P127, DOI 10.1097/DER.0000000000000045; Blauvelt A, 2017, LANCET, V389, P2287, DOI 10.1016/S0140-6736(17)31191-1; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Chang J, 2017, JAMA DERMATOL, V153, P275, DOI 10.1001/jamadermatol.2016.4467; Chopra R, 2017, J ALLERGY CLIN IMMUN, V140, P1708, DOI 10.1016/j.jaci.2017.04.052; Czarnowicki T, 2017, J ALLERGY CLIN IMMUN, V140, P134, DOI 10.1016/j.jaci.2016.09.060; Czarnowicki T, 2017, J ALLERGY CLIN IMMUN, V139, P1723, DOI 10.1016/j.jaci.2017.04.004; Egawa G, 2016, J ALLERGY CLIN IMMUN, V138, P350, DOI 10.1016/j.jaci.2016.06.002; Eichenfield LF, 2017, J AM ACAD DERMATOL, V77, P641, DOI 10.1016/j.jaad.2017.06.010; Elias MS, 2017, J ALLERGY CLIN IMMUN, V140, P1299, DOI 10.1016/j.jaci.2017.01.039; Engebretsen KA, 2017, J ALLERGY CLIN IMMUN, V139, P1568, DOI 10.1016/j.jaci.2016.11.021; Floudas A, 2017, J IMMUNOL, V199, P707, DOI 10.4049/jimmunol.1602185; Gehring U, 2001, J ALLERGY CLIN IMMUN, V108, P847, DOI 10.1067/mai.2001.119026; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Guttman-Yassky E, 2017, J ALLERGY CLIN IMMUN, V140, P1032, DOI 10.1016/j.jaci.2017.01.027; Han Y, 2017, J ALLERGY CLIN IMMUN, V140, P888, DOI 10.1016/j.jaci.2017.04.015; Ishii N, 2013, J PHARMACOL EXP THER, V346, P105, DOI 10.1124/jpet.113.205542; Jain M, 2017, INT J CLIN PHARM TH, V55, P606, DOI 10.5414/CP203023; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; Johansson EK, 2017, J ALLERGY CLIN IMMUN, V140, P1572, DOI 10.1016/j.jaci.2017.04.008; Kalhan TA, 2017, J ALLERGY CLIN IMMUN, V139, P2000, DOI 10.1016/j.jaci.2016.10.038; Kawakami Y, 2017, J ALLERGY CLIN IMMUN, V139, P997, DOI 10.1016/j.jaci.2016.06.034; Kelleher M, 2015, J ALLERGY CLIN IMMUN, V135, P930, DOI 10.1016/j.jaci.2014.12.013; Kelleher MM, 2016, J ALLERGY CLIN IMMUN, V137, P1111, DOI 10.1016/j.jaci.2015.12.1312; Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029; Khattri S, 2017, EXP DERMATOL, V26, P28, DOI 10.1111/exd.13112; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Kritas SK, 2013, INT J IMMUNOPATH PH, V26, P855, DOI 10.1177/039463201302600403; Langan SM, 2017, J ALLERGY CLIN IMMUN, V140, P1580, DOI 10.1016/j.jaci.2017.02.043; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Margolis DJ, 2014, JAMA DERMATOL, V150, P254, DOI 10.1001/jamadermatol.2013.7954; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Paller AS, 2017, J ALLERGY CLIN IMMUN, V139, P152, DOI 10.1016/j.jaci.2016.07.019; Powers CE, 2015, J DERMATOL, V42, P1137, DOI 10.1111/1346-8138.13072; Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490; Saeki H, 2017, BRIT J DERMATOL, V177, P419, DOI 10.1111/bjd.15493; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sehra S, 2010, J IMMUNOL, V184, P3186, DOI 10.4049/jimmunol.0901860; Serezani APM, 2017, J ALLERGY CLIN IMMUN, V139, P142, DOI 10.1016/j.jaci.2016.07.012; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Thijs JL, 2017, J ALLERGY CLIN IMMUN, V140, P730, DOI 10.1016/j.jaci.2017.03.023; Totte J, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2118-x; Uong P, 2017, J ALLER CL IMM-PRACT, V5, P1782, DOI 10.1016/j.jaip.2017.03.039; Vakharia PP, 2017, ANN ALLERG ASTHMA IM, V119, P548, DOI 10.1016/j.anai.2017.09.076; Wadonda-Kabondo N, 2003, BRIT J DERMATOL, V149, P1023, DOI 10.1111/j.1365-2133.2003.05605.x; Wang ZP, 2017, J ALLERGY CLIN IMMUN, V139, P1205, DOI 10.1016/j.jaci.2016.09.019; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Williams MR, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-015-0567-4; Wollenberg A, 2017, J ALLERGY CLIN IMMUN, V138, pAB20; Zeeuwen PLJM, 2013, CURR OPIN ALLERGY CL, V13, P514, DOI 10.1097/ACI.0b013e328364ebeb; Zhu YN, 2017, J ALLERGY CLIN IMMUN, V140, P1310, DOI 10.1016/j.jaci.2017.01.025	53	14	15	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1740	1747		10.1016/j.jaci.2018.10.012	http://dx.doi.org/10.1016/j.jaci.2018.10.012			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	30359683				2022-12-18	WOS:000452315800006
J	Zeng, C; Vanoni, S; Wu, D; Caldwell, JM; Wheeler, JC; Arora, K; Noah, TK; Waggoner, L; Besse, JA; Yamani, AN; Uddin, J; Rochman, M; Wen, T; Chehade, M; Collins, MH; Mukkada, VA; Putnam, PE; Naren, AP; Rothenberg, ME; Hogan, SP				Zeng, Chang; Vanoni, Simone; Wu, David; Caldwell, Julie M.; Wheeler, Justin C.; Arora, Kavisha; Noah, Taeko K.; Waggoner, Lisa; Besse, John A.; Yamani, Amnah N.; Uddin, Jazib; Rochman, Mark; Wen, Ting; Chehade, Mirna; Collins, Margaret H.; Mukkada, Vincent A.; Putnam, Philip E.; Naren, Anjaparavanda P.; Rothenberg, Marc E.; Hogan, Simon P.			Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Solute carrier family 9; subfamily A; member 3/sodium-hydrogen exchanger member 3; ion transport; eosinophilic esophagitis; dilated intercellular spaces; IL-13	NONEROSIVE REFLUX DISEASE; INTRACELLULAR PH; GROWTH-FACTOR; GENE-EXPRESSION; GASTROESOPHAGEAL-REFLUX; IL-13; CHILDREN; EPIDEMIOLOGY; INVOLVEMENT; ISOFORM	Background: Eosinophilic esophagitis (EoE) is characterized by histopathologic modifications of esophageal tissue, including eosinophil-rich inflammation, basal zone hyperplasia, and dilated intercellular spaces (DIS). The underlying molecular processes that drive the histopathologic features of EoE remain largely unexplored. Objective: We sought to investigate the involvement of solute carrier family 9, subfamily A, member 3 (SLC9A3) in esophageal epithelial intracellular pH (pH(i)) and DIS formation and the histopathologic features of EoE. Methods: We examined expression of esophageal epithelial gene networks associated with regulation of pH(i) in the EoE transcriptome of primary esophageal epithelial cells and an in vitro esophageal epithelial 3-dimensional model system (EPC2-ALI). Molecular and cellular analyses and ion transport assays were used to evaluate the expression and function of SLC9A3. Results: We identified altered expression of gene networks associated with regulation of pH(i) and acid-protective mechanisms in esophageal biopsy specimens from pediatric patients with EoE (healthy subjects, n = 6; patients with EoE, n = 10). The most dysregulated gene central to regulating pHi was SLC9A3. SLC9A3 expression was increased within the basal layer of esophageal biopsy specimens from patients with EoE, and expression positively correlated with disease severity (eosinophils/high-power field) and DIS (healthy subjects, n = 10; patients with EoE, n = 10). Analyses of esophageal epithelial cells revealed IL-13-induced, signal transducer and activator of transcription 6-dependent SLC9A3 expression and Na+-dependent proton secretion and that SLC9A3 activity correlated positively with DIS formation. Finally, we showed that IL-13-mediated, Na+-dependent proton secretion was the primary intracellular acid-protective mechanism within the esophageal epithelium and that blockade of SLC9A3 transport abrogated IL-13-induced DIS formation. Conclusions: SLC9A3 plays a functional role in DIS formation, and pharmacologic interventions targeting SLC9A3 function may suppress the histopathologic manifestations in patients with EoE.	[Zeng, Chang; Vanoni, Simone; Wu, David; Caldwell, Julie M.; Noah, Taeko K.; Waggoner, Lisa; Besse, John A.; Yamani, Amnah N.; Uddin, Jazib; Rochman, Mark; Wen, Ting; Rothenberg, Marc E.; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Arora, Kavisha; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Wheeler, Justin C.; Collins, Margaret H.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Mukkada, Vincent A.; Putnam, Philip E.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Nutr & Hepatol, Cincinnati, OH 45229 USA; [Vanoni, Simone] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria; [Chehade, Mirna] Icahn Sch Med Mt Sinai, Jaffe Food Allergy Inst, Mt Sinai Ctr Eosinophil Disorders, New York, NY 10029 USA; [Hogan, Simon P.] Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Paracelsus Private Medical University; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, 109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu	Mukkada, Vincent/AAF-6995-2019; Vanoni, Simone/AAJ-8108-2020	Mukkada, Vincent/0000-0003-4225-5506; Vanoni, Simone/0000-0002-4464-2959; Besse, John/0000-0002-9874-5822	National Institutes of Health [DK090119, AI112626]; Food Allergy Research Education; Crohn's Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, R01DK080834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Research Education; Crohn's Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health grants DK090119 and AI112626, Food Allergy Research & Education, and the Crohn's Colitis Foundation of America (to S.P.H.).	Abu-Sultaneh SMA, 2011, DIGEST DIS SCI, V56, P97, DOI 10.1007/s10620-010-1259-5; Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Amin MR, 2006, AM J PHYSIOL-CELL PH, V291, pC887, DOI 10.1152/ajpcell.00630.2005; Arias A, 2016, ALIMENT PHARM THER, V43, P3, DOI 10.1111/apt.13441; Arora AS, 2003, MAYO CLIN PROC, V78, P830, DOI 10.4065/78.7.830; Barlow WJ, 2005, GASTROENTEROLOGY, V128, P771, DOI 10.1053/j.gastro.2004.08.014; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, pe1; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; Caviglia R, 2005, AM J GASTROENTEROL, V100, P543, DOI 10.1111/j.1572-0241.2005.40978.x; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Clayburgh DR, 2006, J CLIN INVEST, V116, P2682, DOI 10.1172/JCI29218; Collins MH, 2017, DIS ESOPHAGUS, V30, DOI 10.1111/dote.12470; Collins Margaret H, 2008, Gastrointest Endosc Clin N Am, V18, P59, DOI 10.1016/j.giec.2007.09.014; Collins MH, 2014, DIGEST DIS, V32, P68, DOI 10.1159/000357012; D'Mello RJ, 2016, MUCOSAL IMMUNOL, V9, P744, DOI 10.1038/mi.2015.98; Davis BP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86355; Dellon ES, 2018, GASTROENTEROLOGY, V154, P319, DOI 10.1053/j.gastro.2017.06.067; Dellon ES, 2014, GASTROENTEROL CLIN N, V43, P201, DOI 10.1016/j.gtc.2014.02.002; Di Sario A, 2001, J HEPATOL, V34, P378, DOI 10.1016/S0168-8278(00)00062-3; Doherty TA, 2015, J ALLERGY CLIN IMMUN, V136, P792, DOI 10.1016/j.jaci.2015.05.048; Faubion WA, 1998, J PEDIATR GASTR NUTR, V27, P90, DOI 10.1097/00005176-199807000-00016; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Harada H, 2003, MOL CANCER RES, V1, P729; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Kartashov AV, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0720-3; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; Klinnert MD, 2014, J PEDIATR GASTR NUTR, V59, P308, DOI 10.1097/MPG.0000000000000451; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LI M, 1991, ENDOCRINOLOGY, V129, P656, DOI 10.1210/endo-129-2-656; Liacouras CA, 2004, CURR OPIN PEDIATR, V16, P560, DOI 10.1097/01.mop.0000141071.47572.eb; Liacouras CA, 1998, J PEDIATR GASTR NUTR, V26, P380, DOI 10.1097/00005176-199804000-00004; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00116; Malakooti J, 2006, BIOCHEM J, V396, P327, DOI 10.1042/BJ20051391; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; MOOLENAAR WH, 1986, J EXP BIOL, V124, P359; Mueller S, 2008, HISTOPATHOLOGY, V53, P676, DOI 10.1111/j.1365-2559.2008.03187.x; Noffsinger AE, 2009, ARCH PATHOL LAB MED, V133, P1087, DOI 10.1043/1543-2165-133.7.1087; Orlando Lori A, 2009, Curr Gastroenterol Rep, V11, P190; Orlando R., 2006, GI MOTILITY ONLINE, DOI [10.1038/gimo15., DOI 10.1038/GIMO15]; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; Praetorius J, 2000, AM J PHYSIOL-GASTR L, V278, pG197, DOI 10.1152/ajpgi.2000.278.2.G197; Prasad GA, 2009, CLIN GASTROENTEROL H, V7, P1055, DOI 10.1016/j.cgh.2009.06.023; Purdy JK, 2008, AM J CLIN PATHOL, V130, P508, DOI 10.1309/D3PCF6D6YYMQRX9A; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; Ravelli A, 2014, J PEDIATR GASTR NUTR, V59, P589, DOI 10.1097/MPG.0000000000000491; Rochman M, 2015, MUCOSAL IMMUNOL, V8, P785, DOI 10.1038/mi.2014.109; RODRIGO J, 1975, ACTA ANAT, V92, P242; Rothenberg ME, 2015, J ALLERGY CLIN IMMUN, V135, P500, DOI 10.1016/j.jaci.2014.07.049; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; Schreiber R, 2005, J MEMBRANE BIOL, V205, P129, DOI 10.1007/s00232-005-0778-z; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Schwark JR, 1998, PFLUG ARCH EUR J PHY, V436, P797, DOI 10.1007/s004240050704; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Shrode LD, 1997, J BIOENERG BIOMEMBR, V29, P393, DOI 10.1023/A:1022407116339; Spencer AG, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007790; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Su HW, 2009, AM J PHYSIOL-CELL PH, V296, pC13, DOI 10.1152/ajpcell.00263.2008; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Tobey NA, 2008, DIS ESOPHAGUS, V21, P757, DOI 10.1111/j.1442-2050.2008.00841.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VAIRO G, 1992, J BIOL CHEM, V267, P19043; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; WANG Z, 1993, J BIOL CHEM, V268, P11925; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	73	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2018	142	6					1843	1855		10.1016/j.jaci.2018.03.017	http://dx.doi.org/10.1016/j.jaci.2018.03.017			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	HD2BJ	29729938	Green Accepted, Bronze			2022-12-18	WOS:000452315800019
J	Cervantes-Luevano, KE; Caronni, N; Castiello, MC; Fontana, E; Piperno, GM; Naseem, A; Uva, P; Bosticardo, M; Marcovecchio, GE; Notarangelo, LD; Cicalese, MP; Aiuti, A; Villa, A; Benvenuti, F				Cervantes-Luevano, Karla E.; Caronni, Nicoletta; Castiello, Maria C.; Fontana, Elena; Piperno, Giulia M.; Naseem, Asma; Uva, Paolo; Bosticardo, Marita; Marcovecchio, Genni E.; Notarangelo, Luigi D.; Cicalese, Maria P.; Aiuti, Alessandro; Villa, Anna; Benvenuti, Federica			Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Neutrophil extracellular traps; Wiskott-Aldrich syndrome; type I interferon; autoimmunity	SYNDROME PROTEIN-DEFICIENCY; B-CELL COMPARTMENT; EXTRACELLULAR TRAPS; NETTING NEUTROPHILS; ACTIN DYNAMICS; BONE-MARROW; WASP; GRANULOPOIESIS; PHAGOCYTOSIS; HOMEOSTASIS	Background: Wiskott-Aldrich syndrome (WAS) is a rare primary immunodeficiency caused by mutations in Wiskott-Aldrich syndrome protein (WASp), a key regulator of cytoskeletal dynamics in hematopoietic cells. A high proportion of patients experience autoimmunity caused by a breakdown in T-and B-cell tolerance. Moreover, excessive production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs) contributes to autoimmune signs; however, the factors that trigger excessive innate activation have not been defined. Objective: Neutrophil extracellular traps (NETs) emerged as major initiating factors in patients with diseases such as systemic lupus erythematosus and rheumatoid arthritis. In this study we explored the possible involvement of aberrant neutrophil functions in patients with WAS. Methods: We evaluated the expression of a set of granulocyte genes associated with NETs in a cohort of patients with WAS and the presence of NET inducers in sera. Using a mouse model of WAS, we analyzed NET release by WASp-null neutrophils and evaluated the composition and homeostasis of neutrophils in vivo. By using depletion experiments, we assessed the effect of neutrophils in promoting inflammation and reactivity against autoantigens. Results: Transcripts of genes encoding neutrophil enzymes and antimicrobial peptides were increased in granulocytes of patients with WAS, and serum-soluble factors triggered NET release. WASp-null neutrophils showed increased spontaneous NETosis, induced IFN-I production by pDCs, and activated B cells through B-cell activating factor. Consistently, their depletion abolished constitutive pDC activation, normalized circulating IFN-I levels, and, importantly, abolished production of autoantibodies directed against double-stranded DNA, nucleosomes, and myeloperoxidase. Conclusions: These findings reveal that neutrophils are involved in the pathogenic loop that causes excessive activation of innate cells and autoreactive B cells, thus identifying novel mechanisms that contribute to the autoimmunity of WAS.	[Cervantes-Luevano, Karla E.; Caronni, Nicoletta; Piperno, Giulia M.; Naseem, Asma; Benvenuti, Federica] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Castiello, Maria C.; Bosticardo, Marita; Marcovecchio, Genni E.; Cicalese, Maria P.; Aiuti, Alessandro; Villa, Anna] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy TIGET, Milan, Italy; [Fontana, Elena] Humanitas Clin & Res Ctr, Milan, Italy; [Fontana, Elena; Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan Unit, Milan, Italy; [Uva, Paolo] CRS4, Sci & Technol Pk Polaris, Pula, Croatia; [Bosticardo, Marita; Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Cicalese, Maria P.; Aiuti, Alessandro] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, Milan, Italy; [Cicalese, Maria P.; Aiuti, Alessandro] Ist Sci San Raffaele, Pediat Immunohematol & Bone Marrow Transplantat U, Milan, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Benvenuti, F (corresponding author), Area Ric, Cellular Immunol, Padriciano 99, I-34149 Trieste, Italy.	benvenuti@icgeb.org	Piperno, Giulia Maria/AAA-3976-2022; Bosticardo, Marita/ABA-2688-2021; Caronni, Nicoletta/AAN-1866-2020; Castiello, Maria Carmina/K-9767-2016; Fontana, Elena/K-3845-2016; Benvenuti, Federica/O-1100-2013; Uva, Paolo/A-2877-2011; NASEEM, ASMA/AAC-6478-2019; Marcovecchio, Genni Enza/AAN-2557-2020; AIUTI, Alessandro/K-3918-2016	Bosticardo, Marita/0000-0002-1771-4523; Caronni, Nicoletta/0000-0002-3263-7108; Castiello, Maria Carmina/0000-0003-2581-9648; Fontana, Elena/0000-0001-8853-3335; Uva, Paolo/0000-0002-9524-8492; Benvenuti, Federica/0000-0002-1908-8052; Piperno, Giulia Maria/0000-0003-4467-7315; AIUTI, Alessandro/0000-0002-5398-1717; NASEEM, ASMA/0000-0003-3612-2336	Italian Telethon grant [GGP14281]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; ICGEB postdoctoral fellowship; CONACyT postdoctoral fellowship; AIRC fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER	Italian Telethon grant(Fondazione Telethon); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICGEB postdoctoral fellowship; CONACyT postdoctoral fellowship; AIRC fellowship(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Italian Telethon grant GGP14281 to F.B. and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (to L.D.N.). K.E.C.-L. is supported by an ICGEB postdoctoral fellowship and CONACyT postdoctoral fellowship. N.C. is supported by an AIRC fellowship. The autoantibody arrays (UT Southwestern Medical Center and Microarray Core Facility) were performed in collaboration with Q.-Z. Li (Center for Immunology, University of Texas Southwestern Medical Center at Dallas, Dallas, Tex).	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau R, 2017, ANNU REV IMMUNOL, V35, P337, DOI 10.1146/annurev-immunol-051116-052225; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Caielli S, 2016, J EXP MED, V213, P697, DOI 10.1084/jem.20151876; Carmona-Rivera C, 2001, INDUCTION QUANTIFICA; Castiello MC, 2015, J ALLERGY CLIN IMMUN, V136, P692, DOI 10.1016/j.jaci.2015.01.035; Castiello MC, 2014, J AUTOIMMUN, V50, P42, DOI 10.1016/j.jaut.2013.10.006; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Coquery CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102284; Crestani E, 2015, J ALLERGY CLIN IMMUN, V136, P1401, DOI 10.1016/j.jaci.2015.08.010; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Du HQ, 2015, SCAND J IMMUNOL, V81, P483, DOI 10.1111/sji.12282; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Gupta AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092890; Hagglof T, 2016, NAT IMMUNOL, V17, P1407, DOI 10.1038/ni.3583; Hatch EM, 2016, J CELL BIOL, V215, P27, DOI 10.1083/jcb.201603053; Hoffmann MH, 2013, ANN RHEUM DIS, V72, P1239, DOI 10.1136/annrheumdis-2012-202218; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Hummel M, 2008, BIOINFORMATICS, V24, P78, DOI 10.1093/bioinformatics/btm531; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kolhatkar NS, 2015, J EXP MED, V212, P1663, DOI 10.1084/jem.20150585; Kumar S, 2011, BLOOD, V118, P12, DOI 10.1182/blood.V118.21.16.16; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; Liu CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3707; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Maillard MH, 2007, J EXP MED, V204, P381, DOI 10.1084/jem.20061338; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Nguyen DD, 2012, GASTROENTEROLOGY, V143, P719, DOI 10.1053/j.gastro.2012.06.008; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Palanichamy A, 2014, J IMMUNOL, V192, P906, DOI 10.4049/jimmunol.1302112; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Prete F, 2013, J EXP MED, V210, P355, DOI 10.1084/jem.20120363; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sur Chowdhury Chanchal, 2014, Arthritis Res Ther, V16, pR122, DOI 10.1186/ar4579; Telles RW, 2010, RHEUMATOL INT, V30, P779, DOI 10.1007/s00296-009-1067-4; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yu Yangsheng, 2013, J Clin Cell Immunol, V4	53	14	14	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2018	142	5					1605	+		10.1016/j.jaci.2017.11.063	http://dx.doi.org/10.1016/j.jaci.2017.11.063			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GZ5BL	29447842	Green Accepted, Bronze			2022-12-18	WOS:000449429800022
J	Bullon, P; Castejon-Vega, B; Roman-Malo, L; Jimenez-Guerrero, MP; Cotan, D; Forbes-Hernandez, TY; Varela-Lopez, A; Perez-Pulido, AJ; Giampieri, F; Quiles, JL; Battino, M; Sanchez-Alcazar, JA; Cordero, MD				Bullon, Pedro; Castejon-Vega, Beatriz; Roman-Malo, Lourdes; Paz Jimenez-Guerrero, Maria; Cotan, David; Forbes-Hernandez, Tamara Y.; Varela-Lopez, Alfonso; Perez-Pulido, Antonio J.; Giampieri, Francesca; Quiles, Jose L.; Battino, Maurizio; Sanchez-Alcazar, Jose A.; Cordero, Mario D.			Autophagic dysfunction in patients with Papillon-Lefevre syndrome is restored by recombinant cathepsin C treatment	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Papillon-Lefevre syndrome; cathepsin C; autophagy; lysosomal permeabilization	LYSOSOMAL MEMBRANE PERMEABILIZATION; STORAGE; IDENTIFICATION; ACCUMULATION; INHIBITION; DEFICIENCY; ACTIVATION; MUTATIONS; PROTEASES; FAMILIES	Background: Cathepsin C (CatC) is a lysosomal enzyme involved in activation of serine proteases from immune and inflammatory cells. Several loss-of-function mutations in the CatC gene have been shown to be the genetic mark of Papillon-Lefevre syndrome (PLS), a rare autosomal recessive disease characterized by severe early-onset periodontitis, palmoplantar hyperkeratosis, and increased susceptibility to infections. Deficiencies or dysfunction in other cathepsin family proteins, such as cathepsin B or D, have been associated with autophagic and lysosomal disorders. Objectives: Here we characterized the basis for autophagic dysfunction in patients with PLS by analyzing skin fibroblasts derived from patients with several mutations in the CatC gene and reduced enzymatic activity. Methods: Skin fibroblasts were isolated from patients with PLS assessed by using genetic analysis. Authophagic flux dysfunction was evaluated by examining accumulation of p62/SQSTM1 and a bafilomycin assay. Ultrastructural analysis further confirmed abnormal accumulation of autophagic vesicles in mutant cells. A recombinant CatC protein was produced by a baculovirus system in insect cell cultures. Results: Mutant fibroblasts from patients with PLS showed alterations in oxidative/antioxidative status, reduced oxygen consumption, and a marked autophagic dysfunction associated with autophagosome accumulation. These alterations were accompanied by lysosomal permeabilization, cathepsin B release, and NLR family pyrin domain containing 3 (NLRP3) inflammasome activation. Treatment of mutant fibroblasts with recombinant CatC improved cell growth and autophagic flux and partially restored lysosomal permeabilization. Conclusions: Our data provide a novel molecular mechanism underlying PLS. Impaired autophagy caused by insufficient lysosomal function might represent a new therapeutic target for PLS.	[Bullon, Pedro; Castejon-Vega, Beatriz; Roman-Malo, Lourdes] Univ Seville, Sch Dent, Res Lab, Seville, Spain; [Bullon, Pedro; Roman-Malo, Lourdes] Univ Seville, Sch Dent, Dept Periodontol, Seville, Spain; [Paz Jimenez-Guerrero, Maria; Cotan, David; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, CABD, Seville, Spain; [Paz Jimenez-Guerrero, Maria; Cotan, David; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville, Spain; [Forbes-Hernandez, Tamara Y.; Giampieri, Francesca; Battino, Maurizio] Univ Politecn Marche, Sez Biochim, Dipartimento Sci Clin Specialist & Odontostomatol, Ancona, Italy; [Varela-Lopez, Alfonso; Quiles, Jose L.; Cordero, Mario D.] Univ Granada, Biomed Res Ctr CIBM, Inst Nutr & Food Technol Jose Mataix, Dept Physiol, Armilla, Spain; [Perez-Pulido, Antonio J.] Univ Pablo de Olavide, CSIC, Junta de Andalucia, CABD, Seville, Spain	University of Sevilla; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Universidad Pablo de Olavide; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Cordero, MD (corresponding author), Univ Granada, Biomed Res Ctr, Dept Physiol, Inst Nutr & Food Technol Jose Mataix Verdu, Granada 18100, Spain.	mdcormor@ugr.es	Bullon, Pedro/E-6319-2010; Varela-López, Alfonso/F-8055-2016; Perez-Pulido, Antonio J/K-3384-2012; Quiles, José L./C-6911-2013; Forbes Hernandez, Tamara/AAB-1872-2021; Giampieri, Francesca/I-1911-2015; Battino, Maurizio/E-6103-2012	Bullon, Pedro/0000-0003-4873-4196; Varela-López, Alfonso/0000-0002-0504-5086; Perez-Pulido, Antonio J/0000-0003-3343-2822; Quiles, José L./0000-0002-9048-9086; Forbes Hernandez, Tamara/0000-0001-7021-9276; Giampieri, Francesca/0000-0002-8151-9132; Battino, Maurizio/0000-0002-7250-1782; Castejon Vega, Beatriz/0000-0003-0286-2395	Proyecto de Investigacion de Excelencia de la Junta de Andalucia [CTS113]; Instituto de Salud Carlos III, Spain [PI16/00786]; Fondo Europeo de Desarrollo Regional (FEDER-Union Europea)	Proyecto de Investigacion de Excelencia de la Junta de Andalucia; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER-Union Europea)	Supported by Proyecto de Investigacion de Excelencia de la Junta de Andalucia CTS113 and grant PI16/00786, Instituto de Salud Carlos III, Spain, and Fondo Europeo de Desarrollo Regional (FEDER-Union Europea). In memorian of Dr Ognjen Culic.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aflaki E, 2016, AGING CELL, V15, P77, DOI 10.1111/acel.12409; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Bullon P, 2014, J EUR ACAD DERMATOL, V28, P1049, DOI 10.1111/jdv.12265; Codogno P, 2014, NAT REV MOL CELL BIO, V15, P153, DOI 10.1038/nrm3751; Guarino C, 2017, BIOCHEM PHARMACOL, V131, P52, DOI 10.1016/j.bcp.2017.02.009; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo H, 2016, J LIPID RES, V57, P1644, DOI 10.1194/jlr.M066522; Hart PS, 2000, J MED GENET, V37, P927, DOI 10.1136/jmg.37.12.927; Hewitt C, 2004, HUM MUTAT, V23, P222, DOI 10.1002/humu.10314; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Lefevre C, 2001, J INVEST DERMATOL, V117, P1657, DOI 10.1046/j.0022-202x.2001.01595.x; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Methot N, 2007, J BIOL CHEM, V282, P20836, DOI 10.1074/jbc.M702615200; Mizunoe Y, 2017, AUTOPHAGY, V13, P642, DOI 10.1080/15548627.2016.1274850; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Qiu GF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/746289; Roberts H, 2016, J LEUKOCYTE BIOL, V100, P433, DOI 10.1189/jlb.5A1015-489R; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Sreeramulu B, 2015, CLIN COSMET INVESTIG, V7, P75, DOI 10.2147/CCIDE.S76080; Tatti M, 2013, AUTOPHAGY, V9, P241, DOI 10.4161/auto.22557; Wyatt K, 2012, Health Technol Assess, V16, P1, DOI 10.3310/hta16390; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Yu T, 2015, J MOL MED, V93, P31, DOI 10.1007/s00109-014-1225-3	32	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1131	+		10.1016/j.jaci.2018.01.018	http://dx.doi.org/10.1016/j.jaci.2018.01.018			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29410039	Green Published			2022-12-18	WOS:000446327300014
J	Sereni, L; Castiello, MC; Marangoni, F; Anselmo, A; di Silvestre, D; Motta, S; Draghici, E; Mantero, S; Thrasher, AJ; Giliani, S; Aiuti, A; Mauri, P; Notarangelo, LD; Bosticardo, M; Villa, A				Sereni, Lucia; Castiello, Maria Carmina; Marangoni, Francesco; Anselmo, Achille; di Silvestre, Dario; Motta, Sara; Draghici, Elena; Mantero, Stefano; Thrasher, Adrian J.; Giliani, Silvia; Aiuti, Alessandro; Mauri, Pierluigi; Notarangelo, Luigi D.; Bosticardo, Marita; Villa, Anna			Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Wiskott-Aldrich syndrome; platelet deficiency; CD40 ligand; autoantibodies; autoimmunity	SYNDROME PROTEIN-DEFICIENCY; X-LINKED THROMBOCYTOPENIA; SOLUBLE CD40 LIGAND; B-CELL COMPARTMENT; ACTIVATED PLATELETS; PROPLATELET FORMATION; ADAPTIVE IMMUNITY; WASP(-) MICE; GENE-THERAPY; IN-VIVO	Background: Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency characterized by eczema, infections, and susceptibility to autoimmunity and malignancies. Thrombocytopenia is a constant finding, but its pathogenesis remains elusive. Objective: To dissect the basis of the WAS platelet defect, we used a novel conditional mouse model (CoWas) lacking Wiskott-Aldrich syndrome protein (WASp) only in the megakaryocytic lineage in the presence of a normal immunologic environment, and in parallel we analyzed samples obtained from patients with WAS. Methods: Phenotypic and functional characterization of megakaryocytes and platelets in mutant CoWas mice and patients with WAS with and without autoantibodies was performed. Platelet antigen expression was examined through a protein expression profile and cluster proteomic interaction network. Platelet immunogenicity was tested by using ELISAs and B-cell and platelet cocultures. Results: CoWas mice showed increased megakaryocyte numbers and normal thrombopoiesis in vitro, but WASp-deficient platelets had short lifespan and high expression of activation markers. Proteomic analysis identified signatures compatible with defects in cytoskeletal reorganization and metabolism yet surprisingly increased antigen-processing capabilities. In addition, WASp-deficient platelets expressed high levels of surface and soluble CD40 ligand and were capable of inducing B-cell activation in vitro. WASp-deficient platelets were highly immunostimulatory in mice and triggered the generation of antibodies specific for WASp-deficient platelets, even in the context of a normal immune system. Patients with WAS also showed platelet hyperactivation and increased plasma soluble CD40 ligand levels correlating with the presence of autoantibodies. Conclusion: Overall, these findings suggest that intrinsic defects in WASp-deficient platelets decrease their lifespan and dysregulate immune responses, corroborating the role of platelets as modulators of inflammation and immunity.	[Sereni, Lucia; Castiello, Maria Carmina; Draghici, Elena; Aiuti, Alessandro; Bosticardo, Marita; Villa, Anna] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy SR TIGET, Div Regenerat Med Stem Cells & Gene Therapy, Milan, Italy; [Sereni, Lucia; Aiuti, Alessandro] Univ Vita Salute San Raffaele, Milan, Italy; [Marangoni, Francesco] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Anselmo, Achille; Mantero, Stefano] Humanitas Clin & Res Ctr, Milan, Italy; [di Silvestre, Dario; Motta, Sara; Mauri, Pierluigi] Natl Res Council ITB CNR, Inst Biomed Technol, Prote & Metab Lab, Segrate, Italy; [Mantero, Stefano; Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan Unit, Milan, Italy; [Thrasher, Adrian J.] UCL, Inst Child Hlth, Mol & Cellular Immunol Sect, London, England; [Giliani, Silvia] Univ Brescia, Dept Mol & Translat Med, A Nocivelli Inst Mol Med, Brescia, Italy; [Giliani, Silvia] Spedali Civil Brescia, Dept Lab, Cytogenet & Clin Genet Unit, Brescia, Italy; [Aiuti, Alessandro] Ist Sci San Raffaele, Pediat Immunohematol Unit, Milan, Italy; [Notarangelo, Luigi D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of London; University College London; University of Brescia; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Villa, A (corresponding author), Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy TIGET, Div Regenerat Med Stem Cells & Gene Therapy, Milan, Italy.	villa.anna@hsr.it	di silvestre, dario/AAB-5037-2022; Mauri, Pietro Luigi/AAC-3095-2019; Bosticardo, Marita/ABA-2688-2021; Mantero, Stefano/AAE-5515-2021; Anselmo, Achille/H-7010-2018; Castiello, Maria Carmina/K-9767-2016; Giliani, Silvia/AAX-8843-2020; Marangoni, Francesco/I-9087-2012; AIUTI, Alessandro/K-3918-2016; Motta, Sara/P-9635-2018	di silvestre, dario/0000-0002-7143-6229; Mauri, Pietro Luigi/0000-0003-4364-0393; Bosticardo, Marita/0000-0002-1771-4523; Anselmo, Achille/0000-0001-6431-8518; Castiello, Maria Carmina/0000-0003-2581-9648; Giliani, Silvia/0000-0001-8137-4642; Marangoni, Francesco/0000-0002-2490-849X; AIUTI, Alessandro/0000-0002-5398-1717; Mantero, Stefano/0000-0003-0608-2724; SERENI, LUCIA/0000-0002-8234-3490; Motta, Sara/0000-0001-8421-6287; Thrasher, Adrian/0000-0002-6097-6115	Italian Telethon foundation; National Institute of Allergy and Infectious Diseases, National Institutes of Health; GlaxoSmithKline; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; PNR-CNR Aging Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222] Funding Source: NIH RePORTER	Italian Telethon foundation(Fondazione Telethon); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PNR-CNR Aging Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Italian Telethon foundation (Telethon Core Grant) and supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. L.S. has conducted this study as fulfillment of her PhD in Molecular Medicine, Program in Basic and Applied Immunology, San Raffaele University, Milan, Italy. GlaxoSmithKline is the financial sponsor of an ongoing Wiskott-Aldrich syndrome gene therapy program in which some of the patients listed in this study are participating. This study was also supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. This work was also supported by PNR-CNR Aging Program 2012-2014 to A.V.	ABRAMS C, 1991, THROMB HAEMOSTASIS, V65, P467; Attar A., 2014, GLOBAL J HEMATOL BLO, V1, P20, DOI [10.15379/2408-9877.2014.01.01.4, DOI 10.15379/2408-9877.2014.01.01.4, 10.15379/2408-9877.2014.01.01.4.]; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; AULT KA, 1992, AM J CLIN PATHOL, V98, P637, DOI 10.1093/ajcp/98.6.637; Becker-Herman S, 2011, J EXP MED, V208, P2033, DOI 10.1084/jem.20110200; Bender M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5746; Bosticardo M, 2014, CURR GENE THER, V14, P413, DOI 10.2174/1566523214666140918103731; Bosticardo M, 2011, J ALLERGY CLIN IMMUN, V127, P1376, DOI 10.1016/j.jaci.2011.03.030; Bosticardo M, 2009, BLOOD, V113, P6288, DOI 10.1182/blood-2008-12-115253; Brigida I, 2014, J ALLERGY CLIN IMMUN, V133, P799, DOI 10.1016/j.jaci.2013.12.1043; Castiello MC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00490; Castiello MC, 2014, J AUTOIMMUN, V50, P42, DOI 10.1016/j.jaut.2013.10.006; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Crestani E, 2015, J ALLERGY CLIN IMMUN, V136, P1401, DOI 10.1016/j.jaci.2015.08.010; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Elzey BD, 2005, CELL IMMUNOL, V238, P1, DOI 10.1016/j.cellimm.2005.12.005; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Elzey BD, 2011, THROMB RES, V127, P180, DOI 10.1016/j.thromres.2010.10.011; Eto K, 2016, BLOOD, V127, P1234, DOI 10.1182/blood-2015-07-607903; Feist E, 2016, CLIN IMMUNOL, V172, P83, DOI 10.1016/j.clim.2016.07.018; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; Gerrits AJ, 2015, BLOOD, V126, P1367, DOI 10.1182/blood-2014-09-602573; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Haddad E, 1999, BLOOD, V94, P509, DOI 10.1182/blood.V94.2.509.414k09_509_518; Hoylaerts MF, 2003, J THROMB HAEMOST, V1, P1140, DOI 10.1046/j.1538-7836.2003.00249.x; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; Jordan MB, 2003, BLOOD, V101, P594, DOI 10.1182/blood-2001-11-0061; Kajiwara M, 1999, BRIT J HAEMATOL, V107, P254, DOI 10.1046/j.1365-2141.1999.01694.x; Kolhatkar NS, 2015, J EXP MED, V212, P1663, DOI 10.1084/jem.20150585; Lam FW, 2015, COMPR PHYSIOL, V5, P1265, DOI 10.1002/cphy.c140074; Mahlaoui N, 2013, BLOOD, V121, P1510, DOI 10.1182/blood-2012-08-448118; Manfredi AA, 2010, CURR OPIN HEMATOL, V17, P3, DOI 10.1097/MOH.0b013e3283324f97; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Marathe BM, 2009, EXP HEMATOL, V37, P1353, DOI 10.1016/j.exphem.2009.08.007; Maugeri N, 2011, BLOOD, V118, P3359, DOI 10.1182/blood-2011-02-337337; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; Meyer-Bahlburg A, 2008, BLOOD, V112, P4158, DOI 10.1182/blood-2008-02-140814; Moulding DA, 2013, IMMUNOL REV, V256, P282, DOI 10.1111/imr.12114; MULLEN CA, 1993, BLOOD, V82, P2961; Nagahama M, 2002, EUR J HAEMATOL, V69, P303, DOI 10.1034/j.1600-0609.2002.02774.x; OCHS HD, 1980, BLOOD, V55, P243; Olsson M, 2005, BLOOD, V105, P3577, DOI 10.1182/blood-2004-08-2980; Pala F, 2015, J CLIN INVEST, V125, P3941, DOI 10.1172/JCI82249; Palazzo A, 2016, J THROMB HAEMOST, V14, P2524, DOI 10.1111/jth.13519; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; Prislovsky A, 2008, EXP HEMATOL, V36, P609, DOI 10.1016/j.exphem.2007.12.019; Prislovsky A, 2013, EXP HEMATOL, V41, P789, DOI 10.1016/j.exphem.2013.05.003; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Recher M, 2012, BLOOD, V119, P2819, DOI 10.1182/blood-2011-09-379412; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sereni L, 2017, J LEUKOCYTE BIOL, P1; Shcherbina A, 1999, BRIT J HAEMATOL, V106, P875, DOI 10.1046/j.1365-2141.1999.01637.x; Simon KL, 2014, J ALLERGY CLIN IMMUN, V133, P896, DOI 10.1016/j.jaci.2013.08.050; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sokolic R, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00049; Sprague DL, 2007, IMMUNOL RES, V39, P185, DOI 10.1007/s12026-007-0074-3; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Westerberg L, 2005, BLOOD, V105, P1144, DOI 10.1182/blood-2004-03-1003; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; ZHU QL, 1995, BLOOD, V86, P3797, DOI 10.1182/blood.V86.10.3797.bloodjournal86103797	66	14	14	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2018	142	4					1272	1284		10.1016/j.jaci.2017.12.1000	http://dx.doi.org/10.1016/j.jaci.2017.12.1000			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GV7RG	29421274	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000446327300025
J	Aglas, L; Gilles, S; Bauer, R; Huber, S; Araujo, GR; Mueller, G; Scheiblhofer, S; Amisi, M; Dang, HH; Briza, P; Bohle, B; Horejs-Hoeck, J; Traidl-Hoffmann, C; Ferreira, F				Aglas, Lorenz; Gilles, Stefanie; Bauer, Renate; Huber, Sara; Araujo, Galber R.; Mueller, Geoffrey; Scheiblhofer, Sandra; Amisi, Marie; Hieu-Hoa Dang; Briza, Peter; Bohle, Barbara; Horejs-Hoeck, Jutta; Traidl-Hoffmann, Claudia; Ferreira, Fatima			Context matters: T(H)2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							ALLERGIC CONTACT-DERMATITIS; GENOME-WIDE ASSOCIATION; T-CELL DIFFERENTIATION; COLLABORATIVE CROSS; RAPID IDENTIFICATION; MOLECULAR-MECHANISMS; IMMUNE DEVIATION; TRANSGENIC MICE; INHIBITION; DISEASE		[Aglas, Lorenz; Bauer, Renate; Huber, Sara; Araujo, Galber R.; Scheiblhofer, Sandra; Hieu-Hoa Dang; Briza, Peter; Horejs-Hoeck, Jutta; Ferreira, Fatima] Univ Salzburg, Dept Mol Biol, Salzburg, Austria; [Gilles, Stefanie; Amisi, Marie; Traidl-Hoffmann, Claudia] Tech Univ Munich, UNIKA T, Inst Environm Med, Augsburg, Germany; [Gilles, Stefanie; Amisi, Marie; Traidl-Hoffmann, Claudia] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Augsburg, Germany; [Gilles, Stefanie; Amisi, Marie; Traidl-Hoffmann, Claudia] CK CARE, Davos, Switzerland; [Mueller, Geoffrey] NIEHS, Genome Integr & Struct Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Bohle, Barbara] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Bohle, Barbara] Med Univ Vienna, Christian Doppler Lab Immunomodulat, Vienna, Austria	Salzburg University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Medical University of Vienna; Medical University of Vienna	Ferreira, F (corresponding author), Univ Salzburg, Dept Mol Biol, Salzburg, Austria.	Fatima.ferreira@sbg.ac.at	Horejs-Hoeck, Jutta/AAF-1735-2019; Ferreira, Fatima/E-4889-2011; Araujo, Galber/P-5936-2019; Huber, Sara/AAG-6474-2019; Ferreira, Fatima/AAB-4321-2019; Briza, Peter/D-7309-2012; Aglas, Lorenz/L-3996-2015; Horejs-Hoeck, Jutta/E-5010-2011; Mueller, Geoffrey A/I-2909-2017; Gilles-Stein, Stefanie/AAA-3741-2021	Horejs-Hoeck, Jutta/0000-0002-0984-204X; Ferreira, Fatima/0000-0003-0989-2335; Araujo, Galber/0000-0001-6038-8893; Huber, Sara/0000-0003-3589-4924; Ferreira, Fatima/0000-0003-0989-2335; Briza, Peter/0000-0002-4941-6782; Aglas, Lorenz/0000-0002-1236-5934; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Mueller, Geoffrey A/0000-0001-8361-5323; Gilles-Stein, Stefanie/0000-0002-5159-2558; Bohle, Barbara/0000-0002-5105-7985; Scheiblhofer, Sandra/0000-0003-2867-9054	Austrian Science Funds (FWF) [P23417, P27589, SFB F4610]; University of Salzburg priority program "Allergy-Cancer-BioNano Research Centre"; Doctorate School Plus Program "Biomolecules" of the University of Salzburg; Intramural Research Program of the National Institute of Environmental Health Sciences [Z01-ES102906-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102906] Funding Source: NIH RePORTER	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); University of Salzburg priority program "Allergy-Cancer-BioNano Research Centre"; Doctorate School Plus Program "Biomolecules" of the University of Salzburg; Intramural Research Program of the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Austrian Science Funds (FWF Projects P23417, P27589, and SFB F4610), by the University of Salzburg priority program "Allergy-Cancer-BioNano Research Centre," by the Doctorate School Plus Program "Biomolecules" of the University of Salzburg, and by the Intramural Research Program of the National Institute of Environmental Health Sciences (grant no. Z01-ES102906-01, REL).	Asam C, 2014, CLIN EXP ALLERGY, V44, P1083, DOI 10.1111/cea.12361; Atamni HJA, 2016, MAMM GENOME, V27, P565, DOI 10.1007/s00335-016-9658-3; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Beaulieu E, 2011, NAT REV RHEUMATOL, V7, P340, DOI 10.1038/nrrheum.2011.59; Behboudi S, 2000, IMMUNOLOGY, V99, P361, DOI 10.1046/j.1365-2567.2000.00979.x; Bellinghausen I, 2001, J ALLERGY CLIN IMMUN, V108, P242, DOI 10.1067/mai.2001.117177; Bentley JK, 2014, J ALLERGY CLIN IMMUN, V134, P1433, DOI 10.1016/j.jaci.2014.05.029; Blomeke B, 2009, ALLERGY, V64, P279, DOI 10.1111/j.1398-9995.2008.01704.x; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Chapman NM, 2014, IMMUNOL RES, V59, P23, DOI 10.1007/s12026-014-8527-y; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chitsazan A, 2016, PIGM CELL MELANOMA R, V29, P459, DOI 10.1111/pcmr.12487; Christensen AD, 2013, CLIN EXP IMMUNOL, V171, P220, DOI 10.1111/cei.12005; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dittrich AM, 2008, J IMMUNOL, V181, P7307, DOI 10.4049/jimmunol.181.10.7307; Eriksson D, 2016, J INTERN MED, V280, P595, DOI 10.1111/joim.12569; Ferguson B, 2015, ONCOGENE, V34, P2879, DOI 10.1038/onc.2014.227; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Fischer H, 2006, EUR J IMMUNOL, V36, P267, DOI 10.1002/eji.200535149; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Hayashi T, 2005, J IMMUNOL, V174, P5864, DOI 10.4049/jimmunol.174.9.5864; Hecker KH, 1999, IMMUNOLOGY, V96, P372; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jang Eun Ryoung, 2016, Commun Integr Biol, V9, pe1188241, DOI 10.1080/19420889.2016.1188241; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jun YJ, 2014, CLIN EXP ALLERGY, V44, P197, DOI 10.1111/cea.12195; Jung SH, 2013, BRIT J DERMATOL, V168, P112, DOI 10.1111/bjd.12069; Kamijo S, 2009, J IMMUNOL, V183, P6087, DOI 10.4049/jimmunol.0901039; Kim EH, 2014, J IMMUNOL, V192, P985, DOI 10.4049/jimmunol.1302378; Kim WJ, 2018, J ALLERGY CLIN IMMUN, V141, P137, DOI 10.1016/j.jaci.2017.04.007; Kutty RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167246; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin JQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10562; Liu W, 2014, HUM GENET, V133, P661, DOI 10.1007/s00439-013-1404-2; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; MENNE T, 1983, INT J DERMATOL, V22, P22, DOI 10.1111/j.1365-4362.1983.tb02108.x; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Morahan G, 2008, MAMM GENOME, V19, P390, DOI 10.1007/s00335-008-9134-9; Morimoto T, 2014, J TOXICOL SCI, V39, P163, DOI 10.2131/jts.39.163; Nacak M, 2007, BASIC CLIN PHARMACOL, V101, P101, DOI 10.1111/j.1742-7843.2007.00077.x; Nakakura S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00299; Ngo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059149; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Pervan CL, 2017, EXP EYE RES, V158, P137, DOI 10.1016/j.exer.2016.07.012; Ram R, 2014, GENETICS, V198, P75, DOI 10.1534/genetics.114.163014; Reich K, 2003, J ALLERGY CLIN IMMUN, V112, P1191, DOI 10.1016/j.jaci.2003.09.012; Rogala AR, 2014, MAMM GENOME, V25, P95, DOI 10.1007/s00335-013-9499-2; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Ruder C, 2009, J CLIN INVEST, V119, P2184, DOI 10.1172/JCI37760; Schappi GF, 1997, J ALLERGY CLIN IMMUN, V100, P656, DOI 10.1016/S0091-6749(97)70170-2; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Seidler DG, 2011, J IMMUNOL, V187, P6108, DOI 10.4049/jimmunol.1100373; Smith M, 2014, ALLERGY, V69, P913, DOI 10.1111/all.12419; Stolina M, 2007, J IMMUNOL, V179, P7497, DOI 10.4049/jimmunol.179.11.7497; Takeuchi M, 1998, J IMMUNOL, V160, P1589; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vocanson M, 2006, J INVEST DERMATOL, V126, P815, DOI 10.1038/sj.jid.5700174; WALKER FB, 1967, INT ARCH ALLER A IMM, V32, P453, DOI 10.1159/000229956; Wandu WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128906; Zhou Y, 2016, CLIN REV ALLERG IMMU, V50, P345, DOI 10.1007/s12016-016-8538-7; Zhu ZL, 2016, MOL IMMUNOL, V78, P98, DOI 10.1016/j.molimm.2016.09.003	67	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					984	+		10.1016/j.jaci.2018.05.004	http://dx.doi.org/10.1016/j.jaci.2018.05.004			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	29782896	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000443726500033
J	Mensah, GA; Kiley, JP; Gibbons, GH				Mensah, George A.; Kiley, James P.; Gibbons, Gary H.			Generating evidence to inform an update of asthma clinical practice guidelines: Perspectives from the National Heart, Lung, and Blood Institute	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; clinical practice guideline; allergen; bronchial thermoplasty; immunotherapy; inhaled corticosteroids; long-acting muscarinic antagonists	MANAGEMENT; DISEASE; BURDEN	Asthma is the most prevalent chronic respiratory disease worldwide. Its increasing prevalence and evidence of suboptimal control require renewed efforts in the development and widespread implementation of clinical practice guidelines for prevention, treatment, and control. Given the rapidly changing landscape and evolving best practices for guideline development, the National Heart, Lung, and Blood Institute made a commitment to support rigorous systematic evidence reviews that frontline health care providers and stakeholders could use to create new or update existing guidelines. This article describes the protocols, key questions, methodology, and analytic framework to support the update of the 2007 National Asthma Education and Prevention Program Expert Panel Report 3 (EPR-3) on the diagnosis and management of asthma in adults and children. It also describes the expert panel's practical experience in managing asthmatic patients across the age and severity spectrum. The article explains the process for ensuring that the expert panel's deliberations are conducted in accordance with the Institute of Medicine's standards and recommendations for guideline development. The outcome of this ambitious effort will be an update of the EPR-3 asthma guidelines and publication of the key recommendations in the Journal of Allergy and Clinical Immunology. Importantly, several novel approaches will be explored and incorporated as appropriate to accelerate adoption and sustained implementation of the guidelines.	[Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kiley, James P.] NHLBI, Div Lung Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [Gibbons, Gary H.] NHLBI, Off Director, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mensah, GA (corresponding author), NHLBI, CTRIS, 6705 Rockledge Dr,Suite 6070, Bethesda, MD 20892 USA.	George.Mensah@nih.gov						Agency for Healthcare Research and Quality, 2016, ROL IMM MAN ASTHM SY; Agency for Healthcare Research and Quality, 2016, FRACT EXH NITR OX CL; Agency for Healthcare Research and Quality, 2017, EFF IND ALL RED ROL; Agency for Healthcare Research and Quality. Systematic Review of Intermittent, 2016, INH CORT LONG ACT MU; Akinbami Lara J, 2012, NCHS Data Brief, P1; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2018, J ALLERGY CLIN IMMUN; Busse WW, 2007, J ALLERGY CLIN IMMUN, V120, P1012, DOI 10.1016/j.jaci.2007.09.016; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; Chan WV, 2017, J AM COLL CARDIOL, V69, P1076, DOI 10.1016/j.jacc.2016.11.004; D'Anci KE, 2017, AHRQ COMP EFFECTIVEN; Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003; Gibbons GH, 2013, J AM COLL CARDIOL, V62, P1396, DOI 10.1016/j.jacc.2013.08.003; Goff DC, 2013, CIRCULATION, V2014, P129, DOI DOI 10.1161/01.CIR.0000437741.48606; IOM (Institute of Medicine), 2011, CLIN PRACTICE GUIDEL; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kaur BP, 2015, INT ARCH ALLERGY IMM, V168, P71, DOI 10.1159/000441687; Leas BF., 2018, COMP EFFECTIVENESS R; Leas BF, 2018, J ALLERGY CLIN IMMUN, V141, P1854, DOI 10.1016/j.jaci.2018.02.001; Lin SY, 2018, COMP EFFECTIVENESS R; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; National Asthma Education and Prevention Program, 1997, NAT I HLTH PUBL NAT, V97; National Heart Lung and Blood Advisory Council Asthma Expert Working Group, 2014, GUID DIAGN MAN ASTHM; National Heart Lung and Blood Institute, 2014, MAN OV OB AD SYST EV; National Heart Lung and Blood Institute., 2014, MAN BLOOD CHOL AD SY; National Heart Lung and Blood Institute, 2014, LIF INT RED CARD RIS; National Heart Lung and Blood Institute, 2014, MAN BLOOD PRESS AD S; National Heart Lung and Blood Institute., 2014, ASS CARD RISK SYST E; National Heart Lung and Blood Institute National Asthma Education Program, 1991, J ALLERGY CLIN IMMUN, V88, P425, DOI DOI 10.1016/0091-6749(91)92135-N; National Heart Lung Blood Institute, 2014, EVIDENCE BASED MANAG; National Institutes of Health, 2017, NIH ALM LEG CHRON; Nurmagambetov T, 2018, ANN AM THORAC SOC, V15, P348, DOI 10.1513/AnnalsATS.201703-259OC; Sobieraj DM, 2018, COMP EFFECTIVENESS R; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sullivan PW, 2014, J ASTHMA, V51, P769, DOI 10.3109/02770903.2014.906607; Wang Z, 2018, MAYO CLIN PROC, V93, P191, DOI 10.1016/j.mayocp.2017.11.012; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	38	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2018	142	3					744	748		10.1016/j.jaci.2018.07.004	http://dx.doi.org/10.1016/j.jaci.2018.07.004			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GS5RJ	30036600	Bronze			2022-12-18	WOS:000443726500004
J	Cascio, S; Medsger, TA; Hawse, WF; Watkins, SC; Milcarek, C; Moreland, LW; Lafyatis, RA; Fuschiotti, P				Cascio, Sandra; Medsger, Thomas A., Jr.; Hawse, William F.; Watkins, Simon C.; Milcarek, Christine; Moreland, Larry W.; Lafyatis, Robert A.; Fuschiotti, Patrizia			14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T(C)2 and CD8(+) lymphocytes from patients with scleroderma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T(C)2; IL-13; T-bet; 14-3-3; systemic sclerosis	NF-KAPPA-B; SYSTEMIC-SCLEROSIS PATIENTS; CELL-DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; SKIN-DISEASE; CD8+T CELLS; DNA-BINDING; EFFECTOR	Background: IL-13-producing CD8(+) T cells have been implicated in the pathogenesis of type 2-driven inflammatory human conditions. We have shown that CD8(+)IL-13(+) cells play a critical role in cutaneous fibrosis, the most characteristic feature of systemic sclerosis (SSc; scleroderma). However, the molecular mechanisms underlying production of IL-13 and other type 2 cytokines by CD8(+) T cells remain unclear. Objective: We sought to establish the molecular basis of IL-13 overproduction by CD8(+) T cells from patients with SSc, focusing on T-bet modulation of GATA-3 activity, which we showed to underlie IL-13 overproduction in CD8(+) IL-13(+) cells from patients with SSc. Methods: Biochemical and biophysical methods were used to determine the expression and association of T-bet, GATA-3, and regulatory factors in CD8(+) T cells isolated from the blood and lesional skin of patients with SSc with severe skin thickening. Chromatin immunoprecipitation analysis determined GATA-3 binding to the IL-13 promoter. ImageStream analysis and confocal microscopy visualized the subcellular localization of T-bet and GATA-3. Transcript levels were decreased by small interfering RNAs. Results: Interaction of T-bet with the adaptor protein 14-3-3z in the cytosol of CD8(+) T cells from patients with SSc reduces T-bet translocation into the nucleus and its ability to associate with GATA-3, allowing more GATA-3 to bind to the IL-13 promoter and inducing IL-13 upregulation. Strikingly, we show that this mechanism is also found during type 2 polarization of CD8(+) T cells (T(C)2) from healthy donors. Conclusions: We identified a novel molecular mechanism underlying type 2 cytokine production by CD8(+) T cells, revealing a more complete picture of the complex pathway leading to SSc disease pathogenesis.	[Cascio, Sandra; Hawse, William F.; Milcarek, Christine; Fuschiotti, Patrizia] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Medsger, Thomas A., Jr.; Moreland, Larry W.; Lafyatis, Robert A.; Fuschiotti, Patrizia] Univ Pittsburgh, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, S709 BST,200 Lothrop St, Pittsburgh, PA 15261 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA; [Cascio, Sandra] RiMED Fdn, Palermo, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fuschiotti, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, S709 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	paf23@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Moreland, Larry/0000-0003-4483-0359; Cascio, Sandra/0000-0003-4234-0508	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R03 AR065755]; University of Pittsburgh; Scleroderma Research Fund; Taub Fund; Zale Foundation; Shoemaker Endowment; RiMED Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR065755] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Pittsburgh(University of Pittsburgh); Scleroderma Research Fund; Taub Fund; Zale Foundation; Shoemaker Endowment; RiMED Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R03 AR065755, University of Pittsburgh (to P.F.). The Scleroderma Research Fund, Taub Fund (Chicago, Ill), Zale Foundation (Dallas, Tex), and Shoemaker Endowment (Pittsburgh, Pa; to T.A.M.) and the RiMED Foundation (to S.C.).	Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Betts RJ, 2009, PHARMACOL THERAPEUT, V121, P123, DOI 10.1016/j.pharmthera.2008.09.001; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chen A, 2011, MOL CELL BIOL, V31, P3445, DOI 10.1128/MCB.05383-11; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Cousins DJ, 2002, J IMMUNOL, V169, P2498, DOI 10.4049/jimmunol.169.5.2498; Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P104, DOI 10.1016/j.jaci.2015.01.020; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Evans CM, 2013, BRIEF FUNCT GENOMICS, V12, P499, DOI 10.1093/bfgp/elt025; Fuschiotti P, 2016, IMMUNOTARGETS THER, V5, P21, DOI 10.2147/ITT.S82037; Fuschiotti P, 2013, ARTHRITIS RHEUM-US, V65, P236, DOI 10.1002/art.37706; Fuschiotti P, 2011, IMMUNOL RES, V50, P188, DOI 10.1007/s12026-011-8222-1; Fuschiotti P, 2009, ARTHRITIS RHEUM-US, V60, P1119, DOI 10.1002/art.24432; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Geskin LJ, 2015, BLOOD, V125, P2798, DOI 10.1182/blood-2014-07-590398; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LEROY EC, 1988, J RHEUMATOL, V15, P202; Li G, 2017, J INVEST DERMATOL, V137, P1042, DOI 10.1016/j.jid.2016.11.037; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Makris D, 2008, CHEST, V134, P483, DOI 10.1378/chest.07-2626; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Medsger TA, 2003, RHEUM DIS CLIN N AM, V29, P255, DOI 10.1016/S0889-857X(03)00023-1; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Medsger TA, 2011, ARTHRITIS RHEUM-US, V63, P1738, DOI 10.1002/art.30489; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oh S, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/589672; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Rice LM, 2016, RHEUMATOLOGY, V55, P377, DOI 10.1093/rheumatology/kev335; Rice LM, 2015, ARTHRITIS RHEUMATOL, V67, P3004, DOI 10.1002/art.39287; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Tan FK, 2006, RHEUMATOLOGY, V45, P694, DOI 10.1093/rheumatology/kei244; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wan YY, 2014, TRENDS IMMUNOL, V35, P233, DOI 10.1016/j.it.2014.04.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weinmann AS, 2014, ADV IMMUNOL, V124, P171, DOI 10.1016/B978-0-12-800147-9.00006-6; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	63	14	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					109	+		10.1016/j.jaci.2017.10.029	http://dx.doi.org/10.1016/j.jaci.2017.10.029			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29155097	Green Accepted, Bronze			2022-12-18	WOS:000437837500015
J	KleinJan, A; Tindemans, I; Montgomery, JE; Lukkes, M; de Bruijn, MJW; van Nimwegen, M; Bergen, I; Moellering, RE; Hoogsteden, HC; Boon, L; Amsen, D; Hendriks, RW				KleinJan, Alex; Tindemans, Irma; Montgomery, Jeffrey E.; Lukkes, Melanie; de Bruijn, Marjolein J. W.; van Nimwegen, Menno; Bergen, Ingrid; Moellering, Raymond E.; Hoogsteden, Henk C.; Boon, Louis; Amsen, Derk; Hendriks, R. W.			The Notch pathway inhibitor stapled alpha-helical peptide derived from mastermind-like 1 (SAHM1) abrogates the hallmarks of allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergic asthma; Notch signaling; Gata3; T(H)2 immunity; house dust mite; recombination signal-binding protein for IgJ kappa region; stapled alpha-helical peptide derived from mastermind-like 1	CD4(+) T-CELLS; TRANSCRIPTION FACTOR GATA-3; DENDRITIC CELLS; AIRWAY INFLAMMATION; FUNCTIONAL-DIFFERENTIATION; ADAPTIVE IMMUNITY; EXPRESSION; LUNG; ACTIVATION; INNATE	Background: The Notch signaling pathway has been implicated in the pathogenesis of allergic airway inflammation. Targeting the active Notch transactivation complex by using the cell-permeable, hydrocarbon-stapled synthetic peptide stapled alpha-helical peptide derived from mastermind-like 1 (SAHM1) resulted in genome-wide suppression of Notch-activated genes in leukemic cells and other models. However, the efficacy of SAHM1 in allergic asthma models has remained unexplored. Objective: We aimed to investigate the therapeutic efficacy of SAHM1 in a house dust mite (HDM)-driven asthma model. Methods: Topical therapeutic intervention with SAHM1 or a control peptide was performed during sensitization, challenge, or both with HDM in mice. Airway inflammation was assessed by using multicolor flow cytometry, and bronchial hyperreactivity was studied. Additionally, SAHM1 therapy was investigated in mice with established allergic airway inflammation and in a model in which we neutralized IFN-gamma during HDM challenge to support the T(H)2 response and exacerbate asthma. Results: SAHM1 treatment during the challenge phase led to a marked reduction of eosinophil and T cell numbers in bronchoalveolar lavage fluid compared with those in diluenttreated or control peptide-treated mice. Likewise, T-cell cytokine content and bronchial hyperreactivity were reduced. SAHM1 treatment dampened T(H)2 inflammation during ongoing HDM challenge and enhanced recovery after established asthma. Additionally, in the presence of anti-IFN-gamma antibodies, SAHM1 downregulated expression of the key T(H)2 transcription factor GATA3 and intracellular IL-4 in bronchoalveolar lavage fluid T cells, but expression of the T(H)17 transcription factor retinoic acid-related orphan receptor gamma t or intracellular IL-17 was not affected. SAHM1 therapy also reduced serum IgE levels. Conclusions: Therapeutic intervention of Notch signaling by SAHM1 inhibits allergic airway inflammation in mice and is therefore an interesting new topical treatment opportunity in asthmatic patients.	[KleinJan, Alex; Tindemans, Irma; Lukkes, Melanie; de Bruijn, Marjolein J. W.; van Nimwegen, Menno; Bergen, Ingrid; Hoogsteden, Henk C.; Hendriks, R. W.] Erasmus MC, Dept Pulm Med, Rm Ee2251,POB 2040, NL-3000 CA Rotterdam, Netherlands; [Montgomery, Jeffrey E.; Moellering, Raymond E.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Montgomery, Jeffrey E.; Moellering, Raymond E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Boon, Louis] Epirus Biopharmaceut Netherlands, Utrecht, Netherlands; [Amsen, Derk] Sanquin, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Chicago; University of Chicago	KleinJan, A (corresponding author), Erasmus MC, Dept Pulm Med, Rm Ee2251,POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.kleinjan@erasmusmc.nl	Boon, Laurence/HCI-3629-2022	KleinJan, Alex/0000-0003-0226-1362; Boon, Louis/0000-0002-0937-9171	V Foundation for Cancer Research; National Institutes of Health [R00CA175399]; Lung Foundation Netherlands [3.2.12.087, 3.2.12.067]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008720] Funding Source: NIH RePORTER	V Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Foundation Netherlands; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the V Foundation for Cancer Research and the National Institutes of Health (R00CA175399; to R.E.M.) and by the Lung Foundation Netherlands grants 3.2.12.087 and 3.2.12.067 (to I.T. and M.L.).	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2015, TRENDS IMMUNOL, V36, P802, DOI 10.1016/j.it.2015.10.007; [Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2012.01.004; Ashley JW, 2015, J CELL BIOCHEM, V116, P2598, DOI 10.1002/jcb.25205; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bleck B, 2010, J IMMUNOL, V185, P6636, DOI 10.4049/jimmunol.1000719; Chen YR, 2013, MOL BIOL REP, V40, P1531, DOI 10.1007/s11033-012-2198-3; Cheng PY, 2010, IMMUNOL REV, V234, P105, DOI 10.1111/j.0105-2896.2009.00871.x; COOTE J, 2016, AM J RESP CRIT CARE, V193; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Gomi K, 2016, STEM CELL REV REP, V12, P454, DOI 10.1007/s12015-016-9656-6; Gu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047288; Guest RV, 2016, P NATL ACAD SCI USA, V113, P12250, DOI 10.1073/pnas.1600067113; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; KleinJan A, 1997, J ALLERGY CLIN IMMUN, V99, P515, DOI 10.1016/S0091-6749(97)70079-4; KleinJan A, 2014, J IMMUNOL, V192, P1385, DOI 10.4049/jimmunol.1301888; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Lafkas D, 2015, NATURE, V528, P127, DOI 10.1038/nature15715; Laky K, 2015, IMMUNITY, V42, P80, DOI 10.1016/j.immuni.2014.12.027; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li BWS, 2016, EUR J IMMUNOL, V46, P1392, DOI 10.1002/eji.201546119; Lloyd CM, 2015, CURR OPIN IMMUNOL, V34, P52, DOI 10.1016/j.coi.2015.02.001; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maekawa Y, 2015, NAT MED, V21, P55, DOI 10.1038/nm.3758; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Rzepecka J, 2013, INT J PARASITOL, V43, P211, DOI 10.1016/j.ijpara.2012.12.001; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Sundlisaeter E, 2012, AM J PATHOL, V181, P1099, DOI 10.1016/j.ajpath.2012.06.003; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tindemans I, 2017, J ALLERGY CLIN IMMUN, V140, P1079, DOI 10.1016/j.jaci.2016.11.046; Tindemans I, 2014, IMMUNITY, V41, P191, DOI 10.1016/j.immuni.2014.06.006; Tran IT, 2013, J CLIN INVEST, V123, P1590, DOI 10.1172/JCI65477; Tsao PN, 2016, P NATL ACAD SCI USA, V113, P8242, DOI 10.1073/pnas.1511236113; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; zu Horste GM, 2016, CELL REP, V16, P392, DOI 10.1016/j.celrep.2016.05.088	49	14	15	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					76	+		10.1016/j.jaci.2017.08.042	http://dx.doi.org/10.1016/j.jaci.2017.08.042			18	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29111218	Bronze, Green Accepted			2022-12-18	WOS:000437837500012
J	Panchal, N; Houghton, B; Diez, B; Ghosh, S; Ricciardelli, I; Thrasher, AJ; Gaspar, HB; Booth, C				Panchal, Neelam; Houghton, Ben; Diez, Begona; Ghosh, Sujal; Ricciardelli, Ida; Thrasher, Adrian J.; Gaspar, H. Bobby; Booth, Claire			Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						X-linked lymphoproliferative disease; T-cell gene therapy; follicular helper T cells; T-cell cytotoxicity	FOLLICULAR-HELPER-CELLS; NATURAL-KILLER-CELLS; MICE DEFICIENT; INFECTED CELLS; SAP; THERAPY; IMMUNODEFICIENCY; DIFFERENTIATION; INTERLEUKIN-21; REQUIREMENT	Background: X-linked lymphoproliferative disease 1 arises from mutations in the SH2D1A gene encoding SLAM-associated protein (SAP), an adaptor protein expressed in T, natural killer (NK), and NKT cells. Defects lead to abnormalities of T-cell and NK cell cytotoxicity and T cell-dependent humoral function. Clinical manifestations include hemophagocytic lymphohistiocytosis, lymphoma, and dysgammaglobulinemia. Curative treatment is limited to hematopoietic stem cell transplantation, with outcomes reliant on a good donor match. Objectives: Because most symptoms arise from defective T-cell function, we investigated whether transfer of SAP gene-corrected T cells could reconstitute known effector cell defects. Methods: CD3(+) lymphocytes from Sap-deficient mice were transduced with a gammaretroviral vector encoding human SAP cDNA before transfer into sublethally irradiated Sap-deficient recipients. After immunization with the T-dependent antigen 4-hydroxy-3-nitrophenylacetly chicken gammaglobulin (NP-CGG), recovery of humoral function was evaluated through germinal center formation and antigen-specific responses. To efficiently transduce CD3(+) cells from patients, we generated an equivalent lentiviral SAP vector. Functional recovery was demonstrated by using in vitro cytotoxicity and T follicular helper cell function assays alongside tumor clearance in an in vivo lymphoblastoid cell line lymphoma xenograft model. Results: In Sap-deficient mice 20% to 40% engraftment of gene-modified T cells led to significant recovery of germinal center formation and NP-specific antibody responses. Gene-corrected T cells from patients demonstrated improved cytotoxicity and T follicular helper cell function in vitro. Adoptive transfer of gene-corrected cytotoxic T lymphocytes from patients reduced tumor burden to a level comparable with that seen in healthy donor cytotoxic T lymphocytes in an in vivo lymphoma model. Conclusions: These data demonstrate that autologous T-cell gene therapy corrects SAP-dependent defects and might offer an alternative therapeutic option for patients with X-linked lymphoproliferative disease 1.	[Panchal, Neelam; Houghton, Ben; Diez, Begona; Ghosh, Sujal; Ricciardelli, Ida; Thrasher, Adrian J.; Gaspar, H. Bobby; Booth, Claire] UCL GOS Inst Child Hlth, Mol & Cellular Immunol Sect, 30 Guilford St, London WC1N 1EH, England; [Ghosh, Sujal] Heinrich Heine Univ, Ctr Child & Adolescent Hlth, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Thrasher, Adrian J.; Gaspar, H. Bobby; Booth, Claire] Great Ormond St Hosp NHS Trust, Dept Paediat Immunol, London, England	University of London; University College London; Heinrich Heine University Dusseldorf; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Booth, C (corresponding author), UCL GOS Inst Child Hlth, Mol & Cellular Immunol Sect, 30 Guilford St, London WC1N 1EH, England.	c.booth@ucl.ac.uk	Ricciardelli, Ida/ABC-8937-2020; Diez Cabezas, Begoña/ABE-7805-2021; Booth, Claire/I-3667-2016	Diez Cabezas, Begoña/0000-0003-0083-1034; Thrasher, Adrian/0000-0002-6097-6115; Booth, Claire/0000-0002-2626-5037	Action Medical Research; Bloodwise; Wellcome Trust [104807/Z/14/Z]; Great Ormond Street Children's Charity; NIHR Great Ormond Street Hospital Biomedical Research Centre; MRC [MR/L012855/1] Funding Source: UKRI	Action Medical Research; Bloodwise; Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Children's Charity; NIHR Great Ormond Street Hospital Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Action Medical Research and Bloodwise. C.B. is in receipt of a Wellcome Trust Early Postdoctoral Training Fellowship. A.J.T. is in receipt of a Wellcome Trust Principal Research Fellowship (104807/Z/14/Z); B.H. is also supported on this fellowship. H.B.G. is supported by the Great Ormond Street Children's Charity. This research was supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Al-Alem U, 2005, BLOOD, V106, P2069, DOI 10.1182/blood-2004-07-2731; Baumann JG, 2004, J VIROL, V78, P12537, DOI 10.1128/JVI.78.22.12537-12547.2004; Biasco L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010314; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; Booth C, 2016, TRENDS MOL MED, V22, P317, DOI 10.1016/j.molmed.2016.02.002; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deeks SG, 2002, MOL THER, V5, P788, DOI 10.1006/mthe.2002.0611; Dupre L, 2005, BLOOD, V105, P4383, DOI 10.1182/blood-2004-08-3269; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Ma CS, 2015, J ALLERGY CLIN IMMUN, V136, P993, DOI 10.1016/j.jaci.2015.05.036; Mitsuyasu RT, 2000, BLOOD, V96, P785, DOI 10.1182/blood.V96.3.785.015k10_785_793; Nakajima H, 2000, EUR J IMMUNOL, V30, P3309, DOI 10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Oliveira G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8265; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rivat C, 2013, BLOOD, V121, P1073, DOI 10.1182/blood-2012-07-445858; SEEMAYER TA, 1995, PEDIATR RES, V38, P471, DOI 10.1203/00006450-199510000-00001; Sharifi R, 2004, BLOOD, V103, P3821, DOI 10.1182/blood-2003-09-3359; Tangye SG, 2000, J IMMUNOL, V165, P2932, DOI 10.4049/jimmunol.165.6.2932; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wu CB, 2000, IMMUNOGENETICS, V51, P805, DOI 10.1007/s002510000215	33	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2018	142	1					235	+		10.1016/j.jaci.2018.02.053	http://dx.doi.org/10.1016/j.jaci.2018.02.053			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GM1OC	29705247	Green Published, hybrid			2022-12-18	WOS:000437837500026
J	Kuschnir, FC; Felix, MMR; Kuschnir, MCC; Bloch, KV; Jordao, EADC; Sole, D; da Cunha, AJLA; Szklo, M				Kuschnir, Fabio Chigres; Rocha Felix, Mara Morelo; Caetano Kuschnir, Maria Cristina; Bloch, Katia Vergetti; de Oliveira Costa Jordao, Erica Azevedo; Sole, Dirceu; Ledo Alves da Cunha, Antonio Jose; Szklo, Moyses			Severe asthma is associated with metabolic syndrome in Brazilian adolescents	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHILDREN; ALLERGIES; PHASE-3		[Kuschnir, Fabio Chigres] State Univ Rio de Janeiro UERJ, Dept Pediat, Fac Med Sci, Rio De Janeiro, Brazil; [Rocha Felix, Mara Morelo; de Oliveira Costa Jordao, Erica Azevedo] State Univ Rio de Janeiro UERJ, Postgrad Sch, Fac Med Sci, Rio De Janeiro, Brazil; [Caetano Kuschnir, Maria Cristina] Univ Estado Rio De Janeiro, Adolescent Hlth Studies Ctr NESA UERJ, Fac Med Sci, Rio De Janeiro, Brazil; [Bloch, Katia Vergetti; Szklo, Moyses] Univ Fed Rio de Janeiro, Publ Hlth Studies Inst IESC, Rio De Janeiro, Brazil; [Sole, Dirceu] Fed Univ Sao Paulo UNIFESP, Div Allergy Clin Immunol & Rheumatol, Dept Pediat, Sao Paulo, Brazil; [Ledo Alves da Cunha, Antonio Jose] Fed Univ Rio de Janeiro IPPMG UFRJ, Inst Puericultura & Pediat Martagao Gesteira, Dept Pediat, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Kuschnir, FC (corresponding author), State Univ Rio de Janeiro UERJ, Dept Pediat, Fac Med Sci, Rio De Janeiro, Brazil.	fabkuschnir@gmail.com	Felix, Mara Morelo Rocha/S-1188-2019; Bloch, Katia Vergetti/GLN-2877-2022; AZEVEDO DE OLIVEIRA JORDÃO, ÉRICA/GXM-3312-2022; da Cunha, Antonio Jose Ledo Alves/O-5914-2019; Solé, Dirceu/D-7789-2013	Bloch, Katia Vergetti/0000-0002-6992-3159; da Cunha, Antonio Jose Ledo Alves/0000-0003-3592-1849; Szklo, Moyses/0000-0001-9433-6266; Muller, Christoph/0000-0002-1163-2527; KUSCHNIR, FABIO/0000-0003-1432-2396	Department of Science and Technology of the Science, Technology and Strategic Inputs Secretariat from the Brazilian Ministry of Health (Decit/SCTIE/MS); Health Sector Fund (CT-Saude) of the Ministry of Science, Technology and Innovation (MCTI) [FINEP 01090421, CNPq 565037/2010-2]; Research Incentive Fund of the Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [405.009/2012-7]	Department of Science and Technology of the Science, Technology and Strategic Inputs Secretariat from the Brazilian Ministry of Health (Decit/SCTIE/MS); Health Sector Fund (CT-Saude) of the Ministry of Science, Technology and Innovation (MCTI); Research Incentive Fund of the Hospital de Clinicas de Porto Alegre (FIPE-HCPA)	This study was funded by the Department of Science and Technology of the Science, Technology and Strategic Inputs Secretariat from the Brazilian Ministry of Health (Decit/SCTIE/MS), the Health Sector Fund (CT-Saude) of the Ministry of Science, Technology and Innovation (MCTI) (protocols FINEP 01090421 and CNPq 565037/2010-2), and the Research Incentive Fund of the Hospital de Clinicas de Porto Alegre (FIPE-HCPA Process 405.009/2012-7).	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bloch KV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1442-x; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Cureau Felipe Vogt, 2016, Rev Saude Publica, V50 Suppl 1, p4s, DOI 10.1590/S01518-8787.2016050006683; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Figueiredo VC, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006741; Forno E, 2015, J ALLERGY CLIN IMMUN, V136, P304, DOI 10.1016/j.jaci.2015.01.010; GINA Science Committee, 2016, GLOB STRAT ASTHM MAN; Kuschnir MCC, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S01518-8787.2016050006701, 10.1590/s01518-8787.2016050006701]; Lai CKW, 2009, THORAX, V64, P476, DOI 10.1136/thx.2008.106609; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Perez MK, 2014, IMMUNOL ALLERGY CLIN, V34, P777, DOI 10.1016/j.iac.2014.07.002; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16	16	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1947	+		10.1016/j.jaci.2018.01.026	http://dx.doi.org/10.1016/j.jaci.2018.01.026			17	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29427644	Bronze			2022-12-18	WOS:000432148200055
J	Nagao, M; Inagaki, S; Kawano, T; Azuma, Y; Nomura, N; Noguchi, Y; Ohta, S; Kawaguchi, A; Odajima, H; Ohya, Y; Fujisawa, T; Izuhara, K				Nagao, Mizuho; Inagaki, Shinichiro; Kawano, Toshiki; Azuma, Yoshinori; Nomura, Noriko; Noguchi, Yasuhiko; Ohta, Shoichiro; Kawaguchi, Atsushi; Odajima, Hiroshi; Ohya, Yukihiro; Fujisawa, Takao; Izuhara, Kenji			SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CELL CARCINOMA ANTIGENS; GUIDELINES; MANAGEMENT; PSORIASIS; SEVERITY		[Nagao, Mizuho; Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan; [Inagaki, Shinichiro; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Div Allergy, Dept Med Subspecialties, Tokyo, Japan; [Kawano, Toshiki; Odajima, Hiroshi] Fukuoka Natl Hosp, Dept Pediat, Fukuoka, Japan; [Azuma, Yoshinori; Nomura, Noriko; Noguchi, Yasuhiko] Shino Test Corp, Sagamihara, Kanagawa, Japan; [Ohta, Shoichiro; Izuhara, Kenji] Saga Med Sch, Div Med Biochem, Dept Biomol Sci, Saga, Japan; [Kawaguchi, Atsushi] Saga Med Sch, Ctr Comprehens Community Med, Saga, Japan	National Center for Child Health & Development - Japan; Shino Test Corporation; Saga University; Saga University	Fujisawa, T (corresponding author), Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan.	fujisawa@mie-m.hosp.go.jp; kizuhara@cc.saga-u.ac.jp	Ohya, Yukihiro/Y-9002-2019; Fujisawa, Takao/ABB-2359-2021	Ohya, Yukihiro/0000-0002-1560-3942; Fujisawa, Takao/0000-0002-9196-9436; Inagaki, Shinichiro/0000-0001-7652-7763	Saga Medical School	Saga Medical School	This work was supported in part by Grants-in-Aid for Scientific Research from the Saga Medical School (to K.I.). Y.A., N.N., and Y.N. are employees of Shino-Test Corporation.	Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Fujisawa T, 2009, PEDIATR ALLERGY IMMU, V20, P633, DOI 10.1111/j.1399-3038.2009.00851.x; Mitsuishi K, 2005, CLIN EXP ALLERGY, V35, P1327, DOI 10.1111/j.1365-2222.2005.02353.x; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; Ohta S, 2012, ANN CLIN BIOCHEM, V49, P277, DOI 10.1258/acb.2011.011065; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; Thijs J, 2015, CURR OPIN ALLERGY CL, V15, P453, DOI 10.1097/ACI.0000000000000198; Watanabe Y, 2016, BRIT J DERMATOL, V174, P1327, DOI 10.1111/bjd.14426; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972	10	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1934	+		10.1016/j.jaci.2018.01.021	http://dx.doi.org/10.1016/j.jaci.2018.01.021			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29421276	Bronze			2022-12-18	WOS:000432148200051
J	Pepper, AN; Ledford, DK				Pepper, Amber N.; Ledford, Dennis K.			Nasal and ocular challenges	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Nasal challenge; ocular challenge; allergen challenge; provocation test; allergic rhinitis; allergic conjunctivitis; local allergic rhinitis; nonallergic rhinitis	CONJUNCTIVAL PROVOCATION TEST; ALLERGIC RHINITIS; RHINOCONJUNCTIVITIS COMMITTEE; CLINICAL IMMUNOLOGY; SPANISH SOCIETY; EXPOSURE; DIAGNOSIS; CHAMBER; ASPIRIN; ASTHMA	Nasal and ocular challenges facilitate the evaluation of subjective and objective responses to defined allergen or irritant exposure. Nasal and ocular allergen challenges are the gold standard to diagnose allergic rhinitis and conjunctivitis, respectively, and aid in the evaluation of novel therapies in clinical trials. Additionally, nasal and ocular allergen challenges might help identify medically relevant allergens in clinical practice. Nonspecific or irritant challenges evaluate mucosal hyperreactivity. Direct mucosal challenges, which can be performed in an office or research setting, expose the participant to higher allergen doses than common in the natural environment. Park studies and environmental chambers, which are most practical in clinical trials, more closely simulate natural allergen exposure. International consensus guidelines for nasal and ocular challenges do not exist. Therefore the positivity criteria, methodologies, and extract or allergen preparations used in challenges vary in the literature. Regardless of these limitations, nasal and ocular challenges are helpful clinical and research tools for nasal and ocular diseases.	Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL USA; James A Haley Vet Affairs Hosp, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Ledford, DK (corresponding author), James A Haley Vet Affairs Med Ctr, Dept Internal Med, Div Allergy Immunol, 13000 Bruce B Downs Blvd,Suite 111D, Tampa, FL 33612 USA.	dledford@health.usf.edu			Genentech/Roche; AstraZeneca; Novartis; Teva; Circassia	Genentech/Roche(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Circassia	D. K. Ledford reports grants and personal fees from Genentech/Roche; grants, personal fees, and other funding from AstraZeneca; personal fees from Novartis; personal fees from Teva; personal fees and other funding from Circassia; and personal fees from Mylan outside the submitted work.	ABELSON MB, 1990, ARCH OPHTHALMOL-CHIC, V108, P84, DOI 10.1001/archopht.1990.01070030090035; Alonso-Llamazares A, 2002, ALLERGY, V57, P632, DOI 10.1034/j.1398-9995.2002.t01-1-13447.x; Anderson DF, 1996, J ALLERGY CLIN IMMUN, V98, P1000, DOI 10.1016/S0091-6749(96)80022-4; Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; Bousquet J, 2011, ALLERGY, V66, P765, DOI 10.1111/j.1398-9995.2011.02590.x; Campo P, 2016, IMMUNOL ALLERGY CLIN, V36, P321, DOI 10.1016/j.iac.2015.12.008; Casadevall J, 2000, THORAX, V55, P921, DOI 10.1136/thorax.55.11.921; Dordal MT, 2011, J INVEST ALLERG CLIN, V21, P1; Ellis AK, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0082-0; Ellis AK, 2013, ANN ALLERG ASTHMA IM, V111, P323, DOI 10.1016/j.anai.2013.07.019; Fauquert JL, 2017, ALLERGY, V72, P43, DOI 10.1111/all.12986; Gelardi M, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0126-z; Glacy J, AGENCY HEALTHCARE RE; Gomes PJ, 2013, CLIN OPHTHALMOL, V7, P157, DOI 10.2147/OPTH.S38732; Hellings PW, 2012, RHINOLOGY, V50, P339, DOI [10.4193/Rhin11.252, 10.4193/Rhino11.252]; Hohlfeld JM, 2010, CLIN EXP ALLERGY, V40, P998, DOI 10.1111/j.1365-2222.2010.03498.x; Jacobs RL, 2012, J ALLERGY CLIN IMMUN, V130, P122, DOI 10.1016/j.jaci.2012.03.031; Koskela H, 2000, CLIN EXP ALLERGY, V30, P1627; Kvenshagen BK, 2010, ALLERGOL IMMUNOPATH, V38, P321, DOI 10.1016/j.aller.2010.01.007; Lee RU, 2010, ANN ALLERG ASTHMA IM, V105, P130, DOI 10.1016/j.anai.2010.05.020; Leonardi A, 2013, EXP EYE RES, V117, P106, DOI 10.1016/j.exer.2013.07.019; Lindvik H, 2017, CLIN EXP ALLERGY, V47, P785, DOI 10.1111/cea.12899; Litvyakova LI, 2001, ANN ALLERG ASTHMA IM, V86, P355, DOI 10.1016/S1081-1206(10)62478-7; Lluch-Bernal M, 2015, J INVEST ALLERG CLIN, V25, P396; Loureiro G, 2012, ALLERGIC RHINITIS, P153; Meltzer EO, 2016, J ALLER CL IMM-PRACT, V4, P682, DOI 10.1016/j.jaip.2016.02.006; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Pfaar O, 2017, ALLERGY, V72, P1035, DOI 10.1111/all.13133; Rosner-Friese K, 2015, J ALLERGY CLIN IMMUN, V135, P636, DOI 10.1016/j.jaci.2014.10.045; Scadding GW, 2014, MIDDLETONS ALLERGY P, P652; Simon RA, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0508-7; Soliman M, 2014, ANN ALLERG ASTHMA IM, V113, P250, DOI 10.1016/j.anai.2014.06.018; Suojalehto H, 2014, LARYNGOSCOPE, V124, pE213, DOI 10.1002/lary.24590; White A, 2006, ANN ALLERG ASTHMA IM, V97, P190, DOI 10.1016/S1081-1206(10)60012-9; Zuberbier T, 2017, J ALLERGY CLIN IMMUN, V139, P1158, DOI 10.1016/j.jaci.2016.08.025	35	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1570	1577		10.1016/j.jaci.2017.11.066	http://dx.doi.org/10.1016/j.jaci.2017.11.066			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29501480				2022-12-18	WOS:000432148200004
J	Salo, PM; Wilkerson, J; Rose, KM; Cohn, RD; Calatroni, A; Mitchell, HE; Sever, ML; Gergen, PJ; Thorne, PS; Zeldin, DC				Salo, Paivi M.; Wilkerson, Jesse; Rose, Kathryn M.; Cohn, Richard D.; Calatroni, Agustin; Mitchell, Herman E.; Sever, Michelle L.; Gergen, Peter J.; Thorne, Peter S.; Zeldin, Darryl C.			Bedroom allergen exposures in US households	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Allergen; indoor; exposure; home; allergy	1ST NATIONAL-SURVEY; UNITED-STATES; ENVIRONMENTAL ASSESSMENT; PRACTICE PARAMETER; PARTICLE RESUSPENSION; ALTERNARIA-ALTERNATA; CHILDHOOD ASTHMA; MITE ALLERGEN; RISK-FACTOR; HOMES	Background: Bedroom allergen exposures contribute to allergic disease morbidity because people spend considerable time in bedrooms, where they come into close contact with allergen reservoirs. Objective: We investigated participant and housing characteristics, including sociodemographic, regional, and climatic factors, associated with bedroom allergen exposures in a nationally representative sample of the US population. Methods: Data were obtained from National Health and Nutrition Examination Survey 2005-2006. Information on participant and housing characteristics was collected by using questionnaires and environmental assessments. Concentrations of 8 indoor allergens (Alt a 1, Bla g 1, Can f 1, Fel d 1, Der f 1, Der p 1, Mus m 1, and Rat n 1) in dust vacuumed from nearly 7000 bedrooms were measured by using immunoassays. Exposure levels were classified as increased based on percentile (75th/90th) cutoffs. We estimated the burden of exposure to multiple allergens and used multivariable logistic regression to identify independent predictors for each allergen and household allergen burden. Results: Almost all participants (>99%) had at least 1 and 74.2% had 3 to 6 allergens detected. More than two thirds of participants (72.9%) had at least 1 allergen and 18.2% had 3 or more allergens exceeding increased levels. Although exposure variability showed significant racial/ethnic and regional differences, high exposure burden to multiple allergens was most consistently associated with the presence of pets and pests, living in mobile homes/trailers and older and rental homes, and living in nonmetropolitan areas. Conclusions: Exposure to multiple allergens is common. Despite highly variable exposures, bedroom allergen burden is strongly associated with the presence of pets and pests.	[Salo, Paivi M.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Wilkerson, Jesse; Rose, Kathryn M.; Cohn, Richard D.] Social & Sci Syst, Durham, NC USA; [Calatroni, Agustin; Mitchell, Herman E.; Sever, Michelle L.] Rho Fed Syst Div, Chapel Hill, NC USA; [Gergen, Peter J.] NIAID, Div Allergy Immunol & Transplantat, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Thorne, Peter S.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa	Zeldin, DC (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,Rm A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Thorne, Peter/0000-0002-5045-0929	Intramural Research Program of the National Institutes of Health/National Institute of Environmental Health Sciences [Z01-ES-025041]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM2AI117870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025041, P30ES005605, Z01ES025041] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported in part by the Intramural Research Program of the National Institutes of Health/National Institute of Environmental Health Sciences (grant no. Z01-ES-025041).	[Anonymous], 2014, LAB PROC MAN COCKR B; [Anonymous], 2006, ALL DUST COLL PROC M; [Anonymous], 2014, LAB PROC MAN IND ALL; [Anonymous], 2014, SURV METH AN GUID; Antens CJM, 2006, CLIN EXP ALLERGY, V36, P1525, DOI 10.1111/j.1365-2222.2006.02603.x; Arbes SJ, 2004, J ALLERGY CLIN IMMUN, V114, P111, DOI 10.1016/j.jaci.2004.04.036; Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V111, P408, DOI 10.1067/mai.2003.16; Arlian Larry G, 2002, Curr Allergy Asthma Rep, V2, P401, DOI 10.1007/s11882-002-0074-2; Baechler M.C., 2010, BUILDING AM BEST PRA, V7.1; Bhan N, 2015, AM J PUBLIC HEALTH, V105, P1269, DOI 10.2105/AJPH.2014.302172; Boor BE, 2015, INDOOR AIR, V25, P441, DOI 10.1111/ina.12148; Bush RK, 2004, J ALLERGY CLIN IMMUN, V113, P227, DOI 10.1016/j.jaci.2003.11.023; Cohn RD, 2006, ENVIRON HEALTH PERSP, V114, P522, DOI 10.1289/ehp.8561; Cohn RD, 2004, J ALLERGY CLIN IMMUN, V113, P1167, DOI 10.1016/j.jaci.2003.12.592; Crain EF, 2002, ENVIRON HEALTH PERSP, V110, P939, DOI 10.1289/ehp.02110939; Custovic A, 2015, CLIN EXP ALLERGY, V45, P54, DOI 10.1111/cea.12450; Dharmage S, 1999, CLIN EXP ALLERGY, V29, P1481, DOI 10.1046/j.1365-2222.1999.00640.x; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Erwin EA, 2005, IMMUNOL ALLERGY CLIN, V25, P1, DOI 10.1016/j.iac.2004.09.008; Gergen PJ, 2017, J ALLERGY CLIN IMMUN; Gold DR, 2017, J ALLERGY CLIN IMMUN, V140, P933, DOI 10.1016/j.jaci.2017.04.024; Gore RB, 2006, J ALLERGY CLIN IMMUN, V117, P649, DOI 10.1016/j.jaci.2005.12.1351; Hamilton RG, 2005, CURR ALLERGY ASTHM R, V5, P394, DOI 10.1007/s11882-005-0013-0; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Kanchongkittiphon W, 2015, ENVIRON HEALTH PERSP, V123, P6, DOI [10.1289/ehp.1307922, 10.1289/ehp.123-A6]; Kerkhof M, 2009, ALLERGY, V64, P1202, DOI 10.1111/j.1398-9995.2009.02016.x; Kettleson EM, 2015, ENVIRON RES, V138, P130, DOI 10.1016/j.envres.2015.02.003; King EM, 2013, J IMMUNOL METHODS, V387, P89, DOI 10.1016/j.jim.2012.09.015; Kitch BT, 2000, ENVIRON HEALTH PERSP, V108, P301, DOI 10.2307/3454347; Konradsen JR, 2015, J ALLERGY CLIN IMMUN, V135, P616, DOI 10.1016/j.jaci.2014.08.026; Matsui EC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2589; National Center for Health Statistics, 2009, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2005, PUBL DAT GEN REL FIL; National Center for Health Statistics at Centers for Disease Control and Prevention, 2017, NATL HLTH NUTR EXAMI; National Center for Health Statistics. Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; O'Meara T, 2000, CLIN REV ALLERG IMMU, V18, P341, DOI 10.1385/CRIAI:18:3:341; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Parker JD, 2009, ENVIRON HEALTH PERSP, V117, P140, DOI 10.1289/ehp.11497; Phipatanakul W, 2012, ANN ALLERG ASTHMA IM, V109, P375, DOI 10.1016/j.anai.2012.09.019; Portnoy J, 2013, J ALLERGY CLIN IMMUN, V132, pe1; Portnoy J, 2013, ANN ALLERG ASTHMA IM, V111, P465, DOI 10.1016/j.anai.2013.09.018; Portnoy J, 2013, J ALLERGY CLIN IMMUN, V132, P802, DOI 10.1016/j.jaci.2013.04.061; Portnoy JM, 2012, ANN ALLERG ASTHMA IM, V109, P229, DOI 10.1016/j.anai.2012.02.015; Rauh VA, 2008, ANN NY ACAD SCI, V1136, P276, DOI 10.1196/annals.1425.032; Rosenfeld L, 2011, J URBAN HEALTH, V88, P14, DOI 10.1007/s11524-010-9527-4; Salo PM, 2008, J ALLERGY CLIN IMMUN, V121, P678, DOI 10.1016/j.jaci.2007.12.1164; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Salo PM, 2005, J ALLERGY CLIN IMMUN, V116, P623, DOI 10.1016/j.jaci.2005.05.030; Schmechel D, 2008, J ALLERGY CLIN IMMUN, V121, P763, DOI 10.1016/j.jaci.2007.09.046; Schroder PC, 2015, PEDIAT ALLERG IMM-UK, V26, P95, DOI 10.1111/pai.12341; Spilak MP, 2014, BUILD ENVIRON, V81, P60, DOI 10.1016/j.buildenv.2014.06.010; Takaro TK, 2015, J EXPO SCI ENV EPID, V25, P580, DOI 10.1038/jes.2015.7; Tovey E, 2012, CURR ALLERGY ASTHM R, V12, P465, DOI 10.1007/s11882-012-0285-0; van Strien RT, 2004, ALLERGY, V59, P645, DOI 10.1111/j.1398-9995.2004.00470.x; Vojta PJ, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110527; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wegienka G, 2012, CLIN EXP ALLERGY, V42, P909, DOI 10.1111/j.1365-2222.2011.03946.x; Wegienka G, 2013, CURR ALLERGY ASTHM R, V13, P255, DOI 10.1007/s11882-013-0343-2; Wilson J, 2010, ENVIRON RES, V110, P189, DOI 10.1016/j.envres.2009.10.007	59	14	14	3	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2018	141	5					1870	+		10.1016/j.jaci.2017.08.033	http://dx.doi.org/10.1016/j.jaci.2017.08.033			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GF7KX	29198587	Green Accepted, Bronze			2022-12-18	WOS:000432148200031
J	Longo, C; Bartlett, G; Schuster, T; Ducharme, FM; MacGibbon, B; Barnett, TA				Longo, Cristina; Bartlett, Gillian; Schuster, Tibor; Ducharme, Francine M.; MacGibbon, Brenda; Barnett, Tracie A.			The obese-asthma phenotype in children: An exacerbating situation?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; obesity; inhaled corticosteroid monotherapy; inhaled corticosteroid combination therapy; marginal structural Cox model	BODY-MASS INDEX; MARGINAL STRUCTURAL MODELS; CANADIAN THORACIC SOCIETY; PERSISTENT ASTHMA; NONOBESE CHILDREN; RISK; INFLAMMATION; MANAGEMENT; SEVERITY; OVERWEIGHT/OBESITY	Background: Current evidence regarding the relationship between childhood obesity, decreased response to inhaled corticosteroids (ICSs), and poor asthma control is conflicting. Objectives: We assessed whether obesity (1) is associated with time to first exacerbation among children with asthma initiating step 3 maintenance therapies and (2) modifies the effectiveness of step 3 therapies. Methods: A retrospective cohort study was conducted from clinical data linked to health and drug administrative databases. The cohort consisted of children aged 2 to 18 years with specialist-confirmed asthma who initiated medium/high-dose ICS monotherapy or low/medium-dose ICS with leukotriene receptor antagonist/long-acting beta-agonist (combination therapy) at the Montreal Children's Hospital Asthma Center from 2000 to 2007. Children were classified as exposed to step 3 therapies when they were dispensed a corresponding drug claim during follow-up, whereas those without claims were classified as nonadherers. Marginal structural Cox models were used to estimate the effect of obesity (body mass index > 97th percentile) and treatment on time to exacerbation, which was defined as any emergency department visit, hospitalization, or use of oral corticosteroids for asthma. Results: Of the 4621 cohort patients, 231 initiated ICS monotherapy, and 97 initiated combination therapy. The hazard ratio (HR) for obesity was 1.67 (95% CI, 1.41-1.98). Compared with nonobese nonadherers, the HR for obese nonadherers was 1.54 (95% CI, 0.97-2.45); the HR for ICS monotherapy in obese and nonobese children was 0.85 (95% CI, 0.47-1.52) and 0.58 (95% CI, 0.37-0.91), respectively; and the HR for combination therapy in obese and nonobese children was 0.50 (95% CI, 0.13-1.89) and 0.46 (95% CI, 0.23-0.92), respectively. Conclusion: Obesity might be a determinant of shorter exacerbation-free time in children with asthma; however, we could not rule out a differential response to step 3 therapies by obesity status, potentially because of a lack of precision.	[Longo, Cristina; Bartlett, Gillian; Schuster, Tibor] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Ducharme, Francine M.; Barnett, Tracie A.] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Ducharme, Francine M.] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Ducharme, Francine M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [MacGibbon, Brenda] Univ Quebec Montreal, Dept Math, Montreal, PQ, Canada; [Barnett, Tracie A.] INRS Inst Armand Frappier, Dept Epidemiol & Biostat, Laval, PQ, Canada	McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal; University of Quebec; Institut national de la recherche scientifique (INRS)	Barnett, TA (corresponding author), CHU St Justine, Ctr Rech, INRS Inst Armand Frappier, 5757 Ave Decelles,Suite 100A, Montreal, PQ H3S 2C3, Canada.	tracie.barnett@iaf.inrs.ca	Bartlett, Gillian/C-3720-2014; Ducharme, Francine/N-8332-2013	Bartlett, Gillian/0000-0001-6297-9240; Ducharme, Francine/0000-0001-5096-0614	Fonds de la Recherche du Quebec en Sante (FRQ-S)	Fonds de la Recherche du Quebec en Sante (FRQ-S)	Supported by Fonds de la Recherche du Quebec en Sante (FRQ-S). The FRQ-S had no role in the study design, data collection, analysis, interpretation, or writing of the manuscript.	Ahmadizar F, 2016, EUR RESPIR J, V48, P1063, DOI 10.1183/13993003.00766-2016; Ali Z, 2013, RESP MED, V107, P1287, DOI 10.1016/j.rmed.2013.03.019; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2004, STAT ANN BIBL NAT QU, P46; [Anonymous], 2006, STAT ANN BIBL NAT QU; Bartlett G., 2001, PATTERNS BENZODIAZEP; Belamarich PF, 2000, PEDIATRICS, V106, P1436, DOI 10.1542/peds.106.6.1436; Black MH, 2013, AM J EPIDEMIOL, V178, P1120, DOI 10.1093/aje/kwt093; Boulet LP, 2007, RESP MED, V101, P2240, DOI 10.1016/j.rmed.2007.06.031; British Thoracic Society, 2005, BRIT GUID MAN ASTHM; Camargo CA, 2010, J ASTHMA, V47, P76, DOI 10.3109/02770900903338494; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dietitians Canada, 2010, PAED CHILD HEALT-CAN, V15, P77, DOI 10.1093/pch/15.2.77; Ducharme FM, 2015, CAN RESPIR J, V22, P135, DOI 10.1155/2015/101572; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Giese JK, 2014, J AM ASSOC NURSE PRA, V26, P102, DOI 10.1111/1745-7599.12029; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Howe CJ, 2012, EPIDEMIOLOGY, V23, P574, DOI 10.1097/EDE.0b013e31824d1ccb; Howe CJ, 2011, AM J EPIDEMIOL, V173, P569, DOI 10.1093/aje/kwq385; Jensen ME, 2013, EUR RESPIR J, V42, P1012, DOI 10.1183/09031936.00124912; Jensen ME, 2012, CURR OPIN ALLERGY CL, V12, P186, DOI 10.1097/ACI.0b013e3283508df5; Kwong KY, 2006, J ASTHMA, V43, P661, DOI 10.1080/02770900600925270; Lang JE, 2016, THORAX, V71, P238, DOI 10.1136/thoraxjnl-2015-207662; Lang JE, 2012, J ASTHMA, V49, P456, DOI 10.3109/02770903.2012.677895; Lougheed MD, 2012, CAN RESPIR J, V19, P127, DOI 10.1155/2012/635624; Luder E, 1998, J PEDIATR-US, V132, P699, DOI 10.1016/S0022-3476(98)70363-4; Mannino David M, 2002, MMWR Surveill Summ, V51, P1; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; National Center for Health Statistics (U.S.), 2012, NAT SURV ASTHM US 20; National Heart Lung and Blood Institute, 2012, 3 NAT HEART LUNG BLO; Novosad Shannon, 2013, J Allergy (Cairo), V2013, P538642, DOI 10.1155/2013/538642; Pando S, 2010, PHARMACOTHERAPY, V30, P1109, DOI 10.1592/phco.30.11.1109; Papoutsakis C, 2013, J ACAD NUTR DIET, V113, P77, DOI 10.1016/j.jand.2012.08.025; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Pradeepan S, 2013, CURR ALLERGY ASTHM R, V13, P434, DOI 10.1007/s11882-013-0354-z; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Rastogi D, 2015, AM J RESP CRIT CARE, V191, P149, DOI 10.1164/rccm.201409-1587OC; Rastogi D, 2012, CHEST, V141, P895, DOI 10.1378/chest.11-0930; Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Sutherland ER, 2010, ALLERGY ASTHMA PROC, V31, P20, DOI 10.2500/aap.2010.31.3307; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Sutherland ER, 2013, OBESITY LUNG DIS GUI; Tantisira KG, 2001, THORAX, V56, P64; Todd DC, 2007, CLIN EXP ALLERGY, V37, P1049, DOI 10.1111/j.1365-2222.2007.02748.x; World Health Organization, 2005, PREV CHRON DIS VIT I; World Health Organization, 2007, 2021 CURR STAT ISS C; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	58	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1239	+		10.1016/j.jaci.2017.10.052	http://dx.doi.org/10.1016/j.jaci.2017.10.052			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29382592	Bronze			2022-12-18	WOS:000429197800010
J	Ramakrishnan, KA; Rae, W; Barcenas-Morales, G; Gao, YF; Pengelly, RJ; Patel, SV; Kumararatne, DS; Ennis, S; Doffinger, R; Faust, SN; Williams, AP				Ramakrishnan, Kesava A.; Rae, William; Barcenas-Morales, Gabriela; Gao, Yifang; Pengelly, Reuben J.; Patel, Sanjay V.; Kumararatne, Dinakantha S.; Ennis, Sarah; Doffinger, Rainer; Faust, Saul N.; Williams, Anthony P.			Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									[Ramakrishnan, Kesava A.; Pengelly, Reuben J.; Ennis, Sarah; Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Fac Med, Southampton, Hants, England; [Ramakrishnan, Kesava A.; Pengelly, Reuben J.; Ennis, Sarah; Faust, Saul N.; Williams, Anthony P.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Rae, William; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Rae, William; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Biomed Res Ctr, Southampton, Hants, England; [Rae, William; Williams, Anthony P.] Univ Hosp Southampton, Dept Allergy Asthma & Clin Immunol, Southampton, Hants, England; [Barcenas-Morales, Gabriela; Kumararatne, Dinakantha S.; Doffinger, Rainer] Cambridge Univ Hosp NHS Fdn Trust, Dept Clin Biochem & Immunol, Addenbrookes Hosp, Cambridge, England; [Barcenas-Morales, Gabriela] Univ Autonoma Mexico, Fac Estudios Super, Lab Inmunol, Cuautitlan, Edo De Mexico, Mexico; [Gao, Yifang; Williams, Anthony P.] CRUK NIHR Expt Canc Med Ctr, Southampton, Hants, England; [Patel, Sanjay V.; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Immunol & Infect Dis, Southampton, Hants, England; [Doffinger, Rainer] Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge, England; [Williams, Anthony P.] Univ Southampton, Univ Hosp Southampton NHS Fdn Trust, WISH Lab, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidad Nacional Autonoma de Mexico; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Cambridge; University of Southampton; University Hospital Southampton NHS Foundation Trust	Faust, SN (corresponding author), Univ Southampton, Fac Med, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Southampton, Inst Life Sci, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, NIHR Biomed Res Ctr, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Immunol & Infect Dis, Southampton, Hants, England.	s.faust@soton.ac.uk	Rae, William/AGX-6005-2022; Faust, Saul/J-9779-2014	Rae, William/0000-0003-0095-2514; Faust, Saul/0000-0003-3410-7642; Barcenas Morales, Gabriela/0000-0003-0063-8795; Pengelly, Reuben/0000-0001-7022-645X; Gao, Yifang/0000-0003-2817-9391	Cancer Research UK; National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre, Southampton; Southampton NIHR Wellcome Trust Clinical Research Facility; Universidad Nacional Autonoma de Mexico - Direccion General de Asuntos del Personal Academico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT) [IN220815, PIAPI-1642]; NIHR/Cambridge Biomedical Research Centre	Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre, Southampton; Southampton NIHR Wellcome Trust Clinical Research Facility; Universidad Nacional Autonoma de Mexico - Direccion General de Asuntos del Personal Academico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT); NIHR/Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	Y.G. and A.P.W. were supported by Cancer Research UK and the National Institute for Health Research (NIHR) Experimental Cancer Medicine Centre, Southampton. K.A.R., W.R., S.V.P., and S.N.F. received support from the Southampton NIHR Wellcome Trust Clinical Research Facility. G.B.-M. was supported by grants from Universidad Nacional Autonoma de Mexico - Direccion General de Asuntos del Personal Academico - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT; grant nos. IN220815 and PIAPI-1642). R.D. was supported by the NIHR/Cambridge Biomedical Research Centre.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Cavadini P, 2005, J CLIN INVEST, V115, P728, DOI 10.1172/JCI200523087; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Meloni A, 2008, J CLIN ENDOCR METAB, V93, P4389, DOI 10.1210/jc.2008-0935; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Vincent T, 2015, AUTOIMMUN REV, V14, P528, DOI 10.1016/j.autrev.2015.01.015; Walter JE, 2015, J CLIN INVEST, V125, P4135, DOI 10.1172/JCI80477; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	10	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2018	141	4					1479	+		10.1016/j.jaci.2017.11.014	http://dx.doi.org/10.1016/j.jaci.2017.11.014			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	GB6QV	29225085	Bronze, Green Accepted			2022-12-18	WOS:000429197800034
J	Jimenez-Reinoso, A; Marin, AV; Subias, M; Lopez-Lera, A; Roman-Ortiz, E; Payne, K; Ma, CS; Arbore, G; Kolev, M; Freeley, SJ; Kemper, C; Tangye, SG; Fernandez-Malave, E; de Cordoba, SR; Lopez-Trascasa, M; Regueiro, JR				Jimenez-Reinoso, Anais; Marin, Ana V.; Subias, Marta; Lopez-lera, Alberto; Roman-Ortiz, Elena; Payne, Kathryn; Ma, Cindy S.; Arbore, Giuseppina; Kolev, Martin; Freeley, Simon J.; Kemper, Claudia; Tangye, Stuart G.; Fernandez-Malave, Edgar; de Cordoba, Santiago Rodriguez; Lopez-Trascasa, Margarita; Regueiro, Jose R.			Human plasma C3 is essential for the development of memory B, but not T, lymphocytes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FACTOR-I DEFICIENCY; COMPLEMENT ACTIVATION; COMPONENT; MUTATIONS; PATHWAY; CELLS		[Jimenez-Reinoso, Anais; Marin, Ana V.; Fernandez-Malave, Edgar; Regueiro, Jose R.] Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain; [Jimenez-Reinoso, Anais; Marin, Ana V.; Fernandez-Malave, Edgar; Regueiro, Jose R.] 12 Octubre Hlth Res Inst Imas12, Madrid, Spain; [Subias, Marta; de Cordoba, Santiago Rodriguez] Hosp Univ La Paz, IdiPAZ, CSIC, Ctr Invest Biol, Madrid, Spain; [Subias, Marta; Lopez-lera, Alberto; de Cordoba, Santiago Rodriguez; Lopez-Trascasa, Margarita] Hosp Univ La Paz, IdiPAZ, Ctr Invest Biomed Red Enfermedade Raras CIBERER, Madrid, Spain; [Lopez-lera, Alberto; Lopez-Trascasa, Margarita] Hosp Univ La Paz, IdiPAZ, Immunol Unit, Madrid, Spain; [Roman-Ortiz, Elena] Hosp La Fe, Serv Nefrol Pediat, Valencia, Spain; [Payne, Kathryn; Ma, Cindy S.; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia; [Ma, Cindy S.; Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Arbore, Giuseppina; Kolev, Martin; Freeley, Simon J.; Kemper, Claudia] Kings Coll London, MRC, Ctr Transplantat, Div Transplant Immunol & Mucosal Biol, London, England	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitari i Politecnic La Fe; Garvan Institute of Medical Research; University of New South Wales Sydney; University of London; King's College London	Regueiro, JR (corresponding author), Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain.; Regueiro, JR (corresponding author), 12 Octubre Hlth Res Inst Imas12, Madrid, Spain.	regueiro@med.ucm.es	Jiménez Reinoso, Anaïs/K-2453-2014; Arbore, Giuseppina/AAN-1899-2020; Tangye, Stuart G/H-4023-2014; Marin, Ana V./K-2446-2014; S, Cindy/B-2340-2012; Lera, Alberto López/V-4181-2019; López-Trascasa, Margarita/L-2699-2014; Regueiro, José R./B-5499-2014; Rodriguez de Cordoba, Santiago/K-6727-2014	Jiménez Reinoso, Anaïs/0000-0001-8229-1881; Arbore, Giuseppina/0000-0002-8318-7557; Tangye, Stuart G/0000-0002-5360-5180; Marin, Ana V./0000-0002-7541-3729; S, Cindy/0000-0001-5387-8413; López-Trascasa, Margarita/0000-0001-8594-282X; Regueiro, José R./0000-0001-8442-7762; Kemper, Claudia/0000-0003-4196-1417; Rodriguez de Cordoba, Santiago/0000-0001-6401-1874; Lopez Lera, Alberto/0000-0002-9596-6910; Kolev, Martin/0000-0002-7208-3875	Medical Research Council [MR/J006742/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health		da Silva KR, 2016, IMMUNOBIOLOGY, V221, P641, DOI 10.1016/j.imbio.2016.01.005; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Elvington M, 2017, J CLIN INVEST, V127, P970, DOI 10.1172/JCI89412; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Gonzalez-Rubio C, 2001, ARCH NEUROL-CHICAGO, V58, P1923, DOI 10.1001/archneur.58.11.1923; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Ponce-Castro IM, 2008, MOL IMMUNOL, V45, P2764, DOI 10.1016/j.molimm.2008.02.008; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Okura Y, 2016, J ALLERGY CLIN IMMUN, V137, P640, DOI 10.1016/j.jaci.2015.08.017; PANTAZIS P, 1990, MOL IMMUNOL, V27, P283, DOI 10.1016/0161-5890(90)90141-L; Randall KL, 2011, J EXP MED, V208, P2305, DOI 10.1084/jem.20110345; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Schramm EC, 2015, BLOOD, V125, P2359, DOI 10.1182/blood-2014-10-609073; Tangye SG, 2017, J ALLERGY CLIN IMMUN, V139, P933, DOI 10.1016/j.jaci.2016.07.016; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; TOSATO G, 2007, CURR PROTOC IMMUNOL, V7, P22; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vince N, 2011, J ALLERGY CLIN IMMUN, V127, P538, DOI 10.1016/j.jaci.2010.10.019; YSSEL H, 1989, J IMMUNOL, V142, P2279	25	14	15	3	13	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2018	141	3					1151	+		10.1016/j.jaci.2017.09.037	http://dx.doi.org/10.1016/j.jaci.2017.09.037			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FY6PR	29113906	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000426974800044
J	Harford, TJ; Rezaee, F; Scheraga, RG; Olman, MA; Piedimonte, G				Harford, Terri J.; Rezaee, Fariba; Scheraga, Rachel G.; Olman, Mitchell A.; Piedimonte, Giovanni			Asthma predisposition and respiratory syncytial virus infection modulate transient receptor potential vanilloid 1 function in children's airways	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							INCREASED EXPRESSION; SENSITIZATION; ACTIVATION; CHANNELS		[Harford, Terri J.; Rezaee, Fariba; Piedimonte, Giovanni] Cleveland Clin, Ctr Pediat Res, Pediat Inst, Cleveland, OH 44106 USA; [Harford, Terri J.; Rezaee, Fariba; Piedimonte, Giovanni] Childrens Hosp, Cleveland, OH 44104 USA; [Scheraga, Rachel G.; Olman, Mitchell A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Piedimonte, G (corresponding author), Cleveland Clin, Ctr Pediat Res, Pediat Inst, Cleveland, OH 44106 USA.; Piedimonte, G (corresponding author), Childrens Hosp, Cleveland, OH 44104 USA.	PIEDIMG@ccf.org	Rezaee, Fariba/AAI-1437-2021	Rezaee, Fariba/0000-0002-7625-3341; Harford, Terri/0000-0001-6590-0673; Scheraga, Rachel/0000-0001-5113-543X	US National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (NHLBI) [RO1 HL-61007]; National Institute of Allergy and Infectious Diseases [K08 AI112781]; NHLBI [RO1 HL119792, K08 HL13380]; Cystic Fibrosis Foundation [PIEDIM16G0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL133380, R01HL133721, R01HL119792, R01HL061007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI112781] Funding Source: NIH RePORTER	US National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These experiments were funded in part by grants from the US National Institutes of Health (NIH): National Heart, Lung, and Blood Institute (NHLBI) RO1 HL-61007 to G.P.; National Institute of Allergy and Infectious Diseases K08 AI112781 to F.R.; NHLBI RO1 HL119792 to M.A.O.; and NHLBI K08 HL13380 to R.G.S. Funding was also provided by the Cystic Fibrosis Foundation Grant PIEDIM16G0 to G.P.	Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Hlavackova I, 2013, INT J MOL SCI, V14, P8000, DOI 10.3390/ijms14048000; Hu DE, 2005, BRIT J PHARMACOL, V146, P576, DOI 10.1038/sj.bjp.0706350; Kuddus MR, 2016, PROTEIN EXPRES PURIF, V122, P15, DOI 10.1016/j.pep.2016.02.002; Lin RL, 2009, J APPL PHYSIOL, V106, P1917, DOI 10.1152/japplphysiol.00065.2009; McGarvey LP, 2014, J ALLERGY CLIN IMMUN, V133, P704, DOI 10.1016/j.jaci.2013.09.016; Omar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171681; Poncet P, 2010, ALLERGY, V65, P571, DOI 10.1111/j.1398-9995.2009.02231.x; Shahali Y, 2012, FEBS J, V279, P1445, DOI 10.1111/j.1742-4658.2012.08536.x; Shahali Y, 2012, ELECTROPHORESIS, V33, P462, DOI 10.1002/elps.201100324; Tiotiu A, 2016, ANN ALLERG ASTHMA IM, V117, P527, DOI 10.1016/j.anai.2016.09.426; Yu HM, 2012, J BIOCHEM MOL TOXIC, V26, P179, DOI 10.1002/jbt.20413	14	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2018	141	1					414	+		10.1016/j.jaci.2017.07.015	http://dx.doi.org/10.1016/j.jaci.2017.07.015			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FR8GH	28982576	Green Accepted, Bronze			2022-12-18	WOS:000419312200050
J	Mirzakhani, H; O'Connor, G; Bacharier, LB; Zeiger, RS; Schatz, MX; Weiss, ST; Litonjua, AA				Mirzakhani, Hooman; O'Connor, George; Bacharier, Leonard B.; Zeiger, Robert S.; Schatz, Michael X.; Weiss, Scott T.; Litonjua, Augusto A.			Asthma control status in pregnancy, body mass index, and maternal vitamin D levels	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ASSOCIATION; VALIDATION; SUPPLEMENTATION; CLASSIFICATION; EXACERBATIONS; SEVERITY; OUTCOMES; CHILDREN; OBESITY; TRIAL		[Mirzakhani, Hooman; Weiss, Scott T.; Litonjua, Augusto A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Litonjua, Augusto A.] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; [O'Connor, George] Boston Univ, Boston Med Ctr, Dept Med, Boston, MA 02215 USA; [Bacharier, Leonard B.] Washington Univ, Dept Pediat, Div Pediat Allergy Immunol & Pulm Med, St Louis, MO 63130 USA; [Zeiger, Robert S.; Schatz, Michael X.] Kaiser Permanente Southern Calif Reg, Dept Allergy & Res & Evaluat, San Diego, CA USA; [Zeiger, Robert S.; Schatz, Michael X.] Kaiser Permanente Southern Calif Reg, Dept Allergy & Res & Evaluat, Pasadena, CA USA; [Weiss, Scott T.] Partners Hlth Care, Partners Ctr Personalized Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston Medical Center; Boston University; Washington University (WUSTL); Kaiser Permanente; Kaiser Permanente; Partners Healthcare System	Litonjua, AA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA.; Litonjua, AA (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA.	augusto.litonjua@channing.harvard.edu		Bacharier, Leonard/0000-0003-0432-2704; Litonjua, Augusto/0000-0003-0422-5875; Zeiger, Robert/0000-0001-5788-5063; Mirzakhani, Hooman/0000-0002-2290-4436	National Heart, Lung, and Blood Institute [U01 HL091528]; National Research Service Award [T32-HL007427]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007427, R01HL091075, U01HL091528, R01HL091528] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study has received research support for Vitamin D Antenatal Asthma Reduction Trial (VDAART) by U01 HL091528 (to S.T.W. and A.A.L.) from the National Heart, Lung, and Blood Institute; and National Research Service Award T32-HL007427 (to H.M.).	Ali Z, 2013, J ASTHMA ALLERGY, V6, P53, DOI 10.2147/JAA.S43183; Baffi Cynthia Wilson, 2015, Asthma Res Pract, V1, P1; de Aguiar MM, 2014, RESP MED, V108, P1589, DOI 10.1016/j.rmed.2014.09.009; de Araujo GV, 2016, EUR J OBSTET GYN R B, V203, P25, DOI 10.1016/j.ejogrb.2016.05.010; Ekwaru JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111265; Ersfeld DL, 2004, CLIN BIOCHEM, V37, P867, DOI 10.1016/j.clinbiochem.2004.06.006; Kallen B, 2000, EUR J EPIDEMIOL, V16, P167, DOI 10.1023/A:1007678404911; Korn S, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-25; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Mirzakhani H, 2015, CLIN EXP ALLERGY, V45, P114, DOI 10.1111/cea.12430; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Palmsten K, 2016, J ALLER CL IMM-PRACT, V4, P310, DOI 10.1016/j.jaip.2015.11.019; Quinto KB, 2011, J ALLERGY CLIN IMMUN, V128, P964, DOI 10.1016/j.jaci.2011.06.031; Schatz M, 2005, ANN ALLERG ASTHMA IM, V95, P234, DOI 10.1016/S1081-1206(10)61219-7; SCHATZ M, 1988, Journal of Allergy and Clinical Immunology, V81, P509, DOI 10.1016/0091-6749(88)90187-X; Schatz M, 2003, J ALLERGY CLIN IMMUN, V112, P283, DOI 10.1067/mai.2003.1516; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Vanlint S, 2013, NUTRIENTS, V5, P949, DOI 10.3390/nu5030949	19	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2017	140	5					1453	+		10.1016/j.jaci.2017.03.053	http://dx.doi.org/10.1016/j.jaci.2017.03.053			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FL5RV	28606587	Green Accepted, Bronze			2022-12-18	WOS:000414304300031
J	Allen-Brady, K; Firszt, R; Fang, JC; Wong, J; Smith, KR; Peterson, KA				Allen-Brady, Kristina; Firszt, Rafael; Fang, John C.; Wong, Jathine; Smith, Ken R.; Peterson, Kathryn A.			Population-based familial aggregation of eosinophilic esophagitis suggests a genetic contribution	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Eosinophilic esophagitis; family clustering; familiality analysis; Utah Population Database	UTAH MORMONS; DYSPHAGIA; DISEASE; PREVALENCE; RISK; HERITABILITY; PEDIGREES; FEATURES; CANCER; ADULTS	Background: Prior familial clustering studies have observed an increased risk of eosinophilic esophagitis (EoE) mostly among first-degree relatives, suggesting a genetic contribution to EoE, and twin studies have suggested a powerful contribution from environmental factors. Objective: This study sought to clarify the contribution of genetic factors to EoE through estimation of familial aggregation and risk of EoE in extended relatives. Methods: The Utah Population Database, a population-based genealogy resource linked to electronic medical records for health care systems across the state of Utah, was used to identify EoE cases and age, sex, and birthplace-matched controls at a 5:1 ratio. Logistic regression was used to determine the odds of EoE among relatives of EoE probands compared with the odds of EoE among relatives of controls. Results: There were 4,423 EoE cases and 24,322 controls. The population-attributable risk of EoE was 31% (95% CI, 28% to 34%), suggesting a relatively strong genetic contribution. Risks of EoE were significantly increased among first-degree relatives (odds ratio [OR], 7.19; 95% CI, 5.65-9.14), particularly first-degree relatives of EoE cases diagnosed < 18 years of age (OR, 16.3; 95% CI, 9.4-28.3); second-degree relatives (OR, 1.99; 95% CI, 1.49-2.65); and first cousins (OR, 1.35; 95% CI, 1.03-1.77), providing evidence of a genetic contribution. However, spouses of EoE probands were observed to be at increased risk of EoE (OR, 2.86; 95% CI, 1.31-6.25), suggesting either positive assortative mating or a shared environmental contribution to EoE. Conclusions: This study supports a significant genetic contribution to EoE as evidenced by increased risk of EoE in distant relatives.	[Allen-Brady, Kristina; Fang, John C.; Peterson, Kathryn A.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Firszt, Rafael] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Wong, Jathine; Smith, Ken R.] Univ Utah, Huntsman Canc Inst Utah Populat Database Resource, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Allen-Brady, K (corresponding author), Genet Epidemiol, 391 Chipeta Way,Suite D, Salt Lake City, UT 84108 USA.	kristina.allen@utah.edu	Smith, Ken/B-6451-2011	Smith, Ken/0000-0003-0682-3705	UPDB from the Huntsman Cancer Foundation [P30 CA2014]; University of Utah; University of Utah's Program in Personalized Health and Center for Clinical and Translational Science; National Center for Research Resources grant, Sharing Statewide Health Data for Genetic Research [R01 RR021746]; Utah State Department of Health	UPDB from the Huntsman Cancer Foundation; University of Utah; University of Utah's Program in Personalized Health and Center for Clinical and Translational Science; National Center for Research Resources grant, Sharing Statewide Health Data for Genetic Research; Utah State Department of Health	We acknowledge partial support for the UPDB through grant P30 CA2014 from the Huntsman Cancer Foundation, the University of Utah, and from the University of Utah's Program in Personalized Health and Center for Clinical and Translational Science. UPDB research is also supported in part by the National Center for Research Resources grant, Sharing Statewide Health Data for Genetic Research (R01 RR021746, GM, PI) with additional support from the Utah State Department of Health and the University of Utah.	Alberici A, 2014, CURR ALZHEIMER RES, V11, P909, DOI 10.2174/1567205011666141107151606; Alexander ES, 2014, J ALLERGY CLIN IMMUN, V134, P1084, DOI 10.1016/j.jaci.2014.07.021; Arias A, 2016, ALIMENT PHARM THER, V43, P3, DOI 10.1111/apt.13441; ATTWOOD SEA, 1993, DIGEST DIS SCI, V38, P109, DOI 10.1007/BF01296781; Bai Y, 2000, AM J EPIDEMIOL, V151, P927; Blanchard C, 2006, J ALLERGY CLIN IMMUN, V118, P1054, DOI 10.1016/j.jaci.2006.07.038; Blangero J, 2013, ADV GENET, V81, P1, DOI 10.1016/B978-0-12-407677-8.00001-4; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Collins MH, 2008, CLIN GASTROENTEROL H, V6, P621, DOI 10.1016/j.cgh.2008.01.004; JORDE LB, 1989, ANN HUM GENET, V53, P339, DOI 10.1111/j.1469-1809.1989.tb01803.x; Jorde LB, 1981, INFORMATION SCI HUMA, V56, P105; Kapel RC, 2008, GASTROENTEROLOGY, V134, P1316, DOI 10.1053/j.gastro.2008.02.016; Katzka DA, 2007, GASTROINTEST ENDOSC, V65, P335, DOI 10.1016/j.gie.2006.10.049; KELLY KJ, 1995, GASTROENTEROLOGY, V109, P1503, DOI 10.1016/0016-5085(95)90637-1; Kerber RA, 2005, CANCER-AM CANCER SOC, V103, P1906, DOI 10.1002/cncr.20989; KERBER RA, 1995, GENET EPIDEMIOL, V12, P291, DOI 10.1002/gepi.1370120306; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Meyer GW, 2005, GASTROINTEST ENDOSC, V61, P932, DOI 10.1016/S0016-5107(05)00508-0; Noel RJ, 2004, NEW ENGL J MED, V351, P940, DOI 10.1056/NEJM200408263510924; Patel SM, 2005, GASTROINTEST ENDOSC, V61, P165, DOI 10.1016/S0016-5107(04)02459-9; Peters U, 2015, GUT, V64, P1623, DOI 10.1136/gutjnl-2013-306705; Prasad GA, 2007, AM J GASTROENTEROL, V102, P2627, DOI 10.1111/j.1572-0241.2007.01512.x; Ronkainen J, 2007, GUT, V56, P615, DOI 10.1136/gut.2006.107714; Rothenberg ME, 2015, GASTROENTEROLOGY, V148, P1143, DOI 10.1053/j.gastro.2015.02.002; Rybnicek DA, 2014, DIS ESOPHAGUS, V27, P703, DOI 10.1111/dote.12141; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Spergel JM, 2009, J PEDIATR GASTR NUTR, V48, P30, DOI 10.1097/MPG.0b013e3181788282; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zink DA, 2007, GASTROINTEST ENDOSC, V65, P330, DOI 10.1016/j.gie.2006.07.021	31	14	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1138	1143		10.1016/j.jaci.2016.12.979	http://dx.doi.org/10.1016/j.jaci.2016.12.979			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28192145	Bronze			2022-12-18	WOS:000412172900025
J	Forno, E; Sordillo, J; Brehm, J; Chen, W; Benos, T; Yan, Q; Avila, L; Soto-Quiros, M; Cloutier, MM; Colon-Semidey, A; Alvarez, M; Acosta-Perez, E; Weiss, ST; Litonjua, AA; Canino, G; Celedon, JC				Forno, Erick; Sordillo, Joanne; Brehm, John; Chen, Wei; Benos, Takis; Yan, Qi; Avila, Lydiana; Soto-Quiros, Manuel; Cloutier, Michelle M.; Colon-Semidey, Angel; Alvarez, Maria; Acosta-Perez, Edna; Weiss, Scott T.; Litonjua, Augusto A.; Canino, Glorisa; Celedon, Juan C.			Genome-wide interaction study of dust mite allergen on lung function in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Childhood asthma; lung function; dust mite allergen; genome-wide interaction study; gene-by-environment interactions; CEBP beta	PUERTO-RICAN CHILDREN; CHILDHOOD ASTHMA; AIRWAY INFLAMMATION; RISK-FACTORS; P-I; EXPOSURE; GENE; ASSOCIATION; POPULATION; EXACERBATIONS	Background: Childhood asthma is likely the result of gene-by-environment (G x E) interactions. Dust mite is a known risk factor for asthma morbidity. Yet, there have been no genome-wide G x E studies of dust mite allergen on asthmarelated phenotypes. Objective: We sought to identify genetic variants whose effects on lung function in children with asthma are modified by the level of dust mite allergen exposure. Methods: A genome-wide interaction analysis of dust mite allergen level and lung function was performed in a cohort of Puerto Rican children with asthma (Puerto Rico Genetics of Asthma and Lifestyle [PRGOAL]). Replication was attempted in 2 independent cohorts, the Childhood Asthma Management Program (CAMP) and the Genetics of Asthma in Costa Rica Study. Results: Single nucleotide polymorphism (SNP) rs117902240 showed a significant interaction effect on FEV1 with dust mite allergen level in PRGOAL (interaction P = 3.1 x 10(-8)), and replicated in the same direction in CAMP white children and CAMP Hispanic children (combined interaction P = .0065 for replication cohorts and 7.4 x 10(-9) for all cohorts). Rs117902240 was positively associated with FEV1 in children exposed to low dust mite allergen levels, but negatively associated with FEV1 in children exposed to high levels. This SNP is on chromosome 8q24, adjacent to a binding site for CCAAT/enhancer-binding protein beta, a transcription factor that forms part of the IL-17 signaling pathway. None of the SNPs identified for qFEV(1)/forced vital capacity replicated in the independent cohorts. Conclusions: Dust mite allergen exposure modifies the estimated effect of rs117902240 on FEV1 in children with asthma. Analysis of existing data suggests that this SNP may have transcription factor regulatory functions.	[Forno, Erick; Brehm, John; Chen, Wei; Yan, Qi; Celedon, Juan C.] Childrens Hosp Pittsburgh, UPMC, Div Pediat Pulm Med Allergy & Immunol, Pittsburgh, PA 15213 USA; [Forno, Erick; Brehm, John; Chen, Wei; Benos, Takis; Yan, Qi; Celedon, Juan C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Sordillo, Joanne; Weiss, Scott T.; Litonjua, Augusto A.] Harvard Med Sch, Dept Med, Channing Div Network Med, Boston, MA USA; [Sordillo, Joanne; Weiss, Scott T.; Litonjua, Augusto A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Avila, Lydiana; Soto-Quiros, Manuel] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Dept Pediat Pulmonol, San Jose, Costa Rica; [Cloutier, Michelle M.] Univ Connecticut, Hlth Ctr, Dept Pediat, Farmington, CT USA; [Colon-Semidey, Angel; Alvarez, Maria] Univ Puerto Rico, Dept Pediat, San Juan, PR 00936 USA; [Acosta-Perez, Edna; Canino, Glorisa] Univ Puerto Rico, Behav Sci Res Inst, San Juan, PR 00936 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Connecticut; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Celedon, JC (corresponding author), Childrens Hosp Pittsburgh, UPMC, Div Pulm Med Allergy & Immunol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	juan.celedon@chp.edu	Chen, Wei/AAX-5994-2020; Alvarez, Maria/GZH-1345-2022; Avila, Lydiana/D-5638-2015; Forno, Erick/I-1476-2019; Pérez, Edna Acosta/AAW-6672-2021	Chen, Wei/0000-0001-7196-8703; Avila, Lydiana/0000-0002-9579-1591; Forno, Erick/0000-0001-6497-9885; acosta, edna/0000-0001-7101-3157	US National Institutes of Health (NIH) [HL125666]; Children's Hospital of UPMC; US NIH [HL079966, HL117191]; Heinz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125666, R37HL066289, R01HL117191, R01HL079966] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of UPMC; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heinz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	E.F.'s contribution was supported by the US National Institutes of Health (NIH) (grant no. HL125666) and by the Children's Hospital of UPMC. J.C.C.'s contribution was supported by the US NIH (grant nos. HL079966 and HL117191), and by an endowment from the Heinz Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Blatter Joshua, 2014, Ann Am Thorac Soc, V11, P925, DOI 10.1513/AnnalsATS.201402-077OC; Brehm JM, 2015, AM J RESP CRIT CARE, V192, P47, DOI 10.1164/rccm.201501-0037OC; Brehm JM, 2012, J ALLERGY CLIN IMMUN, V129, P1484, DOI 10.1016/j.jaci.2012.03.035; Bunyavanich S, 2012, CLIN EXP ALLERGY, V42, P229, DOI 10.1111/j.1365-2222.2011.03874.x; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Chen WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137979; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; De Alba J, 2010, EUR RESPIR J, V35, P1377, DOI 10.1183/09031936.00022908; de Blay F, 2014, RESP MED, V108, P1430, DOI 10.1016/j.rmed.2014.07.017; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Ghitany Engy M., 2012, Environmental Health and Preventive Medicine, V17, P377, DOI 10.1007/s12199-011-0263-5; Forno E, 2012, J ALLERGY CLIN IMMUN, V130, P83, DOI 10.1016/j.jaci.2012.03.020; Forno E, 2010, CHEST, V138, P1156, DOI 10.1378/chest.09-2426; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Han YY, 2015, ANN ALLERG ASTHMA IM, V115, P288, DOI 10.1016/j.anai.2015.07.020; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hwang YJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03242; Ishikawa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00383; Jacobs TS, 2014, J ALLERGY CLIN IMMUN, V134, P737, DOI 10.1016/j.jaci.2014.03.028; Joost O, 2002, AM J RESP CRIT CARE, V165, P795, DOI 10.1164/ajrccm.165.6.2102057; Kanchongkittiphon W, 2014, ASIAN PAC J ALLERGY, V32, P103; Kitch BT, 2004, CHEST, V126, P1875, DOI 10.1378/chest.126.6.1875; Lau S, 2000, LANCET, V356, P1392, DOI 10.1016/S0140-6736(00)02842-7; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091950; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mosbech H, 2014, J ALLERGY CLIN IMMUN, V134, P568, DOI 10.1016/j.jaci.2014.03.019; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Ortiz RA, 2015, IMMUNOL ALLERGY CLIN, V35, P19, DOI 10.1016/j.iac.2014.09.014; Palmer LJ, 2000, EUR J HUM GENET, V8, P853, DOI 10.1038/sj.ejhg.5200551; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramsey CD, 2005, GENES IMMUN, V6, P236, DOI 10.1038/sj.gene.6364170; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sharma S, 2009, AM J RESP CRIT CARE, V179, P356, DOI 10.1164/rccm.200808-1268OC; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V136, P885, DOI 10.1016/j.jaci.2015.02.035; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Thomsen SF, 2011, RESP MED, V105, P1147, DOI 10.1016/j.rmed.2011.03.007; Wang L, 2014, ALLERGY, V69, P1181, DOI 10.1111/all.12188; World Health Organization, 2014, ASTHMA; Wu KH, 2014, AM J RESP CRIT CARE, V190, P619, DOI 10.1164/rccm.201403-0460OC; Zayats T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122501; Zhang ZL, 2015, AM J RESP CELL MOL, V52, P387, DOI 10.1165/rcmb.2014-0263OC; ZOCK JP, 1994, EUR RESPIR J, V7, P1254, DOI 10.1183/09031936.94.07071254	58	14	15	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					996	+		10.1016/j.jaci.2016.12.967	http://dx.doi.org/10.1016/j.jaci.2016.12.967			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28167095	Green Accepted, Bronze			2022-12-18	WOS:000412172900011
J	Gobl, C; Focke-Tejkl, M; Najafi, N; Schrank, E; Madl, T; Kosol, S; Madritsch, C; Dorofeeva, Y; Flicker, S; Thalhamer, J; Valenta, R; Zangger, K; Tjandra, N				Gobl, Christoph; Focke-Tejkl, Margarete; Najafi, Nazanin; Schrank, Evelyne; Madl, Tobias; Kosol, Simone; Madritsch, Christoph; Dorofeeva, Yulia; Flicker, Sabine; Thalhamer, Josef; Valenta, Rudolf; Zangger, Klaus; Tjandra, Nico			Flexible IgE epitope-containing domains of Phl p 5 cause high allergenic activity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GRASS-POLLEN ALLERGEN; RECOMBINANT; VACCINE		[Gobl, Christoph; Schrank, Evelyne; Kosol, Simone; Zangger, Klaus] Karl Franzens Univ Graz, Inst Chem Organ & Bioorgan Chem, Graz, Austria; [Gobl, Christoph; Madl, Tobias] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany; [Gobl, Christoph; Madl, Tobias] Tech Univ Munich, Dept Chem, Biomol NMR, Garching, Germany; [Gobl, Christoph; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bldg 10, Bethesda, MD 20892 USA; [Focke-Tejkl, Margarete; Najafi, Nazanin; Madritsch, Christoph; Dorofeeva, Yulia; Flicker, Sabine; Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Graz, Austria; [Thalhamer, Josef] Univ Salzburg, Dept Mol Biol, Div Allergy & Immunol, Salzburg, Austria; [Gobl, Christoph] Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada	University of Graz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University of Vienna; Medical University of Graz; Salzburg University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Valenta, R (corresponding author), Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	rudolf.valenta@meduniwien.ac.at; klaus.zangger@uni-graz.at; tjandran@nhlbi.nih.gov	Thalhamer, Josef/E-5787-2011; Goebl, Christoph/G-7578-2016; Madl, Tobias/B-1682-2012	Thalhamer, Josef/0000-0003-2285-6400; Madl, Tobias/0000-0002-9725-5231; Kosol, Simone/0000-0001-7913-4818; Valenta, Rudolf/0000-0001-5944-3365; Madritsch, Christoph/0000-0001-7044-7420; Flicker, Sabine/0000-0003-4768-8693; Gobl, Christoph/0000-0001-8614-1434	Austrian Academy of Sciences; Austrian Science Fund (FWF) (DK Molecular Enzymology) [W901]; National Heart, Lung, and Blood Institute of the National Institutes of Health; Austrian Science Fund (FWF) [F4605, F4607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048] Funding Source: NIH RePORTER	Austrian Academy of Sciences; Austrian Science Fund (FWF) (DK Molecular Enzymology)(Austrian Science Fund (FWF)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Christoph Gobl and Evelyne Schrank thank the Austrian Academy of Sciences for a DOC and a DOCfFORTE fellowship, respectively. Financial support to K.Z. by the Austrian Science Fund (FWF) (DK Molecular Enzymology W901) is gratefully acknowledged. We thank Motoshi Suzuki and Kang Chen for technical assistance, Vanessa Morris for carefully reading the manuscript, and Verena Hameter for help with protein purification.; This work was supported by the Intramural Research Program of National Heart, Lung, and Blood Institute of the National Institutes of Health to N.T. and by the Austrian Science Fund (FWF) (grant nos. F4605 and F4607 to R.V. and S.F., respectively).	Bufe A, 1996, J BIOL CHEM, V271, P27193, DOI 10.1074/jbc.271.44.27193; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Focke-Tejkl M, 2015, J ALLERGY CLIN IMMUN, V135, P1207, DOI 10.1016/j.jaci.2014.09.012; Focke-Tejkl M, 2014, J ALLERGY CLIN IMMUN, V133, P836, DOI 10.1016/j.jaci.2013.08.038; Gieras A, 2016, J ALLERGY CLIN IMMUN, V137, P1557, DOI 10.1016/j.jaci.2015.08.055; Maglio O, 2002, PROTEIN ENG, V15, P635, DOI 10.1093/protein/15.8.635; Rajashankar K, 2002, ACTA CRYSTALLOGR D, V58, P1175, DOI 10.1107/S0907444902007254; VRTALA S, 1993, J IMMUNOL, V151, P4773; Zieglmayer P, 2016, EBIOMEDICINE, V11, P43, DOI 10.1016/j.ebiom.2016.08.022	9	14	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2017	140	4					1187	+		10.1016/j.jaci.2017.05.005	http://dx.doi.org/10.1016/j.jaci.2017.05.005			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FI7JL	28532654	Bronze, Green Accepted			2022-12-18	WOS:000412172900041
J	Brestoff, JR; Zaydman, MA; Scott, MG; Gronowski, AM				Brestoff, Jonathan R.; Zaydman, Mark A.; Scott, Mitchell G.; Gronowski, Ann M.			Diagnosis of red meat allergy with antigen-specific IgE tests in serum	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PORK-CAT SYNDROME; ALPHA-GAL; INDUCED ANAPHYLAXIS; TICK BITES; GALACTOSE-ALPHA-1,3-GALACTOSE; SENSITIZATION; ANTIBODIES; GELATIN; CETUXIMAB; RELEVANCE		[Brestoff, Jonathan R.; Zaydman, Mark A.; Scott, Mitchell G.; Gronowski, Ann M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Brestoff, JR (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	brestoff@wustl.edu	Brestoff, Jonathan R./I-7000-2019	Brestoff, Jonathan R./0000-0002-7018-7400	Department of Pathology & Immunology at the Washington University School of Medicine in St Louis	Department of Pathology & Immunology at the Washington University School of Medicine in St Louis	This study was supported by funds from the Department of Pathology & Immunology at the Washington University School of Medicine in St Louis (to J.R.B.).	Alvarez-Perea A, 2014, J INVEST ALLERG CLIN, V24, P209; Apostolovic D, 2014, ALLERGY, V69, P1308, DOI 10.1111/all.12462; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; Calamari AM, 2015, EUR ANN ALLERGY CLIN, V47, P161; Caponetto P, 2013, J ALLER CL IMM-PRACT, V1, P302, DOI 10.1016/j.jaip.2013.01.007; Carrapatoso I, 2014, J INVEST ALLERG CLIN, V24, P206; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Cornmins SP, 2012, AM J RESP CRIT CARE, V185, P723, DOI 10.1164/rccm.201111-2017OC; Ebo DG, 2013, ACTA CLIN BELG, V68, P206, DOI 10.2143/ACB.3278; Fischer J, 2014, J ALLERGY CLIN IMMUN, V134, P755, DOI 10.1016/j.jaci.2014.05.051; Gonzalez-Quintela A, 2014, CLIN EXP ALLERGY, V44, P1061, DOI 10.1111/cea.12326; Hamsten C, 2013, ALLERGY, V68, P549, DOI 10.1111/all.12128; Jacquenet S, 2009, J ALLERGY CLIN IMMUN, V124, P603, DOI 10.1016/j.jaci.2009.06.014; Kollmann D, 2017, ALLERGY, V72, P266, DOI 10.1111/all.12948; Kusuma AaK AC, 2009, NEDERLANDS TIJDSCHRI, V19, P223; Arcediano AM, 2014, J INVEST ALLERG CLIN, V24, P450; Michel S, 2014, ALLERGY, V69, P403, DOI 10.1111/all.12344; Morisset M, 2012, ALLERGY, V67, P609, DOI 10.1111/j.1398-9995.2012.02799.x; Mozzicato SM, 2014, J ALLER CL IMM-PRACT, V2, P637, DOI 10.1016/j.jaip.2014.04.016; Muglia C, 2015, J ALLER CL IMM-PRACT, V3, P796, DOI 10.1016/j.jaip.2015.04.004; Mullins RJ, 2012, J ALLERGY CLIN IMMUN, V129, P1334, DOI 10.1016/j.jaci.2012.02.038; Platts-Mills TAE, 2016, J ALLERGY CLIN IMMUN, V137, P1662, DOI 10.1016/j.jaci.2016.04.010; Posthumus J, 2013, J ALLERGY CLIN IMMUN, V131, P923, DOI 10.1016/j.jaci.2012.12.665; Saleh Hana, 2012, Clin Mol Allergy, V10, P5, DOI 10.1186/1476-7961-10-5; Steinke JW, 2015, J ALLERGY CLIN IMMUN, V135, P589, DOI 10.1016/j.jaci.2014.12.1947; Uyttebroek A, 2014, J CLIN ANESTH, V26, P574, DOI 10.1016/j.jclinane.2014.04.014; Wen LP, 2015, ALLERGY ASTHMA IMMUN, V7, P92, DOI 10.4168/aair.2015.7.1.92	29	14	14	1	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					608	+		10.1016/j.jaci.2017.01.032	http://dx.doi.org/10.1016/j.jaci.2017.01.032			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28279684				2022-12-18	WOS:000406855500041
J	Johansson, E; Myers, JMB; Martin, LJ; He, H; Pilipenko, V; Mersha, T; Weirauch, M; Salomonis, N; Ryan, P; LeMasters, GK; Bernstein, DI; Lockey, J; Hershey, GKK				Johansson, Elisabet; Myers, Jocelyn M. Biagini; Martin, Lisa J.; He, Hua; Pilipenko, Valentina; Mersha, Tesfaye; Weirauch, Matthew; Salomonis, Nathan; Ryan, Patrick; LeMasters, Grace K.; Bernstein, David I.; Lockey, James; Hershey, Gurjit K. Khurana			KIF3A genetic variation is associated with pediatric asthma in the presence of eczema independent of allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI		[Johansson, Elisabet; Myers, Jocelyn M. Biagini; Mersha, Tesfaye; LeMasters, Grace K.; Hershey, Gurjit K. Khurana] Univ Cincinnati, Div Asthma Res, Cincinnati, OH 45220 USA; [Martin, Lisa J.; He, Hua; Pilipenko, Valentina] Univ Cincinnati, Div Human Genet, Cincinnati, OH USA; [Weirauch, Matthew] Univ Cincinnati, Ctr Autoimmune Genom & Etiol, Cincinnati, OH USA; [Salomonis, Nathan] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH USA; [Ryan, Patrick] Univ Cincinnati, Div Epidemiol & Biostat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Ryan, Patrick] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [LeMasters, Grace K.; Lockey, James] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Bernstein, David I.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hershey, GKK (corresponding author), Univ Cincinnati, Div Asthma Res, Cincinnati, OH 45220 USA.	Gurjit.Hershey@cchmc.org	Weirauch, Matthew/M-5459-2019; Ryan, Patrick/HDO-1133-2022; Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946; Biagini, Jocelyn/0000-0002-4378-6133	National Institutes of Health (NIH); NIH; American Heart Association [US2015/030984]; NIH [R01HL132344, R01 ES011170-08]; NIEHS (National Institute of Environmental Health Sciences); Industry Refractory Ceramic Fibers; University of Cincinnati; GlaxoSmithKlein; Merck; Novartis; Genentech; AstraSenzeca; Pearl; Circassia Pharmeaceuticals; TEVA; AZ; SANOFI; Adare Pharmaceuticals, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR070549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES011170, R01ES019890] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Industry Refractory Ceramic Fibers; University of Cincinnati; GlaxoSmithKlein; Merck(Merck & Company); Novartis(Novartis); Genentech(Roche HoldingGenentech); AstraSenzeca; Pearl(Luxembourg National Research Fund); Circassia Pharmeaceuticals; TEVA(Teva Pharmaceutical Industries); AZ; SANOFI; Adare Pharmaceuticals, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	E. Johansson's institute has received a grant and support for travel from the National Institutes of Health (NIH) for this work. J. M. B. Myers' institute has received a grant and support for travel from the NIH for this work and has received grants from NIH for other works. L. J. Martin's institution has received a grant from the NIH for this work and grants from the American Heart Association for this work and for Methods for Assessing Responsiveness to Asthma Treatment Based on VNN-1 Expression and Promoter Methylation (Patent # US2015/030984). H. He has received a grant from the NIH for this work. T. Mersha's institution has received an NIH grant (no. R01HL132344) for other works P. Ryan's institute has received a grant from the NIEHS (National Institute of Environmental Health Sciences) for this work. G. K. LeMasters' institute has received a grant from the NIH for this work, grants from the NIH and Industry Refractory Ceramic Fibers for other work, and a government patent for her work. D. I. Bernstein's institution has received a grant from the University of Cincinnati for this work and grants from GlaxoSmithKlein, Merck, Novartis, Genentech, AstraSenzeca, Pearl, and Circassia Pharmeaceuticals for other work; has personally received board membership from ABAI (The American Board of Allergy and Immunology) National Task Force PP; consultancy fees from TEVA and Merck; payment for lectures from Merck and AZ; and payment for the development of educational presentations from SANOFI. J. Lockey's institute has received a grant from the NIH (grant no. R01 ES011170-08) for this work. G. K. K. Hershey's institute has received a grant from the NIH for this work and a grant from Adare Pharmaceuticals, Inc, for other work. The rest of the authors declare that they have no relevant conflicts of interest.	Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Kovacic MB, 2012, PEDIAT ALLER IMM PUL, V25, P104, DOI 10.1089/ped.2011.0116; Kovacic MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023714; LeMasters GK, 2006, J PEDIATR-US, V149, P505, DOI 10.1016/j.jpeds.2006.06.035; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010	9	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2017	140	2					595	+		10.1016/j.jaci.2017.02.003	http://dx.doi.org/10.1016/j.jaci.2017.02.003			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	FC5BK	28238750	Green Accepted, Bronze			2022-12-18	WOS:000406855500036
J	Nicholas, B; Dudley, S; Tariq, K; Howarth, P; Lunn, K; Pink, S; Sterk, PJ; Adcock, IM; Monk, P; Djukanovic, R				Nicholas, Ben; Dudley, Sarah; Tariq, Kamran; Howarth, Peter; Lunn, Kerry; Pink, Sandy; Sterk, Peter J.; Adcock, Ian M.; Monk, Phillip; Djukanovic, Ratko		U-BIOPRED study grp	Susceptibility to influenza virus infection of bronchial biopsies in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Nicholas, Ben; Tariq, Kamran; Howarth, Peter; Djukanovic, Ratko] Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Clin & Expt Sci,Southampton Gen Hosp, Southampton, Hants, England; [Nicholas, Ben; Tariq, Kamran; Howarth, Peter; Pink, Sandy; Djukanovic, Ratko] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Nicholas, Ben; Tariq, Kamran; Howarth, Peter; Pink, Sandy; Djukanovic, Ratko] Southampton Gen Hosp, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Dudley, Sarah; Lunn, Kerry; Monk, Phillip] Synairgen Res Ltd, Southampton Gen Hosp, Southampton, Hants, England; [Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Amsterdam, Netherlands; [Adcock, Ian M.] Imperial Coll, Natl Heart & Lung Inst, Fac Med, London, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London	Nicholas, B (corresponding author), Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Clin & Expt Sci,Southampton Gen Hosp, Southampton, Hants, England.; Nicholas, B (corresponding author), Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England.; Nicholas, B (corresponding author), Southampton Gen Hosp, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England.	B.L.Nicholas@soton.ac.uk	Sterk, P.J./AAK-8175-2020; Adcock, Ian/L-3217-2019	Adcock, Ian/0000-0003-2101-8843; Nicholas, Benjamin/0000-0003-1467-9643; Djukanovic, Ratko/0000-0001-6039-5612; Howarth, Peter/0000-0003-0619-7927	Innovative Medicines Initiative Joint Undertaking [115010]; MRC [G1001367] Funding Source: UKRI; Medical Research Council [G1000758, G1001367] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10085] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish	Innovative Medicines Initiative Joint Undertaking; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The Unbiased BIOmarkers Predictive of REspiratory Disease outcomes project is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115010.	Gerke AK, 2014, RESPIROLOGY, V19, P116, DOI 10.1111/resp.12165; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Myles P, 2013, EUR RESPIR J, V41, P824, DOI 10.1183/09031936.00015512; Nicholas B, 2015, J IMMUNOL, V194, P6144, DOI 10.4049/jimmunol.1402283; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	9	14	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2017	140	1					309	+		10.1016/j.jaci.2016.12.964	http://dx.doi.org/10.1016/j.jaci.2016.12.964			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EZ2LY	28259448	Green Submitted, Bronze			2022-12-18	WOS:000404542000042
J	Devine, RE; McCleary, N; Sheikh, A; Nwaru, BI				Devine, Rebecca E.; McCleary, Nicola; Sheikh, Aziz; Nwaru, Bright I.			Acid-suppressive medications during pregnancy and risk of asthma and allergy in children: A systematic review and meta-analysis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PRENATAL EXPOSURE; CHILDHOOD ASTHMA; DRUG-USE; CROSSOVER		[Devine, Rebecca E.] Borders Gen Hosp, Natl Hlth Serv Borders Headquarters, Dept Publ Hlth, Melrose, Roxburgh, Scotland; [McCleary, Nicola; Sheikh, Aziz; Nwaru, Bright I.] Univ Edinburgh, Asthma UK Ctr Appl Res, Med Informat Ctr, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Nwaru, Bright I.] Univ Tampere, Sch Hlth Sci, Tampere, Finland	University of Edinburgh; Tampere University	Nwaru, BI (corresponding author), Univ Edinburgh, Asthma UK Ctr Appl Res, Med Informat Ctr, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland.; Nwaru, BI (corresponding author), Univ Tampere, Sch Hlth Sci, Tampere, Finland.	bright.nwaru@uta.fi		Sheikh, Aziz/0000-0001-7022-3056; McCleary, Nicola/0000-0002-4394-703X	Institute for Advanced Social Research Fellowship, University of Tampere, Finland; School of Health Sciences, University of Tampere, Finland; Farr Institute and Asthma UK Centre for Applied Research; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Institute for Advanced Social Research Fellowship, University of Tampere, Finland; School of Health Sciences, University of Tampere, Finland; Farr Institute and Asthma UK Centre for Applied Research; Asthma UK	B. I. Nwaru was supported by the Institute for Advanced Social Research Fellowship, University of Tampere, Finland; School of Health Sciences, University of Tampere, Finland; and Farr Institute and Asthma UK Centre for Applied Research. The rest of the authors declare that they have no relevant conflicts of interest.	Andersen ABT, 2012, ALIMENT PHARM THER, V35, P1190, DOI 10.1111/j.1365-2036.2012.05073.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Soriano LC, 2016, ALIMENT PHARM THER, V43, P427, DOI 10.1111/apt.13486; Dehlink E, 2009, CLIN EXP ALLERGY, V39, P246, DOI 10.1111/j.1365-2222.2008.03125.x; Devine RE, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.1; Grant RL., 2014, BMJ, V348, pf7450, DOI [DOI 10.1136/BMJ.F7450, 10.1136/bmj.f7450]; Guddat C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-34; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hak E, 2013, DRUG SAFETY, V36, P1097, DOI 10.1007/s40264-013-0093-z; Kallen B, 2013, PEDIAT ALLERG IMM-UK, V24, P28, DOI 10.1111/pai.12034; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mulder B, 2014, CLIN EXP ALLERGY, V44, P261, DOI 10.1111/cea.12227; Mulder B, 2013, J ALLERGY CLIN IMMUN, V132, P1438, DOI 10.1016/j.jaci.2013.07.012; Scholl I, 2007, FASEB J, V21, P1264, DOI 10.1096/fj.06-7223com; Simpson CR, 2010, J ROY SOC MED, V103, P98, DOI 10.1258/jrsm.2009.090348; Soriano LC, 2015, GASTROENTEROLOGY, V148, pS135; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Wang Y, 2014, J CLIN MED PRACT, V18, P88; Yitshak-Sade M, 2016, J CLIN PHARMACOL, V56, P116, DOI 10.1002/jcph.574	20	14	14	2	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2017	139	6					1985	+		10.1016/j.jaci.2016.09.046	http://dx.doi.org/10.1016/j.jaci.2016.09.046			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EW7VG	28081850	Green Accepted, Bronze			2022-12-18	WOS:000402724600030
J	Wood, RA; Burks, AW				Wood, Robert A.; Burks, A. Wesley			LEAPing forward with the new guidelines	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Food allergy; peanut allergy; prevention; guidelines	PEANUT CONSUMPTION; RISK; FEASIBILITY; ALLERGY; INFANTS		[Wood, Robert A.] Johns Hopkins Univ, Sch Med, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA; [Burks, A. Wesley] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Wood, RA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 600 N Wolfe St, Baltimore, MD 21287 USA.	rwood@jhmi.edu		Burks, Wesley/0000-0003-1873-5702	National Institutes of Health (NIH); Aimmune; Astellas; DBV; Hal-Allergy; Food Allergy & Anaphylaxis Network; NIH; Wallace Research Foundation; Food Allergy Research and Education; NIH AITC Review Panel; NIH HAI Study Section; World Allergy Organization; Aimmune Therapeutics; Epiva Biosciences; Genentech; Merck; Stallergenes; Valeant Pharmaceuticals North America; PPD Development; Allertein; Sanofi US Services	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aimmune; Astellas(Astellas Pharmaceuticals); DBV; Hal-Allergy(HAL Allergy Group); Food Allergy & Anaphylaxis Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallace Research Foundation; Food Allergy Research and Education; NIH AITC Review Panel(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HAI Study Section(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Allergy Organization; Aimmune Therapeutics; Epiva Biosciences; Genentech(Roche HoldingGenentech); Merck(Merck & Company); Stallergenes; Valeant Pharmaceuticals North America; PPD Development; Allertein; Sanofi US Services	R.A. Wood is employed by Johns Hopkins University; has received grants from the National Institutes of Health (NIH), Aimmune, Astellas, DBV, and Hal-Allergy; and has received royalties from UpToDate. A. W. Burks has received grants from the Food Allergy & Anaphylaxis Network, the NIH, and the Wallace Research Foundation; has received personal fees from Food Allergy Research and Education, the NIH AITC Review Panel, the NIH HAI Study Section, the World Allergy Organization, Aimmune Therapeutics, Epiva Biosciences, Genentech, Merck, Stallergenes, Valeant Pharmaceuticals North America, PPD Development, Allertein, and Sanofi US Services; and has received nonfinancial support from Regeneron Pharmaceuticals.	[Anonymous], 2001, WHO INFANT FEEDING R; Boyce JA, 2011, J AM ACAD DERMATOL, V64, P175, DOI [10.1016/j.jaad.2010.11.020, 10.1016/j.nutres.2011.01.001]; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Feeney M, 2016, J ALLERGY CLIN IMMUN, V138, P1108, DOI 10.1016/j.jaci.2016.04.016; Fleischer DM, 2015, J ALLERGY CLIN IMMUN, V136, P258, DOI 10.1016/j.jaci.2015.06.001; Ierodiakonou D, 2016, JAMA-J AM MED ASSOC, V316, P1181, DOI 10.1001/jama.2016.12623; Koplin JJ, 2016, J ALLERGY CLIN IMMUN, V138, P1131, DOI 10.1016/j.jaci.2016.04.011; Levin M, 2017, J ALLERGY C IN PRESS; O'Connor C, 2016, J ALLERGY CLIN IMMUN, V137, P1263, DOI 10.1016/j.jaci.2015.11.029; Palmer DJ, 2013, J ALLERGY CLIN IMMUN, V132, P387, DOI 10.1016/j.jaci.2013.05.002; Perkin MR, 2016, NEW ENGL J MED, V374, P1733, DOI 10.1056/NEJMoa1514210; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V126, P1191, DOI 10.1016/j.jaci.2010.08.036; Tan JWL, 2016, J ALLERGY CLIN IMMUN, V137, pAB398, DOI 10.1016/j.jaci.2015.12.1235; Togias A, 2017, J ALLERGY CLIN IMMUN, V139, P29, DOI 10.1016/j.jaci.2016.10.010	14	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2017	139	1					52	53		10.1016/j.jaci.2016.11.005	http://dx.doi.org/10.1016/j.jaci.2016.11.005			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EK5WM	28065282	Bronze			2022-12-18	WOS:000393996800006
J	Albenali, LH; Danby, S; Moustafa, M; Brown, K; Chittock, J; Shackley, F; Cork, MJ				Albenali, Lujain H.; Danby, Simon; Moustafa, Manar; Brown, Kirsty; Chittock, John; Shackley, Fiona; Cork, Michael J.			Vitamin D and antimicrobial peptide levels in patients with atopic dermatitis and atopic dermatitis complicated by eczema herpeticum: A pilot study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							D SUPPLEMENTATION; CATHELICIDIN; TRIAL; DEFICIENCY; CHILDREN; SKIN		[Albenali, Lujain H.; Danby, Simon; Brown, Kirsty; Chittock, John] Univ Sheffield, Sch Med, Acad Unit Dermatol Res, Fac Med Dent & Hlth,Dept Infect & Immun, Sheffield, S Yorkshire, England; [Albenali, Lujain H.; Moustafa, Manar; Shackley, Fiona; Cork, Michael J.] Sheffield Childrens Hosp, Peadiat Dermatol Allergy Clin, Sheffield, S Yorkshire, England; [Albenali, Lujain H.] Kuwait Minist Hlth, Kuwait, Kuwait	University of Sheffield; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Albenali, LH (corresponding author), Univ Sheffield, Sch Med, Acad Unit Dermatol Res, Fac Med Dent & Hlth,Dept Infect & Immun, Sheffield, S Yorkshire, England.; Albenali, LH (corresponding author), Sheffield Childrens Hosp, Peadiat Dermatol Allergy Clin, Sheffield, S Yorkshire, England.; Albenali, LH (corresponding author), Kuwait Minist Hlth, Kuwait, Kuwait.	l.albenali@sheffield.ac.uk		Cork, Michael/0000-0003-4428-2428; CHITTOCK, JOHN/0000-0002-1595-7441				Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; Al-Mutairi N, 2012, INDIAN J DERMATOL VE, V78, P342, DOI 10.4103/0378-6323.95451; Amestejani M, 2012, J DRUGS DERMATOL, V11, P327; Beck LA, 2009, J ALLERGY CLIN IMMUN, V124, P260, DOI 10.1016/j.jaci.2009.05.020; Bikle DD, 2012, REV ENDOCR METAB DIS, V13, P3, DOI 10.1007/s11154-011-9194-0; Camargo CA, 2014, J ALLERGY CLIN IMMUN, V134, P831, DOI 10.1016/j.jaci.2014.08.002; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; Hata TR, 2008, J INVEST DERMATOL, V128, pS62; Hata TR, 2014, J EUR ACAD DERMATOL, V28, P781, DOI 10.1111/jdv.12176; Hata TR, 2010, BRIT J DERMATOL, V163, P659, DOI 10.1111/j.1365-2133.2010.09892.x; Hata TR, 2008, J ALLERGY CLIN IMMUN, V122, P829, DOI 10.1016/j.jaci.2008.08.020; Heine G, 2013, BRIT J DERMATOL, V168, P855, DOI 10.1111/bjd.12077; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; Javanbakht MH, 2011, J DERMATOL TREAT, V22, P144, DOI 10.3109/09546630903578566; Peroni DG, 2011, BRIT J DERMATOL, V164, P1078, DOI 10.1111/j.1365-2133.2010.10147.x; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Sidbury R, 2008, BRIT J DERMATOL, V159, P245, DOI 10.1111/j.1365-2133.2008.08601.x	18	14	16	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1715	+		10.1016/j.jaci.2016.05.039	http://dx.doi.org/10.1016/j.jaci.2016.05.039			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27523434	Bronze, Green Accepted			2022-12-18	WOS:000390019300031
J	Tordesillas, L; Rahman, AH; Hartmann, BM; Sampson, HA; Berin, MC				Tordesillas, Leticia; Rahman, Adeeb H.; Hartmann, Boris M.; Sampson, Hugh A.; Berin, M. Cecilia			Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANAPHYLAXIS		[Tordesillas, Leticia; Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Tordesillas, Leticia; Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Rahman, Adeeb H.] Icahn Sch Med Mt Sinai, Human Immune Monitoring Core, New York, NY 10029 USA; [Rahman, Adeeb H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom, New York, NY 10029 USA; [Hartmann, Boris M.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Sampson, Hugh A.; Berin, M. Cecilia] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.; Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA.; Berin, MC (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.	cecilia.berin@mssm.edu	Hartmann, Boris M./A-6121-2010	Hartmann, Boris M./0000-0002-5649-6776; berin, cecilia/0000-0002-9051-9249	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118644] Funding Source: NIH RePORTER; NIAID NIH HHS [U24 AI118644] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Khodoun MV, 2011, P NATL ACAD SCI USA, V108, P12413, DOI 10.1073/pnas.1105695108; Kleine-Tebbe J, 2006, INT ARCH ALLERGY IMM, V141, P79, DOI 10.1159/000094495; Laidlaw TM, 2012, BLOOD, V119, P3790, DOI 10.1182/blood-2011-10-384826; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rahman AH, 2016, CYTOM PART A, V89A, P601, DOI 10.1002/cyto.a.22826; Smit JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028917; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030	10	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2016	138	6					1741	+		10.1016/j.jaci.2016.06.048	http://dx.doi.org/10.1016/j.jaci.2016.06.048			20	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EF0MK	27531074	Bronze, Green Accepted			2022-12-18	WOS:000390019300041
J	Moens, L; Frans, G; Bosch, B; Bossuyt, X; Verbinnen, B; Poppe, W; Boeckx, N; Slatter, M; Brusselmans, C; Diaz, G; Tousseyn, T; Flipts, H; Corveleyn, A; Dierickx, D; Meyts, I				Moens, Leen; Frans, Glynis; Bosch, Barbara; Bossuyt, Xavier; Verbinnen, Bert; Poppe, Willy; Boeckx, Nancy; Slatter, Mary; Brusselmans, Caroline; Diaz, George; Tousseyn, Thomas; Flipts, Helena; Corveleyn, Anniek; Dierickx, Daan; Meyts, Isabelle			Successful hematopoietic stem cell transplantation for myelofibrosis in an adult with warts-hypogammaglobulinemia-immunodeficiency-myelokathexis syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							WHIM-SYNDROME; CHOLINERGIC URTICARIA; CXCR4; TEMPERATURE; CETIRIZINE; CXCL12; TRIAL		[Moens, Leen; Frans, Glynis; Bossuyt, Xavier; Verbinnen, Bert] Univ Hosp Leuven, Dept Microbiol & Immunol, Expt Immunol Lab, Leuven, Belgium; [Bosch, Barbara] Univ Hosp Leuven, Dept Pediat Pulmonol, Leuven, Belgium; [Bossuyt, Xavier; Boeckx, Nancy; Brusselmans, Caroline] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Verbinnen, Bert] Thomas More Kempen, Biomed Lab Technol Life Sci & Chem, Geel, Belgium; [Poppe, Willy] Univ Hosp Gasthuisberg, Dept Obstet Gynaecol, Herestr, Leuven, Belgium; [Boeckx, Nancy] Katholieke Univ Leuven, Dept Oncol, Leuven, Belgium; [Slatter, Mary] Great North Childrens Hosp, Dept Paediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Diaz, George] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tousseyn, Thomas] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium; [Tousseyn, Thomas] Katholieke Univ Leuven, Translat Cell & Tissue Res, Leuven, Belgium; [Flipts, Helena; Corveleyn, Anniek] Univ Hosp Leuven, Dept Human Genet, Leuven, Belgium; [Dierickx, Daan] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Hematol, Lab Expt Hematol, Leuven, Belgium; [Meyts, Isabelle] Katholieke Univ Leuven, Dept Microbiol & Immunol, Childhood Immunol, Leuven, Belgium; [Meyts, Isabelle] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Icahn School of Medicine at Mount Sinai; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Meyts, I (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Childhood Immunol, Leuven, Belgium.; Meyts, I (corresponding author), Univ Hosp Leuven, Dept Pediat, Leuven, Belgium.	Isabelle.Meyts@uzleuven.be	Meyts, Isabelle/Z-3295-2019; Diaz, George/AAF-6199-2021; Bossuyt, Xavier/B-2085-2019	Bossuyt, Xavier/0000-0001-6856-8485; Tousseyn, Thomas/0000-0002-0397-1086				Al Ustwani O, 2014, BRIT J HAEMATOL, V164, P15, DOI 10.1111/bjh.12574; Altrichter S, 2015, J DERMATOL, V42, P422, DOI 10.1111/1346-8138.12765; Altrichter S, 2014, J DERMATOL SCI, V75, P88, DOI 10.1016/j.jdermsci.2014.04.007; Barbui T, 2016, AM J HEMATOL, V91, P430, DOI 10.1002/ajh.24288; Bogani C, 2008, STEM CELLS, V26, P1920, DOI 10.1634/stemcells.2008-0377; Cascio G, 2015, J IMMUNOL, V194, P5509, DOI 10.4049/jimmunol.1402419; Cohen SB, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-71; Doncker AV, 2011, CLIN MICROBIOL INFEC, V17, P135, DOI 10.1111/j.1469-0691.2010.03187.x; FAERMAN I, 1982, DIABETOLOGIA, V22, P96; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gunga HC, 2009, RESP PHYSIOL NEUROBI, V169, pS63, DOI 10.1016/j.resp.2009.04.005; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Kimberger O, 2009, BRIT J ANAESTH, V103, P226, DOI 10.1093/bja/aep134; Krivan G, 2010, EUR J HAEMATOL, V84, P274, DOI 10.1111/j.1600-0609.2009.01368.x; Magerl M, 2012, BRIT J DERMATOL, V166, P1095, DOI 10.1111/j.1365-2133.2012.10822.x; McDermott DH, 2015, CELL, V160, P686, DOI 10.1016/j.cell.2015.01.014; McDermott DH, 2014, BLOOD, V123, P2308, DOI 10.1182/blood-2013-09-527226; Montresor A, 2015, ONCOTARGET, V6, P34245, DOI 10.18632/oncotarget.5196; Opatz O, 2010, RESUSCITATION, V81, P1588, DOI 10.1016/j.resuscitation.2010.05.025; Zuberbier T, 1996, DERMATOLOGY, V193, P324, DOI 10.1159/000246281; Zuberbier T, 2014, ALLERGY, V69, P868, DOI 10.1111/all.12313; ZUBERBIER T, 1995, ACTA DERM-VENEREOL, V75, P147	22	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1485	+		10.1016/j.jaci.2016.04.057	http://dx.doi.org/10.1016/j.jaci.2016.04.057			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27484033	Bronze, Green Accepted			2022-12-18	WOS:000389542700041
J	Schwartz, C; Eberle, JU; Hoyler, T; Diefenbach, A; Lechmann, M; Voehringer, D				Schwartz, Christian; Eberle, Joerg U.; Hoyler, Thomas; Diefenbach, Andreas; Lechmann, Matthias; Voehringer, David			Opposing functions of thymic stromal lymphopoietin-responsive basophils and dendritic cells in a mouse model of atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFLAMMATION; TRIGGER; TSLP; SKIN		[Schwartz, Christian; Eberle, Joerg U.; Voehringer, David] Univ Hosp Erlangen, Dept Infect Biol, Erlangen, Germany; [Schwartz, Christian; Eberle, Joerg U.; Voehringer, David] Friedrich Alexander Univ Erlangen Nuremberg FAU, Erlangen, Germany; [Hoyler, Thomas] Inst Med Microbiol & Hyg IMMH, Freiburg, Germany; [Diefenbach, Andreas] Univ Mainz Med Ctr, Res Ctr Immunol, Mainz, Germany; [Diefenbach, Andreas] Univ Mainz Med Ctr, Inst Med Microbiol & Hyg, Mainz, Germany; [Lechmann, Matthias] Univ Hosp Erlangen, Dept Immunomodulat, Erlangen, Germany; [Schwartz, Christian] Trinity Coll Dublin, Sch Med, Trinity Biomed Sci Inst, Dublin, Ireland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Trinity College Dublin	Schwartz, C (corresponding author), Univ Hosp Erlangen, Dept Infect Biol, Erlangen, Germany.; Schwartz, C (corresponding author), Friedrich Alexander Univ Erlangen Nuremberg FAU, Erlangen, Germany.; Schwartz, C (corresponding author), Trinity Coll Dublin, Sch Med, Trinity Biomed Sci Inst, Dublin, Ireland.	david.voehringer@uk-erlangen.de	Voehringer, David/K-2776-2019; Diefenbach, Andreas/T-2589-2018; Schwartz, Christian/K-3716-2015	Diefenbach, Andreas/0000-0002-9176-9530; Schwartz, Christian/0000-0002-7084-268X; Eberle, Jorg/0000-0003-3806-7166; Hoyler, Thomas/0000-0003-4798-3692				Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Hochberg EP, 2001, BLOOD, V98, P1116, DOI 10.1182/blood.V98.4.1116; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sottini A, 2010, CLIN IMMUNOL, V136, P217, DOI 10.1016/j.clim.2010.04.005; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tatsuno K, 2015, J INVEST DERMATOL, V135, P3017, DOI 10.1038/jid.2015.318; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	13	14	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1443	+		10.1016/j.jaci.2016.04.031	http://dx.doi.org/10.1016/j.jaci.2016.04.031			14	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27372565				2022-12-18	WOS:000389542700027
J	Yang, G; Zhang, H; Liu, Y; Feng, Y; Luo, XQ; Liu, ZQ; Geng, XR; Wang, S; Zheng, PY; Feng, BS; Liu, ZG; Yang, PC; Li, HB; Wu, SD				Yang, Gui; Zhang, Hong; Liu, Yi; Feng, Ying; Luo, Xiang-Qian; Liu, Zhi-Qiang; Geng, Xiao-Rui; Wang, Shuai; Zheng, Peng-Yuan; Feng, Bai-Sui; Liu, Zhi-Gang; Yang, Ping-Chang; Li, Hua-Bin; Wu, Shan-Dong			Alternation of circadian clock modulates forkhead box protein-3 gene transcription in CD4(+) T cells in the intestine	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Yang, Gui; Liu, Yi; Feng, Ying; Wu, Shan-Dong] Hangzhou Zheda Dixun Biol Gene Engn Co LTD, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hong] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Yang, Gui; Liu, Zhi-Qiang; Geng, Xiao-Rui; Wang, Shuai; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Ctr Allergy & Immunol, Shenzhen, Peoples R China; [Luo, Xiang-Qian; Li, Hua-Bin] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Yang, Gui; Liu, Zhi-Qiang; Geng, Xiao-Rui; Wang, Shuai] Longgang ENT Hosp, Shenzhen, Peoples R China; [Zheng, Peng-Yuan] Zhengzhou Univ, Hosp 5, Dept Gastroenterol, Zhengzhou, Peoples R China; [Feng, Bai-Sui] Zhengzhou Univ, Hosp 2, Dept Gastroenterol, Zhengzhou, Peoples R China	Shanghai Jiao Tong University; Shenzhen University; Shanghai Jiao Tong University; Zhengzhou University; Zhengzhou University	Yang, G; Feng, Y (corresponding author), Hangzhou Zheda Dixun Biol Gene Engn Co LTD, Hangzhou, Zhejiang, Peoples R China.; Yang, G (corresponding author), Shenzhen Univ, Sch Med, Ctr Allergy & Immunol, Shenzhen, Peoples R China.; Luo, XQ (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.; Yang, G (corresponding author), Longgang ENT Hosp, Shenzhen, Peoples R China.	allergyli@163.com; shandongrwu@sina.com	Yang, Ping-Chang/K-4669-2019					Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Erren TC, 2009, J PINEAL RES, V46, P245, DOI 10.1111/j.1600-079X.2009.00665.x; Geiger SS, 2015, IMMUNOLOGY, V146, P349, DOI 10.1111/imm.12525; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ohnmacht C, 2010, J IMMUNOL, V184, P344, DOI 10.4049/jimmunol.0901841; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Reardon C, 2011, IMMUNITY, V35, P223, DOI 10.1016/j.immuni.2011.05.015; van Esch BCAM, 2010, CLIN EXP ALLERGY, V40, P1414, DOI 10.1111/j.1365-2222.2010.03500.x; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656	14	14	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2016	138	5					1446	+		10.1016/j.jaci.2016.04.035	http://dx.doi.org/10.1016/j.jaci.2016.04.035			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	EE4AA	27475735	Bronze			2022-12-18	WOS:000389542700028
J	Chandrasekaran, P; Zimmerman, O; Paulson, M; Sampaio, EP; Freeman, AF; Sowerwine, KJ; Hurt, D; Alcantara-Montiel, JC; Hsu, AP; Holland, SM				Chandrasekaran, Prabha; Zimmerman, Ofer; Paulson, Michelle; Sampaio, Elizabeth P.; Freeman, Alexandra F.; Sowerwine, Kathryn J.; Hurt, Darell; Alcantara-Montiel, Julio C.; Hsu, Amy P.; Holland, Steven M.			Distinct mutations at the same positions of STAT3 cause either loss or gain of function	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GRANULAR LYMPHOCYTIC-LEUKEMIA; HYPER-IGE SYNDROME		[Chandrasekaran, Prabha; Zimmerman, Ofer; Paulson, Michelle; Sampaio, Elizabeth P.; Freeman, Alexandra F.; Sowerwine, Kathryn J.; Hsu, Amy P.; Holland, Steven M.] NIAID, Immunopathogenesis Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Chandrasekaran, Prabha] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Hurt, Darell] NIAID, Bioinformat & Computat Biosci Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Alcantara-Montiel, Julio C.] CINVES TAV IPN, Dept Mol Biomed, Mexico City, DF, Mexico	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Holland, SM (corresponding author), NIAID, Immunopathogenesis Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	smh@nih.gov	Zimmerman, Ofer/GRT-0020-2022	Zimmerman, Ofer/0000-0002-1684-4684; Alcantara Montiel, Julio Cesar/0000-0001-8783-2456; Hsu, Amy/0000-0001-6841-2122	Intramural NIH HHS [Z01 AI000646-16] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, ZIAAI000646] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Duvander AS, 2006, I FRAMTIDSSTUDIER, P2; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Haapaniemi EM, 2015, BLOOD, V125, P639, DOI 10.1182/blood-2014-04-570101; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Jerez A, 2012, BLOOD, V120, P3048, DOI 10.1182/blood-2012-06-435297; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Nicolaou NC, 2008, J ALLERGY CLIN IMMUN, V122, P500, DOI 10.1016/j.jaci.2008.06.033; Ohgami RS, 2013, LEUKEMIA, V27, P2244, DOI 10.1038/leu.2013.104; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; Rawshani A, 2014, DIABETOLOGIA, V57, P1375, DOI 10.1007/s00125-014-3225-9; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049	13	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1222	1224		10.1016/j.jaci.2016.05.007	http://dx.doi.org/10.1016/j.jaci.2016.05.007			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27345172	Green Accepted, Bronze			2022-12-18	WOS:000385499400037
J	Choy, DF; Jia, GQ; Abbas, AR; Morshead, KB; Lewin-Koh, N; Dua, R; Rivera, P; Moonsamy, P; Fontecha, M; Balasubramanyam, A; Santini, C; Bassett, E; Ray, JM; Cabanski, CR; Bradley, MS; Maciuca, R; Mosesova, S; Scheerens, H; Arron, JR				Choy, David F.; Jia, Guiquan; Abbas, Alexander R.; Morshead, Katrina B.; Lewin-Koh, Nicholas; Dua, Rajiv; Rivera, Pauline; Moonsamy, Priscilla; Fontecha, Marcel; Balasubramanyam, Aarthi; Santini, Chris; Bassett, Ekaterina; Ray, Jill M.; Cabanski, Christopher R.; Bradley, Mary S.; Maciuca, Romeo; Mosesova, Sofia; Scheerens, Heleen; Arron, Joseph R.			Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MAST-CELLS; POLYMORPHISMS; SIGLEC-8		[Choy, David F.; Jia, Guiquan; Abbas, Alexander R.; Morshead, Katrina B.; Lewin-Koh, Nicholas; Bassett, Ekaterina; Ray, Jill M.; Cabanski, Christopher R.; Bradley, Mary S.; Maciuca, Romeo; Mosesova, Sofia; Scheerens, Heleen; Arron, Joseph R.] Genentech Inc, San Francisco, CA 94080 USA; [Dua, Rajiv; Rivera, Pauline; Moonsamy, Priscilla; Fontecha, Marcel; Balasubramanyam, Aarthi; Santini, Chris] Roche Mol Diagnost, Pleasanton, CA USA	Roche Holding; Genentech; Roche Holding	Arron, JR (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	arron.joseph@gene.com		Arron, Joseph/0000-0001-7677-9979				Arron JR, 2014, AM J RESP CRIT CARE, V189; Austin CJD, 2015, DRUG DISCOV TODAY, V20, P609, DOI 10.1016/j.drudis.2014.11.007; Bochner BS, 2009, CLIN EXP ALLERGY, V39, P317, DOI 10.1111/j.1365-2222.2008.03173.x; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Gao PS, 2010, EUR J HUM GENET, V18, P713, DOI 10.1038/ejhg.2009.239; Lee JS, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-138; O'Byrne PM, 2012, CLIN EXP ALLERGY, V42, P706, DOI 10.1111/j.1365-2222.2012.03965.x; Syed F, 2007, BIOMARKERS, V12, P414, DOI 10.1080/13547500701192652; Yokoi H, 2008, J ALLERGY CLIN IMMUN, V121, P499, DOI 10.1016/j.jaci.2007.10.004	10	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1230	1233		10.1016/j.jaci.2016.06.008	http://dx.doi.org/10.1016/j.jaci.2016.06.008			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27474124	Bronze			2022-12-18	WOS:000385499400040
J	Khan, DA				Khan, David A.			Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Review						Pharmacogenetics; pharmacogenomics; drug allergy; adverse drug reactions; drug hypersensitivity; beta-lactam; nonsteroidal anti-inflammatory drug; abacavir; carbamazepine	STEVENS-JOHNSON-SYNDROME; ASPIRIN-INTOLERANT ASTHMA; LEUKOTRIENE C-4 SYNTHASE; EXACERBATED RESPIRATORY-DISEASE; TOXIC EPIDERMAL NECROLYSIS; GENOME-WIDE ASSOCIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INDUCED HYPERSENSITIVITY REACTIONS; ALPHA PROMOTER POLYMORPHISMS; CHRONIC URTICARIA	Adverse drug reactions (ADRs) are a relatively common cause of morbidity and mortality. Many factors can contribute to ADRs, including genetics. The degree to which genetics contributes to ADRs is not entirely clear and varies by drug, as well as the type of ADR. Pharmacogenetics and, more recently, pharmacogenomics have been applied to the field of ADRs for both predictable ADRs and hypersensitivity drug reactions. Evaluations for glucose-6-phosphate dehydrogenase and thiopurine S-methyltransferase are commonplace clinical tests to reduce hematologic problems associated with drugs, such as dapsone and azathioprine, respectively. Numerous pharmacogenetic associations have been discovered for immediate hypersensitivity reactions to beta-lactams, aspirin, and nonsteroidal anti-inflammatory drugs; however, the clinical utility of testing for these genetic associations has not been established. In contrast, pharmacogenetic testing for HLA-B*1502 before carbamazepine in patients of certain Asian ethnicities and testing for HLA-B*5701 before abacavir treatment are recommended. This review will focus on pharmacogenetics and pharmacogenomics and their role in reducing ADRs, especially those caused by drug hypersensitivity reactions.	[Khan, David A.] Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Khan, DA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Allergy & Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dave.khan@utsouthwestern.edu			Vanberg Family Foundation	Vanberg Family Foundation	Supported by the Vanberg Family Foundation.	Agundez JAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047571; Cornejo-Garcia JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090966; Cornejo-Garcia JA, 2013, PHARMACOGENOMICS, V14, P1857, DOI 10.2217/pgs.13.166; Apter AJ, 2008, J ALLERGY CLIN IMMUN, V122, P152, DOI 10.1016/j.jaci.2008.03.037; Ayuso P, 2013, PHARMACOGENOMICS, V14, P1871, DOI 10.2217/pgs.13.155; Bae JS, 2007, J ALLERGY CLIN IMMUN, V119, P449, DOI 10.1016/j.jaci.2006.10.006; Bernstein JA, 2014, J ALLERGY CLIN IMMUN, V133, P1270, DOI 10.1016/j.jaci.2014.02.036; BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358; Bigby M, 2001, ARCH DERMATOL, V137, P765; Bursztejn AC, 2013, ALLERGY, V68, P1076, DOI 10.1111/all.12196; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Chang HS, 2015, PHARMACOGENOMICS J, V15, P316, DOI 10.1038/tpj.2014.78; Chang HS, 2011, ALLERGY ASTHMA IMMUN, V3, P256, DOI 10.4168/aair.2011.3.4.256; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chen SH, 2010, CLIN PHARMACOL THER, V88, P191, DOI 10.1038/clpt.2010.94; Choi JH, 2009, J CLIN PHARM THER, V34, P231, DOI 10.1111/j.1365-2710.2008.00979.x; Choi JH, 2006, TOHOKU J EXP MED, V208, P49, DOI 10.1620/tjem.208.49; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cornejo-Garcia JA, 2012, CLIN EXP ALLERGY, V42, P1772, DOI 10.1111/j.1365-2222.2012.04078.x; Cornejo-Garcia JA, 2012, ALLERGY, V67, P1181, DOI 10.1111/j.1398-9995.2012.02867.x; Demoly P, 2001, CURR OPIN ALLERGY CL, V1, P305, DOI 10.1097/01.all.0000011031.16814.e0; Devi K, 2005, Indian J Dermatol Venereol Leprol, V71, P325; Dubovsky SL, 2015, EXPERT OPIN DRUG MET, V11, P369, DOI 10.1517/17425255.2015.998996; Dursun AB, 2008, ANN ALLERG ASTHMA IM, V100, P420, DOI 10.1016/S1081-1206(10)60465-6; Esmaeilzadeh H, 2015, CLIN IMMUNOL, V160, P349, DOI 10.1016/j.clim.2015.05.012; Esmaeilzadeh H, 2015, EXPERT REV RESP MED, V9, P511, DOI 10.1586/17476348.2015.1081062; Fernandez CA, 2014, BLOOD, V124, P1266, DOI 10.1182/blood-2014-03-563742; Gao N, 2008, EUR J CLIN PHARMACOL, V64, P971, DOI 10.1007/s00228-008-0486-6; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Genin E, 2014, PHARMACOGENOMICS J, V14, P281, DOI 10.1038/tpj.2013.40; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; Gueant JL, 2015, J ALLERGY CLIN IMMUN, V135, P253, DOI 10.1016/j.jaci.2014.07.047; Gueant-Rodriguez RM, 2008, PHARMACOGENOMICS J, V8, P162, DOI 10.1038/sj.tpj.6500456; Gueant-Rodriguez RM, 2006, PHARMACOGENET GENOM, V16, P713, DOI 10.1097/01.fpc.0000230409.00276.44; Guglielmi L, 2006, ALLERGY, V61, P921, DOI 10.1111/j.1398-9995.2006.01067.x; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Huang CZ, 2012, INT J CLIN PHARM TH, V50, P461, DOI 10.5414/CP201691; Huang CZ, 2009, EUR J CLIN PHARMACOL, V65, P895, DOI 10.1007/s00228-009-0659-y; HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; In KH, 1997, J CLIN INVEST, V99, P1130, DOI 10.1172/JCI119241; Ingelman-Sundberg M, 2004, TRENDS PHARMACOL SCI, V25, P193, DOI 10.1016/j.tips.2004.02.007; Isidoro-Garcia M, 2005, J ALLERGY CLIN IMMUN, V115, P206, DOI 10.1016/j.jaci.2004.08.033; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305; Kamaliah MD, 1998, INT J DERMATOL, V37, P520, DOI 10.1046/j.1365-4362.1998.00490.x; Kaniwa N, 2008, PHARMACOGENOMICS, V9, P1617, DOI 10.2217/14622416.9.11.1617; Kawagishi Y, 2002, J ALLERGY CLIN IMMUN, V109, P936, DOI 10.1067/mai.2002.124466; Kedda MA, 2004, J ALLERGY CLIN IMMUN, V113, P889, DOI 10.1016/j.jaci.2004.02.008; Khan LM, 2013, EUR J CLIN PHARMACOL, V69, P1985, DOI 10.1007/s00228-013-1563-z; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013818; Kim SH, 2009, ALLERGY, V64, P213, DOI 10.1111/j.1398-9995.2008.01795.x; Kim SH, 2011, BRIT J DERMATOL, V165, P976, DOI 10.1111/j.1365-2133.2011.10467.x; Kim SH, 2011, EPILEPSY RES, V97, P190, DOI 10.1016/j.eplepsyres.2011.08.010; Kim SH, 2007, PHARMACOGENET GENOM, V17, P295, DOI 10.1097/01.fpc.0000239977.61841.fe; Kim SH, 2007, PHARMACOGENOMICS, V8, P1143, DOI 10.2217/14622416.8.9.1143; Kim SH, 2013, IMMUNOL ALLERGY CLIN, V33, P177, DOI 10.1016/j.iac.2012.10.003; Kim SH, 2006, CLIN EXP ALLERGY, V36, P433, DOI 10.1111/j.1365-2222.2006.02457.x; Kim SH, 2005, J KOREAN MED SCI, V20, P926, DOI 10.3346/jkms.2005.20.6.926; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kim SH, 2005, ALLERGY, V60, P760, DOI 10.1111/j.1398-9995.2005.00780.x; Kohyama K, 2012, MOL MED REP, V5, P477, DOI 10.3892/mmr.2011.680; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Kutszegi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140136; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lee MH, 2012, INTERN MED J, V42, P411, DOI 10.1111/j.1445-5994.2011.02567.x; Lesko LJ, 2014, BRIT J CLIN PHARMACO, V77, P606, DOI 10.1111/bcp.12299; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Lonjou C, 2008, PHARMACOGENET GENOM, V18, P99, DOI 10.1097/FPC.0b013e3282f3ef9c; Lorenz M, 2012, ACTA DERM-VENEREOL, V92, P194, DOI 10.2340/00015555-1268; Maggo SDS, 2016, CLIN PHARMACOKINET, V55, P419, DOI 10.1007/s40262-015-0324-9; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mastalerz L, 2006, BRIT J DERMATOL, V154, P256, DOI 10.1111/j.1365-2133.2005.06851.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mehta TY, 2009, INDIAN J DERMATOL VE, V75, P579, DOI 10.4103/0378-6323.57718; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; Ming L, 2011, J INT MED RES, V39, P388, DOI 10.1177/147323001103900206; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Motulsky Arno G, 2006, J Zhejiang Univ Sci B, V7, P169, DOI 10.1631/jzus.2006.B0169; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nam YH, 2012, J KOREAN MED SCI, V27, P1292, DOI 10.3346/jkms.2012.27.11.1292; Niihara H, 2012, J DERMATOL, V39, P594, DOI 10.1111/j.1346-8138.2011.01457.x; Oussalah A, 2016, ALLERGY, V71, P443, DOI 10.1111/all.12821; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Pacor ML, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/62489; Palikhe N, 2008, ALLERGY ASTHMA PROC, V29, P250, DOI 10.2500/aap.2008.29.3116; Palikhe NS, 2012, J HUM GENET, V57, P494, DOI 10.1038/jhg.2012.55; Park BL, 2013, HUM GENET, V132, P313, DOI 10.1007/s00439-012-1247-2; Park BL, 2010, BMB REP, V43, P445, DOI 10.5483/BMBRep.2010.43.6.445; Park HJ, 2008, J CLIN PHARM THER, V33, P691, DOI 10.1111/j.1365-2710.2008.00957.x; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Qiao HL, 2007, EUR J CLIN PHARMACOL, V63, P263, DOI 10.1007/s00228-006-0245-5; Qiao HL, 2005, ALLERGY, V60, P1053, DOI 10.1111/j.1398-9995.2005.00816.x; Qiao HL, 2004, ALLERGY, V59, P1326, DOI 10.1111/j.1398-9995.2004.00625.x; Quiralte J, 1999, J ALLERGY CLIN IMMUN, V103, P685, DOI 10.1016/S0091-6749(99)70243-5; Rajic V, 2015, LEUKEMIA LYMPHOMA, V56, P3103, DOI 10.3109/10428194.2015.1020802; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Sanchez-Borges M, 2009, J INVEST ALLERG CLIN, V19, P375; Saokaew S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094294; Shin SW, 2012, DNA CELL BIOL, V31, P1604, DOI 10.1089/dna.2012.1688; Somkrua R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-118; Sousa-Pinto B, 2015, J ALLERGY CLIN IMMUN, V136, P1092, DOI 10.1016/j.jaci.2015.03.019; Steenholdt C, 2012, ALIMENT PHARM THER, V36, P650, DOI 10.1111/apt.12010; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Tangamornsuksan W, 2013, JAMA DERMATOL, V149, P1025, DOI 10.1001/jamadermatol.2013.4114; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Temesgen Z, 2004, IMMUNOL ALLERGY CLIN, V24, P521, DOI 10.1016/j.iac.2004.03.006; Then SM, 2011, ASIAN PAC J ALLERGY, V29, P290; Van Sambeek R, 2000, J ALLERGY CLIN IMMUN, V106, P72, DOI 10.1067/mai.2000.107603; VESELL ES, 1968, SCIENCE, V159, P1479, DOI 10.1126/science.159.3822.1479; VESELL ES, 1969, J CLIN INVEST, V48, P2202, DOI 10.1172/JCI106186; VESELL ES, 1968, SCIENCE, V161, P72, DOI 10.1126/science.161.3836.72; Vidal C, 2013, J ALLERGY CLIN IMMUN, V132, P989, DOI 10.1016/j.jaci.2013.04.045; Vogel F., 1959, ERG INN MED KINDERHK, V12, P52, DOI 10.1007/978-3-642-94744-5_2; WHO, 1972, 498 WHO; Yang J, 2005, EUR J CLIN PHARMACOL, V61, P803, DOI 10.1007/s00228-005-0047-1; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; Zahari Z, 2014, DRUG METAB PHARMACOK, V29, P29, DOI 10.2133/dmpk.DMPK-13-RV-032; Zhang FR, 2013, NEW ENGL J MED, V369, P1620, DOI 10.1056/NEJMoa1213096	120	14	15	1	19	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					943	955		10.1016/j.jaci.2016.08.002	http://dx.doi.org/10.1016/j.jaci.2016.08.002			13	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27720019	Bronze			2022-12-18	WOS:000385499400001
J	Zhang, JH; Chen, J; Allen-Philbey, K; Baruhupolage, CP; Tachie-Menson, T; Mangat, SC; Garrod, DR; Robinson, C				Zhang, Jihui; Chen, Jie; Allen-Philbey, Kimberley; Baruhupolage, Chathuri Perera; Tachie-Menson, Theresa; Mangat, Shannon C.; Garrod, David R.; Robinson, Clive			Innate generation of thrombin and intracellular oxidants in airway epithelium by allergen Der p 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HYPER-IGE SYNDROME; GRANULAR LYMPHOCYTIC-LEUKEMIA; STAT3 MUTATIONS; INFLAMMATION; SUBSET; ASTHMA; PAR-1; CELLS; MICE		[Zhang, Jihui; Chen, Jie; Allen-Philbey, Kimberley; Baruhupolage, Chathuri Perera; Tachie-Menson, Theresa; Mangat, Shannon C.; Robinson, Clive] St Georges Univ London, Inst Infect & Immun, London, England; [Garrod, David R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Zhang, Jihui] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	St Georges University London; University of Manchester; Chinese Academy of Sciences; Institute of Microbiology, CAS	Robinson, C (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	c.robinson@sgul.ac.uk		Tachie-Menson, Theresa/0000-0003-0872-4030; Robinson, Clive/0000-0001-6253-7864	MRC [G9630879] Funding Source: UKRI; Medical Research Council [G9630879] Funding Source: Medline; Wellcome Trust [087650] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Antoniak S, 2013, J CLIN INVEST, V123, P1310, DOI 10.1172/JCI66125; Arachiche A, 2013, J BIOL CHEM, V288, P32553, DOI 10.1074/jbc.M113.472373; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI 10.1089/ARS.2008.2425; Couronne L, 2013, HAEMATOLOGICA, V98, P1748, DOI 10.3324/haematol.2013.085068; de Boer JD, 2015, AM J PHYSIOL-LUNG C, V309, pL768, DOI 10.1152/ajplung.00102.2015; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Heimall J, 2011, CLIN IMMUNOL, V139, P75, DOI 10.1016/j.clim.2011.01.001; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Ives ML, 2013, J ALLERGY CLIN IMMUN, V132, P400, DOI 10.1016/j.jaci.2013.05.029; Jerez A, 2013, BLOOD, V122, P2453, DOI 10.1182/blood-2013-04-494930; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kristensen T, 2014, J MOL DIAGN, V16, P382, DOI 10.1016/j.jmoldx.2014.02.005; Liu JY, 2011, EUR J PEDIATR, V170, P661, DOI 10.1007/s00431-010-1349-6; Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Newton GK, 2014, J MED CHEM, V57, P9447, DOI 10.1021/jm501102h; Ohgami RS, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2013.101543; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Schimke LF, 2010, J ALLERGY CLIN IMMUN, V126, P611, DOI 10.1016/j.jaci.2010.06.029; Terada M, 2004, AM J RESP CRIT CARE, V169, P373, DOI 10.1164/rccm.200308-1156OC	22	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2016	138	4					1224	1227		10.1016/j.jaci.2016.05.006	http://dx.doi.org/10.1016/j.jaci.2016.05.006			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DZ0AP	27345173	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000385499400038
J	Sarnowski, C; Laprise, C; Malerba, G; Moffatt, MF; Dizier, MH; Morin, A; Vincent, QB; Rohde, K; Esparza-Gordillo, J; Margaritte-Jeannin, P; Liang, LM; Lee, YA; Bousquet, J; Siroux, V; Pignatti, PF; Cookson, WO; Lathrop, M; Pastinen, T; Demenais, F; Bouzigon, E				Sarnowski, Chloe; Laprise, Catherine; Malerba, Giovanni; Moffatt, Miriam F.; Dizier, Marie-Helene; Morin, Andreanne; Vincent, Quentin B.; Rohde, Klaus; Esparza-Gordillo, Jorge; Margaritte-Jeannin, Patricia; Liang, Liming; Lee, Young-Ae; Bousquet, Jean; Siroux, Valerie; Pignatti, Pier Franco; Cookson, William O.; Lathrop, Mark; Pastinen, Tomi; Demenais, Florence; Bouzigon, Emmanuelle			DNA methylation within melatonin receptor 1A (MTNR1A) mediates paternally transmitted genetic variant effect on asthma plus rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Linkage analysis; positional cloning; asthma; allergic rhinitis; parent-of-origin effect; DNA methylation; genetic association study	GENOME-WIDE ASSOCIATION; ALLERGIC RHINITIS; POPULATION; PHENOTYPE; DISEASE; LINKAGE; RISK; FAMILIES; ATOPY; CTCF	Background: Asthma and allergic rhinitis (AR) are common allergic comorbidities with a strong genetic component in which epigenetic mechanisms might be involved. Objective: We aimed to identify novel risk loci for asthma and AR while accounting for parent-of-origin effect. Methods: We performed a series of genetic analyses, taking into account the parent-of-origin effect in families ascertained through asthma: (1) genome-wide linkage scan of asthma and AR in 615 European families, (2) association analysis with 1233 single nucleotide polymorphisms (SNPs) covering the significant linkage region in 162 French Epidemiological Study on the Genetics and Environment of Asthma families with replication in 154 Canadian Saguenay-Lac-Saint-Jean asthma study families, and (3) association analysis of disease and significant SNPs with DNA methylation (DNAm) at CpG sites in 40 Saguenay-Lac-Saint-Jean asthma study families. Results: We detected a significant paternal linkage of the 4q35 region to asthma and allergic rhinitis comorbidity (AAR; P = 7.2 x 10(-5)). Association analysis in this region showed strong evidence for the effect of the paternally inherited G allele of rs10009104 on AAR (P = 1.1 x 10(-5), reaching the multipletesting corrected threshold). This paternally inherited allele was also significantly associated with DNAm levels at the cg02303933 site (P = 1.7 x 10(-4)). Differential DNAm at this site was found to mediate the identified SNP-AAR association. Conclusion: By integrating genetic and epigenetic data, we identified that a differentially methylated CpG site within the melatonin receptor 1A (MTNR1A) gene mediates the effect of a paternally transmitted genetic variant on the comorbidity of asthma and AR. This study provides a novel insight into the role of epigenetic mechanisms in patients with allergic respiratory diseases.	[Sarnowski, Chloe; Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Demenais, Florence; Bouzigon, Emmanuelle] INSERM, Genet Variat & Human Dis Unit, UMR946, Paris, France; [Sarnowski, Chloe; Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Demenais, Florence; Bouzigon, Emmanuelle] Univ Paris Diderot, Inst Univ Hematol, Sorbonne Paris Cite, Paris, France; [Laprise, Catherine; Morin, Andreanne] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; [Malerba, Giovanni; Pignatti, Pier Franco] Univ Verona, Dept Mother & Child & Biol Genet, Sect Biol & Genet, Verona, Italy; [Moffatt, Miriam F.; Cookson, William O.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Vincent, Quentin B.] INSERM, Lab Human Genet Infect Dis, Necker Branch, UMR1163, Paris, France; [Vincent, Quentin B.] Univ Paris 05, Imagine Inst, Paris, France; [Morin, Andreanne; Lathrop, Mark; Pastinen, Tomi] McGill Univ, Montreal, PQ, Canada; [Morin, Andreanne; Lathrop, Mark; Pastinen, Tomi] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Rohde, Klaus; Esparza-Gordillo, Jorge; Lee, Young-Ae] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Esparza-Gordillo, Jorge] Charite Univ Med Berlin, Clin Pediat Allergy Expt & Clin Res Ctr, Berlin, Germany; [Liang, Liming] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Bousquet, Jean] Hop Arnaud de Villeneuve, Serv Malad Resp, Montpellier, France; [Siroux, Valerie] Univ Grenoble Alpes, Grenoble, France; [Siroux, Valerie] INSERM, Grenoble, France; [Siroux, Valerie] CHU Grenoble, IAB, Team Environm Epidemiol Appl Reprod & Resp Hlth, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Chicoutimi; University of Verona; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; McGill University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard T.H. Chan School of Public Health; Universite de Montpellier; CHU de Montpellier; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bouzigon, E (corresponding author), Univ Paris Diderot, INSERM, Inst Genet Mol, UMR946, 27 Rue Juliette Dodu, F-75010 Paris, France.	emmanuelle.bouzigon@inserm.fr	Dizier, Marie-Hélène/K-8463-2018; Bouzigon, Emmanuelle/L-2766-2017; siroux, valerie/N-1865-2013; Bousquet, Jean/O-4221-2019; Malerba, Giovanni/T-3278-2019; Demenais, Florence/G-3298-2013; Cookson, William/HHC-1790-2022	Dizier, Marie-Hélène/0000-0001-8460-7667; Bouzigon, Emmanuelle/0000-0001-5756-4286; siroux, valerie/0000-0001-7329-7237; Demenais, Florence/0000-0001-8361-0936; Sarnowski, Chloe/0000-0002-6090-7099; Laprise, Catherine/0000-0001-5526-9945	French National Agency for Research [ANR-CES-2009, ANR-11-BSV1-027-GWIS-AM]; Programme Hospitalier de Recherche Clinique (PHRC EvAdA project); Region Ile-de-France (DIM-SEnT grant); European Commission [018996]; French Ministry of Higher Education and Research; Wellcome Trust [WT084703MA]; Asthma UK; Canadian Institutes of Health Research (CIHR); Canada Research Chair; CIHR; FRSQ; Italian Ministry of University and Research	French National Agency for Research(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique (PHRC EvAdA project); Region Ile-de-France (DIM-SEnT grant)(Region Ile-de-France); European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Higher Education and Research; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Supported in part by the French National Agency for Research (ANR-CES-2009, ANR-11-BSV1-027-GWIS-AM), Programme Hospitalier de Recherche Clinique (PHRC 2012-EvAdA project), and Region Ile-de-France (DIM-SEnT grant). Genotyping of the asthma-ascertained samples was supported by grants from the European Commission (contract 018996), the French Ministry of Higher Education and Research, the Wellcome Trust (WT084703MA), and Asthma UK. The Canada Research Chair held by C.L. and the funding support from the Canadian Institutes of Health Research (CIHR) enabled the maintenance and continuation of the Saguenay-Lac-Saint-Jean asthma study. C.L. is the Director of the Inflammation and Remodeling Strategic Group of the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and a member of the Allergen Network. T.P. holds a Canada Research Chair and is supported by CIHR and FRSQ. The Italian family collection was supported by the Italian Ministry of University and Research.	Altmuller Janine, 2005, BMC Pulm Med, V5, P1, DOI 10.1186/1471-2466-5-1; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bouzigon E, 2004, HUM MOL GENET, V13, P3103, DOI 10.1093/hmg/ddh340; Bu LM, 2006, CLIN EXP ALLERGY, V36, P204, DOI 10.1111/j.1365-2222.2006.02397.x; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; Dizier MH, 2014, J ALLERGY CLIN IMMUN, V134, P576, DOI 10.1016/j.jaci.2013.12.1074; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Grundberg E, 2013, AM J HUM GENET, V93, P876, DOI 10.1016/j.ajhg.2013.10.004; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Harb H, 2015, J ALLERGY CLIN IMMUN, V135, P15, DOI 10.1016/j.jaci.2014.11.009; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li JY, 2015, CURR OPIN ALLERGY CL, V15, P33, DOI 10.1097/ACI.0000000000000124; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Malerba G, 2007, CLIN EXP ALLERGY, V37, P83, DOI 10.1111/j.1365-2222.2006.02615.x; Marseglia L, 2014, INT J MOL SCI, V15, P13482, DOI 10.3390/ijms150813482; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Masri S, 2013, NAT REV NEUROSCI, V14, P69, DOI 10.1038/nrn3393; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Shin IS, 2014, IMMUNOBIOLOGY, V219, P901, DOI 10.1016/j.imbio.2014.08.004; Vincent Q, 2006, BIOMETRICS, V62, P1071, DOI 10.1111/j.1541-0420.2006.00610.x; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang IV, 2012, J ALLERGY CLIN IMMUN, V130, P1243, DOI 10.1016/j.jaci.2012.07.052; Zhou JY, 2010, GENET EPIDEMIOL, V34, P151, DOI 10.1002/gepi.20445	36	14	14	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2016	138	3					748	753		10.1016/j.jaci.2015.12.1341	http://dx.doi.org/10.1016/j.jaci.2015.12.1341			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DY9ZM	27038909	Bronze			2022-12-18	WOS:000385496000010
J	Erwin, EA; Kruszewski, PG; Russo, JM; Schuyler, AJ; Platts-Mills, TAE				Erwin, Elizabeth A.; Kruszewski, Patrice G.; Russo, John M.; Schuyler, Alexander J.; Platts-Mills, Thomas A. E.			IgE antibodies and response to cow's milk elimination diet in pediatric eosinophilic esophagitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DISEASE; PEANUT		[Erwin, Elizabeth A.] Nationwide Childrens Hosp, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA; [Kruszewski, Patrice G.] Emory Univ, Div Pediat Gastroenterol Hepatol & Nutr, Atlanta, GA 30322 USA; [Russo, John M.] Nationwide Childrens Hosp, Div Pediat Gastroenterol Hepatol & Nutr, Columbus, OH USA; [Schuyler, Alexander J.; Platts-Mills, Thomas A. E.] Univ Virginia, Asthma & Allerg Dis Ctr, Charlottesville, VA USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Emory University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Virginia	Erwin, EA (corresponding author), Nationwide Childrens Hosp, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA.	Elizabeth.Erwin@nationwidechildrens.org		Platts-Mills, Thomas/0000-0002-1263-329X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI059317, R01AI020565] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI059317, R01 AI020565] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Clayton F, 2014, GASTROENTEROLOGY, V147, P602, DOI 10.1053/j.gastro.2014.05.036; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Erwin EA, 2015, J ALLER CL IMM-PRACT, V3, P896, DOI 10.1016/j.jaip.2015.05.015; Erwin EA, 2014, ANN ALLERG ASTHMA IM, V112, P545, DOI 10.1016/j.anai.2014.03.007; Kagalwalla AF, 2012, J PEDIATR GASTR NUTR, V55, P711, DOI 10.1097/MPG.0b013e318268da40; Kettaneh-Wold N, 2006, MULTI MEGAVARIATE 2; Kottyan LC, 2014, NAT GENET, V46, P895, DOI 10.1038/ng.3033; Kruszewski PG, 2015, DIS ESOPHAGUS, DOI [10.1111/dote.11239, DOI 10.1111/D0TE.11239]; Lane JP, 2015, J ALLERGY CLIN IMMUN, V135, P1654, DOI 10.1016/j.jaci.2015.01.024; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Varga EM, 2013, J ALLERGY CLIN IMMUN, V131, P1419, DOI 10.1016/j.jaci.2012.08.037; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007	13	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					625	628		10.1016/j.jaci.2016.01.048	http://dx.doi.org/10.1016/j.jaci.2016.01.048			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	27113847	Bronze, Green Accepted			2022-12-18	WOS:000380835800046
J	Schieck, M; Schouten, JP; Michel, S; Suttner, K; Toncheva, AA; Gaertner, VD; Illig, T; Lipinski, S; Franke, A; Klintschar, M; Kalayci, O; Sahiner, UM; Birben, E; Melen, E; Pershagen, G; Freidin, MB; Ogorodova, LM; Granell, R; Henderson, J; Brunekreef, B; Smit, HA; Vogelberg, C; von Berg, A; Bufe, A; Heinzmann, A; Laub, O; Rietschel, E; Simma, B; Genuneit, J; Jonigk, D; Postma, DS; Koppelman, GH; Vonk, JM; Timens, W; Boezen, HM; Kabesch, M				Schieck, Maximilian; Schouten, Jan P.; Michel, Sven; Suttner, Kathrin; Toncheva, Antoaneta A.; Gaertner, Vincent D.; Illig, Thomas; Lipinski, Simone; Franke, Andre; Klintschar, Michael; Kalayci, Omer; Sahiner, Umit M.; Birben, Esra; Melen, Erik; Pershagen, Goeran; Freidin, Maxim B.; Ogorodova, Ludmila M.; Granell, Raquel; Henderson, John; Brunekreef, Bert; Smit, Henriette A.; Vogelberg, Christian; von Berg, Andrea; Bufe, Albrecht; Heinzmann, Andrea; Laub, Otto; Rietschel, Ernst; Simma, Burkhard; Genuneit, Jon; Jonigk, Danny; Postma, Dirkje S.; Koppelman, Gerard H.; Vonk, Judith M.; Timens, Wim; Boezen, H. Marike; Kabesch, Michael			Doublesex and mab-3 related transcription factor 1 (DMRT1) is a sex-specific genetic determinant of childhood-onset asthma and is expressed in testis and macrophages	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; genetic association; DMRT1; interaction; rs3812523; sex; single nucleotide polymorphism	GENOME; ASSOCIATION; VARIANTS; HEALTH; RISK	Background: Asthma is a disease affecting more boys than girls in childhood and more women than men in adulthood. The mechanisms behind these sex-specific differences are not yet understood. Objective: We analyzed whether and how genetic factors contribute to sex-specific predispositionto childhood-onset asthma. Methods: Interactions between sex and polymorphisms on childhood asthma risk were evaluated in the Multicentre Asthma Genetics in Childhood Study (MAGICS)/Phase II International Study of Asthma and Allergies in Childhood (ISAAC II) population on a genome-wide level, and findings were validated in independent populations. Genetic fine mapping of sex-specific asthma association signals was performed, and putatively causal polymorphisms were characterized in vitro by using electrophoretic mobility shift and luciferase activity assays. Gene and protein expression of the identified gene doublesex and mab-3 related transcription factor 1 (DMRT1) were measured in different human tissues by using quantitative real-time PCR and immunohistochemistry. Results: Polymorphisms in the testis-associated gene DMRT1 displayed interactions with sex on asthma status in a population of primarily clinically defined asthmatic children and nonasthmatic control subjects (lowest P = 5.21 x 10(-6)). Replication of this interaction was successful in 2 childhood populations clinically assessed for asthma but showed heterogeneous results in other population-based samples. Polymorphism rs3812523 located in the putative DMRT1 promoter was associated with allele-specific changes in transcription factor binding and promoter activity in vitro. DMRT1 expression was observed not only in the testis but also in lung macrophages. Conclusion: DMRT1 might influence sex-specific patterns of childhood asthma, and its expression in testis tissue and lung macrophages suggests a potential involvement in hormone or immune cell regulation.	[Schieck, Maximilian; Michel, Sven; Toncheva, Antoaneta A.; Gaertner, Vincent D.; Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Campus St Hedwig,Steinmetzstr 1-3, Regensburg, Germany; [Schieck, Maximilian; Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Klintschar, Michael] Hannover Med Sch, Inst Legal Med, Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Schouten, Jan P.; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Suttner, Kathrin] Tech Univ Munich, ZAUM Ctr Allergy & Environm, Munich, Germany; [Suttner, Kathrin] Helmholtz Ctr Munich, Munich, Germany; [Illig, Thomas] Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Lipinski, Simone; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Kalayci, Omer; Sahiner, Umit M.; Birben, Esra] Hacettepe Univ, Dept Pediat, Pediat Allergy & Asthma Unit, Ankara, Turkey; [Melen, Erik; Pershagen, Goeran] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Melen, Erik] Sachs Children & Youth Hosp, Stockholm, Sweden; [Freidin, Maxim B.] Res Inst Med Genet, Tomsk, Russia; [Ogorodova, Ludmila M.] Siberian State Med Univ, Tomsk, Russia; [Granell, Raquel; Henderson, John] Univ Bristol, Fac Med & Dent, Sch Social & Community Med, Bristol, Avon, England; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Vogelberg, Christian] Tech Univ Dresden, Univ Childrens Hosp, Dresden, Germany; [von Berg, Andrea] Marien Hosp, Res Inst Prevent Allerg Dis, Childrens Dept, Wesel, Germany; [Bufe, Albrecht] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Heinzmann, Andrea] Albert Ludwigs Univ, Univ Childrens Hosp, Freiburg, Germany; [Laub, Otto] Kinder & Jugendarztpraxis Laub, Rosenheim, Germany; [Rietschel, Ernst] Univ Cologne, Univ Childrens Hosp, Cologne, Germany; [Simma, Burkhard] Landeskrankenhaus Feldkirch, Univ Teaching Hosp, Childrens Dept, Feldkirch, Germany; [Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pulmonol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, GRIAC Res Inst,Dept Pediat Pulmonol & Pediat Alle, Groningen, Netherlands	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Groningen; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Hacettepe University; Karolinska Institutet; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Siberian State Medical University; University of Bristol; Utrecht University; Utrecht University; Utrecht University Medical Center; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; St. Marien Hospital; Ruhr University Bochum; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; University of Groningen; University of Groningen; University of Groningen	Kabesch, M (corresponding author), Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, Campus St Hedwig,Steinmetzstr 1-3, Regensburg, Germany.	michael.kabesch@ukr.de	Schieck, Maximilian/D-4121-2013; Sahiner, Umit M/AAT-4811-2020; Kabesch, Michael/GZM-1583-2022; Toncheva, Antoaneta A/D-7169-2013; Granell, Raquel/AAB-5256-2022; Vonk, Judith/K-8477-2019; Timens, Wim/K-5570-2013; Freydin, Maxim/A-5603-2011; Granell, Raquel/AAY-4846-2020; Ogorodova, Ludmila M/S-5058-2016; Koppelman, Gerard/AAG-9187-2020; Freidin, Maxim B/A-8222-2014; Franke, Andre/B-2151-2010; Kabesch, Michael/AAB-5701-2020; Genuneit, Jon/I-9323-2012; Vonk, Judith M/ABA-3009-2020; Lipinski, Simone/L-9818-2017; Gaertner, Vincent/E-2049-2014	Schieck, Maximilian/0000-0001-5878-0546; Toncheva, Antoaneta A/0000-0001-5019-5174; Granell, Raquel/0000-0002-4890-4012; Vonk, Judith/0000-0001-7531-4547; Timens, Wim/0000-0002-4146-6363; Freydin, Maxim/0000-0002-1439-6259; Ogorodova, Ludmila M/0000-0002-2962-1076; Freidin, Maxim B/0000-0002-1439-6259; Franke, Andre/0000-0003-1530-5811; Genuneit, Jon/0000-0001-5764-1528; Vonk, Judith M/0000-0001-7531-4547; Lipinski, Simone/0000-0002-9322-7372; Koppelman, Gerard/0000-0001-8567-3252; BIRBEN, ESRA/0000-0003-1192-309X; Gaertner, Vincent/0000-0001-5330-652X	German Ministry of Education and Research (BMBF), National Genome Research Network (NGFN) [01GS0810]; DFG through the cluster of excellence REBIRTH [EXC 62/1]; Dutch Asthma Foundation [3.4.01.26, 3.2.06.022, 3.4.09.081, 3.2.10.085CO]; ZonMw (a Dutch organization for health research and development) [912-03-031]; Ministry of the Environment; European Commission, GABRIEL [018996, LSH-2004-1.2.5-1]; Netherlands Lung Foundation [AF 95.09, AF 98.48, AF 3.2.02.51, AF 3.2.07.015]; University Medical Center Groningen; UK Medical Research Council [102215/2/13/2]; Wellcome Trust [102215/2/13/2]; Swedish Research Council; Swedish Heart-Lung Foundation; Stockholm County Council (ALF); SFO (Strategic Research Area) Epidemiology Program at Karolinska Institutet; European Community [the GABRIEL project] [018996]; MRC [G0401540] Funding Source: UKRI; Medical Research Council [G9815508, MC_PC_15018, G0401540] Funding Source: researchfish	German Ministry of Education and Research (BMBF), National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); DFG through the cluster of excellence REBIRTH(German Research Foundation (DFG)); Dutch Asthma Foundation; ZonMw (a Dutch organization for health research and development)(Netherlands Organization for Health Research and Development); Ministry of the Environment(Ministry of the Environment, Japan); European Commission, GABRIEL(European Commission); Netherlands Lung Foundation; University Medical Center Groningen; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); SFO (Strategic Research Area) Epidemiology Program at Karolinska Institutet; European Community [the GABRIEL project]; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the German Ministry of Education and Research (BMBF) as part of the National Genome Research Network (NGFN grant 01GS0810). M.S. received funding from the DFG through the cluster of excellence REBIRTH (EXC 62/1). The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study is supported by the Dutch Asthma Foundation grants 3.4.01.26, 3.2.06.022, 3.4.09.081, and 3.2.10.085CO), the ZonMw (a Dutch organization for health research and development; grant 912-03-031), and the Ministry of the Environment. Genome-wide genotyping was funded by the European Commission as part of GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community; contract no. 018996) under the Integrated Program (LSH-2004-1.2.5-1, post genomic approaches to understand the molecular basis of asthma aiming at a preventive or therapeutic control). The Dutch Asthma Genetics study was supported by the Netherlands Lung Foundation (grants AF 95.09, AF 98.48, AF 3.2.02.51, and AF 3.2.07.015) and a grant from the University Medical Center Groningen. The UK Medical Research Council and the Wellcome Trust (joint grant code 102215/2/13/2) and the University of Bristol provided core support for the Avon Longitudinal Study of Parents and Children (ALSPAC). The Children, Allergy, Milieu, Stockholm an Epidemiological Study (BAMSE) was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, the Stockholm County Council (ALF), the SFO (Strategic Research Area) Epidemiology Program at Karolinska Institutet, and the European Community (contract no. 018996 [the GABRIEL project]).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aggarwal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/476357; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Barbaro M, 2009, EUR J HUM GENET, V17, P1439, DOI 10.1038/ejhg.2009.70; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JK, 2001, ENDOCRINOLOGY, V142, P1167, DOI 10.1210/en.142.3.1167; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Genuneit J, 2014, AM J RESP CRIT CARE, V190, P588, DOI 10.1164/rccm.201403-0428LE; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grabe Niels, 2002, In Silico Biology, V2, pS1; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Jorgensen A, 2012, MOL HUM REPROD, V18, P523, DOI 10.1093/molehr/gas030; Krentz AD, 2011, DEV BIOL, V356, P63, DOI 10.1016/j.ydbio.2011.05.658; Mandhane PJ, 2005, AM J RESP CRIT CARE, V172, P45, DOI 10.1164/rccm.200412-1738OC; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Meyers DA, 2014, LANCET RESP MED, V2, P405, DOI 10.1016/S2213-2600(14)70012-8; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers RA, 2014, HUM MOL GENET, V23, P5251, DOI 10.1093/hmg/ddu222; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Schaarschmidt H, 2015, J ALLERGY CLIN IMMUN, V136, P802, DOI 10.1016/j.jaci.2015.01.047; Schatz M, 2003, ANN ALLERG ASTHMA IM, V91, P553, DOI 10.1016/S1081-1206(10)61533-5; Schieck M, 2014, ALLERGY, V69, P1171, DOI 10.1111/all.12450; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Soto-Ramirez N, 2013, J EPIDEMIOL, V23, P399, DOI 10.2188/jea.JE20120201; Suttner K, 2009, J ALLERGY CLIN IMMUN, V123, P82, DOI 10.1016/j.jaci.2008.09.047; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ying M, 2007, BBA-MOL CELL RES, V1773, P804, DOI 10.1016/j.bbamcr.2007.03.006	35	14	15	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2016	138	2					421	431		10.1016/j.jaci.2015.12.1305	http://dx.doi.org/10.1016/j.jaci.2015.12.1305			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DS5PY	26906082	Green Submitted, Bronze			2022-12-18	WOS:000380835800012
J	Skevaki, C; Van den Berg, J; Jones, N; Garssen, J; Vuillermin, P; Levin, M; Landay, A; Renz, H; Calder, PC; Thornton, CA				Skevaki, Chrysanthi; Van den Berg, Jolice; Jones, Nicholas; Garssen, Johan; Vuillermin, Peter; Levin, Michael; Landay, Alan; Renz, Harald; Calder, Philip C.; Thornton, Catherine A.			Immune biomarkers in the spectrum of childhood noncommunicable diseases	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Biomarkers; noncommunicable diseases; children; inflammation; microRNA; blood; urine; breath; mass spectrometry	EXHALED NITRIC-OXIDE; INFLAMMATORY-BOWEL-DISEASE; ATOPIC-DERMATITIS; CELIAC-DISEASE; ENVIRONMENTAL DETERMINANTS; ENDOTHELIAL DYSFUNCTION; AUTOIMMUNE-THYROIDITIS; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; LUPUS-ERYTHEMATOSUS	A biomarker is an accurately and reproducibly quantifiable biological characteristic that provides an objective measure of health status or disease. Benefits of biomarkers include identification of therapeutic targets, monitoring of clinical interventions, and development of personalized (or precision) medicine. Challenges to the use of biomarkers include optimizing sample collection, processing and storage, validation, and often the need for sophisticated laboratory and bioinformatics approaches. Biomarkers offer better understanding of disease processes and should benefit the early detection, treatment, and management of multiple noncommunicable diseases (NCDs). This review will consider the utility of biomarkers in patients with allergic and other immune-mediated diseases in childhood. Typically, biomarkers are used currently to provide mechanistic insight or an objective measure of disease severity, with their future role in risk stratification/disease prediction speculative at best. There are many lessons to be learned from the biomarker strategies used for cancer in which biomarkers are in routine clinical use and industry-wide standardized approaches have been developed. Biomarker discovery and validation in children with disease lag behind those in adults; given the early onset and therefore potential lifelong effect of many NCDs, there should be more studies incorporating cohorts of children. Many pediatric biomarkers are at the discovery stage, with a long path to evaluation and clinical implementation. The ultimate challenge will be optimization of prevention strategies that can be implemented in children identified as being at risk of an NCD through the use of biomarkers.	[Skevaki, Chrysanthi; Van den Berg, Jolice; Jones, Nicholas; Garssen, Johan; Vuillermin, Peter; Levin, Michael; Landay, Alan; Renz, Harald; Calder, Philip C.; Thornton, Catherine A.] Int Inflammat In FLAME Network World Univ Network, Umea, Sweden; [Skevaki, Chrysanthi; Renz, Harald] Univ Marburg, Univ Hosp Giessen & Marburg GmbH Baldingerstr, Inst Lab Med & Pathobiochem, Mol Diagnost, Marburg, Germany; [Van den Berg, Jolice; Landay, Alan] Rush Univ, Med Ctr Chicago, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Jones, Nicholas; Thornton, Catherine A.] Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Garssen, Johan] Univ Utrecht, Beta Fac, Div Pharmacol, Utrecht Inst Pharmaceut Sci, NL-3508 TC Utrecht, Netherlands; [Vuillermin, Peter] Deakin Univ, Sch Med, Child Hlth Res Unit, Barwon Hlth, Geelong, Vic 3217, Australia; [Levin, Michael] Univ Cape Town, Div Asthma & Allergy, ZA-7925 Cape Town, South Africa; [Levin, Michael] Red Cross Childrens Hosp, Dept Pediat & Child Hlth, Cape Town, South Africa; [Calder, Philip C.] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO9 5NH, Hants, England; [Calder, Philip C.] Southampton Univ Hosp NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton SO9 5NH, Hants, England	Philipps University Marburg; University Hospital of Giessen & Marburg; Rush University; Swansea University; Utrecht University; Deakin University; University of Cape Town; University of Southampton; University of Southampton	Thornton, CA (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	c.a.thornton@swansea.ac.uk	garssen, johan/I-7159-2016; Calder, Philip C/E-9739-2013; Levin, Michael/AAT-2370-2020	Calder, Philip C/0000-0002-6038-710X; Levin, Michael/0000-0003-2439-7981; Jones, Nicholas/0000-0003-4846-5117	Deutsche Forschungsgemeinschaft [SFB 1021]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	C.L.S. and H.R. are supported by the Deutsche Forschungsgemeinschaft-funded SFB 1021.	Alduraywish SA, 2016, ALLERGY, V71, P77, DOI 10.1111/all.12784; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], 2014, GLOBAL ATLAS ALLERGY; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batstra MR, 1999, CLIN CHEM, V45, P2269; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bel EH, 2014, NEW ENGL J MED, V371, P1189, DOI 10.1056/NEJMoa1403291; Bruyndonckx L, 2014, J PEDIATR-US, V165, P300, DOI 10.1016/j.jpeds.2014.04.015; Bullens DMA, 2015, CLIN EXP ALLERGY, V45, P232, DOI 10.1111/cea.12389; Calder PC, 2014, ENDOCR METAB IMMUNE, V14, P236, DOI 10.2174/1871530314666140709091650; Cambuli VM, 2008, J CLIN ENDOCR METAB, V93, P3051, DOI 10.1210/jc.2008-0476; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Chandran V, 2014, ARTHRITIS RHEUMATOL, V66, pS704; Chiang LL, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-12; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Churov AV, 2015, AUTOIMMUN REV, V14, P1029, DOI 10.1016/j.autrev.2015.07.005; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cozzani E, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/321359; Dahlbom I, 2005, CLIN DIAGN LAB IMMUN, V12, P254, DOI 10.1128/CDLI.12.2.254-258.2005; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Decochez K, 2000, DIABETES CARE, V23, P1072, DOI 10.2337/diacare.23.8.1072; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Draibe JB, 2014, ARTHRITIS RHEUMATOL, V66, pS818; Ellis KL, 2004, PEDIATR DERMATOL, V21, P619, DOI 10.1111/j.0736-8046.2004.21600.x; Ezzat MHM, 2011, J EUR ACAD DERMATOL, V25, P334, DOI 10.1111/j.1468-3083.2010.03794.x; Ezzat MHM, 2009, INT J DERMATOL, V48, P822, DOI 10.1111/j.1365-4632.2009.04069.x; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Farook VS, 2015, PEDIATR OBES, V10, P320, DOI 10.1111/ijpo.270; Folsgaard NV, 2012, CLIN EXP ALLERGY, V42, P1596, DOI 10.1111/j.1365-2222.2012.04048.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Freue GVC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002963; Frohnert BI, 2016, PEDIATR DIABETES, V17, P3, DOI 10.1111/pedi.12323; Fujisawa T, 2009, PEDIATR ALLERGY IMMU, V20, P633, DOI 10.1111/j.1399-3038.2009.00851.x; Fusi A, 2015, LANCET ONCOL, V16, P1285, DOI 10.1016/S1470-2045(15)00307-1; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gogate S, 2008, CURR OPIN ALLERGY CL, V8, P154, DOI 10.1097/ACI.0b013e3282f60f61; Goodsaid Federico M, 2007, Drug Discov Today Technol, V4, P47, DOI 10.1016/j.ddtec.2007.10.010; Goodson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098799; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grodzinsky E, 2001, CLIN DIAGN LAB IMMUN, V8, P564, DOI 10.1128/CDLI.8.3.564-570.2001; Grzybowska-Chlebowczyk U, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/512695; Guo FH, 1997, J CLIN INVEST, V100, P829, DOI 10.1172/JCI119598; Gupta R, 2010, INDIAN J PEDIATR, V77, P41, DOI 10.1007/s12098-010-0006-4; Hacohen Y, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000081; Halmerbauer G, 1997, ALLERGY, V52, P765, DOI 10.1111/j.1398-9995.1997.tb01236.x; Halonen M, 2013, AM J RESP CRIT CARE, V188, P35, DOI 10.1164/rccm.201207-1265OC; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; He YQ, 2015, CLIN CHEM, V61, P1138, DOI 10.1373/clinchem.2015.241190; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hinz D, 2012, ALLERGY, V67, P380, DOI 10.1111/j.1398-9995.2011.02767.x; Hirsch S, 2015, EXPERT OPIN DRUG DIS, V10, P483, DOI 10.1517/17460441.2015.1025745; Holm T, 2014, ALLERGY, V69, P104, DOI 10.1111/all.12308; Hon KLE, 2004, CLIN EXP DERMATOL, V29, P293, DOI 10.1111/j.1365-2230.2004.01501.x; Huang H, 2014, IMMUNOL LETT, V162, P62, DOI 10.1016/j.imlet.2014.07.014; Huang Y, 2014, J PROTEOME RES, V13, P5715, DOI 10.1021/pr5007069; Huang YX, 2014, J PEDIATR GASTR NUTR, V59, P505, DOI 10.1097/MPG.0000000000000450; Hubenthal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140155; Hugle B, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-28; Ilie M, 2016, VIRCHOWS ARCH; Jasek M, 2014, ARTHRITIS RHEUMATOL, V66, pS1110; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Kabelitz M, 2003, EUR J ENDOCRINOL, V148, P301, DOI 10.1530/eje.0.1480301; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Kataoka Y, 2014, J DERMATOL, V41, P221, DOI 10.1111/1346-8138.12440; Khalyfa A, 2016, CHEST, V149, P786, DOI 10.1378/chest.15-0799; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Kim YS, 2004, PROTEOMICS, V4, P3353, DOI 10.1002/pmic.200401026; Klaassen EMM, 2015, AM J RESP CRIT CARE, V191, P201, DOI 10.1164/rccm.201408-1537OC; Konradsen JR, 2015, PEDIAT ALLERG IMM-UK, V26, P772, DOI 10.1111/pai.12457; Kopylov U, 2014, INFLAMM BOWEL DIS, V20, P742, DOI 10.1097/01.MIB.0000442681.85545.31; Kos Z, 2016, HISTOPATHOLOGY, V68, P70, DOI 10.1111/his.12795; Lampasona V, 2010, DIABETES CARE, V33, P104, DOI 10.2337/dc08-2305; Lee HS, 2014, DIABETES-METAB RES, V30, P424, DOI 10.1002/dmrr.2510; Leung TF, 2012, J EUR ACAD DERMATOL, V26, P518, DOI 10.1111/j.1468-3083.2011.04083.x; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Li YR, 2015, NAT MED, V21, P1018, DOI 10.1038/nm.3933; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Lu TX, 2012, J ALLERGY CLIN IMMUN, V129, P1064, DOI 10.1016/j.jaci.2012.01.060; Luo X, 2016, ALLERGY ASTHMA IMMUN, V8, P132, DOI 10.4168/aair.2016.8.2.132; Lv YN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; M'Koma AE, 2014, WORLD J GASTRO SURG, V6, P208, DOI 10.4240/wjgs.v6.i11.208; Madsen R, 2012, J PROTEOME RES, V11, P3796, DOI 10.1021/pr300296v; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maksymowych WP, 2014, CLIN EXP RHEUMATOL, V32, pS35; Malmborg P, 2013, J PEDIATR GASTR NUTR, V57, P29, DOI 10.1097/MPG.0b013e31828f21b4; Mayumi S, 2016, PEDIAT ALLERGY IMMUN; McGhee Julie L, 2004, BMC Pediatr, V4, P13, DOI 10.1186/1471-2431-4-13; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Midyat L, 2015, PEDIAT PULMONOL; Miyahara H, 2011, CLIN EXP ALLERGY, V41, P186, DOI 10.1111/j.1365-2222.2010.03634.x; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Muro Y, 2012, RHEUMATOLOGY, V51, P1508, DOI 10.1093/rheumatology/kes073; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Odhiambo JA, 2009, J ALLERGY CLIN IMMUN, V124, P1251, DOI 10.1016/j.jaci.2009.10.009; Oh SY, 2010, EUR J CLIN NUTR, V64, P245, DOI 10.1038/ejcn.2009.148; Orivuori L, 2015, CLIN EXP ALLERGY, V45, P928, DOI 10.1111/cea.12522; Park H, 2015, J BIOL CHEM, V290, P2831, DOI 10.1074/jbc.M114.591420; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Penders J, 2013, J ALLERGY CLIN IMMUN, V132, P601, DOI 10.1016/j.jaci.2013.05.043; Perl A, 2015, ANN NY ACAD SCI, V1346, P33, DOI 10.1111/nyas.12756; Pilia S, 2011, DIABETIC MED, V28, P896, DOI 10.1111/j.1464-5491.2011.03313.x; Prescott Susan, 2011, Ann Nutr Metab, V59 Suppl 1, P28, DOI 10.1159/000334150; Prescott SL, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-21; Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019; Prescott SL, 2009, CURR OPIN ALLERGY CL, V9, P417, DOI 10.1097/ACI.0b013e328330634f; Rebane A, 2015, ADV EXP MED BIOL, V888, P331, DOI 10.1007/978-3-319-22671-2_17; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Rifai N, 2006, CLIN CHEM, V52, P1635, DOI 10.1373/clinchem.2006.074492; Rosenbaum L, 2011, NEW ENGL J MED, V365, P2345, DOI 10.1056/NEJMp1112235; Russell MD, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00007; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Sawant Deepali V, 2015, Microrna, V4, P36; Schoeters GER, 2011, AM J CLIN NUTR, V94, p1964S, DOI 10.3945/ajcn.110.001545; Shen L, 2012, CLIN IMMUNOL, V145, P251, DOI 10.1016/j.clim.2012.09.013; Shi LN, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-7; Shin HJ, 2006, J BIOMED INFORM, V39, P227, DOI 10.1016/j.jbi.2005.04.002; Shorter JH, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/3/037108; Smith AD, 2004, AM J RESP CRIT CARE, V169, P473, DOI 10.1164/rccm.200310-1376OC; Smith D, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027101; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Song JS, 2015, ALLERGY, V70, P674, DOI 10.1111/all.12599; Stoicea N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00011; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Su KW, 2011, ALLERGY ASTHMA PROC, V32, P366, DOI 10.2500/aap.2011.32.3468; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Tansley SL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4198; Thompson JA, 2013, CLIN SCI, V125, P19, DOI 10.1042/CS20120673; Thomsen SF, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.24642; Torok KS, 2010, PEDIATR RHEUMATOL, V8, DOI 10.1186/1546-0096-8-15; Tran NH, 2015, THER ADV MED ONCOL, V7, P252, DOI 10.1177/1758834015591952; van de Kant KDG, 2012, PEDIAT ALLERG IMM-UK, V23, P259, DOI 10.1111/j.1399-3038.2011.01244.x; van Schaardenburg D, 2014, ARTHRITIS RHEUMATOL, V66, pS837; van Wietmarschen HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044331; Venkataraman D, 2014, J ALLERGY CLIN IMMUN, V134, P876, DOI 10.1016/j.jaci.2014.07.033; Vermeersch P, 2013, AUTOIMMUN REV, V12, P998, DOI 10.1016/j.autrev.2013.03.014; Vickery BP, 2010, ANN ALLERG ASTHMA IM, V105, P444, DOI 10.1016/j.anai.2010.09.030; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012; West PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112445; Whiteaker JR, 2007, J PROTEOME RES, V6, P3962, DOI 10.1021/pr070202v; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Whiteley P, 2006, PEDIATR INT, V48, P292, DOI 10.1111/j.1442-200X.2006.02207.x; WITTEMANN B, 1990, ARTHRITIS RHEUM, V33, P1378, DOI 10.1002/art.1780330910; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yu HH, 2016, J MICROBIOL IMMUNOL, V49, P264, DOI 10.1016/j.jmii.2014.05.012; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101; Zholudev A, 2004, AM J GASTROENTEROL, V99, P2235, DOI 10.1111/j.1572-0241.2004.40369.x; Zhou QH, 2015, ANN RHEUM DIS, V74, P1265, DOI 10.1136/annrheumdis-2013-204377	165	14	14	0	16	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2016	137	5					1302	1316		10.1016/j.jaci.2016.03.012	http://dx.doi.org/10.1016/j.jaci.2016.03.012			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	DM2MF	27155027	Bronze, Green Accepted			2022-12-18	WOS:000376180200002
J	Kim, TG; Kim, M; Lee, JJ; Kim, SH; Je, JH; Lee, Y; Song, MJ; Choi, Y; Chung, YW; Park, CG; Cho, JW; Lee, MG; Lee, YS; Kim, HP				Kim, Tae-Gyun; Kim, Mikyoung; Lee, Jong-Joo; Kim, Sung Hee; Je, Jeong Hwan; Lee, Yangsin; Song, Min-Ji; Choi, Yeeun; Chung, Youn Wook; Park, Chae Gyu; Cho, Jin Won; Lee, Min-Geol; Lee, Yeon-Su; Kim, Hyoung-Pyo			CCCTC-binding factor controls the homeostatic maintenance and migration of Langerhans cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						CCCTC-binding factor; dendritic cells; homeostasis; immune modulation; Langerhans cells; migration	DERMAL DENDRITIC CELLS; REGULATORY T-CELLS; CONTACT HYPERSENSITIVITY; IN-VIVO; V(D)J RECOMBINATION; REVEALS PRINCIPLES; PROTEIN CTCF; MICE; SKIN; EXPRESSION	Background: Langerhans cells (LCs) are skin-resident dendritic cells (DCs) that orchestrate skin immunity. CCCTC-binding factor (CTCF) is a highly conserved DNA-binding protein that regulates higher-order chromatin organization and is involved in various gene regulation processes. Objective: We sought to clarify a possible role for CTCF in LC homeostasis and function in vivo. Methods: We used a conditional gene deletion mouse system to generate DC-and LC-specific CTCF-ablated mice. Short hairpin RNA-mediated RNA interference was used to silence CTCF expression in human monocyte-derived Langerhans cells. DC populations were assessed by using flow cytometry and immunofluorescence. Gene expression arrays were performed to identify genes regulated by CTCF in LCs. Contact hypersensitivity and epicutaneous sensitization responses were measured to examine the functional significance of CTCF ablation. Results: DC-specific CTCF deletion led to a reduced pool of systemic DCs, with LCs most severely affected. Decreases in epidermal LC numbers were specifically associated with self-turnover defects. Interestingly, CTCF-deficient LCs demonstrated impaired migration out of the epidermis. Whole-transcriptome analyses revealed that genes that promoted cell adhesion were highly expressed, but CCR7 was downregulated in CTCF-depleted LCs. Hapten-induced contact hypersensitivity responses were more sustained in LC-specific CTCF-deficient mice, whereas epicutaneous sensitization to protein antigen was attenuated, indicating that CTCF-dependent LC homeostasis is required for optimal immune function of LCs in a context-dependent manner. Conclusion: Our results show that CTCF positively regulates the homeostatic pool and the efficient emigration of LCs, which are required for modulating the functional immune network of the skin.	[Kim, Tae-Gyun; Kim, Mikyoung; Lee, Jong-Joo; Song, Min-Ji; Choi, Yeeun; Chung, Youn Wook; Kim, Hyoung-Pyo] Yonsei Univ, Coll Med, Inst Trop Med, Dept Environm Med Biol, Seoul 120752, South Korea; [Kim, Tae-Gyun; Lee, Jong-Joo; Choi, Yeeun; Park, Chae Gyu; Lee, Min-Geol; Kim, Hyoung-Pyo] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Kim, Sung Hee; Je, Jeong Hwan; Lee, Min-Geol] Yonsei Univ, Coll Med, Dept Dermatol, Seoul 120752, South Korea; [Park, Chae Gyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Lee, Yangsin; Cho, Jin Won] Yonsei Univ, Grad Sch, Dept Integrated OMICS Biomed Sci, Seoul 120752, South Korea; [Lee, Yeon-Su] Natl Canc Ctr, Canc Genom Branch, Goyang, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; National Cancer Center - Korea (NCC)	Kim, HP (corresponding author), Yonsei Univ, Coll Med, Inst Trop Med, Dept Environm Med Biol, 50-1 Yonsei Ro, Seoul 120752, South Korea.	kimhp@yuhs.ac		Park, Chae Gyu/0000-0003-1906-1308; Kim, Hyoung-Pyo/0000-0003-1441-8822; Lee, Min-Geol/0000-0001-7040-5335; Cho, Jin Won/0000-0003-4527-1755; Chung, Youn Wook/0000-0002-4382-1410; Kim, Tae-Gyun/0000-0002-2116-4579	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2011-0030086, 2012M3A9B4028272, NRF-2013R1A1A2008812, NRF-2013R1A2A1A01008067]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	Supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP; NRF-2011-0030086, 2012M3A9B4028272, and NRF-2013R1A1A2008812 to H.P.-K. and NRF-2013R1A2A1A01008067 to J.W.C.).	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397; Antonopoulos C, 2008, J LEUKOCYTE BIOL, V83, P361, DOI 10.1189/jlb.0604352; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Clausen BE, 2010, IMMUNOL CELL BIOL, V88, P351, DOI 10.1038/icb.2010.40; de Aguero MG, 2012, J CLIN INVEST, V122, P1700, DOI 10.1172/JCI59725; de Almeida CR, 2011, IMMUNITY, V35, P501, DOI 10.1016/j.immuni.2011.07.014; de Almeida CR, 2009, J IMMUNOL, V182, P999, DOI 10.4049/jimmunol.182.2.999; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Flacher V, 2014, EMBO MOL MED, V6, P1191, DOI 10.15252/emmm.201303283; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Helft J, 2010, IMMUNOL REV, V234, P55, DOI 10.1111/j.0105-2896.2009.00885.x; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Honda T, 2010, J ALLERGY CLIN IMMUN, V125, P1154, DOI 10.1016/j.jaci.2009.12.005; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Jakob T, 2001, J ALLERGY CLIN IMMUN, V108, P688, DOI 10.1067/mai.2001.118797; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kaplan DH, 2010, TRENDS IMMUNOL, V31, P446, DOI 10.1016/j.it.2010.08.006; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kawamura T, 2012, J CLIN INVEST, V122, P722, DOI 10.1172/JCI58618; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kissenpfennig A, 2005, MOL CELL BIOL, V25, P88, DOI 10.1128/MCB.25.1.88-99.2005; Koesters C, 2007, IMMUNOL LETT, V109, P165, DOI 10.1016/j.imlet.2007.02.006; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee CH, 2015, EXP DERMATOL, V24, P67, DOI 10.1111/exd.12583; Lin SG, 2015, P NATL ACAD SCI USA, V112, P1815, DOI 10.1073/pnas.1424936112; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nikolic T, 2014, CELL MOL IMMUNOL, V11, P58, DOI 10.1038/cmi.2013.41; Noordegraaf M, 2010, J INVEST DERMATOL, V130, P2752, DOI 10.1038/jid.2010.223; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Romani N, 2012, J INVEST DERMATOL, V132, P872, DOI 10.1038/jid.2011.437; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Shih HY, 2012, P NATL ACAD SCI USA, V109, pE3493, DOI 10.1073/pnas.1214131109; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Sparber F, 2014, J DTSCH DERMATOL GES, V12, P1107, DOI 10.1111/ddg.12506; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stoitzner P, 2003, J INVEST DERMATOL, V120, P266, DOI 10.1046/j.1523-1747.2003.12042.x; Taveirne S, 2011, J LEUKOCYTE BIOL, V90, P61, DOI 10.1189/jlb.1010581; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P946, DOI 10.1167/iovs.11-8747	72	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2015	136	3					713	724		10.1016/j.jaci.2015.03.033	http://dx.doi.org/10.1016/j.jaci.2015.03.033			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CQ9EA	25936568	Bronze			2022-12-18	WOS:000360913300024
J	Anzilotti, C; Kienzler, AK; Lopez-Granados, E; Gooding, S; Davies, B; Pandit, H; Lucas, M; Price, A; Littlewood, T; van der Burg, M; Patel, SY; Chapel, H				Anzilotti, Consuelo; Kienzler, Anne-Kathrin; Lopez-Granados, Eduardo; Gooding, Sarah; Davies, Benjamin; Pandit, Hemant; Lucas, Mary; Price, Andrew; Littlewood, Timothy; van der Burg, Mirjam; Patel, Smita Y.; Chapel, Helen			Key stages of bone marrow B-cell maturation are defective in patients with common variable immunodeficiency disorders	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Anzilotti, Consuelo; Kienzler, Anne-Kathrin; Lopez-Granados, Eduardo; Gooding, Sarah; Lucas, Mary; Littlewood, Timothy; Patel, Smita Y.; Chapel, Helen] Univ Oxford, Oxford Univ Hosp, Nuffield Dept Med, Oxford, England; [Davies, Benjamin; Pandit, Hemant; Price, Andrew] Univ Oxford, Nuffield Orthopaed Hosp, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [van der Burg, Mirjam] Univ Med Ctr Rotterdam, Dept Immunol, Erasmus MC, Rotterdam, Netherlands	University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Erasmus University Rotterdam; Erasmus MC	Anzilotti, C (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.	helen.chapel@ndm.ox.ac.uk	Davies, Benjamin/AAO-3893-2020; Davies, Ben/GYD-9163-2022	Davies, Benjamin/0000-0002-4878-0697; Davies, Ben/0000-0003-3405-507X; Anzilotti, Consuelo/0000-0003-4528-0651; Pandit, Hemant/0000-0001-7392-8561; Kienzler, Anne-Kathrin/0000-0002-3082-9210; Patel, Smita/0000-0002-6207-2208				Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2012, J ALLERGY CLIN IMMUN, V130, P1197, DOI 10.1016/j.jaci.2012.05.046; Driessen GJ, 2011, BLOOD, V118, P6814, DOI 10.1182/blood-2011-06-361881; Espeli M, 2006, SEMIN IMMUNOL, V18, P56, DOI 10.1016/j.smim.2005.11.002; Keller M, 2014, CLIN EXP IMMUNOL, V177, P269, DOI 10.1111/cei.12255; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Ochtrop MLG, 2011, BLOOD, V118, P309, DOI 10.1182/blood-2010-11-321695; Orange JS, 2011, J ALLERGY CLIN IMMUN, V127, P1360, DOI 10.1016/j.jaci.2011.02.039; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912	11	14	14	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					487	+		10.1016/j.jaci.2014.12.1943	http://dx.doi.org/10.1016/j.jaci.2014.12.1943			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25725990	Bronze			2022-12-18	WOS:000359004900034
J	Douladiris, N; Linhart, B; Swoboda, I; Gstottner, A; Vassilopoulou, E; Stolz, F; Valenta, R; Papadopoulos, NG				Douladiris, Nikolaos; Linhart, Birgit; Swoboda, Ines; Gstoettner, Antonia; Vassilopoulou, Emilia; Stolz, Frank; Valenta, Rudolf; Papadopoulos, Nikolaos G.			In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PARVALBUMIN; IMMUNOTHERAPY		[Douladiris, Nikolaos; Vassilopoulou, Emilia; Papadopoulos, Nikolaos G.] Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece; [Linhart, Birgit; Swoboda, Ines; Gstoettner, Antonia; Valenta, Rudolf] Med Univ Vienna, Div Immunopathol, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Vassilopoulou, Emilia] Univ Nicosia, Nicosia, Cyprus; [Stolz, Frank] Biomay AG, Vienna, Austria	National & Kapodistrian University of Athens; Medical University of Vienna; University of Nicosia	Douladiris, N (corresponding author), Univ Athens, Dept Allergy, Pediat Clin 2, Athens, Greece.	birgit.linhart@meduniwien.ac.at	Papadopoulos, Nikolaos/ABE-1774-2021; Vassilopoulou, Emilia/AAE-7270-2021; N.G., Papadopoulos/L-8670-2013	Papadopoulos, Nikolaos/0000-0002-4448-3468; Vassilopoulou, Emilia/0000-0002-2665-5908; N.G., Papadopoulos/0000-0002-4448-3468; Swoboda, Ines/0000-0002-9164-1721; Valenta, Rudolf/0000-0001-5944-3365; Linhart, Birgit/0000-0001-6857-3049	Austrian Science Fund (FWF) [P 23350] Funding Source: researchfish; Austrian Science Fund FWF [F 4605] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bugajska-Schretter A, 1998, J ALLERGY CLIN IMMUN, V101, P67, DOI 10.1016/S0091-6749(98)70195-2; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Sampson HA, 2003, PEDIATRICS, V111, P1601; Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576; Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290; Tsabouri S, 2012, PEDIAT ALLERG IMM-UK, V23, P608, DOI 10.1111/j.1399-3038.2012.01275.x; Zuidmeer-Jongejan L, 2015, INT ARCH ALLERGY IMM, V166, P41, DOI 10.1159/000371657; Zuidmeer-Jongejan Laurian, 2012, Clin Transl Allergy, V2, P5, DOI 10.1186/2045-7022-2-5	8	14	15	0	11	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					493	+		10.1016/j.jaci.2015.01.015	http://dx.doi.org/10.1016/j.jaci.2015.01.015			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CO2RS	25746971	Green Accepted			2022-12-18	WOS:000359004900036
J	Nakagomi, D; Suzuki, K; Meguro, K; Hosokawa, J; Tamachi, T; Takatori, H; Suto, A; Matsue, H; Ohara, O; Nakayama, T; Shimada, S; Nakajima, H				Nakagomi, Daiki; Suzuki, Kotaro; Meguro, Kazuyuki; Hosokawa, Junichi; Tamachi, Tomohiro; Takatori, Hiroaki; Suto, Akira; Matsue, Hiroyuki; Ohara, Osamu; Nakayama, Toshinori; Shimada, Shinji; Nakajima, Hiroshi			Matrix metalloproteinase 12 is produced by M2 macrophages and plays important roles in the development of contact hypersensitivity	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Nakagomi, Daiki; Suzuki, Kotaro; Meguro, Kazuyuki; Hosokawa, Junichi; Tamachi, Tomohiro; Takatori, Hiroaki; Suto, Akira; Nakajima, Hiroshi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Matsue, Hiroyuki] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba, Japan; [Ohara, Osamu] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Nakayama, Toshinori] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Shimada, Shinji] Yamanashi Univ, Dept Dermatol, Grad Sch Med, Yamanashi, Japan	Chiba University; Chiba University; Kazusa DNA Research Institute; Chiba University; Japan Science & Technology Agency (JST); University of Yamanashi	Nakagomi, D (corresponding author), Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan.	suzuki_k@faculty.chiba-u.jp; nakajimh@faculty.chiba-u.jp	Tamachi, Tomohiro/I-1468-2017; Nakajima, Hiroshi/AFU-9313-2022; Nakayama, Toshinori/E-1067-2017; Ohara, Osamu/G-5448-2015	Tamachi, Tomohiro/0000-0001-8295-1472; Nakajima, Hiroshi/0000-0001-8595-9381; Nakayama, Toshinori/0000-0002-1434-2007; Ohara, Osamu/0000-0002-3328-9571; Suto, Akira/0000-0002-2593-565X	Grants-in-Aid for Scientific Research [26221305] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Li W, 2009, J MED CHEM, V52, P1799, DOI 10.1021/jm900093d; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004	5	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2015	135	5					1397	+		10.1016/j.jaci.2014.10.055	http://dx.doi.org/10.1016/j.jaci.2014.10.055			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CH4DA	25542885				2022-12-18	WOS:000353980700039
J	Jacobs, RL; Andrews, CP; Ramirez, DA; Rather, CG; Harper, N; Jimenez, F; Martinez, H; Manoharan, M; Carrillo, A; Gerardi, M; Esch, RE; He, W; Ahuja, SK				Jacobs, Robert L.; Andrews, Charles P.; Ramirez, Daniel A.; Rather, Cynthia G.; Harper, Nathan; Jimenez, Fabio; Martinez, Hernan; Manoharan, Muthu; Carrillo, Andrew; Gerardi, Margit; Esch, Robert E.; He, Weijing; Ahuja, Sunil K.			Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							POLLEN; IGE; IMMUNOTHERAPY; PLACEBO		[Jacobs, Robert L.; Andrews, Charles P.; Ramirez, Daniel A.; Rather, Cynthia G.] Biogen Res Chamber, San Antonio, TX 78201 USA; [Harper, Nathan; Jimenez, Fabio; Martinez, Hernan; Manoharan, Muthu; Carrillo, Andrew; Gerardi, Margit; He, Weijing; Ahuja, Sunil K.] South Texas Vet Hlth Care Syst, Vet Adm Ctr Personalized Med, San Antonio, TX USA; [Harper, Nathan; Jimenez, Fabio; Martinez, Hernan; Manoharan, Muthu; Carrillo, Andrew; He, Weijing; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Esch, Robert E.] Greer Labs, Lenoir, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Jacobs, RL (corresponding author), Biogen Res Chamber, San Antonio, TX 78201 USA.	robert.jacobs7025@sbcglobal.net	Manoharan, Muthu Saravanan/L-4851-2019	Andrews, Charles/0000-0002-8944-8404				Bernstein JA, 2012, J ALLERGY CLIN IMMUN, V130, P128, DOI 10.1016/j.jaci.2012.05.032; Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Ciprandi G, 2014, EXPERT REV CLIN IMMU, V10, P321, DOI 10.1586/1744666X.2014.872032; de Vos G, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0430-z; Devillier P, 2011, ALLERGY, V66, P163, DOI 10.1111/j.1398-9995.2010.02473.x; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Horak F, 1998, ALLERGY, V53, P849, DOI 10.1111/j.1398-9995.1998.tb03990.x; Jacobs RL, 2012, J ALLERGY CLIN IMMUN, V130, P122, DOI 10.1016/j.jaci.2012.03.031; Liu LY, 2003, J ALLERGY CLIN IMMUN, V111, P818, DOI 10.1067/mai.2003.1346; Majori M, 1997, RESPIRATION, V64, P45; U.S. Food and Drug Administration Center for Biologics Evaluation and Research, 2011, ALL PROD ADV COMM; Woodfolk JA, 2005, CLIN REV ALLERG IMMU, V28, P43, DOI 10.1385/CRIAI:28:1:043	13	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2015	135	4					1071	1075		10.1016/j.jaci.2014.09.047	http://dx.doi.org/10.1016/j.jaci.2014.09.047			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CF0MQ	25458003				2022-12-18	WOS:000352238600034
J	Bonnelykke, K; Raaschou-Nielsen, O; Tjonneland, A; Ulrik, CS; Bisgaard, H; Andersen, ZJ				Bonnelykke, Klaus; Raaschou-Nielsen, Ole; Tjonneland, Anne; Ulrik, Charlotte Suppli; Bisgaard, Hans; Andersen, Zorana Jovanovic			Postmenopausal hormone therapy and asthma-related hospital admission	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							REPLACEMENT THERAPY; UNITED-STATES; POPULATION; SENSITIZATION; ONSET		[Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, DK-1168 Copenhagen, Denmark; [Bonnelykke, Klaus; Bisgaard, Hans] Univ Copenhagen, Gentofte Hosp, Danish Pediat Asthma Ctr, DK-1168 Copenhagen, Denmark; [Raaschou-Nielsen, Ole; Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Ulrik, Charlotte Suppli] Hvidovre Univ Hosp, Dept Resp Med, Copenhagen, Denmark; [Ulrik, Charlotte Suppli] Univ Copenhagen, Copenhagen, Denmark; [Andersen, Zorana Jovanovic] Univ Copenhagen, Ctr Epidemiol & Screening, Dept Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Danish Cancer Society; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bonnelykke, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen Prospect Studies Asthma Childhood, DK-1168 Copenhagen, Denmark.	kb@copsac.com	Bisgaard, Hans/N-4761-2016; Raaschou-Nielsen, Ole/GOK-0338-2022; Andersen, Zorana Jovanovic/P-4983-2014	Bisgaard, Hans/0000-0003-4131-7592; Raaschou-Nielsen, Ole/0000-0002-1223-0909; Tjonneland, Anne/0000-0003-4385-2097; Bonnelykke, Klaus/0000-0003-2003-1018; Andersen, Zorana Jovanovic/0000-0003-4138-9828				Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Barr RG, 2004, ARCH INTERN MED, V164, P379, DOI 10.1001/archinte.164.4.379; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; CDC National Center for Health Statistics, 2001, NAT HLTH NUTR EX SUR; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Jarvis D, 2008, ALLERGY, V63, P95, DOI 10.1111/j.1398-9995.2007.01530.x; Jensen Annette Ostergaard, 2010, Clin Epidemiol, V2, P67; Lange P, 2001, THORAX, V56, P613, DOI 10.1136/thorax.56.8.613; National Asthma Education and Prevention Programme, EXP PAN GUID DIAGN M; Ogra PL, 2010, AGEING RES REV, V9, P101, DOI 10.1016/j.arr.2009.07.007; Real FG, 2006, THORAX, V61, P34, DOI 10.1136/thx.2005.040881; Romieu I, 2010, THORAX, V65, P292, DOI 10.1136/thx.2009.116079; Salo PM, 2014, J ALLERGY CLIN IMMUN, V134, P350, DOI 10.1016/j.jaci.2013.12.1071; Song WJ, 2014, CLIN EXP ALLERGY, V44, P553, DOI 10.1111/cea.12239; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; Ticconi C, 2013, PULM PHARMACOL THER, V26, P617, DOI 10.1016/j.pupt.2013.08.004; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104	18	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2015	135	3					813	816		10.1016/j.jaci.2014.11.019	http://dx.doi.org/10.1016/j.jaci.2014.11.019			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	CD4PF	25579482	Bronze			2022-12-18	WOS:000351065000030
J	Ji, H; Zhang, X; Oh, SH; Mayhew, CN; Ulm, A; Somineni, HK; Ericksen, M; Wells, JM; Hershey, GKK				Ji, Hong; Zhang, Xue; Oh, Sunghee; Mayhew, Christopher N.; Ulm, Ashley; Somineni, Hari K.; Ericksen, Mark; Wells, James M.; Hershey, Gurjit K. Khurana			Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Induced pluripotent stem cells; nasal epithelial cells; DNA methylation; gene expression; epigenetic memory; asthma	DIFFERENTIAL EXPRESSION ANALYSIS; SMALL-MOLECULE COMPOUNDS; HUMAN IPS CELLS; THERAPEUTIC OPPORTUNITIES; EPIGENETIC MEMORY; CHILDHOOD ASTHMA; AIRWAY EPITHELIA; SOMATIC-CELLS; REDOX CONTROL; GENE FAMILY	Background: Induced pluripotent stem cells (iPSCs) hold tremendous potential, both as a biological tool to uncover the pathophysiology of disease by creating relevant human cell models and as a source of cells for cell-based therapeutic applications. Studying the reprogramming process will also provide significant insight into tissue development. Objective: We sought to characterize the derivation of iPSC lines from nasal epithelial cells (NECs) isolated from nasal mucosa samples of children, a highly relevant and easily accessible tissue for pediatric populations. Methods: We performed detailed comparative analysis on the transcriptomes and methylomes of NECs, iPSCs derived from NECs (NEC-iPSCs), and embryonic stem cells (ESCs). Results: NEC-iPSCs express pluripotent cell markers, can differentiate into all 3 germ layers in vivo and in vitro, and have a transcriptome and methylome remarkably similar to those of ESCs. However, residual DNA methylation marks exist, which are differentially methylated between NEC-iPSCs and ESCs. A subset of these methylation markers related to epithelium development and asthma and specific to NEC-iPSCs persisted after several passages in vitro, suggesting the retention of an epigenetic memory of their tissue of origin. Our analysis also identified novel candidate genes with dynamic gene expression and DNA methylation changes during reprogramming, which are indicative of possible roles in airway epithelium development. Conclusion: NECs are an excellent tissue source to generate iPSCs in pediatric asthmatic patients, and detailed characterization of the resulting iPSC lines would help us better understand the reprogramming process and retention of epigenetic memory.	[Ji, Hong; Ulm, Ashley; Somineni, Hari K.; Ericksen, Mark; Hershey, Gurjit K. Khurana] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA; [Zhang, Xue] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Oh, Sunghee] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH USA; [Mayhew, Christopher N.; Wells, James M.] Cincinnati Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH USA; [Wells, James M.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Wells, James M.] Kim Sook Za Childrens Hosp, Med Ctr Res Fdn, Div Human Genet, Cheongju, South Korea	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Ji, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA.	Hong.Ji@cchmc.org	Mayhew, Christopher N/AGB-4929-2022	Khurana Hershey, Gurjit/0000-0001-6663-977X; Mayhew, Chris/0000-0002-7408-1726; Ji, Hong/0000-0002-9558-0620	National Institutes of Health/National Center for Advancing Translational Sciences [8UL1TR000077-04, U19 AI070412, 2U19AI70235];  [R21AI101375]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101375, U19AI070235, U19AI070412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092456] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Advancing Translational Sciences; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by R21AI101375 (to H.J.), National Institutes of Health/National Center for Advancing Translational Sciences 8UL1TR000077-04 (to H.J.), U19 AI070412 (to H.J.), and 2U19AI70235 (to G.K.K.H.).	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI 10.1089/ARS.2008.2425; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dizier MH, 2012, J ALLERGY CLIN IMMUN, V129, P1547, DOI 10.1016/j.jaci.2012.04.010; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fitzpatrick AM, 2012, ANTIOXID REDOX SIGN, V17, P375, DOI 10.1089/ars.2011.4198; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Islam T, 2008, AM J RESP CRIT CARE, V177, P388, DOI 10.1164/rccm.200706-863OC; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim K, 2011, NAT BIOTECHNOL, V29, P1117, DOI 10.1038/nbt.2052; Krieg P, 1997, GENOMICS, V43, P339, DOI 10.1006/geno.1997.4818; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Longmire TA, 2012, CELL STEM CELL, V10, P398, DOI 10.1016/j.stem.2012.01.019; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Planello Aline C, 2014, Cell Regen, V3, P4, DOI 10.1186/2045-9769-3-4; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Poole A, 2014, J ALLERGY CLIN IMMUN, V133, P670, DOI 10.1016/j.jaci.2013.11.025; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Suzuki T, 2014, AM J RESP CRIT CARE, V189, P183, DOI 10.1164/rccm.201306-1039OC; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455; Voelkel C, 2010, P NATL ACAD SCI USA, V107, P7805, DOI 10.1073/pnas.0914517107; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	65	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2015	135	1					236	244		10.1016/j.jaci.2014.08.038	http://dx.doi.org/10.1016/j.jaci.2014.08.038			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AY0PG	25441642	Green Accepted			2022-12-18	WOS:000347298200028
J	Csuka, D; Munthe-Fog, L; Hein, E; Zotter, Z; Prohaszka, Z; Farkas, H; Varga, L; Garred, P				Csuka, Dorottya; Munthe-Fog, Lea; Hein, Estrid; Zotter, Zsuzsanna; Prohaszka, Zoltan; Farkas, Henriette; Varga, Lilian; Garred, Peter			Activation of the ficolin-lectin pathway during attacks of hereditary angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Hereditary angioedema; C1-inhibitor; ficolins; MASPs; lectin pathway; edematous attack	MANNOSE-BINDING LECTIN; COMPLEMENT; C1-INHIBITOR; MBL; DEFICIENCY; SPECIFICITIES; INHIBITOR; PROTEIN; MASPS; C1	Background: The activation of plasma enzyme systems is insufficiently controlled in hereditary angioedema due to the deficiency of C1-inhibitor (C1-INH) (HAE-C1-INH). Recently, it was suggested that the ficolin-lectin pathway (ficolin-LP) might play a more dominant role than the mannose-binding lectin-lectin pathway in the pathomechanism of HAE-C1-INH. Objective: Because the role of the ficolin-LP during edematous attacks is still enigmatic, we analyzed its activity during such episodes. Methods: Thirty-five patients with HAE-C1-INH, who have experienced severe attacks on 106 occasions, were enrolled. We analyzed blood samples drawn during attacks, and obtained 35 samples from the same patients during symptom-free periods. The serum levels of ficolin-2, ficolin-3, MASP-2, ficolin-3/MASP-2 complex, C1-INH, and C4, as well as the extent of ficolin-3-mediated terminal complement complex (FCN3-TCC) deposition, were measured using ELISA-based methods. Results: Levels of MASP-2 and of the ficolin-3/MASP-2 complex were elevated (P < .0001 and .033, respectively), whereas that of FCN3-TCC was lower (P < .0001) during attacks than during the symptom-free period. During symptom-free periods, FCN3-TCC deposition was significantly related to concentrations of ficolin-3 (R = 0.2778; P = .0022), antigenic C1-INH (R = 0.3152; P = .0006), and C4 (R = 0.5307; P < .0001). Both ficolin-3 and MASP-2 levels correlated inversely with the time from the onset of the attack until blood sampling. Conclusions: There is a marked heterogeneity of the pathomechanism and development of hereditary angioedema attacks in different patients. Our results suggest that the activation of the ficolin-LP may deplete the innately low level of C1-INH and thus, it may contribute to the uncontrolled activation of plasma cascade systems, and thereby to edema formation.	[Csuka, Dorottya; Zotter, Zsuzsanna; Prohaszka, Zoltan; Farkas, Henriette; Varga, Lilian] Semmelweis Univ, Dept Internal Med 3, H-1125 Budapest, Hungary; [Csuka, Dorottya; Munthe-Fog, Lea; Hein, Estrid; Garred, Peter] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Clin Immunol,Mol Med Lab, Copenhagen, Denmark	Semmelweis University; Rigshospitalet; University of Copenhagen	Csuka, D (corresponding author), Semmelweis Univ, Fac Med, Dept Internal Med 3, Kutvolgyi Ut 4, H-1125 Budapest, Hungary.	csuka.dorottya@med.semmelweis-univ.hu	; Prohaszka, Zoltan/F-2191-2010	Garred, Peter/0000-0002-2876-8586; Prohaszka, Zoltan/0000-0003-1761-7982; Farkas, Henriette/0000-0003-2929-1721; Munthe-Fog, Lea/0000-0003-1345-176X; Csuka, Dorottya/0000-0003-3610-9852; Varga, Lilian/0000-0002-5484-364X	National Excellence Program - Elaborating and operating an inland student and researcher personal support system' [TAMOP 4.2.4. A/1-11-1-2012-0001, A1-EPFK-14-0092]; European Union; European Social Fund; Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [100886]	National Excellence Program - Elaborating and operating an inland student and researcher personal support system'; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was realized in the frames of TAMOP 4.2.4. A/1-11-1-2012-0001 "National Excellence Program - Elaborating and operating an inland student and researcher personal support system'' (grant no. A1-EPFK-14-0092). The project was subsidized by the European Union and cofinanced by the European Social Fund. The equipment and the infrastructure of the research was supported by the Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) 100886 (HF) grant, the Novo Nordisk Research Foundation, the Svend Andersen Foundation, the Danish Medical Research Council, and the Capital Region of Denmark.	AGOSTONI A, 1992, MEDICINE, V71, P206, DOI 10.1097/00005792-199207000-00003; Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Csuka D, 2013, MOL IMMUNOL, V54, P271, DOI 10.1016/j.molimm.2012.12.015; Csuka D, 2013, J IMMUNOL METHODS, V387, P237, DOI 10.1016/j.jim.2012.10.018; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Farkas H, 2001, LANCET, V358, P1695, DOI 10.1016/S0140-6736(01)06720-4; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Konings J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074043; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Nielsen EW, 1996, SCAND J IMMUNOL, V44, P185; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Skjoedt MO, 2010, IMMUNOBIOLOGY, V215, P921, DOI 10.1016/j.imbio.2009.10.006; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Varga L, 2008, CLIN EXP IMMUNOL, V153, P68, DOI 10.1111/j.1365-2249.2008.03671.x; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; ZICCARDI RJ, 1982, J IMMUNOL, V128, P2505; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	28	14	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2014	134	6					1388	+		10.1016/j.jaci.2014.05.030	http://dx.doi.org/10.1016/j.jaci.2014.05.030			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AW1UG	25042985				2022-12-18	WOS:000346075400022
J	Jun, YJ; Park, SJ; Kim, TH; Lee, SH; Lee, KJ; Hwang, SM; Lee, SH				Jun, Young Joon; Park, Se Jin; Kim, Tae Hoon; Lee, Seung Hoon; Lee, Ki Jeong; Hwang, Soo Min; Lee, Sang Hag			Expression of 11 beta-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						11 beta-Hydroxysteroid dehydrogenase 1; 11 beta-hydroxysteroid dehydrogenase 2; CYP11B1; CYP11A1; chronic rhinosinusitis with nasal polyps; chronic rhinosinusitis without nasal polyps; glucocorticoid; cortisol	GENE-EXPRESSION; HUMAN LUNG; TYPE-1; MODULATION; LOCALIZATION; INACTIVATION; METABOLISM; INDUCTION; ALPHA	Background: It has been suggested that glucocorticoids might act in target tissues to increase their own intracellular availability in response to inflammatory stimuli. These mechanisms depend on the local metabolism of glucocorticoids catalyzed by 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1) and 11 beta-hydroxysteroid dehydrogenase 2 (11 beta-HSD2). Objective: This study is to investigate the effect of chronic rhinosinusitis (CRS) on expression of 11 beta-HSD1, 11 beta-HSD2, steroidogenic enzymes (cytochrome P450, family 11, subfamily B, polypeptide 1 [CYP11B1] and cytochrome P450, family 11, subfamily A, polypeptide 1 [CYP11A1]), and endogenous cortisol levels in human sinus mucosa. Expression levels were compared with those of healthy control subjects. Methods: The expression levels of 11 beta-HSD1, 11 beta-HSD2, CYP11B1, CYP11A1, and cortisol were measured in healthy control subjects, patients with CRS with nasal polyps, and patients with CRS without nasal polyps by using real-time PCR, Western blotting, immunohistochemistry, and ELISA. Expression levels of 11 beta-HSD1, 11 beta-HSD2, CYP11B1, CYP11A1, and cortisol were determined in cultured epithelial cells treated with CRS-relevant cytokines. The conversion ratio of cortisone to cortisol was evaluated by using the small interfering RNA technique, 11 beta-HSD1 inhibitor, and measurement of 11 beta-HSD1 activity. Results: 11 beta-HSD1, CYP11B1, and cortisol levels increased in patients with CRS with nasal polyps and those with CRS without nasal polyps, but 11 beta-HSD2 expression decreased. In cultured epithelial cells treated with IL-4, IL-5, IL-13, IL-1 beta, TNF-alpha, and TGF-beta 1, 11 beta-HSD1 expression and activity increased in parallel with expression levels of CYP11B1 and cortisol, but the production of 11 beta-HSD2 decreased. The small interfering RNA technique or the measurement of 11 beta-HSD1 activity showed that the sinus epithelium activates cortisone to cortisol in an 11 beta-HSD-dependent manner. Conclusion: These results indicate that CRS-relevant cytokines can modulate the expression of 11 beta-HSD1, 11 beta-HSD2, and CYP11B1 in the sinus mucosa, resulting in increasing intracellular concentrations of bioactive glucocorticoids.	[Jun, Young Joon] Soonchunhyang Univ, Kumi Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Kumi, South Korea; [Park, Se Jin] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Chunchon, South Korea; [Kim, Tae Hoon; Lee, Seung Hoon; Lee, Ki Jeong; Hwang, Soo Min; Lee, Sang Hag] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 126-1 5 Ka, Seoul 136705, South Korea	Soonchunhyang University; Hallym University; Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 126-1 5 Ka, Seoul 136705, South Korea.	sanghag@kumc.or.kr	Jun, Young Joon/AAP-7026-2020	Jun, Young Joon/0000-0002-3687-2367	Communication Disorders Center [ED-12094]; Korea University [K1325551]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2010-0004094]; Korea University	Communication Disorders Center; Korea University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology(National Research Foundation of Korea); Korea University	Supported by a Grant-in-Aid for Scientific Research from the Communication Disorders Center (ED-12094), Korea University, and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0004094). This research was also supported by a Korea University grant (K1325551).	Adcock IM, 2012, CURR OPIN PHARMACOL, V12, P246, DOI 10.1016/j.coph.2012.02.006; Benitez P, 2006, LARYNGOSCOPE, V116, P770, DOI 10.1097/01.mlg.0000205218.37514.0f; Cai TQ, 2001, J STEROID BIOCHEM, V77, P117, DOI 10.1016/S0960-0760(01)00041-3; Chan Y, 2009, CURR OPIN OTOLARYNGO, V17, P204, DOI 10.1097/MOO.0b013e32832ac393; Chapman KE, 2006, ANN NY ACAD SCI, V1088, P265, DOI 10.1196/annals.1366.030; Cirillo N, 2011, J CELL BIOCHEM, V112, P1499, DOI 10.1002/jcb.23081; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Davies E, 2003, CLIN EXP PHARMACOL P, V30, P437, DOI 10.1046/j.1440-1681.2003.03867.x; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Ergang P, 2010, MOL CELL ENDOCRINOL, V323, P155, DOI 10.1016/j.mce.2010.03.003; Escher G, 1997, J EXP MED, V186, P189, DOI 10.1084/jem.186.2.189; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Friedberg M, 2003, J CLIN ENDOCR METAB, V88, P385, DOI 10.1210/jc.2002-020510; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Heiniger CD, 2001, FEBS LETT, V507, P351, DOI 10.1016/S0014-5793(01)03004-6; Hennebold JD, 1998, ARCH DERMATOL RES, V290, P413, DOI 10.1007/s004030050328; Hostettler N, 2012, ALLERGY, V67, P227, DOI 10.1111/j.1398-9995.2011.02749.x; Hu AH, 2009, AM J PHYSIOL-LUNG C, V296, pL790, DOI 10.1152/ajplung.90572.2008; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Kaur K, 2010, ANN RHEUM DIS, V69, P1185, DOI 10.1136/ard.2009.107466; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Melvin TAN, 2012, CURR OPIN OTOLARYNGO, V20, P194, DOI 10.1097/MOO.0b013e3283533632; MONDER C, 1993, VITAM HORM, V47, P187, DOI 10.1016/S0083-6729(08)60447-1; MURPHY BEP, 1978, J CLIN ENDOCR METAB, V47, P243, DOI 10.1210/jcem-47-2-243; Noti M, 2009, SEMIN IMMUNOPATHOL, V31, P237, DOI 10.1007/s00281-009-0159-2; Piccirillo JF, 2002, OTOLARYNG HEAD NECK, V126, P41, DOI 10.1067/mhn.2002.121022; Sewer MB, 2003, MICROSC RES TECHNIQ, V61, P300, DOI 10.1002/jemt.10339; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Smith RE, 1996, CLIN EXP PHARMACOL P, V23, P549, DOI 10.1111/j.1440-1681.1996.tb02776.x; Smith RE, 1996, J CLIN ENDOCR METAB, V81, P3244, DOI 10.1210/jc.81.9.3244; Stegk JP, 2009, MOL CELL ENDOCRINOL, V301, P104, DOI 10.1016/j.mce.2008.10.030; Suzuki S, 2005, TOHOKU J EXP MED, V207, P293, DOI 10.1620/tjem.207.293; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/endo.142.5.8168; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268	41	14	16	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2014	134	4					926	+		10.1016/j.jaci.2014.03.033	http://dx.doi.org/10.1016/j.jaci.2014.03.033			15	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AQ9GC	24810847				2022-12-18	WOS:000343155700022
J	Dizier, MH; Margaritte-Jeannin, P; Madore, AM; Moffatt, M; Brossard, M; Lavielle, N; Sarnowski, C; Just, J; Cookson, W; Lathrop, M; Laprise, C; Bouzigon, E; Demenais, F				Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Madore, Anne-Marie; Moffatt, Miriam; Brossard, Myriam; Lavielle, Nolwenn; Sarnowski, Chloe; Just, Jocelyne; Cookson, William; Lathrop, Mark; Laprise, Catherine; Bouzigon, Emmanuelle; Demenais, Florence			The nuclear factor I/A (NFIA) gene is associated with the asthma plus rhinitis phenotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Positional cloning; association study; family-based association study; logistic regression; asthma; rhinitis; family sample	ALLERGIC RHINITIS; DIFFERENTIATION; POLYMORPHISMS; ENVIRONMENT; DISEASE; SCALE; EGEA; RISK; CELL	Background: A previous genome-wide linkage scan in 295 families of the French Epidemiological Study on the Genetics and Environment of Asthma (EGEA) showed strong evidence of linkage of the 1p31 region to the combined asthma plus allergic rhinitis (AR) phenotype. Objective: Our purpose was to conduct fine-scale mapping of the 1p31 linkage region to identify the genetic variants associated with asthma plus AR. Methods: Association analyses with the asthma plus rhinitis phenotype were first conducted in the EGEA family sample using the family-based association method (FBAT) and logistic regression. The test of homogeneity of association between asthma plus AR versus asthma alone or AR alone was also applied. Replication of EGEA findings was sought in French-Canadian and United Kingdom family samples. Results: We found a significant association between asthma plus rhinitis and a 1p31 genetic variant (P = 2 x 10(-5) for rs12122228, which reached the multiple testing-corrected threshold) in EGEA using FBAT. There was evidence of heterogeneity of association between asthma plus AR versus asthma alone or AR alone (P = .03). A Meta-analysis of FBAT results from EGEA and French-Canadian families improved evidence for both association and heterogeneity (P = 5 x 10(-6) and P = .008, respectively), whereas a meta-analysis of EGEA, French-Canadian, and United Kingdom samples based on logistic regression slightly increased the evidence for heterogeneity. Conclusion: The single nucleotide polymorphism specifically associated to asthma plus rhinitis is located in the flanking 5' untranslated region of the nuclear factor I/A (NFIA) gene, a strong candidate gene for asthma and AR.	[Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Brossard, Myriam; Lavielle, Nolwenn; Sarnowski, Chloe; Bouzigon, Emmanuelle; Demenais, Florence] INSERM, Genet Variat & Human Dis Unit, U946, Paris, France; [Dizier, Marie-Helene; Margaritte-Jeannin, Patricia; Brossard, Myriam; Lavielle, Nolwenn; Sarnowski, Chloe; Bouzigon, Emmanuelle; Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, Sorbonne Paris Cite, F-75010 Paris, France; [Madore, Anne-Marie; Laprise, Catherine] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; [Moffatt, Miriam; Cookson, William] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Just, Jocelyne] UMPC Paris, Hop Trousseau, AP HP, Ctr Asthme & Allergies, Paris, France; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Quebec; University of Quebec Chicoutimi; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; McGill University	Dizier, MH (corresponding author), Univ Paris Diderot, UMR946, 27 Rue Juliette Dodu, F-75010 Paris, France.	Marie-Helene.Dizier@inserm.fr	Cookson, William/HHC-1790-2022; Dizier, Marie-Hélène/K-8463-2018; Demenais, Florence/G-3298-2013; Brossard, Myriam/P-2640-2019; Bouzigon, Emmanuelle/L-2766-2017	Dizier, Marie-Hélène/0000-0001-8460-7667; Demenais, Florence/0000-0001-8361-0936; Bouzigon, Emmanuelle/0000-0001-5756-4286; Sarnowski, Chloe/0000-0002-6090-7099; Laprise, Catherine/0000-0001-5526-9945	GWIS-AM [ANR-11-BSV1-027]; European Commission [018996]; French Ministry of Higher Education and Research; Wellcome Trust [WT084703MA]; Asthma UK; French-Canadian study; Medical Research Council [G1000758] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish	GWIS-AM; European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Higher Education and Research; Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; French-Canadian study; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Supported in part by the GWIS-AM grant (ANR-11-BSV1-027). Genotyping of the asthma-ascertained samples was supported by grants from the European Commission (018996), the French Ministry of Higher Education and Research, the Wellcome Trust (WT084703MA), and Asthma UK. C. L. is the chairholder of the Canada Research Chair on genetic determinants in asthma and the director of the Inflammation and Remodeling Strategic Group of the Respiratory Health Network of the Fonds de la recherche en sante du Quebec (FRSQ) and member of Allergen network, which partially support the French-Canadian study.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andiappan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019719; Annesi-Maesano I, 2001, CHEST, V120, P1755, DOI 10.1378/chest.120.5.1755; Bosse Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-98; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Dizier MH, 2007, HUM HERED, V63, P162, DOI 10.1159/000099828; Dizier MH, 2005, GENES IMMUN, V6, P95, DOI 10.1038/sj.gene.6364163; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Morris AP, 2010, GENET EPIDEMIOL, V34, P335, DOI 10.1002/gepi.20486; O'Brien P, 2011, CANCER RES, V71, P7345, DOI 10.1158/0008-5472.CAN-11-1874; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Pinto LA, 2013, CLIN EXP ALLERGY, V43, P1152, DOI 10.1111/cea.12175; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rasanen M, 1998, ALLERGY, V53, P885, DOI 10.1111/j.1398-9995.1998.tb03996.x; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	25	14	15	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2014	134	3					576	+		10.1016/j.jaci.2013.12.1074	http://dx.doi.org/10.1016/j.jaci.2013.12.1074			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AO5GR	24560411				2022-12-18	WOS:000341372400009
J	Chinen, J; Notarangelo, LD; Shearer, WT				Chinen, Javier; Notarangelo, Luigi D.; Shearer, William T.			Advances in basic and clinical immunology in 2013	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Genotype versus phenotype expressions; immunology; immunoreconstitution; intravenous immunoglobulin; primary immunodeficiencies; newborn screening for severe combined immunodeficiency; whole-genome sequencing	STEM-CELL TRANSPLANTATION; WISKOTT-ALDRICH SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; FUNCTION STAT1 MUTATIONS; CHAIN-ASSOCIATED PROTEIN; SIGNAL TRANSDUCER; T-CELLS; ANTIBODY DEFICIENCY	A significant number of contributions to our understanding of primary immunodeficiencies (PIDs) in pathogenesis, diagnosis, and treatment were published in the Journal in 2013. For example, deficiency of mast cell degranulation caused by signal transducer and activator of transcription 3 deficiency was demonstrated to contribute to the difference in the frequency of severe allergic reactions in patients with autosomal dominant hyper-IgE syndrome compared with that seen in atopic subjects with similar high IgE serum levels. High levels of nonglycosylated IgA were found in patients with Wiskott-Aldrich syndrome, and these abnormal antibodies might contribute to the nephropathy seen in these patients. New described genes causing immunodeficiency included caspase recruitment domain 11 (CARD11), mucosa-associated lymphoid tissue 1 (MALT1) for combined immunodeficiencies, and tetratricopeptide repeat domain 7A (TTC7A) for mutations associated with multiple atresia with combined immunodeficiency. Other observations expand the spectrum of clinical presentation of specific gene defects (eg, adult-onset idiopathic T-cell lymphopenia and early-onset autoimmunity might be due to hypomorphic mutations of the recombination-activating genes). Newborn screening in California established the incidence of severe combined immunodeficiency at 1 in 66,250 live births. The use of hematopoietic stem cell transplantation for PIDs was reviewed, with recommendations to give priority to research oriented to establish the best regimens to improve the safety and efficacy of bone marrow transplantation. These represent only a fraction of significant research done in patients with PIDs that has accelerated the quality of care of these patients. Genetic analysis of patients has demonstrated multiple phenotypic expressions of immune deficiency in patients with nearly identical genotypes, suggesting that additional genetic factors, possibly gene dosage, or environmental factors are responsible for this diversity.	[Chinen, Javier; Shearer, William T.] Texas Childrens Hosp, Baylor Coll Med, Immunol Allergy & Rheumatol Sect, Dept Pediat, Houston, TX 77030 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Notarangelo, Luigi D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Baylor College of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shearer, WT (corresponding author), Texas Childrens Hosp, 1102 Bates St,FC 330-01, Houston, TX 77030 USA.	wtsheare@texaschildrenshospital.org	Notarangelo, Luigi D/F-9718-2016	Notarangelo, Luigi D/0000-0002-8335-0262; Shearer, William/0000-0002-2483-2130	National Institutes of Health [AI082978]; David Fund; Immunobiology Research Center; Jeffrey Modell Diagnostic Research Center of Texas Children's Hospital; National Institutes of Health (NIH) [AI082978]; March of Dimes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI082973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David Fund; Immunobiology Research Center; Jeffrey Modell Diagnostic Research Center of Texas Children's Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grant AI082978, the David Fund, the Immunobiology Research Center, and the Jeffrey Modell Diagnostic Research Center of Texas Children's Hospital.; L. D. Notarangelo is a board member for the Program in Molecular and Cellular Medicine, Boston, Massachusetts, and for Pediatric University Hospital "Meyer," Florence, Italy; is employed by Boston Children's Hospital; has received research support from the National Institutes of Health (NIH) and the March of Dimes; and has received royalties from UpToDate. W. T. Shearer has received research support from the NIH (AI082978) and is employed by Baylor College of Medicine. J. Chinen declares that he has no relevant conflicts of interest.	Abbott JK, 2013, J ALLERGY CLIN IMMUN, V132, P1246, DOI 10.1016/j.jaci.2013.07.019; Abraham RS, 2013, J ALLERGY CLIN IMMUN, V131, P1421, DOI 10.1016/j.jaci.2012.09.016; Agarwal S, 2013, J ALLERGY CLIN IMMUN, V131, P1699, DOI 10.1016/j.jaci.2013.01.036; Al-Herz W, 2013, J ALLERGY CLIN IMMUN, V131, P658, DOI 10.1016/j.jaci.2012.11.033; Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Al-Mousa H, 2013, J ALLERGY CLIN IMMUN, V131, P1244, DOI 10.1016/j.jaci.2012.12.663; Al-Zahrani D, 2013, J ALLERGY CLIN IMMUN, V132, P993, DOI 10.1016/j.jaci.2013.04.055; Allenspach EJ, 2013, J ALLERGY CLIN IMMUN, V132, P223, DOI 10.1016/j.jaci.2012.11.052; Alsina L, 2013, J ALLERGY CLIN IMMUN, V132, P741, DOI 10.1016/j.jaci.2013.03.038; Bacon CM, 2013, J ALLERGY CLIN IMMUN, V131, P1237, DOI 10.1016/j.jaci.2012.10.027; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cattaneo F, 2013, J ALLERGY CLIN IMMUN, V131, P1136, DOI 10.1016/j.jaci.2012.12.667; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Chew GYJ, 2013, J ALLERGY CLIN IMMUN, V131, P1130, DOI 10.1016/j.jaci.2012.06.023; Cole T, 2013, J ALLERGY CLIN IMMUN, V132, P1150, DOI 10.1016/j.jaci.2013.05.031; Dinwiddie DL, 2013, J ALLERGY CLIN IMMUN, V131, P594, DOI 10.1016/j.jaci.2012.10.062; Driessen GJ, 2013, J ALLERGY CLIN IMMUN, V131, P1367, DOI 10.1016/j.jaci.2013.01.053; Ducruet T, 2013, J ALLERGY CLIN IMMUN, V131, P585, DOI 10.1016/j.jaci.2012.08.022; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Farnault L, 2013, J ALLERGY CLIN IMMUN, V131, P1230, DOI 10.1016/j.jaci.2012.08.047; Geeden J, 2013, J ALLERGY CLIN IMMUN, V132, P222; Gelfand EW, 2013, J ALLERGY CLIN IMMUN, V131, P1001, DOI 10.1016/j.jaci.2013.02.028; Giancane G, 2013, J ALLERGY CLIN IMMUN, V132, P1451, DOI 10.1016/j.jaci.2013.05.034; Greil J, 2013, J ALLERGY CLIN IMMUN, V131, P1376, DOI 10.1016/j.jaci.2013.02.012; Haddad E, 2013, J ALLERGY CLIN IMMUN, V131, P994, DOI 10.1016/j.jaci.2013.01.047; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V132, P969, DOI 10.1016/j.jaci.2013.06.032; Henderson LA, 2013, J ALLERGY CLIN IMMUN, V131, P1227, DOI 10.1016/j.jaci.2012.07.045; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Horn B, 2013, J ALLERGY CLIN IMMUN, V131, P1306, DOI 10.1016/j.jaci.2013.03.014; Hsu AP, 2013, J ALLERGY CLIN IMMUN, V131, P1586, DOI 10.1016/j.jaci.2013.02.038; Ives ML, 2013, J ALLERGY CLIN IMMUN, V132, P400, DOI 10.1016/j.jaci.2013.05.029; Jabara HH, 2013, J ALLERGY CLIN IMMUN, V132, P151, DOI 10.1016/j.jaci.2013.04.047; Jackson J, 2013, J ALLERGY CLIN IMMUN, V132, P889, DOI 10.1016/j.jaci.2013.05.046; Kamae C, 2013, J ALLERGY CLIN IMMUN, V131, P1437, DOI 10.1016/j.jaci.2012.10.059; Kienzler AK, 2013, J ALLERGY CLIN IMMUN, V131, P1695, DOI 10.1016/j.jaci.2013.01.018; Kim VHD, 2013, J ALLERGY CLIN IMMUN, V131, P1233, DOI 10.1016/j.jaci.2012.09.020; Koker MY, 2013, J ALLERGY CLIN IMMUN, V132, P1156, DOI 10.1016/j.jaci.2013.05.039; Kolly L, 2013, J ALLERGY CLIN IMMUN, V131, P1635, DOI 10.1016/j.jaci.2012.07.043; Kuo CY, 2013, J ALLERGY CLIN IMMUN, V131, P1693, DOI 10.1016/j.jaci.2013.01.019; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Lang PA, 2013, J ALLERGY CLIN IMMUN, V131, P815, DOI 10.1016/j.jaci.2012.08.050; Lawrence MG, 2013, J ALLERGY CLIN IMMUN, V132, P1444, DOI 10.1016/j.jaci.2013.05.040; Lev A, 2013, J ALLERGY CLIN IMMUN, V131, P831, DOI 10.1016/j.jaci.2012.10.040; Magerus-Chatinet A, 2013, J ALLERGY CLIN IMMUN, V131, P486, DOI 10.1016/j.jaci.2012.06.011; Maggina P, 2013, J ALLERGY CLIN IMMUN, V131, P292, DOI 10.1016/j.jaci.2012.10.008; Martinez-Gallo M, 2013, J ALLERGY CLIN IMMUN, V131, P468, DOI 10.1016/j.jaci.2012.10.029; Mazerolles F, 2013, J ALLERGY CLIN IMMUN, V131, P1146, DOI 10.1016/j.jaci.2012.12.1519; Mehling M, 2013, J ALLERGY CLIN IMMUN, V131, P1440, DOI 10.1016/j.jaci.2012.12.1520; Mizesko MC, 2013, J ALLERGY CLIN IMMUN, V131, P840, DOI 10.1016/j.jaci.2012.12.1568; Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042; Notarangelo LD, 2013, J ALLERGY CLIN IMMUN, V132, P1164, DOI 10.1016/j.jaci.2013.08.035; Notarangelo LD, 2013, J ALLERGY CLIN IMMUN, V131, P1297, DOI 10.1016/j.jaci.2013.01.020; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Parvaneh N, 2013, J ALLERGY CLIN IMMUN, V131, P314, DOI 10.1016/j.jaci.2012.11.051; de Diego RP, 2013, J ALLERGY CLIN IMMUN, V131, P1157, DOI 10.1016/j.jaci.2013.01.008; Pieper K, 2013, J ALLERGY CLIN IMMUN, V131, P959, DOI 10.1016/j.jaci.2013.01.046; Poliani PL, 2013, J ALLERGY CLIN IMMUN, V131, P597, DOI 10.1016/j.jaci.2012.11.002; Romberg N, 2013, J ALLERGY CLIN IMMUN, V131, P1691, DOI 10.1016/j.jaci.2013.01.004; Sampaio EP, 2013, J ALLERGY CLIN IMMUN, V131, P1624, DOI 10.1016/j.jaci.2013.01.052; Shimizu M, 2013, J ALLERGY CLIN IMMUN, V131, P587, DOI 10.1016/j.jaci.2012.08.040; Siegel AM, 2013, J ALLERGY CLIN IMMUN, V132, P1388, DOI 10.1016/j.jaci.2013.08.045; Slatter M, 2013, J ALLERGY CLIN IMMUN, V131, P1705, DOI 10.1016/j.jaci.2013.03.036; Stepensky P, 2013, J ALLERGY CLIN IMMUN, V131, P477, DOI 10.1016/j.jaci.2012.11.050; Tassone L, 2013, J ALLERGY CLIN IMMUN, V131, P607, DOI 10.1016/j.jaci.2012.05.041; Toyoda H, 2013, J ALLERGY CLIN IMMUN, V132, P226, DOI 10.1016/j.jaci.2013.01.040; Uzel G, 2013, J ALLERGY CLIN IMMUN, V131, P1611, DOI 10.1016/j.jaci.2012.11.054; van der Heijden J, 2013, J ALLERGY CLIN IMMUN, V131, P1408, DOI 10.1016/j.jaci.2013.02.009; van Loosdregt J, 2013, J ALLERGY CLIN IMMUN, V131, P1443, DOI 10.1016/j.jaci.2013.02.026; Wang XW, 2013, J ALLERGY CLIN IMMUN, V131, P1242, DOI 10.1016/j.jaci.2012.11.005; Watanabe Y, 2013, J ALLERGY CLIN IMMUN, V132, P648, DOI 10.1016/j.jaci.2013.03.046; Wildbaum G, 2013, J ALLERGY CLIN IMMUN, V132, P761, DOI 10.1016/j.jaci.2013.04.018	72	14	17	0	12	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2014	133	4					967	976		10.1016/j.jaci.2014.01.026	http://dx.doi.org/10.1016/j.jaci.2014.01.026			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AD8QW	24589342	Green Accepted, Bronze			2022-12-18	WOS:000333531700004
J	Dijkstra, KK; Hoeks, SBEA; Prakken, BJ; de Roock, S				Dijkstra, Krijn K.; Hoeks, Sanne B. E. A.; Prakken, Berent J.; de Roock, Sytze			T(H)17 differentiation capacity develops within the first 3 months of life	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							T-CELLS; MICROBIOTA		[Dijkstra, Krijn K.; Hoeks, Sanne B. E. A.; Prakken, Berent J.; de Roock, Sytze] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol, Ctr Mol & Cellular Intervent, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Dijkstra, KK (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Lab Translat Immunol, Ctr Mol & Cellular Intervent, Utrecht, Netherlands.	sroock@umcutrecht.nl		Dijkstra, Krijn/0000-0002-5417-5397				Afzali B, 2013, EUR J IMMUNOL, V43, P2043, DOI 10.1002/eji.201243296; Belderbos ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033419; de Roock S, 2013, J ALLERGY CLIN IMMUN, V132, P754, DOI 10.1016/j.jaci.2013.04.014; de Roock S, 2011, J ALLERGY CLIN IMMUN, V128, P1369, DOI 10.1016/j.jaci.2011.08.006; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	9	14	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2014	133	3					891	894		10.1016/j.jaci.2013.09.022	http://dx.doi.org/10.1016/j.jaci.2013.09.022			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EK	24188977				2022-12-18	WOS:000332397600037
J	Dupont, C; Bourrier, T; de Blay, F; Guenard-Bilbault, L; Sauvage, C; Cousin, MO; Kanny, G; Jarlot, S; Karila, C				Dupont, Christophe; Bourrier, Thierry; de Blay, Frederic; Guenard-Bilbault, Lydie; Sauvage, Christine; Cousin, Marie-Odile; Kanny, Gisele; Jarlot, Sophie; Karila, Chantal			Peanut Epicutaneous Immunotherapy (EPIT) In Peanut-Allergic Children: 18 Months Treatment In The Arachild Study	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	FEB 28-MAR 04, 2014	San Diego, CA	Amer Acad Allergy Asthma & Immunol					[Dupont, Christophe] Hop Necker Enfants Malad, Paris, France; [Bourrier, Thierry] Lenval Hosp, Nice, France; [de Blay, Frederic; Guenard-Bilbault, Lydie] CHRU Strasbourg, Strasbourg, France; [Sauvage, Christine; Cousin, Marie-Odile] St Vincent de Paul Hosp, Lille, France; [Kanny, Gisele; Jarlot, Sophie] CHU Nancy Hop Cent, Nancy, France; [Karila, Chantal] Hop Necker Enfants Malad, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite			Kanny, Gisèle/AHA-8910-2022						0	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2		S		357	AB102	AB102		10.1016/j.jaci.2013.12.381	http://dx.doi.org/10.1016/j.jaci.2013.12.381			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	297FO					2022-12-18	WOS:000330241300355
J	Sterk, PJ; Lutter, R				Sterk, Peter J.; Lutter, Rene			Asthma phenotyping: T(H)2-high, T(H)2-low, and beyond	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						Biomarkers; eosinophils; periostin; sputum; transcriptomics	GENE-EXPRESSION; DISEASES; INFLAMMATION; CELLS		[Sterk, Peter J.; Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1100 DE Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1100 DE Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sterk, PJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Resp Med, F5-259,POB 22700, NL-1100 DE Amsterdam, Netherlands.	p.j.sterk@amc.nl	Sterk, P.J./AAK-8175-2020					Auffray C, 2010, CHEST, V137, P1410, DOI 10.1378/chest.09-1850; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Bousquet J, 2011, GENOME MED, V3, DOI 10.1186/gm259; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; CORRIGAN CJ, 1988, LANCET, V1, P1129; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Petsky HL, 2012, THORAX, V67, P199, DOI 10.1136/thx.2010.135574; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sung JY, 2012, BIOTECHNOL J, V7, P946, DOI 10.1002/biot.201100305; Wheelock CE, 2013, EUR RESPIR J, V42, P802, DOI 10.1183/09031936.00078812; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yick CY, 2013, AM J RESP CRIT CARE, V187, P1076, DOI 10.1164/rccm.201210-1886OC	15	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2014	133	2					395	396		10.1016/j.jaci.2013.10.008	http://dx.doi.org/10.1016/j.jaci.2013.10.008			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	AC3EF	24290288				2022-12-18	WOS:000332397100012
J	Schadenberg, AWL; van den Broek, T; Siemelink, MA; Algra, SO; de Jong, PR; Jansen, NJG; Prakken, BJ; van Wijk, F				Schadenberg, Alvin W. L.; van den Broek, Theo; Siemelink, Marten A.; Algra, Selma O.; de Jong, Petrus R.; Jansen, Nicolaas J. G.; Prakken, Berent J.; van Wijk, Femke			Differential homeostatic dynamics of human regulatory T-cell subsets following neonatal thymectomy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							FOXP3		[Schadenberg, Alvin W. L.; van den Broek, Theo; de Jong, Petrus R.; Prakken, Berent J.; van Wijk, Femke] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands; [Schadenberg, Alvin W. L.; van den Broek, Theo; de Jong, Petrus R.; Prakken, Berent J.; van Wijk, Femke] Univ Med Ctr Utrecht, Lab Translat Immunol, Utrecht, Netherlands; [Schadenberg, Alvin W. L.; van den Broek, Theo; Algra, Selma O.; de Jong, Petrus R.; Jansen, Nicolaas J. G.] Univ Med Ctr Utrecht, Dept Pediat Intens Care Pediat Cardiothorac Surg, Utrecht, Netherlands; [Siemelink, Marten A.] Univ Med Ctr Utrecht, Dept Expt Cardiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schadenberg, AWL (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands.	F.vanwijk@umcutrecht.nl	, van den Broek T/I-9651-2019	, van den Broek T/0000-0002-2781-5731; de Jong, Petrus/0000-0003-2321-1153				den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Long SA, 2011, J IMMUNOL, V187, P3511, DOI 10.4049/jimmunol.1003880; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034662; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Tulic MK, 2012, J ALLERGY CLIN IMMUN, V129, P199, DOI 10.1016/j.jaci.2011.10.016; van Gent R, 2011, BLOOD, V118, P627, DOI 10.1182/blood-2011-03-341396; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435	9	14	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2014	133	1					277	280		10.1016/j.jaci.2013.08.030	http://dx.doi.org/10.1016/j.jaci.2013.08.030			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	281MM	24139831				2022-12-18	WOS:000329105700043
J	Lopez-Bravo, M; de la Escalera, MM; Dominguez, PM; Gonzalez-Cintado, L; del Fresno, C; Martin, P; del Hoyo, GM; Ardavin, C				Lopez-Bravo, Maria; Minguito de la Escalera, Maria; Dominguez, Pilar M.; Gonzalez-Cintado, Leticia; del Fresno, Carlos; Martin, Pilar; Martinez del Hoyo, Gloria; Ardavin, Carlos			IL-4 blocks T(H)1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T(H)2 responses; IL-4; dendritic cells; monocyte-derived dendritic cells; house dust mite-induced allergic reactions	ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; TH2; MACROPHAGES; RECEPTORS; INFLAMMATION; MECHANISMS; ALLERGEN; CSF	Background: Whereas recent research has characterized the mechanism by which dendritic cells (DCs) induce T(H)1/T(H)17 responses, the functional specialization enabling DCs to polarize T(H)2 responses remains undefined. Because IL-4 is essential during T(H)2 responses not only by acting on CD4(+) T cells through the activation of GATA-3 but also by regulating IgE class-switching, epithelial cell permeability, and muscle contractility, we hypothesized that IL-4 could also have a role in the conditioning of DCs during T(H)2 responses. Objective: We sought to analyze whether IL-4 exerts an immunomodulatory function on DCs during their differentiation, leading to their functional specialization for the induction of T(H)2 responses. Methods: Monocyte-derived DCs (moDCs) conditioned by IL-4 during their differentiation (IL-4-conditioned moDCs [IL-4-moDCs]) were analyzed for T(H)1-polarizing/inflammatory cytokine production in response to Toll-like receptor stimulation. The acetylation level of the promoters of the genes encoding these cytokines was analyzed by using chromatin immunoprecipitation. Gene expression profiling of IL-4-moDCs was defined by using mouse genome microarrays. IL-4-moDCs were tested for their capacity to induce house dust mitemediated allergic reactions. Results: Our data suggest that IL-4 inhibits T(H)1-polarizing/inflammatory cytokine gene expression on IL-4-moDCs through the deacetylation of the promoters of these genes, leading to their transcriptional repression. Microarray analyses confirmed that IL-4 upregulated T(H)2-related genes as eosinophil-associated ribonucleases, eosinophil/basophil chemokines, and M2 genes. IL-4 licensed moDCs for the induction of T(H)2 responses, causing house dust mite-mediated allergic airway inflammation. Conclusion: This study describes a new role for IL-4 by demonstrating that moDCs are conditioned by IL-4 for the induction of T(H)2 responses by blocking T(H)1-polarizing/inflammatory cytokine production through histone hypoacetylation and upregulating T(H)2-related genes.	[Lopez-Bravo, Maria; Minguito de la Escalera, Maria; Dominguez, Pilar M.; Gonzalez-Cintado, Leticia; del Fresno, Carlos; Martin, Pilar; Martinez del Hoyo, Gloria; Ardavin, Carlos] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Ardavin, C (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Darwin 3, Madrid 28049, Spain.	ardavin@cnb.csic.es	Martinez del Hoyo, Gloria/K-4750-2015; Del Fresno, Carlos/F-2624-2016; Del Fresno, Carlos/ABD-7766-2020; Martin, Pilar/F-8193-2014; Del Fresno Sánchez, CArlos/AAY-1525-2021	Martinez del Hoyo, Gloria/0000-0003-2588-2575; Del Fresno, Carlos/0000-0003-1771-7254; Del Fresno, Carlos/0000-0003-1771-7254; Martin, Pilar/0000-0002-2392-1764; Lopez-Bravo, Maria/0000-0002-1898-9465; Dominguez, Pilar M/0000-0002-5775-4351	Spanish Ministerio de Ciencia e Innovacion [SAF 2009-11592]; Ministerio de Sanidad [RD07/0064/0027]; Fundacion Genoma Espana (MACIA project)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); Fundacion Genoma Espana (MACIA project)	Supported by the Spanish Ministerio de Ciencia e Innovacion (Grant SAF 2009-11592), Ministerio de Sanidad (Grant RD07/0064/0027), and Fundacion Genoma Espana (MACIA project) to C.A.	Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Balic A, 2004, EUR J IMMUNOL, V34, P3047, DOI 10.1002/eji.200425167; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Dubsky P, 2007, EUR J IMMUNOL, V37, P1678, DOI 10.1002/eji.200636329; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Hochrein H, 2000, J EXP MED, V192, P823, DOI 10.1084/jem.192.6.823; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nakano H, 2013, MUCOSAL IMMUNOL, V6, P678, DOI 10.1038/mi.2012.106; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Sebastian C, 2008, J IMMUNOL, V180, P5898, DOI 10.4049/jimmunol.180.9.5898; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x	28	14	15	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2013	132	6					1409	+		10.1016/j.jaci.2013.08.039	http://dx.doi.org/10.1016/j.jaci.2013.08.039			24	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	259PG	24139608				2022-12-18	WOS:000327538200020
J	Ownby, DR				Ownby, Dennis R.			Will the real inner-city allergen please stand up?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ENVIRONMENTAL INTERVENTION; MOUSE ALLERGEN; ASTHMA; CHILDREN; EXPOSURE		Georgia Regents Univ, Dept Pediat, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Ownby, DR (corresponding author), Georgia Regents Univ, Dept Pediat, 1022 15th St, Augusta, GA 30912 USA.	downby@gru.edu						Ahluwalia SK, 2013, J ALLERGY CLIN IMMUN, V132, P830, DOI 10.1016/j.jaci.2013.05.005; Bryant-Stephens T, 2009, J ALLERGY CLIN IMMUN, V123, P1199, DOI 10.1016/j.jaci.2009.04.030; Forno E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040383; KANG BC, 1993, J ALLERGY CLIN IMMUN, V92, P802, DOI 10.1016/0091-6749(93)90057-M; Krop EJM, 2007, INT ARCH ALLERGY IMM, V144, P296, DOI 10.1159/000106318; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Phipatanakul W, 2004, ANN ALLERG ASTHMA IM, V92, P420, DOI 10.1016/S1081-1206(10)61777-2; Pongracic JA, 2008, ANN ALLERG ASTHMA IM, V101, P35, DOI 10.1016/S1081-1206(10)60832-0; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Salo PW, 2009, ENVIRON HEALTH PERSP, V117, P387, DOI 10.1289/ehp.11847; Sheehan WJ, 2010, J ALLERGY CLIN IMMUN, V125, P575, DOI 10.1016/j.jaci.2010.01.023; Vantassel S.M., 2012, CONTROLLING HOUSE MI; Wilson J, 2010, ENVIRON RES, V110, P189, DOI 10.1016/j.envres.2009.10.007	13	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2013	132	4					836	837		10.1016/j.jaci.2013.06.046	http://dx.doi.org/10.1016/j.jaci.2013.06.046			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	227FR	23978444				2022-12-18	WOS:000325096500009
J	Aydogan, M; Yologlu, N; Gacar, G; Uyan, ZS; Eser, I; Karaoz, E				Aydogan, Metin; Yologlu, Nail; Gacar, Gulcin; Uyan, Zeynep Seda; Eser, Isil; Karaoz, Erdal			Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IN-VITRO		[Aydogan, Metin; Yologlu, Nail; Eser, Isil] Kocaeli Univ, Fac Med, Dept Pediat Allergy & Immunol, Kocaeli, Turkey; [Gacar, Gulcin; Karaoz, Erdal] Kocaeli Univ, Ctr Stem Cell & Gene Therapies Res & Practice, Stem Cell Dept, Inst Hlth Sci, Kocaeli, Turkey; [Uyan, Zeynep Seda] Kocaeli Univ, Fac Med, Dept Pediat, Kocaeli, Turkey	Kocaeli University; Kocaeli University; Kocaeli University	Aydogan, M (corresponding author), Kocaeli Univ, Fac Med, Dept Pediat Allergy & Immunol, Kocaeli, Turkey.	mmetinaydogan@hotmail.com	Gacar, Gulcin/A-8042-2016; Karaoz, Erdal/AAO-1470-2020	Gacar, Gulcin/0000-0003-2960-6826; 				Brennan PJ, 2009, J ALLERGY CLIN IMMUN, V124, P1259, DOI 10.1016/j.jaci.2009.09.009; Castells MC, 2008, J ALLERGY CLIN IMMUN, V122, P574, DOI 10.1016/j.jaci.2008.02.044; Grillo-Lopez AJ, 1999, SEMIN ONCOL, V26, P66; Hong DI, 2012, EXPERT REV CLIN IMMU, V8, P43, DOI [10.1586/eci.11.75, 10.1586/ECI.11.75]; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M	7	14	15	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2013	132	2					478	480		10.1016/j.jaci.2013.02.004	http://dx.doi.org/10.1016/j.jaci.2013.02.004			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	194KL	23582516				2022-12-18	WOS:000322631700028
J	Allenspach, EJ; Bellodi, C; Jeong, D; Kopmar, N; Nakamura, T; Ochs, HD; Ruggero, D; Skoda-Smith, S; Shimamura, A; Torgerson, TR				Allenspach, Eric J.; Bellodi, Cristian; Jeong, David; Kopmar, Noam; Nakamura, Tomoka; Ochs, Hans D.; Ruggero, Davide; Skoda-Smith, Suzanne; Shimamura, Akiko; Torgerson, Troy R.			Common variable immunodeficiency as the initial presentation of dyskeratosis congenita	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Allenspach, Eric J.; Ochs, Hans D.; Skoda-Smith, Suzanne; Shimamura, Akiko; Torgerson, Troy R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Allenspach, Eric J.; Nakamura, Tomoka; Ochs, Hans D.; Skoda-Smith, Suzanne; Shimamura, Akiko; Torgerson, Troy R.] Seattle Childrens Hosp, Seattle, WA USA; [Bellodi, Cristian; Kopmar, Noam; Ruggero, Davide] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Bellodi, Cristian; Kopmar, Noam; Ruggero, Davide] Univ Calif San Francisco, Dept Urol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Jeong, David] Inst Asthma & Allergy, Chevy Chase, MD USA; [Nakamura, Tomoka; Shimamura, Akiko] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Allenspach, EJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	troy.torgerson@seattlechildrens.org	Bellodi, Cristian/J-8157-2013; Bellodi, Cristian/N-2341-2015	Bellodi, Cristian/0000-0001-8047-5329; Allenspach, Eric/0000-0001-7346-5835	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI092423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098057] Funding Source: NIH RePORTER; NIAID NIH HHS [R03 AI092423] Funding Source: Medline; NIDDK NIH HHS [R01 DK098057] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Giri Neelam, 2011, BMC Blood Disord, V11, P3, DOI 10.1186/1471-2326-11-3; Jyonouchi S, 2011, PEDIAT ALLERG IMM-UK, V22, P313, DOI 10.1111/j.1399-3038.2010.01136.x; Khan S, 2011, CLIN EXP IMMUNOL, V163, P96, DOI 10.1111/j.1365-2249.2010.04280.x; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673; Orange JS, 2011, J ALLERGY CLIN IMMUN, V127, P1360, DOI 10.1016/j.jaci.2011.02.039; Parry EM, 2011, J MED GENET, V48, P327, DOI 10.1136/jmg.2010.085100; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002	10	14	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2013	132	1					223	226		10.1016/j.jaci.2012.11.052	http://dx.doi.org/10.1016/j.jaci.2012.11.052			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	173BF	23403051	Green Accepted			2022-12-18	WOS:000321052300031
J	Farnault, L; Chambost, H; Michel, G; Thuret, I; de Saint Basile, G; Fischer, A; Picard, C; Picard, C; Orlanducci, F; Farnarier, C; Moretta, A; Olive, D				Farnault, Laure; Chambost, Herve; Michel, Gerard; Thuret, Isabelle; de Saint Basile, Genevieve; Fischer, Alain; Picard, Capucine; Picard, Christophe; Orlanducci, Florence; Farnarier, Catherine; Moretta, Alessandro; Olive, Daniel			Persistence of natural killer cells with expansion of a hypofunctional CD56(-)CD16(+) KIR(+)NKG2C(+) subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							NK CELLS; RECEPTOR		[Farnault, Laure; Orlanducci, Florence; Olive, Daniel] Aix Marseille Univ, INSERM, UMR 1068,IBiSA Canc Immunomonitor Platform, Inst Paoli Calmettes,IFR 137, Marseille, France; [Chambost, Herve; Michel, Gerard; Thuret, Isabelle] Hop Timone Enfants, Dept Paediat Haematol, APHM, Marseille, France; [de Saint Basile, Genevieve; Fischer, Alain] Hop Necker Enfants Malad, Unite Immunol Hematol Pediat, CEREDIH, APHP, Paris, France; [de Saint Basile, Genevieve; Fischer, Alain; Picard, Capucine] Univ Paris Descartes Sorbonne, Imagine Inst, Fac Med Necker, Paris, France; [Fischer, Alain] INSERM, UMR 768, Fac Necker, Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, CEDI, APHP, Paris, France; [Picard, Capucine] INSERM, U980, Lab Genet Humaine Malad Infectieuses, Fac Necker,APHP, Paris, France; [Picard, Christophe] EFS Alpes Mediterranee, Marseille, France; [Farnarier, Catherine] Hop Conception, Lab Immunol, APHM, Marseille, France; [Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Genoa	Olive, D (corresponding author), Aix Marseille Univ, INSERM, UMR 1068,IBiSA Canc Immunomonitor Platform, Inst Paoli Calmettes,IFR 137, Marseille, France.	daniel.olive@inserm.fr	Picard, Capucine/H-3914-2017; de Saint Basile, Genevieve/G-9731-2017	Picard, Capucine/0000-0001-8788-5056; de Saint Basile, Genevieve/0000-0002-1913-5269; CHAMBOST, HERVE/0000-0002-5319-1969				Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; O'Shea JJ, 2004, MOL IMMUNOL, V41, P727, DOI 10.1016/j.molimm.2004.04.014; Pai Sung-Yun, 2008, J Allergy Clin Immunol, V122, P1113, DOI 10.1016/j.jaci.2008.08.026; Roberts JL, 2007, BLOOD, V109, P3198, DOI 10.1182/blood-2006-08-043166	7	14	16	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2013	131	4					1230	+		10.1016/j.jaci.2012.08.047	http://dx.doi.org/10.1016/j.jaci.2012.08.047			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	120QT	23069490				2022-12-18	WOS:000317187200035
J	Bochner, BS; Rothenberg, ME; Boyce, JA; Finkelman, F				Bochner, Bruce S.; Rothenberg, Marc E.; Boyce, Joshua A.; Finkelman, Fred			Advances in mechanisms of allergy and clinical immunology in 2012	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Dendritic cells; cytokines; immunotherapy; mast cell; basophil; eosinophil; T cells; regulatory T cells	THYMIC STROMAL LYMPHOPOIETIN; TOLEROGENIC DENDRITIC CELLS; REGULATORY T-CELLS; SUBLINGUAL IMMUNOTHERAPY; AIRWAY INFLAMMATION; T(H)2 CELLS; RECEPTOR; ASTHMA; SENSITIZATION; REACTIVITY	Manuscripts published in the "Mechanisms of allergy and clinical immunology" section of the Journal of Allergy and Clinical Immunology during 2012 enhanced our knowledge of the involvement of cytokines and other mediators in allergic disorders and described novel approaches for understanding mechanisms of allergic and immunologic diseases. Also published were articles focused on mechanisms of allergen-specific immunotherapy and the development of novel antiallergic treatments, as well as strategies to achieve tolerance to allergens. The highlights of these studies and their potential clinical implications are summarized in this review. (J Allergy Clin Immunol 2013;131:661-7.)	[Bochner, Bruce S.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Dept Med, Baltimore, MD USA; [Rothenberg, Marc E.; Finkelman, Fred] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Dept Pediat, Cincinnati, OH USA; [Boyce, Joshua A.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Johns Hopkins University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital	Bochner, BS (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, 5501 Hopkins Bayview Circle,Rm 2B-71, Baltimore, MD 21224 USA.	bbochner@jhmi.edu			National Institutes of Health (NIH); Dana Foundation; Department of Defense(DOD); Veterans Administration; DOD	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Department of Defense(DOD)(United States Department of Defense); Veterans Administration(US Department of Veterans Affairs); DOD(United States Department of Defense)	B. S. Bochner is a Scientific Advisory Board member for Allakos and Merck; has consultancy arrangements with TEVA, Sanofi-Aventis, United States Diagnostic Standards, Medicis, Pharmacyclics, Hoffman-La Roche, and Tarsa Therapeutics; is employed by Johns Hopkins University; has received one or more grants from or has one or more grants pending with the National Institutes of Health (NIH) and the Dana Foundation; has received royalties from Elsevier and from UpToDate; and owns stock/stock options in Allakos and in Glycomimetics. M. E. Rothenberg is a Board member for the International Eosinophil Society and for the American Partnership for Eosinophilic Disorders; serves as Consultant and Director of the Scientific Advisory Board of, owns stock/stock options in, and has received one or more payments for travel/accommodations/meeting expenses from Immune Pharm; has received one or more grants from or has one or more grants pending with the NIH and the Department of Defense(DOD); is the inventor of patents that are owned by CCHMC; and has received royalties from Teva Pharmaceuticals. J. A. Boyce has been supported by one or more grants from, has received one or more consulting fees or honoraria from, and has received one or more payments for lecturing from or is on the speakers' bureau for Merck and has consultancy arrangements with Calcimedica. F. Finkelman has received one or more grants from or has one or more grants pending with the NIH, the Veterans Administration, and the DOD and has a pending patent for desensitization.	Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Bellinghausen I, 2012, J ALLERGY CLIN IMMUN, V130, P1384, DOI 10.1016/j.jaci.2012.08.039; Bochner Bruce S., 2003, Journal of Allergy and Clinical Immunology, V111, pS819, DOI 10.1067/mai.2003.149; Bohm M, 2012, J ALLERGY CLIN IMMUN, V129, P1085, DOI 10.1016/j.jaci.2011.11.012; Bogiatzi SI, 2012, J ALLERGY CLIN IMMUN, V130, P233, DOI 10.1016/j.jaci.2012.04.038; Brand S, 2012, J ALLERGY CLIN IMMUN, V129, P1602, DOI 10.1016/j.jaci.2011.12.963; Cho HJ, 2012, J ALLERGY CLIN IMMUN, V129, P529, DOI 10.1016/j.jaci.2011.11.024; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; Hirota JA, 2012, J ALLERGY CLIN IMMUN, V129, P1116, DOI 10.1016/j.jaci.2011.11.033; Hsia BJ, 2012, J ALLERGY CLIN IMMUN, V130, P205, DOI 10.1016/j.jaci.2012.03.002; James LK, 2012, J ALLERGY CLIN IMMUN, V130, P663, DOI 10.1016/j.jaci.2012.04.006; Kagalwalla AF, 2012, J ALLERGY CLIN IMMUN, V129, P1387, DOI 10.1016/j.jaci.2012.03.005; Kapoor S, 2012, J ALLERGY CLIN IMMUN, V129, P1094, DOI 10.1016/j.jaci.2011.10.048; Kim H, 2012, J ALLERGY CLIN IMMUN, V129, P1529, DOI 10.1016/j.jaci.2012.01.051; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035; Luckey U, 2012, J ALLERGY CLIN IMMUN, V130, P781, DOI 10.1016/j.jaci.2012.06.022; Massoud AH, 2012, J ALLERGY CLIN IMMUN, V129, P1656, DOI 10.1016/j.jaci.2012.02.050; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Nakahigashi K, 2012, J ALLERGY CLIN IMMUN, V129, P536, DOI 10.1016/j.jaci.2011.11.034; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Parmentier CN, 2012, J ALLERGY CLIN IMMUN, V129, P1136, DOI 10.1016/j.jaci.2012.01.057; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Santiago HC, 2012, J ALLERGY CLIN IMMUN, V130, P248, DOI 10.1016/j.jaci.2012.02.045; Sedej M, 2012, J ALLERGY CLIN IMMUN, V129, P492, DOI 10.1016/j.jaci.2011.08.015; Sibilano R, 2012, J ALLERGY CLIN IMMUN, V130, P751, DOI 10.1016/j.jaci.2012.03.032; Swamy RS, 2012, J ALLERGY CLIN IMMUN, V130, P215, DOI 10.1016/j.jaci.2012.04.021; Tang YF, 2012, J ALLERGY CLIN IMMUN, V129, P1611, DOI 10.1016/j.jaci.2011.12.976; Tulic MK, 2012, J ALLERGY CLIN IMMUN, V129, P199, DOI 10.1016/j.jaci.2011.10.016; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Wang CH, 2012, J ALLERGY CLIN IMMUN, V129, P1367, DOI 10.1016/j.jaci.2012.01.038; Weigmann B, 2012, J ALLERGY CLIN IMMUN, V129, P1126, DOI 10.1016/j.jaci.2011.11.036; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Yagil Z, 2012, J ALLERGY CLIN IMMUN, V129, P1357, DOI 10.1016/j.jaci.2011.11.051; Zimmer A, 2012, J ALLERGY CLIN IMMUN, V129, P1020, DOI 10.1016/j.jaci.2012.02.014	43	14	15	1	25	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					661	667		10.1016/j.jaci.2012.12.676	http://dx.doi.org/10.1016/j.jaci.2012.12.676			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23352632				2022-12-18	WOS:000315587800005
J	Campbell-Harding, G; Sawkins, H; Bedke, N; Holgate, ST; Davies, DE; Andrews, AL				Campbell-Harding, Gemma; Sawkins, Hannah; Bedke, Nicole; Holgate, Stephen T.; Davies, Donna E.; Andrews, Allison-Lynn			The innate antiviral response upregulates IL-13 receptor alpha 2 in bronchial fibroblasts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Virus; cytokine receptors; fibroblasts; type I interferon	DOUBLE-STRANDED-RNA; AIRWAY EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-3; RHINOVIRUS INFECTION; INTERLEUKIN-13 RECEPTOR; ASTHMA PATHOGENESIS; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; GENE-EXPRESSION; ATOPIC ASTHMA	Background: IL-13 is key mediator of allergic inflammation in asthmatic patients. We have previously shown that the decoy receptor IL-13 receptor (IL-13R) alpha 2 attenuates responses of fibroblasts to IL-13. Because the expression of IL-13R alpha 2 can be regulated by IFN-gamma, a type II interferon, we hypothesized that innate antiviral responses characterized by type I interferon expression can also induce IL-13R alpha 2 expression. Objective: We sought to induce an innate antiviral response in primary fibroblasts using exposure to double-stranded RNA (dsRNA) and to examine the expression and function of IL-13R alpha 2. Methods: Primary human fibroblasts were cultured from endobronchial biopsy specimens obtained from healthy or asthmatic volunteers and challenged with dsRNA. Upregulation of IL-13R alpha 2 mRNA was measured by using real-time quantitative PCR, and cell-surface IL-13R alpha 2 protein expression was measured by using fluorescence-activated cell sorting. Eotaxin release was determined by means of ELISA. Results: Direct treatment with IFN-beta led to an upregulation of IL-13R alpha 2. Exposure to dsRNA rapidly induced IFN-beta mRNA in fibroblasts, and this was followed by significant induction of IL-13R alpha 2 mRNA and cell-surface protein expression, which was dependent on de novo protein synthesis. A neutralizing antibody to the IFN-alpha/beta receptor blocked cell-surface expression of IL-13R alpha 2 in the presence of dsRNA. Pretreatment of fibroblasts with dsRNA led to attenuation of IL-13-stimulated eotaxin production. However, the presence of an IL13R alpha 2 neutralizing antibody restored IL-13-stimulated eotaxin production in dsRNA-treated cells. Conclusion: IFN-beta induces IL-13R alpha 2 expression, leading to a consequential suppression of responsiveness to IL-13. These data suggest cross-talk between T(H)1 and T(H)2 pathways and point to an immunomodulatory role for IL-13R alpha 2 in human bronchial fibroblasts during viral infection. (J Allergy Clin Immunol 2013; 131:849-55.)	Univ Southampton, Acad Unit Clin & Expt Sci, Fac Med, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; Univ Southampton, Southampton NIHR Resp Biomed Res Unit, Fac Med, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Andrews, AL (corresponding author), Southampton Gen Hosp, Mail Point 888, Southampton SO16 6YD, Hants, England.	ala@soton.ac.uk	Davies, Donna E/H-2993-2012; Bashevoy, Gemma/D-4198-2017	Bashevoy, Gemma/0000-0002-2727-7523; Davies, Donna/0000-0002-5117-2991	Medical Research Council; Synairgen; British Lung Foundation; Medical Research Council [G0501506, G0900453, G19/34] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [10/060, RF06/01] Funding Source: researchfish; MRC [G0501506, G19/34, G0900453] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Synairgen; British Lung Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Disclosure of potential conflict of interest: S. T. Holgate has shares in Synairgen, has received research support from the Medical Research Council and Synairgen, and is Vice President of the British Lung Foundation. D. E. Davies is cofounder of, has shares in, is a consultant for, and receives research support from Synairgen. The rest of the authors declare that they have no relevant conflicts of interest.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Andrews AL, 2002, J BIOL CHEM, V277, P46073, DOI 10.1074/jbc.M209560200; Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; BARDIN PG, 1995, CHEST, V107, pS157, DOI 10.1378/chest.107.3_Supplement.157S; Bedke N, 2009, J IMMUNOL, V182, P3660, DOI 10.4049/jimmunol.0802471; Bengtson SH, 2007, INT IMMUNOPHARMACOL, V7, P1880, DOI 10.1016/j.intimp.2007.07.002; Brightling CE, 2010, CLIN EXP ALLERGY, V40, P42, DOI 10.1111/j.1365-2222.2009.03383.x; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Daines MO, 2002, J BIOL CHEM, V277, P10387, DOI 10.1074/jbc.M108109200; Davoine F, 2008, J ALLERGY CLIN IMMUN, V122, P69, DOI 10.1016/j.jaci.2008.03.028; de Kluijver J, 2002, EUR RESPIR J, V20, P274, DOI 10.1183/09031936.02.00247202; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; Gratzl S, 2000, J ALLERGY CLIN IMMUN, V105, P1035, DOI 10.1067/mai.2000.105317; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; Grunberg K, 2001, AM J RESP CRIT CARE, V164, P1816; Heinecke L, 2008, J ALLERGY CLIN IMMUN, V121, P1155, DOI 10.1016/j.jaci.2008.02.009; Hilton DJ, 1996, P NATL ACAD SCI USA, V93, P497, DOI 10.1073/pnas.93.1.497; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuo C, 2011, AM J PHYSIOL-LUNG C, V300, pL951, DOI 10.1152/ajplung.00411.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Miloux B, 1997, FEBS LETT, V401, P163, DOI 10.1016/S0014-5793(96)01462-7; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Papadopoulos NG, 2002, THORAX, V57, P328, DOI 10.1136/thorax.57.4.328; Pawankar R, 1997, J CLIN INVEST, V99, P1492, DOI 10.1172/JCI119311; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Uller L, 2010, THORAX, V65, P626, DOI 10.1136/thx.2009.125930; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wicks J, 2006, THORAX, V61, P313, DOI 10.1136/thx.2005.050005; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yamaya M, 2003, VIRAL IMMUNOL, V16, P99, DOI 10.1089/088282403322017857; Zhang ZX, 1997, BIOCHEM BIOPH RES CO, V237, P90, DOI 10.1006/bbrc.1997.7082; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	50	14	14	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2013	131	3					849	+		10.1016/j.jaci.2012.08.030	http://dx.doi.org/10.1016/j.jaci.2012.08.030			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	098ZM	23069489	Bronze			2022-12-18	WOS:000315587800029
J	Dinwiddie, DL; Kingsmore, SF; Caracciolo, S; Rossi, G; Moratto, D; Mazza, C; Sabelli, C; Bacchetta, R; Passerini, L; Magri, C; Bell, CJ; Miller, NA; Hateley, SL; Saunders, CJ; Zhang, L; Schroth, GP; Barlati, S; Badolato, R				Dinwiddie, Darrell L.; Kingsmore, Stephen F.; Caracciolo, Sonia; Rossi, Giuseppe; Moratto, Daniele; Mazza, Cinzia; Sabelli, Cristiano; Bacchetta, Rosa; Passerini, Laura; Magri, Chiara; Bell, Callum J.; Miller, Neil A.; Hateley, Shannon L.; Saunders, Carol J.; Zhang, Lu; Schroth, Gary P.; Barlati, Sergio; Badolato, Raffaele			Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									[Dinwiddie, Darrell L.; Kingsmore, Stephen F.; Miller, Neil A.; Saunders, Carol J.] Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA; [Dinwiddie, Darrell L.; Kingsmore, Stephen F.; Saunders, Carol J.; Badolato, Raffaele] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Dinwiddie, Darrell L.; Kingsmore, Stephen F.; Saunders, Carol J.] Childrens Mercy Hosp, Dept Pathol, Kansas City, MO 64108 USA; [Caracciolo, Sonia; Moratto, Daniele; Mazza, Cinzia; Sabelli, Cristiano] Univ Brescia, Ist Med Mol Angelo Nocivelli, Pediat Clin, Brescia, Italy; [Rossi, Giuseppe] Spedali Civil Brescia, Div Ematol, I-25125 Brescia, Italy; [Bacchetta, Rosa; Passerini, Laura] San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy; [Magri, Chiara; Barlati, Sergio] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, Sez Biol & Genet, Brescia, Italy; [Bell, Callum J.; Hateley, Shannon L.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Zhang, Lu; Schroth, Gary P.] Illumina, Hayward, CA USA; [Dinwiddie, Darrell L.; Kingsmore, Stephen F.; Saunders, Carol J.] Univ Missouri, Sch Med, Kansas City, MO 64108 USA	Children's Mercy Hospital; Children's Mercy Hospital; Children's Mercy Hospital; University of Brescia; Hospital Spedali Civili Brescia; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); University of Brescia; National Center for Genome Resources (NCGR); Illumina; University of Missouri System; University of Missouri Kansas City	Dinwiddie, DL (corresponding author), Childrens Mercy Hosp, Ctr Pediat Genom Med, Kansas City, MO 64108 USA.	badolato@med.unibs.it	Badolato, Raffaele/A-8081-2010; Magri, Chiara/I-4691-2017; Sabelli, Cristiano/N-2195-2018; Rossi, Giuseppe/K-3376-2016; Passerini, Laura/J-7791-2016	Badolato, Raffaele/0000-0001-7375-5410; Magri, Chiara/0000-0001-9933-8666; Sabelli, Cristiano/0000-0001-8833-5179; Rossi, Giuseppe/0000-0001-8377-2898; Passerini, Laura/0000-0002-4020-7386; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631; Bacchetta, Rosa/0000-0002-0606-6268	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001449, UL1 TR000041] Funding Source: Medline; NIAID NIH HHS [AI066569, U01 AI066569] Funding Source: Medline; NICHD NIH HHS [U19 HD077693] Funding Source: Medline; PHS HHS [AIO66569] Funding Source: Medline; Telethon [TGT11A04, GGP07241] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Telethon(Fondazione Telethon)		Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Badolato R, 2012, BLOOD, V119, P3185, DOI 10.1182/blood-2012-01-404350; Barlati S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-49; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Engelhardt KR, 2009, J ALLERGY CLIN IMMUN, V124, P1289, DOI 10.1016/j.jaci.2009.10.038; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Florescu A, 2007, THER DRUG MONIT, V29, P437, DOI 10.1097/FTD.0b013e318074df6e; Notarangelo LD, 2006, ADV IMMUNOL, V89, P321, DOI 10.1016/S0065-2776(05)89008-X; Torgerson TR, 2007, J ALLERGY CLIN IMMUN, V120, P744, DOI 10.1016/j.jaci.2007.08.044; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	10	14	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					594	597		10.1016/j.jaci.2012.10.062	http://dx.doi.org/10.1016/j.jaci.2012.10.062			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23374272	Bronze, Green Accepted			2022-12-18	WOS:000314661500045
J	Farkas, H; Csuka, D; Zotter, Z; Varga, L; Fust, G				Farkas, Henriette; Csuka, Dorottya; Zotter, Zsuzsanna; Varga, Lilian; Fuest, George			Prophylactic therapy in children with hereditary angioedema	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INHIBITOR DEFICIENCY; MANAGEMENT		[Farkas, Henriette; Csuka, Dorottya; Zotter, Zsuzsanna; Varga, Lilian; Fuest, George] Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary	Semmelweis University	Farkas, H (corresponding author), Semmelweis Univ, Dept Internal Med 3, H-1085 Budapest, Hungary.	farkash@kut.sote.hu	Csuka, Dorottya/F-2224-2010	Csuka, Dorottya/0000-0003-3610-9852; Farkas, Henriette/0000-0003-2929-1721; Varga, Lilian/0000-0002-5484-364X				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; BARAKAT AJ, 1993, AM J DIS CHILD, V147, P931, DOI 10.1001/archpedi.1993.02160330021005; Bork K, 2006, AM J MED, V119, P267, DOI 10.1016/j.amjmed.2005.09.064; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Farkas H, 2007, PEDIATRICS, V120, pE713, DOI 10.1542/peds.2006-3303; Sardana N, 2011, PEDIATRICS, V128, P1173, DOI 10.1542/peds.2011-0546; Zanichelli A, 2011, ALLERGY, V66, P192, DOI 10.1111/j.1398-9995.2010.02433.x	7	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2013	131	2					579	582		10.1016/j.jaci.2012.08.001	http://dx.doi.org/10.1016/j.jaci.2012.08.001			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086CT	23014586				2022-12-18	WOS:000314661500039
J	Tunis, MC; Dawicki, W; Carson, KR; Wang, J; Marshall, JS				Tunis, Matthew C.; Dawicki, Wojciech; Carson, Kaitlyn R.; Wang, Jun; Marshall, Jean S.			Mast cells and IgE activation do not alter the development of oral tolerance in a murine model	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cell; regulatory T cell; oral tolerance; antihistamine; ovalbumin; peanut; IgE	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLASMACYTOID DENDRITIC CELLS; SKIN PATHOLOGY; FOOD ALLERGY; PIVOTAL ROLE; HISTAMINE; MICE; EFFECTOR; ANAPHYLAXIS; INNATE	Background: In addition to their well-known role as potent effector cells in patients with allergic disease, mast cells have important immunomodulatory roles regulating tolerance in allograft rejection models. The roles of mast cells in oral tolerance development have not previously been examined. Objective: We sought to evaluate the importance of mast cells, IgE-mediated mast cell activation, and histamine receptor 1 or 2 blockade on oral tolerance development in mice. Methods: Oral tolerance was assessed in 2 mast cell-deficient murine strains (Kit(W-sh/W-sh) and Kit(W/W-v) mice) and control mice. Mice were fed ovalbumin (OVA) or peanut butter for 1 week and then immunized and boosted with relevant protein antigens. Antibody responses were assessed by using ELISA. The oral antihistamines pyrilamine and ranitidine were administered during tolerance induction to OVA. IgE-mediated mast cell activation was initiated during oral tolerance induction or OVA immunization. OVA-specific regulatory T cells were assessed in the Peyer patches, mesenteric lymph nodes, and spleens by using flow cytometry after adoptive transfer. Results: Oral tolerance was successfully induced to OVA and peanut butter in mast cell-deficient mice. Kit(W-sh/W-sh) mice had higher proportions of antigen-specific regulatory T cells in the mesenteric lymph nodes than mast cell-containing control mice. However, mast cell reconstitution studies suggested this effect was mast cell independent. Oral antihistamine treatments with pyrilamine or ranitidine did not impair tolerance and neither did IgE-mediated activation. Conclusions: Mast cells are not necessary for the induction of oral tolerance, and allergic activation of mast cells does not impair tolerance to OVA. Oral antihistamine treatments do not disrupt the development of oral tolerance. (J Allergy Clin Immunol 2012;130:705-15.)	[Tunis, Matthew C.; Dawicki, Wojciech; Carson, Kaitlyn R.; Wang, Jun; Marshall, Jean S.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Marshall, Jean S.] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 4R2, Canada; [Wang, Jun] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Tunis, Matthew C.; Wang, Jun; Marshall, Jean S.] Dalhousie Univ, Dalhousie Inflammat Grp, Halifax, NS B3H 4R2, Canada; [Wang, Jun] Dalhousie Univ, IWK Hlth Ctr, Capital Hlth, Canadian Ctr Vaccinol, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Marshall, JS (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,Room 7C, Halifax, NS B3H 4R2, Canada.	jean.marshall@dal.ca	MARSHALL, JEAN/K-4014-2012	Marshall, Jean S./0000-0002-5642-1379	AllerGen NCE, Inc.; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research	AllerGen NCE, Inc.; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Supported by AllerGen NCE, Inc. M.C.T is supported by a studentship from the Natural Sciences and Engineering Research Council of Canada.; M. C. Tunis has received research support from the Natural Sciences and Engineering Research Council of Canada. J. S. Marshall has received research support from the AllerGen Network of Centres of Excellence, Inc, and the Canadian Institutes for Health Research. The rest of the authors declare that they have no relevant conflicts of interest.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; [Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Arias K, 2011, J ALLERGY CLIN IMMUN, V127, P1552, DOI 10.1016/j.jaci.2011.03.044; Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Chacon-Salinas R, 2011, J IMMUNOL, V186, P25, DOI 10.4049/jimmunol.1001657; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dawicki W, 2010, J IMMUNOL, V184, P2116, DOI 10.4049/jimmunol.0803894; de Vries VC, 2010, TRANSPL P, V42, P2759, DOI 10.1016/j.transproceed.2010.05.168; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Forward NA, 2009, J IMMUNOL, V183, P3014, DOI 10.4049/jimmunol.0802509; GALLI SJ, 1992, ANN NY ACAD SCI, V664, P69, DOI 10.1111/j.1749-6632.1992.tb39750.x; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Green TD, 2010, CURR ALLERGY ASTHM R, V10, P391, DOI 10.1007/s11882-010-0142-y; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Itoh Naoka, 2010, Allergology International, V59, P43, DOI 10.2332/allergolint.09-OA-0107; Jawdat DM, 2006, J IMMUNOL, V177, P1755, DOI 10.4049/jimmunol.177.3.1755; Kalesnikoff J, 2010, CHEM IMMUNOL ALLERGY, V95, P45, DOI 10.1159/000315937; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; Katz HR, 2011, IMMUNITY, V35, P668, DOI 10.1016/j.immuni.2011.11.004; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; KITAMURA Y, 1978, BLOOD, V52, P447; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839; Mazzoni A, 2001, J CLIN INVEST, V108, P1865, DOI 10.1172/JCI200113930; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Muller UR, 2008, J ALLERGY CLIN IMMUN, V122, P1001, DOI 10.1016/j.jaci.2008.08.007; Muller U, 2001, J ALLERGY CLIN IMMUN, V107, P81, DOI 10.1067/mai.2001.111852; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Patriarca G, 2003, ALIMENT PHARM THER, V17, P459, DOI 10.1046/j.1365-2036.2003.01468.x; Perrier C, 2011, CLIN EXP ALLERGY, V41, P20, DOI 10.1111/j.1365-2222.2010.03639.x; Piconese S, 2011, LAB INVEST, V91, P627, DOI 10.1038/labinvest.2011.3; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; Rharbaoui F, 2005, J IMMUNOL, V174, P1317, DOI 10.4049/jimmunol.174.3.1317; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sayed BA, 2007, IMMUNOL REV, V217, P53, DOI 10.1111/j.1600-065X.2007.00524.x; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P352, DOI 10.1016/j.jaci.2008.12.1119; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stelekati E, 2007, IMMUNOBIOLOGY, V212, P505, DOI 10.1016/j.imbio.2007.03.012; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Vickery BP, 2009, CURR OPIN ALLERGY CL, V9, P364, DOI 10.1097/ACI.0b013e32832d9add; Wang M, 2010, J ALLERGY CLIN IMMUN, V126, pe1; Wang MQ, 2010, J ALLERGY CLIN IMMUN, V126, P306, DOI 10.1016/j.jaci.2010.05.017	57	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					705	+		10.1016/j.jaci.2012.04.011	http://dx.doi.org/10.1016/j.jaci.2012.04.011			12	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22607990				2022-12-18	WOS:000308463500020
J	Westermann-Clark, E; Fitzhugh, DJ; Lockey, RF				Westermann-Clark, Emma; Fitzhugh, David J.; Lockey, Richard F.			Increasing cost of epinephrine autoinjectors	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ANAPHYLAXIS; AVAILABILITY; ALLERGY		[Westermann-Clark, Emma] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA; [Fitzhugh, David J.; Lockey, Richard F.] Univ S Florida, Coll Med, Div Allergy & Immunol, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Westermann-Clark, E (corresponding author), Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA.	rlockey@health.usf.edu						[Anonymous], MICR 1 0 HEALTHC SER; Burks AW, 2012, J ALLERGY CLIN IMMUN, V129, P906, DOI 10.1016/j.jaci.2012.02.001; Kaplan MS, 2011, CURR ALLERGY ASTHM R, V11, P65, DOI 10.1007/s11882-010-0155-6; Rawas-Qalaji M, 2009, ANN ALLERG ASTHMA IM, V102, P500, DOI 10.1016/S1081-1206(10)60124-X; Simons FER, 2010, ANN ALLERG ASTHMA IM, V104, P405, DOI 10.1016/j.anai.2010.01.023; Simons FER, 2001, J ALLERGY CLIN IMMUN, V108, P1040, DOI 10.1067/mai.2001.119916; Simons FER, 2005, ANN ALLERG ASTHMA IM, V94, P534, DOI 10.1016/S1081-1206(10)61129-5	7	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2012	130	3					822	823		10.1016/j.jaci.2012.06.018	http://dx.doi.org/10.1016/j.jaci.2012.06.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	001LZ	22828415				2022-12-18	WOS:000308463500043
J	Cockcroft, DW; Nair, P				Cockcroft, Donald W.; Nair, Parameswaran			Methacholine test and the diagnosis of asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							AIRWAY HYPERRESPONSIVENESS		[Cockcroft, Donald W.] Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada; [Nair, Parameswaran] McMaster Univ, Hamilton, ON, Canada	University of Saskatchewan; McMaster University	Cockcroft, DW (corresponding author), Royal Univ Hosp, Saskatoon, SK S7N 0W8, Canada.	don.cockcroft@usask.ca						Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V117, P1244, DOI 10.1016/j.jaci.2006.02.038; COCKCROFT DW, 1990, AM REV RESPIR DIS, V142, P497, DOI 10.1164/ajrccm/142.3.497; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sumino K, 2012, J ALLERGY CLIN IMMUN, V130, P69, DOI 10.1016/j.jaci.2012.02.025; WOOLCOCK AJ, 1988, CLIN ALLERGY, V18, P165, DOI 10.1111/j.1365-2222.1988.tb02856.x	7	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2012	130	2					556	556		10.1016/j.jaci.2012.05.050	http://dx.doi.org/10.1016/j.jaci.2012.05.050			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	981WC	22743302				2022-12-18	WOS:000307002200051
J	Levin, M; Muloiwa, R; Le Souef, P; Motala, C				Levin, Michael; Muloiwa, Rudzani; Le Souef, Peter; Motala, Cassim			Ascaris sensitization is associated with aeroallergen sensitization and airway hyperresponsiveness but not allergic disease in urban Africa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ATOPY; IGE; TEENAGERS; ASTHMA		[Levin, Michael; Motala, Cassim] Red Cross War Mem Childrens Hosp, Div Allergy, Cape Town, South Africa; [Muloiwa, Rudzani] Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, Cape Town, South Africa; [Le Souef, Peter] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia	University of Western Australia	Levin, M (corresponding author), Red Cross War Mem Childrens Hosp, Div Allergy, Cape Town, South Africa.	michael.levin@uct.ac.za	Muloiwa, Rudzani/AAY-7338-2020; Levin, Michael/AAT-2370-2020; Muloiwa, Rudzani/AAG-8139-2021; Le Souef, Peter N/H-5256-2014	Muloiwa, Rudzani/0000-0002-4527-0827; Levin, Michael/0000-0003-2439-7981; Le Souef, Peter/0000-0003-0930-1654				Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Calvert J, 2010, J ALLERGY CLIN IMMUN, V125, P100, DOI 10.1016/j.jaci.2009.09.010; Cooper PJ, 2003, AM J RESP CRIT CARE, V168, P313, DOI 10.1164/rccm.200211-1320OC; GODFREY RC, 1976, NATURE, V259, P484, DOI 10.1038/259484a0; Levin ME, 2008, PEDIAT ALLERG IMM-UK, V19, P449, DOI 10.1111/j.1399-3038.2007.00663.x; Levin ME, 2011, SAMJ S AFR MED J, V101, P472; PRITCHARD DI, 1993, PARASITE IMMUNOL, V15, P5, DOI 10.1111/j.1365-3024.1993.tb00566.x; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; Yemaneberhan H, 1997, LANCET, V350, P85, DOI 10.1016/S0140-6736(97)01151-3	9	14	14	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2012	130	1					265	267		10.1016/j.jaci.2012.03.033	http://dx.doi.org/10.1016/j.jaci.2012.03.033			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	977GN	22560477	Bronze			2022-12-18	WOS:000306644800039
J	Repesse, Y; Dasgupta, S; Navarrete, AM; Delignat, S; Kaveri, SV; Lacroix-Desmazes, S				Repesse, Yohann; Dasgupta, Suryasarathi; Navarrete, Ana-Maria; Delignat, Sandrine; Kaveri, Srinivas V.; Lacroix-Desmazes, Sebastien			Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							DOMAIN		[Repesse, Yohann] Univ Paris 06, INSERM, Paris, France; Univ Paris 05, Paris, France; INSERM, Lab Int associe, F-75654 Paris 13, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Repesse, Y (corresponding author), Univ Paris 06, INSERM, Paris, France.	Sebastien.Lacroix-Desmazes@crc.jussieu.fr		Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; REPESSE, Yohann/0000-0003-3809-3858; Kaveri, Srini/0000-0002-0837-4053				Dasgupta S, 2007, P NATL ACAD SCI USA, V104, P8965, DOI 10.1073/pnas.0702120104; Dasgupta S, 2007, BLOOD, V109, P610, DOI 10.1182/blood-2006-05-022756; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; Jacquemin M, 2003, BLOOD, V101, P1351, DOI 10.1182/blood-2002-05-1369; Miclea RD, 2007, AAPS J, V9, pE251, DOI 10.1208/aapsj0902028; Navarrete AM, 2011, VACCINE, V29, P2649, DOI 10.1016/j.vaccine.2011.01.095	6	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2012	129	4					1172	1173		10.1016/j.jaci.2012.01.048	http://dx.doi.org/10.1016/j.jaci.2012.01.048			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	917AP	22336079				2022-12-18	WOS:000302144600044
J	Bozhinov, A; Handzhiyski, Y; Genov, K; Daskalovska, V; Niwa, T; Ivanov, I; Mironova, R				Bozhinov, Angelina; Handzhiyski, Yordan; Genov, Krasimir; Daskalovska, Vera; Niwa, Toshimitsu; Ivanov, Ivan; Mironova, Roumyana			Advanced glycation end products contribute to the immunogenicity of IFN-beta pharmaceuticals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							VERSUS-HOST-DISEASE; ESCHERICHIA-COLI; CELLS; MICE		[Bozhinov, Angelina; Handzhiyski, Yordan; Ivanov, Ivan; Mironova, Roumyana] Bulgarian Acad Sci, Dept Gene Regulat, Inst Mol Biol Roumen Tsanev, Sofia, Bulgaria; [Genov, Krasimir] Mil Med Acad, Dept Neurol & Neurosurg, Sofia, Bulgaria; [Daskalovska, Vera] Ss Cyril & Methodius Univ, Dept Neurol, Fac Med, Skopje, Macedonia; [Niwa, Toshimitsu] Nagoya Univ, Dept Adv Med Uremia, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Bulgarian Academy of Sciences; Medical University Sofia; Military Medical Academy Sofia; Saints Cyril & Methodius University of Skopje; Nagoya University	Bozhinov, A (corresponding author), Bulgarian Acad Sci, Dept Gene Regulat, Inst Mol Biol Roumen Tsanev, Sofia, Bulgaria.	rumym@bio21.bas.bg	Mironova, Roumyana/D-7413-2013					Corona T, 1999, NEUROLOGY, V52, P425, DOI 10.1212/WNL.52.2.425-a; Damasiewicz-Bodzek A, 2011, J EUR ACAD DERMATOL; Guijarro C, 2011, NEUROL SCI, V32, P309, DOI 10.1007/s10072-010-0432-0; Guo Baozhu, 2008, Inflammation & Allergy Drug Targets, V7, P163, DOI 10.2174/187152808785748182; Humpert PM, 2009, J LEUKOCYTE BIOL, V86, P589, DOI 10.1189/jlb.1008646; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Malucchi S, 2004, NEUROLOGY, V62, P2031, DOI 10.1212/01.WNL.0000129265.73259.9E; Mironova R, 2003, J BIOL CHEM, V278, P51068, DOI 10.1074/jbc.M307470200; Mironova R, 2008, ANN NY ACAD SCI, V1126, P181, DOI 10.1196/annals.1433.006; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241	11	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2012	129	3					855	858		10.1016/j.jaci.2011.10.035	http://dx.doi.org/10.1016/j.jaci.2011.10.035			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	904IW	22154379				2022-12-18	WOS:000301189300038
J	Leung, DY; Searing, DA; Jackson, LP; Richers, BN; Goleva, E				Leung, D. Y.; Searing, D. A.; Jackson, L. P.; Richers, B. N.; Goleva, E.			Steroid Requirements and Immune Associations With Vitamin D Are Stronger In Children Than Adults With Asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI)	MAR 02-06, 2012	Orlando, FL	Amer Acad Allergy Asthma & Immunol (AAAAI)					[Leung, D. Y.; Searing, D. A.; Jackson, L. P.; Richers, B. N.; Goleva, E.] Natl Jewish Hlth, Denver, CO USA	National Jewish Health									0	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2012	129	2		S			AB127	AB127		10.1016/j.jaci.2011.12.422	http://dx.doi.org/10.1016/j.jaci.2011.12.422			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	903QL		Green Accepted			2022-12-18	WOS:000301133400482
J	Santos, KS; Galvao, CE; Gadermaier, G; Resende, VMF; Martins, CD; Misumi, DS; Yang, AC; Ferreira, F; Palma, MS; Kalil, J; Castro, FFM				Santos, Keity Souza; Galvao, Clovis Eduardo; Gadermaier, Gabriele; Ferreira Resende, Virginia Maria; Martins, Carlo de Oliveira; Misumi, Denise Shimbo; Yang, Ariana Campos; Ferreira, Fatima; Palma, Mario Sergio; Kalil, Jorge; Morato Castro, Fabio Fernandes			Allergic reactions to manioc (Manihot esculenta Crantz): Identification of novel allergens with potential involvement in latex-fruit syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CROSS-REACTIVITY; CASSAVA; FOOD		[Santos, Keity Souza; Ferreira Resende, Virginia Maria; Martins, Carlo de Oliveira; Misumi, Denise Shimbo; Kalil, Jorge; Morato Castro, Fabio Fernandes] Univ Sao Paulo, Sch Med, FMUSP, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil; [Santos, Keity Souza; Ferreira Resende, Virginia Maria; Martins, Carlo de Oliveira; Palma, Mario Sergio; Kalil, Jorge; Morato Castro, Fabio Fernandes] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Galvao, Clovis Eduardo; Yang, Ariana Campos; Morato Castro, Fabio Fernandes] FMUSP, Clin Hosp, Div Allergy, Sao Paulo, Brazil; [Gadermaier, Gabriele; Ferreira, Fatima] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Palma, Mario Sergio] Univ Sao Paulo State UNESP, Inst Biosci Rio Claro, Dept Biol, Ctr Study Social Insects, Sao Paulo, Brazil; [Kalil, Jorge] Heart Inst INCOR, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Salzburg University; Universidade Estadual Paulista; Universidade de Sao Paulo	Santos, KS (corresponding author), Univ Sao Paulo, Sch Med, FMUSP, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil.	keity@usp.br	Ferreira, Fatima/E-4889-2011; KALIL, JORGE/C-8029-2012; Palma, Mario/N-3903-2019; Santos, Keity/E-2553-2012; Martins, Carlo/D-4008-2018; Santos, Keity Souza/Q-5704-2019; Resende, Virgínia/H-5417-2013; Palma, Mario Sergio/E-7800-2012; Souza, Keity/AEX-0817-2022; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/AAB-4321-2019; Santos, Keity/M-9401-2015; Castro, Fabio FM/C-1082-2017; Castro, Fabio/AAP-5433-2020	Ferreira, Fatima/0000-0003-0989-2335; KALIL, JORGE/0000-0001-8415-4274; Martins, Carlo/0000-0003-1287-8884; Santos, Keity Souza/0000-0001-5271-4011; Resende, Virgínia/0000-0002-9225-5654; Palma, Mario Sergio/0000-0002-7363-8211; Souza, Keity/0000-0001-5271-4011; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Castro, Fabio FM/0000-0002-6211-5773; 				de Souza CRB, 2008, PROTEIN PEPTIDE LETT, V15, P900; Beezhold DH, 1999, J ALLERGY CLIN IMMUN, V103, P1166, DOI 10.1016/S0091-6749(99)70194-6; Benndorf D, 2008, ALLERGY, V63, P454, DOI 10.1111/j.1398-9995.2007.01603.x; Chen YH, 2005, ALLERGY, V60, P1518, DOI 10.1111/j.1398-9995.2005.00918.x; D'Amato A, 2010, J PROTEOMICS, V73, P1368, DOI 10.1016/j.jprot.2010.03.002; GALVAO CES, 2003, J ALLERGY CLIN IMMUN, pS61; Gaspar A, 2003, ALLERGY, V58, P683, DOI 10.1034/j.1398-9995.2003.00184.x; Ibero M, 2007, J INVEST ALLERG CLIN, V17, P409; Nakamura R, 2009, REGUL TOXICOL PHARM, V55, P300, DOI 10.1016/j.yrtph.2009.08.002; Ocmant A, 2009, CLIN EXP ALLERGY, V39, P1234, DOI 10.1111/j.1365-2222.2009.03292.x; Wagner S, 2005, INT ARCH ALLERGY IMM, V136, P90, DOI 10.1159/000082938	11	14	15	0	15	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2011	128	6					1367	1369		10.1016/j.jaci.2011.07.019	http://dx.doi.org/10.1016/j.jaci.2011.07.019			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	865WX	21855976				2022-12-18	WOS:000298342700036
J	Bernstein, DI; Kissling, GE; Hershey, GK; Yucesoy, B; Johnson, VJ; Cartier, A; Gautrin, D; Sastre, J; Boulet, LP; Malo, JL; Quirce, S; Tarlo, SM; Langmeyer, S; Luster, MI; Lummus, ZL				Bernstein, David I.; Kissling, Grace E.; Hershey, Gurjit Khurana; Yucesoy, Berran; Johnson, Victor J.; Cartier, Andre; Gautrin, Denyse; Sastre, Joaquin; Boulet, Louis-Philippe; Malo, Jean-Luc; Quirce, Santiago; Tarlo, Susan M.; Langmeyer, Stacy; Luster, Michael I.; Lummus, Zana L.			Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor alpha	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							IL4RA		[Bernstein, David I.; Langmeyer, Stacy; Lummus, Zana L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Kissling, Grace E.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Hershey, Gurjit Khurana] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Yucesoy, Berran; Johnson, Victor J.; Luster, Michael I.] NIOSH, CDC, Hlth Effects Lab Div, Morgantown, WV USA; [Cartier, Andre; Gautrin, Denyse; Malo, Jean-Luc] Univ Montreal, Hop Sacre Coeur, Quebec City, PQ, Canada; [Sastre, Joaquin; Quirce, Santiago] Univ Autonoma Madrid, Dept Allergy, E-28049 Madrid, Spain; [Boulet, Louis-Philippe] Univ Laval, Hop Laval, Ste Foy, PQ G1K 7P4, Canada; [Tarlo, Susan M.] Univ Toronto, Toronto, ON M5S 1A1, Canada	University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cincinnati Children's Hospital Medical Center; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Universite de Montreal; Autonomous University of Madrid; Laval University; University of Toronto	Bernstein, DI (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	Bernstdd@ucmail.uc.edu	s, q/AAD-7171-2020	Khurana Hershey, Gurjit/0000-0001-6663-977X; Johnson, Victor J./0000-0002-3471-6483; Tarlo, Susan/0000-0002-4746-5310	Intramural NIH HHS [Z01 ES045005-11, Z01 ES045005] Funding Source: Medline; NIEHS NIH HHS [Z01-ES045005] Funding Source: Medline; NIOSH CDC HHS [1-R01 OH008795, R01 OH008795] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES045005, ZIAES045005, ZIAES103106] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIOSH CDC HHS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bernstein DI, 2006, ANN ALLERG ASTHMA IM, V97, P800, DOI 10.1016/S1081-1206(10)60972-6; Bernstein DI, 2002, AM J RESP CRIT CARE, V166, P445, DOI 10.1164/rccm.2109018; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Risma KA, 2002, J IMMUNOL, V169, P1604, DOI 10.4049/jimmunol.169.3.1604; Tee RD, 1998, J ALLERGY CLIN IMMUN, V101, P709, DOI 10.1016/S0091-6749(98)70181-2; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wisnewski AV, 2004, J ALLERGY CLIN IMMUN, V113, P1178, DOI 10.1016/j.jaci.2004.03.009	8	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2011	128	2					418	420		10.1016/j.jaci.2011.03.007	http://dx.doi.org/10.1016/j.jaci.2011.03.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	799IQ	21489615	Green Accepted			2022-12-18	WOS:000293280800027
J	Kelly, HW				Kelly, H. William			Inhaled corticosteroid dosing: Double for nothing?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Asthma; clinical trials; inhaled corticosteroids; long-acting beta(2)-agonist; outcomes	DRY POWDER INHALER; DOSE-RESPONSE RELATIONSHIP; FLUTICASONE PROPIONATE TREATMENT; EXHALED NITRIC-OXIDE; STEP-UP THERAPY; MOMETASONE FUROATE; BECLOMETHASONE DIPROPIONATE; PERSISTENT ASTHMA; INDUCED BRONCHOCONSTRICTION; COMBINATION THERAPY	Two recent trials from the National Heart, Lung, and Blood Institute's asthma clinical trials networks raise a concern about using double the dose of an inhaled corticosteroid (ICS) as a positive control arm in clinical trials of add-on therapy. The literature evaluating the response to doubling the dose of an ICS is briefly reviewed. The vast majority of studies do not demonstrate a significant positive benefit from doubling the dose of an ICS but do show improvement with 4-fold increases that is equal to or greater than that of add-on long-acting bronchodilators. It is recommended that doubling the dose of an ICS no longer be considered a positive comparator arm in clinical trials, although it might be beneficial in individual patients. (J Allergy Clin Immunol 2011;128:278-81.)	Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA	University of New Mexico	Kelly, HW (corresponding author), Univ New Mexico, Dept Pediat, MSC10-5590,1 Univ New Mexico, Albuquerque, NM 87131 USA.	hwkelly@salud.unm.edu			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	H. W. Kelly has served on a GlaxoSmithKline steering committee for a US Food and Drug Administration-mandated long-acting beta<INF>2</INF>-agonist safety study in children and has also received research support from GlaxoSmithKline.	Ahrens RC, 2001, AM J RESP CRIT CARE, V164, P1138, DOI 10.1164/ajrccm.164.7.2008112; AYRES JG, 1995, EUR RESPIR J, V8, P579; Baraniuk J, 1999, CHEST, V116, P625, DOI 10.1378/chest.116.3.625; Bateman ED, 2008, PULM PHARMACOL THER, V21, P489, DOI 10.1016/j.pupt.2007.11.002; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bateman Eric D, 2003, Am J Respir Med, V2, P275; Bergmann KC, 2004, SWISS MED WKLY, V134, P50; Bernstein DI, 1999, RESP MED, V93, P603, DOI 10.1016/S0954-6111(99)90099-9; Bisgaard H, 1999, AM J RESP CRIT CARE, V160, P126, DOI 10.1164/ajrccm.160.1.9811024; Bouros D, 1999, EUR RESPIR J, V14, P627, DOI 10.1034/j.1399-3003.1999.14c24.x; Bousquet J, 2000, EUR RESPIR J, V16, P808, DOI 10.1183/09031936.00.16580800; Busse W, 2003, J ALLERGY CLIN IMMUN, V111, P57, DOI 10.1067/mai.2003.38; Busse WW, 1999, J ALLERGY CLIN IMMUN, V104, P1215, DOI 10.1016/S0091-6749(99)70016-3; Condemi JJ, 1999, ANN ALLERG ASTHMA IM, V82, P383, DOI 10.1016/S1081-1206(10)63288-7; DAHL R, 1993, CHEST, V104, P1352, DOI 10.1378/chest.104.5.1352; Deeks ED, 2008, DRUGS, V68, P1741, DOI 10.2165/00003495-200868120-00010; Djukanovic R, 2010, RESP MED, V104, P1425, DOI 10.1016/j.rmed.2010.04.004; Ducharme FM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005533.pub2; Foresi A, 2000, CHEST, V117, P440, DOI 10.1378/chest.117.2.440; Gappa M, 2009, PEDIATR PULM, V44, P1132, DOI 10.1002/ppul.21120; Gelfand EW, 2006, J PEDIATR-US, V148, P377, DOI 10.1016/j.jpeds.2005.10.028; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Greenstone IR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005533; Hansel TT, 2006, CLIN THER, V28, P906, DOI 10.1016/j.clinthera.2006.06.014; Hofstra WB, 2000, PEDIATR PULM, V29, P415, DOI 10.1002/(SICI)1099-0496(200006)29:6<415::AID-PPUL1>3.0.CO;2-7; Ind PW, 2003, RESP MED, V97, P555, DOI 10.1053/rmed.2003.1483; Inman MD, 2001, AM J RESP CRIT CARE, V164, P569, DOI 10.1164/ajrccm.164.4.2007063; Kelly HW, 2009, ANN PHARMACOTHER, V43, P519, DOI 10.1345/aph.1L546; Kelly HW, 1998, ANN PHARMACOTHER, V32, P220, DOI 10.1345/aph.17014; Kelsen SG, 1999, J ASTHMA, V36, P703, DOI 10.3109/02770909909055422; Kemp JP, 2000, J ALLERGY CLIN IMMUN, V106, P485, DOI 10.1067/mai.2000.109431; Kips JC, 2000, AM J RESP CRIT CARE, V161, P996, DOI 10.1164/ajrccm.161.3.9812056; Lalloo UG, 2003, CHEST, V123, P1480, DOI 10.1378/chest.123.5.1480; Langdon CG, 2005, RESP MED, V99, P1275, DOI 10.1016/j.rmed.2005.05.024; Leach CL, 2002, CHEST, V122, P510, DOI 10.1378/chest.122.2.510; Lee DKC, 2005, CHEST, V127, P851, DOI 10.1378/chest.127.3.851; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Lim S, 2000, THORAX, V55, P837, DOI 10.1136/thorax.55.10.837; Lipworth BJ, 2005, ANN ALLERG ASTHMA IM, V94, P675, DOI 10.1016/S1081-1206(10)61327-0; Masoli M, 2005, THORAX, V60, P730, DOI 10.1136/thx.2004.039180; Masoli M, 2004, ARCH DIS CHILD, V89, P902, DOI 10.1136/adc.2003.035709; Masoli M, 2004, EUR RESPIR J, V23, P552, DOI 10.1183/09031936.04.00076604; Masoli M, 2004, THORAX, V59, P16; Mitchell C, 2003, PULM PHARMACOL THER, V16, P299, DOI 10.1016/S1094-5539(03)00071-3; Murray JJ, 1999, ALLERGY ASTHMA PROC, V20, P173, DOI 10.2500/108854199778553028; Nathan RA, 2001, ANN ALLERG ASTHMA IM, V86, P203, DOI 10.1016/S1081-1206(10)62692-0; Nayak AS, 2000, ANN ALLERG ASTHMA IM, V84, P417, DOI 10.1016/S1081-1206(10)62275-2; Ni Chroinin M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005535; *NIH, 2007, FULL REP EXP PAN GUI; Noonan M, 2001, ANN ALLERG ASTHMA IM, V86, P36, DOI 10.1016/S1081-1206(10)62353-8; O'Byrne PM, 2001, AM J RESP CRIT CARE, V164, P1392, DOI 10.1164/ajrccm.164.8.2104102; O'Connor B, 2001, ANN ALLERG ASTHMA IM, V86, P397, DOI 10.1016/S1081-1206(10)62485-4; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pearlman DS, 1999, ANN ALLERG ASTHMA IM, V82, P257, DOI 10.1016/S1081-1206(10)62606-3; Pedersen S, 2009, PULM PHARMACOL THER, V22, P214, DOI 10.1016/j.pupt.2008.12.013; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Petersen R, 2004, EUR RESPIR J, V24, P932, DOI 10.1183/09031936.04.00141303; Phillips K, 2004, THORAX, V59, P21, DOI 10.1136/thx.2003.015289; Pohunek P, 2006, PEDIAT ALLERG IMM-UK, V17, P458, DOI 10.1111/j.1399-3038.2006.00425.x; Powell H, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004109.PUB2, 10.1002/14651858.CD004109.pub2]; ROSENHALL L, 1982, EUR J RESPIR DIS, V63, P154; RUSSELL G, 1995, ANN ALLERG ASTHMA IM, V75, P423; Shapiro G, 1998, J PEDIATR-US, V132, P976, DOI 10.1016/S0022-3476(98)70394-4; Sharpe M, 2001, DRUGS, V61, P1325, DOI 10.2165/00003495-200161090-00011; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Simons FER, 2001, J PEDIATR-US, V138, P694, DOI 10.1067/mpd.2001.112899; Sin DD, 2004, JAMA-J AM MED ASSOC, V292, P367, DOI 10.1001/jama.292.3.367; STIKSA G, 1982, EUR J RESPIR DIS, V63, P266; Subbarao P, 2006, J ALLERGY CLIN IMMUN, V117, P1008, DOI 10.1016/j.jaci.2005.11.048; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P730, DOI 10.1067/mai.2002.122712; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Vaessen-Verberne AAPH, 2010, AM J RESP CRIT CARE, V182, P1221, DOI 10.1164/rccm.201002-0193OC; van Noord JA, 1999, THORAX, V54, P207, DOI 10.1136/thx.54.3.207; Verberne AAPH, 1998, AM J RESP CRIT CARE, V158, P213, DOI 10.1164/ajrccm.158.1.9706048; von Mutius E, 2010, NEW ENGL J MED, V362, P1042, DOI 10.1056/NEJMe1002058; Wasserman RL, 2006, ANN ALLERG ASTHMA IM, V96, P808, DOI 10.1016/S1081-1206(10)61343-9; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590; Zhang LJ, 2011, PEDIATRICS, V127, P129, DOI 10.1542/peds.2010-1223; Zimmerman B, 2004, PEDIATR PULM, V37, P122, DOI 10.1002/ppul.10404	80	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2011	128	2					278	U272		10.1016/j.jaci.2011.05.002	http://dx.doi.org/10.1016/j.jaci.2011.05.002			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	799IQ	21621831				2022-12-18	WOS:000293280800004
J	Hofmann, SC; Pfender, N; Weckesser, S; Blank, S; Huss-Marp, J; Spillner, E; Jakob, T				Hofmann, S. C.; Pfender, Nikolai; Weckesser, Steffi; Blank, Simon; Huss-Marp, Johannes; Spillner, Edzard; Jakob, Thilo			Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy Reply	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MOLECULAR-CLONING; EXPRESSION		[Hofmann, S. C.; Pfender, Nikolai; Weckesser, Steffi; Jakob, Thilo] Univ Freiburg, Dept Dermatol, Allergy Res Grp, Univ Med Ctr Freiburg, D-7800 Freiburg, Germany; [Blank, Simon; Spillner, Edzard] Univ Hamburg, Dept Chem, Inst Biochem & Mol Biol, Hamburg, Germany; [Huss-Marp, Johannes] Phadia GmbH, Freiburg, Germany	University of Freiburg; University of Hamburg	Hofmann, SC (corresponding author), Univ Freiburg, Dept Dermatol, Allergy Res Grp, Univ Med Ctr Freiburg, Hauptstr 7, D-7800 Freiburg, Germany.	jakob@uniklinik-freiburg.de	Jakob, Thilo/J-1621-2012; Blank, Simon/M-7708-2013; Spillner, E./G-3799-2010					Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331; Hofmann SC, 2011, J ALLERGY CLIN IMMUN, V127, P265, DOI 10.1016/j.jaci.2010.06.042; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Peiren N, 2006, FEBS LETT, V580, P4895, DOI 10.1016/j.febslet.2006.08.005; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Sturm GJ, 2011, J ALLERGY CLIN IMMUN, V128, P247, DOI 10.1016/j.jaci.2011.02.021	6	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2011	128	1					248	248		10.1016/j.jaci.2011.02.020	http://dx.doi.org/10.1016/j.jaci.2011.02.020			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	785RE					2022-12-18	WOS:000292245600045
J	Datta, S; Milner, JD				Datta, Shrimati; Milner, Joshua D.			Altered T-cell receptor signaling in the pathogenesis of allergic disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						T-cell receptor; T(H)2; atopy	IMMUNOLOGICAL SYNAPSE; AUTOIMMUNE ARTHRITIS; DOCK8 MUTATIONS; OMENN-SYNDROME; CUTTING EDGE; ACTIVATION; MICE; RESPONSES; KINASE; IMMUNODEFICIENCY	Mounting evidence from animal models has demonstrated that alterations in T-cell receptor (TCR) signaling alone can lead to dramatically skewed differentiation of naive T cells into T(H)2 cells, to T(H)2 effector functions, and to T(H)2-related diseases. There is significant potential relevance of these observations to human disease. Specifically, a number of immunodeficiencies associated with atopic disease might have atopy as a manifestation because of aberrant TCR signaling. It is therefore important to attempt to identify a role for defects in TCR signaling in the pathogenesis of common atopic diseases. (J Allergy Clin Immunol 2011;127:351-4.)	[Datta, Shrimati; Milner, Joshua D.] NIAID, Lab Allerg Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Milner, JD (corresponding author), 9000 Rockville Pike,NIH Bldg 10 12S236A, Bethesda, MD 20892 USA.	jdmilner@niaid.nih.gov			National Institutes of Health/National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001098, ZIAAI001099] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institutes of Health/National Institute of Allergy and Infectious Diseases.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Boutin Y, 1997, J IMMUNOL, V159, P5802; Boyton RJ, 2002, J IMMUNOL, V168, P1018, DOI 10.4049/jimmunol.168.3.1018; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Gerwien J, 1999, J IMMUNOL, V163, P1742; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Jakob T, 2008, J ALLERGY CLIN IMMUN, V121, P179, DOI 10.1016/j.jaci.2007.07.018; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Levin D, 2008, EUR J IMMUNOL, V38, P3339, DOI 10.1002/eji.200838584; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Marrella V, 2007, J CLIN INVEST, V117, P1260, DOI 10.1172/JCI30928; Milner JD, 2007, P NATL ACAD SCI USA, V104, P576, DOI 10.1073/pnas.0610289104; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Siggs OM, 2007, IMMUNITY, V27, P912, DOI 10.1016/j.immuni.2007.11.013; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	33	14	15	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2011	127	2					351	354		10.1016/j.jaci.2010.11.033	http://dx.doi.org/10.1016/j.jaci.2010.11.033			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	714KH	21281865	Green Accepted			2022-12-18	WOS:000286808000006
J	Arnez, LEA; Venegas, EN; Ober, C; Thompson, EE				Arnez, Lucia Elena Alvarado; Venegas, Evaristo N.; Ober, Carole; Thompson, Emma E.			Sequence variation in the IL4 gene and resistance to Trypanosoma cruzi infection in Bolivians	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							MAJOR ALLERGEN; CHAGAS-DISEASE; T-CELLS; ASTHMA; IL-31; IGE; INTERLEUKIN-31; POLYMORPHISMS; INFLAMMATION; ACTIVATION		[Arnez, Lucia Elena Alvarado; Ober, Carole; Thompson, Emma E.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Venegas, Evaristo N.] Lab DIANA Histocompatibil & Immunogenet, Cochabamba, Bolivia	University of Chicago	Arnez, LEA (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	eethomps@uchicago.edu	Arnez, Lucia Elena Alvarado/D-4690-2016	Arnez, Lucia Elena Alvarado/0000-0002-3537-6361; Ober, Carole/0000-0003-4626-9809	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072414, T32HL007605] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL072414, T32 HL007605] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2010, NATURE, V465, pS3; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Cunha-Neto E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000900032; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Ip WK, 2007, IMMUNOLOGY, V122, P532, DOI 10.1111/j.1365-2567.2007.02668.x; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Lei Z, 2008, ALLERGY, V63, P327, DOI 10.1111/j.1398-9995.2007.01566.x; Nakamura Y, 2001, ALLERGY, V56, P385, DOI 10.1034/j.1398-9995.2001.056005385.x; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Niyonsaba F, 2010, J IMMUNOL, V184, P3526, DOI 10.4049/jimmunol.0900712; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Ohashi Y, 1998, SCAND J IMMUNOL, V47, P596; Okano M, 2008, CLIN EXP ALLERGY, V38, P1891, DOI 10.1111/j.1365-2222.2008.03116.x; Okuda M, 2005, ACTA OTO-LARYNGOL, V125, P736, DOI 10.1080/00016480510026944; Perrigoue JG, 2007, J EXP MED, V204, P481, DOI 10.1084/jem.20061791; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; REED SG, 1988, J IMMUNOL, V140, P4342; Ribeiro BM, 2008, HUM IMMUNOL, V69, P484, DOI 10.1016/j.humimm.2008.05.013; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Sone T, 2005, CLIN EXP ALLERGY, V35, P664, DOI 10.1111/j.1365-2222.2005.02221.x; Sun J, 2007, CLIN EXP ALLERGY, V37, P901, DOI 10.1111/j.1365-2222.2007.02723.x; Suzuki M, 1996, MOL IMMUNOL, V33, P451, DOI 10.1016/0161-5890(95)00147-6; Verra F, 2004, ACTA TROP, V90, P205, DOI 10.1016/j.actatropica.2003.11.014; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X	26	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2011	127	1					279	282		10.1016/j.jaci.2010.10.026	http://dx.doi.org/10.1016/j.jaci.2010.10.026			16	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	702SY	21211660	Green Accepted			2022-12-18	WOS:000285917300045
J	Spahn, J; Sheth, K; Yeh, WS; Stempel, DA; Stanford, RH				Spahn, Joseph; Sheth, Ketan; Yeh, Wei-Shi; Stempel, David A.; Stanford, Richard H.			Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Fluticasone propionate; salmeterol; combination; asthma; utilization; emergency department; hospitalization exacerbations; drug holiday	PROPENSITY SCORE; AIRWAY INFLAMMATION; SEPTEMBER EPIDEMIC; DOUBLE-BLIND; BUDESONIDE; SALMETEROL; INFECTION; CHILDREN; HOSPITALIZATION; EXACERBATIONS	Background: Asthma exacerbations occur year-round; however, peak asthma-related events occur in the fall and are frequently associated with viral respiratory infections. Objective: To compare the rates of asthma-related emergency department (ED) visits and hospitalizations in the fall (September, October, November) between users and nonusers of fluticasone propionate plus salmeterol in a single inhaler (FSC) in the preceding summer. Methods: This was a retrospective, observational study using health care claims from a large managed care database. Patients age 4 to 55 years with both a medical claim for asthma and a pharmacy claim for FSC were categorized into 3 age groups: children (4-11 years), adolescents (12-18 years), and adults (19-55 years). Results: There were 201,973 observations of FSC dispensings and 184,143 observations without FSC. Across all age groups, summertime dispensings of FSC were associated with a significantly lower (P <.001) risk of an asthma-related ED visit (4-11 years: adjusted odds ratio [OR], 0.54, 95% CI, 0.49-0.60; 12-18 years: OR, 0.59, 95% Cl, 0.54-0.64; 19-55 years: OR, 0.53, 95% CI, 0.51-0.55) or hospitalization (4-11 years: OR, 0.43, 95% CI, 0.35-0.54; 12-18 years: OR, 0.49, 95% CI, 0.40-0.60; 19-55 years: OR, 0.61, 95% CI, 0.57-0.65) in the subsequent fall. This protective effect persisted even for patients with fall dispensings of FSC. The risk of oral corticosteroid dispensing in the fall was also significantly reduced in all age groups. Conclusion: Summertime dispensings of FSC were associated with a decreased risk of serious asthma-related outcomes in the subsequent fall. Continuous use of FSC before seasonal viral exposure may decrease seasonally related exacerbations. (J Allergy Clin Immunol 2009;124:1197-203.)	[Spahn, Joseph] Natl Jewish Hlth, Denver, CO USA; [Sheth, Ketan] Lafayette Allergy & Asthma Clin, Lafayette, IN USA; [Yeh, Wei-Shi] Univ N Carolina, Chapel Hill, NC USA; [Stempel, David A.; Stanford, Richard H.] GlaxoSmithKline Inc, Res Triangle Pk, NC USA	National Jewish Health; University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline	Spahn, J (corresponding author), Natl Jewish Med & Res Ctr, Ira J & Jacqueline Neimark Lab Clin Pharmacol Ped, 1400 Jackson St, Denver, CO 80206 USA.	spahnj@njc.org			GlaxoSmithKline, Research Triangle Park, NC; Merck	GlaxoSmithKline, Research Triangle Park, NC(GlaxoSmithKline); Merck(Merck & Company)	Disclosure of potential conflict of interest: R. H. Stanford and D. A. Stempel are employees of GlaxoSmith Kline. J. Spahn has received honoraria and served as a consultant for GlaxoSmithKline, has received research support from Merck, and has served as an expert witness for GlaxoSmithKline. K. Sheth has received honoraria from Alcon, AstraZeneca, and Sanofi; has served its a consultant for Sepracor (Altana): and has received honoraria and served as a consultant for GlaxoSmithKline. W.-S. Yeh has received consulting fees from GlaxoSmithKline.	[Anonymous], 3 NAT HEART LUNG BLO; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chanez Pascal, 2004, Proc Am Thorac Soc, V1, P184, DOI 10.1513/pats.200402-006MS; CONNETT G, 1993, ARCH DIS CHILD, V68, P85, DOI 10.1136/adc.68.1.85; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Doull IJM, 2003, J PEDIATR-US, V142, pS21, DOI 10.1067/mpd.2003.22; Dowling RB, 1999, EUR RESPIR J, V14, P363, DOI 10.1034/j.1399-3003.1999.14b21.x; Fleming DM, 2000, THORAX, V55, P662, DOI 10.1136/thorax.55.8.662; Gergen PJ, 2002, J PEDIATR-US, V141, P631, DOI 10.1067/mpd.2002.127510; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Johnston NW, 2006, J ALLERGY CLIN IMMUN, V117, P557, DOI 10.1016/j.jaci.2005.11.034; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; LAITINEN LA, 1992, J ALLERGY CLIN IMMUN, V90, P32, DOI 10.1016/S0091-6749(06)80008-4; Lin RY, 2007, ANN ALLERG ASTHMA IM, V98, P139, DOI 10.1016/S1081-1206(10)60686-2; Nelson HS, 2003, J ALLERGY CLIN IMMUN, V112, P29, DOI 10.1067/mai.2003.1558; Orsida BE, 2001, AM J RESP CRIT CARE, V164, P117, DOI 10.1164/ajrccm.164.1.2006003; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pendergraft TB, 2005, J ASTHMA, V42, P265, DOI 10.1081/JAS-200057893; Sears MR, 2007, J ALLERGY CLIN IMMUN, V120, P526, DOI 10.1016/j.jaci.2007.05.047; Silverman RA, 2005, ARCH PEDIAT ADOL MED, V159, P818, DOI 10.1001/archpedi.159.9.818; STONE RA, 1995, MED CARE, V33, pAS56; Svedmyr J, 1999, ACTA PAEDIATR, V88, P42; Wallin A, 2003, J ALLERGY CLIN IMMUN, V112, P72, DOI 10.1067/mai.2003.1518	25	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2009	124	6					1197	1203		10.1016/j.jaci.2009.08.042	http://dx.doi.org/10.1016/j.jaci.2009.08.042			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	536VH	19910037				2022-12-18	WOS:000273071500009
J	Lenox, LE; Kambayashi, T; Okumura, M; Prieto, C; Sauer, K; Bunte, RM; Jordan, MS; Koretzky, GA; Nichols, KE				Lenox, Laurie E.; Kambayashi, Taku; Okumura, Mariko; Prieto, Christopher; Sauer, Karsten; Bunte, Ralph M.; Jordan, Martha S.; Koretzky, Gary A.; Nichols, Kim E.			Mutation of tyrosine 145 of lymphocyte cytosolic protein 2 protects mice from anaphylaxis and arthritis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; neutrophils; Fc receptors; integrins; signal transduction; SLP-76; passive systemic anaphylaxis; localized Shwartzman reaction; arthritis	FC-EPSILON-RI; AFFINITY IGE RECEPTOR; ELECTROPERMEABILIZED HUMAN NEUTROPHILS; INDUCED JOINT INFLAMMATION; TEC FAMILY KINASES; MAST-CELLS; PHOSPHORYLATED SLP-76; RHEUMATOID-ARTHRITIS; SHWARTZMAN REACTION; SIGNALING PATHWAYS	Background: Lymphocyte cytosolic protein 2, also known as Sire homology 2 domain-containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76), is an essential adaptor molecule in myeloid cells, where it regulates Fc is an element of RI-induced mast cell (MC) and Fc gamma R- and integrin-induced neutrophil (polymorphonuclear leukocyte [PMN]) functions. SLP-76 contains 3 N-terminal tyrosines at residues 112, 128, and 145 that together are critical for its function. Objective: We sought to explore the relative importance of tyrosines 112, 128, and 145 of SLP-76 during MC and PMN activation. Methods: We examined in vitro MC and PMN functions using cells isolated from knock-in mice harboring phenylalanine substitution mutations at tyrosines 112 and 128 (Y112/128F) or 145 (Y145F). We also examined the effects of these mutations on in vivo MC and PMN activation using models of anaphylaxis, dermal inflammation, and serum-induced arthritis. Results: Mutations at Y112/Y128 and Y145 both interfered with SLP-76 activity; however, Y145F had a greater effect than Y112/128F on most in vitro FcR-induced functions. In vitro functional defects were recapitulated in vivo, where mice expressing Y145F exhibited greater attenuation of MC-dependent passive systemic anaphylaxis and PMN-mediated inflammatory responses. Notably, the Y145F mutation completely protected mice against development of joint-specific inflammation in the MC and PMN-dependent K/B x N model of arthritis. Conclusion: Our data indicate that Y145 is the most critical tyrosine supporting SLP-76 function in myeloid cells. Future efforts to dissect how Y145 mediates SLP-76-dependent signaling in MCs and PMNs will increase our understanding of these lineages and provide insights into the treatment of allergy and inflammation. (J Allergy Clin Immunol 2009;124:1088-98.)	[Lenox, Laurie E.; Prieto, Christopher; Nichols, Kim E.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Lenox, Laurie E.; Kambayashi, Taku; Okumura, Mariko; Prieto, Christopher; Jordan, Martha S.; Koretzky, Gary A.; Nichols, Kim E.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Kambayashi, Taku; Okumura, Mariko; Jordan, Martha S.; Koretzky, Gary A.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA USA; [Bunte, Ralph M.] Univ Penn, Univ Lab Anim Resources, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Scripps Research Institute; University of Pennsylvania	Nichols, KE (corresponding author), Childrens Hosp Philadelphia, Div Oncol, Wood Bldg,4th Floor Oncol Mail Box,3615 Civ Ctr B, Philadelphia, PA 19104 USA.	nicholsk@email.chop.edu	Nichols, Kim/AAP-8592-2020; Koretzky, Gary/AAU-5381-2021; Nichols, Kim/E-9353-2016	Nichols, Kim/0000-0002-5581-6555; Nichols, Kim/0000-0002-5581-6555	National Institutes of Health; Sandier Program for Asthma Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandier Program for Asthma Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institutes of Health (L.E.L., G.A.K., and K.E.N.) and the Sandier Program for Asthma Research (T.K.). The authors declare no competing financial interests.; Disclosure of potential conflict of interest: L. E. Lenox and T. Kambayashi have received research support from the National Institutes of Health.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; ARGENBRIGHT LW, 1992, J CLIN INVEST, V89, P259, DOI 10.1172/JCI115570; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Bezman NA, 2008, J EXP MED, V205, P1775, DOI 10.1084/jem.20080240; Boross P, 2008, J IMMUNOL, V180, P5083, DOI 10.4049/jimmunol.180.7.5083; Boudreau RTM, 2004, J LEUKOCYTE BIOL, V76, P1075, DOI 10.1189/jlb.1003498; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Clemens RA, 2007, J IMMUNOL, V178, P4606, DOI 10.4049/jimmunol.178.7.4606; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Fang N, 1996, J IMMUNOL, V157, P3769; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; HALPERN BN, 1964, P SOC EXP BIOL MED, V115, P273, DOI 10.3181/00379727-115-28889; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hines C, 2002, CLIN REV ALLERG IMMU, V22, P149, DOI 10.1385/CRIAI:22:2:149; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kang SM, 2008, MOL CELLS, V25, P64; Kawakami Y, 1999, J LEUKOCYTE BIOL, V65, P286, DOI 10.1002/jlb.65.3.286; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Kim HY, 2006, J CLIN INVEST, V116, P2484, DOI 10.1172/JCI27219; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Naucler C, 2002, J LEUKOCYTE BIOL, V71, P701; Newbrough SA, 2003, IMMUNITY, V19, P759; NIESSEN HWM, 1994, BBA-MOL CELL RES, V1223, P267, DOI 10.1016/0167-4889(94)90236-4; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; Silverman MA, 2006, MOL CELL BIOL, V26, P1826, DOI 10.1128/MCB.26.5.1826-1838.2006; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; SMOLEN JE, 1990, BIOCHIM BIOPHYS ACTA, V1052, P133, DOI 10.1016/0167-4889(90)90068-O; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Song JS, 1999, J IMMUNOL, V163, P802; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Tuosto L, 1996, J EXP MED, V184, P1161, DOI 10.1084/jem.184.3.1161; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Victoratos P, 2009, IMMUNITY, V30, P130, DOI 10.1016/j.immuni.2008.10.019; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Watts GM, 2005, J IMMUNOL, V174, P3668, DOI 10.4049/jimmunol.174.6.3668; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wu JN, 2004, J IMMUNOL, V172, P6768, DOI 10.4049/jimmunol.172.11.6768; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P	78	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2009	124	5					1088	1098		10.1016/j.jaci.2009.08.038	http://dx.doi.org/10.1016/j.jaci.2009.08.038			11	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	523XI	19895996	Green Accepted			2022-12-18	WOS:000272108000032
J	Friend, JC; Hilligoss, DM; Marquesen, M; Wrick, J; Estwick, T; Turner, ML; Cowen, EW; Anderson, V; Holland, SM; Malech, HL				Friend, Julia C.; Hilligoss, Dianne M.; Marquesen, Martha; Wrick, Jean; Estwick, Tyra; Turner, Maria L.; Cowen, Edward W.; Anderson, Victoria; Holland, Steven M.; Malech, Harry L.			Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							OSTEOMYELITIS; FEATURES		[Friend, Julia C.; Hilligoss, Dianne M.; Marquesen, Martha; Wrick, Jean; Estwick, Tyra; Malech, Harry L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Anderson, Victoria; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Turner, Maria L.; Cowen, Edward W.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malech, HL (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hmalech@nih.gov		Malech, Harry/0000-0001-5874-5775	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI000645] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000645-16, Z01 AI000645-17] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Galluzzo ML, 2008, CLIN INFECT DIS, V46, P745, DOI 10.1086/527446; Guide SV, 2003, J INFECT DIS, V187, P845, DOI 10.1086/368388; HERMAN TE, 2002, J PERINATOL, V3, P255; Malech HL, 2007, CURR OPIN HEMATOL, V14, P29, DOI 10.1097/00062752-200701000-00007; Mayer CW, 2006, ALLERGY ASTHMA PROC, V27, P544, DOI 10.2500/aap.2006.27.2938; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Soria X, 2008, J AM ACAD DERMATOL, V58, P891, DOI 10.1016/j.jaad.2008.01.011; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	8	14	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2009	124	1					164	166		10.1016/j.jaci.2009.04.009	http://dx.doi.org/10.1016/j.jaci.2009.04.009			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	469OR	19477489	Green Accepted			2022-12-18	WOS:000267909700022
J	Kim, HJ; Kim, JH; Shin, YK; Lee, SI; Ahn, KM				Kim, Hee-Jin; Kim, Ji-Hyun; Shin, Young Kee; Lee, Sang-Il; Ahn, Kang-Mo			A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							STAT3 MUTATIONS; DEFICIENCY		[Kim, Hee-Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Kim, Ji-Hyun] Chung Ang Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151, South Korea; [Lee, Sang-Il; Ahn, Kang-Mo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea.	kmaped@skku.edu	Kim, Sun/GSN-4867-2022; Kim, Hee Jin/F-4594-2014; Shin, Young Kee/C-8929-2011; Ahn, Kangmo/F-4609-2014	Shin, Young Kee/0000-0003-0896-718X; 				Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037	8	14	14	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					956	958		10.1016/j.jaci.2009.01.068	http://dx.doi.org/10.1016/j.jaci.2009.01.068			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19348930	Bronze, Green Submitted			2022-12-18	WOS:000265058600026
J	Nowak-Wegrzyn, AH; Bencharitiwong, R; Schwarz, J; David, G; Eggleston, P; Gergen, PJ; Liu, AH; Pongracic, JA; Sarpong, S; Sampson, HA				Nowak-Wegrzyn, Anna H.; Bencharitiwong, Ramon; Schwarz, John; David, Gloria; Eggleston, Peyton; Gergen, Peter J.; Liu, Andrew H.; Pongracic, Jacqueline A.; Sarpong, Sampson; Sampson, Hugh A.			Mediator release assay for assessment of biological potency of German cockroach allergen extracts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Cockroach; cockroach allergy; cockroach extract; rat basophil leukemia cells; passive sensitization; mediator release; mediator release assay; extract potency; ID(50)EAL; biologic potency; cockroach extract standardization	INNER-CITY CHILDREN; PRICK TEST; IN-VITRO; IGE; DIAGNOSIS; POLLEN; EXPOSURE; MORBIDITY; BASOPHILS; ASTHMA	Background: Cockroach is an important allergen in inner-city asthma. The diagnosis and treatment of cockroach allergy has been impeded by the lack of standardized cockroach extracts. Objective: We investigated the utility of a mediator release assay based on rat basophil leukemia (RBL) cells for comparing the potency of German cockroach extracts. Methods: RBL cells (line 2H3) transfected with human Fc epsilon RI were passively sensitized with sera from subjects with cockroach allergy and stimulated with serial dilutions of 3 commercial cockroach extracts (1:10 weight/volume). In addition, the in-house prepared extract was tested in separate experiments with pooled sera that produced optimal performance in the RBL assay. N-hexosaminidase release (NHR) was used as a marker of RBL cell degranulation and was examined in relation to the intradermal skin test (ID(50)EAL) and serum cockroach-specific and total IgE levels. Results: The median cockroach-specific IgE concentration in 60 subjects was 0.72 kU(A)/L (interquartile range, 0.35-2.97 kU(A)/L); 19 sera (responders) produced a minimum 10% NHR to more than 1 extract. Responders had higher median cockroach-specific IgE (7.4 vs 1.0 kU(A)/L) and total IgE (429 vs 300 kU/L) levels than nonresponders. Ranking of extract potency was consistent between the mediator release assay and the ID50EAL. For the in-house prepared cockroach extract, the dose-response curves were shifted according to the concentration of the extract. NHR was reproducible between different experiments by using pooled sera. Conclusion: The mediator release assay measures biologic potency and correlates with the ID50EAL. It should be further evaluated to determine whether it could be used to replace intradermal skin test titration for assessing the potency of cockroach extract. (J Allergy Clin Immunol 2009;123:949-55.)	[Nowak-Wegrzyn, Anna H.] Mt Sinai Sch Med, Dept Pediat, Div Pediat Allergy & Immunol, New York, NY 10029 USA; [Schwarz, John; David, Gloria] Rho Inc, Chapel Hill, NC USA; [Eggleston, Peyton] Johns Hopkins Univ, Sch Med, Div Pediat Allergy & Immunol, Baltimore, MD USA; [Gergen, Peter J.] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA; [Liu, Andrew H.] Natl Jewish Med & Res Ctr, Div Pediat Allergy & Immunol, Denver, CO USA; [Liu, Andrew H.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Pongracic, Jacqueline A.] Childrens Mem Hosp, Div Pediat Allergy & Immunol, Chicago, IL 60614 USA; [Sarpong, Sampson] Howard Univ, Dept Pediat & Child Hlth, Washington, DC 20059 USA	Icahn School of Medicine at Mount Sinai; Rho; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Ann & Robert H. Lurie Children's Hospital of Chicago; Howard University	Nowak-Wegrzyn, AH (corresponding author), Mt Sinai Sch Med, Dept Pediat, Div Pediat Allergy & Immunol, Box 1198,1 Gustave L Levy Pl, New York, NY 10029 USA.	anna.nowak-wegrzyn@mssm.edu		Nowak-Wegrzyn, Anna/0000-0002-0960-9854	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-25496, NO1-AI-25482, AI 059318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496, K23AI059318] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in whole or in part by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under contract nos. N01-AI-25496 and NO1-AI-25482. A. Nowak-Wegrzyn is supported in part by NIH NIAID AI 059318.	[Anonymous], 1997, J ALLERGY CLIN IMMUN, V99, P583; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; BAER H, 1974, J ALLERGY CLIN IMMUN, V54, P157, DOI 10.1016/0091-6749(74)90052-9; BAER H, 1970, J ALLERGY, V45, P347, DOI 10.1016/0021-8707(70)90043-2; BERNSTEIN IL, 1977, INT ARCH ALLER A IMM, V55, P215, DOI 10.1159/000231929; Chapman MD, 2008, ALLERGY, V63, P310; Chew GL, 2008, J ALLERGY CLIN IMMUN, V121, P240, DOI 10.1016/j.jaci.2007.08.024; Dibbern DA, 2003, J IMMUNOL METHODS, V274, P37, DOI 10.1016/S0022-1759(02)00369-1; Ebo DG, 2005, CYTOM PART B-CLIN CY, V64B, P28, DOI 10.1002/cyto.b.20042; Eggleston PA, 1999, J ALLERGY CLIN IMMUN, V104, P842, DOI 10.1016/S0091-6749(99)70296-4; Eggleston PA, 1998, J ALLERGY CLIN IMMUN, V102, P563, DOI 10.1016/S0091-6749(98)70272-6; Gergen PJ, 1999, J ALLERGY CLIN IMMUN, V103, P501, DOI 10.1016/S0091-6749(99)70477-X; Gruber C, 2000, ALLERGY, V55, P476; Hoffmann A, 1999, ALLERGY, V54, P446, DOI 10.1034/j.1398-9995.1999.00917.x; HOFFMANN A, 1997, ARB P EHRLICH I BUND, V91, P203; James R, 2006, ARB P EHRLICH I BUND, V95, p[117, 155]; Jarzab J, 2000, J INVEST ALLERG CLIN, V10, P24; JOHANSSON SGO, 1986, J ALLERGY CLIN IMMUN, V77, P555, DOI 10.1016/0091-6749(86)90344-1; Kadooka Y, 2000, INT ARCH ALLERGY IMM, V122, P264, DOI 10.1159/000024408; Kaul S, 2007, CLIN EXP ALLERGY, V37, P141, DOI 10.1111/j.1365-2222.2006.02618.x; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; Mita H, 2000, CLIN EXP ALLERGY, V30, P1582, DOI 10.1046/j.1365-2222.2000.00921.x; Morrow KS, 2001, CLIN REV ALLERG IMMU, V21, P141, DOI 10.1385/CRIAI:21:2-3:141; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P769, DOI 10.1016/j.jaci.2007.01.036; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; OSTERGAARD PA, 1990, ALLERGY, V45, P231, DOI 10.1111/j.1398-9995.1990.tb00488.x; Page K, 2006, ALLERGY, V61, P988, DOI 10.1111/j.1398-9995.2006.01103.x; Palmer GW, 2005, CLIN IMMUNOL, V115, P302, DOI 10.1016/j.clim.2005.02.011; Patterson ML, 2002, CLIN EXP ALLERGY, V32, P721, DOI 10.1046/j.1365-2222.2002.01397.x; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; Ricci G, 2003, ALLERGY, V58, P38, DOI 10.1034/j.1398-9995.2003.23761.x; Ritz C, 2005, J STAT SOFTW, V12, P1; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Shreffler WG, 2006, CURR OPIN ALLERGY CL, V6, P226, DOI 10.1097/01.all.0000225165.83144.2f; Slater JE, 2007, CLIN EXP ALLERGY, V37, P1033, DOI 10.1111/j.1365-2222.2007.02751.x; The R Development Core Team, R LANG ENV STAT COMP; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; Trivedi L, 2003, J ALLERGY CLIN IMMUN, V111, P777, DOI 10.1067/mai.2003.1338; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; van Ree R, 2007, J ALLERGY CLIN IMMUN, V119, P270, DOI 10.1016/j.jaci.2006.10.033; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Wisnivesky JP, 2007, J ALLERGY CLIN IMMUN, V120, P113, DOI 10.1016/j.jaci.2007.03.044	43	14	14	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2009	123	4					949	955		10.1016/j.jaci.2009.01.070	http://dx.doi.org/10.1016/j.jaci.2009.01.070			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	431JW	19348929	Green Accepted, Bronze			2022-12-18	WOS:000265058600025
J	Willis-Owen, SAG; Valdar, W				Willis-Owen, Saffron A. G.; Valdar, William			Deciphering gene-environment interactions through mouse models of allergic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mouse; model; gene-environment interaction; plethysmography; asthma	NECROSIS-FACTOR-ALPHA; OF-FUNCTION VARIANTS; SOUTH-FORE PEOPLE; PAPUA-NEW-GUINEA; COMPLEX TRAITS; ATOPIC ECZEMA; MURINE MODEL; HAY-FEVER; FILAGGRIN EXPRESSION; LUNG INFLAMMATION	Identifying the genetic origins of human complex traits is a time-consuming and labor-intensive process that has as yet only yielded a relatively small number of confirmed susceptibility genes and an even smaller number of confirmed susceptibility alleles. One potential explanation for these difficulties might be the presence of unrecognized environmental factors that moderate the contribution of genetic loci to disease and vary between populations. These factors need not necessarily be limited to environmental parameters of intuitive importance (eg, cigarette smoke or allergen exposure) but also can include more cryptic sources of variation associated with the specific study environment (eg, study apparatus or ambient temperature). Analysis of these interactions in human subjects, although a gold standard, is time-consuming and constrained by ethical and technical issues. Investigations in mouse models, on the other hand, represent a simple and flexible system in which to explore gene-environment interaction effects. In this review we discuss the utility of mouse models in the detection of gene-environment interaction effects and consider the limitations on their application. (J Allergy Clin Immunol 2009;123:14-23.)	[Willis-Owen, Saffron A. G.] Natl Heart & Lung Inst, London SW3 6LY, England; [Valdar, William] Wellcome Trust Ctr Human Genet, Oxford, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics	Willis-Owen, SAG (corresponding author), Natl Heart & Lung Inst, Guy Scadding Bldg,Dovehouse St, London SW3 6LY, England.	s.willis-owen@imperial.ac.uk	Valdar, William/AAE-4354-2019	Willis-Owen, Saffron/0000-0003-2633-1150	Medical Research Council [G0701612] Funding Source: Medline; MRC [G0701612] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Basu K, 2008, ALLERGY, V63, P1211, DOI 10.1111/j.1398-9995.2008.01660.x; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Beghe B, 2004, ALLERGY, V59, P61, DOI 10.1046/j.1398-9995.2003.00352.x; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bilolikar H, 2005, EUR RESPIR J, V26, P637, DOI 10.1183/09031936.05.00071104; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Chagani T, 1999, AM J RESP CRIT CARE, V160, P278, DOI 10.1164/ajrccm.160.1.9808032; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; De Benedetto A, 2008, J INVEST DERMATOL, V128, P1594, DOI 10.1038/sj.jid.5701208; Devor M, 2007, EUR J NEUROSCI, V26, P681, DOI 10.1111/j.1460-9568.2007.05704.x; Di Somma C, 2003, HUM IMMUNOL, V64, P359, DOI 10.1016/S0198-8859(02)00819-4; Dizier MH, 2007, EUR J HUM GENET, V15, P810, DOI 10.1038/sj.ejhg.5201830; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Eder W, 2006, ALLERGY, V61, P1117, DOI 10.1111/j.1398-9995.2006.01128.x; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P334, DOI 10.1016/j.jaci.2007.11.028; Gelfand EW, 2002, AM J RESP CRIT CARE, V166, P5, DOI 10.1164/rccm.2204023; Gelman A, 2007, DATA ANAL USING REGR; Guo SW, 2000, HUM HERED, V50, P286, DOI 10.1159/000022931; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HOPPER JL, 1990, GENET EPIDEMIOL, V7, P277, DOI 10.1002/gepi.1370070406; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Kannan MS, 2003, AM J PHYSIOL-LUNG C, V285, pL29, DOI 10.1152/ajplung.00085.2003; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; Koppelman GH, 2007, J ALLERGY CLIN IMMUN, V120, P1266, DOI 10.1016/j.jaci.2007.10.007; Kraft P, 2005, PHILOS T R SOC B, V360, P1609, DOI 10.1098/rstb.2005.1692; Kumar RK, 2002, AM J RESP CELL MOL, V27, P267, DOI 10.1165/rcmb.F248; Laitinen T, 1998, AM J RESP CRIT CARE, V157, P1073, DOI 10.1164/ajrccm.157.4.9704041; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Li YF, 2006, AM J RESP CRIT CARE, V173, P970, DOI 10.1164/rccm.200508-1256OC; Lillehammer M, 2008, GENETICS, V179, P1539, DOI 10.1534/genetics.107.084483; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Louis R, 2000, EUR RESPIR J, V16, P604, DOI 10.1034/j.1399-3003.2000.16d06.x; Lynch M, 1998, GENETICS ANAL QUANTI; Malm-Erjefalt M, 2001, AM J RESP CELL MOL, V24, P352, DOI 10.1165/ajrcmb.24.3.4357; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pennisi E, 2000, SCIENCE, V288, P248; Persson CGA, 2002, AM J RESP CRIT CARE, V166, P6, DOI 10.1164/rccm.2204001; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Rook GAW, 1998, IMMUNOL TODAY, V19, P113, DOI 10.1016/S0167-5699(97)01204-8; Sandford AJ, 2004, INT J TUBERC LUNG D, V8, P519; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Skadhauge LR, 1999, EUR RESPIR J, V13, P8, DOI 10.1183/09031936.99.13100899; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; TURNER KJ, 1985, INT ARCH ALLER A IMM, V77, P158, DOI 10.1159/000233772; Valdar W, 2006, GENETICS, V174, P959, DOI 10.1534/genetics.106.060004; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; Wa TCLK, 1999, CLIN EXP ALLERGY, V29, P1204; Wagers S, 2004, J APPL PHYSIOL, V96, P2019, DOI 10.1152/japplphysiol.00924.2003; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wang TN, 2004, CLIN EXP ALLERGY, V34, P184, DOI 10.1111/j.1365-2222.2004.01867.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Wenzel S, 2006, AM J RESP CRIT CARE, V174, P1173, DOI 10.1164/rccm.2609002; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Winchester EC, 2000, HUM GENET, V107, P591, DOI 10.1007/s004390000410; Witte JS, 2002, EUR J HUM GENET, V10, P82, DOI 10.1038/sj.ejhg.5200746; WOOLCOCK AJ, 1983, EUR J RESPIR DIS, V64, P571; Xisto DG, 2005, AM J RESP CRIT CARE, V171, P829, DOI 10.1164/rccm.200408-997OC; Yang IA, 2005, AM J RESP CRIT CARE, V171, P171, DOI 10.1164/rccm.200402-194OC; Ying S, 2006, J ALLERGY CLIN IMMUN, V118, P1386, DOI 10.1016/j.jaci.2006.08.030; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	80	14	14	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2009	123	1					14	23		10.1016/j.jaci.2008.09.016	http://dx.doi.org/10.1016/j.jaci.2008.09.016			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	399IP	18926561				2022-12-18	WOS:000262793900003
J	Shefler, I; Mekori, YA; Mor, A				Shefler, Irit; Mekori, Yoseph A.; Mor, Adam			Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CONTACT; INDUCTION		[Shefler, Irit; Mekori, Yoseph A.; Mor, Adam] Meir Hosp, Lab Allergy & Clin Immunol, Kefar Sava, Israel; [Mekori, Yoseph A.; Mor, Adam] Meir Hosp, Dept Med, Kefar Sava, Israel; [Mekori, Yoseph A.] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Shefler, I (corresponding author), Meir Hosp, Lab Allergy & Clin Immunol, Kefar Sava, Israel.	ymekori@clalit.org.il						Baram D, 2001, J IMMUNOL, V167, P4008, DOI 10.4049/jimmunol.167.7.4008; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Brill A, 2004, CLIN EXP ALLERGY, V34, P1725, DOI 10.1111/j.1365-2222.2004.02093.x; Inamura N, 1998, J IMMUNOL, V160, P4026; KIRSHENBAUN AS, 2002, LEUKEMIA RES, V27, P677; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Salamon P, 2005, ALLERGY, V60, P1316, DOI 10.1111/j.1398-9995.2005.00886.x; Salamon P, 2008, J ALLERGY CLIN IMMUN, V121, P448, DOI 10.1016/j.jaci.2007.08.054; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200	12	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2008	122	6					1222	1225		10.1016/j.jaci.2008.07.024	http://dx.doi.org/10.1016/j.jaci.2008.07.024			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	383ZA	18760455				2022-12-18	WOS:000261711800025
J	Pacheco, K; Maier, L; Silveira, L; Goetz, K; Noteware, K; Luna, B; du Bois, R; Murphy, J; Rose, C				Pacheco, Karin; Maier, Lisa; Silveira, Lori; Goetz, Kelly; Noteware, Kristyn; Luna, Bevin; du Bois, Ron; Murphy, Jim; Rose, Cecile			Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Laboratory animal; allergy; asthma; Toll-like receptor 4; endotoxin	WORK-RELATED SYMPTOMS; RESPIRATORY SYMPTOMS; OCCUPATIONAL ASTHMA; INFLAMMATORY RESPONSE; ENDOTOXIN EXPOSURE; POULTRY HOUSES; LIPOPOLYSACCHARIDE; DETERMINANTS; ALLERGY; DUST	Background: Researchers and technicians working with laboratory animals (LAs) are exposed to animal allergen and endotoxin, which can interact to potentiate or inhibit symptoms or allergic responses. We hypothesized that functional genetic variants of Toll-like receptor 4 (TLR4), a key surface receptor for endotoxin, interface between worker and workplace and affect animal sensitization, symptoms, or both. Objective: We sought to determine whether TLR4/8551 variants alter the risk for LA sensitization, symptoms, or both. Methods: Three hundred thirty-five researchers, 195 of whom worked with animals, completed questions on workplace practices and symptoms and underwent skin prick tests or RASTs to common and animal allergens. Real-time PCR assessed TLR4/8551 and TLR4/8851 variants. Nominal logistic regression was used to analyze the contribution of demographic, exposure, and genetic variables to outcomes of interest. Results: Twenty-one percent of workers were LA sensitized, and 29% reported I or more symptoms to LAs. The TLR4/8551 G variant, which is less responsive to endotoxin, was detected in 9% and in linkage disequilibrium with the TLR4/8851 T allele. The G variant significantly associated with atopy and LA sensitization. Workers with the G variant spent significantly longer hours in high endotoxin/animal allergen tasks compared with those with the AA variant, which is perhaps less affected by endotoxin exposures. In multivariate analyses the G variant and longer animal research hours increased the risk of 1,A sensitization. Job tasks and LA sensitization, but not TLR4 variants, were predictors of LA-induced symptoms. Conclusion: Workers with TLR4 variants that reduce responsiveness to endotoxin have higher risks for LA and other allergen sensitization but spend longer hours in tasks with high endotoxin and animal allergen exposures. (J Allergy Clin Immunol 2008;122:896-902.)	[Pacheco, Karin; Maier, Lisa; Silveira, Lori; Goetz, Kelly; Noteware, Kristyn; Luna, Bevin; du Bois, Ron; Murphy, Jim; Rose, Cecile] Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Dept Med, Denver, CO 80206 USA; [Pacheco, Karin; Maier, Lisa; Murphy, Jim; Rose, Cecile] Univ Colorado, Sch Publ Hlth, Dept Environm Occupat Hlth, Denver, CO 80202 USA; [Maier, Lisa; Rose, Cecile] Univ Colorado, Sch Med, Dept Med, Denver, CO 80202 USA	National Jewish Health; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Pacheco, K (corresponding author), Natl Jewish Med & Res Ctr, Div Environm & Occupat Hlth Sci, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	pachecok@njc.org	Maier, Lisa/AAA-4378-2020		National Institute of Allergy and Infectious Diseases [1 K23 AI053572, 1 R01 AI59618]; National Institutes of Health; General Clinical Research Centers; National Institutes of Environmental Health Sciences; National Heart. Lung, and Blood Institute; Department of Energy C; Health Research and Services Administration; National Institute of Allergy and Infectious Diseases; Agency for Toxic Substances and Disease Registry;  [M01 RR000051]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059618, K23AI053572] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart. Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Energy C(United States Department of Energy (DOE)); Health Research and Services Administration; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by 1 K23 AI053572 and 1 R01 AI59618 from the National Institute of Allergy and Infectious Diseases and M01 RR000051.; Disclosure of potential conflict of interest: K. Pacheco received grant and salary support from the National Institutes of Health and the General Clinical Research Centers and has organizational interests with the ACCP and American Medical Association. L Maier receives grant Support from the National Institutes of Environmental Health Sciences, the National Heart. Lung, and Blood Institute. and the Department of Energy C. Rose receives grant support front the Health Research and Services Administration, the National Institute of Allergy and Infectious Diseases. and the Agency for Toxic Substances and Disease Registry. The rest of the authors have declared that they have no conflict of interest.	AGRUP G, 1986, BRIT J IND MED, V43, P192; Alexis NE, 2004, J ALLERGY CLIN IMMUN, V114, P1325, DOI 10.1016/j.jaci.2004.09.002; AOYAMA K, 1992, BRIT J IND MED, V49, P41; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Borghetti C, 2002, MED CLIN-BARCELONA, V118, P251, DOI 10.1016/S0025-7753(02)72352-X; Bottcher MF, 2004, J ALLERGY CLIN IMMUN, V114, P561, DOI 10.1016/j.jaci.2004.04.050; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; CULLINAN P, 1994, OCCUP ENVIRON MED, V51, P589, DOI 10.1136/oem.51.9.589; Cullinan P, 1999, EUR RESPIR J, V13, P1139, DOI 10.1034/j.1399-3003.1999.13e33.x; Dosman JA, 2006, AM J IND MED, V49, P761, DOI 10.1002/ajim.20339; Dosman JA, 2004, EUR RESPIR J, V24, P698, DOI 10.1183/09031936.04.00112102; Douwes J, 2004, J ALLERGY CLIN IMMUN, V114, P1051, DOI 10.1016/j.jaci.2004.08.004; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eldridge MW, 2000, J ALLERGY CLIN IMMUN, V105, P475, DOI 10.1067/mai.2000.104552; Gautrin D, 2000, AM J RESP CRIT CARE, V162, P1222, DOI 10.1164/ajrccm.162.4.2001023; Gautrin D, 2001, AM J RESP CRIT CARE, V163, P899, DOI 10.1164/ajrccm.163.4.2008011; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Kirychuk SP, 2006, J OCCUP ENVIRON MED, V48, P741, DOI 10.1097/01.jom.0000216215.39521.3c; Larsson BM, 1999, AM J IND MED, V35, P142, DOI 10.1002/(SICI)1097-0274(199902)35:2&lt;142::AID-AJIM6&gt;3.0.CO;2-9; LARSSON K, 1994, AM J IND MED, V25, P57, DOI 10.1002/ajim.4700250115; Latza U, 2004, ARCH ENVIRON HEALTH, V59, P519, DOI 10.1080/00039890409605168; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; Lieutier-Colas F, 2001, CLIN EXP ALLERGY, V31, P1449, DOI 10.1046/j.1365-2222.2001.01180.x; MCKINLAY KP, 1993, THORAX, V48, P1289, DOI 10.1136/thx.48.12.1289-a; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Pacheco KA, 2003, AM J RESP CRIT CARE, V167, P983, DOI 10.1164/rccm.2112062; Pacheco KA, 2006, ANN OCCUP HYG, V50, P563, DOI 10.1093/annhyg/me1019; Radon K, 2002, ANN AGR ENV MED, V9, P207; Radon K, 2001, EUR RESPIR J, V17, P747, DOI 10.1183/09031936.01.17407470; Rylander R, 2006, INT ARCH OCC ENV HEA, V79, P487, DOI 10.1007/s00420-005-0072-5; SCHWARTZ DA, 1992, ANN INTERN MED, V116, P630, DOI 10.7326/0003-4819-116-8-630; SCHWARTZ DA, 1995, AM J RESP CRIT CARE, V151, P47, DOI 10.1164/ajrccm.151.1.7812571; SMID T, 1994, AM J IND MED, V25, P877, DOI 10.1002/ajim.4700250611; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; VENABLES KM, 1988, BRIT J IND MED, V45, P660; VENABLES KM, 1993, THORAX, V48, P214, DOI 10.1136/thx.48.3.214; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Yang IA, 2004, GENES IMMUN, V5, P41, DOI 10.1038/sj.gene.6364037	39	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	NOV	2008	122	5					896	902		10.1016/j.jaci.2008.08.025	http://dx.doi.org/10.1016/j.jaci.2008.08.025			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	372ZF	18835634	Green Accepted			2022-12-18	WOS:000260940100006
J	Catalli, AE; Thomson, JV; Babirad, IM; Duong, M; Doyle, TM; Howie, KJ; Newbold, P; Craggs, RI; Foster, M; Gauvreau, GM; O'Byrne, PM; Sehmi, R				Catalli, Adriana E.; Thomson, Jennifer V.; Babirad, Irene M.; Duong, MyLinh; Doyle, Tracey M.; Howie, Karen J.; Newbold, Paul; Craggs, Richard I.; Foster, Martyn; Gauvreau, Gail M.; O'Byrne, Paul M.; Sehmi, Roma			Modulation of beta 1-integrins on hemopoietic progenitor cells after allergen challenge in asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						adhesion; integrins; fibronectin; vascular cell adhesion molecule 1; egress; mobilization; asthma; allergen; inflammation	COLONY-STIMULATING FACTOR; MOBILIZED PERIPHERAL-BLOOD; MARROW CD34(+) CELLS; BONE-MARROW; ADHESION MOLECULES; CIRCULATING EOSINOPHILS; AIRWAY RESPONSIVENESS; INTEGRINS LFA-1; IL-5 RECEPTOR; CORD BLOOD	Background: Mobilization of hemopoietic progenitor cells from the bone marrow (BM) is a feature of inflammatory asthmatic responses. Understanding the mechanisms regulating progenitor cell mobilization and trafficking to the peripheral circulation might be important for the development of effective asthma therapies. Objective: We investigated the role of adhesion molecules in the mobilization of hemopoietic progenitor cells from the BM during an allergen-induced asthmatic response. Methods: BM and peripheral blood samples were obtained from dual-responders with mild asthma before and at several time points after allergen challenge. Fluctuations in expression and adhesive properties of beta 1- and beta 2-integrins on CD34(+)CD45(+) progenitor cells were assessed by using flow cytometry and adhesion to protein-coated wells, respectively. Results: On BM-derived CD34(+)CD45(+) cells, expression of very late antigen (VLA) 4, but not VLA-5 or Mac-1, decreased significantly 24 hours after allergen challenge and had begun to recover by 48 hours after challenge. In peripheral blood allergen challenge induced a significant decrease in VLA-4 levels after 6 hours, which had not recovered by 96 hours after challenge. Similarly, VLA-5 expression decreased, most prominently at 72 to 96 hours after allergen challenge. In contrast, Mac-1 levels did not change. Chemokine-stimulated adhesion of BM-derived CD34+CD45+ cells to fibronectin was significantly attenuated 24 hours after challenge. Furthermore, adhesion to fibronectin and vascular cell adhesion molecule I was greatly reduced by anti-VLA-4 or anti-VLA-5 antibodies. Conclusions: Preferential downregulation of beta 1-integrin expression on progenitor cells can reduce the tethering forces to BM components, thus facilitating their egress to the peripheral circulation during an allergic inflammatory response.	[Catalli, Adriana E.; Thomson, Jennifer V.; Babirad, Irene M.; Doyle, Tracey M.; Sehmi, Roma] St Josephs Healthcare, Firestone Inst Resp Hlth, Asthma Res Grp, Hamilton, ON, Canada; [Catalli, Adriana E.; Thomson, Jennifer V.; Babirad, Irene M.; Duong, MyLinh; Doyle, Tracey M.; Howie, Karen J.; Gauvreau, Gail M.; O'Byrne, Paul M.; Sehmi, Roma] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Newbold, Paul; Craggs, Richard I.; Foster, Martyn] AstraZeneca R&D Charnwood, Loughborough, Leics, England	McMaster University; McMaster University; AstraZeneca	Sehmi, R (corresponding author), St Josephs Hosp, Firestone Inst Resp Hlth, Luke Wing,Rm L314-6,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	sehmir@mcmaster.ca		O'Byrne, Paul/0000-0003-0979-281X	Canadian Institutes of Health Research; AstraZeneca, United Kingdom; Father Sean O'Sullivan Postdoctoral Fellowship award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca, United Kingdom(AstraZeneca); Father Sean O'Sullivan Postdoctoral Fellowship award	Supported by a grant from the Canadian Institutes of Health Research and all educational grant from AstraZeneca, United Kingdom. Adriana Catalli holds a Father Sean O'Sullivan Postdoctoral Fellowship award.	Cameron L, 2000, J IMMUNOL, V164, P1538, DOI 10.4049/jimmunol.164.3.1538; Carstanjen D, 2005, TRANSFUSION, V45, P1192, DOI 10.1111/j.1537-2995.2005.00172.x; Chan JYH, 2001, BRIT J HAEMATOL, V112, P541, DOI 10.1046/j.1365-2141.2001.02439.x; COCKCROFT DW, 1987, AM REV RESPIR DIS, V135, P264; Cockcroft DW, 1985, AIRWAY RESPONSIVENES, P22; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Dorman SC, 2005, J ALLERGY CLIN IMMUN, V115, P501, DOI 10.1016/j.jaci.2004.11.017; Dorman SC, 2004, AM J RESP CRIT CARE, V169, P573, DOI 10.1164/rccm.200307-1004OC; GIBSON PG, 1991, AM REV RESPIR DIS, V143, P331, DOI 10.1164/ajrccm/143.2.331; GIBSON PG, 1990, CLIN EXP ALLERGY, V20, P661, DOI 10.1111/j.1365-2222.1990.tb02705.x; Gigant C, 2001, J HEMATOTH STEM CELL, V10, P807, DOI 10.1089/152581601317210908; Gonlugur U, 2004, CELL TISSUE RES, V318, P473, DOI 10.1007/s00441-004-0925-3; Hidalgo A, 2001, EXP HEMATOL, V29, P345, DOI 10.1016/S0301-472X(00)00668-8; Imamura R, 2005, J IMMUNOL, V175, P2647, DOI 10.4049/jimmunol.175.4.2647; KERST JM, 1993, BLOOD, V81, P344; Martin C, 2006, BRIT J HAEMATOL, V134, P326, DOI 10.1111/j.1365-2141.2006.06181.x; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; Papayannopoulou T, 2000, SEMIN HEMATOL, V37, P11, DOI 10.1016/S0037-1963(00)90084-2; PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Papayannopoulou T, 2001, BLOOD, V97, P1282, DOI 10.1182/blood.V97.5.1282; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Priestley GV, 2007, BLOOD, V109, P109, DOI 10.1182/blood-2006-06-026427; Prosper F, 1998, J CLIN INVEST, V101, P2456, DOI 10.1172/JCI188; Robinson DS, 1999, AM J RESP CELL MOL, V20, P9, DOI 10.1165/ajrcmb.20.1.3449; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Sehmi R, 1996, AM J RESP CELL MOL, V15, P645, DOI 10.1165/ajrcmb.15.5.8918371; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Sehmi R, 2003, IMMUNOLOGY, V109, P536, DOI 10.1046/j.1365-2567.2003.01686.x; SOLIGO D, 1990, BRIT J HAEMATOL, V76, P323, DOI 10.1111/j.1365-2141.1990.tb06363.x; Southam DS, 2005, J ALLERGY CLIN IMMUN, V115, P95, DOI 10.1016/j.jaci.2004.09.022; Sovalat H, 2003, J HEMATOTH STEM CELL, V12, P473, DOI 10.1089/152581603322448187; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Thomas J, 2002, CURR OPIN HEMATOL, V9, P183, DOI 10.1097/00062752-200205000-00002; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Velders GA, 2002, BLOOD, V100, P327, DOI 10.1182/blood.V100.1.327; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Wagner JG, 2000, PHARMACOL REV, V52, P349; Wardlaw AJ, 2001, CLIN MED, V1, P214, DOI 10.7861/clinmedicine.1-3-214; Watanabe T, 1997, BONE MARROW TRANSPL, V19, P1175, DOI 10.1038/sj.bmt.1700814; Winkler IG, 2006, EXP HEMATOL, V34, P996, DOI 10.1016/j.exphem.2006.04.005; Wood LJ, 1998, AM J RESP CELL MOL, V18, P759, DOI 10.1165/ajrcmb.18.6.3006; Ying S, 2006, CELL MOL IMMUNOL, V3, P321	43	14	15	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					803	810		10.1016/j.jaci.2008.07.021	http://dx.doi.org/10.1016/j.jaci.2008.07.021			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	18760454				2022-12-18	WOS:000259989000028
J	Stingone, JA; Claudio, L				Stingone, Jeanette A.; Claudio, Luz			Disparities in allergy testing and health outcomes among urban children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergies; medical care; asthma management; health disparities; minority children	INNER-CITY ASTHMA; ENVIRONMENTAL INTERVENTION; CHILDHOOD ASTHMA; SPECIALTY CARE; DIESEL EXHAUST; MEDICATION USE; RHINITIS; IMMUNOTHERAPY; SENSITIZATION; COMMUNITIES	Background: Previous research has found that treating allergies and reducing exposure to allergens can reduce asthma morbidity. Objective: We sought to examine whether urban asthmatic children were receiving care for allergies as part of a comprehensive asthma management plan. Methods: A cross-sectional study, consisting of a parent-reported questionnaire, was conducted in 26 randomly selected New York City public elementary schools during the 2002-2003 school year. Results: In a sample of 5250 children aged 5 to 12 years, 13.0% were found to have current asthma. The prevalence of allergy diagnosis was 21.0%. Less than half (47.3%) of the subjects with current asthma reported a physician's diagnosis of allergies. The frequency of a reported allergy diagnosis varied with race/ethnicity, ranging from 14.4% in Mexican American children to 67.9% in white children. Only 54.9% of asthmatic children with an allergy diagnosis reported allergy testing. Children from lower-/middle-income households and children with public forms of health insurance were the least likely to report testing (adjusted odds ratios, 0.18 and 0.46). Higher frequencies of reported allergy testing were associated with education on allergen avoidance, use of allergy medications, lower exposure to household allergens, and lower prevalence of wheezing. Conclusions: Many children do not receive comprehensive asthma treatment that includes management of allergies and education on avoidance of household allergens. Lower reported allergy testing might indicate lower access to medical care among middle-income families who are ineligible for public programs but who do not have the income to access higher-quality care. Interventions aimed at improving medical care and adherence to treatment guidelines are necessary to decrease asthma morbidity.	[Stingone, Jeanette A.; Claudio, Luz] Mt Sinai Sch Med, Dept Community & Prevent Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Claudio, L (corresponding author), 1 Gustave Levy Pl,Box 1057, New York, NY 10029 USA.	Luz.Claudio@mssm.edu		Stingone, Jeanette/0000-0003-3508-8260	New York State Assembly; Children's Environmental Health and Disease Prevention [R827039]	New York State Assembly; Children's Environmental Health and Disease Prevention	Supported by the New York State Assembly through SEARCH and by a supplement grant to the Mount Sinai Center for Children's Environmental Health and Disease Prevention (EPA Region 2, grant R827039).	Abramson MJ, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001186, DOI 10.1002/14651858.CD001186]; Annesi-Maesano I, 2007, RESP MED, V101, P1721, DOI 10.1016/j.rmed.2007.02.022; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969; Bobb C, 2003, RESP MED, V97, P1180, DOI 10.1016/S0954-6111(03)00189-6; Bousquet J, 2001, ANN ALLERG ASTHMA IM, V87, P38, DOI 10.1016/S1081-1206(10)62193-X; Cabana M, 2002, AMBUL PEDIATR, V2, P456, DOI 10.1367/1539-4409(2002)002<0456:ROASCB>2.0.CO;2; Callahan KA, 2003, ANN ALLERG ASTHMA IM, V90, P302, DOI 10.1016/S1081-1206(10)61798-X; Claudio L, 2006, ANN EPIDEMIOL, V16, P332, DOI 10.1016/j.annepidem.2005.06.046; Crain EF, 2002, ENVIRON HEALTH PERSP, V110, P939, DOI 10.1289/ehp.02110939; Diaz T, 2000, PEDIATRICS, V105, P1188, DOI 10.1542/peds.105.6.1188; Dong CC, 2005, TOXICOL SCI, V88, P202, DOI 10.1093/toxsci/kfi280; Eldeirawi KM, 2006, J ASTHMA, V43, P279, DOI 10.1080/0277090060022869; Frieri M, 2002, J ASTHMA, V39, P405, DOI 10.1081/JAS-120004033; Gipson J S, 2000, Proc (Bayl Univ Med Cent), V13, P407; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Kattan M, 1997, PEDIATR PULM, V24, P253, DOI 10.1002/(SICI)1099-0496(199710)24:4<253::AID-PPUL4>3.0.CO;2-L; Miyabara Y, 1998, J ALLERGY CLIN IMMUN, V102, P805, DOI 10.1016/S0091-6749(98)70021-1; *NIH NAEPP, 2007, 3 NIH NAEPP; *OFF CIT HLTH INS, 2008, HLTH INS CHILD MED C; Persell SD, 2007, J GEN INTERN MED, V22, P1523, DOI 10.1007/s11606-007-0334-x; Rastogi D, 2006, CHEST, V129, P619, DOI 10.1378/chest.129.3.619; Recio-Vega R, 2007, ALLERGY ASTHMA PROC, V28, P353, DOI 10.2500/aap.2007.28.2939; Roberts G, 2006, J ALLERGY CLIN IMMUN, V117, P263, DOI 10.1016/j.jaci.2005.09.054; Sandrini A, 2003, J ALLERGY CLIN IMMUN, V111, P313, DOI 10.1067/mai.2003.64; Schatz M, 2005, J ALLERGY CLIN IMMUN, V116, P1307, DOI 10.1016/j.jaci.2005.09.027; Schwindt CD, 2006, J ASTHMA, V43, P439, DOI 10.1080/02770900600758234; Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194; Stelmach R, 2005, CHEST, V128, P3140, DOI 10.1378/chest.128.5.3140; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; Valerio M, 2006, CHEST, V129, P594, DOI 10.1378/chest.129.3.594; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Williams SG, 2006, J NATL MED ASSOC, V98, P249; Wu F, 2007, ENVIRON HEALTH PERSP, V115, P971, DOI 10.1289/ehp.8989; Yoon EY, 2005, J ASTHMA, V42, P555, DOI 10.1080/02770900500215798	34	14	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					748	753		10.1016/j.jaci.2008.08.001	http://dx.doi.org/10.1016/j.jaci.2008.08.001			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	19014766				2022-12-18	WOS:000259989000019
J	Taylor, DR; Hannah, D				Taylor, D. Robin; Hannah, Debbie			Management of beta-agonist overuse: Why and how?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INHALED CORTICOSTEROIDS; ASTHMA; TRIAL; TERBUTALINE		[Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand; [Hannah, Debbie] Dunedin Publ Hosp, Dunedin, New Zealand	University of Otago; Dunedin Public Hospital	Taylor, DR (corresponding author), Univ Otago, Dunedin Sch Med, Dunedin, New Zealand.	robin.taylor@stonebow.otago.ac.nz						Agarwal SK, 2000, J ALLERGY CLIN IMMUN, V105, P91, DOI 10.1016/S0091-6749(00)90183-0; Aldridge RE, 2000, AM J RESP CRIT CARE, V161, P1459, DOI 10.1164/ajrccm.161.5.9906052; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; LAI CKW, 1989, AM REV RESPIR DIS, V140, P917, DOI 10.1164/ajrccm/140.4.917; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Tattersfield AE, 2001, LANCET, V357, P257, DOI 10.1016/S0140-6736(00)03611-4; TaylorRobinson D, 1996, INT J STD AIDS, V7, P19, DOI 10.1258/0956462961917159; Wenzel S, 2006, J ALLERGY CLIN IMMUN, V117, P508, DOI 10.1016/j.jaci.2005.12.1316	11	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2008	122	4					836	838		10.1016/j.jaci.2008.07.025	http://dx.doi.org/10.1016/j.jaci.2008.07.025			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	359LU	18760453	Bronze			2022-12-18	WOS:000259989000036
J	Idee, JM; Corot, C				Idee, Jean-Marc; Corot, Claire			Anaphylactic shock after first exposure to a macrocyclic gadolinium chelate: A few comments	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ADVERSE-REACTIONS; CONTRAST-MEDIA		[Idee, Jean-Marc; Corot, Claire] Div Res, Guerbet, Roissy, France		Idee, JM (corresponding author), Div Res, Guerbet, Roissy, France.	ideej@guerbet-group.com						Hasdenteufel F, 2008, J ALLERGY CLIN IMMUN, V121, P527, DOI 10.1016/j.jaci.2007.08.027; Idee JM, 2006, FUND CLIN PHARMACOL, V20, P563, DOI 10.1111/j.1472-8206.2006.00447.x; Kalogeromitros DC, 2007, INT ARCH ALLERGY IMM, V144, P150, DOI 10.1159/000103227; Li A, 2006, BRIT J RADIOL, V79, P368, DOI 10.1259/bjr/88469693; Murphy KJ, 1996, AM J ROENTGENOL, V167, P847, DOI 10.2214/ajr.167.4.8819369; Runge V M, 2000, J Magn Reson Imaging, V12, P205, DOI 10.1002/1522-2586(200008)12:2<205::AID-JMRI1>3.0.CO;2-P; White GW, 2006, INVEST RADIOL, V41, P272, DOI 10.1097/01.rli.0000186569.32408.95	7	14	14	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2008	122	1					215	216		10.1016/j.jaci.2008.05.013	http://dx.doi.org/10.1016/j.jaci.2008.05.013			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	325RD	18547628				2022-12-18	WOS:000257605100039
J	Darveau, ME; Jacques, E; Rouabhia, M; Hamid, Q; Chakir, J				Darveau, Marie-Eve; Jacques, Eric; Rouabhia, Mahmoud; Hamid, Qutayba; Chakir, Jamila			Increased T-cell survival by structural bronchial cells derived from asthmatic subjects cultured in an engineered human mucosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; apoptosis; T cells; engineered human bronchial mucosa; cytokines	FAS LIGAND EXPRESSION; GROWTH-FACTOR BETA-1; MESSENGER-RNA; APOPTOSIS; LYMPHOCYTES; RECEPTOR; EOSINOPHILS; DEATH; CYTOKINES; BCL-X(L)	Background: Interaction between lymphocytes and structural cells has been proposed as a key factor in regulating inflammation in asthma. Objective: This study was designed to investigate the effect of epithelial cells and fibroblasts on T-lymphocyte survival by using a 3-dimensional tissue-engineered model. Methods: Engineered human bronchial mucosal tissues were produced by using fibroblasts, epithelial cells, and autologous T cells from asthmatic and healthy donors. T-cell apoptosis and apoptotic marker expression by T cells were evaluated by using the terminal deoxynucleotidyl transferase biotinylated d-UTP nick end-labeling technique and immunofluorescence, respectively. Cytokines implicated in T-cell survival were measured by means of ELISA in culture supernatants. Results: We demonstrated histologically that we were able to generate a well-structured engineered bronchial mucosa by using epithelial cells, fibroblasts, and T cells cultured from healthy and asthmatic subjects. Structural cells from asthmatic subjects cultured in this model induced a significant decrease in the ability of T cells to undergo apoptosis represented by a decrease in DNA fragmentation and proapoptotic molecule expression (Bcl-2-associated X protein and Fas ligand). Structural cells from healthy control subjects have no effect. Among cytokines measured in the supernatants, only TGF-beta 1 was significantly increased in the model derived from cells of asthmatic subjects. Conclusion: These results support the concept that bronchial structural cells might play a critical role in the regulation of inflammation in asthma by increasing the survival of T lymphocytes. The results also further validated the model as a tool for investigating the interaction between inflammatory and structural cells.	[Darveau, Marie-Eve; Jacques, Eric; Chakir, Jamila] Hop Laval, Ctr Rech, Inst Univ Cardiol & Pneumol, Ste Foy, PQ G1V 4G5, Canada; [Rouabhia, Mahmoud] Univ Laval, Fac Med Dent, Laval, PQ, Canada; [Hamid, Qutayba] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	Laval University; Laval University; McGill University	Chakir, J (corresponding author), Hop Laval, Ctr Rech, Inst Univ Cardiol & Pneumol, 2725 Chemin St Foy, Ste Foy, PQ G1V 4G5, Canada.	jamila.chakir@med.ulaval.ca		Rouabhia, Mahmoud/0000-0003-2205-8281				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Akdis CA, 2000, CURR OPIN IMMUNOL, V12, P641, DOI 10.1016/S0952-7915(00)00156-4; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; AZZAWI M, 1992, AM REV RESPIR DIS, V145, P1477, DOI 10.1164/ajrccm/145.6.1477; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; CHAKIR J, 2000, ASTHMA MECH PROTOCOL, P53; Chen WJ, 2001, J EXP MED, V194, P439, DOI 10.1084/jem.194.4.439; CORRIGAN CJ, 1992, IMMUNOL TODAY, V13, P501, DOI 10.1016/0167-5699(92)90026-4; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Genestier L, 1999, J EXP MED, V189, P231, DOI 10.1084/jem.189.2.231; Gombert W, 1996, IMMUNOLOGY, V89, P397, DOI 10.1046/j.1365-2567.1996.d01-759.x; Hamzaoui A, 1999, MEDIAT INFLAMM, V8, P237, DOI 10.1080/09629359990405; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Jayaraman S, 1999, J IMMUNOL, V162, P1717; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Krug N, 1999, J ALLERGY CLIN IMMUN, V103, P649, DOI 10.1016/S0091-6749(99)70238-1; Lombardi G, 2000, J IMMUNOL, V165, P3782, DOI 10.4049/jimmunol.165.7.3782; Melis M, 2002, EUR RESPIR J, V19, P257, DOI 10.1183/09031936.02.00239202; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Orchansky PL, 1997, J BIOL CHEM, V272, P22940, DOI 10.1074/jbc.272.36.22940; Spinozzi F, 1998, FASEB J, V12, P1747, DOI 10.1096/fasebj.12.15.1747; Spinozzi F, 1998, ANN INTERN MED, V128, P363, DOI 10.7326/0003-4819-128-5-199803010-00004; Vignola A M, 2002, Paediatr Respir Rev, V3, P41, DOI 10.1053/prrv.2001.0166; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; WALKER C, 1991, J ALLERGY CLIN IMMUN, V88, P935, DOI 10.1016/0091-6749(91)90251-I; Williams O, 2001, TRENDS IMMUNOL, V22, P107, DOI 10.1016/S1471-4906(00)01797-X; Yarovinsky TO, 2003, AM J RESP CELL MOL, V28, P607, DOI 10.1165/rcmb.2002-0105OC; Zhang JA, 2003, J IMMUNOL, V170, P3495, DOI 10.4049/jimmunol.170.7.3495	33	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2008	121	3					692	699		10.1016/j.jaci.2007.11.023	http://dx.doi.org/10.1016/j.jaci.2007.11.023			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	273GR	18194810				2022-12-18	WOS:000253918900023
J	Greenberger, PA				Greenberger, Paul A.			Immunologic lung disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hypersensitivity; innate; adaptive; eosinophilia; lymphocyte; immunologic	ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; OBSTRUCTIVE PULMONARY-DISEASE; REACTIVE AIRWAY DYSFUNCTION; HYPERSENSITIVITY PNEUMONITIS; ALVEOLAR MACROPHAGES; T-LYMPHOCYTES; FOLLOW-UP; EXPRESSION; TUBERCULOSIS; UPDATE	The lung is an extremely complex organ and participates in initial responses to inhaled antigens, infectious agents, and irritants or as a response to exposure through the oral, parenteral, or transdermal routes. There can be constriction of the airways or involvement or even destruction of the lung parenchyma, depending on the condition. This review focuses on selected aspects of the pulmonary innate and adaptive immune responses; the new condition World Trade Center cough, which can cause an asthma-like presentation and resemble reactive airways dysfunction syndrome; and the diagnosis and treatment of various immunologic lung conditions. Innate immune responses occur in the acute respiratory distress syndrome and in transfusion-related acute lung injury. Adaptive immune responses involve specialized mucosal and systemic immune responses, lymphocytes, and antibodies and can result in CD4(+) T(H)1 and T(H)2 phenotypes, such as T(H)1 for tuberculosis and T(H)2 for asthma.	Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Greenberger, PA (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, 676 N St Clair St 14018, Chicago, IL 60611 USA.	p-greenberger@northwestem.edu			NHLBI NIH HHS [5R01 HL 068546-23] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Agostini C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-20; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Barczyk A, 2006, J ALLERGY CLIN IMMUN, V117, P1484, DOI 10.1016/j.jaci.2006.02.013; Borges JB, 2006, AM J RESP CRIT CARE, V174, P268, DOI 10.1164/rccm.200506-976OC; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chen BM, 2004, SARCOIDOSIS VASC DIF, V21, P199; Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x; Eppinger TM, 1999, J ALLERGY CLIN IMMUN, V104, P1265, DOI 10.1016/S0091-6749(99)70023-0; Fabbri LM, 2006, AM J RESP CRIT CARE, V173, P1056, DOI 10.1164/rccm.2603005; Fink JN, 2005, AM J RESP CRIT CARE, V171, P792, DOI 10.1164/rccm.200409-1205WS; Galdi E, 2005, SCAND J WORK ENV HEA, V31, P224, DOI 10.5271/sjweh.873; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Greenberger PA, 2004, ALLERGY ASTHMA PROC, V25, P219; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; HAMAGAMI S, 1992, CHEST, V101, P1044, DOI 10.1378/chest.101.4.1044; Higashi N, 2004, J ALLERGY CLIN IMMUN, V114, P1353, DOI 10.1016/j.jaci.2004.09.027; Israel-Assayag E, 1999, AM J RESP CRIT CARE, V159, P1830, DOI 10.1164/ajrccm.159.6.9810087; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Khan AJ, 2007, CURR OPIN PULM MED, V13, P137, DOI 10.1097/MCP.0b013e32802c7ceb; KITA H, 2003, MIDDLETONS ALLERGY P, P305; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Lacasse Y, 2003, AM J RESP CRIT CARE, V168, P952, DOI 10.1164/rccm.200301-137OC; McClellan JS, 1999, ANN ALLERG ASTHMA IM, V83, P357, DOI 10.1016/S1081-1206(10)62831-1; Miotto D, 2003, EUR RESPIR J, V22, P602, DOI 10.1183/09031936.03.00046402; Moran JV, 2002, ALLERGY ASTHMA PROC, V23, P265; Moss RB, 2006, MED MYCOL, V44, pS269, DOI 10.1080/13693780600835757; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Perry LP, 1998, MODERN PATHOL, V11, P432; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Prince Joseph E., 2003, Journal of Allergy and Clinical Immunology, V111, pS613; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Taha RA, 1999, AM J RESP CRIT CARE, V160, P1119, DOI 10.1164/ajrccm.160.4.9807120; Tsao TCY, 2002, CHEST, V122, P1285, DOI 10.1378/chest.122.4.1285; van der Ent CK, 2007, THORAX, V62, P276, DOI 10.1136/thx.2004.035519; Vemuri P, 2002, ANN ALLERG ASTHMA IM, V88, P640, DOI 10.1016/S1081-1206(10)61898-4; von Gunten S, 2007, J ALLERGY CLIN IMMUN, V119, P1005, DOI 10.1016/j.jaci.2007.01.023; Wang XR, 2005, EUR RESPIR J, V26, P881, DOI 10.1183/09031936.05.00125604; Wark PAB, 2003, J ALLERGY CLIN IMMUN, V111, P952, DOI 10.1067/mai.2003.1388; Wesselkamper SC, 2005, AM J RESP CRIT CARE, V172, P1399, DOI 10.1164/rccm.200502-286OC; Yew WW, 2007, AM J RESP CRIT CARE, V175, P541, DOI 10.1164/rccm.200611-1653UP; Zacharisen MC, 2002, ANN ALLERG ASTHMA IM, V88, P175, DOI 10.1016/S1081-1206(10)61993-X	47	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2008	121	2		2			S393	S397		10.1016/j.jaci.2007.07.039	http://dx.doi.org/10.1016/j.jaci.2007.07.039			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266IB	18241689				2022-12-18	WOS:000253426600008
J	Cannady, SB; Batra, PS; Leahy, R; Citardi, MJ; Janocha, A; Ricci, K; Comhair, SAA; Bodine, M; Wang, Z; Hazen, SL; Erzurum, SC				Cannady, Steven B.; Batra, Pete S.; Leahy, Rachel; Citardi, Martin J.; Janocha, Allison; Ricci, Kristin; Comhair, Suzy A. A.; Bodine, Melanie; Wang, Zeneng; Hazen, Stanley L.; Erzurum, Serpil C.			Signal transduction and oxidative processes in sinonasal polyposis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						nasal polyposis; chronic sinusitis; nitric oxide; signal transducer and activator of transcription 1; superoxide dismutase; arginine; nitrite; nitrate	NITRIC-OXIDE SYNTHASE; HUMAN AIRWAY EPITHELIUM; SUPEROXIDE-DISMUTASE; INTERFERON-GAMMA; NASAL POLYPOSIS; FREE-RADICALS; NO; RHINOSINUSITIS; PROLIFERATION; VASODILATORS	Background: Nasal polyposis is characterized by impaired regulation of nasal tissue growth and is associated with chronic inflammation, sinus infections, and low levels of nitric oxide (NO). Based on its critical role in mediating cell growth and antimicrobial function, decrease of NO levels has been implicated in the pathogenesis of nasal polyposis. Objective: We sought to evaluate mechanisms for the low NO level in polyposis, including factors regulating NO synthase (NOS) expression and activity and NO consumptive processes in nasal epithelial cells and nasal lavage fluid. Methods: Eighteen patients with nasal polyposis and 8 healthy control subjects were studied. Nasal brushings, nasal lavage fluid, and nasal biopsy specimens were collected and analyzed. Results: NO metabolite levels (nitrite and nitrate) in nasal lavage fluid from patients with polyps were less than those in control subjects, but activation of signal transduction and inducer of transcription 1, which regulates inducible NOS gene expression and protein expression, was present at higher levels in polyp than in healthy control tissue. Levels of arginine, methylarginine, and endogenous NOS inhibitors were similar between polyp and control tissue. In contrast, superoxide dismutase activity of polyp tissues was lower than that seen in control tissue and associated with increased nitrotyrosine, a biomarker of oxidant consumptive products of NO. Conclusion: Taken together, these data suggest that the nasal polyp environment is characterized by abnormalities in NO metabolism that might predispose to altered regulation of tissue growth and infection. Clinical implications: Identification of NO metabolic abnormalities might lead to novel treatments for sinonasal polyposis targeted against the pathways identified within this study.	[Cannady, Steven B.; Batra, Pete S.; Citardi, Martin J.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Head & Neck Inst, Cleveland, OH 44195 USA; [Leahy, Rachel; Janocha, Allison; Ricci, Kristin; Comhair, Suzy A. A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Leahy, Rachel; Janocha, Allison; Ricci, Kristin; Comhair, Suzy A. A.] Cleveland Clin, Lerner Res Inst, Dept Pulm Allergy & Crit Care Med, Cleveland, OH 44195 USA; [Bodine, Melanie; Wang, Zeneng; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Bodine, Melanie; Wang, Zeneng; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Cannady, SB (corresponding author), Cleveland Clin, Lerner Res Inst, Head & Neck Inst, 9500 Euclid Ave NC22, Cleveland, OH 44195 USA.	cannads@ccf.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, P01HL081064, R37HL060917, R01HL069170] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BalfourLynn IM, 1996, ARCH DIS CHILD, V75, P319, DOI 10.1136/adc.75.4.319; Baraldi E, 1997, AM J RESP CRIT CARE, V155, P1680, DOI 10.1164/ajrccm.155.5.9154876; Bernardes JF, 2004, OTOLARYNG HEAD NECK, V131, P696, DOI 10.1016/j.otohns.2004.05.013; Cheng YK, 2006, LARYNGOSCOPE, V116, P417, DOI 10.1097/01.MLG.0000199738.37455.55; Citardi MJ, 2006, AM J RHINOL, V20, P353, DOI 10.2500/ajr.2006.20.2858; Colantonio D, 2002, CLIN EXP ALLERGY, V32, P698, DOI 10.1046/j.1365-2222.2002.01379.x; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Comhair SAA, 2000, LANCET, V355, P624, DOI 10.1016/S0140-6736(99)04736-4; Dagli M, 2004, LARYNGOSCOPE, V114, P1200, DOI 10.1097/00005537-200407000-00013; DeRaeve HR, 1997, AM J PHYSIOL-LUNG C, V272, pL148, DOI 10.1152/ajplung.1997.272.1.L148; Dotsch J, 1996, EUR RESPIR J, V9, P2537, DOI 10.1183/09031936.96.09122537; Dowling RB, 1998, AM J RESP CELL MOL, V19, P950, DOI 10.1165/ajrcmb.19.6.2904; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Guo FH, 1997, J CLIN INVEST, V100, P829, DOI 10.1172/JCI119598; GUO FH, 1995, P NATL ACAD SCI USA, V92, P7809, DOI 10.1073/pnas.92.17.7809; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Jorissen M, 2001, ALLERGY, V56, P1026, DOI 10.1034/j.1398-9995.2001.00145.x; Kang BH, 2004, AM J RHINOL, V18, P191, DOI 10.1177/194589240401800401; Karlidag T, 2005, ANN OTO RHINOL LARYN, V114, P122, DOI 10.1177/000348940511400207; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P113, DOI 10.3109/00016489709118001; Lindberg S, 1997, ACTA OTO-LARYNGOL, V117, P728, DOI 10.3109/00016489709113468; Lundberg JON, 1996, ARCH DIS CHILD, V75, P323, DOI 10.1136/adc.75.4.323; LUNDBERG JON, 1994, EUR RESPIR J, V7, P1501, DOI 10.1183/09031936.94.07081501; Mannick Joan B, 2006, Proc Am Thorac Soc, V3, P161, DOI 10.1513/pats.200505-048BG; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Meltzer EO, 2006, OTOLARYNG HEAD NECK, V135, pS31, DOI 10.1016/j.otohns.2006.09.014; Mygind N, 2000, THORAX, V55, pS79, DOI 10.1136/thorax.55.suppl_2.S79; NAKAKI T, 1990, EUR J PHARM-MOLEC PH, V189, P347, DOI 10.1016/0922-4106(90)90031-R; NUNOKAWA Y, 1992, BIOCHEM BIOPH RES CO, V188, P409, DOI 10.1016/0006-291X(92)92400-R; Piccirillo JF, 2002, OTOLARYNG HEAD NECK, V126, P41, DOI 10.1067/mhn.2002.121022; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Ramis I, 1996, EUR RESPIR J, V9, P202, DOI 10.1183/09031936.96.09020202; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Zheng S, 2004, AM J PHYSIOL-LUNG C, V287, pL374, DOI 10.1152/ajplung.00039.2004	37	14	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2007	120	6					1346	1353		10.1016/j.jaci.2007.07.067	http://dx.doi.org/10.1016/j.jaci.2007.07.067			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	241JX	17935768				2022-12-18	WOS:000251653800015
J	Bermejo-Martin, JF; Garcia-Arevalo, MC; Alonso, A; De Lejarazu, RO; Pino, M; Resino, S; Tenorio, A; Tenorio, A; Bernardo, D; Leon, AJ; Garrote, JA; Ardura, J; Dominguez-Gil, M; Eiros, JM; Blanco-Quiros, A; Munoz-Fernandez, MA; Kelvin, DJ; Arranz, E				Bermejo-Martin, Jesus F.; Garcia-Arevalo, M. Carmen; Alonso, Ana; De Lejarazu, Raul O.; Pino, Maria; Resino, Salvador; Tenorio, Alberto; Tenorio, Alberto; Bernardo, David; Leon, Alberto J.; Garrote, Jose A.; Ardura, Julio; Dominguez-Gil, Marta; Eiros, Jose M.; Blanco-Quiros, Alfredo; Munoz-Fernandez, M. Angeles; Kelvin, David J.; Arranz, Eduardo			Persistence of proinflarnmatory response after severe respiratory syncytial virus disease in children	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							INFECTION		Univ Valladolid, Lab Inmunol Mucosas, Valladolid, Spain; HCU Pediat, Valladolid, Spain; HCU Virol, Valladolid, Spain; HGU Gregorio Maranon, Madrid, Spain; UHN, Div Expt Therapeut, Toronto, ON, Canada; HCU Unidad Invest, Valladolid, Spain	Universidad de Valladolid; General University Gregorio Maranon Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bermejo-Martin, JF (corresponding author), Univ Valladolid, Lab Inmunol Mucosas, Valladolid, Spain.	bermejo@ped.uva.es	Bermejo-Martin, Jesus F/J-4574-2019; Bernardo, David/GXH-8727-2022; Resino, Salvador/B-2430-2008; Arranz, Eduardo/I-4958-2015; Garrote, Jose A/B-1257-2013; García-Arévalo, Carmen/N-6120-2018	Bermejo-Martin, Jesus F/0000-0002-7998-6268; Resino, Salvador/0000-0001-8783-0450; Arranz, Eduardo/0000-0003-1957-3186; Garrote, Jose A/0000-0003-1797-6520; Munoz-Fernandez/0000-0002-0813-4500; Eiros, Jose M/0000-0002-5357-6340; Bernardo, David/0000-0002-2843-6696				Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Martinon-Torres F, 2002, PEDIATRICS, V109, P68, DOI 10.1542/peds.109.1.68; Oh JW, 2002, PEDIAT ALLERG IMM-UK, V13, P350, DOI 10.1034/j.1399-3038.2002.02018.x; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; PANUSKA JR, 1995, J CLIN INVEST, V96, P2445, DOI 10.1172/JCI118302; Rutigliano JA, 2004, J IMMUNOL, V173, P3408, DOI 10.4049/jimmunol.173.5.3408; Schwarze J, 2000, AM J RESP CRIT CARE, V162, P380, DOI 10.1164/ajrccm.162.2.9903057	9	14	14	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2007	119	6					1547	1550		10.1016/j.jaci.2007.03.014	http://dx.doi.org/10.1016/j.jaci.2007.03.014			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	178PO	17451801	Bronze			2022-12-18	WOS:000247232800038
J	Deykin, A				Deykin, Aaron			Biomarker-driven care in asthma: Are we there?	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma therapy; biomarkers; sputum eosinophils; methacholine; nitric oxide	EXHALED NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; INHALED FLUTICASONE PROPIONATE; SPUTUM EOSINOPHIL COUNTS; PERSISTENT ASTHMA; CORTICOSTEROIDS; HYPERRESPONSIVENESS; MEDICATION; REDUCTION; THERAPY	Clinical asthma management is limited by the lack of straightforward and clinically applicable techniques to assess control and appropriately adjust therapy. The availability of biomarkers associated with airway caliber, responsiveness, or inflammation has prompted interest in the application of these measures as surrogate asthma end points in clinical trials. Use of a biomarker as a surrogate outcome. in practice is most appropriate in settings in which the effects of therapy on clinical disease, as experienced by patients, are fully captured by that biomarker. Recent studies suggest that although asthma therapies can alter various biomarkers, the relationship between these biomarker changes and important clinical outcomes is inconsistent. Because symptom-driven titration of therapy is feasible and effective, additional data demonstrating clinically important benefits of biomarker-driven care in asthma are needed to justify the logistic and economic burdens associated with clinical dissemination of these techniques.	Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Deykin, A (corresponding author), Brigham & Womens Hosp, Div Pulm, 75 Francis St, Boston, MA 02115 USA.	adeykin@partners.org						[Anonymous], 1997, NIH PUBLICATION; Berlyne GS, 2000, J ALLERGY CLIN IMMUN, V106, P638, DOI 10.1067/mai.2000.109622; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Deykin A, 2002, AM J RESP CRIT CARE, V165, P1597, DOI 10.1164/rccm.2201081; Fahy JV, 2001, AM J RESP CRIT CARE, V163, P1470, DOI 10.1164/ajrccm.163.6.9901105; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Holt S, 2001, BRIT MED J, V323, P253, DOI 10.1136/bmj.323.7307.253; Jenkins CR, 2005, EUR RESPIR J, V26, P36, DOI 10.1183/09031936.05.00144704; Jones SL, 2001, AM J RESP CRIT CARE, V164, P738, DOI 10.1164/ajrccm.164.5.2012125; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Leuppi JD, 2001, AM J RESP CRIT CARE, V163, P406, DOI 10.1164/ajrccm.163.2.9912091; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; *NAEEP, 2003, NIH PUBL; *NHLBI WHO, 2002, NIH PUBL; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sovijarvi ARA, 2003, THORAX, V58, P500, DOI 10.1136/thorax.58.6.500	21	14	18	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					565	568		10.1016/j.jaci.2006.06.007	http://dx.doi.org/10.1016/j.jaci.2006.06.007			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950271				2022-12-18	WOS:000240649000005
J	Lieberman, A; Rea, W; Curtis, L				Lieberman, Allan; Rea, William; Curtis, Luke			Adverse health effects of indoor mold exposure	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Ctr Environm & Occupat Med, N Charleston, SC USA; Ctr Environm Hlth, Dallas, TX USA; Norwegian Amer Hosp, Chicago, IL USA		Lieberman, A (corresponding author), Ctr Environm & Occupat Med, N Charleston, SC USA.							[Anonymous], 2003, J OCCUP ENVIRON MED, V45, P470; Bush RK, 2006, J ALLERGY CLIN IMMUN, V117, P326, DOI 10.1016/j.jaci.2005.12.001; Curtis Luke, 2004, Journal of Nutritional & Environmental Medicine (Abingdon), V14, P261, DOI 10.1080/13590840400010318	3	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2006	118	3					763	763		10.1016/j.jaci.2006.06.037	http://dx.doi.org/10.1016/j.jaci.2006.06.037			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	086BV	16950304	Bronze			2022-12-18	WOS:000240649000040
J	Metcalfe, DD; Boyce, JA				Metcalfe, Dean D.; Boyce, Joshua A.			Mast cell biology in evolution	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						mast cell; allergy; inflammation; asthma	ANTI-IGE; RECRUITMENT; TRYPTASE; DISEASE; LOCUS		NIAID, NIH, Lab Allerg Dis, Bethesda, MD 20892 USA; Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital	Metcalfe, DD (corresponding author), NIAID, NIH, Lab Allerg Dis, Bldg 10,Rm 11C205,10 Ctr Dr,MSC1881, Bethesda, MD 20892 USA.	dmetcalfe@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000607, Z01AI000513] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bannert N, 2001, J VIROL, V75, P10808, DOI 10.1128/JVI.75.22.10808-10814.2001; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Caughey GH, 2006, J ALLERGY CLIN IMMUN, V117, P1411, DOI 10.1016/j.jaci.2006.02.026; Chang TW, 2006, J ALLERGY CLIN IMMUN, V117, P1203, DOI 10.1016/j.jaci.2006.04.005; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Clejan S, 2002, J CELL MOL MED, V6, P583, DOI 10.1111/j.1582-4934.2002.tb00456.x; Corren J, 2003, J ALLERGY CLIN IMMUN, V111, P87, DOI 10.1067/mai.2003.49; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Johnson EN, 2002, J ALLERGY CLIN IMMUN, V109, P592, DOI 10.1067/mai.2002.122636; KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Kulka M, 2006, J LEUKOCYTE BIOL, V79, P339, DOI 10.1189/jlb.1004600; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; Okayama Y, 2001, J IMMUNOL, V166, P4705, DOI 10.4049/jimmunol.166.7.4705; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Schwartz LB, 2003, J IMMUNOL, V170, P5667, DOI 10.4049/jimmunol.170.11.5667; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; Urban JF, 2000, J IMMUNOL, V164, P2046, DOI 10.4049/jimmunol.164.4.2046	23	14	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2006	117	6					1227	1229		10.1016/j.jaci.2006.03.031	http://dx.doi.org/10.1016/j.jaci.2006.03.031			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	053UX	16750978				2022-12-18	WOS:000238332300003
J	Didier, A; Melac, M; Combebias, A; Andre, C				Didier, A; Melac, M; Combebias, A; Andre, C			Efficacy and safety of sublingual immunotherapy [SLIT] tablets in grass pollen rhinoconjunctivitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract	62nd Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology	MAR 03-07, 2006	Miami Beach, FL	Amer Acad Allergy, Asthma & Immunol					Hop Rangueil, Toulouse, France; Dept Med, Stallergenes, Antony, France	CHU de Toulouse; Stallergenes Greer			m, m/GZB-2153-2022						0	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2006	117	3					721	721		10.1016/j.jaci.2006.01.022	http://dx.doi.org/10.1016/j.jaci.2006.01.022			1	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	025JY					2022-12-18	WOS:000236263100043
J	Dinakar, C; Craff, M; Laskowski, D				Dinakar, C; Craff, M; Laskowski, D			Infants and toddlers without asthma with eczema have elevated exhaled nitric oxide levels	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDHOOD ASTHMA; CHILDREN						Dariusz, Laskowski/ABA-1773-2021	Dariusz, Laskowski/0000-0001-9922-0350				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; DEPAZ FB, 2002, AN ESP PEDIATR, V57, P12; Dinakar C, 2004, CURR ALLERGY ASTHM R, V4, P454, DOI 10.1007/s11882-004-0011-7; Frank TL, 1998, AM J RESP CRIT CARE, V158, P1032, DOI 10.1164/ajrccm.158.4.9707143; Franklin PJ, 2004, PEDIATR PULM, V37, P24, DOI 10.1002/ppul.10382; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; Henriksen AH, 2000, EUR RESPIR J, V15, P849, DOI 10.1034/j.1399-3003.2000.15e07.x; Mahut B, 2004, J ALLERGY CLIN IMMUN, V113, P252, DOI 10.1016/j.jaci.2003.10.038; Withers NJ, 1998, AM J RESP CRIT CARE, V158, P352, DOI 10.1164/ajrccm.158.2.9705079	10	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2006	117	1					212	213		10.1016/j.jaci.2005.09.037	http://dx.doi.org/10.1016/j.jaci.2005.09.037			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IK	16387608				2022-12-18	WOS:000235687100034
J	Pate, AD; Hamilton, RG; Ashley, PJ; Zeldin, DC; Halsey, JF				Pate, AD; Hamilton, RG; Ashley, PJ; Zeldin, DC; Halsey, JF			Proficiency testing of allergen measurements in residential dust	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergens; ELISA; quality control samples; residential dust	MITE ALLERGEN; EXPOSURE; CHILDREN; DESIGN	Background: Analyses of household dust for allergens are more common with increased efforts to reduce and control asthma. Currently, no laboratory accreditation or quality assurance program specific to household dust allergen analyses exists. Moreover, there is an absence of peer-reviewed data on within-laboratory and between-laboratory variability that is achievable for these analyses. Objectives: The purpose of this study was to characterize the levels of intralaboratory and interlaboratory variability in analyses of allergen concentrations in residential dust and to investigate the utility of quality control samples for monitoring laboratory performance. Methods: Aliquots from homogeneous batches of dust and dust extracts were provided to 8 commercial, academic, and municipal laboratories to be analyzed for as many as 6 allergens (Der p 1, Der 11, Fel d 1, Can f 1, Bla g 1, Mus to 1) by using ELISA techniques. Results: Coefficients of variation on the estimated geometric means from the analytical results ranged between 61% and 93%. In most cases, between-laboratory variability was the dominant component of total variability. In spite of this between-laboratory variability, reasonable agreement was observed between the means of allergen levels in the reference laboratory characterizations and the estimated geometric means from the model fitting of results across participating laboratories. Conclusion: The results from this study indicate that, in most cases, participating laboratories could measure the concentrations of allergens by using ELISA procedures with a level of accuracy and precision that may be acceptable in many situations.	Battelle Mem Inst, Columbus, OH 43201 USA; Johns Hopkins Univ, Sch Med, Dermatol Allergy & Clin Immunol Reference Lab, Baltimore, MD 21218 USA; US Dept Housing & Urban Dev, Off Healthy Homes & Lead Hazard Control, Washington, DC USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; IBT Reference Lab, Lenexa, KS USA	Battelle Memorial Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Pate, AD (corresponding author), 505 King Ave, Columbus, OH 43201 USA.	patea@battelle.org	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025041, ZIAES025041, Z01ES025044] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arbes SJ, 2003, J ALLERGY CLIN IMMUN, V111, P408, DOI 10.1067/mai.2003.16; CARTER SE, 1998, CURR OPIN PEDIATR, V10, P594; CLICKNER RP, 2001, NATL SURVEY LEAD ALL, V2; Huss K, 2001, J ALLERGY CLIN IMMUN, V107, P48, DOI 10.1067/mai.2001.111146; Marks GB, 1995, CLIN EXP ALLERGY, V25, P1190, DOI 10.1111/j.1365-2222.1995.tb03043.x; Mitakakis TZ, 2002, J ALLERGY CLIN IMMUN, V109, P122, DOI 10.1067/mai.2002.120523; Mitchell H, 1997, PEDIATR PULM, V24, P237; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; *NAT AC SCI I MED, 2000, CLEAR AIR ASTHM IND; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; PLATTSMILLS TAE, 1995, J ALLERGY CLIN IMMUN, V96, P435, DOI 10.1016/S0091-6749(95)70284-9; Takaro TK, 2004, J EXPO ANAL ENV EPID, V14, pS133, DOI 10.1038/sj.jea.7500367; Tovey ER, 2003, ALLERGY, V58, P790, DOI 10.1034/j.1398-9995.2003.00228.x	13	14	14	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2005	116	4					844	850		10.1016/j.jaci.2005.06.016	http://dx.doi.org/10.1016/j.jaci.2005.06.016			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	017IF	16210059				2022-12-18	WOS:000235686600019
J	Wang, JL; Mayer, L; Cunningham-Rundles, C				Wang, JL; Mayer, L; Cunningham-Rundles, C			Use of GM-CSF in the treatment of colitis associated with chronic granulomatous disease	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							COLONY-STIMULATING FACTOR; CROHNS-DISEASE		Mt Sinai Sch Med, Div Clin Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Wang, JL (corresponding author), Mt Sinai Sch Med, Div Clin Immunol, 1 Gustave L Levy Pl,Box 1198, New York, NY 10029 USA.							Dejaco C, 2003, DIGESTION, V68, P63, DOI 10.1159/000074517; Dieckgraefe BK, 2002, LANCET, V360, P1478, DOI 10.1016/S0140-6736(02)11437-1; Drumm B, 2003, LANCET, V361, P1830, DOI 10.1016/S0140-6736(03)13435-6; Hage CA, 2003, CHEST, V124, P2395, DOI 10.1378/chest.124.6.2395; HURST D, 1993, AM J PEDIAT HEMATOL, V15, P71; Myrup B, 1998, GUT, V42, P127, DOI 10.1136/gut.42.1.127; ROE TF, 1992, NEW ENGL J MED, V326, P1666, DOI 10.1056/NEJM199206183262504; Schappi MG, 2001, ARCH DIS CHILD, V84, P147, DOI 10.1136/adc.84.2.147; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003	10	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2005	115	5					1092	1094		10.1016/j.jaci.2005.01.016	http://dx.doi.org/10.1016/j.jaci.2005.01.016			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	925LR	15867874	Bronze			2022-12-18	WOS:000229055100032
J	Covar, RA; Cool, C; Szefler, SJ				Covar, RA; Cool, C; Szefler, SJ			Progression of asthma in childhood	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						airway inflammation; airway remodeling; asthma; eosinophils; progression	CLINICAL CHARACTERISTICS; AIRWAY INFLAMMATION; MANAGEMENT PROGRAM; BASEMENT-MEMBRANE; TERM TREATMENT; LUNG-FUNCTION; RISK-FACTORS; FOLLOW-UP; CHILDREN; BUDESONIDE	In general, asthma runs a variable course. However, there are children with asthma who are at risk for progressive disease that can lead to failure to attain peak lung growth and eventually can result in clinical and functional impairment. We present a case of a 14-year-old girl who has demonstrated a deterioration in lung function at least in the past 6 years. This has been associated with increasing medication requirements, including chronic oral corticosteroid and a steroid-sparing medication, the presence of comorbidities, and the occurrence of frequent exacerbations. The patient has evidence of airway inflammation and remodeling based on biomarkers and biopsy findings. It remains a challenge to determine patients at risk for irreversible airflow obstruction, presumably a result of airway remodeling. Histopathologic studies from biopsy samples provide the best evidence for this. However, bronchoscopy and biopsy require technical expertise and cannot be routinely used. Clinically, once a patient increases medication requirements, this should serve as a marker of disease progression. Biomarkers of airway inflammation such as exhaled nitric oxide, exhaled breath condensates, and induced sputum analysis may have the potential to monitor disease progression. Additional efforts are necessary to understand the mechanisms involved in this phenomenon and to discover specific modalities of treatment to target the structural changes of airway remodeling.	Natl Jewish Med & Res Ctr, Dept Pediat, Ira J & Jacqueline Neimark Lab Clin Pharmacol, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Pediat Clin Pharmacol & Allergy, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Clin Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Boulder, CO 80309 USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	Covar, RA (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Ira J & Jacqueline Neimark Lab Clin Pharmacol, 1400 Jackson St, Denver, CO 80206 USA.	covarr@njc.org						Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033; Corrigan Chris J, 2002, Am J Respir Med, V1, P47; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HILL MR, 1990, CLIN PHARMACOL THER, V48, P390, DOI 10.1038/clpt.1990.167; Jenkins HA, 2003, CHEST, V124, P1318, DOI 10.1378/chest.124.4.1318; Jenkins HA, 2003, CHEST, V124, P32, DOI 10.1378/chest.124.1.32; Jongepier H, 2004, CLIN EXP ALLERGY, V34, P757, DOI 10.1111/j.1365-2222.2004.1938.x; Koumbourlis AC, 2004, PEDIATR PULM, V38, P339, DOI 10.1002/ppul.20062; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P1, DOI 10.1067/mai.2003.62; *NIH, 1997, GUID DIAGN MAN ASTHM; Olivieri D, 1997, AM J RESP CRIT CARE, V155, P1864, DOI 10.1164/ajrccm.155.6.9196087; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; ROORDA RJ, 1994, J ALLERGY CLIN IMMUN, V93, P575, DOI 10.1016/S0091-6749(94)70069-9; SPAHN JD, 2003, PEDIAT ALLERGY PRINC, P444; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Taussig LM, 2003, J ALLERGY CLIN IMMUN, V111, P661, DOI 10.1067/mai.2003.162; ten Brinke A, 2001, AM J RESP CRIT CARE, V164, P744, DOI 10.1164/ajrccm.164.5.2011026; Ulrik CS, 1999, EUR RESPIR J, V14, P892, DOI 10.1034/j.1399-3003.1999.14d27.x; WAALKENS HJ, 1993, AM REV RESPIR DIS, V148, P1252, DOI 10.1164/ajrccm/148.5.1252; Ward C, 2002, THORAX, V57, P309, DOI 10.1136/thorax.57.4.309; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Zeiger RS, 1999, J ALLERGY CLIN IMMUN, V103, P376, DOI 10.1016/S0091-6749(99)70460-4	26	14	15	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					700	707		10.1016/j.jaci.2005.01.034	http://dx.doi.org/10.1016/j.jaci.2005.01.034			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15805987				2022-12-18	WOS:000228373400006
J	Omata, N; Ohshima, Y; Yasutomi, M; Yamada, A; Karasuyama, H; Mayumi, M				Omata, N; Ohshima, Y; Yasutomi, M; Yamada, A; Karasuyama, H; Mayumi, M			Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						food allergy; oral tolerance; IgE; ovalbumin; anergy; clonal deletion	FC-EPSILON-RI; FOOD ALLERGY; TRANSGENIC MICE; IN-VIVO; DENDRITIC CELLS; MAST-CELL; TOLERANCE; ACTIVATION; DIFFERENTIATION; MECHANISMS	Background: Some patients outgrow their food allergies even though their serum antigen-specific IgE levels remain high. Objective: To elucidate the role of T cells in outgrowing food allergies in the presence of antigen-specific IgE, we tracked antigen-specific T-cell responses after oral antigen administration. Methods: Ovalbumin (OVA)-specific T-cell receptor (TCR) and OVA-specific IgE transgenic (Tg) mice (OVA-TCR/IgE-Tg) and OVA-specific TCR Tg (OVA-TCR-Tg) mice were fed with high doses of OVA or, PBS every other day. After 7 administrations, OVA-specific proliferation and cytokine production of mononuclear cells of the spleen, mesenteric lymph nodes, and Peyer's patches and the number of splenic CD4(+)CD25(+) T cells were analyzed. Results: Without OVA administration, the splenocytes from OVA-TCR/IgE-Tg mice exhibited a higher proliferative response and produced more IL-4 and IL-10 and less IFN-gamma than those from OVA-TCR-Tg mice. The proliferative responses of the splenocytes from either OVA-TCR/IgE-Tg mice or OVA-TCR-Tg mice fed with OVA were significantly reduced compared with those from PBS-fed mice. The number of OVA-specific TCR(+) T cells decreased in the spleen from OVA-fed mice, whereas the number of CD4+CD25+ T cells increased. The suppressed proliferation of splenocytes of OVA-fed mice was partially resumed by neutralization of TGF-beta 1, but not of IL-10. Conclusion: The presence of OVA-specific IgE modulated the OVA-specific responses of the splenocytes. Irrespective of the presence of OVA-specific IgE, repetitive oral administration of OVA induced tolerance, which seems to be composed of clonal deletion/anergy and TGF-beta 1-mediated active suppression.	Univ Fukui, Fac Med Sci, Dept Pediat, Yoshida, Fukui 9101193, Japan; Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo, Japan	University of Fukui; Tokyo Medical & Dental University (TMDU)	Ohshima, Y (corresponding author), Univ Fukui, Fac Med Sci, Dept Pediat, 23-3 Shimoaizuki,Matsuoka Cho, Yoshida, Fukui 9101193, Japan.	yohshima@finsrsa.fukui-med.ac.jp	Karasuyama, Hajime/A-7966-2011	Karasuyama, Hajime/0000-0003-0689-0836; Yasutomi, Motoko/0000-0003-1165-3632; Ohshima, Yusei/0000-0002-4488-0308				Asai K, 2002, J IMMUNOL, V169, P4723, DOI 10.4049/jimmunol.169.9.4723; Benson JM, 2000, J CLIN INVEST, V106, P1031, DOI 10.1172/JCI10738; Bryce PJ, 2004, IMMUNITY, V20, P381, DOI 10.1016/S1074-7613(04)00080-9; Eigenmann PA, 2002, PEDIAT ALLERG IMM-UK, V13, P162, DOI 10.1034/j.1399-3038.2002.01015.x; Frossard CP, 2001, PEDIATR RES, V49, P417, DOI 10.1203/00006450-200103000-00018; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Hashimoto A, 2001, CELL IMMUNOL, V207, P36, DOI 10.1006/cimm.2000.1738; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Marth T, 2000, EUR J IMMUNOL, V30, P3478, DOI 10.1002/1521-4141(2000012)30:12<3478::AID-IMMU3478>3.0.CO;2-A; Matsuoka K, 1999, INT IMMUNOL, V11, P987, DOI 10.1093/intimm/11.6.987; Maurer D, 1997, ADV EXP MED BIOL, V417, P175; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P901, DOI 10.1067/mai.2002.124965; Novak N, 2001, J IMMUNOL, V167, P797, DOI 10.4049/jimmunol.167.2.797; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Sato E, 2003, J ALLERGY CLIN IMMUN, V111, P143, DOI 10.1067/mai.2003.9; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; von Bubnoff D, 2001, J ALLERGY CLIN IMMUN, V108, P329, DOI 10.1067/mai.2001.117457; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Wood RA, 2003, PEDIATRICS, V111, P1631; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Zhang XM, 2001, J IMMUNOL, V167, P4245, DOI 10.4049/jimmunol.167.8.4245	25	14	23	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2005	115	4					822	827		10.1016/j.jaci.2004.12.1121	http://dx.doi.org/10.1016/j.jaci.2004.12.1121			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	916GM	15806005				2022-12-18	WOS:000228373400024
J	Hamilton, RG				Hamilton, RG			Science behind the discovery of IgE	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item																			0	14	15	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					648	652		10.1016/j.jaci.2004.12.007	http://dx.doi.org/10.1016/j.jaci.2004.12.007			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753924				2022-12-18	WOS:000227687000041
J	Hauswirth, DW; Burks, AW				Hauswirth, DW; Burks, AW			Banana anaphylaxis with a negative commercial skin test	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							PRICK TESTS; FRESH FOODS; EXTRACTS; ALLERGY; DIAGNOSIS		Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA	Duke University	Hauswirth, DW (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Box 2898, Durham, NC 27710 USA.							Akkerdaas JH, 2003, INT ARCH ALLERGY IMM, V132, P132, DOI 10.1159/000073714; Grob M, 2002, ANN ALLERG ASTHMA IM, V89, P513, DOI 10.1016/S1081-1206(10)62090-X; ORTOLANI C, 1989, J ALLERGY CLIN IMMUN, V83, P683, DOI 10.1016/0091-6749(89)90083-3; Rance F, 1997, ALLERGY, V52, P1031, DOI 10.1111/j.1398-9995.1997.tb02427.x; Rodriguez J, 2000, J ALLERGY CLIN IMMUN, V106, P968, DOI 10.1067/mai.2000.110467; ROSEN JP, 1994, J ALLERGY CLIN IMMUN, V93, P1068, DOI 10.1016/S0091-6749(94)70056-7; SAMPSON HA, 1988, J ALLERGY CLIN IMMUN, V82, P718, DOI 10.1016/0091-6749(88)90070-X; Sanchez-Monge R, 1999, CLIN EXP ALLERGY, V29, P673, DOI 10.1046/j.1365-2222.1999.00526.x	8	14	16	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2005	115	3					632	633		10.1016/j.jaci.2004.10.034	http://dx.doi.org/10.1016/j.jaci.2004.10.034			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	907AN	15753916				2022-12-18	WOS:000227687000031
J	Brown, RH; Taenkhum, K; Buckley, TJ; Hamilton, RG				Brown, RH; Taenkhum, K; Buckley, TJ; Hamilton, RG			Different latex aeroallergen size distributions between powdered surgical and examination gloves: Significance for environmental avoidance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						latex allergy; allergen; particle size; avoidance therapy	NATURAL-RUBBER LATEX; OCCUPATIONAL ALLERGY; QUANTIFICATION; HOSPITALS	Background: Proactive medical institutions implement latex allergen avoidance to protect workers and patients with latex allergy and to prevent latex sensitization in these groups by creating latex-safe environments that include replacement of natural rubber latex examination and surgical gloves, especially those that are powdered, with synthetic alternatives. We have hypothesized that an apparent decreasing trend in new latex allergy cases in hospitals using only synthetic examination gloves but the occasional powdered latex surgical glove might result from constitutive differences in allergen content (particle size distribution and quantity) between powdered surgical gloves and examination gloves. Objective: Because aerodynamic particle size determines where inhaled airborne allergen deposits in the airway, the aim of this study was to investigate the differential particle size distribution of latex allergen released from powdered latex examination and surgical gloves. Methods: Powdered and nonpowdered latex examination and surgical gloves were processed to create an aerosol in a glove box equipped with air sampling equipment capable of total particle number and mass measurements. Air particulate generated in the glove box was collected on impactors with less than 2.5-mum, 2.5- to 10-mum, and greater than 10-mum particle size limits (4 L/min for 4 hours). All filters were extracted, and latex allergen was quantified by using a latex-CAP inhibition assay with a human IgE anti-latex serum pool. Results: Latex aeroallergen on powdered sterile surgical gloves resided primarily on particles greater than 10 mum in size (P < .006). In contrast, powdered examination gloves released the highest total latex aeroallergen content, with 68% of the particles sized in the respirable 2.5- to 10-mum range and carrying 56% of the airborne latex allergen. Conclusions: Significantly lower quantities and larger sizes of latex allergen-containing particles released from surgical gloves provides one potential explanation as to why an apparent decrease in new cases of latex allergy can occur in hospitals that successfully replace latex examination gloves with synthetic gloves but continue occasional use of powdered surgical gloves.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Brown, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Room 7006, Baltimore, MD 21205 USA.	rbrown2@jhem.jhmi.edu	Buckley, Timothy/AAS-7516-2021		NIAID NIH HHS [AI43654] Funding Source: Medline; NIEHS NIH HHS [P30 ES 03819] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahmed DDF, 2003, IMMUNOL ALLERGY CLIN, V23, P205, DOI 10.1016/S0889-8561(02)00079-6; BAUR X, 1993, LANCET, V342, P1148, DOI 10.1016/0140-6736(93)92127-F; BEEZHOLD D, 1992, ARCH SURG-CHICAGO, V127, P1354; Bollinger ME, 2002, ANN ALLERG ASTHMA IM, V88, P560, DOI 10.1016/S1081-1206(10)61886-8; Brown Robert H, 2003, Jt Comm J Qual Saf, V29, P113; *CDCP, 1987, MMWR-MORBID MORTAL W, V36, P35; Charous BL, 2002, METHODS, V27, P15, DOI 10.1016/S1046-2023(02)00047-6; Charous BL, 2000, ANN ALLERG ASTHMA IM, V85, P285, DOI 10.1016/S1081-1206(10)62531-8; Elliott BA, 2002, J ALLERGY CLIN IMMUN, V110, pS117, DOI 10.1067/mai.2002.125594; Hamilton RG, 2003, J ALLERGY CLIN IMMUN, V111, P1414, DOI 10.1067/mai.2003.1520; Hamilton RG, 2002, J ALLERGY CLIN IMMUN, V109, pS259, DOI 10.1016/S0091-6749(02)81925-X; Heilman DK, 1996, J ALLERGY CLIN IMMUN, V98, P325, DOI 10.1016/S0091-6749(96)70157-4; Hunt LW, 2002, J ALLERGY CLIN IMMUN, V110, pS96, DOI 10.1067/mai.2002.125442; Ownby DR, 2003, ANN ALLERG ASTHMA IM, V90, P42, DOI 10.1016/S1081-1206(10)61648-1; Ownby DR, 2002, J ALLERGY CLIN IMMUN, V110, pS27, DOI 10.1067/mai.2002.125336; Swanson M, 2001, ANN ALLERG ASTHMA IM, V87, P307, DOI 10.1016/S1081-1206(10)62245-4; Swanson MC, 2002, J ALLERGY CLIN IMMUN, V110, pS15, DOI 10.1067/mai.2002.125338; SWANSON MC, 1994, J ALLERGY CLIN IMMUN, V94, P445, DOI 10.1016/0091-6749(94)90199-6; TARLO SM, 1994, J ALLERGY CLIN IMMUN, V93, P985, DOI 10.1016/S0091-6749(94)70045-1; TOMAZIC VJ, 1994, J ALLERGY CLIN IMMUN, V93, P751, DOI 10.1016/0091-6749(94)90255-0; VANDENPLAS O, 1995, AM J RESP CRIT CARE, V151, P887; YUNGINGER JW, 1994, J ALLERGY CLIN IMMUN, V93, P836, DOI 10.1016/0091-6749(94)90374-3	22	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2004	114	2					358	363		10.1016/j.jaci.2004.04.003	http://dx.doi.org/10.1016/j.jaci.2004.04.003			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	847OU	15316516				2022-12-18	WOS:000223405600023
J	Hederos, CA				Hederos, CA			Neuropsychologic changes and inhaled corticosteroids	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							CHILDREN; BUDESONIDE; ASTHMA		VC Gripen, Primary Care Res Unit, S-65112 Karlstad, Sweden		Hederos, CA (corresponding author), VC Gripen, Primary Care Res Unit, Box 547, S-65112 Karlstad, Sweden.	carl-axel.hederos@liv.se						BENDER B, 1995, J ALLERGY CLIN IMMUN, V95, P523, DOI 10.1016/S0091-6749(95)70314-4; Bender BG, 1998, PEDIATRICS, V101, P355, DOI 10.1542/peds.101.3.355; CONNETT G, 1991, LANCET, V338, P634, DOI 10.1016/0140-6736(91)90646-7; Hadjikoumi I, 2002, ARCH DIS CHILD, V86, P202, DOI 10.1136/adc.86.3.202; LEWIS LD, 1983, LANCET, V2, P634; MELIN A, 1998, PSYCHOL DISTURBANCES, V4, P34; MEYSBOOM RH, 1988, ANN INTERN MED, V109, P983; SATEL SL, 1990, CLIN PEDIATR, V29, P382, DOI 10.1177/000992289002900704; SIN D, 2003, EUR RESPIR J, V21, P633; Stores G, 1998, ARCH DIS CHILD, V78, P413, DOI 10.1136/adc.78.5.413; Szefler S, 2000, NEW ENGL J MED, V343, P1054	11	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2004	114	2					451	452		10.1016/j.jaci.2004.03.045	http://dx.doi.org/10.1016/j.jaci.2004.03.045			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	847OU	15341026	Bronze			2022-12-18	WOS:000223405600038
J	Macedo-Soares, MF; Itami, DM; Lima, C; Perini, A; Faquim-Mauro, EL; Martins, MA; Macedo, MS				Macedo-Soares, MF; Itami, DM; Lima, C; Perini, A; Faquim-Mauro, EL; Martins, MA; Macedo, MS			Lung eosinophilic inflammation and airway hyperreactivity are enhanced by murine anaphylactic, but not nonanaphylactic, IgG1 antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						anaphylactic IgG1; nonanaphylactic IgG1; eosinophilic inflammation; airway hyperreactivity	INDUCED BRONCHIAL HYPERREACTIVITY; FC-GAMMA RECEPTOR; MAST-CELLS; ASTHMA MODEL; SYSTEMIC-ANAPHYLAXIS; ARTHUS REACTION; DEFICIENT MICE; IN-VIVO; T-CELLS; MOUSE	Background: Chronic airway inflammation is a fundamental feature of bronchial asthma, which is characterized by the accumulation and activation of inflammatory cells, such as mast cells and eosinophils, that are tightly regulated by T(H)2 cytokines and chemokines. Recently, we demonstrated, in a marine model of asthma with immunosuppressed mice reconstituted with antigen-specific IgE or IgG1 antibodies, that IgE, but not IgG1, participates in potentiation of airway inflammation and induction of airway hyperreactivity (AHR). The IgG1 antibody, however, did not elicit passive cutaneous anaphylactic reactions, which was in contrast to IgE. Objectives: Because 2 types of murine IgG1 have been demonstrated with regard to anaphylactic activity, the present experiments were undertaken to determine the role of anaphylactic and nonanaphylactic IgG1 antibodies in the development of antigen-induced eosinophilia and AHR in this model. Methods: Dinitrophenyl-conjugated, heat-coagulated hen's egg white was implanted in immunosuppressed mice reconstituted with anaphylactic or nonanaphylactic IgG1. Intratracheal challenge with aggregated dinitrophenyl-ovalbumin was performed on day 14, and lung inflammatory and mechanical parameters were evaluated after 48 hours. Results: Our results demonstrated that reconstitution of immunosuppressed mice with anaphylactic IgG1 antibodies in contrast to nonanaphylactic IgG1 antibodies potentiates their ability to have pulmonary eosinophilic inflammation and AHR. IL-5 and eotaxin levels in bronchoalveolar lavage fluid from anaphylactic IgG1-reconstituted mice were also higher than those in nonanaphylactic IgG1-reconstituted mice. Conclusions: These results indicate that the anaphylactic property of marine IgG1 molecules is essential for their capacity to enhance lung eosinophilic inflammation and to induce AHR.	Univ Sao Paulo, ICB, Dept Immunol, IBS, BR-05508900 Sao Paulo, Brazil; Butantan Inst, Immunopathol Lab, Sao Paulo, Brazil; Univ Sao Paulo, Dept Med, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo	Macedo, MS (corresponding author), Univ Sao Paulo, ICB, Dept Immunol, IBS, Av Prof Lineu Prestes 1730, BR-05508900 Sao Paulo, Brazil.	mamacedo@usp.br	Lima, Carla/B-6750-2019; Faquim-Mauro, Eliana L/C-9636-2012; Martins, Milton A/D-6658-2012; Faquim-Mauro, Eliana/M-2489-2017; Martins, Milton A/L-7541-2017	Lima, Carla/0000-0002-8161-966X; Faquim-Mauro, Eliana/0000-0001-8083-4272; 				BROIDE DH, 1991, J ALLERGY CLIN IMMUN, V88, P637, DOI 10.1016/0091-6749(91)90158-K; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; Crosby JR, 2002, J IMMUNOL, V168, P4050, DOI 10.4049/jimmunol.168.8.4050; DAERON M, 1980, CELL IMMUNOL, V49, P178, DOI 10.1016/0008-8749(80)90067-2; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Faquim-Mauro EL, 2003, IMMUNOBIOLOGY, V207, P169, DOI 10.1078/0171-2985-00231; Faquim-Mauro EL, 2000, INT IMMUNOL, V12, P1733, DOI 10.1093/intimm/12.12.1733; FAQUIMMAURO EL, 2001, REV SOC BRAS MED TRO, V34, P58; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GAUR A, 1993, J IMMUNOL, V150, P1663; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hogan SP, 1998, J IMMUNOL, V161, P1501; Itami DM, 2003, ALLERGY, V58, P1117, DOI 10.1034/j.1398-9995.2003.00206.x; Kaminuma O, 1997, AM J RESP CELL MOL, V16, P448, DOI 10.1165/ajrcmb.16.4.9115756; Kobayashi T, 2000, J IMMUNOL, V164, P3855, DOI 10.4049/jimmunol.164.7.3855; Kon OM, 1999, INT ARCH ALLERGY IMM, V118, P133, DOI 10.1159/000024049; Lefort J, 1996, J CLIN INVEST, V97, P1117, DOI 10.1172/JCI118505; Maezawa Y, 2003, INT ARCH ALLERGY IMM, V131, P2, DOI 10.1159/000070473; Mayr SI, 2002, J IMMUNOL, V169, P2061, DOI 10.4049/jimmunol.169.4.2061; Mehlhop PD, 1997, P NATL ACAD SCI USA, V94, P1344, DOI 10.1073/pnas.94.4.1344; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; MOTA I, 1968, LIFE SCI PT 1 PHYSI, V7, P1289, DOI 10.1016/0024-3205(68)90258-0; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234; Nagai H, 1996, CLIN EXP ALLERGY, V26, P642, DOI 10.1046/j.1365-2222.1996.993357.x; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Park SW, 2003, INT ARCH ALLERGY IMM, V131, P283, DOI 10.1159/000072140; SCHLEIMER RP, 1986, AM REV RESPIR DIS, V133, P614; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; TITUS RG, 1981, J IMMUNOL METHODS, V45, P65, DOI 10.1016/0022-1759(81)90094-6; Wakayama H, 1998, CLIN EXP IMMUNOL, V114, P154; Wang J, 1998, J CLIN INVEST, V102, P1132, DOI 10.1172/JCI2686; WASSERMAN SI, 1988, ANN ALLERGY, V60, P477; WASSERMAN SI, 1992, J ALLERGY CLIN IMMUN, V90, P661; WATSON JW, 1990, AM REV RESPIR DIS, V142, P1093, DOI 10.1164/ajrccm/142.5.1093; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Yuasa T, 2001, J EXP MED, V193, P563, DOI 10.1084/jem.193.5.563; Zar J.J., 2010, BIOSTAT ANAL, Vfifth; ZWEIMAN B, 1993, CURR OPIN IMMUNOL, V5, P950, DOI 10.1016/0952-7915(93)90111-5	47	14	15	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2004	114	1					97	104		10.1016/j.jaci.2004.03.033	http://dx.doi.org/10.1016/j.jaci.2004.03.033			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	836DA	15241350				2022-12-18	WOS:000222534300014
J	Morwood, K; Bourne, H; Gold, M; Gillis, D; Benson, EM				Morwood, K; Bourne, H; Gold, M; Gillis, D; Benson, EM			Phenotypic variability: Clinical presentation between the 6th year and the 60th year in a family with X-linked agammaglobulinemia	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							GENE; DISEASE		IMVS, Dept Immunol, Adelaide, SA 5000, Australia; Westmead Hosp, ICPMR, Dept Immunopathol, Wentworthville, Australia; Womens & Childrens Hosp, Adelaide, SA, Australia	Institute Medical & Veterinary Science Australia; University of Sydney; Womens & Childrens Hospital Australia	Morwood, K (corresponding author), IMVS, Dept Immunol, Rundle St POB 14, Adelaide, SA 5000, Australia.							BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; CONLEY ME, 1994, HUM MOL GENET, V3, P1751, DOI 10.1093/hmg/3.10.1751; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; Kornfeld SJ, 1997, J ALLERGY CLIN IMMUN, V100, P702, DOI 10.1016/S0091-6749(97)70176-3; Paul S, 2001, APPL ECON, V33, P11, DOI 10.1080/00036840122017; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; SCHROEDER HW, 2001, CLIN IMMUNOLOGY PRIN; SUMMERFIELD JA, 1995, LANCET, V345, P886, DOI 10.1016/S0140-6736(95)90009-8; Vihinen M, 1998, NUCLEIC ACIDS RES, V26, P242, DOI 10.1093/nar/26.1.242	9	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2004	113	4					783	785		10.1016/j.jaci.2003.10.061	http://dx.doi.org/10.1016/j.jaci.2003.10.061			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	814DY	15112668				2022-12-18	WOS:000220956600030
J	Shearer, WT; Cunningham-Rundles, C; Ochs, HD				Shearer, WT; Cunningham-Rundles, C; Ochs, HD			Primary immunodeficiency: Looking backwards, looking forwards	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						primary immunodeficiency; severe combined immunodeficiency; bone marrow stem cell transplantation; gene therapy; United States Immunodeficieny Network; complement defiency; white blood cell defects; immunoreconstitution	GENE-THERAPY; BONE-MARROW; TRANSPLANTATION; DEFICIENCY; DISEASE		Texas Childrens Hosp, Dept Allergy & Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; Mt Sinai Med Ctr, Dept Med, New York, NY 10029 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle	Shearer, WT (corresponding author), Texas Childrens Hosp, Dept Allergy & Immunol, 6621 Fannin St, Houston, TX 77030 USA.			Shearer, William/0000-0002-2483-2130				Barker JN, 2001, BLOOD, V97, P2957, DOI 10.1182/blood.V97.10.2957; Binstadt BA, 2003, J ALLERGY CLIN IMMUN, V111, P697, DOI 10.1067/mai.2003.1380; Buckley Rebecca H., 2003, Journal of Allergy and Clinical Immunology, V111, pS733; Buckley RH, 2002, LANCET, V360, P1185, DOI 10.1016/S0140-6736(02)11290-6; Buckley RH, 2004, J ALLERGY CLIN IMMUN, V113, P793, DOI 10.1016/j.jaci.2004.01.764; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chinen J, 2004, J ALLERGY CLIN IMMUN, V113, P595, DOI 10.1016/j.jaci.2004.01.765; Cunningham-Rundles C, 2004, J ALLERGY CLIN IMMUN, V113, P747, DOI 10.1016/j.jaci.2004.01.761; GATTI RA, 1968, LANCET, V2, P1366; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Lindegren Mary Lou, 2004, Morbidity and Mortality Weekly Report, V53, P1; Markert ML, 2004, J ALLERGY CLIN IMMUN, V113, P734, DOI 10.1016/j.jaci.2004.01.766; Morwood K, 2004, J ALLERGY CLIN IMMUN, V113, P783, DOI 10.1016/j.jaci.2003.10.061; Nelson Robert P. Jr., 2003, Journal of Allergy and Clinical Immunology, V111, pS720; Orange JS, 2004, J ALLERGY CLIN IMMUN, V113, P725, DOI 10.1016/j.jaci.2004.01.762; Rosen FS, 2000, IMMUNOL REV, V178, P8, DOI 10.1034/j.1600-065X.2000.17881.x; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Seeborg FO, 2004, J ALLERGY CLIN IMMUN, V113, P627, DOI 10.1016/j.jaci.2004.01.763; Sleasman John W., 2003, Journal of Allergy and Clinical Immunology, V111, pS582; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Tangsinmankong N, 2004, J ALLERGY CLIN IMMUN, V113, P742, DOI 10.1016/j.jaci.2004.01.768; Wen L, 2004, J ALLERGY CLIN IMMUN, V113, P585, DOI 10.1016/j.jaci.2004.02.003	24	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	2004	113	4					607	609		10.1016/j.jaci.2004.02.018	http://dx.doi.org/10.1016/j.jaci.2004.02.018			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	814DY	15100662				2022-12-18	WOS:000220956600004
J	Mullin, D				Mullin, D			Prometheus in Gloucestershire: Edward Jenner, 1749-1823	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Biographical-Item									Edward Jenner Museum, Berkeley GL13 9BH, Glos, England		Mullin, D (corresponding author), Edward Jenner Museum, Church Lane, Berkeley GL13 9BH, Glos, England.							BARON J, 1827, LIFE E JENNER MD, P231; BARON J, 1838, LIFE E JENNER, V2, P168; BAXBY D, 1981, JENNERS SMALLPOX VAC, P12; *BIBLE, PSALM, V91, P5; Carrick Moore J., 1817, HIST PRACTICE VACCIN, P2; FENNER F, 1988, SMALLPOX ITS ERADICA, P118; FISHER RB, 1991, E JENNER 1749 1823, P110; FOSBROKE TD, 1821, BERKELEY MANUSCRIPTS, P222; HADWEN W, 1896, CASE VACCINATION, P7; HOPKINS R, 1983, PRINCES PEASANTS SMA, P224; HUNTER J, 1976, LETTERS PAST, P9; JAMES FE, 1993, T BRISTOL GLOUCESTER, P194; JAMES FE, 1993, CIRENCESTER GRAMMER, P194; JENNER E, 1801, ORIGIN VACCINE INOCU, P1; Jenner Edward., 1798, INQUIRY CAUSES EFFEC; LEFANU W, 1985, BIBLIO E JENNER, P9; LETTSOM JC, 1804, MEMOIR E JENNER MD, P2; SCOTT EL, 1974, E JENNER FRS CUCKOO, P235	18	14	14	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2003	112	4					810	814						5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	730LA	14564373				2022-12-18	WOS:000185831200030
J	Kepley, CL; Cohen, N				Kepley, CL; Cohen, N			Evidence for human mast cell nonreleaser phenotype	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							HUMAN BASOPHILS		Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Surg, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Kepley, CL (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, 1112 E Clay St,McGuire Hall,Rm 4-114,Box 980263, Richmond, VA 23298 USA.							ISHIZAKA T, 1973, J IMMUNOL, V111, P500; KEPLEY C, 1994, J IMMUNOL METHODS, V175, P1, DOI 10.1016/0022-1759(94)90326-3; Kepley CL, 1999, J ALLERGY CLIN IMMUN, V104, P279, DOI 10.1016/S0091-6749(99)70367-2; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; KEPLEY CL, 1995, J IMMUNOL, V154, P6548; KNOL EF, 1992, J ALLERGY CLIN IMMUN, V90, P92, DOI 10.1016/S0091-6749(06)80015-1; NGUYEN KL, 1990, J ALLERGY CLIN IMMUN, V85, P1020, DOI 10.1016/0091-6749(90)90046-7; Yamaguchi M, 1996, J ALLERGY CLIN IMMUN, V97, P1279, DOI 10.1016/S0091-6749(96)70196-3	8	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2003	112	2					457	459		10.1067/mai.2003.1671	http://dx.doi.org/10.1067/mai.2003.1671			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	709WY	12897759	Green Published			2022-12-18	WOS:000184650600037
J	Barderas, R; Villaba, M; Batanero, E; Pascual, CY; Rodriguez, R				Barderas, R; Villaba, M; Batanero, E; Pascual, CY; Rodriguez, R			Role of profilin and polcalcin in chenopod pollen allergy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter							ALBUM		Hosp Insfantil La Paz, Serv Alergia, Madrid, Spain		Barderas, R (corresponding author), Univ Complutense, Fac Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain.		RODRIGUEZ, ROSALIA/K-4993-2014; Barderas, Rodrigo/K-3560-2014	RODRIGUEZ, ROSALIA/0000-0002-4280-3691; Barderas, Rodrigo/0000-0003-3539-7469				Barderas R, 2002, INT ARCH ALLERGY IMM, V127, P47, DOI 10.1159/000048168; Batanero E, 1996, EUR J BIOCHEM, V241, P772, DOI 10.1111/j.1432-1033.1996.00772.x; EMBERLIN JC, 1997, ALLERGY ALLERGIC DIS, P852; Ledesma A, 1998, ALLERGY, V53, P520, DOI 10.1111/j.1398-9995.1998.tb04090.x; LOMBARDERO M, 1985, ANN ALLERGY, V54, P430; Lombardero M., 1991, ALLERGENIC POLLEN PO, P128; WURTZEN PA, 1995, ALLERGY, V50, P489, DOI 10.1111/j.1398-9995.1995.tb01184.x	7	14	15	0	2	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2003	111	5					1132	1133		10.1067/mai.2003.1445	http://dx.doi.org/10.1067/mai.2003.1445			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	679DA	12743583				2022-12-18	WOS:000182904500033
J	Matheu, V; Treschow, A; Navikas, V; Issazadeh-Navikas, S				Matheu, V; Treschow, A; Navikas, V; Issazadeh-Navikas, S			Upregulation of B7 molecules (CD80 and CD86) and exacerbated eosinophilic pulmonary inflammatory response in mice lacking the IFN-beta gene	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; cytokines; allergy; costimulation; inflammation	ANTIGEN-INDUCED EOSINOPHIL; INTERFERON-BETA; AIRWAY HYPERRESPONSIVENESS; IGE PRODUCTION; MURINE MODEL; ALPHA; GAMMA; RECEPTOR; CELLS; COSTIMULATION	Background: IFN-beta has been shown to be effective as therapy for multiple sclerosis. Some reports attributed its beneficial effects to the capacity to induce a T(H)2 response. However, other studies have suggested that endogenous type I IFN might downregulate the allergic response in mice. Objective: We sought to define the differential role of endogenous IFN-beta in controlling the development of allergic inflammation. Methods: We assessed whether deletion of the gene encoding IFN-beta (IFNB) with knockout mice participated in the development of allergic response in ovalbumin (OVA)-sensitized and OVA-challenged mice. Results: OVA-sensitized and OVA-challenged mice with lack of the IFNB gene had more severe pulmonary inflammation with increased lung local response, including IL-4, IL-5, IL-13, IgE eosinophilia, and goblet cells, than their litter mates (IFN-beta(+/-)), whereas no differences were observed in regard to local levels of IFN-gamma. Moreover, systemic response with IgE production is also enhanced. Lack of IFN-beta also results in significantly higher antigen-specific T cells, with higher levels of IL-4, IL-5, and IL-13, whereas no significant differences in IFN-gamma response could be observed. We have also detected a higher ratio of CD4(+)/CD8(+) T cells and increased expression of B7.1/B7.2 on B cells and antigen-presenting cells in IFNB knockout mice. Conclusions: These results demonstrate that IFN-beta plays an important role in inummoregulation of allergic response in mice. The stronger pulmonary inflammation could be a consequence of significantly expanded antigen-specific CD4(+) T(H)2 cells as a result of efficient antigen presentation by antigen-presenting cells and hence increased production of IgE by B cells. (J Allergy Clin Inummol 2003; 111: 550-7.).	Lund Univ, Inst Cell & Mol Biol, Sect Med Inflammat Res, S-22184 Lund, Sweden	Lund University	Issazadeh-Navikas, S (corresponding author), Lund Univ, Inst Cell & Mol Biol, Sect Med Inflammat Res, BMC 111, S-22184 Lund, Sweden.		Issazadeh-Navikas, Shohreh/AAI-7900-2021; Matheu, Victor/AAU-3043-2020	Matheu, Victor/0000-0002-0469-800X				Acaba L, 2000, Bol Asoc Med P R, V92, P59; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; BOGUNIEWICZ M, 1995, J ALLERGY CLIN IMMUN, V95, P133, DOI 10.1016/S0091-6749(95)70162-1; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Ceretelli S, 1998, ANN HEMATOL, V77, P161, DOI 10.1007/s002770050434; CRIMI E, 1983, ALLERGY, V38, P553, DOI 10.1111/j.1398-9995.1983.tb04139.x; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Dow SW, 1999, HUM GENE THER, V10, P1905, DOI 10.1089/10430349950017266; Erjefalt JS, 1997, CLIN EXP ALLERGY, V27, P1344; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; Hamelmann E, 1997, P NATL ACAD SCI USA, V94, P1350, DOI 10.1073/pnas.94.4.1350; Hofstra CL, 1998, AM J RESP CELL MOL, V19, P826, DOI 10.1165/ajrcmb.19.5.3027; Holt PG, 1999, NATURE, V402, pB12; Huang YM, 2001, CYTOKINE, V13, P264, DOI 10.1006/cyto.2000.0835; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; King CL, 1996, EUR J IMMUNOL, V26, P2448, DOI 10.1002/eji.1830261027; Knott PG, 2000, AM J RESP CRIT CARE, V161, P1340, DOI 10.1164/ajrccm.161.4.9906078; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Krinzman SJ, 1996, J CLIN INVEST, V98, P2693, DOI 10.1172/JCI119093; Lack G, 1996, J IMMUNOL, V157, P1432; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Maeda Y, 1997, PHARMACOLOGY, V55, P32, DOI 10.1159/000139510; Mark DA, 2000, AM J RESP CELL MOL, V22, P265, DOI 10.1165/ajrcmb.22.3.3747; Martin LB, 1996, INT ARCH ALLERGY IMM, V109, P207, DOI 10.1159/000237239; MATHEU V, 2001, ALLERGOL IMMUNOL CLI, V16, P282; Mathur M, 1999, AM J RESP CELL MOL, V21, P498, DOI 10.1165/ajrcmb.21.4.3714; Mujtaba MG, 1999, J ALLERGY CLIN IMMUN, V104, P1037, DOI 10.1016/S0091-6749(99)70086-2; NAKAJIMA H, 1994, J IMMUNOL, V153, P1264; Obase Y, 2001, ANN ALLERG ASTHMA IM, V86, P304, DOI 10.1016/S1081-1206(10)63303-0; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; Platanias LC, 1996, J BIOL CHEM, V271, P23630, DOI 10.1074/jbc.271.39.23630; Rani MRS, 1996, J BIOL CHEM, V271, P22878, DOI 10.1074/jbc.271.37.22878; ROSENBLUM MG, 1990, J INTERFERON RES, V10, P141, DOI 10.1089/jir.1990.10.141; Satoh Y, 1999, J INTERF CYTOK RES, V19, P887, DOI 10.1089/107999099313415; Schandene L, 1996, J CLIN INVEST, V97, P309, DOI 10.1172/JCI118417; Shen H, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-9; Takeda K, 2001, AM J PHYSIOL-LUNG C, V281, pL394, DOI 10.1152/ajplung.2001.281.2.L394; TEN RM, 1989, J EXP MED, V169, P1757, DOI 10.1084/jem.169.5.1757; Tsuyuki S, 1997, J EXP MED, V185, P1671, DOI 10.1084/jem.185.9.1671; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Zhang Y, 1997, AM J RESP CRIT CARE, V155, P661, DOI 10.1164/ajrccm.155.2.9032210; Zuberi RI, 2000, J IMMUNOL, V164, P2667, DOI 10.4049/jimmunol.164.5.2667	49	14	14	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2003	111	3					550	557		10.1067/mai.2003.112	http://dx.doi.org/10.1067/mai.2003.112			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	656YW	12642836	Bronze			2022-12-18	WOS:000181639500017
J	Eddleston, J; Christiansen, SC; Jenkins, GR; Koziol, JA; Zuraw, BL				Eddleston, J; Christiansen, SC; Jenkins, GR; Koziol, JA; Zuraw, BL			Bradykinin increases the in vivo expression of the CXC chemokine receptors CXCR1 and CXCR2 in patients with allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bradykinin; IL-8; allergic; rhinitis; CXCR1; CXCR2	INTERLEUKIN-8 GENE-EXPRESSION; BRONCHIAL EPITHELIAL-CELLS; AUTOCRINE REGULATION; ASTHMATIC SUBJECTS; TISSUE KALLIKREIN; NEUTROPHIL; CHALLENGE; CHEMOATTRACTANT; ANTIGEN; EOTAXIN	Background: Increased levels of bradykinin and IL-8 have been detected within the airways of individuals with active symptoms of allergic rhinitis and asthma. Objective: We sought to investigate the in vivo effect of bradykinin on the expression of the IL-8 receptors CXCR1 and CXCR2 in nasal cells. Methods: Nasal samples were obtained from patients with active allergic rhinitis; patients with mild, quiescent allergic rhinitis; and healthy control subjects. CXCR1 and CXCR2 mRNA expression in the nasal cells was measured by means of quantitative real-time RT-PCR in baseline samples from all subjects, as well as in samples obtained after in vivo bradykinin challenge in healthy control subjects and patients with mild allergic rhinitis. CXCR1 and CXCR2 cell-surface expression was also assessed by means of flow cytometry in nasal epithelial cells at baseline and after ex vivo bradykinin challenge. Results: No difference was seen in CXCR1 or CXCR2 mRNA expression between healthy control subjects and patients with quiescent allergic rhinitis at baseline; however, patients with active allergic rhinitis had increased baseline expression of both CXCR1 and CXCR2 mRNA. In vivo nasal bradykinin challenge significantly increased CXCR1 and CXCR2 mRNA expression in patients with quiescent allergic rhinitis but had no effect in healthy control subjects. Low levels of CXCR1 but not CXCR2 cell-surface expression was detected in nasal epithelial cells at baseline, and ex vivo bradykinin challenge induced CXCR2 cell-surface expression in nasal epithelial cells from patients with mild allergic rhinitis. Conclusion: This study demonstrates the in vivo regulation of chemokine receptors by means of bradykinin in human airway tissue in patients with allergic rhinitis.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Eddleston, J (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Zuraw, Bruce/0000-0003-0640-6768	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061003] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL61003] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BECKER S, 1993, AM J RESP CELL MOL, V8, P20, DOI 10.1165/ajrcmb/8.1.20; BECKER S, 1994, AM J PHYSIOL, V266, P278; Browning DD, 2000, AM J PHYSIOL-LUNG C, V279, pL1129, DOI 10.1152/ajplung.2000.279.6.L1129; CHRISTIANSEN SC, 1992, AM REV RESPIR DIS, V145, P900, DOI 10.1164/ajrccm/145.4_Pt_1.900; CHRISTIANSEN SC, 1987, J CLIN INVEST, V79, P188, DOI 10.1172/JCI112782; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; DOUGLASS JA, 1994, AM J RESP CRIT CARE, V150, P1108, DOI 10.1164/ajrccm.150.4.7921444; FULLER RW, 1987, AM REV RESPIR DIS, V135, P176; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; John M, 1998, AM J RESP CELL MOL, V18, P84, DOI 10.1165/ajrcmb.18.1.2813; Koyama S, 1998, AM J PATHOL, V153, P1885, DOI 10.1016/S0002-9440(10)65702-1; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Lukacs NW, 1998, J LEUKOCYTE BIOL, V63, P746, DOI 10.1002/jlb.63.6.746; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; NAKAMURA H, 1991, J BIOL CHEM, V266, P19611; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; PROUD D, 1983, J CLIN INVEST, V72, P1678, DOI 10.1172/JCI111127; PROUD D, 1988, AM REV RESPIR DIS, V137, P613, DOI 10.1164/ajrccm/137.3.613; Saito H, 2000, INT ARCH ALLERGY IMM, V122, P50, DOI 10.1159/000053633; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Stellato C, 2001, J IMMUNOL, V166, P1457, DOI 10.4049/jimmunol.166.3.1457; SVENSSON C, 1990, J ALLERGY CLIN IMMUN, V85, P828, DOI 10.1016/0091-6749(90)90064-B; Turner P, 2001, J ALLERGY CLIN IMMUN, V107, P105, DOI 10.1067/mai.2001.111145; Ying S, 1999, J IMMUNOL, V163, P6321; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; YOUSEFI S, 1995, J IMMUNOL, V154, P5481; Zlotnik A, 1999, CRIT REV IMMUNOL, V19, P1	31	14	16	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2003	111	1					106	112		10.1067/mai.2003.19	http://dx.doi.org/10.1067/mai.2003.19			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	636PR	12532104				2022-12-18	WOS:000180465500016
J	Sorkness, RL; Gern, JE; Grindle, KA; Mosser, AG; Rosenthal, LA; Mikus, LD; Lemanske, RF				Sorkness, RL; Gern, JE; Grindle, KA; Mosser, AG; Rosenthal, LA; Mikus, LD; Lemanske, RF			Persistence of viral RNA in 2 rat strains differing in susceptibility to postbronchiolitis airway dysfunction	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; parainfluenza virus	VIRUS; BRONCHIOLITIS	After viral bronchiolitis at an early age, a chronic asthma-like syndrome develops in BN, but not F344, rats. We hypothesized that the BN strain is less effective at clearing virus from the involved tissues. Weanling BN and F344 rats were inoculated with Sendai virus, and lung and peribronchial lymph nodes were harvested from each strain at 5 to 84 days after infection; control tissues were obtained from noninfected rats. Lung viral titers were similar for the 2 strains, with no infectious virus detectable by day 10. However, viral RNA was detected consistently by means of RT-PCR analyses in lungs and lymph nodes of both strains from days 10 to 27 and was still present at day 84 in some of the tissues from each strain. In contrast, there were strain-related differences in immune responses because IL-13 levels remained increased in the lung secretions of BN rats at 4 weeks after inoculation. Thus although Sendai virus could persist for at least 3 months after an acute infection in rats, this did not differ with strain. The persistent increase in IL-13 suggests instead that the strain-related variability in virus-associated airway pathology might be determined by the host response to infection rather than by the intensity or duration of infection.	Univ Wisconsin, Clin Sci Ctr 9988, Morris Inst Resp Res, Madison, WI 53792 USA; Univ Wisconsin, Sch Pharm, Dept Med, Madison, WI 53792 USA; Univ Wisconsin, Sch Pharm, Dept Pediat, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sorkness, RL (corresponding author), Univ Wisconsin, Clin Sci Ctr 9988, Morris Inst Resp Res, Room K4-948,600 Highland Ave, Madison, WI 53792 USA.		Rosenthal, Louis/A-8868-2008		NHLBI NIH HHS [HL 56396] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056396] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CASTLEMAN WL, 1987, AM J PATHOL, V129, P277; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Kumar A, 1997, AM J RESP CRIT CARE, V155, P130, DOI 10.1164/ajrccm.155.1.9001301; Mikus LD, 2001, AM J RESP CELL MOL, V24, P74, DOI 10.1165/ajrcmb.24.1.4125; MORI I, 1995, J GEN VIROL, V76, P1251, DOI 10.1099/0022-1317-76-5-1251; Sorkness RL, 1999, AM J RESP CRIT CARE, V160, P705, DOI 10.1164/ajrccm.160.2.9810002; TAYLOR K, 1994, LAB ANIM, V28, P31, DOI 10.1258/002367794781065861; TYLER KL, 2001, FIELDS VIROLOGY, P199; Uhl EW, 1996, AM J RESP CRIT CARE, V154, P1834, DOI 10.1164/ajrccm.154.6.8970378; Wennergren G, 2001, EUR RESPIR J, V18, P1044, DOI 10.1183/09031936.01.00254101	10	14	14	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	2002	110	4					607	609		10.1067/mai.2002.128241	http://dx.doi.org/10.1067/mai.2002.128241			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	602JJ	12373269				2022-12-18	WOS:000178501900011
J	Swanson, MC; Ramalingam, M				Swanson, MC; Ramalingam, M			Starch and natural rubber allergen interaction in the production of latex gloves: A hand-held aerosol	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on Natural Rubber Latex Sensitivity	FEB 09-10, 2001	SAN FRANCISCO, CA	Malaysian Rubber Res Inst		starch; natural rubber allergen; latex; gloves	QUANTIFICATION; AEROALLERGEN	Starch powders continue to be used as donning agents on natural rubber (NR) gloves. NR aeroallergens are an important aspect of human sensitivity to latex. Asthma, upper airway, and ocular symptoms are associated with these airborne proteins. These bioaerosols feature starch as the carrier. The association of NR allergen and starch is demonstrated in NR glove manufacturing, in laboratory simulation, and as occupational aeroallergens in health care environments. Four aspects of latex allergen affinity for starch powders were examined by using a competitive IgE immunoassay for NR latex. Allergen content was assessed in finished gloves before and after powder process points and related to the allergen content of the raw latex source material. In another manufacturing process, allergen uptake by two different starch powders was quantified. NR allergen affinity for the starches was also determined under laboratory conditions. Finally, NR aeroallergens carried by starch powder in production facilities were measured. This article outlines the sources, mechanisms, and conditions for NR allergens to interact with two different starches. The quantitative airborne allergen data are used to compare and contrast various occupational indices of NR allergen exposure. Powdered NR gloves continue to cause concern; however, the technology used for contemporary glove powder applications may be advanced and improved enough to consistently produce powdered gloves with a low allergen content.	Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Contract Latex Dippers Sdn Bhd, Kuala Lumpur, Malaysia	Mayo Clinic	Swanson, MC (corresponding author), Mayo Clin & Mayo Fdn, Dept Immunol, 407 Guggenheim Bldg, Rochester, MN 55905 USA.	swansonm@mayo.edu						[Anonymous], 1999, FED REG, V64; Charous BL, 2000, ANN ALLERG ASTHMA IM, V85, P285, DOI 10.1016/S1081-1206(10)62531-8; Fitt LE, 1995, US Patent, Patent No. [5 385 608, 5385608]; REED CE, 1999, ASTHMA WORKPLACE, P235; Swanson M, 2000, J ALLERGY CLIN IMMUN, V105, pS55, DOI 10.1016/S0091-6749(00)90597-9; Swanson M, 2001, ANN ALLERG ASTHMA IM, V87, P307, DOI 10.1016/S1081-1206(10)62245-4; SWANSON MC, 1994, J ALLERGY CLIN IMMUN, V94, P445, DOI 10.1016/0091-6749(94)90199-6; Swanson MC, 1996, NATO ASI 2, V11, P257; Swanson MC, 1999, J ALLERGY CLIN IMMUN, V103, pS160; SWANSON MC, 1999, P 8 INT C IND AIR QU, V1, P290; TARLO SM, 1994, J ALLERGY CLIN IMMUN, V93, P985, DOI 10.1016/S0091-6749(94)70045-1; TRUSCOTT W, 1995, IMMUNOL ALLERGY CLIN, V15, P89; *USP, NF 17 MON ABS DUST P; WHISTLER RL, 1985, FOOD CHEM, P112	14	14	14	1	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2		S			S15	S20		10.1067/mai.2002.125338	http://dx.doi.org/10.1067/mai.2002.125338			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Allergy; Immunology	586ET	12170238				2022-12-18	WOS:000177572200003
J	Vianna, EO; Boaventura, LC; Terra-Filho, J; Nakama, GY; Martinez, JAB; Martin, RJ				Vianna, EO; Boaventura, LC; Terra-Filho, J; Nakama, GY; Martinez, JAB; Martin, RJ			Morning-to-evening variation in exercise-induced bronchospasm	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; exercise-induced asthma; bronchial hyperreactivity; airivay obstruction; circadian rhythm; pulmonaly ventilation	BRONCHIAL RESPONSIVENESS; INDUCED ASTHMA; CIRCADIAN VARIATION; INHALED STEROIDS; DRUG EFFICACY; CHILDREN; CHRONOTHERAPY; INFLAMMATION; CHALLENGE; ALLERGEN	Background: Exercise is one of the most common triggers of asthmatic symptoms. Many factors, including hyperventilation, determine the prevalence and severity of exercise-induced bronchospasm (EIB). However, the influence of time of day has not been adequately described. Objective: We sought to compare morning and evening EIB and minute ventilation during exercise (VE). Methods: Twenty-two patients with stable asthma and 12 control subjects underwent exercise challenge at 7 Am and 6 Pm. The time of the first challenge was randomly assigned; the second challenge was performed within 1 week of the first. The primary outcomes were EIB intensity (maximum fall in FEV1) and VE. Results: The asthma group exhibited lower EIB values in the morning: 14.8% +/- 3.7% at 7 AM vs 21.4% +/- 4.2% at 6 PM (P = .004)-ie, 0.37 +/- 0.09 L vs 0.53 +/- 0.10 L, respectively (P = .002). VE was higher at 7 AM (55.4 +/- 4.7 L/min) than at 6 Pm (52.4 +/- 4.3 L/min; P = .03). Baseline FEV1 increased from 2.33 +/- 0.13 L (morning) to 2.49 +/- 0.15 L (evening; P = .04), and a significant correlation between baseline FEV1 and EIB was found in the evening (r = +0.5; P = .049) but not in the morning. Post-exercise FEV1 was similar at 7 AM (1.96 +/- 0.13 L) and 6 PM (1.97 +/- 0.14 L). For the control group, no changes were detected in FEV1 fall or VE. Conclusion: Baseline airway caliber contributes to the mechanisms of the morning-to-evening EIB enhancement.	Univ Sao Paulo, Sch Med, Div Pulm, Dept Med, BR-14048900 Ribeirao Preto, SP, Brazil; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO USA	Universidade de Sao Paulo; National Jewish Health	Vianna, EO (corresponding author), Univ Sao Paulo, Sch Med, Div Pulm, Dept Med, Av Bandeirantes,3900, BR-14048900 Ribeirao Preto, SP, Brazil.		Baddini-Martinez, Jose/E-3098-2012; Vianna, Elcio/I-2508-2016	Baddini-Martinez, Jose/0000-0001-8160-5084; Vianna, Elcio/0000-0003-1902-6326				*ACCP ATS JOINT CO, 1975, CHEST, V67, P583; Anderson SD, 2000, J ALLERGY CLIN IMMUN, V106, P453, DOI 10.1067/mai.2000.109822; BAROR O, 1977, J ALLERGY CLIN IMMUN, V60, P163, DOI 10.1016/0091-6749(77)90119-1; BONNET R, 1991, J APPL PHYSIOL, V71, P1598, DOI 10.1152/jappl.1991.71.4.1598; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; BUNDGAARD A, 1983, EUR J RESPIR DIS, V64, P424; Cabral ALB, 1999, AM J RESP CRIT CARE, V159, P1819, DOI 10.1164/ajrccm.159.6.9805093; Cochran WG., 1989, AMES IOWA STATE U PR, V8; CROPP GJA, 1979, J ALLERGY CLIN IMMUN, V64, P627, DOI 10.1016/0091-6749(79)90026-5; EGGLESTON PA, 1979, J ALLERGY CLIN IMMUN, V64, P642, DOI 10.1016/0091-6749(79)90028-9; EGGLESTON PA, 1976, J ALLERGY CLIN IMMUN, V58, P414, DOI 10.1016/0091-6749(76)90122-6; Jarjour NN, 1999, CHRONOBIOL INT, V16, P631, DOI 10.3109/07420529908998732; JOHNSON JD, 1979, J ALLERGY CLIN IMMUN, V64, P634, DOI 10.1016/0091-6749(79)90027-7; KONDO S, 1991, CHEST, V100, P640, DOI 10.1378/chest.100.3.640; MAHLER DA, 1991, AM REV RESPIR DIS, V144, P39, DOI 10.1164/ajrccm/144.1.39; MARTIN RJ, 1991, AM REV RESPIR DIS, V143, P351, DOI 10.1164/ajrccm/143.2.351; MARTIN RJ, 1990, AM REV RESPIR DIS, V141, P33, DOI 10.1164/ajrccm/141.1.33; Martin RJ, 1999, CHRONOBIOL INT, V16, P623, DOI 10.3109/07420529908998731; MCFADDEN ER, 1994, NEW ENGL J MED, V330, P1362, DOI 10.1056/NEJM199405123301907; MUSSAFFI H, 1986, J ALLERGY CLIN IMMUN, V77, P48, DOI 10.1016/0091-6749(86)90321-0; Pincus DJ, 1997, J ALLERGY CLIN IMMUN, V100, P771, DOI 10.1016/S0091-6749(97)70272-0; PINCUS DJ, 1995, J ALLERGY CLIN IMMUN, V95, P1172, DOI 10.1016/S0091-6749(95)70073-0; SLY PD, 1986, PEDIATR PULM, V2, P344, DOI 10.1002/ppul.1950020606; VANAALDEREN WMC, 1989, THORAX, V44, P803, DOI 10.1136/thx.44.10.803; Villaran C, 1999, J ALLERGY CLIN IMMUN, V104, P547, DOI 10.1016/S0091-6749(99)70322-2	25	14	16	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2002	110	2					236	240	UNSP 1/81/125981	10.1067/mai.2002.125981	http://dx.doi.org/10.1067/mai.2002.125981			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	585DY	12170263				2022-12-18	WOS:000177509800007
J	Wood, RA				Wood, RA			Food manufacturing and the consumer: Accidents waiting allergic to happen	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ANAPHYLAXIS; INGESTION		Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Wood, RA (corresponding author), Johns Hopkins Univ Hosp, CMSC 1102,600 N Wolfe St, Baltimore, MD 21287 USA.							*FOOD SAF APPL NUT, 2002, FOOD ALL PARTN; GERN JE, 1991, NEW ENGL J MED, V324, P976, DOI 10.1056/NEJM199104043241407; HAMBURGER RN, 1992, ANN ALLERGY, V68, P200; JONES RT, 1992, ANN ALLERGY, V68, P223; Joshi P, 2002, J ALLERGY CLIN IMMUN, V109, P1019, DOI 10.1067/mai.2002.123305; Kemp SF, 1996, JAMA-J AM MED ASSOC, V275, P1636, DOI 10.1001/jama.275.21.1636; McKenna C, 1997, ANN ALLERG ASTHMA IM, V79, P234, DOI 10.1016/S1081-1206(10)63008-6; Vierk K, 2002, J ALLERGY CLIN IMMUN, V109, P1022, DOI 10.1067/mai.2002.124500	8	14	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	2002	109	6					920	922		10.1067/mai.2002.124889	http://dx.doi.org/10.1067/mai.2002.124889			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	566RU	12063518				2022-12-18	WOS:000176442700004
J	Allen, BR				Allen, BR			Tacrolimus ointment: Its place in the therapy of atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material							ADULT PATIENTS; EFFICACY; SAFETY; FK-506		Univ Nottingham Hosp, Nottingham NG7 2UH, England	University of Nottingham	Allen, BR (corresponding author), Univ Nottingham Hosp, B Floor,South Block,Derby Rd, Nottingham NG7 2UH, England.							Bekersky I, 2001, J AM ACAD DERMATOL, V44, pS17, DOI 10.1067/mjd.2001.109816; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; Finlay AY, 2001, J AM ACAD DERMATOL, V45, pS64, DOI 10.1067/mjd.2001.117010; *FUJ HEALTHC INC, 2000, 50777 NDA FUJ HEALTH; Fukaya M, 2000, DERMATOLOGY, V201, P242, DOI 10.1159/000018495; GOTO T, 1991, TRANSPL P, V23, P2713; Hanifin JM, 2001, J AM ACAD DERMATOL, V44, pS28, DOI 10.1067/mjd.2001.109810; Hughes J, 1997, CLIN DERMATOL, V15, P715, DOI 10.1016/S0738-081X(97)00020-5; Kang S, 2001, J AM ACAD DERMATOL, V44, pS58, DOI 10.1067/mjd.2001.109812; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Krupnick A, 2001, J INVEST DERMATOL, V117, P533; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; NAKAGAWA H, 1994, LANCET, V344, P883, DOI 10.1016/S0140-6736(94)92855-X; Paller A, 2001, J AM ACAD DERMATOL, V44, pS47, DOI 10.1067/mjd.2001.109813; Reitamo S, 2000, ARCH DERMATOL, V136, P999, DOI 10.1001/archderm.136.8.999; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P547, DOI 10.1067/mai.2002.121832; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P539, DOI 10.1067/mai.2002.121831; Remitz A, 2001, J ALLERGY CLIN IMMUN, V107, P196, DOI 10.1067/mai.2001.112131; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; Soter NA, 2001, J AM ACAD DERMATOL, V44, pS39, DOI 10.1067/mjd.2001.109817; SULZBERGER MB, 1952, J INVEST DERMATOL, V19, P101, DOI 10.1038/jid.1952.72; Williams HC, 2000, CLIN EXP DERMATOL, V25, P522, DOI 10.1046/j.1365-2230.2000.00698.x; 2001, BRIT NATL FORMULARY, P535	23	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2002	109	3					401	403		10.1067/mai.2002.122637	http://dx.doi.org/10.1067/mai.2002.122637			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	534KW	11897982				2022-12-18	WOS:000174586400003
J	Szczeklik, A; Nizankowska, E; Mastalerz, L; Bochenek, G				Szczeklik, A; Nizankowska, E; Mastalerz, L; Bochenek, G			Myocardial ischemia possibly mediated by cysteinyl leukotrienes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Jagiellonian Univ, Sch Med, Dept Med, PL-31066 Krakow, Poland	Jagiellonian University	Szczeklik, A (corresponding author), Jagiellonian Univ, Sch Med, Dept Med, Ul Skawinska 8, PL-31066 Krakow, Poland.		Mastalerz, Lucyna/U-5974-2018	Mastalerz, Lucyna/0000-0002-8994-0036				Allen S, 1998, CIRCULATION, V97, P2406, DOI 10.1161/01.CIR.97.24.2406; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; FOLCO G, 1999, NOVEL INHIBITORS LEU, P205; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Sala A, 1996, BLOOD, V87, P1824; Sampson A. P., 2001, Clinical and Experimental Allergy Reviews, V1, P170, DOI 10.1046/j.1472-9725.2001.00034.x; Szczeklik A, 1999, J ALLERGY CLIN IMMUN, V104, P5, DOI 10.1016/S0091-6749(99)70106-5; Vigorito C, 1997, INT J CLIN LAB RES, V27, P178, DOI 10.1007/BF02912454	8	14	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	2002	109	3					572	573		10.1067/mai.2002.121700	http://dx.doi.org/10.1067/mai.2002.121700			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	534KW	11898009	Bronze, Green Submitted			2022-12-18	WOS:000174586400029
J	Vigano, A; Pinti, M; Nasi, M; Moretti, L; Balli, F; Mussini, C; Bricalli, D; Sala, N; Bugarini, R; Vella, S; Principi, N; Cossarizza, A				Vigano, A; Pinti, M; Nasi, M; Moretti, L; Balli, F; Mussini, C; Bricalli, D; Sala, N; Bugarini, R; Vella, S; Principi, N; Cossarizza, A			Markers of cell death-activation in lymphocytes of vertically HIV-infected children naive to highly active antiretroviral therapy: The role of age	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						HIV apoptosis; mitochondria; CD95; CD95L; pediatric AIDS	CD8(+) T-CELLS; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; HIV-1-INFECTED CHILDREN; SHORTENED TELOMERES; THYMUS VOLUME; APOPTOSIS; IMMUNODEFICIENCY; EXPRESSION; EXPANSION	Background: Apoptosis plays a major role in depicting CD4(+) lymphocytes during infection with HIV-1. Few data exist on its role during HIV infection of children. Sensitivity of peripheral blood lymphocytes (PBLs) to apoptotic stimuli and the importance of the patient's age remain unclear. Objectives: We sought to analyze the following: (1) markers of cell death-activation (CD95, CD45 isciforms, and CD28) in PBLs from vertically HIV-infected children of different ages before highly active antiretroviral therapy; (2) changes in other PBL populations; (3) PBL sensitivity to cell death and mitochondrial damages; and (4) role of age during progression of infection. Methods: Cell culture techniques and flow cytometry were used to analyze surface antigens, PBL susceptibility to apoptosis, or PBL susceptibility to change of mitochondrial membrane potential. Results: Donor age had a strong negative correlation with numbers of CD4+ and CD8(+) T cells. Virgin T lymphocyte (CD45RA(+), CD95(-)) levels and those of CD95(+) cells showed no correlation with the children's clinical status but did show a correlation with patient age. CD28(-) T lymphocytes were markedly augmented in HIV-infected children but were unrelated to stage of infection or age. A relevant decrease in B lymphocytes and an increase in natural killer cells were also found. Finally, PBLs from HIV-positive children had a marked tendency to undergo apoptosis and mitochondrial damage. Conclusion: Changes in PBL phenotype, increased expression of CD95, and high sensitivity to apoptosis suggest that a precocious aging of the immune system occurs in HIV-infected children.	Univ Modena & Reggio Emilia, Sch Med, Sect Gen Pathol, Dept Biomed Sci, I-41100 Modena, Italy; Univ Modena & Reggio Emilia, Sch Med, Dept Pediat, I-41100 Modena, Italy; Univ Milan, Sch Med, Dept Pediat 4, Milan, Italy; Azienda Policlin, Infect Dis Clin, Modena, Italy; Ist Super Sanita, Epidemiol & Biostat Lab, I-00161 Rome, Italy; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; University of Milan; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Sch Med, Sect Gen Pathol, Dept Biomed Sci, Via Campi 287, I-41100 Modena, Italy.		VELLA, STEFANO/ABI-3368-2020; Pinti, Marcello/C-9351-2015; Nasi, Milena/J-4425-2016; Mussini, Cristina/K-8672-2016; VELLA, STEFANO/V-8440-2019; Vella, Stefano/GZM-0519-2022	Pinti, Marcello/0000-0001-9118-1262; Nasi, Milena/0000-0003-3079-8001; Mussini, Cristina/0000-0002-6615-4198; VELLA, STEFANO/0000-0003-2347-5984; Cossarizza, Andrea/0000-0002-5381-1558				[Anonymous], 1994, MMWR Recomm Rep, V43, P1; AZUMA M, 1993, J IMMUNOL, V150, P1147; BARBIERI D, 1994, BIOCHEM BIOPH RES CO, V201, P1109, DOI 10.1006/bbrc.1994.1820; Baumler CB, 1996, BLOOD, V88, P1741; Bohler T, 1999, AIDS, V13, P779, DOI 10.1097/00002030-199905070-00006; Brugnoni D, 1997, CLIN EXP IMMUNOL, V109, P412, DOI 10.1046/j.1365-2249.1997.4871386.x; Caruso A, 1998, J CLIN INVEST, V101, P137, DOI 10.1172/JCI195; CORY S, 1994, NATURE, V367, P317, DOI 10.1038/367317a0; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; COSSARIZZA A, 1994, EXP CELL RES, V214, P323, DOI 10.1006/excr.1994.1264; Cossarizza A, 1999, EXP CELL RES, V247, P304, DOI 10.1006/excr.1999.4387; Cossarizza A, 1997, AIDS, V11, P19, DOI 10.1097/00002030-199701000-00004; COSSARIZZA A, 1991, BLOOD, V77, P1263; Cossarizza A, 2000, AIDS, V14, P345, DOI 10.1097/00002030-200003100-00007; Cossarizza A, 1993, BIOCHEM BIOPH RES CO, P197; Dalod M, 1996, AIDS RES HUM RETROV, V12, P497, DOI 10.1089/aid.1996.12.497; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Fiorentino S, 1996, J VIROL, V70, P2022, DOI 10.1128/JVI.70.3.2022-2026.1996; Franceschi C, 1997, CELL DEATH DIFFER, V4, P815, DOI 10.1038/sj.cdd.4400305; Gibb DM, 2000, LANCET, V355, P1331, DOI 10.1016/S0140-6736(00)02117-6; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; McCloskey TW, 1998, CLIN IMMUNOL IMMUNOP, V87, P33, DOI 10.1006/clin.1997.4496; McCloskey TW, 1998, BLOOD, V92, P4230, DOI 10.1182/blood.V92.11.4230.423k22_4230_4237; MIYAWAKI T, 1992, J IMMUNOL, V149, P3753; Monteiro J, 1996, J IMMUNOL, V156, P3587; Mugnaini EN, 1999, AIDS RES HUM RETROV, V15, P265, DOI 10.1089/088922299311448; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Niehues T, 1998, PEDIATR RES, V44, P265, DOI 10.1203/00006450-199808000-00021; Niehues T, 2000, PEDIATR RES, V47, P418, DOI 10.1203/00006450-200003000-00022; Nociari MM, 1999, J IMMUNOL, V162, P3327; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; SANSONI P, 1993, BLOOD, V82, P2767; Stricker K, 1998, CELL DEATH DIFFER, V5, P222, DOI 10.1038/sj.cdd.4400332; VANKERCKHOVE C, 1992, J EXP MED, V175, P57, DOI 10.1084/jem.175.1.57; Vigano' A, 1999, AIDS, V13, pF29, DOI 10.1097/00002030-199904010-00001; Vigano A, 2000, AIDS, V14, P251, DOI 10.1097/00002030-200002180-00007; VINGERHOETS JH, 1995, CLIN EXP IMMUNOL, V100, P425; Wack A, 1998, INT IMMUNOL, V10, P1281, DOI 10.1093/intimm/10.9.1281	39	14	14	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	2001	108	3					439	445		10.1067/mai.2001.117791	http://dx.doi.org/10.1067/mai.2001.117791			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	476FK	11544465				2022-12-18	WOS:000171215400017
J	Golden, DBK				Golden, DBK			Fatal insect allergy after discontinuation of venom immunotherapy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Letter									Johns Hopkins Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Golden, DBK (corresponding author), Johns Hopkins Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.							Elberink JNGO, 1997, J ALLERGY CLIN IMMUN, V99, P153, DOI 10.1016/S0091-6749(97)70314-2; Golden DBK, 1998, J ALLERGY CLIN IMMUN, V101, P298, DOI 10.1016/S0091-6749(98)70239-8; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; Portnoy J M, 1999, J Allergy Clin Immunol, V103, P963, DOI 10.1016/S0091-6749(99)70450-1; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936	5	14	14	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2001	107	5					925	926		10.1067/mai.2001.115095	http://dx.doi.org/10.1067/mai.2001.115095			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	434JX	11344366				2022-12-18	WOS:000168812300027
J	Vachier, I; Chavis, C; Majori, M; Farce, M; Bousquet, J; Godard, P; Chanez, P				Vachier, I; Chavis, C; Majori, M; Farce, M; Bousquet, J; Godard, P; Chanez, P			Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						lipoxins; leukotriene B-4; 5-lipoxygenase; glucocorticoids; polymorphonuclear cells; asthma	HUMAN NEUTROPHILS; ARACHIDONIC-ACID; LEUKOTRIENES; 5-LIPOXYGENASE; LEUKOCYTES; LIPOXINS; TRANSLOCATION; BIOSYNTHESIS; INHIBITION; EXPRESSION	Background: Human blood polymorphonuclear cells, which biosynthesize eicosanoids from the 5-lipoxygenase (5-LO) pathway, are Likely to be involved in asthma, in which glucocorticoids represent the first line of therapy. Their effects on leukotriene release after a short course of treatment, which have been reported in several studies, are controversial. Objective: We sought to investigate whether long-term oral glucocorticoids inhibit Lipid mediators from the 5-LO pathway. Methods: Twelve normal control subjects, 29 asthmatic subjects, and 50 glucocorticoid-dependent asthmatic subjects were included in the study. Polymorphonuclear cells were studied for endogenous and transcellular metabolism of eicosanoids, Results: Total leukotriene Bq production was significantly lower in cells from glucocorticioid-dependent asthmatic subjects (mean +/- SD, 177 +/- 26 ng/10(7) cells) than in control subjects (406 +/- 27), untreated asthmatic subjects (421 +/- 34), and asthmatic subjects treated with inhaled glucocorticoids (290 +/- 56), When incubated with arachidonic acid, these polymorphonuclear cells released very low amounts of 5(S)- and 12(S)hydroxy-eicosatetraenoic acid (HETE), whereas endogenous 15(S)-HETE was found in substantial amounts. The transformation of exogenous 15(S)-HETE into 5(S),15(S)-diHETE and lipoxins was significantly more important in untreated asthmatic subjects than in control subjects and glucocorticoid-dependent asthmatic subjects. Conclusion: This study showed that long-term oral corticotherapy affects the 5-LO activity and leads to a decrease production of all metabolites in contrast to short-term or inhaled glucocorticoids. This study also questions the site of action of glucocorticoids in regulating the availability of arachidonic acid and potential eicosanoid regulation, as previously held in phospholipase A2 studies.	CHU Montpellier, Hop Arnaud Villeneuve, INSERM U454, Clin Malad Resp, F-34295 Montpellier 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Chanez, P (corresponding author), CHU Montpellier, Hop Arnaud Villeneuve, INSERM U454, Clin Malad Resp, 371 Av Doyen Gaston Giraud, F-34295 Montpellier 5, France.		Vachier, Isabelle/AAV-5731-2020; Bousquet, Jean/O-4221-2019	Vachier, Isabelle/0000-0003-2730-5165; Majori, Maria/0000-0001-7453-7247; chanez, pascal/0000-0003-4059-0917				[Anonymous], 1987, AM REV RESPIR DIS, V136, P225; BARNES PJ, 1993, ANNU REV MED, V44, P229, DOI 10.1146/annurev.me.44.020193.001305; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P2148, DOI 10.1073/pnas.76.5.2148; BORGEAT P, 1989, CAN J PHYSIOL PHARM, V67, P936, DOI 10.1139/y89-147; CHANEZ P, 1996, AM J RESP CRIT CARE, V153, P212; CHAVIS C, 1995, BIOCHEM BIOPH RES CO, V207, P273, DOI 10.1006/bbrc.1995.1183; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; CHAVIS C, 1992, EICOSANOIDS, V5, P203; CYPCAR D, 1993, J ALLERGY CLIN IMMUN, V92, P362, DOI 10.1016/0091-6749(93)90114-U; FOGH K, 1992, AGENTS ACTIONS, V35, P227, DOI 10.1007/BF01997504; FREELAND HS, 1989, J ALLERGY CLIN IMMUN, V83, P634, DOI 10.1016/0091-6749(89)90076-6; GADALETA D, 1994, J AM COLL SURGEONS, V178, P309; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; GERRITSEN ME, 1991, BIOCHIM BIOPHYS ACTA, V1065, P63, DOI 10.1016/0005-2736(91)90011-V; HAINES KA, 1986, BIOCHEM J, V233, P583, DOI 10.1042/bj2330583; HENDERSON WR, 1994, ANN INTERN MED, V121, P684, DOI 10.7326/0003-4819-121-9-199411010-00010; Holgate ST, 1999, AM J RESP CRIT CARE, V159, pA700; Hood PP, 1999, THORAX, V54, P1075, DOI 10.1136/thx.54.12.1075; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Kerkhoff C, 1997, BIOCHEM BIOPH RES CO, V237, P632, DOI 10.1006/bbrc.1997.7201; KONIG W, 1990, EICOSANOIDS, V3, P1; Majori M, 1998, EUR RESPIR J, V11, P133, DOI 10.1183/09031936.98.11010133; Nelson D H, 1980, Endocr Rev, V1, P180; NEVALAINEN TJ, 1993, CLIN CHEM, V39, P2453; PAGGIARO PL, 1995, MEDIAT INFLAMM, V4, P251, DOI 10.1155/S0962935195000408; RADEAU T, 1992, INT ARCH ALLERGY IMM, V97, P209, DOI 10.1159/000236121; ROBERTS RL, 1985, BLOOD, V65, P433; ROBINSON C, 1990, ADV PROSTAG THROMB L, V20, P209; SAMPSON AP, 1992, BRIT J CLIN PHARMACO, V33, P423, DOI 10.1111/j.1365-2125.1992.tb04062.x; Sanak M, 2000, EUR RESPIR J, V16, P44, DOI 10.1034/j.1399-3003.2000.16a08.x; Sano A, 1999, AM J RESP CRIT CARE, V159, P1903, DOI 10.1164/ajrccm.159.6.9810005; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS43, DOI 10.1007/BF01844203; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; SEBALDT RJ, 1990, P NATL ACAD SCI USA, V87, P6974, DOI 10.1073/pnas.87.18.6974; SERHAN C, 1994, LIPOXIN BIOSYNTHESIS; SHINDO K, 1994, CHEST, V105, P1038, DOI 10.1378/chest.105.4.1038; SHIRATSUKI N, 1990, PROSTAG LEUKOTR ESS, V40, P285, DOI 10.1016/0952-3278(90)90051-L; SORENSON DK, 1988, J STEROID BIOCHEM, V29, P271, DOI 10.1016/0022-4731(88)90276-2; THOMAS E, 1995, BIOCHEM PHARMACOL, V49, P243, DOI 10.1016/S0006-2952(94)00403-X; Uz T, 1999, J NEUROCHEM, V73, P693, DOI 10.1046/j.1471-4159.1999.0730693.x; Vachier I, 1998, LUNG BIOL HEALTH DIS, V114, P507; Vachier I, 1998, AM J RESP CRIT CARE, V158, P963, DOI 10.1164/ajrccm.158.3.9710085; VANDERHOEK JY, 1988, ANN NY ACAD SCI, V524, P240, DOI 10.1111/j.1749-6632.1988.tb38547.x; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046	44	14	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	2001	107	5					824	831		10.1067/mai.2001.113868	http://dx.doi.org/10.1067/mai.2001.113868			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	434JX	11344349				2022-12-18	WOS:000168812300010
J	Beasley, R; Burgess, C; Holt, S				Beasley, R; Burgess, C; Holt, S			Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Editorial Material						benzalkonium chloride; asthma; paradoxical bronchoconstriction; nebulizer solutions	IPRATROPIUM BROMIDE; PRESERVATIVES; RELEASE; RISKS		Wellington Sch Med, Dept Med, Wellington, New Zealand	University of Otago	Beasley, R (corresponding author), Wellington Sch Med, Dept Med, POB 7343, Wellington, New Zealand.		Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X				Asmus MJ, 1999, J ALLERGY CLIN IMMUN, V104, pS53, DOI 10.1016/S0091-6749(99)70274-5; Asmus MJ, 2001, J ALLERGY CLIN IMMUN, V107, P68, DOI 10.1067/mai.2001.111591; BEASLEY CRW, 1987, BRIT MED J, V294, P1197, DOI 10.1136/bmj.294.6581.1197-a; Beasley R, 1998, PHARMACOTHERAPY, V18, P130; Beasley R, 1999, PHARMACOTHERAPY, V19, P473, DOI 10.1592/phco.19.6.473.31043; BOUCHER M, 1992, ANN PHARMACOTHER, V26, P772, DOI 10.1177/106002809202600604; COLEMAN JW, 1981, BIOCHEM J, V198, P615, DOI 10.1042/bj1980615; KWONG T, 1990, NEW ZEAL MED J, V103, P457; MENENDEZ R, 1989, J ALLERGY CLIN IMMUN, V84, P272, DOI 10.1016/0091-6749(89)90336-9; MISZKIEL KA, 1988, BRIT J CLIN PHARMACO, V26, P295, DOI 10.1111/j.1365-2125.1988.tb05280.x; MISZKIEL KA, 1988, BRIT J CLIN PHARMACO, V25, P157, DOI 10.1111/j.1365-2125.1988.tb03286.x; RAFFERTY P, 1988, THORAX, V43, P446, DOI 10.1136/thx.43.6.446; READ GW, 1979, J PHARMACOL EXP THER, V211, P711; ZHANG YG, 1990, AM REV RESPIR DIS, V141, P1405, DOI 10.1164/ajrccm/141.6.1405	14	14	15	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2001	107	2					222	223		10.1067/mai.2001.112941	http://dx.doi.org/10.1067/mai.2001.112941			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	403YV	11174185				2022-12-18	WOS:000167071400004
J	Seminario, MC; Guo, J; Bochner, BS; Beck, LA; Georas, SN				Seminario, MC; Guo, J; Bochner, BS; Beck, LA; Georas, SN			Human eosinophils constitutively express nuclear factor of activated T cells p and c	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						eosinophils; cytokines; transcriptional regulation; nuclear factor of activated T cells; HMGI/Y	PERIPHERAL-BLOOD EOSINOPHILS; TRANSCRIPTION FACTOR NFAT1; COLONY-STIMULATING FACTOR; GENE-EXPRESSION; MESSENGER-RNA; HMG I(Y); NF-AT; INTERLEUKIN-4 PROMOTER; ALLERGIC INFLAMMATION; CYCLOSPORINE-A	Background: Eosinophils are now known to produce a variety of proinflammatory cytokines, although the molecular factors that regulate their production are poorly understood. The expression of almost all of the cytokines produced by eosinophils, including the proallergic cytokine IL-4, is now known to be regulated at the level of transcription by members of the nuclear factor of activated T cells (NFAT) family of transcription factors. Objective: We sought to characterize the expression of different NFAT proteins in resting and activated eosinophils. Methods: Nuclear and whole cell extracts were obtained from both peripheral blood eosinophils and those obtained from bronchoalveolar lavage fluid of asthmatic subjects after endobronchial allergen challenge. NFAT expression was determined by using immunoprecipitation and Western blot analysis, DNA-binding essays, and RT-PCR analysis of eosinophil mRNA. Results: Both peripheral blood and bronchoalveolar lavage fluid eosinophils expressed NFATp and NFATc protein. Unlike activated T cells, which express multiple NFATc isoforms, eosinophils preferentially express the approximately 85-kd isoform. In addition, eosinophils were found to constitutively express NFATc mRNA. A brief incubation with the T(H)2 cytokines IL-4 and IL-5 was sufficient to induce the nuclear translocation of NFATc. Eosinophil nuclear extracts contain multiple factors that can specifically recognize the IL-4 promoter P1 NFAT site In DNA-binding assays, including NFATp. Conclusion: NFATp and NFATc can regulate the expression of cytokines and other genes in eosinophils but appear to be regulated by a novel signal transduction mechanism in these cells.	Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Clin Immunol, Baltimore, MD 21224 USA; Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Pulm Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Georas, SN (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Clin Immunol, Rm 4B-41,5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045839] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI045839] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bosse M, 1996, IMMUNOLOGY, V87, P149; BRAUN RK, 1993, EUR J IMMUNOL, V23, P956, DOI 10.1002/eji.1830230429; BROIDE DH, 1992, J CLIN INVEST, V90, P1414, DOI 10.1172/JCI116008; Chen RB, 2000, J IMMUNOL, V164, P825, DOI 10.4049/jimmunol.164.2.825; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cron RQ, 1999, J IMMUNOL, V162, P860; DUBUCQUOI S, 1994, J EXP MED, V179, P703, DOI 10.1084/jem.179.2.703; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Handen JS, 1997, J BIOL CHEM, V272, P1665, DOI 10.1074/jbc.272.3.1665; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Kim JT, 1997, J IMMUNOL, V159, P926; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; KleinHessling S, 1996, P NATL ACAD SCI USA, V93, P15311, DOI 10.1073/pnas.93.26.15311; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LEVISCHAFFER F, 1995, BLOOD, V85, P2579, DOI 10.1182/blood.V85.9.2579.bloodjournal8592579; LIU MC, 1991, AM REV RESPIR DIS, V144, P51, DOI 10.1164/ajrccm/144.1.51; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; MATSUMOTO K, 1995, BLOOD, V86, P1437, DOI 10.1182/blood.V86.4.1437.bloodjournal8641437; Meng Q, 1997, ALLERGY, V52, P1095, DOI 10.1111/j.1398-9995.1997.tb00181.x; Minshall E, 2000, J ALLERGY CLIN IMMUN, V105, P232, DOI 10.1016/S0091-6749(00)90070-8; Moller GM, 1996, AM J RESP CELL MOL, V14, P439; MOQBEL R, 1995, J IMMUNOL, V155, P4939; MOQBEL R, 1994, J ALLERGY CLIN IMMUN, V94, P1183, DOI 10.1016/0091-6749(94)90330-1; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nakajima H, 1996, J IMMUNOL, V156, P4859; Nakamura Y, 1999, J ALLERGY CLIN IMMUN, V103, P215, DOI 10.1016/S0091-6749(99)70493-8; Nakamura Y, 2000, J ALLERGY CLIN IMMUN, V105, P1146, DOI 10.1067/mai.2000.107045; NONAKA M, 1995, J IMMUNOL, V155, P3234; Nutku E, 2000, J ALLERGY CLIN IMMUN, V106, P288, DOI 10.1067/mai.2000.107932; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Romagnani S, 2000, J ALLERGY CLIN IMMUN, V105, P399, DOI 10.1067/mai.2000.104575; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEMINARIO MC, 1994, CURR OPIN IMMUNOL, V6, P860, DOI 10.1016/0952-7915(94)90005-1; Tan JQ, 1999, J IMMUNOL, V163, P21; TARA D, 1993, J IMMUNOL, V151, P3617; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Viola JPB, 1998, BLOOD, V91, P2223, DOI 10.1182/blood.V91.7.2223.2223_2223_2230; Yamaguchi Y, 1998, BLOOD, V91, P3447, DOI 10.1182/blood.V91.9.3447.3447_3447_3458; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; Ying S, 1996, EUR J IMMUNOL, V26, P70, DOI 10.1002/eji.1830260111	50	14	15	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2001	107	1					143	152		10.1067/mai.2001.111931	http://dx.doi.org/10.1067/mai.2001.111931			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	394PW	11150004				2022-12-18	WOS:000166533300024
J	Assanasen, P; Baroody, FM; Abbott, DJ; Naureckas, E; Solway, J; Naclerio, RM				Assanasen, P; Baroody, FM; Abbott, DJ; Naureckas, E; Solway, J; Naclerio, RM			Natural and induced allergic responses increase the ability of the nose to warm and humidify air	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						allergic inflammation; nasal conditioning; water gradient; humidification; allergy	DRY AIR; MEDIATOR RELEASE; NASAL-MUCOSA; HISTAMINE; CHALLENGE; COLD; REACTIVITY; ACTIVATION; INHALATION	Background: We have previously shown that subjects with seasonal allergic rhinitis: out of season had a reduced ability to warm and humidify air compared with normal subjects. Objective: We sought to investigate whether allergic reactions induced by either seasonal exposure or nasal challenge with antigen would decrease the capacity of the nose to condition cold, dry air. Methods: We performed two prospective studies comparing the effects of allergic inflammation induced by either seasonal exposure or nasal challenge with antigen, on nasal conditioning capacity (NCC). The total water gradient (WG) across the nose was used to represent the NCC. In the first study the NCC was measured and compared before and during the allergy season in 10 subjects with seasonal allergic rhinitis, In the second study, 20 subjects with seasonal allergic rhinitis were recruited outside of the allergy season. NCC was measured and compared before and 24 hours after challenge with antigen. Results: In the first study, seasonal allergic subjects in season showed a significant increase in NCC when compared with their preseason baseline (total WG in season: 2050 +/- 138 mg vs total WG preseason: 1524 +/- 100 mg; P < .01). In the second study, antigen challenge led to early-phase and late-phase responses. There was a statistically significant increase in NCC 24 hours after antigen challenge compared with that before antigen challenge (total WG after antigen challenge: 1938 +/- 101 mg vs total WG before antigen challenge: 1648 +/- 84 mg; P = .01). Conclusion: Allergic reactions induced by either seasonal exposure or antigen challenge increase the ability of the nose to condition inspired air. We speculate that allergic inflammation increases this ability by changing the perimeter of the nasal cavity.	Univ Chicago, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Naclerio, RM (corresponding author), Univ Chicago, Sect Otolaryngol Head & Neck Surg, 5841 S Maryland Ave,MC 1035, Chicago, IL 60637 USA.		Solway, Julian/B-1116-2008	Solway, Julian/0000-0002-0898-8530	NIAID NIH HHS [AI 01236] Funding Source: Medline; NIDCD NIH HHS [DC 02714] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002714] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON SD, 1995, ASTHMA RHINITIS, P1178; Baroody FM, 1999, J APPL PHYSIOL, V86, P659, DOI 10.1152/jappl.1999.86.2.659; BISGAARD H, 1990, J ALLERGY CLIN IMMUN, V85, P891, DOI 10.1016/0091-6749(90)90074-E; CAUNA N, 1975, ANAT REC, V181, P1, DOI 10.1002/ar.1091810102; CAUNA N, 1982, NOSE, P44; Chung JH, 1997, ANN ALLERG ASTHMA IM, V78, P307, DOI 10.1016/S1081-1206(10)63187-0; COLE P, 1954, J Laryngol Otol, V68, P613, DOI 10.1017/S0022215100050040; COLLINS JG, 1988, ADV DATA VITAL HLTH, V155; CRUZ AA, 1991, AM REV RESPIR DIS, V143, P761, DOI 10.1164/ajrccm/143.4_Pt_1.761; DAVIES RJ, 1992, ADVANCES IN ALLERGOLOGY AND CLINICAL IMMUNOLOGY, P233; DVORACEK JE, 1984, J ALLERGY CLIN IMMUN, V73, P363, DOI 10.1016/0091-6749(84)90409-3; ILLIOPOULOS O, 1990, J ALLERGY CLIN IMMUN, V86, P851; Jankowski R., 1993, Rhinology (Utrecht), V31, P97; KLEMENTSSON H, 1990, CLIN EXP ALLERGY, V20, P539, DOI 10.1111/j.1365-2222.1990.tb03147.x; NACLERIO RM, 1983, AM REV RESPIR DIS, V128, P597; Naclerio RM, 1997, ALLERGY, V52, P7, DOI 10.1111/j.1398-9995.1997.tb04816.x; PELIKAN Z, 1978, ANN ALLERGY, V41, P37; PHILIP G, 1993, AM REV RESPIR DIS, V148, P1616, DOI 10.1164/ajrccm/148.6_Pt_1.1616; PIPKORN U, 1987, J CLIN INVEST, V80, P957, DOI 10.1172/JCI113188; PROCTOR DF, 1977, RESP PHYSIOL, V30, P109, DOI 10.1016/0034-5687(77)90025-1; Rouadi P, 1999, J APPL PHYSIOL, V87, P400, DOI 10.1152/jappl.1999.87.1.400; SMITH JM, 1993, ALLERGIC NONALLERGIC, P15; TOGIAS A, 1987, J ALLERGY CLIN IMMUN, V79, P599, DOI 10.1016/S0091-6749(87)80155-0; TOGIAS A, 1990, AM REV RESPIR DIS, V141, P1428, DOI 10.1164/ajrccm/141.6.1428; TOGIAS AG, 1988, AM REV RESPIR DIS, V137, P625, DOI 10.1164/ajrccm/137.3.625; WACHS M, 1989, J ALLERGY CLIN IMMUN, V84, P492, DOI 10.1016/0091-6749(89)90362-X; WALDEN SM, 1988, J ALLERGY CLIN IMMUN, V81, P940, DOI 10.1016/0091-6749(88)90157-1; WALDEN SM, 1991, AM REV RESPIR DIS, V144, P642, DOI 10.1164/ajrccm/144.3_Pt_1.642	28	14	15	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	2000	106	6					1045	1052						8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	384ER	11112885				2022-12-18	WOS:000165930300004
J	Abe, M; Kurosawa, M; Igarashi, Y; Ishikawa, O; Miyachi, Y				Abe, M; Kurosawa, M; Igarashi, Y; Ishikawa, O; Miyachi, Y			Influence of IgE-mediated activation of cultured human mast cells on proliferation and type I collagen production by human dermal fibroblasts	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Meeting on New Trends in Immunopharmacology 1998	JUL   25, 1998	TOKYO, JAPAN			cultured human mast cells; histamine; ketotifen; human dermal fibroblasts; proliferation; collagen	GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; STEEL FACTOR; FIBROSIS; TRYPTASE; MOUSE; PROCOLLAGEN; HISTAMINE; SKIN	Background: Mast cells have been suggested to be involved in fibrotic conditions, but it still remains unknown whether IgE-mediated activation of human mast cells promotes fibrogenesis by human fibroblasts. Objective: The purpose of this study was to determine whether IgE-mediated activation of cultured human mast cells can promote fibrogenesis by cultured human dermal fibroblasts. Methods: Mast cells derived from human umbilical cord blood cells were incubated with IgE and then activated by anti-IgE, and histamine release was measured. IgE-sensitized mast cells were cocultured with fibroblasts from normal dermis and activated with anti-IgE to induce histamine release, after which proliferation and type I collagen synthesis by the fibroblasts mere determined. Results: Coculture of subconfluent human dermal fibroblasts with IgE-sensitized mast cells did not affect fibroblast proliferation. However, fibroblast proliferation was increased by activated mast cells, and a significant increase was observed in the presence of 10(5) or 3 x 10(5) mast cells/mL. The promotion of fibroblast proliferation by mast cells (3 x 10(5)/mL) was partly inhibited by ketotifen at a concentration that significantly reduced histamine release from mast cells. On the other hand, IgE-mediated activation of mast cells did not increase type I collagen production by confluent human dermal fibroblasts. Conclusion: IgE-mediated activation of cultured human mast cells could increase the proliferation of human dermal fibroblasts, but did not promote type I collagen production by the fibroblasts under the conditions tested.	Hirosaki Univ, Sch Med, Dept Geriatr Med, Hirosaki, Aomori 0368562, Japan; Gunma Univ, Sch Med, Dept Dermatol, Maebashi, Gumma 371, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan	Hirosaki University; Gunma University; Kyoto University	Kurosawa, M (corresponding author), Hirosaki Univ, Sch Med, Dept Geriatr Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.			Ishikawa, Osamu/0000-0002-7655-0610				Abe M, 1998, CLIN EXP ALLERGY, V28, P1509; BIENENSTOCK J, 1985, INT ARCH ALLER A IMM, V77, P126, DOI 10.1159/000233766; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; DAY R, 1987, AM REV RESPIR DIS, V136, P908, DOI 10.1164/ajrccm/136.4.908; DAYTON ET, 1989, J IMMUNOL, V142, P4307; FRANZEN L, 1980, CELL TISSUE KINET, V13, P635, DOI 10.1111/j.1365-2184.1980.tb00502.x; FURITSU T, 1989, P NATL ACAD SCI USA, V86, P10039, DOI 10.1073/pnas.86.24.10039; GORDON JR, 1994, J EXP MED, V180, P2027, DOI 10.1084/jem.180.6.2027; Gruber B L, 1995, Int Rev Immunol, V12, P259, DOI 10.3109/08830189509056717; Gruber BL, 1997, J IMMUNOL, V158, P2310; HAWKINS RA, 1985, ANN INTERN MED, V102, P182, DOI 10.7326/0003-4819-102-2-182; Igarashi Y, 1996, CLIN EXP ALLERGY, V26, P597; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; JORDANA M, 1988, THORAX, V43, P552, DOI 10.1136/thx.43.7.552; KANAYAMA N, 1992, GYNECOL OBSTET INVES, V34, P24, DOI 10.1159/000292719; Kanbe N, 1999, CLIN EXP ALLERGY, V29, P105; KATZ HR, 1985, J ALLERGY CLIN IMMUN, V78, P250; Kofford MW, 1997, J BIOL CHEM, V272, P7127, DOI 10.1074/jbc.272.11.7127; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; SAITO H, 1995, INT ARCH ALLERGY IMM, V107, P63, DOI 10.1159/000236932; Saito H, 1996, J IMMUNOL, V157, P343; WALKER M, 1990, J RHEUMATOL, V17, P57; Zhou LJ, 1997, J DERMATOL SCI, V14, P217, DOI 10.1016/S0923-1811(96)00577-4	27	14	14	0	1	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUL	2000	106	1	2	S			S72	S77		10.1067/mai.2000.106059	http://dx.doi.org/10.1067/mai.2000.106059			6	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	339NF	10887337				2022-12-18	WOS:000088482600010
J	Routes, JM; Nelson, HS; Noda, JA; Simon, FT				Routes, JM; Nelson, HS; Noda, JA; Simon, FT			Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						asthma; Chlamydia pneumoniae	STRAIN TWAR; INFECTION		Natl Jewish Med & Res Ctr, Dept Med, Div Clin Immunol & Allergy, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Routes, JM (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Div Clin Immunol & Allergy, 1400 Jackson St, Denver, CO 80206 USA.		Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773				ALLEGRA L, 1994, EUR RESPIR J, V7, P2165, DOI 10.1183/09031936.94.07122165; DALES RE, 1988, AM REV RESPIR DIS, V138, P317, DOI 10.1164/ajrccm/138.2.317; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; HAHN DL, 1995, J FAM PRACTICE, V41, P345; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225	5	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	2000	105	2	1				391	392		10.1016/S0091-6749(00)90093-9	http://dx.doi.org/10.1016/S0091-6749(00)90093-9			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	285RQ	10669864				2022-12-18	WOS:000085402200028
J	Stevenson, DD; Simon, RA; Christensen, SC				Stevenson, DD; Simon, RA; Christensen, SC			Lack of cross-reactivity between selective COX-2 inhibitors and aspirin (ASA) in ASA, sensitive asthmatic subjects	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Scripps Clin, La Jolla, CA USA; Scripps Res Inst, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute									0	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		806	S273	S273		10.1016/S0091-6749(00)91234-X	http://dx.doi.org/10.1016/S0091-6749(00)91234-X			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530100802
J	Turjanmaa, K; Reinikka-Railo, H; Reunala, T; Palosuo, T				Turjanmaa, K; Reinikka-Railo, H; Reunala, T; Palosuo, T			Continued decrease in natural rubber latex (NRL) allergen levels of medical gloves in nationwide market surveys in Finland and co-occurring decrease in NRL allergy prevalence in a large university hospital	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									Univ Tampere, Dept Dermatol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Natl Agcy Med, Helsinki, Finland; Natl Publ Hlth Inst, Helsinki, Finland	Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare									0	14	14	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	2000	105	1	2	S		1094	S373	S373		10.1016/S0091-6749(00)91520-3	http://dx.doi.org/10.1016/S0091-6749(00)91520-3			1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	287WR					2022-12-18	WOS:000085530101088
J	Cummings, RH				Cummings, RH			Pressurized metered dose inhalers: Chlorofluorocarbon to hydrofluoroalkane transition - Valve performance	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						valve performance; propellant replacement; propellants; extractives; metered dose inhalers; chlorofluorocarbon; hydrofluoroalkane		This article reviews the issues related to the performance of valves in metered dose inhalers with respect to chlorofluorocarbon propellant replacement Reformulation of existing chlorofluorocarbon-based products with hydrofluoroalkane propellants has been a much more difficult task than initially anticipated, complicated by the need to concurrently develop better performing valves with cleaner extractive profiles, This paper will examine issues related to the reformulation and development of new valves and the tests and procedures used to evaluate valve performance. Evaluation of valve performance will consider the tests performed: mechanisms by which valves fail and analytic testing errors that can complicate the interpretation of results.	Magellan Labs Inc, Morrisville, NC 27560 USA		Cummings, RH (corresponding author), 140 Southctr Ct, Morrisville, NC 27560 USA.							CYR TD, 1991, PHARMACEUT RES, V8, P658, DOI 10.1023/A:1015825311750; *US FDA, 1998, HFD210 FOOD DRUG ADM; 1990, US PHARMACOPEIA, P1760; 1990, US PHARMACOPEIA, pCH601	4	14	14	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					S230	S235		10.1016/S0091-6749(99)70036-9	http://dx.doi.org/10.1016/S0091-6749(99)70036-9			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10588980				2022-12-18	WOS:000084289200036
J	Newman, S; Pitcairn, G; Steed, K; Harrison, A; Nagel, J				Newman, S; Pitcairn, G; Steed, K; Harrison, A; Nagel, J			Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						bronchodilators; asthma therapy; drug deposition; pressurized metered dose inhaler	AEROSOL; LUNG; INHALATION; CHALLENGE; DELIVERY; PATTERNS; DEVICE	The imaging technique of gamma scintigraphy has been used to quantify the total amount of drug deposited in the lungs and the pattern of regional lung deposition, for formulations of Berodual (Boehringer Ingelheim GmbH) delivered from pressurized metered dose inhalers formulated with chlorofluorocarbons, and with hydrofluoroalkane-134a or -227, Data were expressed as the mass of fenoterol deposited in the lungs from the Berodual formulations. All the formulations tested gave a whole lung deposition less than 20% of the metered (exvalve) dose. The mass of fenoterol deposited in the lungs for a solution formulation containing hydrofluoroalkane-134a was inversely proportional to the actuator nozzle diameter. The data suggest that the total and regional lung deposition of hydrofluoroalkane-based pressurized aerosol formulations is highly product-specific and that changes in bioavailability can be brought about by varying both the constituents of the formulation and the design of the actuator.	Pharmaceut Profiles Ltd, Nottingham NG7 2QP, England; Boehringer Ingelheim Ltd, Bracknell, Berks, England; Boehringer Ingelheim GmbH, Ingelheim, Germany	Boehringer Ingelheim; Boehringer Ingelheim	Newman, S (corresponding author), Pharmaceut Profiles Ltd, Highfields Sci Pk 2 Faraday Bldg, Nottingham NG7 2QP, England.							DOLOVICH M, 1983, CHEST, V84, P36, DOI 10.1378/chest.84.1.36; EVANS AE, 1992, THORAX, V47, pP239; Farr SJ, 1996, J AEROSOL MED, V9, pS27; Laube BL, 1998, J ALLERGY CLIN IMMUN, V101, P475, DOI 10.1016/S0091-6749(98)70376-8; Leach CL, 1998, EUR RESPIR J, V12, P1346, DOI 10.1183/09031936.98.12061346; Leach CL, 1998, RESP MED, V92, P3, DOI 10.1016/S0954-6111(98)90211-6; Lewis DA, 1998, RESP DRUG DELIVERY, VVI, P363; MELCHOR R, 1993, THORAX, V48, P506, DOI 10.1136/thx.48.5.506; NEWMAN SP, 1991, THORAX, V46, P712, DOI 10.1136/thx.46.10.712; NEWMAN SP, 1989, THORAX, V44, P706, DOI 10.1136/thx.44.9.706; Newman SP, 1996, J AEROSOL MED, V9, pS37; NEWMAN SP, 1993, CRIT REV THER DRUG, V10, P65; NEWMAN SP, 1998, PHARM SCI, V1, pS209; NEWMAN SP, 1998, PHARM TECH, V22, P78; NEWMAN SP, 1998, RESP DRUG DELIVERY, V6, P9; Partridge MR, 1998, EUR RESPIR J, V11, P1006, DOI 10.1183/09031936.98.11051006; PITCAIRN GR, 1997, J AEROSOL MED, V3, P187; POLLI GP, 1969, J PHARM SCI, V58, P484, DOI 10.1002/jps.2600580422; RICHARDS JC, 1998, RESP DRUG DELIVERY, V6, P405; SMITH IJ, 1995, J AEROSOL MED, V8, pS19; STEED KP, 1995, INT J PHARM, V123, P291, DOI 10.1016/0378-5173(95)00150-H	21	14	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1999	104	6					S253	S257		10.1016/S0091-6749(99)70042-4	http://dx.doi.org/10.1016/S0091-6749(99)70042-4			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	266FD	10588986				2022-12-18	WOS:000084289200042
J	Redfern, DC				Redfern, DC			Contact sensitivity to multiple local anesthetics	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article									Allergy & Immunol, Waterloo, IA 50702 USA		Redfern, DC (corresponding author), Allergy & Immunol, 2055 Kimball Ave,Suite 310, Waterloo, IA 50702 USA.							DESWARTE RD, 1997, ALLERGIC DIS DIAGNOS, P385	1	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1999	104	4	1				890	891		10.1016/S0091-6749(99)70305-2	http://dx.doi.org/10.1016/S0091-6749(99)70305-2			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	248NG	10518839				2022-12-18	WOS:000083281200026
J	Hirata, N; Takeuchi, K; Ukai, K; Jin, C; Yoshida, T; Sakakura, Y				Hirata, N; Takeuchi, K; Ukai, K; Jin, C; Yoshida, T; Sakakura, Y			Expression and localization of histamine H-2 receptor messenger RNA in human nasal mucosa	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						histamine H2 receptor; mRNA; allergic rhinitis; reverse transcription-polymerase chain reaction; nasal scrapings; nasal mucosa; in situ hybridization	GOBLET CELL SECRETION; ALLERGIC RHINITIS; GROWTH-FACTORS; SMALL NUMBERS; GENE; INHIBITION; RELEASE; ANTAGONISTS; MACROPHAGES; EMBRYOS	Background: Histamine is an important chemical mediator in allergic rhinitis. Histamine H-2 receptor (H2R) stimulation controls histamine release and mediates mucus secretion, suggesting that H2R might play some role in allergic rhinitis. Objective: The objective of this study was to examine whether H2R mRNA expression is increased in patients with allergic rhinitis compared with normal subjects and to determine the localization of H2R mRNA in the human nasal mucosa. Methods: We extracted RNA from scrapings of the inferior turbinate mucosa of 11 patients with allergic rhinitis. H2R and beta-actin mRNA were amplified by RT-PCR. In situ hybridization with a digoxigenin-labeled H2R cRNA probe was performed on surgical specimens of nasal turbinate of patients with allergic rhinitis, Results: The mean +/- SD of H2R/beta-actin ratios were 0.12 +/- 0.16 for the scraping of normal subjects and 0.35 +/- 0.20 for the scrapings of patients with allergic rhinitis; the difference was statistically significant (P < .01). H2R mRNA was Localized in the epithelium, serous cells, and mucous cells. Conclusion: These data suggest that H2R mRNA is localized in the epithelium and the submucosal glands and that increased H2R may be playing some role in patients with allergic rhinitis.	Mie Univ, Sch Med, Dept Otorhinolaryngol, Tsu, Mie 514, Japan; Norman Bethune Univ Med Sci, Clin Coll 2, Dept Otorhinolaryngol, Changchun, Peoples R China; Mie Univ, Sch Med, Dept Pathol, Tsu, Mie 514, Japan	Mie University; Jilin University; Mie University	Sakakura, Y (corresponding author), Mie Univ, Sch Med, Dept Otorhinolaryngol, 2-174 Edobashi, Tsu, Mie 514, Japan.		Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217				ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; BACKER MD, 1993, BIOCHEM BIOPH RES CO, V197, P1601; BLACK JW, 1972, NATURE, V236, P385, DOI 10.1038/236385a0; BROOKS CD, 1982, J ALLERGY CLIN IMMUN, V70, P373, DOI 10.1016/0091-6749(82)90027-6; CARPENTER GB, 1983, J ALLERGY CLIN IMMUN, V71, P412, DOI 10.1016/0091-6749(83)90071-4; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DARNELL JE, 1982, NATURE, V297, P365, DOI 10.1038/297365a0; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; FUJIMOTO M, 1994, CLIN IMMUNOL IMMUNOP, V73, P96, DOI 10.1006/clin.1994.1174; GANTZ I, 1991, BIOCHEM BIOPH RES CO, V178, P1386, DOI 10.1016/0006-291X(91)91047-G; GRUBER BL, 1994, IMMUNOLOGY INFLAMMAT, P337; HILL SJ, 1990, PHARMACOL REV, V42, P45; Iriyoshi N, 1996, CLIN EXP ALLERGY, V26, P379, DOI 10.1111/j.1365-2222.1996.tb00553.x; Ishihara A, 1995, CLIN CANCER RES, V1, P1035; KNIGHT DA, 1992, AM REV RESPIR DIS, V146, P137, DOI 10.1164/ajrccm/146.1.137; LICHTENSTEIN LM, 1975, J PHARMACOL EXP THER, V192, P441; LICHTENSTEIN LM, 1973, NATURE, V244, P287, DOI 10.1038/244287a0; NAKAZAWA T, 1992, ANN ALLERGY, V68, P319; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; RAPPOLEE DA, 1989, J CELL BIOCHEM, V39, P1, DOI 10.1002/jcb.240390102; RAPPOLEE DA, 1990, AM J RESP CELL MOL, V2, P3, DOI 10.1165/ajrcmb/2.1.3; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; SATOH S, 1994, J JPN RHINOL SOC, V32, P7; SHELTON D, 1994, CLIN OTOLARYNGOL, V19, P45, DOI 10.1111/j.1365-2273.1994.tb01146.x; Takeyama K, 1996, AM J RESP CRIT CARE, V154, P231, DOI 10.1164/ajrccm.154.1.8680685; Tamaoki J, 1997, J ALLERGY CLIN IMMUN, V99, P233, DOI 10.1016/S0091-6749(97)70102-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TECOTT LH, 1987, IN SITU HYBRIDIZATIO, P3; TESTA B, 1989, ARCH OTOLARYNGOL, V115, P950; TING S, 1980, J ALLERGY CLIN IMMUN, V65, P196; WHITE MV, 1990, J ALLERGY CLIN IMMUN, V86, P599, DOI 10.1016/S0091-6749(05)80223-4	34	14	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				944	949		10.1016/S0091-6749(99)70443-4	http://dx.doi.org/10.1016/S0091-6749(99)70443-4			6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329833				2022-12-18	WOS:000080470200034
J	Qiu, DW; Tan, WC				Qiu, DW; Tan, WC			Dithiothreitol has a dose-response effect on cell surface antigen expression	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						dithiothreitol; induced sputum; CD11a; CD11b; very late antigen-4; inflammatory cells	INDUCED SPUTUM; EOSINOPHILS; INFLAMMATION	Background: The use of Dithiothreitol (DTT) to improve cell dispersion is an integral step in induced sputum examination, which has become an important noninvasive method of assessing airway inflammation. Several studies have shown that sputum treatment with DTT does not affect cell morphology, differential cell counts, and cytokine levels in the supernatant. However, the effect of DTT on cell surface marker expression has not been systematically studied. Objective: We have investigated the effect of different DTT concentrations on antigen expression on peripheral blood cells compared with antigen expression on PBS-treated cells, Methods: Peripheral blood from different healthy donors was incubated with either DTT or PBS, washed, and then incubated with different fluorescence-labeled antibodies. Analysis was performed after lysis of erythrocytes on a calibrated flow cytometer, Respective cell populations were identified, and the mean fluorescence intensity of surface-marker expression for each cell population was compared between DTT- and PBS-treated cells. Results: We found that DTT decreased the expression of CD11a and CD49d on lymphocytes and eosinophils, The expression of CD11a on neutrophils was also decreased after DTT treatment, DTT increased CD11b expression on lymphocytes, neutrophils, and eosinophils. DTT might also have a mild effect on cell activation. It decreased the expression of CD2 on lymphocytes and variably affected the expression of EG2 in eosinophils, although it had no significant effect on HLA-DR expression on lymphocytes. Conclusion: Our findings show that DTT can affect antigen expression on lymphocytes, neutrophils, and eosinophils and suggest the need for further investigation of similar consequences on induced sputum analysis.	Natl Univ Singapore, Dept Med, Singapore 119260, Singapore	National University of Singapore	Qiu, DW (corresponding author), Natl Univ Singapore, Dept Med, Singapore 119260, Singapore.							Efthimiadis A, 1997, EUR RESPIR J, V10, P1336, DOI 10.1183/09031936.97.10061336; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; HANSEL TT, 1991, CLIN EXP IMMUNOL, V86, P271; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; LOPPOW D, 1998, AM J RESP CRIT CARE, V157, pA813; LUNDAHL J, 1995, J IMMUNOL METHODS, V180, P93, DOI 10.1016/0022-1759(94)00303-E; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; POPOV T, 1994, CLIN EXP ALLERGY, V24, P778, DOI 10.1111/j.1365-2222.1994.tb00990.x; TAI PC, 1984, NATURE, V309, P182, DOI 10.1038/309182a0; TAN WC, 1997, AM J RESP CRIT CAR S, V155, pA626; Thurau AM, 1996, CYTOMETRY, V23, P150, DOI 10.1002/(SICI)1097-0320(19960201)23:2<150::AID-CYTO8>3.0.CO;2-O; WALKER C, 1993, J IMMUNOL, V150, P4061; WOOTEN OJ, 1978, ANN ALLERGY, V41, P150	13	14	15	0	6	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1999	103	5	1				873	876		10.1016/S0091-6749(99)70432-X	http://dx.doi.org/10.1016/S0091-6749(99)70432-X			4	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	199FP	10329822				2022-12-18	WOS:000080470200023
J	Day, J				Day, J			Pros and cons of the use of antihistamines in managing allergic rhinitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							AZELASTINE NASAL SPRAY; CELL-MEDIATOR RELEASE; LATE-PHASE REACTION; H1-RECEPTOR ANTAGONISTS; ANTIALLERGIC ACTIVITY; HISTAMINE-RELEASE; DRIVING PERFORMANCE; H-1 ANTIHISTAMINE; DOUBLE-BLIND; CETIRIZINE	Histamine H-1-receptor antagonists are generally considered first-line therapy for the management of allergic rhinitis, Other than histamine antagonism, several of the second-generation antihistamines have also shown inhibitory effects on chemical mediators of inflammation such as leukotrienes, prostaglandins, and kinins, This article reviews the pharmacology, clinical use, and side effect profiles of the commonly used H-1-receptor antagonists.	Queens Univ, Dept Med, Div Allergy & Immunol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Day, J (corresponding author), Queens Univ, Dept Med, Div Allergy & Immunol, Kingston, ON K7L 3N6, Canada.							Abdelaziz MM, 1998, J ALLERGY CLIN IMMUN, V101, P410, DOI 10.1016/S0091-6749(98)70256-8; ANDERSSON M, 1991, ALLERGY, V46, P540, DOI 10.1111/j.1398-9995.1991.tb00618.x; BAUMGARTEN CR, 1994, J PHARM U THER, V3, P43; Bernstein DI, 1997, ANN ALLERG ASTHMA IM, V79, P443, DOI 10.1016/S1081-1206(10)63041-4; BETTS T, 1984, BRIT MED J, V288, P281, DOI 10.1136/bmj.288.6413.281; BHATTI JZ, 1989, CLIN EXP ALLERGY, V19, P609, DOI 10.1111/j.1365-2222.1989.tb02754.x; BOUSQUET J, 1988, J ALLERGY CLIN IMMUN, V82, P881, DOI 10.1016/0091-6749(88)90094-2; BOUSQUET J, 1996, HISTAMINE H1 RECEPTO, P101; Bovet D, 1944, CR SOC BIOL, V138, P99; BRANNAN MD, 1995, CLIN PHARMACOL THER, V58, P269, DOI 10.1016/0009-9236(95)90243-0; CAMPOLIRICHARDS DM, 1990, DRUGS, V40, P762, DOI 10.2165/00003495-199040050-00009; CHARLESWORTH EN, 1989, J ALLERGY CLIN IMMUN, V83, P905, DOI 10.1016/0091-6749(89)90104-8; CHERIASAMMARI S, 1995, CLIN EXP ALLERGY, V25, P729, DOI 10.1111/j.1365-2222.1995.tb00010.x; Ciprandi G, 1997, CLIN EXP ALLERGY, V27, P1175; Ciprandi G, 1996, J ALLERGY CLIN IMMUN, V98, P1088, DOI 10.1016/S0091-6749(96)80196-5; CIPRANDI G, 1993, INT ARCH ALLERGY IMM, V100, P185, DOI 10.1159/000236407; CLISSOLD SP, 1989, DRUGS, V37, P42, DOI 10.2165/00003495-198937010-00003; Day JH, 1998, J ALLERGY CLIN IMMUN, V101, P638, DOI 10.1016/S0091-6749(98)70172-1; DOUGLAS WW, 1980, PHARMACOL BASIS THER, P622; ESTELLE F, 1994, DRUG SAFETY, V10, P350, DOI 10.2165/00002018-199410050-00002; FALLIERS CJ, 1991, ANN ALLERGY, V66, P257; GENGO FM, 1990, ANN ALLERGY, V64, P520; KIRKEGAARD J, 1983, BRIT J DIS CHEST, V77, P113, DOI 10.1016/0007-0971(83)90017-7; KONNO S, 1993, LIFE SCI, V53, P201; LaForce C, 1996, ANN ALLERG ASTHMA IM, V76, P181, DOI 10.1016/S1081-1206(10)63420-5; LITTLE MM, 1989, J ALLERGY CLIN IMMUN, V83, P862, DOI 10.1016/0091-6749(89)90096-1; McCue JD, 1996, ARCH FAM MED, V5, P464, DOI 10.1001/archfami.5.8.464; MELTZER EO, 1990, J OCCUP ENVIRON MED, V32, P327, DOI 10.1097/00043764-199004000-00013; MELTZER EO, 1994, ANN ALLERGY, V72, P354; MIADONNA A, 1995, CLIN EXP ALLERGY, V25, P364, DOI 10.1111/j.1365-2222.1995.tb01055.x; Morganroth J, 1997, J CLIN PHARMACOL, V37, P1065, DOI 10.1002/j.1552-4604.1997.tb04289.x; NACLERIO RM, 1990, AM REV RESPIR DIS, V142, P167, DOI 10.1164/ajrccm/142.1.167; NACLERIO RM, 1989, LARYNGOSCOPE, V99, P596; NICHOLSON AN, 1982, BRIT J CLIN PHARMACO, V13, P199, DOI 10.1111/j.1365-2125.1982.tb01356.x; RATNER PH, 1994, J ALLERGY CLIN IMMUN, V94, P818, DOI 10.1016/0091-6749(94)90148-1; REDIER H, 1992, J ALLERGY CLIN IMMUN, V90, P215, DOI 10.1016/0091-6749(92)90074-C; Rihoux JP, 1997, INT ARCH ALLERGY IMM, V113, P339, DOI 10.1159/000237595; RIMMER SJ, 1990, CLIN EXP ALLERGY, V20, P3, DOI 10.1111/j.1365-2222.1990.tb02456.x; ROTH T, 1987, J ALLERGY CLIN IMMUN, V80, P94, DOI 10.1016/S0091-6749(87)80197-5; SALE M, 1996, ANN ALLERG ASTHMA IM, V76, P91; SALE M, 1996, ANN ALLERG ASTHMA IM, V76, P93; SEIDEL WF, 1987, ANN ALLERGY, V59, P58; SHIN MH, 1992, CLIN EXP ALLERGY, V22, P289, DOI 10.1111/j.1365-2222.1992.tb03085.x; Simons FER, 1996, ALLERGY ASTHMA PROC, V17, P185, DOI 10.2500/108854196778996895; SIMONS FER, 1994, J PEDIATR-US, V124, P979; Simons FER, 1996, PEDIAT ALLERG IMM-UK, V7, P22, DOI 10.1111/j.1399-3038.1996.tb00101.x; SIMONS FER, 1991, ANN ALLERGY, V66, P5; SNYDER SH, 1987, ANN ALLERGY, V59, P4; Storms W W, 1994, Ear Nose Throat J, V73, P382; TOGIAS AG, 1989, ANN ALLERGY, V63, P465; TOGIAS AG, 1986, JAMA-J AM MED ASSOC, V255, P225, DOI 10.1001/jama.255.2.225; VUURMAN EFPM, 1993, ANN ALLERGY, V71, P121; WEILER JM, 1994, J ALLERGY CLIN IMMUN, V94, P972, DOI 10.1016/0091-6749(94)90115-5	53	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1999	103	3	2	S			S395	S399		10.1016/S0091-6749(99)70219-8	http://dx.doi.org/10.1016/S0091-6749(99)70219-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	179CL	10069900				2022-12-18	WOS:000079305900006
J	Isomaki, P; Aversa, G; Chang, CCJ; Luukkainen, R; Nikkari, S; Toivanen, P; deVries, JE; Punnonen, J				Isomaki, P; Aversa, G; Chang, CCJ; Luukkainen, R; Nikkari, S; Toivanen, P; deVries, JE; Punnonen, J			Expression of soluble human signaling lymphocytic activation molecule in vivo	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						arthritis; allergy; lymphocyte	T-CELLS; RHEUMATOID-ARTHRITIS; CYTOKINE PRODUCTION; REACTIVE ARTHRITIS; PROLIFERATION; PROFILE; SUBSET; SLAM	Background: Signaling lymphocytic activation molecule (SLAM) is a novel glycoprotein expressed on activated T and B cells. Ligation of cell surface SLAM, either by anti-SLAM mAbs or the recombinant soluble form of SLAM (sSLAM), enhanced the proliferation of T and B cells in vitro. In addition, the engagement of SLAM on T cells preferentially induced IFN-gamma production even by allergen-specific T-H2 clones. Objective: In this study we investigated the expression of sSLAM in vivo in healthy individuals and in disease conditions that are associated with increased T-H1- or T-H2-cell responses. Methods: The expression of mRNA encoding sSLAM in peripheral blood and synovial fluid (SF) lymphocytes was studied by using reverse transcriptase-PCR, and the presence of sSLAM protein in serum and SF samples was investigated by using a specific ELISA. Results: Lymphocytes from patients with rheumatoid arthritis (RA) and healthy individuals consistently expressed mRNA encoding sSLAM. In addition, sSLAM protein mas present in 38% of serum and 54% of SF samples from patients with RA and in 47% of serum samples from healthy individuals. The revels of sSLAM in positive serum and SF samples from patients with Rd. and in positive serum samples from healthy individuals were not significantly different. In contrast, the levels of sSLAM were significantly lower in patients with reactive arthritis or in patients with elevated IgE levels than in patients with RA. Similarly, the frequency of positive SF samples mas significantly lower in reactive arthritis (28%) than in RA (54%). Conclusion: These results indicate that sSLAM is present in serum and SF, further suggesting that sSLAM regulates T- and B-cell function in vivo. Moreover, these data suggest an association between low sSLAM production and the occurrence of T-H2 responses in vivo.	Turku Univ, Dept Med Microbiol, Turku Immunol Ctr, FIN-20520 Turku, Finland; DNAX Res Inst, Palo Alto, CA USA; Satalinna Hosp, Harjavalta, Finland	University of Turku; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Isomaki, P (corresponding author), Mathilda & Terence Kennedy Inst Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.							ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315; Aversa G, 1997, J IMMUNOL, V158, P4036; Carballido JM, 1997, J IMMUNOL, V159, P4316; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Dolhain RJEM, 1996, ARTHRITIS RHEUM-US, V39, P1961, DOI 10.1002/art.1780391204; Isomaki P, 1997, J IMMUNOL, V159, P2986; KAY AB, 1991, J EXP MED, V173, P775, DOI 10.1084/jem.173.3.775; LAHESMAA R, 1992, J IMMUNOL, V148, P3079; LIBLAU RS, 1995, IMMUNOL TODAY, V34, P37; MILTENBURG AMM, 1992, SCAND J IMMUNOL, V35, P603, DOI 10.1111/j.1365-3083.1992.tb03260.x; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SCHLAAK J, 1992, EUR J IMMUNOL, V22, P2771, DOI 10.1002/eji.1830221103; SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562, DOI 10.1073/pnas.91.18.8562; Yin Z., 1997, Arthritis and Rheumatism, V40, pS37	17	14	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1999	103	1	1				114	118		10.1016/S0091-6749(99)70534-8	http://dx.doi.org/10.1016/S0091-6749(99)70534-8			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	158JM	9893194				2022-12-18	WOS:000078112300018
J	Duplantier, JE; Freeman, TM; Bahna, SL; Good, RA; Sher, MR				Duplantier, JE; Freeman, TM; Bahna, SL; Good, RA; Sher, MR			Successful rush immunotherapy for anaphylaxis to imported fire ants	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							EXTRACTS; VENOM		Univ S Florida, All Childrens Hosp, Div Allergy & Immunol, St Petersburg, FL 33701 USA; Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA	State University System of Florida; University of South Florida; United States Department of Defense; United States Air Force	Duplantier, JE (corresponding author), Univ S Florida, All Childrens Hosp, Div Allergy & Immunol, 801 6th St S, St Petersburg, FL 33701 USA.							BERNSTEIN JA, 1994, ANN ALLERGY, V73, P423; FREEMAN TM, 1992, J ALLERGY CLIN IMMUN, V90, P210, DOI 10.1016/0091-6749(92)90073-B; Freeman TM, 1997, ANN ALLERG ASTHMA IM, V78, P369, DOI 10.1016/S1081-1206(10)63198-5; PORTNOY J, 1994, ANN ALLERGY, V73, P409; Stafford CT, 1996, ANN ALLERG ASTHMA IM, V77, P87, DOI 10.1016/S1081-1206(10)63493-X; TRACY JM, 1995, J ALLERGY CLIN IMMUN, V95, P824, DOI 10.1016/S0091-6749(95)70125-7	6	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1998	101	6	1				855	856		10.1016/S0091-6749(98)70318-5	http://dx.doi.org/10.1016/S0091-6749(98)70318-5			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZW470	9648718				2022-12-18	WOS:000074414200025
J	Fasler, S; Aversa, G; de Vries, JE; Yssel, H				Fasler, S; Aversa, G; de Vries, JE; Yssel, H			Antagonistic peptides specifically inhibit proliferation, cytokine production, CD40L expression, and help for IgE synthesis by Der p 1-specific human T-cell clones	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Der p 1; allergen-specific T lymphocytes; allergen derived peptides; cytokine production; CD40L; IgE synthesis	SERUM-FREE MEDIUM; HUMAN B-CELLS; HYPER-IGM; INTERFERON-GAMMA; RECEPTOR LIGAND; IL-4 PRODUCTION; ALLERGEN; DERMATOPHAGOIDES; INDUCTION; EPITOPES	Background: Allergic disorders are characterized by IgE antibody responses to a multitude of allergens as a result of the ability of these antibodies to specifically bind to high-affinity IgE receptors on mast cells and basophils. This interaction results in receptor activation and release of soluble mediators such as histamine and leukotrienes, which cause allergic reactions in various target organs. Because the synthesis of IgE is tightly regulated by cytokines and CD40 ligand (L) interactions, CD4(+) helper T cells are obvious targets, with the aim to modulate allergen-induced IgE responses. Objectives: Because of the central role of allergen-specific T-helper type 2 (T-H2) cells in the pathway leading to IgE synthesis in vitro and in vivo, we have evaluated the possibility of inhibiting allergen-induced activation of these cells by using allergen-derived peptides that have been modified by single amino acid substitutions. Methods: Three cloned human T-H2-like CD4(+) T-cell lines, specific for Der p 1, the major allergen in house dust, were used in this study. Upon activation with Der p 1 or specific Der p 1-dervived wild-type peptides, these T-cell clones produce high levels of IL-4 and IL-5 and low levels of interferon-gamma and IL-2, respectively, and furthermore give help to B cells for the production of IgE in vitro. Modified synthetic peptides were generated by the introduction of single amino acid substitutions into two different T-cell activation-inducing epitopes on Der p 1. The effects of these modified peptides were studied in Der p 1-induced proliferation, cytokine production, and in vitro IgE production assays. Results: Several substituted Der p 1-derived peptides failed to induce T-cell proliferation, in contrast to the native peptides. In addition, some of these peptides acted as antagonists by strongly inhibiting wild-type peptide-induced proliferation as well as the production of interferon-gamma, IL-2, IL-4, and IL-5, although the production of the latter two cytokines was less affected than that of interferon-gamma, even at a 100-fold molar excess of the antagonistic peptides, In addition, the presence of an excess of each of the antagonistic peptides during the activation of Der p I-specific T-cell clones prevented induction of CD40L expression, resulting in a failure of these cells to give help to B cells for the production of IgE in vitro, even in the presence of exogenous IL-4. Conclusions: Substitution of certain amino acid residues in immunogenic Der p 1-derived peptides results in the generation of peptides that fail to induce proliferation of Der p 1-specific T-cell clones, In addition, these modified peptides have strong antagonistic activities on Der p 1-induced proliferation, cytokine production, and CD40L expression by allergen-specific T-cell clones as well as on T cell-mediated IgE production by B cells. These findings suggest that modified peptides interfere with allergen-induced activation of T cells, including the production of cytokines and the expression of surface molecules important for successful T cell-B cell interactions, and may therefore have therapeutic potential by inhibiting the expansion and function of allergen-specific T-H2 cells.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Human Immunol, Palo Alto, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Yssel, H (corresponding author), Hop Arnaud de Villeneuve, INSERM, U454, 371 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.		Yssel, Hans/C-6406-2009; Yssel, Hans/AFV-2907-2022	Yssel, Hans/0000-0001-7454-1836; Yssel, Hans/0000-0001-7454-1836				ABRAMS JS, 1994, CURR PROTOCOL IMMUNO, V6; ALEXANDER J, 1994, INT IMMUNOL, V6, P363, DOI 10.1093/intimm/6.3.363; ALEXANDER J, 1993, J IMMUNOL, V150, P1; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; AVERSA G, 1993, J EXP MED, V177, P1757; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHAPMAN MD, 1987, J IMMUNOL, V139, P1479; CHUA KY, 1993, INT ARCH ALLERGY IMM, V101, P364, DOI 10.1159/000236478; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DISANTO JP, 1993, NATURE, V361, P541, DOI 10.1038/361541a0; EVAVOLD BD, 1992, J IMMUNOL, V148, P347; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; FASLER S, 1995, J IMMUNOL, V155, P4199; FIGDOR CG, 1982, BLOOD, V60, P46; FULEIHAN R, 1993, P NATL ACAD SCI USA, V90, P2170, DOI 10.1073/pnas.90.6.2170; HEYMANN PW, 1989, J ALLERGY CLIN IMMUN, V83, P1055, DOI 10.1016/0091-6749(89)90447-8; HIGGINS JA, 1994, J ALLERGY CLIN IMMUN, V93, P891, DOI 10.1016/0091-6749(94)90383-2; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; Ikagawa S, 1996, J ALLERGY CLIN IMMUN, V97, P53, DOI 10.1016/S0091-6749(96)70283-X; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; LANIER L L, 1991, Methods (Orlando), V2, P192, DOI 10.1016/S1046-2023(05)80061-1; MALEFYT RD, 1995, INT IMMUNOL, V7, P1405, DOI 10.1093/intimm/7.9.1405; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; PUNNONEN J, 1994, J IMMUNOL, V152, P1094; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SPITS H, 1982, J IMMUNOL, V128, P95; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Tsitoura DC, 1996, J IMMUNOL, V156, P2801; VANNEERVEN JR, 1993, J IMMUNOL, V151, P2326; VANNEERVEN RJJ, 1993, J IMMUNOL, V151, P2326; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; WINDHAGEN A, 1995, IMMUNITY, V2, P373, DOI 10.1016/1074-7613(95)90145-0; YSSEL H, 1994, INT IMMUNOL, V6, P1091, DOI 10.1093/intimm/6.7.1091; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2; YSSEL H, 1992, J IMMUNOL, V148, P738	40	14	21	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				521	530		10.1016/S0091-6749(98)70406-3	http://dx.doi.org/10.1016/S0091-6749(98)70406-3			10	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564806	Bronze			2022-12-18	WOS:000073113500015
J	Sarpong, SB; Karrison, T				Sarpong, SB; Karrison, T			Season sf birth and cockroach allergen sensitization in children with asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							DUST		Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Div Allergy & Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Sarpong, SB (corresponding author), Univ Chicago, Childrens Hosp, Dept Ped MC 6057, Div Allergy & Immunol, 5839 S Maryland Ave, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001450] Funding Source: NIH RePORTER; NIAID NIH HHS [KO8 AI 01450-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BJORKSTEN F, 1980, CLIN ALLERGY, V10, P581; FRICK OL, 1987, ALLERGY TXB, P347; KANG BC, 1992, ANN ALLERGY, V68, P237; KEMP AS, 1979, MED J AUSTRALIA, V1, P263, DOI 10.5694/j.1326-5377.1979.tb112072.x; REED CE, 1958, J ALLERGY, V29, P300, DOI 10.1016/0021-8707(58)90036-4; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sarpong SB, 1996, ANN ALLERG ASTHMA IM, V76, P257, DOI 10.1016/S1081-1206(10)63437-0; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; SMITH JM, 1979, CLIN ALLERGY, V9, P153, DOI 10.1111/j.1365-2222.1979.tb01536.x; WARNER JO, 1978, ARCH DIS CHILD, V53, P710, DOI 10.1136/adc.53.9.710	10	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1998	101	4	1				566	568		10.1016/S0091-6749(98)70369-0	http://dx.doi.org/10.1016/S0091-6749(98)70369-0			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	ZH469	9564817				2022-12-18	WOS:000073113500027
J	Grote, M; Fischer, S; Muller, WD; Valenta, R				Grote, M; Fischer, S; Muller, WD; Valenta, R			In situ localization of a high molecular weight cross-reactive allergen in pollen and plant-derived food by immunogold electron microscopy	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						cross-reactive allergen; birch pollen; grass pollen; mugwort pollen; apple; celery; Art v 1	BIRCH-POLLEN; FIXATION TECHNIQUES; ANHYDROUS FIXATION; V-I; IDENTIFICATION; PROTEINS; PROFILIN; SECTIONS; BET-V-1; VAPOR	Background: A high molecular weight (60 kd) allergen has been recently identified as a cross-reactive moiety in pollen and plant-derived food. While the cross-reactive allergen has been characterized by immunochemical techniques, little is known concerning its biologic properties. Objective: In this investigation we studied the in situ localization of the 60 kd cross-reactive allergen in tree, grass, and weed pollen, as well as in plant-derived food (apple and celery). Methods: A monoclonal antibody (3A4) that was raised against the major mugwort pollen allergen, Art v 1, was used to demonstrate the presence of related allergens in nitrocellulose-blotted pollen and plant-food extracts. The tissue localization of the cross-reactive allergen was investigated by immunogold electronmicroscopy. Results: Monoclonal antibody 3A4 recognized IgE epitopes of the 60 kd mugwort allergen and cross-reacted with moieties of comparable molecular weights in birch and timothy grass pollen, as well as in apple and celery extracts. In pollen and plant-derived food the allergen could be localized intracellularly in ribosome-rich areas in the mitochondria and the nucleus. No labeling was observed in the pollen or cell walls or in organelles that are engaged in storage (e.g., starch granules and lipid particles). Conclusion: Tree, grass, and weed pollen, as well as plant-derived foods, contain a high molecular weight Art v 1-cross-reactive allergen that maps to similar cell compartments.	Univ Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany; Univ Vienna, Inst Gen & Expt Pathol, Vienna, Austria; Univ Jena, Inst Clin Immunol, D-6900 Jena, Germany	University of Munster; University of Vienna; Friedrich Schiller University of Jena	Grote, M (corresponding author), Univ Munster, Inst Med Phys & Biophys, Robert Koch Str 33, D-48149 Munster, Germany.			Valenta, Rudolf/0000-0001-5944-3365				Bauer L, 1996, CLIN EXP ALLERGY, V26, P1161, DOI 10.1111/j.1365-2222.1996.tb00503.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; DELAHOZ F, 1990, MOL IMMUNOL, V27, P651, DOI 10.1016/0161-5890(90)90008-N; EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X; Fischer S, 1996, J ALLERGY CLIN IMMUN, V98, P189, DOI 10.1016/S0091-6749(96)70242-7; FUCHS T, 1997, IN PRESS J ALLERGY C; GROTE M, 1992, MICROSC RES TECHNIQ, V21, P242, DOI 10.1002/jemt.1070210307; GROTE M, 1984, HISTOCHEMISTRY, V81, P489, DOI 10.1007/BF00489755; GROTE M, 1994, J HISTOCHEM CYTOCHEM, V42, P427, DOI 10.1177/42.3.8308259; GROTE M, 1993, MOLECULAR BIOLOGY AND IMMUNOLOGY OF ALLERGENS, P201; GROTE M, 1991, J HISTOCHEM CYTOCHEM, V39, P1395, DOI 10.1177/39.10.1940310; Heiss S, 1996, J ALLERGY CLIN IMMUN, V98, P938, DOI 10.1016/S0091-6749(96)80010-8; HIRSCHWEHR R, 1992, J ALLERGY CLIN IMMUN, V90, P927, DOI 10.1016/0091-6749(92)90465-E; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laffer S, 1996, J IMMUNOL, V157, P4953; Lebecque S, 1997, J ALLERGY CLIN IMMUN, V99, P374, DOI 10.1016/S0091-6749(97)70056-3; STAFF IA, 1990, HISTOCHEM J, V22, P276, DOI 10.1007/BF01387183; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; Valenta R, 1995, CURR OPIN IMMUNOL, V7, P751, DOI 10.1016/0952-7915(95)80043-3; Valenta R, 1996, J ALLERGY CLIN IMMUN, V97, P893, DOI 10.1016/S0091-6749(96)80062-5	22	14	14	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1998	101	2	1				250	257		10.1016/S0091-6749(98)70390-2	http://dx.doi.org/10.1016/S0091-6749(98)70390-2			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YZ342	9500759				2022-12-18	WOS:000072244800015
J	Yanagihara, Y; Basaki, Y; Kajiwara, K; Ikizawa, K				Yanagihara, Y; Basaki, Y; Kajiwara, K; Ikizawa, K			A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappa B	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article; Proceedings Paper	Conference on New Trends in Immunopharmacology	JUL   06, 1996	TOKYO, JAPAN	Novartis Pharma KK, Tokyo, Japan		antioxidant; nuclear factor-kappa B; signal transducers and activators of transcription 6; IL-4; CD40; germline C epsilon transcription; deletional switch recombination; mature C epsilon transcription	HUMAN-IMMUNODEFICIENCY-VIRUS; GERMLINE EPSILON-PROMOTER; PROTEIN-KINASE-C; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; IL-4 RECEPTOR; CELLS; CD40; EXPRESSION; INTERLEUKIN-4	The binding site for nuclear factor-kappa B (NF-kappa B) is present at the promoter region of the germline C epsilon gene, but there is little information on whether this factor is involved in regulating IgE synthesis by human B cells. Accordingly, we studied the role of NF-kappa B in germline C epsilon transcription by using two human Burkitt's lymphoma B cell lines, DND39 and DG75. In both cell lines, n-acetyl-L-cysteine (NAG), a potent thiol antioxidant, inhibited the triggering of the nuclear expression of NF-kappa B by IL-4 and by anti-CD40 monoclonal antibody. Although IL-4 activated signal transducers and activators of transcription (STAT) 6 in addition to NF-kappa B, NAC treatment or the transfection of decoy oligodeoxynucleotides for NF-kappa B or STAT6 only partly blocked IL-4-induced germline C epsilon transcription. However, these two decoy oligodeoxynucleotides together almost completely abrogated IL-4-induced germline C epsilon transcription. Of note, CD40-mediated enhancement of IL-4-driven germline C epsilon transcription was markedly decreased by NAC or by a decoy oligodeoxynucleotide for NF-kappa B. The effect of NAC was also examined on deletional switch recombination underlying the isotype switch to IgE. NAC inhibited the generation of S mu/S epsilon switch fragments in normal human B cells costimulated with IL-4 and anti-CD40 monoclonal antibody. It also abolished IL-4-induced upregulation of CD40 but promoted upregulation of CD23. These results suggest that coordination of NF-kappa B and STAT6 may be required for induction of germline C epsilon transcription by IL-4, and that CD40-mediated NF-kappa B activation may be important in regulating both enhancement of germline C epsilon transcription and class switching to IgE.	Natl Sagamihara Hosp, Clin Res Ctr Allergy, Kanagawa 228, Japan		Yanagihara, Y (corresponding author), Natl Sagamihara Hosp, Clin Res Ctr Allergy, 18-1 Sakuradai, Kanagawa 228, Japan.							ALBRECHT B, 1994, INT IMMUNOL, V6, P1143, DOI 10.1093/intimm/6.8.1143; Albrecht B, 1996, J IMMUNOL, V157, P1538; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; FUJITA K, 1995, INT IMMUNOL, V7, P1529, DOI 10.1093/intimm/7.9.1529; GASCAN H, 1991, J IMMUNOL, V147, P8; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; HORNER AA, 1995, J EXP MED, V181, P1239, DOI 10.1084/jem.181.3.1239; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Ikizawa K, 1996, CELL IMMUNOL, V170, P134, DOI 10.1006/cimm.1996.0143; IKIZAWA K, 1994, J ALLERGY CLIN IMMUN, V94, P620, DOI 10.1016/0091-6749(94)90138-4; IKIZAWA K, 1995, CLIN EXP IMMUNOL, V100, P383; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Izuhara K, 1996, J BIOL CHEM, V271, P619, DOI 10.1074/jbc.271.2.619; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; JUMPER MD, 1994, J IMMUNOL, V152, P438; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; PAGANELLI R, 1995, J EXP MED, V181, P423, DOI 10.1084/jem.181.1.423; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; PUNNONEN J, 1995, J IMMUNOL, V155, P4248; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; RIGLEY KP, 1991, INT IMMUNOL, V3, P197, DOI 10.1093/intimm/3.2.197; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SHAPIRA S, 1991, P NATL ACAD SCI USA, V147, P7528; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; Snapper CM, 1996, J IMMUNOL, V156, P183; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; TOKER A, 1994, J BIOL CHEM, V269, P32358; Wang DZ, 1996, INT IMMUNOL, V8, P977, DOI 10.1093/intimm/8.7.977; Yanagihara Y, 1997, CELL IMMUNOL, V176, P66, DOI 10.1006/cimm.1996.1071; Yanagihara Y, 1996, J ALLERGY CLIN IMMUN, V98, pS224, DOI 10.1016/S0091-6749(96)70070-2; Yanagihara Y, 1995, J ALLERGY CLIN IMMUN, V96, P1145, DOI 10.1016/S0091-6749(95)70199-0	35	14	15	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	DEC	1997	100	6	2	S			S33	S38		10.1016/S0091-6749(97)70002-2	http://dx.doi.org/10.1016/S0091-6749(97)70002-2			6	Allergy; Immunology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	YR026	9440542	Bronze			2022-12-18	WOS:000071449600002
J	Yates, AB; Mehrotra, D; Moffitt, JE				Yates, AB; Mehrotra, D; Moffitt, JE			Candida endocarditis in a child with hyperimmunoglobulinemia E syndrome	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						hyperimmunoglobulinemia E syndrome; Candida endocarditis; immunodeficiency	INFECTIVE ENDOCARDITIS; THERAPY	Hyperimmunoglobulin E syndrome (HIE) is a disorder characterized by extremely elevated serum levels of IgE and recurrent infections, Patients are particularly predisposed to have staphylococcal abscesses, usually involving skin, lungs, and joints; but they are also at risk for infections with other bacteria and fungi. We report the case of a 46-month-old bog with HIE who had Candida endocarditis and sepsis with a large fungal mass extending through the tricuspid valve and into the surrounding heart tissue, requiring surgical Excision and replacement with a prosthetic valve. He had an indwelling central line for previous antibiotic therapy and had oral thrush for a month before presentation, which had been treated with oral nystatin. He was first seen with very dark urine, a new murmur, petechial rash, in shock, and disseminated intravascular coagulation. The white blood cell count was 35,700 with 70% segmented neutrophils, 9% banded neutrophils, 15% lymphocytes, 4% monocytes, and 2% eosinophils. Hemoglobin was 7.1, and platelet count was 14,000. Prothrombin time was 15.5, and partial thromboplastin time was 31; fibrinogen level was 110 mg/ml, and fibrin degradation products were greater than 40 mg/ml, Serum IgE was 38,664 and 44,510 on repeat measurement, He has had recurrent staphylococcal pneumonias with pneumatoceles, twice requiring segmental lung resection. Blood and tricuspid valve cultures grew Candida albicans. He was treated with amybotericin and flucytosine, and later smirched to fluconazole, with good response to therapy, A literature search revealed no other reported case of Candida endocarditis in patients with HIE. Fungal endocarditis is a rare complication, which may occur in patients with HIE and indwelling central catheters.			Yates, AB (corresponding author), UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT PEDIAT,DIV ALLERGY IMMUNOL,2500 N STATE ST,JACKSON,MS 39216, USA.							BUCKLEY RH, 1972, PEDIATRICS, V49, P59; BUCKLEY RH, 1992, JAMA-J AM MED ASSOC, V268, P2797, DOI 10.1001/jama.268.20.2797; BUCKLEY RH, 1989, IMMUNOLOGIC DISORDER, P320; CITAK M, 1992, ANN THORAC SURG, V54, P755, DOI 10.1016/0003-4975(92)91023-3; DATO VM, 1990, PEDIATR INFECT DIS J, V9, P309, DOI 10.1097/00006454-199005000-00002; LEUNG DYM, 1988, HEMATOL ONCOL CLIN N, V2, P81; MUEHRCKE DD, 1995, ANN THORAC SURG, V60, P538, DOI 10.1016/0003-4975(95)00469-2; QUIE PG, 1988, CURRENT THERAPY ALLE, V3, P313; SAIMAN L, 1993, J PEDIATR-US, V122, P847, DOI 10.1016/S0022-3476(09)90006-3	9	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1997	99	6	1				770	772		10.1016/S0091-6749(97)80010-3	http://dx.doi.org/10.1016/S0091-6749(97)80010-3			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	XH193	9215244	Bronze			2022-12-18	WOS:A1997XH19300009
J	Boxer, M; Roberts, M; Grammer, L				Boxer, M; Roberts, M; Grammer, L			Cumin anaphylaxis: A case report	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							LINKED IMMUNOSORBENT ASSAY; ANTIBODIES; ELISA		NORTHWESTERN UNIV,SCH MED,CHICAGO,IL	Northwestern University	Boxer, M (corresponding author), ALBERT EINSTEIN COLL MED,560 NO BLVD,GREAT NECK,NY 11021, USA.			Grammer, Leslie/0000-0001-6860-2014				Benito M, 1996, ANN ALLERG ASTHMA IM, V76, P416, DOI 10.1016/S1081-1206(10)63456-4; BOCK SA, 1993, J ALLERGY CLIN IMMUN, V91, P1232, DOI 10.1016/0091-6749(93)90329-E; ENGVALL E, 1972, J IMMUNOL, V109, P129; Joseph BE, 1995, ANN ALLERGY, V74, P55; SEPULVEDA R, 1979, CLIN ALLERGY, V9, P359, DOI 10.1111/j.1365-2222.1979.tb02494.x	5	14	15	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAY	1997	99	5					722	723		10.1016/S0091-6749(97)70039-3	http://dx.doi.org/10.1016/S0091-6749(97)70039-3			2	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WY600	9155844				2022-12-18	WOS:A1997WY60000025
J	Grossman, J; Ratner, PH; Nathan, R; Adelglass, J; deJong, B				Grossman, J; Ratner, PH; Nathan, R; Adelglass, J; deJong, B			Pranlukast (Ultair(TM), SB 205312, ONO-1078), an oral leukotriene receptor antagonist, relieves symptoms in patients with seasonal allergic rhinitis (SAR).	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Meeting Abstract									ALLERGY CARE CONSULTANTS LTD,TUCSON,AZ; SMITHKLINE BEECHAM,COLLEGEVILLE,PA	GlaxoSmithKline									0	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JAN	1997	99	1	2	S			1799	1799						1	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	WH142					2022-12-18	WOS:A1997WH14201793
J	Naclerio, RM; Hubbard, W; Lichtenstein, LM; KageySobotka, A; Proud, D				Naclerio, RM; Hubbard, W; Lichtenstein, LM; KageySobotka, A; Proud, D			Origin of late phase histamine release	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							CHALLENGE		JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV CLIN IMMUNOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008290, R01AI031335] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32272] Funding Source: Medline; NIAID NIH HHS [AI08290, AI31335] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ILIOPOULOS O, 1992, J IMMUNOL, V148, P2223; LIU MC, 1988, PROSTAGLANDINS, V35, P67, DOI 10.1016/0090-6980(88)90275-4; NACLERIO RM, 1985, NEW ENGL J MED, V313, P65, DOI 10.1056/NEJM198507113130201; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; PROUD D, 1992, J ALLERGY CLIN IMMUN, V89, P1098, DOI 10.1016/0091-6749(92)90293-B	5	14	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	OCT	1996	98	4					721	723		10.1016/S0091-6749(96)70118-5	http://dx.doi.org/10.1016/S0091-6749(96)70118-5			3	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VM665	8876545	hybrid			2022-12-18	WOS:A1996VM66500002
J	Roches, AD; Paradis, L; Bougeard, YH; Godard, P; Bousquet, J; Chanez, P				Roches, AD; Paradis, L; Bougeard, YH; Godard, P; Bousquet, J; Chanez, P			Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						skin prick test; corticosteroids; asthma	MEDIATOR RELEASE; HISTAMINE; RESPONSES; STEROIDS; INVIVO; REACTIVITY; INHIBITION; EXTRACT; RAGWEED; ASTHMA	Background: Medications can modulate the results of skin prick tests (SPTs). Short-term corticosteroid therapy does not alter IgE-mediated skin tests, but the impact of long-term oral corticosteroid therapy on SPT results is unclear. A prospective study runs carried out ill patients with steroid-dependent asthma who received oral corticosteroids for a long period to determine whether this treatment reduced skin test reactivity. Methods: Thirty-three patients with steroid-dependent asthma (median age, 59 years) were compared with 66 patients with asthma who served as a control group, matched for age, sex, and atopic status. SPTs with codeine phosphate and a screening battery of standardized allergen extracts were performed before commencement and after at least 1 year of daily oral prednisone treatment (median duration, 2 years; median daily dose, 20 mg). Results: Fifteen patients with corticosteroid-dependent asthma were allergic before treatment, and their sensitization was not changed by long-term treatment with oral corticosteroids. The median wheal diameters induced by codeine phosphate were similar in both groups. The median wheal diameters induced by allergens, and more specifically, by Dermatophagoides pteronyssinus and D. farinae were similar in both groups and did not change in the steroid group after treatment. Conclusions: Systemic corticosteroid therapy (prednisone, 10 to 60 mg/day) for 2 or more years does not seem to alter SPT reactivity.	HOP ARNAUD DE VILLENEUVE, SERV MALAD RESP, F-34295 MONTPELLIER 5, FRANCE	Universite de Montpellier; CHU de Montpellier			Bousquet, Jean/O-4221-2019	chanez, pascal/0000-0003-4059-0917				ANDERSSON M, 1987, J ALLERGY CLIN IMMUN, V79, P345, DOI 10.1016/0091-6749(87)90153-9; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; ATKINS PC, 1990, J ALLERGY CLIN IMMUN, V86, P360, DOI 10.1016/S0091-6749(05)80099-5; BOUSQUET J, 1985, J ALLERGY CLIN IMMUN, V76, P734, DOI 10.1016/0091-6749(85)90680-3; BOUSQUET J, 1985, CLIN ALLERGY, V15, P29, DOI 10.1111/j.1365-2222.1985.tb02251.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BOUSQUET J, 1993, ALLERGY PRINCIPLES P, P573; COCKCROFT DW, 1987, J ALLERGY CLIN IMMUN, V79, P734, DOI 10.1016/0091-6749(87)90204-1; DAHL R, 1982, EUR J RESPIR DIS, V63, P167; DAHL R, 1982, EUR J RESPIR DIS, V63, P132; DREBORG S, 1988, ALLERGY S10, V44, P1; DUNSKY EH, 1977, J ALLERGY CLIN IMMUN, V59, P142, DOI 10.1016/0091-6749(77)90216-0; GOETTE DK, 1979, CUTIS, V23, P477; OLSON R, 1990, J ALLERGY CLIN IMMUN, V86, P153, DOI 10.1016/S0091-6749(05)80060-0; ONORATO J, 1986, J ALLERGY CLIN IMMUN, V78, P1139, DOI 10.1016/0091-6749(86)90263-0; PIPKORN U, 1987, J CLIN INVEST, V80, P957, DOI 10.1172/JCI113188; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; SCHLEIMER RP, 1993, EUR J CLIN PHARMACOL, V45, pS43, DOI 10.1007/BF01844203; SCHLEIMER RP, 1981, NATURE, V292, P454, DOI 10.1038/292454a0; SCHLEIMER RP, 1983, J CLIN INVEST, V71, P1830, DOI 10.1172/JCI110938; SCHLEIMER RP, 1993, ALLERGY PRINCIPLES P, P893; SLOTT RI, 1974, J ALLERGY CLIN IMMUN, V54, P229, DOI 10.1016/0091-6749(74)90065-7; TALBOT S, 1987, ANN ALLERGY, V58, P363; ZWEIMAN B, 1976, J ALLERGY CLIN IMMUN, V58, P657, DOI 10.1016/0091-6749(76)90177-9	24	14	14	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	SEP	1996	98	3					522	527						6	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VJ428	8828529				2022-12-18	WOS:A1996VJ42800008
J	Du, T; Sapienza, S; Wang, CG; Renzi, PM; Pantano, R; Rossi, P; Martin, JG				Du, T; Sapienza, S; Wang, CG; Renzi, PM; Pantano, R; Rossi, P; Martin, JG			Effect of nedocromil sodium on allergen-induced airway responses and changes in the quantity of airway smooth muscle in rats	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						ovalbumin; airway inflammation; bronchoalveolar lavage; airway smooth muscle; Brown Norway rat	EXERCISE-INDUCED ASTHMA; HUMAN-LUNG FRAGMENTS; ANTIGEN CHALLENGE; GUINEA-PIGS; CELLS; PROLIFERATION; RELEASE; SHEEP; BRONCHOCONSTRICTION; HYPERRESPONSIVENESS	Background: Allergen exposures induce growth of airway smooth muscle in the Brown Norway rat. Objective: The purpose of the study was to examine the role of mediators associated with the early and late responses in the induction of airway smooth muscle growth. Methods: Nedocromil sodium was administered to block early and late responses in ovalbumin-sensitized and ovalbumin-challenged rats undergoing single or multiple challenges (5 time at 5-day intervals) was ovalbumin. Airway smooth muscle was quantitated by morphometry on lungs removed 2 days after the final challenge. Results: Nedocromil sodium administered before ovalbumin challenge blocked both the early and late responses. When administered 2 hours after ovalbumin challenge, it also blocked the late response. Rats undergoing challenge with aerosolized ovalbumin five times at 5-day intervals were also treated with nedocromil before (n = 10) or 2 hours after (n = 10) each ovalbumin inhalation, respectively. The quantity of airway smooth muscle standardized for size was grater after ovalbumin challenge (0.069 +/- 0.005) compared with saline controls (0.033 +/- 0.003, p < 0.005). Nedocromil significantly reduced the airway smooth muscle (0.036 +/- 0.003, p < 0.005) when administered before ovalbumin. However, the airway smooth muscle in rats that received nedocromil 2 hours after ovalbumin challenge (0.046 +/- 0.003), although lower than in ovalbumin-challenged rats (p < 0.01), was still significantly higher than in saline-treated rats (p < 0.05). Conclusions: Allergen-induced early responses, late responses, and airway inflammation are antagonized by nedocromil. The mediators of both the early and late responses contribute to allergen-induced airway smooth muscle growth, a process that can be prevented by administration of nedocromil.	MCGILL UNIV,MEAKINS CHRISTIE LABS,ROYAL VICTORIA HOSP,MONTREAL,PQ H2X 2P2,CANADA; MCGILL UNIV,CTR EXCELLENCE CANADA,RESP HLTH NETWORK,MONTREAL,PQ H2X 2P2,CANADA	McGill University; Royal Victoria Hospital; McGill University				Martin, James/0000-0001-7574-5363				ABRAHAM WM, 1988, AM REV RESPIR DIS, V138, P1565, DOI 10.1164/ajrccm/138.6.1565; ABRAHAM WM, 1988, J APPL PHYSIOL, V65, P1062, DOI 10.1152/jappl.1988.65.3.1062; ABRAHAM WM, 1989, DRUGS, V37, P78, DOI 10.2165/00003495-198900371-00015; BRIODE D, 1986, EUR J RESPIR DI S147, V69, P196; BRUIJNZEEL PLB, 1985, FEBS LETT, V189, P350; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; CHITANO P, 1989, American Review of Respiratory Disease, V139, pA370; CHURCH MK, 1975, BRIT J PHARMACOL, V55, P423, DOI 10.1111/j.1476-5381.1975.tb06947.x; CHURCH MK, 1989, DRUGS, V37, P101, DOI 10.2165/00003495-198900371-00018; CRIMI E, 1989, J ALLERGY CLIN IMMUN, V83, P985, DOI 10.1016/0091-6749(89)90116-4; DAHLEN S-E, 1989, American Review of Respiratory Disease, V139, pA328; EADY RP, 1985, BRIT J PHARMACOL, V85, P323, DOI 10.1111/j.1476-5381.1985.tb08864.x; EBINA M, 1990, AM REV RESPIR DIS, V141, P1327, DOI 10.1164/ajrccm/141.5_Pt_1.1327; HEARD BE, 1973, J PATHOL, V110, P319, DOI 10.1002/path.1711100406; HUTSON PA, 1988, BRIT J PHARMACOL, V94, P6, DOI 10.1111/j.1476-5381.1988.tb11493.x; KLEINERMAN J, 1987, J ALLERGY CLIN IMMUN, V80, P406, DOI 10.1016/0091-6749(87)90061-3; LAL S, 1984, THORAX, V39, P809, DOI 10.1136/thx.39.11.809; MATTOLI S, 1990, INT ARCH ALLER A IMM, V92, P16, DOI 10.1159/000235218; NAPIER FE, 1990, BRIT J PHARMACOL, V100, P247, DOI 10.1111/j.1476-5381.1990.tb15790.x; NOVERAL JP, 1992, AM J PHYSIOL, V263, pL555, DOI 10.1152/ajplung.1992.263.5.L555; NOVERAL JP, 1992, AM J PHYSIOL, V263, pL317, DOI 10.1152/ajplung.1992.263.3.L317; PANETTIERI RA, 1990, AM J PHYSIOL, V259, pL365, DOI 10.1152/ajplung.1990.259.6.L365; Rainey D K, 1989, Eur Respir J Suppl, V6, p561s; RILEY PA, 1987, INT ARCH ALLER A IMM, V82, P108, DOI 10.1159/000234299; ROBERTS JA, 1985, CLIN ALLERGY, V15, P377, DOI 10.1111/j.1365-2222.1985.tb03006.x; SALARI H, 1989, J IMMUNOL, V142, P2821; SAPIENZA S, 1990, AM REV RESPIR DIS, V142, P353, DOI 10.1164/ajrccm/142.2.353; SAPIENZA S, 1991, AM REV RESPIR DIS, V144, P423, DOI 10.1164/ajrccm/144.2.423; SCHELLENBERG RR, 1991, BRIT J PHARMACOL, V103, P1842, DOI 10.1111/j.1476-5381.1991.tb12339.x; SCHLEIMER RP, 1983, J CLIN INVEST, V71, P1830, DOI 10.1172/JCI110938; SHAW RJ, 1985, BRIT J DIS CHEST, V79, P385, DOI 10.1016/0007-0971(85)90073-7; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P227, DOI 10.1159/000234507; THOREL T, 1988, INT ARCH ALLER A IMM, V85, P232, DOI 10.1159/000234508; WANG CG, 1993, AM REV RESPIR DIS, V148, P413, DOI 10.1164/ajrccm/148.2.413; YOUNGCHAIYUD P, 1986, CLIN ALLERGY, V16, P129, DOI 10.1111/j.1365-2222.1986.tb00756.x	35	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	1996	98	2					400	407		10.1016/S0091-6749(96)70164-1	http://dx.doi.org/10.1016/S0091-6749(96)70164-1			8	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VC995	8757217				2022-12-18	WOS:A1996VC99500019
J	Kemp, JP; Pearlman, DS; Tinkelman, DG; Weiler, JM; Bernstein, D; Busse, W; DeGraff, A; Diamond, L; Dockhorn, R; Village, P; Mansfield, L; Pierson, W; Seltzer, J; Spector, S; Goldstein, M; Lawrence, M; DEletto, TA				Kemp, JP; Pearlman, DS; Tinkelman, DG; Weiler, JM; Bernstein, D; Busse, W; DeGraff, A; Diamond, L; Dockhorn, R; Village, P; Mansfield, L; Pierson, W; Seltzer, J; Spector, S; Goldstein, M; Lawrence, M; DEletto, TA			An evaluation of the efficacy and safety of azelastine in patients with chronic asthma	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						azelastine; albuterol sulfate; asthma symptoms; backup medication; pulmonary function	ALLERGIC RHINITIS; INHIBITION; BRONCHOSPASM	Background: Azelastine, an oral nonsteroidal, antinflammatory drug with a good safety profile, has demonstrated relief of symptoms in patients with asthma. Objective: The study was designed to evaluate the efficacy and safety of azelastine, a novel antiallergy compound, in patients with asthma who required maintenance therapy. Methods: During this 16-week, double-blind, randomized, parallel-group study, patients received orally administered azelastine (4 mg twice daily), albuterol sulfate (4 mg twice daily), or placebo. Results: Overall, patients in the azelastine group used 2.5 times less backup medication (p = 0.024) for relief of their asthma symptoms than patients in the placebo group. Reductions in asthma symptoms in the azelastine group were also noted throughout the double-blind treatment period. Moreover, the azelastine group had statistically significant improvements in FEV(1) after the first dose of medication. The only notable adverse experiences in the azelastine group were alterations in taste perception and a small mean increase in body weight. Conclusion: Oral administration of azelastine to patients with asthma resulted in overall improvement in airway function while reducing the requirement for adjunctive antiasthma medications..										ATKINS PC, 1978, J ALLERGY CLIN IMMUN, V62, P149, DOI 10.1016/0091-6749(78)90099-4; BUSSE WW, 1986, J ALLERGY CLIN IMMUN, V78, P525, DOI 10.1016/0091-6749(86)90099-0; CHAND N, 1983, J ALLERGY CLIN IMMUN, V71, P149, DOI 10.1016/0091-6749(83)90365-2; CHAND N, 1983, EUR J PHARMACOL, V96, P227, DOI 10.1016/0014-2999(83)90311-4; CHURCH MK, 1991, ASTHMA ITS PATHOLOGY, P561; Diamantis W., 1981, PHARMACOLOGIST, V23, P149; HOWARTH PH, 1985, AM REV RESPIR DIS, V132, P986; KATAYAMA S, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1196; LITTLE MM, 1987, J ALLERGY CLIN IMMUN, V79, P204; MELTZER E, 1990, Annals of Allergy, V64, P78; MELTZER EO, 1988, J ALLERGY CLIN IMMUN, V82, P447, DOI 10.1016/0091-6749(88)90018-8; TANIGUCHI K, 1984, BIOCHEM PHARMACOL, V33, P3165, DOI 10.1016/0006-2952(84)90072-8; TINKELMAN DG, 1990, AM REV RESPIR DIS, V141, P569, DOI 10.1164/ajrccm/141.3.569; TOOGOOD JH, 1993, J RESPIR DIS, V14, P221; WEILER JM, 1988, J ALLERGY CLIN IMMUN, V82, P801, DOI 10.1016/0091-6749(88)90082-6	15	14	14	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1218	1224						7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607					2022-12-18	WOS:A1996VD60700008
J	Tarlo, SM; Wai, Y; Dolovich, J; Summerbell, R				Tarlo, SM; Wai, Y; Dolovich, J; Summerbell, R			Occupational asthma induced by Chrysonilia sitophila in the logging industry	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article							RESPIRATORY-DISEASE; ALTERNARIA; NEUROSPORA; ALLERGY		MCMASTER UNIV,MED CTR,HAMILTON,ON,CANADA; ONTARIO MINIST HLTH,TORONTO,ON M5W 1R5,CANADA	McMaster University	Tarlo, SM (corresponding author), TORONTO HOSP,WESTERN DIV,ASTHMA CTR,399 BATHURST ST,EC4-009,TORONTO,ON M5T 2S8,CANADA.			Tarlo, Susan/0000-0002-4746-5310				ABDELRAHMAN TMA, 1990, BOT MAG TOKYO, V103, P313, DOI 10.1007/BF02488642; Arx JA von, 1981, SYDOWIA, V34, P13; BEAUMONT F, 1983, ANN ALLERGY, V55, P740; COTE J, 1991, BRIT J IND MED, V48, P279; DARKE CS, 1976, THORAX, V31, P294, DOI 10.1136/thx.31.3.294; FINK JN, 1993, ALLERGY PRINCIPLES P, V2, P1415; HARRIES MG, 1985, LANCET, V1, P1063; HASNAIN SM, 1985, NEW ZEAL MED J, V98, P342; KLAUSTERMEYER WB, 1977, CLIN ALLERGY, V7, P227, DOI 10.1111/j.1365-2222.1977.tb01447.x; LICORISH K, 1985, J ALLERGY CLIN IMMUN, V76, P819, DOI 10.1016/0091-6749(85)90755-9; MALLING HJ, 1986, ALLERGY, V41, P342, DOI 10.1111/j.1398-9995.1986.tb00311.x; Malloch D., 1981, MOULDS THEIR ISOLATI; OHALLAREN MT, 1991, NEW ENGL J MED, V324, P359; SALVAGGIO J, 1981, J ALLERGY CLIN IMMUN, V68, P327, DOI 10.1016/0091-6749(81)90131-7; Shaw Dorothy E., 1993, Mycologist, V7, P182, DOI 10.1016/S0269-915X(09)80393-5; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; YASSIN S, 1992, J APPL BACTERIOL, V72, P377, DOI 10.1111/j.1365-2672.1992.tb01849.x	17	14	14	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	JUN	1996	97	6					1409	1413		10.1016/S0091-6749(96)70211-7	http://dx.doi.org/10.1016/S0091-6749(96)70211-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	VD607	8648039				2022-12-18	WOS:A1996VD60700031
J	Nyhan, DP; Shampaine, EL; Hirshman, CA; Hamilton, RG; Frank, SM; Baumgartner, WA; Adkinson, NF				Nyhan, DP; Shampaine, EL; Hirshman, CA; Hamilton, RG; Frank, SM; Baumgartner, WA; Adkinson, NF			Single doses of intravenous protamine result in the formation of protamine-specific IgE and IgG antibodies	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						protamine; immunoglobulins; intravenous; antibody; heart surgery	HYPERSENSITIVITY; SULFATE; RISK	Background: Protamine reactions are a well-recognized and serious complication of intravenous protamine administration. IgE-mediated anaphylaxis occurs after initial sensitization and subsequent re-exposure to antigens. Subcutaneous protamine in insulin preparations is associated with protamine-specific IgE and IgG antibody production. In contrast, the influence of intravenous protamine administration cn protamine-specific IgE and IgG antibody formation has never been investigated. Methods: Sera from 93 patients were analyzed for protamine-specific IgE and Ige antibodies both before and 4 to 6 weeks after exposure to single doses of intravenous protamine. Specific clinical variables were assessed by univariate and multivariate analyses to determine independent predictors of protamine-specific antibody production. Results: In patients who were previously seronegative, intravenous protamine administration resulted in protamine-specific IgE and Ige antibody production in 17 of 93 (18%) and 15 of 93 (16%) patients, respectively. As determined by multivariate analysis, male gender (p = 0.06) and insulin-dependent diabetes mellitus (p = 0.002) were associated with protamine-specific Ige bur not IgE antibody production. Conclusion: Single-dose intravenous protamine resulted in protamine-specific IgE and/or IgG antibody production in 26 of 93 (28%) of patients. Seroconversion was associated with male gender and insulin-dependent diabetes mellitus. Patients responding immunologically to protamine may be at increased risk for experiencing reactions on subsequent exposure.	JOHNS HOPKINS UNIV,SCH MED,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH MED,DIV CLIN IMMUNOL & ALLERGY,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH MED,DIV CARDIAC SURG,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI031867] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI31867] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHUNG F, 1984, CAN ANAESTH SOC J, V31, P314, DOI 10.1007/BF03007897; DOOLAN L, 1981, ANAESTH INTENS CARE, V9, P147, DOI 10.1177/0310057X8100900209; GELL PGH, 1975, CLIN ASPECTS IMMUNOL, P761; GOTTSCHLICH GM, 1988, ANN ALLERGY, V61, P277; GRANT JA, 1988, J ALLERGY CLIN IMMUN, V81, P238; HAMILTON RG, 1980, J LAB CLIN MED, V96, P1022; HAMILTON RG, 1979, J IMMUNOL, V122, P1073; HARROW JC, 1988, J CARDIOTHORAC ANEST, V2, P225; HOSMER DW, APPL LOGISTIC REGRES, P109; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; LEVY JH, 1986, ANESTH ANALG, V65, P739; LOWENSTEIN E, 1988, AM REV RESPIR DIS, V127, P245; MCINTYRE RW, 1986, AM J CARDIOL, V58, P857, DOI 10.1016/0002-9149(86)90371-1; MOREL DR, 1987, ANESTHESIOLOGY, V66, P597, DOI 10.1097/00000542-198705000-00002; NYHAN D, 1989, ANESTH REV S, V16, P10; ROGERS FD, 1976, SPACE CURVES MATH EL, P133; SHARATH MD, 1985, J THORAC CARDIOV SUR, V90, P86; STEWART WJ, 1984, CIRCULATION, V70, P788, DOI 10.1161/01.CIR.70.5.788; VONTZ FK, 1982, AM SURGEON, V48, P549; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; WEISS ME, 1989, NEW ENGL J MED, V320, P886, DOI 10.1056/NEJM198904063201402	21	14	16	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	APR	1996	97	4					991	997		10.1016/S0091-6749(96)80075-3	http://dx.doi.org/10.1016/S0091-6749(96)80075-3			7	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UG086	8655896				2022-12-18	WOS:A1996UG08600015
J	Yoshihara, S; Geppetti, P; Lindan, A; Hara, M; Chan, BD; Nadel, JA				Yoshihara, S; Geppetti, P; Lindan, A; Hara, M; Chan, BD; Nadel, JA			Tachykinins mediate the potentiation of antigen-induced bronchoconstriction by cold air in guinea pigs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						cold air; tachykinin; neurokinin 2 receptor antagonist; SR 48968; antigen challenge; bronchoconstriction; sensory nerve; airway	NEUROGENIC INFLAMMATION; VASCULAR EXTRAVASATION; NEUTRAL ENDOPEPTIDASE; SUBSTANCE-P; ASTHMA; HISTAMINE; TRACHEA; BRADYKININ; RELEASE	The role of tachykinins in the potentiation of antigen-evoked bronchoconstriction induced by inhalation of cold air was studied in guinea pigs. Cold air was delivered through a tracheal cannula to anethetized, artificially ventilated guinea pigs sensitized with ovalbumin and pretreated with atropine (1.4 mu mol/kg). Inhalation of cold air increased total pulmonary resistance (R(L)) in a time-dependent manner; inhalation of cold air for 10 or 15 minutes, but not for 5 minutes, produced a significant increase in R(L). Aerosolized ovalbumin (5 breaths) increased R(L) in a dose-dependent manner (0.5% to 5%). Inhalation of cold air for 5 minutes significantly enhanced both the peak and the duration of the increased in R(L) induced by 0.5% ovalbumin. The tachykinin neurokinin 2-receptor antagonist, SR 48968 (0.3 mu mol/kg intravenously) inhibited both the peak and the duration of the bronchoconstriction induced by 5-minute inhibited of cold air and ovalbumin (0.5%), whereas it did not affect the response to ovalbumin (0.5%) alone. These findings suggest that exposure to cold air potentiates the bronchoconstriction response to antigen and that this potentiation is mediated by tachykinin release from sensory nerves.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Geppetti, Pierangelo/AHA-7897-2022	Linden, Anders/0000-0003-1258-2928				BARNES PJ, 1986, LANCET, V1, P242; BERTRAND C, 1993, J IMMUNOL, V151, P4902; BERTRAND C, 1993, AM J PHYSIOL, V265, pL507, DOI 10.1152/ajplung.1993.265.5.L507; BERTRAND C, 1993, J IMMUNOL, V150, P1479; DOSMAN JA, 1991, AM REV RESPIR DIS, V144, P45, DOI 10.1164/ajrccm/144.1.45; DUNN CJ, 1988, AM REV RESPIR DIS, V137, P541, DOI 10.1164/ajrccm/137.3.541; DUSSER DJ, 1988, J APPL PHYSIOL, V65, P2585, DOI 10.1152/jappl.1988.65.6.2585; EMONDSALT X, 1992, LIFE SCI, V50, P101; GEPPETTI P, 1993, REGUL PEPTIDES, V47, P1, DOI 10.1016/0167-0115(93)90268-D; LARSSON K, 1993, BRIT MED J, V307, P1326, DOI 10.1136/bmj.307.6915.1326; MARTINS MA, 1991, AM J PHYSIOL, V261, pL449, DOI 10.1152/ajplung.1991.261.6.L449; NADEL JA, 1992, AM REV RESPIR DIS, V145, pS48, DOI 10.1164/ajrccm/145.2_Pt_2.S48; NADEL JA, 1994, MODULATION NEUROGENI, P351; PIEDIMONTE G, 1990, J CLIN INVEST, V86, P1409, DOI 10.1172/JCI114855; RICCIARDOLO FLM, 1994, BRIT J PHARMACOL, V113, P508, DOI 10.1111/j.1476-5381.1994.tb17018.x; ROSSI OVJ, 1993, THORAX, V48, P244, DOI 10.1136/thx.48.3.244; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; SOLWAY J, 1991, J APPL PHYSIOL, V71, P2077, DOI 10.1152/jappl.1991.71.6.2077; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; YOSHIHARA S, 1995, AM J RESP CRIT CARE, V151, P1011; YOSHIHARA S, 1995, IN PRESS EUR J PHARM	21	14	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	MAR	1996	97	3					756	760		10.1016/S0091-6749(96)80152-7	http://dx.doi.org/10.1016/S0091-6749(96)80152-7			5	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	UA975	8613631				2022-12-18	WOS:A1996UA97500005
